Citrus Sinensis ID: 039322
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 708 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VZG8 | 1045 | Probable LRR receptor-lik | yes | no | 0.985 | 0.667 | 0.490 | 0.0 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.974 | 0.616 | 0.503 | 0.0 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.987 | 0.621 | 0.359 | 1e-114 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.970 | 0.550 | 0.359 | 1e-113 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.983 | 0.631 | 0.344 | 1e-111 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.981 | 0.631 | 0.323 | 1e-110 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.964 | 0.545 | 0.338 | 1e-106 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.970 | 0.602 | 0.337 | 1e-105 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.932 | 0.581 | 0.331 | 1e-104 | |
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.967 | 0.687 | 0.333 | 2e-98 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 700 bits (1807), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 346/706 (49%), Positives = 489/706 (69%), Gaps = 8/706 (1%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPM-LTRPGLDFN 59
M S+ L++++N+ G +P S LT L+ L L N LSG IPP + N LT LD N
Sbjct: 333 MESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTN 392
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
+FT +LP +CRGG L+ + +NHF+G +PK LR+C SLIRVR N+ +G+ISEA G+
Sbjct: 393 NFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGV 452
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
YP L FIDLS N+F+G++S+NW + KL +S N+ITG IP EI N +QL LDLS N
Sbjct: 453 YPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSN 512
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
I GE+P+ + +N +++L L GN+ +G++P I L +LEYLDLS+NRF++ +P L N
Sbjct: 513 RITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNN 572
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
L +L+Y+ LS N +P+ L KL QL LD S+N GEI Q SL++LE+L+LSHN
Sbjct: 573 LPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHN 632
Query: 300 NLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGV---KGM 356
NLSG IP F+ + ++ +D+S N LQGP+P++ AFRNAP +A +GNK LCG V +G+
Sbjct: 633 NLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGL 692
Query: 357 QPCKVFLSHK-QNSRVKWFAIVFPVLGALFLSMALIAIFILRKRKSDSGDRQSSNQNPHG 415
+PC + S K R I+ P++GA+ + IFI ++++ + + +++
Sbjct: 693 KPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGE 752
Query: 416 LFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPL--P 473
SI +F+GK+ Y EI++AT +FD +Y IG GGHG VY+A+LP+ ++A+KK +
Sbjct: 753 TLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSS 811
Query: 474 CDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAA 533
+ ++EFL E++ALTEIRHRN+VK +GFCSH R++FLVYE +ERGSL +L +D A
Sbjct: 812 ISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEA 871
Query: 534 QELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593
++L W +R+NV+KGVA ALSY+HHD P IVH+DISS N+LL +YEA ++DFG AK LK
Sbjct: 872 KKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLK 931
Query: 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL 653
P+SSNW+ AGTYGYVAPELAY MK+TEKCDVYSFGVL LE IKG+HP D +S +SSS
Sbjct: 932 PDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPP 991
Query: 654 NTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTM 699
+ ++L I D RLP P+ ++E+++ I++VA CL+ P++RPTM
Sbjct: 992 DATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTM 1037
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 684 bits (1766), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/709 (50%), Positives = 485/709 (68%), Gaps = 19/709 (2%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPM-LTRPGLDFN 59
M S+ LDL+QN+ G +P S N T L+ L L N+LSG IPP + N LT LD N
Sbjct: 413 MESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTN 472
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
+FT + P VC+G LQ + NH +G IPK LR+C SLIR R N TG+I EA GI
Sbjct: 473 NFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGI 532
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
YP+L FID S N F+GEISSNW K PKLG L +S NNITG IP EI N +QL LDLS N
Sbjct: 533 YPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTN 592
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
++ GE+P+ +G L +L+ L L GNQ +GR+P + L +LE LDLS+N F++ +P+ +
Sbjct: 593 NLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDS 652
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
LKLH + LS N+F +P+ L KL QL++LD SHN GEIP Q+ SL+SL+KL+LSHN
Sbjct: 653 FLKLHDMNLSRNKFDGSIPR-LSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHN 711
Query: 300 NLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGV--KGMQ 357
NLSG IP FEG+ ++ +DIS+N+L+GP+P++ FR A +AL+ N GLC + + ++
Sbjct: 712 NLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLK 771
Query: 358 PCKVFLSHKQNSR-VKWFAIVFPVLGALFLSMALIA---IFILRKRKSDSGDRQSSNQNP 413
PC+ K+N V W I+ P+LG L + +++ A + +RKRK +G R + +
Sbjct: 772 PCRELKKPKKNGNLVVW--ILVPILGVLVI-LSICANTFTYCIRKRKLQNG-RNTDPETG 827
Query: 414 HGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLP 473
+ SI + +GK Y +I+ +TN+FD + IG GG+ VYRA L ++A+K+ H +
Sbjct: 828 ENM-SIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANL-QDTIIAVKRLHDTID 885
Query: 474 CDQIAD---QKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSD 530
++I+ ++EFL EVKALTEIRHRN+VK +GFCSH RH+FL+YE +E+GSL +L++D
Sbjct: 886 -EEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLAND 944
Query: 531 TAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590
A+ L W++R+NV+KGVA ALSY+HHD PIVH+DISS N+LLD +Y A ++DFG AK
Sbjct: 945 EEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAK 1004
Query: 591 FLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISS 650
LK +SSNW+ AGTYGYVAPE AYTMK+TEKCDVYSFGVL+LE I GKHP D +S +SS
Sbjct: 1005 LLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSS 1064
Query: 651 SSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTM 699
S ++L I D R+ P +EKL+ ++E+A CL +PESRPTM
Sbjct: 1065 SP-GEALSLRSISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTM 1112
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 412 bits (1059), Expect = e-114, Method: Compositional matrix adjust.
Identities = 262/729 (35%), Positives = 388/729 (53%), Gaps = 30/729 (4%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSL--ENPMLTRPGLDF 58
+R+L+ LDL+ N G +PP NLT++++L L +N+LSG IP L +P+ +DF
Sbjct: 372 LRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWV---VDF 428
Query: 59 --NHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEA 116
N + +P +C+ L + N G IP + C SL+++R+ N LTG
Sbjct: 429 SENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTE 488
Query: 117 LGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDL 176
L NL+ I+L +N F G + G C KL L+++ N + +P EI S L ++
Sbjct: 489 LCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNV 548
Query: 177 SLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPEN 236
S N + G IP E+ L L L N F G LPPE+GSL LE L LS NRF+ ++P
Sbjct: 549 SSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFT 608
Query: 237 LGNLLKLHYLGLSNNQFVLELPKELEKLVQLS-ELDASHNLFGGEIPFQICSLKSLEKLN 295
+GNL L L + N F +P +L L L ++ S+N F GEIP +I +L L L+
Sbjct: 609 IGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLS 668
Query: 296 LSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGG-VK 354
L++N+LSG IP FE + + + S N L G +P++ F+N + + GNKGLCGG ++
Sbjct: 669 LNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLR 728
Query: 355 GMQPCKVFLSH----KQNSRVKWFAIVFPVLGALFLSMALIAIFI-LRKRKSDSGDRQSS 409
P H K S + I+ +S+ LIAI + + +
Sbjct: 729 SCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVH 788
Query: 410 NQNPHGLFSILNF--EGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKK 467
++ P S + F + + +I+ AT F Y +G G G+VY+A +PSG+ +A+KK
Sbjct: 789 DKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKK 848
Query: 468 FH---SPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH--ARHSFLVYELLERGS 522
+ F E+ L +IRHRNIV+ Y FC H + + L+YE + RGS
Sbjct: 849 LESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGS 908
Query: 523 LAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAH 582
L +L + + W R + G A+ L+YLHHDC P I+H+DI S N+L+D +EAH
Sbjct: 909 LGELLHGG-KSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAH 967
Query: 583 VADFGIAKFLK-PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
V DFG+AK + P S + + AG+YGY+APE AYTMK+TEKCD+YSFGV++LE + GK P
Sbjct: 968 VGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAP 1027
Query: 642 RD------FLSLISSSSLNTDIALDEILDPRLPPPSRSV-QEKLISIMEVAFSCLNESPE 694
L+ + + + EILDP L V +I++ ++A C SP
Sbjct: 1028 VQPLEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPS 1087
Query: 695 SRPTMKVVT 703
RPTM+ V
Sbjct: 1088 DRPTMREVV 1096
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 409 bits (1050), Expect = e-113, Method: Compositional matrix adjust.
Identities = 264/734 (35%), Positives = 393/734 (53%), Gaps = 47/734 (6%)
Query: 4 LSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPM-LTRPGLDFNHFT 62
L+ILDL NQ G +P S L L++L+L N+L G +P SL + LTR L N
Sbjct: 506 LNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLN 565
Query: 63 SYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPN 122
+ H +C + F V+ N F+ IP L N +L R+RL N LTG I LG
Sbjct: 566 GTI-HPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRE 624
Query: 123 LTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIV 182
L+ +D+S N G I C KL ++++ N ++G IP +G SQL L LS N V
Sbjct: 625 LSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFV 684
Query: 183 GEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLK 242
+P EL L L L GN G +P EIG+L L L+L N+F+ S+P+ +G L K
Sbjct: 685 ESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSK 744
Query: 243 LHYLGLSNNQFVLELPKELEKLVQL-SELDASHNLFGGEIPFQICSLKSLEKLNLSHNNL 301
L+ L LS N E+P E+ +L L S LD S+N F G+IP I +L LE L+LSHN L
Sbjct: 745 LYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQL 804
Query: 302 SGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKGMQPCKV 361
+G +P ++ + +++S N L G + F P ++ GN GLCG + C
Sbjct: 805 TGEVPGSVGDMKSLGYLNVSFNNLGGKL--KKQFSRWPADSFLGNTGLCG--SPLSRCNR 860
Query: 362 FLSHKQNSRVKWFAIV----FPVLGALFLSMALIAIFILRK----RKSDSGDRQSS---- 409
S+ + + ++V L A+ L + +IA+F ++ +K G +
Sbjct: 861 VRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSS 920
Query: 410 -NQNPHG-LFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKK 467
+Q H LF + + +++I+ AT++ ++ IG+GG G VY+AEL +G+ VA+KK
Sbjct: 921 SSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKK 980
Query: 468 FHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH--SFLVYELLERGSLAA 525
L D + K F EVK L IRHR++VK G+CS + L+YE ++ GS+
Sbjct: 981 I---LWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWD 1037
Query: 526 ILSSDTAAQE-----LGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE 580
L D E L W R+ + G+A + YLHHDC PPIVH+DI S N+LLD E
Sbjct: 1038 WLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNME 1097
Query: 581 AHVADFGIAKFL------KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLE 634
AH+ DFG+AK L +S+ W FA +YGY+APE AY++K TEK DVYS G++++E
Sbjct: 1098 AHLGDFGLAKVLTENCDTNTDSNTW--FACSYGYIAPEYAYSLKATEKSDVYSMGIVLME 1155
Query: 635 AIKGKHPRDF-----LSLISSSSLNTDI---ALDEILDPRLPPPSRSVQEKLISIMEVAF 686
+ GK P D + ++ + ++ A D+++DP+L P ++ ++E+A
Sbjct: 1156 IVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIAL 1215
Query: 687 SCLNESPESRPTMK 700
C SP+ RP+ +
Sbjct: 1216 QCTKTSPQERPSSR 1229
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 401 bits (1031), Expect = e-111, Method: Compositional matrix adjust.
Identities = 257/747 (34%), Positives = 385/747 (51%), Gaps = 51/747 (6%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPM-LTRPGLDFN 59
+ L +L L +NQ G +P +S L NL +L L N L+G IP + L L N
Sbjct: 336 IEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQN 395
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
+ +P + L +S+NH G IP L S++I + L +NNL+GNI +
Sbjct: 396 SLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITT 455
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
L + L+RN+ G SN K + + + N G IPRE+GN S LQ L L+ N
Sbjct: 456 CKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADN 515
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
GE+P+E+G L+ L L + N+ TG +P EI + L+ LD+ N F+ ++P +G+
Sbjct: 516 GFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGS 575
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLE-KLNLSH 298
L +L L LSNN +P L L +L+EL NLF G IP ++ SL L+ LNLS+
Sbjct: 576 LYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSY 635
Query: 299 NNL------------------------SGSIPNCFEGIRGISVIDISDNQLQGPVPNSTA 334
N L SG IP+ F + + + S N L GP+P
Sbjct: 636 NKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---L 692
Query: 335 FRNAPVEALKGNKGLCG-------GVKGMQPCKVFLSHKQNSRVKWFAIVFPVLGALFLS 387
RN + + GN+GLCG + P + K AI V+G + L
Sbjct: 693 LRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLM 752
Query: 388 MALIAIFILRKRKSDSGDRQSSNQNPHGLFSILNFEGK--LVYDEIVRATNDFDAQYCIG 445
+ + ++++R+ Q P + + F K + ++V AT++FD + +G
Sbjct: 753 LIALIVYLMRRPVRTVASSAQDGQ-PSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVG 811
Query: 446 NGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIAD-QKEFLIEVKALTEIRHRNIVKFYGF 504
G G+VY+A LP+G +A+KK S + F E+ L IRHRNIVK +GF
Sbjct: 812 RGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGF 871
Query: 505 CSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIV 564
C+H + L+YE + +GSL IL + L WS+R + G A L+YLHHDC P I
Sbjct: 872 CNHQGSNLLLYEYMPKGSLGEILHDPSC--NLDWSKRFKIALGAAQGLAYLHHDCKPRIF 929
Query: 565 HQDISSKNLLLDLEYEAHVADFGIAKFLK-PESSNWTEFAGTYGYVAPELAYTMKITEKC 623
H+DI S N+LLD ++EAHV DFG+AK + P S + + AG+YGY+APE AYTMK+TEK
Sbjct: 930 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKS 989
Query: 624 DVYSFGVLVLEAIKGKHP-------RDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQE 676
D+YS+GV++LE + GK P D ++ + S + D +LD RL +
Sbjct: 990 DIYSYGVVLLELLTGKAPVQPIDQGGDVVNWV-RSYIRRDALSSGVLDARLTLEDERIVS 1048
Query: 677 KLISIMEVAFSCLNESPESRPTMKVVT 703
+++++++A C + SP +RP+M+ V
Sbjct: 1049 HMLTVLKIALLCTSVSPVARPSMRQVV 1075
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 398 bits (1023), Expect = e-110, Method: Compositional matrix adjust.
Identities = 265/820 (32%), Positives = 397/820 (48%), Gaps = 125/820 (15%)
Query: 4 LSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDF--NHF 61
L +L L++N F G +P + LT +K L L N L+G IP + N ++ +DF N
Sbjct: 261 LEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGN-LIDAAEIDFSENQL 319
Query: 62 TSYLP---------------HNVCRG---------GALQYFGVSENHFQGTIPKILRNCS 97
T ++P N+ G L+ +S N GTIP+ L+
Sbjct: 320 TGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLP 379
Query: 98 SLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNI 157
L+ ++L N L G I +G Y N + +D+S N G I +++ + L L++ N +
Sbjct: 380 YLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKL 439
Query: 158 TGGIPR------------------------EIGNSSQLQALDLSLNHIVGEIPKELGKLN 193
+G IPR E+ N L AL+L N + G I +LGKL
Sbjct: 440 SGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLK 499
Query: 194 SLTELILRGNQFTGRLPPEIGSL------------------------VDLEYLDLSANRF 229
+L L L N FTG +PPEIG+L V ++ LDLS N+F
Sbjct: 500 NLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKF 559
Query: 230 NNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLK 289
+ + + LG L+ L L LS+N+ E+P L +L EL NL IP ++ L
Sbjct: 560 SGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLT 619
Query: 290 SLE-KLNLSHNNLSGSIPNCFEGIRGISVI------------------------DISDNQ 324
SL+ LN+SHNNLSG+IP+ ++ + ++ +IS+N
Sbjct: 620 SLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNN 679
Query: 325 LQGPVPNSTAFRNAPVEALKGNKGLCGGVKGMQPCKVFLSHKQNSRVKW----------F 374
L G VP++ F+ GN GLC + C+ + H +S++ W
Sbjct: 680 LVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSH--CQPLVPHS-DSKLNWLINGSQRQKIL 736
Query: 375 AIVFPVLGALFLSMALIAIFILRKRKSDSGDRQSSNQNPHGLFSILNFEGKLVYDEIVRA 434
I V+G++FL + + + KR+ + P + S + Y +V A
Sbjct: 737 TITCIVIGSVFL-ITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDA 795
Query: 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
T +F +G G G+VY+AE+ G+V+A+KK +S + + F E+ L +IR
Sbjct: 796 TRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNS--RGEGASSDNSFRAEISTLGKIR 853
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
HRNIVK YGFC H + L+YE + +GSL L L W+ R + G A+ L Y
Sbjct: 854 HRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCY 913
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK-PESSNWTEFAGTYGYVAPEL 613
LHHDC P IVH+DI S N+LLD ++AHV DFG+AK + S + + AG+YGY+APE
Sbjct: 914 LHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEY 973
Query: 614 AYTMKITEKCDVYSFGVLVLEAIKGKHP-------RDFLSLISSSSLNTDIALDEILDPR 666
AYTMK+TEKCD+YSFGV++LE I GK P D ++ + S N I E+ D R
Sbjct: 974 AYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNM-IPTIEMFDAR 1032
Query: 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
L + ++ ++++A C + SP SRPTM+ V +
Sbjct: 1033 LDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMI 1072
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 386 bits (991), Expect = e-106, Method: Compositional matrix adjust.
Identities = 265/784 (33%), Positives = 390/784 (49%), Gaps = 101/784 (12%)
Query: 7 LDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYL 65
+D N+ G +P S+ L +L L L N L G IP SL N +T L N + +
Sbjct: 462 IDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSI 521
Query: 66 PHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISE---------- 115
P + AL+ F + N QG +P L N +L R+ +SN G+IS
Sbjct: 522 PSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSF 581
Query: 116 -------------ALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIP 162
LG NL + L +N F G I +GK +L L++S N+++G IP
Sbjct: 582 DVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIP 641
Query: 163 REIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYL 222
E+G +L +DL+ N++ G IP LGKL L EL L N+F G LP EI SL ++ L
Sbjct: 642 VELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTL 701
Query: 223 DLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIP 282
L N N S+P+ +GNL L+ L L NQ LP + KL +L EL S N GEIP
Sbjct: 702 FLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIP 761
Query: 283 FQICSLKSLEK-LNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTA------- 334
+I L+ L+ L+LS+NN +G IP+ + + +D+S NQL G VP
Sbjct: 762 VEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGY 821
Query: 335 ---------------FRNAPVEALKGNKGLCGGVKGMQPCKVFLSHKQNSRVKWFAIVFP 379
F +A GN GLCG + C S Q S ++
Sbjct: 822 LNLSYNNLEGKLKKQFSRWQADAFVGNAGLCG--SPLSHCNRAGSKNQRSLSPKTVVIIS 879
Query: 380 VLGAL-FLSMALIAIFILRKRKSD-----------SGDRQSSNQNPHGLFSILNFEGKLV 427
+ +L +++ ++ I + K+ D SS+Q P LFS + +
Sbjct: 880 AISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAP--LFSNGGAKSDIK 937
Query: 428 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEV 487
+D+I+ AT+ + ++ IG+GG G VY+AEL +G+ +A+KK L D + K F EV
Sbjct: 938 WDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKI---LWKDDLMSNKSFNREV 994
Query: 488 KALTEIRHRNIVKFYGFCSHARH--SFLVYELLERGSLAAILSSDTAAQE---LGWSQRM 542
K L IRHR++VK G+CS + L+YE + GS+ L ++ ++ LGW R+
Sbjct: 995 KTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRL 1054
Query: 543 NVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTE- 601
+ G+A + YLH+DC PPIVH+DI S N+LLD EAH+ DFG+AK L TE
Sbjct: 1055 KIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTES 1114
Query: 602 ---FAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIA 658
FAG+YGY+APE AY++K TEK DVYS G++++E + GK P + + TD+
Sbjct: 1115 NTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAM-----FDEETDMV 1169
Query: 659 --LDEILDPRLPPPSRSVQEKLIS----------------IMEVAFSCLNESPESRPTMK 700
++ +LD PP +EKLI ++E+A C P+ RP+ +
Sbjct: 1170 RWVETVLD---TPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSR 1226
Query: 701 VVTQ 704
++
Sbjct: 1227 QASE 1230
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 382 bits (982), Expect = e-105, Method: Compositional matrix adjust.
Identities = 256/758 (33%), Positives = 389/758 (51%), Gaps = 71/758 (9%)
Query: 4 LSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFT 62
L ++DL+ N G +P S+ L+ L+E ++ N SG IP ++ N L + LD N +
Sbjct: 324 LKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQIS 383
Query: 63 SYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPN 122
+P + L F N +G+IP L +C+ L + L+ N+LTG I L + N
Sbjct: 384 GLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRN 443
Query: 123 LTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIV 182
LT + L N G I G C L L + N ITG IP IG+ ++ LD S N +
Sbjct: 444 LTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLH 503
Query: 183 GEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLK 242
G++P E+G + L + L N G LP + SL L+ LD+SAN+F+ +P +LG L+
Sbjct: 504 GKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVS 563
Query: 243 LHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLE-KLNLSHNNL 301
L+ L LS N F +P L L LD N GEIP ++ +++LE LNLS N L
Sbjct: 564 LNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRL 623
Query: 302 SGSIPNCFEGIRGISVIDISDNQLQGPV-----------------------PNSTAFRNA 338
+G IP+ + +S++D+S N L+G + P++ FR
Sbjct: 624 TGKIPSKIASLNKLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQL 683
Query: 339 PVEALKGNKGLCGGVKGMQPCKVFLSHKQN---------SRV-KWFAIVFPVLGALFLSM 388
+ L+GNK LC + FL++++ SR K + ++ + M
Sbjct: 684 SPQDLEGNKKLCSSTQD----SCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLM 739
Query: 389 ALIAIFILRKRKSDSGDRQSSNQNPHGL----FSILNFEGKLVYDEIVRATNDFDAQYCI 444
L A+ ++R R++ +R S + F LNF D+I+R + + I
Sbjct: 740 ILGAVAVIRARRNIDNERDSELGETYKWQFTPFQKLNFS----VDQIIRCLVEPNV---I 792
Query: 445 GNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQK------EFLIEVKALTEIRHRNI 498
G G G VYRA++ +G+V+A+KK P + D+K F EVK L IRH+NI
Sbjct: 793 GKGCSGVVYRADVDNGEVIAVKKLW-PAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNI 851
Query: 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
V+F G C + L+Y+ + GSL ++L + L W R ++ G A L+YLHHD
Sbjct: 852 VRFLGCCWNRNTRLLMYDYMPNGSLGSLLH-ERRGSSLDWDLRYRILLGAAQGLAYLHHD 910
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP----ESSNWTEFAGTYGYVAPELA 614
C PPIVH+DI + N+L+ L++E ++ADFG+AK + SN AG+YGY+APE
Sbjct: 911 CLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSN--TVAGSYGYIAPEYG 968
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGKHPRD-----FLSLISSSSLNTDIALDEILDPRLPP 669
Y+MKITEK DVYS+GV+VLE + GK P D + L+ N E+LD L
Sbjct: 969 YSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRGSL--EVLDSTLRS 1026
Query: 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707
+ + ++++ ++ A C+N SP+ RPTMK V ++
Sbjct: 1027 RTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLK 1064
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 381 bits (979), Expect = e-104, Method: Compositional matrix adjust.
Identities = 259/782 (33%), Positives = 391/782 (50%), Gaps = 122/782 (15%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
M+SL+ +DL+ N F G +P S NL+NL+EL+L NN++G IP L N L + +D N
Sbjct: 322 MKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDAN 381
Query: 60 HFTSYLP---------------HNVCRGGA---------LQYFGVSENHFQGTIPKIL-- 93
+ +P N G LQ +S+N+ G++P L
Sbjct: 382 QISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQ 441
Query: 94 ----------------------RNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRN 131
NC+SL+R+RL +N +TG I + +G NL+F+DLS N
Sbjct: 442 LRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSEN 501
Query: 132 DFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGK 191
+ G + C +L LN+S N + G +P + + ++LQ LD+S N + G+IP LG
Sbjct: 502 NLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGH 561
Query: 192 LNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHY-LGLSN 250
L SL LIL N F G +P +G +L+ LDLS+N + ++PE L ++ L L LS
Sbjct: 562 LISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSW 621
Query: 251 NQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFE 310
N +P+ + L +LS LD SHN+ G++ + L++L LN+SHN SG +
Sbjct: 622 NSLDGFIPERISALNRLSVLDISHNMLSGDLS-ALSGLENLVSLNISHNRFSGYL----- 675
Query: 311 GIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKGMQPCKVFLSHK---- 366
P+S FR ++GN GLC KG + C V S +
Sbjct: 676 -------------------PDSKVFRQLIGAEMEGNNGLCS--KGFRSCFVSNSSQLTTQ 714
Query: 367 ---QNSRVKWFAIVFPVLGALFLSMALIAIFILRKRKSDSGDRQSSNQ------NPHGLF 417
+ R++ + + A+ + ++A+ ++ D D ++ P F
Sbjct: 715 RGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGENLWTWQFTP---F 771
Query: 418 SILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQI 477
LNF + V +V IG G G VY+AE+P+ +V+A+KK P+ +
Sbjct: 772 QKLNFTVEHVLKCLVEGN-------VIGKGCSGIVYKAEMPNREVIAVKKLW-PVTVPNL 823
Query: 478 ADQKE-------FLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSD 530
++ + F EVK L IRH+NIV+F G C + L+Y+ + GSL ++L
Sbjct: 824 NEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHER 883
Query: 531 TAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590
+ LGW R +I G A L+YLHHDC PPIVH+DI + N+L+ ++E ++ DFG+AK
Sbjct: 884 SGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAK 943
Query: 591 FLK----PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP----- 641
+ SSN AG+YGY+APE Y+MKITEK DVYS+GV+VLE + GK P
Sbjct: 944 LVDDGDFARSSN--TIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTI 1001
Query: 642 RDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKV 701
D L ++ DI +++D L S E+++ + VA C+N PE RPTMK
Sbjct: 1002 PDGLHIVDWVKKIRDI---QVIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMKD 1058
Query: 702 VT 703
V
Sbjct: 1059 VA 1060
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 360 bits (924), Expect = 2e-98, Method: Compositional matrix adjust.
Identities = 252/755 (33%), Positives = 387/755 (51%), Gaps = 70/755 (9%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
+ L LDL N G +PPS+ LTN+ ++ L N+L+G IPP L N L N
Sbjct: 228 LSKLVDLDLALNDLVGHIPPSLGGLTNVVQIELYNNSLTGEIPPELGNLKSLRLLDASMN 287
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
T +P +CR L+ + EN+ +G +P + +L +R+ N LTG + + LG+
Sbjct: 288 QLTGKIPDELCRV-PLESLNLYENNLEGELPASIALSPNLYEIRIFGNRLTGGLPKDLGL 346
Query: 120 YPNLTFIDLSRNDFYGE------------------------ISSNWGKCPKLGTLNVSMN 155
L ++D+S N+F G+ I + C L + ++ N
Sbjct: 347 NSPLRWLDVSENEFSGDLPADLCAKGELEELLIIHNSFSGVIPESLADCRSLTRIRLAYN 406
Query: 156 NITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGS 215
+G +P + L+L N GEI K +G ++L+ LIL N+FTG LP EIGS
Sbjct: 407 RFSGSVPTGFWGLPHVNLLELVNNSFSGEISKSIGGASNLSLLILSNNEFTGSLPEEIGS 466
Query: 216 LVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHN 275
L +L L S N+F+ S+P++L +L +L L L NQF EL ++ +L+EL+ + N
Sbjct: 467 LDNLNQLSASGNKFSGSLPDSLMSLGELGTLDLHGNQFSGELTSGIKSWKKLNELNLADN 526
Query: 276 LFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAF 335
F G+IP +I SL L L+LS N SG IP + ++ ++ +++S N+L G +P S A
Sbjct: 527 EFTGKIPDEIGSLSVLNYLDLSGNMFSGKIPVSLQSLK-LNQLNLSYNRLSGDLPPSLA- 584
Query: 336 RNAPVEALKGNKGLCGGVKGMQPCKVFLSHKQNSRVKWFAIVFPVLGALFLSMALIAIFI 395
++ + GN GLCG +KG+ C K+ V W VL A+ L +A +A F
Sbjct: 585 KDMYKNSFIGNPGLCGDIKGL--CGSENEAKKRGYV-WLLRSIFVLAAMVL-LAGVAWFY 640
Query: 396 LRKRKSDSGDRQSSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRA 455
+ R ++ +++++F KL + E D IG G G VY+
Sbjct: 641 FKYRTFKKARAMERSK-----WTLMSFH-KLGFSE-HEILESLDEDNVIGAGASGKVYKV 693
Query: 456 ELPSGQVVAIKKFHS-----PLPCDQIADQK------EFLIEVKALTEIRHRNIVKFYGF 504
L +G+ VA+K+ + CD K F EV+ L +IRH+NIVK +
Sbjct: 694 VLTNGETVAVKRLWTGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCC 753
Query: 505 CSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIV 564
CS LVYE + GSL +L S LGW R +I A+ LSYLHHD PPIV
Sbjct: 754 CSTRDCKLLVYEYMPNGSLGDLLHSSKGGM-LGWQTRFKIILDAAEGLSYLHHDSVPPIV 812
Query: 565 HQDISSKNLLLDLEYEAHVADFGIAKFLK-----PESSNWTEFAGTYGYVAPELAYTMKI 619
H+DI S N+L+D +Y A VADFG+AK + P+S + AG+ GY+APE AYT+++
Sbjct: 813 HRDIKSNNILIDGDYGARVADFGVAKAVDLTGKAPKSM--SVIAGSCGYIAPEYAYTLRV 870
Query: 620 TEKCDVYSFGVLVLEAIKGKHP-------RDFLSLISSSSLNTDIALDEILDPRLPPPSR 672
EK D+YSFGV++LE + K P +D + + S+ I + ++DP+L
Sbjct: 871 NEKSDIYSFGVVILEIVTRKRPVDPELGEKDLVKWVCSTLDQKGI--EHVIDPKL---DS 925
Query: 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707
+E++ I+ V C + P +RP+M+ V + ++
Sbjct: 926 CFKEEISKILNVGLLCTSPLPINRPSMRRVVKMLQ 960
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 708 | ||||||
| 147767326 | 1032 | hypothetical protein VITISV_008862 [Viti | 0.992 | 0.681 | 0.558 | 0.0 | |
| 225456159 | 1038 | PREDICTED: probable LRR receptor-like se | 0.983 | 0.670 | 0.553 | 0.0 | |
| 359491509 | 1032 | PREDICTED: probable LRR receptor-like se | 0.992 | 0.681 | 0.555 | 0.0 | |
| 147772402 | 996 | hypothetical protein VITISV_022117 [Viti | 0.988 | 0.702 | 0.551 | 0.0 | |
| 359491512 | 1078 | PREDICTED: probable LRR receptor-like se | 0.983 | 0.645 | 0.555 | 0.0 | |
| 225456161 | 1037 | PREDICTED: probable LRR receptor-like se | 0.981 | 0.670 | 0.546 | 0.0 | |
| 255545702 | 1008 | receptor protein kinase, putative [Ricin | 0.994 | 0.698 | 0.530 | 0.0 | |
| 297846642 | 1007 | hypothetical protein ARALYDRAFT_891227 [ | 0.975 | 0.686 | 0.514 | 0.0 | |
| 186511602 | 1045 | Leucine-rich repeat-containing protein [ | 0.985 | 0.667 | 0.490 | 0.0 | |
| 297846638 | 1123 | hypothetical protein ARALYDRAFT_473694 [ | 0.975 | 0.615 | 0.514 | 0.0 |
| >gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 785 bits (2026), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/707 (55%), Positives = 514/707 (72%), Gaps = 4/707 (0%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
+RSL L+++QNQ G +P S+ NL NL+ L L N LS IPP + L +D N
Sbjct: 325 LRSLVDLEISQNQLNGSIPTSLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDTN 384
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
+ +LP +C+GG+L+ F V +N G IP+ L+NC SL R RL N LTGNISEA G+
Sbjct: 385 QLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLKNCPSLARARLQRNQLTGNISEAFGV 444
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
PNL I+LS N FYGE+S NWG+C KL L+++ NNITG IP + G S+QL L+LS N
Sbjct: 445 CPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLSSN 504
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
H+VGEIPK+LG ++SL +LIL N+ +G +PPE+GSL DL YLDLS NR N S+PE+LGN
Sbjct: 505 HLVGEIPKKLGSVSSLWKLILNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLGN 564
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
L L+YL LSNN+ +P ++ KL LS LD SHNL GEIP QI L+SLEKLNLSHN
Sbjct: 565 CLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSHN 624
Query: 300 NLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKGMQPC 359
NLSG IP FE + G+ +DIS N LQG +PNS AF+N +E L+GNKGLCG VKG+QPC
Sbjct: 625 NLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQPC 684
Query: 360 KVFLSHKQNSRVKWFAIVFPVLGALFLSMALIAIFILRKRKSDSGDRQSSNQNPHGLFSI 419
+ + K + F I+F +LGAL + A I I ++ + + ++ ++ + LFSI
Sbjct: 685 ENRSATKGTHKAV-FIIIFSLLGALLILSAFIGISLISQGRRNAKMEKAGDVQTENLFSI 743
Query: 420 LNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIAD 479
F+G+ Y+ I+ AT DFD YCIG GGHGSVY+AELPSG +VA+KK H D +A
Sbjct: 744 STFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHR-FDID-MAH 801
Query: 480 QKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWS 539
QK+F+ E++ALTEI+HRNIVK GFCSH+RHSFLVYE LERGSL ILS + A+E+GW
Sbjct: 802 QKDFMNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWG 861
Query: 540 QRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599
R+N+IKGVA ALSYLHHDC PPIVH+DISS N+LLD +YEAHV+DFG AKFLK +SSNW
Sbjct: 862 TRVNIIKGVAHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNW 921
Query: 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIAL 659
+ AGTYGYVAPELAYTMK+TEKCDVYSFGVL LE ++G+HP D +S +S+S ++ L
Sbjct: 922 STLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVMRGRHPGDLISSLSASPGKDNVVL 981
Query: 660 DEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
++LDPRLPPP+ + +++S++++A +CLN SP+SRPTM++V+Q +
Sbjct: 982 KDVLDPRLPPPTLRDEAEVMSVIQLATACLNGSPQSRPTMQMVSQML 1028
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 780 bits (2013), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/717 (55%), Positives = 510/717 (71%), Gaps = 21/717 (2%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
++SL L+L++NQ G +P S+ NLTNL+ L L N LSG+IP + L +D N
Sbjct: 328 LKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNQLSGYIPQEIGKLHKLVVLEIDTN 387
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
LP +C+ G+L F VS+NH G IPK L+NC +L R N LTGNISE +G
Sbjct: 388 QLFGSLPEGICQAGSLVRFAVSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGNISEVVGD 447
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
PNL FIDLS N F+GE+S NWG+CP+L L ++ NNITG IP + G S+ L LDLS N
Sbjct: 448 CPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGISTNLTLLDLSSN 507
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
H+VGEIPK++G L SL LIL NQ +G +PPE+GSL LEYLDLSANR N S+PE+LG+
Sbjct: 508 HLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELGSLSHLEYLDLSANRLNGSIPEHLGD 567
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
L LHYL LSNN+ +P ++ KL LS+LD SHNL G IP QI L+SLE L+LSHN
Sbjct: 568 CLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSHNLLAGGIPPQIQGLQSLEMLDLSHN 627
Query: 300 NLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKGMQPC 359
NL G IP FE + +S +DIS NQLQGP+P+S AFRNA +E LKGNK LCG VKG+QPC
Sbjct: 628 NLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGNVKGLQPC 687
Query: 360 KVFLSHKQN----SRVKWFAIVFPVLGALFLSMALIAIFILRKRKS-----DSGDRQSSN 410
K Q S F I+FP+LGAL L A I IF++ +R+ + GD Q+
Sbjct: 688 KYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLFAFIGIFLIAERRERTPEIEEGDVQND- 746
Query: 411 QNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHS 470
LFSI NF+G+ +Y+EI++AT DFD YCIG GGHGSVY+AELPS +VA+KK H
Sbjct: 747 -----LFSISNFDGRTMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLH- 800
Query: 471 PLPCD-QIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSS 529
P D ++A+QK+FL E++ALTEI+HRNIVK GFCSH RH FLVYE LERGSLA ILS
Sbjct: 801 --PSDTEMANQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSR 858
Query: 530 DTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA 589
+ A++LGW+ R+N+IKGVA AL+Y+HHDC PPIVH+D+SS N+LLD +YEAH++DFG A
Sbjct: 859 E-EAKKLGWATRVNIIKGVAHALAYMHHDCSPPIVHRDVSSNNILLDSQYEAHISDFGTA 917
Query: 590 KFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLIS 649
K LK +SSN + AGT+GY+APELAYTMK+TEK DV+SFGV+ LE IKG+HP D + +S
Sbjct: 918 KLLKLDSSNQSILAGTFGYLAPELAYTMKVTEKTDVFSFGVIALEVIKGRHPGDQILSLS 977
Query: 650 SSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
S +IAL+++LDPRLPP + + ++I+I++ A CL +P+SRPTM+ V+Q +
Sbjct: 978 VSPEKDNIALEDMLDPRLPPLTPQDEGEVIAILKQAIECLKANPQSRPTMQTVSQML 1034
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 779 bits (2011), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/707 (55%), Positives = 511/707 (72%), Gaps = 4/707 (0%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
+RSL L+++QNQ G +P + NL NL+ L L N LS IPP + L +D N
Sbjct: 325 LRSLVDLEISQNQLNGSIPTLLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDTN 384
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
+ +LP +C+GG+L+ F V +N G IP+ L+NC SL R RL N LTGNISEA G+
Sbjct: 385 QLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLKNCPSLARARLQGNQLTGNISEAFGV 444
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
PNL I+LS N FYGE+S NWG+C KL L+++ NNITG IP + G S+QL L+LS N
Sbjct: 445 CPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLSSN 504
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
H+VGEIPK+LG ++SL +LIL N+ +G +PPE+GSL DL YLDLS NR N S+PE+LGN
Sbjct: 505 HLVGEIPKKLGSVSSLWKLILNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLGN 564
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
L L+YL LSNN+ +P ++ KL LS LD SHNL GEIP QI L+SLEKLNLSHN
Sbjct: 565 CLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSHN 624
Query: 300 NLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKGMQPC 359
NLSG IP FE + G+ +DIS N LQG +PNS AF+N +E L+GNKGLCG VKG+QPC
Sbjct: 625 NLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQPC 684
Query: 360 KVFLSHKQNSRVKWFAIVFPVLGALFLSMALIAIFILRKRKSDSGDRQSSNQNPHGLFSI 419
+ + K + F I+F +LGAL + A I I ++ + + ++ ++ + LFSI
Sbjct: 685 ENRSATKGTHKAV-FIIIFSLLGALLILSAFIGISLISQGRRNAKMEKAGDVQTENLFSI 743
Query: 420 LNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIAD 479
F+G+ Y+ I+ AT DFD YCIG GGHGSVY+AELPSG +VA+KK H D +A
Sbjct: 744 STFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHR-FDID-MAH 801
Query: 480 QKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWS 539
QK+F+ E++ALTEI+HRNIVK GFCSH+RHSFLVYE LERGSL ILS + A+E+GW
Sbjct: 802 QKDFVNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWG 861
Query: 540 QRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599
R+N+IKGV+ ALSYLHHDC PPIVH+DISS N+LLD +YEAHV+DFG AKFLK +SSNW
Sbjct: 862 TRVNIIKGVSHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNW 921
Query: 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIAL 659
+ AGTYGYVAPELAYTMK+TEKCDVYSFGVL LE ++G+HP D +S +S S ++ L
Sbjct: 922 STLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVMRGRHPGDLISSLSDSPGKDNVVL 981
Query: 660 DEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
++LDPRLPPP+ + ++ S++++A +CLN SP+SRPTM++V+Q +
Sbjct: 982 KDVLDPRLPPPTFRDEAEVTSVIQLATACLNGSPQSRPTMQMVSQML 1028
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 773 bits (1995), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/713 (55%), Positives = 515/713 (72%), Gaps = 13/713 (1%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
++SL L+L++NQ G +P S+ NLTNL+ L L N LSG+IP + L +D N
Sbjct: 286 LKSLVDLELSENQLNGSIPTSLGNLTNLETLFLRDNQLSGYIPQEIGKLHKLVVLEIDTN 345
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
LP +C+GG+L+ F VS+NH G IPK L+NC +L R N LTGNISE +G
Sbjct: 346 QLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLKNCKNLTRALFGGNQLTGNISEVVGD 405
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
PNL +I++S N F+GE+S NWG+ P+L L ++ NNITG IP + G S+ L LDLS N
Sbjct: 406 CPNLEYINVSYNSFHGELSHNWGRYPRLQRLEMAWNNITGSIPEDFGISTDLTLLDLSSN 465
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
H+ GEIPK++G + SL +LIL NQ +G +PPE+GSL DL YLDLSANR N S+PE+LG+
Sbjct: 466 HLFGEIPKKMGSVTSLWKLILNDNQLSGNIPPELGSLADLGYLDLSANRLNGSIPEHLGD 525
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
L L+YL LSNN+ +P ++ KL LS+LD SHNL G+IP QI L+SLE LNLSHN
Sbjct: 526 CLGLNYLNLSNNKLSHGIPVQMGKLGHLSQLDLSHNLLTGDIPPQIEGLQSLENLNLSHN 585
Query: 300 NLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKGMQPC 359
NLSG IP FE + G+S +DIS NQLQGP+PNS AFR+A +EALKGNKGLCG VK ++PC
Sbjct: 586 NLSGFIPKAFEEMLGLSDVDISYNQLQGPIPNSKAFRDATIEALKGNKGLCGNVKRLRPC 645
Query: 360 K----VFLSHKQNSRVKWFAIVFPVLGALFLSMALIAIFILRKRKSDSGD-RQSSNQNPH 414
K V + S F I+FP+LGAL L A I IF++ R+ + + ++ QN
Sbjct: 646 KYGSGVDQQPVKKSHKVVFIIIFPLLGALVLLFAFIGIFLIAARRERTPEIKEGEVQN-- 703
Query: 415 GLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPC 474
LFSI F+G+ +Y+EI++AT DFD YCIG GGHGSVY+AELPS +VA+KK H P
Sbjct: 704 DLFSISTFDGRTMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLH---PS 760
Query: 475 D-QIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAA 533
D ++A+QK+FL E++ALTEI+HRNIVK GFCSH RH FLVYE LERGSLA ILS + A
Sbjct: 761 DTEMANQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSRE-EA 819
Query: 534 QELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593
++LGW+ R+N+IKGVA AL+Y+HHDC PPIVH+DISS N+LLD +YEAH++DFG AK LK
Sbjct: 820 KKLGWATRVNIIKGVAHALAYMHHDCSPPIVHRDISSNNILLDSQYEAHISDFGTAKLLK 879
Query: 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL 653
+SSN + AGT+GY+APELAYTMK+TEK DV+SFGV+ LE IKG+HP D + +S S
Sbjct: 880 LDSSNQSILAGTFGYLAPELAYTMKVTEKTDVFSFGVIALEVIKGRHPGDQILSLSVSPE 939
Query: 654 NTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
+IAL+++LDPRLPP + + ++I+I++ A CL +P+SRPTM+ V+Q +
Sbjct: 940 KDNIALEDMLDPRLPPLTPQDEGEVIAIIKQATECLKANPQSRPTMQTVSQML 992
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491512|ref|XP_002278614.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 771 bits (1990), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/717 (55%), Positives = 510/717 (71%), Gaps = 21/717 (2%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
++SL L+L++NQ G +P S+ NLTNL+ L L N+LSG+ P + L +D N
Sbjct: 335 LKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNHLSGYFPKEIGKLHKLVVLEIDTN 394
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
+ LP +C+GG+L F VS+N G IPK ++NC +L R N LTGNISE +G
Sbjct: 395 RLSGSLPEGICQGGSLVRFTVSDNLLSGPIPKSMKNCRNLTRALFGGNQLTGNISEVVGD 454
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
PNL +IDLS N F+GE+S NWG+CP+L L ++ N+ITG IP + G S+ L LDLS N
Sbjct: 455 CPNLEYIDLSYNRFHGELSHNWGRCPQLQRLEMAGNDITGSIPEDFGISTNLTLLDLSSN 514
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
H+VGEIPK++G L SL EL L NQ +G +PPE+GSL L +LDLSANR N S+ ENLG
Sbjct: 515 HLVGEIPKKMGSLTSLLELKLNDNQLSGSIPPELGSLFSLAHLDLSANRLNGSITENLGA 574
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
L LHYL LSNN+ +P ++ KL LS+LD SHNL GEIP QI L+SLE LNLSHN
Sbjct: 575 CLNLHYLNLSNNKLSNRIPAQMGKLSHLSQLDLSHNLLSGEIPPQIEGLESLENLNLSHN 634
Query: 300 NLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKGMQPC 359
NLSG IP FE +RG+S IDIS NQLQGP+PNS AFR+A +E LKGNK LCG VKG+QPC
Sbjct: 635 NLSGFIPKAFEEMRGLSDIDISYNQLQGPIPNSKAFRDATIELLKGNKDLCGNVKGLQPC 694
Query: 360 KVFLSHKQNSRVKW----FAIVFPVLGALFLSMALIAIFILRKRKS-----DSGDRQSSN 410
K Q K F IVFP+LGAL L A I IF++ +R + GD Q+
Sbjct: 695 KNDSGAGQQPVKKGHKIVFIIVFPLLGALVLLFAFIGIFLIAERTKRTPEIEEGDVQND- 753
Query: 411 QNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHS 470
LFSI F+G+ +Y+EI++AT DFD YCIG GGHGSVY+AEL SG +VA+KK ++
Sbjct: 754 -----LFSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGSVYKAELSSGNIVAVKKLYA 808
Query: 471 PLPCD-QIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSS 529
D +A+Q++F EV+ALTEI+HRNIVK GFCSH RHSFLVYE LERGSLAA+LS
Sbjct: 809 ---SDIDMANQRDFFNEVRALTEIKHRNIVKLLGFCSHPRHSFLVYEYLERGSLAAMLSR 865
Query: 530 DTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA 589
+ A++LGW+ R+N+IKGVA ALSY+HHDC PPIVH+DISS N+LLD +YE H++DFG A
Sbjct: 866 E-EAKKLGWATRINIIKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEPHISDFGTA 924
Query: 590 KFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLIS 649
K LK +SSN + AGT+GYVAPE AYTMK+TEK DVYSFGV+ LE IKG+HP D + +S
Sbjct: 925 KLLKLDSSNQSALAGTFGYVAPEHAYTMKVTEKTDVYSFGVITLEVIKGRHPGDQILSLS 984
Query: 650 SSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
S +I L+++LDPRLPP + + ++ISI+ +A +CL+ +PESRPTMK+++Q +
Sbjct: 985 VSPEKENIVLEDMLDPRLPPLTAQDEGEVISIINLATACLSVNPESRPTMKIISQML 1041
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 766 bits (1978), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/717 (54%), Positives = 510/717 (71%), Gaps = 22/717 (3%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
++SL L+L++NQ G +P S+ NLTNL+ L L N LSG+ P + L +D N
Sbjct: 328 LKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNRLSGYFPQEIGKLHKLVVLEIDTN 387
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
LP +C+GG+L+ F VS+NH G IPK L+NC +L R N LTGN+SE +G
Sbjct: 388 QLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGNVSEVVGD 447
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
PNL FIDLS N F+GE+S NWG+CP+L L ++ NNITG IP + G S+ L LDLS N
Sbjct: 448 CPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGISTNLILLDLSSN 507
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
H+VGEIPK++G L SL LIL NQ +G +PPE+GSL LEYLDLSANR N S+PE+LG+
Sbjct: 508 HLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELGSLSHLEYLDLSANRLNGSIPEHLGD 567
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
L LHYL LSNN+ +P ++ KL LS+LD SHNL G IP QI L+SLE L+LSHN
Sbjct: 568 CLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSHNLLTGGIPAQIQGLESLEMLDLSHN 627
Query: 300 NLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKGMQPC 359
NL G IP FE + +S +DIS NQLQGP+P+S AFRNA +E LKGNK LCG VKG+QPC
Sbjct: 628 NLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGNVKGLQPC 687
Query: 360 KVFLSHKQN----SRVKWFAIVFPVLGALFLSMALIAIFILRKRKS-----DSGDRQSSN 410
K Q S F I+FP+LGAL L A I IF++ +R+ + GD Q++
Sbjct: 688 KYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLSAFIGIFLIAERRERTPEIEEGDVQNN- 746
Query: 411 QNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHS 470
L SI F+G+ +Y+EI++AT DFD YCIG GGHGSVY+AELPSG +VA+KK H
Sbjct: 747 -----LLSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSGNIVAVKKLH- 800
Query: 471 PLPCD-QIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSS 529
P D +A+QK+FL +V+A+TEI+HRNIV+ GFCS+ RHSFLVYE LERGSLA ILS
Sbjct: 801 --PSDMDMANQKDFLNKVRAMTEIKHRNIVRLLGFCSYPRHSFLVYEYLERGSLATILSR 858
Query: 530 DTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA 589
+ A++LGW+ R+ +IKGVA ALSY+HHDC PPIVH+DISS N+LLD +YEAH+++ G A
Sbjct: 859 E-EAKKLGWATRVKIIKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEAHISNLGTA 917
Query: 590 KFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLIS 649
K LK +SSN ++ AGT GYVAPE AYTMK+TEK DVYSFGV+ LE IKG+HP D + IS
Sbjct: 918 KLLKVDSSNQSKLAGTVGYVAPEHAYTMKVTEKTDVYSFGVIALEVIKGRHPGDQILSIS 977
Query: 650 SSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
S +I L ++LDPRLPP + + ++++I+++A +CLN +P+SRPTM++++Q +
Sbjct: 978 VSP-EKNIVLKDMLDPRLPPLTPQDEGEVVAIIKLATACLNANPQSRPTMEIISQML 1033
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545702|ref|XP_002513911.1| receptor protein kinase, putative [Ricinus communis] gi|223546997|gb|EEF48494.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 726 bits (1875), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/712 (53%), Positives = 499/712 (70%), Gaps = 8/712 (1%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDF-N 59
+ SLS L+L++N+ G +P S+ NL+ L+ L L N LSG IP + N N
Sbjct: 299 LNSLSNLELSENKLTGSIPASLGNLSRLELLFLKNNQLSGPIPEQIANLSKLSLLQLQSN 358
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
T YLP N+C+ LQ F V++N +G IPK +R+C SL+R+ L N GNISE G+
Sbjct: 359 QLTGYLPQNICQSKVLQNFSVNDNRLEGPIPKSMRDCKSLVRLHLEGNQFIGNISEDFGV 418
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
YP L F+D+ N F+GEISS WG CP LGTL +S NNI+G IP EIGN+++LQ LD S N
Sbjct: 419 YPYLQFVDIRYNKFHGEISSKWGMCPHLGTLLISGNNISGIIPPEIGNAARLQGLDFSSN 478
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
+VG IPKELGKL SL + L NQ + +P E GSL DLE LDLSANRFN S+P N+GN
Sbjct: 479 QLVGRIPKELGKLTSLVRVNLEDNQLSDGVPSEFGSLTDLESLDLSANRFNQSIPGNIGN 538
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
L+KL+YL LSNNQF E+P +L KLV LS+LD S N GEIP ++ ++SLE LNLS N
Sbjct: 539 LVKLNYLNLSNNQFSQEIPIQLGKLVHLSKLDLSQNFLIGEIPSELSGMQSLEVLNLSRN 598
Query: 300 NLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKGMQPC 359
NLSG IP + + G+S IDIS N+L+GPVP++ AF+N+ +EA +GNKGLCG V+G+QPC
Sbjct: 599 NLSGFIPGDLKEMHGLSSIDISYNKLEGPVPDNKAFQNSSIEAFQGNKGLCGHVQGLQPC 658
Query: 360 KVFLSHKQNSRVK-----WFAIVFPVLGALFLSMALIAIFILRKRKSDSGDRQSSNQNPH 414
K S +Q S +K + I P+ GA + L +F KR ++ + + S+Q
Sbjct: 659 KPS-STEQGSSIKFHKRLFLVISLPLFGAFLILSFLGVLFFQSKRSKEALEAEKSSQESE 717
Query: 415 GLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPC 474
+ I +F+GK ++DEI+ AT+ F+ YCIG GG GSVY+A+L SG VA+KK H
Sbjct: 718 EILLITSFDGKSMHDEIIEATDSFNDIYCIGKGGCGSVYKAKLSSGSTVAVKKLHQSHDA 777
Query: 475 DQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQ 534
+ QKEF E++ALTEI+HRNIVKFYGFCS++ +SFLVYE +E+GSLA IL + AA+
Sbjct: 778 WK-PYQKEFWSEIRALTEIKHRNIVKFYGFCSYSAYSFLVYECIEKGSLATILRDNEAAK 836
Query: 535 ELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594
EL W +R N+IKGVA+ALSY+HHDC PPIVH+DISSKN+LLD E EA V+DFGIA+ L
Sbjct: 837 ELEWFKRANIIKGVANALSYMHHDCSPPIVHRDISSKNILLDSENEARVSDFGIARILNL 896
Query: 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN 654
+SS+ T AGT+GY+APELAY++ +TEKCDVYSFGVL LE I GKHP + +S ISSSS
Sbjct: 897 DSSHRTALAGTFGYMAPELAYSIVVTEKCDVYSFGVLALEVINGKHPGEIISSISSSSST 956
Query: 655 TDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
+ L+ I+D RLP PS VQ +L++I+ +AF+CLN +P+ RPTM+++ +
Sbjct: 957 RKMLLENIVDLRLPFPSPEVQVELVNILNLAFTCLNSNPQVRPTMEMICHML 1008
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297846642|ref|XP_002891202.1| hypothetical protein ARALYDRAFT_891227 [Arabidopsis lyrata subsp. lyrata] gi|297337044|gb|EFH67461.1| hypothetical protein ARALYDRAFT_891227 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 703 bits (1815), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/712 (51%), Positives = 492/712 (69%), Gaps = 21/712 (2%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPM-LTRPGLDFN 59
M S+ L+L+QN G +P S N T LK L L YN+LSG IPP + N LT L N
Sbjct: 296 MESMIDLELSQNNLTGSIPSSFGNFTKLKSLYLSYNHLSGAIPPGVANSSELTELQLAIN 355
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
+F+ +LP N+C+GG LQ+ + +NH +G IPK LR+C SLIR + N GNISEA G+
Sbjct: 356 NFSGFLPKNICKGGKLQFIALYDNHLKGPIPKSLRDCKSLIRAKFVGNKFVGNISEAFGV 415
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
YP+L FIDLS N F GEISSNW K PKLG L +S NNITG IP EI N QL LDLS N
Sbjct: 416 YPDLNFIDLSHNKFNGEISSNWQKSPKLGALIMSNNNITGAIPPEIWNMKQLGELDLSAN 475
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
++ GE+P+ +G L +L+ L L GNQ +GR+P I L +LE LDLS+NRF++ +P+ +
Sbjct: 476 NLSGELPEAIGNLTNLSRLRLNGNQLSGRVPAGISFLTNLESLDLSSNRFSSQIPQTFDS 535
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
LKLH + LS N F +P L KL QL+ LD SHN GEIP Q+ SL+SL+KLNLSHN
Sbjct: 536 FLKLHEMNLSRNNFDGRIPG-LTKLTQLTHLDLSHNQLDGEIPSQLSSLQSLDKLNLSHN 594
Query: 300 NLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGV--KGMQ 357
NLSG IP FE ++ ++ IDIS+N+L+GP+P++ AF+NA +AL+GN+GLC + + ++
Sbjct: 595 NLSGFIPTTFESMKALTFIDISNNKLEGPLPDNPAFQNATSDALEGNRGLCSNIPKQRLK 654
Query: 358 PCKV----FLSHKQNSRV-KWFAIVFPVLGAL-FLSMALIAI-FILRKRKSDSGDRQSSN 410
C + F K+N + W I+ P+LGAL LS+ A + +RKRK +G S
Sbjct: 655 SCPITSGGFQKPKKNGNLLVW--ILVPILGALVILSICAGAFTYYIRKRKPHNGRNTDSE 712
Query: 411 QNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHS 470
+ SI + +GK Y +I+ +TN+FD +Y IG+GG+ VY+A LP +VA+K+ H
Sbjct: 713 TGEN--MSIFSVDGKFKYQDIIESTNEFDQRYLIGSGGYSKVYKANLPDA-IVAVKRLHD 769
Query: 471 PLPCDQIAD---QKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAIL 527
+ ++I+ ++EFL EV+ALTEIRHRN+VK +GFCSH RH+FL+YE +E+GSL +L
Sbjct: 770 TID-EEISKPVVKQEFLNEVRALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLL 828
Query: 528 SSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFG 587
+++ A+ L W++R+N++KGVA ALSY+HHD PIVH+DISS N+LLD +Y A ++DFG
Sbjct: 829 ANEEEAKRLTWTKRINIVKGVAHALSYMHHDRSTPIVHRDISSGNILLDNDYTAKISDFG 888
Query: 588 IAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSL 647
AK LK +SSNW+ AGTYGYVAPE AYTMK+TEKCDVYSFGVL+LE I GKHP D ++
Sbjct: 889 TAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILEVIMGKHPGDLVAS 948
Query: 648 ISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTM 699
+SSS T ++L I D R+ P +EKLI ++EVA SCL P+SRPTM
Sbjct: 949 LSSSPGET-LSLRSISDERILEPRGQNREKLIKMVEVALSCLQADPQSRPTM 999
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|186511602|ref|NP_849538.2| Leucine-rich repeat-containing protein [Arabidopsis thaliana] gi|281185491|sp|Q8VZG8.3|Y4885_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At4g08850; Flags: Precursor gi|18086327|gb|AAL57627.1| AT4g08850/T32A17_160 [Arabidopsis thaliana] gi|224589610|gb|ACN59338.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332657282|gb|AEE82682.1| Leucine-rich repeat-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 700 bits (1807), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 346/706 (49%), Positives = 489/706 (69%), Gaps = 8/706 (1%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPM-LTRPGLDFN 59
M S+ L++++N+ G +P S LT L+ L L N LSG IPP + N LT LD N
Sbjct: 333 MESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTN 392
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
+FT +LP +CRGG L+ + +NHF+G +PK LR+C SLIRVR N+ +G+ISEA G+
Sbjct: 393 NFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGV 452
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
YP L FIDLS N+F+G++S+NW + KL +S N+ITG IP EI N +QL LDLS N
Sbjct: 453 YPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSN 512
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
I GE+P+ + +N +++L L GN+ +G++P I L +LEYLDLS+NRF++ +P L N
Sbjct: 513 RITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNN 572
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
L +L+Y+ LS N +P+ L KL QL LD S+N GEI Q SL++LE+L+LSHN
Sbjct: 573 LPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHN 632
Query: 300 NLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGV---KGM 356
NLSG IP F+ + ++ +D+S N LQGP+P++ AFRNAP +A +GNK LCG V +G+
Sbjct: 633 NLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGL 692
Query: 357 QPCKVFLSHK-QNSRVKWFAIVFPVLGALFLSMALIAIFILRKRKSDSGDRQSSNQNPHG 415
+PC + S K R I+ P++GA+ + IFI ++++ + + +++
Sbjct: 693 KPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGE 752
Query: 416 LFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPL--P 473
SI +F+GK+ Y EI++AT +FD +Y IG GGHG VY+A+LP+ ++A+KK +
Sbjct: 753 TLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSS 811
Query: 474 CDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAA 533
+ ++EFL E++ALTEIRHRN+VK +GFCSH R++FLVYE +ERGSL +L +D A
Sbjct: 812 ISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEA 871
Query: 534 QELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593
++L W +R+NV+KGVA ALSY+HHD P IVH+DISS N+LL +YEA ++DFG AK LK
Sbjct: 872 KKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLK 931
Query: 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL 653
P+SSNW+ AGTYGYVAPELAY MK+TEKCDVYSFGVL LE IKG+HP D +S +SSS
Sbjct: 932 PDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPP 991
Query: 654 NTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTM 699
+ ++L I D RLP P+ ++E+++ I++VA CL+ P++RPTM
Sbjct: 992 DATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTM 1037
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297846638|ref|XP_002891200.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata] gi|297337042|gb|EFH67459.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 700 bits (1807), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/708 (51%), Positives = 490/708 (69%), Gaps = 17/708 (2%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPM-LTRPGLDFN 59
M S+ L L+QN G +P S N T L+ L L N+LSG IP + N LT LD N
Sbjct: 416 MESMIDLALSQNNLTGSIPSSFGNFTKLESLYLRDNHLSGTIPRGVANSSELTELLLDIN 475
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
+FT +LP N+C+GG LQ F + NH +G IPK LR+C SLIR + N GNISEA G+
Sbjct: 476 NFTGFLPENICKGGKLQNFSLDYNHLEGHIPKSLRDCKSLIRAKFVGNKFIGNISEAFGV 535
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
YP+L FIDLS N F GEISSNW K PKLG L +S NNITG IP EI N QL LDLS N
Sbjct: 536 YPDLDFIDLSHNKFNGEISSNWQKSPKLGALIMSNNNITGAIPPEIWNMKQLGELDLSTN 595
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
++ GE+P+ +G L L++L+L GN+ +GR+P + L +LE LDLS+NRF++ +P+ +
Sbjct: 596 NLTGELPEAIGNLTGLSKLLLNGNKLSGRVPTGLSFLTNLESLDLSSNRFSSQIPQTFDS 655
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
LKLH + LS N F +P L KL QL+ LD SHN GEIP Q+ SL+SL+KLNLSHN
Sbjct: 656 FLKLHEMNLSKNNFDGRIPG-LTKLTQLTHLDLSHNQLDGEIPSQLSSLQSLDKLNLSHN 714
Query: 300 NLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGV--KGMQ 357
NLSG IP FE ++ ++ IDIS+N+L+GP+P++ AF+NA +AL+GN+GLC + + ++
Sbjct: 715 NLSGFIPTTFESMKALTFIDISNNKLEGPLPDNPAFQNATSDALEGNRGLCSNIPKQRLK 774
Query: 358 PCKVFLSHKQNSRV-KWFAIVFPVLGAL-FLSMALIAI-FILRKRKSDSGDRQSSNQNPH 414
C+ F K+N + W I+ P+LGAL LS+ A + +RKRK +G S +
Sbjct: 775 SCRGFQKPKKNGNLLVW--ILVPILGALVILSICAGAFTYYIRKRKPHNGRNTDSETGEN 832
Query: 415 GLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPC 474
SI + +GK Y +I+ +TN+FD +Y IG+GG+ VY+A LP +VA+K+ H +
Sbjct: 833 --MSIFSVDGKFKYQDIIESTNEFDQRYLIGSGGYSKVYKANLPDA-IVAVKRLHDTID- 888
Query: 475 DQIAD---QKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDT 531
++I+ ++EFL EV+ALTEIRHRN+VK +GFCSH RH+FL+YE +E+GSL +L+++
Sbjct: 889 EEISKPVVKQEFLNEVRALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANEE 948
Query: 532 AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591
A+ L W++R+N++KGVA ALSY+HHD PIVH+DISS N+LLD +Y A ++DFG AK
Sbjct: 949 EAKRLTWTKRINIVKGVAHALSYMHHDRSTPIVHRDISSGNILLDNDYTAKISDFGTAKL 1008
Query: 592 LKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS 651
LK +SSNW+ AGTYGYVAPE AYTMK+TEKCDVYSFGVL+LE I GKHP D ++ +SSS
Sbjct: 1009 LKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILEVIMGKHPGDLVASLSSS 1068
Query: 652 SLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTM 699
T ++L I D R+ P +EKLI ++EVA SCL P+SRPTM
Sbjct: 1069 PGET-LSLRSISDERILEPRGQNREKLIKMVEVALSCLQADPQSRPTM 1115
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 708 | ||||||
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.985 | 0.667 | 0.470 | 4.6e-176 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.975 | 0.616 | 0.488 | 7.7e-174 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.988 | 0.635 | 0.349 | 4e-106 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.981 | 0.630 | 0.347 | 1.4e-105 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.593 | 0.370 | 0.346 | 7.7e-105 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.898 | 0.565 | 0.361 | 2.9e-103 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.593 | 0.368 | 0.349 | 7.2e-102 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.973 | 0.551 | 0.345 | 6.2e-101 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.977 | 0.552 | 0.341 | 1.9e-99 | |
| TAIR|locus:2032697 | 1123 | PEPR1 "PEP1 receptor 1" [Arabi | 0.967 | 0.609 | 0.310 | 5.4e-94 |
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1710 (607.0 bits), Expect = 4.6e-176, P = 4.6e-176
Identities = 332/706 (47%), Positives = 471/706 (66%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPM-LTRPGLDFN 59
M S+ L++++N+ G +P S LT L+ L L N LSG IPP + N LT LD N
Sbjct: 333 MESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTN 392
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
+FT +LP +CRGG L+ + +NHF+G +PK LR+C SLIRVR N+ +G+ISEA G+
Sbjct: 393 NFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGV 452
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
YP L FIDLS N+F+G++S+NW + KL +S N+ITG IP EI N +QL LDLS N
Sbjct: 453 YPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSN 512
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPEXXXX 239
I GE+P+ + +N +++L L GN+ +G++P I L +LEYLDLS+NRF++ +P
Sbjct: 513 RITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNN 572
Query: 240 XXXXXXXXXXXXQFXXXXXXXXXXXXXXSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
LD S+N GEI Q SL++LE+L+LSHN
Sbjct: 573 LPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHN 632
Query: 300 NLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGV---KGM 356
NLSG IP F+ + ++ +D+S N LQGP+P++ AFRNAP +A +GNK LCG V +G+
Sbjct: 633 NLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGL 692
Query: 357 QPCKVFLSHKQNS-RVKWFAIVFPVLGALFLSMALIAIFILRKRKSDSGDRQSSNQNPHG 415
+PC + S K + R I+ P++GA+ + IFI ++++ + + +++
Sbjct: 693 KPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGE 752
Query: 416 LFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCD 475
SI +F+GK+ Y EI++AT +FD +Y IG GGHG VY+A+LP+ ++A+KK +
Sbjct: 753 TLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSS 811
Query: 476 --QIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAA 533
+ ++EFL E++ALTEIRHRN+VK +GFCSH R++FLVYE +ERGSL +L +D A
Sbjct: 812 ISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEA 871
Query: 534 QELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593
++L W +R+NV+KGVA ALSY+HHD P IVH+DISS N+LL +YEA ++DFG AK LK
Sbjct: 872 KKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLK 931
Query: 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL 653
P+SSNW+ AGTYGYVAPELAY MK+TEKCDVYSFGVL LE IKG+HP D +S +SSS
Sbjct: 932 PDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPP 991
Query: 654 NTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTM 699
+ ++L I D RLP P+ ++E+++ I++VA CL+ P++RPTM
Sbjct: 992 DATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTM 1037
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1689 (599.6 bits), Expect = 7.7e-174, P = 7.7e-174
Identities = 346/708 (48%), Positives = 467/708 (65%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPM-LTRPGLDFN 59
M S+ LDL+QN+ G +P S N T L+ L L N+LSG IPP + N LT LD N
Sbjct: 413 MESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTN 472
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
+FT + P VC+G LQ + NH +G IPK LR+C SLIR R N TG+I EA GI
Sbjct: 473 NFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGI 532
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
YP+L FID S N F+GEISSNW K PKLG L +S NNITG IP EI N +QL LDLS N
Sbjct: 533 YPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTN 592
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPEXXXX 239
++ GE+P+ +G L +L+ L L GNQ +GR+P + L +LE LDLS+N F++ +P+
Sbjct: 593 NLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDS 652
Query: 240 XXXXXXXXXXXXQFXXXXXXXXXXXXXXSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
+F ++LD SHN GEIP Q+ SL+SL+KL+LSHN
Sbjct: 653 FLKLHDMNLSRNKFDGSIPRLSKLTQL-TQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHN 711
Query: 300 NLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGV--KGMQ 357
NLSG IP FEG+ ++ +DIS+N+L+GP+P++ FR A +AL+ N GLC + + ++
Sbjct: 712 NLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLK 771
Query: 358 PCKVFLSHKQNSR-VKWFAIVFPVLGAL-FLSM-ALIAIFILRKRKSDSGDRQSSNQNPH 414
PC+ K+N V W I+ P+LG L LS+ A + +RKRK +G R + +
Sbjct: 772 PCRELKKPKKNGNLVVW--ILVPILGVLVILSICANTFTYCIRKRKLQNG-RNTDPETGE 828
Query: 415 GLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPC 474
+ SI + +GK Y +I+ +TN+FD + IG GG+ VYRA L ++A+K+ H +
Sbjct: 829 NM-SIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTID- 885
Query: 475 DQIAD---QKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDT 531
++I+ ++EFL EVKALTEIRHRN+VK +GFCSH RH+FL+YE +E+GSL +L++D
Sbjct: 886 EEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDE 945
Query: 532 AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591
A+ L W++R+NV+KGVA ALSY+HHD PIVH+DISS N+LLD +Y A ++DFG AK
Sbjct: 946 EAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKL 1005
Query: 592 LKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS 651
LK +SSNW+ AGTYGYVAPE AYTMK+TEKCDVYSFGVL+LE I GKHP D +S +SSS
Sbjct: 1006 LKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSS 1065
Query: 652 SLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTM 699
++L I D R+ P +EKL+ ++E+A CL +PESRPTM
Sbjct: 1066 P-GEALSLRSISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTM 1112
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1050 (374.7 bits), Expect = 4.0e-106, P = 4.0e-106
Identities = 251/719 (34%), Positives = 362/719 (50%)
Query: 4 LSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLE-NPMLTRPGLDFNHFT 62
L LDL+ N+ G +P + L L +L L N L G IPP + + + N +
Sbjct: 357 LEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLS 416
Query: 63 SYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPN 122
+P + CR L + N G IP+ L+ C SL ++ L N LTG++ L N
Sbjct: 417 GPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQN 476
Query: 123 LTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIV 182
LT ++L +N G IS++ GK L L ++ NN TG IP EIGN +++ ++S N +
Sbjct: 477 LTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLT 536
Query: 183 GEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPEXXXXXXX 242
G IPKELG ++ L L GN+F+G + E+G LV LE L LS NR +P
Sbjct: 537 GHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTR 596
Query: 243 XXXXXXXXXQFXXXXXXXXXXXXXXS-ELDASHNLFGGEIPFQICSLKSLEKLNLSHNNL 301
L+ SHN G IP + +L+ LE L L+ N L
Sbjct: 597 LMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKL 656
Query: 302 SGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKG-MQPCK 360
SG IP + + + +IS+N L G VP++ F+ GN GLC + QP
Sbjct: 657 SGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLV 716
Query: 361 VFLSHKQN------SRVKWFAIVFPVLGALFLSMALIAIFILRKRKSDSGDRQSSNQNPH 414
K N R K I V+G++FL + + + KR+ + P
Sbjct: 717 PHSDSKLNWLINGSQRQKILTITCIVIGSVFL-ITFLGLCWTIKRREPAFVALEDQTKPD 775
Query: 415 GLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPC 474
+ S + Y +V AT +F +G G G+VY+AE+ G+V+A+KK +S
Sbjct: 776 VMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSR--G 833
Query: 475 DQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQ 534
+ + F E+ L +IRHRNIVK YGFC H + L+YE + +GSL L
Sbjct: 834 EGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNC 893
Query: 535 ELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594
L W+ R + G A+ L YLHHDC P IVH+DI S N+LLD ++AHV DFG+AK +
Sbjct: 894 LLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDL 953
Query: 595 E-SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLS----LIS 649
S + + AG+YGY+APE AYTMK+TEKCD+YSFGV++LE I GK P L L++
Sbjct: 954 SYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVN 1013
Query: 650 --SSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
S+ I E+ D RL + ++ ++++A C + SP SRPTM+ V +
Sbjct: 1014 WVRRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMI 1072
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1045 (372.9 bits), Expect = 1.4e-105, P = 1.4e-105
Identities = 251/722 (34%), Positives = 371/722 (51%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLE-NPMLTRPGLDFN 59
+++LS LDL+ N G +P L L L L N+LSG IPP L L + N
Sbjct: 360 LKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDN 419
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
H + +P +C + + N+ G IP + C +L+++RL NNL G L
Sbjct: 420 HLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCK 479
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
N+T I+L +N F G I G C L L ++ N TG +PREIG SQL L++S N
Sbjct: 480 QVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSN 539
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPEXXXX 239
+ GE+P E+ L L + N F+G LP E+GSL LE L LS N + ++P
Sbjct: 540 KLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGN 599
Query: 240 XXXXXXXXXXXXQFXXXXXXXXXXXXXXS-ELDASHNLFGGEIPFQICSLKSLEKLNLSH 298
F L+ S+N GEIP ++ +L LE L L++
Sbjct: 600 LSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNN 659
Query: 299 NNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKGM-- 356
NNLSG IP+ F + + + S N L GP+P RN + + GN+GLCG
Sbjct: 660 NNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCI 716
Query: 357 --QPCKVFLSHKQNSRV---KWFAIVFPVLGALFLSMALIAIFILRKRKSDSGDRQSSNQ 411
QP S + + K AI V+G + L + + ++++R+ Q
Sbjct: 717 QTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQ 776
Query: 412 NPHGLFSILNFEGK--LVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFH 469
P + + F K + ++V AT++FD + +G G G+VY+A LP+G +A+KK
Sbjct: 777 -PSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLA 835
Query: 470 SPLPCDQIAD-QKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILS 528
S + F E+ L IRHRNIVK +GFC+H + L+YE + +GSL IL
Sbjct: 836 SNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILH 895
Query: 529 SDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588
+ L WS+R + G A L+YLHHDC P I H+DI S N+LLD ++EAHV DFG+
Sbjct: 896 DPSC--NLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGL 953
Query: 589 AKFLK-PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP------ 641
AK + P S + + AG+YGY+APE AYTMK+TEK D+YS+GV++LE + GK P
Sbjct: 954 AKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQ 1013
Query: 642 -RDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
D ++ + S + D +LD RL + +++++++A C + SP +RP+M+
Sbjct: 1014 GGDVVNWVRSY-IRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMR 1072
Query: 701 VV 702
V
Sbjct: 1073 QV 1074
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 636 (228.9 bits), Expect = 7.7e-105, Sum P(2) = 7.7e-105
Identities = 158/456 (34%), Positives = 246/456 (53%)
Query: 270 LDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPV 329
L+ S N G IP +I +L L L++SHN LSG + + G+ + ++IS N+ G +
Sbjct: 617 LNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDL-SALSGLENLVSLNISHNRFSGYL 675
Query: 330 PNSTAFRNAPVEALKGNKGLCGGVKGMQPCKVFLSHKQNSRVKWFAIVFPVLGALFLSM- 388
P+S FR ++GN GLC KG + C V S + ++ + + L +S+
Sbjct: 676 PDSKVFRQLIGAEMEGNNGLCS--KGFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLISVT 733
Query: 389 ALIAIF----ILRKRKSDSGDRQSSNQNPHGLFSILNFEGKLVY--DEIVRATNDFDAQY 442
A++A+ ++R ++ D S + F+ KL + + +++ + +
Sbjct: 734 AVLAVLGVLAVIRAKQMIRDDNDSETGENLWTWQFTPFQ-KLNFTVEHVLKCLVEGNV-- 790
Query: 443 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKE-------FLIEVKALTEIRH 495
IG G G VY+AE+P+ +V+A+KK P+ + ++ + F EVK L IRH
Sbjct: 791 -IGKGCSGIVYKAEMPNREVIAVKKLW-PVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRH 848
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
+NIV+F G C + L+Y+ + GSL ++L + LGW R +I G A L+YL
Sbjct: 849 KNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYL 908
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP----ESSNWTEFAGTYGYVAP 611
HHDC PPIVH+DI + N+L+ ++E ++ DFG+AK + SSN AG+YGY+AP
Sbjct: 909 HHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSN--TIAGSYGYIAP 966
Query: 612 ELAYTMKITEKCDVYSFGVLVLEAIKGKHP-----RDFLSLISSSSLNTDIALDEILDPR 666
E Y+MKITEK DVYS+GV+VLE + GK P D L ++ DI +++D
Sbjct: 967 EYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWVKKIRDI---QVIDQG 1023
Query: 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVV 702
L S E+++ + VA C+N PE RPTMK V
Sbjct: 1024 LQARPESEVEEMMQTLGVALLCINPIPEDRPTMKDV 1059
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1023 (365.2 bits), Expect = 2.9e-103, P = 2.9e-103
Identities = 239/661 (36%), Positives = 348/661 (52%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLE--NPMLTRPGLDF 58
+R+L+ LDL+ N G +PP NLT++++L L +N+LSG IP L +P+ +DF
Sbjct: 372 LRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWV---VDF 428
Query: 59 --NHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEA 116
N + +P +C+ L + N G IP + C SL+++R+ N LTG
Sbjct: 429 SENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTE 488
Query: 117 LGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDL 176
L NL+ I+L +N F G + G C KL L+++ N + +P EI S L ++
Sbjct: 489 LCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNV 548
Query: 177 SLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPEX 236
S N + G IP E+ L L L N F G LPPE+GSL LE L LS NRF+ ++P
Sbjct: 549 SSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFT 608
Query: 237 XXXXXXXXXXXXXXXQFXXXXXXXXXXXXXXS-ELDASHNLFGGEIPFQICSLKSLEKLN 295
F ++ S+N F GEIP +I +L L L+
Sbjct: 609 IGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLS 668
Query: 296 LSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGG-VK 354
L++N+LSG IP FE + + + S N L G +P++ F+N + + GNKGLCGG ++
Sbjct: 669 LNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLR 728
Query: 355 GMQPCKVFLSH----KQNS--RVKWFAIVFPVLGALFLSMALIAIFILRKRKSDSGDRQS 408
P H K S R + IV V+G + L + I + LR +
Sbjct: 729 SCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAP-YV 787
Query: 409 SNQNPHGLFSILNFEGK--LVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIK 466
++ P S + F K +I+ AT F Y +G G G+VY+A +PSG+ +A+K
Sbjct: 788 HDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVK 847
Query: 467 KFHSPLPCDQIADQK---EFLIEVKALTEIRHRNIVKFYGFCSH--ARHSFLVYELLERG 521
K S + F E+ L +IRHRNIV+ Y FC H + + L+YE + RG
Sbjct: 848 KLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRG 907
Query: 522 SLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEA 581
SL +L + + W R + G A+ L+YLHHDC P I+H+DI S N+L+D +EA
Sbjct: 908 SLGELLHGGKS-HSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEA 966
Query: 582 HVADFGIAKFLK-PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKH 640
HV DFG+AK + P S + + AG+YGY+APE AYTMK+TEKCD+YSFGV++LE + GK
Sbjct: 967 HVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKA 1026
Query: 641 P 641
P
Sbjct: 1027 P 1027
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 638 (229.6 bits), Expect = 7.2e-102, Sum P(2) = 7.2e-102
Identities = 163/467 (34%), Positives = 251/467 (53%)
Query: 270 LDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPV 329
L+ S N G+IP +I SL L L+LSHN L G + I + ++IS N G +
Sbjct: 616 LNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAP-LANIENLVSLNISYNSFSGYL 674
Query: 330 PNSTAFRNAPVEALKGNKGLCGGVKGMQPCKVFLSHKQN---------SRVKWFAIVFPV 380
P++ FR + L+GNK LC + C FL++++ SR + + +
Sbjct: 675 PDNKLFRQLSPQDLEGNKKLCSSTQ--DSC--FLTYRKGNGLGDDGDASRTRKLRLTLAL 730
Query: 381 LGALFLSMALI-AIFILRKRKSDSGDRQSSNQNPHGL----FSILNFEGKLVYDEIVRAT 435
L L + + ++ A+ ++R R++ +R S + F LNF D+I+R
Sbjct: 731 LITLTVVLMILGAVAVIRARRNIDNERDSELGETYKWQFTPFQKLNFS----VDQIIRCL 786
Query: 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQK------EFLIEVKA 489
+ + IG G G VYRA++ +G+V+A+KK P + D+K F EVK
Sbjct: 787 VEPNV---IGKGCSGVVYRADVDNGEVIAVKKLW-PAMVNGGHDEKTKNVRDSFSAEVKT 842
Query: 490 LTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA 549
L IRH+NIV+F G C + L+Y+ + GSL ++L + L W R ++ G A
Sbjct: 843 LGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH-ERRGSSLDWDLRYRILLGAA 901
Query: 550 DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP----ESSNWTEFAGT 605
L+YLHHDC PPIVH+DI + N+L+ L++E ++ADFG+AK + SN AG+
Sbjct: 902 QGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTV--AGS 959
Query: 606 YGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRD-----FLSLISSSSLNTDIALD 660
YGY+APE Y+MKITEK DVYS+GV+VLE + GK P D + L+ N +L
Sbjct: 960 YGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRG-SL- 1017
Query: 661 EILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707
E+LD L + + ++++ ++ A C+N SP+ RPTMK V ++
Sbjct: 1018 EVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLK 1064
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1001 (357.4 bits), Expect = 6.2e-101, P = 6.2e-101
Identities = 253/732 (34%), Positives = 375/732 (51%)
Query: 4 LSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPM-LTRPGLDFNHFT 62
L+ILDL NQ G +P S L L++L+L N+L G +P SL + LTR L N
Sbjct: 506 LNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLN 565
Query: 63 SYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPN 122
+ H +C + F V+ N F+ IP L N +L R+RL N LTG I LG
Sbjct: 566 GTI-HPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRE 624
Query: 123 LTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIV 182
L+ +D+S N G I C KL ++++ N ++G IP +G SQL L LS N V
Sbjct: 625 LSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFV 684
Query: 183 GEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPEXXXXXXX 242
+P EL L L L GN G +P EIG+L L L+L N+F+ S+P+
Sbjct: 685 ESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSK 744
Query: 243 XXXXXXXXXQFXXXX-XXXXXXXXXXSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNL 301
S LD S+N F G+IP I +L LE L+LSHN L
Sbjct: 745 LYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQL 804
Query: 302 SGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKGMQPCKV 361
+G +P ++ + +++S N L G + F P ++ GN GLCG
Sbjct: 805 TGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGNTGLCGSPLSRCNRVR 862
Query: 362 FLSHKQNSRVKWFAIVFPV--LGALFLSMALIAIFILRK----RKSDSGDR-----QSSN 410
+ +Q + I+ + L A+ L + +IA+F ++ +K G SS+
Sbjct: 863 SNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSS 922
Query: 411 QNPHG-LFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFH 469
Q H LF + + +++I+ AT++ ++ IG+GG G VY+AEL +G+ VA+KK
Sbjct: 923 QATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKI- 981
Query: 470 SPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH--SFLVYELLERGSLAAIL 527
L D + K F EVK L IRHR++VK G+CS + L+YE ++ GS+ L
Sbjct: 982 --LWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWL 1039
Query: 528 SSDTAAQE-----LGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAH 582
D E L W R+ + G+A + YLHHDC PPIVH+DI S N+LLD EAH
Sbjct: 1040 HEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAH 1099
Query: 583 VADFGIAKFL------KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAI 636
+ DFG+AK L +S+ W FA +YGY+APE AY++K TEK DVYS G++++E +
Sbjct: 1100 LGDFGLAKVLTENCDTNTDSNTW--FACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIV 1157
Query: 637 KGKHPRD--F---LSLISSSSLNTDIA---LDEILDPRLPPPSRSVQEKLISIMEVAFSC 688
GK P D F + ++ + ++A D+++DP+L P ++ ++E+A C
Sbjct: 1158 TGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQC 1217
Query: 689 LNESPESRPTMK 700
SP+ RP+ +
Sbjct: 1218 TKTSPQERPSSR 1229
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 987 (352.5 bits), Expect = 1.9e-99, P = 1.9e-99
Identities = 250/733 (34%), Positives = 375/733 (51%)
Query: 4 LSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNN-LSGFIPPSLEN-PMLTRPGLDFNHF 61
++++DL NQ G +P S LT L EL ++YNN L G +P SL N LTR N F
Sbjct: 507 MTVIDLADNQLSGSIPSSFGFLTAL-ELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKF 565
Query: 62 TSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYP 121
+ +C + F V+EN F+G IP L ++L R+RL N TG I G
Sbjct: 566 NGSISP-LCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKIS 624
Query: 122 NLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHI 181
L+ +D+SRN G I G C KL ++++ N ++G IP +G L L LS N
Sbjct: 625 ELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKF 684
Query: 182 VGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPEXXXXXX 241
VG +P E+ L ++ L L GN G +P EIG+L L L+L N+ + +P
Sbjct: 685 VGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLS 744
Query: 242 XXXXXXXXXXQFXXXX-XXXXXXXXXXSELDASHNLFGGEIPFQICSLKSLEKLNLSHNN 300
S LD S+N F G IP I +L LE L+LSHN
Sbjct: 745 KLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQ 804
Query: 301 LSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKGMQPCK 360
L G +P ++ + +++S N L+G + F +A GN GLCG + C
Sbjct: 805 LVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNAGLCGSP--LSHCN 860
Query: 361 VFLSHKQNS-RVKWFAIVFPV--LGALFLSMALIAIF------ILRK-RKSDSGDRQSSN 410
S Q S K I+ + L A+ L + +I +F + +K R +S +S+
Sbjct: 861 RAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSS 920
Query: 411 QNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHS 470
+ LFS + + +D+I+ AT+ + ++ IG+GG G VY+AEL +G+ +A+KK
Sbjct: 921 SSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKI-- 978
Query: 471 PLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH--SFLVYELLERGSLAAIL- 527
L D + K F EVK L IRHR++VK G+CS + L+YE + GS+ L
Sbjct: 979 -LWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLH 1037
Query: 528 -SSDTAAQE-LGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVAD 585
+ +T +E LGW R+ + G+A + YLH+DC PPIVH+DI S N+LLD EAH+ D
Sbjct: 1038 ANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGD 1097
Query: 586 FGIAKFLKPESSNWTE----FAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
FG+AK L TE FAG+YGY+APE AY++K TEK DVYS G++++E + GK P
Sbjct: 1098 FGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMP 1157
Query: 642 RDFL-----SLIS--SSSLNT---DIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNE 691
+ + ++ + L+T A ++++D L +E ++E+A C
Sbjct: 1158 TEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKS 1217
Query: 692 SPESRPTMKVVTQ 704
P+ RP+ + ++
Sbjct: 1218 YPQERPSSRQASE 1230
|
|
| TAIR|locus:2032697 PEPR1 "PEP1 receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 911 (325.7 bits), Expect = 5.4e-94, Sum P(2) = 5.4e-94
Identities = 226/729 (31%), Positives = 368/729 (50%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLE-NPMLTRPGLDFNH 60
+SL+ L + QN G LP ++ + LK L N+ G IPP L N L N
Sbjct: 387 QSLTQLLVYQNNLTGELPVEMTEMKKLKIATLFNNSFYGAIPPGLGVNSSLEEVDFIGNK 446
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
T +P N+C G L+ + N GTIP + +C ++ R L NNL+G + E +
Sbjct: 447 LTGEIPPNLCHGRKLRILNLGSNLLHGTIPASIGHCKTIRRFILRENNLSGLLPEFSQDH 506
Query: 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNH 180
+L+F+D + N+F G I + G C L ++N+S N TG IP ++GN L ++LS N
Sbjct: 507 -SLSFLDFNSNNFEGPIPGSLGSCKNLSSINLSRNRFTGQIPPQLGNLQNLGYMNLSRNL 565
Query: 181 IVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPEXXXXX 240
+ G +P +L SL + N G +P + L L LS NRF+ +P+
Sbjct: 566 LEGSLPAQLSNCVSLERFDVGFNSLNGSVPSNFSNWKGLTTLVLSENRFSGGIPQFLPEL 625
Query: 241 XXXXXXXXXXXQFXXXX-XXXXXXXXXXSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
F +LD S N GEIP ++ L L +LN+S+N
Sbjct: 626 KKLSTLQIARNAFGGEIPSSIGLIEDLIYDLDLSGNGLTGEIPAKLGDLIKLTRLNISNN 685
Query: 300 NLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFR--NAPVEALKGNKGLC------- 350
NL+GS+ + +G+ + +D+S+NQ GP+P++ + + P + GN LC
Sbjct: 686 NLTGSL-SVLKGLTSLLHVDVSNNQFTGPIPDNLEGQLLSEP-SSFSGNPNLCIPHSFSA 743
Query: 351 --GGVKGMQPCKVFLSHKQNSRVKWFAIVFPVLGALFLSMALIA-IFILRKRKSDSGDRQ 407
++ CK +++ W ++ VL +L + + ++A +FI +R+ ++
Sbjct: 744 SNNSRSALKYCKDQSKSRKSGLSTWQIVLIAVLSSLLVLVVVLALVFICLRRRKGRPEKD 803
Query: 408 SSNQNPHGLFSILNFEG-KLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIK 466
+ + EG L+ ++++ AT++ + +Y IG G HG VYRA L SG+V A+K
Sbjct: 804 A--------YVFTQEEGPSLLLNKVLAATDNLNEKYTIGRGAHGIVYRASLGSGKVYAVK 855
Query: 467 KFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAI 526
+ + I + + E+ + ++RHRN++K GF ++Y + +GSL +
Sbjct: 856 RL---VFASHIRANQSMMREIDTIGKVRHRNLIKLEGFWLRKDDGLMLYRYMPKGSLYDV 912
Query: 527 LSSDTAAQE-LGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVAD 585
L + + L WS R NV GVA L+YLH+DC PPIVH+DI +N+L+D + E H+ D
Sbjct: 913 LHGVSPKENVLDWSARYNVALGVAHGLAYLHYDCHPPIVHRDIKPENILMDSDLEPHIGD 972
Query: 586 FGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKH----- 640
FG+A+ L + + GT GY+APE A+ + DVYS+GV++LE + K
Sbjct: 973 FGLARLLDDSTVSTATVTGTTGYIAPENAFKTVRGRESDVYSYGVVLLELVTRKRAVDKS 1032
Query: 641 -PR--DFLSLI----SSSSLNTDIALDEILDPRLPPP--SRSVQEKLISIMEVAFSCLNE 691
P D +S + SSS+ N + + I+DP L S++E+++ + E+A SC +
Sbjct: 1033 FPESTDIVSWVRSALSSSNNNVEDMVTTIVDPILVDELLDSSLREQVMQVTELALSCTQQ 1092
Query: 692 SPESRPTMK 700
P RPTM+
Sbjct: 1093 DPAMRPTMR 1101
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| scaffold_104022.1 | annotation not avaliable (782 aa) | ||||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 708 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-90 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-45 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-44 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-44 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-43 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-43 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-41 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-36 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-28 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-16 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-09 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 6e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 9e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| COG5238 | 388 | COG5238, RNA1, Ran GTPase-activating protein (RanG | 0.001 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.002 | |
| COG4248 | 637 | COG4248, COG4248, Uncharacterized protein with pro | 0.002 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.002 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 303 bits (777), Expect = 1e-90
Identities = 227/724 (31%), Positives = 358/724 (49%), Gaps = 56/724 (7%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPP---SLENPMLTRPGLD 57
+++L L L QN+ G +PPS+ +L L L L N+LSG IP L+N L L
Sbjct: 259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQN--LEILHLF 316
Query: 58 FNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEAL 117
N+FT +P + LQ + N F G IPK L ++L + L++NNLTG I E L
Sbjct: 317 SNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL 376
Query: 118 GIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLS 177
NL + L N GEI + G C L + + N+ +G +P E + LD+S
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436
Query: 178 LNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENL 237
N++ G I + SL L L N+F G LP GS LE LDLS N+F+ +VP L
Sbjct: 437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKL 495
Query: 238 GNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLS 297
G+L +L L LS N+ E+P EL +L LD SHN G+IP + L +L+LS
Sbjct: 496 GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS 555
Query: 298 HNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVK--G 355
N LSG IP + + ++IS N L G +P++ AF A+ GN LCGG G
Sbjct: 556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG 615
Query: 356 MQPCKVFLSHKQNSRVKWFAIVFPVLGALFLSMALIAI-FILRKRKSDSGDRQSSNQNPH 414
+ PCK + + WF + LGA FL +AL+A F+ + +++ ++ N++
Sbjct: 616 LPPCKRV----RKTPSWWF-YITCTLGA-FLVLALVAFGFVFIRGRNNLELKRVENED-- 667
Query: 415 GLFSILNFEGK----LVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQ----VVAIK 466
G + + F+ K + ++I+ + + + I G G+ Y+ + V I
Sbjct: 668 GTWELQFFDSKVSKSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEIN 724
Query: 467 KFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAI 526
+S +P +IAD + +++H NIVK G C + ++L++E +E +L+ +
Sbjct: 725 DVNS-IPSSEIAD----------MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEV 773
Query: 527 LSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADF 586
L + L W +R + G+A AL +LH C P +V ++S + +++D + E H+
Sbjct: 774 LRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-L 826
Query: 587 GIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLS 646
+ L ++ + A YVAPE T ITEK D+Y FG++++E + GK P D
Sbjct: 827 SLPGLLCTDTKCFISSA----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882
Query: 647 LISSSSLN------TDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
+ S + +D LD +DP + Q +++ +M +A C P +RP
Sbjct: 883 GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAN 942
Query: 701 VVTQ 704
V +
Sbjct: 943 DVLK 946
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 5e-45
Identities = 82/264 (31%), Positives = 124/264 (46%), Gaps = 23/264 (8%)
Query: 443 CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKF 501
+G+G G+VY+A +G++VA+K ++ + E++ L + H NIV+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 502 YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFP 561
H +LV E E G L LS L + + + L YLH +
Sbjct: 64 IDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHSN--- 117
Query: 562 PIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE-LAYTMKIT 620
I+H+D+ +N+LLD +ADFG+AK L SS+ T F GT Y+APE L
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 621 EKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIAL-DEILDPRLP---PPSRSVQE 676
K DV+S GV++ E + GK P F S ++ + L IL P L P S E
Sbjct: 178 PKVDVWSLGVILYELLTGKPP--F----SGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231
Query: 677 KLISIMEVAFSCLNESPESRPTMK 700
+ +++ CLN+ P RPT +
Sbjct: 232 EAKDLIK---KCLNKDPSKRPTAE 252
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 5e-44
Identities = 108/354 (30%), Positives = 168/354 (47%), Gaps = 26/354 (7%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLL------------------------YNNL 38
SL +LDL N G +P S++NLT+L+ L L YNNL
Sbjct: 165 SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224
Query: 39 SGFIPPSL-ENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCS 97
SG IP + L L +N+ T +P ++ LQY + +N G IP + +
Sbjct: 225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQ 284
Query: 98 SLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNI 157
LI + L+ N+L+G I E + NL + L N+F G+I P+L L + N
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 158 TGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLV 217
+G IP+ +G + L LDLS N++ GEIP+ L +L +LIL N G +P +G+
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACR 404
Query: 218 DLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLF 277
L + L N F+ +P L +++L +SNN + + L L + N F
Sbjct: 405 SLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKF 464
Query: 278 GGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPN 331
G +P K LE L+LS N SG++P + + + +S+N+L G +P+
Sbjct: 465 FGGLP-DSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPD 517
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 5e-44
Identities = 97/264 (36%), Positives = 140/264 (53%), Gaps = 3/264 (1%)
Query: 75 LQYFGVSENHFQGTIPK-ILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDF 133
+Q +S N G IP I SSL + L++NN TG+I G PNL +DLS N
Sbjct: 95 IQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNML 152
Query: 134 YGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLN 193
GEI ++ G L L++ N + G IP + N + L+ L L+ N +VG+IP+ELG++
Sbjct: 153 SGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMK 212
Query: 194 SLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQF 253
SL + L N +G +P EIG L L +LDL N +P +LGNL L YL L N+
Sbjct: 213 SLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKL 272
Query: 254 VLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIR 313
+P + L +L LD S N GEIP + L++LE L+L NN +G IP +
Sbjct: 273 SGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLP 332
Query: 314 GISVIDISDNQLQGPVPNSTAFRN 337
+ V+ + N+ G +P + N
Sbjct: 333 RLQVLQLWSNKFSGEIPKNLGKHN 356
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-43
Identities = 100/312 (32%), Positives = 164/312 (52%), Gaps = 4/312 (1%)
Query: 23 SNLTNLKELVLLYNNLSGFIPPSL-ENPMLTRPGLDFNHFTSYLPHNV-CRGGALQYFGV 80
+N + + + L N+SG I ++ P + L N + +P ++ +L+Y +
Sbjct: 66 NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125
Query: 81 SENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSN 140
S N+F G+IP+ + +L + L++N L+G I +G + +L +DL N G+I ++
Sbjct: 126 SNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183
Query: 141 WGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELIL 200
L L ++ N + G IPRE+G L+ + L N++ GEIP E+G L SL L L
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDL 243
Query: 201 RGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKE 260
N TG +P +G+L +L+YL L N+ + +P ++ +L KL L LS+N E+P+
Sbjct: 244 VYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPEL 303
Query: 261 LEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDI 320
+ +L L L N F G+IP + SL L+ L L N SG IP ++V+D+
Sbjct: 304 VIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDL 363
Query: 321 SDNQLQGPVPNS 332
S N L G +P
Sbjct: 364 STNNLTGEIPEG 375
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 3e-43
Identities = 75/260 (28%), Positives = 117/260 (45%), Gaps = 23/260 (8%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G G G VY A + +G++VAIK D++ L E+K L +++H NIV+ Y
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKK---KIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
+LV E E G L +L E + ++ + AL YLH
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE---DEARFYLRQILSALEYLHSKG--- 117
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEK 622
IVH+D+ +N+LLD + +ADFG+A+ L P T F GT Y+APE+ +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDP-GEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 623 CDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS--VQEKLIS 680
D++S GV++ E + GK P F +I P+ P P + +
Sbjct: 177 VDIWSLGVILYELLTGKPP--F-----PGDDQLLELFKKIGKPKPPFPPPEWDISPEAKD 229
Query: 681 IMEVAFSCLNESPESRPTMK 700
++ L + PE R T +
Sbjct: 230 LIR---KLLVKDPEKRLTAE 246
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 7e-43
Identities = 66/194 (34%), Positives = 103/194 (53%), Gaps = 11/194 (5%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G GG G+VY A +G+ VAIK D + +E L E++ L ++ H NIVK Y
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE---DSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
G H +LV E E GSL +L + +L + + ++ + + L YLH +
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---G 112
Query: 563 IVHQDISSKNLLLD-LEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE-LAYTMKIT 620
I+H+D+ +N+LLD + +ADFG++K L + S GT Y+APE L +
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 621 EKCDVYSFGVLVLE 634
EK D++S GV++ E
Sbjct: 173 EKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 5e-41
Identities = 111/324 (34%), Positives = 164/324 (50%), Gaps = 23/324 (7%)
Query: 4 LSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTS 63
L LDL+ N G +P + + ++LK L L N L G IP SL N LT
Sbjct: 142 LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTN--LTS---------- 189
Query: 64 YLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNL 123
L++ ++ N G IP+ L SL + L NNL+G I +G +L
Sbjct: 190 -----------LEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSL 238
Query: 124 TFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVG 183
+DL N+ G I S+ G L L + N ++G IP I + +L +LDLS N + G
Sbjct: 239 NHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSG 298
Query: 184 EIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKL 243
EIP+ + +L +L L L N FTG++P + SL L+ L L +N+F+ +P+NLG L
Sbjct: 299 EIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNL 358
Query: 244 HYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSG 303
L LS N E+P+ L L +L N GEIP + + +SL ++ L N+ SG
Sbjct: 359 TVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSG 418
Query: 304 SIPNCFEGIRGISVIDISDNQLQG 327
+P+ F + + +DIS+N LQG
Sbjct: 419 ELPSEFTKLPLVYFLDISNNNLQG 442
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 9e-41
Identities = 113/328 (34%), Positives = 161/328 (49%), Gaps = 2/328 (0%)
Query: 4 LSILDLNQNQFKGVLPPSVSNLT-NLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFT 62
+ ++L+ NQ G +P + + +L+ L L NN +G IP P L L N +
Sbjct: 95 IQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP-RGSIPNLETLDLSNNMLS 153
Query: 63 SYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPN 122
+P+++ +L+ + N G IP L N +SL + L SN L G I LG +
Sbjct: 154 GEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKS 213
Query: 123 LTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIV 182
L +I L N+ GEI G L L++ NN+TG IP +GN LQ L L N +
Sbjct: 214 LKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLS 273
Query: 183 GEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLK 242
G IP + L L L L N +G +P + L +LE L L +N F +P L +L +
Sbjct: 274 GPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR 333
Query: 243 LHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS 302
L L L +N+F E+PK L K L+ LD S N GEIP +CS +L KL L N+L
Sbjct: 334 LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLE 393
Query: 303 GSIPNCFEGIRGISVIDISDNQLQGPVP 330
G IP R + + + DN G +P
Sbjct: 394 GEIPKSLGACRSLRRVRLQDNSFSGELP 421
|
Length = 968 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 5e-39
Identities = 70/284 (24%), Positives = 106/284 (37%), Gaps = 55/284 (19%)
Query: 444 IGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI 498
+G G G VY+ L VA+K +EFL E + + ++ H NI
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK---EDASEQQIEEFLREARIMRKLDHPNI 63
Query: 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
VK G C+ +V E + G L L +EL S ++ +A + YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN----------WTEFAGTYGY 608
+H+D++++N L+ ++DFG+++ L + W
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-------- 171
Query: 609 VAPELAYTMKITEKCDVYSFGVLVLEAI-------KGKHPRDFLSLISSSSLNTDIALDE 661
APE K T K DV+SFGVL+ E G + L +
Sbjct: 172 -APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGY--------- 221
Query: 662 ILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
RLP P E L +M C E PE RPT + +
Sbjct: 222 ----RLPKPPNCPPE-LYKLML---QCWAEDPEDRPTFSELVEI 257
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 69/284 (24%), Positives = 110/284 (38%), Gaps = 56/284 (19%)
Query: 444 IGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI 498
+G G G VY+ +L VA+K +EFL E + + ++ H N+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK---EDASEQQIEEFLREARIMRKLDHPNV 63
Query: 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
VK G C+ ++V E +E G L + L +L S ++ +A + YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN----------WTEFAGTYGY 608
+H+D++++N L+ ++DFG+++ L + W
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-------- 170
Query: 609 VAPELAYTMKITEKCDVYSFGVLVLEAI-------KGKHPRDFLSLISSSSLNTDIALDE 661
APE K T K DV+SFGVL+ E G + L + +
Sbjct: 171 -APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGY--------- 220
Query: 662 ILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
RLP P E L +M C E PE RPT + +
Sbjct: 221 ----RLPQPPNCPPE-LYDLML---QCWAEDPEDRPTFSELVEI 256
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 5e-37
Identities = 78/278 (28%), Positives = 121/278 (43%), Gaps = 50/278 (17%)
Query: 437 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
F+ IG GG G VY+A +G+ VAIK + + +++ + E++ L + +H
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKV----IKLESKEKKEKIINEIQILKKCKH 56
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMN------VIKGVA 549
NIVK+YG ++V E GSL +L S +Q + V K +
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKS--------TNQTLTESQIAYVCKELL 108
Query: 550 DALSYLH--HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG 607
L YLH I+H+DI + N+LL + E + DFG++ L + GT
Sbjct: 109 KGLEYLHSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR-NTMVGTPY 162
Query: 608 YVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667
++APE+ K D++S G+ +E +GK P S L AL +I
Sbjct: 163 WMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY--------SELPPMKALFKI--ATN 212
Query: 668 PPPSRSVQEKLISIME-----VAF--SCLNESPESRPT 698
PP L + + F CL ++PE RPT
Sbjct: 213 GPP------GLRNPEKWSDEFKDFLKKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 66/281 (23%), Positives = 109/281 (38%), Gaps = 59/281 (20%)
Query: 444 IGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI 498
+G G G VY+ L + VA+K +++EFL E + ++ H NI
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLK---EGASEEEREEFLEEASIMKKLSHPNI 63
Query: 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH-H 557
V+ G C+ ++V E + G L L ++L + + +A + YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG--EKLTLKDLLQMALQIAKGMEYLESK 121
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS-----------NWTEFAGTY 606
+ VH+D++++N L+ ++DFG+++ + + W
Sbjct: 122 NF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM------ 171
Query: 607 GYVAPELAYTMKITEKCDVYSFGVLVLEAI-------KGKHPRDFLSLISSSSLNTDIAL 659
APE K T K DV+SFGVL+ E G + L L+
Sbjct: 172 ---APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED--------- 219
Query: 660 DEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
RLP P + ++L +M C PE RPT
Sbjct: 220 ----GYRLPRP-ENCPDELYELML---QCWAYDPEDRPTFS 252
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 69/285 (24%), Positives = 118/285 (41%), Gaps = 50/285 (17%)
Query: 444 IGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
+G G G VY+ +L VA+K + ++K+FL E + + ++ H N+V
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVK---TLKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 500 KFYGFCSHARHSFLVYELLERGSL------AAILSSDTAAQELGWSQRMNVIKGVADALS 553
+ G C+ +LV E +E G L + + L ++ +A +
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN-----------WTEF 602
YL VH+D++++N L+ + ++DFG+++ + + W
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-- 174
Query: 603 AGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDE 661
APE T K DV+SFGVL+ E G P LS N ++ L+
Sbjct: 175 -------APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-------NEEV-LEY 219
Query: 662 ILDP-RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
+ RLP P ++L +M SC PE RPT + ++
Sbjct: 220 LRKGYRLPKPE-YCPDELYELML---SCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 70/272 (25%), Positives = 121/272 (44%), Gaps = 44/272 (16%)
Query: 443 CIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKF 501
+G G GSVY A +G+++A+K L D + + E++ L+ ++H NIV++
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKS--VELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 502 YGFC-SHARHSFLVY-ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA----DALSYL 555
YG +++ ++ E + GSL+++L E VI+ + L+YL
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-------PVIRKYTRQILEGLAYL 117
Query: 556 H-HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEF----AGTYGYVA 610
H + IVH+DI N+L+D + +ADFG AK L E GT ++A
Sbjct: 118 HSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRL--GDIETGEGTGSVRGTPYWMA 171
Query: 611 PELAYTMKITEKCDVYSFGVLVLEAIKGKHP----RDFLSLISSSSLNTDIALDEILDPR 666
PE+ + D++S G V+E GK P + ++ + + + P
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP-------PE 224
Query: 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
+P + E+ + CL P+ RPT
Sbjct: 225 IPE---HLSEEAKDFLR---KCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 74/268 (27%), Positives = 119/268 (44%), Gaps = 24/268 (8%)
Query: 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
+D + +G G G VY+ P+G++ A+KK H +K+ L E+K L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVD---GDEEFRKQLLRELKTLRSCE 57
Query: 495 HRNIVKFYG-FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRM--NVIKGVADA 551
+VK YG F S +V E ++ GSLA +L + + + + + +
Sbjct: 58 SPYVVKCYGAFYKEGEIS-IVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKG 111
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAP 611
L YLH I+H+DI NLL++ + E +ADFGI+K L+ F GT Y++P
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSP 169
Query: 612 ELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD-PRLPPP 670
E + D++S G+ +LE GK P S L + I D P P
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL-----MQAICDGPPPSLP 224
Query: 671 SRSVQEKLISIMEVAFSCLNESPESRPT 698
+ + + +CL + P+ RP+
Sbjct: 225 AEEFSPEFRDFIS---ACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 77/270 (28%), Positives = 118/270 (43%), Gaps = 48/270 (17%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI--EVKALTEIRHRNIVK 500
IG G G VY+A + +G+ VAIKK + Q + LI E+ + + +H NIV
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMR-------LRKQNKELIINEILIMKDCKHPNIVD 79
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMN------VIKGVADALSY 554
+Y ++V E ++ GSL I++ RMN V + V L Y
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDIIT--------QNFVRMNEPQIAYVCREVLQGLEY 131
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
LH ++H+DI S N+LL + +ADFG A L E S GT ++APE+
Sbjct: 132 LHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI 188
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGKHPR-DF-----LSLISSSSLNTDIALDEILDPRLP 668
K D++S G++ +E +G+ P L LI++ + P L
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-----------PPLK 237
Query: 669 PPSRSVQEKLISIMEVAFSCLNESPESRPT 698
P + E + CL + PE RP+
Sbjct: 238 NPEKWSPE-FKDFLN---KCLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 78/274 (28%), Positives = 132/274 (48%), Gaps = 40/274 (14%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
+G+G G V+ + VAIK S D + Q++F EV+AL +RH++++ +
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKS----DDLLKQQDFQKEVQALKRLRHKHLISLFA 69
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563
CS +++ EL+E+GSL A L S Q L + +++ VA+ ++YL
Sbjct: 70 VCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ---NS 125
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAKFLK-----PESSN----WTEFAGTYGYVAPELA 614
+H+D++++N+L+ + VADFG+A+ +K WT APE A
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT---------APEAA 176
Query: 615 YTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDP-RLPPPSR 672
+ K DV+SFG+L+ E G+ P +N D+I R+P P++
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYP--------GMNNHEVYDQITAGYRMPCPAK 228
Query: 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
QE + IM C PE RP+ K + +++
Sbjct: 229 CPQE-IYKIM---LECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 74/269 (27%), Positives = 121/269 (44%), Gaps = 18/269 (6%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH-RNIVKFY 502
+G G G VY A ++VA+K L + + + FL E++ L + H NIVK Y
Sbjct: 8 LGEGSFGEVYLARDR--KLVALKVLAKKLE-SKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
F +LV E ++ GSL +L L S+ + ++ + AL YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121
Query: 563 IVHQDISSKNLLLDLEY-EAHVADFGIAKFLKPESSN------WTEFAGTYGYVAPELAY 615
I+H+DI +N+LLD + + DFG+AK L S + GT GY+APE+
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 616 TM---KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672
+ + D++S G+ + E + G P + S++S I L+ P S
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241
Query: 673 SVQEKLIS-IMEVAFSCLNESPESRPTMK 700
S E + ++ L + P++R +
Sbjct: 242 SNPELISKAASDLLKKLLAKDPKNRLSSS 270
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 71/260 (27%), Positives = 111/260 (42%), Gaps = 22/260 (8%)
Query: 443 CIGNGGHGSVYRAE-LPSGQVVAIKKFH-SPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
IG G G VY+ L +G VAIK+ + + + + E+ L ++H NIVK
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQ---EIDLLKNLKHPNIVK 63
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
+ G + +++ E E GSL I+ E S + V L+YLH
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE---SLVAVYVYQVLQGLAYLHEQ-- 118
Query: 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKIT 620
++H+DI + N+L + +ADFG+A L S + GT ++APE+ +
Sbjct: 119 -GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 621 EKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLIS 680
D++S G V+E + G P LN AL I+ PP + +L
Sbjct: 178 TASDIWSLGCTVIELLTGNPP--------YYDLNPMAALFRIVQDDHPPLPEGISPELKD 229
Query: 681 IMEVAFSCLNESPESRPTMK 700
+ C + P RPT K
Sbjct: 230 FL---MQCFQKDPNLRPTAK 246
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 78/267 (29%), Positives = 125/267 (46%), Gaps = 43/267 (16%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIAD-QKEFLIEVKALTEIRH---RNI 498
IG G +G+VYR +P+G+VVA+K + P D ++D Q+E V L+++R NI
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQRE----VALLSQLRQSQPPNI 64
Query: 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
K+YG +++ E E GS+ ++ A + +I+ V AL Y+H
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMK----AGPIAEKYISVIIREVLVALKYIHKV 120
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMK 618
++H+DI + N+L+ + DFG+A L SS + F GT ++APE+
Sbjct: 121 ---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEV----- 172
Query: 619 ITE------KCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD---PRLPP 669
ITE K D++S G+ + E G P S ++ A+ I PRL
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPPY--------SDVDAFRAMMLIPKSKPPRLED 224
Query: 670 PSRSVQEKLISIMEVAFSCLNESPESR 696
S + E +CL+E P+ R
Sbjct: 225 NGYSK-----LLREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 73/268 (27%), Positives = 130/268 (48%), Gaps = 29/268 (10%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
+G+G G V+ + VAIK + + +F+ E K + ++ H N+V+ YG
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-----EGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563
C+ R F+V E + G L L +LG +++ V +A+ YL + F
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLR--ERKGKLGTEWLLDMCSDVCEAMEYLESNGF--- 121
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAKFLKPE---SSNWTEFAGTYGYVAPELAYTMKIT 620
+H+D++++N L+ + V+DFG+A+++ + SS T+F + PE+ + +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYSRFS 179
Query: 621 EKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILD-PRLPPPSRSVQEKL 678
K DV+SFGVL+ E +GK P + S+S + ++ L P+L P
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERF---SNSEVVESVSAGYRLYRPKLAPT-------- 228
Query: 679 ISIMEVAFSCLNESPESRPTMKVVTQQV 706
+ + +SC +E PE RP K + Q+
Sbjct: 229 -EVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 67/210 (31%), Positives = 112/210 (53%), Gaps = 18/210 (8%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI-----EVKALTEIRHRN 497
IG+G GSVY SG+++A+K+ P D+K ++ E+ L E++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH 557
IV++ G A H + E + GS+AA+L++ A +E + N ++ + L+YLH+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE---TLVRNFVRQILKGLNYLHN 124
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWT------EFAGTYGYVAP 611
I+H+DI N+L+D + ++DFGI+K L+ S + G+ ++AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 612 ELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
E+ T K D++S G LV+E + GKHP
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 69/214 (32%), Positives = 99/214 (46%), Gaps = 32/214 (14%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIK--KFHSPLPC--DQIADQKEFLIEVKALTEIRHRNI 498
IG G G VY A L +G+++A+K + P +IAD E+K L ++H N+
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIAD------EMKVLELLKHPNL 61
Query: 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA----DALSY 554
VK+YG H ++ E G+L +L E G +VI+ + L+Y
Sbjct: 62 VKYYGVEVHREKVYIFMEYCSGGTLEELL-------EHGRILDEHVIRVYTLQLLEGLAY 114
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTE----FAGTYGYVA 610
LH IVH+DI N+ LD + DFG A LK ++ E AGT Y+A
Sbjct: 115 LHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA 171
Query: 611 PELAYTMKITEK---CDVYSFGVLVLEAIKGKHP 641
PE+ K D++S G +VLE GK P
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 68/271 (25%), Positives = 112/271 (41%), Gaps = 28/271 (10%)
Query: 437 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
++ IG G G VY G++ +K+ L ++++ L EVK L ++ H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKE--IDLSNMSEKEREDALNEVKILKKLNH 58
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQE-LGWSQRMNVIKGVADALSY 554
NI+K+Y +V E + G L+ + + Q ++ + AL Y
Sbjct: 59 PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 555 LH--HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE 612
LH I+H+DI +N+ L + DFGI+K L GT Y++PE
Sbjct: 119 LHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE 173
Query: 613 LAYTMKITEKCDVYSFGVLVLEAIKGKHP---RDFLSLISSSSLNTDIALDEILDPRLPP 669
L K D++S G ++ E KHP + L L +IL + PP
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA-----------LKILKGQYPP 222
Query: 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
+L +++ S L + PE RP++
Sbjct: 223 IPSQYSSELRNLVS---SLLQKDPEERPSIA 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 71/266 (26%), Positives = 118/266 (44%), Gaps = 26/266 (9%)
Query: 437 DFDAQYCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
DF+ IG G G V++ + +V A+K+ L +++E + E + L ++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQID--LSKMNRREREEAIDEARVLAKLDS 58
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTA---AQELGWSQRMNVIKGVADAL 552
I+++Y +V E E G L +L ++ W + ++ G L
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114
Query: 553 SYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE 612
++LH I+H+DI S NL LD + D G+AK L ++ GT Y++PE
Sbjct: 115 AHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE 171
Query: 613 LAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIAL-DEILDPRLPPPS 671
L EK DV++ GV++ E GKHP D N AL +I+ PP S
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD---------ANNQGALILKIIRGVFPPVS 222
Query: 672 RSVQEKLISIMEVAFSCLNESPESRP 697
+ ++L +++ CL + RP
Sbjct: 223 QMYSQQLAQLID---QCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 81/268 (30%), Positives = 128/268 (47%), Gaps = 29/268 (10%)
Query: 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
FD +G G +GSVY+A +GQVVAIK +P + D +E + E+ L +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKV----VPVE--EDLQEIIKEISILKQCD 56
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSLAAI--LSSDTAAQELGWSQRMNVIKGVADAL 552
IVK+YG ++V E GS++ I +++ T +E + ++ L
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEE----EIAAILYQTLKGL 112
Query: 553 SYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE 612
YLH +H+DI + N+LL+ E +A +ADFG++ L + GT ++APE
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPE 169
Query: 613 LAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672
+ + K D++S G+ +E +GK P S ++ A+ I P PPP+
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGKPPY--------SDIHPMRAIFMI--PNKPPPTL 219
Query: 673 SVQEKLISIMEVAF--SCLNESPESRPT 698
S EK S F CL + PE RP+
Sbjct: 220 SDPEKW-SPEFNDFVKKCLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 78/285 (27%), Positives = 121/285 (42%), Gaps = 51/285 (17%)
Query: 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
+ IG G G V + GQ VA+K L D A Q FL E +T +RH
Sbjct: 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKC----LKDDSTAAQA-FLAEASVMTTLRH 59
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
N+V+ G ++V E + +GSL L S A + +Q++ V + + YL
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYL 118
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK--FLKPESS----NWTEFAGTYGYV 609
F VH+D++++N+L+ + A V+DFG+AK +S WT
Sbjct: 119 EEKNF---VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--------- 166
Query: 610 APELAYTMKITEKCDVYSFGVLVLEAI---KGKHPRDFLSLISSSSLNTDIALDEILDP- 665
APE K + K DV+SFG+L+ E + +PR I L +++
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR--------------IPLKDVVPHV 212
Query: 666 ----RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
R+ P E + +V C P RPT K + +Q+
Sbjct: 213 EKGYRMEAPEGCPPE----VYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 4e-23
Identities = 63/231 (27%), Positives = 115/231 (49%), Gaps = 22/231 (9%)
Query: 480 QKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWS 539
+ EF+ E K + ++ H +V+ YG C+ R ++V E + G L L + S
Sbjct: 43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLRE--HGKRFQPS 100
Query: 540 QRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE---S 596
Q + + K V + ++YL F +H+D++++N L+D + V+DFG+++++ + S
Sbjct: 101 QLLEMCKDVCEGMAYLESKQF---IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157
Query: 597 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNT 655
S ++F + PE+ K + K DV++FGVL+ E GK P + + N+
Sbjct: 158 SVGSKFPVRWS--PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-------NS 208
Query: 656 DIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
+ RL P + EK+ +IM +SC +E E RPT + + +
Sbjct: 209 ETVEKVSQGLRLYRPHLA-SEKVYAIM---YSCWHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 75/266 (28%), Positives = 125/266 (46%), Gaps = 30/266 (11%)
Query: 444 IGNGGHGSVYRA--ELPSGQV--VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
IG G G V R +LP + VAIK + Q D FL E + + H NI+
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD---FLTEASIMGQFDHPNII 68
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
+ G + +R ++ E +E GSL L + + Q + +++G+A + YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG--YVAPE-LAYT 616
+ VH+D++++N+L++ V+DFG+++ L+ + +T G + APE +AY
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183
Query: 617 MKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP-RLPPPSRSV 674
K T DV+SFG+++ E + G+ P +S N D+ + + D RLPPP
Sbjct: 184 -KFTSASDVWSFGIVMWEVMSYGERPYWDMS-------NQDV-IKAVEDGYRLPPP-MDC 233
Query: 675 QEKLISIMEVAFSCLNESPESRPTMK 700
L +M C + RPT
Sbjct: 234 PSALYQLM---LDCWQKDRNERPTFS 256
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 66/270 (24%), Positives = 128/270 (47%), Gaps = 33/270 (12%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
+G+G G V+ + + VAIK + ++ +F+ E K + ++ H +V+ YG
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-----DFIEEAKVMMKLSHPKLVQLYG 66
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563
C+ + ++V E +E G L L +L +++ + V + + YL + F
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNSF--- 121
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAKFLKPE---SSNWTEFAGTYGYVAPELAYTMKIT 620
+H+D++++N L+ V+DFG+ +++ + SS+ +F + PE+ K +
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFP--VKWSPPEVFNFSKYS 179
Query: 621 EKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIAL---DEILDPRLPPPSRSVQE 676
K DV+SFGVL+ E +GK P + S+ + + P+L
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFE-----KKSNYEVVEMISRGFRLYRPKLAS------- 227
Query: 677 KLISIMEVAFSCLNESPESRPTMKVVTQQV 706
+++ EV +SC +E PE RPT + + +
Sbjct: 228 --MTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 84/276 (30%), Positives = 125/276 (45%), Gaps = 41/276 (14%)
Query: 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIAD-QKEFLIEVKALTEI 493
F CIG G G VY+A + + QVVAIK D+I D Q+E I+ L++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQE--IQF--LSQC 56
Query: 494 RHRNIVKFYGFCSHARHSFL-------VYELLERGSLAAILSSDTAAQELGWSQRMNVIK 546
R I K+YG SFL + E GS +L +L + +++
Sbjct: 57 RSPYITKYYG-------SFLKGSKLWIIMEYCGGGSCLDLLKP----GKLDETYIAFILR 105
Query: 547 GVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTY 606
V L YLH + +H+DI + N+LL E + +ADFG++ L S F GT
Sbjct: 106 EVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTP 162
Query: 607 GYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPR 666
++APE+ EK D++S G+ +E KG+ P S L+ L I P+
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPL--------SDLHPMRVLFLI--PK 212
Query: 667 LPPPSRSVQEKLIS--IMEVAFSCLNESPESRPTMK 700
PP S++ S + CLN+ P+ RP+ K
Sbjct: 213 NNPP--SLEGNKFSKPFKDFVSLCLNKDPKERPSAK 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 85/284 (29%), Positives = 127/284 (44%), Gaps = 44/284 (15%)
Query: 437 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPL-PCDQIAD-QKEFLIEVKALTEI 493
D++ IG+G +G VY+A ++ +G++VAIK L P D Q+E + L E
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI--KLEPGDDFEIIQQEISM----LKEC 57
Query: 494 RHRNIVKFYGFCSHARHSFL--VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADA 551
RH NIV ++G S+ R L V E GSL I L Q V +
Sbjct: 58 RHPNIVAYFG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGP--LSELQIAYVCRETLKG 113
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAP 611
L+YLH +H+DI N+LL + + +ADFG++ L + F GT ++AP
Sbjct: 114 LAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAP 170
Query: 612 ELA---YTMKITEKCDVYSFGVLVLEAIKGK------HPRDFLSLISSSSLNTDIALDEI 662
E+A KCD+++ G+ +E + + HP L LIS S+
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN---------- 220
Query: 663 LDPRLPPPSRSVQEKLISIMEVAF--SCLNESPESRPTMKVVTQ 704
PPP +EK + F CL + P+ RPT + Q
Sbjct: 221 ----FPPPKLKDKEKWSPVFH-DFIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 80/284 (28%), Positives = 121/284 (42%), Gaps = 53/284 (18%)
Query: 444 IGNGGHGSV----YRAELPSGQV--VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G+G GSV Y + SG+ VA+K A +KEFL E + ++ H
Sbjct: 3 LGHGNFGSVVKGVYL--MKSGKEVEVAVKTLK---QEHIAAGKKEFLREASVMAQLDHPC 57
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAIL--SSDTAAQELGWSQRMNVIKGVADALSYL 555
IV+ G C LV EL G L L + +L + VA ++YL
Sbjct: 58 IVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYL 111
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG-----YVA 610
F VH+D++++N+LL ++A ++DFG+++ L S + A T G + A
Sbjct: 112 ESKHF---VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYA 166
Query: 611 PELAYTMKITEKCDVYSFGVLVLEAI-------KGKHPRDFLSLISSSSLNTDIALDEIL 663
PE K + K DV+S+GV + EA + ++++ S
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE----------- 215
Query: 664 DPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707
RLP P QE + SIM SC PE RPT + R
Sbjct: 216 --RLPRPEECPQE-IYSIML---SCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 77/279 (27%), Positives = 121/279 (43%), Gaps = 38/279 (13%)
Query: 436 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQI-ADQKEFLIEVKALTEI 493
+D++ IG G VY A LP+ + VAIK+ + ++ E EV+A+++
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKR----IDLEKCQTSVDELRKEVQAMSQC 56
Query: 494 RHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALS 553
H N+VK+Y +LV L GSL I+ S L + V+K V L
Sbjct: 57 NHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLE 116
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW----TEFAGTYGYV 609
YLH + +H+DI + N+LL + +ADFG++ L F GT ++
Sbjct: 117 YLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173
Query: 610 APELAYTMK-ITEKCDVYSFGVLVLEAIKGKHP-------RDFLSLISS--SSLNTDIAL 659
APE+ + K D++SFG+ +E G P + + + + SL T
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADY 233
Query: 660 DEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
S+S + K+IS CL + P RPT
Sbjct: 234 K--------KYSKSFR-KMIS------LCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 6e-22
Identities = 69/271 (25%), Positives = 120/271 (44%), Gaps = 28/271 (10%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
IG G G VY+ L VA+K S LP D +++FL E + L + H NIVK G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPD---LKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563
C + ++V EL+ GSL L + + + + A + YL
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYLESKN---C 114
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT----YGYVAPELAYTMKI 619
+H+D++++N L+ ++DFG+++ + E +T G + APE +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 620 TEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEI-LDPRLPPPSRSVQEK 677
T + DV+S+G+L+ E G P ++ + I R+P P + E+
Sbjct: 173 TSESDVWSYGILLWETFSLGDTP--------YPGMSNQQTRERIESGYRMPAP-QLCPEE 223
Query: 678 LISIMEVAFSCLNESPESRPTMKVVTQQVRI 708
+ +M C PE+RP+ + +++I
Sbjct: 224 IYRLML---QCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 35/282 (12%)
Query: 437 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQ-KEFLI-EVKALTEI 493
D++ IG G G+V + G+++ K+ + ++ K+ L+ EV L E+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDY----GNMTEKEKQQLVSEVNILREL 56
Query: 494 RHRNIVKFYG-FCSHARHS-FLVYELLERGSLAAILSSDTAA-QELGWSQRMNVIKGVAD 550
+H NIV++Y + + ++V E E G LA ++ + + ++ +
Sbjct: 57 KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 551 ALSYLHH--DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGY 608
AL H+ D ++H+D+ N+ LD + DFG+AK L +SS + GT Y
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYY 176
Query: 609 VAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP---RDFLSLISSSSLNTDIALDEILDP 665
++PE M EK D++S G L+ E P R+ L L S +I +
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS-----------KIKEG 225
Query: 666 RLPP-PSRSVQE--KLISIMEVAFSCLNESPESRPTMKVVTQ 704
+ P R E ++I S LN P+ RP+ + + Q
Sbjct: 226 KFRRIPYRYSSELNEVIK------SMLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 18/214 (8%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G +G VY+A + +G++VAIKK L + K L E+K L E+ H NI+K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIK--LRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH-HDCFP 561
H +LV+E ++ L ++ + L S + + + L++ H H
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL- 120
Query: 562 PIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKI-T 620
H+D+ +NLL++ E +ADFG+A+ +T + T Y APEL K +
Sbjct: 121 ---HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 621 EKCDVYSFGVLVLEAIK------GKHPRDFLSLI 648
D++S G + E + GK D L I
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 4e-21
Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI-EVKALTEIRHRNIVKF 501
IG G G+VY A ++ +GQ VAIK+ + Q +KE +I E+ + E +H NIV +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNL-----QQQPKKELIINEILVMRENKHPNIVNY 81
Query: 502 YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFP 561
++V E L GSL +++ +T E Q V + AL +LH +
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDE---GQIAAVCRECLQALEFLHSN--- 134
Query: 562 PIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITE 621
++H+DI S N+LL ++ + DFG + PE S + GT ++APE+
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 622 KCDVYSFGVLVLEAIKGKHP 641
K D++S G++ +E ++G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 5e-21
Identities = 74/269 (27%), Positives = 128/269 (47%), Gaps = 31/269 (11%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
IG+G G V+ + VAIK + +++F+ E + + ++ H +V+ YG
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-----EGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTA--AQELGWSQRMNVIKGVADALSYLHHDCFP 561
C+ LV+E +E G L+ L + +QE ++V +G+A YL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMA----YLESSNV- 121
Query: 562 PIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE---SSNWTEFAGTYGYVAPELAYTMK 618
+H+D++++N L+ V+DFG+ +F+ + SS T+F + +PE+ K
Sbjct: 122 --IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFP--VKWSSPEVFSFSK 177
Query: 619 ITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEK 677
+ K DV+SFGVL+ E +GK P + S +S + T A + PRL
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRS--NSEVVETINAGFRLYKPRLASQ------- 228
Query: 678 LISIMEVAFSCLNESPESRPTMKVVTQQV 706
S+ E+ C E PE RP+ ++ Q+
Sbjct: 229 --SVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 66/261 (25%), Positives = 110/261 (42%), Gaps = 21/261 (8%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G G G V + P+G+++A+K + A QK+ L E+ L + IV FY
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
G + + E ++ GSL IL + + V L+YLH
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKE--VQGRIPERILGKIAVAVLKGLTYLHEKH--K 121
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEK 622
I+H+D+ N+L++ + + DFG++ L + F GT Y+APE + K
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSVK 179
Query: 623 CDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD---PRLPPPSRSVQEKLI 679
D++S G+ ++E G+ P + L I++ PRL PS
Sbjct: 180 SDIWSLGLSLIELATGRFPYPPENDPPDGIFEL---LQYIVNEPPPRL--PSGKFSPDFQ 234
Query: 680 SIMEVAFSCLNESPESRPTMK 700
+ + CL + P RP+ K
Sbjct: 235 DFVNL---CLIKDPRERPSYK 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 70/259 (27%), Positives = 122/259 (47%), Gaps = 26/259 (10%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
+G G G V+ + VA+K D K+FL E + + ++RH +++ Y
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKP-----GTMDPKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563
C+ ++V EL++ GSL L L Q +++ VA ++YL +
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQNY--- 124
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAG-TYGYVAPELAYTMKITEK 622
+H+D++++N+L+ VADFG+A+ +K + E A + APE A + + K
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 623 CDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP--RLPPPSRSVQEKLI 679
DV+SFG+L+ E + G+ P + T+ + + +D R+P P ++L
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGM---------TNAEVLQQVDQGYRMPCPP-GCPKELY 234
Query: 680 SIMEVAFSCLNESPESRPT 698
IM C E P+ RPT
Sbjct: 235 DIM---LDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 8e-20
Identities = 73/260 (28%), Positives = 116/260 (44%), Gaps = 26/260 (10%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G G V++ + + QVVAIK D+I D ++ E+ L++ + K+Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 68
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
G +++ E L GS +L A Q ++K + L YLH +
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---K 121
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEK 622
+H+DI + N+LL + + +ADFG+A L F GT ++APE+ K
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 623 CDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEIL--DPRLPPPSRSVQEKLIS 680
D++S G+ +E KG+ P N+D+ +L P+ PP+ E
Sbjct: 182 ADIWSLGITAIELAKGEPP------------NSDMHPMRVLFLIPKNNPPTL-TGEFSKP 228
Query: 681 IMEVAFSCLNESPESRPTMK 700
E +CLN+ P RPT K
Sbjct: 229 FKEFIDACLNKDPSFRPTAK 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 1e-19
Identities = 62/200 (31%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI-EVKALTEIRHRNIVKF 501
IG G G+V+ A ++ +GQ VAIK+ + Q +KE +I E+ + E+++ NIV F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINL-----QKQPKKELIINEILVMKELKNPNIVNF 81
Query: 502 YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFP 561
F+V E L GSL +++ +T E +Q V + AL +LH +
Sbjct: 82 LDSFLVGDELFVVMEYLAGGSLTDVVT-ETCMDE---AQIAAVCRECLQALEFLHAN--- 134
Query: 562 PIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITE 621
++H+DI S N+LL ++ + DFG + PE S + GT ++APE+
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 622 KCDVYSFGVLVLEAIKGKHP 641
K D++S G++ +E ++G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 80/294 (27%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 434 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTE 492
T F+ IG G +G VY+A +GQ+VAIK I D++E E+K E
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI------IEDEEE---EIKE--E 52
Query: 493 IR-------HRNIVKFYGFCSHARHS------FLVYELLERGSLAAILSSDTAAQELGWS 539
H NI FYG +LV EL GS+ +D
Sbjct: 53 YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV-----TDLVKGLRKKG 107
Query: 540 QRMN------VIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593
+R+ +++ L+YLH + ++H+DI +N+LL E + DFG++ L
Sbjct: 108 KRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164
Query: 594 PESSNWTEFAGTYGYVAPELAYTMK-----ITEKCDVYSFGVLVLEAIKGKHPRDFLSLI 648
F GT ++APE+ + + DV+S G+ +E GK P
Sbjct: 165 STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL------ 218
Query: 649 SSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAF--SCLNESPESRPTMK 700
++ AL +I PR PPP+ + S F CL ++ E RP M+
Sbjct: 219 --CDMHPMRALFKI--PRNPPPTLK-SPENWSKKFNDFISECLIKNYEQRPFME 267
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 68/239 (28%), Positives = 120/239 (50%), Gaps = 29/239 (12%)
Query: 444 IGNGGHGSVYRAEL-PSG---QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
IG G G V R L G VAIK S Q +++FL E + + H NI+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ---RRDFLSEASIMGQFDHPNII 68
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
G + +R ++ E +E G+L + L + + Q + +++G+A + YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMN 126
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG-----YVAPELA 614
+ VH+D++++N+L++ V+DFG+++FL+ ++S+ T + G + APE
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 615 YTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDI--ALDEILDPRLPPP 670
K T DV+S+G+++ E + G+ P +S N D+ A+++ D RLPPP
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-------NQDVINAIEQ--DYRLPPP 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 444 IGNGGHGSVYRAELPSGQ------VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G G G V+ E + +VA+K D +K+F E + LT +H N
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA---RKDFEREAELLTNFQHEN 69
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSS-----------DTAAQELGWSQRMNVIK 546
IVKFYG C+ +V+E +E G L L S D+ EL SQ + +
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 547 GVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT- 605
+A + YL F VH+D++++N L+ + + DFG+++ + ++++ G
Sbjct: 130 QIASGMVYLASQHF---VHRDLATRNCLVGYDLVVKIGDFGMSRDVY--TTDYYRVGGHT 184
Query: 606 ---YGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHP 641
++ PE K T + DV+SFGV++ E GK P
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 61/200 (30%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI-EVKALTEIRHRNIVKF 501
IG G G+VY A ++ +GQ VAI++ + Q +KE +I E+ + E ++ NIV +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQPKKELIINEILVMRENKNPNIVNY 82
Query: 502 YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFP 561
++V E L GSL +++ +T E Q V + AL +LH +
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDE---GQIAAVCRECLQALEFLHSN--- 135
Query: 562 PIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITE 621
++H+DI S N+LL ++ + DFG + PE S + GT ++APE+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 622 KCDVYSFGVLVLEAIKGKHP 641
K D++S G++ +E I+G+ P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 71/270 (26%), Positives = 121/270 (44%), Gaps = 45/270 (16%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFH----SPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
+G G G V+ VAIK SP + FL E + + ++RH +V
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---------EAFLQEAQVMKKLRHEKLV 64
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
+ Y S ++V E + +GSL L + L Q +++ +A ++Y+
Sbjct: 65 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMN 122
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT---YGYVAPELAYT 616
+ VH+D+ + N+L+ VADFG+A+ + E + +T G + APE A
Sbjct: 123 Y---VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALY 177
Query: 617 MKITEKCDVYSFGVLVLE-AIKGKHPRDFLSLISSSSLNTDIALDEILDP-----RLPPP 670
+ T K DV+SFG+L+ E KG+ P + +++ E+LD R+P P
Sbjct: 178 GRFTIKSDVWSFGILLTELTTKGRVP--YPGMVNR----------EVLDQVERGYRMPCP 225
Query: 671 SRSVQEKLISIMEVAFSCLNESPESRPTMK 700
+ S+ ++ C + PE RPT +
Sbjct: 226 PECPE----SLHDLMCQCWRKEPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 71/260 (27%), Positives = 126/260 (48%), Gaps = 28/260 (10%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
+G G G V+ VA+K P A FL E + + ++RH +V+ Y
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEA----FLQEAQIMKKLRHDKLVQLYA 68
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563
CS ++V E + +GSL L S ++L Q +++ +A+ ++YL +
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRNY--- 124
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT---YGYVAPELAYTMKIT 620
+H+D++++N+L+ +ADFG+A+ + E +T G + APE A + T
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLI--EDDEYTAREGAKFPIKWTAPEAANYGRFT 182
Query: 621 EKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEI-LDPRLPPPSRSVQEKL 678
K DV+SFG+L+ E + G+ P ++ N ++ L+++ R+P P +E L
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVPYPGMT-------NREV-LEQVERGYRMPRPPNCPEE-L 233
Query: 679 ISIMEVAFSCLNESPESRPT 698
+M C ++ PE RPT
Sbjct: 234 YDLML---QCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 7e-19
Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 35/272 (12%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIK--KFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
+G G S Y+A ++ +G ++A+K + +Q + E++ + + H +I++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
G H L E + GS++ +LS A +E + +N + + LSYLH +
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLSYLHEN-- 122
Query: 561 PPIVHQDISSKNLLLDLE-YEAHVADFGIAKFLKPESSNWTEFA----GTYGYVAPELAY 615
I+H+D+ NLL+D +ADFG A L + + EF GT ++APE+
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 616 TMKITEKCDVYSFGVLVLEAIKGKHP------RDFLSLISS-SSLNTDIALDEILDPRLP 668
+ CDV+S G +++E K P + L+LI +S T ++ E L P L
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL- 240
Query: 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
+V CL PE RP +
Sbjct: 241 -------------RDVTLRCLELQPEDRPPSR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 8e-19
Identities = 76/282 (26%), Positives = 129/282 (45%), Gaps = 46/282 (16%)
Query: 444 IGNGGHGSVYRAEL----PSGQ--VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G G G V+ AE P+ +VA+K P +A +K+F E + LT ++H +
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEH 68
Query: 498 IVKFYGFCSHARHSFLVYELLERGSL----------AAILSSDTAAQ---ELGWSQRMNV 544
IVKFYG C +V+E ++ G L A IL Q ELG SQ +++
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 545 IKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAG 604
+A + YL F VH+D++++N L+ + DFG+++ + S+++ G
Sbjct: 129 ASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVY--STDYYRVGG 183
Query: 605 ----TYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIAL 659
++ PE K T + DV+SFGV++ E GK P +S++ + I
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP---WFQLSNTEVIECITQ 240
Query: 660 DEILD-PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
+L+ PR+ P + ++ C P+ R +K
Sbjct: 241 GRVLERPRVCPK---------EVYDIMLGCWQREPQQRLNIK 273
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 73/266 (27%), Positives = 123/266 (46%), Gaps = 37/266 (13%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFH----SPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
+GNG G V+ VA+K SP + FL E + + ++RH +V
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---------ESFLEEAQIMKKLRHDKLV 64
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
+ Y S ++V E + +GSL L D + L +++ VA ++Y+
Sbjct: 65 QLYAVVSE-EPIYIVTEYMSKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAYIERMN 122
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT---YGYVAPELAYT 616
+ +H+D+ S N+L+ +ADFG+A+ + E + +T G + APE A
Sbjct: 123 Y---IHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALY 177
Query: 617 MKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEI-LDPRLPPPSRSV 674
+ T K DV+SFG+L+ E + KG+ P +N L+++ R+P P
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVP--------YPGMNNREVLEQVERGYRMPCP---- 225
Query: 675 QEKLISIMEVAFSCLNESPESRPTMK 700
Q+ IS+ E+ C + PE RPT +
Sbjct: 226 QDCPISLHELMLQCWKKDPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 70/268 (26%), Positives = 122/268 (45%), Gaps = 31/268 (11%)
Query: 444 IGNGGHGSVYRAELPS-GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G G +G VY VA+K + + +EFL E + EI+H N+V+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
G C+ +++ E + G+L L + QE+ + + ++ A+ YL F
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF-- 125
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT---YGYVAPE-LAYTMK 618
+H+D++++N L+ + VADFG+++ + ++ +T AG + APE LAY K
Sbjct: 126 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN-K 181
Query: 619 ITEKCDVYSFGVLVLE-AIKGKHPRDFLSLISS-SSLNTDIALDEILDPRLPPPSRSVQE 676
+ K DV++FGVL+ E A G P + L L ++ P PP
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMER---PEGCPP------ 232
Query: 677 KLISIMEVAFSCLNESPESRPTMKVVTQ 704
+ E+ +C +P RP+ + Q
Sbjct: 233 ---KVYELMRACWQWNPSDRPSFAEIHQ 257
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 61/200 (30%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI-EVKALTEIRHRNIVKF 501
IG G G+VY A ++ +GQ VAIK+ + Q +KE +I E+ + E ++ NIV +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNL-----QQQPKKELIINEILVMRENKNPNIVNY 81
Query: 502 YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFP 561
++V E L GSL +++ +T E Q V + AL +LH +
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDE---GQIAAVCRECLQALDFLHSN--- 134
Query: 562 PIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITE 621
++H+DI S N+LL ++ + DFG + PE S + GT ++APE+
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 622 KCDVYSFGVLVLEAIKGKHP 641
K D++S G++ +E ++G+ P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 72/266 (27%), Positives = 128/266 (48%), Gaps = 31/266 (11%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
IG G G+V + E +GQ VA+K + CD A + FL E +T++ H+N+V+ G
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKN----IKCDVTA--QAFLEETAVMTKLHHKNLVRLLG 66
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563
H ++V EL+ +G+L L + A + Q + VA+ + YL +
Sbjct: 67 VILH-NGLYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESK---KL 121
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKC 623
VH+D++++N+L+ + A V+DFG+A+ + + ++ + APE K + K
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLP--VKWTAPEALKHKKFSSKS 178
Query: 624 DVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP--RLPPPSRSVQEKLIS 680
DV+S+GVL+ E G+ P +SL E ++ R+ PP +
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKMSLKEVK---------ECVEKGYRMEPPE-GCPADVYV 228
Query: 681 IMEVAFSCLNESPESRPTMKVVTQQV 706
+M SC P+ RP+ + +++
Sbjct: 229 LMT---SCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 71/272 (26%), Positives = 112/272 (41%), Gaps = 42/272 (15%)
Query: 444 IGNGGHGSVYRAE-LPSGQ----VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI 498
+G+G G+VY+ +P G+ VAIK KE L E + + H ++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP---KANKEILDEAYVMASVDHPHV 71
Query: 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL--H 556
V+ G C ++ L+ +L+ G L + + +G +N +A +SYL
Sbjct: 72 VRLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK 128
Query: 557 HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTY--GYVAPELA 614
+VH+D++++N+L+ + DFG+AK L + + G ++A E
Sbjct: 129 R-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 615 YTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILD-----PRLP 668
T K DV+S+GV V E + G P + I EI D RLP
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYE------------GIPAVEIPDLLEKGERLP 231
Query: 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
P I + V C ESRPT K
Sbjct: 232 QPPICT----IDVYMVLVKCWMIDAESRPTFK 259
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 74/273 (27%), Positives = 128/273 (46%), Gaps = 36/273 (13%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKE---FLIEVKALTEIRHRNIV 499
+G+G G VY+A+ +G A K QI ++E F++E+ L+E +H NIV
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKII-------QIESEEELEDFMVEIDILSECKHPNIV 65
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
Y + +++ E + G+L +I+ + L Q V + + +AL++LH
Sbjct: 66 GLYEAYFYENKLWILIEFCDGGALDSIM--LELERGLTEPQIRYVCRQMLEALNFLHSH- 122
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAY--TM 617
++H+D+ + N+LL L+ + +ADFG++ K F GT ++APE+ T
Sbjct: 123 --KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180
Query: 618 KITE---KCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD---PRLPPPS 671
K K D++S G+ ++E + + P LN L +IL P L PS
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPPH--------HELNPMRVLLKILKSEPPTLDQPS 232
Query: 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQ 704
+ S + SCL + P+ RPT + +
Sbjct: 233 KWSS----SFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 73/269 (27%), Positives = 111/269 (41%), Gaps = 38/269 (14%)
Query: 444 IGNGGHGSVYRAEL--PSGQV--VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
+G+G G V R E G+V VA+K S D + D FL E + + H N++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD---FLKEAAIMHSLDHENLI 59
Query: 500 KFYGFCSHARHSF-LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
+ YG H +V EL GSL L A S + +A+ + YL
Sbjct: 60 RLYGVV--LTHPLMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWT-------EFAGTYGYVAP 611
F +H+D++++N+LL + + + DFG+ + L ++ FA + AP
Sbjct: 117 RF---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA----WCAP 169
Query: 612 ELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSL-NTDIALDEILDPRLPP 669
E T + DV+ FGV + E G+ P + L S L D + RL
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEP--WAGLSGSQILKKIDKEGE-----RLER 222
Query: 670 PSRSVQEKLISIMEVAFSCLNESPESRPT 698
P Q+ I V C +P RPT
Sbjct: 223 PEACPQD----IYNVMLQCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G HG V++A + +G+ VA+KK I +Q L E+KAL +H +VK
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQ--ALREIKALQACQHPYVVKLL 65
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSD----TAAQELGWSQRMNVIKGVADALSYLHHD 558
H LV E + L+ +L + AQ + RM ++KGVA Y+H +
Sbjct: 66 DVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYM-RM-LLKGVA----YMHAN 118
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN-WTEFAGTYGYVAPELAY-T 616
I+H+D+ NLL+ + +ADFG+A+ E ++ T Y APEL Y
Sbjct: 119 ---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 617 MKITEKCDVYSFGVLVLEAIKG 638
K D+++ G + E + G
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 5e-18
Identities = 76/262 (29%), Positives = 128/262 (48%), Gaps = 31/262 (11%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQK--EFLIEVKALTEIRHRNIVK 500
IG+G G+VY A ++ + +VVAIKK + +++K + + EV+ L ++RH N ++
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKM---SYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 501 FYGFCSHARHS-FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
+ G C H+ +LV E GS + IL + + L + + G L+YLH
Sbjct: 80 YKG-CYLREHTAWLVMEYC-LGSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLHSHE 135
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTM-- 617
+H+DI + N+LL +ADFG A + P +S F GT ++APE+ M
Sbjct: 136 ---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPYWMAPEVILAMDE 188
Query: 618 -KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQE 676
+ K DV+S G+ +E + K P ++ + S+L IA ++ P+ S +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSAL-YHIAQND-------SPTLSSND 238
Query: 677 KLISIMEVAFSCLNESPESRPT 698
SCL + P+ RP+
Sbjct: 239 WSDYFRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 69/235 (29%), Positives = 103/235 (43%), Gaps = 16/235 (6%)
Query: 438 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHR 496
F+ IG G G V + + ++ A+K + + C + + L E + L E+ H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMK-YMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 497 NIVKF-YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
+V Y F + +LV +LL G L LS E Q I + AL YL
Sbjct: 61 FLVNLWYSFQDE-ENMYLVVDLLLGGDLRYHLSQKVKFSE---EQVKFWICEIVLALEYL 116
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAY 615
H I+H+DI N+LLD + H+ DF IA + P++ T +GT GY+APE+
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT-TSTSGTPGYMAPEVLC 172
Query: 616 TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDI-ALDEILDPRLPP 669
+ D +S GV E ++GK P S ++ I A E D P
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYR----GHSRTIRDQIRAKQETADVLYPA 223
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 74/280 (26%), Positives = 128/280 (45%), Gaps = 43/280 (15%)
Query: 444 IGNGGHGSVYRAE----LPSGQ--VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G G G V+ AE LP +VA+K + +++F E + LT ++H++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE----SARQDFQREAELLTVLQHQH 68
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSS------------DTAAQELGWSQRMNVI 545
IV+FYG C+ R +V+E + G L L S D A +L Q + +
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 546 KGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAG- 604
+A + YL F VH+D++++N L+ + DFG+++ + S+++ G
Sbjct: 129 SQIASGMVYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYRVGGR 183
Query: 605 ---TYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALD 660
++ PE K T + D++SFGV++ E GK P LS NT+ A++
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS-------NTE-AIE 235
Query: 661 EILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
I R R+ ++ +IM+ C P+ R +K
Sbjct: 236 CITQGRELERPRTCPPEVYAIMQ---GCWQREPQQRMVIK 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 80/296 (27%), Positives = 123/296 (41%), Gaps = 67/296 (22%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G G +G V + +G++VAIKKF + + +K L EVK L ++RH NIV
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDV--KKTALREVKVLRQLRHENIVNLK 66
Query: 503 GFCSHARHSFLVYELLERGSLAAI------LSSDTAAQELGWSQRMNVIKGVADALSYLH 556
+LV+E +ER L + L D A + W Q + A++Y H
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLELLEASPGGLPPD-AVRSYIW-QLLQ-------AIAYCH 117
Query: 557 -HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK-PESSNWTEFAGTYGYVAPEL- 613
H+ I+H+DI +N+L+ + DFG A+ L+ +S T++ T Y APEL
Sbjct: 118 SHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELL 173
Query: 614 ----AYTMKITEKCDVYSFGVLVLEAIK------GKHPRDFLSLI--------------- 648
Y + DV++ G ++ E + G D L LI
Sbjct: 174 VGDTNYGKPV----DVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229
Query: 649 SSSSLNTDIALDEILDP----RLPPPSRSVQEKLISIMEVAF--SCLNESPESRPT 698
SS+ +A E P R P +S + F +CL P+ R T
Sbjct: 230 SSNPRFAGVAFPEPSQPESLERRYP-------GKVSSPALDFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 9e-18
Identities = 74/260 (28%), Positives = 113/260 (43%), Gaps = 24/260 (9%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQ--KEFLIEVKALTEIRHRNIVK 500
+G+G GSVY L G A+K+ S Q + K+ E+ L++++H NIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEV-SLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
+ G + ++ EL+ GSLA +L + E + + L YLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE---PVIRLYTRQILLGLEYLHDR-- 121
Query: 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE-LAYTMKI 619
VH+DI N+L+D +ADFG+AK + E S F G+ ++APE +A
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWMAPEVIAQQGGY 179
Query: 620 TEKCDVYSFGVLVLEAIKGKHP-RDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKL 678
D++S G VLE GK P + + + L I P S + K
Sbjct: 180 GLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPI------PDHLSDEAKD 233
Query: 679 ISIMEVAFSCLNESPESRPT 698
I++ CL P RPT
Sbjct: 234 F-ILK----CLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEF---LIEVKALTEIRHRNIV 499
+G G G V + +G++ A+K +I +KE L E L+ I H IV
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKK----KKIIKRKEVEHTLTERNILSRINHPFIV 56
Query: 500 K-FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVAD---ALSYL 555
K Y F + +LV E G L + LS + E ++ A+ AL YL
Sbjct: 57 KLHYAFQTE-EKLYLVLEYAPGGELFSHLSKEGRFSE-ERARFY-----AAEIVLALEYL 109
Query: 556 H-HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
H I+++D+ +N+LLD + + DFG+AK L E S F GT Y+APE+
Sbjct: 110 HSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL 165
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGKHP 641
+ D +S GVL+ E + GK P
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 73/281 (25%), Positives = 115/281 (40%), Gaps = 46/281 (16%)
Query: 444 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI 498
+G G G V +G+ VA+K + +D + E++ L + H NI
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER---EIEILRTLDHENI 68
Query: 499 VKFYGFC--SHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
VK+ G C R L+ E L GSL L L + + + + YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK--RLLLFSSQICKGMDYLG 126
Query: 557 HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYV------- 609
+H+D++++N+L++ E ++DFG+AK L PE + Y YV
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL-PEDKD-------YYYVKEPGESP 175
Query: 610 ----APELAYTMKITEKCDVYSFGVLVLEAI----KGKHP-RDFLSLIS-SSSLNTDIAL 659
APE T K + DV+SFGV + E + P +FL +I + L
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235
Query: 660 DEILDP--RLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
E+L RLP P E + ++ C P+ RP+
Sbjct: 236 LELLKEGERLPRPPSCPDE----VYDLMKLCWEAEPQDRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 70/269 (26%), Positives = 123/269 (45%), Gaps = 27/269 (10%)
Query: 444 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G G V+ L + VA+K LP D A +FL E + L + H NIV+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA---KFLQEARILKQYSHPNIVRLI 59
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
G C+ + ++V EL++ G L ++ L + + +++ A + YL
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKH--- 114
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT----YGYVAPELAYTMK 618
+H+D++++N L+ + ++DFG+++ + E + G + APE +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 619 ITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEK 677
+ + DV+SFG+L+ EA G P L S+ T A+++ RLP P +
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANL-----SNQQTREAIEQ--GVRLPCPEL-CPDA 224
Query: 678 LISIMEVAFSCLNESPESRPTMKVVTQQV 706
+ +ME C P RP+ V Q++
Sbjct: 225 VYRLME---RCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 73/258 (28%), Positives = 116/258 (44%), Gaps = 22/258 (8%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G G VY+ + + +VVAIK D+I D ++ E+ L++ I ++Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYITRYY 68
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
G +++ E L GS +L + + ++KG L YLH +
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKG----LDYLHSE---R 121
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEK 622
+H+DI + N+LL + + +ADFG+A L F GT ++APE+ K
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 623 CDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIM 682
D++S G+ +E KG+ P +S L+ L L P+ PP+ Q
Sbjct: 182 ADIWSLGITAIELAKGEPP--------NSDLHPMRVL--FLIPKNSPPTLEGQYSK-PFK 230
Query: 683 EVAFSCLNESPESRPTMK 700
E +CLN+ P RPT K
Sbjct: 231 EFVEACLNKDPRFRPTAK 248
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 72/277 (25%), Positives = 134/277 (48%), Gaps = 29/277 (10%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI------EVKALTEIRHR 496
IG G +G VY A + +G+++A+K+ P D ++ + E++ L ++ H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 497 NIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQE-LGWSQRMNVIKGVADALSYL 555
NIV++ GF + + + E + GS+ + L + +E L V++G L+YL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG----LAYL 124
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW--TEFAGTYGYVAPEL 613
H I+H+D+ + NLL+D + ++DFGI+K N G+ ++APE+
Sbjct: 125 HSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 614 --AYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671
+Y+ + K D++S G +VLE G+ P I+ A+ ++ + R PP
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--------AMFKLGNKRSAPPI 233
Query: 672 RSVQEKLISIMEVAF--SCLNESPESRPTMKVVTQQV 706
+S + + F +C +P++RPT + + Q
Sbjct: 234 PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP 270
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (205), Expect = 2e-17
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 443 CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKF 501
+G G +G VY+A + +G++VA+KK + I L E+ L E++H NIVK
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGI--PSTALREISLLKELKHPNIVKL 63
Query: 502 YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA----DALSYLHH 557
R +LV+E + L L D L N+IK + L+Y H
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYL--DKRPGPL----SPNLIKSIMYQLLRGLAYCHS 116
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL---- 613
I+H+D+ +N+L++ + +ADFG+A+ +T T Y APE+
Sbjct: 117 HR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGS 173
Query: 614 -AYTMKITEKCDVYSFGVLVLEAIKGK 639
Y+ + D++S G + E I GK
Sbjct: 174 KHYSTAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 441 QYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHR 496
Q IG G G V+R L VAIK Q +++FL E + + H
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ---RQDFLSEASIMGQFSHH 66
Query: 497 NIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
NI++ G + + + ++ E +E G+L L E Q + +++G+A + YL
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLS 124
Query: 557 HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK--PESSNWTEFAGTYG--YVAPE 612
+ VH+D++++N+L++ E V+DFG+++ L+ PE + +T G + APE
Sbjct: 125 DMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT-YTTSGGKIPIRWTAPE 180
Query: 613 LAYTMKITEKCDVYSFGVLVLEAIK-GKHP 641
K T DV+SFG+++ E + G+ P
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 75/273 (27%), Positives = 125/273 (45%), Gaps = 32/273 (11%)
Query: 445 GNGGHGSVYR---AELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKF 501
G+ G S+Y A +G++VA+K C Q + + E+ L + H NIVK+
Sbjct: 15 GHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQ-QNTSGWKKEINILKTLYHENIVKY 71
Query: 502 YGFCSHA--RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
G CS + L+ E + GSL L +L +Q + + + + ++YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH 127
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFA----GTYGYVAPELAY 615
+ +H+D++++N+LLD + + DFG+AK + PE + + A E
Sbjct: 128 Y---IHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 616 TMKITEKCDVYSFGVLVLEAI-----KGKHPRDFLSLIS-SSSLNTDIALDEILD--PRL 667
K + DV+SFGV + E + K P+ F +I T + L E+L+ RL
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL 243
Query: 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
P P QE I +M+ +C + RPT +
Sbjct: 244 PCPKNCPQEVYI-LMK---NCWETEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 5e-17
Identities = 72/264 (27%), Positives = 114/264 (43%), Gaps = 34/264 (12%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G G V++ + + +VVAIK D+I D ++ E+ L++ + K+Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 68
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
G +++ E L GS +L L +Q +++ + L YLH +
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE---K 121
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEK 622
+H+DI + N+LL E +ADFG+A L F GT ++APE+ K
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 623 CDVYSFGVLVLEAIKGK------HPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQE 676
D++S G+ +E KG+ HP L LI ++ PP
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN---------------PPTLEGNYS 226
Query: 677 KLISIMEVAFSCLNESPESRPTMK 700
K + E +CLN+ P RPT K
Sbjct: 227 K--PLKEFVEACLNKEPSFRPTAK 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 43/276 (15%)
Query: 444 IGNGGHGSVYR---AELPSGQV---VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G G G VY + G+ VAIK + + ++ EFL E + E +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQE-------LGWSQRMNVIKGVAD 550
+V+ G S + + +V EL+ +G L + L S E + + + +AD
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG--- 607
++YL F VH+D++++N ++ + + DFG+ + + T++ G
Sbjct: 131 GMAYLAAKKF---VHRDLAARNCMVAEDLTVKIGDFGMTRDI-----YETDYYRKGGKGL 182
Query: 608 ----YVAPELAYTMKITEKCDVYSFGVLVLE-AIKGKHPRDFLSLISSSSLNTDIALDEI 662
++APE T K DV+SFGV++ E A + P LS + L +
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--------NEEVLKFV 234
Query: 663 LDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
+D + +KL+ +M + C +P+ RPT
Sbjct: 235 IDGGHLDLPENCPDKLLELMRM---CWQYNPKMRPT 267
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 72/262 (27%), Positives = 116/262 (44%), Gaps = 22/262 (8%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G G GSV + + +P+G V+A K H + + +K+ L E++ + E R IV FY
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIG---AKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQE--LGWSQRMNVIKGVADALSYL---HH 557
G + + + E ++ GSL I LG + V + L+YL H
Sbjct: 70 GAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYNVHR 124
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTM 617
I+H+DI N+L++ + + DFG++ L ++ F GT Y++PE
Sbjct: 125 -----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD--TFVGTSTYMSPERIQGG 177
Query: 618 KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEK 677
K T K DV+S G+ ++E GK P F ++ + LD + PP R
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237
Query: 678 LISIMEVAFS-CLNESPESRPT 698
+ CL + P RPT
Sbjct: 238 FPEDLRDFVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 31/210 (14%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKE-FLI----EVKALTEIRHRN 497
IG G +G VY+A +G++VA+KK ++ ++KE F I E+K L ++RH N
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI-------RMENEKEGFPITAIREIKLLQKLRHPN 59
Query: 498 IVKFYGFC-SHARHS-FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
IV+ S + S ++V+E ++ L +L S + SQ +K + + L YL
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYL 116
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS-NWTEFAGTYGYVAPEL- 613
H + I+H+DI N+L++ + +ADFG+A+ +S ++T T Y PEL
Sbjct: 117 HSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 614 ----AYTMKITEKCDVYSFGVLVLEAIKGK 639
Y ++ D++S G ++ E GK
Sbjct: 174 LGATRYGPEV----DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 73/264 (27%), Positives = 118/264 (44%), Gaps = 25/264 (9%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLI---EVKALTEIRHRNIVK 500
+G G +G+VY GQ++A+K+ + +A +KE+ EV L ++H NIV+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELD-TSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
+ G C + E + GS+++IL+ E + + K + D ++YLH++C
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC- 122
Query: 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTE------FAGTYGYVAPELA 614
+VH+DI N++L + DFG A+ L + T GT ++APE+
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674
K D++S G V E GK P L+ + + I L PRLP S
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPP---LASMDRLAAMFYIGAHRGLMPRLP---DSF 234
Query: 675 QEKLISIMEVAFSCLNESPESRPT 698
I + SCL RP+
Sbjct: 235 SAAAIDFVT---SCLTRDQHERPS 255
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 75/266 (28%), Positives = 127/266 (47%), Gaps = 27/266 (10%)
Query: 444 IGNGGHGSVY--RAELPSGQVVAIKK--FHSP-LPCDQIADQKEF---LIEVKALTE-IR 494
+G+G G VY R + ++A+K+ H+P D+ K + EV + E +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRM-NVIKGVADALS 553
H NIV++Y ++V +L+E L +S ++ +R+ N+ + AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL 613
YLH + IVH+D++ N++L + + + DFG+AK K S T GT Y PE+
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILYSCPEI 184
Query: 614 AYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673
EK DV++FG ++ + + P F S + SL T I ++ + +P
Sbjct: 185 VKNEPYGEKADVWAFGCILYQMCTLQPP--FYS-TNMLSLATKI-VEAVYEP-------- 232
Query: 674 VQEKLIS--IMEVAFSCLNESPESRP 697
+ E + S + +V SCL E+RP
Sbjct: 233 LPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 60/243 (24%), Positives = 91/243 (37%), Gaps = 59/243 (24%)
Query: 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIAD---------QKEFLI 485
+DF IG G +V A E + + AIK I D K I
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIK----------ILDKRQLIKEKKVKYVKI 50
Query: 486 EVKALTEI-RHRNIVKFYGFCSHARHS-FLVYELLERGSLAAILS-----SDTAAQELGW 538
E + LT + H I+K Y + + + V E G L + + +
Sbjct: 51 EKEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTR---- 105
Query: 539 SQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN 598
+ AL YLH I+H+D+ +N+LLD + + DFG AK L P SS
Sbjct: 106 ----FYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158
Query: 599 WTE--------------------FAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKG 638
+ F GT YV+PEL + D+++ G ++ + + G
Sbjct: 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218
Query: 639 KHP 641
K P
Sbjct: 219 KPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-16
Identities = 80/257 (31%), Positives = 114/257 (44%), Gaps = 34/257 (13%)
Query: 88 TIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGK-CPK 146
+ L N L + LN N L NISE L + NLT +DL N+ +I G
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNISELLEL-TNLTSLDLDNNNIT-DIPPLIGLLKSN 141
Query: 147 LGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFT 206
L L++S N I +P + N L+ LDLS N + ++PK L L++L L L GN+ +
Sbjct: 142 LKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199
Query: 207 GRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQ 266
LPPEI L LE LDLS N + +L NL L L LSNN+
Sbjct: 200 -DLPPEIELLSALEELDLSNNS-IIELLSSLSNLKNLSGLELSNNKLE------------ 245
Query: 267 LSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
++P I +L +LE L+LS+N + S + + + +D+S N L
Sbjct: 246 -------------DLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLS 290
Query: 327 GPVPNSTAFRNAPVEAL 343
+P L
Sbjct: 291 NALPLIALLLLLLELLL 307
|
Length = 394 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
+G G GSV + L + ++ K + P + QK+ L E++ + IVK+YG
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDL--QKQILRELEINKSCKSPYIVKYYG 66
Query: 504 FCSHARHSFL--VYELLERGSLAAIL------SSDTAAQELGWSQRMNVIKGVADALSYL 555
S + E E GSL +I + LG + + V LSYL
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVLKGLSYL 121
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE--- 612
H I+H+DI N+LL + + + DFG++ L +S F GT Y+APE
Sbjct: 122 HSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFTGTSFYMAPERIQ 176
Query: 613 -LAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
Y++ DV+S G+ +LE + + P
Sbjct: 177 GKPYSI----TSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 70/259 (27%), Positives = 117/259 (45%), Gaps = 27/259 (10%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI--EVKALTEIRHRNIVK 500
IG G G V A E SG+ VA+K D Q+ L+ EV + + +H+N+V+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM------DLRKQQRRELLFNEVVIMRDYQHQNVVE 82
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
Y +++ E L+ G+L I+S +E Q V + V AL YLH
Sbjct: 83 MYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEE----QIATVCESVLQALCYLHSQ-- 136
Query: 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKIT 620
++H+DI S ++LL L+ ++DFG + + GT ++APE+
Sbjct: 137 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 621 EKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLIS 680
+ D++S G++V+E + G+ P S S + A+ + D PPP K+
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPP-----YFSDSPVQ---AMKRLRDS--PPPKLKNAHKISP 245
Query: 681 IM-EVAFSCLNESPESRPT 698
++ + L P+ R T
Sbjct: 246 VLRDFLERMLTREPQERAT 264
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 86/292 (29%), Positives = 132/292 (45%), Gaps = 52/292 (17%)
Query: 444 IGNGGHGSVYRAEL--------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
+G G GSV EL +G+VVA+KK L ++F E++ L ++H
Sbjct: 12 LGKGNFGSV---ELCRYDPLQDNTGEVVAVKK----LQHSTAEHLRDFEREIEILKSLQH 64
Query: 496 RNIVKFYGFC-SHARHSF-LVYELLERGSLAAILSS-----DTAAQELGWSQRMNVIKGV 548
NIVK+ G C S R + LV E L GSL L D L SQ + KG
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ---ICKG- 120
Query: 549 ADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEF-----A 603
+ YL + VH+D++++N+L++ E + DFG+ K L P+ + + +
Sbjct: 121 ---MEYLGSKRY---VHRDLATRNILVESENRVKIGDFGLTKVL-PQDKEYYKVREPGES 173
Query: 604 GTYGYVAPELAYTMKITEKCDVYSFGVLVLEAI----KGKHP-RDFLSLISSSSLNTDIA 658
+ Y APE K + DV+SFGV++ E K P +F+ ++ + I
Sbjct: 174 PIFWY-APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV 232
Query: 659 --LDEILDP--RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
L E+L RLP P ++ +IM+ C N P RP+ + QV
Sbjct: 233 YHLIELLKNNGRLPAPP-GCPAEIYAIMK---ECWNNDPSQRPSFSELALQV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 39/265 (14%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI--EVKALTEIRHRNIVK 500
IG G G V A + +G+ VA+KK D Q+ L+ EV + + +H NIV+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM------DLRKQQRRELLFNEVVIMRDYQHPNIVE 80
Query: 501 FYGFCSHARHSFLV-------YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALS 553
Y S+LV E LE G+L I++ +E Q V V ALS
Sbjct: 81 MYS-------SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLAVLKALS 129
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL 613
+LH ++H+DI S ++LL + ++DFG + E GT ++APE+
Sbjct: 130 FLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEV 186
Query: 614 AYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673
+ + D++S G++V+E + G+ P + L A+ I D LPP ++
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPP-----YFNEPPLQ---AMKRIRD-NLPPKLKN 237
Query: 674 VQEKLISIMEVAFSCLNESPESRPT 698
+ + + L P R T
Sbjct: 238 LHKVSPRLRSFLDRMLVRDPAQRAT 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 71/279 (25%), Positives = 127/279 (45%), Gaps = 33/279 (11%)
Query: 430 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFH--SPLPCDQIADQKEFLIEV 487
EI R + D + +G G G V+ VAIK + +P + FL E
Sbjct: 2 EIPRESLRLDVK--LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-------EAFLQEA 52
Query: 488 KALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKG 547
+ + ++RH +V Y S ++V E + +GSL L + + L Q +++
Sbjct: 53 QIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLK-EGDGKYLKLPQLVDMAAQ 110
Query: 548 VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT-- 605
+AD ++Y+ + +H+D+ + N+L+ +ADFG+A+ + E + +T G
Sbjct: 111 IADGMAYIERMNY---IHRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKF 165
Query: 606 -YGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEIL 663
+ APE A + T K DV+SFG+L+ E + KG+ P +N ++
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP-------YPGMVNREVLEQVER 218
Query: 664 DPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVV 702
R+P P + S+ E+ C + P+ RPT + +
Sbjct: 219 GYRMPCPQGCPE----SLHELMKLCWKKDPDERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 71/287 (24%), Positives = 122/287 (42%), Gaps = 55/287 (19%)
Query: 437 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHR 496
+ IG G G V + G VA+K + A + FL E +T++RH
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHS 59
Query: 497 NIVKFYGFCSHARHS-FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
N+V+ G + ++V E + +GSL L S LG + V +A+ YL
Sbjct: 60 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAG-TYGYVAPELA 614
+ F VH+D++++N+L+ + A V+DFG+ K E+S+ + + APE
Sbjct: 119 EANNF---VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEAL 171
Query: 615 YTMKITEKCDVYSFGVLVLEAI---KGKHPRDFLSLISSSSLNTDIALDEILDPRLP--- 668
K + K DV+SFG+L+ E + +PR I L +++ PR+
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPR--------------IPLKDVV-PRVEKGY 216
Query: 669 --------PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707
PP + +V C + +RP+ + +Q+
Sbjct: 217 KMDAPDGCPP---------VVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 66/212 (31%), Positives = 98/212 (46%), Gaps = 12/212 (5%)
Query: 432 VRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKAL 490
R+ +F+ IG G +G VYRA + SG++VA+KK D I L E+ L
Sbjct: 3 CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--LREITLL 60
Query: 491 TEIRHRNIVKFYGFC--SHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGV 548
+RH NIV+ H FLV E E+ LA++L D SQ ++ +
Sbjct: 61 LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLL--DNMPTPFSESQVKCLMLQL 117
Query: 549 ADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGY 608
L YLH + I+H+D+ NLLL + +ADFG+A+ + T T Y
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWY 174
Query: 609 VAPELAYTMKI-TEKCDVYSFGVLVLEAIKGK 639
APEL T D+++ G ++ E + K
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 35/212 (16%)
Query: 444 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIAD---QKEFLIEVKALTEIRHRNIV 499
+G GG G V ++ + A+K I + Q+ E + L E H IV
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKK----RHIVETGQQEHIFSEKEILEECNHPFIV 56
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILS-----SDTAAQELGWSQRMNVIKGVADALSY 554
K Y ++ +++ E G L IL + A+ I V A Y
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFY--------IACVVLAFEY 108
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
LH+ I+++D+ +NLLLD + DFG AK LK WT F GT YVAPE+
Sbjct: 109 LHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEI- 163
Query: 615 YTMKITEK-----CDVYSFGVLVLEAIKGKHP 641
I K D +S G+L+ E + G+ P
Sbjct: 164 ----ILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 444 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLI--EVKALTEIRHRNIVK 500
IG G G V A + SG++VA+KK D Q+ L+ EV + + +H N+V+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
Y ++V E LE G+L I++ +E Q V V ALS LH
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLKALSVLHAQ-- 135
Query: 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKIT 620
++H+DI S ++LL + ++DFG + E GT ++APEL +
Sbjct: 136 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 621 EKCDVYSFGVLVLEAIKGKHP 641
+ D++S G++V+E + G+ P
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 67/237 (28%), Positives = 108/237 (45%), Gaps = 39/237 (16%)
Query: 437 DFDAQY----CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALT 491
D ++Y IG+G +G V A + SG+ VAIKK P D K L E+K L
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI--PHAFDVPTLAKRTLRELKILR 59
Query: 492 EIRHRNIVK----FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMN---- 543
+H NI+ + + ++V +L+E L I+ SD E + +
Sbjct: 60 HFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTE----EHIRYFLY 114
Query: 544 -VIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL--KPE--SSN 598
+++G L Y+H ++H+D+ NLL++ + E + DFG+A+ L P
Sbjct: 115 QLLRG----LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF 167
Query: 599 WTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAI------KGKHPRDFLSLI 648
TE+ T Y APEL ++ + T D++S G + E + GK+ L LI
Sbjct: 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLI 224
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 71/265 (26%), Positives = 127/265 (47%), Gaps = 33/265 (12%)
Query: 444 IGNGGHGSVY--RAELPSGQ--VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
IG G G V R +LP + VAIK + Q +++FL E + + H NI+
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ---RRDFLSEASIMGQFDHPNII 68
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
G + ++ +V E +E GSL A L + Q + +++G+A + YL
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMG 126
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK--PESSNWTEFAGTYG--YVAPELAY 615
+ VH+D++++N+L++ V+DFG+++ L+ PE++ +T G + APE
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA-YTTRGGKIPIRWTAPEAIA 182
Query: 616 TMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDI--ALDEILDPRLPPPSR 672
K T DV+S+G+++ E + G+ P +S N D+ A++E RLP P
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMS-------NQDVIKAIEE--GYRLPAP-- 231
Query: 673 SVQEKLISIMEVAFSCLNESPESRP 697
+ ++ ++ C + RP
Sbjct: 232 --MDCPAALHQLMLDCWQKDRNERP 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-15
Identities = 35/91 (38%), Positives = 51/91 (56%)
Query: 126 IDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEI 185
+ L G I ++ K L ++N+S N+I G IP +G+ + L+ LDLS N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 186 PKELGKLNSLTELILRGNQFTGRLPPEIGSL 216
P+ LG+L SL L L GN +GR+P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI--EVKALTEIRHRNIVK 500
IG G G V A E +G+ VA+KK D Q+ L+ EV + + H N+V
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM------DLRKQQRRELLFNEVVIMRDYHHENVVD 83
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
Y ++V E LE G+L I++ +E Q V V ALSYLH+
Sbjct: 84 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLSVLRALSYLHNQ-- 137
Query: 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKIT 620
++H+DI S ++LL + ++DFG + E GT ++APE+ +
Sbjct: 138 -GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196
Query: 621 EKCDVYSFGVLVLEAIKGKHP 641
+ D++S G++V+E I G+ P
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 70/276 (25%), Positives = 118/276 (42%), Gaps = 22/276 (7%)
Query: 435 TNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI 493
+F + IG G VY+A L G+VVA+KK D A Q L E+ L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQD-CLKEIDLLKQL 59
Query: 494 RHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRM--NVIKGVADA 551
H N++K+ +V EL + G L+ ++ Q+ +R + A
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKH-FKKQKRLIPERTIWKYFVQLCSA 118
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAP 611
L ++H I+H+DI N+ + + D G+ +F +++ GT Y++P
Sbjct: 119 LEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 612 ELAYTMKITEKCDVYSFGVLVLE--AIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669
E + K D++S G L+ E A++ D ++L S +I PP
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS--------LCKKIEKCDYPP 227
Query: 670 -PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQ 704
P+ E+L ++ C+N PE RP + V Q
Sbjct: 228 LPADHYSEELRDLVSR---CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 64/259 (24%), Positives = 116/259 (44%), Gaps = 26/259 (10%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
+G G G V+ + VA+K Q FL E + ++H +V+ Y
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-----AFLEEANLMKTLQHDKLVRLYA 68
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563
+ +++ E + +GSL L SD ++ + ++ +A+ ++Y+ +
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKNY--- 124
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT---YGYVAPELAYTMKIT 620
+H+D+ + N+L+ +ADFG+A+ + E + +T G + APE T
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 621 EKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLI 679
K DV+SFG+L+ E + GK P +S N+D+ R+P + ++L
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMS-------NSDVMSALQRGYRMPRM-ENCPDELY 234
Query: 680 SIMEVAFSCLNESPESRPT 698
IM+ +C E E RPT
Sbjct: 235 DIMK---TCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 43/279 (15%)
Query: 444 IGNGGHGSVYRA---ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
+G+G G+V + S + VA+K + + A + E L E + ++ + IV+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPALKDELLREANVMQQLDNPYIVR 60
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
G C A LV EL E G L L + E ++ ++ V+ + YL F
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITE---LVHQVSMGMKYLEETNF 116
Query: 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG-----YVAPELAY 615
VH+D++++N+LL ++ A ++DFG++K L + + + A T+G + APE
Sbjct: 117 ---VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHGKWPVKWYAPECMN 171
Query: 616 TMKITEKCDVYSFGVLVLEAI-------KGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668
K + K DV+SFGVL+ EA KG + +I S R+
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-------------RME 218
Query: 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707
P R E + +M++ C + RP VV ++R
Sbjct: 219 CPQRCPPE-MYDLMKL---CWTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-15
Identities = 76/259 (29%), Positives = 121/259 (46%), Gaps = 25/259 (9%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG+G G+VY A ++ + +VVAIKK S ++ + EVK L I+H N +++
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKM-SYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
G ++LV E GS + +L + + L + + G L+YLH
Sbjct: 92 GCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHSH---N 145
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTM---KI 619
++H+DI + N+LL + +ADFG A P +S F GT ++APE+ M +
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMDEGQY 201
Query: 620 TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLI 679
K DV+S G+ +E + K P L +++ S IA +E P+ E
Sbjct: 202 DGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNE-------SPTLQSNEWSD 251
Query: 680 SIMEVAFSCLNESPESRPT 698
SCL + P+ RPT
Sbjct: 252 YFRNFVDSCLQKIPQDRPT 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 43/279 (15%)
Query: 444 IGNGGHGSVYRAEL----PSGQ--VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G G G V+ AE P +VA+K D +K+F E + LT ++H +
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNA--RKDFHREAELLTNLQHEH 68
Query: 498 IVKFYGFCSHARHSFLVYELLERGSL----------AAILSSDTAAQELGWSQRMNVIKG 547
IVKFYG C +V+E ++ G L A +++ EL SQ +++ +
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 548 VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAG--- 604
+A + YL F VH+D++++N L+ + DFG+++ + S+++ G
Sbjct: 129 IAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRDVY--STDYYRVGGHTM 183
Query: 605 -TYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEI 662
++ PE K T + DV+S GV++ E GK P +S++ + I +
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP---WYQLSNNEVIECITQGRV 240
Query: 663 LD-PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
L PR P +E + ++ C P R +K
Sbjct: 241 LQRPRTCP-----KE----VYDLMLGCWQREPHMRLNIK 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 8e-15
Identities = 74/262 (28%), Positives = 126/262 (48%), Gaps = 26/262 (9%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
+G+G G VY+A+ +A K +++ D +++E++ L H IVK G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED---YMVEIEILATCNHPYIVKLLG 76
Query: 504 FCSHARHSFLVYELLERGSLAAI-LSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
+++ E G++ AI L D E Q + + + +AL YLH
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVICRQMLEALQYLHSM---K 130
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGI-AKFLKPESSNWTEFAGTYGYVAPELAY--TMKI 619
I+H+D+ + N+LL L+ + +ADFG+ AK +K F GT ++APE+ TMK
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR-DSFIGTPYWMAPEVVMCETMKD 189
Query: 620 TE---KCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQE 676
T K D++S G+ ++E + + P L+ + + IA E P L PS+ E
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSE--PPTLSQPSKWSME 244
Query: 677 KLISIMEVAFSCLNESPESRPT 698
++ A L++ PE+RP+
Sbjct: 245 -FRDFLKTA---LDKHPETRPS 262
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 74/261 (28%), Positives = 124/261 (47%), Gaps = 29/261 (11%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQ-KEFLIEVKALTEIRHRNIVKF 501
IG+G G+VY A + +VVA+KK Q ++ ++ + EVK L +++H N +++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKM--SYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 502 YGFCSHARHS-FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
G C H+ +LV E GS + +L + + L + + G L+YLH
Sbjct: 87 KG-CYLKEHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHSHN- 141
Query: 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTM--- 617
++H+DI + N+LL + +ADFG A P +S F GT ++APE+ M
Sbjct: 142 --MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FVGTPYWMAPEVILAMDEG 195
Query: 618 KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEK 677
+ K DV+S G+ +E + K P ++ + S+L IA ++ P+ E
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPP--LFNMNAMSAL-YHIAQND-------SPTLQSNEW 245
Query: 678 LISIMEVAFSCLNESPESRPT 698
S CL + P+ RP
Sbjct: 246 TDSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 67/271 (24%), Positives = 109/271 (40%), Gaps = 36/271 (13%)
Query: 444 IGNGGHGSVYRAELPS-GQVVAIKKFHSPLPCDQI---ADQKEFLIEVKALTEIRHRNIV 499
I G +G V+ A+ S G + AIK + + + L E L++ + +V
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKV----IKKADMIRKNQVDQVLTERDILSQAQSPYVV 56
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
K Y ++ +LV E L G LA++L + + E I + AL YLH +
Sbjct: 57 KLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE---DVARIYIAEIVLALEYLHSN- 112
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKF--------LKPESSNWTEFAGTYGYVAP 611
I+H+D+ N+L+D + DFG++K L + GT Y+AP
Sbjct: 113 --GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 612 ELAYTMKITEKCDVYSFGVLVLEAIKGKHP--RDFLSLISSSSLNTDIALDEILDPRLPP 669
E+ ++ D +S G ++ E + G P + I + LN I E D +
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE--DVEVSD 228
Query: 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
+ + KL L PE R K
Sbjct: 229 EAIDLISKL----------LVPDPEKRLGAK 249
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 72/268 (26%), Positives = 117/268 (43%), Gaps = 34/268 (12%)
Query: 444 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G G +G VY A S QV +AIK+ +P + E+ + ++HRNIV++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKE----IPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
G S + E + GSL+A+L S + + K + + L YLH +
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---Q 128
Query: 563 IVHQDISSKNLLLDLEYEA--HVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKIT 620
IVH+DI N+L++ Y ++DFG +K L + F GT Y+APE +
Sbjct: 129 IVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPE------VI 181
Query: 621 EK--------CDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672
+K D++S G ++E GK P F+ L + + + +I P + P S
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPP--FIELGEPQAAMFKVGMFKI-HPEI-PESL 237
Query: 673 SVQEKLISIMEVAFSCLNESPESRPTMK 700
S + K C P+ R +
Sbjct: 238 SAEAK-----NFILRCFEPDPDKRASAH 260
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 64/224 (28%), Positives = 94/224 (41%), Gaps = 45/224 (20%)
Query: 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKE---FLIEVKALT 491
+DF+ +G G G V SG+ A+K +I K+ L E + L
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK----AKIVKLKQVEHVLNEKRILQ 56
Query: 492 EIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAIL------SSDT----AAQELGWSQR 541
IRH +V YG + +LV E + G L + L AAQ
Sbjct: 57 SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ------- 109
Query: 542 MNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTE 601
V AL YLH IV++D+ +NLLLD + + DFG AK +K + +T
Sbjct: 110 ------VVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--YT- 157
Query: 602 FAGTYGYVAPEL----AYTMKITEKCDVYSFGVLVLEAIKGKHP 641
GT Y+APE+ Y + D ++ G+L+ E + G P
Sbjct: 158 LCGTPEYLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 70/279 (25%), Positives = 115/279 (41%), Gaps = 49/279 (17%)
Query: 444 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G+G G VY VA+K P C + D+ +FL+E +++ H+N
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSE-QDESDFLMEALIMSKFNHQN 70
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRM----NVIKGVADALS 553
IV+ G F++ EL+ G L + L + E S M + VA
Sbjct: 71 IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLEYE---AHVADFGIAKFLKPESSNWTEFAGT----Y 606
YL + F +H+DI+++N LL + A +ADFG+A+ + +++ G
Sbjct: 131 YLEENHF---IHRDIAARNCLLTCKGPGRVAKIADFGMARDIY--RASYYRKGGRAMLPI 185
Query: 607 GYVAPELAYTMKITEKCDVYSFGVLVLEAIK-------GKHPRDFLSLISSSSLNTDIAL 659
++ PE T K DV+SFGVL+ E G+ ++ + ++
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG------- 238
Query: 660 DEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
RL PP + + IM C +PE RP
Sbjct: 239 ------RLDPP-KGCPGPVYRIMT---DCWQHTPEDRPN 267
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 76/284 (26%), Positives = 123/284 (43%), Gaps = 52/284 (18%)
Query: 438 FDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFL-IEVKALTEI-R 494
F+ +GNG +G VY+ + +GQ+ AIK D D++E + +E+ L +
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVM------DVTEDEEEEIKLEINMLKKYSH 71
Query: 495 HRNIVKFYGF------CSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGV 548
HRNI +YG H +LV E GS+ L +T L + + +
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICREI 130
Query: 549 ADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGY 608
L++LH ++H+DI +N+LL E + DFG++ L F GT +
Sbjct: 131 LRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 187
Query: 609 VAPELAYTMKITE-----KCDVYSFGVLVLEAIKGK------HPRDFLSLISSSSLNTDI 657
+APE+ + + + D++S G+ +E +G HP L LI
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI--------- 238
Query: 658 ALDEILDPRLPPP---SRSVQEKLISIMEVAFSCLNESPESRPT 698
PR PPP S+ +K I +E CL ++ SRP+
Sbjct: 239 -------PRNPPPKLKSKKWSKKFIDFIE---GCLVKNYLSRPS 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 19/177 (10%)
Query: 443 CIGNGGHGSVYRA-ELPSGQVVAIK----KFHSPLPCDQIADQKEFLIEVKALTEI-RHR 496
+G+G GSVY A +G++VAIK KF+S C L EVK+L ++ H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-------LREVKSLRKLNEHP 58
Query: 497 NIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
NIVK + V+E +E G+L ++ + S ++I + L+++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIH 116
Query: 557 HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL 613
F H+D+ +NLL+ +ADFG+A+ ++ +T++ T Y APE+
Sbjct: 117 KHGF---FHRDLKPENLLVSGPEVVKIADFGLAREIR-SRPPYTDYVSTRWYRAPEI 169
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR------HR 496
IG G +G V++ +GQ+VAIKKF + + + +I+ AL EIR H
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF--------VESEDDPVIKKIALREIRMLKQLKHP 60
Query: 497 NIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
N+V R LV+E + L + + + + +I A+++ H
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 557 -HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAY 615
H+C +H+D+ +N+L+ + + + DFG A+ L ++T++ T Y APEL
Sbjct: 118 KHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLV 173
Query: 616 -TMKITEKCDVYSFGVLVLEAIKG 638
+ DV++ G + E + G
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 77/265 (29%), Positives = 133/265 (50%), Gaps = 29/265 (10%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKF-HSPLPCDQIADQKEFLIEVKALTEIRHRNIVKF 501
IG+G G+VY A ++ + +VVAIKK +S ++ ++ + EV+ L ++RH N +++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE--KWQDIIKEVRFLQKLRHPNTIQY 80
Query: 502 YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH-HDCF 560
G ++LV E GS + +L + + L + V G L+YLH H+
Sbjct: 81 RGCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHSHN-- 135
Query: 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTM--- 617
++H+D+ + N+LL + DFG A + P + F GT ++APE+ M
Sbjct: 136 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEG 189
Query: 618 KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEK 677
+ K DV+S G+ +E + K P ++ + S+L IA +E P L S E
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPP--LFNMNAMSAL-YHIAQNE--SPAL--QSGHWSEY 242
Query: 678 LISIMEVAFSCLNESPESRPTMKVV 702
+ ++ SCL + P+ RPT +V+
Sbjct: 243 FRNFVD---SCLQKIPQDRPTSEVL 264
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 64/274 (23%), Positives = 114/274 (41%), Gaps = 28/274 (10%)
Query: 437 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
DF +G G +GSVY+ + L Q A+K+ + ++++ + E++ L + H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK--EREDAVNEIRILASVNH 58
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAA-----QELGWSQRMNVIKGVAD 550
NI+ + +V E G L+ +S ++ W + +++G
Sbjct: 59 PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG--- 115
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVA 610
L LH I+H+D+ S N+LL + D GI+K LK + T+ GT Y+A
Sbjct: 116 -LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK-TQI-GTPHYMA 169
Query: 611 PELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670
PE+ + K D++S G L+ E P + S+ L ++ + PP
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRY-----KVQRGKYPPI 221
Query: 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQ 704
+ L + + S L P+ RP +
Sbjct: 222 PPIYSQDLQNFIR---SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKF-HSPLPCDQIADQKEFLIEVKALTEIRHRNIVKF 501
+G G +G V + + +GQ+VAIKKF S D +K + E++ L ++RH N+V
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESE---DDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 502 YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFP 561
+ +LV+E ++ L + + L S+ + + + + H
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSH--- 119
Query: 562 PIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAY-TMKIT 620
I+H+DI +N+L+ + DFG A+ L +T++ T Y APEL K
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179
Query: 621 EKCDVYSFGVLVLEAIKG 638
D+++ G LV E + G
Sbjct: 180 RAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 73/278 (26%), Positives = 115/278 (41%), Gaps = 36/278 (12%)
Query: 444 IGNGGHGSVYRAELPSGQVVA---IKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
IGNG G V E G A +K+ + D+ Q FL EV+ E+ H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE---QLLFLQEVQPYRELNHPNVLQ 59
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIK---GVADALSYLHH 557
G C + LV E G L L S+ +Q+ + + VA L +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGM-VAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTE--FAGTYGYVAPELA- 614
F +H D++ +N L + + D+G+A PE T+ A ++APEL
Sbjct: 119 ADF---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 615 ------YTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLS---LISSSSLNTDIALDEILD 664
T+K +++S GV + E P LS ++ DI L +
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK--- 232
Query: 665 PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVV 702
P+L ++ +M+ F L PE+RPT + V
Sbjct: 233 PQLDLK---YSDRWYEVMQ--FCWL--DPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 68/299 (22%), Positives = 125/299 (41%), Gaps = 65/299 (21%)
Query: 444 IGNGGHGSVYRAEL--PSGQ-------VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
+G G G VY+ EL P+ + + +K+ P Q+EF E + +++++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP------KVQQEFRQEAELMSDLQ 66
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSLAAIL-------------SSDTAAQELGWSQR 541
H NIV G C+ + + +++E L G L L +T L S
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 542 MNVIKGVADALSYL--HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599
+++ +A + YL HH VH+D++++N L+ ++DFG+++ + S+++
Sbjct: 127 LHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIY--SADY 179
Query: 600 TEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHP------RDFLSLI 648
++ PE K T + D++SFGV++ E G P ++ + +I
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239
Query: 649 SSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707
S L LP P + + C NE P RP K + ++R
Sbjct: 240 RSRQL-------------LPCPEDCPA----RVYALMIECWNEIPARRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 77/283 (27%), Positives = 119/283 (42%), Gaps = 40/283 (14%)
Query: 435 TNDFDAQYCIGNGGHGSVYR-AELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI 493
T+ ++ IG G +G VY+ G + A+K D I+D E E++A I
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL------DPISDVDE---EIEAEYNI 71
Query: 494 -----RHRNIVKFYGFCSHARHS-----FLVYELLERGSLAAILSSD-TAAQELGWSQRM 542
H N+VKFYG A +LV EL GS+ ++ Q L +
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131
Query: 543 NVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEF 602
++ G L +LH++ I+H+D+ N+LL E + DFG++ L
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188
Query: 603 AGTYGYVAPEL-----AYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDI 657
GT ++APE+ Y +CDV+S G+ +E G P L + T
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP-----LFDMHPVKTLF 243
Query: 658 ALDEILDPRLPPPSRSVQEKLI-SIMEVAFSCLNESPESRPTM 699
+ PR PPP+ EK S CL + E+RP++
Sbjct: 244 KI-----PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSV 281
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 76/284 (26%), Positives = 124/284 (43%), Gaps = 45/284 (15%)
Query: 442 YC----IGNGGHGSV--YRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
YC +G G +G V R Q V IKK + L ++K E + L++++H
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYV-IKKLN--LRNASRRERKAAEQEAQLLSQLKH 58
Query: 496 RNIVKFYGFCSHARHS--------FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKG 547
NIV + R S ++V E G L L + + L +Q +
Sbjct: 59 PNIVAY-------RESWEGEDGLLYIVMGFCEGGDLYHKLK-EQKGKLLPENQVVEWFVQ 110
Query: 548 VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG 607
+A AL YLH I+H+D+ ++N+ L V D GIA+ L+ + + GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPY 167
Query: 608 YVAPELAYTMKITEKCDVYSFGVLVLEAIKGKH---PRDFLSLISSSSLNTDIALDEILD 664
Y++PEL K DV++ G V E KH +D SL+ I++
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY-----------RIIE 216
Query: 665 PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708
+LPP + +L ++ + L++ PE RP++K + +Q I
Sbjct: 217 GKLPPMPKDYSPELGELIA---TMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 62/266 (23%), Positives = 113/266 (42%), Gaps = 41/266 (15%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
+G G G V++ L VA+K LP + + +FL E + L + H NIVK G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQEL---KIKFLSEARILKQYDHPNIVKLIG 59
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH-HDCFPP 562
C+ + ++V EL+ G + L EL Q + A ++YL +C
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNC--- 114
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG----------YVAPE 612
+H+D++++N L+ ++DFG+++ E G Y + APE
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGMSR---------QEDDGIYSSSGLKQIPIKWTAPE 164
Query: 613 LAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDP-RLPPPS 671
+ + + DV+S+G+L+ E L + + A +++ R+ P
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFS-------LGVCPYPGMTNQQAREQVEKGYRMSCPQ 217
Query: 672 RSVQEKLISIMEVAFSCLNESPESRP 697
+ + + +V C + PE+RP
Sbjct: 218 KCPDD----VYKVMQRCWDYKPENRP 239
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 65/255 (25%), Positives = 114/255 (44%), Gaps = 25/255 (9%)
Query: 459 SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH--ARHSFLVYE 516
+G+ VA+K + IAD K+ E++ L + H NIVK+ G C+ L+ E
Sbjct: 32 TGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88
Query: 517 LLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD 576
L GSL L + L Q++ + + YL + VH+D++++N+L++
Sbjct: 89 FLPSGSLKEYLPRNKNKINL--KQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVE 143
Query: 577 LEYEAHVADFGIAKFLKPESSNWT---EFAGTYGYVAPELAYTMKITEKCDVYSFGVLVL 633
E++ + DFG+ K ++ + +T + + APE K DV+SFGV +
Sbjct: 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203
Query: 634 EAI-----KGKHPRDFLSLISSSSLNTDIA-LDEILD--PRLPPPSRSVQEKLISIMEVA 685
E + + FL +I + + L +L+ RLP P + E++ +M
Sbjct: 204 ELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPP-NCPEEVYQLMR-- 260
Query: 686 FSCLNESPESRPTMK 700
C P R T +
Sbjct: 261 -KCWEFQPSKRTTFQ 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 72/284 (25%), Positives = 122/284 (42%), Gaps = 40/284 (14%)
Query: 444 IGNGGHGSVYRA----ELPSG---QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHR 496
+G+G G VY L G VA+K ++KEFL E ++ H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG---ATDQEKKEFLKEAHLMSNFNHP 59
Query: 497 NIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQE----LGWSQRMNVIKGVADAL 552
NIVK G C +++ EL+E G L + L + L + +++ VA
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 553 SYLHHDCFPPIVHQDISSKNLLL-----DLEYEAHVADFGIAKFLKPESSNWTEFAG--- 604
YL F +H+D++++N L+ D + + DFG+A+ + S++ G
Sbjct: 120 VYLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY--KSDYYRKEGEGL 174
Query: 605 -TYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEI 662
++APE K T + DV+SFGVL+ E + G+ P L+ N ++
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-------NQEVLQHVT 227
Query: 663 LDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
RL P + +K+ +M +C + P RPT + + +
Sbjct: 228 AGGRLQKP-ENCPDKIYQLMT---NCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 61/259 (23%), Positives = 116/259 (44%), Gaps = 27/259 (10%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
+G G G V+ VAIK + FL E + +++H +V+ Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ-----GSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563
+ +++ E +E GSL L + + L ++ +++ +A+ ++++ +
Sbjct: 69 VVTQ-EPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERKNY--- 123
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT---YGYVAPELAYTMKIT 620
+H+D+ + N+L+ +ADFG+A+ + E + +T G + APE T
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFT 181
Query: 621 EKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLI 679
K DV+SFG+L+ E + G+ P ++ N ++ + R+P P +E
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYPGMT-------NPEVIQNLERGYRMPRPDNCPEE--- 231
Query: 680 SIMEVAFSCLNESPESRPT 698
+ E+ C E PE RPT
Sbjct: 232 -LYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 76/286 (26%), Positives = 122/286 (42%), Gaps = 52/286 (18%)
Query: 438 FDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLI-EVKALTEI-R 494
F+ +GNG +G VY+ + +GQ+ AIK D D++E + E+ L +
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM------DVTGDEEEEIKQEINMLKKYSH 61
Query: 495 HRNIVKFYGFCSHAR------HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGV 548
HRNI +YG +LV E GS+ ++ +T L + + +
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK-NTKGNTLKEEWIAYICREI 120
Query: 549 ADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGY 608
LS+LH ++H+DI +N+LL E + DFG++ L F GT +
Sbjct: 121 LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 177
Query: 609 VAPELAYTMKITE-----KCDVYSFGVLVLEAIKGK------HPRDFLSLISSSSLNTDI 657
+APE+ + + K D++S G+ +E +G HP L LI
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--------- 228
Query: 658 ALDEILDPRLPPP---SRSVQEKLISIMEVAFSCLNESPESRPTMK 700
PR P P S+ +K S +E SCL ++ RPT +
Sbjct: 229 -------PRNPAPRLKSKKWSKKFQSFIE---SCLVKNHSQRPTTE 264
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 67/268 (25%), Positives = 110/268 (41%), Gaps = 14/268 (5%)
Query: 437 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
+F + IG G VYRA L G VA+KK D A + + E+ L ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA-DCIKEIDLLKQLNH 61
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
N++K+Y +V EL + G L+ ++ + L V K S L
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL--IPEKTVWKYFVQLCSAL 119
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAY 615
H ++H+DI N+ + + D G+ +F +++ GT Y++PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 616 TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP-PSRSV 674
K D++S G L+ E + P +N +I PP PS
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP------FYGDKMNLYSLCKKIEQCDYPPLPSDHY 233
Query: 675 QEKLISIMEVAFSCLNESPESRPTMKVV 702
E+L ++ + C+N PE RP + V
Sbjct: 234 SEELRQLVNM---CINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKF- 501
IG G +G V A + +G+ VAIKK + + ++D L E+K L +RH +IV+
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 502 YGFCSHARHSF----LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH 557
+ +R F +V+EL+E I ++D E + + AL Y+H
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE----HHQFFLYQLLRALKYIHT 121
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK--FLK-PESSNWTEFAGTYGYVAPEL- 613
+ H+D+ KN+L + + + + DFG+A+ F P + WT++ T Y APEL
Sbjct: 122 ---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 614 -AYTMKITEKCDVYSFGVLVLEAIKGK 639
++ K T D++S G + E + GK
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 3e-13
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 43/230 (18%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG+G +G V A +G+ VAIKK D + D K L E+K L +RH NI+
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 503 G-FCSHARHSF----LVYELLERGSLAAILSSDTAAQELGWSQRM-----NVIKGVADAL 552
+ F +V EL+E L ++ S Q L + +++G L
Sbjct: 66 DILRPPSPEDFNDVYIVTELME-TDLHKVIKSP---QPLT-DDHIQYFLYQILRG----L 116
Query: 553 SYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS---NWTEFAGTYGYV 609
YLH ++H+D+ N+L++ + + DFG+A+ + P+ TE+ T Y
Sbjct: 117 KYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173
Query: 610 APEL-----AYTMKITEKCDVYSFGVLVLEAI------KGKHPRDFLSLI 648
APEL YT I D++S G + E + G+ D L+LI
Sbjct: 174 APELLLSSSRYTKAI----DIWSVGCIFAELLTRKPLFPGRDYIDQLNLI 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 78/278 (28%), Positives = 129/278 (46%), Gaps = 29/278 (10%)
Query: 436 NDFDAQYCIGNGGHGSVYR-AELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
+DF+ +G G G V++ + PSG ++A K H + + A + + + E++ L E
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECN 61
Query: 495 HRNIVKFYG-FCSHARHSFLVYELLERGSLAAIL--SSDTAAQELGWSQRMNVIKGVADA 551
IV FYG F S S + E ++ GSL +L + Q LG + VIKG
Sbjct: 62 SPYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKG---- 115
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAP 611
L+YL I+H+D+ N+L++ E + DFG++ L +N F GT Y++P
Sbjct: 116 LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSP 171
Query: 612 ELAYTMKITEKCDVYSFGVLVLEAIKGKHP-----RDFLSLISSSSLNTDIALDEILDPR 666
E + + D++S G+ ++E G++P L L+ + D A E PR
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE-TSPR 230
Query: 667 LPPPSRSV------QEKLISIMEVAFSCLNESPESRPT 698
PP R + ++I E+ +NE P P+
Sbjct: 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPS 268
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 35/232 (15%)
Query: 437 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK---FHSPLPCDQIADQKEFLIEVKALTE 492
+ IG G +G V A P+G VAIKK F C + L E+K L
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT------LREIKILRR 59
Query: 493 IRHRNIVKFY------GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIK 546
+H NI+ F S ++V EL+E L ++ + Q L +
Sbjct: 60 FKHENIIGILDIIRPPSFESF-NDVYIVQELMET-DLYKLIKT----QHLSNDHIQYFLY 113
Query: 547 GVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN---WTEFA 603
+ L Y+H ++H+D+ NLLL+ + + DFG+A+ PE + TE+
Sbjct: 114 QILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 604 GTYGYVAPELAYTMK-ITEKCDVYSFGVLVLEAIK------GKHPRDFLSLI 648
T Y APE+ K T+ D++S G ++ E + GK L+LI
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI 222
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 59/277 (21%), Positives = 110/277 (39%), Gaps = 46/277 (16%)
Query: 444 IGNGGHGSVYRAELPSG------QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G G G V+ A+ +V +K Q EF E+ ++ H+N
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK---TKDENLQSEFRRELDMFRKLSHKN 69
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAIL------SSDTAAQELGWSQRMNVIKGVADA 551
+V+ G C A +++ E + G L L L Q++ + +A
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG---Y 608
+ +L + F VH+D++++N L+ + E V+ ++K +S + + +
Sbjct: 130 MDHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIPLRW 184
Query: 609 VAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL-NTDIALDEIL---- 663
+APE + K DV+SFGVL+ E + + L ++ +E+L
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWE------------VFTQGELPFYGLSDEEVLNRLQ 232
Query: 664 --DPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
LP P +L +M C +P+ RP+
Sbjct: 233 AGKLELPVPE-GCPSRLYKLMT---RCWAVNPKDRPS 265
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 70/277 (25%), Positives = 128/277 (46%), Gaps = 27/277 (9%)
Query: 436 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
+DF+ +G G G V + + PSG ++A K H + + A + + + E++ L E
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECN 61
Query: 495 HRNIVKFYG-FCSHARHSFLVYELLERGSLAAIL-SSDTAAQELGWSQRMNVIKGVADAL 552
IV FYG F S S + E ++ GSL +L + +E+ + V++G L
Sbjct: 62 SPYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG----L 116
Query: 553 SYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE 612
+YL I+H+D+ N+L++ E + DFG++ L +N F GT Y++PE
Sbjct: 117 AYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPE 172
Query: 613 LAYTMKITEKCDVYSFGVLVLEAIKGKHP------RDFLSLISSSSLNTDIALDEILDPR 666
+ + D++S G+ ++E G++P ++ ++ ++ + + PR
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR 232
Query: 667 LPPPSRSV------QEKLISIMEVAFSCLNESPESRP 697
PP R V ++I E+ +NE P P
Sbjct: 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP 269
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 20/207 (9%)
Query: 444 IGNGGHGSVYRA--ELPSGQV-VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
+G+G G V + ++ Q+ VAIK + ++ + + E + E + + ++ + IV+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE---NEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
G C A LV E+ G L LS E+ S + ++ V+ + YL F
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG-----YVAPELAY 615
VH+D++++N+LL ++ A ++DFG++K L + S + A + G + APE
Sbjct: 117 ---VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWYAPECIN 171
Query: 616 TMKITEKCDVYSFGVLVLEAIK-GKHP 641
K + + DV+S+G+ + EA G+ P
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 13/203 (6%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
+G+G G VY+A+ V+A K +++ D +++E+ L H NIVK
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELED---YMVEIDILASCDHPNIVKLLD 69
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563
+ + +++ E G++ A++ + L Q V K +AL+YLH + I
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHEN---KI 124
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITE-- 621
+H+D+ + N+L L+ + +ADFG++ F GT ++APE+ +
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 622 ---KCDVYSFGVLVLEAIKGKHP 641
K DV+S G+ ++E + + P
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKE-----FLIEVKALTEIRHRN 497
+G G + VY+A +G++VAIKK + + K+ L E+K L E++H N
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKL----GERKEAKDGINFTALREIKLLQELKHPN 63
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSD----TAAQELGWSQRMNVIKGVADALS 553
I+ H + LV+E +E L ++ T A + ++G L
Sbjct: 64 IIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT--LRG----LE 116
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL 613
YLH + I+H+D+ NLL+ + +ADFG+A+ + T T Y APEL
Sbjct: 117 YLH-SNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPEL 173
Query: 614 AYTMKI-TEKCDVYSFGVLVLEAIKGK 639
+ + D++S G + E +
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 68/271 (25%), Positives = 114/271 (42%), Gaps = 47/271 (17%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKF---HSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
IG+G G+VY+ P+G++ A+K H QI E++ L ++ H N+V
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR------EIEILRDVNHPNVV 135
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
K + H ++ E ++ GSL +D +V + + ++YLH
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQ-------FLADVARQILSGIAYLHRR- 187
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE-----LA 614
IVH+DI NLL++ +ADFG+++ L GT Y++PE L
Sbjct: 188 --HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLN 245
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGKHP------RDFLSLISSSSLNTDIALDEILDPRLP 668
+ D++S GV +LE G+ P D+ SL+ + ++ P
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS---------QPPEA 296
Query: 669 PPSRSVQEK-LISIMEVAFSCLNESPESRPT 698
P + S + + IS CL P R +
Sbjct: 297 PATASREFRHFISC------CLQREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G G G V A + +GQ VAIKK P +A K E+K L +RH NI+
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLA--KRTYRELKLLKHLRHENIISLS 75
Query: 503 G-FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFP 561
F S + V ELL L +L+S ++ +++G L Y+H
Sbjct: 76 DIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILRG----LKYVHS---A 127
Query: 562 PIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYT-MKIT 620
+VH+D+ N+L++ + + DFG+A + + T + T Y APE+ T K
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLA---RIQDPQMTGYVSTRYYRAPEIMLTWQKYD 184
Query: 621 EKCDVYSFGVLVLEAIKGK 639
+ D++S G + E ++GK
Sbjct: 185 VEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 70/273 (25%), Positives = 119/273 (43%), Gaps = 33/273 (12%)
Query: 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
+D++ +G+G +G VY+A L +G++ A+K P D + ++ + VK E +
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE-PGDDFSLIQQEIFMVK---ECK 64
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
H NIV ++G ++ E GSL I EL Q V + L+Y
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRETLQGLAY 121
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
LH +H+DI N+LL + +ADFG+A + + F GT ++APE+A
Sbjct: 122 LHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA 178
Query: 615 YTMK---ITEKCDVYSFGVLVLEAIKGK------HPRDFLSLISSSSLNTDIALDEILDP 665
K + CD+++ G+ +E + + HP L L+S S+
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ----------- 227
Query: 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
PP + + + L ++P+ RPT
Sbjct: 228 --PPKLKDKTKWSSTFHNFVKISLTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 80/300 (26%), Positives = 129/300 (43%), Gaps = 38/300 (12%)
Query: 426 LVYDEIVRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFL 484
+++D ++ ++ IG G +G V++ +G A+K P I ++ E
Sbjct: 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD---PIHDIDEEIEAE 64
Query: 485 IEV-KALTEIRHRNIVKFYGF-----CSHARHSFLVYELLERGSLAAILSSDTAAQELGW 538
+ KAL++ H N+VKFYG + +LV EL GS+ +D L
Sbjct: 65 YNILKALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-----TDLVKGFLKR 117
Query: 539 SQRMN---VIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595
+RM + + +AL L H +H+D+ N+LL E + DFG++ L
Sbjct: 118 GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177
Query: 596 SSNWTEFAGTYGYVAPEL-----AYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISS 650
GT ++APE+ +CDV+S G+ +E G P
Sbjct: 178 RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL-------- 229
Query: 651 SSLNTDIALDEILDPRLPPPSRSVQEKLIS--IMEVAFSCLNESPESRPTMKVVTQQVRI 708
+ L+ AL +I PR PPP+ Q +L S + CL + E RPT+ + Q V I
Sbjct: 230 ADLHPMRALFKI--PRNPPPTLH-QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 69/279 (24%), Positives = 118/279 (42%), Gaps = 33/279 (11%)
Query: 437 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
DF+ IG+G +G VY+A + +G++ AIK D Q+E ++ + + +H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIM----MKDCKH 65
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
NIV ++G ++ E GSL I E SQ V + L YL
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSE---SQIAYVSRETLQGLYYL 122
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAY 615
H +H+DI N+LL +ADFG++ + + F GT ++APE+A
Sbjct: 123 HSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 179
Query: 616 TMK---ITEKCDVYSFGVLVLEAIKGK------HPRDFLSLISSSSLNTDIALDEILDPR 666
+ + CD+++ G+ +E + + HP L L++ S+
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ------------ 227
Query: 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
PP + + S L ++P+ RPT + + Q
Sbjct: 228 -PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-12
Identities = 49/158 (31%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 246 LGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSI 305
LGL N +P ++ KL L ++ S N G IP + S+ SLE L+LS+N+ +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 306 PNCFEGIRGISVIDISDNQLQGPVPNSTAFR--NAPVEALKGNKGLCGGVKGMQPCKVFL 363
P + + +++++ N L G VP + R + N GLC G+ G++ C L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLC-GIPGLRACGPHL 541
Query: 364 SHKQNSRVKWFAIVFPVLGALFLSMALIAIFILRKRKS 401
S K I F V A FL + + A+ ++R++
Sbjct: 542 S----VGAK-IGIAFGVSVA-FLFLVICAMCWWKRRQN 573
|
Length = 623 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 11/204 (5%)
Query: 443 CIGNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
+G G G VY ++ +G+ +A+K+ P + + E++ L ++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
+YG + E + GS+ L + A E + + + + + YLH +
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTE---TVTRKYTRQILEGVEYLHSN-- 123
Query: 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWT---EFAGTYGYVAPELAYTM 617
IVH+DI N+L D + DFG +K L+ S+ T GT +++PE+
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 618 KITEKCDVYSFGVLVLEAIKGKHP 641
K DV+S G V+E + K P
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 55/195 (28%), Positives = 87/195 (44%), Gaps = 24/195 (12%)
Query: 459 SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY--GFCSHARHSFLVYE 516
+G VAIK + P ++ + F E + H NIV G F V+E
Sbjct: 2 TGHEVAIKLLRTDAPEEE-HQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFE 59
Query: 517 LLERGSLAAILSSDTA--AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLL 574
+ +L +L++D A A E G ++ V DAL+ H+ IVH+D+ +N++
Sbjct: 60 YVPGRTLREVLAADGALPAGETG-----RLMLQVLDALACAHNQ---GIVHRDLKPQNIM 111
Query: 575 L---DLEYEAHVADFGIAKFL-------KPESSNWTEFAGTYGYVAPELAYTMKITEKCD 624
+ + A V DFGI L + TE GT Y APE +T D
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 625 VYSFGVLVLEAIKGK 639
+Y++G++ LE + G+
Sbjct: 172 LYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 63/275 (22%), Positives = 119/275 (43%), Gaps = 29/275 (10%)
Query: 430 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKA 489
EI R + + + +G G G V+ A VA+K + FL E
Sbjct: 2 EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKP-----GSMSVEAFLAEANV 54
Query: 490 LTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA 549
+ ++H +VK + + +++ E + +GSL L SD + + ++ +A
Sbjct: 55 MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIA 112
Query: 550 DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT---Y 606
+ ++++ + +H+D+ + N+L+ +ADFG+A+ + E + +T G
Sbjct: 113 EGMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPI 167
Query: 607 GYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP 665
+ APE T K DV+SFG+L++E + G+ P +S N ++
Sbjct: 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-------NPEVIRALERGY 220
Query: 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
R+P P +E + + C PE RPT +
Sbjct: 221 RMPRPENCPEE----LYNIMMRCWKNRPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 65/270 (24%), Positives = 109/270 (40%), Gaps = 14/270 (5%)
Query: 437 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
+F + IG G VYRA L + VA+KK D A Q + + E+ L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ-DCVKEIDLLKQLNH 61
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
N++K+ +V EL + G L+ ++ + L V K S +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL--IPERTVWKYFVQLCSAV 119
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAY 615
H ++H+DI N+ + + D G+ +F +++ GT Y++PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 616 TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP-PSRSV 674
K D++S G L+ E + P +N +I PP P+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP------FYGDKMNLFSLCQKIEQCDYPPLPTEHY 233
Query: 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQ 704
EKL E+ C+ P+ RP + V Q
Sbjct: 234 SEKL---RELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 67/272 (24%), Positives = 116/272 (42%), Gaps = 42/272 (15%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEF---LIEVKALTEIRHRNIV 499
+G G +GSVY+ P+G +A+K+ L D+ +F ++E+ L + IV
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLEL------DESKFNQIIMELDILHKAVSPYIV 62
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
FYG ++ E ++ GSL + + A + + + V L +L +
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE- 121
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE------- 612
I+H+D+ N+L++ + + DFG++ L +S G Y+APE
Sbjct: 122 -HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL--VASLAKTNIGCQSYMAPERIKSGGP 178
Query: 613 ---LAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD---PR 666
YT+ + DV+S G+ +LE G++P + N L I+D P
Sbjct: 179 NQNPTYTV----QSDVWSLGLSILEMALGRYPYP-----PETYANIFAQLSAIVDGDPPT 229
Query: 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
LP + ++ CLN+ P RPT
Sbjct: 230 LPSGYSDDAQDFVA------KCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 63/263 (23%), Positives = 104/263 (39%), Gaps = 48/263 (18%)
Query: 463 VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGS 522
VA+K P +++FL EVK L+ + NI + G C+ ++ E +E G
Sbjct: 49 VAVKV---LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105
Query: 523 LAAILS------SDTAAQELGWSQR--MNVIKGVADALSYLHHDCFPPIVHQDISSKNLL 574
L L S A S + + +A + YL F VH+D++++N L
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF---VHRDLATRNCL 162
Query: 575 LDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYV-----------APELAYTMKITEKC 623
+ Y +ADFG+++ L ++ Y V A E K T K
Sbjct: 163 VGKNYTIKIADFGMSRNL---------YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKS 213
Query: 624 DVYSFGVLVLE--AIKGKHPRDFLS----LISSSSLNTDIALDEILDPRLPPPSRSVQEK 677
DV++FGV + E + + P + L+ + ++ D LP P ++
Sbjct: 214 DVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIY----LPRPPNCPKD- 268
Query: 678 LISIMEVAFSCLNESPESRPTMK 700
I E+ C E RPT +
Sbjct: 269 ---IYELMLECWRRDEEDRPTFR 288
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 36/224 (16%)
Query: 436 NDFDAQYCIGNGGHGSVYRAELPSGQV---VAIKKFHSPLPCDQIADQKEFLIEVKALTE 492
ND Q IG G G V +A + + AIK+ D D ++F E++ L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 63
Query: 493 I-RHRNIVKFYGFCSHARHSFLVYELLERGSL------AAILSSDTA-------AQELGW 538
+ H NI+ G C H + +L E G+L + +L +D A A L
Sbjct: 64 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 539 SQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN 598
Q ++ VA + YL F +H+D++++N+L+ Y A +ADFG+++
Sbjct: 124 QQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR------GQ 174
Query: 599 WTEFAGTYG-----YVAPE-LAYTMKITEKCDVYSFGVLVLEAI 636
T G ++A E L Y++ T DV+S+GVL+ E +
Sbjct: 175 EVYVKKTMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 6e-12
Identities = 37/89 (41%), Positives = 48/89 (53%)
Query: 173 ALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNS 232
L L + G IP ++ KL L + L GN G +PP +GS+ LE LDLS N FN S
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 233 VPENLGNLLKLHYLGLSNNQFVLELPKEL 261
+PE+LG L L L L+ N +P L
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 66/273 (24%), Positives = 111/273 (40%), Gaps = 44/273 (16%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQ------KEFLIEVKALTEIRHR 496
+G+G G+V++ +P G + I P+ I D+ +E + A+ + H
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKI-----PVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69
Query: 497 NIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
IV+ G C A LV +L GSL + + L + +N +A + YL
Sbjct: 70 YIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLE 126
Query: 557 HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELA 614
+VH++++++N+LL + +ADFG+A L P+ ++E ++A E
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 615 YTMKITEKCDVYSFGVLVLEAIK-------GKHPRDFLSLISSSSLNTDIALDEILDPRL 667
+ T + DV+S+GV V E + G P + L+ RL
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE-------------RL 230
Query: 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
P Q I + V C RPT K
Sbjct: 231 AQP----QICTIDVYMVMVKCWMIDENVRPTFK 259
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 71/286 (24%), Positives = 116/286 (40%), Gaps = 70/286 (24%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN---IV 499
IG G G+V + PSG ++A+K+ S + D+ +QK L+++ + +R + IV
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTV--DE-KEQKRLLMDLDVV--MRSSDCPYIV 66
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRM----NVIKGVA----DA 551
KFYG ++ EL++ +S D + + + ++ +A A
Sbjct: 67 KFYGALFREGDCWICMELMD-------ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKA 119
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAP 611
L+YL + I+H+D+ N+LLD + DFGI+ L +S T AG Y+AP
Sbjct: 120 LNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAP 176
Query: 612 ELAYTMKITE--------KCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEIL 663
E +I + DV+S G+ + E GK P + +
Sbjct: 177 E-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP--------------KWNSVF 217
Query: 664 D----------PRLPPPSRSVQEKLISIMEVAF--SCLNESPESRP 697
D P L E+ S V F CL + RP
Sbjct: 218 DQLTQVVKGDPPILSNSE----EREFSPSFVNFINLCLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 70/268 (26%), Positives = 114/268 (42%), Gaps = 34/268 (12%)
Query: 443 CIGNGGHGSVYRA--ELPSGQV--VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI 498
CIG G G VY+ P + VA+K + C + +++FL E + + H +I
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKN---CTSPSVREKFLQEAYIMRQFDHPHI 69
Query: 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
VK G + ++V EL G L + L L + + ++ AL+YL
Sbjct: 70 VKLIGVITE-NPVWIVMELAPLGELRSYLQ--VNKYSLDLASLILYSYQLSTALAYLESK 126
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG-----YVAPEL 613
F VH+DI+++N+L+ + DFG++++L+ ES + + G ++APE
Sbjct: 127 RF---VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY----YKASKGKLPIKWMAPES 179
Query: 614 AYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672
+ T DV+ FGV + E + G P + N D+ RLP P
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK-------NNDVIGRIENGERLPMPP- 231
Query: 673 SVQEKLISIMEVAFSCLNESPESRPTMK 700
+ L S+M C P RP
Sbjct: 232 NCPPTLYSLMT---KCWAYDPSKRPRFT 256
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPCDQIADQKEFLIEVKALTEIRHRNIVKF 501
+G G G VY ++ +G+ +A K+ P + + E++ L ++H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 502 YG-FCSHARHSFLVY-ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
YG A + ++ E + GS+ L + A E S + + + +SYLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE---SVTRKYTRQILEGMSYLHSNM 126
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP---ESSNWTEFAGTYGYVAPELAYT 616
IVH+DI N+L D + DFG +K L+ + GT +++PE+
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183
Query: 617 MKITEKCDVYSFGVLVLEAIKGKHP 641
K DV+S G V+E + K P
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 27/206 (13%)
Query: 448 GHGSVYRAEL----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
G GS RA L S Q A+K+ P + D ++ E L +++H NIV F
Sbjct: 9 GEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAFKE 65
Query: 504 FCSHARHSFLVYELLERGSL--------AAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
H ++V E + G L + DT L W +M + + ++
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI---LQWFVQMCL------GVQHI 116
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAY 615
H ++H+DI SKN+ L + + DFG A+ L + + GT YV PE+
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWE 173
Query: 616 TMKITEKCDVYSFGVLVLEAIKGKHP 641
M K D++S G ++ E KHP
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIK--KFHSPLPCDQIADQKE-FLI----EVKALTEIRH 495
I G +G VYRA + +G++VA+K K +KE F I E+ L +++H
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEK---------EKEGFPITSLREINILLKLQH 63
Query: 496 RNIV--KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALS 553
NIV K S+ ++V E +E L +++ +T Q S+ ++ + ++
Sbjct: 64 PNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLM--ETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA-KFLKPESSNWTEFAGTYGYVAPE 612
+LH + I+H+D+ + NLLL+ + DFG+A ++ P +T+ T Y APE
Sbjct: 121 HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYTQLVVTLWYRAPE 176
Query: 613 LAY-TMKITEKCDVYSFGVLVLEAIKGK 639
L + + D++S G + E + K
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 52/196 (26%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G +G VY+A +G+VVA+KK L + + E+ L E+ H NIVK
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH-HDCFP 561
+LV+E L + L + + + + + + + L++ H H
Sbjct: 66 DVIHTENKLYLVFEFLHQ-DLKKFMDA-SPLSGIPLPLIKSYLFQLLQGLAFCHSHR--- 120
Query: 562 PIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKI-T 620
++H+D+ +NLL++ E +ADFG+A+ +T T Y APE+ K +
Sbjct: 121 -VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 179
Query: 621 EKCDVYSFGVLVLEAI 636
D++S G + E +
Sbjct: 180 TAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 57/211 (27%), Positives = 87/211 (41%), Gaps = 35/211 (16%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHR-----N 497
I G GSVY A+ +G AIK D IA + + VKA I
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKK---SDMIAKNQ--VTNVKAERAIMMIQGESPY 58
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELG-----WSQRMNVIKGVADAL 552
+ K Y + +LV E L G A+++ + LG W++ I V +
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLI------KTLGGLPEDWAK--QYIAEVVLGV 110
Query: 553 SYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK--FLKPESSNWTEFAGTYGYVA 610
LH I+H+DI +NLL+D + DFG+++ + F GT Y+A
Sbjct: 111 EDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLA 161
Query: 611 PELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
PE + + D +S G ++ E + G P
Sbjct: 162 PETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 70/278 (25%), Positives = 121/278 (43%), Gaps = 47/278 (16%)
Query: 438 FDAQYCIGNGGHGSVY--RAELPSGQVVAIKKFHSPLPC-DQIADQKEFLIEVKALTEIR 494
++ IG G G +Y +A+ S V + + +P ++ A +KE ++ L +++
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVIL----LAKMK 57
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSL--------AAILSSDTAAQELGWSQRMNVIK 546
H NIV F+ F+V E + G L + S D Q L W ++++
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED---QILSWFVQISL-- 112
Query: 547 GVADALSYLHHDCFPPIVHQDISSKNLLLDLE-YEAHVADFGIAKFLKPESSNWTEFA-- 603
L ++H I+H+DI S+N+ L A + DFGIA+ L ++ E A
Sbjct: 113 ----GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL----NDSMELAYT 161
Query: 604 --GTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDE 661
GT Y++PE+ K D++S G ++ E KHP ++L+ + +
Sbjct: 162 CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP------FEGNNLHQLVL--K 213
Query: 662 ILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTM 699
I P S + L S++ F SP RP++
Sbjct: 214 ICQGYFAPISPNFSRDLRSLISQLFKV---SPRDRPSI 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEV---KALTEIRHRNIV 499
IG G +G+VY+A +L +G+ VA+KK PL + I L E+ K L H NIV
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLKQLESFEHPNIV 64
Query: 500 KFYGFC-----SHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
+ C LV+E +++ LA LS L ++++ + + +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSK-CPKPGLPPETIKDLMRQLLRGVDF 122
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
LH IVH+D+ +N+L+ + + +ADFG+A+ E + T T Y APE+
Sbjct: 123 LHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPEVL 178
Query: 615 YTMKITEKCDVYSFGVLVLE 634
D++S G + E
Sbjct: 179 LQSSYATPVDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 63/216 (29%), Positives = 95/216 (43%), Gaps = 28/216 (12%)
Query: 439 DAQY----CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI 493
D +Y IG G +G V A + + VAIKK + D D K L E+K L +
Sbjct: 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF--DNRIDAKRTLREIKLLRHL 61
Query: 494 RHRNIVKFYGFCS-HARHSF----LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGV 548
H N++ R +F +VYEL++ L I+ S +Q L + +
Sbjct: 62 DHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRS---SQTLSDDHCQYFLYQL 117
Query: 549 ADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGY 608
L Y+H ++H+D+ NLLL+ + + DFG+A+ + TE+ T Y
Sbjct: 118 LRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWY 174
Query: 609 VAPEL-----AYTMKITEKCDVYSFGVLVLEAIKGK 639
APEL YT I DV+S G + E + K
Sbjct: 175 RAPELLLNCSEYTTAI----DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 15/213 (7%)
Query: 486 EVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVI 545
E+ L+ ++H NI+ +Y + E G+L + Q + +
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIV-RQKGQLFEEEMVLWYL 107
Query: 546 KGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT 605
+ A+SY+H I+H+DI + N+ L + DFGI+K L E S GT
Sbjct: 108 FQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGT 164
Query: 606 YGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDP 665
Y++PEL +K K D+++ G ++ E + K D + +L I
Sbjct: 165 PYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNLVVKIVQGN---- 217
Query: 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
P S E LIS++ S L + PE RPT
Sbjct: 218 YTPVVSVYSSE-LISLVH---SLLQQDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-11
Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 3/95 (3%)
Query: 152 VSMNN--ITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRL 209
+ ++N + G IP +I LQ+++LS N I G IP LG + SL L L N F G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 210 PPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLH 244
P +G L L L+L+ N + VP LG L LH
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL-LH 516
|
Length = 623 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 39/224 (17%)
Query: 433 RATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKE-FLI----E 486
R + FD IG G +G VY+A + +G++VA+KK ++ ++KE F I E
Sbjct: 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-------RLDNEKEGFPITAIRE 56
Query: 487 VKALTEIRHRNIVKFY----------GFCSHARHSFLVYELLERGSLAAILSSDTAAQEL 536
+K L ++ HRNIV F +LV+E ++ L +L S
Sbjct: 57 IKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLV--HF 113
Query: 537 GWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596
+ +K + + L+Y H F +H+DI N+LL+ + + +ADFG+A+ E
Sbjct: 114 SEDHIKSFMKQLLEGLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170
Query: 597 SN-WTEFAGTYGYVAPEL-----AYTMKITEKCDVYSFGVLVLE 634
S +T T Y PEL Y I DV+S G ++ E
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAI----DVWSCGCILGE 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 73/268 (27%), Positives = 122/268 (45%), Gaps = 29/268 (10%)
Query: 437 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIAD-QKEFLIEVKALTEIR 494
D Q +G+G G+VY+A L + +++A+K +P D + QK+ + E++ L +
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKV----IPLDITVELQKQIMSELEILYKCD 57
Query: 495 HRNIVKFYG-FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALS 553
I+ FYG F R S + E ++ GSL LG R+ V V L+
Sbjct: 58 SPYIIGFYGAFFVENRIS-ICTEFMDGGSLDVYRK--IPEHVLG---RIAV--AVVKGLT 109
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL 613
YL I+H+D+ N+L++ + + DFG++ L +S + GT Y+APE
Sbjct: 110 YLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPER 164
Query: 614 AYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD---PRLPPP 670
+ DV+S G+ +E G+ P + S + + L I+D P LP
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDEDPPVLPVG 223
Query: 671 SRSVQEKLISIMEVAFSCLNESPESRPT 698
S EK + + C+ + P+ RP
Sbjct: 224 QFS--EKFVHFIT---QCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 10/206 (4%)
Query: 436 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
N F+ +G G +G V + + ++VAIKKF +++ + L E+K L ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETT--LRELKMLRTLK 58
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
NIV+ +LV+E +E+ L + + + I + A+ +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP---EKVRSYIYQLIKAIHW 115
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES-SNWTEFAGTYGYVAPEL 613
H + IVH+DI +NLL+ + DFG A+ L S +N+TE+ T Y +PEL
Sbjct: 116 CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL 172
Query: 614 AYTMKITEKCDVYSFGVLVLEAIKGK 639
+ D++S G ++ E G+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 437 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI--EVKALTEI 493
D + +G G G V+ + S A+K P + I ++E + E + L E+
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIP---EVIRLKQEQHVHNEKRVLKEV 58
Query: 494 RHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKG------ 547
H I++ + R +++ E + G L + L + S R + G
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---------SGRFSNSTGLFYASE 109
Query: 548 VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG 607
+ AL YLH IV++D+ +N+LLD E + DFG AK L+ + WT GT
Sbjct: 110 IVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--WT-LCGTPE 163
Query: 608 YVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
Y+APE+ + + D ++ G+L+ E + G P
Sbjct: 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-11
Identities = 67/288 (23%), Positives = 121/288 (42%), Gaps = 50/288 (17%)
Query: 444 IGNGGHGSVYRAELP----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
+G G GSV A+L S Q VA+K + + +D +EFL E + E H N++
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS--SDIEEFLREAACMKEFDHPNVI 64
Query: 500 KFYGFCSHARHS------FLVYELLERGSLAAILSSDTAAQE---LGWSQRMNVIKGVAD 550
K G +R ++ ++ G L L +E L + + +A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTY---- 606
+ YL F +H+D++++N +L+ VADFG++K + ++G Y
Sbjct: 125 GMEYLSSKNF---IHRDLAARNCMLNENMTVCVADFGLSKKI---------YSGDYYRQG 172
Query: 607 -------GYVAPELAYTMKITEKCDVYSFGVLVLE-AIKGKHPRDFLSLISSSSLNTDIA 658
++A E T DV++FGV + E +G+ P + N++I
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-------NSEIY 225
Query: 659 LDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
I RL P +++ + E+ C + P+ RP+ + + Q+
Sbjct: 226 NYLIKGNRLKQPPDCLED----VYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 87/307 (28%), Positives = 128/307 (41%), Gaps = 59/307 (19%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFT 62
L LDLN N+ + + + LTNL L L NN++ IPP +
Sbjct: 94 PLPSLDLNLNRLRSNISELL-ELTNLTSLDLDNNNITD-IPPLIGLL------------- 138
Query: 63 SYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPN 122
L+ +S+N + ++P LRN +L + L+ N+L+ ++ + L N
Sbjct: 139 ---------KSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSN 187
Query: 123 LTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIV 182
L +DLS N IS +P EI S L+ LDLS N I+
Sbjct: 188 LNNLDLSGNK----ISD---------------------LPPEIELLSALEELDLSNNSII 222
Query: 183 GEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLK 242
E+ L L +L+ L L N+ LP IG+L +LE LDLS N+ ++ +LG+L
Sbjct: 223 -ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS--ISSLGSLTN 278
Query: 243 LHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS 302
L L LS N LP L L+ L + L + L S+ N +N
Sbjct: 279 LRELDLSGNSLSNALP--LIALLLLLLELLLNLLLTLKALEL--KLNSILLNNNILSNGE 334
Query: 303 GSIPNCF 309
S P
Sbjct: 335 TSSPEAL 341
|
Length = 394 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 80/281 (28%), Positives = 120/281 (42%), Gaps = 45/281 (16%)
Query: 444 IGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPCDQIADQKE---FLIEVKALTEIRHR 496
IG G G VY L A+K ++I D +E FL E + + H
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSL------NRITDLEEVEQFLKEGIIMKDFSHP 56
Query: 497 NIVKFYGFCSHARHSFLV-YELLERGSLAAILSSD----TAAQELGWSQRMNVIKGVADA 551
N++ G C + S LV ++ G L + S+ T +G+ + VA
Sbjct: 57 NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQ------VAKG 110
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK--FLKPESS--NWTEFAGTYG 607
+ YL F VH+D++++N +LD + VADFG+A+ + K S N T
Sbjct: 111 MEYLASKKF---VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK 167
Query: 608 YVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHP-RDFLSLISSSSLNTDIALDEILDP 665
++A E T K T K DV+SFGVL+ E + +G P D S DI + +
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF--------DITVYLLQGR 219
Query: 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
RL P + EV SC + PE RPT + ++
Sbjct: 220 RLLQPEYCPD----PLYEVMLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 65/284 (22%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 444 IGNGGHGSVYRAELPSGQV-------VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHR 496
+G G G VY + G V VAIK + + ++ EFL E + E
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCH 69
Query: 497 NIVKFYGFCSHARHSFLVYELLERGSLAAILSS------DTAAQELGWSQRMNVIKG-VA 549
++V+ G S + + ++ EL+ RG L + L S + Q ++M + G +A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 550 DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG-- 607
D ++YL+ + F VH+D++++N ++ ++ + DFG+ + + E+ + + G G
Sbjct: 130 DGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYYRK--GGKGLL 183
Query: 608 ---YVAPELAYTMKITEKCDVYSFGVLVLE-AIKGKHPRDFLSLISSSSLNTDIALDEIL 663
+++PE T DV+SFGV++ E A + P +S + L ++
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--------NEQVLRFVM 235
Query: 664 DPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707
+ L + + L +M + C +P+ RP+ + ++
Sbjct: 236 EGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 47/151 (31%), Positives = 79/151 (52%), Gaps = 10/151 (6%)
Query: 548 VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK-FLKPESSNWTEFAGTY 606
++ AL+YLH I+++D+ N+LLD E + D+G+ K L+P + + F GT
Sbjct: 105 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTP 160
Query: 607 GYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNT-DIALDEILDP 665
Y+APE+ D ++ GVL+ E + G+ P D + + NT D IL+
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 220
Query: 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESR 696
++ P RS+ K S+++ S LN+ P+ R
Sbjct: 221 QIRIP-RSLSVKAASVLK---SFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSP-----LPCDQIADQKEFLIEVKALTEIRHRN 497
IG G +G+VY+A + SG VA+K LP ++ +E + +K L H N
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP---LSTVREVAL-LKRLEAFDHPN 63
Query: 498 IVKFYGFCSHARHS-----FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADAL 552
IV+ C+ +R LV+E +++ L L L ++++ L
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDK-VPPPGLPAETIKDLMRQFLRGL 121
Query: 553 SYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE 612
+LH +C IVH+D+ +N+L+ + +ADFG+A+ + + T T Y APE
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPE 177
Query: 613 LAYTMKITEKCDVYSFGVLVLEAIKGK 639
+ D++S G + E + K
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 61/226 (26%), Positives = 92/226 (40%), Gaps = 14/226 (6%)
Query: 444 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKE-FLIEVKALT-EIRHRNIVK 500
+G G G V+ AEL + Q AIK + + D E ++E + L+ H +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
Y + F V E L G L + S + + + L +LH
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSK-- 115
Query: 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKIT 620
IV++D+ N+LLD + +ADFG+ K + F GT Y+APE+ K
Sbjct: 116 -GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYN 174
Query: 621 EKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPR 666
D +SFGVL+ E + G+ P L I +D PR
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSP---FHGHDEEELFQSIRMDNPCYPR 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 66/272 (24%), Positives = 112/272 (41%), Gaps = 42/272 (15%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQK------EFLIEVKALTEIRHR 496
+G+G G+VY+ +P G+ V I P+ + + EF+ E + + H
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKI-----PVAIKILNETTGPKANVEFMDEALIMASMDHP 69
Query: 497 NIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
++V+ G C LV +L+ G L + +G +N +A + YL
Sbjct: 70 HLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLE 126
Query: 557 HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTY--GYVAPELA 614
+VH+D++++N+L+ + DFG+A+ L+ + + G ++A E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 615 YTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILD-----PRLP 668
+ K T + DV+S+GV + E + G P D I EI D RLP
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD------------GIPTREIPDLLEKGERLP 231
Query: 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
P I + V C +SRP K
Sbjct: 232 QPPICT----IDVYMVMVKCWMIDADSRPKFK 259
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G+G +GSV A + +G+ VAIKK P + A K E+ L ++H N++
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFA--KRAYRELTLLKHMQHENVIGLL 80
Query: 503 G-FCS----HARHSFLVYELLERGSLAAILS---SDTAAQELGWSQRMNVIKGVADALSY 554
F S F + + L I+ S+ Q L + ++ G L Y
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVY----QMLCG----LKY 132
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
+H I+H+D+ NL ++ + E + DFG+A+ E T + T Y APE+
Sbjct: 133 IHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVI 186
Query: 615 YT-MKITEKCDVYSFGVLVLEAIKGK 639
M + D++S G ++ E + GK
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 59/234 (25%), Positives = 102/234 (43%), Gaps = 19/234 (8%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPCDQIADQKEFLIEVKALTEIRHRNIVKF 501
+G G G VY + +G+ +A+K+ P + + E++ L + H IV++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 502 YGFCSHARHSFL--VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
YG L E + GS+ L S A E + + + + +SYLH +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE---NVTRKYTRQILEGVSYLHSNM 126
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP---ESSNWTEFAGTYGYVAPELAYT 616
IVH+DI N+L D + DFG +K L+ + GT +++PE+
Sbjct: 127 ---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 617 MKITEKCDVYSFGVLVLEAIKGKHP-RDFLSLISSSSLNTDIALDEILDPRLPP 669
K D++S G V+E + K P +F ++ + + T + +P LPP
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT-----QPTNPVLPP 232
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G+G +GSV A + +G VA+KK P I K E++ L ++H N++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 503 GFCSHARH------SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
+ AR +LV L+ A L++ Q+L +I + L Y+H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 137
Query: 557 HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYT 616
I+H+D+ NL ++ + E + DFG+A+ E T + T Y APE+
Sbjct: 138 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLN 191
Query: 617 -MKITEKCDVYSFGVLVLEAIKGK 639
M + D++S G ++ E + G+
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 65/289 (22%), Positives = 113/289 (39%), Gaps = 58/289 (20%)
Query: 444 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHR 496
+G G G V +AE VA+K ++ D + + E++ + I +H+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEK--DLSDLVSEMEMMKMIGKHK 76
Query: 497 NIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKG--------- 547
NI+ G C+ ++V E G+L L + E +
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 548 ----VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK------FLKPESS 597
VA + +L +H+D++++N+L+ ++ +ADFG+A+ + +
Sbjct: 137 FAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT-- 191
Query: 598 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTD 656
T ++APE + T + DV+SFGVL+ E G P
Sbjct: 192 --TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY------------PG 237
Query: 657 IALDEILD-----PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
I ++E+ R+ P QE L +M C +E P RPT K
Sbjct: 238 IPVEELFKLLKEGYRMEKPQNCTQE-LYHLMR---DCWHEVPSQRPTFK 282
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 35/211 (16%)
Query: 444 IGNGGHGSV-YRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV--- 499
+G+G +G+V + +G VAIKK + P + A K E++ L ++H N++
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFA--KRAYRELRLLKHMKHENVIGLL 80
Query: 500 ----------KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA 549
+F+ F +LV + L ++ + +++ ++KG
Sbjct: 81 DVFTPDLSLDRFHDF-------YLVMPFMGT-DLGKLMKHEKLSEDRIQFLVYQMLKG-- 130
Query: 550 DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYV 609
L Y+H I+H+D+ NL ++ + E + DFG+A + S T + T Y
Sbjct: 131 --LKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA---RQTDSEMTGYVVTRWYR 182
Query: 610 APELAYT-MKITEKCDVYSFGVLVLEAIKGK 639
APE+ M T+ D++S G ++ E + GK
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 64/262 (24%), Positives = 113/262 (43%), Gaps = 29/262 (11%)
Query: 444 IGNGGHGSVYRA--ELPSGQ--VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
+G G G + R +LPS + VAI + Q ++ FL E L + H NIV
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ---RRGFLAEALTLGQFDHSNIV 69
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
+ G + +V E + G+L + L +L Q M ++ G+A + YL
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMG 127
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG--YVAPELAYTM 617
+ VH+ +++ +L++ + ++ F + K E+ +T +G + APE
Sbjct: 128 Y---VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYH 183
Query: 618 KITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP-RLPPPSRSVQ 675
+ DV+SFG+++ E + G+ P +S D+ + + D RLP P R+
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERPYWDMS-------GQDV-IKAVEDGFRLPAP-RNCP 234
Query: 676 EKLISIMEVAFSCLNESPESRP 697
L +M C + RP
Sbjct: 235 NLLHQLM---LDCWQKERGERP 253
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 39/225 (17%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFH-SPLPCDQIADQKEF---------LIEVKALTE 492
+G G +G V +A +G++VAIKK + D D++ L E+K + E
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 493 IRHRNIVKFYG-FCSHARHSF--LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA 549
I+H NI+ + F LV +++ L ++ E SQ ++ +
Sbjct: 77 IKHENIMGLVDVYVEG---DFINLVMDIMA-SDLKKVVDRKIRLTE---SQVKCILLQIL 129
Query: 550 DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA-KFLKPESS----------- 597
+ L+ LH + +H+D+S N+ ++ + +ADFG+A ++ P S
Sbjct: 130 NGLNVLH-KWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 598 --NWTEFAGTYGYVAPELAY-TMKITEKCDVYSFGVLVLEAIKGK 639
T T Y APEL K D++S G + E + GK
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 54/188 (28%), Positives = 91/188 (48%), Gaps = 31/188 (16%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKE-FLI----EVKALTEIRHRN 497
IG G G V++A + Q+VA+KK + ++KE F I E+K L ++H N
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV-------LMENEKEGFPITALREIKILQLLKHEN 72
Query: 498 IVKFYGFC-------SHARHSF-LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA 549
+V C + + SF LV+E E LA +LS+ L +++ +K +
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV--MKMLL 129
Query: 550 DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK-FLKPESSNWTEFAG---T 605
+ L Y+H I+H+D+ + N+L+ + +ADFG+A+ F ++S + T
Sbjct: 130 NGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 606 YGYVAPEL 613
Y PEL
Sbjct: 187 LWYRPPEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 64/295 (21%), Positives = 118/295 (40%), Gaps = 53/295 (17%)
Query: 444 IGNGGHGSVYRAE------LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G G G V +A VA+K ++ D L E L ++ H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD---LLSEFNLLKQVNHPH 64
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAIL--SSDTAAQELGWSQRMNVIK--------- 546
++K YG CS L+ E + GSL + L S LG N
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 547 GVADALSYLHHDCFP-------PIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599
+ D +S+ +VH+D++++N+L+ + ++DFG+++ + E S
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 600 TEFAG--TYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-------GKHPRDFLSLISS 650
G ++A E + T + DV+SFGVL+ E + G P +L+ +
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT 244
Query: 651 SSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
R+ P + E++ ++M +C + P+ RPT ++++
Sbjct: 245 GY-------------RMERPE-NCSEEMYNLM---LTCWKQEPDKRPTFADISKE 282
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 52/197 (26%), Positives = 72/197 (36%), Gaps = 40/197 (20%)
Query: 169 SQLQALDLSLNHIVGE----IPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDL 224
LQ L L N + E + L SL EL L N TGR+P + SL
Sbjct: 23 LCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLN-ETGRIPRGLQSL-------- 73
Query: 225 SANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQ---LSELDASHNLFGGEI 281
+ L L L LS+N + LE L++ L EL ++N G
Sbjct: 74 ---------LQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRG 124
Query: 282 -PFQICSLKS----LEKLNLSHNNLSG----SIPNCFEGIRGISVIDISDNQLQGPVPNS 332
LK LEKL L N L G ++ R + +++++N +
Sbjct: 125 LRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDA---- 180
Query: 333 TAFRNAPVEALKGNKGL 349
R A E LK N L
Sbjct: 181 -GIR-ALAEGLKANCNL 195
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 65/288 (22%), Positives = 119/288 (41%), Gaps = 43/288 (14%)
Query: 444 IGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI 498
+G G +Y+ L Q+VAIK Q + F E + E+ H NI
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE---FQQEASLMAELHHPNI 69
Query: 499 VKFYGFCSHARHSFLVYELLERGSLAAIL-----------SSD---TAAQELGWSQRMNV 544
V G + + +++E L +G L L SSD T L +++
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 545 IKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAG 604
+A + YL F VH+D++++N+L+ + ++D G+++ + S+++
Sbjct: 130 AIQIAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLSREIY--SADYYRVQP 184
Query: 605 T----YGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIAL 659
++ PE K + D++SFGV++ E G P S N ++ +
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-------NQEV-I 236
Query: 660 DEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707
+ + +L P S ++ S+M C E P RP K + ++R
Sbjct: 237 EMVRKRQLLPCSEDCPPRMYSLMT---ECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 21/152 (13%)
Query: 548 VADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTY 606
+ L +LH I+++D+ N+LLD E +ADFG+ K + F GT
Sbjct: 105 IVLGLQFLHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160
Query: 607 GYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD-- 664
Y+APE+ D ++ GVL+ E + G+ P + + D IL+
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE--------GDDEDELFQSILEDE 212
Query: 665 PRLPPPSRSVQEKLISIMEVAFSCLNESPESR 696
R P R + ++ SI++ S L ++PE R
Sbjct: 213 VRYP---RWLSKEAKSILK---SFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 20/221 (9%)
Query: 444 IGNGGHGSVY--RAELP--SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
+G G G V+ R +GQ+ A+K ++ D+ +E L E+ H IV
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIV 61
Query: 500 KF-YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
K Y F + + +L+ + L G L LS + E + +A AL +LH
Sbjct: 62 KLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE---EDVKFYLAELALALDHLHS- 116
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMK 618
I+++D+ +N+LLD E + DFG++K F GT Y+APE+
Sbjct: 117 --LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 174
Query: 619 ITEKCDVYSFGVLVLEAI------KGKHPRDFLSLISSSSL 653
T+ D +SFGVL+ E + +GK ++ +++I + L
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL 215
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 437 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
DF+ +G G G V + PSG ++A K H + + A + + + E+K L E
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNS 58
Query: 496 RNIVKFYG-FCSHARHSFLVYELLERGSLAAILSSDTAAQE--LGWSQRMNVIKGVADAL 552
IV FYG F S S + E ++ GSL +L E LG + V L
Sbjct: 59 PYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGL 112
Query: 553 SYLH--HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVA 610
+YL H I+H+D+ N+L++ E + DFG++ L +N F GT Y++
Sbjct: 113 TYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMS 166
Query: 611 PELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
PE T + D++S G+ ++E G++P
Sbjct: 167 PERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 63/260 (24%), Positives = 109/260 (41%), Gaps = 24/260 (9%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLI--EVKALTEIRHRNIVK 500
+G G G V+ ++V IK+ +P +Q+ + E + L + H NI++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQ----IPVEQMTKDERLAAQNECQVLKLLSHPNIIE 63
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
+Y + +V E G+LA + + ++ L LHH
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQK----RCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 561 PPIVHQDISSKNLLLDLEYEA-HVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKI 619
I+H+D+ ++N+LLD + DFGI+K L +S +T GT Y++PEL
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPELCEGKPY 178
Query: 620 TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLI 679
+K D+++ G ++ E K R F + N + +I+ P S L
Sbjct: 179 NQKSDIWALGCVLYELASLK--RAF------EAANLPALVLKIMSGTFAPISDRYSPDLR 230
Query: 680 SIMEVAFSCLNESPESRPTM 699
++ S LN P RP +
Sbjct: 231 QLIL---SMLNLDPSKRPQL 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 35/281 (12%)
Query: 431 IVRATNDFDAQYCIGNGGHGSVYRA-ELPSGQ----VVAIKKFH---SPLPCDQIADQKE 482
I++ T +F +G+G G+VY+ +P G+ VAIK+ SP KE
Sbjct: 3 ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP------KANKE 55
Query: 483 FLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRM 542
L E + + + ++ + G C + L+ +L+ G L + +G +
Sbjct: 56 ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLL 112
Query: 543 NVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEF 602
N +A ++YL +VH+D++++N+L+ + DFG+AK L + +
Sbjct: 113 NWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
Query: 603 AGTY--GYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIAL 659
G ++A E T + DV+S+GV V E + G P D I +S +++ +
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG---IPASEISSILEK 226
Query: 660 DEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
E RLP P I + + C +SRP +
Sbjct: 227 GE----RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 259
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 444 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G G G V AEL G+ A+K + I D E + K + + N +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVL--IDDDVECTMVEKRVLALAWENPFLTH 60
Query: 503 GFCSH--ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADA------LSY 554
+C+ H F V E L G L + Q+ G R ++ + A L +
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHI------QDKG---RFDLYRATFYAAEIVCGLQF 111
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
LH I+++D+ N++LD + +ADFG+ K + + F GT Y+APE+
Sbjct: 112 LHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL 168
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGKHP 641
+K T D +SFGVL+ E + G+ P
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 37/226 (16%)
Query: 444 IGNGGHGSVYRAELPSG----QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
IGNG G V E+ SG QVV +K+ + +Q +FL E + ++H N++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVV-VKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQ----ELGWSQRMNVIKGVADALSYL 555
+ G C+ LV E G L L S A+ + QRM +A L +L
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHL 116
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK-------FLKPESSNWTEFAGTYGY 608
H + F +H D++ +N LL + + D+G++ ++ P+ W +
Sbjct: 117 HKNNF---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL-WVPLR----W 168
Query: 609 VAPELA-------YTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLS 646
+APEL + T++ +V+S GV + E + G P LS
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS 214
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVA 610
L +LH I+++D+ N+LLD + +ADFG+ K + F GT Y+A
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIA 164
Query: 611 PELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
PE+ K E D +SFGVL+ E + G+ P
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-09
Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 444 IGNGGHGSVYRAELPS-GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG GG G VY A P + VA+KK L + +K FL E K ++ H IV Y
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFP- 561
CS + +E +L ++L S + L S+ + V LS H C
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHKICATI 126
Query: 562 ------PIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE---------------SSNWT 600
++H+D+ N+LL L E + D+G A F K E S+ T
Sbjct: 127 EYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186
Query: 601 ---EFAGTYGYVAPELAYTMKITEKCDVYSFGVLV 632
+ GT Y+APE + +E D+Y+ GV++
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVIL 221
|
Length = 932 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 62/217 (28%), Positives = 94/217 (43%), Gaps = 38/217 (17%)
Query: 444 IGNGGHG---SVYRAELPSGQVVAIKK----FHSPLPCDQIADQKEFLIEVKALTEIR-H 495
+G G +G S AE + VAIKK F + K L E+K L R H
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILA------KRALRELKLLRHFRGH 61
Query: 496 RNIVKFYG----FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADA 551
+NI Y F + +L EL+E L I+ S Q L + + I +
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCG 117
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP----ESSNWTEFAGTYG 607
L Y+H ++H+D+ NLL++ + E + DFG+A+ + TE+ T
Sbjct: 118 LKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174
Query: 608 YVAPEL-----AYTMKITEKCDVYSFGVLVLEAIKGK 639
Y APE+ +YT I DV+S G ++ E + K
Sbjct: 175 YRAPEIMLSFQSYTKAI----DVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFL-IEVKALTEIRHRNIVKF 501
+G G G VY + +G+ +A+K+ + + + L E++ L +RH IV++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 502 YGFC--SHARHSFLVY-ELLERGSLAAILSSDTAAQE-LGWSQRMNVIKGVADALSYLHH 557
YG C ++ E + GS+ L + A E + +++GV SYLH
Sbjct: 70 YG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGV----SYLHS 124
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP---ESSNWTEFAGTYGYVAPELA 614
+ IVH+DI N+L D + DFG +K ++ + GT +++PE+
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGKHP 641
K DV+S V+E + K P
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 58/245 (23%), Positives = 103/245 (42%), Gaps = 45/245 (18%)
Query: 478 ADQKEFLI-EVKALTEI-RHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSD----- 530
+ ++E L+ E+K ++ + H NIV G C+ ++ E G L L
Sbjct: 79 SSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFL 138
Query: 531 TAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590
T L +S + VA +++L +H+D++++N+LL + DFG+A+
Sbjct: 139 TLEDLLSFSYQ------VAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189
Query: 591 FLKPESSNWTEFAGTY---GYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHP----- 641
+ + SN+ ++APE + T + DV+S+G+L+ E G +P
Sbjct: 190 DIMND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248
Query: 642 --RDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTM 699
F LI R+ P + E + IM+ +C + P RPT
Sbjct: 249 VDSKFYKLIKEGY-------------RMAQPEHAPAE-IYDIMK---TCWDADPLKRPTF 291
Query: 700 KVVTQ 704
K + Q
Sbjct: 292 KQIVQ 296
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 68/242 (28%), Positives = 106/242 (43%), Gaps = 19/242 (7%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIK--KFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
+G G G V E +G+ A+K K + D++A L E + L RH +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQNSRHPFLTA 59
Query: 501 F-YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKG-VADALSYLHHD 558
Y F +H R F V E G L LS + E R + AL YLH +
Sbjct: 60 LKYSFQTHDRLCF-VMEYANGGELFFHLSRERVFSE----DRARFYGAEIVSALDYLHSE 114
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMK 618
+V++D+ +NL+LD + + DFG+ K + + F GT Y+APE+
Sbjct: 115 --KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 619 ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPR-LPPPSRSVQEK 677
D + GV++ E + G+ P F + L I ++EI PR L P ++S+
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLP--FYNQ-DHEKLFELILMEEIRFPRTLSPEAKSLLSG 229
Query: 678 LI 679
L+
Sbjct: 230 LL 231
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 8e-09
Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 438 FDAQYCIGNGGHGSVYRA---ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
++ + CIG G +G VY+A G+ AIKKF + E+ L E++
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGD-KEQYTGISQSACREIALLRELK 60
Query: 495 HRNIVKFYG-FCSHARHS-FLVYELLERGSLAAILSSDTAAQELGWSQRM--NVIKGVAD 550
H N+V F HA S +L+++ E L I+ A+ + M +++ + +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAH----VADFGIAKF----LKPESSNWTEF 602
+ YLH + ++H+D+ N+L+ E + D G+A+ LKP
Sbjct: 120 GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP-------L 169
Query: 603 AG------TYGYVAPEL 613
A T Y APEL
Sbjct: 170 ADLDPVVVTIWYRAPEL 186
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 44/168 (26%), Positives = 79/168 (47%), Gaps = 18/168 (10%)
Query: 480 QKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSD------TAA 533
+ +FL E+K ++ +++ NI++ G C ++ E +E G L LS T A
Sbjct: 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 534 QELGWSQRMNVI---KGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590
+ N++ +A + YL F VH+D++++N L+ Y +ADFG+++
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASLNF---VHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 591 FLKPESSNWTEFAG----TYGYVAPELAYTMKITEKCDVYSFGVLVLE 634
L S ++ G ++A E K T DV++FGV + E
Sbjct: 178 NLY--SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 61/237 (25%), Positives = 94/237 (39%), Gaps = 12/237 (5%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHF 61
+L LDL+ N+ + LP + NL NLK L L +N+LS L L N
Sbjct: 140 SNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKI 198
Query: 62 TSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYP 121
+ LP + AL+ +S N + L N +L + L++N L ++ E++G
Sbjct: 199 SD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLS 255
Query: 122 NLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREI-GNSSQLQALDLSLNH 180
NL +DLS N S+ G L L++S N+++ +P L+L L
Sbjct: 256 NLETLDLSNN--QISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLT- 312
Query: 181 IVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENL 237
EL + L + N T P + L L L N + S
Sbjct: 313 ---LKALELKLNSILLNNNILSNGETS-SPEALSILESLNNLWTLDNALDESNLNRY 365
|
Length = 394 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 32/210 (15%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFH-----SPLPCDQIADQKEFLIEVKALTEIRHRN 497
IG G +G VY+A + + + +A+KK +P I E+ L E++H N
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-------EISLLKEMQHGN 62
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRM------NVIKGVADA 551
IV+ + +LV+E L+ L D++ + + R+ +++G+A
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIA-- 116
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEA-HVADFGIAKFLKPESSNWTEFAGTYGYVA 610
Y H ++H+D+ +NLL+D A +ADFG+A+ +T T Y A
Sbjct: 117 --YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRA 171
Query: 611 PE-LAYTMKITEKCDVYSFGVLVLEAIKGK 639
PE L + + D++S G + E + K
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 45/148 (30%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK-FLKPESSNWTEFAGTYGYV 609
AL++LH I+++D+ N+LLD E + D+G+ K ++P + T F GT Y+
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYI 163
Query: 610 APELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNT-DIALDEILDPRLP 668
APE+ D ++ GVL+ E + G+ P D + + + NT D IL+ ++
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR 223
Query: 669 PPSRSVQEKLISIMEVAFSCLNESPESR 696
P RS+ K S+++ LN+ P+ R
Sbjct: 224 IP-RSLSVKASSVLK---GFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 42/226 (18%)
Query: 437 DFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKAL 490
D + IG G G V RA + + + +K+F S D ++F E++ L
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE------NDHRDFAGELEVL 56
Query: 491 TEI-RHRNIVKFYGFCSHARHSFLVYELLERGSL------AAILSSDTA-------AQEL 536
++ H NI+ G C + + ++ E G+L + +L +D A A L
Sbjct: 57 CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116
Query: 537 GWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596
Q + VA + YL F +H+D++++N+L+ + +ADFG+++
Sbjct: 117 TSQQLLQFASDVATGMQYLSEKQF---IHRDLAARNVLVGENLASKIADFGLSR------ 167
Query: 597 SNWTEFAGTYG-----YVAPE-LAYTMKITEKCDVYSFGVLVLEAI 636
T G ++A E L Y++ T K DV+SFGVL+ E +
Sbjct: 168 GEEVYVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G+G +GSV A + Q VA+KK P + + E++ L ++H N++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 503 GFCSHA------RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
+ A +LV L+ A L++ Q+L +I + L Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLM-----GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH 135
Query: 557 HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYT 616
I+H+D+ N+ ++ + E + DFG+A+ E T + T Y APE+
Sbjct: 136 S---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE---MTGYVATRWYRAPEIMLN 189
Query: 617 -MKITEKCDVYSFGVLVLEAIKGK 639
M + D++S G ++ E +KGK
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIK--KFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
+G G G V E SG+ A+K K + D++A L E + L RH +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHT---LTESRVLKNTRHPFLTS 59
Query: 501 F-YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKG--VADALSYLHH 557
Y F + R F V E + G L LS +E +S+ G + AL YLH
Sbjct: 60 LKYSFQTKDRLCF-VMEYVNGGELFFHLS-----RERVFSEDRTRFYGAEIVSALDYLHS 113
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTM 617
IV++D+ +NL+LD + + DFG+ K +++ F GT Y+APE+
Sbjct: 114 G---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDN 170
Query: 618 KITEKCDVYSFGVLVLEAIKGKHP 641
D + GV++ E + G+ P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 12/223 (5%)
Query: 444 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKF- 501
+G GG G V ++ +G++ A KK + + +K L+E + L ++ IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKK-RLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 502 YGFCSHARHSFLVYELLERGSLA-AILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
Y F S H LV L+ G L I + E+ + ++ + + +LH
Sbjct: 60 YAFESKT-HLCLVMSLMNGGDLKYHIYNVGERGLEM--ERVIHYSAQITCGILHLHS--- 113
Query: 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKIT 620
IV++D+ +N+LLD + ++D G+A L + T+ AGT GY+APE+ +
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEEPYS 172
Query: 621 EKCDVYSFGVLVLEAIKGKHP-RDFLSLISSSSLNTDIALDEI 662
D ++ G + E + G+ P +D ++ L DE+
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 68/276 (24%), Positives = 110/276 (39%), Gaps = 55/276 (19%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHR--NIVK 500
IG+G G VY+ +G V+A+K+ + K L+++ + + H IVK
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRR---TGNKEENKRILMDLDVVLK-SHDCPYIVK 78
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMN----------VIKGVAD 550
YG+ F+ EL+ T +L +R+ + +
Sbjct: 79 CYGYFITDSDVFICMELMS-----------TCLDKL--LKRIQGPIPEDILGKMTVAIVK 125
Query: 551 ALSYL--HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGY 608
AL YL H ++H+D+ N+LLD + DFGI+ L +S T AG Y
Sbjct: 126 ALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLV-DSKAKTRSAGCAAY 180
Query: 609 VAPELAYTMKITEK----CDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDI-ALDEIL 663
+APE K DV+S G+ ++E G+ P + T+ L +IL
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK--------NCKTEFEVLTKIL 232
Query: 664 --DPRLPPPSRSVQEKLISIMEVAFSCLNESPESRP 697
+P PP+ S ++ CL + RP
Sbjct: 233 QEEPPSLPPNEGFSPDFCSFVD---LCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 5/95 (5%)
Query: 548 VADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTY 606
V AL +LH H ++++D+ N+LLD E +ADFG+ K T F GT
Sbjct: 105 VTLALMFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160
Query: 607 GYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
Y+APE+ ++ D ++ GVL+ E + G+ P
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK-FLKPESSNWTEFAGTYGYV 609
AL++LH I+++D+ N+LLD + + D+G+ K L P + T F GT Y+
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYI 163
Query: 610 APELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669
APE+ + D ++ GVL+ E + G+ P D ++ + +NT+ L +++ L
Sbjct: 164 APEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT--DNPDMNTEDYLFQVI---LEK 218
Query: 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVT 703
P R + + V LN+ P+ R + T
Sbjct: 219 PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQT 252
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 16/161 (9%)
Query: 486 EVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAA--QELGWSQRMN 543
EV L+ ++H NIV++ + ++V + E G L +++ E Q ++
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPE---DQILD 105
Query: 544 VIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFA 603
+ AL ++H I+H+DI S+N+ L + + DFGIA+ L ++ E A
Sbjct: 106 WFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL----NSTVELA 158
Query: 604 ----GTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKH 640
GT Y++PE+ K D+++ G ++ E KH
Sbjct: 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 67/242 (27%), Positives = 105/242 (43%), Gaps = 20/242 (8%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSP--LPCDQIADQKEFLIEVKALTEIRHRNIVK 500
+G G G V E +G+ A+K + D++A + E + L RH +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTRHPFLTA 59
Query: 501 F-YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKG-VADALSYLHHD 558
Y F +H R F V E G L LS + E +R + AL YLH
Sbjct: 60 LKYAFQTHDRLCF-VMEYANGGELFFHLSRERVFTE----ERARFYGAEIVSALEYLHSR 114
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMK 618
+V++DI +NL+LD + + DFG+ K + + F GT Y+APE+
Sbjct: 115 ---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 619 ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPR-LPPPSRSVQEK 677
D + GV++ E + G+ P F + L I ++EI PR L P ++S+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP--FYNQ-DHERLFELILMEEIRFPRTLSPEAKSLLAG 228
Query: 678 LI 679
L+
Sbjct: 229 LL 230
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 60/244 (24%), Positives = 99/244 (40%), Gaps = 19/244 (7%)
Query: 444 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEF---LIEVKALTEIRHRNIV 499
+G GG G V ++ +G++ A KK L ++ +K L E K L ++ R IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK----LDKKRLKKRKGEQMALNEKKILEKVSSRFIV 56
Query: 500 KF-YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH-H 557
Y F + LV L+ G L + + E G+ + + H H
Sbjct: 57 SLAYAFETKD-DLCLVMTLMNGGDLKYHIYN---VGEPGFPEARAIFYAAQIICGLEHLH 112
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTM 617
IV++D+ +N+LLD ++D G+A L AGT GY+APE+
Sbjct: 113 QRR--IVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGE 169
Query: 618 KITEKCDVYSFGVLVLEAIKGKHP-RDFLSLISSSSLNTDIALDEILDP-RLPPPSRSVQ 675
D ++ G + E I G+ P R + L + P + P ++ +
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLC 229
Query: 676 EKLI 679
E L+
Sbjct: 230 EALL 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 444 IGNGGHGSVYRAELP---SGQ---VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497
IG G G V++A P + +VA+K D Q +F E + E H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM---QADFQREAALMAEFDHPN 69
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQ-------------------ELGW 538
IVK G C+ + L++E + G L L + L
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 539 SQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI------AKFL 592
++++ + K VA ++YL F VH+D++++N L+ +ADFG+ A +
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLE 634
K ++ A ++ PE + + T + DV+++GV++ E
Sbjct: 187 KASEND----AIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 224
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 64/286 (22%), Positives = 118/286 (41%), Gaps = 46/286 (16%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIA--DQKEFLIEVKALTEIRHRNIVKF 501
+G G GSV +L +K + D + +EFL E + + H N++K
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 502 YGFC--SHARHSF----LVYELLERGSLAA-ILSSDTAAQELGWSQRMNV--IKGVADAL 552
G C + + ++ ++ G L + +L S + + + +A +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 553 SYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTY---GYV 609
YL + F +H+D++++N +L + VADFG++K ++G Y G +
Sbjct: 127 EYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSK---------KIYSGDYYRQGRI 174
Query: 610 APELAYTMKI--------TEKCDVYSFGVLVLE-AIKGKHPRDFLSLISSSSLNTDIALD 660
A + I T K DV++FGV + E A +G+ P + N +I
Sbjct: 175 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-------NHEIYDY 227
Query: 661 EILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
RL P + ++L +M +SC P+ RPT + + +
Sbjct: 228 LRHGNRLKQPEDCL-DELYDLM---YSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 30/213 (14%)
Query: 444 IGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHR 496
IG G G V +A + + +K++ S D ++F E++ L ++ H
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK------DDHRDFAGELEVLCKLGHHP 56
Query: 497 NIVKFYGFCSHARHSFLVYELLERGSL------AAILSSDTA-------AQELGWSQRMN 543
NI+ G C H + +L E G+L + +L +D A A L Q ++
Sbjct: 57 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 544 VIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFA 603
VA + YL F +H+D++++N+L+ Y A +ADFG+++ +
Sbjct: 117 FAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 173
Query: 604 GTYGYVAPELAYTMKITEKCDVYSFGVLVLEAI 636
L Y++ T DV+S+GVL+ E +
Sbjct: 174 PVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 72/270 (26%), Positives = 109/270 (40%), Gaps = 50/270 (18%)
Query: 444 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLI---EVKAL--------- 490
+G G G V AE +G++ AIK A +K +I EV++L
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIK-----------ALKKGDIIARDEVESLMCEKRIFET 55
Query: 491 -TEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA 549
RH +V + H V E G L + +D ++ + + V
Sbjct: 56 ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSE----PRAVFYAACVV 111
Query: 550 DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYV 609
L YLH + IV++D+ NLLLD E +ADFG+ K + F GT ++
Sbjct: 112 LGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFL 168
Query: 610 APELAYTMKITEKCDVYSFGVLVLEAIKGKHP--RDFLSLISSSSLNTDIALDEILDPR- 666
APE+ T D + GVL+ E + G+ P D + S +N DE+ PR
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-----DEVRYPRF 223
Query: 667 LPPPSRSVQEKLISIMEVAFSCLNESPESR 696
L + S+ +L L +PE R
Sbjct: 224 LSREAISIMRRL----------LRRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 37/212 (17%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKE-----FLIEVKALTEIRHRN 497
IG G +G VY+A + +G++VA+KK ++ + E + E+ L E+ H N
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-------RLETEDEGVPSTAIREISLLKELNHPN 59
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKG----VADALS 553
IV+ +LV+E L+ L + S + G + IK + ++
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDL-DLKKYMDS---SPLTGLDPPL--IKSYLYQLLQGIA 113
Query: 554 YLH-HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE 612
Y H H ++H+D+ +NLL+D E +ADFG+A+ +T T Y APE
Sbjct: 114 YCHSHR----VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 169
Query: 613 L-----AYTMKITEKCDVYSFGVLVLEAIKGK 639
+ Y+ + D++S G + E + +
Sbjct: 170 ILLGSRQYSTPV----DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 16/202 (7%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G +G VY+ +GQ+VA+KK L ++ + E+ L E++H NIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIR--LESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
+L++E L L L S Q + + + + + + H
Sbjct: 66 DVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---R 121
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL-----AYTM 617
++H+D+ +NLL+D + +ADFG+A+ +T T Y APE+ Y+
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 618 KITEKCDVYSFGVLVLEAIKGK 639
+ D++S G + E K
Sbjct: 182 PV----DIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 69/296 (23%), Positives = 120/296 (40%), Gaps = 54/296 (18%)
Query: 444 IGNGGHGSVYRAEL----PSGQ----VVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-- 493
+G G G V RAE S VA+K +AD LI L ++
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLAD----LISEMELMKLIG 75
Query: 494 RHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSS-------------DTAAQELGWSQ 540
+H+NI+ G C+ +++ E +G+L L + ++L +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 541 RMNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK------FLK 593
++ VA + YL C +H+D++++N+L+ + +ADFG+A+ + K
Sbjct: 136 LVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSS 652
S+ ++APE + T + DV+SFG+L+ E G P + +
Sbjct: 192 KTSNGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247
Query: 653 LNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708
L L E R+ PS E + + E C + P RPT K + + +
Sbjct: 248 L-----LRE--GHRMDKPSNCTHELYMLMRE----CWHAVPTQRPTFKQLVEALDK 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 62/260 (23%), Positives = 106/260 (40%), Gaps = 39/260 (15%)
Query: 388 MALIAIFILRKRKSDSGDRQSSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNG 447
+ + L K+K ++ +N K+ Y+ DF+ +G G
Sbjct: 1 IQFLKNLQLHKKKDSDSTKEPKRKN------------KMKYE-------DFNFIRTLGTG 41
Query: 448 GHGSVYRAELPSGQV--VAIKKFHSPLPCDQIADQKEF---LIEVKALTEIRHRNIVKFY 502
G V A + VAIK+F +I QK+ E K L I H V Y
Sbjct: 42 SFGRVILATYKNEDFPPVAIKRFEK----SKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTA-AQELGWSQRMNVIKGVADALSYLHHDCFP 561
G + +LV E + G L + ++G ++ + + L L+
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL-IFEYLQSLN----- 151
Query: 562 PIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITE 621
IV++D+ +NLLLD + + DFG AK + ++ +T GT Y+APE+ + +
Sbjct: 152 -IVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYT-LCGTPEYIAPEILLNVGHGK 207
Query: 622 KCDVYSFGVLVLEAIKGKHP 641
D ++ G+ + E + G P
Sbjct: 208 AADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 66/292 (22%), Positives = 120/292 (41%), Gaps = 59/292 (20%)
Query: 444 IGNGGHGSVYRAELPSGQV---VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
+G G GSV +L VA+K + C + ++ ++FL E + E H N+++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTR-SEMEDFLSEAVCMKEFDHPNVMR 64
Query: 501 FYGFC--SHARHSF----LVYELLERGSLAA-ILSSDTAAQELGWSQRMNV--IKGVADA 551
G C + + ++ ++ G L + +L S +M V + +A
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTY----- 606
+ YL F +H+D++++N +L+ VADFG++K + + G Y
Sbjct: 125 MEYLSSKSF---IHRDLAARNCMLNENMNVCVADFGLSKKI---------YNGDYYRQGR 172
Query: 607 ------GYVAPELAYTMKITEKCDVYSFGVLVLE-AIKGKHPRDFLSLISSSSLNTDIAL 659
++A E T K DV+SFGV + E A +G+ P +
Sbjct: 173 IAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY------------PGVEN 220
Query: 660 DEILD-----PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
EI D RL P + L + + SC +P+ RP+ + + ++
Sbjct: 221 SEIYDYLRQGNRLKQPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 21/212 (9%)
Query: 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
DF +G GG+G V+ A+ +G++VA+K+ L ++ + + L E LT +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSL-LFKLNEVRHVLTERDILTTTK 59
Query: 495 HRNIVK-FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALS 553
+VK Y F + +L E + G +L++ E R + + A+
Sbjct: 60 SEWLVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSED--HARFYMAEMFE-AVD 115
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFA----GTYGYV 609
LH +H+D+ +N L+D + DFG+ S +A G+ Y+
Sbjct: 116 ALHE---LGYIHRDLKPENFLIDASGHIKLTDFGL-------SKGIVTYANSVVGSPDYM 165
Query: 610 APELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
APE+ D +S G ++ E + G P
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 67/273 (24%), Positives = 110/273 (40%), Gaps = 44/273 (16%)
Query: 444 IGNGGHGSVYRA-ELPSGQ----VVAIKKFH---SPLPCDQIADQKEFLIEVKALTEIRH 495
+G+G G+VY+ +P G+ VAIK SP KE L E + +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP------KANKEILDEAYVMAGVGS 68
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
+ + G C + LV +L+ G L + + +G +N +A +SYL
Sbjct: 69 PYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYL 125
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTY--GYVAPEL 613
+VH+D++++N+L+ + DFG+A+ L + + + G ++A E
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 614 AYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILD-----PRL 667
+ T + DV+S+GV V E + G P D I EI D RL
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYD------------GIPAREIPDLLEKGERL 230
Query: 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
P P I + + C E RP +
Sbjct: 231 PQPPICT----IDVYMIMVKCWMIDSECRPRFR 259
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 67/294 (22%), Positives = 127/294 (43%), Gaps = 55/294 (18%)
Query: 444 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G G VY+ L Q VAIK + ++EF E + ++H N
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPN 69
Query: 498 IVKFYG-------------FCSHAR-HSFLVYELLERGSLAAILSSD---TAAQELGWSQ 540
IV G +CSH+ H FLV R + + S+D T L +
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVM----RSPHSDVGSTDDDKTVKSTLEPAD 125
Query: 541 RMNVIKGVADALSYL--HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN 598
++++ +A + +L HH +VH+D++++N+L+ + ++D G+ F + +++
Sbjct: 126 FVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGL--FREVYAAD 178
Query: 599 WTEFAGT----YGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSL 653
+ + G +++PE K + D++S+GV++ E G P S
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS------- 231
Query: 654 NTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707
N D+ ++ I + ++ P + ++M C NE P RP K + ++R
Sbjct: 232 NQDV-IEMIRNRQVLPCPDDCPAWVYTLM---LECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 57/237 (24%), Positives = 97/237 (40%), Gaps = 19/237 (8%)
Query: 428 YDEIVR-------ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQ 480
Y++IVR D+D IG G G V S Q V K S + +D
Sbjct: 28 YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87
Query: 481 KEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQ 540
F E + +V+ + ++ ++V E + G L ++S+ ++ W++
Sbjct: 88 AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--WAK 145
Query: 541 RMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWT 600
V AL +H ++H+D+ N+LLD +ADFG +
Sbjct: 146 FYTA--EVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC 200
Query: 601 EFA-GTYGYVAPELAYTMK----ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS 652
+ A GT Y++PE+ + +CD +S GV + E + G P SL+ + S
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS 257
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 444 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEF---LIEVKALTEIRHRNIV 499
+G GG G V ++ +G++ A KK + ++ +K + ++E + L ++ R IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNK----KRLKKRKGYEGAMVEKRILAKVHSRFIV 56
Query: 500 KF-YGFCSHARHSFLVYELLERGSLA-AILSSDTAAQELGWSQRMNVIKGVADALSYLHH 557
Y F + LV ++ G L I + D + + L +LH
Sbjct: 57 SLAYAFQTKTDLC-LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTM 617
I+++D+ +N+LLD + ++D G+A LK S +AGT G++APEL
Sbjct: 116 R---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGE 172
Query: 618 KITEKCDVYSFGVLVLEAIKGKHP 641
+ D ++ GV + E I + P
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 61/250 (24%), Positives = 100/250 (40%), Gaps = 59/250 (23%)
Query: 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSP--LPCDQIAD---QKEFLIEVKA 489
+DF++ IG G G V + +G + A+K L +Q+A +++ L+E
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 490 LTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAIL-SSDTAAQELGWSQRMNVIKGV 548
++ FY F R+ +L+ E L G + +L DT ++E I
Sbjct: 61 AWVVK-----MFYSF-QDKRNLYLIMEFLPGGDMMTLLMKKDTLSEE----ATQFYIAET 110
Query: 549 ADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEF------ 602
A+ +H F +H+DI NLLLD + ++DFG+ LK ++ TEF
Sbjct: 111 VLAIDAIHQLGF---IHRDIKPDNLLLDAKGHVKLSDFGLCTGLK--KAHRTEFYRNLTH 165
Query: 603 -------------------------------AGTYGYVAPELAYTMKITEKCDVYSFGVL 631
GT Y+APE+ + CD +S GV+
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225
Query: 632 VLEAIKGKHP 641
+ E + G P
Sbjct: 226 MYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH-RNIVKF 501
+G G +G V + +P+G ++A+K+ + + +QK L+++ V F
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQEQKRLLMDLDISMRSVDCPYTVTF 65
Query: 502 YGFCSHARHSFLVYELLERGSL----AAILSSDTAAQE--LGWSQRMNVIKGVADALSYL 555
YG ++ E+++ SL + E LG ++ V + AL YL
Sbjct: 66 YGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILG---KIAV--SIVKALEYL 119
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL-- 613
H ++H+D+ N+L++ + + DFGI+ +L +S T AG Y+APE
Sbjct: 120 HSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPERIN 176
Query: 614 ------AYTMKITEKCDVYSFGVLVLEAIKGKHPRD 643
Y + K DV+S G+ ++E G+ P D
Sbjct: 177 PELNQKGYDV----KSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 43/137 (31%), Positives = 64/137 (46%), Gaps = 15/137 (10%)
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK-FLKPESSNWTEFAGTYGYV 609
AL +LH IV++DI +N+LLD E + DFG++K FL E F GT Y+
Sbjct: 117 ALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 610 APELAYTMKITEKC-DVYSFGVLVLEAIKGKHP------RDFLSLISSSSLNTDIALDEI 662
APE+ K D +S G+L+ E + G P R+ S +S L D
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK----CDPP 229
Query: 663 LDPRLPPPSRSVQEKLI 679
+ P ++ + KL+
Sbjct: 230 FPSFIGPEAQDLLHKLL 246
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 58/234 (24%), Positives = 97/234 (41%), Gaps = 53/234 (22%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKF-------HSPLPCDQI--AD-----QKEFLIEVKA 489
+G G G V+ E+ + Q + +F L +I D + +FL EVK
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 490 LTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSS-------------DTAAQEL 536
L+ ++ NI++ G C ++ E +E G L LSS A L
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 537 ---GWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593
+S ++V +A + YL F VH+D++++N L+ +ADFG+++ L
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSLNF---VHRDLATRNCLVGENLTIKIADFGMSRNL- 188
Query: 594 PESSNWTEFAGTY-----------GYVAPELAYTMKITEKCDVYSFGVLVLEAI 636
+AG Y ++A E K T DV++FGV + E +
Sbjct: 189 --------YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 7/93 (7%)
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVA--DFGIAKFLKPESSNWTEFAGTYGY 608
AL LH ++++D+ +N+LLD Y+ H+A DFG+ K + F GT Y
Sbjct: 105 ALENLHK---FNVIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159
Query: 609 VAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
+APEL T+ D ++ GVL+ E + G P
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 29/96 (30%), Positives = 50/96 (52%), Gaps = 3/96 (3%)
Query: 548 VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG 607
++ L +LH I+++D+ N++LD E +ADFG+ K + F GT
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD 166
Query: 608 YVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRD 643
Y+APE+ + D +++GVL+ E + G+ P D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 13/148 (8%)
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPE 612
+HH ++H+DI S N+LL + DFG +K S+ F GT YVAPE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 613 LAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672
+ ++K D++S GVL+ E + K P D N + + + L R P
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD--------GENMEEVMHKTLAGRYDPLPP 267
Query: 673 SVQEKLISIMEVAFSCLNESPESRPTMK 700
S+ ++ E+ + L+ P+ RP+
Sbjct: 268 SISPEM---QEIVTALLSSDPKRRPSSS 292
|
Length = 496 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVA 610
L LH + IV++D+ +N+LLD ++D G+A + PE GT GY+A
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVGYMA 169
Query: 611 PELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
PE+ + T D ++ G L+ E I G+ P
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 548 VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG 607
+A L +LH I+++D+ N++LD E +ADFG+ K F GT
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPD 166
Query: 608 YVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRD 643
Y+APE+ + D ++FGVL+ E + G+ P D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 39/229 (17%)
Query: 430 EIVRATNDFDAQY----CIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFL 484
E+ + + +Y +G+G +G V A +G+ VAIKK P K
Sbjct: 5 ELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTY 62
Query: 485 IEVKALTEIRHRNIV-------------KFYGFCSHARHSFLVYELLERGSLAAILSSDT 531
E++ L + H N++ F +LV L+ L I+
Sbjct: 63 RELRLLKHMDHENVIGLLDVFTPASSLEDFQDV-------YLVTHLMGA-DLNNIVKC-- 112
Query: 532 AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591
Q+L ++ + L Y+H I+H+D+ N+ ++ + E + DFG+A
Sbjct: 113 --QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLA-- 165
Query: 592 LKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGK 639
+ T + T Y APE+ M + D++S G ++ E + GK
Sbjct: 166 -RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 548 VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG 607
+ AL +LH I+++D+ N+LLD E +ADFG+ K + F GT
Sbjct: 105 ITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPD 161
Query: 608 YVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
Y+APE+ M D ++ GVL+ E + G P
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 60/282 (21%), Positives = 123/282 (43%), Gaps = 37/282 (13%)
Query: 444 IGNGGHGSVYRA---ELPSGQV---VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G G G VY ++ G+ VA+K + + ++ EFL E + +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHH 70
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAIL------SSDTAAQELGWSQRMNVIKG-VAD 550
+V+ G S + + +V EL+ G L + L + + + Q M + +AD
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG--- 607
++YL+ F VH+D++++N ++ ++ + DFG+ + + E+ + + G G
Sbjct: 131 GMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY-ETDYYRK--GGKGLLP 184
Query: 608 --YVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDP 665
++APE T D++SFGV++ E L+ L+ + L ++D
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMDG 237
Query: 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707
+ E++ +M + C +P+ RPT + ++
Sbjct: 238 GYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 60/253 (23%), Positives = 108/253 (42%), Gaps = 51/253 (20%)
Query: 479 DQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLVYELLERGSLAAIL---------- 527
D + + E++ + I +H+NI+ G C+ +++ E +G+L L
Sbjct: 60 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDY 119
Query: 528 SSDTAA---QELGWSQRMNVIKGVADALSYL-HHDCFPPIVHQDISSKNLLLDLEYEAHV 583
S DT ++L + ++ VA + YL C +H+D++++N+L+ + +
Sbjct: 120 SFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKI 175
Query: 584 ADFGIAKFLKPESSNWTEFAGTYG------YVAPELAYTMKITEKCDVYSFGVLVLEAIK 637
ADFG+A+ + N + T ++APE + T + DV+SFGVL+ E
Sbjct: 176 ADFGLAR----DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
Query: 638 -GKHPRDFLSLISSSSLNTDIALDEILD-----PRLPPPSRSVQEKLISIMEVAFSCLNE 691
G P I ++E+ R+ P+ E L IM C +
Sbjct: 232 LGGSPY------------PGIPVEELFKLLKEGHRMDKPANCTHE-LYMIMR---ECWHA 275
Query: 692 SPESRPTMKVVTQ 704
P RPT K + +
Sbjct: 276 VPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 55/222 (24%), Positives = 95/222 (42%), Gaps = 15/222 (6%)
Query: 437 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHR 496
DF+ IG G G V +L + V K + + A+ F E L ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 497 NIVKFYGFCSHARHSFLVYELLERGSLAAILS--SDTAAQELGWSQRMNVIKGVADALSY 554
I + + +LV + G L +LS D +++ ++ + D++
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DSVHQ 120
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFA-GTYGYVAPEL 613
LH+ VH+DI N+L+D+ +ADFG L + + + A GT Y++PE+
Sbjct: 121 LHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174
Query: 614 AYTM-----KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISS 650
M K +CD +S GV + E + G+ P SL+ +
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 48/204 (23%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG+G G V A + G VA+KK P +Q ++ + E+ L + H+NI+
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYR-ELVLLKCVNHKNIISLL 86
Query: 503 GFCSHAR------HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
+ + +LV EL++ +L ++ + + + + ++ + + +LH
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDHERMSY-----LLYQMLCGIKHLH 140
Query: 557 HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW--TEFAGTYGYVAPELA 614
I+H+D+ N+++ + + DFG+A+ +N+ T + T Y APE+
Sbjct: 141 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVI 194
Query: 615 YTMKITEKCDVYSFGVLVLEAIKG 638
M E D++S G ++ E +KG
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-07
Identities = 33/112 (29%), Positives = 53/112 (47%), Gaps = 23/112 (20%)
Query: 7 LDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLP 66
L L+ +G +P +S L +L+ + L N++ G IPPSL +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSI----------------- 465
Query: 67 HNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALG 118
+L+ +S N F G+IP+ L +SL + LN N+L+G + ALG
Sbjct: 466 ------TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 72/299 (24%), Positives = 117/299 (39%), Gaps = 65/299 (21%)
Query: 437 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSP--LPCDQIAD---QKEFLIEVKAL 490
DF++ IG G G V + +G V A+K L +Q+ +++ L+E +L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 491 TEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAIL-SSDTAAQELGWSQRMNVIKGVA 549
++ FY F + +L+ E L G + +L DT +E + I
Sbjct: 62 WVVK-----MFYSF-QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE----ETQFYIAETV 111
Query: 550 DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEF------- 602
A+ +H F +H+DI NLLLD + ++DFG+ LK ++ TEF
Sbjct: 112 LAIDSIHQLGF---IHRDIKPDNLLLDSKGHVKLSDFGLCTGLK--KAHRTEFYRNLNHS 166
Query: 603 ------------------------------AGTYGYVAPELAYTMKITEKCDVYSFGVLV 632
GT Y+APE+ + CD +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 633 LEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNE 691
E + G P F S + + E L + PP + EK ++ + F C E
Sbjct: 227 YEMLIGYPP--FCSETPQETYKKVMNWKETL---IFPPEVPISEKAKDLI-LRFCCEWE 279
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 66/222 (29%), Positives = 90/222 (40%), Gaps = 43/222 (19%)
Query: 437 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIK--KFHSPLPCDQIADQKEFLIEVKALTEI 493
DF+ +G G G V A+ +G+ AIK K L Q + E L E+
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ---VQHVAQEKSILMEL 75
Query: 494 RHRNIVKFY-GFCSHARHSFLVYELLER---GSL------AAILSSDTA----AQELGWS 539
H IV F R VY LLE G L A +D A A+
Sbjct: 76 SHPFIVNMMCSFQDENR----VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE----- 126
Query: 540 QRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599
+ A YLH I+++D+ +NLLLD + V DFG AK K +
Sbjct: 127 --------LVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTF 173
Query: 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
T GT Y+APE+ + + D ++ GVL+ E I G P
Sbjct: 174 T-LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 39/230 (16%)
Query: 436 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKF--HSPLPCDQIADQKEFLIEVKALTE 492
DF+ I NG +G+VY + Q A+KK + + +QI Q+ F +E LT
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQI--QQVF-VERDILTF 57
Query: 493 IRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSS------DTAAQELGWSQRMNVIK 546
+ +V + RH +V E +E G A +L + D A RM +
Sbjct: 58 AENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA--------RMYFAE 109
Query: 547 GVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF-LKPESSNWTE---- 601
V AL YLH+ IVH+D+ NLL+ + DFG++K L ++N E
Sbjct: 110 TVL-ALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIE 165
Query: 602 ----------FAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
GT Y+APE+ + D ++ G+++ E + G P
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 61/291 (20%), Positives = 119/291 (40%), Gaps = 37/291 (12%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQI---------AD-----QKEFLIEVKA 489
+G G G V+ E + K F + +Q D + +FL E+K
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 490 LTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSS--------DTAAQELGWSQR 541
++ ++ NI++ C + ++ E +E G L LS + +S
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 542 MNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTE 601
+ + +A + YL F VH+D++++N L+ Y +ADFG+++ L S ++
Sbjct: 133 IFMATQIASGMKYLSSLNF---VHRDLATRNCLVGKNYTIKIADFGMSRNLY--SGDYYR 187
Query: 602 FAG----TYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL-NT- 655
G +++ E K T DV++FGV + E + + + L + NT
Sbjct: 188 IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTG 247
Query: 656 DIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
+ D+ LP P+ S+ ++ SC + + RP+ + + +
Sbjct: 248 EFFRDQGRQVYLPKPALCPD----SLYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 43/188 (22%), Positives = 83/188 (44%), Gaps = 28/188 (14%)
Query: 460 GQVVAIKKFHSPLPCD-QIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELL 518
G+V K P P +I + LIE L + H ++++ + + L
Sbjct: 80 GRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIR-------------MKDTL 126
Query: 519 ERGSLAAIL----SSD------TAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDI 568
G++ ++ SSD ++ L Q + + K + + L YLH I+H+D+
Sbjct: 127 VSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDV 183
Query: 569 SSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSF 628
++N+ ++ + + D G A+F + + AGT APE+ K K D++S
Sbjct: 184 KTENIFINDVDQVCIGDLGAAQF-PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSA 242
Query: 629 GVLVLEAI 636
G+++ E +
Sbjct: 243 GIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 3/96 (3%)
Query: 548 VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG 607
+A L +LH I+++D+ N++LD E +ADFG+ K + F GT
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD 166
Query: 608 YVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRD 643
Y+APE+ + D ++FGVL+ E + G+ P +
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 9e-07
Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 37/183 (20%)
Query: 479 DQKEFL---IEVKALTEIR---------HRNIVKFYGFCSHARHSFLVYELLERGSLAAI 526
QK F+ I+ K I + N +K Y + + L+ + ++ G L +
Sbjct: 40 TQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL 99
Query: 527 LSSDTAAQELGWSQRMNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLD-LEYEAHVA 584
L + E ++ +I+ + +AL+ LH H+ I+H DI +N+L D + ++
Sbjct: 100 LKKEGKLSE---AEVKKIIRQLVEALNDLHKHN----IIHNDIKLENVLYDRAKDRIYLC 152
Query: 585 DFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKIT-EKCDVYSF-----GVLVLEAIKG 638
D+G+ K + S + GT Y +PE KI D SF GVL E + G
Sbjct: 153 DYGLCKIIGTPSC----YDGTLDYFSPE-----KIKGHNYD-VSFDWWAVGVLTYELLTG 202
Query: 639 KHP 641
KHP
Sbjct: 203 KHP 205
|
Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 62/247 (25%), Positives = 105/247 (42%), Gaps = 26/247 (10%)
Query: 444 IGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
+G GG+G V++ +G++ A+K D E L ++H IV
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 500 KF-YGFCSHARHSFLVYELLERGSL------AAILSSDTAAQELGWSQRMNVIKGVADAL 552
Y F + + +L+ E L G L I DTA L ++ AL
Sbjct: 64 DLIYAFQTGGK-LYLILEYLSGGELFMHLEREGIFMEDTACFYLS---------EISLAL 113
Query: 553 SYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE 612
+LH I+++D+ +N+LLD + + DFG+ K E + F GT Y+APE
Sbjct: 114 EHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE 170
Query: 613 LAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672
+ + D +S G L+ + + G P F + +++ + L P L P +R
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTGAPP--FTAENRKKTIDKILKGKLNLPPYLTPEAR 228
Query: 673 SVQEKLI 679
+ +KL+
Sbjct: 229 DLLKKLL 235
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 58/255 (22%), Positives = 109/255 (42%), Gaps = 51/255 (20%)
Query: 479 DQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLVYELLERGSLAAIL---------- 527
D + + E++ + I +H+NI+ G C+ +++ E +G+L L
Sbjct: 63 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 122
Query: 528 SSDTAA---QELGWSQRMNVIKGVADALSYL-HHDCFPPIVHQDISSKNLLLDLEYEAHV 583
S D A +++ + ++ VA + YL C +H+D++++N+L+ +
Sbjct: 123 SYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKI 178
Query: 584 ADFGIAKFLKPESSNWTEFAGTYG------YVAPELAYTMKITEKCDVYSFGVLVLEAIK 637
ADFG+A+ + +N + T ++APE + T + DV+SFGVL+ E
Sbjct: 179 ADFGLAR----DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
Query: 638 -GKHPRDFLSLISSSSLNTDIALDEILD-----PRLPPPSRSVQEKLISIMEVAFSCLNE 691
G P I ++E+ R+ P+ E L +M C +
Sbjct: 235 LGGSPY------------PGIPVEELFKLLKEGHRMDKPANCTNE-LYMMMR---DCWHA 278
Query: 692 SPESRPTMKVVTQQV 706
P RPT K + + +
Sbjct: 279 IPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 29/209 (13%)
Query: 444 IGNGGHGSVYRAEL---PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
IGNG G V +E+ V +K+ + +Q EFL + ++H NI++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANA---SSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSS------DTAAQELGWSQRMNVIKGVADALSY 554
G C A LV+E E G L + LS ++ L QRM +A +++
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLL---QRMAC--EIAAGVTH 114
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG--YVAPE 612
+H F +H D++ +N L + V D+GI E TE ++APE
Sbjct: 115 MHKHNF---LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171
Query: 613 LA-------YTMKITEKCDVYSFGVLVLE 634
L T + T+ +V++ GV + E
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWE 200
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 45/225 (20%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKE-FLI----EVKALTEIRHRN 497
+G G G VY+A ++ +G+VVA+KK + ++K+ F I E+K L +++H N
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKI-------LMHNEKDGFPITALREIKILKKLKHPN 68
Query: 498 IVK----FY---GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVAD 550
+V R S + L+ +L + + +L SQ + + +
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV--KLTESQIKCYMLQLLE 126
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAG------ 604
++YLH + I+H+DI + N+L+D + +ADFG+A+ N G
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183
Query: 605 -----TYGYVAPELA-----YTMKITEKCDVYSFGVLVLEAIKGK 639
T Y PEL YT + D++ G + E +
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 53/275 (19%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKF 501
+G G +G V++A + + +VVA+KK A Q+ F E+ L E+ H NIVK
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDA-QRTFR-EIMFLQELGDHPNIVKL 72
Query: 502 YGF--CSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGV---------AD 550
+ + +LV+E +E A I R N+++ V
Sbjct: 73 LNVIKAENDKDIYLVFEYMETDLHAVI--------------RANILEDVHKRYIMYQLLK 118
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW-----TEFAGT 605
AL Y+H ++H+D+ N+LL+ + +ADFG+A+ L N T++ T
Sbjct: 119 ALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 606 YGYVAPE--LAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLIS-SSSLNTDIALDEI 662
Y APE L T + T+ D++S G ++ E + GK L +S+LN L++I
Sbjct: 176 RWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGK------PLFPGTSTLNQ---LEKI 225
Query: 663 LDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRP 697
++ + PPS E + S A + L+ P
Sbjct: 226 IEV-IGPPSAEDIESIKS--PFAATMLDSLPSRPR 257
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 551 ALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYV 609
AL +LH +D IV++D+ +N+LLD + DFG++K ++ F GT Y+
Sbjct: 108 ALEHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYL 163
Query: 610 APELAYTMK-ITEKCDVYSFGVLVLEAIKGKHP 641
APE+ K T+ D +S GVLV E G P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 59/302 (19%), Positives = 109/302 (36%), Gaps = 70/302 (23%)
Query: 443 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
C + + + + P+ +VA+KK + L D K E+ +++H NI+ +
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKIN--LDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
++V L+ GS L + L ++K V +AL Y+H F
Sbjct: 66 TSFIVDSELYVVSPLMAYGS-CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGF-- 122
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAK------------FLKPESS----NWTEFAGTY 606
+H+ + + ++LL + + ++ + P+SS W
Sbjct: 123 -IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL------ 175
Query: 607 GYVAPELAYT--MKITEKCDVYSFGV-------------------LVLEAIKGKHPRDFL 645
+PE+ EK D+YS G+ ++LE ++G P
Sbjct: 176 ---SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVP---- 228
Query: 646 SLISSSSL---NTDIALDE-------ILDPRLPPPSRSVQEKLISIMEVAFSCLNESPES 695
L+ S+ ++ D P +R+ E +E+ CL PES
Sbjct: 229 CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVEL---CLQRDPES 285
Query: 696 RP 697
RP
Sbjct: 286 RP 287
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 22/218 (10%)
Query: 485 IEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRM-- 542
E + L+++ H IVKF+ ++ E E L D +EL + +
Sbjct: 51 QEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDL------DCKLEELKHTGKTLS 104
Query: 543 --NVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWT 600
V + L +H+ I+H+D+ +KN+ L + DFG+++ L T
Sbjct: 105 ENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLAT 163
Query: 601 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALD 660
F GT Y++PE K D++S G ++ E H + + L+ + +
Sbjct: 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAH-----AFEGQNFLSVVLRIV 218
Query: 661 EILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
E P LP + +L SIM+ S LN+ P RP+
Sbjct: 219 EGPTPSLP---ETYSRQLNSIMQ---SMLNKDPSLRPS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 9/200 (4%)
Query: 444 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTE-IRHRNIVKF 501
IG G G V A+ G+ A+K + ++ +QK + E L + ++H +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR-KEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 502 YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFP 561
+ + V + + G L L + + E + +A AL YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLHS---I 115
Query: 562 PIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITE 621
IV++D+ +N+LLD + + DFG+ K +S T F GT Y+APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 622 KCDVYSFGVLVLEAIKGKHP 641
D + G ++ E + G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 1/79 (1%)
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEK 622
IV++D+ +N+LLD ++D G+A + PE GT GY+APE+ K T
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 623 CDVYSFGVLVLEAIKGKHP 641
D + G L+ E I+G+ P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 46/207 (22%), Positives = 96/207 (46%), Gaps = 27/207 (13%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKE-----FLIEVKALTEIRHRN 497
+G G + +VY+ +G++VA+K+ H D +E + E+ + E++H N
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIH--------LDAEEGTPSTAIREISLMKELKHEN 59
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH 557
IV+ + LV+E ++ L + + L + + + +++ H
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL---- 613
+ ++H+D+ +NLL++ E +ADFG+A+ + ++ T Y AP++
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175
Query: 614 -AYTMKITEKCDVYSFGVLVLEAIKGK 639
Y+ I D++S G ++ E I G+
Sbjct: 176 RTYSTSI----DIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVA 610
L LH + V++D+ +N+LLD ++D G+A + PE + GT GY+A
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRVGTVGYMA 169
Query: 611 PELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
PE+ + T D + G L+ E I+G+ P
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 444 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G G V+ P G+ VA+KK P + K E+K L +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKM--PNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 503 -----GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH 557
++V EL++ I+S + + +++G L YLH
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG----LKYLHS 121
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP-ESSNWTEFAGTYGYVAPELA-- 614
I+H+DI NLL++ + DFG+A+ +P ES + T+ T Y APE+
Sbjct: 122 ---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178
Query: 615 ---YTMKITEKCDVYSFGVLVLEAIKGK 639
YT + D++S G + E + +
Sbjct: 179 SRHYTSAV----DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 14/222 (6%)
Query: 437 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHR 496
D++ IG G G V S + V K S + +D F E +
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 497 NIVK-FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
+V+ FY F R+ ++V E + G L ++S+ ++ W++ V AL +
Sbjct: 104 WVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--WARFYTA--EVVLALDAI 158
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFA-GTYGYVAPELA 614
H F +H+D+ N+LLD +ADFG + E + A GT Y++PE+
Sbjct: 159 HSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 215
Query: 615 YTMK----ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS 652
+ +CD +S GV + E + G P SL+ + S
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 257
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 47/185 (25%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 527 LSSDTAAQELGWSQRMNVIKGVADALSYL-HHDCFPPIVHQDISSKNLLLDLEYEAHVAD 585
L SD ++ L ++ VA + +L +C VH+D++++N+LL + D
Sbjct: 225 LLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICD 280
Query: 586 FGIAKFLKPESSNWTEFAGTY---GYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHP 641
FG+A+ + SN+ T+ ++APE + T DV+S+G+L+ E G P
Sbjct: 281 FGLARDIM-HDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP 339
Query: 642 RDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKV 701
+ +I S+ I R+ P + QE + ++ C N PE RP+
Sbjct: 340 --YPGMIVDSTFYNKIKSGY----RMAKPDHATQE----VYDIMVKCWNSEPEKRPSFLH 389
Query: 702 VTQQV 706
++ V
Sbjct: 390 LSDIV 394
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 52/223 (23%), Positives = 93/223 (41%), Gaps = 15/223 (6%)
Query: 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
+DF+ IG G G V ++ + + K + + A+ F E L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILS--SDTAAQELGWSQRMNVIKGVADALS 553
+ I + + +LV + G L +LS D +++ ++ + ++
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI-HSIH 119
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFG-IAKFLKPESSNWTEFAGTYGYVAPE 612
LH+ VH+DI N+LLD+ +ADFG K + + + GT Y++PE
Sbjct: 120 QLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 613 LAYTM-----KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISS 650
+ M K +CD +S GV + E + G+ P SL+ +
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 56/231 (24%), Positives = 98/231 (42%), Gaps = 44/231 (19%)
Query: 437 DFDAQYC----IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALT 491
D ++Y +G G +G V+ A + + VA+KK + K L E+K +
Sbjct: 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKK----IVLTDPQSVKHALREIKIIR 57
Query: 492 EIRHRNIVKFY--------------GFCSHARHSFLVYELLERGSLAAILSSDTAAQELG 537
+ H NIVK Y G + ++V E +E LA +L ++E
Sbjct: 58 RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHA 116
Query: 538 WSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE-YEAHVADFGIAKFLKPES 596
+++G L Y+H ++H+D+ N+ ++ E + DFG+A+ + P
Sbjct: 117 RLFMYQLLRG----LKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169
Query: 597 SN---WTEFAGTYGYVAPELA-----YTMKITEKCDVYSFGVLVLEAIKGK 639
S+ +E T Y +P L YT I D+++ G + E + GK
Sbjct: 170 SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 27/81 (33%), Positives = 45/81 (55%)
Query: 86 QGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCP 145
+G IP + L + L+ N++ GNI +LG +L +DLS N F G I + G+
Sbjct: 431 RGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490
Query: 146 KLGTLNVSMNNITGGIPREIG 166
L LN++ N+++G +P +G
Sbjct: 491 SLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 34/94 (36%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK-FLKPESSNWTEFAGTYGYV 609
AL +LH I+++DI +N+LLD E + DFG++K FL E F GT Y+
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 610 APELAYTMKI--TEKCDVYSFGVLVLEAIKGKHP 641
APE+ + D +S GVL E + G P
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 55/255 (21%), Positives = 107/255 (41%), Gaps = 51/255 (20%)
Query: 479 DQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLVYELLERGSLAAILS--------- 528
D + + E++ + I +H+NI+ G C+ +++ E +G+L L
Sbjct: 66 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 125
Query: 529 ----SDTAAQELGWSQRMNVIKGVADALSYL-HHDCFPPIVHQDISSKNLLLDLEYEAHV 583
+ ++L + ++ VA + YL C +H+D++++N+L+ + +
Sbjct: 126 CYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKI 181
Query: 584 ADFGIAK------FLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK 637
ADFG+A+ + K ++ ++APE + T + DV+SFGVL+ E
Sbjct: 182 ADFGLARDIHHIDYYKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
Query: 638 -GKHPRDFLSLISSSSLNTDIALDEILD-----PRLPPPSRSVQEKLISIMEVAFSCLNE 691
G P + ++E+ R+ PS E L +M C +
Sbjct: 238 LGGSPY------------PGVPVEELFKLLKEGHRMDKPSNCTNE-LYMMMR---DCWHA 281
Query: 692 SPESRPTMKVVTQQV 706
P RPT K + + +
Sbjct: 282 VPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 68/241 (28%), Positives = 106/241 (43%), Gaps = 28/241 (11%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIK--KFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
+G G G V E +G+ A+K K + D++A L E + L RH +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT---LTESRVLQNTRHPFLTA 59
Query: 501 F-YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKG--VADALSYLHH 557
Y F +H R F V E G L LS +E +S+ G + AL YLH
Sbjct: 60 LKYSFQTHDRLCF-VMEYANGGELFFHLS-----RERVFSEDRARFYGAEIVSALGYLHS 113
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTM 617
+V++D+ +NL+LD + + DFG+ K + + F GT Y+APE+
Sbjct: 114 C---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 618 KITEKCDVYSFGVLVLEAIKGKHP---RDFLSLISSSSLNTDIALDEILDPR-LPPPSRS 673
D + GV++ E + G+ P +D L I ++EI PR L P ++S
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HEKLFELILMEEIRFPRTLSPEAKS 224
Query: 674 V 674
+
Sbjct: 225 L 225
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 1/79 (1%)
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEK 622
IV++D+ +N+LLD ++D G+A + PE GT GY+APE+ + T
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRVGTVGYMAPEVVKNERYTFS 181
Query: 623 CDVYSFGVLVLEAIKGKHP 641
D + G L+ E I+GK P
Sbjct: 182 PDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 5e-06
Identities = 60/252 (23%), Positives = 111/252 (44%), Gaps = 32/252 (12%)
Query: 428 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEV 487
YD+ N+++ IGNG G V+ + Q K S + ++ + +IEV
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEV 63
Query: 488 KALTEIRHRNIVKFYG-FCSHARHS-FLVYELLERGSLAA-ILSSDTAAQELGWSQRMNV 544
+ E++H+NIV++ F + A +++ E + G L+ I ++ +++
Sbjct: 64 NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123
Query: 545 IKGVADALSYLHHDCFPP----IVHQDISSKNLLLDLEYE-----------------AHV 583
+ + AL+Y H+ P ++H+D+ +N+ L A +
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183
Query: 584 ADFGIAKFLKPESSNWTEFAGTYGYVAPELAY--TMKITEKCDVYSFGVLVLEAIKGKHP 641
DFG++K + ES + GT Y +PEL T +K D+++ G ++ E GK P
Sbjct: 184 GDFGLSKNIGIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
Query: 642 ----RDFLSLIS 649
+F LIS
Sbjct: 243 FHKANNFSQLIS 254
|
Length = 1021 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 46/195 (23%), Positives = 68/195 (34%), Gaps = 34/195 (17%)
Query: 521 GSLAAILSSDTA---AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL 577
SLA IL +E+ W+ V AL LH S N+LL
Sbjct: 1 VSLADILEVRGRPLNEEEI-WA----VCLQCLGALRELHRQ---------AKSGNILLTW 46
Query: 578 EYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK 637
+ + G F PE S + ++APE+ TEK D+YS G+ + EA+
Sbjct: 47 D--GLLKLDGSVAFKTPEQSRPDPY-----FMAPEVIQGQSYTEKADIYSLGITLYEALD 99
Query: 638 GKHPRDFLSLISSSSLNTDIALDEI--LDPRLPPPSRSVQEKLI--SIMEVAFSCLNESP 693
+ P + S +I L+ + DPR V M + C + P
Sbjct: 100 YELPY---NEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRL---CASRLP 153
Query: 694 ESRPTMKVVTQQVRI 708
+ R R
Sbjct: 154 QRREAANHYLAHCRA 168
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 34/126 (26%), Positives = 57/126 (45%), Gaps = 16/126 (12%)
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIA---KFLKPESSNWTEFAGTYGYVAPE-LAYTMK 618
+V++D+ N+LLD ++D G+A KP +S GT+GY+APE L +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 172
Query: 619 ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP----PPSRSV 674
D +S G ++ + ++G P F + D + + LP P RS+
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEID-RMTLTMAVELPDSFSPELRSL 229
Query: 675 QEKLIS 680
E L+
Sbjct: 230 LEGLLQ 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 5/95 (5%)
Query: 548 VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK-FLKPESSNWTEFAGTY 606
VA A+ YLH I+++D+ +N+LLD + + DFG+ K ++PE + T F GT
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTP 160
Query: 607 GYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
Y+APE+ D + G ++ E + G P
Sbjct: 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 66/235 (28%), Positives = 87/235 (37%), Gaps = 42/235 (17%)
Query: 92 ILRNCSSLIRVRLNSNNLTGN----ISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKL 147
+L L +RL N L ++ AL P+L + LS N G I +
Sbjct: 18 LLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLN-ETGRIPRGLQSLLQG 76
Query: 148 GTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIP---KELGKLNSLTELILRGNQ 204
+ LQ LDLS N + + + L + +SL EL L N
Sbjct: 77 -----------------LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNG 119
Query: 205 FTGR-LPPEIGSLVD----LEYLDLSANRFNNSVPENLGNLL----KLHYLGLSNNQFVL 255
R L L D LE L L NR + E L L L L L+NN
Sbjct: 120 LGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGD 179
Query: 256 E----LPKELEKLVQLSELDASHNLFGGEIPFQIC----SLKSLEKLNLSHNNLS 302
L + L+ L LD ++N E + SLKSLE LNL NNL+
Sbjct: 180 AGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKE-----FLIEVKALTEIRHRN 497
IG G +G+V++A + ++VA+K+ ++ D E L E+ L E++H+N
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV-------RLDDDDEGVPSSALREICLLKELKHKN 60
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSS--DTAAQELGWSQRMNVIKGVADALSYL 555
IV+ Y + LV+E ++ L S E+ S ++KG+A S
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS-- 117
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK-FLKPESSNWTEFAGTYGYVAPELA 614
H+ ++H+D+ +NLL++ E +ADFG+A+ F P E T Y P++
Sbjct: 118 HN-----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVL 171
Query: 615 YTMKI-TEKCDVYSFGVLVLEAIKGKHP 641
+ K+ + D++S G + E P
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 548 VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG 607
+A AL YLH IV++D+ +N+LLD + + DFG+ K + + F GT
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPE 161
Query: 608 YVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
Y+APE+ + D + G ++ E + G P
Sbjct: 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 53/240 (22%), Positives = 93/240 (38%), Gaps = 31/240 (12%)
Query: 416 LFSILNFEGKLV--YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKF-HSPL 472
+ I E + Y ++ ND Q I G + V I+ F
Sbjct: 9 INDIKCIESDDIDKYTSVLIKEND---QNSIYKGIFN---------NKEVIIRTFKKFHK 56
Query: 473 PCDQIADQKEFLIEVKALTEIRHRNIVKFYGF----CSHARHSFLVYELLERGSLAAILS 528
+ D E E+K L I NI+K YGF L+ E RG L +L
Sbjct: 57 GHKVLIDITE--NEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD 114
Query: 529 SDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588
+ ++L + ++++ L L+ P +++++S + L+ Y+ + G+
Sbjct: 115 KE---KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGL 169
Query: 589 AKFLKPESSNWTEFAGTYGYVAPELAYTM--KITEKCDVYSFGVLVLEAIKGKHPRDFLS 646
K L F Y + ++ + + T K D+YS GV++ E GK P + L+
Sbjct: 170 EKILSSPPFKNVNFMV---YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226
|
Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 18/215 (8%)
Query: 437 DFDAQYCIGNGGHGSVYRAELPSG----QVVAIKKFHSPLPCDQIADQKEFLIEVKALTE 492
+F+ +G G +G V+ SG ++ A+K + + E + L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 493 IRHRN--IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKG-VA 549
IR + Y F + + L+ + + G L LS +E Q + + G +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLH-LILDYINGGELFTHLSQRERFKE----QEVQIYSGEIV 115
Query: 550 DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK-FLKPESSNWTEFAGTYGY 608
AL +LH I+++DI +N+LLD + DFG++K F + E F GT Y
Sbjct: 116 LALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172
Query: 609 VAPELAYTMKI--TEKCDVYSFGVLVLEAIKGKHP 641
+AP++ + D +S GVL+ E + G P
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 444 IGNGGHGSVY--RAELPSGQVVAIKKFH----SPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G G + +V+ R++L + +VA+K+ PC I EV L ++H N
Sbjct: 13 LGEGTYATVFKGRSKL-TENLVALKEIRLEHEEGAPCTAIR-------EVSLLKNLKHAN 64
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH 557
IV + R LV+E L+ L L D + + + LSY H
Sbjct: 65 IVTLHDIIHTERCLTLVFEYLD-SDLKQYL--DNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE-LAYT 616
I+H+D+ +NLL++ + E +ADFG+A+ + ++ T Y P+ L +
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS 178
Query: 617 MKITEKCDVYSFGVLVLEAIKGK 639
+ + D++ G ++ E G+
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG+G G V A + +GQ VAIKK P + K E+ + + H+NI+
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPF--QNVTHAKRAYRELVLMKLVNHKNIIGLL 81
Query: 503 G-FC-----SHARHSFLVYELLERGSLAAILSSDTAAQELGW--SQRMNVIKGVADALSY 554
F + +LV EL++ +L ++ D + + + Q + IK +
Sbjct: 82 NVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLLYQMLCGIK-------H 133
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
LH I+H+D+ N+++ + + DFG+A+ S T + T Y APE+
Sbjct: 134 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 189
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGK 639
M E D++S G ++ E I+G
Sbjct: 190 LGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 27/89 (30%), Positives = 44/89 (49%), Gaps = 5/89 (5%)
Query: 490 LTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA 549
+ ++ H++IV YG C + +V E +E G L + + W + V K +A
Sbjct: 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLA 115
Query: 550 DALSYLHHDCFPPIVHQDISSKNLLLDLE 578
ALSYL +VH ++ +KN+LL E
Sbjct: 116 SALSYLEDK---DLVHGNVCTKNILLARE 141
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 444 IGNGGHGSVY--RAELPSGQVVAIKKF----HSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G G + +VY R++L + +VA+K+ PC I EV L +++H N
Sbjct: 14 LGEGTYATVYKGRSKL-TDNLVALKEIRLEHEEGAPCTAIR-------EVSLLKDLKHAN 65
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIK----GVADALS 553
IV + + LV+E L++ L L + G S M+ +K + L+
Sbjct: 66 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLD------DCGNSINMHNVKLFLFQLLRGLN 118
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE- 612
Y H ++H+D+ +NLL++ E +ADFG+A+ + ++ T Y P+
Sbjct: 119 YCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDI 175
Query: 613 LAYTMKITEKCDVYSFGVLVLEAIKGK 639
L + + + D++ G + E G+
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 52/231 (22%), Positives = 91/231 (39%), Gaps = 49/231 (21%)
Query: 490 LTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA 549
++++ H ++ +G C + +V E +E G L L + + W ++ V + +A
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLA 127
Query: 550 DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWT-------EF 602
ALSYL +VH ++ +KN+LL +A+ G + F+K + E
Sbjct: 128 SALSYLEDK---NLVHGNVCAKNILLA---RLGLAE-GTSPFIKLSDPGVSFTALSREER 180
Query: 603 AGTYGYVAPE-LAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDE 661
++APE + ++ D +SFG +LE + ++ L E
Sbjct: 181 VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI----------------CFDGEVPLKE 224
Query: 662 ILDP----------RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVV 702
RLP PS LIS CL P RP+ + +
Sbjct: 225 RTPSEKERFYEKKHRLPEPSCKELATLIS------QCLTYEPTQRPSFRTI 269
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 1/109 (0%)
Query: 55 GLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNIS 114
GLD ++P+++ + LQ +S N +G IP L + +SL + L+ N+ G+I
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 115 EALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGT-LNVSMNNITGGIP 162
E+LG +L ++L+ N G + + G N + N GIP
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
DFD + +G G G V E +G + A+K + Q + F E + + I
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQ--ETVSFFEEERDILSIS 58
Query: 495 HRN-IVKF-YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADAL 552
+ I + Y F + +LV E G L ++L+ + +Q + + A+
Sbjct: 59 NSPWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY--LAELVLAI 115
Query: 553 SYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFA----GTYGY 608
+H + VH+DI +N+L+D +ADFG A L ++N + GT Y
Sbjct: 116 HSVHQMGY---VHRDIKPENVLIDRTGHIKLADFGSAARL---TANKMVNSKLPVGTPDY 169
Query: 609 VAPELAYTMKITEK------CDVYSFGVLVLEAIKGKHP 641
+APE+ TM K CD +S GV+ E I G+ P
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-05
Identities = 21/62 (33%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 266 QLSELDASHNLFG--GEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDN 323
L LD S+N + F+ L +L+ L+LS NNL+ P F G+ + +D+S N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFK--GLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
Query: 324 QL 325
L
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 24/58 (41%), Positives = 36/58 (62%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDF 58
+ SL +LDL+ N F G +P S+ LT+L+ L L N+LSG +P +L +L R +F
Sbjct: 465 ITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNF 522
|
Length = 623 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 65/256 (25%), Positives = 103/256 (40%), Gaps = 60/256 (23%)
Query: 436 NDFDAQYCIGNGGHGSVYR--AELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKA---- 489
+DF++ IG G G V R + +G + A+KK + + +KE + V+A
Sbjct: 1 DDFESIKVIGRGAFGEV-RLVQKKDTGHIYAMKKL---RKSEML--EKEQVAHVRAERDI 54
Query: 490 LTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAIL-SSDTAAQELGWSQRMNVIKGV 548
L E + +VK Y + +L+ E L G + +L DT +E + I
Sbjct: 55 LAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE----ETRFYIAET 110
Query: 549 ADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK--------------- 593
A+ +H + +H+DI NLLLD + ++DFG+ LK
Sbjct: 111 ILAIDSIHKLGY---IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167
Query: 594 ----------PESS-----NWTE--------FAGTYGYVAPELAYTMKITEKCDVYSFGV 630
P SS W GT Y+APE+ ++CD +S GV
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227
Query: 631 LVLEAIKGKHPRDFLS 646
++ E + G P F S
Sbjct: 228 IMYEMLVGYPP--FCS 241
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 28/84 (33%), Positives = 43/84 (51%), Gaps = 6/84 (7%)
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFA-GTYGYVAPELAYTM----- 617
VH+DI N+LLD +ADFG L + + + A GT Y++PE+ M
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 618 KITEKCDVYSFGVLVLEAIKGKHP 641
+ +CD +S GV + E + G+ P
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 66/291 (22%), Positives = 118/291 (40%), Gaps = 51/291 (17%)
Query: 444 IGNGGHGSVYRAE--LPSGQVVAIKKF-----HSPLPCDQIADQKEFLIEVKALTEIRHR 496
IG G +G V++A G+ VA+K+ +P I +E + ++ L H
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI---REVAV-LRHLETFEHP 64
Query: 497 NIVKFYGFCSHARHS-----FLVYELLERGSLAAILSSDTAAQELGWSQRM--NVIKGVA 549
N+V+ + C+ +R LV+E +++ L L E G +++ +
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK---VPEPGVPTETIKDMMFQLL 120
Query: 550 DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYV 609
L +LH +VH+D+ +N+L+ + +ADFG+A+ + + T T Y
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYR 176
Query: 610 APELAYTMKITEKCDVYSFGVLVLEAIKGK-------------HPRDFLSLISSSSLNTD 656
APE+ D++S G + E + K D + L D
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236
Query: 657 IALDEILDPRLPPPSRSVQ--EKLISIME-----VAFSCLNESPESRPTMK 700
+AL PR S+S Q EK ++ ++ + CL +P R +
Sbjct: 237 VAL-----PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 3/94 (3%)
Query: 548 VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG 607
+A AL YLH I+++D+ +N+LLD + + DFG+ K S + F GT
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE 161
Query: 608 YVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
Y+APE+ D + G ++ E + G P
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 37/155 (23%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 486 EVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVI 545
E L I H +I++ G ++ + + L+ + L L+ A + + + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLA---AKRNIAICDILAIE 188
Query: 546 KGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN-WTEFAG 604
+ V A+ YLH + I+H+DI ++N+ ++ + + DFG A F ++N + +AG
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245
Query: 605 TYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGK 639
T APEL D++S G+++ E
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 8e-05
Identities = 48/205 (23%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 444 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
IG+G G V Y A L VAIKK P +Q ++ + E+ + + H+NI+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQ-NQTHAKRAYR-ELVLMKCVNHKNIIS 80
Query: 501 FYGFCSHAR------HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
+ + +LV EL++ +L ++ + + + + ++ + + +
Sbjct: 81 LLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKH 134
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
LH I+H+D+ N+++ + + DFG+A+ S T + T Y APE+
Sbjct: 135 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 190
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGK 639
M E D++S G ++ E ++ K
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 14/211 (6%)
Query: 437 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHR 496
DFD IG G G V S + V K S + +D F E +
Sbjct: 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSE 103
Query: 497 NIVK-FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
IV+ Y F ++ ++V E + G L ++S+ ++ W++ V AL +
Sbjct: 104 WIVQLHYAF-QDDKYLYMVMEYMPGGDLVNLMSNYDIPEK--WARFY--TAEVVLALDAI 158
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFA-GTYGYVAPELA 614
H F +H+D+ N+LLD +ADFG + + A GT Y++PE+
Sbjct: 159 HSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVL 215
Query: 615 YTMKIT----EKCDVYSFGVLVLEAIKGKHP 641
+ +CD +S GV + E + G P
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 9e-05
Identities = 48/200 (24%), Positives = 86/200 (43%), Gaps = 36/200 (18%)
Query: 519 ERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL-HHDCFPPIVHQDISSKNLLLDL 577
++ + IL D A L ++ VA +S+L +C +H+D++++N+LL
Sbjct: 196 DQDVTSEILEEDELA--LDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTH 249
Query: 578 EYEAHVADFGIAKFLKPESSNWTEFAGT---YGYVAPELAYTMKITEKCDVYSFGVLVLE 634
+ DFG+A+ ++ + SN+ ++APE + T + DV+S+G+L+ E
Sbjct: 250 GRITKICDFGLARDIRND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWE 308
Query: 635 AIK-GKHP-------RDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAF 686
G P F +I +L P P ++ IM+
Sbjct: 309 IFSLGSSPYPGMPVDSKFYKMIKEGY--------RMLSPECAPS------EMYDIMK--- 351
Query: 687 SCLNESPESRPTMKVVTQQV 706
SC + P RPT K + Q +
Sbjct: 352 SCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 37/162 (22%), Positives = 66/162 (40%), Gaps = 22/162 (13%)
Query: 493 IRHRNIVKFYGFCSHARHSFLVYE--LLERGSLAAILSSDTAAQELGWSQRM--NVIKGV 548
I H I K+YG C + + Y LLE+ + + + ++++ N++K +
Sbjct: 80 IDHLGIPKYYG-CGSFKRCRMYYRFILLEKLVEN---TKEIFKRIKCKNKKLIKNIMKDM 135
Query: 549 ADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL---------KPESSNW 599
L Y+H I H DI +N+++D ++ D+GIA E +
Sbjct: 136 LTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDL 192
Query: 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
GT Y + +T + D+ S G +L+ K P
Sbjct: 193 HR--GTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 7/102 (6%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSL-ENPMLTRPGLDFN 59
+R L ++L+ N +G +PPS+ ++T+L+ L L YN+ +G IP SL + L L+ N
Sbjct: 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500
Query: 60 HFTSYLPHNVCRGGALQY---FGVSENHFQGTIPKILRNCSS 98
+ +P + GG L + F ++N IP LR C
Sbjct: 501 SLSGRVPAAL--GGRLLHRASFNFTDNAGLCGIPG-LRACGP 539
|
Length = 623 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 47/207 (22%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 444 IGNGGHGSVY--RAELPSGQVVAIKKF----HSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G G + +V+ R++L + +VA+K+ PC I EV L +++H N
Sbjct: 14 LGEGTYATVFKGRSKL-TENLVALKEIRLEHEEGAPCTAIR-------EVSLLKDLKHAN 65
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIK----GVADALS 553
IV + + LV+E L++ + G M+ +K + L+
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDK-------DLKQYMDDCGNIMSMHNVKIFLYQILRGLA 118
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE- 612
Y H ++H+D+ +NLL++ E +ADFG+A+ + ++ T Y P+
Sbjct: 119 YCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175
Query: 613 LAYTMKITEKCDVYSFGVLVLEAIKGK 639
L + + + + D++ G + E G+
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 11/94 (11%)
Query: 546 KGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL-----KPESSNWT 600
+ + +AL+YLH I+H+D+ ++N+ LD A + DFG A L P+ W
Sbjct: 192 RRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW- 247
Query: 601 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLE 634
+GT +PEL K D++S G+++ E
Sbjct: 248 --SGTLETNSPELLALDPYCAKTDIWSAGLVLFE 279
|
Length = 392 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 27/206 (13%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFH----SPLPCDQIADQKEFLIEVKALTEIRHRNI 498
+G G + +VY+ +GQ+VA+K +P I E L ++H NI
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-------EASLLKGLKHANI 65
Query: 499 VKFYGFCSHARHSF-LVYELLERGSLAAILSSDTAAQELGWSQRMNV---IKGVADALSY 554
V + H + + V+E + LA + Q G NV + + L+Y
Sbjct: 66 VLLHDII-HTKETLTFVFEYMHT-DLAQYM-----IQHPGGLHPYNVRLFMFQLLRGLAY 118
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE-L 613
+H I+H+D+ +NLL+ E +ADFG+A+ S ++ T Y P+ L
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVL 175
Query: 614 AYTMKITEKCDVYSFGVLVLEAIKGK 639
+ D++ G + +E ++G+
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 35/139 (25%), Positives = 63/139 (45%), Gaps = 15/139 (10%)
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAK--FLKPESSNWTEFAGTYGYVAPELAYTMKITE 621
+H+D++++N+LL + DFG+A+ + P+ ++APE + T
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 622 KCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLIS- 680
+ DV+SFGVL+ E SL +S + ++E RL +R + +
Sbjct: 256 QSDVWSFGVLLWE---------IFSL--GASPYPGVQINEEFCQRLKDGTRMRAPENATP 304
Query: 681 -IMEVAFSCLNESPESRPT 698
I + +C P+ RPT
Sbjct: 305 EIYRIMLACWQGDPKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 38/171 (22%), Positives = 74/171 (43%), Gaps = 23/171 (13%)
Query: 486 EVKALTEIRHRNIVKF--------YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELG 537
E+ AL + H NI+K + ++ F +Y + + D + L
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------DWKDRPLL 266
Query: 538 WSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA-KFLKPES 596
R ++K + A+ Y+H ++H+DI +N+ L+ + + + DFG A F K
Sbjct: 267 KQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322
Query: 597 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSL 647
+ + GT +PE+ E D++S G+++L+ + DF +
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS----HDFCPI 369
|
Length = 501 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 54/235 (22%), Positives = 97/235 (41%), Gaps = 42/235 (17%)
Query: 483 FLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRM 542
F ++++ H+++V YG C S +V E ++ GSL L + + W ++
Sbjct: 46 FFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KL 103
Query: 543 NVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAH--------VADFGIAKFLKP 594
V K +A AL +L + H ++ +KN+LL E + ++D GI+ + P
Sbjct: 104 EVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160
Query: 595 -----ESSNWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLI 648
E W V PE + ++ D +SFG + E G
Sbjct: 161 KEILLERIPW---------VPPECIENPQNLSLAADKWSFGTTLWEIFSGGD-------K 204
Query: 649 SSSSLNTDIALDEILDP-RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVV 702
S+L++ L D +LP P + LI+ C++ P+ RP+ + +
Sbjct: 205 PLSALDSQKKLQFYEDRHQLPAPKWTELANLIN------QCMDYEPDFRPSFRAI 253
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 40/224 (17%)
Query: 438 FDAQYC-IGNGGHGSVYRAELPSG---QVVAIKKFH----SPLPCDQIADQKEFLIEVKA 489
F+ + C +G G +G VY+A+ G + A+K+ S C +IA
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIA----------L 51
Query: 490 LTEIRHRNIVKFYG-FCSHA-RHSFLVYELLERGSLAAILSSDTAAQ------ELGWSQR 541
L E++H N++ F SHA R +L+++ E L I+ A++ +L
Sbjct: 52 LRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMV 110
Query: 542 MNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE----YEAHVADFGIAKF----LK 593
+++ + D + YLH + ++H+D+ N+L+ E +AD G A+ LK
Sbjct: 111 KSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167
Query: 594 PESSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLVLEAI 636
P ++ T+ Y APEL + T+ D+++ G + E +
Sbjct: 168 P-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 21/186 (11%)
Query: 497 NIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQE---LGWSQRMNVIKGVADALS 553
N+V + + FLV + E G L + +S E W+ M V AL
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVV------ALD 99
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL 613
LH + IV +D++ N+LLD H+ +++ + E S E A Y APE+
Sbjct: 100 ALHRE---GIVCRDLNPNNILLD--DRGHIQLTYFSRWSEVEDSCDGE-AVENMYCAPEV 153
Query: 614 AYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673
+ TE CD +S G ++ E + GK L S +NT L+ + + +RS
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKT----LVECHPSGINTHTTLN--IPEWVSEEARS 207
Query: 674 VQEKLI 679
+ ++L+
Sbjct: 208 LLQQLL 213
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 34/169 (20%)
Query: 548 VADALSYL-HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT- 605
VA + +L +C +H+D++++N+LL A + DFG+A+ + + SN+
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMND-SNYVVKGNAR 275
Query: 606 --YGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHP-------RDFLSLISSSSLNT 655
++APE + T + DV+S+G+L+ E GK P F ++
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY--- 332
Query: 656 DIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQ 704
++ P PP ++ SIM+ C N P RPT ++Q
Sbjct: 333 -----QMSRPDFAPP------EIYSIMK---MCWNLEPTERPTFSQISQ 367
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 62/250 (24%), Positives = 93/250 (37%), Gaps = 65/250 (26%)
Query: 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSP--LPCDQIADQKEFLIEVKALTE 492
+DF+ IG G G V+ + +GQV A+K + +QIA E L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIA---HVRAERDILAD 57
Query: 493 IRHRNIVK-FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNV------- 544
IVK +Y F H +LV E + G L + R +V
Sbjct: 58 ADSPWIVKLYYSF-QDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETAR 104
Query: 545 --IKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAK---------- 590
I + AL +H F +H+DI N+L+D + H+ ADFG+ K
Sbjct: 105 FYIAELVLALDSVHKLGF---IHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREY 159
Query: 591 ---------FLKPESSNWTEF----------AGTYGYVAPELAYTMKITEKCDVYSFGVL 631
F + GT Y+APE+ +CD +S GV+
Sbjct: 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVI 219
Query: 632 VLEAIKGKHP 641
+ E + G P
Sbjct: 220 LYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 25/83 (30%), Positives = 42/83 (50%), Gaps = 9/83 (10%)
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIA---KFLKPESSNWTEFAGTYGYVAPE-LAYTMK 618
+V++D+ N+LLD ++D G+A KP +S GT+GY+APE L
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGTA 172
Query: 619 ITEKCDVYSFGVLVLEAIKGKHP 641
D +S G ++ + ++G P
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 57/238 (23%), Positives = 91/238 (38%), Gaps = 41/238 (17%)
Query: 479 DQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGW 538
D F ++++ H+++VK YG C + +V E ++ G L L + L W
Sbjct: 44 DSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW 102
Query: 539 SQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL---DLEYE----AHVADFGIAKF 591
+++V K +A AL YL +VH ++ KN+L+ L ++D GI
Sbjct: 103 --KLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157
Query: 592 LKP-----ESSNWTEFAGTYGYVAPELAY--TMKITEKCDVYSFGVLVLEAIKGKHPRDF 644
+ E W +APE +T D +SFG +LE I
Sbjct: 158 VLSREERVERIPW---------IAPECIRNGQASLTIAADKWSFGTTLLE-ICSNGEEPL 207
Query: 645 LSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVV 702
+L SS RLP P + LI+ C P RP+ + +
Sbjct: 208 STLSSSEKERFYQDQH-----RLPMPDCAELANLIN------QCWTYDPTKRPSFRAI 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 15/139 (10%)
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAK--FLKPESSNWTEFAGTYGYVAPELAYTMKITE 621
+H+D++++N+LL + DFG+A+ + P+ + ++APE + T
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 622 KCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLIS- 680
+ DV+SFGVL+ E SL +S + +DE RL +R +
Sbjct: 261 QSDVWSFGVLLWE---------IFSL--GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP 309
Query: 681 -IMEVAFSCLNESPESRPT 698
+ + C + P RPT
Sbjct: 310 EMYQTMLDCWHGEPSQRPT 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 31/102 (30%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 536 LGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595
LG +Q V + + A+ Y+H + I+H+DI ++N+L++ + + DFG A F +
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313
Query: 596 SSNWTEF--AGTYGYVAPELAYTMKITEKCDVYSFGVLVLEA 635
S + AGT APE+ T D++S G+++ EA
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEA 355
|
Length = 461 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 444 IGNGGHGSV---YRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
IG+G G V Y A L VAIKK P +Q ++ + E+ + + H+NI+
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQ-NQTHAKRAYR-ELVLMKCVNHKNIIG 87
Query: 501 FYGFCSHARH------SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
+ + ++V EL++ +L ++ + + + + ++ + + +
Sbjct: 88 LLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKH 141
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
LH I+H+D+ N+++ + + DFG+A+ S T + T Y APE+
Sbjct: 142 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGK 639
M E D++S G ++ E IKG
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 32/164 (19%)
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS--NWTEFAGTYGY 608
AL +H ++H+D+ S N+ L + DFG +K S + F GT Y
Sbjct: 181 ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYY 237
Query: 609 VAPELAYTMKITEKCDVYSFGVLVLEAI------KGKHPRDFLSLISSSSLNTDIALDEI 662
+APEL + ++K D++S GV++ E + KG R+ + ++
Sbjct: 238 LAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ--------------QV 283
Query: 663 LDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
L + P V + ++++ L+++P RPT TQQ+
Sbjct: 284 LYGKYDPFPCPVSSGMKALLD---PLLSKNPALRPT----TQQL 320
|
Length = 478 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 41/171 (23%), Positives = 70/171 (40%), Gaps = 33/171 (19%)
Query: 483 FLIEVKALTEIRHRNIVKFYGFCSHARHS-FLVYELLERGSLAAIL-----SSDTAAQEL 536
L E L + H+NI+ C F++Y + G+L L Q L
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114
Query: 537 GWSQRMNVIKG--VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594
S + V +A +SYLH ++H+DI+++N ++D E + + D +++ L P
Sbjct: 115 --STQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFP 169
Query: 595 ESSN-----------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLE 634
+ W +A E + + DV+SFGVL+ E
Sbjct: 170 MDYHCLGDNENRPVKW---------MALESLVNKEYSSASDVWSFGVLLWE 211
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 9e-04
Identities = 37/139 (26%), Positives = 65/139 (46%), Gaps = 15/139 (10%)
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAK--FLKPESSNWTEFAGTYGYVAPELAYTMKITE 621
+H+D++++N+LL + DFG+A+ + P+ + ++APE + T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 622 KCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR--SVQEKLI 679
+ DV+SFGVL+ E SL +S + +DE RL +R + +
Sbjct: 255 QSDVWSFGVLLWE---------IFSL--GASPYPGVQIDEEFCRRLKEGTRMRAPEYATP 303
Query: 680 SIMEVAFSCLNESPESRPT 698
I + C + +PE RPT
Sbjct: 304 EIYSIMLDCWHNNPEDRPT 322
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 21/61 (34%), Positives = 29/61 (47%), Gaps = 2/61 (3%)
Query: 122 NLTFIDLSRNDFYGEISSNW-GKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNH 180
NL +DLS N I P L L++S NN+T P L++LDLS N+
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 181 I 181
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 29/108 (26%), Positives = 45/108 (41%), Gaps = 14/108 (12%)
Query: 172 QALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIG-------SLVDLEYLDL 224
+ L L V + +EL ++ L E+ L GN E+ +L + + D
Sbjct: 9 KKLKLETKEDVKGVVEELEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDA 68
Query: 225 SANRFNNSVPENLGNLLK-------LHYLGLSNNQFVLELPKELEKLV 265
R + + NL LLK L + LS+N F E P+EL L+
Sbjct: 69 FTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEFPEELGDLI 116
|
Length = 388 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 28/157 (17%)
Query: 444 IGNGGHGSVYRAELP-SGQVVAIKKF----HSPLPCDQIADQKEFLIEVKALTEIRHRNI 498
+G G + +VY+ +GQ+VA+K+ P I E L +++H NI
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-------EASLLKDLKHANI 65
Query: 499 VKFYGFCSHARHSF-LVYELLERGSLAAILSSDTAAQELGWSQRMNVIK----GVADALS 553
V + H + + LV+E L+ L + G M+ ++ + L+
Sbjct: 66 VTLHDII-HTKKTLTLVFEYLDT-DLKQYMDD------CGGGLSMHNVRLFLFQLLRGLA 117
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590
Y H ++H+D+ +NLL+ E +ADFG+A+
Sbjct: 118 YCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|226699 COG4248, COG4248, Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 63/289 (21%), Positives = 99/289 (34%), Gaps = 48/289 (16%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV---- 499
+G GG +Y QV I +H+P P Q A + L + + +
Sbjct: 19 LGQGGEADLYTLGEVRDQVAKI--YHAPPPAAQ-AQKVAELAAT-PDAPLLNYRVAWPQA 74
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQ---ELGWSQRMNVIKGVADALSYLH 556
+G FL+ ++ + + I S T Q W + V + +A A + LH
Sbjct: 75 TLHGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH 134
Query: 557 H------DCFPPIVHQDISSKNLLLDLE-YEAHVAD------FGIAKFLKPESSNWTEFA 603
D SK +L+D + ++ + G+++F PE F
Sbjct: 135 EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFV 194
Query: 604 GTYGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSS--SLNTDIALD 660
G + T D + VL+ + G+HP + LIS + L TDIA
Sbjct: 195 G------------FERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242
Query: 661 EILD------PRLPPPSRSVQEKLISIMEVAF-SCLNES--PESRPTMK 700
PPP L ++ F ES RPT K
Sbjct: 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291
|
Length = 637 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 27/205 (13%)
Query: 444 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEF--LIEVKALTEIRHRNIVK 500
+G G + +VY+ + +G++VA+K Q + F + E L ++H NIV
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRL-----QEEEGTPFTAIREASLLKGLKHANIVL 67
Query: 501 FYGFCSHARHSFLVYELLERGSLAAI------LSSDTAAQELGWSQRMNVIKGVADALSY 554
+ LV+E + + L + L +++G LSY
Sbjct: 68 LHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFL-----FQLLRG----LSY 118
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
+H I+H+D+ +NLL+ E +ADFG+A+ S ++ T Y P++
Sbjct: 119 IHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175
Query: 615 YTMKITEKC-DVYSFGVLVLEAIKG 638
C D++ G + +E I+G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 60/241 (24%), Positives = 96/241 (39%), Gaps = 50/241 (20%)
Query: 423 EGKLVYDEIVRATN-DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQ 480
E K++ ++I R+ N + IGNG G VY A + + + VAIKK D
Sbjct: 52 EEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ----DPQYKN 107
Query: 481 KEFLIEVKALTEIRHRNIV--KFYGFCSHAR-------------------HSFLVYELLE 519
+E LI + + H NI+ K Y + + H ++ +
Sbjct: 108 RELLI----MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARN 163
Query: 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE- 578
+L L + Q + AL+Y+H I H+D+ +NLL+D
Sbjct: 164 NHALPLFLVKLYSYQ-------------LCRALAYIHSKF---ICHRDLKPQNLLIDPNT 207
Query: 579 YEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAY-TMKITEKCDVYSFGVLVLEAIK 637
+ + DFG AK L + + + Y APEL T D++S G ++ E I
Sbjct: 208 HTLKLCDFGSAKNLLAGQRSVSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMIL 266
Query: 638 G 638
G
Sbjct: 267 G 267
|
Length = 440 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 708 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.45 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.42 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.39 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.37 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.36 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.33 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.33 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.32 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.3 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.29 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.26 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.26 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.24 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.23 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.22 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.16 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.15 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.14 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.99 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.98 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.97 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.96 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.94 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.92 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.89 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.81 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.8 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.79 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.74 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.72 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.7 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.68 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.63 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.63 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-83 Score=763.46 Aligned_cols=679 Identities=31% Similarity=0.515 Sum_probs=488.6
Q ss_pred CCCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEe
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFG 79 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~ 79 (708)
|++|++|+|++|++++..|..|+++++|++|+|++|++.+.+|..+.. ++|+.|++++|.+.+.+|..+..+++|++|+
T Consensus 235 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 314 (968)
T PLN00113 235 LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILH 314 (968)
T ss_pred CCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEE
Confidence 467888888888888778888888888888888888887777766654 6788888888888777777777788888888
Q ss_pred ccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccc
Q 039322 80 VSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITG 159 (708)
Q Consensus 80 l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 159 (708)
+++|.+++..|..+.++++|+.|+|++|.+++..+..+..+++|+.|++++|++.+..+..+..+++|+.|++++|.+.+
T Consensus 315 l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~ 394 (968)
T PLN00113 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEG 394 (968)
T ss_pred CCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecc
Confidence 88888877777777777888888888887777777777777777777777777766655555555555555555555544
Q ss_pred cCCccc------------------------cCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCC
Q 039322 160 GIPREI------------------------GNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGS 215 (708)
Q Consensus 160 ~~~~~~------------------------~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 215 (708)
..|..+ ..+++|+.|++++|.+++..+..+..+++|+.|+|++|++.+..|..+ .
T Consensus 395 ~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~ 473 (968)
T PLN00113 395 EIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-G 473 (968)
T ss_pred cCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-c
Confidence 444444 444445555555555544444444455555555555555554444433 3
Q ss_pred CCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCcee
Q 039322 216 LVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLN 295 (708)
Q Consensus 216 ~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~ 295 (708)
.++|+.|++++|++++..|..+..+++|+.|+|++|++.+..|..+..+++|+.|+|++|.+++..|..+..+++|+.|+
T Consensus 474 ~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 553 (968)
T PLN00113 474 SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553 (968)
T ss_pred cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEE
Confidence 45677777777777777787888888899999999999888888898899999999999999988888899999999999
Q ss_pred cccccccCCCCCcccccccccEEecCCCcCCCCCCCccccccCcccccccccCcCCCCC--CCCCccccccCCCCCccee
Q 039322 296 LSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVK--GMQPCKVFLSHKQNSRVKW 373 (708)
Q Consensus 296 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~--~~~~~~~~~~~~~~~~~~~ 373 (708)
|++|++++.+|..+..+++|+.+++++|++.+.+|....+..+...++.+|+..|+... ..++|... .....|
T Consensus 554 Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~-----~~~~~~ 628 (968)
T PLN00113 554 LSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV-----RKTPSW 628 (968)
T ss_pred CCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc-----ccccee
Confidence 99999998899999999999999999999999888877777788888999999998643 23455321 122334
Q ss_pred EeeehhhHHHHHHHH-HHHHHHHhhhcCCCCCCCCCCCCCCCCcceec-ccCCCchHHHHHHHhccccccceeccccCcc
Q 039322 374 FAIVFPVLGALFLSM-ALIAIFILRKRKSDSGDRQSSNQNPHGLFSIL-NFEGKLVYDEIVRATNDFDAQYCIGNGGHGS 451 (708)
Q Consensus 374 ~~i~~~~~~~~~~~~-~~~~~~~~r~R~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~ 451 (708)
..+++++++++++++ ++++++++++|+..+..+........+..... .......++++ ...|...+.||+|+||.
T Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~ 705 (968)
T PLN00113 629 WFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGA 705 (968)
T ss_pred eeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCee
Confidence 444444444433333 33333333333222111111100000000000 01112333443 35677888999999999
Q ss_pred EEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccCCCHHHHhccc
Q 039322 452 VYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSD 530 (708)
Q Consensus 452 vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 530 (708)
||+|.. .+++.||||.+..... ....|++.+++++||||++++|++.+++..++||||+++|+|.++++
T Consensus 706 Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-- 775 (968)
T PLN00113 706 SYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-- 775 (968)
T ss_pred EEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh--
Confidence 999975 5789999999865211 11235788999999999999999999999999999999999999995
Q ss_pred ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccccccC
Q 039322 531 TAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVA 610 (708)
Q Consensus 531 ~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~a 610 (708)
.++|.++.+++.|+|+|++|||..+.++|+|||+||+||+++.++..++. ||.+...... ....+++.|+|
T Consensus 776 ----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t~~y~a 846 (968)
T PLN00113 776 ----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISSAYVA 846 (968)
T ss_pred ----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----CCccccccccC
Confidence 27899999999999999999996656699999999999999999888875 6655433211 22367899999
Q ss_pred ccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc------ccccccccccccCCCCCCCCchhHHHHHHHHHH
Q 039322 611 PELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS------SLNTDIALDEILDPRLPPPSRSVQEKLISIMEV 684 (708)
Q Consensus 611 PE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 684 (708)
||++.+..++.++|||||||++|||+||+.||+........ ..........+.++...........+..++.++
T Consensus 847 PE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 926 (968)
T PLN00113 847 PETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNL 926 (968)
T ss_pred cccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHH
Confidence 99999999999999999999999999999998632111000 000111223344555443333344556678899
Q ss_pred HHhccCCCCCCCCCHHHHHHHhh
Q 039322 685 AFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 685 i~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+.+||+.||++||||+||++.|+
T Consensus 927 ~~~Cl~~~P~~RPt~~evl~~L~ 949 (968)
T PLN00113 927 ALHCTATDPTARPCANDVLKTLE 949 (968)
T ss_pred HHhhCcCCchhCcCHHHHHHHHH
Confidence 99999999999999999999875
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-50 Score=412.30 Aligned_cols=280 Identities=40% Similarity=0.703 Sum_probs=235.5
Q ss_pred CCCchHHHHHHHhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEE
Q 039322 423 EGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502 (708)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~ 502 (708)
...++|+++..||++|...+.||+|+||.||+|...+|+.||||++...... . ..+|..|++++.+++|||+|+++
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~---~-~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQ---G-EREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCc---c-hhHHHHHHHHHhcCCCcCcccEE
Confidence 4568999999999999999999999999999999999999999987753211 1 45599999999999999999999
Q ss_pred EEEeeCC-eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcE
Q 039322 503 GFCSHAR-HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEA 581 (708)
Q Consensus 503 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 581 (708)
|||.+.+ +.++|||||++|+|.++++..... .++|.+|.+||.++|+||+|||+.+.|.|+|||||++|||+|+++++
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 9999988 599999999999999999876543 78999999999999999999999988889999999999999999999
Q ss_pred EEeecccccccCCCCCccccc-cccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccc-------ccccc
Q 039322 582 HVADFGIAKFLKPESSNWTEF-AGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLI-------SSSSL 653 (708)
Q Consensus 582 kl~Dfg~a~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-------~~~~~ 653 (708)
||+|||+|+............ .||.+|+|||+...+..+.|+||||||+++.|++||+.|.+..... +....
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 999999996544312222222 8999999999999999999999999999999999999987743211 11112
Q ss_pred ccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 NTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+....+++|+++.............+..++.+|++.+|++||+|.||++.|+
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~ 350 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELE 350 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence 223367889998876322222256777999999999999999999999998874
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=372.27 Aligned_cols=258 Identities=28% Similarity=0.397 Sum_probs=217.4
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC-eeEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR-HSFL 513 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-~~~l 513 (708)
.+++..+.||+|..|+||++.++ +++.+|+|++... -+.+.++++.+|++++++.+||+||.++|.|..+. ...+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 46677788999999999999764 6889999999543 23456789999999999999999999999999998 5999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
+||||++|+|++++... +++++....+++.+|++||.|||+.+ +||||||||+|||++..|+|||||||.+....
T Consensus 156 ~mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred ehhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 99999999999999765 34899999999999999999999742 99999999999999999999999999998775
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
.. .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.||... ..........+..+.+...+..+..
T Consensus 231 nS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~---~~~~~~~~~Ll~~Iv~~ppP~lP~~ 305 (364)
T KOG0581|consen 231 NS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP---NPPYLDIFELLCAIVDEPPPRLPEG 305 (364)
T ss_pred hh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc---CCCCCCHHHHHHHHhcCCCCCCCcc
Confidence 43 456789999999999999999999999999999999999999998743 1112223445566666444433332
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
....++..++..|+++||.+|||++|+++|-+|
T Consensus 306 --~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi 338 (364)
T KOG0581|consen 306 --EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFI 338 (364)
T ss_pred --cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHH
Confidence 344568888889999999999999999998654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=389.05 Aligned_cols=251 Identities=25% Similarity=0.445 Sum_probs=218.3
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.+|...+.||+|+|+.||.++. .+|+.||+|++.+..- ......+.+.+|+++.++++|||||+++++|++.+..|+|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l-~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL-KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHh-cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 5799999999999999999976 7899999999987322 2335577899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
.|+|+.++|..+++.+ +.+++++++.+++||+.|+.|||++ +|+|||||..|+|++++.++||+|||+|.....
T Consensus 97 LELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EEecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999999744 4599999999999999999999999 999999999999999999999999999999998
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
+++.....+|||.|.|||++.....+..+||||+||++|-|+.|++||+.. ...+....+.......+..
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk--------~vkety~~Ik~~~Y~~P~~-- 240 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK--------TVKETYNKIKLNEYSMPSH-- 240 (592)
T ss_pred cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc--------hHHHHHHHHHhcCcccccc--
Confidence 888888899999999999999999999999999999999999999999832 1233344444333333321
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
...+-.+||.+++++||.+|||+++|++|
T Consensus 241 --ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 241 --LSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred --cCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 12235688899999999999999999986
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=374.26 Aligned_cols=261 Identities=25% Similarity=0.352 Sum_probs=221.2
Q ss_pred HhccccccceeccccCccEEEE-EeCCCcEEEEEEcCCCCCcchh---HhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQI---ADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
..+.|.+.+.+|+|+||.|-+| ..++|+.||||++++....... .......+|+++|++++||+||++.++|+.++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3467888999999999999999 5568999999999874322211 12334579999999999999999999999999
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC---CcEEEeec
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE---YEAHVADF 586 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Df 586 (708)
..|+||||++||.|.+++-.++. +.+..-..+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999976654 66777889999999999999999 99999999999999766 67999999
Q ss_pred ccccccCCCCCccccccccccccCccccccCCCC---cchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 039322 587 GIAKFLKPESSNWTEFAGTYGYVAPELAYTMKIT---EKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEIL 663 (708)
Q Consensus 587 g~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 663 (708)
|+|...+ ........+||+.|.|||++.+..+. .++|+||+||++|-+++|.+||... .......+.+.
T Consensus 324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~-------~~~~sl~eQI~ 395 (475)
T KOG0615|consen 324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE-------YTDPSLKEQIL 395 (475)
T ss_pred chhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc-------cCCccHHHHHh
Confidence 9999876 45566788999999999999876533 3789999999999999999999732 22222455677
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 664 DPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 664 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.+++...+..+.....+..++|.+|+..||++|||++|+++|-|+
T Consensus 396 ~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 396 KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 778877777888888899999999999999999999999998774
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=385.71 Aligned_cols=255 Identities=29% Similarity=0.518 Sum_probs=208.6
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC-eeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR-HSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-~~~lv 514 (708)
.++.....+|+|+||+||+|.+.....||||.+........ ..++|.+|+.+|.+++|||||+++|++.++. ..++|
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~--~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDE--SRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChH--HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence 44455666999999999999996444499999987543322 2779999999999999999999999999987 79999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEccCCCCCeeeCCCC-cEEEeeccccccc
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP-IVHQDISSKNLLLDLEY-EAHVADFGIAKFL 592 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~ 592 (708)
|||+++|+|.++++.. ....+++..+.++|.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++..
T Consensus 119 tEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 9999999999999874 345699999999999999999999999 7 99999999999999997 9999999999876
Q ss_pred CCCCCccccccccccccCccccc--cCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc-CCCCCC
Q 039322 593 KPESSNWTEFAGTYGYVAPELAY--TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEIL-DPRLPP 669 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 669 (708)
.......+...||+.|||||++. ...++.|+||||||+++|||+||+.||..... ......+. ....+.
T Consensus 195 ~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~~~~v~~~~~Rp~ 266 (362)
T KOG0192|consen 195 VISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQVASAVVVGGLRPP 266 (362)
T ss_pred ccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcCCCCC
Confidence 54333344478999999999999 56899999999999999999999999985432 11111111 112222
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.. ....+..++.+||+.||++||++.+++..|+
T Consensus 267 ~p~~---~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~ 301 (362)
T KOG0192|consen 267 IPKE---CPPHLSSLMERCWLVDPSRRPSFLEIVSRLE 301 (362)
T ss_pred CCcc---CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence 1121 3345778888999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=382.25 Aligned_cols=251 Identities=25% Similarity=0.473 Sum_probs=209.4
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+.+...+.||+|.||.||.|.++....||+|.++.. .-..+.|.+|+++|++|+|++||+++|+|..++..+|||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-----~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-----SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-----ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 456778899999999999999987779999999863 234577889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
|||+.|+|.+||.... +..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+...++
T Consensus 281 E~m~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EecccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 9999999999998733 45689999999999999999999999 9999999999999999999999999999954433
Q ss_pred CCcc-ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 596 SSNW-TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 596 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
.+.. ....-+..|+|||.+..+.++.|||||||||+||||+| |+.||+.+. ..+.+..+..+..-+.+..
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--------n~ev~~~le~GyRlp~P~~ 428 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--------NEEVLELLERGYRLPRPEG 428 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC--------HHHHHHHHhccCcCCCCCC
Confidence 3322 22334689999999999999999999999999999998 999987432 2333444444433333444
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
+++ .+.+++..||+.+|++||||+.+...+
T Consensus 429 CP~---~vY~lM~~CW~~~P~~RPtF~~L~~~l 458 (468)
T KOG0197|consen 429 CPD---EVYELMKSCWHEDPEDRPTFETLREVL 458 (468)
T ss_pred CCH---HHHHHHHHHhhCCcccCCCHHHHHHHH
Confidence 444 477788899999999999999887665
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=351.50 Aligned_cols=259 Identities=24% Similarity=0.340 Sum_probs=216.8
Q ss_pred ccccccceeccccCccEEEE-EeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEE-EEeeCCe-eE
Q 039322 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG-FCSHARH-SF 512 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~-~~~~~~~-~~ 512 (708)
.+|++.++||+|.||+||++ ...+|..||.|.+.-. .-+....+....|+.+|++++|||||++++ .|.++.. .+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~--~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG--MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh--hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 67889999999999999999 5678999999998843 234566788999999999999999999999 4545444 88
Q ss_pred EEEEeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 513 LVYELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCFP-PIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
||||+|..|+|.+.++..+ .++.++++.+|+++.|++.||..+|++..+ -|+||||||.||+++.+|.|||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999996543 456689999999999999999999995432 27899999999999999999999999999
Q ss_pred ccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 591 FLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
.+..........+|||.||+||.+.+.+|+.+|||||+||++|||+.-+.||... ......+.+.+...++.
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~L~~KI~qgd~~~~ 248 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLSLCKKIEQGDYPPL 248 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHHHHHHHHcCCCCCC
Confidence 9987777778899999999999999999999999999999999999999999743 22333445555555443
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
+ ..-.+.++.+||..|+..||+.||+...+++.+
T Consensus 249 p--~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 249 P--DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred c--HHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 2 133456788999999999999999865555544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=358.10 Aligned_cols=201 Identities=30% Similarity=0.491 Sum_probs=181.2
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
..+|...+.||.|+||+||+|+++ ++..||||.+.+.. -..+..+.+..|+.++++++|||||++++++..++..|+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~--l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKK--LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhc--cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 478999999999999999999764 58899999987632 134456778999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC------CcEEEeecc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE------YEAHVADFG 587 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfg 587 (708)
|||||.||+|.+|++.++ .+++...+.++.|+|.||++||++ +||||||||+|||++.. -.+||+|||
T Consensus 87 VMEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 999999999999998765 489999999999999999999999 99999999999999765 458999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDF 644 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~ 644 (708)
+|+...+ .......+|++-|||||++...+|+.|+|+||+|+++|+|++|+.||+.
T Consensus 161 fAR~L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 161 FARFLQP-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhhhCCc-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 9998873 3455678999999999999999999999999999999999999999983
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=343.39 Aligned_cols=262 Identities=23% Similarity=0.360 Sum_probs=210.2
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+.|+...++|+|+||.||+++++ +|+.||||+|.... ++..-.+-.++|++++++++|+|+|.++++|.....+++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese--dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE--DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC--ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 56888899999999999999776 59999999997532 3445567789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
+|||+. ++.+-+.... ..++.+.+.++++|++.|+.|+|++ +++||||||+|||++.+|.+||||||+|+....
T Consensus 80 FE~~dh-TvL~eLe~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYP--NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred eeecch-HHHHHHHhcc--CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 999988 5555565444 3378899999999999999999999 999999999999999999999999999999887
Q ss_pred CCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc----------------ccc
Q 039322 595 ESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN----------------TDI 657 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~----------------~~~ 657 (708)
++..++..+.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+-|...+..+..-.+ ...
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 7778889999999999999887 78999999999999999999999998754432111000 001
Q ss_pred ccccccCCCCCCC---CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 658 ALDEILDPRLPPP---SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 658 ~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
.+..+.-|....+ ....+....-+.++++.|++.||.+|++-+|++.|
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111111111110 01112223457799999999999999999999865
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=353.73 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=213.9
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.++||+|+||.||.++. .+++.||+|++++... ....+.+....|..++.+++||.||+++..|++++.+|+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~i-v~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKI-VEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHh-hhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 47899999999999999999954 4689999999988432 222456788999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
|+||+.||.|..+|++.+ .+++..+.-++..|+.||.|||++ |||||||||+|||+|++|+++|+|||+++...
T Consensus 103 Vld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999997554 489999999999999999999999 99999999999999999999999999999665
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
..+......+||+.|||||++.+..++.++|.||+|+++|||++|..||... ......+.+...+....+..
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~--------~~~~~~~~I~~~k~~~~p~~ 248 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE--------DVKKMYDKILKGKLPLPPGY 248 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc--------cHHHHHHHHhcCcCCCCCcc
Confidence 5555666789999999999999999999999999999999999999999842 23344455555554433332
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCC----CHHHHHHH
Q 039322 674 VQEKLISIMEVAFSCLNESPESRP----TMKVVTQQ 705 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~~ 705 (708)
... +..+++.+.++.||++|- .+.+|.+|
T Consensus 249 ls~---~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 249 LSE---EARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred CCH---HHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 333 366788899999999995 56665543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=384.80 Aligned_cols=255 Identities=25% Similarity=0.449 Sum_probs=214.8
Q ss_pred ccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
.+....+.||+|+||.||+|+.. +.+.||||.+++. .....+++|.+|++++..++|||||+++|+|.+++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~---a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK---AENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc---ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 45667788999999999999643 3567999999874 23346889999999999999999999999999999
Q ss_pred eeEEEEEeccCCCHHHHhccccc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC
Q 039322 510 HSFLVYELLERGSLAAILSSDTA-----------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE 578 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~ 578 (708)
..++|+|||..|+|.+||..+.+ ..+++..+.+.||.|||.||.||-++ .+|||||.++|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence 99999999999999999965431 23488999999999999999999999 89999999999999999
Q ss_pred CcEEEeecccccccCCCCCcc-c-cccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccc
Q 039322 579 YEAHVADFGIAKFLKPESSNW-T-EFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNT 655 (708)
Q Consensus 579 ~~~kl~Dfg~a~~~~~~~~~~-~-~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~ 655 (708)
..|||+|||+++..-..+++. . ...-+.+|||||.+..++++.+||||||||++||+++ |+.||.. ...
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g--------lSn 711 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG--------LSN 711 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc--------cch
Confidence 999999999999654443332 1 2334689999999999999999999999999999998 9999873 334
Q ss_pred ccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 656 DIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
++.++.+.++++-+.++.++. ++++|+.+||+..|++||+++||-..|+
T Consensus 712 ~EVIe~i~~g~lL~~Pe~CP~---~vY~LM~~CW~~~P~~RPsF~eI~~~L~ 760 (774)
T KOG1026|consen 712 QEVIECIRAGQLLSCPENCPT---EVYSLMLECWNENPKRRPSFKEIHSRLQ 760 (774)
T ss_pred HHHHHHHHcCCcccCCCCCCH---HHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence 566666777776555554444 5777888999999999999999988774
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=375.22 Aligned_cols=265 Identities=24% Similarity=0.459 Sum_probs=221.2
Q ss_pred cCCCchHHHHHHHhc---------cccccceeccccCccEEEEEeC----CCcEEEEEEcCCCCCcchhHhHHHHHHHHH
Q 039322 422 FEGKLVYDEIVRATN---------DFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPCDQIADQKEFLIEVK 488 (708)
Q Consensus 422 ~~~~~~~~~~~~~~~---------~~~~~~~ig~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~ 488 (708)
+.+.++|++..++.. ...+.++||.|.||.||+|+++ ....||||.++... ..+.+..|+.|+.
T Consensus 606 YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy---tekqrrdFL~EAs 682 (996)
T KOG0196|consen 606 YIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY---TEKQRRDFLSEAS 682 (996)
T ss_pred ecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc---cHHHHhhhhhhhh
Confidence 445667776655544 3467889999999999999764 23469999998643 3456778999999
Q ss_pred HHHhccCCceeeEEEEEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccC
Q 039322 489 ALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDI 568 (708)
Q Consensus 489 ~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dl 568 (708)
||.++.||||+++.|+....+..+||+|||++|+|+.||+.+. .++++.++..++++||.|++||.+. ++|||||
T Consensus 683 IMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDL 757 (996)
T KOG0196|consen 683 IMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDL 757 (996)
T ss_pred hcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---Cchhhhh
Confidence 9999999999999999999999999999999999999998766 4599999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCcEEEeecccccccCCCCCcc-cccc--ccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCc
Q 039322 569 SSKNLLLDLEYEAHVADFGIAKFLKPESSNW-TEFA--GTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDF 644 (708)
Q Consensus 569 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~--~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~ 644 (708)
.++|||++.+..+|++|||+++..+++.... +... -+.+|+|||.+...+++.++|||||||+|||.++ |+.||+.
T Consensus 758 AARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd 837 (996)
T KOG0196|consen 758 AARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 837 (996)
T ss_pred hhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc
Confidence 9999999999999999999999887665332 2222 2589999999999999999999999999999996 9999884
Q ss_pred cccccccccccccccccccCC-CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 645 LSLISSSSLNTDIALDEILDP-RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
+. ..+.++++.++ +++++.. ++..|.+|+..||++|-.+||.|.|++..|
T Consensus 838 mS--------NQdVIkaIe~gyRLPpPmD----CP~aL~qLMldCWqkdR~~RP~F~qiV~~l 888 (996)
T KOG0196|consen 838 MS--------NQDVIKAIEQGYRLPPPMD----CPAALYQLMLDCWQKDRNRRPKFAQIVSTL 888 (996)
T ss_pred cc--------hHHHHHHHHhccCCCCCCC----CcHHHHHHHHHHHHHHhhcCCCHHHHHHHH
Confidence 32 24445555444 4555433 334589999999999999999999999876
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=355.76 Aligned_cols=255 Identities=25% Similarity=0.366 Sum_probs=214.5
Q ss_pred HHhccccccceeccccCccEEEEE-eCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCe
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARH 510 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 510 (708)
+..++|.+++.||+|+|++|++|+ ..+++.||||++.+.... .....+-+..|-++|.+| .||.|++++.-|.++..
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Ii-ke~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYII-KEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHH-hhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 344899999999999999999994 457999999999763221 112345577889999999 79999999999999999
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
+|+|+||+++|+|.++|++.+ .+++...+.++.+|+.||+|||++ |||||||||+|||+|.|+++||+|||.|.
T Consensus 149 LYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999998765 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-----------c--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccc
Q 039322 591 FLKPESS-----------N--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDI 657 (708)
Q Consensus 591 ~~~~~~~-----------~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~ 657 (708)
.+.+... . ....+||..|.+||++..+..+..+|+|+|||++|+|+.|++||.. .+...
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra--------~Neyl 294 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA--------ANEYL 294 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc--------ccHHH
Confidence 7653211 1 1458899999999999999999999999999999999999999973 23344
Q ss_pred ccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 658 ALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.+++++.-....+.... ....+||++.+..||.+|+|.+|+.+|.
T Consensus 295 iFqkI~~l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 295 IFQKIQALDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHHHHhcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhCc
Confidence 55555555554443333 3477889999999999999999998873
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=353.88 Aligned_cols=262 Identities=24% Similarity=0.386 Sum_probs=212.0
Q ss_pred HHHHHHhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC
Q 039322 429 DEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA 508 (708)
Q Consensus 429 ~~~~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 508 (708)
++++...+++.+...||+|.||+||+|.+. | .||||++....... +..+.|+.|+..+++-+|.||+-+.|||..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~--~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTP--EQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCH--HHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 455566678889999999999999999884 4 59999998754433 4788999999999999999999999999998
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
.. .||+.+|+|-+|+.+++... .+++..+.+.||+|||+|+.|||.+ +|||||||..|||+.++++|||+|||+
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred ce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence 87 99999999999999998655 5689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCC--CCCccccccccccccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 039322 589 AKFLKP--ESSNWTEFAGTYGYVAPELAYT---MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEIL 663 (708)
Q Consensus 589 a~~~~~--~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 663 (708)
+..-.. .........|...|||||++.. .+|+.++||||||+++|||+||..||..... +.+-...-+-+.
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~----dqIifmVGrG~l 610 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR----DQIIFMVGRGYL 610 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh----hheEEEeccccc
Confidence 874332 2233455678899999999874 4688999999999999999999999973211 111111111111
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 664 DPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 664 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.++. .........++.+|+..||.+++++||.+.+|+..|+
T Consensus 611 ~pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~ 651 (678)
T KOG0193|consen 611 MPDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLE 651 (678)
T ss_pred Cccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence 1222 2233445567888999999999999999999998654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=317.79 Aligned_cols=262 Identities=24% Similarity=0.327 Sum_probs=210.0
Q ss_pred ccccccceeccccCccEEEE-EeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.+|...+.+|+|.||.||+| ...+|+.||||+++.....++ -.-...+|++.++.++|+||+.++++|.+.+..-+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG--i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG--INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC--ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence 46788899999999999999 556899999999987432222 134578999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
+|||+. +|...++... ..++..++..++.++.+|++|||++ .|+|||+||.|+|++++|.+||+|||+|+.+.+
T Consensus 80 fEfm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred EEeccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 999986 9999997544 4588999999999999999999999 999999999999999999999999999999988
Q ss_pred CCCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc-------------ccccccc
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL-------------NTDIALD 660 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-------------~~~~~~~ 660 (708)
.....+..+.|..|+|||.+.+. .|+..+|+||.||++.||+.|.+-|......+.... -....+.
T Consensus 154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 87777777899999999988875 589999999999999999999888765432211100 0001111
Q ss_pred cccCCC-CCCC--CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 661 EILDPR-LPPP--SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 661 ~~~~~~-~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
+...-+ .+.+ .........+..+++..++..||.+|.|++|++++
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111111 1111 11223334456899999999999999999999876
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=355.78 Aligned_cols=250 Identities=25% Similarity=0.410 Sum_probs=212.3
Q ss_pred ccccccceeccccCccEEEE-EeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
..|.....||+|+.|.||.| +..+++.||||++... .....+-+.+|+.+|+..+|+|||++++.|...+..|+|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~----~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR----KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEec----cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 46777788999999999999 5567889999999752 223456688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
||||+||+|.|.+.... +++.++..|++++++||+|||.+ ||+|||||.+|||++.+|.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EeecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 99999999999997654 89999999999999999999999 999999999999999999999999999999888
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
........+||+.|||||+.....|++++||||||++++||+-|+.||=...... .+..+.+ .-.+.....
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr--------AlyLIa~-ng~P~lk~~ 492 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------ALYLIAT-NGTPKLKNP 492 (550)
T ss_pred ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH--------HHHHHhh-cCCCCcCCc
Confidence 8778888999999999999999999999999999999999999999985322111 1111111 111222223
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
......+.+++.+|+..||++||++.|+++|
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 3344568889999999999999999999987
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=347.05 Aligned_cols=262 Identities=23% Similarity=0.344 Sum_probs=212.4
Q ss_pred HhccccccceeccccCccEEEEE-eCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCC-e
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHAR-H 510 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~-~ 510 (708)
..++|...++||.|+||+||+|+ ..+|+.||||++++.... .+.-.=.+|++.+++++ ||||+++.+++.+.+ .
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s---~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc---HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 45789999999999999999995 457899999999874322 12223468999999998 999999999999888 9
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
+++|||||+. +|++.++.+ .+.+++..+..|++||++||+|+|++ |+.|||+||+|||+.....+||+|||+|+
T Consensus 85 L~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccc
Confidence 9999999976 999999876 46799999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCccccccccccccCcccc-ccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc-------------ccccccc
Q 039322 591 FLKPESSNWTEFAGTYGYVAPELA-YTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLIS-------------SSSLNTD 656 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~-------------~~~~~~~ 656 (708)
.+... ..++..+.|.+|+|||++ +.+-|+.+.|+||+|||++|+.+-+.-|.+....+ .......
T Consensus 159 ev~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 159 EVRSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred ccccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 77543 445777899999999965 56779999999999999999999999987644321 1111111
Q ss_pred cccccccCCCCCCCCch-----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 657 IALDEILDPRLPPPSRS-----VQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 657 ~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
..+...++-+++..... ......+..+++.+|+++||.+||||+|.+++
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 23334444444433221 12244578899999999999999999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=345.37 Aligned_cols=263 Identities=26% Similarity=0.379 Sum_probs=206.2
Q ss_pred hccccccceeccccCccEEEE-EeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC--Cee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA--RHS 511 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~ 511 (708)
.+.|+...+||+|+||.||+| +..+|+.||+|+++.+... ........+|+.+|+++.||||+++.+...+. ...
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~--~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK--EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC--CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 467888899999999999999 5668999999999864322 23345678999999999999999999999877 689
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
|+|+|||+. +|.-++.... -.+++.++..+++|++.||+|||++ ||+|||||.+|||++.+|.+||+|||+|++
T Consensus 194 YlVFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceee
Confidence 999999988 8988886543 4689999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCc-cccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccc------------cccccc
Q 039322 592 LKPESSN-WTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS------------SLNTDI 657 (708)
Q Consensus 592 ~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~------------~~~~~~ 657 (708)
+...... ++..+.|.+|.|||++.+. .|+.++|+||.|||+.||++|+..|......+.. .+....
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 8776544 7888999999999988764 5999999999999999999999998743211100 000000
Q ss_pred ccc--cccCCCCCCCC---chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 658 ALD--EILDPRLPPPS---RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 658 ~~~--~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
.+. ..+.+..+... +.....+....+|+..++..||.+|.||.+++++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 000 11111111000 0011112345688889999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=336.34 Aligned_cols=256 Identities=27% Similarity=0.386 Sum_probs=209.0
Q ss_pred hccccccceeccccCccEEEE-EeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|+...+||.|..++||+| ..+.++.||||++.-+ .. ..+.+.+.+|+..|+.++||||++++..|..+...|+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLE--kc-~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLE--KC-NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehh--hh-hhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 378999999999999999999 5567899999999752 11 2236889999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||.||.+|++.+.++..-.. .+.+..+..|++++.+||.|||.+ |.||||||+.|||++.+|.|||+|||.+..+.
T Consensus 102 VmpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999999876543 389999999999999999999999 99999999999999999999999999877654
Q ss_pred CCCCcc----ccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 039322 594 PESSNW----TEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 594 ~~~~~~----~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
..+... ...+|++.|||||++.. ..|+.|+|||||||...||.+|..||..+.... .+-.-+....
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--------vLl~tLqn~p 249 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--------VLLLTLQNDP 249 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--------HHHHHhcCCC
Confidence 443322 45689999999998543 468999999999999999999999998544321 1111111111
Q ss_pred C------CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 668 P------PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 668 ~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
+ .+..........+.+++..|+.+||++|||+++++++
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1 0111122233478999999999999999999999876
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=349.32 Aligned_cols=241 Identities=28% Similarity=0.492 Sum_probs=200.9
Q ss_pred cccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEec
Q 039322 439 DAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELL 518 (708)
Q Consensus 439 ~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 518 (708)
...+.+|.|+.|.||.|+.. ++.||||+++.- .+ .+++-|++|+|+||+.+.|+|.....+|||||||
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~el------kE-----TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVREL------KE-----TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhh------hh-----hhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence 44567999999999999985 788999997631 11 3677799999999999999999999999999999
Q ss_pred cCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 039322 519 ERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN 598 (708)
Q Consensus 519 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 598 (708)
..|-|+..|+..+ .++......|..+||.|+.|||.+ .|||||||.-|||++.+..|||+|||-++....- ..
T Consensus 195 a~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-ST 267 (904)
T KOG4721|consen 195 AQGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-ST 267 (904)
T ss_pred ccccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hh
Confidence 9999999997654 478899999999999999999999 9999999999999999999999999999865433 45
Q ss_pred cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHH
Q 039322 599 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKL 678 (708)
Q Consensus 599 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (708)
...++||+.|||||++...+.+.|+|||||||+||||+||..||..........-.....+ .++.+. .++
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL------~LpvPs----tcP 337 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSL------HLPVPS----TCP 337 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcc------cccCcc----cCc
Confidence 5678999999999999999999999999999999999999999975443221111111111 122221 223
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 679 ISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 679 ~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
..|.-|++.||+-.|..||+|++++.||.|
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 357888999999999999999999999976
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=350.27 Aligned_cols=257 Identities=22% Similarity=0.325 Sum_probs=212.6
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchh-HhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCe
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQI-ADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARH 510 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~ 510 (708)
..+.|.+.+.||+|.||+|+.|.+ .+++.||+|++.+....... ...+.+.+|+.++++++ ||||+++++++..+..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 347899999999999999999954 57899999987663221111 23456678999999999 9999999999999999
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC-CcEEEeecccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE-YEAHVADFGIA 589 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a 589 (708)
.++||||+.||+|.+++... .++.+....++++|++.|++|||++ ||+||||||+||+++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999763 3488899999999999999999999 99999999999999999 99999999999
Q ss_pred cccCCCCCccccccccccccCccccccCC-CC-cchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 039322 590 KFLKPESSNWTEFAGTYGYVAPELAYTMK-IT-EKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
......+.......|++.|+|||++.+.. |+ .++||||+|+++|.|++|+.||+... .......+....+
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~--------~~~l~~ki~~~~~ 240 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN--------VPNLYRKIRKGEF 240 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc--------HHHHHHHHhcCCc
Confidence 97743445567789999999999999877 76 68999999999999999999998521 1222233444444
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+.... ..+...++.+|+..||.+|+|+.+++++=|
T Consensus 241 ~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 241 KIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILEHPW 277 (370)
T ss_pred cCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence 4333221 345788999999999999999999997654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=339.25 Aligned_cols=253 Identities=27% Similarity=0.412 Sum_probs=200.5
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC--eeE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR--HSF 512 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--~~~ 512 (708)
.+|...+.||+|+||+||.+... +|+..|||.+... +....+.+.+|+++|++++|||||+++|...... .++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~----~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE----DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecc----cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 46778889999999999999654 4899999998753 1122667899999999999999999999854444 689
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-CCcEEEeecccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL-EYEAHVADFGIAKF 591 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~ 591 (708)
+.|||+++|+|.+++...+. +++++.+..+++||++||+|||++ |||||||||+|||++. ++.+||+|||++..
T Consensus 93 i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 99999999999999987663 599999999999999999999999 9999999999999999 79999999999987
Q ss_pred cCCC---CCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcc-ccccccccccccccccccCCC
Q 039322 592 LKPE---SSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFL-SLISSSSLNTDIALDEILDPR 666 (708)
Q Consensus 592 ~~~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~ 666 (708)
.... ........||+.|||||++..+ ....++||||+||++.||+||+.||... .. ....+.......
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~-------~~~~~~ig~~~~ 240 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE-------AEALLLIGREDS 240 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch-------HHHHHHHhccCC
Confidence 6531 1223457899999999999854 3445999999999999999999998742 10 011111111111
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 667 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.-+.. .+....+++.+|+..||++||||+++++|..
T Consensus 241 ~P~ip~~---ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 241 LPEIPDS---LSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCCCCcc---cCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 1111112 2234667888999999999999999999853
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=330.17 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=215.3
Q ss_pred ccccccceeccccCccEEEE-EeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.+|++.+.||+|.||.|-+| .+..|+.||||.++++.. .+..+.-.+.+|+++|+.++||||+.++++|+..+...+|
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI-kdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI-KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc-ccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 68899999999999999999 457899999999988533 3345566789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||..+|.|+||+..++ .+++.+.+.+++||+.|+.|+|++ +++|||||.+|||+|.++++||+|||++-.+..
T Consensus 132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999998765 489999999999999999999999 999999999999999999999999999987763
Q ss_pred CCCccccccccccccCccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKIT-EKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
....+.++|++-|.+||.+.+.+|. +.+|-||+|+++|-|+.|..||+... ....++.+-.+....+...
T Consensus 206 -~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--------hk~lvrQIs~GaYrEP~~P 276 (668)
T KOG0611|consen 206 -KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--------HKRLVRQISRGAYREPETP 276 (668)
T ss_pred -ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--------HHHHHHHhhcccccCCCCC
Confidence 3456788999999999999988874 68999999999999999999998432 2333344444443333221
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
....-||++|+..+|++|.|..+|..|-|+
T Consensus 277 -----SdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 277 -----SDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred -----chHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 124568889999999999999999998764
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=310.83 Aligned_cols=255 Identities=27% Similarity=0.383 Sum_probs=216.0
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++++.||+|.||.||.|+. +++-.||+|++.+.. .....-..++.+|+++-+.|+||||+++|++|.+....|+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq-i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ-ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH-HHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 37899999999999999999954 467789999987632 1122235689999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
++||...|.+...|..... .++++...+.+..|+|.|+.|+|.+ +|+||||||+|+|++..+..|++|||.+....
T Consensus 100 ilEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999975543 4588899999999999999999999 99999999999999999999999999996432
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
.......+||..|.|||+..+...+..+|+|++|++.||++.|..||+... ..+..+++..-++..+.
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--------~~etYkrI~k~~~~~p~-- 243 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--------HSETYKRIRKVDLKFPS-- 243 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--------hHHHHHHHHHccccCCc--
Confidence 456677899999999999999999999999999999999999999998422 34444444444443332
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.......++|.+|+.++|.+|.+..|+++|-+|
T Consensus 244 --~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 244 --TISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred --ccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 223347789999999999999999999999876
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=345.12 Aligned_cols=249 Identities=28% Similarity=0.389 Sum_probs=213.6
Q ss_pred ccccccceeccccCccEEEEE-eCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|-+.+.||+|.||.||+|+ ..+.+.||+|.+.+.. ...++.+.+.+|++++++++||||+.++++|+...+.|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g--r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG--RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC--CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 577888899999999999995 4568899999998743 2335677899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
+||+.| +|..++...+ .++++.+..++.+++.||.|||+. +|.|||+||+||+++.++.+|+||||+|+.+..
T Consensus 80 te~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred ehhhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 999988 9999997654 489999999999999999999999 999999999999999999999999999998887
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.....+...||+-|||||+..+..|+..+|.||+||++||+++|++||-..+. ....+.+......++.
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si--------~~Lv~~I~~d~v~~p~--- 221 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI--------TQLVKSILKDPVKPPS--- 221 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH--------HHHHHHHhcCCCCCcc---
Confidence 77777888999999999999999999999999999999999999999863221 1122233333333322
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
.....+..++...+.+||.+|.|-.+++.|
T Consensus 222 -~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 222 -TASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -cccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 344568888899999999999999998876
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=314.11 Aligned_cols=239 Identities=25% Similarity=0.334 Sum_probs=207.4
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.+|+..+.||.|+||.|..++.+ +|..+|+|++.+.. .....+.+....|..+++.+.||+++++++.|.+.+..|+|
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~-vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQK-VVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHH-HHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 68899999999999999999665 58899999998732 22234556778899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||++||-|..++++.+ +++++..+.+|.||+.|++|||+. +|++||+||+|||+|.+|.+||+|||+|..+..
T Consensus 123 meyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999997654 489999999999999999999999 999999999999999999999999999997753
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
. ..+.+||+.|+|||.+....+..++|.|||||++|||+.|..||... ......+.+...++..++...
T Consensus 197 r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~--------~~~~iY~KI~~~~v~fP~~fs 265 (355)
T KOG0616|consen 197 R---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD--------NPIQIYEKILEGKVKFPSYFS 265 (355)
T ss_pred c---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC--------ChHHHHHHHHhCcccCCcccC
Confidence 2 45678999999999999999999999999999999999999998732 235556677777776665444
Q ss_pred HHHHHHHHHHHHhccCCCCCCC
Q 039322 675 QEKLISIMEVAFSCLNESPESR 696 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~R 696 (708)
. ++.+|++..++.|-.+|
T Consensus 266 ~----~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 266 S----DAKDLLKKLLQVDLTKR 283 (355)
T ss_pred H----HHHHHHHHHHhhhhHhh
Confidence 3 37788889999998888
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=350.83 Aligned_cols=348 Identities=23% Similarity=0.221 Sum_probs=272.7
Q ss_pred cEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-------------------------CCcccccccCC
Q 039322 5 SILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-------------------------PMLTRPGLDFN 59 (708)
Q Consensus 5 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-------------------------~~l~~l~l~~n 59 (708)
++||+++|++.++.+..|.++++|+++++..|.+. .+|...+. |.|+.||||.|
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence 56888888888888888888888888888888876 44444333 34455555555
Q ss_pred CccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCC
Q 039322 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISS 139 (708)
Q Consensus 60 ~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 139 (708)
.|+.....+|..-.++++|+|++|.|+.....+|.++.+|.+|.|++|+|+.++...|.++++|+.|+|..|+|..+...
T Consensus 160 ~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~l 239 (873)
T KOG4194|consen 160 LISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGL 239 (873)
T ss_pred hhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhh
Confidence 55554445555555666666666666666666666666677777777777766666677777777777777777655566
Q ss_pred CCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCC
Q 039322 140 NWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDL 219 (708)
Q Consensus 140 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L 219 (708)
.|.++++|+.|.|..|.|......+|..+.++++|+|+.|++......++.+++.|+.|+|++|.|..+.++.+...++|
T Consensus 240 tFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL 319 (873)
T KOG4194|consen 240 TFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKL 319 (873)
T ss_pred hhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccc
Confidence 67777777777777777777777788888888888888888887777788889999999999999988888888888999
Q ss_pred CeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCC---CchhhcCcccCCceec
Q 039322 220 EYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGE---IPFQICSLKSLEKLNL 296 (708)
Q Consensus 220 ~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~---~~~~~~~~~~L~~L~l 296 (708)
++|+|++|+|+...+..|..+..|+.|+|++|+|+.+....|.++.+|++|||++|.|+.. ....|..+++|+.|.|
T Consensus 320 ~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l 399 (873)
T KOG4194|consen 320 KELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRL 399 (873)
T ss_pred eeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheee
Confidence 9999999999988888899999999999999999877778899999999999999988753 3456778999999999
Q ss_pred ccccccCCCCCcccccccccEEecCCCcCCCCCCCccccccCcccccccccCcCCCC
Q 039322 297 SHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGV 353 (708)
Q Consensus 297 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~ 353 (708)
.||+|..+...+|.++++|++|||.+|.+...-|+...-..++.+.+......|||.
T Consensus 400 ~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCq 456 (873)
T KOG4194|consen 400 TGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQ 456 (873)
T ss_pred cCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEecc
Confidence 999999888889999999999999999999877765444477888888888999984
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=368.23 Aligned_cols=253 Identities=27% Similarity=0.451 Sum_probs=208.6
Q ss_pred ccccccceeccccCccEEEEEeC--CCc----EEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP--SGQ----VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
......+.||+|+||.||.|... +|. .||||.+++. ....+..+|.+|..+|++++|||||+++|++.+..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~---~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL---SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 45667788999999999999654 343 4999998864 23467889999999999999999999999999999
Q ss_pred eeEEEEEeccCCCHHHHhccccc----ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEee
Q 039322 510 HSFLVYELLERGSLAAILSSDTA----AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVAD 585 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 585 (708)
..++++|||++|+|..||++.+. ...++..+.+.++.|||+|+.||+++ ++|||||.++|+|++....|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999987632 34589999999999999999999999 899999999999999999999999
Q ss_pred cccccccCCCCCcccc-c-cccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccc-c
Q 039322 586 FGIAKFLKPESSNWTE-F-AGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALD-E 661 (708)
Q Consensus 586 fg~a~~~~~~~~~~~~-~-~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~-~ 661 (708)
||+|+.....+++... . .-...|||||.+..+.++.|+|||||||++||++| |..||.... ..+.+. .
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~--------n~~v~~~~ 917 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS--------NFEVLLDV 917 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc--------hHHHHHHH
Confidence 9999954433333222 1 23579999999999999999999999999999998 999987322 222233 4
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 662 ILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
...+++.++.. +++ .+++++..||+.+|++||++..+++.+
T Consensus 918 ~~ggRL~~P~~-CP~---~ly~lM~~CW~~~pe~RP~F~~i~~q~ 958 (1025)
T KOG1095|consen 918 LEGGRLDPPSY-CPE---KLYQLMLQCWKHDPEDRPSFRTIVEQD 958 (1025)
T ss_pred HhCCccCCCCC-CCh---HHHHHHHHHccCChhhCccHHHHHhhh
Confidence 44455555543 333 477889999999999999999999865
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=335.83 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=211.2
Q ss_pred ccccccceeccccCccEEEE-EeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
..|.....||+|.||.||+| ....++.||+|++..... ..+.+.+.+|+.++.+++++||.++||.+..+..++++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~---~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA---EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc---chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 45777789999999999999 456789999999986432 23456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
||||.||++.+.++.... +.+..+.-+++++..|+.|||++ +.+|||||+.||++..+|.+|++|||.+.....
T Consensus 90 Mey~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHHhcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeec
Confidence 999999999999976542 47788888999999999999999 999999999999999999999999999998877
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
........+||+.|||||++....|+.|+||||||++++||.+|.+|+..... ...--.+....+|...
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP---------mrvlflIpk~~PP~L~-- 232 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP---------MRVLFLIPKSAPPRLD-- 232 (467)
T ss_pred hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc---------ceEEEeccCCCCCccc--
Confidence 76666889999999999999988999999999999999999999999874322 1111122222222211
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
......+.+++..|+++||+.||+|.++++|
T Consensus 233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1445568899999999999999999999987
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=347.27 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=203.9
Q ss_pred ccccccceeccccCccEEEEEeCC--C--cE-EEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPS--G--QV-VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~--~--~~-vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
++....++||+|+||.||+|.+.. + .. ||||..+... ........+|++|+++|++++|||||++||++..+.+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 455666899999999999996542 2 23 8999987521 1234567899999999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++|||+|.||+|.++|++... .++..++..++.+.|.||+|||++ +++||||.++|+|++.++.+||+|||+++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999987653 589999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccc-cCCCCC
Q 039322 591 FLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEI-LDPRLP 668 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 668 (708)
.............-+.+|+|||.+..+.++.++|||||||++||+++ |..||...... .....+ .+....
T Consensus 311 ~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~kI~~~~~r~ 382 (474)
T KOG0194|consen 311 AGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAKIVKNGYRM 382 (474)
T ss_pred CCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHHHHhcCccC
Confidence 54311111112235689999999999999999999999999999998 88898754321 222222 222222
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+.+...+ ..+..++.+||..+|++||+|.++.+.++
T Consensus 383 ~~~~~~p---~~~~~~~~~c~~~~p~~R~tm~~i~~~l~ 418 (474)
T KOG0194|consen 383 PIPSKTP---KELAKVMKQCWKKDPEDRPTMSTIKKKLE 418 (474)
T ss_pred CCCCCCH---HHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence 2222222 34667777999999999999999998875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=346.00 Aligned_cols=257 Identities=22% Similarity=0.384 Sum_probs=201.0
Q ss_pred hccccccceeccccCccEEEEEe------CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSH 507 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~ 507 (708)
.++|++.+.||+|+||.||+|.. .+++.||||+++... .......+.+|+++++++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 46899999999999999999963 235689999987532 223456789999999999 89999999999876
Q ss_pred CC-eeEEEEEeccCCCHHHHhccccc------------------------------------------------------
Q 039322 508 AR-HSFLVYELLERGSLAAILSSDTA------------------------------------------------------ 532 (708)
Q Consensus 508 ~~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 532 (708)
++ ..++||||+++|+|.+++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 54 68899999999999999965321
Q ss_pred -----ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCc--ccccccc
Q 039322 533 -----AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGT 605 (708)
Q Consensus 533 -----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~ 605 (708)
...+++..+..++.|+++||+|||++ ||+||||||+||+++.++.+||+|||+++........ .....++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 13478889999999999999999999 9999999999999999999999999999865432221 1223456
Q ss_pred ccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHH
Q 039322 606 YGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEV 684 (708)
Q Consensus 606 ~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 684 (708)
..|+|||++.+..++.++||||||+++|||++ |..||...... ........++.....+. ..+..+.++
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~---~~~~~l~~l 309 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-------EEFCQRLKDGTRMRAPE---NATPEIYRI 309 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-------HHHHHHHhcCCCCCCCC---CCCHHHHHH
Confidence 78999999998889999999999999999997 99998743211 01111111111111111 123358899
Q ss_pred HHhccCCCCCCCCCHHHHHHHhh
Q 039322 685 AFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 685 i~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+.+||+.||++|||+.|+++.|+
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~ 332 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILG 332 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=330.01 Aligned_cols=260 Identities=23% Similarity=0.305 Sum_probs=209.2
Q ss_pred HHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCc----------chhHhHHHHHHHHHHHHhccCCceeeE
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPC----------DQIADQKEFLIEVKALTEIRHRNIVKF 501 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~iv~l 501 (708)
+..++|++...||+|.||.|-+|+. .+++.||||++.+.... ......+...+|+.+|+++.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3458999999999999999999954 57999999999763111 011123578999999999999999999
Q ss_pred EEEEeeC--CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC
Q 039322 502 YGFCSHA--RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY 579 (708)
Q Consensus 502 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~ 579 (708)
+++..++ +..|||+|||..|.+... ...+..+++.+.++++++++.||+|||.+ ||+||||||+|+|++++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 9999875 579999999998877542 22223389999999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCC-----CCccccccccccccCccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCccccccc
Q 039322 580 EAHVADFGIAKFLKPE-----SSNWTEFAGTYGYVAPELAYTMK----ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISS 650 (708)
Q Consensus 580 ~~kl~Dfg~a~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~~l~elltg~~p~~~~~~~~~ 650 (708)
++||+|||.+...... +......+||+.|+|||++.++. .+.+.||||+||.+|.|+.|+.||-.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~------ 321 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD------ 321 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc------
Confidence 9999999999866322 22234578999999999988743 34588999999999999999999852
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 651 SSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.......+.+.+..+..+... +....+.+||++++.+||+.|.+..+|..|.|+
T Consensus 322 --~~~~~l~~KIvn~pL~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 322 --DFELELFDKIVNDPLEFPENP--EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred --chHHHHHHHHhcCcccCCCcc--cccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 223445566666665554332 334568899999999999999999999988764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=390.89 Aligned_cols=353 Identities=37% Similarity=0.511 Sum_probs=316.1
Q ss_pred CCCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEe
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFG 79 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~ 79 (708)
|++|++|+|++|+++...|..++++++|++|+|++|.+.+.+|..+.. ++|+.|++++|.+.+..|..+..+++|++|+
T Consensus 211 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 290 (968)
T PLN00113 211 MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLD 290 (968)
T ss_pred cCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEE
Confidence 578999999999999999999999999999999999999888888876 8999999999999999999999999999999
Q ss_pred ccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccc
Q 039322 80 VSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITG 159 (708)
Q Consensus 80 l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 159 (708)
+++|.+++..|..+.++++|+.|++++|.+++..+..+..+++|++|++++|.+.+..+..+..+++|+.|++++|++++
T Consensus 291 Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~ 370 (968)
T PLN00113 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTG 370 (968)
T ss_pred CcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEe
Confidence 99999999999999999999999999999999999999999999999999999998889899999999999999999999
Q ss_pred cCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCc
Q 039322 160 GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239 (708)
Q Consensus 160 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~ 239 (708)
..|..+..+++|+.|++++|.+.+..|..+..+++|+.|++++|.+++..|..|..+++|+.|++++|.+++..+..+..
T Consensus 371 ~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 450 (968)
T PLN00113 371 EIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWD 450 (968)
T ss_pred eCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhcc
Confidence 99999999999999999999998888888888888888888888888777777777777777777777776655543333
Q ss_pred -----------------------cccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceec
Q 039322 240 -----------------------LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNL 296 (708)
Q Consensus 240 -----------------------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l 296 (708)
.++|+.|++++|++++..|..|..+++|+.|+|++|.+.+..|..+..+++|+.|+|
T Consensus 451 l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 530 (968)
T PLN00113 451 MPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDL 530 (968)
T ss_pred CCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEEC
Confidence 345677777777887788888999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccEEecCCCcCCCCCCC-ccccccCcccccccccCcCCCC
Q 039322 297 SHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPN-STAFRNAPVEALKGNKGLCGGV 353 (708)
Q Consensus 297 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~~~c~~~ 353 (708)
++|.+++.+|..+..+++|+.|++++|++++..|. ...+..+..+.+++|+..+..|
T Consensus 531 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 531 SHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred CCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 99999999999999999999999999999987776 4556778999999999877544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=334.60 Aligned_cols=255 Identities=23% Similarity=0.307 Sum_probs=205.8
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
..++|+..++||+|+||.||.|+- .+|..+|+|++++... ....+.+.++.|-.+|....+|.||+++..|.+++.+|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M-~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM-LKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHH-HhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 357999999999999999999954 5799999999998432 22345667889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
|||||++||++..+|...+ .+++..+..++.+.+-|+..+|+. |+|||||||+|+|+|..|++||+|||++...
T Consensus 218 LiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999997554 489999999999999999999999 9999999999999999999999999998532
Q ss_pred CC-----------------------CCC-----c-------------------cccccccccccCccccccCCCCcchhH
Q 039322 593 KP-----------------------ESS-----N-------------------WTEFAGTYGYVAPELAYTMKITEKCDV 625 (708)
Q Consensus 593 ~~-----------------------~~~-----~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv 625 (708)
.. +.. . ....+|||.|+|||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 10 000 0 013579999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC--CCCCCchhHHHHHHHHHHHHhccCCCCCCCC---CHH
Q 039322 626 YSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPR--LPPPSRSVQEKLISIMEVAFSCLNESPESRP---TMK 700 (708)
Q Consensus 626 wslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ 700 (708)
||+|||+|||+.|.+||.... .....+.++.-+ +..+.. .....+..+||.+|+. ||++|- .++
T Consensus 372 WSLG~ImyEmLvGyPPF~s~t--------p~~T~rkI~nwr~~l~fP~~--~~~s~eA~DLI~rll~-d~~~RLG~~G~~ 440 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSET--------PQETYRKIVNWRETLKFPEE--VDLSDEAKDLITRLLC-DPENRLGSKGAE 440 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHhhhccCCCc--CcccHHHHHHHHHHhc-CHHHhcCcccHH
Confidence 999999999999999997432 233333333322 221111 1112456788999999 999998 477
Q ss_pred HHHHHh
Q 039322 701 VVTQQV 706 (708)
Q Consensus 701 evl~~l 706 (708)
||.+|-
T Consensus 441 EIK~HP 446 (550)
T KOG0605|consen 441 EIKKHP 446 (550)
T ss_pred HHhcCC
Confidence 777663
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.83 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=213.7
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+-|+.++.||.|+-|.|-.|++ .+|+.+|||++.+.... .......+.+|+-+|+-+.|||++++|++++...++|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~-s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL-SSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeecccccc-ccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 5688899999999999999965 57999999999874221 223456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
.||+++|-|.+++-..+ ++++.+..++++||+.|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|..- .
T Consensus 91 lEyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe-~ 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE-V 163 (786)
T ss_pred EEecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc-c
Confidence 99999999999997654 489999999999999999999999 9999999999999999999999999999754 4
Q ss_pred CCCccccccccccccCccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKIT-EKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
++......+|++.|.|||++.+.+|+ .++||||.|||+|.|+||+.||++. +....+..+..+.+.-+
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--------Nir~LLlKV~~G~f~MP--- 232 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--------NIRVLLLKVQRGVFEMP--- 232 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--------cHHHHHHHHHcCcccCC---
Confidence 55566778999999999999999875 5899999999999999999999832 22333344444443322
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
...+.+..+|+.+|+..||++|.|++||.+|.++
T Consensus 233 -s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 233 -SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred -CcCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence 2223357788999999999999999999998764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=333.78 Aligned_cols=260 Identities=23% Similarity=0.348 Sum_probs=207.9
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
....++++||+|.||.|.......+..||||+++.. +....+.+|.+|+++|.+++||||++++|+|..++.+++|+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~---a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD---ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcc---cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 456788899999999999998877899999999874 23345789999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
|||++|+|.+|+..+.... ..-....+|+.|||.|++||.+. ++||||+.++|+|++.++++||+|||+++..-..
T Consensus 615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999998875422 45566778999999999999999 9999999999999999999999999999955444
Q ss_pred CCcc--ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCcccccccccccccccccccc-CCCCCCC
Q 039322 596 SSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK--GKHPRDFLSLISSSSLNTDIALDEIL-DPRLPPP 670 (708)
Q Consensus 596 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 670 (708)
+++. ...+-+.+|||||.+..++++.++|||+||+.+||+++ ...||+....... -+...++. ++.....
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v-----ven~~~~~~~~~~~~~ 765 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV-----VENAGEFFRDQGRQVV 765 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH-----HHhhhhhcCCCCccee
Confidence 4332 22344689999999999999999999999999999985 7888864321100 00111111 1111111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+..++..+.+++.+||..|-++||+++++..+|.
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq 802 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQ 802 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence 1222334556889999999999999999999988764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=325.46 Aligned_cols=258 Identities=26% Similarity=0.458 Sum_probs=200.5
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc--cCCceeeEEEEEeeCC----
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI--RHRNIVKFYGFCSHAR---- 509 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~l~~~~~~~~---- 509 (708)
......++||+|.||.||+|.+. ++.||||+|.. .+.+.|..|-++++.. +|+||++++++-....
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~-------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE-------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH-------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 44566778999999999999884 68999999874 5678899999987654 7999999999887665
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCC------CCeEEccCCCCCeeeCCCCcEEE
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF------PPIVHQDISSKNLLLDLEYEAHV 583 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~------~~ivH~dlk~~Nill~~~~~~kl 583 (708)
.++||+||.+.|+|.+||+.+. ++|....+++..+++||+|||+... |+|+|||||++|||+.+|+++.|
T Consensus 282 eywLVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 7899999999999999998876 8999999999999999999998653 78999999999999999999999
Q ss_pred eecccccccCCCCCc--cccccccccccCccccccCC-CC-----cchhHHHHHHHHHHHHhCCCCCC------cccccc
Q 039322 584 ADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMK-IT-----EKCDVYSFGVLVLEAIKGKHPRD------FLSLIS 649 (708)
Q Consensus 584 ~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~-----~~~DvwslG~~l~elltg~~p~~------~~~~~~ 649 (708)
+|||+|..+.+.... ....+||.+|||||++.+.- +. .+.||||+|.++|||++.-..++ +.-.+.
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 999999988765432 23468999999999987642 22 36899999999999998443321 111110
Q ss_pred -------ccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 650 -------SSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 650 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
..+......+++...|.++...... ..+..+.+.+..||..||+.|.|+.-|-+++
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~ 500 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERM 500 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence 0000111122333334443332222 4456788999999999999999999888765
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=336.76 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=216.7
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe-eE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH-SF 512 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~-~~ 512 (708)
.++|...+++|+|+||.++..+++ +++.||+|.+...... ...+....+|+.++++++|||||.+.+.|.+++. .+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t--~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT--EPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC--chhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 367899999999999999998654 5778999998764322 2334578899999999999999999999999988 99
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
|||+||+||++.+.+.+.+ +..++++.+.+|+.|+..|+.|||++ .|+|||||+.|||++.++.|||+|||+|+..
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred EEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhc
Confidence 9999999999999998766 46689999999999999999999998 9999999999999999999999999999998
Q ss_pred CCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
.++.......+||+.|+.||.+.+.+|..|+|||||||++|||++-+++|..... .....++......+.+.
T Consensus 157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--------~~Li~ki~~~~~~Plp~ 228 (426)
T KOG0589|consen 157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--------SELILKINRGLYSPLPS 228 (426)
T ss_pred CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch--------HHHHHHHhhccCCCCCc
Confidence 8777677788999999999999999999999999999999999999999984322 22233333333333333
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
. +..++..+++.|+.++|+.||++.+++.+
T Consensus 229 ~---ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 229 M---YSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred c---ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2 34468889999999999999999999875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=334.74 Aligned_cols=256 Identities=20% Similarity=0.245 Sum_probs=201.8
Q ss_pred ccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEE
Q 039322 438 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYE 516 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 516 (708)
|+..+.||+|+||.||+|.. .+|+.||+|.+..... ........+.+|++++++++|++|+++++++.+++..++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhh-hhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 67788999999999999965 5789999999875321 112234567889999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 039322 517 LLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596 (708)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 596 (708)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG- 155 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-
Confidence 999999998885433 23488999999999999999999999 9999999999999999999999999999865432
Q ss_pred CccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHH
Q 039322 597 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQE 676 (708)
Q Consensus 597 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (708)
.......|+..|+|||++.+..++.++||||+||++|||++|+.||........ .......+.......+ ..
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~----~~ 227 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----REEVDRRVKEDQEEYS----EK 227 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh----HHHHHHHhhcccccCC----cc
Confidence 223445789999999999999999999999999999999999999974321100 0001111111111111 11
Q ss_pred HHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 039322 677 KLISIMEVAFSCLNESPESRPT-----MKVVTQQVR 707 (708)
Q Consensus 677 ~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~ 707 (708)
....+.+++.+||+.||++||+ ++++++|-+
T Consensus 228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~ 263 (285)
T cd05631 228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI 263 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence 2345788999999999999997 899988743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=341.02 Aligned_cols=246 Identities=22% Similarity=0.268 Sum_probs=199.1
Q ss_pred ceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccC
Q 039322 442 YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLER 520 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 520 (708)
+.||+|+||.||+|.. .+|+.||+|++++... ........+.+|++++++++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999965 4789999999875211 1123345678899999999999999999999999999999999999
Q ss_pred CCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 039322 521 GSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWT 600 (708)
Q Consensus 521 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 600 (708)
|+|.+++.... .+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 153 (323)
T cd05571 80 GELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence 99999986543 489999999999999999999999 999999999999999999999999999975433333344
Q ss_pred cccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHH
Q 039322 601 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLIS 680 (708)
Q Consensus 601 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (708)
...|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+. ....+
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~~~~~~~~~p~----~~~~~ 221 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEEIRFPR----TLSPE 221 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcCCCCCCC----CCCHH
Confidence 56799999999999998899999999999999999999999863221 1111112222221111 12335
Q ss_pred HHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 039322 681 IMEVAFSCLNESPESRP-----TMKVVTQQV 706 (708)
Q Consensus 681 l~~li~~cl~~dP~~RP-----s~~evl~~l 706 (708)
+.+++.+||+.||++|| ++.++++|-
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~ 252 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEHR 252 (323)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHHcCC
Confidence 78899999999999999 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=339.32 Aligned_cols=246 Identities=25% Similarity=0.353 Sum_probs=208.2
Q ss_pred HhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCee
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~ 511 (708)
..++|.+.++||+|.||+|++|..+ +++.+|||++++.... ...+.+..+.|.+++... +||.+++++.+|..+++.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il-~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDIL-QRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeecccee-ccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 4578999999999999999999654 6889999999985433 235677889999998877 599999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
|.||||+.||++..+.+. +.+++..+.-+|..|+.||+|||++ ||||||||.+|||+|.+|++||+|||+++.
T Consensus 445 ~fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence 999999999995544433 4489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 592 LKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
.--.+......+||+.|+|||++.+..|+.++|.|||||++|||+.|..||.. ...++..+.++......+.
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g--------ddEee~FdsI~~d~~~yP~ 589 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG--------DDEEEVFDSIVNDEVRYPR 589 (694)
T ss_pred cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHHhcCCCCCCC
Confidence 55445566778999999999999999999999999999999999999999983 3345556666655544433
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCH
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTM 699 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 699 (708)
.. +.+...++++++.++|++|.-+
T Consensus 590 ~l----s~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 590 FL----SKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred cc----cHHHHHHHHHHhccCcccccCC
Confidence 22 2346678889999999999955
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=329.73 Aligned_cols=246 Identities=21% Similarity=0.297 Sum_probs=196.4
Q ss_pred ceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee----CCeeEEEEEe
Q 039322 442 YCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH----ARHSFLVYEL 517 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----~~~~~lv~e~ 517 (708)
..||+|++|.||+|.. +|+.||||+++.... ......+.+.+|++++++++||||++++|++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999988 689999999976322 222235678899999999999999999999977 3467899999
Q ss_pred ccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 039322 518 LERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS 597 (708)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 597 (708)
+++|+|.+++...+ .+++....+++.|++.|++|||+.. +++||||||+||+++.++.+||+|||++.......
T Consensus 104 ~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 104 CTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999997643 4889999999999999999999842 78899999999999999999999999998654322
Q ss_pred ccccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhH
Q 039322 598 NWTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQ 675 (708)
Q Consensus 598 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (708)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+......... ..
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--------~~~~~~i~~~~~~~~~--~~ 245 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--------KEIYDLIINKNNSLKL--PL 245 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcCCCCCC--CC
Confidence 23467889999999876 6789999999999999999999999974321 1111122111111110 01
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 676 EKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 676 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+..+.+++.+||+.||++|||++|+++.|+
T Consensus 246 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~ 277 (283)
T PHA02988 246 DCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277 (283)
T ss_pred cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 12345889999999999999999999999875
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=336.30 Aligned_cols=250 Identities=23% Similarity=0.294 Sum_probs=203.8
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|... +++.||+|++.... .......+.+.+|++++++++||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE-VIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHH-HhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 36888999999999999999654 68999999986421 11123456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++...+ .+++..+..++.|++.||+|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 80 MEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999996543 488999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+.......+..
T Consensus 154 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~-- 220 (291)
T cd05612 154 R---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKILAGKLEFPRH-- 220 (291)
T ss_pred C---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCcCCCcc--
Confidence 2 2235689999999999988899999999999999999999999874221 11122222222222111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPT-----MKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~ 707 (708)
....+.+++++||+.||.+||+ ++|+++|-+
T Consensus 221 --~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 221 --LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred --CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 1235789999999999999995 999998855
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=309.85 Aligned_cols=262 Identities=23% Similarity=0.261 Sum_probs=204.7
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC--CeeE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA--RHSF 512 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~ 512 (708)
++|+..+.|++|+||.||+|+. ++++.||+|+++-...... -...-.+|+.++.+++|||||.+-++.... +..|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G--FPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG--FPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC--CcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 6788999999999999999955 5788999999986432221 133467899999999999999999988654 5799
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+|||||+. +|...+..-. +++...++..+..|+.+|++|||++ .|+|||||++|+|+.+.|.+||+|||+|+.+
T Consensus 154 ~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 99999988 9999987654 6789999999999999999999999 8999999999999999999999999999999
Q ss_pred CCCCCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccc----------------cccc
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS----------------SLNT 655 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~----------------~~~~ 655 (708)
+.+...++..+.|..|+|||.+.+. .|+.+.|+||+|||+.||+++++-|...+..... ++..
T Consensus 228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 8877778888999999999988765 5899999999999999999999998754322111 1111
Q ss_pred ccccccccCCCCCCCC--chhHH--HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 656 DIALDEILDPRLPPPS--RSVQE--KLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 656 ~~~~~~~~~~~~~~~~--~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
......+..+..+... ..... -...-.+|+...+.+||++|-||+|.++|
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1111001011100000 00000 11234577789999999999999999876
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=332.32 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=199.2
Q ss_pred ccccccceeccccCccEEEEEeCC-----------------CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCce
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPS-----------------GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI 498 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 498 (708)
++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... .......+.+|++++.+++||||
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCCCCe
Confidence 678999999999999999996532 3369999987532 22346679999999999999999
Q ss_pred eeEEEEEeeCCeeEEEEEeccCCCHHHHhcccc----------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 039322 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDT----------------AAQELGWSQRMNVIKGVADALSYLHHDCFPP 562 (708)
Q Consensus 499 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ 562 (708)
+++++++.+.+..++||||+++|+|.+++.... ....+++..+++++.|++.||+|||+. |
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ 158 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---N 158 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence 999999999999999999999999999985432 113468889999999999999999999 9
Q ss_pred eEEccCCCCCeeeCCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh--C
Q 039322 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK--G 638 (708)
Q Consensus 563 ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt--g 638 (708)
++||||||+||+++.++.+||+|||+++........ .....++..|+|||++.++.++.++||||||+++|||++ +
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 999999999999999999999999999865433221 122345778999999988889999999999999999997 5
Q ss_pred CCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 639 KHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 639 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..||............ ............... ....+..+.+++.+||+.||++|||++||.+.|+
T Consensus 239 ~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 239 EQPYGELTDEQVIENA-GEFFRDQGRQVYLFR---PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCcCCHHHHHHHH-HHHhhhccccccccC---CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 5666532211000000 000000000000000 0112345889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=334.93 Aligned_cols=261 Identities=24% Similarity=0.343 Sum_probs=204.9
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||++... +|..||+|.+.... .....+.+.+|++++++++||||+++++++..++..++|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 68999999999999999999654 68889999987532 223456799999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 82 MEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred eecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99999999999996543 4789999999999999999999862 699999999999999999999999999876532
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccc-------c----------
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTD-------I---------- 657 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~-------~---------- 657 (708)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||.............. .
T Consensus 157 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred c--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 2 22345689999999999988899999999999999999999999964321100000000 0
Q ss_pred ---------------------ccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 658 ---------------------ALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 658 ---------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
....+.....+. ........++.+++.+||++||++|||++|+++|-++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPK--LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcC--CCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 000000000000 0001123468899999999999999999999998653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.10 Aligned_cols=250 Identities=24% Similarity=0.272 Sum_probs=204.0
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|... +++.||+|++.... .......+.+.+|++++++++||||+++++++.+++..++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE-ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH-HhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 68999999999999999999664 68899999987521 11123356788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... .+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 97 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999997543 478899999999999999999999 999999999999999999999999999986543
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.. ....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+..
T Consensus 171 ~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~~~p~~-- 237 (329)
T PTZ00263 171 RT---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKILAGRLKFPNW-- 237 (329)
T ss_pred Cc---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHHhcCCcCCCCC--
Confidence 22 235789999999999998899999999999999999999999864221 11122222222222211
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPT-----MKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~ 707 (708)
....+.+++.+||+.||++||+ ++++++|-+
T Consensus 238 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~ 273 (329)
T PTZ00263 238 --FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273 (329)
T ss_pred --CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence 1234778999999999999997 788887743
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=298.29 Aligned_cols=259 Identities=23% Similarity=0.337 Sum_probs=208.2
Q ss_pred hccccccceeccccCccEEEEE-eCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR---- 509 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~---- 509 (708)
.++|++.+.+|+|||+-||.++ ..+++.||+|++.-. ..++.+..++|++..++++|||+++++++...+.
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeecc----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 4789999999999999999995 567889999998753 3466788999999999999999999999875433
Q ss_pred -eeEEEEEeccCCCHHHHhccccccc-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecc
Q 039322 510 -HSFLVYELLERGSLAAILSSDTAAQ-ELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFG 587 (708)
Q Consensus 510 -~~~lv~e~~~~g~L~~~l~~~~~~~-~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 587 (708)
..|++++|...|+|.+.+.....++ .+++.++++|+.+|++||.+||+.. |+++||||||.||++.+++.+++.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence 4899999999999999998765444 6899999999999999999999983 249999999999999999999999999
Q ss_pred cccccCCCCC---------ccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccc
Q 039322 588 IAKFLKPESS---------NWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNT 655 (708)
Q Consensus 588 ~a~~~~~~~~---------~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~ 655 (708)
.++...-.-. .......|..|+|||.+. +...++++|||||||++|+|+.|..||+..-. ..
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~------~G 248 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ------QG 248 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh------cC
Confidence 9875431111 123345789999999875 34578899999999999999999999984321 11
Q ss_pred ccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 656 DIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
....-++..+.+..+.... .+..+.++|++|++.||.+||++.+++.++
T Consensus 249 gSlaLAv~n~q~s~P~~~~--yse~l~~lik~mlqvdP~qRP~i~~ll~~~ 297 (302)
T KOG2345|consen 249 GSLALAVQNAQISIPNSSR--YSEALHQLIKSMLQVDPNQRPTIPELLSKL 297 (302)
T ss_pred CeEEEeeeccccccCCCCC--ccHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 2222233333433332222 455789999999999999999999999876
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=340.90 Aligned_cols=344 Identities=23% Similarity=0.220 Sum_probs=272.1
Q ss_pred cEEECCCCcccccCCccccCCCC--CCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEecc
Q 039322 5 SILDLNQNQFKGVLPPSVSNLTN--LKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVS 81 (708)
Q Consensus 5 ~~L~l~~n~i~~~~~~~~~~l~~--L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~ 81 (708)
..||++++.+..++...+.++-- -++|+|++|+++.+.+..|.+ ++|+++.+.+|.++. +|.......+|+.|+|.
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~-IP~f~~~sghl~~L~L~ 133 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTR-IPRFGHESGHLEKLDLR 133 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhh-cccccccccceeEEeee
Confidence 46899999999887777766544 455999999999877776655 999999999999988 78888888899999999
Q ss_pred CCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccC
Q 039322 82 ENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGI 161 (708)
Q Consensus 82 ~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~ 161 (708)
+|.|+.+-...++-++.|++|||+.|.|+.+....|..-.++++|+|++|.|+.+..+.|..+.+|..|.|+.|+|+...
T Consensus 134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp 213 (873)
T KOG4194|consen 134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLP 213 (873)
T ss_pred ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccC
Confidence 99999888888999999999999999999999999988889999999999999999999999999999999999999888
Q ss_pred CccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccc
Q 039322 162 PREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLL 241 (708)
Q Consensus 162 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~ 241 (708)
+..|..++.|+.|+|.+|+|+-...-.|.++++|+.|.|..|.+.......|..+.++++|+|..|+++..-..++.+++
T Consensus 214 ~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt 293 (873)
T KOG4194|consen 214 QRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLT 293 (873)
T ss_pred HHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccc
Confidence 88899899999999999999844355677788888888887777766666777777777777777777766666677777
Q ss_pred cceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecC
Q 039322 242 KLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDIS 321 (708)
Q Consensus 242 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~ 321 (708)
+|+.|+||+|.|..+.++.++...+|++|+|++|.|+...+..|..+..|+.|+|++|+++.+-..+|.++.+|+.|||+
T Consensus 294 ~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr 373 (873)
T KOG4194|consen 294 SLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR 373 (873)
T ss_pred hhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence 77777777777776667777767777777777777776666677777777777777777776666667777777777777
Q ss_pred CCcCCCCCCCc----cccccCcccccccccCc
Q 039322 322 DNQLQGPVPNS----TAFRNAPVEALKGNKGL 349 (708)
Q Consensus 322 ~N~l~~~~~~~----~~~~~~~~~~~~~n~~~ 349 (708)
+|.+...+.+. ..++.++.+.+.||+..
T Consensus 374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk 405 (873)
T KOG4194|consen 374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK 405 (873)
T ss_pred CCeEEEEEecchhhhccchhhhheeecCceee
Confidence 77666554442 12344555566666543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=335.60 Aligned_cols=246 Identities=22% Similarity=0.268 Sum_probs=198.2
Q ss_pred ceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccC
Q 039322 442 YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLER 520 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 520 (708)
+.||+|+||.||++.. .+|+.||+|+++.... ........+..|++++++++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 3689999999999965 4689999999875321 1123345678899999999999999999999999999999999999
Q ss_pred CCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 039322 521 GSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWT 600 (708)
Q Consensus 521 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 600 (708)
|+|.+++.... .+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++...........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 153 (323)
T cd05595 80 GELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence 99999886543 488999999999999999999999 999999999999999999999999999875433333334
Q ss_pred cccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHH
Q 039322 601 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLIS 680 (708)
Q Consensus 601 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (708)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+.. ....
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~~~~~~~~~p~~----~~~~ 221 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEEIRFPRT----LSPE 221 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCCCCCCCC----CCHH
Confidence 56789999999999988899999999999999999999999863221 11111222222211111 2235
Q ss_pred HHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 039322 681 IMEVAFSCLNESPESRP-----TMKVVTQQV 706 (708)
Q Consensus 681 l~~li~~cl~~dP~~RP-----s~~evl~~l 706 (708)
+.+++.+||++||++|| ++.++++|-
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred HHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 78899999999999998 899998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=304.68 Aligned_cols=257 Identities=23% Similarity=0.348 Sum_probs=216.8
Q ss_pred hccccccceeccccCccEEEE-EeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.+.|++...||+|.|+.||+. ..++|+.+|+|.+....- .....+++.+|+++-+.++||||+++.+.+......|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~--~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhh--ccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 467888889999999999999 456799999998864322 22367889999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC---CCcEEEeeccccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL---EYEAHVADFGIAK 590 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~ 590 (708)
|+|+|.|++|..-+-.+ .-.++..+-...+||.+|++|+|.+ +|||||+||+|+++.+ ..-+||+|||+|.
T Consensus 88 vFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 99999999997766433 2367788889999999999999999 9999999999999954 3458999999999
Q ss_pred ccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 591 FLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
... +.......+|||+|||||++...+++..+|||+-|+++|-|+.|..||+... .....+.++.+....+
T Consensus 162 ~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--------~~rlye~I~~g~yd~~ 232 (355)
T KOG0033|consen 162 EVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYEQIKAGAYDYP 232 (355)
T ss_pred EeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--------HHHHHHHHhccccCCC
Confidence 887 6666777899999999999999999999999999999999999999998422 2334455555555555
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
+..+.....+-.+|+++|+..||++|.|+.|.++|-||
T Consensus 233 ~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi 270 (355)
T KOG0033|consen 233 SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWI 270 (355)
T ss_pred CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchh
Confidence 55566666678899999999999999999999999876
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=335.60 Aligned_cols=247 Identities=22% Similarity=0.273 Sum_probs=199.2
Q ss_pred ceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccC
Q 039322 442 YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLER 520 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 520 (708)
+.||+|+||.||++.. .+|+.||+|++.+... ........+.+|+++++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999965 4689999999875321 1223456788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 039322 521 GSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWT 600 (708)
Q Consensus 521 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 600 (708)
|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...........
T Consensus 80 g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 153 (328)
T cd05593 80 GELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153 (328)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence 99999886543 489999999999999999999999 999999999999999999999999999875433333334
Q ss_pred cccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHH
Q 039322 601 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLIS 680 (708)
Q Consensus 601 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (708)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+.. ....
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--------~~~~~~~~~~~~~~p~~----~~~~ 221 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEDIKFPRT----LSAD 221 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--------HHHHHHhccCCccCCCC----CCHH
Confidence 45789999999999988899999999999999999999999864221 11111111111111111 2235
Q ss_pred HHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 039322 681 IMEVAFSCLNESPESRP-----TMKVVTQQVR 707 (708)
Q Consensus 681 l~~li~~cl~~dP~~RP-----s~~evl~~l~ 707 (708)
+.+++.+||++||++|| ++.|+++|-+
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 253 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF 253 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCC
Confidence 78899999999999997 8999998744
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=322.23 Aligned_cols=254 Identities=21% Similarity=0.326 Sum_probs=202.3
Q ss_pred hccccccceeccccCccEEEEEeC----CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
.++|++.+.||+|+||.||+|.++ .+..||+|.++... .......+.+|+.++++++||||+++++++..++.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 367899999999999999999653 35689999988642 12335678999999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++||||+++|+|.+++.... ..+++.+++.++.|++.|++|||++ +++||||||+||+++.++.++++|||.+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 999999999999999997543 3589999999999999999999999 99999999999999999999999999876
Q ss_pred ccCCCCCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCC
Q 039322 591 FLKPESSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 591 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
........ .....++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ...+.+.+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~~~~ 227 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------DVIKAVEDGFRL 227 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCCCC
Confidence 54322111 112234578999999998899999999999999999875 99998743221 111111121111
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+.+. ..+..+.+++.+||+.+|++||+++|+.+.|+
T Consensus 228 ~~~~---~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~ 263 (266)
T cd05064 228 PAPR---NCPNLLHQLMLDCWQKERGERPRFSQIHSILS 263 (266)
T ss_pred CCCC---CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHH
Confidence 1111 23345888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=335.74 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=199.1
Q ss_pred ceeccccCccEEEEEe----CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEe
Q 039322 442 YCIGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYEL 517 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 517 (708)
+.||+|+||.||++.. .+++.||+|+++.............+..|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999964 357899999987532111223345678899999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 039322 518 LERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS 597 (708)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 597 (708)
+++|+|.+++.... .+.+..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999986543 378889999999999999999999 999999999999999999999999999875443333
Q ss_pred ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHH
Q 039322 598 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEK 677 (708)
Q Consensus 598 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (708)
......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.......+.. .
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~~~~~~~~~~~~~~----~ 223 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILKGKLNLPPY----L 223 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCCC----C
Confidence 33445789999999999988899999999999999999999999974321 11222222332222211 1
Q ss_pred HHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 039322 678 LISIMEVAFSCLNESPESRP-----TMKVVTQQV 706 (708)
Q Consensus 678 ~~~l~~li~~cl~~dP~~RP-----s~~evl~~l 706 (708)
...+.+++.+||++||++|| +++++++|-
T Consensus 224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 23578999999999999999 899988764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=339.57 Aligned_cols=257 Identities=20% Similarity=0.274 Sum_probs=204.2
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|... +++.||+|++++... ........+..|++++..++||||+++++++..++..++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 36889999999999999999765 588999999875211 1123456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 80 MEYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999996543 478999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc-CCCCCCCCch
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEIL-DPRLPPPSRS 673 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 673 (708)
......|++.|+|||++.+..++.++||||+||++|||++|+.||............ ....... .+....+
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~--- 225 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL--KYWKETLQRPVYDDP--- 225 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH--HhccccccCCCCCcc---
Confidence 233457899999999999889999999999999999999999999743221100000 0000000 1111100
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......++.+++.+||..+|++||+++|+++|-+
T Consensus 226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred ccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 0122345788999999999999999999998754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=339.07 Aligned_cols=259 Identities=22% Similarity=0.377 Sum_probs=201.9
Q ss_pred HHhccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEE
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFC 505 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~ 505 (708)
-..++|++.+.||+|+||.||+|... ++..||+|+++... .....+.+.+|+++++.+ +|+||+++++++
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 34468999999999999999998632 34579999997532 223456788999999999 899999999999
Q ss_pred eeCCeeEEEEEeccCCCHHHHhcccc------------------------------------------------------
Q 039322 506 SHARHSFLVYELLERGSLAAILSSDT------------------------------------------------------ 531 (708)
Q Consensus 506 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------ 531 (708)
...+..++||||+++|+|.+++....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999999999999985421
Q ss_pred -------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 039322 532 -------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN 598 (708)
Q Consensus 532 -------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 598 (708)
....+++.++++++.|++.||+|||++ |++||||||+||+++.++.+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 112478899999999999999999999 9999999999999999999999999999865433221
Q ss_pred --cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCchhH
Q 039322 599 --WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQ 675 (708)
Q Consensus 599 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (708)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ................. .
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~--------~~~~~~~~~~~~~~~~~--~ 338 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV--------NSKFYKMVKRGYQMSRP--D 338 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc--------cHHHHHHHHcccCccCC--C
Confidence 112234568999999988889999999999999999997 9999874221 00111111111110000 0
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 676 EKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 676 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+.++.+++.+||+.||++|||+.+|++.|+
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~ 370 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11245889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=333.50 Aligned_cols=244 Identities=22% Similarity=0.302 Sum_probs=196.6
Q ss_pred eccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccCCC
Q 039322 444 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGS 522 (708)
Q Consensus 444 ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~ 522 (708)
||+|+||.||+|... +++.||+|++..... ........+.+|++++++++||||+++++++..++..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 699999999999654 588999999864211 122345678889999999999999999999999999999999999999
Q ss_pred HHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 039322 523 LAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEF 602 (708)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 602 (708)
|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.............
T Consensus 80 L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 153 (312)
T cd05585 80 LFHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF 153 (312)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence 999996543 488999999999999999999999 99999999999999999999999999998644333334456
Q ss_pred cccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHH
Q 039322 603 AGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIM 682 (708)
Q Consensus 603 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 682 (708)
.|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+. .....+.
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--------~~~~~~~~~~~~~~~~----~~~~~~~ 221 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--------NEMYRKILQEPLRFPD----GFDRDAK 221 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCCCCCCC----cCCHHHH
Confidence 789999999999998899999999999999999999999864221 1111222222222111 1234578
Q ss_pred HHHHhccCCCCCCCC---CHHHHHHHh
Q 039322 683 EVAFSCLNESPESRP---TMKVVTQQV 706 (708)
Q Consensus 683 ~li~~cl~~dP~~RP---s~~evl~~l 706 (708)
+++.+||+.||++|| ++.|+++|-
T Consensus 222 ~li~~~L~~dp~~R~~~~~~~e~l~hp 248 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYNGAQEIKNHP 248 (312)
T ss_pred HHHHHHcCCCHHHcCCCCCHHHHHcCC
Confidence 899999999999997 467777664
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=337.24 Aligned_cols=250 Identities=23% Similarity=0.273 Sum_probs=203.0
Q ss_pred ccccccceeccccCccEEEEEeCC--CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPS--GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
++|.+.+.||+|+||.||+|.... +..||+|++..... ......+.+.+|+++++.++||||+++++++.+++..++
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI-IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 679999999999999999996533 36899999864211 112335678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+. |++||||||+|||++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999997543 488999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
.. .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+..
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~p~~- 250 (340)
T PTZ00426 183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQKILEGIIYFPKF- 250 (340)
T ss_pred CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHHHHhcCCCCCCCC-
Confidence 32 2345789999999999988899999999999999999999999974321 11122222222221111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRP-----TMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~ 707 (708)
....+.+++++|++.||++|+ +++|+++|-+
T Consensus 251 ---~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~ 286 (340)
T PTZ00426 251 ---LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286 (340)
T ss_pred ---CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence 123467899999999999995 8999998754
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=328.32 Aligned_cols=263 Identities=19% Similarity=0.254 Sum_probs=201.3
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|.. .+++.||+|+++.... ......+.+|++++++++||||+++++++..++..++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 6799999999999999999965 4688999999875321 12244677899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++ +|.+++.... ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 82 FEYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred EeCCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 999975 9999886443 3478899999999999999999999 999999999999999999999999999976543
Q ss_pred CCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc----------------cccccc
Q 039322 595 ESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS----------------SLNTDI 657 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~----------------~~~~~~ 657 (708)
.........+++.|+|||++.+ ..++.++||||+||++|||+||+.||......... ......
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 3333344578899999998865 45889999999999999999999999643211000 000000
Q ss_pred ccccccCCCCCCCCc--hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 ALDEILDPRLPPPSR--SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+....... .......+..+++.+|++.||++|||++|+++|-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~ 287 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence 011111111100000 00111235779999999999999999999998854
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=330.20 Aligned_cols=257 Identities=26% Similarity=0.339 Sum_probs=223.3
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~ 512 (708)
...|++.+.||+|.||.||++..+ +|+.+|+|++.+..... ....+.+.+|+++|+++. |||||.+.++|++....+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-KEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 367888899999999999999765 49999999998743322 224578999999999998 999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC----CcEEEeeccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE----YEAHVADFGI 588 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~ 588 (708)
+|||++.||.|.+.+... .+++.....++.|++.|++|||+. ||+|||+||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999765 289999999999999999999998 99999999999999654 4799999999
Q ss_pred ccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 039322 589 AKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 589 a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
|....+ .......+||+.|+|||++....++.++||||+|+++|.|++|..||.... .......+....+.
T Consensus 186 a~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~--------~~~~~~~i~~~~~~ 256 (382)
T KOG0032|consen 186 AKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET--------EFEIFLAILRGDFD 256 (382)
T ss_pred ceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC--------hhHHHHHHHcCCCC
Confidence 998876 566778899999999999999999999999999999999999999998433 22333355566666
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.....+........++|+.|+..||.+|+|+.++++|-||
T Consensus 257 f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi 296 (382)
T KOG0032|consen 257 FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWI 296 (382)
T ss_pred CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccc
Confidence 6666677777788999999999999999999999999875
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.04 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=201.5
Q ss_pred hccccccceeccccCccEEEEEe------CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSH 507 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~ 507 (708)
.++|++.+.||+|+||.||+|.. .++..||||+++... .....+.+.+|+++++.+ +||||+++++++..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 46799999999999999999953 235689999987532 223456788999999999 89999999999999
Q ss_pred CCeeEEEEEeccCCCHHHHhccccc-------------------------------------------------------
Q 039322 508 ARHSFLVYELLERGSLAAILSSDTA------------------------------------------------------- 532 (708)
Q Consensus 508 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 532 (708)
++..++||||+++|+|.+++.....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999999864321
Q ss_pred -----------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 533 -----------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 533 -----------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
...+++..+.+++.||+.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 12478899999999999999999999 9999999999999999999999999999865433
Q ss_pred CCcc--ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 596 SSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 596 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
.... ....++..|+|||++.+..++.++||||||+++|||++ |..||...... ....+.+.+......+.
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~ 340 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-------SKFYKMIKEGYRMLSPE 340 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-------HHHHHHHHhCccCCCCC
Confidence 2211 12334567999999999899999999999999999998 88898642210 00011111111111011
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+.++.+++.+||+.||++|||+.||++.|+
T Consensus 341 ---~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~ 372 (375)
T cd05104 341 ---CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372 (375)
T ss_pred ---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 11235889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=337.78 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=196.2
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.+|+..+.||+|+||.||+|.. .+++.||||++.... .......+.+|+++++.++|+||+++++++..++..++|
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 5677888999999999999965 468999999986532 223456789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+.. ...+..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 151 ~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 151 LEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred EecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 9999999986532 246678889999999999999999 999999999999999999999999999987654
Q ss_pred CCCccccccccccccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 039322 595 ESSNWTEFAGTYGYVAPELAYT-----MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
.........|+..|+|||++.. ...+.++|||||||++|||++|+.||........ ......+.......
T Consensus 221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~ 295 (353)
T PLN00034 221 TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW-----ASLMCAICMSQPPE 295 (353)
T ss_pred ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH-----HHHHHHHhccCCCC
Confidence 3333345678999999998743 2234689999999999999999999873211000 00011111101111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......++.+++.+||+.||++|||+.|+++|-+
T Consensus 296 ---~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 296 ---APATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330 (353)
T ss_pred ---CCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 11122345889999999999999999999998854
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=318.48 Aligned_cols=250 Identities=24% Similarity=0.433 Sum_probs=201.9
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
++|++.+.||+|+||.||+|..+++..+|+|.+.... ...+.+..|++++++++||||+++++++..++..++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-----ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 5688899999999999999988888899999976421 22456888999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||.++.....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 79 EFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 9999999999986543 2478999999999999999999999 9999999999999999999999999998865432
Q ss_pred CCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 596 SSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 596 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
... .....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+........+..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~~i~~~~~~~~~~~ 225 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMISRGFRLYRPKL 225 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCCCCCCCC
Confidence 221 122234568999999988889999999999999999999 8999864321 111111111111111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
....+.+++.+||+.+|++||+++|+++.|
T Consensus 226 ---~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ---ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 123578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.50 Aligned_cols=252 Identities=21% Similarity=0.276 Sum_probs=198.4
Q ss_pred eccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccCCC
Q 039322 444 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGS 522 (708)
Q Consensus 444 ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~ 522 (708)
||+|+||+||++.. .+++.||+|.+..... ......+.+..|++++++++|+||+++.+++..++..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL-KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHH-hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 69999999999965 4688999999865311 112234567889999999999999999999999999999999999999
Q ss_pred HHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcccc
Q 039322 523 LAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTE 601 (708)
Q Consensus 523 L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 601 (708)
|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||++............
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence 998875322 234589999999999999999999999 9999999999999999999999999999866544433444
Q ss_pred ccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHH
Q 039322 602 FAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISI 681 (708)
Q Consensus 602 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 681 (708)
..|++.|+|||++.+..++.++||||+|+++|||++|+.||....... ................ ....+..+
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~----~~~~~~~~ 228 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQRILNDSVTY----PDKFSPAS 228 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch----hHHHHHHhhcccCCCC----cccCCHHH
Confidence 578999999999999999999999999999999999999987432110 0011111111111111 11233457
Q ss_pred HHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 039322 682 MEVAFSCLNESPESRP-----TMKVVTQQVR 707 (708)
Q Consensus 682 ~~li~~cl~~dP~~RP-----s~~evl~~l~ 707 (708)
.+++.+||+.||++|| +++++++|-+
T Consensus 229 ~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~ 259 (280)
T cd05608 229 KSFCEALLAKDPEKRLGFRDGNCDGLRTHPL 259 (280)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHhcChh
Confidence 8899999999999999 7888887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=323.02 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=204.6
Q ss_pred ccccccceeccccCccEEEEEeCC------CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPS------GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
++|++.+.||+|+||.||+|.... ...||+|.+.... .......+.+|++.+++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 578999999999999999996532 2579999987532 2234567899999999999999999999999999
Q ss_pred eeEEEEEeccCCCHHHHhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC
Q 039322 510 HSFLVYELLERGSLAAILSSDTA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD 576 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~ 576 (708)
..+++|||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +++||||||+||+++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVG 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEc
Confidence 99999999999999999965421 13478899999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccc
Q 039322 577 LEYEAHVADFGIAKFLKPESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSL 653 (708)
Q Consensus 577 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~ 653 (708)
+++.++|+|||++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~------ 232 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN------ 232 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence 999999999999976533221 1233456788999999988889999999999999999998 9999863221
Q ss_pred ccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 NTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+........+ ...+.++.+++.+||+.||++||+++||+++|+
T Consensus 233 --~~~~~~i~~~~~~~~~---~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 233 --QEVIEMIRSRQLLPCP---EDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281 (283)
T ss_pred --HHHHHHHHcCCcCCCc---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence 1111122222221111 223456889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=299.27 Aligned_cols=259 Identities=23% Similarity=0.356 Sum_probs=222.0
Q ss_pred HHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcch----hHhHHHHHHHHHHHHhc-cCCceeeEEEEEe
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQ----IADQKEFLIEVKALTEI-RHRNIVKFYGFCS 506 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~ 506 (708)
...+.|...+.+|.|..++|-+..+ ++|..+|+|++........ .+-.++-.+|+.+++++ .||+|+.+.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3446788888999999999988844 4688999999865332222 22245677899999999 5999999999999
Q ss_pred eCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeec
Q 039322 507 HARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADF 586 (708)
Q Consensus 507 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 586 (708)
.+...++|+|.|+.|-|.|++... ..++++...+|++|+.+|++|||.. +||||||||+|||++++.++||+||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 999999999999999999999654 4489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCcccccc------CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 039322 587 GIAKFLKPESSNWTEFAGTYGYVAPELAYT------MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALD 660 (708)
Q Consensus 587 g~a~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 660 (708)
|+|+...+ +......+||++|.|||.+.. ..|+..+|.||.|+++|.|+.|..||+.- .....++
T Consensus 168 GFa~~l~~-GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--------kQmlMLR 238 (411)
T KOG0599|consen 168 GFACQLEP-GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--------KQMLMLR 238 (411)
T ss_pred ceeeccCC-chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--------HHHHHHH
Confidence 99998864 456677899999999998753 35788999999999999999999999731 2234567
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 661 EILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
-++.++....+..+.+......+||.+|++.||.+|.|++|+++|-
T Consensus 239 ~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 239 MIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred HHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 7788888888888888888999999999999999999999999874
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=324.11 Aligned_cols=249 Identities=33% Similarity=0.539 Sum_probs=193.0
Q ss_pred ccceeccccCccEEEEEeC-----CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 440 AQYCIGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 440 ~~~~ig~G~~g~vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
..+.||.|.||.||+|.+. .+..|+||.++.. ......+.+.+|++.+++++||||++++|++...+..++|
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeeccccccccccccccccccccccccccccc
Confidence 4578999999999999765 3568999999652 2234578899999999999999999999999988889999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
+||+++|+|.+++.... ...+++.++..|+.||++||+|||++ +++|+||+++||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EE--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred ccccccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 99999999999998762 24589999999999999999999999 999999999999999999999999999987632
Q ss_pred CCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 595 ESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 595 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
.... .........|+|||.+....++.++||||||+++||+++ |+.||..... ......+.+......+
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--------~~~~~~~~~~~~~~~~ 227 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--------EEIIEKLKQGQRLPIP 227 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--------HHHHHHHHTTEETTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccccccceec
Confidence 2221 233456789999999999889999999999999999999 7889764321 1112222222221111
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.. .+..+.+++.+||+.||++|||++++++.|
T Consensus 228 ~~---~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 DN---CPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TT---SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cc---hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11 233477899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=320.93 Aligned_cols=256 Identities=28% Similarity=0.496 Sum_probs=209.2
Q ss_pred HHhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
+...+|++.+.||+|+||.||+|...+++.+|+|.+... .......+..|+++++.++|+||+++++++...+..+
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD----DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc----chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence 445789999999999999999998878999999998763 2234567889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+||||+++|+|.+++.... ...+++.++..++.|++.|++|||+. |++||||+|+||+++.++.+||+|||.+...
T Consensus 79 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 79 IITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred EEEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhc
Confidence 9999999999999997643 34589999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
...........++..|+|||...+..++.++||||||+++|+|++ |+.||..... ......+......+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~ 226 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--------HEVYDQITAGYRMPCP 226 (261)
T ss_pred CCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHHhCCcCCCC
Confidence 443333333445678999999988889999999999999999998 8999864321 1111112211111111
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+..+.+++.+||+.||++|||++++++.|+
T Consensus 227 ---~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~ 259 (261)
T cd05148 227 ---AKCPQEIYKIMLECWAAEPEDRPSFKALREELD 259 (261)
T ss_pred ---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 122345789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=310.96 Aligned_cols=255 Identities=22% Similarity=0.277 Sum_probs=213.4
Q ss_pred ccccccceeccccCccEEEEEeCC-CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
..|+..+.||+|.-|+||+++..+ +..+|+|++.+... .......+...|-+||+.+.||.++.+|+.|+.++..|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l-~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL-ASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHH-hhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 678888999999999999997754 58999999987322 2234456788899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
||||+||+|....+++. .+.+++..++.++..|+-||+|||-. |||+|||||+|||+.++|++.|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999999887654 46699999999999999999999999 999999999999999999999999998753210
Q ss_pred ---------------------------------C-C----------------------CccccccccccccCccccccCC
Q 039322 595 ---------------------------------E-S----------------------SNWTEFAGTYGYVAPELAYTMK 618 (708)
Q Consensus 595 ---------------------------------~-~----------------------~~~~~~~~~~~y~aPE~~~~~~ 618 (708)
. . ......+||=.|.|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 0012356889999999999999
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC
Q 039322 619 ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698 (708)
Q Consensus 619 ~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 698 (708)
.+.++|+|+|||++|||+.|..||.. ....+.+..++...+..+... ..+....+||++.+.+||++|..
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG--------~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKG--------SNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCC--------CCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhc
Confidence 99999999999999999999999973 334556666666555444332 44567889999999999999998
Q ss_pred ----HHHHHHH
Q 039322 699 ----MKVVTQQ 705 (708)
Q Consensus 699 ----~~evl~~ 705 (708)
+.||.+|
T Consensus 382 ~~rGA~eIK~H 392 (459)
T KOG0610|consen 382 SKRGAAEIKRH 392 (459)
T ss_pred cccchHHhhcC
Confidence 8888776
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.97 Aligned_cols=249 Identities=25% Similarity=0.329 Sum_probs=197.0
Q ss_pred ccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHH---HhccCCceeeEEEEEeeCCeeEE
Q 039322 438 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKAL---TEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
|++.+.||+|+||.||+|.. .+++.||||++++... ......+.+..|++++ +.++||||+++++++..++..|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI-IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence 56788999999999999965 4689999999875211 1112344566666654 56679999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|..++.. ..+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++....
T Consensus 80 v~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 80 VMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999988854 2489999999999999999999999 99999999999999999999999999987544
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
..........|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.......+..
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~~~~~p~~- 223 (324)
T cd05589 153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--------EEVFDSIVNDEVRYPRF- 223 (324)
T ss_pred CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCCC-
Confidence 333334456789999999999988899999999999999999999999874321 11112222222211111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRP-----TMKVVTQQV 706 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l 706 (708)
....+.+++.+||+.||++|| ++.+++++-
T Consensus 224 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 224 ---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred ---CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 123577899999999999999 678887764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=307.55 Aligned_cols=265 Identities=23% Similarity=0.300 Sum_probs=205.3
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCc-eeeEEEEEeeCC---
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN-IVKFYGFCSHAR--- 509 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~l~~~~~~~~--- 509 (708)
...|+..+.||+|+||+||+|+. .+|+.||+|+++-.... ........+|+.++++++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence 45677778899999999999954 57899999999864322 113456789999999999999 999999998877
Q ss_pred ---eeEEEEEeccCCCHHHHhcccccc-cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEee
Q 039322 510 ---HSFLVYELLERGSLAAILSSDTAA-QELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVAD 585 (708)
Q Consensus 510 ---~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 585 (708)
..++|+||++. +|.+++...... +.++...+..+.+|++.|++|||++ +|+||||||+||+++++|.+||+|
T Consensus 88 ~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 88 GIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred ccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence 78999999976 999999765532 3467788999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------cc--c
Q 039322 586 FGIAKFLKPESSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS--------SL--N 654 (708)
Q Consensus 586 fg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~--------~~--~ 654 (708)
||+|+-+.-+...++..++|..|.|||++.+. .|+...||||+||+++||++++.-|......... .. .
T Consensus 164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 99999776555557778899999999998876 6899999999999999999999998754322100 00 0
Q ss_pred cccccccccCCC-----CCCCCchhH---HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 655 TDIALDEILDPR-----LPPPSRSVQ---EKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 655 ~~~~~~~~~~~~-----~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
.........+.+ ...+..... ....+..+++.+|++++|++|.|++.+++|
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000011111111 110000111 111367889999999999999999999886
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.23 Aligned_cols=255 Identities=23% Similarity=0.330 Sum_probs=199.2
Q ss_pred ceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 442 YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
+.||+|+||.||+|.. .+++.||+|++++... ........+..|..+++++ +||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV-NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 3699999999999965 4688999999975321 1223345688899999988 69999999999999999999999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 599 (708)
+|+|.+++... ..+++..+..++.|++.||+|||++ |++||||||+||+++.++.+||+|||++..........
T Consensus 80 ~g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 80 GGDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence 99999988644 3489999999999999999999999 99999999999999999999999999987533333333
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc-cccccccccCCCCCCCCchhHHHH
Q 039322 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN-TDIALDEILDPRLPPPSRSVQEKL 678 (708)
Q Consensus 600 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 678 (708)
....|++.|+|||++.+..++.++||||+||++|||++|+.||+........... .......+.......+.. ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~----~~ 229 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS----LS 229 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCC----CC
Confidence 4567899999999999988999999999999999999999999743321111100 111112222222222211 12
Q ss_pred HHHHHHHHhccCCCCCCCCC------HHHHHHHhh
Q 039322 679 ISIMEVAFSCLNESPESRPT------MKVVTQQVR 707 (708)
Q Consensus 679 ~~l~~li~~cl~~dP~~RPs------~~evl~~l~ 707 (708)
..+.+++.+|++.||++||+ ++++++|-+
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPF 264 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCC
Confidence 35788999999999999997 788887643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=334.49 Aligned_cols=247 Identities=22% Similarity=0.266 Sum_probs=198.3
Q ss_pred ceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccC
Q 039322 442 YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLER 520 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 520 (708)
+.||+|+||.||++.. .+|+.||+|++++... ........+..|+++++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999964 4789999999875321 1123345678899999999999999999999999999999999999
Q ss_pred CCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 039322 521 GSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH-DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599 (708)
Q Consensus 521 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 599 (708)
|+|.+++.... .+++..+..++.|++.||+|||+ . ||+||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (325)
T cd05594 80 GELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence 99999886543 48999999999999999999997 6 99999999999999999999999999987544333333
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHH
Q 039322 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLI 679 (708)
Q Consensus 600 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (708)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+.. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--------~~~~~~i~~~~~~~p~~----~~~ 221 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEEIRFPRT----LSP 221 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--------HHHHHHHhcCCCCCCCC----CCH
Confidence 445789999999999988999999999999999999999999863221 11111122222211111 123
Q ss_pred HHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 039322 680 SIMEVAFSCLNESPESRP-----TMKVVTQQVR 707 (708)
Q Consensus 680 ~l~~li~~cl~~dP~~RP-----s~~evl~~l~ 707 (708)
++.+++.+||++||++|+ +++++++|-+
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 254 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence 578899999999999996 8999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.22 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=197.3
Q ss_pred ceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 442 YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
+.||+|+||.||+|..+ +++.||+|++.+... ......+.+..|.+++..+ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI-LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999664 688999999875211 1122345677888888876 69999999999999999999999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 599 (708)
+|+|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..........
T Consensus 80 ~g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 80 GGDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred CchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence 999999886543 488999999999999999999999 99999999999999999999999999987543333334
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHH
Q 039322 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLI 679 (708)
Q Consensus 600 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (708)
....|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+.. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~~~~~~~~----~~~ 221 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILNDEVVYPTW----LSQ 221 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhcCCCCCCCC----CCH
Confidence 456789999999999988899999999999999999999999974321 11222222222222111 223
Q ss_pred HHHHHHHhccCCCCCCCCCH------HHHHHHhh
Q 039322 680 SIMEVAFSCLNESPESRPTM------KVVTQQVR 707 (708)
Q Consensus 680 ~l~~li~~cl~~dP~~RPs~------~evl~~l~ 707 (708)
.+.+++.+|++.||++||++ +++++|-+
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~ 255 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPF 255 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCC
Confidence 57889999999999999998 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=318.77 Aligned_cols=260 Identities=21% Similarity=0.312 Sum_probs=207.3
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|.. .+++.||||.++.... ........+..|+++++.++||||+++++++...+..++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 5789999999999999999965 4789999998764221 2234456789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccccc-ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 515 YELLERGSLAAILSSDTA-AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
+||+++|+|.+++..... ...+++..+..++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999999998854322 23478899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
..........++..|+|||.+.+..++.++|+||+|+++|||++|+.||..... ........+.....++ ..
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~--~~ 229 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLFSLCQKIEQCDYPP--LP 229 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc------cHHHHHHHHhcCCCCC--CC
Confidence 433333345688899999999888899999999999999999999999853211 0011111111111111 11
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+.+++.+||+.+|++||++.+|++.++
T Consensus 230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~ 263 (267)
T cd08228 230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK 263 (267)
T ss_pred hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHH
Confidence 2233456889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.26 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=197.7
Q ss_pred ceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 442 YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
+.||+|+||.||+|.. .+++.||+|++++... ........+..|+.++.++ +||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh-cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 4699999999999965 4688999999976321 1223455678888888777 79999999999999999999999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 599 (708)
+|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 80 GGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence 99999988644 3489999999999999999999999 99999999999999999999999999997543333333
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc-cccccccccCCCCCCCCchhHHHH
Q 039322 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN-TDIALDEILDPRLPPPSRSVQEKL 678 (708)
Q Consensus 600 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 678 (708)
....|+..|+|||++.+..++.++|||||||++|||++|+.||+........... .......+.......+. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----~~~ 229 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLS 229 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC----CCC
Confidence 4567899999999999989999999999999999999999999643221111111 01111122222222111 122
Q ss_pred HHHHHHHHhccCCCCCCCCC------HHHHHHHh
Q 039322 679 ISIMEVAFSCLNESPESRPT------MKVVTQQV 706 (708)
Q Consensus 679 ~~l~~li~~cl~~dP~~RPs------~~evl~~l 706 (708)
..+.+++.+||+.||++||+ +.++++|-
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp 263 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 263 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCC
Confidence 35778999999999999998 57887763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=328.06 Aligned_cols=263 Identities=23% Similarity=0.330 Sum_probs=202.7
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... ++..+|+|.+.... .....+.+.+|++++++++|+||+++++++..++..++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 368999999999999999999664 68889999887532 12345678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++.... .+++..+..++.|++.|++|||+.+ +++||||||+||+++.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 999999999999996543 4788999999999999999999752 79999999999999999999999999987553
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc---------ccccc---cccc
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS---------LNTDI---ALDE 661 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~---------~~~~~---~~~~ 661 (708)
.. ......++..|+|||++.+..++.++|||||||++|||++|+.||.......... ..... ....
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 156 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred hh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence 22 1233468899999999998889999999999999999999999987432110000 00000 0000
Q ss_pred ------ccCCCCCCC----------------CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 662 ------ILDPRLPPP----------------SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 662 ------~~~~~~~~~----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+...+. .........++.+++.+||++||++|||++|+++|-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 000000000 0000011245789999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=340.20 Aligned_cols=252 Identities=22% Similarity=0.322 Sum_probs=206.7
Q ss_pred hccccccceeccccCccEEEEEeCCC-cEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEE-ee----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSG-QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFC-SH---- 507 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~-~~---- 507 (708)
..++++.++|.+|||+.||.|....+ ..||+|++... +........+|+++|++|+ |+|||.+++.. ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 35788899999999999999976555 99999998752 4566788999999999996 99999999933 21
Q ss_pred --CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEee
Q 039322 508 --ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVAD 585 (708)
Q Consensus 508 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 585 (708)
..+.+|.||||.||.|-|++..+... .|++.++++|++++++|+++||.. .|+|||||||.+|||+..+++.||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 13578999999999999999866543 399999999999999999999986 45799999999999999999999999
Q ss_pred cccccccCCCC-Ccc--------ccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 039322 586 FGIAKFLKPES-SNW--------TEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL 653 (708)
Q Consensus 586 fg~a~~~~~~~-~~~--------~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~ 653 (708)
||.|+...... ... -...-|+.|+|||++. +...++|+|||||||+||-|+....||+..+
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------- 262 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------- 262 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------
Confidence 99998543322 111 1134689999999874 5678999999999999999999999998322
Q ss_pred ccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 654 NTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.-++++.++..++. +.....|..||+.||+.||.+||++-+|+..+
T Consensus 263 -----~laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 263 -----KLAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred -----ceeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 23455555554432 44566799999999999999999999998875
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=321.13 Aligned_cols=257 Identities=21% Similarity=0.375 Sum_probs=203.1
Q ss_pred HhccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH 507 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 507 (708)
+.++|++.+.||+|+||.||+|... +++.||+|++.... ......++.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4578999999999999999998643 35679999986421 22345678999999999999999999999999
Q ss_pred CCeeEEEEEeccCCCHHHHhccccc-------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc
Q 039322 508 ARHSFLVYELLERGSLAAILSSDTA-------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE 580 (708)
Q Consensus 508 ~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 580 (708)
++..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCC
Confidence 9999999999999999999865321 12367889999999999999999998 9999999999999999999
Q ss_pred EEEeecccccccCCCCCcc--ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccc
Q 039322 581 AHVADFGIAKFLKPESSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDI 657 (708)
Q Consensus 581 ~kl~Dfg~a~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 657 (708)
++|+|||++.......... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ..
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--------~~ 229 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------EQ 229 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HH
Confidence 9999999987554322211 12345678999999988889999999999999999999 7888863221 11
Q ss_pred ccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 ALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+............. .+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 230 ~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 230 VLRFVMEGGLLDKPDN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHcCCcCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1111122222111111 2235889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=307.92 Aligned_cols=251 Identities=27% Similarity=0.425 Sum_probs=215.3
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+-|++..++|+|+||+||+|.+ .+|..+|||++..+ .+.+++..|+.+|++++.|++|++||.+.....+|+|
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence 3477888999999999999955 46999999998753 4578899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
||||-.|+..|.+..++ +.+++.++..+++.-.+||+|||.. .-+|||||+.|||+..+|.+||+|||.|....+
T Consensus 107 MEYCGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred hhhcCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 99999999999997654 6699999999999999999999998 779999999999999999999999999987765
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.-.......||+.|||||++..-.|+.++||||+|+...||..|++||.....+.... .+....++.....
T Consensus 182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---------MIPT~PPPTF~KP 252 (502)
T KOG0574|consen 182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---------MIPTKPPPTFKKP 252 (502)
T ss_pred hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---------eccCCCCCCCCCh
Confidence 5455667899999999999999999999999999999999999999987543221111 1122333333445
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
..+..++-+++++|+-+.|++|-|+-++++|-
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 66677899999999999999999999999874
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=328.07 Aligned_cols=264 Identities=21% Similarity=0.290 Sum_probs=199.7
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +++.||+|++..... ......+.+|+++++.++||||+++++++..++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 368999999999999999999764 688999999875321 1223457789999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+. ++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 81 v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 81 VFEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred EEECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 999996 58888876543 3478899999999999999999999 99999999999999999999999999997554
Q ss_pred CCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc---------cccccc-----c
Q 039322 594 PESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS---------SLNTDI-----A 658 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~---------~~~~~~-----~ 658 (708)
..........+++.|+|||++.+ ..++.++||||+||++|||++|+.||......... ...... .
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 33333345678899999998765 45788999999999999999999999743211000 000000 0
Q ss_pred cccccCCCCC--CCCchhH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 659 LDEILDPRLP--PPSRSVQ-----EKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 659 ~~~~~~~~~~--~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......... .+..... .....+.+++.+|++.||++|||++|+++|=+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 0000000000 0000000 01235778999999999999999999998743
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=336.08 Aligned_cols=257 Identities=21% Similarity=0.270 Sum_probs=200.4
Q ss_pred cccccceeccccCccEEEEEe----CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCee
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~ 511 (708)
+|++.+.||+|+||.||++.. .+++.||+|++.+..........+.+..|+++++.+ +|++|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999864 358899999987532212223355688899999999 499999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999986543 488999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC-ccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 039322 592 LKPESS-NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 592 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
+..... ......|+..|+|||++.+. .++.++|||||||++|||+||+.||........ .......+.......
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~~~~~~~~~~~~~ 230 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT----QSEVSRRILKCDPPF 230 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC----HHHHHHHHhcCCCCC
Confidence 543322 22345789999999998765 478899999999999999999999963221100 001111111111111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRP-----TMKVVTQQVR 707 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~ 707 (708)
+. .....+.+++.+||+.||++|| +++++++|-+
T Consensus 231 ~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 231 PS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred CC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 11 1223577899999999999999 7889988754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=339.26 Aligned_cols=258 Identities=22% Similarity=0.258 Sum_probs=202.6
Q ss_pred HhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
..++|++.+.||+|+||.||+|... +++.||+|++.+.. .......+.+..|+++++.++||||+++++++.+++..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFE-MIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 3478999999999999999999654 68899999986421 011123455788999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+||||+++|+|.+++... .+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999998643 378888999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCC-ccccccccccccCccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 039322 593 KPESS-NWTEFAGTYGYVAPELAYTM----KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 593 ~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
..... ......|++.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.....
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~ 264 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMDHKN 264 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCCC
Confidence 43322 22345789999999988653 378899999999999999999999974321 111122222111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPES--RPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l~ 707 (708)
..........+..+.+++.+|++.+|++ |||++|+++|-+
T Consensus 265 ~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 265 SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 0000011112345788999999999998 999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.54 Aligned_cols=247 Identities=24% Similarity=0.315 Sum_probs=198.1
Q ss_pred ceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 442 YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
+.||+|+||.||+|... +++.||+|++++... ........+..|.+++..+ +||+|+++++++..++..|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 35899999999999654 578999999875311 1123345677888888866 79999999999999999999999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 599 (708)
+|+|.+++.... .+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 80 GGDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence 999999886543 488999999999999999999999 99999999999999999999999999997654333334
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHH
Q 039322 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLI 679 (708)
Q Consensus 600 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (708)
....|++.|+|||++.+..++.++||||+||++|||++|+.||+.... ......+.......+.. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~~~~i~~~~~~~p~~----~~~ 221 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--------DDLFESILHDDVLYPVW----LSK 221 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCCC----CCH
Confidence 456789999999999988899999999999999999999999974321 12222222222222111 123
Q ss_pred HHHHHHHhccCCCCCCCC-------CHHHHHHHhh
Q 039322 680 SIMEVAFSCLNESPESRP-------TMKVVTQQVR 707 (708)
Q Consensus 680 ~l~~li~~cl~~dP~~RP-------s~~evl~~l~ 707 (708)
++.+++.+|+++||++|| +++++++|-+
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~ 256 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence 577899999999999999 8889887743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=324.75 Aligned_cols=264 Identities=23% Similarity=0.313 Sum_probs=202.2
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|..+ +++.||+|++..... .....+.+.+|++++++++||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence 46889999999999999999764 688999999875322 123356788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||++++.+..+.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 79 FEYVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred EecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9999987776554322 3488999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cccc---------cc
Q 039322 595 ESS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS-------SLNT---------DI 657 (708)
Q Consensus 595 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-------~~~~---------~~ 657 (708)
... ......++..|+|||++.+..++.++||||+||++|||++|+.||......... .... ..
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 322 223456899999999998888999999999999999999999999743211000 0000 00
Q ss_pred ccccccCCCCCCCC----chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 ALDEILDPRLPPPS----RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+...... ......+..+.+++++|+++||++|||++|+++|=+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~ 286 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA 286 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 00000000000000 000112346889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=322.38 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=204.4
Q ss_pred cccccceeccccCccEEEEEeC---CCc--EEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP---SGQ--VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
.....+.||+|.||.||+|..- .|+ .||||.-+.+. ...+.+.|+.|..+|++++||||++++|.|.+ ...
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 3445668999999999999542 233 48889987653 33458889999999999999999999999987 467
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
|+|||.++.|-|..|++.++ ..++......+++||+.||+|||++ .+|||||..+|||+.+...||++|||+++.
T Consensus 466 WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence 99999999999999998665 4688899999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCcccc-ccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCC
Q 039322 592 LKPESSNWTE-FAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 592 ~~~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
++.+.++... ..-+..|||||.+.-.+++.++|||.||+++||++. |..||.+.. ....+..+.++...+
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk--------NsDVI~~iEnGeRlP 612 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK--------NSDVIGHIENGERLP 612 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc--------ccceEEEecCCCCCC
Confidence 8766554333 223579999999999999999999999999999996 999997432 223333444444433
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.+..++. .++.|+.+||++||.+||++.|+...|
T Consensus 613 ~P~nCPp---~LYslmskcWayeP~kRPrftei~~~l 646 (974)
T KOG4257|consen 613 CPPNCPP---ALYSLMSKCWAYEPSKRPRFTEIKAIL 646 (974)
T ss_pred CCCCCCh---HHHHHHHHHhccCcccCCcHHHHHHHH
Confidence 3333333 467788899999999999999988765
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=315.57 Aligned_cols=251 Identities=24% Similarity=0.423 Sum_probs=202.6
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
++|++.+.||+|+||.||.|...++..+|+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-----ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 5788899999999999999988777789999987532 12456899999999999999999999999989999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+.+|+|.+++.... ..+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+.....+
T Consensus 79 e~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 79 EYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 9999999999997543 2589999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 596 SSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 596 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
... .....++..|+|||+..+..++.++||||||+++|+|++ |+.||..... ......+...........
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~ 225 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------SETVEKVSQGLRLYRPHL 225 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHhcCCCCCCCCC
Confidence 221 112335678999999988889999999999999999998 9999863321 111111112111111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+.+++.+||+.+|++||++.++++.++
T Consensus 226 ---~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 ---ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 2346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=320.48 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=205.5
Q ss_pred hccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA 508 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 508 (708)
..+|.+.+.||+|+||.||+|... +++.||+|.++... ..+..+.+.+|++++++++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 357888999999999999999653 34789999987632 123457899999999999999999999999999
Q ss_pred CeeEEEEEeccCCCHHHHhcccc-----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC
Q 039322 509 RHSFLVYELLERGSLAAILSSDT-----------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL 577 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~ 577 (708)
+..++||||+++|+|.+++...+ ....+++.++..++.|++.|++|||++ +++||||||+||+++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~ 157 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGY 157 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcC
Confidence 99999999999999999997543 124578999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccccccCCCCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccc
Q 039322 578 EYEAHVADFGIAKFLKPESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLN 654 (708)
Q Consensus 578 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~ 654 (708)
++.+||+|||++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~------- 230 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN------- 230 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-------
Confidence 99999999999975432221 1123345688999999999999999999999999999998 9999863221
Q ss_pred cccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 655 TDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+.+.......... ..+..+.+++.+||+.||++||++.||++.|+
T Consensus 231 -~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 231 -EEVIECITQGRLLQRPR---TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -HHHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11122222222222111 12345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=328.98 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=198.7
Q ss_pred cccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccC-CceeeEEEEEeeCCeeEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH-RNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~~~~lv 514 (708)
+|++.+.||+|+||.||+|... +++.||+|++.+... ......+.+..|.+++..++| ++|+++++++...+..|+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence 5788899999999999999654 578999999875321 112345667889999999976 5688899999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... .+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 80 MEYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999999986543 478999999999999999999999 999999999999999999999999999875433
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.........|++.|+|||++.+..++.++||||+||++|||+||+.||..... ......+.......+..
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~~~~~~~-- 223 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHNVSYPKS-- 223 (324)
T ss_pred CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCCC--
Confidence 33333455789999999999998899999999999999999999999974321 11122222222221111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTM-----KVVTQQ 705 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 705 (708)
....+.+++.+||++||++||+. +++.+|
T Consensus 224 --~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 224 --LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred --CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 22357789999999999999976 677665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=316.20 Aligned_cols=253 Identities=21% Similarity=0.380 Sum_probs=204.1
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.++|++.+.||+|++|.||+|...+++.||+|.+... ....+.+.+|+.++++++|+||+++++++...+..+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-----TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-----chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 3689999999999999999998888889999997642 12356789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... ...+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 80 TEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 99999999999997543 24578999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 595 ESSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 595 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
.... .....++..|+|||+..++.++.++||||||+++|+|+| |+.||..... ......+......+...
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~ 227 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--------SDVMSALQRGYRMPRME 227 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--------HHHHHHHHcCCCCCCCC
Confidence 2211 122345678999999988889999999999999999998 9999863221 11111111111111111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+..+.+++.+||+.+|++||+++++.+.|+
T Consensus 228 ---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 259 (261)
T cd05072 228 ---NCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259 (261)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 12335788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=342.60 Aligned_cols=252 Identities=20% Similarity=0.218 Sum_probs=202.6
Q ss_pred ccccccceeccccCccEEEEEe-CC-CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PS-GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
..|.+.+.||+|++|.||+|.. .+ ++.||+|.+... .......+..|+++++.++||||+++++++..++..|+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 4589999999999999999954 34 677888876542 23345567889999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 514 VYELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
||||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999999999886432 234578999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 593 KPESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 593 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+......+.
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~~~~~~~~~~ 291 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQVLYGKYDPF 291 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCC
Confidence 43322 12345689999999999988899999999999999999999999863221 112222222222211
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
+.. ....+.+++.+||+.||++||++++++++
T Consensus 292 ~~~---~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 292 PCP---VSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred Ccc---CCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 111 22358889999999999999999999864
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=339.80 Aligned_cols=254 Identities=24% Similarity=0.330 Sum_probs=204.8
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|.+.+.||+|+||.||+|... +|+.||+|+++.... ........+..|++++..++|+||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM-IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH-hhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 46889999999999999999664 689999999875211 1113456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 80 MEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred EcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999999765 3488999999999999999999998 999999999999999999999999999986654
Q ss_pred CC-----------------------------CccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 039322 595 ES-----------------------------SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFL 645 (708)
Q Consensus 595 ~~-----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~ 645 (708)
.. .......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 33 1223456899999999999999999999999999999999999998743
Q ss_pred ccccccccccccccccccC--CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHhh
Q 039322 646 SLISSSSLNTDIALDEILD--PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT-MKVVTQQVR 707 (708)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~l~ 707 (708)
... .....+.. .....+... .....+.+++.+|+. ||++||+ ++|+++|-+
T Consensus 234 ~~~--------~~~~~i~~~~~~~~~p~~~--~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 234 TLQ--------ETYNKIINWKESLRFPPDP--PVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred CHH--------HHHHHHhccCCcccCCCCC--CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 211 11111111 111111111 023457889999997 9999999 999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=315.32 Aligned_cols=253 Identities=24% Similarity=0.429 Sum_probs=203.5
Q ss_pred ccccccceeccccCccEEEEEeCC----CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
++|++.+.||+|+||.||+|.++. ...||||.++... .......+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 678999999999999999997642 4579999987532 233456788999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++||||+++++|.+++.... ..+++..+++++.|++.|++|||+. +++||||+|+||++++++.++|+|||++..
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 81 MIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 99999999999999997644 3589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCcc--ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCC
Q 039322 592 LKPESSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 592 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
........ ....++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ....+.+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~ 227 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--------QDVIKAVEDGYRL 227 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence 65222221 12334578999999998889999999999999999998 9999853221 1111112111111
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+... ..+..+.+++.+||+.+|++||+++|++++|.
T Consensus 228 ~~~~---~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~ 263 (266)
T cd05033 228 PPPM---DCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263 (266)
T ss_pred CCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1111 22345889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=323.30 Aligned_cols=257 Identities=21% Similarity=0.245 Sum_probs=202.1
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
.|+..+.||+|+||.||++.. .+++.||+|++..... ........+.+|++++++++|+||+++++++..++..++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh-hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence 377889999999999999965 4688999999865221 11223456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 80 TLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred eccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999999886432 24589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhH
Q 039322 596 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQ 675 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (708)
.......|+..|+|||++.+..++.++||||+|+++|||++|+.||....... ........+...... ...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~----~~~ 226 (285)
T cd05605 156 -ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV----KREEVERRVKEDQEE----YSE 226 (285)
T ss_pred -CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh----HHHHHHHHhhhcccc----cCc
Confidence 22234568899999999988889999999999999999999999997422100 000011111111111 111
Q ss_pred HHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 039322 676 EKLISIMEVAFSCLNESPESRP-----TMKVVTQQVR 707 (708)
Q Consensus 676 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~ 707 (708)
.....+.+++.+||+.||++|| +++++++|-+
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcC
Confidence 2334578999999999999999 8999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=334.55 Aligned_cols=253 Identities=22% Similarity=0.304 Sum_probs=195.2
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|.. .+++.||+|++++... ........+..|++++.+++|++|+++++++.+++..++|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence 4788999999999999999965 4688999999875211 1122345788899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... .+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 80 MEFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred EcCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999996543 489999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC-----------------------------------ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCC
Q 039322 595 ESS-----------------------------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGK 639 (708)
Q Consensus 595 ~~~-----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~ 639 (708)
... ......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 012346899999999999988999999999999999999999
Q ss_pred CCCCccccccccccccccccccccC----CCCCCCCchhHHHHHHHHHHHHhccC--CCCCCCCCHHHHHHHhh
Q 039322 640 HPRDFLSLISSSSLNTDIALDEILD----PRLPPPSRSVQEKLISIMEVAFSCLN--ESPESRPTMKVVTQQVR 707 (708)
Q Consensus 640 ~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl~~l~ 707 (708)
.||..... ......+.. ..+++.. .. .....+++.+++. .++..||+++|+++|-+
T Consensus 234 ~Pf~~~~~--------~~~~~~i~~~~~~~~~p~~~-~~---s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~ 295 (363)
T cd05628 234 PPFCSETP--------QETYKKVMNWKETLIFPPEV-PI---SEKAKDLILRFCCEWEHRIGAPGVEEIKTNPF 295 (363)
T ss_pred CCCCCCCH--------HHHHHHHHcCcCcccCCCcC-CC---CHHHHHHHHHHcCChhhcCCCCCHHHHhCCCC
Confidence 99974321 111111111 1111111 11 1234556656433 34445799999998743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=309.04 Aligned_cols=263 Identities=25% Similarity=0.368 Sum_probs=203.3
Q ss_pred HhccccccceeccccCccEEEEE-eCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee-----
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH----- 507 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----- 507 (708)
....|...+.||+|+||.|+.|. ..+|+.||||++..+. ......++..+|+++++.++|+||+.+.+.+.-
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F--~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF--ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh--hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 34566667889999999999995 4579999999987543 334567789999999999999999999998865
Q ss_pred CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecc
Q 039322 508 ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFG 587 (708)
Q Consensus 508 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 587 (708)
-+..|+|+|+|+ .+|...++..+ .++......+.+|+.+||.|+|+. +|+|||+||+|++++.+..+||+|||
T Consensus 98 f~DvYiV~elMe-tDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 98 FNDVYLVFELME-TDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred cceeEEehhHHh-hHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 346899999995 49999997654 388899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCC--CCccccccccccccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------c-----
Q 039322 588 IAKFLKPE--SSNWTEFAGTYGYVAPELAY-TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS-------S----- 652 (708)
Q Consensus 588 ~a~~~~~~--~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-------~----- 652 (708)
+|+..... ....+..+.|..|.|||.+. ...|+.+.||||.||++.||++|+.-|.+....... +
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 99987542 33456778899999999654 567999999999999999999999999764322100 0
Q ss_pred ---cccccccccccCCCCCCCCch----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 653 ---LNTDIALDEILDPRLPPPSRS----VQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 653 ---~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
..........+......+... .+.......+|+.+|+..||.+|+|++|.++|
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 001111111111111111111 11122345688889999999999999999986
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=314.57 Aligned_cols=254 Identities=26% Similarity=0.385 Sum_probs=208.2
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+|.+.+.||+|++|.||+|.. .+++.|++|.+.... ......+.+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK--MNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhh--CCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence 477889999999999999965 468899999986422 12345678899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++++|.+++.... ...+++..++.++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 79 EYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred EeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999999997643 24588999999999999999999998 9999999999999999999999999999876554
Q ss_pred CCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhH
Q 039322 596 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQ 675 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (708)
........+++.|+|||+..+..++.++|+||||+++|+|++|+.||..... ............+....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~--- 223 (256)
T cd08529 155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILKIIRGVFPPVSQ--- 223 (256)
T ss_pred cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCcc---
Confidence 4444445688999999999988899999999999999999999999874321 11112222222222111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 676 EKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 676 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+.+++.+||+.+|++||++.+++++-+
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 255 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPS 255 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhhCCC
Confidence 23346889999999999999999999998744
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=316.98 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=201.7
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.+|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++..++..++|
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 6799999999999999999965 578899999986531 12345678899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.++++... .+++..+..++.|++.|++|||+. +++|||++|+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 85 MEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 99999999999986433 478999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC-
Q 039322 595 ESSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP- 670 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 670 (708)
.........++..|+|||.+. ...++.++||||+|+++|||++|+.||........ ...+......++
T Consensus 159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~ 230 (267)
T cd06646 159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--------LFLMSKSNFQPPK 230 (267)
T ss_pred cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--------heeeecCCCCCCC
Confidence 333333456888999999874 34477899999999999999999999853221100 001111111111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
..........+.+++.+||+.+|++|||++++++++
T Consensus 231 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 011112335688999999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=329.91 Aligned_cols=246 Identities=23% Similarity=0.298 Sum_probs=193.0
Q ss_pred ceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHH-HHHhccCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 442 YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVK-ALTEIRHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
+.||+|+||.||+|.. .+|+.||+|++.+.... .......+..|.. +++.++||||+++++++..++..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL-KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 3699999999999966 46899999998752111 1122344555554 5678899999999999999999999999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 599 (708)
+|+|.+++.... .+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++..........
T Consensus 80 ~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (323)
T cd05575 80 GGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153 (323)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence 999999986543 478999999999999999999999 99999999999999999999999999987543333333
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHH
Q 039322 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLI 679 (708)
Q Consensus 600 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (708)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+.......... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~----~~~ 221 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--------AEMYDNILNKPLRLKPN----ISV 221 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcCCCCCCCC----CCH
Confidence 456789999999999998899999999999999999999999874221 11112222222211111 134
Q ss_pred HHHHHHHhccCCCCCCCCCH----HHHHHHh
Q 039322 680 SIMEVAFSCLNESPESRPTM----KVVTQQV 706 (708)
Q Consensus 680 ~l~~li~~cl~~dP~~RPs~----~evl~~l 706 (708)
.+.+++.+|++.||++||++ .|++++-
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~il~~~ 252 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAKDDFLEIKNHV 252 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCCCCHHHHHcCC
Confidence 57889999999999999987 4776653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=326.62 Aligned_cols=245 Identities=26% Similarity=0.352 Sum_probs=192.1
Q ss_pred ceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 442 YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
+.||+|+||.||+|.. .+++.||+|+++..... .....+.+..|..++... +||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 3699999999999965 45788999998753211 112344556677776654 79999999999999999999999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 599 (708)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 80 gg~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 80 GGDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence 999999986543 488999999999999999999999 99999999999999999999999999998654333344
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHH
Q 039322 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLI 679 (708)
Q Consensus 600 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (708)
....|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+. . ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~-~---~~~ 221 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFDSILNDRPHFPR-W---ISK 221 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCC-C---CCH
Confidence 456789999999999988899999999999999999999999974321 1111112111111111 1 123
Q ss_pred HHHHHHHhccCCCCCCCCCHH-HHHHH
Q 039322 680 SIMEVAFSCLNESPESRPTMK-VVTQQ 705 (708)
Q Consensus 680 ~l~~li~~cl~~dP~~RPs~~-evl~~ 705 (708)
.+.+++.+||+.||++||++. ++.+|
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 467889999999999999875 66554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=332.16 Aligned_cols=262 Identities=25% Similarity=0.385 Sum_probs=196.5
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC-----Ce
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA-----RH 510 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~~ 510 (708)
+|++.+.||+|+||.||+|.. .+|+.||||++..... .......+.+|++++++++||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE--HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc--cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 478889999999999999965 4689999999875321 223445788999999999999999999988543 24
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.|+||||+. ++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 79 IYVVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 799999995 68999886543 489999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCC---ccccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cccccc-
Q 039322 591 FLKPESS---NWTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS-------SLNTDI- 657 (708)
Q Consensus 591 ~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-------~~~~~~- 657 (708)
....... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......... ......
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 5432221 2234578999999998865 57889999999999999999999999643211000 000000
Q ss_pred -----------ccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 -----------ALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 -----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+......+...........+.+++.+||+.||++|||++|+++|-+
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~ 292 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence 00000000000000001112345778999999999999999999998743
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=336.37 Aligned_cols=252 Identities=20% Similarity=0.264 Sum_probs=196.4
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
.|+..+.||+|+||.||+|.. .+++.||+|++..... ........+..|++++++++|+||+++++++.+++..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV-LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 578889999999999999954 5688999999875211 11234567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 81 DYIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999986543 478899999999999999999999 9999999999999999999999999997543110
Q ss_pred CC-----------------------------------------------ccccccccccccCccccccCCCCcchhHHHH
Q 039322 596 SS-----------------------------------------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSF 628 (708)
Q Consensus 596 ~~-----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 628 (708)
.. ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 0123468999999999988889999999999
Q ss_pred HHHHHHHHhCCCCCCccccccccccccccccccccC----CCCCCCCchhHHHHHHHHHHHHh--ccCCCCCCCCCHHHH
Q 039322 629 GVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD----PRLPPPSRSVQEKLISIMEVAFS--CLNESPESRPTMKVV 702 (708)
Q Consensus 629 G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~ev 702 (708)
||++|||++|+.||...... .....+.. ...+... ....++.+++.+ |+..+|..||+++|+
T Consensus 235 G~il~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~~~----~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPT--------ETQLKVINWENTLHIPPQV----KLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHH--------HHHHHHHccccccCCCCCC----CCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 99999999999999742211 11111111 1111111 112346677777 556677779999999
Q ss_pred HHHhh
Q 039322 703 TQQVR 707 (708)
Q Consensus 703 l~~l~ 707 (708)
++|-+
T Consensus 303 l~hp~ 307 (381)
T cd05626 303 KAHPF 307 (381)
T ss_pred hcCcc
Confidence 98743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=324.58 Aligned_cols=259 Identities=24% Similarity=0.390 Sum_probs=211.2
Q ss_pred HHHHHHHhccccccceeccccCccEEEEEeCC-CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEe
Q 039322 428 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCS 506 (708)
Q Consensus 428 ~~~~~~~~~~~~~~~~ig~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 506 (708)
+++++-.-.+..+.++||.|.||.||.|.|+. .-.||||.++. +.-+.++|..|..+|+.++|||+|+++|+|.
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-----DtMeveEFLkEAAvMKeikHpNLVqLLGVCT 333 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 333 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-----cchhHHHHHHHHHHHHhhcCccHHHHhhhhc
Confidence 34455455678889999999999999998764 55799999985 3456889999999999999999999999999
Q ss_pred eCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeec
Q 039322 507 HARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADF 586 (708)
Q Consensus 507 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 586 (708)
.+..+|||+|||.+|+|.+||.+... ..++.--.+.+|.||+.|++||.++ ++|||||.++|+|+.++..||++||
T Consensus 334 ~EpPFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADF 409 (1157)
T KOG4278|consen 334 HEPPFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADF 409 (1157)
T ss_pred cCCCeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeecc
Confidence 99999999999999999999987653 4567778899999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCccc-cccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC
Q 039322 587 GIAKFLKPESSNWT-EFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILD 664 (708)
Q Consensus 587 g~a~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 664 (708)
|+++++..+.+... ...-...|+|||-+....++.|+|||+||+++||+.| |-.||...+. ..+..++.
T Consensus 410 GLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl---------SqVY~LLE 480 (1157)
T KOG4278|consen 410 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------SQVYGLLE 480 (1157)
T ss_pred chhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH---------HHHHHHHh
Confidence 99999875544321 1223679999999999999999999999999999998 8888875332 11111111
Q ss_pred CCC-CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 665 PRL-PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 665 ~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+ ...++ .++..+++|++.||++.|.+||+++|+-+.++
T Consensus 481 kgyRM~~Pe---GCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 481 KGYRMDGPE---GCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred ccccccCCC---CCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 111 11112 23345888899999999999999999988764
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=327.62 Aligned_cols=250 Identities=22% Similarity=0.313 Sum_probs=199.6
Q ss_pred cccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv 514 (708)
+|++.+.||+|+||.||+|... +++.||+|++++... ........+..|..++..+ +|++|+++++++...+..++|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 5788899999999999999654 578999999876321 1122344567788888777 589999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... .+++.++..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 80 MEYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred EcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999999986543 488999999999999999999999 999999999999999999999999999975443
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.........|++.|+|||++.+..++.++|||||||++|||+||+.||+.... ......+.......+.
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------~~~~~~i~~~~~~~p~--- 222 (323)
T cd05616 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHNVAYPK--- 222 (323)
T ss_pred CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCC---
Confidence 33334456789999999999999999999999999999999999999974321 1222222222222221
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTM-----KVVTQQ 705 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 705 (708)
....++.+++.+|+++||++|++. .++.+|
T Consensus 223 -~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 223 -SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred -cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 123357889999999999999984 676654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=335.45 Aligned_cols=258 Identities=21% Similarity=0.259 Sum_probs=201.1
Q ss_pred HhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
..++|++.+.||+|+||.||+|... +++.||+|++.+... ........+.+|+.+++.++||||+++++++..++..+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 3578999999999999999999764 588999999864211 11223456788999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 999999999999999643 378899999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC-ccccccccccccCccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 039322 593 KPESS-NWTEFAGTYGYVAPELAYTM----KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 593 ~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
..... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+.+...
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~~~~~i~~~~~ 264 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VGTYSKIMDHKN 264 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCc
Confidence 43322 22355799999999998654 367899999999999999999999974321 111222222111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPES--RPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l~ 707 (708)
.............+.+++.+|+..+|.+ ||+++|+++|-+
T Consensus 265 ~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 265 SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 1110011122335678888999866654 899999998854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=308.46 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=198.8
Q ss_pred HHhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc--cCCceeeEEEEEeeCC-
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI--RHRNIVKFYGFCSHAR- 509 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~l~~~~~~~~- 509 (708)
....+....+.||+|.||.||+|.+. |+.||||+|... +...+.+|.++++.+ +|+||+.+++.-..+.
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr-------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR-------DERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEeccc-------chhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 34567889999999999999999995 889999999762 345677788887765 9999999998875543
Q ss_pred ---eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEccCCCCCeeeCCCCcE
Q 039322 510 ---HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD-----CFPPIVHQDISSKNLLLDLEYEA 581 (708)
Q Consensus 510 ---~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-----~~~~ivH~dlk~~Nill~~~~~~ 581 (708)
.+|||++|++.|||.|||.... ++....++++..+|.||++||.. ..|.|+|||||+.|||+..++.+
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 5799999999999999998754 89999999999999999999964 34789999999999999999999
Q ss_pred EEeecccccccCCCCC----ccccccccccccCccccccCC----C--CcchhHHHHHHHHHHHHh----C------CCC
Q 039322 582 HVADFGIAKFLKPESS----NWTEFAGTYGYVAPELAYTMK----I--TEKCDVYSFGVLVLEAIK----G------KHP 641 (708)
Q Consensus 582 kl~Dfg~a~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~----~--~~~~DvwslG~~l~ellt----g------~~p 641 (708)
-|+|+|+|........ .....+||.+|||||++...- + -..+||||||.++||+.- | +.|
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 9999999987765532 245678999999999986532 1 136999999999999984 2 345
Q ss_pred CCccccccccccccccccc----cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 642 RDFLSLISSSSLNTDIALD----EILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
|...-. .+...++..+ +...|.++..+ ...+.+..+.++++.||..+|..|-|+--+.+.|
T Consensus 436 yyd~Vp---~DPs~eeMrkVVCv~~~RP~ipnrW-~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 436 YYDVVP---SDPSFEEMRKVVCVQKLRPNIPNRW-KSDPALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred cccCCC---CCCCHHHHhcceeecccCCCCCccc-ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 542211 1111112112 22223333322 2235567899999999999999999987776654
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=317.41 Aligned_cols=255 Identities=22% Similarity=0.384 Sum_probs=201.7
Q ss_pred ccccccceeccccCccEEEEEe-----CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
.+|++.+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|++++++++||||+++++++..++.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 5788899999999999999964 246789999987532 22345678899999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHhccccc--------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC
Q 039322 511 SFLVYELLERGSLAAILSSDTA--------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD 576 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~ 576 (708)
.++||||+++|+|.+++..... ...+++.++..++.|++.||+|||++ +++||||||+||+++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIG 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEc
Confidence 9999999999999999853321 23478899999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccc
Q 039322 577 LEYEAHVADFGIAKFLKPESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSL 653 (708)
Q Consensus 577 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~ 653 (708)
+++.+||+|||++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~------ 232 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN------ 232 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------
Confidence 999999999999986543321 1223345678999999988889999999999999999998 9989863221
Q ss_pred ccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 NTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.............+... ..+..+.+++.+||+.||++||++.++.++|+
T Consensus 233 --~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 233 --QEVIEMVRKRQLLPCSE---DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred --HHHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 11111111111111111 12335788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.22 Aligned_cols=254 Identities=22% Similarity=0.281 Sum_probs=199.7
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|... +|+.||||++..... ........+.+|+++++.++||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM-LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 46889999999999999999654 689999999875211 1123345678899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 80 MEYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred ECCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999996543 489999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC--------------------------------------ccccccccccccCccccccCCCCcchhHHHHHHHHHHHH
Q 039322 595 ESS--------------------------------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAI 636 (708)
Q Consensus 595 ~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell 636 (708)
... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 110 001235899999999999888999999999999999999
Q ss_pred hCCCCCCccccccccccccccccccccCC--CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHHhh
Q 039322 637 KGKHPRDFLSLISSSSLNTDIALDEILDP--RLPPPSRSVQEKLISIMEVAFSCLNESPESRPT---MKVVTQQVR 707 (708)
Q Consensus 637 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~l~ 707 (708)
+|..||...... .....+... .+..+.. ......+.+++.+|+. +|.+|++ ++|+++|-+
T Consensus 234 ~G~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~ 298 (364)
T cd05599 234 VGYPPFCSDNPQ--------ETYRKIINWKETLQFPDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298 (364)
T ss_pred cCCCCCCCCCHH--------HHHHHHHcCCCccCCCCC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence 999999743221 111111111 1111110 0112356788889996 9999998 999988643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=332.69 Aligned_cols=255 Identities=20% Similarity=0.296 Sum_probs=197.4
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.+|++.+.||+|+||.||+|.. .+++.||+|... ...+.+|++++++++||||+++++++..++..++|
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 5799999999999999999954 568899999743 23467899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
+|++. ++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|.....
T Consensus 162 ~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 162 LPRYK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred EecCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 99995 6888888653 3478999999999999999999999 999999999999999999999999999975432
Q ss_pred CC-CccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc---------------------c
Q 039322 595 ES-SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS---------------------S 652 (708)
Q Consensus 595 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~---------------------~ 652 (708)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||-........ .
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 21 2233457899999999999888999999999999999999999886321110000 0
Q ss_pred cccccccccc---------cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 653 LNTDIALDEI---------LDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 653 ~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......... ..+...+........+.++.+++.+||+.||++|||++|++++-+
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 0000000000 000001111111233457889999999999999999999998754
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=331.55 Aligned_cols=257 Identities=21% Similarity=0.346 Sum_probs=201.9
Q ss_pred hccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSH 507 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~ 507 (708)
.++|.+.+.||+|+||.||+|... .+..||||+++... .....+.+.+|+++++++. ||||+++++++.+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 468899999999999999999652 13469999987532 2234567999999999996 9999999999999
Q ss_pred CCeeEEEEEeccCCCHHHHhccccc-------------------------------------------------------
Q 039322 508 ARHSFLVYELLERGSLAAILSSDTA------------------------------------------------------- 532 (708)
Q Consensus 508 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 532 (708)
.+..++||||+++|+|.+++.....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999998864310
Q ss_pred --------------------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCee
Q 039322 533 --------------------------------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLL 574 (708)
Q Consensus 533 --------------------------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil 574 (708)
...+++..+..++.|++.||+|||+. +++||||||+||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 12478888999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccc
Q 039322 575 LDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSS 651 (708)
Q Consensus 575 l~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~ 651 (708)
++.++.+||+|||++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--- 346 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--- 346 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh---
Confidence 999999999999999865433221 122346778999999988889999999999999999997 99998642110
Q ss_pred ccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 652 SLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+........ ....+..+.+++.+||+.||++|||+.+|.+.|+
T Consensus 347 ----~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 347 ----STFYNKIKSGYRMAK---PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred ----HHHHHHHhcCCCCCC---CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 000111111111111 1122346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=326.48 Aligned_cols=246 Identities=23% Similarity=0.300 Sum_probs=196.9
Q ss_pred ceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 442 YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
+.||+|+||.||+|... +++.||+|++++... ........+..|.+++..+ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI-LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999664 578999999875311 1123345677888888887 69999999999999999999999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 599 (708)
+|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 80 GGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence 999999886543 489999999999999999999999 99999999999999999999999999987543333333
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHH
Q 039322 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLI 679 (708)
Q Consensus 600 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (708)
....|++.|+|||++.+..++.++||||+||++|+|++|+.||..... ......+.......+. ....
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--------~~~~~~i~~~~~~~~~----~~~~ 221 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--------DELFQSILEDEVRYPR----WLSK 221 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCCCCCC----cCCH
Confidence 445689999999999999999999999999999999999999974321 1111122222221111 1223
Q ss_pred HHHHHHHhccCCCCCCCCCH-----HHHHHHh
Q 039322 680 SIMEVAFSCLNESPESRPTM-----KVVTQQV 706 (708)
Q Consensus 680 ~l~~li~~cl~~dP~~RPs~-----~evl~~l 706 (708)
.+.+++.+||+.||++||++ .+++++-
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~ 253 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKGHP 253 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhcCC
Confidence 57889999999999999999 8888763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=322.16 Aligned_cols=264 Identities=20% Similarity=0.305 Sum_probs=195.9
Q ss_pred ccccccceeccccCccEEEEEe-C-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc---cCCceeeEEEEEee---
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-P-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI---RHRNIVKFYGFCSH--- 507 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~~--- 507 (708)
.+|++.+.||+|+||.||+|.. . +++.||+|.++...... .....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC--CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 3688899999999999999965 2 46789999987533211 1234456677776665 69999999999852
Q ss_pred --CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEee
Q 039322 508 --ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVAD 585 (708)
Q Consensus 508 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 585 (708)
....++||||+. ++|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|
T Consensus 79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 79 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCCCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcc
Confidence 356899999996 599999865432 3478999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc--------ccc
Q 039322 586 FGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN--------TDI 657 (708)
Q Consensus 586 fg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~--------~~~ 657 (708)
||++...... .......+++.|+|||.+.+..++.++||||+||++|||++|+.||............ ...
T Consensus 154 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 154 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred ccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 9999865433 2334456899999999998888999999999999999999999999743221100000 000
Q ss_pred c-----c-ccccCCCCCCCC-chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 A-----L-DEILDPRLPPPS-RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~-----~-~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. . ..........+. .........+.+++.+|++.||++|||+.|+++|-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~ 289 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCC
Confidence 0 0 000000000000 001122345779999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=315.58 Aligned_cols=260 Identities=22% Similarity=0.324 Sum_probs=207.7
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|.+.+.||+|++|.||+|.. .+++.||||.+.... .......+.+.+|+++++.++|+||+++++++..++..+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD-LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehh-hhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 4688899999999999999964 578999999876521 12234456889999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 515 YELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
|||+++++|.+++.... ....+++..++.++.|++.|++|||+. |++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999999986422 234589999999999999999999999 99999999999999999999999999988665
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
..........++..|+|||++.+..++.++||||||+++|+|++|..||...... .......+.....++. .
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~--~ 229 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQCDYPPL--P 229 (267)
T ss_pred cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhhhcCCCCCC--C
Confidence 4433334456888999999998888999999999999999999999998632110 0111111111111111 1
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+.+++.+||+.||++||||.+|++.++
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~ 263 (267)
T cd08229 230 SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAK 263 (267)
T ss_pred cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHh
Confidence 1123446889999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=312.60 Aligned_cols=252 Identities=25% Similarity=0.478 Sum_probs=203.7
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++|+||+++++++...+..++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-----ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 36789999999999999999987778889999987532 2346688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++.... ...+++..+..++.|++.|++|||+. |++||||||+||++++++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 80 TELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 99999999999996544 34589999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCcc-ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCC
Q 039322 595 ESSNW-TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP-RLPPPS 671 (708)
Q Consensus 595 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 671 (708)
..... .....+..|+|||+..+..++.++||||||+++|||++ |+.||..... ......+... ..+.+
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~- 226 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQQVDQGYRMPCP- 226 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCC-
Confidence 22111 11223458999999988889999999999999999999 9999863221 1111111111 11111
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 227 ---~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~ 259 (261)
T cd05068 227 ---PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259 (261)
T ss_pred ---CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 122346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=309.29 Aligned_cols=257 Identities=26% Similarity=0.308 Sum_probs=196.4
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC-----
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR----- 509 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 509 (708)
-.|...+++|.|+||.||+|... +++.||||+...+... --+|+++|+.+.|||||++..+|....
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~--------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY--------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc--------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 46778899999999999999654 5789999998754322 225999999999999999999886432
Q ss_pred eeEEEEEeccCCCHHHHhccc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC-CcEEEeecc
Q 039322 510 HSFLVYELLERGSLAAILSSD-TAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE-YEAHVADFG 587 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg 587 (708)
...+|||||+. +|.++++.. ...++++...++-+.+||.+||+|||+. ||+||||||.|+|+|.+ |.+||||||
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCC
Confidence 34589999988 999998742 1235578888999999999999999998 99999999999999987 899999999
Q ss_pred cccccCCCCCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccccccc-
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS-------SLNTDIA- 658 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-------~~~~~~~- 658 (708)
.|+...++... .....|..|+|||.+.+. .|+.+.||||.||++.||+.|+.-|...+..... +.-..+.
T Consensus 172 SAK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 172 SAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred cceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99988765444 556788999999988875 5999999999999999999999999864432110 0000000
Q ss_pred ------cccccCCCCCCCCc---hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 659 ------LDEILDPRLPPPSR---SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 659 ------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
..+...+.+..... .......+..+++.+++.++|.+|.++.|++.|
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 00111122221110 112233467899999999999999999999875
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=313.35 Aligned_cols=252 Identities=23% Similarity=0.387 Sum_probs=201.8
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.+|.+.+.||+|++|.||+|... .++.||+|.+... ....+.+.+|++++++++|+||+++++++..++..+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 56888999999999999999654 5889999998752 22356788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 81 TEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 99999999999996543 24579999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCcc-ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 595 ESSNW-TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 595 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
..... .....+..|+|||.+.+..++.++||||||+++|||++ |..||+..... .....+........+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~- 227 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKGYRMERP- 227 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCCCCCC-
Confidence 32211 11223568999999988889999999999999999998 99998642211 111111110000111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+..+.+++.+||+.||++|||+.++.+.|+
T Consensus 228 --~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 260 (263)
T cd05052 228 --EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260 (263)
T ss_pred --CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 112345888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.21 Aligned_cols=244 Identities=25% Similarity=0.340 Sum_probs=196.1
Q ss_pred ceeccccCccEEEEEe----CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEe
Q 039322 442 YCIGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYEL 517 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 517 (708)
+.||+|+||.||++.. .+|+.||+|++.... ........+..|++++++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT--LKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHH--hhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 5699999999999854 358899999987521 1122345677899999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 039322 518 LERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS 597 (708)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 597 (708)
+++|+|.+++.... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 80 LRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 99999999986543 489999999999999999999999 999999999999999999999999999986554433
Q ss_pred ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHH
Q 039322 598 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEK 677 (708)
Q Consensus 598 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (708)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.......+.. .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--------~~~~~~i~~~~~~~p~~----~ 221 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--------KETMTMILKAKLGMPQF----L 221 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--------HHHHHHHHcCCCCCCCC----C
Confidence 34456789999999999888889999999999999999999999874321 11112222222221111 1
Q ss_pred HHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039322 678 LISIMEVAFSCLNESPESRPT-----MKVVTQQ 705 (708)
Q Consensus 678 ~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 705 (708)
...+.+++.+||++||++||+ +++++++
T Consensus 222 ~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 222 SPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 235778999999999999999 4556654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=336.76 Aligned_cols=254 Identities=20% Similarity=0.269 Sum_probs=197.4
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|.+.+.||+|+||.||+|.. .+++.||||++.+.. .......+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSE-MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH-HHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 4688899999999999999954 578999999986521 11123356788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 80 MEFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999996543 478899999999999999999999 999999999999999999999999999964321
Q ss_pred CCC-----------------------------------------------ccccccccccccCccccccCCCCcchhHHH
Q 039322 595 ESS-----------------------------------------------NWTEFAGTYGYVAPELAYTMKITEKCDVYS 627 (708)
Q Consensus 595 ~~~-----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 627 (708)
... ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 100 001246899999999999888999999999
Q ss_pred HHHHHHHHHhCCCCCCccccccccccccccccccccC--CCCCCCCchhHHHHHHHHHHHHhccCCCCCCC---CCHHHH
Q 039322 628 FGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD--PRLPPPSRSVQEKLISIMEVAFSCLNESPESR---PTMKVV 702 (708)
Q Consensus 628 lG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ev 702 (708)
+||++|||++|+.||...... .....+.. ..+..+. .......+.+++.+|+. +|.+| |++.|+
T Consensus 234 lGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSH--------ETYRKIINWRETLYFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHH--------HHHHHHHccCCccCCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 999999999999999643211 11111111 1111110 00112357788889997 66665 699999
Q ss_pred HHHhh
Q 039322 703 TQQVR 707 (708)
Q Consensus 703 l~~l~ 707 (708)
++|-+
T Consensus 303 l~hp~ 307 (377)
T cd05629 303 KSHPF 307 (377)
T ss_pred hcCCC
Confidence 98754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=340.81 Aligned_cols=256 Identities=24% Similarity=0.291 Sum_probs=204.1
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC---
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR--- 509 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--- 509 (708)
..++|.+.+.||+|+||.||+|.. .+|+.||||++..... .......+.+|+..+..++|+|++++.+.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 457999999999999999999954 5789999999875322 2344567889999999999999999988775432
Q ss_pred -----eeEEEEEeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEE
Q 039322 510 -----HSFLVYELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHV 583 (708)
Q Consensus 510 -----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl 583 (708)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 3679999999999999986532 234588999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCC--CccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 039322 584 ADFGIAKFLKPES--SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDE 661 (708)
Q Consensus 584 ~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 661 (708)
+|||+++.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--------~~~~~~ 256 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM--------EEVMHK 256 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHH
Confidence 9999998654321 122345789999999999998999999999999999999999999974221 111122
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 662 ILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
.......+.+. .....+.+++.+||+.||++||++.+++++
T Consensus 257 ~~~~~~~~~~~---~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGRYDPLPP---SISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCCCCCCCC---CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 22222211111 123458889999999999999999999876
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=316.72 Aligned_cols=254 Identities=25% Similarity=0.436 Sum_probs=202.2
Q ss_pred ccccccceeccccCccEEEEEe------CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
.+|.+.+.||+|+||.||++.. .++..+|+|.+... .....+.+.+|++++++++|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 6788999999999999999964 23456899998752 2234567899999999999999999999999999
Q ss_pred eeEEEEEeccCCCHHHHhcccc----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC
Q 039322 510 HSFLVYELLERGSLAAILSSDT----------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY 579 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~ 579 (708)
..++||||+++++|.+++.... ....+++.+++.++.|++.||+|||++ |++||||||+||++++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 9999999999999999996443 123489999999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccc
Q 039322 580 EAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTD 656 (708)
Q Consensus 580 ~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 656 (708)
.+||+|||++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||..... .
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--------~ 229 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------N 229 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------H
Confidence 9999999999865432211 122345678999999998889999999999999999998 8999863221 1
Q ss_pred cccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 657 IALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+........... .+.++.+++.+||+.||.+|||+.|+.+.|+
T Consensus 230 ~~~~~i~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~ 277 (288)
T cd05093 230 EVIECITQGRVLQRPRT---CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277 (288)
T ss_pred HHHHHHHcCCcCCCCCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 11122222221111111 2235889999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=323.81 Aligned_cols=245 Identities=25% Similarity=0.338 Sum_probs=192.4
Q ss_pred ceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 442 YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
+.||+|+||.||+|... +++.||||+++..... .......+..|..++... +||||+++++++.+++..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 36999999999999764 5789999998753211 112344566777777764 89999999999999999999999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 599 (708)
+|+|.+++... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..........
T Consensus 80 ~g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 80 GGDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence 99999998653 3478999999999999999999999 99999999999999999999999999987543333333
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHH
Q 039322 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLI 679 (708)
Q Consensus 600 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (708)
....|+..|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+. ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~~~~~~~----~~~~ 221 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--------EELFQSIRMDNPCYPR----WLTR 221 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCc----cCCH
Confidence 455789999999999988899999999999999999999999874221 1111111111111111 1223
Q ss_pred HHHHHHHhccCCCCCCCCCHH-HHHHH
Q 039322 680 SIMEVAFSCLNESPESRPTMK-VVTQQ 705 (708)
Q Consensus 680 ~l~~li~~cl~~dP~~RPs~~-evl~~ 705 (708)
.+.+++.+||+.||++||++. ++.+|
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 577889999999999999997 77654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=311.59 Aligned_cols=260 Identities=23% Similarity=0.340 Sum_probs=208.2
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|++|.||+|... +|+.||+|.++.... ......+.+.+|++++++++|++++++++++...+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 57899999999999999999765 789999998864221 2233467889999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 515 YELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
|||+++|+|.+++.... ....+++.+++.++.|++.|++|||+. |++||||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 99999999999986432 234578999999999999999999999 99999999999999999999999999988654
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
..........++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.......++.+
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~-- 229 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEKCDYPPLP-- 229 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHhhhhcCCCCCCC--
Confidence 433333445678899999999888899999999999999999999999853221 000111111111111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+.+++.+||+.+|++|||+.++++.++
T Consensus 230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~ 263 (267)
T cd08224 230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAK 263 (267)
T ss_pred hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHH
Confidence 1123446889999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=332.50 Aligned_cols=263 Identities=20% Similarity=0.259 Sum_probs=202.7
Q ss_pred HHHHHhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC
Q 039322 430 EIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA 508 (708)
Q Consensus 430 ~~~~~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 508 (708)
+.....++|++.+.||+|+||.||+|..+ +++.||+|++.+.. .......+.+.+|+.+++.++||||+++++++..+
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~-~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE-MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHH-hhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 34445689999999999999999999664 68899999986421 11122345678899999999999999999999999
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
+..++||||+++|+|.+++... .++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999999999999998643 378889999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC-ccccccccccccCccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 039322 589 AKFLKPESS-NWTEFAGTYGYVAPELAYTM----KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEIL 663 (708)
Q Consensus 589 a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 663 (708)
+........ ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+.
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~ 260 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIM 260 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHHHHHHH
Confidence 986643322 22345789999999998653 377899999999999999999999974321 11112222
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHhhC
Q 039322 664 DPRLPPPSRSVQEKLISIMEVAFSCLNESPES--RPTMKVVTQQVRI 708 (708)
Q Consensus 664 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l~~ 708 (708)
.................+.+++.+|+..++.+ ||+++|+++|.++
T Consensus 261 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 261 NHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred cCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 21100000011122345778888999854443 7899999998653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=332.22 Aligned_cols=254 Identities=22% Similarity=0.256 Sum_probs=201.2
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|.+.+.||+|+||.||+|.. .+|+.||+|+++.... ......+.+.+|+.+++.++|+||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 3688899999999999999965 4688999999875321 1123456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 80 MEYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred ECCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999999997652 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCc-cccccccccccCccccc------cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC-
Q 039322 595 ESSN-WTEFAGTYGYVAPELAY------TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPR- 666 (708)
Q Consensus 595 ~~~~-~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 666 (708)
.... .....|++.|+|||++. ...++.++|||||||++|||++|+.||...... .....+....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~~~ 226 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--------KTYNNIMNFQR 226 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH--------HHHHHHHcCCC
Confidence 3322 23356899999999986 455778999999999999999999999743211 1111111110
Q ss_pred -CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 667 -LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 667 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
...+. .......+.+++.+|++ +|++|||++++++|-
T Consensus 227 ~~~~~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 227 FLKFPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred ccCCCC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence 00000 01123357788899998 999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=326.84 Aligned_cols=246 Identities=23% Similarity=0.318 Sum_probs=191.6
Q ss_pred ceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHH-HHHhccCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 442 YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVK-ALTEIRHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
+.||+|+||.||+|.. .+++.||+|++.+... ........+..|.. +++.++||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI-LKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 3699999999999966 4688999999865211 11122344555554 5788999999999999999999999999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 599 (708)
+|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (321)
T cd05603 80 GGELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT 153 (321)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence 99999888643 3478899999999999999999999 99999999999999999999999999987543333333
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHH
Q 039322 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLI 679 (708)
Q Consensus 600 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (708)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+. ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~~~~----~~~~ 221 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--------SQMYDNILHKPLQLPG----GKTV 221 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--------HHHHHHHhcCCCCCCC----CCCH
Confidence 455789999999999988899999999999999999999999864221 1112222222222111 1233
Q ss_pred HHHHHHHhccCCCCCCCCCHH----HHHHHh
Q 039322 680 SIMEVAFSCLNESPESRPTMK----VVTQQV 706 (708)
Q Consensus 680 ~l~~li~~cl~~dP~~RPs~~----evl~~l 706 (708)
.+.+++.+|++.||++||++. |++++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~ 252 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAKADFLEIKNHV 252 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCCCCHHHHhCCC
Confidence 577899999999999999753 666554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=327.46 Aligned_cols=240 Identities=23% Similarity=0.273 Sum_probs=187.8
Q ss_pred ceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHH-HHHhccCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 442 YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVK-ALTEIRHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
+.||+|+||.||+|... +++.||+|++.+..... ......+..|.. +++.++|+||+++++++..++..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh-hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 36999999999999654 57889999987521111 112234444444 5678899999999999999999999999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 599 (708)
+|+|.+++.... .+.+..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~ 153 (325)
T cd05602 80 GGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT 153 (325)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence 999999986543 377888999999999999999999 99999999999999999999999999997543333334
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHH
Q 039322 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLI 679 (708)
Q Consensus 600 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (708)
....|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......+......... ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~~~~----~~~~ 221 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNKPLQLKP----NITN 221 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--------HHHHHHHHhCCcCCCC----CCCH
Confidence 456789999999999998999999999999999999999999864221 1111222222211111 1233
Q ss_pred HHHHHHHhccCCCCCCCCCHH
Q 039322 680 SIMEVAFSCLNESPESRPTMK 700 (708)
Q Consensus 680 ~l~~li~~cl~~dP~~RPs~~ 700 (708)
.+.+++.+|+++||.+||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAK 242 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCC
Confidence 578899999999999999876
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=337.16 Aligned_cols=254 Identities=19% Similarity=0.238 Sum_probs=197.0
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.+|++.+.||+|+||.||+|.. .+++.||||++.+... ......+.+.+|++++++++|+||+++++.+.+++..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV-LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH-HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 3688999999999999999965 4689999999865211 1112345688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+|..+..
T Consensus 80 ~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 80 MDYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999996543 478899999999999999999999 999999999999999999999999999753210
Q ss_pred CC-------------------------------------------CccccccccccccCccccccCCCCcchhHHHHHHH
Q 039322 595 ES-------------------------------------------SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVL 631 (708)
Q Consensus 595 ~~-------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~ 631 (708)
.. .......||+.|+|||++.+..++.++||||+||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 00112468999999999999889999999999999
Q ss_pred HHHHHhCCCCCCccccccccccccccccccccC--CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC---CHHHHHHHh
Q 039322 632 VLEAIKGKHPRDFLSLISSSSLNTDIALDEILD--PRLPPPSRSVQEKLISIMEVAFSCLNESPESRP---TMKVVTQQV 706 (708)
Q Consensus 632 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~~l 706 (708)
+|||++|+.||....... ....+.. .....+. .......+.+++.+|+ .+|++|+ ++.|+++|-
T Consensus 234 lyell~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~--~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~ 302 (376)
T cd05598 234 LYEMLVGQPPFLADTPAE--------TQLKVINWETTLHIPS--QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHP 302 (376)
T ss_pred eeehhhCCCCCCCCCHHH--------HHHHHhccCccccCCC--CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCC
Confidence 999999999997433211 0011111 0111110 0112234667777876 5999999 999999874
Q ss_pred h
Q 039322 707 R 707 (708)
Q Consensus 707 ~ 707 (708)
+
T Consensus 303 ~ 303 (376)
T cd05598 303 F 303 (376)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=311.44 Aligned_cols=249 Identities=27% Similarity=0.477 Sum_probs=200.2
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
.+|++.+.||+|+||.||+|..+++..+|+|.+.... .....+.+|++++++++|+||+++++++...+..++||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-----MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-----CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 4688999999999999999988777889999986532 12356888999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++++|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 79 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 79 EYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred ecCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 9999999999997543 2579999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCcc-ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCc
Q 039322 596 SSNW-TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP-RLPPPSR 672 (708)
Q Consensus 596 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 672 (708)
.... ....++..|+|||...+..++.++||||||+++|||++ |+.||+...... ....+... ....+
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~-- 223 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--------VVESVSAGYRLYRP-- 223 (256)
T ss_pred cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--------HHHHHHcCCcCCCC--
Confidence 2111 11223457999999998889999999999999999999 899986432111 11111111 11111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 224 --~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 --KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11234688999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=316.86 Aligned_cols=255 Identities=20% Similarity=0.328 Sum_probs=202.6
Q ss_pred ccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
.+|++.+.||+|+||.||+|... +++.||+|.++... .......+.+|+.++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 46788899999999999999653 25789999987532 1233567889999999999999999999999999
Q ss_pred eeEEEEEeccCCCHHHHhcccc-------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC
Q 039322 510 HSFLVYELLERGSLAAILSSDT-------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD 576 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~ 576 (708)
..++++||+.+++|.+++.... ....+++..+..++.|++.||+|+|++ |++||||||+||+++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEec
Confidence 9999999999999999985321 123478889999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccc
Q 039322 577 LEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSL 653 (708)
Q Consensus 577 ~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~ 653 (708)
+++.+||+|||+++........ .....+++.|+|||.+.++.++.++||||||+++|||++ |..||.....
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------ 232 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------ 232 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence 9999999999998865432221 123345679999999988889999999999999999998 8888763221
Q ss_pred ccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 NTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+.++...+.... .+..+.+++.+||+.+|++||++++|++.|+
T Consensus 233 --~~~~~~i~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 233 --QDVIEMIRNRQVLPCPDD---CPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred --HHHHHHHHcCCcCCCCCC---CCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 222233333332222122 2334788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=321.22 Aligned_cols=250 Identities=24% Similarity=0.449 Sum_probs=198.6
Q ss_pred ccccccceeccccCccEEEEEeC-CCc----EEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQ----VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
.+|+..+.||+|+||.||+|.+. +++ .||+|+++... .....+++..|+.+++.++||||++++|++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 57999999999999999999653 333 38999987421 223456788999999999999999999999765 5
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred ceeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence 679999999999999997543 3478999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcc--ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC--C
Q 039322 591 FLKPESSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILD--P 665 (708)
Q Consensus 591 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 665 (708)
......... ....++..|+|||++.+..++.++||||||+++|||++ |+.||+...... ...+.. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---------~~~~~~~~~ 228 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGE 228 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---------HHHHHhCCC
Confidence 765433222 22234678999999999899999999999999999998 999987432111 011111 1
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 666 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+.+.. ....+.+++.+||+.+|++||++.++++.+.
T Consensus 229 ~~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~ 266 (316)
T cd05108 229 RLPQPPI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFS 266 (316)
T ss_pred CCCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1111111 2235788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.18 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=199.7
Q ss_pred hccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSH 507 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~ 507 (708)
.++|++.+.||+|+||.||+|... +++.||+|+++... .....+.+..|+++++++ +|+||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 357999999999999999999532 35789999987532 123456788899999999 79999999998865
Q ss_pred C-CeeEEEEEeccCCCHHHHhccccc------------------------------------------------------
Q 039322 508 A-RHSFLVYELLERGSLAAILSSDTA------------------------------------------------------ 532 (708)
Q Consensus 508 ~-~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 532 (708)
+ ...+++|||+++|+|.+++.....
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 4 568899999999999999854221
Q ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCc--cccccccc
Q 039322 533 ----AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTY 606 (708)
Q Consensus 533 ----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~ 606 (708)
...+++..+.+++.||+.||+|||+. ||+||||||+||+++.++.++|+|||++..+...... .....++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 12579999999999999999999999 9999999999999999999999999999876433221 12334567
Q ss_pred cccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc-CCCCCCCCchhHHHHHHHHHH
Q 039322 607 GYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEIL-DPRLPPPSRSVQEKLISIMEV 684 (708)
Q Consensus 607 ~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l 684 (708)
.|+|||++.+..++.++|||||||++|||++ |..||...... ......+ .......+ .....++.++
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~---~~~~~~~~~l 308 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--------EEFCRRLKEGTRMRAP---EYATPEIYSI 308 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--------HHHHHHHhccCCCCCC---ccCCHHHHHH
Confidence 8999999999999999999999999999998 99998632110 0010111 11110000 1123458899
Q ss_pred HHhccCCCCCCCCCHHHHHHHhh
Q 039322 685 AFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 685 i~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+.+||+.+|++||++.|++++|+
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~ 331 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILG 331 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHH
Confidence 99999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=318.09 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=203.4
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.+|+..+.||+|++|.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC----cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 6788999999999999999964 468899999987532 23356788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++... .+++.++..++.|++.|++|||+. |++||||||+||+++.++.++|+|||.+.....
T Consensus 96 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred ecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 9999999999998643 378899999999999999999999 999999999999999999999999999886544
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.........+++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ........+... ....
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~--~~~~ 239 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYLIATNGTPE--LQNP 239 (296)
T ss_pred cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-------hHHHHhcCCCCC--CCCc
Confidence 3333344568899999999988888999999999999999999999986432110 000011111110 0111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
......+.+++.+||.++|++|||++|++++-
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~ 271 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence 12334578899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.39 Aligned_cols=246 Identities=23% Similarity=0.312 Sum_probs=193.4
Q ss_pred ceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 442 YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
+.||+|+||.||+|..+ +|+.||+|.++..... .......+..|.+++... +||+|+++++++.+++..|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 36999999999999664 6889999998753211 112345567778877754 89999999999999999999999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 599 (708)
+|+|.+++... ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 80 GGDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence 99999998654 3478999999999999999999999 99999999999999999999999999987543333334
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHH
Q 039322 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLI 679 (708)
Q Consensus 600 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (708)
....|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+. . ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--------~~~~~~~~~~~~~~~~-~---~~~ 221 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--------DELFESIRVDTPHYPR-W---ITK 221 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCC-C---CCH
Confidence 456789999999999998999999999999999999999999974321 1111111111111111 1 223
Q ss_pred HHHHHHHhccCCCCCCCCCH-HHHHHHh
Q 039322 680 SIMEVAFSCLNESPESRPTM-KVVTQQV 706 (708)
Q Consensus 680 ~l~~li~~cl~~dP~~RPs~-~evl~~l 706 (708)
++.+++.+||+.||++||++ +++.+|-
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~~h~ 249 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIRGHP 249 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHcCC
Confidence 57789999999999999998 4676553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=315.98 Aligned_cols=254 Identities=28% Similarity=0.475 Sum_probs=203.2
Q ss_pred ccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
.+|.+.+.||+|+||.||+|... ++..+++|.+... .....+.+.+|++++++++|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 57888999999999999999642 3456899998652 2344567899999999999999999999999999
Q ss_pred eeEEEEEeccCCCHHHHhcccc-------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC
Q 039322 510 HSFLVYELLERGSLAAILSSDT-------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD 576 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~ 576 (708)
..++||||+++++|.+++.... ....+++..++.++.|++.|++|||++ +++||||||+||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVG 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEc
Confidence 9999999999999999996543 123489999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccc
Q 039322 577 LEYEAHVADFGIAKFLKPESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSL 653 (708)
Q Consensus 577 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~ 653 (708)
.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------ 231 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN------ 231 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------
Confidence 999999999999975543221 1223446788999999998889999999999999999999 9999863221
Q ss_pred ccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 NTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+.+.......... ..+..+.+++.+||+.||++|||+++|++.|+
T Consensus 232 --~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 232 --TEVIECITQGRVLERPR---VCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280 (291)
T ss_pred --HHHHHHHhCCCCCCCCc---cCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 11111122222211111 12345889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=312.11 Aligned_cols=257 Identities=22% Similarity=0.322 Sum_probs=203.9
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcc-hhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCD-QIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
++|+..+.||+|++|.||.|.. .+++.||+|.+....... .....+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5688999999999999999965 468999999987532211 12234678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++....
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999986543 378899999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCcc---ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 594 PESSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 594 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
...... ....++..|+|||++.+..++.++||||+|+++|||++|+.||....... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~- 226 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA--------AIFKIATQPTNP- 226 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--------HHHHHhccCCCC-
Confidence 322111 23457789999999999889999999999999999999999986322110 000111110000
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.........+.+++.+||+.+|++|||+.|++++.++
T Consensus 227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 227 -QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0011223357889999999999999999999998653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=314.43 Aligned_cols=248 Identities=23% Similarity=0.289 Sum_probs=192.8
Q ss_pred eccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccCCC
Q 039322 444 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGS 522 (708)
Q Consensus 444 ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~ 522 (708)
||+|+||.||++.. .+|+.||+|.+...... .......+..|++++++++||||+++++++..+...++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLK-KKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhh-cchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 69999999999965 46899999998642111 11223456679999999999999999999999999999999999999
Q ss_pred HHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 039322 523 LAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEF 602 (708)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 602 (708)
|.+++.... ...+++..+..++.|++.|++|||+. |++||||||+||+++.++.++|+|||++...... ......
T Consensus 80 L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~ 154 (277)
T cd05607 80 LKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQR 154 (277)
T ss_pred HHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeecc
Confidence 998886443 23478999999999999999999999 9999999999999999999999999999866432 222345
Q ss_pred cccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHH
Q 039322 603 AGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIM 682 (708)
Q Consensus 603 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 682 (708)
.++..|+|||++.+..++.++||||+||++|||++|+.||...... ................... .....++.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 227 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK----VAKEELKRRTLEDEVKFEH---QNFTEESK 227 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch----hhHHHHHHHhhcccccccc---ccCCHHHH
Confidence 6889999999999888999999999999999999999998632110 0011111112222221111 11234578
Q ss_pred HHHHhccCCCCCCCCCHHHHHH
Q 039322 683 EVAFSCLNESPESRPTMKVVTQ 704 (708)
Q Consensus 683 ~li~~cl~~dP~~RPs~~evl~ 704 (708)
+++.+||++||++||+++|+++
T Consensus 228 ~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 228 DICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHHhccCHhhCCCCccchh
Confidence 9999999999999999966553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=308.87 Aligned_cols=255 Identities=23% Similarity=0.315 Sum_probs=208.3
Q ss_pred cccccceeccccCccEEEEE-eCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+|+..+.||+|+||.||.++ ..+++.+++|.+.... ........+.+|++++++++|+||+++++++.+.+..+++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR--LSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc--cchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence 47888999999999999995 4568899999986432 12344567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++|+|.+++.... ...+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 79 EYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred EecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999999997653 24579999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhH
Q 039322 596 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQ 675 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (708)
........+++.|+|||+..+..++.++||||+|+++|||++|+.||+.... ......+......+.. .
T Consensus 155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~~~---~ 223 (256)
T cd08221 155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------LNLVVKIVQGNYTPVV---S 223 (256)
T ss_pred cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCCCCCc---c
Confidence 4334456688999999999888889999999999999999999999863221 1122222222222221 2
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 676 EKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 676 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.....+.+++.+||+.+|++||+++|++++..+
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 223457889999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=326.52 Aligned_cols=245 Identities=23% Similarity=0.321 Sum_probs=192.2
Q ss_pred ceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHH-HHHhccCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 442 YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVK-ALTEIRHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
+.||+|+||.||+|.. .+|+.||+|++.+.... .......+..|.. +++.++||||+++++++..++..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 3589999999999965 46899999998753211 1223345555555 4677899999999999999999999999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 599 (708)
+|+|.+++... ..+++..+..++.||+.||+|||+. |++||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 153 (325)
T cd05604 80 GGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT 153 (325)
T ss_pred CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence 99999988643 3488999999999999999999999 99999999999999999999999999987543333334
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHH
Q 039322 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLI 679 (708)
Q Consensus 600 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (708)
....|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......+........+. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~~~~~~~~~~~~----~~~ 221 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--------AEMYDNILHKPLVLRPG----ASL 221 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--------HHHHHHHHcCCccCCCC----CCH
Confidence 456789999999999998899999999999999999999999874321 11112222222211111 223
Q ss_pred HHHHHHHhccCCCCCCCCCHH----HHHHH
Q 039322 680 SIMEVAFSCLNESPESRPTMK----VVTQQ 705 (708)
Q Consensus 680 ~l~~li~~cl~~dP~~RPs~~----evl~~ 705 (708)
.+.+++.+|++++|++||+++ ++++|
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence 477889999999999999875 55554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=334.06 Aligned_cols=252 Identities=19% Similarity=0.255 Sum_probs=194.5
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
.|+..+.||+|+||.||+|.. .+++.||+|++.+.. .........+.+|++++++++|+||+++++++.+++..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~-~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD-VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH-hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 578899999999999999965 568899999987521 111233567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 81 DYIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999986543 478899999999999999999999 9999999999999999999999999997532100
Q ss_pred C-----------------------------------------------CccccccccccccCccccccCCCCcchhHHHH
Q 039322 596 S-----------------------------------------------SNWTEFAGTYGYVAPELAYTMKITEKCDVYSF 628 (708)
Q Consensus 596 ~-----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 628 (708)
. .......||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 00112468999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCccccccccccccccccccccC--CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC---HHHHH
Q 039322 629 GVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD--PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT---MKVVT 703 (708)
Q Consensus 629 G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl 703 (708)
||++|||++|+.||...... .....+.. .....+. ......+..+++.+++ .+|++|++ ++|++
T Consensus 235 Gvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPL--------ETQMKVINWQTSLHIPP--QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHH--------HHHHHHHccCCCcCCCC--cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 99999999999999743211 11111111 1111110 0111223556666765 59999997 99988
Q ss_pred HHh
Q 039322 704 QQV 706 (708)
Q Consensus 704 ~~l 706 (708)
+|-
T Consensus 304 ~hp 306 (382)
T cd05625 304 AHP 306 (382)
T ss_pred cCC
Confidence 763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=323.27 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=197.7
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCeeEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lv 514 (708)
+|+..+.||+|+||.||+|.. .+|+.||+|++.+... ......+.+..|.+++..+. |++|+++.+++..++..++|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 467789999999999999965 4688999999875211 11223456778888888885 57888899999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... .+++.++..++.|++.||+|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 80 ~Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 80 MEYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999986543 489999999999999999999999 999999999999999999999999999875443
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.........|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+..
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~~~~p~~-- 223 (323)
T cd05615 154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHNVSYPKS-- 223 (323)
T ss_pred CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCcc--
Confidence 33333445689999999999988899999999999999999999999874321 12222222222221111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTM-----KVVTQQ 705 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 705 (708)
....+.+++.+|++++|++|++. +++.+|
T Consensus 224 --~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 224 --LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred --CCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 12357789999999999999974 556554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=310.18 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=203.8
Q ss_pred cccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+|++.+.||+|+||.||++... +++.||+|.++... .....+.+..|+.++++++|+||+++++++..++..++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence 4778899999999999999654 68899999986432 1234567888999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++|+|.+++.... ...+++..++.++.|++.|++|||++ +++|+||+|+||++++++.++++|||.+......
T Consensus 78 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 78 EYCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred eeCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 9999999999886433 23478999999999999999999999 9999999999999999999999999999866544
Q ss_pred CCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhH
Q 039322 596 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQ 675 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (708)
........++..|+|||++.+..++.++|+||+|+++|+|++|+.||..... ......+......+.+.
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~--- 222 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--------KNLILKVCQGSYKPLPS--- 222 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--------HHHHHHHhcCCCCCCCc---
Confidence 3333456688999999999888899999999999999999999999873221 11111111222211111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 676 EKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 676 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
.....+.+++.+||+.||++|||+.|++..
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 123357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=315.30 Aligned_cols=257 Identities=21% Similarity=0.357 Sum_probs=202.2
Q ss_pred HhccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH 507 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 507 (708)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... .......+.+|+.++++++|+||+++++++..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4578999999999999999999543 24579999986532 22345568899999999999999999999999
Q ss_pred CCeeEEEEEeccCCCHHHHhccccc-------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc
Q 039322 508 ARHSFLVYELLERGSLAAILSSDTA-------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE 580 (708)
Q Consensus 508 ~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 580 (708)
.+..++||||+++|+|.+++..... ....++..+..++.|++.||+|||++ +++||||||+||+++.++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCc
Confidence 9999999999999999999965321 23457788999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccc
Q 039322 581 AHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDI 657 (708)
Q Consensus 581 ~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 657 (708)
++|+|||+++........ .....++..|+|||.+.++.++.++|||||||++|||++ |..||..... ..
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--------~~ 229 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQ 229 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--------HH
Confidence 999999998855432221 122344678999999988889999999999999999998 7888763211 11
Q ss_pred ccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 ALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+.+.+........ .....+.+++.+||+.||++|||+.++++.++
T Consensus 230 ~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~ 276 (288)
T cd05061 230 VLKFVMDGGYLDQPD---NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276 (288)
T ss_pred HHHHHHcCCCCCCCC---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 222222222211111 11246889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=322.32 Aligned_cols=253 Identities=22% Similarity=0.300 Sum_probs=196.6
Q ss_pred ceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 442 YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
+.||+|+||.||+|.. .+++.||+|++++... ......+.+..|+.++.++ +||+|+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV-HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 3699999999999965 4678999999976321 1223456688899999888 69999999999999999999999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 599 (708)
+|+|.+++.... .+++..+..++.|++.||+|||++ |++||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 80 GGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence 999999886443 489999999999999999999999 99999999999999999999999999987543333333
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHH
Q 039322 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLI 679 (708)
Q Consensus 600 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (708)
....|++.|+|||++.+..++.++||||||+++|||++|+.||+........ .........+.......+.. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~p~~----~~~ 228 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-NTEDYLFQVILEKPIRIPRF----LSV 228 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc-ccHHHHHHHHHhCCCCCCCC----CCH
Confidence 4567899999999999989999999999999999999999999632211000 00011111222222211111 123
Q ss_pred HHHHHHHhccCCCCCCCCC------HHHHHHHh
Q 039322 680 SIMEVAFSCLNESPESRPT------MKVVTQQV 706 (708)
Q Consensus 680 ~l~~li~~cl~~dP~~RPs------~~evl~~l 706 (708)
.+.+++.+|+++||++||+ ++++.+|-
T Consensus 229 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~ 261 (327)
T cd05617 229 KASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT 261 (327)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence 4678999999999999998 46777663
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=343.71 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=200.0
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|... +|+.||+|+++.... ......+++.+|++++++++||||+++++++.+++..++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 57999999999999999999654 689999999976332 2223456799999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccc--------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeec
Q 039322 515 YELLERGSLAAILSSDT--------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADF 586 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 586 (708)
|||++||+|.+++.... .....++..++.++.||++||+|||++ ||+||||||+||+++.++.++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEec
Confidence 99999999999986421 123356778899999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCC------------------ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 039322 587 GIAKFLKPESS------------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLI 648 (708)
Q Consensus 587 g~a~~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~ 648 (708)
|++........ ......||+.|+|||++.+..++.++||||+||++|||+||+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99986521110 011246899999999999989999999999999999999999998642211
Q ss_pred cccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHh
Q 039322 649 SSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRP-TMKVVTQQV 706 (708)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~l 706 (708)
.. ........+.... .....+..+.+++.+|++.||++|| +++++.+.|
T Consensus 238 ki------~~~~~i~~P~~~~---p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L 287 (932)
T PRK13184 238 KI------SYRDVILSPIEVA---PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL 287 (932)
T ss_pred hh------hhhhhccChhhcc---ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 00 0000111111000 1112334578899999999999997 556665544
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=309.54 Aligned_cols=252 Identities=21% Similarity=0.387 Sum_probs=202.1
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.++|++.+.||+|+||.||+|..++++.||+|.+.... ...+.+.+|+.++++++|+||+++++++. .+..+++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-----MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-----CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 46789999999999999999988889999999987532 23457889999999999999999999874 4568999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++..... ..+++.++..++.|++.||+|||+. |++||||+|+||+++.++.++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 79 TEYMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999999999865442 4589999999999999999999998 999999999999999999999999999976653
Q ss_pred CCC-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 595 ESS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 595 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
... ......++..|+|||++.+..++.++||||||+++||+++ |+.||...... .....+......+...
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~ 226 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------EVIQNLERGYRMPRPD 226 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHHHcCCCCCCCC
Confidence 221 1123345678999999988889999999999999999999 99998633211 1111111111111111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+.++.+++.+||+.+|++|||++++.+.|+
T Consensus 227 ---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 227 ---NCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred ---CCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 12335889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=306.87 Aligned_cols=246 Identities=24% Similarity=0.396 Sum_probs=194.9
Q ss_pred eeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccCC
Q 039322 443 CIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERG 521 (708)
Q Consensus 443 ~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 521 (708)
.||+|+||.||+|.. .+++.||+|.+.... .......+.+|++++++++||||+++++++...+..++||||++++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 589999999999965 478899999886532 2234567899999999999999999999999999999999999999
Q ss_pred CHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc--
Q 039322 522 SLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW-- 599 (708)
Q Consensus 522 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-- 599 (708)
+|.+++.... ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++..........
T Consensus 79 ~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 79 DFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred cHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 9999996543 3478999999999999999999999 99999999999999999999999999987544221111
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCchhHHHH
Q 039322 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKL 678 (708)
Q Consensus 600 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (708)
.....+..|+|||.+.++.++.++||||||+++|||++ |..||...... .....+........ ....+
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------~~~~~~~~~~~~~~---~~~~~ 222 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------QTREAIEQGVRLPC---PELCP 222 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------HHHHHHHcCCCCCC---cccCC
Confidence 11223467999999998889999999999999999998 88888632211 00011101000011 11123
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 679 ISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 679 ~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+.+++.+||+.+|++|||+.++.+.|+
T Consensus 223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 46888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=316.83 Aligned_cols=258 Identities=30% Similarity=0.473 Sum_probs=203.0
Q ss_pred ccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEE
Q 039322 438 FDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYE 516 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 516 (708)
|++.+.||+|+||+||++... +++.||+|.+.... ...........|+.++++++||||+++++++.+.+..++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE--IEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT--HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc--ccccccchhhhhhhcccccccccccccccccccccccccccc
Confidence 677899999999999999665 56789999998642 122223344569999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 039322 517 LLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596 (708)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 596 (708)
|+++++|.+++.. ...+++..++.++.|+++||++||+. +++|+||||+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~ 152 (260)
T PF00069_consen 79 YCPGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN 152 (260)
T ss_dssp EETTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred ccccccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999972 24479999999999999999999999 99999999999999999999999999998653334
Q ss_pred CccccccccccccCccccc-cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhH
Q 039322 597 SNWTEFAGTYGYVAPELAY-TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQ 675 (708)
Q Consensus 597 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (708)
.......++..|+|||+.. +..++.++||||+|+++|+|++|..||...... ......................
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-----DQLEIIEKILKRPLPSSSQQSR 227 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-----HHHHHHHHHHHTHHHHHTTSHT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccch-----hhhhhhhhcccccccccccccc
Confidence 4455667899999999988 788999999999999999999999998743110 0011111111100000000000
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 676 EKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 676 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.....+.+++.+||+.||++||++.+++++-++
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 012568999999999999999999999987653
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=311.44 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=200.6
Q ss_pred HhccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH 507 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 507 (708)
..++|.+.+.||+|++|.||+|.+. .+..||+|.+.... .......+..|+.++++++|+||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 3477999999999999999999664 35679999886422 12334678899999999999999999999999
Q ss_pred CCeeEEEEEeccCCCHHHHhccccc----ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC---c
Q 039322 508 ARHSFLVYELLERGSLAAILSSDTA----AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY---E 580 (708)
Q Consensus 508 ~~~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~ 580 (708)
.+..++||||+++++|.+++..... ...+++..+.+++.||+.|++|||++ +++||||||+||+++.++ .
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcc
Confidence 9999999999999999999975532 12489999999999999999999999 999999999999998754 5
Q ss_pred EEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccc
Q 039322 581 AHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDI 657 (708)
Q Consensus 581 ~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 657 (708)
+||+|||+++........ ......+..|+|||++.+..++.++|||||||++|||++ |+.||+..... .
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--------~ 229 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--------E 229 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------H
Confidence 999999999865322211 112233568999999998889999999999999999997 99998742211 1
Q ss_pred ccccccC-CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 ALDEILD-PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+.. .+...+. ..+..+.+++.+||+.+|++|||+.+|+++|+
T Consensus 230 ~~~~~~~~~~~~~~~----~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 230 VMEFVTGGGRLDPPK----GCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHHcCCcCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111111 1111111 12345788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=307.29 Aligned_cols=245 Identities=26% Similarity=0.389 Sum_probs=193.5
Q ss_pred eeccccCccEEEEEe---CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 443 CIGNGGHGSVYRAEL---PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 443 ~ig~G~~g~vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
.||+|+||.||+|.+ .++..+|+|+++... ......+++..|+.+++.++|+||+++++++. .+..++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence 589999999999954 357889999987532 22334677899999999999999999999885 456789999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 599 (708)
+|+|.+++.... .+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+|||++..........
T Consensus 79 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 79 LGPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 999999996543 488999999999999999999999 99999999999999999999999999998664333221
Q ss_pred ---ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCchhH
Q 039322 600 ---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQ 675 (708)
Q Consensus 600 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (708)
....++..|+|||.+....++.++||||||+++|||++ |+.||...... .....+......+.+.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~i~~~~~~~~~~--- 221 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--------EVTQMIESGERMECPQ--- 221 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHCCCCCCCCC---
Confidence 12233578999999888888999999999999999998 99998743221 1111111111111111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 676 EKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 676 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+..+.++|.+||+.||++||++++|.+.|+
T Consensus 222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~ 253 (257)
T cd05116 222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLR 253 (257)
T ss_pred CCCHHHHHHHHHHhccCchhCcCHHHHHHHHh
Confidence 12345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=312.53 Aligned_cols=252 Identities=26% Similarity=0.376 Sum_probs=200.3
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|.+.+.||+|+||.||+|.. .+++.||+|.++... ......+.+|+.+++.++||||+++++++..++..++|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 5788899999999999999964 568899999987531 23345678899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++...+ .+++.+++.++.|++.|++|||+. |++|+||||+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 85 MEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred EeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 99999999999986543 488999999999999999999999 999999999999999999999999999876544
Q ss_pred CCCccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC-
Q 039322 595 ESSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP- 670 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 670 (708)
.........|+..|+|||++. ...++.++||||+||++|+|++|+.||........ ..........++
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--------~~~~~~~~~~~~~ 230 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--------LFLMTKSNFQPPK 230 (267)
T ss_pred cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--------HHhhhccCCCCCc
Confidence 333334557899999999874 45578899999999999999999999753221100 000000011000
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
.......+..+.+++.+||+.+|++||+++++++|
T Consensus 231 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00011123357889999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=306.26 Aligned_cols=245 Identities=24% Similarity=0.366 Sum_probs=192.1
Q ss_pred eeccccCccEEEEEeC---CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 443 CIGNGGHGSVYRAELP---SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 443 ~ig~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
.||+|+||.||+|.+. .+..||+|++.... .....+.+.+|+.++++++|+||+++++++.. +..++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCC
Confidence 3899999999999653 35579999987532 22345679999999999999999999998854 57899999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 599 (708)
+|+|.+++.... ..+++..+++++.|++.|++|||++ |++||||||+||+++.++.+||+|||++..........
T Consensus 78 ~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 78 GGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 999999986433 3589999999999999999999999 99999999999999999999999999998654332221
Q ss_pred ---ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCchhH
Q 039322 600 ---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQ 675 (708)
Q Consensus 600 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (708)
....++..|+|||.+.+..++.++||||||+++||+++ |+.||...... .....+........+ .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~---~ 221 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------EVMSFIEQGKRLDCP---A 221 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCCCCCCC---C
Confidence 11223578999999888889999999999999999996 99998743221 111111111111111 1
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 676 EKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 676 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....++.+++.+||..+|++||++.+|.+.|+
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~ 253 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 12345788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=319.47 Aligned_cols=263 Identities=17% Similarity=0.268 Sum_probs=200.1
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|.+.+.||+|+||.||+|..+ +++.||+|.++.... ......+.+|++++++++||||+++++++..++..++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc---CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 67899999999999999999654 678899999875321 12234577899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++ +|.+++.... ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 83 FEYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred EeCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 999975 8888876443 3478899999999999999999999 999999999999999999999999999976544
Q ss_pred CCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc----------------ccccc
Q 039322 595 ESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS----------------LNTDI 657 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~----------------~~~~~ 657 (708)
.........++..|+|||.+.+ ..++.++||||+|+++|||+||+.||.......... .....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 3333344567899999998765 457889999999999999999999996432110000 00000
Q ss_pred ccccccCCCCCCCC--chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 ALDEILDPRLPPPS--RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+...+.. ........++.+++.+|++.||++|||++|+++|-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 00000001100000 001112345789999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=308.70 Aligned_cols=252 Identities=28% Similarity=0.421 Sum_probs=205.8
Q ss_pred ccccccceeccccCccEEEEEeCC-CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|+..+.||+|+||.||+|...+ ++.||+|.+... ...+++.+|++++++++|+||+++++++..++..+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE------EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH------HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 678999999999999999997654 789999998652 1267899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
+||+.+++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 77 MEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred EecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 99999999999986433 4589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.........++..|+|||++.+..++.++||||||+++|+|++|+.||......... ..... .........
T Consensus 152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--------~~~~~-~~~~~~~~~ 222 (256)
T cd06612 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--------FMIPN-KPPPTLSDP 222 (256)
T ss_pred CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--------hhhcc-CCCCCCCch
Confidence 433334456788999999998888999999999999999999999998743221100 00000 001111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+.+++.+||+.||++|||++|++++=+
T Consensus 223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~ 255 (256)
T cd06612 223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255 (256)
T ss_pred hhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence 122346889999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=308.33 Aligned_cols=252 Identities=25% Similarity=0.433 Sum_probs=201.8
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.++|++.+.||+|+||.||+|..+++..||+|.++... ...+.+.+|+.++++++|++++++++++. .+..+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-----MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-----CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 36789999999999999999988888889999987532 12456899999999999999999999885 4567899
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 79 TEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 99999999999997543 24579999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 595 ESSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 595 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
.... .....++..|+|||...+..++.++||||||+++|+|++ |..||..... ......+......+.+
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~- 225 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------REVLEQVERGYRMPCP- 225 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCC-
Confidence 3221 122335668999999988889999999999999999999 8899864221 1111112111111111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+..+.+++.+||+++|++|||+.++.+.|+
T Consensus 226 --~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 258 (260)
T cd05070 226 --QDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258 (260)
T ss_pred --CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 122346889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=311.91 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=203.8
Q ss_pred hccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA 508 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 508 (708)
.++|.+.+.||+|+||.||+|... .+..||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 367889999999999999999653 24689999986532 234456788999999999999999999999999
Q ss_pred CeeEEEEEeccCCCHHHHhccccc-------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcE
Q 039322 509 RHSFLVYELLERGSLAAILSSDTA-------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEA 581 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 581 (708)
+..++||||+++|+|.+++..... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence 999999999999999999965432 12468899999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccc
Q 039322 582 HVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIA 658 (708)
Q Consensus 582 kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 658 (708)
||+|||+++........ .....++..|+|||.+.++.++.++||||||+++||+++ |+.||..... ...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~~~ 230 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--------EEV 230 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--------HHH
Confidence 99999999765433221 123346788999999988889999999999999999998 9999863221 111
Q ss_pred cccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 659 LDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+..........+... +..+.+++.+||+.+|++|||+.++++.|+
T Consensus 231 ~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 231 LKFVIDGGHLDLPENC---PDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHhcCCCCCCCCCC---CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111122111111111 346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=314.80 Aligned_cols=266 Identities=24% Similarity=0.378 Sum_probs=205.4
Q ss_pred chHHHHHHHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEE
Q 039322 426 LVYDEIVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYG 503 (708)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~ 503 (708)
..++++..+.++|++.+.||+|+||.||+|.. .+++.+|+|.+.... .....+..|+.+++++ +|+||+++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~ 82 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYG 82 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeee
Confidence 34556667789999999999999999999955 468899999876421 1235677899999999 6999999999
Q ss_pred EEe-----eCCeeEEEEEeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC
Q 039322 504 FCS-----HARHSFLVYELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL 577 (708)
Q Consensus 504 ~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~ 577 (708)
++. .++..++||||+++++|.+++.... ....+++..+..++.|++.|+.|||+. +++||||||+||+++.
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~ 159 (286)
T cd06638 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTT 159 (286)
T ss_pred eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECC
Confidence 884 3456899999999999999875322 234578999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccccccCCCCCccccccccccccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 039322 578 EYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYT-----MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS 652 (708)
Q Consensus 578 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~ 652 (708)
++.+||+|||++..............|+..|+|||++.. ..++.++||||+|+++|||++|+.||.........
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~- 238 (286)
T cd06638 160 EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL- 238 (286)
T ss_pred CCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH-
Confidence 999999999999876543333344568899999998753 44788999999999999999999998643211100
Q ss_pred cccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 653 LNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
........+....+ ......+.+++.+||+.||++|||+.|++++..+
T Consensus 239 ----~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 239 ----FKIPRNPPPTLHQP----ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ----hhccccCCCcccCC----CCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 00000000111111 1112358889999999999999999999998764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=310.27 Aligned_cols=260 Identities=23% Similarity=0.311 Sum_probs=201.0
Q ss_pred HHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
.+++.+.....||+|+||.||+|.. .+++.||+|.+... .....+.+.+|++++++++|+||+++++++..++..
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF 80 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence 3455666667899999999999964 46788999988653 223456789999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-CCcEEEeeccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL-EYEAHVADFGIAK 590 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~ 590 (708)
++|+||+++++|.+++.........++..+..++.|++.|++|||+. +++||||||+||+++. ++.++|+|||.+.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999999997543222237888999999999999999999 9999999999999976 6799999999997
Q ss_pred ccCCCCCccccccccccccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 039322 591 FLKPESSNWTEFAGTYGYVAPELAYTMK--ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
.............++..|+|||++.+.. ++.++||||+|+++|+|++|+.||........ ...........+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~ 231 (268)
T cd06624 158 RLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA------AMFKVGMFKIHP 231 (268)
T ss_pred ecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh------hHhhhhhhccCC
Confidence 6644333333456789999999986643 77899999999999999999999863221000 000000000111
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
. ........+.+++.+||+.+|++|||+.|++++-+|
T Consensus 232 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 232 E---IPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred C---CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0 011223457889999999999999999999988553
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=308.08 Aligned_cols=252 Identities=25% Similarity=0.418 Sum_probs=201.2
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.++|++.+.||+|+||.||+|...++..||+|.++... ...+.+.+|++++++++|+||+++++++.. +..++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-----~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-----cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence 36799999999999999999987777789999987522 124578899999999999999999998754 567999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 79 TEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred EEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 99999999999997543 23478999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 595 ESSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 595 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
.... .....++..|+|||+..+..++.++||||||+++|||+| |+.||..... .............+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~~~~~~~~~~~~~--- 223 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMP--- 223 (262)
T ss_pred cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HHHHHHHhcCCCCC---
Confidence 3322 122345678999999988889999999999999999999 8888863221 11111111111111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+..+.+++.+|+++||++||+++++++.|+
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~ 258 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 11223456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=314.22 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=200.9
Q ss_pred HHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeC--
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHA-- 508 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~-- 508 (708)
.+.+.|++.+.||+|+||.||+|.. .+++.||+|.+.... .....+..|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 77 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence 3567889999999999999999965 468899999986521 2345678899999998 699999999998753
Q ss_pred ----CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEe
Q 039322 509 ----RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVA 584 (708)
Q Consensus 509 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~ 584 (708)
...++||||+.+|+|.+++.... ...+++..+..++.|++.|++|||++ +++|+||+|+||+++.++.++|+
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 78 PGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred CCCCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEc
Confidence 46899999999999999987543 24578999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccc
Q 039322 585 DFGIAKFLKPESSNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIAL 659 (708)
Q Consensus 585 Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 659 (708)
|||++..............|+..|+|||++. ...++.++||||+||++|||++|+.||.......... ..
T Consensus 154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~~ 228 (272)
T cd06637 154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----LI 228 (272)
T ss_pred cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----HH
Confidence 9999986543333344567889999999876 3357789999999999999999999986322111000 00
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 660 DEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.......... ...+..+.+++.+||+.+|.+|||++|++++=++
T Consensus 229 ~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 229 PRNPAPRLKS-----KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred hcCCCCCCCC-----CCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0000011111 1122357889999999999999999999987543
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=311.59 Aligned_cols=254 Identities=25% Similarity=0.441 Sum_probs=201.3
Q ss_pred ccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
.+|...+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+++++.++|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 57888999999999999999532 3567999987652 2344568999999999999999999999999999
Q ss_pred eeEEEEEeccCCCHHHHhccccc------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC
Q 039322 510 HSFLVYELLERGSLAAILSSDTA------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL 577 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~ 577 (708)
..+++|||+++|+|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcC
Confidence 99999999999999999975432 13478999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccc
Q 039322 578 EYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLN 654 (708)
Q Consensus 578 ~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~ 654 (708)
++.+||+|||++......... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------- 230 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN------- 230 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-------
Confidence 999999999999755432211 122334678999999988889999999999999999998 8999853221
Q ss_pred cccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 655 TDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...............+. ..+..+.+++.+||+.||++||+++||++.|+
T Consensus 231 -~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 231 -TEAIECITQGRELERPR---TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -HHHHHHHHcCccCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11111111111111111 12235789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=315.05 Aligned_cols=257 Identities=22% Similarity=0.375 Sum_probs=202.7
Q ss_pred HhccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEe
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCS 506 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~ 506 (708)
..++|+..+.||+|+||.||+|... ....+|+|.+.... .......+.+|+++++++ +|+||+++++++.
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3467899999999999999999653 23679999987532 223456788999999999 7999999999999
Q ss_pred eCCeeEEEEEeccCCCHHHHhccc-------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCe
Q 039322 507 HARHSFLVYELLERGSLAAILSSD-------------TAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNL 573 (708)
Q Consensus 507 ~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Ni 573 (708)
.++..+++|||+++|+|.+++... .....+++..++.++.|++.|++|||+. +++||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 999999999999999999999643 2235689999999999999999999998 999999999999
Q ss_pred eeCCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccc
Q 039322 574 LLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISS 650 (708)
Q Consensus 574 ll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~ 650 (708)
+++.++.+||+|||+++.+...... .....++..|+|||+..+..++.++|||||||++|||++ |..||......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 241 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-- 241 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--
Confidence 9999999999999999866433221 112234578999999988889999999999999999997 99998632211
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 651 SSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..............+. .....+.+++.+||+.||++|||+.|+++.|.
T Consensus 242 ------~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~ 289 (293)
T cd05053 242 ------ELFKLLKEGYRMEKPQ---NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289 (293)
T ss_pred ------HHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence 1111111111111111 12335889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.04 Aligned_cols=253 Identities=23% Similarity=0.404 Sum_probs=201.4
Q ss_pred ccccccceeccccCccEEEEEeC----CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
.+|++.+.||+|+||.||+|... .+..+|+|.++... .....+.+..|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 57889999999999999999653 23479999987532 123456889999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++||||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 99999999999999997543 3579999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcc---ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 039322 592 LKPESSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 592 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
........ ....++..|+|||++.+..++.++||||||+++||+++ |+.||...... .....+.+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~~~ 227 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--------DVIKAIEEGYR 227 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--------HHHHHHhCCCc
Confidence 65432221 11223568999999998889999999999999999886 99998643211 11111111111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.. ...+..+.+++.+||+++|++||++.++++.|.
T Consensus 228 ~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 264 (267)
T cd05066 228 LPAP---MDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264 (267)
T ss_pred CCCC---CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence 1111 112345789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=315.76 Aligned_cols=252 Identities=26% Similarity=0.402 Sum_probs=203.6
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.+|+..+.||.|++|.||+|.. .+++.||+|.+... .....+.+.+|+++++.++|+|++++++++..++..++|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ----KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc----cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 5689999999999999999954 57899999998653 223356788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
+||+++++|.+++... .+++.++..++.|++.|++|||+. |++||||+|+||+++.++.+||+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 95 MEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999999998643 379999999999999999999999 999999999999999999999999999886654
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.........++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ....+..... +.....
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~--------~~~~~~~~~~-~~~~~~ 238 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------ALYLIATNGT-PELQNP 238 (296)
T ss_pred ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcCC-cccCCc
Confidence 4333344568889999999988889999999999999999999999987432110 0000100000 000011
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+.+++.+||..||++||++++++++=+
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~ 271 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 122335788999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=314.71 Aligned_cols=257 Identities=20% Similarity=0.258 Sum_probs=201.0
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
.|+..+.||+|+||.||+|.. .+++.||+|.+..... ........+..|+.++++++|++++++++.+...+..++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhc-cchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 366778899999999999955 4688999999865321 11223456778999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 80 TLMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999999985433 23588999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhH
Q 039322 596 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQ 675 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (708)
. ......|+..|+|||++.+..++.++||||+|+++|+|++|+.||....... ............... ...
T Consensus 156 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-----~~~~~~~~~~~~~~~---~~~ 226 (285)
T cd05630 156 Q-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-----KREEVERLVKEVQEE---YSE 226 (285)
T ss_pred c-cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-----hHHHHHhhhhhhhhh---cCc
Confidence 2 2234578999999999998889999999999999999999999997421100 000111111100000 001
Q ss_pred HHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 039322 676 EKLISIMEVAFSCLNESPESRPT-----MKVVTQQVR 707 (708)
Q Consensus 676 ~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~ 707 (708)
.....+.+++.+||+.||++||| ++|+++|-+
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 12335788999999999999999 899988754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.10 Aligned_cols=254 Identities=23% Similarity=0.348 Sum_probs=199.9
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......++..|++++++++||||+++++++..++..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence 3678889999999999999964 578899999986532 223456789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|..+. .+++..+..++.|++.|++|||+. |++|+||||+||+++.++.++|+|||++.....
T Consensus 78 ~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 78 TEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred EecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 9999999997652 367888999999999999999999 999999999999999999999999999976543
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
. ......++..|+|||++.+..++.++||||||+++|+|++|+.||......... .........+.++..+.. ..
T Consensus 148 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~~ 222 (279)
T cd06619 148 S--IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS-LMPLQLLQCIVDEDPPVL--PV 222 (279)
T ss_pred c--cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc-cchHHHHHHHhccCCCCC--CC
Confidence 2 223457889999999999888999999999999999999999998642211100 000011111111111110 01
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+.+++.+||+.+|++||+++|++++-+
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 112335789999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=314.01 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=203.6
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.+|++.+.||+|++|.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc----cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 7899999999999999999965 578999999986532 23356688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++... .+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred ecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 9999999999998643 378899999999999999999999 999999999999999999999999999986654
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.........+++.|+|||...+..++.++||||+|+++|+|++|+.||....... ........+.. .....
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~-------~~~~~~~~~~~--~~~~~ 238 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNGTP--ELQNP 238 (297)
T ss_pred CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch-------heeeeccCCCC--CCCCc
Confidence 4433344568889999999988889999999999999999999999986322110 00000011110 10111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
......+.+++.+||+.+|++||++++++++=
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP 270 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 12234577899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=320.11 Aligned_cols=196 Identities=25% Similarity=0.393 Sum_probs=172.0
Q ss_pred ccccccceeccccCccEEEE-EeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-C-----CceeeEEEEEeeC
Q 039322 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-H-----RNIVKFYGFCSHA 508 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~l~~~~~~~ 508 (708)
.+|.+.+.||+|+||.|.+| +.++++.||||+++.. ..-..+...|+.+|..++ | -|+|+++++|...
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 38899999999999999999 5567999999999863 233456677999999996 4 4899999999999
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC--CcEEEeec
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE--YEAHVADF 586 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~--~~~kl~Df 586 (708)
++.|||+|.+.. +|.++++.+.. ..++...++.++.||+.||.+||+. +|||+||||+|||+.+. ..+||+||
T Consensus 261 ~HlciVfELL~~-NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 261 NHLCIVFELLST-NLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred cceeeeehhhhh-hHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEec
Confidence 999999999966 99999988775 4489999999999999999999999 99999999999999654 36999999
Q ss_pred ccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 039322 587 GIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDF 644 (708)
Q Consensus 587 g~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~ 644 (708)
|.|++....-. ....+..|+|||++.+.+|+.+.||||||||++||++|.+-|..
T Consensus 336 GSSc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 336 GSSCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred ccccccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 99997654322 55678899999999999999999999999999999999887764
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=305.82 Aligned_cols=251 Identities=24% Similarity=0.408 Sum_probs=200.3
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
++|++.+.||+|++|.||+|...++..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence 5788999999999999999988777789999876521 22456888999999999999999999875 45678999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++|+|.+++.... ...+++..+..++.|++.||+|||+. |++|+||+|+||++++++.++|+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 80 EFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 9999999999997543 24478999999999999999999999 9999999999999999999999999999765433
Q ss_pred CCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 596 SSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 596 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
... .....++..|+|||...+..++.++||||||+++|||+| |+.||..... ......+......+.+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~-- 225 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--------REVLEQVERGYRMPCP-- 225 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC--
Confidence 221 122345678999999988889999999999999999999 8999864221 1111111111111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+..+.+++.+||++||++||++++|++.|+
T Consensus 226 -~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 258 (260)
T cd05069 226 -QGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258 (260)
T ss_pred -cccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 123346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=314.47 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=201.7
Q ss_pred hccccccceeccccCccEEEEEeCC-----------------CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCc
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPS-----------------GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 497 (708)
..+|++.+.||+|+||.||+|...+ +..||+|.+.... .....+.+.+|++++++++|+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCCCC
Confidence 3689999999999999999986532 2458999987642 2245678899999999999999
Q ss_pred eeeEEEEEeeCCeeEEEEEeccCCCHHHHhcccc--------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCC
Q 039322 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDT--------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDIS 569 (708)
Q Consensus 498 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk 569 (708)
|+++++++..++..+++|||+++++|.+++.... ....+++..++.++.|++.||+|||+. +++|||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlk 157 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLA 157 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccc
Confidence 9999999999999999999999999999996543 122589999999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCcc
Q 039322 570 SKNLLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK--GKHPRDFL 645 (708)
Q Consensus 570 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt--g~~p~~~~ 645 (708)
|+||+++.++.++|+|||+++........ .....++..|+|||++.++.++.++||||||+++|||++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 99999999999999999998765332211 223345678999999988889999999999999999998 66777532
Q ss_pred ccccccccccccccccc-cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 646 SLISSSSLNTDIALDEI-LDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 646 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..... ....... ...............+.++.+++.+||+.||++|||+.|+++.|+
T Consensus 238 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 238 TDQQV-----IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ChHHH-----HHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 21100 0000000 000000000001112246889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=307.71 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=216.8
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+=|+..+.||+|.|+.|-.|++ =+|+.||||++.+.. -+......+.+|++.|+-++|||||++|++.......|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTK--lD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTK--LDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccc--cchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 5677888899999999999954 479999999998732 2334567889999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-CCcEEEeecccccccC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL-EYEAHVADFGIAKFLK 593 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~ 593 (708)
+|.-.+|+|.||+-++.. .+.+....+++.||+.|+.|+|+. .||||||||+||.+-+ -|-|||.|||++-.+.
T Consensus 96 LELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999999977653 478899999999999999999999 8999999999998754 5889999999999887
Q ss_pred CCCCccccccccccccCccccccCCCCc-chhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITE-KCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
++ ...+..+|+..|-|||.+.+..|+. ++||||+|+|+|.|++|+.||+- .+..+.+-.++|-+...+..
T Consensus 171 PG-~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe--------ANDSETLTmImDCKYtvPsh 241 (864)
T KOG4717|consen 171 PG-KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE--------ANDSETLTMIMDCKYTVPSH 241 (864)
T ss_pred Cc-chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc--------ccchhhhhhhhcccccCchh
Confidence 54 4567789999999999999988874 79999999999999999999972 33456677788877765533
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+..+||.+|+..||++|.+.+||..+-|
T Consensus 242 ----vS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 242 ----VSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred ----hhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 3445889999999999999999999987655
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=322.56 Aligned_cols=262 Identities=22% Similarity=0.310 Sum_probs=198.0
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC---
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR--- 509 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--- 509 (708)
..++|++.+.||+|+||.||+|.. .+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ--NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc--chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 357899999999999999999965 4688999999875432 2234567889999999999999999999986543
Q ss_pred ---eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeec
Q 039322 510 ---HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADF 586 (708)
Q Consensus 510 ---~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 586 (708)
..|+||||+++ ++.+.+.. .+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence 47999999976 66666532 378899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cccc----
Q 039322 587 GIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS-------SLNT---- 655 (708)
Q Consensus 587 g~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-------~~~~---- 655 (708)
|+++..... .......++..|+|||++.+..++.++||||+||++|+|++|+.||......... ....
T Consensus 168 g~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 168 GLARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CCccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 999754322 2233457889999999999989999999999999999999999999743211000 0000
Q ss_pred ---ccccccccCCC--CC--------------CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 656 ---DIALDEILDPR--LP--------------PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 656 ---~~~~~~~~~~~--~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........... .+ ............+.+++.+||+.||++|||+.|+++|-+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 00000000000 00 000000011245789999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=307.89 Aligned_cols=254 Identities=22% Similarity=0.350 Sum_probs=195.9
Q ss_pred ccccceeccccCccEEEEEeCC-Cc--EEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC------
Q 039322 438 FDAQYCIGNGGHGSVYRAELPS-GQ--VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA------ 508 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------ 508 (708)
|.+.+.||+|+||.||+|...+ +. .||+|.++.... .....+.+..|+++++.++|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC--TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence 3567889999999999997643 32 689999875322 234467789999999999999999999987432
Q ss_pred CeeEEEEEeccCCCHHHHhcccc---cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEee
Q 039322 509 RHSFLVYELLERGSLAAILSSDT---AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVAD 585 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 585 (708)
...+++|||+++|+|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECC
Confidence 24689999999999999884322 223478999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccc
Q 039322 586 FGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEI 662 (708)
Q Consensus 586 fg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 662 (708)
||++......... .....+++.|+|||...+..++.++||||||+++|||++ |+.||...... ...+.+
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~ 227 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--------EIYDYL 227 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHH
Confidence 9999876433221 122345678999999998889999999999999999999 88898642211 111111
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 663 LDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......... .....+.+++.+||+.||++|||+.++++.|+
T Consensus 228 ~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 269 (272)
T cd05075 228 RQGNRLKQPP---DCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269 (272)
T ss_pred HcCCCCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1111111111 12335789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.65 Aligned_cols=262 Identities=21% Similarity=0.327 Sum_probs=199.6
Q ss_pred ccccccceeccccCccEEEEEeC-----------------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCce
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-----------------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI 498 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 498 (708)
++|++.+.||+|+||.||++... ++..||+|+++... .......+.+|++++++++|+||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCc
Confidence 57999999999999999998532 23469999987532 22345688999999999999999
Q ss_pred eeEEEEEeeCCeeEEEEEeccCCCHHHHhccccc--------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCC
Q 039322 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTA--------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISS 570 (708)
Q Consensus 499 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~ 570 (708)
+++++++..++..++||||+++|+|.+++..... ...+++.++..++.|++.|++|||+. +++||||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp 158 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLAT 158 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCh
Confidence 9999999999999999999999999999965431 12477889999999999999999999 999999999
Q ss_pred CCeeeCCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCccc
Q 039322 571 KNLLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK--GKHPRDFLS 646 (708)
Q Consensus 571 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt--g~~p~~~~~ 646 (708)
+||+++.++.++|+|||++..+...... .....++..|+|||...++.++.++|||||||++|||++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 9999999999999999999865433211 112234678999999888889999999999999999998 777875322
Q ss_pred cccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 647 LISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........ .............+... ..+..+.+++.+||+.||++||++.||++.|+
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 239 DEQVIENT-GEFFRDQGRQVYLPKPA---LCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred hHHHHHHH-HHHHhhccccccCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11100000 00000000000001111 12245889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=307.04 Aligned_cols=253 Identities=29% Similarity=0.423 Sum_probs=204.9
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|++|.||+|.. .+++.+++|.+.... ....+.+.+|++++++++||||+++++++..++..+++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 6789999999999999999965 457889999987532 22467889999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 ~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 79 MEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EeCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 99999999999986542 3488999999999999999999998 999999999999999999999999999986654
Q ss_pred CCCccccccccccccCccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC-C
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTM---KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP-P 670 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 670 (708)
.........++..|+|||.+.+. .++.++||||+|+++|||++|+.||....... .........+.+ .
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--------~~~~~~~~~~~~~~ 225 (262)
T cd06613 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--------ALFLISKSNFPPPK 225 (262)
T ss_pred hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhccCCCcc
Confidence 33333445678899999998776 78899999999999999999999986422110 000011110111 1
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
.......+.++.+++.+||+.+|.+|||+++++.+
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11122344568899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.82 Aligned_cols=256 Identities=23% Similarity=0.410 Sum_probs=203.4
Q ss_pred hccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA 508 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 508 (708)
.++|+..+.||+|+||.||+|..+ ++..||+|++.... .......+.+|+.++++++||||+++++++.++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 467999999999999999999753 46789999987532 223456789999999999999999999999999
Q ss_pred CeeEEEEEeccCCCHHHHhcccc-------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCC
Q 039322 509 RHSFLVYELLERGSLAAILSSDT-------------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDIS 569 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk 569 (708)
+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +++|||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~ 157 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLA 157 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence 99999999999999999996432 123478899999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccc
Q 039322 570 SKNLLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLS 646 (708)
Q Consensus 570 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~ 646 (708)
|+||+++.++.++|+|||++......... ......+..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999998755332211 122334678999999988889999999999999999997 888875322
Q ss_pred cccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 647 LISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. ......+.+....+... ..+.++.+++.+||+.||++|||+.|+++.|+
T Consensus 238 ~--------~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 238 H--------EEVIYYVRDGNVLSCPD---NCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred H--------HHHHHHHhcCCCCCCCC---CCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1 11222222222221111 12346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.91 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=197.4
Q ss_pred ccccccceeccccCccEEEEEeCC-Cc--EEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPS-GQ--VVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~ 511 (708)
++|++.+.||+|+||.||+|...+ +. .+++|.++... .....+.+.+|++++.++ +||||+++++++...+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA---SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC---CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 578899999999999999996643 33 47888876421 123356789999999999 799999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccc-------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC
Q 039322 512 FLVYELLERGSLAAILSSDT-------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE 578 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~ 578 (708)
++|+||+++|+|.+++.... ....+++..++.++.|++.|++|||++ |++||||||+||+++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGEN 155 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCC
Confidence 99999999999999996533 113478999999999999999999998 99999999999999999
Q ss_pred CcEEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccc
Q 039322 579 YEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDI 657 (708)
Q Consensus 579 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 657 (708)
+.+||+|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||..... ..
T Consensus 156 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--------~~ 226 (297)
T cd05089 156 LASKIADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--------AE 226 (297)
T ss_pred CeEEECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HH
Confidence 99999999998643211 11112233567999999988889999999999999999997 9999864321 11
Q ss_pred ccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 ALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.............+. .....+.+++.+||+.+|.+|||++++++.|+
T Consensus 227 ~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 273 (297)
T cd05089 227 LYEKLPQGYRMEKPR---NCDDEVYELMRQCWRDRPYERPPFAQISVQLS 273 (297)
T ss_pred HHHHHhcCCCCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111111111111111 12345789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=313.54 Aligned_cols=262 Identities=22% Similarity=0.261 Sum_probs=200.1
Q ss_pred cccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+|++.+.||+|++|.||+|... +++.||+|.++.... .....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence 4788899999999999999654 688999999875321 1223467888999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||++ ++|.+++........+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 9997 58998886654445689999999999999999999999 9999999999999999999999999999765433
Q ss_pred CCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------ccc--------cccc
Q 039322 596 SSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS--------SLN--------TDIA 658 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~--------~~~--------~~~~ 658 (708)
........+++.|+|||.+.+. .++.++||||||+++|+|+||+.||......... ... ....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 3333344678899999987654 4688999999999999999999998632210000 000 0000
Q ss_pred cc----cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 659 LD----EILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 659 ~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. .+....... .......++.+++.+||+.||++|||+.+++++=+
T Consensus 235 ~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~ 284 (285)
T cd07861 235 YKNTFPKWKKGSLRS---AVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284 (285)
T ss_pred HHhhccccCcchhHH---hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence 00 000000000 00112345778999999999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.92 Aligned_cols=254 Identities=22% Similarity=0.387 Sum_probs=199.0
Q ss_pred cccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
+|++.+.||+|+||.||+|... ....+++|.+.... .......+.+|+.+++.++||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence 4778899999999999999642 23568899887532 12345678899999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHhcccc---------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCC
Q 039322 511 SFLVYELLERGSLAAILSSDT---------------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDIS 569 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk 569 (708)
.++++||+.+|+|.+++.... ....+++..++.++.|++.|++|||+. +++|||||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dik 154 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLA 154 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhh
Confidence 999999999999999986432 123478999999999999999999998 99999999
Q ss_pred CCCeeeCCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccc
Q 039322 570 SKNLLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLS 646 (708)
Q Consensus 570 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~ 646 (708)
|+||++++++.+||+|||+++........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||+...
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999865433221 122345678999999888889999999999999999998 999986322
Q ss_pred cccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 647 LISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. . ............ .......++.+++.+||+.+|++||+++|+++.|+
T Consensus 235 ~~--------~-~~~~~~~~~~~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~ 284 (290)
T cd05045 235 PE--------R-LFNLLKTGYRME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284 (290)
T ss_pred HH--------H-HHHHHhCCCCCC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 11 0 011111111000 00112346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=332.83 Aligned_cols=249 Identities=27% Similarity=0.461 Sum_probs=205.2
Q ss_pred cccccceeccccCccEEEEE-eCCCc----EEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 437 DFDAQYCIGNGGHGSVYRAE-LPSGQ----VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~-~~~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
..+..++||+|+||+||+|. .+.|+ +||+|++... ...+..+++..|+-+|.+++|||+++++|+|.... .
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~---t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF---TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc---CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 34566789999999999994 45544 6899998763 23345788999999999999999999999998876 7
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
.||++|++.|+|.|+++.++ ..+..+..+.|..|||+||.|||++ .+|||||.++|||+++...+||.|||+|+.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred HHHHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 79999999999999998766 4588899999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCccccc--cccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CC
Q 039322 592 LKPESSNWTEF--AGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP-RL 667 (708)
Q Consensus 592 ~~~~~~~~~~~--~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 667 (708)
..++...+... .-.+.|||=|.+....++.++|||||||.+||++| |..|++.....+.. +-+..+ ++
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~--------dlle~geRL 919 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP--------DLLEKGERL 919 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh--------HHHhccccC
Confidence 87765544333 33578999999999999999999999999999998 99999865432221 111121 23
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
+.++ ....+++.++.+||..|+..||+|+++...+
T Consensus 920 sqPp----iCtiDVy~~mvkCwmid~~~rp~fkel~~~f 954 (1177)
T KOG1025|consen 920 SQPP----ICTIDVYMVMVKCWMIDADSRPTFKELAEEF 954 (1177)
T ss_pred CCCC----CccHHHHHHHHHHhccCcccCccHHHHHHHH
Confidence 3332 3445688888999999999999999998765
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.48 Aligned_cols=259 Identities=22% Similarity=0.356 Sum_probs=202.1
Q ss_pred HHhccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEE
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFC 505 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~ 505 (708)
...++|.+.+.||+|+||.||+|.+. .++.||+|+++... .....+.+..|++++.++. ||||+++++++
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 34467888999999999999999753 34679999997632 1223457889999999997 99999999999
Q ss_pred eeCCeeEEEEEeccCCCHHHHhccccc-----------------------------------------------------
Q 039322 506 SHARHSFLVYELLERGSLAAILSSDTA----------------------------------------------------- 532 (708)
Q Consensus 506 ~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------- 532 (708)
..++..++||||+++|+|.++++..+.
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999965321
Q ss_pred ------------------------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCC
Q 039322 533 ------------------------------------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISS 570 (708)
Q Consensus 533 ------------------------------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~ 570 (708)
...+++..++.++.|++.||+|||+. +++||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence 12367788899999999999999998 999999999
Q ss_pred CCeeeCCCCcEEEeecccccccCCCCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccc
Q 039322 571 KNLLLDLEYEAHVADFGIAKFLKPESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSL 647 (708)
Q Consensus 571 ~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~ 647 (708)
+||+++.++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999986533221 1122356788999999988889999999999999999998 8999863221
Q ss_pred ccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 648 ISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. ......+........ .......+.+++.+||+.+|++||+++|+++.|+
T Consensus 348 ~--------~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 397 (401)
T cd05107 348 N--------EQFYNAIKRGYRMAK--PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397 (401)
T ss_pred h--------HHHHHHHHcCCCCCC--CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 1 111111111111000 0112346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=308.64 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=196.0
Q ss_pred ccccccceeccccCccEEEEEeC-CCc----EEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQ----VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
.+|++.+.||+|+||.||+|.+. +++ .+++|.+.... ......++..|+..+++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc---chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 57888999999999999999653 444 47778875321 12334577888889999999999999998864 45
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++++||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||.++
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccce
Confidence 678999999999999997543 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CC
Q 039322 591 FLKPESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILD-PR 666 (708)
Q Consensus 591 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 666 (708)
...+... ......++..|+|||.+.++.++.++||||||+++||+++ |+.||....... ...++. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---------~~~~~~~~~ 228 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---------VPDLLEKGE 228 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---------HHHHHHCCC
Confidence 6543322 1233456778999999988889999999999999999998 999986432111 011111 11
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 667 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+.... ....+.+++.+||..||++|||+.|+++.|.
T Consensus 229 ~~~~~~~---~~~~~~~li~~c~~~~p~~Rps~~el~~~l~ 266 (279)
T cd05111 229 RLAQPQI---CTIDVYMVMVKCWMIDENVRPTFKELANEFT 266 (279)
T ss_pred cCCCCCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1111111 1234678899999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=307.90 Aligned_cols=254 Identities=22% Similarity=0.380 Sum_probs=199.3
Q ss_pred ccccceeccccCccEEEEEeCC----CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe---
Q 039322 438 FDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH--- 510 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~--- 510 (708)
|.+.+.||+|+||.||+|.... +..||+|.++.... .......+..|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 5678899999999999996532 36799999875321 22345678999999999999999999998866554
Q ss_pred ---eEEEEEeccCCCHHHHhcccc---cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEe
Q 039322 511 ---SFLVYELLERGSLAAILSSDT---AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVA 584 (708)
Q Consensus 511 ---~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~ 584 (708)
.++++||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEEC
Confidence 799999999999999985432 224589999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCcc--ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccccccc
Q 039322 585 DFGIAKFLKPESSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDE 661 (708)
Q Consensus 585 Dfg~a~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 661 (708)
|||+++......... ....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ....+.
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--------~~~~~~ 227 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--------HEIYDY 227 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHH
Confidence 999998664433221 12234678999999988889999999999999999999 8888864221 111222
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 662 ILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.........+. .....+.+++.+||+.||++|||+.|++++|+
T Consensus 228 ~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~ 270 (273)
T cd05035 228 LRHGNRLKQPE---DCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270 (273)
T ss_pred HHcCCCCCCCc---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 22222111111 22346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=308.44 Aligned_cols=251 Identities=27% Similarity=0.389 Sum_probs=204.3
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
..|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+..|++++++++|+||+++++++.+++..++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 45778889999999999999754 58899999987531 123456789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++... .+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 81 MEYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 9999999999998643 378899999999999999999999 999999999999999999999999999976654
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.........++..|+|||++.+..++.++||||||+++|||++|+.||....... ..... ....+ ....
T Consensus 154 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~-~~~~~--~~~~ 222 (277)
T cd06640 154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------VLFLI-PKNNP--PTLT 222 (277)
T ss_pred CccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------Hhhhh-hcCCC--CCCc
Confidence 3333334567889999999988889999999999999999999999986322110 00101 00101 1122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+..+.+++.+||+.+|++||++++++++-.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 234567889999999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.65 Aligned_cols=253 Identities=23% Similarity=0.378 Sum_probs=201.3
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+.|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++|+||+++++++..++..++|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 67899999999999999999664 5889999998752 334567788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|..++.... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 88 IEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 99999999998875433 3478999999999999999999998 999999999999999999999999999875443
Q ss_pred CCCccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 039322 595 ESSNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
.........++..|+|||++. ...++.++||||||+++|||++|+.||..... ......+.....+.
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~~~~ 234 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEPPT 234 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHHhcCCCcc
Confidence 333334556788999999885 34467799999999999999999999863221 11111111111110
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.........++.+++.+||+.+|++||+++|++++-
T Consensus 235 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 270 (292)
T cd06644 235 -LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHP 270 (292)
T ss_pred -CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 001112234578899999999999999999998863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.68 Aligned_cols=262 Identities=21% Similarity=0.328 Sum_probs=198.7
Q ss_pred ccccccceeccccCccEEEEEeCC---------------CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPS---------------GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 500 (708)
++|++.+.||+|+||.||++.... ...||+|.++... .......+.+|++++++++|+|+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 689999999999999999986532 2358999987532 1234567899999999999999999
Q ss_pred EEEEEeeCCeeEEEEEeccCCCHHHHhcccc---------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCC
Q 039322 501 FYGFCSHARHSFLVYELLERGSLAAILSSDT---------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSK 571 (708)
Q Consensus 501 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~ 571 (708)
+++++...+..++||||+++++|.+++.... ....+++..++.++.|++.|++|||+. +++||||||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~ 158 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR 158 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence 9999999999999999999999999986432 112368899999999999999999999 9999999999
Q ss_pred CeeeCCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh--CCCCCCcccc
Q 039322 572 NLLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK--GKHPRDFLSL 647 (708)
Q Consensus 572 Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt--g~~p~~~~~~ 647 (708)
||+++.++.+||+|||++......... .....++..|+|||...++.++.++||||||+++|+|++ |..||+....
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 999999999999999999765332211 122334678999999988889999999999999999998 5667653221
Q ss_pred ccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 648 ISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........ .............. ....+..+.+++.+||+.||++|||+++|++.|+
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQVIENTG-EFFRNQGRQIYLSQ---TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHH-HhhhhccccccCCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11000000 00000000000000 0012246889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.66 Aligned_cols=260 Identities=24% Similarity=0.341 Sum_probs=201.8
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|... ++..+|+|.+.... ......++.+|++++++++||||+++++++..++..++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence 36889999999999999999654 68889999986532 223456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++... ..+++..+..++.|+++||+|||+.+ +++||||+|+||+++.++.+||+|||++.....
T Consensus 78 ~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 78 MEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred eeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 9999999999999754 34789999999999999999999732 899999999999999999999999999875532
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccc------------------
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTD------------------ 656 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~------------------ 656 (708)
. ......++..|+|||...+..++.++||||||+++|+|++|+.||..............
T Consensus 153 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 153 S--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred c--ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 2 22345678999999998888899999999999999999999999863221100000000
Q ss_pred ----------cccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 657 ----------IALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 657 ----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+.......+ .........++.+++.+||+.+|++|||++|++++-+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPP--KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCc--cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 000000000000 0000112345889999999999999999999998865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=306.63 Aligned_cols=252 Identities=25% Similarity=0.487 Sum_probs=204.3
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.++|.+.+.||+|++|.||+|..++++.||||.+.... ...+.+.+|+.++++++|+||+++++++......++|
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence 46899999999999999999988788899999987532 2346788999999999999999999999998999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++.... ...+++..+..++.|++.|++|||++ +++|+||+|+||++++++.+||+|||.+.....
T Consensus 80 ~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 80 TEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999997643 24589999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCC
Q 039322 595 ESSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP-RLPPPS 671 (708)
Q Consensus 595 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 671 (708)
.... ......+..|+|||.+.+..++.++||||+|+++|++++ |+.||..... ......+... ..+.+.
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~ 227 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--------REVLEQVERGYRMPRPP 227 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCC
Confidence 2111 122234568999999998889999999999999999998 9999863221 1111111111 111111
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. .+..+.+++.+||+.+|++||+++++.+.|+
T Consensus 228 -~---~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 228 -N---CPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred -C---CCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 1 1345889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=302.43 Aligned_cols=245 Identities=24% Similarity=0.409 Sum_probs=196.4
Q ss_pred eeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccCCC
Q 039322 443 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGS 522 (708)
Q Consensus 443 ~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~ 522 (708)
.||+|+||.||+|...+++.||+|.++... .......+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 689999999999988888999999987532 12334568899999999999999999999999999999999999999
Q ss_pred HHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc-cc
Q 039322 523 LAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW-TE 601 (708)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~ 601 (708)
|.+++.... ..+++..+..++.|++.||.|+|+. |++||||+|+||+++.++.+||+|||++.......... ..
T Consensus 79 L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 79 FLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 999986543 3478999999999999999999998 99999999999999999999999999987543221111 12
Q ss_pred ccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCchhHHHHH
Q 039322 602 FAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP-RLPPPSRSVQEKLI 679 (708)
Q Consensus 602 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 679 (708)
..++..|+|||+..++.++.++||||||+++|++++ |..||....... ....+... ....+ ...+.
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~----~~~~~ 221 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--------AREQVEKGYRMSCP----QKCPD 221 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--------HHHHHHcCCCCCCC----CCCCH
Confidence 234568999999988889999999999999999998 999986432111 00111111 11111 11234
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 680 SIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 680 ~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.+++.+||+.+|++||++.|+++.|.
T Consensus 222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 222 DVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 6889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=312.76 Aligned_cols=254 Identities=19% Similarity=0.246 Sum_probs=198.7
Q ss_pred ccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEE
Q 039322 438 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYE 516 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 516 (708)
|+..+.||+|+||+||+|.. .+++.||+|.+..... ........+.+|++++++++|++|+++.+++..++..++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI-KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh-hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 56678899999999999965 4688999999865321 112234557889999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 039322 517 LLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596 (708)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 596 (708)
|+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05632 81 IMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG- 155 (285)
T ss_pred eccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC-
Confidence 999999999886433 23589999999999999999999999 9999999999999999999999999999765332
Q ss_pred CccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHH
Q 039322 597 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQE 676 (708)
Q Consensus 597 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (708)
.......|+..|+|||++.+..++.++|+||+|+++|||++|+.||........ ................ ..
T Consensus 156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~~~~~~~----~~ 227 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLETEEVYS----AK 227 (285)
T ss_pred CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhccccccC----cc
Confidence 222345789999999999888899999999999999999999999874221000 0001111111111111 11
Q ss_pred HHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039322 677 KLISIMEVAFSCLNESPESRPT-----MKVVTQQ 705 (708)
Q Consensus 677 ~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 705 (708)
....+.+++.+||+.||++||+ +++++++
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 2235778999999999999999 7788775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.41 Aligned_cols=252 Identities=28% Similarity=0.411 Sum_probs=204.8
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||.|++|.||+|... +++.||+|.+.... .......+.+|++++++++|+||+++++++.++...++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence 36788899999999999999654 68899999987532 123456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
+||+++++|.+++... .+++..++.++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+.....
T Consensus 78 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 78 MEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred EEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 9999999999999754 489999999999999999999999 999999999999999999999999999987764
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.........++..|+|||.+.+..++.++||||||+++|+|+||+.||...... .....+.....+.....
T Consensus 151 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------~~~~~~~~~~~~~~~~~- 221 (274)
T cd06609 151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------RVLFLIPKNNPPSLEGN- 221 (274)
T ss_pred cccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--------HHHHHhhhcCCCCCccc-
Confidence 433344556788999999999888999999999999999999999998632210 11111111111110000
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+..+.+++.+||..+|++|||+++++++-+
T Consensus 222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~ 253 (274)
T cd06609 222 -KFSKPFKDFVSLCLNKDPKERPSAKELLKHKF 253 (274)
T ss_pred -ccCHHHHHHHHHHhhCChhhCcCHHHHhhChh
Confidence 03345888999999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.92 Aligned_cols=256 Identities=22% Similarity=0.371 Sum_probs=200.7
Q ss_pred hccccccceeccccCccEEEEEeC--------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP--------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFC 505 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~ 505 (708)
.++|.+.+.||+|+||.||+|... ++..+|+|.++... .......+..|+++++++ +|+||+++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 367999999999999999999642 23569999987532 223456788899999999 799999999999
Q ss_pred eeCCeeEEEEEeccCCCHHHHhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 039322 506 SHARHSFLVYELLERGSLAAILSSDTA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKN 572 (708)
Q Consensus 506 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N 572 (708)
...+..++||||+++|+|.+++..... ...+++.++..++.|++.||+|||+. |++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 999999999999999999999975431 23488999999999999999999998 99999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCCCcc--ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccc
Q 039322 573 LLLDLEYEAHVADFGIAKFLKPESSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLIS 649 (708)
Q Consensus 573 ill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~ 649 (708)
|+++.++.+||+|||.+.......... ....++..|+|||.+.+..++.++||||+|+++|||++ |+.||.....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-- 248 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 248 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--
Confidence 999999999999999987654322111 11223468999999988889999999999999999998 8888863221
Q ss_pred ccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 650 SSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+........+ ......+.+++.+||+.+|++|||+.+|++.|+
T Consensus 249 ------~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~ 297 (307)
T cd05098 249 ------EELFKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297 (307)
T ss_pred ------HHHHHHHHcCCCCCCC---CcCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 1111111111111111 112346788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.34 Aligned_cols=256 Identities=21% Similarity=0.311 Sum_probs=203.1
Q ss_pred hccccccceeccccCccEEEEEeCC-----CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee-C
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPS-----GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH-A 508 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~ 508 (708)
.++|.+.+.||+|+||.||+|...+ +..|++|.+... ......+.+.+|+.++++++|+||+++++++.. +
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 4688999999999999999997655 678999998643 233456778899999999999999999998766 4
Q ss_pred CeeEEEEEeccCCCHHHHhcccccc-----cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEE
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAA-----QELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHV 583 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl 583 (708)
...++++||+++|+|.+++...... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEE
Confidence 6789999999999999999764432 4589999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccc
Q 039322 584 ADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALD 660 (708)
Q Consensus 584 ~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 660 (708)
+|||+++.+.+.... .....++..|+|||++.+..++.++||||||+++||+++ |+.||....... ...
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~ 230 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--------MAA 230 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--------HHH
Confidence 999999865433221 122345678999999988889999999999999999999 999987432111 011
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 661 EILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.+....... ...+..+.+++.+||+.||++|||+.|+++.|.
T Consensus 231 ~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 274 (280)
T cd05043 231 YLKDGYRLAQP---INCPDELFAVMACCWALDPEERPSFSQLVQCLT 274 (280)
T ss_pred HHHcCCCCCCC---CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 11111000011 112335789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=308.44 Aligned_cols=258 Identities=23% Similarity=0.348 Sum_probs=197.2
Q ss_pred ccccceeccccCccEEEEEe-----CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC--Ce
Q 039322 438 FDAQYCIGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA--RH 510 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~ 510 (708)
|...+.||+|+||.||.+.. .+++.||+|.++... .....+.+.+|++++++++||||+++++++... ..
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 38889999999999988642 367889999987532 123456788999999999999999999988654 46
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++||||+++|+|.+++... .+++.+++.++.|++.|++|||++ +++||||||+||+++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccc
Confidence 78999999999999999653 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc---cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc------ccccccccc
Q 039322 591 FLKPESSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS------LNTDIALDE 661 (708)
Q Consensus 591 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~------~~~~~~~~~ 661 (708)
........ .....++..|+|||...+..++.++||||||+++|||+||..||.......... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 66533221 122335667999999988889999999999999999999999976422110000 000001111
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 662 ILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+.....+ .....+..+.+++.+||+.+|++|||++++++.|+
T Consensus 236 ~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~ 279 (283)
T cd05080 236 LLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279 (283)
T ss_pred hhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 111111110 01112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=312.83 Aligned_cols=256 Identities=21% Similarity=0.367 Sum_probs=202.0
Q ss_pred hccccccceeccccCccEEEEEe--------CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL--------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFC 505 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~ 505 (708)
..+|.+.+.||+|+||.||+|.. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc---chHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 47889999999999999999963 134579999987532 223456789999999999 899999999999
Q ss_pred eeCCeeEEEEEeccCCCHHHHhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 039322 506 SHARHSFLVYELLERGSLAAILSSDTA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKN 572 (708)
Q Consensus 506 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N 572 (708)
...+..++||||+++|+|.+++..... ...+++.++..++.|++.||+|||++ |++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 999999999999999999999975421 23578899999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccc
Q 039322 573 LLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLIS 649 (708)
Q Consensus 573 ill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~ 649 (708)
|+++.++.+||+|||.+......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~- 246 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 246 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-
Confidence 99999999999999999866433222 122335678999999988889999999999999999998 78887632211
Q ss_pred ccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 650 SSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+........+ ...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 247 -------~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~ 294 (304)
T cd05101 247 -------ELFKLLKEGHRMDKP---ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294 (304)
T ss_pred -------HHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 111111111111111 122345888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=305.83 Aligned_cols=254 Identities=24% Similarity=0.439 Sum_probs=201.6
Q ss_pred hccccccceeccccCccEEEEEeC-CC---cEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SG---QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
.++|+..+.||+|+||.||+|... ++ ..+|+|.++... .....+.+..|++++++++|+|++++.+++...+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 357888999999999999999764 23 379999987532 22345678899999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++||||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++.
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccce
Confidence 999999999999999996543 3589999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCcc---ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC
Q 039322 591 FLKPESSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPR 666 (708)
Q Consensus 591 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (708)
......... .....+..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~i~~~~ 227 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKAINDGF 227 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhcCC
Confidence 654322211 11223457999999988889999999999999999997 9999863221 11112221111
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 667 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+... ..+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 228 ~~~~~~---~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~ 265 (268)
T cd05063 228 RLPAPM---DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265 (268)
T ss_pred CCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 111111 22346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=328.46 Aligned_cols=253 Identities=22% Similarity=0.304 Sum_probs=196.4
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|+..+.||+|+||.||+|.. .+++.||+|+++.... ........+..|++++.+++|++|+++++++.+++..++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM-LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 3688899999999999999965 4688999999874211 1123356788899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 80 MEFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred EeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999996543 488999999999999999999999 999999999999999999999999999875422
Q ss_pred CCC-----------------------------------ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCC
Q 039322 595 ESS-----------------------------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGK 639 (708)
Q Consensus 595 ~~~-----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~ 639 (708)
... ......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 100 011346899999999999989999999999999999999999
Q ss_pred CCCCccccccccccccccccccccC--CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHHh
Q 039322 640 HPRDFLSLISSSSLNTDIALDEILD--PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT---MKVVTQQV 706 (708)
Q Consensus 640 ~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~l 706 (708)
.||...... .....+.. .....+... .......+++.+++ .||++|++ ++|+++|-
T Consensus 234 ~Pf~~~~~~--------~~~~~i~~~~~~~~~p~~~--~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp 294 (360)
T cd05627 234 PPFCSETPQ--------ETYRKVMNWKETLVFPPEV--PISEKAKDLILRFC-TDSENRIGSNGVEEIKSHP 294 (360)
T ss_pred CCCCCCCHH--------HHHHHHHcCCCceecCCCC--CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCC
Confidence 999743221 11111111 111111100 01224667777766 49999984 78888764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=310.42 Aligned_cols=252 Identities=24% Similarity=0.367 Sum_probs=199.1
Q ss_pred ccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEE
Q 039322 438 FDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYE 516 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 516 (708)
|++.+.||+|+||.||+|... ++..+++|.+... .....+.+.+|+++++.++|||++++++++..++..++|+|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 677888999999999999654 5778899988642 23446678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 039322 517 LLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596 (708)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 596 (708)
|+++++|.+++.... ..+++..+..++.|++.||+|||+. |++||||+|+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 83 FCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred ecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 999999999876432 3589999999999999999999999 99999999999999999999999999997654333
Q ss_pred CccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 597 SNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 597 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
.......++..|+|||++. +..++.++||||+||++|||++|+.||...... ...........+..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~~- 228 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEPPTL- 228 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--------HHHHHHhhcCCCCC-
Confidence 3334456889999999874 345678999999999999999999998642211 11111111000000
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.........+.+++.+||+.||.+||++.+++++-+
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 001112345889999999999999999999998743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.26 Aligned_cols=256 Identities=21% Similarity=0.369 Sum_probs=202.2
Q ss_pred hccccccceeccccCccEEEEEe------CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSH 507 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~ 507 (708)
.++|.+.+.||+|+||.||+|.. ..+..||+|+++... .....+.+.+|+++++++ +|+||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 36899999999999999999963 134579999987532 223456789999999999 79999999999999
Q ss_pred CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecc
Q 039322 508 ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFG 587 (708)
Q Consensus 508 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 587 (708)
.+..++||||+.+|+|.++++.... ..+++.++..++.|++.|++|||++ +++|+||||+||+++.++.++++|||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999999965332 3379999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC
Q 039322 588 IAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILD 664 (708)
Q Consensus 588 ~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 664 (708)
++......... .....++..|+|||.+.+..++.++||||+|+++|||++ |+.||...... ........
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--------~~~~~~~~ 258 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--------SKFYKLIK 258 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--------HHHHHHHH
Confidence 99865433221 122345678999999998889999999999999999998 99998632211 11111111
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 665 PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 665 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....... .......+.+++.+||+++|++|||+.|+++.|+
T Consensus 259 ~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~ 299 (302)
T cd05055 259 EGYRMAQ--PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299 (302)
T ss_pred cCCcCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 1111100 0111345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=292.35 Aligned_cols=266 Identities=19% Similarity=0.335 Sum_probs=219.9
Q ss_pred HHHHHHHhccccccceeccccCccEEEE-EeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEE
Q 039322 428 YDEIVRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFC 505 (708)
Q Consensus 428 ~~~~~~~~~~~~~~~~ig~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~ 505 (708)
|++..+.+++ .||+|+|+.|-.+ ...+|..||||++.+. ....++++.+|++++.+.+ |+||+.++++|
T Consensus 75 F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq----~gHsR~RvfREVe~f~~Cqgh~nilqLiefF 145 (463)
T KOG0607|consen 75 FEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQ----PGHSRSRVFREVETFYQCQGHKNILQLIEFF 145 (463)
T ss_pred HHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcC----CchHHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence 5666666654 4999999999988 5678999999999873 4467889999999999995 99999999999
Q ss_pred eeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc---EE
Q 039322 506 SHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE---AH 582 (708)
Q Consensus 506 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~k 582 (708)
+++...|+|||-|.||+|.+++.++.. +++.+..++.++||.||.|||++ ||.|||+||+|||...... +|
T Consensus 146 Edd~~FYLVfEKm~GGplLshI~~~~~---F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 146 EDDTRFYLVFEKMRGGPLLSHIQKRKH---FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred cccceEEEEEecccCchHHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCcee
Confidence 999999999999999999999976653 89999999999999999999999 9999999999999977654 79
Q ss_pred EeecccccccCCCC-------CccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCcccc---
Q 039322 583 VADFGIAKFLKPES-------SNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSL--- 647 (708)
Q Consensus 583 l~Dfg~a~~~~~~~-------~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~--- 647 (708)
|+||.++....... ......+|+..|||||+.. ...|+.+.|.||||+++|-|++|..||...=.
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC 299 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC 299 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence 99999886543211 1234578999999999753 23578899999999999999999999974321
Q ss_pred ccccc----cccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 648 ISSSS----LNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 648 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.|..+ ......++.+.++.+..+...|...+.+-.+++...+..||.+|.++.++++|-++
T Consensus 300 GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~ 364 (463)
T KOG0607|consen 300 GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWV 364 (463)
T ss_pred CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccc
Confidence 11111 11234567788888888888888888888899999999999999999999987653
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.46 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=204.8
Q ss_pred ccccccceeccccCccEEEEEeC--CCc--EEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP--SGQ--VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
++....+.||+|.||.|++|.|. +|+ .||||.++.+... .....|.+|+.+|.+++|+|++++||+..+ ...
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 44556678999999999999664 344 5999999875322 257889999999999999999999999988 678
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
.+|+|.++.|+|.+.|++ .....+-......++.|||.||.||.++ ++|||||..+|+++.....|||+|||+.+-
T Consensus 186 mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred hHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceec
Confidence 899999999999999987 3335578889999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCcccc---ccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 039322 592 LKPESSNWTE---FAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 592 ~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
.......+.+ ......|.|||.+...+++.++|||+|||.+|||+| |+.||..... ...++.+-++..
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------~qIL~~iD~~er 333 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------IQILKNIDAGER 333 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--------HHHHHhcccccc
Confidence 7655554432 224579999999999999999999999999999998 8899864332 233333333333
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
-+.+..+ +++++++++.||..+|++||||..+.+.
T Consensus 334 LpRPk~c---sedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 334 LPRPKYC---SEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CCCCCCC---hHHHHHHHHHhccCCccccccHHHHHHh
Confidence 3333333 4468888999999999999999998643
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.17 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=203.8
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+..|++++++++|+||+++++++..++..++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence 367999999999999999999664 6889999998642 23445678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++++|.+++.... ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 80 v~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 80 LIEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred EeeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 999999999999986543 3589999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 039322 594 PESSNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
..........++..|+|||.+. ...++.++||||||+++|||++|+.||...... .....+.....+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~ 226 (280)
T cd06611 155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--------RVLLKILKSEPP 226 (280)
T ss_pred ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--------HHHHHHhcCCCC
Confidence 4433344556889999999875 334677999999999999999999998743211 111111111100
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...........+.+++.+||+.+|++||++.+++++-+
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 227 -TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264 (280)
T ss_pred -CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence 00011122345788999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=305.10 Aligned_cols=249 Identities=26% Similarity=0.444 Sum_probs=201.4
Q ss_pred ceeccccCccEEEEEeCC----CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEe
Q 039322 442 YCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYEL 517 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 517 (708)
+.||+|+||.||+|.... +..|++|.+...... ...+.+.+|++.++.++|+|++++++++...+..++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE---EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch---hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence 368999999999996643 788999998864321 2467889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhccccc------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 518 LERGSLAAILSSDTA------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 518 ~~~g~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
+++++|.+++..... ...+++.+++.++.|++.|++|||++ +++||||+|+||+++.++.++|+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccc
Confidence 999999999976521 25589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC--CccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCC
Q 039322 592 LKPES--SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 592 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
..... .......++..|+|||.+....++.++||||+|+++|||++ |..||+.... .............
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~ 226 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEYLRKGYRL 226 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence 65432 12233456789999999988889999999999999999999 6999874321 1111111111111
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+ ...+.++.+++.+||+.+|++|||+.|++++|+
T Consensus 227 ~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 PKP---EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCC---ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111 112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=305.33 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=206.1
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+|++.+.||+|+||.+|.+.. .+|+.||+|.+..... .....+++.+|++++++++||||+++++++...+..++|+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence 478889999999999999954 4688999999864211 1234567899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 79 DYCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred ecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 99999999999865432 3478899999999999999999998 9999999999999999999999999999866543
Q ss_pred CCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhH
Q 039322 596 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQ 675 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (708)
........++..|+|||+..+..++.++|+||||+++|+|++|+.||..... ......+..+..+....
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~~~~--- 223 (256)
T cd08218 155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--------KNLVLKIIRGSYPPVSS--- 223 (256)
T ss_pred hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--------HHHHHHHhcCCCCCCcc---
Confidence 3333345678899999999888899999999999999999999999863221 11122222222221111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 676 EKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 676 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
....++.+++.+||+.+|++||++.||+++-++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 223458899999999999999999999987543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=304.12 Aligned_cols=254 Identities=26% Similarity=0.361 Sum_probs=203.3
Q ss_pred cccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC-CeeEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA-RHSFLV 514 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-~~~~lv 514 (708)
+|++.+.||+|++|.||++..+ +++.||+|.+..... .....+.+..|++++++++|+|++++++.+... ...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence 4788999999999999999654 578899999865321 223456788999999999999999999988644 467899
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++.... ...+++.+++.++.|++.|+++||+. |++||||+|+||+++.++.++|+|||++.....
T Consensus 79 ~e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 79 MGFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ecccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999999997543 24589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.........+++.|+|||+..+..++.++||||+|+++|+|++|+.||+.... ............+...
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~~~--- 223 (257)
T cd08223 155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--------NSLVYRIIEGKLPPMP--- 223 (257)
T ss_pred cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhcCCCCCc---
Confidence 33334455688999999999998899999999999999999999999873221 1111112222221111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+.+++.+||+.+|++|||+.+++++-+
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 256 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 123346889999999999999999999998744
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=305.82 Aligned_cols=258 Identities=28% Similarity=0.403 Sum_probs=205.9
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|++|.||+|.. .++..+|+|++..... ....+.+.+|++.++.++|+|++++++.+..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence 4688999999999999999964 4688999999875321 12567789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
+|++++++|.+++........+++..+..++.|++.|++|||+. |++||||+|+||++++++.++|+|||++..+..
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999999999997654334689999999999999999999999 999999999999999999999999999886654
Q ss_pred CCCc----cccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 039322 595 ESSN----WTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 595 ~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
.... .....++..|+|||++... .++.++|+||||+++|+|++|+.||...... ...........+.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~ 226 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--------KVLMLTLQNDPPS 226 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--------hhHHHHhcCCCCC
Confidence 3322 1334678899999998776 7889999999999999999999998643211 1111111111100
Q ss_pred CC--chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 670 PS--RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 670 ~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. ......+..+.+++.+||+.||++||+++++++|-+
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~ 266 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence 00 001123456789999999999999999999998754
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=312.36 Aligned_cols=256 Identities=21% Similarity=0.371 Sum_probs=200.4
Q ss_pred hccccccceeccccCccEEEEEeC--------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP--------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFC 505 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~ 505 (708)
.++|.+.+.||+|+||.||+|... ++..||+|.++... .......+..|+++++++ +||||+++++++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 368899999999999999999642 24579999987532 223456788999999999 699999999999
Q ss_pred eeCCeeEEEEEeccCCCHHHHhcccc-------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 039322 506 SHARHSFLVYELLERGSLAAILSSDT-------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKN 572 (708)
Q Consensus 506 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N 572 (708)
...+..++||||+++|+|.+++.... ....+++.++.+++.|++.||+|||++ |++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 99999999999999999999996532 123588999999999999999999998 99999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCCCcc--ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccc
Q 039322 573 LLLDLEYEAHVADFGIAKFLKPESSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLIS 649 (708)
Q Consensus 573 ill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~ 649 (708)
|+++.++.+||+|||.++......... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~- 243 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE- 243 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 999999999999999998654322211 12234467999999988889999999999999999999 88898643211
Q ss_pred ccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 650 SSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
............... .....++.+++.+||+.+|++|||+.|+++.|+
T Consensus 244 -------~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 291 (314)
T cd05099 244 -------ELFKLLREGHRMDKP---SNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291 (314)
T ss_pred -------HHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 111111111111111 112235778999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.24 Aligned_cols=257 Identities=23% Similarity=0.360 Sum_probs=203.0
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|... +++.||+|.++... .......+.+|++++++++|+||+++++++..++..++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence 36888999999999999999764 78999999986532 223456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++........+++..+..++.|++.|+.|||+.+ +++||||+|+||+++.++.++|+|||.+..+..
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 999999999999876433346899999999999999999999742 899999999999999999999999999976532
Q ss_pred CCCccccccccccccCccccccCC------CCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMK------ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
. ......++..|+|||.+.+.. ++.++|+||+||++|+|++|+.||...... ........+.....+
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~ 228 (286)
T cd06622 156 S--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQLSAIVDGDPP 228 (286)
T ss_pred C--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHHHHHHHhhcCCC
Confidence 2 223345788999999886543 477999999999999999999998632110 001111222222211
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. .......+.+++.+||+.+|++||++++++++-+
T Consensus 229 ~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 229 TL---PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred CC---CcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 11 1123456788999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=311.24 Aligned_cols=251 Identities=26% Similarity=0.382 Sum_probs=201.9
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+.|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+.+..|++++++++||||+++++++..++..++|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence 4566778899999999999965 457889999987532 123456789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++.. ..+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 81 MEYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EEccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 999999999999864 3478999999999999999999998 999999999999999999999999999986654
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.........++..|+|||++.+..++.++||||||+++|||++|+.||...... .....+.....+. ..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~~~~~~~~~---~~ 222 (277)
T cd06642 154 TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--------RVLFLIPKNSPPT---LE 222 (277)
T ss_pred cchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--------hHHhhhhcCCCCC---CC
Confidence 333333446788999999999888999999999999999999999998632211 0011111111111 11
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+..+.+++.+||+.+|++||++.+++++-+
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 123345889999999999999999999998754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.38 Aligned_cols=262 Identities=21% Similarity=0.291 Sum_probs=198.5
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC----
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA---- 508 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~---- 508 (708)
..++|+..+.||+|+||.||+|.. ..++.||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc--ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 457899999999999999999965 4688999999875332 223456788899999999999999999988643
Q ss_pred --CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeec
Q 039322 509 --RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADF 586 (708)
Q Consensus 509 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 586 (708)
...++||||+++ ++.+.+.. .+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+||
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence 357999999976 67766642 378899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------c-c----
Q 039322 587 GIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS-------L-N---- 654 (708)
Q Consensus 587 g~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-------~-~---- 654 (708)
|+++..... .......++..|+|||++.+..++.++|||||||++|+|++|+.||.......... . .
T Consensus 164 g~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 164 GLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999865432 22334578999999999998889999999999999999999999997432110000 0 0
Q ss_pred --cccccccccC----------------CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 655 --TDIALDEILD----------------PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 655 --~~~~~~~~~~----------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+.. ...+............+.+++.+|++.||++|||+.|+++|-+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~ 313 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence 0000000000 0000000011112345789999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=307.36 Aligned_cols=260 Identities=27% Similarity=0.410 Sum_probs=198.1
Q ss_pred ccccccceeccccCccEEEEEe-----CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC--
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA-- 508 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-- 508 (708)
.+|++.+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 5788899999999999999964 35789999998753 233456789999999999999999999987543
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
...++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcc
Confidence 46889999999999999996543 3479999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcc---ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccc-------cc
Q 039322 589 AKFLKPESSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTD-------IA 658 (708)
Q Consensus 589 a~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~-------~~ 658 (708)
+.......... ....++..|+|||+..+..++.++||||||+++|||++|..|+.............. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence 98764333221 112234569999999888899999999999999999998877543221100000000 00
Q ss_pred cccccCCC-CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 659 LDEILDPR-LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 659 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+.+..... ..+... ..+..+.+++.+||+.+|++|||+.||++.|+
T Consensus 235 ~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05081 235 LIELLKNNGRLPAPP---GCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281 (284)
T ss_pred HHHHHhcCCcCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 00111111 111111 12335889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.64 Aligned_cols=262 Identities=25% Similarity=0.322 Sum_probs=198.3
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC-----e
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR-----H 510 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-----~ 510 (708)
+|+..+.||+|+||.||+|.. .+|+.||+|++.... ......+.+.+|+++++.++|+||+++++++..++ .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF--QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc--cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence 478889999999999999965 478999999986532 22334567889999999999999999999998776 7
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++|+||+. ++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEEEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecccccee
Confidence 899999997 4788877543 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-ccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc-------cc-----
Q 039322 591 FLKPESS-NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN-------TD----- 656 (708)
Q Consensus 591 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-------~~----- 656 (708)
....... ......++..|+|||++.+. .++.++||||+||++|||++|+.||............ ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 6543322 22334678899999998764 4788999999999999999999999743321100000 00
Q ss_pred ---cccccccCCCCCCCCc-----hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 657 ---IALDEILDPRLPPPSR-----SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 657 ---~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+......++.. ........+.+++.+|++.||++|||++|+++|-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 0000000000000000 00111345788999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=303.60 Aligned_cols=251 Identities=25% Similarity=0.432 Sum_probs=200.8
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
.+|++.+.||+|+||.||+|...+++.+|+|.+.... .....+.+|++++++++||+++++++++......++||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-----MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-----CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 5788889999999999999987778899999987532 12456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++++|.+++.... ..++++.++.++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 79 EFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred EcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 9999999999986543 3478999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 596 SSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 596 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
... .....++.+|+|||+..++.++.++||||+|+++|||++ |+.||...... ..............+..
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~ 225 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--------EVVETINAGFRLYKPRL 225 (256)
T ss_pred cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHhCCCCCCCCCC
Confidence 211 112234678999999988889999999999999999998 99998632211 11111111000000011
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1245889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=306.82 Aligned_cols=253 Identities=23% Similarity=0.404 Sum_probs=198.2
Q ss_pred hccccccceeccccCccEEEEEe-CCCc----EEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQ----VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
..+|+..+.||+|+||.||+|.+ .+|+ .||+|+++... .......+..|+.+++.++|+||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence 36788999999999999999964 3444 48999987532 223456788999999999999999999999754
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccc
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA 589 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 589 (708)
..++++||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCce
Confidence 4679999999999999997543 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcc--ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC
Q 039322 590 KFLKPESSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPR 666 (708)
Q Consensus 590 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (708)
+......... ....++..|+|||...+..++.++|||||||++|||++ |..||+...... ....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~ 228 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--------IPDLLEKGE 228 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHCCC
Confidence 8664332221 12234678999999988889999999999999999998 899986422110 000011111
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 667 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+.. ......+.+++.+||+.||++||++.++++.++
T Consensus 229 ~~~~~---~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~ 266 (279)
T cd05109 229 RLPQP---PICTIDVYMIMVKCWMIDSECRPRFRELVDEFS 266 (279)
T ss_pred cCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111 112345788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=302.54 Aligned_cols=249 Identities=26% Similarity=0.425 Sum_probs=202.2
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.++|++.+.||+|+||.||+|... |+.||+|.++... ...+++.+|+.++++++|+||+++++++...+..++|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 367899999999999999999875 7899999997632 1467789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.++....
T Consensus 79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred EEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccc
Confidence 999999999999975442 3589999999999999999999999 999999999999999999999999999986532
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
.. .....+..|+|||++.++.++.++||||||+++|||++ |..||...... ........ ..... .
T Consensus 155 ~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~-~~~~~--~ 220 (256)
T cd05039 155 GQ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPHVEK-GYRME--A 220 (256)
T ss_pred cc---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHhc-CCCCC--C
Confidence 21 12334668999999988889999999999999999997 99998632211 00011000 10000 0
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+..+.+++.+||..+|++|||++|+++.|+
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 254 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHh
Confidence 0112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.76 Aligned_cols=254 Identities=27% Similarity=0.396 Sum_probs=201.5
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcch-----hHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQ-----IADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
+|.+...||+|++|.||+|.. .+++.||+|.+........ ....+.+.+|++++++++||||+++++++..++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999965 4688999999876433221 1123568899999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++|+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999996543 478899999999999999999999 99999999999999999999999999988
Q ss_pred ccCCCCC------ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC
Q 039322 591 FLKPESS------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD 664 (708)
Q Consensus 591 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 664 (708)
....... ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~ 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--------QAIFKIGE 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--------HHHHHHhc
Confidence 6642211 112235788999999998888999999999999999999999998742211 11111111
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 665 PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 665 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+.. .......+.+++.+||+.||++||++.|++++=.
T Consensus 227 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 266 (267)
T cd06628 227 NASPEI---PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266 (267)
T ss_pred cCCCcC---CcccCHHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence 111111 1122345788999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.41 Aligned_cols=256 Identities=23% Similarity=0.357 Sum_probs=202.3
Q ss_pred cccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCc--chhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPC--DQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+|...+.||+|+||.||+|...+++.+|+|.+...... ........+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47788999999999999998878999999998753221 1123346788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999996543 478999999999999999999999 999999999999999999999999999875432
Q ss_pred CC------CccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 039322 595 ES------SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 595 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
.. .......++..|+|||++.+..++.++||||+|+++|+|++|+.||......... ..... .....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-----~~~~~-~~~~~~ 228 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM-----FYIGA-HRGLMP 228 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH-----HHhhh-ccCCCC
Confidence 11 1122345788999999999888999999999999999999999998642211100 00000 000011
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.... .....+.+++.+||+.+|++||++.|++++=+
T Consensus 229 ~~~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 264 (265)
T cd06631 229 RLPD---SFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264 (265)
T ss_pred CCCC---CCCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 1111 12345788999999999999999999998643
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=304.76 Aligned_cols=246 Identities=26% Similarity=0.437 Sum_probs=197.2
Q ss_pred ceeccccCccEEEEEeCC--C--cEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEe
Q 039322 442 YCIGNGGHGSVYRAELPS--G--QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYEL 517 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 517 (708)
+.||+|++|.||+|.+.+ + ..||+|.+...... ...+.+..|++.+++++|+||+++++++.. ...++|+||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence 358999999999996543 3 36999998864321 456789999999999999999999999988 889999999
Q ss_pred ccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 039322 518 LERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS 597 (708)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 597 (708)
+++|+|.+++..... ..+++..++.++.|++.||+|||++ +++|+||+|+||+++.++.+||+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 77 APLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred cCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999999976543 4589999999999999999999999 999999999999999999999999999987654322
Q ss_pred cc---ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc--CCCCCCCC
Q 039322 598 NW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEIL--DPRLPPPS 671 (708)
Q Consensus 598 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 671 (708)
.. ....++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+. ......+
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~- 223 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--------QILKKIDKEGERLERP- 223 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHhcCCcCCCC-
Confidence 21 12346788999999988889999999999999999998 99998632211 1111111 0111111
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 224 ---~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 ---EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=311.99 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=197.8
Q ss_pred hccccccceeccccCccEEEEEeC-CCc--EEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCe
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQ--VVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARH 510 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 510 (708)
.++|++.+.||+|+||.||+|... ++. .+|+|.++... .......+.+|++++.++ +|+||+++++++..++.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC---CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 468899999999999999999754 444 45777765421 223456788999999999 89999999999999999
Q ss_pred eEEEEEeccCCCHHHHhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC
Q 039322 511 SFLVYELLERGSLAAILSSDTA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL 577 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~ 577 (708)
.++||||+++|+|.+++..... ...+++.+++.++.|++.|++|||+. |++||||||+||+++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecC
Confidence 9999999999999999965431 23578999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccc
Q 039322 578 EYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTD 656 (708)
Q Consensus 578 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 656 (708)
++.+||+|||++...... ........+..|+|||.+.+..++.++||||||+++|||+| |..||......
T Consensus 160 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------- 230 (303)
T cd05088 160 NYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------- 230 (303)
T ss_pred CCcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--------
Confidence 999999999998643211 11112234568999999888888999999999999999998 99998632211
Q ss_pred cccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 657 IALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
............... ......+.+++.+||+.+|++||+++++++.++
T Consensus 231 ~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~ 278 (303)
T cd05088 231 ELYEKLPQGYRLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278 (303)
T ss_pred HHHHHHhcCCcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111111111000001 112335789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=305.36 Aligned_cols=252 Identities=27% Similarity=0.499 Sum_probs=200.3
Q ss_pred ccccccceeccccCccEEEEEeC-CC---cEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SG---QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
.+|++.+.||+|+||.||+|... ++ ..||+|.+.... .......|..|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 56888999999999999999754 23 369999987532 234467899999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++||||+++|+|.+++.... ..+++.+++.++.|++.|++|||++ |++||||||+||+++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 81 MIITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EEEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccc
Confidence 99999999999999997543 3579999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCcc--cc-c--cccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc-C
Q 039322 592 LKPESSNW--TE-F--AGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEIL-D 664 (708)
Q Consensus 592 ~~~~~~~~--~~-~--~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~-~ 664 (708)
........ .. . ..+..|+|||.+.+..++.++||||+|+++||+++ |..||...... .....+. +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--------~~~~~i~~~ 227 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------DVINAIEQD 227 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcC
Confidence 54322211 11 1 12457999999998889999999999999999986 99998643211 1111111 1
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 665 PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 665 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+.+. +.+..+.+++.+||+.+|.+||+++++++.|+
T Consensus 228 ~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 266 (269)
T cd05065 228 YRLPPPM----DCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266 (269)
T ss_pred CcCCCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111111 22345788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=317.01 Aligned_cols=249 Identities=29% Similarity=0.405 Sum_probs=202.2
Q ss_pred cccccceeccccCccEEEEE-eCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
-|.-.+.||.|+||.||-|+ ..+.+.||||++.... ....+....+..|++.+++++|||++.+-|+|..+...|+||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySG-KQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-KQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccc-cccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 35556779999999999995 4578899999998643 233456778999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
|||-| +-.|.+.-++ +++.+-++..|..+...||+|||+. +.||||||+.|||+++.|.|||+|||.|....+.
T Consensus 106 EYClG-SAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 106 EYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHHhc-cHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 99965 7777776554 5688899999999999999999999 9999999999999999999999999999877654
Q ss_pred CCccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 596 SSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
..++|||.|||||++. .+.|+-++||||+||...||.-.++|+=.+..+ ..+..+-...- +.-
T Consensus 180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM--------SALYHIAQNes--PtL 245 (948)
T KOG0577|consen 180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNES--PTL 245 (948)
T ss_pred ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH--------HHHHHHHhcCC--CCC
Confidence 4578999999999885 578999999999999999999999995322221 11111111111 111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
...++...|..++..|+++-|.+|||.+++++|-
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 1234555688888899999999999999998873
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=329.17 Aligned_cols=260 Identities=22% Similarity=0.250 Sum_probs=191.5
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC-----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA----- 508 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~----- 508 (708)
..+|++.+.||+|+||.||+|.. .+++.||||++... .....+|+.++++++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~--------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD--------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC--------cchHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 46799999999999999999965 46889999988642 12234699999999999999999887432
Q ss_pred ---CeeEEEEEeccCCCHHHHhccc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-cEEE
Q 039322 509 ---RHSFLVYELLERGSLAAILSSD-TAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY-EAHV 583 (708)
Q Consensus 509 ---~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl 583 (708)
...++||||+++ ++.+++... .....+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceee
Confidence 246799999985 777776432 2234589999999999999999999999 999999999999998665 7999
Q ss_pred eecccccccCCCCCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------ccc
Q 039322 584 ADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS-------LNT 655 (708)
Q Consensus 584 ~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-------~~~ 655 (708)
+|||+|+...... ......+++.|+|||++.+. .++.++||||+||++|||++|..||.......... ...
T Consensus 213 ~DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 213 CDFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred eccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9999998664332 22345679999999987654 68999999999999999999999997432110000 000
Q ss_pred ccccc----cccCCCCCCCC-chh-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 656 DIALD----EILDPRLPPPS-RSV-----QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 656 ~~~~~----~~~~~~~~~~~-~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..... .+.+..++... ... ...+.++.+++.+||.+||++|||+.|+++|-+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 00000 00000011000 000 012346789999999999999999999998754
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=343.32 Aligned_cols=260 Identities=22% Similarity=0.333 Sum_probs=200.1
Q ss_pred HHhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC--C
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA--R 509 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~ 509 (708)
...++|.+.+.||+|+||.||+|... +++.||+|.+.... ........+..|+.++++++||||++++++|... .
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~--l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG--LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc--cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 34578999999999999999999654 57789999987532 1223467789999999999999999999988653 5
Q ss_pred eeEEEEEeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEEccCCCCCeeeCCC------
Q 039322 510 HSFLVYELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCF----PPIVHQDISSKNLLLDLE------ 578 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~----~~ivH~dlk~~Nill~~~------ 578 (708)
.+|+||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+... .+||||||||+|||++.+
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 6899999999999999997532 22458999999999999999999998521 259999999999999642
Q ss_pred -----------CcEEEeecccccccCCCCCccccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 039322 579 -----------YEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLVLEAIKGKHPRDFL 645 (708)
Q Consensus 579 -----------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~ 645 (708)
+.+||+|||++....... ......|++.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 348999999998654322 2234578999999998854 45788999999999999999999999632
Q ss_pred ccccccccccccccccccC-CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 646 SLISSSSLNTDIALDEILD-PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
... ......+.. +.++. ......+.++|..||+.+|++||++.|++++-+
T Consensus 247 ~~~-------~qli~~lk~~p~lpi-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 247 NNF-------SQLISELKRGPDLPI-----KGKSKELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred CcH-------HHHHHHHhcCCCCCc-----CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 211 011111111 11111 112345889999999999999999999987543
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=322.51 Aligned_cols=245 Identities=23% Similarity=0.251 Sum_probs=189.6
Q ss_pred eccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc---cCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 444 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI---RHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 444 ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
||+|+||.||+|.. .+++.||||++.+... ........+..|..++... +||+|+++++++..++..++||||++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI-VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHH-hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 69999999999965 4689999999864211 1112234455677776655 69999999999999999999999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 599 (708)
+|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++..........
T Consensus 80 ~g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 80 GGELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred CChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence 99999998653 3489999999999999999999999 99999999999999999999999999997543333333
Q ss_pred ccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHH
Q 039322 600 TEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKL 678 (708)
Q Consensus 600 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (708)
....|+..|+|||++.+. .++.++||||+||++|||++|+.||..... ......+.......+... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~---~~ 222 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMYRNIAFGKVRFPKNV---LS 222 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHHHHHHcCCCCCCCcc---CC
Confidence 456789999999988754 478899999999999999999999864221 111112222111111111 12
Q ss_pred HHHHHHHHhccCCCCCCCC----CHHHHHHHh
Q 039322 679 ISIMEVAFSCLNESPESRP----TMKVVTQQV 706 (708)
Q Consensus 679 ~~l~~li~~cl~~dP~~RP----s~~evl~~l 706 (708)
..+.+++.+||+.||++|| ++.++++|-
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~ 254 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKEHP 254 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCc
Confidence 3467889999999999998 678887764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=301.89 Aligned_cols=245 Identities=29% Similarity=0.422 Sum_probs=192.8
Q ss_pred ceeccccCccEEEEEeC--C--CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEe
Q 039322 442 YCIGNGGHGSVYRAELP--S--GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYEL 517 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 517 (708)
+.||+|+||.||+|... + +..||+|.+..... ....+++..|+++++++.|+||+++++++. .+..++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence 36999999999999542 2 36899999876422 135667899999999999999999999876 4567999999
Q ss_pred ccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 039322 518 LERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS 597 (708)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 597 (708)
+++|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.......
T Consensus 77 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 77 APLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 99999999997544 479999999999999999999999 999999999999999999999999999986654332
Q ss_pred cccc---ccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 598 NWTE---FAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 598 ~~~~---~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
.... ..++..|+|||...+..++.++||||||+++|+|++ |..||....... ....+......+.+
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~-- 220 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--------VIAMLESGERLPRP-- 220 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHHcCCcCCCC--
Confidence 2211 223467999999988889999999999999999998 999986432110 11111111110111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 221 -~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~ 253 (257)
T cd05060 221 -EECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253 (257)
T ss_pred -CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 112245889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.10 Aligned_cols=255 Identities=23% Similarity=0.289 Sum_probs=196.7
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||++.. .+++.||+|++.+.. .......+.+.+|..++..++|+||+++++++..++..|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE-MLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH-HhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 4788999999999999999965 468899999986411 11123355688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 80 MDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred EecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999996532 3488999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCc-cccccccccccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC----
Q 039322 595 ESSN-WTEFAGTYGYVAPELAYT-----MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD---- 664 (708)
Q Consensus 595 ~~~~-~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 664 (708)
.... .....|++.|+|||++.. ..++.++||||+||++|||++|+.||...... .....+..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~--------~~~~~i~~~~~~ 226 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHKEH 226 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH--------HHHHHHHcCCCc
Confidence 3322 223468999999999863 45678999999999999999999998643211 11111111
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCC--CCCCHHHHHHHhh
Q 039322 665 PRLPPPSRSVQEKLISIMEVAFSCLNESPE--SRPTMKVVTQQVR 707 (708)
Q Consensus 665 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~l~ 707 (708)
..++... ...+..+.+++.+|+..+++ .||+++++++|-+
T Consensus 227 ~~~~~~~---~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 227 FQFPPDV---TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred ccCCCcc---CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 0111111 11233567778887765444 3889999998754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=302.07 Aligned_cols=239 Identities=23% Similarity=0.385 Sum_probs=186.9
Q ss_pred eeccccCccEEEEEeCC-------------CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 443 CIGNGGHGSVYRAELPS-------------GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 443 ~ig~G~~g~vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
.||+|+||.||+|.... ...|++|++... .......+.+|+.+++.++||||+++++++..+.
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 58999999999996532 225888987652 2334567888999999999999999999999999
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc-------EE
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE-------AH 582 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-------~k 582 (708)
..++||||+++|+|..++.... ..+++..+++++.||+.|++|||++ +++||||||+||+++.++. ++
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999999999886533 3489999999999999999999999 9999999999999987654 89
Q ss_pred EeecccccccCCCCCccccccccccccCccccc-cCCCCcchhHHHHHHHHHHHH-hCCCCCCccccccccccccccccc
Q 039322 583 VADFGIAKFLKPESSNWTEFAGTYGYVAPELAY-TMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALD 660 (708)
Q Consensus 583 l~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~ 660 (708)
++|||.+...... ....++..|+|||.+. +..++.++||||||+++|||+ +|..||....... ..
T Consensus 153 l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---------~~ 219 (262)
T cd05077 153 LSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE---------KE 219 (262)
T ss_pred eCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH---------HH
Confidence 9999998754322 2345778899999876 456888999999999999998 5888876322110 00
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 661 EILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........... ....++.+++.+||+.||++||++.++++++.
T Consensus 220 ~~~~~~~~~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 RFYEGQCMLVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHhcCccCCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 11111111111 11235789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=316.43 Aligned_cols=256 Identities=21% Similarity=0.367 Sum_probs=197.8
Q ss_pred ccccccceeccccCccEEEEEe------CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeC
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHA 508 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~ 508 (708)
++|++.+.||+|+||.||+|.. .+++.||||+++... .......+.+|+.++.++ +|+||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 6899999999999999999953 357789999987532 123356788999999999 689999999988654
Q ss_pred -CeeEEEEEeccCCCHHHHhccccc-------------------------------------------------------
Q 039322 509 -RHSFLVYELLERGSLAAILSSDTA------------------------------------------------------- 532 (708)
Q Consensus 509 -~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 532 (708)
...++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 467899999999999999864320
Q ss_pred ---------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCc--ccc
Q 039322 533 ---------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN--WTE 601 (708)
Q Consensus 533 ---------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~ 601 (708)
...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......... ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12368888999999999999999999 9999999999999999999999999999865332221 122
Q ss_pred ccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHH
Q 039322 602 FAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLIS 680 (708)
Q Consensus 602 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (708)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ...............+.. ...+
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~---~~~~ 310 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGTRMRAPDY---TTPE 310 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------HHHHHHHhccCCCCCCCC---CCHH
Confidence 335678999999988889999999999999999997 99998642211 001111111111111111 1235
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 681 IMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 681 l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+.+++.+||+.||++|||+.|++++|+
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~ 337 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLG 337 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 788899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=301.81 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=197.3
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEe-eCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCS-HARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-~~~~~~lv 514 (708)
.+|.+.+.||+|+||.||+|... |+.||+|.++.. ...+.+.+|+.++++++|++++++++++. .++..++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 57889999999999999999774 788999998642 22457889999999999999999999764 45678999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
+||+++++|.+++..... ..+++..+..++.|++.||+|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred EECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 999999999999975442 3478999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
.. ....++..|+|||+..+..++.++||||||+++|||++ |+.||....... ....+.. ..... .
T Consensus 155 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--------~~~~~~~-~~~~~--~ 220 (256)
T cd05082 155 TQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEK-GYKMD--A 220 (256)
T ss_pred cC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhc-CCCCC--C
Confidence 22 22334568999999988889999999999999999998 999986322110 0011100 00000 0
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 254 (256)
T cd05082 221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence 1112345788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.19 Aligned_cols=262 Identities=16% Similarity=0.227 Sum_probs=193.7
Q ss_pred ccceeccc--cCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEE
Q 039322 440 AQYCIGNG--GHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYE 516 (708)
Q Consensus 440 ~~~~ig~G--~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 516 (708)
+..+||+| +|++||++.. .+|+.||+|.+..... .......+.+|+++++.++||||+++++++..++..++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 45679999 6789999954 5789999999875321 12334567889999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 039322 517 LLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596 (708)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 596 (708)
|+++|+|.+++..+.. ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.++++||+.+.......
T Consensus 80 ~~~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 80 FMAYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred ccCCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999999965432 3488999999999999999999999 99999999999999999999999998654332111
Q ss_pred C-------ccccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc-----
Q 039322 597 S-------NWTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEI----- 662 (708)
Q Consensus 597 ~-------~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 662 (708)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||....................
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT 235 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence 1 1122346778999999876 3588999999999999999999999974321100000000000000
Q ss_pred --------------cCCCC---------CC------CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 663 --------------LDPRL---------PP------PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 663 --------------~~~~~---------~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+... .+ ...........+.+++.+||+.||++|||++|++++-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 00000 00 00011122346889999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=303.75 Aligned_cols=253 Identities=25% Similarity=0.335 Sum_probs=189.0
Q ss_pred ceeccccCccEEEEEeCC---CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEec
Q 039322 442 YCIGNGGHGSVYRAELPS---GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELL 518 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 518 (708)
+.||+|+||.||+|...+ +..+|+|.++... .......+.+|+.++++++||||+++++++.+....++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence 358999999999996543 4579999887532 1233457889999999999999999999999999999999999
Q ss_pred cCCCHHHHhccccc--ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 039322 519 ERGSLAAILSSDTA--AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596 (708)
Q Consensus 519 ~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 596 (708)
++|+|.+++..... ....++..+..++.|++.|++|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 99999999975432 23457788889999999999999999 99999999999999999999999999997543222
Q ss_pred Cc--cccccccccccCccccccC-------CCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC
Q 039322 597 SN--WTEFAGTYGYVAPELAYTM-------KITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPR 666 (708)
Q Consensus 597 ~~--~~~~~~~~~y~aPE~~~~~-------~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (708)
.. .....++..|+|||++.+. .++.++||||||+++|||++ |+.||......................+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 11 1234567889999987642 35779999999999999996 99998643211100000000000111111
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 667 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. ......+.+++.+|| .+|++|||++||.+.|.
T Consensus 235 ~~------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 235 LK------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cC------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11 111234677888999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=311.98 Aligned_cols=263 Identities=17% Similarity=0.227 Sum_probs=199.6
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|.+.+.||+|+||.||+|... +++.||+|.++.... ......+.+|++++++++|+||+++++++..++..++|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc---cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 67899999999999999999654 688999999875321 12244577899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+. ++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 83 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 83 FEYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred Eeccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 99997 58998886543 3478999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------ccccccccc-----
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS-------LNTDIALDE----- 661 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-------~~~~~~~~~----- 661 (708)
.........+++.|+|||.+.+. .++.++||||||+++|||++|+.||.......... .........
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 33333445678899999987654 47889999999999999999999997432110000 000000000
Q ss_pred -ccCCCCCCCC-----chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 662 -ILDPRLPPPS-----RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 662 -~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+... .........+.+++.+|++.||.+|||++|+++|-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0000000000 000112335789999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.06 Aligned_cols=262 Identities=24% Similarity=0.376 Sum_probs=204.0
Q ss_pred hHHHHHHHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEE
Q 039322 427 VYDEIVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGF 504 (708)
Q Consensus 427 ~~~~~~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~ 504 (708)
+..++..+.+.|++.+.||+|+||.||+|.. .+++.||+|.+... .....++..|+.+++++ +|+||++++++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~ 81 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGA 81 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeee
Confidence 3445555678999999999999999999965 46889999998642 12345678899999998 69999999999
Q ss_pred Eee------CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC
Q 039322 505 CSH------ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE 578 (708)
Q Consensus 505 ~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~ 578 (708)
+.. .+..+++|||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +++|+||+|+||+++.+
T Consensus 82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~ 157 (282)
T cd06636 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN 157 (282)
T ss_pred hhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 853 457899999999999999986543 23478888999999999999999999 99999999999999999
Q ss_pred CcEEEeecccccccCCCCCccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 039322 579 YEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL 653 (708)
Q Consensus 579 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~ 653 (708)
+.++|+|||++..............++..|+|||.+. ...++.++||||||+++|||++|+.||.......
T Consensus 158 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~---- 233 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR---- 233 (282)
T ss_pred CCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh----
Confidence 9999999999876543333334456889999999875 3457789999999999999999999986322110
Q ss_pred ccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 NTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......... ........+..+.+++.+||+.||.+|||+.|++++=+
T Consensus 234 ----~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~ 281 (282)
T cd06636 234 ----ALFLIPRNPP--PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281 (282)
T ss_pred ----hhhhHhhCCC--CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence 0001111111 10111123446889999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.07 Aligned_cols=259 Identities=26% Similarity=0.382 Sum_probs=203.5
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||+||+|.. .+|+.||+|++.... .....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 6788899999999999999965 468899999876531 123467789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++...+ .+++..+..++.+++.|+.|||+.+ +++||||+|+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 82 MEFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 99999999999986543 4899999999999999999999742 899999999999999999999999999865432
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccc---ccccccccCCCCCCCC
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNT---DIALDEILDPRLPPPS 671 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 671 (708)
. ......++..|+|||++.++.++.++|||||||++|+|++|+.||+............ ............+..
T Consensus 157 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 233 (284)
T cd06620 157 S--IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL- 233 (284)
T ss_pred h--ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC-
Confidence 2 1223568899999999988889999999999999999999999997432211000000 011112221111111
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.....+..+.+++.+||++||++|||++|++++.
T Consensus 234 -~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 234 -PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0112334688999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=308.74 Aligned_cols=263 Identities=25% Similarity=0.327 Sum_probs=194.1
Q ss_pred cccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc---cCCceeeEEEEEee-----
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI---RHRNIVKFYGFCSH----- 507 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~~----- 507 (708)
+|++.+.||+|+||.||+|... +++.||+|.++...... .....+.+|+++++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED--GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC--CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 4788899999999999999654 68899999987532211 1123455677766655 69999999998864
Q ss_pred CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecc
Q 039322 508 ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFG 587 (708)
Q Consensus 508 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 587 (708)
....++||||+.+ +|.+++..... ..+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||
T Consensus 79 ~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 79 ETKVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred CceEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccC
Confidence 3457999999985 89888865432 4489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------ccccccc-
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS-------LNTDIAL- 659 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-------~~~~~~~- 659 (708)
++...... .......++..|+|||++.+..++.++||||+||++|+|++|+.||.......... .......
T Consensus 154 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 154 LARIYSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred ccccccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 99865432 22234567899999999988889999999999999999999999986432110000 0000000
Q ss_pred ------ccccCCCCCCC-CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 660 ------DEILDPRLPPP-SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 660 ------~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+..... ..........+.+++.+|+++||++|||+.|+++|-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~ 287 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 00000000000 0011122345789999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=309.25 Aligned_cols=263 Identities=25% Similarity=0.367 Sum_probs=203.8
Q ss_pred HHHHHHHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEE
Q 039322 428 YDEIVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFC 505 (708)
Q Consensus 428 ~~~~~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~ 505 (708)
++++..++++|.+.+.||+|+||.||+|.. .+++.+|+|.+.... ...+.+.+|+.+++++ +|||++++++++
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 345556778999999999999999999965 468899999986421 2245677899999998 799999999998
Q ss_pred eeC-----CeeEEEEEeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC
Q 039322 506 SHA-----RHSFLVYELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY 579 (708)
Q Consensus 506 ~~~-----~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~ 579 (708)
... +..++||||+++|+|.++++... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 754 35899999999999999886422 234589999999999999999999998 999999999999999999
Q ss_pred cEEEeecccccccCCCCCccccccccccccCccccccCC-----CCcchhHHHHHHHHHHHHhCCCCCCccccccccccc
Q 039322 580 EAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMK-----ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN 654 (708)
Q Consensus 580 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~ 654 (708)
.+||+|||++..............++..|+|||.+.... ++.++||||+|+++|||++|+.||......
T Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------ 239 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------ 239 (291)
T ss_pred CEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------
Confidence 999999999986654333334456788999999875433 578999999999999999999998642211
Q ss_pred cccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 655 TDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+..... +...........+.+++.+||+.+|++||++.|+++|=+
T Consensus 240 --~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~ 289 (291)
T cd06639 240 --KTLFKIPRNPP-PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289 (291)
T ss_pred --HHHHHHhcCCC-CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcc
Confidence 01111111100 000011122345889999999999999999999998754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=319.42 Aligned_cols=262 Identities=21% Similarity=0.281 Sum_probs=198.2
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC----
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA---- 508 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~---- 508 (708)
..++|.+.+.||+|+||.||+|.. ..++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc--CchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 357899999999999999999964 4688999999875332 223456788899999999999999999987543
Q ss_pred --CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeec
Q 039322 509 --RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADF 586 (708)
Q Consensus 509 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 586 (708)
...|+||||+++ ++.+++.. .+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+||
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence 357999999975 77777642 378899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc-------c----
Q 039322 587 GIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN-------T---- 655 (708)
Q Consensus 587 g~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-------~---- 655 (708)
|+++..... .......++..|+|||++.+..++.++|||||||++|||++|+.||............ .
T Consensus 171 G~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 171 GLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CCccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 999865432 2223457899999999999989999999999999999999999999743211000000 0
Q ss_pred ---ccccccccCC--------------C--CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 656 ---DIALDEILDP--------------R--LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 656 ---~~~~~~~~~~--------------~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......... . .+............+.+++.+|++.||++|||+.|+++|-+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 0000000000 0 00000000111235789999999999999999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=304.40 Aligned_cols=239 Identities=21% Similarity=0.356 Sum_probs=185.5
Q ss_pred eeccccCccEEEEEeCC-------------------------CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCc
Q 039322 443 CIGNGGHGSVYRAELPS-------------------------GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497 (708)
Q Consensus 443 ~ig~G~~g~vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 497 (708)
.||+|+||.||+|.... ...||+|++... .......+.+|+.++++++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS----HRDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH----HHHHHHHHHHHHHHHhcCCCCC
Confidence 58999999999996421 135888987642 2233567888999999999999
Q ss_pred eeeEEEEEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC
Q 039322 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL 577 (708)
Q Consensus 498 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~ 577 (708)
|+++++++..+...++||||+++|+|.+++.... ..+++..+..++.|+++||+|||++ +++||||||+||+++.
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~ 152 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLAR 152 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEec
Confidence 9999999999999999999999999999986533 3578999999999999999999999 9999999999999976
Q ss_pred CC-------cEEEeecccccccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHH-hCCCCCCccccc
Q 039322 578 EY-------EAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLI 648 (708)
Q Consensus 578 ~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell-tg~~p~~~~~~~ 648 (708)
.+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||......
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred cCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 43 3899999988644322 22356788999998865 55789999999999999995 699998643211
Q ss_pred cccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 649 SSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. ...........+... ...+.+++.+||+.+|++|||+.++++.|.
T Consensus 229 ~---------~~~~~~~~~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 E---------KERFYEKKHRLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H---------HHHHHHhccCCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 011111111111111 124788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=305.39 Aligned_cols=261 Identities=20% Similarity=0.339 Sum_probs=199.6
Q ss_pred ccccccceeccccCccEEEEEe-----CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC--
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA-- 508 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-- 508 (708)
.-|++.+.||+|+||.||.+.. .+++.||+|.++... .......+.+|++++++++|||++++.+++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 4578889999999999999963 357889999987532 223456799999999999999999999998775
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
...++||||+++++|.+++.... ..+++..+..++.|++.||+|||++ |++||||||+||+++.++.++|+|||+
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcc
Confidence 56889999999999999986543 3479999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc---cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc-------ccccccccc
Q 039322 589 AKFLKPESSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLIS-------SSSLNTDIA 658 (708)
Q Consensus 589 a~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~-------~~~~~~~~~ 658 (708)
++........ .....++..|+|||++.+..++.++||||||+++|||+++..|+....... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 9866433221 123446678999999988889999999999999999999877643211000 000000000
Q ss_pred cccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 659 LDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+....+.. ...+..+.+++.+||+.+|++|||++++++.++
T Consensus 236 ~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 281 (284)
T cd05079 236 VRVLEEGKRLPRP---PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE 281 (284)
T ss_pred HHHHHcCccCCCC---CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 0111111111111 112346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=323.51 Aligned_cols=256 Identities=21% Similarity=0.245 Sum_probs=193.9
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
..|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+||+++++++..++..++|
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 46999999999999999999664 578899996432 2356799999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
||++. ++|.+++.... ..+++.+++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 239 ~e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 239 LPKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred EEccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 99995 68988886432 3589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC-----CCC
Q 039322 595 ESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD-----PRL 667 (708)
Q Consensus 595 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~ 667 (708)
.... .....||..|+|||++.+..++.++|||||||++|||++|..|+-................+.+.. ..+
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 2221 223568999999999999899999999999999999999876542111000000000000000000 000
Q ss_pred C----------------------CCCchhH---HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 P----------------------PPSRSVQ---EKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~----------------------~~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+ .....+. .....+.+++.+||+.||++|||+.|+++|-+
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~ 457 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL 457 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence 0 0000011 11235778999999999999999999999854
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=312.04 Aligned_cols=255 Identities=22% Similarity=0.371 Sum_probs=200.4
Q ss_pred ccccccceeccccCccEEEEEeC--------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEe
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP--------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCS 506 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~ 506 (708)
.+|.+.+.||+|+||.||+|... .+..||+|.++... .....+++.+|+++++++ +|+||+++++++.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA---TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 46889999999999999999642 12368999887532 223456889999999999 7999999999999
Q ss_pred eCCeeEEEEEeccCCCHHHHhcccc-------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCe
Q 039322 507 HARHSFLVYELLERGSLAAILSSDT-------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNL 573 (708)
Q Consensus 507 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Ni 573 (708)
.++..++++||+++|+|.+++.... ....+++.++..++.|++.||+|||++ |++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence 9999999999999999999996532 223578999999999999999999999 999999999999
Q ss_pred eeCCCCcEEEeecccccccCCCCCcc--ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccc
Q 039322 574 LLDLEYEAHVADFGIAKFLKPESSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISS 650 (708)
Q Consensus 574 ll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~ 650 (708)
+++.++.+||+|||+++......... ....++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--- 242 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---
Confidence 99999999999999998654322211 12233567999999998889999999999999999998 8888863221
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 651 SSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+........+. .....+.+++.+||+.+|++|||+.|+++.|+
T Consensus 243 -----~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~ 291 (334)
T cd05100 243 -----EELFKLLKEGHRMDKPA---NCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291 (334)
T ss_pred -----HHHHHHHHcCCCCCCCC---CCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 11111111111111111 12335889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=301.12 Aligned_cols=252 Identities=21% Similarity=0.399 Sum_probs=201.6
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.++|++.+.||+|+||.||+|...++..+|+|.+... ....+.+.+|++++++++|+||+++.+++.+ +..+++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 4789999999999999999998777888999988752 1235678899999999999999999999887 778999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... ...+++.++..++.|++.||+|||+. |++|+||+|+||+++.++.+||+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 79 TEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999999997643 24578899999999999999999998 999999999999999999999999999976543
Q ss_pred CCCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 595 ESSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 595 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
.... .....++..|+|||++....++.++|+||||+++|+++| |+.||...... .....+.. ....+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~-~~~~~-- 223 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--------EVIRALER-GYRMP-- 223 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHhC-CCCCC--
Confidence 2211 122345678999999988889999999999999999999 89998642211 00111111 11100
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+..+.+++.+||+.+|++||++.++.+.|+
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~ 258 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 01122345889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.12 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=199.2
Q ss_pred ccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEE
Q 039322 438 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYE 516 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 516 (708)
|.....||+|+||.||++.. .+++.||||.+... .....+.+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 44446699999999999965 46889999998642 23445678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 039322 517 LLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596 (708)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 596 (708)
|+++++|.+++... .+++.++..++.|++.|++|||++ +++||||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 100 FLEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred CCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 99999999988542 378999999999999999999999 99999999999999999999999999987654333
Q ss_pred CccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHH
Q 039322 597 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQE 676 (708)
Q Consensus 597 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (708)
.......++..|+|||...+..++.++||||||+++|||++|+.||........ .........+.... ...
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~----~~~ 243 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-----MRRIRDNLPPRVKD----SHK 243 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhcCCCcccc----ccc
Confidence 333445688999999999888899999999999999999999999864321110 00111111111111 111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 677 KLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 677 ~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
....+.+++.+||..||++|||++|++++-
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 273 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQHP 273 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 233577889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=283.48 Aligned_cols=253 Identities=22% Similarity=0.361 Sum_probs=201.8
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCeeEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~l 513 (708)
++.+....||.|..|.|++++.. +|...|||.+++. .+.++.+++...++++..-. +|.||+.+|||..+...++
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt---~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT---GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc---CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 55667778999999999999765 5899999999874 45567888999999876664 9999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
.||.|.. ..+..++.-. +++++.-+-++...++.||.||.++| +|+|||+||+|||+|+.|++|+||||.+.++.
T Consensus 169 cMelMs~-C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHHHHHH-HHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee
Confidence 9999854 5566654333 45788888899999999999999997 99999999999999999999999999998775
Q ss_pred CCCCccccccccccccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 594 PESSNWTEFAGTYGYVAPELAYT---MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
+. ...+..+|-+.|||||.+.- ..|+.++||||||+.++||.||+.||.... ...+.+..+.+...+ .
T Consensus 244 dS-kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~-------tdFe~ltkvln~ePP-~ 314 (391)
T KOG0983|consen 244 DS-KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK-------TDFEVLTKVLNEEPP-L 314 (391)
T ss_pred cc-cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC-------ccHHHHHHHHhcCCC-C
Confidence 43 33355678899999998864 358889999999999999999999997421 122333344442221 1
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
-.........+.+++..|+.+|+.+||.+.++++|
T Consensus 315 L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 315 LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11111134568889999999999999999999986
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=306.92 Aligned_cols=251 Identities=27% Similarity=0.410 Sum_probs=203.5
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.+|.+.+.||+|+||.||+|.. .+++.||+|.+... .....+.+..|+.++++++||||+++++++..++..++|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ----QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc----cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 6889999999999999999964 46889999998642 223456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
+||+++++|.+++... .+++.++..++.|++.|++|||+. |++|+||+|+||+++.++.++|+|||++....+
T Consensus 95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred EecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999999998653 378899999999999999999999 999999999999999999999999999876654
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.........+++.|+|||.+....++.++||||||+++|++++|+.||....... ......... .+.....
T Consensus 168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~--------~~~~~~~~~-~~~~~~~ 238 (293)
T cd06647 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------ALYLIATNG-TPELQNP 238 (293)
T ss_pred cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh--------heeehhcCC-CCCCCCc
Confidence 4444444568889999999988888999999999999999999999987432110 000010000 0111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
......+.+++.+||+.+|++||++++++.|-
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 12334588899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=311.46 Aligned_cols=194 Identities=21% Similarity=0.354 Sum_probs=159.3
Q ss_pred cceeccccCccEEEEEeC---CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee--CCeeEEEE
Q 039322 441 QYCIGNGGHGSVYRAELP---SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH--ARHSFLVY 515 (708)
Q Consensus 441 ~~~ig~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~ 515 (708)
.+.||+|+||.||+|... +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...+++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 457999999999999754 46789999987531 13446789999999999999999999854 45688999
Q ss_pred EeccCCCHHHHhcccc------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee----CCCCcEEEee
Q 039322 516 ELLERGSLAAILSSDT------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL----DLEYEAHVAD 585 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~D 585 (708)
||+.+ +|.+++.... ....+++..+..++.|++.||+|||++ ||+||||||+||++ +.++.+||+|
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 80 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 99865 8888875332 123488999999999999999999999 99999999999999 4567899999
Q ss_pred cccccccCCCCC---ccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCc
Q 039322 586 FGIAKFLKPESS---NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDF 644 (708)
Q Consensus 586 fg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~ 644 (708)
||+++....... ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 999987643321 22345789999999988764 578899999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=308.12 Aligned_cols=264 Identities=22% Similarity=0.333 Sum_probs=201.8
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|+..+.||+|++|.||+|... +|+.||+|.+..... .....+.+.+|++++++++|+|++++++++..++..++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence 36888899999999999999765 689999999865321 112345678999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||++++++..++... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 79 FEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred EeccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 9999998888876543 2489999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc--------c--------ccc
Q 039322 595 ESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL--------N--------TDI 657 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~--------~--------~~~ 657 (708)
.........++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||........... . ...
T Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 153 PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 4433344567889999998876 4578899999999999999999999864321100000 0 000
Q ss_pred ccccccCCCCCCCC---chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 ALDEILDPRLPPPS---RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+...... .........+.+++.+||+.+|++||++.|+++|-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~ 285 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence 00000000000000 001122356889999999999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=306.38 Aligned_cols=258 Identities=28% Similarity=0.418 Sum_probs=203.6
Q ss_pred HhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCC--
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHAR-- 509 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~-- 509 (708)
++++|++.+.||+|++|.||+|..+ +++.+++|++.... ...+.+.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 5689999999999999999999764 67899999987531 2356789999999999 6999999999997644
Q ss_pred ----eeEEEEEeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEe
Q 039322 510 ----HSFLVYELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVA 584 (708)
Q Consensus 510 ----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~ 584 (708)
..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEEC
Confidence 4899999999999999986532 234589999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCccccccccccccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccc
Q 039322 585 DFGIAKFLKPESSNWTEFAGTYGYVAPELAYT-----MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIAL 659 (708)
Q Consensus 585 Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 659 (708)
|||.+..............++..|+|||++.. ..++.++||||||+++|+|++|+.||...... ...
T Consensus 156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~ 227 (275)
T cd06608 156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--------RAL 227 (275)
T ss_pred CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--------HHH
Confidence 99999866543333445668899999998753 34677899999999999999999998632211 111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 660 DEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
..+.... .+...........+.+++.+||+.||++|||++|++++=++
T Consensus 228 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 228 FKIPRNP-PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HHhhccC-CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 1111111 11111112234568899999999999999999999987543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=315.41 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=198.7
Q ss_pred eeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccCC
Q 039322 443 CIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERG 521 (708)
Q Consensus 443 ~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 521 (708)
++|+|.||+||.|+.. +...+|||-+.. .+....+-+.+|+...++++|+|||+++|.+.+++..-|.||-++||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe----kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE----KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccc----ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 6999999999999765 456799998765 23345567889999999999999999999999999999999999999
Q ss_pred CHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC-CCCcEEEeecccccccCCCCCccc
Q 039322 522 SLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD-LEYEAHVADFGIAKFLKPESSNWT 600 (708)
Q Consensus 522 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~ 600 (708)
+|.+.+...-..-+-.+.++-.+.+||.+||.|||++ .|||||||-+|||+. -.|.+||+|||-++....-+....
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE 734 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE 734 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence 9999997655333337788889999999999999999 999999999999994 579999999999988776666667
Q ss_pred cccccccccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHH
Q 039322 601 EFAGTYGYVAPELAYTMK--ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKL 678 (708)
Q Consensus 601 ~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (708)
...||..|||||++..++ |+.++|||||||.+.||.||++||-..+.... ..++.-+...-++- +.+..
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------AMFkVGmyKvHP~i---Peels 805 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------AMFKVGMYKVHPPI---PEELS 805 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------hhhhhcceecCCCC---cHHHH
Confidence 789999999999998764 78899999999999999999999864332111 11111111112222 22333
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 039322 679 ISIMEVAFSCLNESPESRPTMKVVTQ 704 (708)
Q Consensus 679 ~~l~~li~~cl~~dP~~RPs~~evl~ 704 (708)
.+...+|.+|+.+||.+||++.++++
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhcc
Confidence 45677888999999999999999986
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=310.96 Aligned_cols=249 Identities=25% Similarity=0.409 Sum_probs=198.4
Q ss_pred ccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEE
Q 039322 438 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYE 516 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 516 (708)
|+....||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++|||++++++++..++..++|+|
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc----cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 44455799999999999965 468999999986421 2235668899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 039322 517 LLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596 (708)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 596 (708)
|+++++|.+++.. ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 99 FLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred cCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 9999999998754 2378999999999999999999999 99999999999999999999999999987654443
Q ss_pred CccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHH
Q 039322 597 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQE 676 (708)
Q Consensus 597 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (708)
.......++..|+|||++.+..++.++||||||+++|||++|+.||....... ....+.. ...........
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~-~~~~~~~~~~~ 242 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--------AMKRLRD-SPPPKLKNAHK 242 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhc-cCCCCccccCC
Confidence 33344668899999999988889999999999999999999999986322111 0111100 00000011111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 677 KLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 677 ~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
....+.+++.+||+.+|++||++++++++-
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 233578899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=297.31 Aligned_cols=247 Identities=26% Similarity=0.429 Sum_probs=196.8
Q ss_pred ceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccCC
Q 039322 442 YCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERG 521 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 521 (708)
+.||+|++|.||+|...+++.||+|.+..... ....+.+.+|++++++++|+||+++++++...+..++||||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 36899999999999876699999999876432 135678999999999999999999999999999999999999999
Q ss_pred CHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc--
Q 039322 522 SLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW-- 599 (708)
Q Consensus 522 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-- 599 (708)
+|.+++.... ..+++..+..++.+++.|++|||++ +++||||+|+||+++.++.+||+|||++..........
T Consensus 78 ~l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 78 SLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 9999996543 3478899999999999999999999 99999999999999999999999999997654222111
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCchhHHHH
Q 039322 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKL 678 (708)
Q Consensus 600 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (708)
.....+..|+|||.+.++.++.++|+||||+++|||+| |..||........ ....... .....+ ...+
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~-----~~~~~~~--~~~~~~----~~~~ 221 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT-----RERIESG--YRMPAP----QLCP 221 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH-----HHHHhcC--CCCCCC----ccCC
Confidence 11233567999999988889999999999999999999 8888863221100 0001000 011111 1123
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 679 ISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 679 ~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 45888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=303.70 Aligned_cols=248 Identities=28% Similarity=0.369 Sum_probs=186.5
Q ss_pred eeccccCccEEEEEeCC---CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 443 CIGNGGHGSVYRAELPS---GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 443 ~ig~G~~g~vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
.||+|+||.||+|...+ ...+|+|.+.... .......+.+|++.++.++|+||+++++++...+..++||||++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 58999999999996543 3468888876422 22345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccccc--ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 039322 520 RGSLAAILSSDTA--AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS 597 (708)
Q Consensus 520 ~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 597 (708)
+|+|.+++..... ....++.....++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 9999999976542 22346788899999999999999999 999999999999999999999999999875433221
Q ss_pred c--cccccccccccCcccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccc-c--C
Q 039322 598 N--WTEFAGTYGYVAPELAYT-------MKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEI-L--D 664 (708)
Q Consensus 598 ~--~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~-~--~ 664 (708)
. .....++..|+|||+... ..++.++||||+|+++|||++ |..||...... ...... . .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~~~~~~~~~~~ 227 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--------QVLKQVVREQD 227 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhhccC
Confidence 1 122345678999998643 346789999999999999999 78887633211 001110 0 0
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 665 PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 665 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
..++.+ .........+.+++..|| .||++|||++||++.|
T Consensus 228 ~~~~~~-~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 228 IKLPKP-QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ccCCCC-cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 111111 111122344667788898 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=316.01 Aligned_cols=254 Identities=25% Similarity=0.372 Sum_probs=206.6
Q ss_pred ccccccceeccccCccEEEEEeCCC-cEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSG-QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+-|.+...||.|+||.||+|..++. -..|.|++.. ...++.+.++-|++||..+.||+||++++.|..++.+|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 3567788899999999999976643 3455677654 3446788899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
.|||.||-.+..+-.-+ ..+++.++.-+++|++.||.|||++ .|||||||+.|||++-+|.++|+|||.+.....
T Consensus 108 iEFC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred EeecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh
Confidence 99999999988875433 5589999999999999999999999 999999999999999999999999999876544
Q ss_pred CCCccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 039322 595 ESSNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
.......+.||+.|||||+.. ..+|+.++||||||+.+.||..+.+|-..... ...+-.+.. .-++
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--------MRVllKiaK-SePP 253 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAK-SEPP 253 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--------HHHHHHHhh-cCCC
Confidence 444566789999999999864 35789999999999999999999999542211 111111111 1122
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+..+...+.+++++|+.+||..||+++++++|-+
T Consensus 254 TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 254 TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 22234456677999999999999999999999999854
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=300.96 Aligned_cols=247 Identities=24% Similarity=0.382 Sum_probs=191.1
Q ss_pred eeccccCccEEEEEeCC-Cc--EEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeEEEEEec
Q 039322 443 CIGNGGHGSVYRAELPS-GQ--VVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLVYELL 518 (708)
Q Consensus 443 ~ig~G~~g~vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~ 518 (708)
.||+|+||.||+|...+ +. .+++|.++... .....+.+.+|+++++++ +||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC---CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 58999999999997643 43 46888876421 223456788999999999 7999999999999999999999999
Q ss_pred cCCCHHHHhcccc-------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEee
Q 039322 519 ERGSLAAILSSDT-------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVAD 585 (708)
Q Consensus 519 ~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 585 (708)
++|+|.+++.... ....+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence 9999999996543 123478999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC
Q 039322 586 FGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILD 664 (708)
Q Consensus 586 fg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 664 (708)
||++...... ........+..|+|||++....++.++||||||+++|||++ |..||...... .....+..
T Consensus 156 fgl~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~~~~~~~ 226 (270)
T cd05047 156 FGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELYEKLPQ 226 (270)
T ss_pred CCCccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--------HHHHHHhC
Confidence 9998632211 11112233567999999988889999999999999999997 99998632211 11111111
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 665 PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 665 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........ .....+.+++.+||+.+|.+|||+.|+++.|+
T Consensus 227 ~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 266 (270)
T cd05047 227 GYRLEKPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLN 266 (270)
T ss_pred CCCCCCCC---cCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 10000111 12235789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=302.09 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=196.2
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCc-chhHhHHHHHHHHHHHHhccCCceeeEEEEEee--CCee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPC-DQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH--ARHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~ 511 (708)
.+|...+.||+|+||.||+|.. .+++.||+|.+...... ........+.+|+.++++++||||+++++++.+ .+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688899999999999999965 46889999998653221 122345678899999999999999999999875 3577
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++++||+++++|.+++.... .+++...+.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999996543 378899999999999999999998 999999999999999999999999999875
Q ss_pred cCCCC---CccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 039322 592 LKPES---SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 592 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
..... .......++..|+|||.+.+..++.++||||+|+++|||++|+.||...... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--------~~~~~~~~~~~~ 227 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--------AAIFKIATQPTN 227 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--------HHHHHHhcCCCC
Confidence 53211 1122345788999999998888999999999999999999999998732211 101111100000
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
+ .........+.+++ +||..+|++||+++|+++|
T Consensus 228 ~--~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 228 P--QLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred C--CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0 11111223456666 7888999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.61 Aligned_cols=257 Identities=21% Similarity=0.273 Sum_probs=198.9
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|.+.+.||+|+||.||++... +++.||+|.+.+.. .........+.+|..++..++|++|+++++++.+++..|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE-MLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 47889999999999999999654 67889999986421 11123345678899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 80 MDYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred EeCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999997532 3478899999999999999999999 999999999999999999999999999986654
Q ss_pred CCCc-cccccccccccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC--C
Q 039322 595 ESSN-WTEFAGTYGYVAPELAYT-----MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDP--R 666 (708)
Q Consensus 595 ~~~~-~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~ 666 (708)
.... .....|++.|+|||++.+ +.++.++||||+|+++|||++|+.||...... .....+... +
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~ 226 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHEER 226 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--------HHHHHHHcCCCc
Confidence 3322 223568999999998865 45788999999999999999999999643211 111111111 1
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHhh
Q 039322 667 LPPPSRSVQEKLISIMEVAFSCLNESPES--RPTMKVVTQQVR 707 (708)
Q Consensus 667 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l~ 707 (708)
.+.+ ......+..+.+++.+|+..++++ |++++++++|-+
T Consensus 227 ~~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~ 268 (331)
T cd05624 227 FQFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF 268 (331)
T ss_pred ccCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence 1111 111122345778888999876655 568999987743
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=304.92 Aligned_cols=261 Identities=26% Similarity=0.329 Sum_probs=201.9
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC--CeeE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA--RHSF 512 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~ 512 (708)
++|+..+.||.|++|.||+|.. .+++.+|+|.+.... ......++.+|++++++++||||+++++++... +..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 3678889999999999999976 468899999987532 224467789999999999999999999998653 4789
Q ss_pred EEEEeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 513 LVYELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
+||||+++++|.+++.... ....++...+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 9999999999999875322 234578899999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC---CCCC
Q 039322 592 LKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD---PRLP 668 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 668 (708)
..... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||+...... ...........+ +.+.
T Consensus 155 ~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd06621 155 LVNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP---LGPIELLSYIVNMPNPELK 229 (287)
T ss_pred ccccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC---CChHHHHHHHhcCCchhhc
Confidence 43221 123456789999999988889999999999999999999999987442200 000111111111 1111
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
............+.+++.+||+.+|++|||+.|++++-+
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 230 DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 111111123456889999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=301.34 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=203.5
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee--CCeeEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH--ARHSFL 513 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~l 513 (708)
+|++.+.||.|+||.||+|.. .+++.||+|.+..... .....+++..|++++++++|+||+++++++.. +...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence 477889999999999999954 5688999999865321 23446678899999999999999999998864 456799
Q ss_pred EEEeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEEccCCCCCeeeCCCCcEEEeecc
Q 039322 514 VYELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLH-----HDCFPPIVHQDISSKNLLLDLEYEAHVADFG 587 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh-----~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 587 (708)
+|||+++++|.+++.... ....+++..++.++.|++.|++||| +. +++|+||+|+||+++.++.+||+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccc
Confidence 999999999999996542 2346899999999999999999999 76 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
++..............++..|+|||.+.+..++.++||||||+++|+|++|+.||+.... ....+.+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~ 227 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--------LQLASKIKEGKF 227 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--------HHHHHHHhcCCC
Confidence 998765544333445688999999999988899999999999999999999999874321 111112222222
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
+..+ ......+.+++.+|++.+|++||++.+|+++
T Consensus 228 ~~~~---~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 RRIP---YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCc---cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111 1233468899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=300.14 Aligned_cols=247 Identities=26% Similarity=0.391 Sum_probs=189.6
Q ss_pred ceeccccCccEEEEEeC----CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEe-eCCeeEEEEE
Q 039322 442 YCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCS-HARHSFLVYE 516 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-~~~~~~lv~e 516 (708)
+.||+|+||.||+|... ++..||+|.+... ......+.+.+|+.+++.++||||+++++++. .++..++|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI---TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc---CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence 35899999999999653 2457999987542 22344677889999999999999999999875 4556889999
Q ss_pred eccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 039322 517 LLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596 (708)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 596 (708)
|+.+|+|.+++.... ...++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 78 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 78 YMKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 999999999996543 3367788899999999999999998 99999999999999999999999999997553221
Q ss_pred C----ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCccccccccccccccccccccCCCCCCCC
Q 039322 597 S----NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKG-KHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 597 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
. ......++..|+|||...+..++.++||||||+++|||++| ..||..... ................
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 224 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--------FDITVYLLQGRRLLQP 224 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHhcCCCCCCC
Confidence 1 11123456789999999888899999999999999999995 556653211 1111112221111111
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. .+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 225 ~~---~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~ 257 (262)
T cd05058 225 EY---CPDPLYEVMLSCWHPKPEMRPTFSELVSRIE 257 (262)
T ss_pred Cc---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 11 1235889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=329.02 Aligned_cols=265 Identities=17% Similarity=0.240 Sum_probs=193.3
Q ss_pred HHHHHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccC------CceeeEE
Q 039322 430 EIVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH------RNIVKFY 502 (708)
Q Consensus 430 ~~~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~l~ 502 (708)
++....++|++.+.||+|+||.||+|.. ..++.||||+++... .....+..|+++++.++| .++++++
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 3444568899999999999999999965 467889999986421 223345567777777654 4589999
Q ss_pred EEEeeC-CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC--
Q 039322 503 GFCSHA-RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY-- 579 (708)
Q Consensus 503 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-- 579 (708)
+++..+ ++.++|||++ +++|.+++.... .+++..+..++.||+.||+|||++. ||+||||||+|||++.++
T Consensus 198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 198 RYFQNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTV 271 (467)
T ss_pred EEEEcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcc
Confidence 988765 5788999988 678998886543 4899999999999999999999732 999999999999998765
Q ss_pred --------------cEEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 039322 580 --------------EAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFL 645 (708)
Q Consensus 580 --------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~ 645 (708)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 49999999886432 2234567899999999999999999999999999999999999999743
Q ss_pred ccccccccc-------cc--------cccccccC------CCCCCC---------CchhHHHHHHHHHHHHhccCCCCCC
Q 039322 646 SLISSSSLN-------TD--------IALDEILD------PRLPPP---------SRSVQEKLISIMEVAFSCLNESPES 695 (708)
Q Consensus 646 ~~~~~~~~~-------~~--------~~~~~~~~------~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~ 695 (708)
......... .. .....+.+ +...+. ..........+.+||.+||++||++
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 211000000 00 00000000 000000 0000011235779999999999999
Q ss_pred CCCHHHHHHHhhC
Q 039322 696 RPTMKVVTQQVRI 708 (708)
Q Consensus 696 RPs~~evl~~l~~ 708 (708)
|||++|+++|-++
T Consensus 429 R~ta~e~L~Hp~~ 441 (467)
T PTZ00284 429 RLNARQMTTHPYV 441 (467)
T ss_pred CCCHHHHhcCccc
Confidence 9999999998553
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=309.50 Aligned_cols=255 Identities=23% Similarity=0.288 Sum_probs=204.3
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|+..+.||+|++|.||+|... +++.||+|.+..... ......+.+..|+++++.++|+||+++++.+...+..++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM-IKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc-chHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 36888899999999999999664 589999999976322 2223556789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+.+++|.+++.... ...+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 80 MDYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999987543 34589999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCc-----------------------------cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 039322 595 ESSN-----------------------------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFL 645 (708)
Q Consensus 595 ~~~~-----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~ 645 (708)
.... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 11235788999999999888999999999999999999999998633
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC----HHHHHHH
Q 039322 646 SLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT----MKVVTQQ 705 (708)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~~ 705 (708)
.. ......+.......+.. ......+.+++.+||+.||++||| ++|++++
T Consensus 236 ~~--------~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 236 NR--------DETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred ch--------HHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 21 11122222222221111 113456889999999999999999 8888876
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=315.98 Aligned_cols=262 Identities=22% Similarity=0.335 Sum_probs=197.0
Q ss_pred HHHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC--
Q 039322 432 VRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA-- 508 (708)
Q Consensus 432 ~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-- 508 (708)
....++|.+.+.||+|+||.||+|.. .+++.||||.+.... ........+.+|++++++++|+||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh--hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 34557899999999999999999964 568899999987532 1223345677899999999999999999987543
Q ss_pred ----CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEe
Q 039322 509 ----RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVA 584 (708)
Q Consensus 509 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~ 584 (708)
...++++|++ +++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 3568999988 6799988753 2489999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccccc
Q 039322 585 DFGIAKFLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS-------SLNTD 656 (708)
Q Consensus 585 Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-------~~~~~ 656 (708)
|||++...... .....++..|+|||++.+ ..++.++||||+||++|+|++|+.||......... .....
T Consensus 161 Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 161 DFGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred CCccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999865432 234568999999999876 46888999999999999999999998643211000 00000
Q ss_pred ccc--------ccccCCCCCCCCc-hh----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 657 IAL--------DEILDPRLPPPSR-SV----QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 657 ~~~--------~~~~~~~~~~~~~-~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
... ..... .++.... .. ......+.+++.+|++.||++|||++|+++|-+
T Consensus 238 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~ 300 (343)
T cd07878 238 EVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300 (343)
T ss_pred HHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 000 00000 0000000 00 011224678999999999999999999998743
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=302.58 Aligned_cols=251 Identities=27% Similarity=0.443 Sum_probs=201.0
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc---CCceeeEEEEEeeCCeeE
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR---HRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~l~~~~~~~~~~~ 512 (708)
.|+..+.||+|+||.||+|.. .+++.||+|.+..... ....+++.+|++++++++ |||++++++++..+...+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP---DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence 467788999999999999965 5789999999875322 234567888999999996 999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+||||+++++|.+++... .+++..++.++.|++.|++|||+. |++||||+|+||+++.++.++|+|||.+...
T Consensus 79 lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999999999999998643 488999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
...........|+..|+|||.+.++ .++.++||||||+++|+|++|+.||.......... .......+.+..
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~-- 224 (277)
T cd06917 152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-----LIPKSKPPRLED-- 224 (277)
T ss_pred CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-----ccccCCCCCCCc--
Confidence 6544434445688899999987654 46889999999999999999999987432111000 000000111111
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+.+++.+||+.||++||++.|++++-+
T Consensus 225 ---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~ 257 (277)
T cd06917 225 ---NGYSKLLREFVAACLDEEPKERLSAEELLKSKW 257 (277)
T ss_pred ---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChH
Confidence 113346889999999999999999999988644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=306.10 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=204.8
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~l 513 (708)
...|++.++||+||.+.||++...+.+.||+|++.... .+......|..|+..|.+++ |..|+++++|-..++..|+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~--~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE--ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh--cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 36799999999999999999988888899998876422 33455678999999999995 9999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||=+ .+|..+|+...... .+| .++.++.|+..|+.++|.+ ||||.||||.|+|+- .|.+||+|||.|..+.
T Consensus 438 vmE~Gd-~DL~kiL~k~~~~~-~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKKSID-PDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeeccc-ccHHHHHHhccCCC-chH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 999764 49999998765322 234 7889999999999999999 999999999999985 5899999999999887
Q ss_pred CCCCc--cccccccccccCccccccCC-----------CCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 039322 594 PESSN--WTEFAGTYGYVAPELAYTMK-----------ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALD 660 (708)
Q Consensus 594 ~~~~~--~~~~~~~~~y~aPE~~~~~~-----------~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 660 (708)
++... ....+||+.||+||.+.... .++++||||+|||+|+|+.|+.||.... .....+.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~aKl~ 583 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQIAKLH 583 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHHHHHH
Confidence 66543 35678999999999886432 5578999999999999999999987322 1344566
Q ss_pred cccCCCC--CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 661 EILDPRL--PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 661 ~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
++.++.. ..+...... ++.++++.|+..||++|||..|+++|
T Consensus 584 aI~~P~~~Iefp~~~~~~---~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 584 AITDPNHEIEFPDIPEND---ELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred hhcCCCccccccCCCCch---HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 6777643 222111111 27889999999999999999999986
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=314.89 Aligned_cols=256 Identities=22% Similarity=0.280 Sum_probs=196.8
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||++..+ +++.||+|++.+.. .........+..|+.++..++|++|+++++++.+++..++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-MLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHH-HHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 46889999999999999999764 57889999986411 11122344578899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 80 MDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred EeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999997532 3478999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCc-cccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC--
Q 039322 595 ESSN-WTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPR-- 666 (708)
Q Consensus 595 ~~~~-~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 666 (708)
.... .....|++.|+|||++. ...++.++|||||||++|||++|+.||...... .....+....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~ 226 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHKER 226 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH--------HHHHHHhCCCcc
Confidence 3222 23356899999999886 345788999999999999999999999743211 1111111111
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHh
Q 039322 667 LPPPSRSVQEKLISIMEVAFSCLNESPES--RPTMKVVTQQV 706 (708)
Q Consensus 667 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l 706 (708)
...+ .........+.+++.+|+..+|.+ ||+++|+++|-
T Consensus 227 ~~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~ 267 (332)
T cd05623 227 FQFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHP 267 (332)
T ss_pred ccCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCC
Confidence 1111 111122345778888988665544 78999999874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=300.40 Aligned_cols=254 Identities=28% Similarity=0.393 Sum_probs=201.9
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+|...+.||+|++|.||+|.. .+++.||+|.++..... ......+..|++++++++|+||+++++++...+..++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence 477889999999999999965 46889999998764322 345678999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 79 EYCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred ecCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 9999999999997543 378899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcc----ccccccccccCccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 039322 596 SSNW----TEFAGTYGYVAPELAYTMK---ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 596 ~~~~----~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
.... ....++..|+|||++.+.. .+.++||||||+++|++++|+.||......... .........+.++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~~~ 228 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI----MFHVGAGHKPPIP 228 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH----HHHHhcCCCCCCC
Confidence 3222 1345788999999988766 788999999999999999999998632110000 0000000111111
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
. .......+.+++.+||+.+|++|||++|++.+=
T Consensus 229 ~----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~ 262 (264)
T cd06626 229 D----SLQLSPEGKDFLDRCLESDPKKRPTASELLQHP 262 (264)
T ss_pred c----ccccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence 1 111234577899999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=300.95 Aligned_cols=249 Identities=27% Similarity=0.403 Sum_probs=201.1
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+-|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+.+.+|++.+++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence 3467788999999999999965 468899999976431 223456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 81 MEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred EEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 9999999999998643 378999999999999999999998 999999999999999999999999999876544
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.........++..|+|||.+.+..++.++||||||+++|+|++|..||...... .....+.....+. ..
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~---~~ 222 (277)
T cd06641 154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--------KVLFLIPKNNPPT---LE 222 (277)
T ss_pred chhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--------HHHHHHhcCCCCC---CC
Confidence 333333456788999999998888899999999999999999999998632211 1111111111111 11
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
...+..+.+++.+||+.+|.+||++++++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1223457889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=301.15 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=199.5
Q ss_pred ccccccceeccccCccEEEEEeC-CCc----EEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQ----VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
.+|++.+.||+|+||.||+|..+ +|+ .||+|...... .......+.+|++++++++|+||+++++++.. ..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 67889999999999999999653 233 58999887542 23445678899999999999999999999987 78
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++|+||+++|+|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.++
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred eEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccc
Confidence 899999999999999997543 3489999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCccc--cccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 039322 591 FLKPESSNWT--EFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 591 ~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
.......... ...++..|+|||.+....++.++|+||||+++||+++ |+.||+.... ......+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~ 229 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEIPDLLEKGER 229 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhCCCC
Confidence 7653332221 1223568999999988889999999999999999998 9999874321 111111111111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.+.. ....+.+++.+||..+|++||++.++++.|+
T Consensus 230 ~~~~~~---~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~ 266 (279)
T cd05057 230 LPQPPI---CTIDVYMVLVKCWMIDAESRPTFKELINEFS 266 (279)
T ss_pred CCCCCC---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 111111 1235778899999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.57 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=208.0
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|++|.||+|... +++.||+|.+..... ......+..|++.+.+++|+|++++++++..++..++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence 36888999999999999999665 589999999876422 14567899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH-DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
+||+++++|.+++... ..+++..++.++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+....
T Consensus 78 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 78 LEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred EEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999999754 348999999999999999999999 8 99999999999999999999999999998765
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
..........++..|+|||...+..++.++|+||||+++|+|++|+.||..... .........+...........
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 226 (264)
T cd06623 152 NTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDGPPPSLPAE 226 (264)
T ss_pred cCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcCCCCCCCcc
Confidence 444443455678999999999888899999999999999999999999874321 011111122222211111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
..+..+.+++.+||+.+|++||++.|++++=
T Consensus 227 --~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~ 257 (264)
T cd06623 227 --EFSPEFRDFISACLQKDPKKRPSAAELLQHP 257 (264)
T ss_pred --cCCHHHHHHHHHHccCChhhCCCHHHHHhCH
Confidence 0344688999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=301.79 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=185.2
Q ss_pred eeccccCccEEEEEeCCC---cEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 443 CIGNGGHGSVYRAELPSG---QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 443 ~ig~G~~g~vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
.||+|+||.||+|...++ ..+++|.+.... .....+.+.+|+.+++.++||||+++++++......++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA---SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC---ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 589999999999965433 346677765421 22346789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccccc-ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCC--
Q 039322 520 RGSLAAILSSDTA-AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES-- 596 (708)
Q Consensus 520 ~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-- 596 (708)
+|+|.+++..... ....++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 9999999975432 23456778889999999999999998 99999999999999999999999999986432211
Q ss_pred CccccccccccccCcccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCC
Q 039322 597 SNWTEFAGTYGYVAPELAYT-------MKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 597 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
.......++..|+|||+... ..++.++||||||+++|||++ |..||.....................++...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence 11233467889999998743 235678999999999999997 5678753221100000000001111122221
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
. .....+.+++..|| .+|++||+++||++.|
T Consensus 236 ~------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 236 L------PYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred C------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 1 12235777888999 6799999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=304.11 Aligned_cols=257 Identities=24% Similarity=0.347 Sum_probs=205.4
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|+..+.||+|++|.||+|..+ +++.||+|.+.... .....+++.+|++++++++||||+++++++..++..+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence 36788899999999999999665 68899999987632 124567789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH-DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
+||+++++|.+++.... ..+++..+..++.|++.|++|||+ . +++|+||+|+||+++.++.++|+|||.+....
T Consensus 78 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 78 MEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 99999999999997543 458899999999999999999999 7 99999999999999999999999999987553
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
.... ....++..|+|||...+..++.++||||+|+++|+|++|+.||....... .......+.......+....
T Consensus 153 ~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~- 226 (265)
T cd06605 153 NSLA--KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP---DGIFELLQYIVNEPPPRLPS- 226 (265)
T ss_pred HHHh--hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc---ccHHHHHHHHhcCCCCCCCh-
Confidence 2221 12567889999999988889999999999999999999999986432100 00111122222221111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+.++|.+||..||++|||+.+++++-+
T Consensus 227 -~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 259 (265)
T cd06605 227 -GKFSPDFQDFVNLCLIKDPRERPSYKELLEHPF 259 (265)
T ss_pred -hhcCHHHHHHHHHHcCCCchhCcCHHHHhhCch
Confidence 113446889999999999999999999998744
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=308.74 Aligned_cols=264 Identities=20% Similarity=0.277 Sum_probs=198.2
Q ss_pred cccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+|++.+.||+|++|.||+|... +|+.||+|.++.... .......+.+|++++++++|+||+++++++.+.+..++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence 4778889999999999999654 689999999875321 1122356778999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+.+ +|.+++.... ..+++..++.++.||++||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 79 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 79 EYCDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred ecCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 99974 8888876433 3489999999999999999999999 9999999999999999999999999999865543
Q ss_pred CCccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------c-cc--ccccccccc
Q 039322 596 SSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS--------S-LN--TDIALDEIL 663 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~--------~-~~--~~~~~~~~~ 663 (708)
........++..|+|||++.+.. ++.++||||+|+++|+|+||+.|+......... . .. .........
T Consensus 153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 33334456788999999887644 688999999999999999999986321110000 0 00 000000000
Q ss_pred CCC-CCCCC--c----hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 664 DPR-LPPPS--R----SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 664 ~~~-~~~~~--~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
+.. ..... . ........+.+++.+||+.||.+|||++|+++|-++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 000 00000 0 001123467889999999999999999999988653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.22 Aligned_cols=249 Identities=25% Similarity=0.316 Sum_probs=202.8
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|.+.+.||+|++|.||+|... +++.||+|++..... ......+.+.+|++++++++||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 36888999999999999999654 689999999865211 1123456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++... ..++...+..++.|++.||+|||+. |++||||+|+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 80 MEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999999654 3488999999999999999999998 999999999999999999999999999986643
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
. .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||..... ..............+..
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~-- 220 (290)
T cd05580 154 R---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILEGKVRFPSF-- 220 (290)
T ss_pred C---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCCccCCcc--
Confidence 3 2334678999999999888889999999999999999999999864321 11112222222221111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 039322 675 QEKLISIMEVAFSCLNESPESRP-----TMKVVTQQV 706 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l 706 (708)
....+.+++.+||..||.+|| +++|++++-
T Consensus 221 --~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~ 255 (290)
T cd05580 221 --FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP 255 (290)
T ss_pred --CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence 134578899999999999999 888888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=299.59 Aligned_cols=255 Identities=22% Similarity=0.328 Sum_probs=199.1
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCc-chhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC--Cee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPC-DQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA--RHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~ 511 (708)
++|++.+.||+|+||.||.|.. .+++.||+|.+...... ......+.+.+|++++++++|+||+++++++.++ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5788999999999999999965 45899999988643222 1223456788999999999999999999998764 467
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
+++|||+++++|.+++.... .+++....+++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999986543 378889999999999999999999 999999999999999999999999999875
Q ss_pred cCCCC---CccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc-CCCC
Q 039322 592 LKPES---SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEIL-DPRL 667 (708)
Q Consensus 592 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ 667 (708)
..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ....... .+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~~ 227 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--------AAIFKIATQPTN 227 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH--------HHHHHHhcCCCC
Confidence 53211 1123345788999999998888999999999999999999999998632111 0111111 1111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
+. ........+.+++.+|+. +|++||+++|++++-++
T Consensus 228 ~~---~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 228 PV---LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264 (265)
T ss_pred CC---CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence 11 112233457788889995 99999999999987553
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=297.90 Aligned_cols=246 Identities=26% Similarity=0.446 Sum_probs=197.1
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
++|++.+.||+|+||.||+|.. +++.||+|.++.+ ...+.+.+|+.++++++|||++++++++..+ ..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD------VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 6789999999999999999975 5788999998652 1245788999999999999999999998764 478999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++++|.+++.... ...+++..++.++.|++.|++|||+. |++||||||+||+++.++.+||+|||.+......
T Consensus 78 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 78 ELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred ECCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 9999999999997543 23578999999999999999999998 9999999999999999999999999998754322
Q ss_pred CCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 596 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
......+..|+|||.+.++.++.++|+||||+++|||++ |+.||....... ..............
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~--- 219 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--------VKECVEKGYRMEPP--- 219 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--------HHHHHhCCCCCCCC---
Confidence 122334578999999988889999999999999999998 999986432211 01111111111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+..+.+++.+||+.+|++||+++++++.|+
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 122345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=302.06 Aligned_cols=256 Identities=22% Similarity=0.379 Sum_probs=201.8
Q ss_pred ccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
++|+..+.||+|+||.||+|..+ +.+.|++|.+... ......+.+..|++++++++|+||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT---KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc---cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 67889999999999999999753 3467999987652 12224567899999999999999999999999989
Q ss_pred eeEEEEEeccCCCHHHHhcccccc------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEE
Q 039322 510 HSFLVYELLERGSLAAILSSDTAA------QELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHV 583 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl 583 (708)
..++||||+++|+|.+++...... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEE
Confidence 999999999999999999755422 1589999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCC-CccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccccccc
Q 039322 584 ADFGIAKFLKPES-SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDE 661 (708)
Q Consensus 584 ~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 661 (708)
+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--------~~~~~~ 230 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------EEVLNR 230 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--------HHHHHH
Confidence 9999987543221 12233456778999999988888999999999999999998 7888853211 111111
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 662 ILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......... ....+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 231 ~~~~~~~~~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQAGKLELPV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCcCCCC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111111000 0112235889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=300.99 Aligned_cols=258 Identities=26% Similarity=0.438 Sum_probs=201.6
Q ss_pred cccccceeccccCccEEEEEeCC--CcEEEEEEcCCCCCc------chhHhHHHHHHHHHHHHh-ccCCceeeEEEEEee
Q 039322 437 DFDAQYCIGNGGHGSVYRAELPS--GQVVAIKKFHSPLPC------DQIADQKEFLIEVKALTE-IRHRNIVKFYGFCSH 507 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~~--~~~vavK~~~~~~~~------~~~~~~~~~~~e~~~l~~-l~h~~iv~l~~~~~~ 507 (708)
+|++.+.||+|+||.||+|.... ++.+|+|.+...... .......++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999997654 688999988642211 112334567788888765 699999999999999
Q ss_pred CCeeEEEEEeccCCCHHHHhccc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeec
Q 039322 508 ARHSFLVYELLERGSLAAILSSD-TAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADF 586 (708)
Q Consensus 508 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 586 (708)
++..+++|||+++++|.+++... .....+++..+++++.|++.|+.|||+.. +++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988542 12345889999999999999999999631 8999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 039322 587 GIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPR 666 (708)
Q Consensus 587 g~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (708)
|.+....... ......++..|+|||+..+..++.++||||||+++|+|++|+.||...... ..........
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--------~~~~~~~~~~ 229 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--------SLATKIVEAV 229 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--------HHHHHHhhcc
Confidence 9998655433 334556889999999999888999999999999999999999998632211 1111111221
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 667 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+... ......+.+++.+||+.||++||++.|+..+++
T Consensus 230 ~~~~~~--~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 YEPLPE--GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcCCc--ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111111 112345888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=297.18 Aligned_cols=251 Identities=27% Similarity=0.438 Sum_probs=199.8
Q ss_pred ccccceeccccCccEEEEEeCC-----CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 438 FDAQYCIGNGGHGSVYRAELPS-----GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
+++.+.||+|+||.||++...+ +..||+|++.... .....+.+..|++++++++|+||+++++++.+.+..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence 3567889999999999997653 3789999987532 1225678899999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
++|||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++...
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceec
Confidence 99999999999999975442 2289999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCccc-cccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCC
Q 039322 593 KPESSNWT-EFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 593 ~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
........ ...++..|+|||.+.+..++.++||||+|+++|+|++ |..||+.... ...............
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~ 225 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEYLKKGYRLPK 225 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCCCC
Confidence 54322211 2336789999999988889999999999999999998 7888763211 111111111111111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
... .+..+.+++.+|++.||++|||+.|+++.|
T Consensus 226 ~~~---~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 PEN---CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCc---CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111 334588899999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=300.54 Aligned_cols=257 Identities=23% Similarity=0.372 Sum_probs=201.9
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcc--hhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCD--QIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
+|+..+.||+|++|.||+|.. .+++.||+|++....... .....+.+..|++++++++|+||+++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477888999999999999964 578999999987533221 12245788999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-cEEEeeccccccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY-EAHVADFGIAKFL 592 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~ 592 (708)
|+||+++++|.+++.... .+++..+..++.|++.||+|||++ |++|+||+|+||+++.++ .++|+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999996533 478999999999999999999999 999999999999998776 5999999999876
Q ss_pred CCCCC----ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 039322 593 KPESS----NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 593 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
..... ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||........ ............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~- 228 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-----LALIFKIASATT- 228 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-----HHHHHHHhccCC-
Confidence 54321 11234578899999999888889999999999999999999999863221100 011111100000
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
...........+.+++.+||..+|++||++.|++++-
T Consensus 229 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~ 265 (268)
T cd06630 229 -APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265 (268)
T ss_pred -CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCc
Confidence 1111122345688899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=302.94 Aligned_cols=250 Identities=26% Similarity=0.392 Sum_probs=199.5
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
.|...+.||+|++|.||+|.. .+++.+|+|++... .....+.+.+|+.+++.++|+||+++++++..++..++++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR----KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc----chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 455567899999999999964 47889999987642 2234566889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++++|.+++.. .++++..+..++.|++.|++|||++ +++||||+|+||+++.++.++|+|||.+......
T Consensus 96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 96 EFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred eccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 99999999999865 2378999999999999999999999 9999999999999999999999999988755433
Q ss_pred CCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhH
Q 039322 596 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQ 675 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (708)
........++..|+|||...+..++.++||||+|+++|||++|+.||...... .......... .+......
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--------~~~~~~~~~~-~~~~~~~~ 239 (285)
T cd06648 169 VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--------QAMKRIRDNL-PPKLKNLH 239 (285)
T ss_pred CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHHHHhcC-CCCCcccc
Confidence 33333456889999999998888999999999999999999999998632211 1111111110 00000111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 676 EKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 676 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.....+.+++.+||+.+|++|||+.+++++-
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 270 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLNHP 270 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHccCc
Confidence 1234588999999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=299.11 Aligned_cols=251 Identities=26% Similarity=0.398 Sum_probs=197.9
Q ss_pred ccccccceeccccCccEEEEEeCC----CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
.+|.+.+.||+|+||.||+|...+ ...||||...... .....+.+.+|+.++++++||||+++++++.+ +..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 568889999999999999996533 3468999886532 13456689999999999999999999999875 457
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++||||+++|+|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence 89999999999999997543 3479999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCcc-ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCC
Q 039322 592 LKPESSNW-TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP-RLP 668 (708)
Q Consensus 592 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 668 (708)
........ ....++..|+|||.+....++.++||||||+++||+++ |+.||...... .....+... ..+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~~~~~~~~~~~~ 228 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--------DVIGRIENGERLP 228 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHcCCcCC
Confidence 54332211 22234568999999888889999999999999999996 99998643211 111111111 111
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+ . ..+..+.+++.+||..+|.+|||+.++++.|.
T Consensus 229 ~~-~---~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~ 263 (270)
T cd05056 229 MP-P---NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263 (270)
T ss_pred CC-C---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11 1 12345888999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=297.73 Aligned_cols=238 Identities=24% Similarity=0.391 Sum_probs=187.6
Q ss_pred ceeccccCccEEEEEeCCCc-----------EEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 442 YCIGNGGHGSVYRAELPSGQ-----------VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
+.||+|+||.||+|...+.. .|++|.+.... .....+.+|+.++++++||||+++++++.. +.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence 35899999999999765432 47788766421 126778899999999999999999999988 77
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-------cEEE
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY-------EAHV 583 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-------~~kl 583 (708)
.++||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +++||||||+||+++.++ .+||
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEe
Confidence 8999999999999999976442 588999999999999999999998 999999999999999887 7999
Q ss_pred eecccccccCCCCCccccccccccccCccccccC--CCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccc
Q 039322 584 ADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTM--KITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALD 660 (708)
Q Consensus 584 ~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 660 (708)
+|||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||..... .....
T Consensus 150 ~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--------~~~~~ 217 (259)
T cd05037 150 SDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--------SEKER 217 (259)
T ss_pred CCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--------hhHHH
Confidence 99999986543 2234466789999998776 78899999999999999999 5777653221 01111
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 661 EILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........+... ...+.+++.+||..+|.+|||+.|+++.|.
T Consensus 218 ~~~~~~~~~~~~-----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 218 FYQDQHRLPMPD-----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HHhcCCCCCCCC-----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111111111111 146889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=302.96 Aligned_cols=255 Identities=28% Similarity=0.428 Sum_probs=206.3
Q ss_pred HhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
..+.|+..+.||+|++|.||+|... +++.||+|++..... ..+.+..|++.+++++|+|++++++++..++..+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 4467888899999999999999765 688999999875321 4567889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+|+||+++++|.+++.... ..+++..+..++.|++.||+|||+. |++|+||+|+||+++.++.++|+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred EEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 9999999999999997654 3589999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
...........++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+.....+. ..
T Consensus 167 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~-~~ 237 (286)
T cd06614 167 TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--------RALFLITTKGIPP-LK 237 (286)
T ss_pred ccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhcCCCC-Cc
Confidence 43333333445778999999998888999999999999999999999998643211 0011111111111 11
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........+.+++.+||+.+|.+||++.+++++-.
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 11113346889999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=314.62 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=196.2
Q ss_pred cccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC--eeEEEE
Q 039322 439 DAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR--HSFLVY 515 (708)
Q Consensus 439 ~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--~~~lv~ 515 (708)
+...+||+|+|-+||+|.+ .+|..||==.++...-.......++|..|+.+|+.|+||||++++.++.+.. ..-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4556799999999999944 4566665322211111123355688999999999999999999999998765 477999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC-CcEEEeecccccccCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE-YEAHVADFGIAKFLKP 594 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~ 594 (708)
|.+..|+|..|.++++. ...+.+..|++||.+||.|||++ .|+|+|||||-+|||++.+ |.|||+|.|+|.....
T Consensus 123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999987763 78899999999999999999997 4799999999999999765 8999999999997754
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
. .....+|||.|||||+.. ..|+..+||||||+++.||+|+..||.- -.......+++..+..+....
T Consensus 199 s--~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE-------C~n~AQIYKKV~SGiKP~sl~-- 266 (632)
T KOG0584|consen 199 S--HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE-------CTNPAQIYKKVTSGIKPAALS-- 266 (632)
T ss_pred c--ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh-------hCCHHHHHHHHHcCCCHHHhh--
Confidence 3 334589999999999876 6799999999999999999999999862 112233344444433322111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
.-...++.++|.+|+.. .++|||+.|++++
T Consensus 267 kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 267 KVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 11134588999999999 8999999999875
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=302.36 Aligned_cols=262 Identities=23% Similarity=0.354 Sum_probs=202.3
Q ss_pred ccccccceeccccCccEEEEEeC-----CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee--C
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH--A 508 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~ 508 (708)
.+|++.+.||+|+||.||+|... +++.||||.+...... ...+.+.+|+++++.++|+||+++++++.. +
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE---QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch---HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 56788899999999999999643 3678999999764221 356789999999999999999999999977 5
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
...++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccc
Confidence 57899999999999999997544 2489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcc---ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc------cccccccc
Q 039322 589 AKFLKPESSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS------SLNTDIAL 659 (708)
Q Consensus 589 a~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~------~~~~~~~~ 659 (708)
+.......... ....++..|+|||...+..++.++||||||+++|||++|+.|+......... ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 98765332221 1223456799999998888999999999999999999999997642211100 00000111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 660 DEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+......+. ....+.++.+++.+||+.+|++|||+.||++.|+
T Consensus 236 ~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05038 236 LELLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281 (284)
T ss_pred HHHHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence 111111111110 1112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=304.10 Aligned_cols=265 Identities=21% Similarity=0.254 Sum_probs=198.2
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
++++|.+.+.||+|+||.||+|.. .+|+.||+|.+..... ......+.+|+++++.++|+||+++.+++..++..+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 79 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence 357899999999999999999964 4688999999875321 122345678999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+|+||+. +++.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++..
T Consensus 80 lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred EEEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccccccc
Confidence 9999996 67877765433 3467888999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------ccccc------c
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS--------SLNTD------I 657 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~--------~~~~~------~ 657 (708)
...........++..|+|||++.+. .++.++||||+|+++|||++|+.||+........ ..... .
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 4333333444578899999988754 4788999999999999999999999743211000 00000 0
Q ss_pred cc----ccccCCCCCCCCc---hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 AL----DEILDPRLPPPSR---SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~----~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. ..+.....+.... ........+.+++.+|++.||++|||++|++.|=+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~ 290 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence 00 0000000000000 00011345778999999999999999999998744
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=305.79 Aligned_cols=264 Identities=23% Similarity=0.360 Sum_probs=201.6
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc--chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence 46888999999999999999764 5899999998753321 13356788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
+||++++++.++.... ..+++.++..++.|++.|++|||+. +++|||++|+||++++++.++|+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 79 FEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred EecCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999999998877543 2389999999999999999999999 999999999999999999999999999986654
Q ss_pred CCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------cccc--------cc
Q 039322 595 ESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS--------SLNT--------DI 657 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~--------~~~~--------~~ 657 (708)
.........++..|+|||+..+ ..++.++||||||+++|||++|+.||......... .... ..
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 4433344567899999998865 34678999999999999999999998632211000 0000 00
Q ss_pred ccccccCCCCCCCC---chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 ALDEILDPRLPPPS---RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+...... .........+.+++.+||+.+|++||++++++++-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 285 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence 00000000000000 001122456889999999999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.42 Aligned_cols=264 Identities=23% Similarity=0.277 Sum_probs=200.2
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcch-hHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQ-IADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+|++.+.||+|++|.||+|.. .+++.||||.++....... ......+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477788999999999999965 4689999999976432211 12345677899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+ +|+|.+++.... ..+++..++.++.|+++||+|||++ +++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 889999996543 3589999999999999999999999 999999999999999999999999999987655
Q ss_pred CCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc-------------cccccc
Q 039322 595 ESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN-------------TDIALD 660 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-------------~~~~~~ 660 (708)
.........++..|+|||.+.+ ..++.++||||||+++|||++|..||............ ......
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 4333344456788999998765 45788999999999999999998777532211000000 000000
Q ss_pred cccCCCCCCC---CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 661 EILDPRLPPP---SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 661 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.......... ..........+.+++.+||++||++|||++|++++=
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~ 283 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP 283 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCc
Confidence 0000000000 001112235688999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.78 Aligned_cols=193 Identities=22% Similarity=0.361 Sum_probs=158.3
Q ss_pred ceeccccCccEEEEEeC---CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee--CCeeEEEEE
Q 039322 442 YCIGNGGHGSVYRAELP---SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH--ARHSFLVYE 516 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~e 516 (708)
..||+|+||.||+|... ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 57999999999999754 45789999986521 23457789999999999999999999854 457899999
Q ss_pred eccCCCHHHHhcccc------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee----CCCCcEEEeec
Q 039322 517 LLERGSLAAILSSDT------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL----DLEYEAHVADF 586 (708)
Q Consensus 517 ~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~Df 586 (708)
|+.+ +|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+||++ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9875 7877775322 123478999999999999999999999 99999999999999 55678999999
Q ss_pred ccccccCCCCC---ccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCc
Q 039322 587 GIAKFLKPESS---NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDF 644 (708)
Q Consensus 587 g~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~ 644 (708)
|+++....... ......+++.|+|||++.+. .++.++||||+||++|||+||+.||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 99986643322 12345678999999988764 578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=296.96 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=201.7
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+|+..+.||+|++|.||+|.. .+++.+|+|.+..... .......+..|++++++++|||++++++.+..++..++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence 478889999999999999955 4688999999875321 2234678899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC-CcEEEeecccccccCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE-YEAHVADFGIAKFLKP 594 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~ 594 (708)
||+++++|.+++.... ...+++..+.+++.|++.|++|||++ +++||||+|+||+++.+ +.+||+|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 79 EYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999999997543 23478999999999999999999999 99999999999999865 4589999999986643
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.. ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||+.... .............+...
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~-- 223 (256)
T cd08220 155 KS-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--------PALVLKIMSGTFAPISD-- 223 (256)
T ss_pred Cc-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--------HHHHHHHHhcCCCCCCC--
Confidence 32 22335678899999999888889999999999999999999999864221 11111111111111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.....+.+++.+||+.+|++|||++|++++=
T Consensus 224 -~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p 254 (256)
T cd08220 224 -RYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254 (256)
T ss_pred -CcCHHHHHHHHHHccCChhhCCCHHHHhhCC
Confidence 1234588999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.67 Aligned_cols=257 Identities=21% Similarity=0.256 Sum_probs=196.7
Q ss_pred hccccccceeccccCccEEEEEeC---CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP---SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
..+|.+.+.||+|+||.||++... .++.||+|.+... ....+|++++++++||||+++++++......
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 357999999999999999999643 3578999987642 2345799999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++|||++. ++|.+++... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.++|+|||++..
T Consensus 162 ~lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EEEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 99999996 5888888432 4589999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc---------------ccc
Q 039322 592 LKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS---------------SLN 654 (708)
Q Consensus 592 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~---------------~~~ 654 (708)
....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||......... ...
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 5443222 23456899999999999888999999999999999999999998642211000 000
Q ss_pred cc------cccccc---cCCCCCCCCc-hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 655 TD------IALDEI---LDPRLPPPSR-SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 655 ~~------~~~~~~---~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. ...... ..+....+.. .......++.+++.+|+..||++|||+.|++.+-+
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 00 000000 0000000000 00112345778999999999999999999998743
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=302.14 Aligned_cols=263 Identities=19% Similarity=0.274 Sum_probs=197.5
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|++|.||+|..+ +++.||+|.+...... .....+.+|++++++++|+||+++++++..++..++|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 67899999999999999999664 6889999998753211 1234567899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+.+ +|.+++.... ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+++....
T Consensus 82 ~e~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 82 FEYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred EecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 999985 9999886543 3578999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------cccccccc------
Q 039322 595 ESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS--------SLNTDIAL------ 659 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~--------~~~~~~~~------ 659 (708)
.........++..|+|||+..+ ..++.++||||+|+++|+|++|+.||......... ........
T Consensus 156 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 156 PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 2222233356789999998865 45788999999999999999999998643210000 00000000
Q ss_pred ccccCCCCCCC--Cc---h--hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 660 DEILDPRLPPP--SR---S--VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 660 ~~~~~~~~~~~--~~---~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........... .. . .......+.+++.+|++.+|++|||+.|++++-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~ 290 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 00000000000 00 0 0001145678999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=298.28 Aligned_cols=253 Identities=27% Similarity=0.362 Sum_probs=201.3
Q ss_pred cccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCc-chhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPC-DQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+|+..+.||+|++|.||+|... +++.|++|.+...... ...+..+.+.+|++++++++|+||+++++++..++..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999765 7899999998653211 1123456789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
+||+++++|.+++.... .+++..+..++.|++.|++|||+. |++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999996543 478999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC-CCCCCCCc
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD-PRLPPPSR 672 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 672 (708)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||...... ........ ...+..
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~-- 223 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--------AAVFKIGRSKELPPI-- 223 (258)
T ss_pred cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--------HHHHHHHhcccCCCc--
Confidence 32 223456788999999987766 889999999999999999999998632210 00000000 111111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+.+++.+||+.+|++||++++++++-.
T Consensus 224 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 257 (258)
T cd06632 224 -PDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257 (258)
T ss_pred -CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence 1112345788999999999999999999998643
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=299.97 Aligned_cols=239 Identities=22% Similarity=0.392 Sum_probs=186.9
Q ss_pred eeccccCccEEEEEeCC--------CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 443 CIGNGGHGSVYRAELPS--------GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 443 ~ig~G~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.||+|+||.||+|.... ...||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 58999999999996532 234888887542 233456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc--------EEEeec
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE--------AHVADF 586 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Df 586 (708)
|||+++|+|.+++.... ..+++..+..++.|++.|++|||++ +++||||||+||+++.++. ++++||
T Consensus 78 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999999999997654 3578999999999999999999999 9999999999999987765 699999
Q ss_pred ccccccCCCCCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCC-CCCCccccccccccccccccccccC
Q 039322 587 GIAKFLKPESSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGK-HPRDFLSLISSSSLNTDIALDEILD 664 (708)
Q Consensus 587 g~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 664 (708)
|.+....+. ....++..|+|||++.+. .++.++||||||+++|||++|. .||....... . .....
T Consensus 153 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--------~-~~~~~ 219 (258)
T cd05078 153 GISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--------K-LQFYE 219 (258)
T ss_pred ccccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--------H-HHHHH
Confidence 998754322 234577899999998764 4788999999999999999985 5554221110 0 00111
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 665 PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 665 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+.. ...++.+++.+||+.||++|||++++++.|.
T Consensus 220 ~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 DRHQLPAP----KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ccccCCCC----CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11111111 1235789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=317.17 Aligned_cols=191 Identities=23% Similarity=0.357 Sum_probs=163.7
Q ss_pred HhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
...+|++.+.||+|+||.||+|... +++.||+|..... ....|+.++++++|+||+++++++..++..+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 3457999999999999999999654 5778999985432 2345899999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+|+|++. ++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 134 lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EEEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 9999995 58888886433 4589999999999999999999999 9999999999999999999999999999753
Q ss_pred CCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p 641 (708)
... .......|+..|+|||++.+..++.++|||||||++|||+++..|
T Consensus 208 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~ 255 (357)
T PHA03209 208 VVA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST 255 (357)
T ss_pred ccC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence 322 222345689999999999998999999999999999999985554
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=305.43 Aligned_cols=254 Identities=23% Similarity=0.276 Sum_probs=196.9
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||++... +++.||+|.+..... ......+.+.+|+++++.++||||+++++.+..++..++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 36888999999999999999654 578999999875321 1123356788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||+++....
T Consensus 80 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 80 MEYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999996543 478999999999999999999999 999999999999999999999999999863211
Q ss_pred CCC---------------ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccc
Q 039322 595 ESS---------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIAL 659 (708)
Q Consensus 595 ~~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 659 (708)
... ......++..|+|||.+.+..++.++|+||||+++|||++|+.||..... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--------~~~~ 225 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------EELF 225 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHH
Confidence 000 01123467889999999888899999999999999999999999863211 1111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHH
Q 039322 660 DEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT---MKVVTQQ 705 (708)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 705 (708)
..........+... ...+..+.+++.+||+.||++||+ +.+++++
T Consensus 226 ~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 226 GQVISDDIEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHhcccCCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11111111111110 122345789999999999999998 4555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=303.15 Aligned_cols=252 Identities=25% Similarity=0.417 Sum_probs=196.2
Q ss_pred ccccccceeccccCccEEEEEeC-CCc----EEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQ----VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
++|+..+.||+|+||.||+|... +|+ .||+|.+.... ......++.+|+.++++++||||+++++++..+ .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 67888899999999999999653 444 57889876532 223345688999999999999999999998764 4
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++++||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence 678999999999999987543 3478999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 039322 591 FLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 591 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
........ .....++..|+|||++.+..++.++||||||+++|||++ |+.||......... .... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-----~~~~--~~~~~ 230 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-----DLLE--KGERL 230 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----HHHH--CCCCC
Confidence 65433221 122345678999999988889999999999999999997 99998642211100 0000 01111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+.+. .....+.+++.+||..+|++||+++++++.++
T Consensus 231 ~~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~ 266 (303)
T cd05110 231 PQPP----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFS 266 (303)
T ss_pred CCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111 12245788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=299.46 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=194.6
Q ss_pred ceeccccCccEEEEEeCC-------CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 442 YCIGNGGHGSVYRAELPS-------GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+.||+|+||.||+|...+ ++.+|+|.+.... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 358999999999997542 2579999886532 123456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccc----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-----cEEEee
Q 039322 515 YELLERGSLAAILSSDT----AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY-----EAHVAD 585 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-----~~kl~D 585 (708)
|||+++++|.+++.... ....+++.++..++.|++.|++|||+. +++|+||+|+||+++.++ .++++|
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999999999996532 123478899999999999999999998 999999999999999877 899999
Q ss_pred cccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccc
Q 039322 586 FGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEI 662 (708)
Q Consensus 586 fg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 662 (708)
||++......... .....++..|+|||.+.++.++.++||||||+++|||++ |+.||....... ....+
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--------~~~~~ 226 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--------VLQHV 226 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--------HHHHH
Confidence 9998755332211 122345678999999999899999999999999999998 999986322111 11111
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 663 LDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........ ....+..+.+++.+||..+|++||+++++++.|+
T Consensus 227 ~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 227 TAGGRLQK---PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred hcCCccCC---cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11111111 1122346789999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=298.56 Aligned_cols=259 Identities=24% Similarity=0.362 Sum_probs=199.7
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcch------hHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQ------IADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
+|...+.||+|++|.||+|.. .+|+.||+|.++....... ....+.+..|++++++++|+|++++++++..++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999954 4688999998864221111 112356888999999999999999999999999
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccc
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA 589 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 589 (708)
..++||||+++++|.+++... ..+++..+..++.|++.|+.|||++ +++||||+|+||+++.++.++++|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999999765 3488999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC--ccccccccccccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 039322 590 KFLKPESS--NWTEFAGTYGYVAPELAYTMK--ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDP 665 (708)
Q Consensus 590 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 665 (708)
........ ......++..|+|||.+.... ++.++||||+|+++|++++|..||.......... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~-- 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF----KLGNKRS-- 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH----Hhhcccc--
Confidence 76532211 122345788999999887654 7889999999999999999999986322110000 0000000
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 666 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+..........+.+++.+||+.+|++|||+++|++|-+
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (272)
T cd06629 230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271 (272)
T ss_pred CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence 111111111223456889999999999999999999998854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=302.93 Aligned_cols=251 Identities=29% Similarity=0.411 Sum_probs=198.2
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
..|+..+.||+|+||.||+|... +++.||+|.+..... ......+.+.+|+++++.++||||+++.+++.+++..++|
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 56888899999999999999654 688999999864321 2223456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
+||+. |++.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 57777775433 3489999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 595 ESSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
. ....++..|+|||++. .+.++.++||||||+++|||+||+.||....... ..........+ .
T Consensus 168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--------~~~~~~~~~~~--~ 233 (307)
T cd06607 168 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNDSP--T 233 (307)
T ss_pred C----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--------HHHHHhcCCCC--C
Confidence 2 2345778999999874 3567889999999999999999999986432111 00000000000 0
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.........+.+++.+||+.+|++||++.+++++.+
T Consensus 234 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 234 LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 111223456889999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=301.13 Aligned_cols=249 Identities=22% Similarity=0.270 Sum_probs=194.9
Q ss_pred eccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccCCC
Q 039322 444 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGS 522 (708)
Q Consensus 444 ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~ 522 (708)
||+|+||+||+|.. .+|+.||+|.+..... ........+..|++++++++||||+++++++...+..|+||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL-KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhh-hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 69999999999954 4688999999865321 112234567789999999999999999999999999999999999999
Q ss_pred HHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 039322 523 LAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEF 602 (708)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 602 (708)
|.+++..... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+..... .......
T Consensus 80 L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~ 154 (277)
T cd05577 80 LKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGR 154 (277)
T ss_pred HHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccc
Confidence 9999975442 4589999999999999999999999 999999999999999999999999999876543 2222345
Q ss_pred cccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHH
Q 039322 603 AGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIM 682 (708)
Q Consensus 603 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 682 (708)
.++..|+|||+..+..++.++||||+|+++|+|++|+.||....... ............... ........+.
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~----~~~~~~~~~~ 226 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV----EKEELKRRTLEMAVE----YPDKFSPEAK 226 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc----cHHHHHhcccccccc----CCccCCHHHH
Confidence 67889999999988889999999999999999999999986432100 000001111111111 1111234578
Q ss_pred HHHHhccCCCCCCCC-----CHHHHHHHh
Q 039322 683 EVAFSCLNESPESRP-----TMKVVTQQV 706 (708)
Q Consensus 683 ~li~~cl~~dP~~RP-----s~~evl~~l 706 (708)
+++.+||+.||++|| ++.++++|-
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~ll~h~ 255 (277)
T cd05577 227 DLCEALLQKDPEKRLGCRGGSADEVREHP 255 (277)
T ss_pred HHHHHHccCChhHccCCCcccHHHHHhCh
Confidence 999999999999999 777788764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=297.21 Aligned_cols=254 Identities=23% Similarity=0.336 Sum_probs=203.1
Q ss_pred cccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+|.+.+.||+|+||.||+|..+ +|..||+|.+.... ......+.+.+|++++++++|+||+++++++...+..++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK--MPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhh--ccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence 4778889999999999999654 58899999986521 11234567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc-EEEeecccccccCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE-AHVADFGIAKFLKP 594 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfg~a~~~~~ 594 (708)
||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||+|+||++++++. +|++|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 79 EYCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred ecCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 99999999999965432 3478999999999999999999999 9999999999999998864 69999999987654
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.........++..|+|||+..+..++.++||||||+++|||++|+.||..... .............+..
T Consensus 155 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~--- 223 (257)
T cd08225 155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL--------HQLVLKICQGYFAPIS--- 223 (257)
T ss_pred CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHhcccCCCCC---
Confidence 43333445688999999999888899999999999999999999999863221 1111111111111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+.+++.+||..+|++|||+.|++++-+
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~ 256 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILKRPF 256 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence 112235889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=292.82 Aligned_cols=250 Identities=30% Similarity=0.454 Sum_probs=203.6
Q ss_pred cccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+|+..+.||+|++|.||++... +++.+++|++..... ...+.+.+|++++++++|++++++++++..++..++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 4778889999999999999764 688999999876321 35678999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++++|.+++.... ..+++..+..++.|++.|+++||+. +++||||+|+||+++.++.++|+|||.+......
T Consensus 77 e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 77 EFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred ecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 9999999999987643 4589999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhH
Q 039322 596 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQ 675 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (708)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......... .......+.... ..
T Consensus 152 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~----~~ 221 (253)
T cd05122 152 KA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF-----KIATNGPPGLRN----PE 221 (253)
T ss_pred cc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH-----HHHhcCCCCcCc----cc
Confidence 32 344568899999999988888999999999999999999999987432110000 000000011111 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 676 EKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 676 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
.....+.+++.+||+.||++|||+.|++++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 113458899999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=301.99 Aligned_cols=264 Identities=22% Similarity=0.310 Sum_probs=198.6
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+|+..+.||+|++|.||+|.. .+|+.||||.++..... ....+.+..|++++++++||||+++++++.+++..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc--cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence 478889999999999999965 46889999998753321 123457889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+. ++|.+++.... ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 79 EFLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred eccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9996 58998886543 24589999999999999999999999 9999999999999999999999999998765443
Q ss_pred CCccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------ccccc---cccccc-
Q 039322 596 SSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS-------LNTDI---ALDEIL- 663 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-------~~~~~---~~~~~~- 663 (708)
........++..|+|||...+.. ++.++||||||+++|||+||+.||.......... ..... ......
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 33333445678999999877654 5789999999999999999999986432110000 00000 000000
Q ss_pred ----CCCCCCCC--chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 664 ----DPRLPPPS--RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 664 ----~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+...... .........+.+++.+||+.||++|||++|++++-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 283 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCC
Confidence 00000000 000111235778999999999999999999998744
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=300.16 Aligned_cols=256 Identities=21% Similarity=0.370 Sum_probs=194.8
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHH-HHhccCCceeeEEEEEeeCCeeEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKA-LTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
++|++.+.||+|+||.||+|... +|+.||+|.++..... ....++..|+.. ++..+||||+++++++..++..++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS---QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc---HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence 46888999999999999999654 6999999998764321 233455566665 666789999999999999999999
Q ss_pred EEEeccCCCHHHHhccc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 514 VYELLERGSLAAILSSD-TAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+|||++ |+|.+++... .....+++..++.++.|++.||+|||++. +++||||||+||+++.++.+||+|||.+...
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999997 5888887542 22346899999999999999999999853 8999999999999999999999999999865
Q ss_pred CCCCCccccccccccccCcccccc----CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYT----MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
.... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||..... .............+
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~ 226 (283)
T cd06617 155 VDSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-------PFQQLKQVVEEPSP 226 (283)
T ss_pred cccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-------CHHHHHHHHhcCCC
Confidence 4221 2233467889999998765 3467899999999999999999999863211 00111111111111
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+ ....+..+.+++.+||+.+|++||++.+++++-+
T Consensus 227 ~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 263 (283)
T cd06617 227 QLP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPF 263 (283)
T ss_pred CCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 000 0112346889999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=298.05 Aligned_cols=257 Identities=23% Similarity=0.276 Sum_probs=203.0
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
..+.|+..++||+|+||.||.... .+|+.||.|.+.+.. ............|-.++++++.+.||.+-.+|+.++.+|
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKR-iKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKR-IKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHH-HHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 346789999999999999999854 469999999886521 112223445778999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+|+..|.||+|.-+|...+. ..++++.+..+|.+|+.||++||+. +||+||+||+|||+|+.|+++|+|.|+|..+
T Consensus 262 lVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999999977664 4589999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC-CCCC
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL-PPPS 671 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 671 (708)
.... .....+||.+|||||++.++.|+...|.||+||++|||+.|+.||..... .. -.+-++.+. ..+.
T Consensus 338 ~~g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke--------Kv-k~eEvdrr~~~~~~ 407 (591)
T KOG0986|consen 338 PEGK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE--------KV-KREEVDRRTLEDPE 407 (591)
T ss_pred CCCC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh--------hh-hHHHHHHHHhcchh
Confidence 6443 33455999999999999999999999999999999999999999863211 00 011111111 1111
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRP-----TMKVVTQQ 705 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 705 (708)
........+..++.+..+++||++|. .+++|.+|
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 12222334466667788999999997 44455443
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=299.91 Aligned_cols=263 Identities=23% Similarity=0.317 Sum_probs=201.2
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+|++.+.||+|++|.||+|.. .+|+.||+|++...... ....+.+.+|+.++++++||||+++++++..++..++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE--GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc--chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence 478889999999999999965 46899999998763211 233567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+ +++|.+++.... ..+++.+++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 79 EYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred ccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 999 999999986543 4589999999999999999999999 9999999999999999999999999999866543
Q ss_pred CC-ccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccc---ccc---ccc
Q 039322 596 SS-NWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS-------SLN---TDI---ALD 660 (708)
Q Consensus 596 ~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-------~~~---~~~---~~~ 660 (708)
.. ......++..|+|||++.+.. ++.++||||+|+++|||++|..||......... ... ... ...
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 22 233456889999999886544 688999999999999999998887532210000 000 000 000
Q ss_pred cccCCCCCCCC-----chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 661 EILDPRLPPPS-----RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 661 ~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.....+... ....+....+.+++.+|++.+|++|||++++++|-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~ 284 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence 00000000000 000122357889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=300.17 Aligned_cols=263 Identities=19% Similarity=0.300 Sum_probs=200.5
Q ss_pred cccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+|+..+.||+|++|.||+|... +|+.||||.++.... ....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence 4788899999999999999764 688999999876422 123456778999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++ +|.+++........+++..+..++.|++.||+|||+. +++||||+|+||++++++.++++|||++......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 99985 8999887655445689999999999999999999999 9999999999999999999999999999765433
Q ss_pred CCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc-------cccccccc-----c
Q 039322 596 SSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL-------NTDIALDE-----I 662 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-------~~~~~~~~-----~ 662 (708)
........++..|+|||++.+. .++.++||||+|+++|+|++|+.||........... ........ .
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 3333344578899999987654 468899999999999999999999874321100000 00000000 0
Q ss_pred cCCCCCCCCc-----hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 663 LDPRLPPPSR-----SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 663 ~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.....+.... ..+.....+.+++.+|++.||.+||+++|++++=
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~ 282 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHP 282 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCC
Confidence 0011111000 0011234678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=301.70 Aligned_cols=263 Identities=22% Similarity=0.256 Sum_probs=199.0
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC--CeeE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA--RHSF 512 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~ 512 (708)
++|++.+.||+|+||.||+|..+ +++.+|+|.++..... ......+.+|+.++++++||||+++++++..+ +..+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 57899999999999999999765 6889999998753221 12234577899999999999999999999877 8899
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+||||+.+ +|.+++.... ..+++..++.++.|++.||+|||++ +++||||+|+||+++.++.++|+|||.+...
T Consensus 83 lv~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred EEehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99999975 9999886543 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccccccc-------cc------cc
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN-------TD------IA 658 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-------~~------~~ 658 (708)
...........++..|+|||.+.+.. ++.++|+||+|+++|+|++|+.||............ .. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 54433334456788999999887644 688999999999999999999998643211000000 00 00
Q ss_pred ccccc-----CCCCCCCCchhHH--HHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 659 LDEIL-----DPRLPPPSRSVQE--KLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 659 ~~~~~-----~~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
+.... ............. ....+.+++.+||+.||++|||+.|++++=
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~ 291 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCC
Confidence 00000 0000000000001 234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=295.16 Aligned_cols=254 Identities=23% Similarity=0.373 Sum_probs=195.6
Q ss_pred ccccceeccccCccEEEEEeC----CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC----
Q 039322 438 FDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR---- 509 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~---- 509 (708)
|.+.+.||+|+||.||+|... +++.||||++.... ......+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 567788999999999999643 46889999987533 22334667889999999999999999999886542
Q ss_pred --eeEEEEEeccCCCHHHHhcccc---cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEe
Q 039322 510 --HSFLVYELLERGSLAAILSSDT---AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVA 584 (708)
Q Consensus 510 --~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~ 584 (708)
..++++||+.+|+|.+++.... ....+++..+.+++.|++.|++|||+. +++||||||+||+++.++.+|++
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEEC
Confidence 2478999999999998875322 123478899999999999999999998 99999999999999999999999
Q ss_pred ecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccccccc
Q 039322 585 DFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDE 661 (708)
Q Consensus 585 Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 661 (708)
|||+++........ .....++..|++||......++.++||||||+++|||++ |+.||..... ......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--------~~~~~~ 227 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--------SEIYNY 227 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--------HHHHHH
Confidence 99999865432211 122345678999999988888999999999999999999 8888763221 111111
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 662 ILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+......... ......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 228 ~~~~~~~~~~---~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~ 270 (273)
T cd05074 228 LIKGNRLKQP---PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270 (273)
T ss_pred HHcCCcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111111100 112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=302.65 Aligned_cols=263 Identities=27% Similarity=0.373 Sum_probs=201.2
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|++|.||+|..+ +++.||+|.++.... .....+.+.+|++++++++|+||+++++++..++..++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence 36888999999999999999765 588999999875321 223457789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||++++.+..+.... ..+++.+++.++.|++.|++|||+. +++|+|++|+||++++++.+||+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 79 FEYVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred EecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 9999987777665432 3478999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-ccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------cccc----ccccc
Q 039322 595 ESS-NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS--------SLNT----DIALD 660 (708)
Q Consensus 595 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~--------~~~~----~~~~~ 660 (708)
... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||......... .... .....
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 432 23345678899999999887 7889999999999999999999998643211000 0000 00000
Q ss_pred cccCC-CCCCCC--ch-----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 661 EILDP-RLPPPS--RS-----VQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 661 ~~~~~-~~~~~~--~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
..... ..+... .. .......+.+++++||+.+|++|||+++++++=
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 286 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHP 286 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCC
Confidence 00000 000000 00 001145688999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=301.57 Aligned_cols=263 Identities=23% Similarity=0.289 Sum_probs=198.7
Q ss_pred ccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEE
Q 039322 438 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYE 516 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 516 (708)
|++.+.||.|++|.||+|.. .+|+.||+|++..... .......+.+|++++++++|+|++++++++.+++..+++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence 56778899999999999965 4799999999875321 11234567889999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 039322 517 LLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596 (708)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 596 (708)
|++ ++|.+++..... ..+++..+..++.|+++||+|||++ +++||||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 79 FLD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred ccC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 995 699999865442 3589999999999999999999998 99999999999999999999999999997654333
Q ss_pred CccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc-------ccc------ccc---
Q 039322 597 SNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL-------NTD------IAL--- 659 (708)
Q Consensus 597 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-------~~~------~~~--- 659 (708)
.......++..|+|||++.+. .++.++||||||+++|+|++|+.||........... ... ...
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 333334568899999987664 468899999999999999999999864321100000 000 000
Q ss_pred -ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 660 -DEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 660 -~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....................+.+++.+||+.||++|||++|++++-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 282 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence 000000000000111112346889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=300.33 Aligned_cols=245 Identities=26% Similarity=0.397 Sum_probs=196.3
Q ss_pred cceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 441 QYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 441 ~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
...||+|+||.||+|.. .+++.||+|++... .......+.+|+.+++.++|+|++++++++..++..++||||++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 35799999999999966 47889999987542 22345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 599 (708)
+++|.+++... .+++..+..++.|++.|++|||+. |++||||+|+||+++.++.++|+|||++..........
T Consensus 101 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~ 173 (292)
T cd06657 101 GGALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173 (292)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence 99999987542 378999999999999999999999 99999999999999999999999999987654333333
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHH
Q 039322 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLI 679 (708)
Q Consensus 600 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (708)
....++..|+|||.+.+..++.++|+||+|+++|+|++|..||......... ........+.... ......
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~~----~~~~~~ 244 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-----KMIRDNLPPKLKN----LHKVSP 244 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhhCCcccCC----cccCCH
Confidence 4456789999999988888899999999999999999999998642211100 0011111111111 111233
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 680 SIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 680 ~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
.+.+++.+||+.+|.+||++.+++++
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 57788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=325.53 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=200.3
Q ss_pred HHhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC---
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA--- 508 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--- 508 (708)
+-..+|+....||+||||.||+++.+ ||+.||||++.... .......+.+|++.+.+++|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence 34578889999999999999999765 89999999998632 334567789999999999999999997443100
Q ss_pred --------------------------------------------------------------------------------
Q 039322 509 -------------------------------------------------------------------------------- 508 (708)
Q Consensus 509 -------------------------------------------------------------------------------- 508 (708)
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence
Q ss_pred ------------------------------------CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHH
Q 039322 509 ------------------------------------RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADAL 552 (708)
Q Consensus 509 ------------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l 552 (708)
-.+||-||||+..++.++++.+.... .....|+++++|++||
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGL 710 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHH
Confidence 01478899999988888876554211 4678899999999999
Q ss_pred HHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC------------------CCCCccccccccccccCcccc
Q 039322 553 SYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK------------------PESSNWTEFAGTYGYVAPELA 614 (708)
Q Consensus 553 ~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~------------------~~~~~~~~~~~~~~y~aPE~~ 614 (708)
+|+|++ |+|||||||.|||+++++.|||+|||+|+... .+....+..+||.-|+|||++
T Consensus 711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 999999 99999999999999999999999999998721 111134567899999999998
Q ss_pred ccCC---CCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCC
Q 039322 615 YTMK---ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNE 691 (708)
Q Consensus 615 ~~~~---~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 691 (708)
.+.. |+.|+|+||+||+++||+. ||.- ...+...+..+.++.++.++....+....=..+|++++++
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T-------sMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT-------SMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSH 857 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCc-------hHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcC
Confidence 7654 9999999999999999984 4541 2223444555666777666444444444556889999999
Q ss_pred CCCCCCCHHHHHHH
Q 039322 692 SPESRPTMKVVTQQ 705 (708)
Q Consensus 692 dP~~RPs~~evl~~ 705 (708)
||.+||||.|+++.
T Consensus 858 dP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 858 DPSKRPTATELLNS 871 (1351)
T ss_pred CCccCCCHHHHhhc
Confidence 99999999999864
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=297.76 Aligned_cols=247 Identities=19% Similarity=0.210 Sum_probs=187.2
Q ss_pred eeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHH---hccCCceeeEEEEEeeCCeeEEEEEec
Q 039322 443 CIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALT---EIRHRNIVKFYGFCSHARHSFLVYELL 518 (708)
Q Consensus 443 ~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~---~l~h~~iv~l~~~~~~~~~~~lv~e~~ 518 (708)
.||+|+||.||++.. .+++.||+|.+.+..... ......+.+|..+++ ..+|++|+.+++++..++..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEcccccc-chHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 489999999999965 468899999987532211 112233444444333 347999999999999999999999999
Q ss_pred cCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 039322 519 ERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN 598 (708)
Q Consensus 519 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 598 (708)
++|+|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 80 ~~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 80 NGGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999999986543 489999999999999999999999 99999999999999999999999999987553322
Q ss_pred cccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHH
Q 039322 599 WTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEK 677 (708)
Q Consensus 599 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (708)
.....++..|+|||...+ ..++.++||||+||++|+|++|+.||....... ......... . .........
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~-~--~~~~~~~~~ 222 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD------KHEIDRMTL-T--VNVELPDSF 222 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC------HHHHHHHhh-c--CCcCCcccc
Confidence 223468999999998864 457899999999999999999999986322110 000111000 0 000111123
Q ss_pred HHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 039322 678 LISIMEVAFSCLNESPESRP-----TMKVVTQQVR 707 (708)
Q Consensus 678 ~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~ 707 (708)
..++.+++.+||+.||++|| |++|+++|-.
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~ 257 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF 257 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence 34688999999999999999 6999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=298.46 Aligned_cols=253 Identities=26% Similarity=0.337 Sum_probs=203.6
Q ss_pred cccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+|++.+.||+|+||.||+|... +++.||+|.+..... ......+.+.+|++++++++||||+++++++..++..++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 4788899999999999999664 689999999875321 12234578899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+.+++|.+++... ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 80 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 80 DLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred eCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 999999999999754 3488999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhH
Q 039322 596 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQ 675 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (708)
. ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||....... ...............+ .
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~----~ 223 (258)
T cd05578 154 T-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-----RDQIRAKQETADVLYP----A 223 (258)
T ss_pred c-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-----HHHHHHHhccccccCc----c
Confidence 2 2234567889999999988889999999999999999999999987433210 0111111111111111 1
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCH--HHHHHHh
Q 039322 676 EKLISIMEVAFSCLNESPESRPTM--KVVTQQV 706 (708)
Q Consensus 676 ~~~~~l~~li~~cl~~dP~~RPs~--~evl~~l 706 (708)
..+..+.+++.+||+.||.+||++ +|++++=
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~ 256 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLKNHP 256 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHhcCC
Confidence 123568899999999999999999 8888763
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=282.97 Aligned_cols=253 Identities=24% Similarity=0.291 Sum_probs=207.1
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
..++|+..+++|+|.||.|-.++- .+|+.||+|++++....+ ..+.+.-..|-++++..+||.+..+-..|...++.|
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviia-kdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIA-KDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheee-hHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 468999999999999999999954 479999999999854332 344556678999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
.||||+.||.|.-+++..+ .+++...+.+-..|+.||.|||++ +||+||+|.+|.++|.||++||+|||++..-
T Consensus 245 FVMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999998886543 488888999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
-..+......+||+.|.|||++....|+.++|.|.+|+++|||++|+.||.... .+..+.-++-..+..+..
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d--------h~kLFeLIl~ed~kFPr~ 390 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD--------HEKLFELILMEDLKFPRT 390 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc--------hhHHHHHHHhhhccCCcc
Confidence 555566678899999999999999999999999999999999999999997322 122222222233333222
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRP-----TMKVVTQQ 705 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 705 (708)
..+ +...|+...+.+||++|. .+.||.+|
T Consensus 391 ls~----eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 391 LSP----EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred CCH----HHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 222 245667788999999997 56666554
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=300.46 Aligned_cols=266 Identities=21% Similarity=0.264 Sum_probs=197.7
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCe---
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARH--- 510 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~--- 510 (708)
++|+..+.||+|+||.||+|.. .+++.||+|.++..... ......+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE--EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc--cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 3688899999999999999965 46899999998753211 123456888999999995 6999999999977665
Q ss_pred --eEEEEEeccCCCHHHHhccccc--ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-CCcEEEee
Q 039322 511 --SFLVYELLERGSLAAILSSDTA--AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL-EYEAHVAD 585 (708)
Q Consensus 511 --~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~D 585 (708)
.|+||||+++ ++.+++..... ...+++..++.++.||+.||+|||++ +++||||+|+||+++. ++.+||+|
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEee
Confidence 8999999986 89888865432 24579999999999999999999999 9999999999999998 88999999
Q ss_pred cccccccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------ccccc
Q 039322 586 FGIAKFLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS-------LNTDI 657 (708)
Q Consensus 586 fg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-------~~~~~ 657 (708)
||++..+...........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.......... .....
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 155 LGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9999865443333334456889999998765 457889999999999999999999986432111000 00000
Q ss_pred cc------cccc-CCCCCCC--CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 AL------DEIL-DPRLPPP--SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~------~~~~-~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. .... .+...+. ..........+.++|.+||++||++||+++|+++|=+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~ 293 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence 00 0000 0000000 0001123456889999999999999999999998743
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=290.57 Aligned_cols=254 Identities=27% Similarity=0.378 Sum_probs=206.6
Q ss_pred cccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC--CeeEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA--RHSFL 513 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~l 513 (708)
+|...+.||+|++|.||+|... +++.|++|++...... ....+.+.+|++++++++|+||+++++.+... +..++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS--EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence 4677889999999999999765 6899999998764321 34567889999999999999999999999988 88999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
|+||+++++|.+++.... .+++..++.++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 79 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 999999999999997543 589999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC-CCCCCC
Q 039322 594 PESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD-PRLPPP 670 (708)
Q Consensus 594 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 670 (708)
.... ......++..|+|||...+...+.++||||||+++|+|++|..||..... .......... ......
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~ 225 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAALYKIGSSGEPPEI 225 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHhccccCCCcCC
Confidence 5433 13445688999999999888899999999999999999999999874330 0011111111 111111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
+ ......+.+++.+|++.+|++||++.|++++-++
T Consensus 226 ~---~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 226 P---EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred C---cccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 1 1124568899999999999999999999987553
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=293.49 Aligned_cols=246 Identities=26% Similarity=0.340 Sum_probs=198.0
Q ss_pred eccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccCCC
Q 039322 444 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGS 522 (708)
Q Consensus 444 ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~ 522 (708)
||.|++|.||+|... +++.||+|++.+... ......+.+.+|++++++++||||+++++++.+++..++++||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI-VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcc-hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 699999999999764 488999999875322 122345679999999999999999999999999999999999999999
Q ss_pred HHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 039322 523 LAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEF 602 (708)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 602 (708)
|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 80 L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~ 152 (262)
T cd05572 80 LWTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTF 152 (262)
T ss_pred HHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccc
Confidence 999996543 378999999999999999999998 99999999999999999999999999998665432 22334
Q ss_pred cccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC--CCCCCCCchhHHHHHH
Q 039322 603 AGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD--PRLPPPSRSVQEKLIS 680 (708)
Q Consensus 603 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 680 (708)
.++..|+|||.+.+..++.++|+||+|+++|+|++|+.||..... ........+.. .....+ ... ...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~-~~~---~~~ 222 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILKGNGKLEFP-NYI---DKA 222 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhccCCCCCCC-ccc---CHH
Confidence 678899999998888899999999999999999999999874321 01111222221 111111 111 346
Q ss_pred HHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 039322 681 IMEVAFSCLNESPESRPT-----MKVVTQQVR 707 (708)
Q Consensus 681 l~~li~~cl~~dP~~RPs-----~~evl~~l~ 707 (708)
+.+++.+||+.+|++||+ ++|++++-+
T Consensus 223 ~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~ 254 (262)
T cd05572 223 AKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW 254 (262)
T ss_pred HHHHHHHHccCChhhCcCCcccCHHHHhcChh
Confidence 889999999999999999 899988643
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=290.63 Aligned_cols=255 Identities=26% Similarity=0.381 Sum_probs=207.3
Q ss_pred cccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+|.+.+.||.|++|.||++... +++.||+|.+.... ......+.+.+|++++++++|+|++++.+.+..++..++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN--MSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc--CChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence 4778899999999999999654 68899999987532 12345667889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 516 ELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
||+++++|.+++.... ....+++..+..++.+++.|++|||+. |++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 9999999999997643 135589999999999999999999999 999999999999999999999999999987655
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.........+++.|+|||...+..++.++||||+|+++|+|++|+.||+.... .............+.+.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~-- 225 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--------LELALKILKGQYPPIPS-- 225 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--------HHHHHHHhcCCCCCCCC--
Confidence 44333445688899999998888899999999999999999999999874321 11111111221221111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+.+++.+||+.+|++|||+.|++++-.
T Consensus 226 -~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 257 (258)
T cd08215 226 -QYSSELRNLVSSLLQKDPEERPSIAQILQSPF 257 (258)
T ss_pred -CCCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence 12345788999999999999999999998744
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=298.50 Aligned_cols=257 Identities=25% Similarity=0.358 Sum_probs=195.3
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCeeEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~l 513 (708)
++|...+.||+|+||.||++.. .+++.||+|.+..... ......+.+|+.++.++. |+||+++++++..++..++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 4566778899999999999965 4689999999875321 244667889999999996 9999999999999999999
Q ss_pred EEEeccCCCHHHHhccc--ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 514 VYELLERGSLAAILSSD--TAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
+|||+.. ++.++.... .....+++..+..++.|++.||+|||+.. +++||||||+||+++.++.+||+|||++..
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 9999865 655543211 11245899999999999999999999742 899999999999999999999999999976
Q ss_pred cCCCCCccccccccccccCccccccC---CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 039322 592 LKPESSNWTEFAGTYGYVAPELAYTM---KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
...... .....++..|+|||++.+. .++.++||||+|+++|||++|+.||..... .............+
T Consensus 158 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~ 229 (288)
T cd06616 158 LVDSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VFDQLTQVVKGDPP 229 (288)
T ss_pred hccCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HHHHHhhhcCCCCC
Confidence 543222 2334678899999998766 688899999999999999999999863221 00111111111110
Q ss_pred C-CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 669 P-PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 669 ~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
. ........+..+.+++.+||+++|++|||+++|+++-
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0 1111122345688999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=277.15 Aligned_cols=258 Identities=22% Similarity=0.253 Sum_probs=214.3
Q ss_pred HHhccccccc-eeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEee--
Q 039322 433 RATNDFDAQY-CIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSH-- 507 (708)
Q Consensus 433 ~~~~~~~~~~-~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~-- 507 (708)
..+++|.+.. +||-|-.|.|-...+ .+|+.+|+|++.. .....+|++..-.. .|||||.+++++..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D---------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD---------SPKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc---------CHHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 3466776654 689999999998855 4789999999864 34567788875555 69999999998853
Q ss_pred --CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC---CcEE
Q 039322 508 --ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE---YEAH 582 (708)
Q Consensus 508 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~k 582 (708)
.+.+.+|||.|+||.|.+.++.++. +.+++.++..|..||+.|+.|||+. +|+||||||+|+|.+.. ..+|
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lK 204 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLK 204 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceE
Confidence 4578899999999999999987653 6699999999999999999999999 99999999999999653 5689
Q ss_pred EeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 039322 583 VADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEI 662 (708)
Q Consensus 583 l~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 662 (708)
|+|||+|..-.. .......+-|+.|.|||++...+|+...|+||+|+++|-|++|.+||..... ..........+
T Consensus 205 LtDfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg----~aispgMk~rI 279 (400)
T KOG0604|consen 205 LTDFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKRRI 279 (400)
T ss_pred ecccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC----ccCChhHHhHh
Confidence 999999986543 3345667889999999999999999999999999999999999999974332 22223334556
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 663 LDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
..+.+..+...|.+.+....++|+.++..+|.+|.|+.|+++|-||
T Consensus 280 ~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi 325 (400)
T KOG0604|consen 280 RTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI 325 (400)
T ss_pred hccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence 6677777777888888999999999999999999999999998775
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=298.30 Aligned_cols=251 Identities=28% Similarity=0.392 Sum_probs=197.6
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+.|...+.||+|+||.||+|.. .+++.||+|.+..... ........+..|++++++++|+|++++++++.+++..++|
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 3477788999999999999965 4688999999875322 1223456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+.+ ++.+.+.... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 104 ~e~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 104 MEYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred EeCCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 999975 8888775433 4489999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 595 ESSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
. ....++..|+|||++. .+.++.++||||||+++|||++|+.||..... ......+........
T Consensus 178 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~~~~~- 244 (317)
T cd06635 178 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNESPTL- 244 (317)
T ss_pred c----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHhccCCCC-
Confidence 2 2345788999999874 45688899999999999999999999863211 111111111111111
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........+.+++.+||+.+|++||++.+++++..
T Consensus 245 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 245 -QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred -CCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 11123345789999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=301.54 Aligned_cols=265 Identities=27% Similarity=0.298 Sum_probs=198.2
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC--Cee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA--RHS 511 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~ 511 (708)
.++|++.+.||+|+||.||+|.. .+|+.||+|.++...... .....+.+|++++++++|+||+++++++... +..
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD--GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC--CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 46899999999999999999965 468999999986432111 1233466799999999999999999998765 568
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++||||+.+ +|.+++.... ..+++.+++.++.|++.|++|||+. |++||||+|+||+++.++.+||+|||.+..
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeee
Confidence 999999975 8888886543 4589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc-------cccc---c-
Q 039322 592 LKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN-------TDIA---L- 659 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-------~~~~---~- 659 (708)
............++..|+|||.+.+ ..++.++||||+|+++|||++|+.||............ .... .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 6544333334456788999998865 45788999999999999999999998643221100000 0000 0
Q ss_pred -----ccccCCCCCCC--CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 660 -----DEILDPRLPPP--SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 660 -----~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+..+.. ..........+.+++.+|++.||++|||++|+++|-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~ 292 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00000000000 0000112345778999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=292.20 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=205.0
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+|++.+.||+|++|.||++.. .+++.+|+|.+..... .......+.+|++++++++|+||+++.+++......++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence 477889999999999999954 4688999999875321 2234567888999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 516 ELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
||+++++|.+++.... ....+++..++.++.|++.|++|||+. |++|+||+|+||+++.++.+|++|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 9999999999986532 124578999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
. ......++..|+|||...+..++.++|+||+|+++|+|++|+.||+..... .....+.....+....
T Consensus 156 ~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~-- 223 (256)
T cd08530 156 N--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--------DLRYKVQRGKYPPIPP-- 223 (256)
T ss_pred C--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCCCCCCch--
Confidence 3 223345788999999998888999999999999999999999998743211 1111122222222211
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
....++.+++.+|++.+|++||++.|++++-
T Consensus 224 -~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p 254 (256)
T cd08530 224 -IYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254 (256)
T ss_pred -hhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence 3345688999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=292.33 Aligned_cols=245 Identities=24% Similarity=0.286 Sum_probs=186.7
Q ss_pred ceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHH-HHhccCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 442 YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKA-LTEIRHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
+.||+|+||.||+|.. .+|+.||+|.+++.... .......+..|..+ ....+|+|++++++++..++..++|+||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 4689999999999965 46889999998753111 11222334455544 445589999999999999999999999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 599 (708)
+++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++..... .
T Consensus 81 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~ 150 (260)
T cd05611 81 GGDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----N 150 (260)
T ss_pred CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----c
Confidence 999999996543 478999999999999999999999 999999999999999999999999999875432 2
Q ss_pred ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHH
Q 039322 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLI 679 (708)
Q Consensus 600 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (708)
....++..|+|||...+..++.++||||+|+++|+|++|..||..... ..............+.........
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~ 222 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--------DAVFDNILSRRINWPEEVKEFCSP 222 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcccCCCCcccccCCH
Confidence 234578899999999888889999999999999999999999863221 111111111111111111112234
Q ss_pred HHHHHHHhccCCCCCCCCCH---HHHHHH
Q 039322 680 SIMEVAFSCLNESPESRPTM---KVVTQQ 705 (708)
Q Consensus 680 ~l~~li~~cl~~dP~~RPs~---~evl~~ 705 (708)
.+.+++.+||+.+|++||++ +|++.|
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 68899999999999999966 566554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=300.10 Aligned_cols=253 Identities=24% Similarity=0.329 Sum_probs=210.9
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
...|.+...||+|.|+.|..|.+ .++..||||.+.+.. -+......+.+|+++|+.++|||||+++.+.+.+..+|+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~--ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQ--LNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcc--cChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 46789999999999999999965 469999999998743 233445568999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+.+|.+.+++..++. ........++.|+.+|++|||++ .|||||||++||+++.+.++||+|||++.++.
T Consensus 133 V~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999987764 44588889999999999999999 99999999999999999999999999999887
Q ss_pred CCCCccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
.........|++.|.|||+..+.++ .+++|+||+|+++|-|+.|..||+...... .-+..+.+++..+..
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~--------Lr~rvl~gk~rIp~~ 277 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE--------LRPRVLRGKYRIPFY 277 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc--------ccchheeeeecccce
Confidence 3455577899999999999998776 468999999999999999999999533211 112222233322221
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
. ..+..+++++++-.+|.+|++.+++.++-|+
T Consensus 278 m----s~dce~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 278 M----SCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred e----echhHHHHHHhhccCccccCCHHHhhhhccc
Confidence 1 1236688899999999999999999988764
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=288.08 Aligned_cols=250 Identities=27% Similarity=0.411 Sum_probs=203.8
Q ss_pred cccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+|++.+.||+|++|.||+|... +++.|++|.+...... ....+.+.+|++++++++|+|++++++++..++..+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK--EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC--HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence 4778899999999999999654 6789999999864321 245678999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++++|.+++... ..+++..++.++.|++.|+.|||+. |++||||+|+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 79 EYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred ecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999999998654 3489999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhH
Q 039322 596 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQ 675 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (708)
........++..|+|||...+..++.++||||+|+++|+|++|+.||...... ...........+..+.
T Consensus 153 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~--- 221 (254)
T cd06627 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM--------AALFRIVQDDHPPLPE--- 221 (254)
T ss_pred cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHhccCCCCCCC---
Confidence 44334456889999999988877889999999999999999999998632210 0000111111111111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 676 EKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 676 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
.....+.+++.+||+.+|++|||+.+++.+
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 123457889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=303.01 Aligned_cols=261 Identities=24% Similarity=0.349 Sum_probs=197.7
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC----
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA---- 508 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~---- 508 (708)
..++|+..+.||+|+||.||+|.. .+++.||+|.+..... .......+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ--NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc--ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 457899999999999999999965 4789999999875322 223455677899999999999999999988643
Q ss_pred --CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeec
Q 039322 509 --RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADF 586 (708)
Q Consensus 509 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 586 (708)
...++||||+.+ +|.+.+... ++...+..++.|++.||+|||+. |++||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence 357999999965 888877532 78899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccc-----
Q 039322 587 GIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS-------SLN----- 654 (708)
Q Consensus 587 g~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-------~~~----- 654 (708)
|++....... ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||......... ...
T Consensus 163 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 163 GLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ccceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9998654322 223346788999999999989999999999999999999999998643211000 000
Q ss_pred -----------------cccccccccCCCC-CCCCc-hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 655 -----------------TDIALDEILDPRL-PPPSR-SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 655 -----------------~~~~~~~~~~~~~-~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
............. +.... ........+.+++.+||+.||++|||+.|++++=
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 0000000000000 00000 0112234578999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=296.42 Aligned_cols=264 Identities=22% Similarity=0.301 Sum_probs=197.0
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|++|.||+|... +|+.||+|.+..... .......+.+|++++++++|+||+++++++..++..++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 57889999999999999999654 688999999865321 112345688899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-CCcEEEeecccccccC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL-EYEAHVADFGIAKFLK 593 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~ 593 (708)
|||++ +++.+++..... ..+++..++.++.||+.||+|||++ +++||||+|+||+++. ++.+||+|||++....
T Consensus 80 ~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred Eeccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 99996 488888754432 3367888999999999999999999 9999999999999985 5679999999997654
Q ss_pred CCCCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc-------ccc------cc
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN-------TDI------AL 659 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-------~~~------~~ 659 (708)
..........++..|+|||++.+. .++.++||||+|+++|+|+||+.||............ ... ..
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 333333445678899999988664 4788999999999999999999998643211000000 000 00
Q ss_pred cccc--CCCCCCCC--chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 660 DEIL--DPRLPPPS--RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 660 ~~~~--~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.... .+...... .........+.+++.+|++.+|++||++.+++++=
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~ 285 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHE 285 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 0000 00000000 00111234578899999999999999999999864
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=278.81 Aligned_cols=203 Identities=23% Similarity=0.340 Sum_probs=170.4
Q ss_pred ccccccceeccccCccEEEEEe-C--C--CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee-CC
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-P--S--GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH-AR 509 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~--~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~ 509 (708)
..|+....||+|.||.||+|.- + + .+.+|+|+|+.... ...-.....+|+.+++.++|||++.+..+|.. +.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd--~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD--GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC--CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 5788999999999999999932 2 2 23799999986422 22224467789999999999999999999876 78
Q ss_pred eeEEEEEeccCCCHHHHhcccc--cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC----CcEEE
Q 039322 510 HSFLVYELLERGSLAAILSSDT--AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE----YEAHV 583 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~----~~~kl 583 (708)
..++++||.+. +|...++-++ ..+.++...+..|+.||..|+.|||++ =|+||||||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence 89999999988 9999886544 345689999999999999999999999 68999999999999888 89999
Q ss_pred eecccccccCCCCC---ccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCc
Q 039322 584 ADFGIAKFLKPESS---NWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLVLEAIKGKHPRDF 644 (708)
Q Consensus 584 ~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~p~~~ 644 (708)
+|+|+|+.+...-. .....+.|..|.|||.+.+.+ |+.+.||||.||++.||+|.++-|..
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 99999998865432 224567899999999988765 88999999999999999998887754
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=320.13 Aligned_cols=257 Identities=25% Similarity=0.420 Sum_probs=206.8
Q ss_pred hccccccceeccccCccEEEEEeC----C----CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP----S----GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFC 505 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~ 505 (708)
.++..+.+.+|+|.||.|++|... . ...||||+++... ...+.+.+..|+++|+.+ +|+||+.++|+|
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA---SSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc---CcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 345566679999999999999542 1 4579999998643 225678899999999999 599999999999
Q ss_pred eeCCeeEEEEEeccCCCHHHHhcccc-----------cc--cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 039322 506 SHARHSFLVYELLERGSLAAILSSDT-----------AA--QELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKN 572 (708)
Q Consensus 506 ~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N 572 (708)
...+..++|+||+..|+|.++++..+ .. ..++..+.+.++.|||.|++||++. ++|||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence 99999999999999999999997665 01 2388999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCCCcc-cccc--ccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccc
Q 039322 573 LLLDLEYEAHVADFGIAKFLKPESSNW-TEFA--GTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLI 648 (708)
Q Consensus 573 ill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~--~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~ 648 (708)
||++.+..+||+|||+|+...+..... .... -...|||||.+....++.++||||||+++||++| |..||.....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~- 527 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP- 527 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-
Confidence 999999999999999999765544433 2222 2467999999999999999999999999999998 8999863110
Q ss_pred cccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 649 SSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+.+.++.....+..+.+ +++++++.||+.+|++||++.|+.+.+.
T Consensus 528 ------~~~l~~~l~~G~r~~~P~~c~~---eiY~iM~~CW~~~p~~RP~F~~~~~~~~ 577 (609)
T KOG0200|consen 528 ------TEELLEFLKEGNRMEQPEHCSD---EIYDLMKSCWNADPEDRPTFSECVEFFE 577 (609)
T ss_pred ------HHHHHHHHhcCCCCCCCCCCCH---HHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence 1122333444444344444433 4678888999999999999999998764
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=289.04 Aligned_cols=254 Identities=22% Similarity=0.311 Sum_probs=198.4
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCc-chhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC--Cee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPC-DQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA--RHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~ 511 (708)
.+|++.+.||+|++|.||+|.. .+++.||+|.+...... ........+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4788999999999999999965 46899999987542211 1223456789999999999999999999998764 468
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++++||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999986543 378899999999999999999999 999999999999999999999999999986
Q ss_pred cCCC---CCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 039322 592 LKPE---SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 592 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
.... ........++..|+|||++.+..++.++|+||||+++|+|++|+.||...... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~ 227 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--------AAIFKIATQPTK 227 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--------HHHHHHHcCCCC
Confidence 5321 11123346789999999998888899999999999999999999998632211 111111111110
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
+ .........+.+++.+||+ +|.+||++.+++.|.
T Consensus 228 ~--~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 228 P--MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred C--CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 0 1111223457888999999 579999999998874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=304.99 Aligned_cols=254 Identities=27% Similarity=0.389 Sum_probs=198.5
Q ss_pred cccccceeccccCccEEEEE-eCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC------
Q 039322 437 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR------ 509 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~------ 509 (708)
-|...+.||+|+||.||+|+ -.+|+.||||.++... .....+...+|++++++++|+|||++++.-+...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 45566779999999999997 4579999999998732 3455778889999999999999999998875543
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC--CCCc--EEEee
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD--LEYE--AHVAD 585 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~--~kl~D 585 (708)
...+|||||.+|+|...+........+++.+.+.++.+++.||.|||++ ||+||||||.||++- ++|+ .||+|
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeec
Confidence 5689999999999999999888778899999999999999999999999 999999999999994 3343 69999
Q ss_pred cccccccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccc------c-------
Q 039322 586 FGIAKFLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISS------S------- 651 (708)
Q Consensus 586 fg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~------~------- 651 (708)
||.|+..+++ +.....+||..|.+||+... +.|+..+|.|||||++|+++||..||........ .
T Consensus 168 fG~Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 168 FGAARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccccccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 9999987644 47788999999999999884 7788899999999999999999999964322100 0
Q ss_pred ----ccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC
Q 039322 652 ----SLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRP 697 (708)
Q Consensus 652 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 697 (708)
.......-.-.....++.+..........+...+..++..+|++|-
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 0000011111112233444344444455566666677777777776
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=296.86 Aligned_cols=266 Identities=20% Similarity=0.271 Sum_probs=196.5
Q ss_pred cccccceeccccCccEEEEEeC---CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC--Cee
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP---SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA--RHS 511 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~ 511 (708)
+|++.+.||+|++|.||+|... +++.||+|.+..... ......+.+.+|+.++++++||||+++++++... +..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 4778889999999999999664 478999999886321 1112245678899999999999999999999888 789
Q ss_pred EEEEEeccCCCHHHHhccccc--ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC----CCcEEEee
Q 039322 512 FLVYELLERGSLAAILSSDTA--AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL----EYEAHVAD 585 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~----~~~~kl~D 585 (708)
++||||+++ ++.+++..... ...+++..++.++.|++.|++|||+. +++||||||+||+++. ++.+||+|
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 999999975 77776643322 23588999999999999999999999 9999999999999999 89999999
Q ss_pred cccccccCCCCC---ccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc-ccccc--
Q 039322 586 FGIAKFLKPESS---NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL-NTDIA-- 658 (708)
Q Consensus 586 fg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-~~~~~-- 658 (708)
||++........ ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||........... .....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999986543322 12334678899999987664 478899999999999999999999874322110000 00000
Q ss_pred ----------------------cc----cccCCCCCCCCc-hhH----HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 659 ----------------------LD----EILDPRLPPPSR-SVQ----EKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 659 ----------------------~~----~~~~~~~~~~~~-~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. .......+.... ... .....+.+++.+|++.||++|||+.|+++|-+
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 00 000000000000 000 12346889999999999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=293.65 Aligned_cols=259 Identities=20% Similarity=0.229 Sum_probs=184.2
Q ss_pred ccccccceeccccCccEEEEEeCC----CcEEEEEEcCCCCCcchhHh-------HHHHHHHHHHHHhccCCceeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPCDQIAD-------QKEFLIEVKALTEIRHRNIVKFYGF 504 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~l~~~ 504 (708)
++|.+.+.||+|+||.||+|...+ +..+|+|+..........+. ......+...+..+.|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 689999999999999999997644 34566776433211100000 0112233444566789999999997
Q ss_pred EeeCC----eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc
Q 039322 505 CSHAR----HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE 580 (708)
Q Consensus 505 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 580 (708)
+.... ..++++|++.. ++.+.++... ..++..+..++.|++.||+|||++ +++||||||+||+++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCc
Confidence 76543 34678887744 6766664322 257788999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCC-------ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccc-cc
Q 039322 581 AHVADFGIAKFLKPESS-------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISS-SS 652 (708)
Q Consensus 581 ~kl~Dfg~a~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-~~ 652 (708)
++|+|||+|+.+..... ......||+.|+|||+..+..++.++|||||||++|||++|+.||........ ..
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999986643221 11234689999999999999999999999999999999999999974421110 00
Q ss_pred cccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 653 LNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.........+..+....+ ..+..+.+++..||+.+|++||+++++++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKCDFIKRLHEGKIKIK-----NANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHHHHHHHhhhhhhccC-----CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 000111122222222111 1134578889999999999999999999876
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=295.86 Aligned_cols=256 Identities=24% Similarity=0.363 Sum_probs=195.8
Q ss_pred hccccccceeccccCccEEEEEeCC-CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~ 512 (708)
.++|++.+.||+|++|.||+|..++ ++.||||.++... .......+..|+.++.+.. |+||+++++++..+...+
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC---ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 3678999999999999999997754 8899999987532 1223456677777766664 999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
++|||+.+ ++.+++.... ..+++..+..++.|++.|++|||+.. +++||||+|+||+++.++.+||+|||++...
T Consensus 91 ~v~e~~~~-~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 91 ICMELMST-CLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EEeeccCc-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99999854 7777765432 35899999999999999999999732 8999999999999999999999999999765
Q ss_pred CCCCCccccccccccccCccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMK----ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
.... ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... ............+
T Consensus 166 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~ 237 (296)
T cd06618 166 VDSK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEEPP 237 (296)
T ss_pred cCCC-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCCCC
Confidence 4322 223345778999999987553 788999999999999999999998632110 1111111221111
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+ .......++.+++.+||+.||++||++.+++++-+
T Consensus 238 ~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 238 SLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred CCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 110 00122346889999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.73 Aligned_cols=270 Identities=17% Similarity=0.197 Sum_probs=188.7
Q ss_pred HhccccccceeccccCccEEEEEeCC--CcEEEEEEcCCC-------------CCcchhHhHHHHHHHHHHHHhccCCce
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELPS--GQVVAIKKFHSP-------------LPCDQIADQKEFLIEVKALTEIRHRNI 498 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~~--~~~vavK~~~~~-------------~~~~~~~~~~~~~~e~~~l~~l~h~~i 498 (708)
..++|++.+.||+|+||.||++..+. +..++.|.+... ...........+.+|++++++++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35789999999999999999985432 222222211100 000111234568899999999999999
Q ss_pred eeEEEEEeeCCeeEEEEEeccCCCHHHHhccccc--ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC
Q 039322 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTA--AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD 576 (708)
Q Consensus 499 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~ 576 (708)
+++++++..++..|+|+|++.+ ++.+++..... ........+..++.|++.||+|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 9999999999999999999854 77777653321 12234667888999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCC-Ccccccccccc-
Q 039322 577 LEYEAHVADFGIAKFLKPESSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPR-DFLSLISSSSL- 653 (708)
Q Consensus 577 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~-~~~~~~~~~~~- 653 (708)
.++.+||+|||++..+...... .....|+..|+|||++.+..++.++|||||||++|||++|+.++ ...........
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 9999999999999876543322 23457899999999999989999999999999999999987643 22111000000
Q ss_pred --------cccc------ccccccC-CCCCCCCchhH------HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 --------NTDI------ALDEILD-PRLPPPSRSVQ------EKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 --------~~~~------~~~~~~~-~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.... ....+++ ........... .....+.+++.+|++.||++|||+.|+++|-+
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 0000 0000000 00000000000 01234677889999999999999999998744
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=291.98 Aligned_cols=245 Identities=24% Similarity=0.346 Sum_probs=195.3
Q ss_pred eccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccCCC
Q 039322 444 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGS 522 (708)
Q Consensus 444 ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~ 522 (708)
||+|+||.||++... +|+.||+|.+..... ......+.+.+|++++++++|+||+++++.+..++..++++||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999765 489999999875321 112446678899999999999999999999999999999999999999
Q ss_pred HHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCC-----
Q 039322 523 LAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS----- 597 (708)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~----- 597 (708)
|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 80 L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 80 LASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999997543 489999999999999999999999 999999999999999999999999999875443311
Q ss_pred ---ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 598 ---NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 598 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
......++..|+|||.......+.++||||||+++|++++|+.||..... ..............+...
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~- 224 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--------EEIFQNILNGKIEWPEDV- 224 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCCcCCCccc-
Confidence 22344578899999999888889999999999999999999999863321 111112222122111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCH---HHHHHH
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTM---KVVTQQ 705 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~---~evl~~ 705 (708)
.....+.+++.+||+.+|++|||+ .+++++
T Consensus 225 -~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 225 -EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred -cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 023457899999999999999999 666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=295.52 Aligned_cols=255 Identities=22% Similarity=0.285 Sum_probs=197.2
Q ss_pred cccccceeccccCccEEEEEe----CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCee
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~ 511 (708)
+|++.+.||+|+||.||.|.. .+|+.||+|+++...........+.+..|+++++++ +|++|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477888999999999999965 368899999987532222223456788899999999 599999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999996543 478899999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCC-ccccccccccccCccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 039322 592 LKPESS-NWTEFAGTYGYVAPELAYTM--KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 592 ~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
...... ......++..|+|||.+... .++.++||||||+++|+|++|+.||...... ...............+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~~~ 230 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK----NSQAEISRRILKSEPP 230 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc----ccHHHHHHHhhccCCC
Confidence 543321 12235578899999988753 4678999999999999999999998632110 0001111111111111
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRP-----TMKVVTQQ 705 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 705 (708)
.+ ......+.+++.+||+.||++|| ++++++.+
T Consensus 231 ~~----~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 231 YP----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CC----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11 11233577899999999999997 78888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=302.86 Aligned_cols=261 Identities=24% Similarity=0.364 Sum_probs=195.1
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC-----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA----- 508 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~----- 508 (708)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... .......+.+|+.++++++|+||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 46899999999999999999964 578999999986421 123345678899999999999999999987544
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
...++|+||+.+ ++.+++... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred ceEEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence 357999999975 888877543 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc---cccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cccccc
Q 039322 589 AKFLKPESSN---WTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS-------SLNTDI 657 (708)
Q Consensus 589 a~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-------~~~~~~ 657 (708)
+......... .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||......... ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 9765432221 123467889999998654 45888999999999999999999999643211000 000000
Q ss_pred ccccccCCC-------CCCC-C----chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 658 ALDEILDPR-------LPPP-S----RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 658 ~~~~~~~~~-------~~~~-~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
....+.... .+.. . ...+.....+.+++.+||+.||++|||+.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp 293 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 000000000 0000 0 00112234688999999999999999999999873
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=293.59 Aligned_cols=262 Identities=25% Similarity=0.350 Sum_probs=198.0
Q ss_pred ccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC--CeeEEE
Q 039322 438 FDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA--RHSFLV 514 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~lv 514 (708)
|++.+.||+|++|.||+|... +++.+|+|.+.... ........+.+|++++++++|+|++++++++... +..++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 567889999999999999765 58899999998643 1223345688899999999999999999999888 889999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
+||+++ +|.+++.... ..+++..++.++.|++.|++|||+. +++|+||+|+||++++++.+||+|||.+.....
T Consensus 79 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 79 FEYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred eccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 999975 8988886542 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-ccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc----------ccccccccc-
Q 039322 595 ESS-NWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS----------LNTDIALDE- 661 (708)
Q Consensus 595 ~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~----------~~~~~~~~~- 661 (708)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||+......... .........
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 332 1233456788999997765 457889999999999999999999986432110000 000000000
Q ss_pred ----ccCCCCCCCCc---hhHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 662 ----ILDPRLPPPSR---SVQE-KLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 662 ----~~~~~~~~~~~---~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........... .... ....+.+++.+||+.+|++||++++++++-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~ 286 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcC
Confidence 00000000000 0001 1456889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=296.87 Aligned_cols=258 Identities=19% Similarity=0.245 Sum_probs=192.3
Q ss_pred ceeccc--cCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEec
Q 039322 442 YCIGNG--GHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELL 518 (708)
Q Consensus 442 ~~ig~G--~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 518 (708)
..||+| +||+||+|.. .+|+.||+|.+..... .....+.+.+|+.+++.++||||++++++|..++..++|+||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence 346666 8899999965 4799999999875322 2234578899999999999999999999999999999999999
Q ss_pred cCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 039322 519 ERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN 598 (708)
Q Consensus 519 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 598 (708)
.+|++.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 82 AYGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred cCCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99999999876432 3478999999999999999999998 9999999999999999999999999865433221111
Q ss_pred c-------ccccccccccCccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc--cc----------c-
Q 039322 599 W-------TEFAGTYGYVAPELAYTM--KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL--NT----------D- 656 (708)
Q Consensus 599 ~-------~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~--~~----------~- 656 (708)
. ....++..|+|||++.+. .++.++||||+||++|||++|+.||........... .. .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence 0 112345679999998763 478899999999999999999999864321000000 00 0
Q ss_pred c---------------ccc---------cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 657 I---------------ALD---------EILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 657 ~---------------~~~---------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. ... ........ ..........+.+++++||+.||++|||++|++++-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR--TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred hhhhhhccchhhhhcccccchhcccccccccccccc--chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 0 000 00000000 0112234557889999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=289.70 Aligned_cols=261 Identities=24% Similarity=0.315 Sum_probs=196.2
Q ss_pred ccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc---cCCceeeEEEEEeeCCe---
Q 039322 438 FDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI---RHRNIVKFYGFCSHARH--- 510 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~~~~~--- 510 (708)
|++.+.||+|+||.||+|..+ +++.||+|.++..... ......+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE--EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc--chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 567889999999999999775 4899999999754321 12234566787777666 59999999999988776
Q ss_pred --eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 511 --SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 511 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
.+++|||+.+ +|.+++..... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.
T Consensus 79 ~~~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 79 LKLTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred ceeEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCc
Confidence 8999999975 89998865432 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc--------ccc--c
Q 039322 589 AKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN--------TDI--A 658 (708)
Q Consensus 589 a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~--------~~~--~ 658 (708)
+..+.... ......++..|+|||.+.+..++.++||||||+++|||++|+.||+........... ... .
T Consensus 154 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 154 ARIYSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ceeccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 98764332 223345788999999999888999999999999999999999998743211000000 000 0
Q ss_pred c----ccccCCCCC-CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 659 L----DEILDPRLP-PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 659 ~----~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
. ......... ............+.+++.+||+.||++||+++|++++=
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~ 285 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCc
Confidence 0 000000000 11111123345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=287.39 Aligned_cols=252 Identities=21% Similarity=0.289 Sum_probs=193.1
Q ss_pred HHHHHHhcccccccee--ccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEE
Q 039322 429 DEIVRATNDFDAQYCI--GNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGF 504 (708)
Q Consensus 429 ~~~~~~~~~~~~~~~i--g~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~ 504 (708)
.+.....++|++.+.+ |+|+||.||++.. .+++.+|+|.+..... ... |+.....+ +|+||++++++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~----~~~-----e~~~~~~~~~h~~iv~~~~~ 77 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF----NAI-----EPMVHQLMKDNPNFIKLYYS 77 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc----chh-----hHHHHHHhhcCCCEEEEEEE
Confidence 3444555777887776 9999999999964 4688899999865211 111 22222222 69999999999
Q ss_pred EeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-cEEE
Q 039322 505 CSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY-EAHV 583 (708)
Q Consensus 505 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl 583 (708)
+..++..++||||+++|+|.+++.... .+++.++..++.|+++|++|||+. +++||||+|+||+++.++ .++|
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l 151 (267)
T PHA03390 78 VTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYL 151 (267)
T ss_pred EecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEE
Confidence 999999999999999999999997543 589999999999999999999999 999999999999999998 9999
Q ss_pred eecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 039322 584 ADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEIL 663 (708)
Q Consensus 584 ~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 663 (708)
+|||.+...... ....++..|+|||++.+..++.++||||+|+++|||++|+.||....... .. ........
T Consensus 152 ~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~-~~~~~~~~ 223 (267)
T PHA03390 152 CDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LD-LESLLKRQ 223 (267)
T ss_pred ecCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hh-HHHHHHhh
Confidence 999998765422 22357889999999998889999999999999999999999987322110 00 00111111
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHhh
Q 039322 664 DPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT-MKVVTQQVR 707 (708)
Q Consensus 664 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~l~ 707 (708)
..... ........+.+++.+||+.+|.+||+ ++|+++|=+
T Consensus 224 ~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~ 264 (267)
T PHA03390 224 QKKLP----FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264 (267)
T ss_pred cccCC----cccccCHHHHHHHHHHhccChhhCCchHHHHhcCCc
Confidence 11111 11133456889999999999999996 699998743
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.47 Aligned_cols=263 Identities=24% Similarity=0.324 Sum_probs=198.4
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC-----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA----- 508 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~----- 508 (708)
.++|.+.+.||+|+||.||+|.. .+++.||||.+..... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD--NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 46799999999999999999964 4689999999875321 223345677899999999999999999988654
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
...++|+||+. ++|.+++... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 34799999996 6899888654 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccc---------------ccc
Q 039322 589 AKFLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLIS---------------SSS 652 (708)
Q Consensus 589 a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~---------------~~~ 652 (708)
+..............++..|+|||.+.. ..++.++||||||+++|+|++|+.||....... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 155 ARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred ccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 9866443333344567889999998764 458899999999999999999999986432100 000
Q ss_pred cccccccccccCC--CCCCC--CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 653 LNTDIALDEILDP--RLPPP--SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 653 ~~~~~~~~~~~~~--~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
............. ..... ..........+.+++.+||+.+|++|||++|+++|-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~ 292 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCc
Confidence 0000000000000 00000 001112345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=291.74 Aligned_cols=263 Identities=24% Similarity=0.309 Sum_probs=202.6
Q ss_pred ccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEE
Q 039322 438 FDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYE 516 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 516 (708)
|++.+.||+|++|.||+|... +++.+++|.+...... ......+..|++++++++|++|+++++++..++..++|+|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES--EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc--chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence 566788999999999999654 6889999998764322 1345678889999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 039322 517 LLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596 (708)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 596 (708)
|+++ ++.+++.... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 79 FMDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred ccCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 9975 8888886543 4589999999999999999999999 99999999999999999999999999998765543
Q ss_pred CccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc-------ccccccccc-----
Q 039322 597 SNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN-------TDIALDEIL----- 663 (708)
Q Consensus 597 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~----- 663 (708)
.......++..|+|||.+.+. .++.++|+||+|+++|+|+||+.||............ .........
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 233345678899999998776 6889999999999999999999998643321100000 000000000
Q ss_pred ------CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 664 ------DPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 664 ------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.................+.+++.+||++||.+||++++++.+-+|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 000001011122345678899999999999999999999987553
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=295.78 Aligned_cols=255 Identities=22% Similarity=0.291 Sum_probs=196.0
Q ss_pred cccccceeccccCccEEEEEe----CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCee
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~ 511 (708)
+|++.+.||+|++|.||++.. .+++.||||++++..........+.+..|+++++++ +|++|+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467788999999999999964 357889999987532222223456788999999999 599999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999998643 3478999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCCc-cccccccccccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 039322 592 LKPESSN-WTEFAGTYGYVAPELAYTMK--ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 592 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
....... .....++..|+|||...+.. .+.++||||||+++|||++|..||....... ..............+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~ 230 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN----SQSEISRRILKSKPP 230 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc----hHHHHHHHHHccCCC
Confidence 5433222 22345789999999987655 7789999999999999999999986322110 000111111111111
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
.+. .....+.+++.+||+.||++|||+.++.+.
T Consensus 231 ~~~----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~ 263 (288)
T cd05583 231 FPK----TMSAEARDFIQKLLEKDPKKRLGANGADEI 263 (288)
T ss_pred CCc----ccCHHHHHHHHHHhcCCHhhccCcchHHHH
Confidence 111 122357889999999999999997766443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=290.91 Aligned_cols=259 Identities=20% Similarity=0.265 Sum_probs=193.0
Q ss_pred ccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeC--CeeEE
Q 039322 438 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHA--RHSFL 513 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~--~~~~l 513 (708)
|++.+.||+|+||.||+|.. .+++.||+|.++..... ........|+.+++++. |+|++++++++.++ +..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS---LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC---chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 56778899999999999965 46889999998763221 12233457888888885 99999999999887 88999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
|+||++ |++.+++.... ..+++.+++.++.|++.||+|||+. +++||||+|+||+++. +.+||+|||++....
T Consensus 78 v~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 78 VFELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred EEecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 999997 48888876433 3589999999999999999999999 9999999999999999 999999999998664
Q ss_pred CCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccccccc-----cc
Q 039322 594 PESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS-------SLNTDIA-----LD 660 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-------~~~~~~~-----~~ 660 (708)
.... .....++..|+|||+... ..++.++||||+||++|||++|+.||......... ....... ..
T Consensus 151 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 151 SKPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred cCCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence 3322 233457889999997644 55788999999999999999999999643221100 0000000 00
Q ss_pred cccCCCCCCCC-----chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 661 EILDPRLPPPS-----RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 661 ~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+...+... ......+..+.+++.+||+++|++||++++++++=+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~ 281 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence 00000000000 001123467899999999999999999999998744
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.40 Aligned_cols=265 Identities=25% Similarity=0.341 Sum_probs=199.7
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee----CC
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH----AR 509 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----~~ 509 (708)
..+|++.+.||+|++|.||+|.. .+|+.||+|.+..... .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 37899999999999999999964 4699999999875322 22335667789999999999999999998753 34
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccc
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA 589 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 589 (708)
..++||||+. |+|.+++.... .+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccc
Confidence 6899999996 58999886443 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC----ccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccc---
Q 039322 590 KFLKPESS----NWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS-------SLN--- 654 (708)
Q Consensus 590 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-------~~~--- 654 (708)
........ ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......... +..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 76543221 1123467889999998765 45788999999999999999999999643221000 000
Q ss_pred -----cccccccccC---CCCCCC-CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 655 -----TDIALDEILD---PRLPPP-SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 655 -----~~~~~~~~~~---~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.........+ .....+ .......+..+.+++.+||+.+|++|||+++++++-++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 0000000000 000000 00112234568899999999999999999999987653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=297.54 Aligned_cols=261 Identities=17% Similarity=0.218 Sum_probs=191.9
Q ss_pred ccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 440 AQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 440 ~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
+.+.+|.|+++.||++.. +++.||+|++.... ......+.+..|++++++++|+||+++++++...+..+++|||++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDS--CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccc--cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 334445555555555544 68999999987632 123456789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCC--
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS-- 597 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-- 597 (708)
+|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.+........
T Consensus 83 ~~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 83 YGSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 9999999976532 3478999999999999999999999 999999999999999999999999998875532221
Q ss_pred -----ccccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc--cc-------cccc----
Q 039322 598 -----NWTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS--SL-------NTDI---- 657 (708)
Q Consensus 598 -----~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~--~~-------~~~~---- 657 (708)
......++..|+|||++.. ..++.++||||+|+++|||++|+.||......... .. ....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence 1123456778999999865 34788999999999999999999999743211000 00 0000
Q ss_pred ---cccc----ccCCC--CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 ---ALDE----ILDPR--LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ---~~~~----~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.... ..++. ..............+.+++.+||+.||++|||++|++++-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 0000 00000 00011111223346888999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=293.69 Aligned_cols=253 Identities=25% Similarity=0.356 Sum_probs=204.0
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCeeEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~l 513 (708)
++|.+.+.||+|++|.||+|... +++.||+|++..... ......+.+..|.+++++++ |+||+++++++..++..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL-IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc-cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 46888999999999999999654 789999999875221 12233567889999999998 9999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++++|.+++.... .+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 80 v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 80 VLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999997543 489999999999999999999999 99999999999999999999999999988654
Q ss_pred CCCC--------------------ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 039322 594 PESS--------------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL 653 (708)
Q Consensus 594 ~~~~--------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~ 653 (708)
.... ......++..|+|||......++.++||||+|++++++++|+.||.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------ 227 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------ 227 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------
Confidence 3221 12234568899999998888889999999999999999999999874321
Q ss_pred ccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCH----HHHHHHhh
Q 039322 654 NTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTM----KVVTQQVR 707 (708)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~l~ 707 (708)
..............+. .....+.+++.+||+.+|++||++ +++++|-.
T Consensus 228 --~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 228 --YLTFQKILKLEYSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred --HHHHHHHHhcCCCCCC----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence 1111222222211111 113457899999999999999999 99988753
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=290.08 Aligned_cols=247 Identities=19% Similarity=0.196 Sum_probs=187.2
Q ss_pred eeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHH---HHHhccCCceeeEEEEEeeCCeeEEEEEec
Q 039322 443 CIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVK---ALTEIRHRNIVKFYGFCSHARHSFLVYELL 518 (708)
Q Consensus 443 ~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~---~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 518 (708)
.||+|+||.||+|.. .+++.||+|.+.+..... ......+..|.. .++...||+|+.+.+++..++..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeecccccc-chhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 489999999999965 468899999987532111 111222334433 344457999999999999999999999999
Q ss_pred cCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 039322 519 ERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN 598 (708)
Q Consensus 519 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 598 (708)
.+|+|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++...... .
T Consensus 80 ~g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~ 151 (278)
T cd05606 80 NGGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--K 151 (278)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--C
Confidence 999999988643 3489999999999999999999998 9999999999999999999999999998755322 2
Q ss_pred cccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHH
Q 039322 599 WTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEK 677 (708)
Q Consensus 599 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (708)
.....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||......... .............+ ...
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~----~~~ 222 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----EIDRMTLTMAVELP----DSF 222 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-----HHHHHhhccCCCCC----CcC
Confidence 2334688999999998754 5889999999999999999999998743211100 00000100111111 112
Q ss_pred HHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 039322 678 LISIMEVAFSCLNESPESRP-----TMKVVTQQVR 707 (708)
Q Consensus 678 ~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~ 707 (708)
...+.+++.+|+..+|.+|| ++.+++++-+
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~ 257 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPF 257 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcc
Confidence 34688899999999999999 9999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=328.65 Aligned_cols=254 Identities=28% Similarity=0.384 Sum_probs=203.7
Q ss_pred HhccccccceeccccCccEEEE-EeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
.+-+|.....||.|.||.||.| ...+|+..|+|-++-.... ....+...+|+.++..++|||+|+++|+-.+.+..+
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3456777889999999999999 4567999999988764322 344567889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
|.||||++|+|.+.+...+. .++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..+
T Consensus 1311 IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence 99999999999999965543 56677778899999999999999 9999999999999999999999999999987
Q ss_pred CCCCC----ccccccccccccCccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 039322 593 KPESS----NWTEFAGTYGYVAPELAYTMK---ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDP 665 (708)
Q Consensus 593 ~~~~~----~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 665 (708)
..... ......||+.|||||++.+.. ...++||||+||++.||+||+.||...+..+ ..+..+--+
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-------aIMy~V~~g 1457 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-------AIMYHVAAG 1457 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-------HHHhHHhcc
Confidence 65432 234578999999999998643 5568999999999999999999986433222 122222222
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 666 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
..+.-++. ...+-.+++.+|+..||++|-++.|++++
T Consensus 1458 h~Pq~P~~---ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 HKPQIPER---LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCCCCchh---hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 33332222 23345677779999999999999999876
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=300.05 Aligned_cols=262 Identities=24% Similarity=0.362 Sum_probs=197.0
Q ss_pred HhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeC--C
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHA--R 509 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~--~ 509 (708)
..++|++.+.||+|+||.||+|... +++.||+|++..... .......+.+|+.+++++ +|+||+++++++... .
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR--NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC--cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 3578999999999999999999654 688999998865321 123345677899999999 999999999998654 3
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccc
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA 589 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 589 (708)
..++||||+. ++|.+++... .+++..+..++.|++.||+|||+. |++||||+|+||+++.++.+||+|||.+
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccch
Confidence 6899999997 4999988653 478899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC-----ccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccc--
Q 039322 590 KFLKPESS-----NWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS-------SLN-- 654 (708)
Q Consensus 590 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-------~~~-- 654 (708)
........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 86543321 2233467889999998755 45788999999999999999999998642211000 000
Q ss_pred ----------cccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 655 ----------TDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 655 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
..........................+.+++.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000011111111111111124568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=294.69 Aligned_cols=267 Identities=24% Similarity=0.333 Sum_probs=198.6
Q ss_pred HHhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC--
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR-- 509 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-- 509 (708)
+..++|++.+.||+|+||.||+|..+ +|+.||+|.++..... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc--cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 45688999999999999999999764 5889999998753221 123456778999999999999999999987654
Q ss_pred --------eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcE
Q 039322 510 --------HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEA 581 (708)
Q Consensus 510 --------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 581 (708)
..++|+||+++ ++.+.+.... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.+
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence 78999999986 7777775432 3589999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCC-ccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc------
Q 039322 582 HVADFGIAKFLKPESS-NWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL------ 653 (708)
Q Consensus 582 kl~Dfg~a~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~------ 653 (708)
||+|||.+........ ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...........
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999986654332 1223356788999998765 3468899999999999999999999874321100000
Q ss_pred -ccccccccc--------cCCCCCC--C-CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 -NTDIALDEI--------LDPRLPP--P-SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 -~~~~~~~~~--------~~~~~~~--~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........+ .++.... . .......+..+.+++.+||+.||.+||++++++++-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 301 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 000000000 0000000 0 0000012346889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=294.44 Aligned_cols=251 Identities=28% Similarity=0.401 Sum_probs=196.3
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+.|...+.||+|++|.||+|... +++.+|+|.+...... ......++.+|+++++.++|+|++++.+++..++..++|
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 45777888999999999999654 6788999998642111 223345788899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+. |++.+++.... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 94 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 99996 58888775433 3478999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 595 ESSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
. ....++..|+|||.+. .+.++.++||||||+++|+|++|+.||...... .....+.....+..
T Consensus 168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~~- 234 (308)
T cd06634 168 A----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNESPAL- 234 (308)
T ss_pred c----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--------HHHHHHhhcCCCCc-
Confidence 2 2345788999999874 345788999999999999999999997632211 11111111111110
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........+.+++.+||+.+|++||++++++++-+
T Consensus 235 -~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 235 -QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 11123345789999999999999999999998765
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.47 Aligned_cols=248 Identities=28% Similarity=0.400 Sum_probs=193.3
Q ss_pred ccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEE
Q 039322 438 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYE 516 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 516 (708)
|...+.||+|+||.||+|.. .+++.||+|.+..... ........+..|++++++++|+|++++++++.+.+..++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 55567799999999999965 4688999999865322 122344578889999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 039322 517 LLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596 (708)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 596 (708)
|+. |++.+++.... ..+++.++..++.|++.|++|||+. |++||||+|+||+++.++.+||+|||++.....
T Consensus 102 ~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 102 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred cCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 996 57888775433 4588999999999999999999999 999999999999999999999999999864322
Q ss_pred CccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 597 SNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 597 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
.....++..|+|||++. .+.++.++||||||+++|+|++|..||....... ..........+.. .
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~--~ 241 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNDSPTL--Q 241 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHhcCCCCC--C
Confidence 22346788999999874 3567889999999999999999999986322111 0000100011100 0
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.......+.+++.+||+++|++||++.+++++-
T Consensus 242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~ 274 (313)
T cd06633 242 SNEWTDSFRGFVDYCLQKIPQERPASAELLRHD 274 (313)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 111223578899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=297.36 Aligned_cols=265 Identities=23% Similarity=0.263 Sum_probs=194.6
Q ss_pred cccc-ccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhH----------hHHHHHHHHHHHHhccCCceeeEEE
Q 039322 436 NDFD-AQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIA----------DQKEFLIEVKALTEIRHRNIVKFYG 503 (708)
Q Consensus 436 ~~~~-~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~----------~~~~~~~e~~~l~~l~h~~iv~l~~ 503 (708)
++|. +.+.||+|+||.||+|.. .+++.||||.++......... ....+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 5565 456799999999999965 468999999987532211000 0124778999999999999999999
Q ss_pred EEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEE
Q 039322 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHV 583 (708)
Q Consensus 504 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl 583 (708)
++..++..++||||+. |+|.+++... ..+++.....++.|++.||+|||+. |++||||+|+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 9999999999999997 5999988643 3488999999999999999999998 9999999999999999999999
Q ss_pred eecccccccCC--------------CCCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 039322 584 ADFGIAKFLKP--------------ESSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLI 648 (708)
Q Consensus 584 ~Dfg~a~~~~~--------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~ 648 (708)
+|||++..... .........++..|+|||.+.+. .++.++||||+|+++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999976541 11112233467889999988764 3688999999999999999999998643211
Q ss_pred ccccc-------ccccccccc--------cCCCCCCC-CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 649 SSSSL-------NTDIALDEI--------LDPRLPPP-SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 649 ~~~~~-------~~~~~~~~~--------~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..... ......... .....+.. ..........+.+++.+||+.+|++|||++|++.+-+
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 00000 000000000 00000000 0000112345789999999999999999999998754
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=292.15 Aligned_cols=265 Identities=23% Similarity=0.313 Sum_probs=194.1
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR---- 509 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~---- 509 (708)
.++|++.+.||+|+||.||+|.. .+++.||||.+....... .....+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC--CchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 36799999999999999999965 468899999986532211 22345678999999999999999999987654
Q ss_pred ----eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEee
Q 039322 510 ----HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVAD 585 (708)
Q Consensus 510 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 585 (708)
..++||||+.+ ++.+++.... ..+++.+++.++.|++.||+|||++ +++|+||+|+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECc
Confidence 35999999975 8888875432 3589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCc----cccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------c
Q 039322 586 FGIAKFLKPESSN----WTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS-------L 653 (708)
Q Consensus 586 fg~a~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-------~ 653 (708)
||++......... .....++..|+|||.+.+.. ++.++||||||+++|||++|..||.......... .
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999865432211 12345678899999876643 6889999999999999999999986432110000 0
Q ss_pred ccccc------cccccCCCCCCCCc-hhH------HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 NTDIA------LDEILDPRLPPPSR-SVQ------EKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 ~~~~~------~~~~~~~~~~~~~~-~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..... .........+.... ... .....+.+++.+||+.||++|||++|+++|-+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~ 309 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence 00000 00000000000000 000 01234678999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=298.95 Aligned_cols=262 Identities=24% Similarity=0.346 Sum_probs=200.9
Q ss_pred cccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC-----e
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR-----H 510 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-----~ 510 (708)
+|++.+.||+|++|.||+|... +++.||+|++..... .....+.+.+|+++++.++|+||+++.+++...+ .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD--DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc--cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 4788899999999999999764 589999999876321 2334567899999999999999999999998775 7
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.|++|||+.+ +|.+++.... .+++..++.++.|++.||+|||+. |++||||||+||+++.++.++|+|||.+.
T Consensus 79 ~~lv~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 79 VYIVTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred eEEEecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 8999999984 8998886543 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC---CccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cc------
Q 039322 591 FLKPES---SNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS-------SL------ 653 (708)
Q Consensus 591 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-------~~------ 653 (708)
...... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||......... ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence 765443 123345678899999999887 7899999999999999999999998643211000 00
Q ss_pred --ccccccccccCC-CCCCCC---chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 --NTDIALDEILDP-RLPPPS---RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 --~~~~~~~~~~~~-~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
............ ...... .........+.+++.+||+++|++|||+++++++-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 291 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence 000000000000 000000 000112346789999999999999999999998744
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=288.26 Aligned_cols=256 Identities=21% Similarity=0.252 Sum_probs=198.5
Q ss_pred cccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCc-chhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPC-DQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+|.+.+.||+|+||.||++... .+..+++|+++..... .......++..|+.++++++||||+++++++.+++..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999654 3445666665532111 1122344577889999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 515 YELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
+||+++++|.+++.... ....+++..++.++.|++.|++|||+. |++|+||+|+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999886432 234689999999999999999999999 9999999999999975 569999999998765
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
..........++..|+|||...+..++.++|+||+|+++|+|++|..||..... ............+..
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------~~~~~~~~~~~~~~~--- 225 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--------LSVVLRIVEGPTPSL--- 225 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHcCCCCCC---
Confidence 444434445678899999998888888999999999999999999999863221 111111112211111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......++.+++.+||+.+|++||++.|++++=+
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 259 (260)
T cd08222 226 PETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259 (260)
T ss_pred cchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence 1233446888999999999999999999998744
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.14 Aligned_cols=262 Identities=26% Similarity=0.341 Sum_probs=197.3
Q ss_pred HHHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee-CC
Q 039322 432 VRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH-AR 509 (708)
Q Consensus 432 ~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~ 509 (708)
...+++|++.+.||+|+||.||+|.. .+++.||+|.+.+.... ....+.+..|++++++++||||+++.+++.. .+
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST--PVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc--cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34678899999999999999999964 47899999988653221 2335667889999999999999999999876 45
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccc
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA 589 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 589 (708)
..++++||+ +++|.++++.. .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence 789999998 56899888643 378888999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------cccccccccc
Q 039322 590 KFLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS-------SLNTDIALDE 661 (708)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-------~~~~~~~~~~ 661 (708)
..... ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||......... ..........
T Consensus 156 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 156 RIQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 75432 2223456789999998765 56889999999999999999999998643211000 0000000000
Q ss_pred cc---------CCC--CC-CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 662 IL---------DPR--LP-PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 662 ~~---------~~~--~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
+. ... .+ +...........+.+++.+||+.+|++|||+++++.+=
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 00 000 00 00001111235688999999999999999999998763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=281.95 Aligned_cols=245 Identities=26% Similarity=0.325 Sum_probs=198.5
Q ss_pred eccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccCCC
Q 039322 444 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGS 522 (708)
Q Consensus 444 ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~ 522 (708)
||+|+||.||++... +++.||+|.+..... ........+..|++++++++|+||+++++.+..++..++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999654 588999999876422 122345678899999999999999999999999999999999999999
Q ss_pred HHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCccccc
Q 039322 523 LAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEF 602 (708)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 602 (708)
|.+++.... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+.............
T Consensus 80 L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (250)
T cd05123 80 LFSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF 153 (250)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence 999996543 489999999999999999999998 99999999999999999999999999998765433333455
Q ss_pred cccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHH
Q 039322 603 AGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIM 682 (708)
Q Consensus 603 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 682 (708)
.++..|+|||...+...+.++|+||||+++|++++|+.||..... ..............+... ...+.
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~----~~~l~ 221 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILKDPLRFPEFL----SPEAR 221 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhcCCCCCCCCC----CHHHH
Confidence 678899999999888889999999999999999999999863321 111222222222222111 33578
Q ss_pred HHHHhccCCCCCCCCCH---HHHHHHhh
Q 039322 683 EVAFSCLNESPESRPTM---KVVTQQVR 707 (708)
Q Consensus 683 ~li~~cl~~dP~~RPs~---~evl~~l~ 707 (708)
+++.+||..||++||++ +++.++-+
T Consensus 222 ~~i~~~l~~~p~~R~~~~~~~~l~~~~~ 249 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGGAEEIKAHPF 249 (250)
T ss_pred HHHHHHhcCCHhhCCCcccHHHHHhCCC
Confidence 89999999999999999 78877643
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=286.96 Aligned_cols=261 Identities=24% Similarity=0.353 Sum_probs=196.5
Q ss_pred ccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCeeEEEE
Q 039322 438 FDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~ 515 (708)
|.+.+.||+|++|.||+|... +++.||||.+...... .......+|+..+++++ |+|++++++++..++..++||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc---hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence 567889999999999999765 5788999998753221 22334557889999998 999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+ +|+|.+++.... ...+++..+..++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus 78 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 78 EYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred ecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 999 789999886544 24589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc--------cc-----cccccccc
Q 039322 596 SSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS--------SL-----NTDIALDE 661 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~--------~~-----~~~~~~~~ 661 (708)
. ......++..|+|||++.. ..++.++|+||||+++|||++|+.||......... .. ........
T Consensus 153 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 153 P-PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred C-CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 2 2233567889999998754 45788999999999999999999998643211000 00 00000000
Q ss_pred ccCCCCCCCCc-----hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 662 ILDPRLPPPSR-----SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 662 ~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+...+.... ........+.+++.+||+.||++|||++|++.+-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~ 282 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence 11111110000 00111356889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=294.04 Aligned_cols=265 Identities=22% Similarity=0.334 Sum_probs=197.6
Q ss_pred HHHHHHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee
Q 039322 429 DEIVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH 507 (708)
Q Consensus 429 ~~~~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 507 (708)
.++....++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+.+|++++++++|+||+++++++..
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 45566779999999999999999999954 578999999987532 122335668889999999999999999998864
Q ss_pred C------CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcE
Q 039322 508 A------RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEA 581 (708)
Q Consensus 508 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 581 (708)
. ...+++++++ +++|.+++... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 3 3467888876 77999887543 389999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------c
Q 039322 582 HVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS-------L 653 (708)
Q Consensus 582 kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-------~ 653 (708)
||+|||++..... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.......... .
T Consensus 160 kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 160 KILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred EEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999875432 2233467889999998766 467889999999999999999999986422110000 0
Q ss_pred ccccccccccC----------CCCCCCC--chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 654 NTDIALDEILD----------PRLPPPS--RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 654 ~~~~~~~~~~~----------~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
........+.+ +..+... .........+.+++.+|++.||++||++.+++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 00000000000 0000000 00001133578999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=294.39 Aligned_cols=257 Identities=21% Similarity=0.337 Sum_probs=192.2
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR---- 509 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~---- 509 (708)
..+|...+.||+|+||.||+|.. .+|+.||+|++...... ......+.+|++++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS--EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc--ccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 47899999999999999999965 46899999998764321 122456788999999999999999999986542
Q ss_pred --eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecc
Q 039322 510 --HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFG 587 (708)
Q Consensus 510 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 587 (708)
..++|+||+.. ++.++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred CceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence 46899999964 7777652 2478999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------ccccccc
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS-------LNTDIAL 659 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-------~~~~~~~ 659 (708)
++..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... .......
T Consensus 163 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 163 LARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9875432 2223467889999998876 457889999999999999999999997432110000 0000000
Q ss_pred --------ccccC--CCCCCCC--chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 660 --------DEILD--PRLPPPS--RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 660 --------~~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
..... +..+... .........+.+++.+||+.||++||+++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0000000 0001123457899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=270.87 Aligned_cols=260 Identities=20% Similarity=0.274 Sum_probs=207.0
Q ss_pred HHHHHhccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEE
Q 039322 430 EIVRATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503 (708)
Q Consensus 430 ~~~~~~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~ 503 (708)
++.....+++..-.+-+|.||.||+|.+. +.+.|.+|.++... ..-+...+..|..++..+.|||+..+.+
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A---S~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA---SQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc---cHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 44444566777778999999999999553 34457778776531 1223556888999999999999999999
Q ss_pred EEee-CCeeEEEEEeccCCCHHHHhc-----ccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC
Q 039322 504 FCSH-ARHSFLVYELLERGSLAAILS-----SDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL 577 (708)
Q Consensus 504 ~~~~-~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~ 577 (708)
++.+ .+..+.++.++.-|+|..|+. .....+.++..+...++.|++.|++|||++ +|||.||.++|+++++
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 8855 467889999999999999997 344456688899999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccccccCCCCCcc--ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccc
Q 039322 578 EYEAHVADFGIAKFLKPESSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLN 654 (708)
Q Consensus 578 ~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~ 654 (708)
...+||+|=.+++...+.++.. ...-.+..||+||.+....++.++||||||+++|||+| |+.||...+.
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP------- 504 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP------- 504 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-------
Confidence 9999999999999877765542 33345789999999999999999999999999999998 9999864332
Q ss_pred cccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 655 TDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.+...-+.|+..-..+..+++ ++..++.-||..+|++||+++|++.-|
T Consensus 505 -fEm~~ylkdGyRlaQP~NCPD---eLf~vMacCWallpeeRPsf~Qlv~cL 552 (563)
T KOG1024|consen 505 -FEMEHYLKDGYRLAQPFNCPD---ELFTVMACCWALLPEERPSFSQLVICL 552 (563)
T ss_pred -HHHHHHHhccceecCCCCCcH---HHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 333333444443333344444 477788899999999999999998755
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=287.16 Aligned_cols=262 Identities=24% Similarity=0.334 Sum_probs=200.1
Q ss_pred ccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEE
Q 039322 438 FDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYE 516 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 516 (708)
|+..+.||+|++|.||+|... +++.||+|.+.... ......+.+..|++++++++|+|++++++++...+..++|+|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence 456778999999999999665 58999999988643 122335667889999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 039322 517 LLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596 (708)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 596 (708)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+.......
T Consensus 79 ~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 79 YCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred CcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 998 49999997653 3489999999999999999999999 99999999999999999999999999998765443
Q ss_pred CccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------cccccc---cccc--c
Q 039322 597 SNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS-------LNTDIA---LDEI--L 663 (708)
Q Consensus 597 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-------~~~~~~---~~~~--~ 663 (708)
.......++..|+|||.+.+. .++.++||||||+++||+++|+.||.......... ...... .... .
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 333344567889999988766 78899999999999999999999986432110000 000000 0000 0
Q ss_pred CCCCCC---CC--chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 664 DPRLPP---PS--RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 664 ~~~~~~---~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+...+. .. .........+.+++.+||..||++||++++++.+=+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~ 281 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence 000000 00 001112446889999999999999999999998744
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=291.34 Aligned_cols=265 Identities=23% Similarity=0.296 Sum_probs=194.2
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR---- 509 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~---- 509 (708)
.++|++.+.||+|+||.||+|... +++.||+|.+......+ .....+.+|++++++++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD--GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC--CcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 478999999999999999999654 68899999986532211 12345678999999999999999999875433
Q ss_pred ----eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEee
Q 039322 510 ----HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVAD 585 (708)
Q Consensus 510 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 585 (708)
..++|+||+.+ ++.+.+.... ..+++.++..++.|+++||+|||+. |++|+||||+||++++++.++|+|
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence 46999999975 7777765432 4589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCc-----------cccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 039322 586 FGIAKFLKPESSN-----------WTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL 653 (708)
Q Consensus 586 fg~a~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~ 653 (708)
||++......... .....++..|+|||.+.+. .++.++||||+|+++|||++|+.||...........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999765432211 1233567889999987654 478899999999999999999999864322100000
Q ss_pred --------c-----ccccccc----ccCCCCCCCCc-hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 --------N-----TDIALDE----ILDPRLPPPSR-SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 --------~-----~~~~~~~----~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. ....... ......+.... ........+.+++.+|++.||++|||+.|++++-+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~ 310 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCC
Confidence 0 0000000 00011111000 00111246789999999999999999999998743
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=292.77 Aligned_cols=262 Identities=22% Similarity=0.315 Sum_probs=196.1
Q ss_pred HHHhccccccceeccccCccEEEEE-eCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC-
Q 039322 432 VRATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR- 509 (708)
Q Consensus 432 ~~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~- 509 (708)
....++|++.+.||+|+||.||+|. ..+|+.||||.+.... ......+.+..|++++++++|+||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 3346789999999999999999995 4578999999986532 12233456889999999999999999999987543
Q ss_pred -----eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEe
Q 039322 510 -----HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVA 584 (708)
Q Consensus 510 -----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~ 584 (708)
..++||||+ +++|.+++.. ..+++..+..++.|++.|++|||+. |++||||||+||+++.++.++|+
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 458999998 6799988854 2489999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------cccc
Q 039322 585 DFGIAKFLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS-------LNTD 656 (708)
Q Consensus 585 Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-------~~~~ 656 (708)
|||++...... .....++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||.......... ....
T Consensus 161 dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 161 DFGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ecccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999765322 223456889999998876 457889999999999999999999987432110000 0000
Q ss_pred cccccc--------cC--CCCCCC--CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 657 IALDEI--------LD--PRLPPP--SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 657 ~~~~~~--------~~--~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.....+ .. +..... ..........+.+++.+|++.||++|||+.+++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~ 299 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP 299 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 000000 00 000000 000011233578999999999999999999999763
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=244.90 Aligned_cols=261 Identities=20% Similarity=0.282 Sum_probs=199.6
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+|...++||+|.||+||+|+. .+++.||+|.++.+.. +..-.....+|+.+++.++|+|||++++....++..-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 466677899999999999965 4688999999986432 2233567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
|||.. +|..+..... ..++.+..+.++.|+.+|+.|+|++ ++.|||+||.|.++..+|+.|++|||+|+-++-+
T Consensus 81 e~cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred HHhhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 99965 8888876543 4588899999999999999999999 9999999999999999999999999999977655
Q ss_pred CCccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHh-CCCCCCcccccccc--------cccc-----ccccc
Q 039322 596 SSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSS--------SLNT-----DIALD 660 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~--------~~~~-----~~~~~ 660 (708)
-.-+...+.|..|.+|.++.+.+ |+...|+||-||++.|+.. |++.|......... .... ...+.
T Consensus 155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 44556667899999999998866 7889999999999999996 55556542211100 0000 01111
Q ss_pred cccCCCCCCCCchhHHHHH----HHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 661 EILDPRLPPPSRSVQEKLI----SIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~----~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
+...-...+....+.+... .=.+++.+.+.-+|.+|.++++.+++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111111122223333222 23567778888899999999999886
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=313.29 Aligned_cols=149 Identities=26% Similarity=0.333 Sum_probs=132.1
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|.+.+.||+|+||.||+|... +++.||||+++.... ........+..|+.+++.++|+||+++++++...+..|+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 368999999999999999999664 688999999875321 222345678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
||||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999996543 478899999999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=287.49 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=207.0
Q ss_pred cceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEecc
Q 039322 441 QYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 441 ~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
.+++|.|.||+||-|.+ ++|+.||||++.+-. -......++.+|+.+++++.||.||.+.-.|+.++..+.|||-+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlr--Fp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLR--FPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeeccc--CCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence 46799999999999965 579999999998732 222445789999999999999999999999999999999999997
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC---CcEEEeecccccccCCCC
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE---YEAHVADFGIAKFLKPES 596 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~ 596 (708)
|.-|.-.+.. .+.++++.....++.||..||+|||.+ +|+|+||||+|||+.+. .++||||||+|+.+.. .
T Consensus 647 GDMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-k 720 (888)
T KOG4236|consen 647 GDMLEMILSS--EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-K 720 (888)
T ss_pred chHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch-h
Confidence 6444444443 235688999999999999999999999 99999999999999654 5799999999998764 3
Q ss_pred CccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHH
Q 039322 597 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQE 676 (708)
Q Consensus 597 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (708)
+.....+||+.|.|||++....|.+.-|+||.|+++|--++|..||... +...+.+.+..+..++..|.+
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----------EdIndQIQNAaFMyPp~PW~e 790 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED----------EDINDQIQNAAFMYPPNPWSE 790 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc----------cchhHHhhccccccCCCchhh
Confidence 4556789999999999999999999999999999999999999998621 222334444555555666777
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 677 KLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 677 ~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......++|...++..-.+|-|...-+.|.|
T Consensus 791 is~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 791 ISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred cCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 7777788999999999999999988877765
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=295.52 Aligned_cols=261 Identities=22% Similarity=0.323 Sum_probs=196.7
Q ss_pred HhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe--
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH-- 510 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~-- 510 (708)
..++|++.+.||+|++|.||+|... +++.||+|++.... ......+.+.+|+.++++++|+|++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc--chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 3578999999999999999999664 68899999987532 122344667889999999999999999998866554
Q ss_pred ----eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeec
Q 039322 511 ----SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADF 586 (708)
Q Consensus 511 ----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 586 (708)
.++|+||+ +++|.+++.. ..+++..++.++.|++.|++|||+. |++||||+|+||+++.++.++|+||
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence 89999998 5699998864 3489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------cccccc
Q 039322 587 GIAKFLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS-------LNTDIA 658 (708)
Q Consensus 587 g~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-------~~~~~~ 658 (708)
|++...... .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.......... ......
T Consensus 163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 163 GLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 999865432 233457889999998765 357889999999999999999999986432110000 000000
Q ss_pred c--------ccccCC---CCCCCC-chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 659 L--------DEILDP---RLPPPS-RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 659 ~--------~~~~~~---~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. ..++.. ...... .........+.+++.+|++.||++|||+.|++++-+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~ 300 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCC
Confidence 0 000000 000000 000112456889999999999999999999998743
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=293.48 Aligned_cols=259 Identities=21% Similarity=0.285 Sum_probs=190.9
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC------
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA------ 508 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------ 508 (708)
.+|.+.+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~----~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD----PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC----CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 6899999999999999999965 468899999986532 23456788899999999999999999776543
Q ss_pred --------CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-CC
Q 039322 509 --------RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL-EY 579 (708)
Q Consensus 509 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~ 579 (708)
...++|+||+. ++|.+++... .+++..++.++.|++.||+|||+. |++||||||+||+++. ++
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~ 152 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence 35789999997 4898888542 378999999999999999999999 9999999999999974 56
Q ss_pred cEEEeecccccccCCCCC---ccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc----
Q 039322 580 EAHVADFGIAKFLKPESS---NWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS---- 651 (708)
Q Consensus 580 ~~kl~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~---- 651 (708)
.+|++|||.+........ ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.........
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 789999999976532211 1123457889999997654 45788999999999999999999999643211000
Q ss_pred ---ccccc----c---cc-cccc-CCCCCCCC--chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 652 ---SLNTD----I---AL-DEIL-DPRLPPPS--RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 652 ---~~~~~----~---~~-~~~~-~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
..... . .. .... .......+ ........++.+++.+||+.||++|||++|++++=
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~ 301 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHP 301 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCC
Confidence 00000 0 00 0000 00000000 00011234577899999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=276.18 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=202.6
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~ 512 (708)
..+|.+..+||+|+||.|.+|.- .+.+.||||++++++..++ .+.+.-+.|-++|.-. +-|.++.+..+|..-+.+|
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec-CcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 46899999999999999999954 4567899999998654332 3344556677777655 5789999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
.||||+.||+|.-.++..+ ++.++.+..+|..||-||-|||++ ||++||||.+|||++.+|++||+|||++..-
T Consensus 427 FVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999988886544 377788999999999999999999 9999999999999999999999999999854
Q ss_pred CCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
--++.......||+.|+|||.+...+|+.++|.||||+++|||+.|+.||+. ...++....+++.....+..
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG--------eDE~elF~aI~ehnvsyPKs 572 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG--------EDEDELFQAIMEHNVSYPKS 572 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHHHHccCcCccc
Confidence 4455556678999999999999999999999999999999999999999984 33456666777766554433
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCC
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRP 697 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RP 697 (708)
. +.+.+.+.+..+.+.|.+|.
T Consensus 573 l----SkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 573 L----SKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred c----cHHHHHHHHHHhhcCCcccc
Confidence 2 23356777788999999996
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=311.16 Aligned_cols=258 Identities=23% Similarity=0.258 Sum_probs=206.9
Q ss_pred HHHHhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 431 IVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 431 ~~~~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
+.-..++|.+.++||+|+||.|..++++ +++.||+|++.+... -...+...|..|-.+|..-+.+-|+.+...|.+++
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eM-lKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEM-LKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHH-hhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 3334579999999999999999999764 588999999986221 11245678999999999999999999999999999
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccc
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA 589 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 589 (708)
++|+|||||+||+|...+++.. +++++.++.++..|+-||+-+|+. |+|||||||+|||+|..|++||+|||.+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhH
Confidence 9999999999999999998765 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC-ccccccccccccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 039322 590 KFLKPESS-NWTEFAGTYGYVAPELAYT-----MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEIL 663 (708)
Q Consensus 590 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 663 (708)
-.+..++. .....+|||.|.+||++.. +.|++..|.||+||++|||+.|..||..... -.....++
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl--------veTY~KIm 294 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL--------VETYGKIM 294 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH--------HHHHHHHh
Confidence 88875554 3456789999999999852 5688999999999999999999999974322 12222222
Q ss_pred CC--CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHHh
Q 039322 664 DP--RLPPPSRSVQEKLISIMEVAFSCLNESPESRPT---MKVVTQQV 706 (708)
Q Consensus 664 ~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~l 706 (708)
+- .+..| .....+....+||.+.+. +|+.|-. ++++..|-
T Consensus 295 ~hk~~l~FP--~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 295 NHKESLSFP--DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred chhhhcCCC--cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 22 22222 111234456677766665 6788876 88887764
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=288.36 Aligned_cols=261 Identities=24% Similarity=0.307 Sum_probs=191.1
Q ss_pred cccccceeccccCccEEEEEeC-C--CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeC----
Q 039322 437 DFDAQYCIGNGGHGSVYRAELP-S--GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHA---- 508 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~---- 508 (708)
+|++.+.||+|+||.||++... . +..||+|.+..... .....+.+.+|+++++++ +||||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS--KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 4778889999999999999654 3 77899999875321 122355678899999999 599999999876432
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
...++++||+. ++|.+++... ..+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||.
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 45788899886 5899988643 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC----ccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------ccccc
Q 039322 589 AKFLKPESS----NWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS-------SLNTD 656 (708)
Q Consensus 589 a~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-------~~~~~ 656 (708)
+........ ......|+..|+|||...+ ..++.++||||+|+++|+|++|+.||......... .....
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 986543211 1233468899999998765 45889999999999999999999998743210000 00000
Q ss_pred cccccccC-----------CCCCCC-CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 657 IALDEILD-----------PRLPPP-SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 657 ~~~~~~~~-----------~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.....+.. ...... ..........+.+++.+|++.||++|||+.|++++=
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~ 293 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000000 000000 000011134688999999999999999999998763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=269.41 Aligned_cols=255 Identities=26% Similarity=0.361 Sum_probs=196.4
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHH-HHhccCCceeeEEEEEeeCCeeEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKA-LTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+.+-...||.|+||+|++-.+ +.|+..|||+++... ...+++++..|.+. ++.-++|+||+++|.+..++..|+.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n---~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN---IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc---chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 444556799999999999955 579999999998743 24567889999886 5555799999999999999999999
Q ss_pred EEeccCCCHHHHhcccc--cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 515 YELLERGSLAAILSSDT--AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
||.|.- +++.+.+.-. ....+++.-+-+|+...++||.||.+.. .|+|||+||+|||++..|.+||||||.+...
T Consensus 142 MELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 142 MELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred HHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhH
Confidence 999965 7766553211 2345788888899999999999999886 8999999999999999999999999998765
Q ss_pred CCCCCccccccccccccCccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC--
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTM--KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP-- 668 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 668 (708)
.. +...+.-+|-..|||||.+... .++.+|||||||+.+||+.||+.||..-. ...+.+..+..+..+
T Consensus 219 v~-SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-------svfeql~~Vv~gdpp~l 290 (361)
T KOG1006|consen 219 VD-SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-------SVFEQLCQVVIGDPPIL 290 (361)
T ss_pred HH-HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-------HHHHHHHHHHcCCCCee
Confidence 42 2334555778899999988643 48889999999999999999999986211 011222222222222
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
............+..+|.-|+-+|-.+||.+.++.++
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2222333455678888999999999999999998753
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=293.81 Aligned_cols=257 Identities=23% Similarity=0.411 Sum_probs=212.2
Q ss_pred HHHHHHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEe
Q 039322 429 DEIVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCS 506 (708)
Q Consensus 429 ~~~~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~ 506 (708)
+.....+..|++..+||+|.+|.||+++. ++|+.+|+|+..... ...+++..|.++++.. .|||++.++|++.
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----d~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----DEEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-----cccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 33344567889999999999999999954 568889999987643 2345566788888877 5999999999985
Q ss_pred e-----CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcE
Q 039322 507 H-----ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEA 581 (708)
Q Consensus 507 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 581 (708)
. ++.+|+|||||.+||..|+++.-. +.++.|+.+..|++.++.|+.+||.. .++|||+|-.|||++.++.|
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence 3 568999999999999999998766 67799999999999999999999999 89999999999999999999
Q ss_pred EEeecccccccCCCCCccccccccccccCccccccC-----CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccc
Q 039322 582 HVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTM-----KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTD 656 (708)
Q Consensus 582 kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~ 656 (708)
|++|||.+...+.........+||+.|||||++... .|+.++|+||||++..||.-|.+|+-.+-
T Consensus 163 KLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH---------- 232 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH---------- 232 (953)
T ss_pred EEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc----------
Confidence 999999999887666666778999999999998643 46778999999999999999999975322
Q ss_pred cccccccC--CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 657 IALDEILD--PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 657 ~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
.++.++. +..++....+..+..++-++|..|+.+|.++||++.++++|
T Consensus 233 -PmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 233 -PMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -hhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 2222222 12223333456777889999999999999999999999876
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=270.75 Aligned_cols=225 Identities=20% Similarity=0.171 Sum_probs=178.0
Q ss_pred ccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccCCCHHH
Q 039322 447 GGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAA 525 (708)
Q Consensus 447 G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~ 525 (708)
|.+|.||++.. .+++.||+|+++... .+..|...+....||||+++++++...+..++||||+++|+|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 88999999955 578899999987531 22334455555679999999999999999999999999999999
Q ss_pred HhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcccccccc
Q 039322 526 ILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT 605 (708)
Q Consensus 526 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 605 (708)
++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...... .....++
T Consensus 75 ~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~ 145 (237)
T cd05576 75 HISKFL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVE 145 (237)
T ss_pred HHHHhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcC
Confidence 986543 389999999999999999999998 9999999999999999999999999988655432 1223456
Q ss_pred ccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHH
Q 039322 606 YGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVA 685 (708)
Q Consensus 606 ~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 685 (708)
..|+|||...+..++.++||||+|+++|||++|+.|++...... ........+. .....+.+++
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------~~~~~~~~~~------~~~~~~~~li 209 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------NTHTTLNIPE------WVSEEARSLL 209 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------ccccccCCcc------cCCHHHHHHH
Confidence 78999999988888999999999999999999998875321100 0000001111 1223578899
Q ss_pred HhccCCCCCCCCCH-----HHHHHH
Q 039322 686 FSCLNESPESRPTM-----KVVTQQ 705 (708)
Q Consensus 686 ~~cl~~dP~~RPs~-----~evl~~ 705 (708)
.+|++.||++||++ +|+++|
T Consensus 210 ~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 210 QQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred HHHccCCHHHhcCCCccchHHHHcC
Confidence 99999999999996 777765
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=272.89 Aligned_cols=267 Identities=20% Similarity=0.272 Sum_probs=202.6
Q ss_pred chHHHHHHHhccccccceeccccCccEEEEE-eCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-C-C----ce
Q 039322 426 LVYDEIVRATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-H-R----NI 498 (708)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-~----~i 498 (708)
+.|..-...+++|.+...+|+|.||.|-... ...+..||||+++. -..-.+..+-|+++++++. + | -+
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-----V~kYreAa~iEi~vLqki~~~DP~g~~rc 153 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-----VDKYREAALIEIEVLQKINESDPNGKFRC 153 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-----HHHHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence 3333333346899999999999999999994 44578999999975 2234567788999999994 2 2 37
Q ss_pred eeEEEEEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-
Q 039322 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL- 577 (708)
Q Consensus 499 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~- 577 (708)
+.+.+||...++.|+|+|.+ |-|+.+++..+.. .+++...+..+++|++++++|||+. +++|-||||+||++.+
T Consensus 154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss 228 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSS 228 (415)
T ss_pred EeeehhhhccCceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEecc
Confidence 88889999999999999988 4599999987654 5589999999999999999999999 9999999999999942
Q ss_pred -------------------CCcEEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhC
Q 039322 578 -------------------EYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKG 638 (708)
Q Consensus 578 -------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg 638 (708)
+..++++|||.|++.... ....+.|..|.|||++.+-.++.++||||+|||++|+.||
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG 305 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG 305 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence 235899999999865432 2567789999999999999999999999999999999999
Q ss_pred CCCCCcccccccc-------cccc--------------ccc-----------cccccCCCCCCC--CchhHHHHHHHHHH
Q 039322 639 KHPRDFLSLISSS-------SLNT--------------DIA-----------LDEILDPRLPPP--SRSVQEKLISIMEV 684 (708)
Q Consensus 639 ~~p~~~~~~~~~~-------~~~~--------------~~~-----------~~~~~~~~~~~~--~~~~~~~~~~l~~l 684 (708)
...|...+..+.. +... ... .+.+.+...+.. ......+...+.+|
T Consensus 306 ~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL 385 (415)
T KOG0671|consen 306 ETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL 385 (415)
T ss_pred ceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence 9988643211000 0000 000 011111111000 01122344579999
Q ss_pred HHhccCCCCCCCCCHHHHHHH
Q 039322 685 AFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 685 i~~cl~~dP~~RPs~~evl~~ 705 (708)
+++|+..||.+|+|+.|+++|
T Consensus 386 l~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 386 LRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHccCccccccHHHHhcC
Confidence 999999999999999999986
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=298.82 Aligned_cols=349 Identities=25% Similarity=0.302 Sum_probs=282.0
Q ss_pred CCCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCcc-CCCCccccCCCCccEEe
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFT-SYLPHNVCRGGALQYFG 79 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~~l~~L~~L~ 79 (708)
|+++++|-|...++. ..|+.++.+.+|+.|.+++|++..+.-.....|.|+.+.+..|++. +-+|+.+..+..|+.||
T Consensus 31 Mt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lD 109 (1255)
T KOG0444|consen 31 MTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILD 109 (1255)
T ss_pred hhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhccccccCCCCchhcccccceeee
Confidence 567788888888887 5788888888899999999988754444445588889999988887 44888888999999999
Q ss_pred ccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccc
Q 039322 80 VSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITG 159 (708)
Q Consensus 80 l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 159 (708)
||+|++. ..|..+..-+++-.|+||+|+|..|+...|-++..|-.||||+|++... |.....+.+|++|.|++|.+..
T Consensus 110 LShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~L-PPQ~RRL~~LqtL~Ls~NPL~h 187 (1255)
T KOG0444|consen 110 LSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEML-PPQIRRLSMLQTLKLSNNPLNH 187 (1255)
T ss_pred cchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhc-CHHHHHHhhhhhhhcCCChhhH
Confidence 9999998 7888888889999999999999988888889999999999999999744 4566788889999999998875
Q ss_pred cCCccccCCCCCCEEeccccccc-ccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCC
Q 039322 160 GIPREIGNSSQLQALDLSLNHIV-GEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLG 238 (708)
Q Consensus 160 ~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~ 238 (708)
.--..+-.+++|++|.+++.+-+ .-+|.++..+.+|..++|+.|.+. ..|+.+..+++|+.|+||+|+|+ .......
T Consensus 188 fQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~ 265 (1255)
T KOG0444|consen 188 FQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEG 265 (1255)
T ss_pred HHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHH
Confidence 54455666777888888887655 356777888888888888888888 88888888888888888888888 4444566
Q ss_pred ccccceeecccCcccccCCChhhhhhcccchhhcccccCCC-CCchhhcCcccCCceecccccccCCCCCcccccccccE
Q 039322 239 NLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGG-EIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISV 317 (708)
Q Consensus 239 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~-~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 317 (708)
.+.+|+.|+||+|+++ ..|++++++++|+.|++.+|+++- -+|..++.+.+|+.+..++|.+. .+|..+.++..|+.
T Consensus 266 ~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~k 343 (1255)
T KOG0444|consen 266 EWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQK 343 (1255)
T ss_pred HHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHH
Confidence 6778888888888888 788888888888888888888764 45777788888888888888887 88888888888888
Q ss_pred EecCCCcCCCCCCCccccccCcccccccccCcCCCCCCC
Q 039322 318 IDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKGM 356 (708)
Q Consensus 318 l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~~ 356 (708)
|.|+.|++...+.....++.+.++.+..||-.--+|+..
T Consensus 344 L~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMPPKP~ 382 (1255)
T KOG0444|consen 344 LKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMPPKPN 382 (1255)
T ss_pred hcccccceeechhhhhhcCCcceeeccCCcCccCCCCcc
Confidence 888888888777766777778888888888776665543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=286.35 Aligned_cols=242 Identities=24% Similarity=0.281 Sum_probs=193.9
Q ss_pred hccccccceeccccCccEEEEE-eCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~ 512 (708)
+.+|.+...+|.|+|+.|-.+. ..+++..++|.+.+.. ..-.+|+.++... +||||+++.+.+.++.+.|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA--------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc--------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 5678888889999999998884 4578889999998641 1223466665555 6999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee-CCCCcEEEeecccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL-DLEYEAHVADFGIAKF 591 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfg~a~~ 591 (708)
+|||.+.|+-+.+.+.... ....++..|+.+|+.|+.|||++ ||||||+||+|||+ ++.++++|+|||.++.
T Consensus 393 ~v~e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred eeehhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhh
Confidence 9999999997777765433 23377788999999999999999 99999999999999 5889999999999987
Q ss_pred cCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 592 LKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
..++ ....+-|..|.|||+.....+++++|+||||+++|+|++|+.||...... .+....+..+.+.
T Consensus 466 ~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~~s--- 532 (612)
T KOG0603|consen 466 LERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPKFS--- 532 (612)
T ss_pred Cchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCccc---
Confidence 6544 33345688999999999999999999999999999999999998743221 2222233333222
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+....+|+.+|++.||.+||+|.++..|-+
T Consensus 533 ---~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w 565 (612)
T KOG0603|consen 533 ---ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPW 565 (612)
T ss_pred ---cccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence 233345678888999999999999999987754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=262.37 Aligned_cols=252 Identities=24% Similarity=0.332 Sum_probs=205.3
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~ 512 (708)
..+|+..++||+|+|+.|..++++ +.+.||+|++++....+ .++..-.+.|..+..+. +||.+|-+..+|..+...+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nd-dedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCC-cccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 378999999999999999999764 57789999998743322 23445566777777766 6999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
.|.||++||+|.-+++.. ++++++.++.+...|.-||.|||+. ||++||+|..|||++..|++|+.|+|+...-
T Consensus 328 fvieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999998877654 3589999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
-.++......+||+.|.|||.+.+..|...+|.|++|++++||+.|+.||+..+.........+-.+..++...+..+..
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs 481 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS 481 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce
Confidence 55566667789999999999999999999999999999999999999999976643333333333444455554444322
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCC
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRP 697 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RP 697 (708)
.. .....+++.-+++||++|.
T Consensus 482 ls----vkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 482 LS----VKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ee----hhhHHHHHHhhcCCcHHhc
Confidence 21 1234566788999999986
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-33 Score=271.28 Aligned_cols=257 Identities=27% Similarity=0.391 Sum_probs=195.2
Q ss_pred ccccccceeccccCccEEEE-EeCCCcEEEEEEcCCCCCcchhHh-----HHHHHHHHHHHHhccCCceeeEEEEEee-C
Q 039322 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIAD-----QKEFLIEVKALTEIRHRNIVKFYGFCSH-A 508 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~ 508 (708)
++|-..+.||+|+|+.||+| +....+.||||+-... ..+..+ .+...+|.++.+.+.||.||++|+||.- .
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlN--K~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLN--KNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhc--cchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 56778889999999999999 5566888999986532 223222 2457889999999999999999999965 4
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC---CCcEEEee
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL---EYEAHVAD 585 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~D 585 (708)
+.+|-|+|||+|-+|+.||+.++. +++++.+.|+.||+.||.||.+.. |+|+|-||||.|||+-. -|.+||.|
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 678999999999999999987654 789999999999999999999874 58999999999999954 47899999
Q ss_pred cccccccCCCCCc-------cccccccccccCccccccC----CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc
Q 039322 586 FGIAKFLKPESSN-------WTEFAGTYGYVAPELAYTM----KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN 654 (708)
Q Consensus 586 fg~a~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~ 654 (708)
||++..++.+.+. .....||.+|+|||.+.-+ +.+.|+||||.|+++|+++.|+.||......... ..
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI-Lq 695 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI-LQ 695 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH-Hh
Confidence 9999988765543 2346799999999987543 4678999999999999999999999743221000 00
Q ss_pred cccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039322 655 TDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQ 704 (708)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 704 (708)
.+..+.+ ..-.+++.+ ....+...+|++|+++.-++|....++..
T Consensus 696 eNTIlkA-tEVqFP~KP----vVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 ENTILKA-TEVQFPPKP----VVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhchhcc-eeccCCCCC----ccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 0111111 111122221 11223567788999999999988877654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-33 Score=255.12 Aligned_cols=265 Identities=23% Similarity=0.332 Sum_probs=194.8
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee------
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH------ 507 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~------ 507 (708)
.+.|+...+||+|.||.||+|+. +.|+.||+|++.-..+... -.....+|++++..++|+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeG--fpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEG--FPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccC--CcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 36677788999999999999965 4577889977643211111 13456789999999999999999988743
Q ss_pred --CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEee
Q 039322 508 --ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVAD 585 (708)
Q Consensus 508 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 585 (708)
....|+||++|+. +|...+.... .+++..++.++..++..||.|+|.. .|+|||+|+.|+|++.+|.+||+|
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeec
Confidence 2357999999987 8998886543 5688999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCC----CCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccc------------
Q 039322 586 FGIAKFLKPE----SSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLI------------ 648 (708)
Q Consensus 586 fg~a~~~~~~----~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~------------ 648 (708)
||+++.+... ...++..+.|..|.+||.+.+ ..++++.|||..||++.||+|+.+-+......
T Consensus 168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs 247 (376)
T KOG0669|consen 168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS 247 (376)
T ss_pred cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence 9999755322 223566788999999998776 45899999999999999999999887642211
Q ss_pred ----cccccccccccccccCCCCCCCCc-hhHHHH------HHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 649 ----SSSSLNTDIALDEILDPRLPPPSR-SVQEKL------ISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 649 ----~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~------~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+..........++--+.++.... ...+.. ..-.+|+..++..||.+|++++++++|-.
T Consensus 248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 000111111111111111111000 001111 13457788999999999999999998754
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-33 Score=276.34 Aligned_cols=255 Identities=22% Similarity=0.318 Sum_probs=206.2
Q ss_pred hccccccceeccccCccEEEEEeCCCc-EEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQ-VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
..+++....||-|+||.|-.+..++.+ .+|+|.+++. ...+....+.+..|-++|.+.+.|.||++|--|.+.+..|+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~-hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKK-HIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHh-hccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 356667778999999999999775443 3899998873 33445667788899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
.||-|-||.++..+..++ .++......++..+.+|++|||++ |||+|||||+|.+++.+|-+||.|||+|..+.
T Consensus 498 LmEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hHHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999997655 488889999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
.+ ......+||+.|.|||.+.+...+.++|.||||+++|||++|.+||.....+ ......++-+-.-.++.
T Consensus 572 ~g-~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm----ktYn~ILkGid~i~~Pr---- 642 (732)
T KOG0614|consen 572 SG-RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM----KTYNLILKGIDKIEFPR---- 642 (732)
T ss_pred cC-CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH----HHHHHHHhhhhhhhccc----
Confidence 54 4446689999999999999999999999999999999999999999854321 11111111111111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPT-----MKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~ 707 (708)
.....-.++|++.+..+|.+|.- ..|+.+|-|
T Consensus 643 --~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 643 --RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred --ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 11223567888999999999985 667777665
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=261.83 Aligned_cols=241 Identities=29% Similarity=0.421 Sum_probs=193.0
Q ss_pred cCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccCCCHHHH
Q 039322 448 GHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAI 526 (708)
Q Consensus 448 ~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 526 (708)
+||.||+|... +|+.+|+|++...... ...+.+.+|++.+++++|+|++++++++......++++||+++++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 57999999765 4899999998764221 1167899999999999999999999999999999999999999999999
Q ss_pred hcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccc
Q 039322 527 LSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTY 606 (708)
Q Consensus 527 l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 606 (708)
+..... +++..++.++.+++.++++||+. +++|+||+|+||+++.++.++++|||.+....... ......++.
T Consensus 78 ~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 150 (244)
T smart00220 78 LKKRGR---LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTP 150 (244)
T ss_pred HHhccC---CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCc
Confidence 865432 78999999999999999999999 99999999999999999999999999998765432 334456788
Q ss_pred cccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHH
Q 039322 607 GYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAF 686 (708)
Q Consensus 607 ~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 686 (708)
.|+|||...+..++.++||||+|+++|++++|..||+... ......+.......... .........+.+++.
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~ 222 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-------QLLELFKKIGKPKPPFP-PPEWKISPEAKDLIR 222 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHhccCCCCc-cccccCCHHHHHHHH
Confidence 9999999988888999999999999999999999986321 11111111111111111 110002346888999
Q ss_pred hccCCCCCCCCCHHHHHHHh
Q 039322 687 SCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 687 ~cl~~dP~~RPs~~evl~~l 706 (708)
+||..+|++||++.+++++=
T Consensus 223 ~~l~~~p~~Rp~~~~~~~~~ 242 (244)
T smart00220 223 KLLVKDPEKRLTAEEALQHP 242 (244)
T ss_pred HHccCCchhccCHHHHhhCC
Confidence 99999999999999999863
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-34 Score=288.73 Aligned_cols=323 Identities=26% Similarity=0.362 Sum_probs=284.4
Q ss_pred CCCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeee--CCCCCCCCCcccccccCCCccCCCCccccCCCCccEE
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGF--IPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYF 78 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~--~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L 78 (708)
+.+|++|.+++|+++. .-+.++.++.|+.+.+.+|+++.. ++..|....|+.|+||+|.+.. .|..+..-.++..|
T Consensus 54 lqkLEHLs~~HN~L~~-vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~E-vP~~LE~AKn~iVL 131 (1255)
T KOG0444|consen 54 LQKLEHLSMAHNQLIS-VHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLRE-VPTNLEYAKNSIVL 131 (1255)
T ss_pred HhhhhhhhhhhhhhHh-hhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhhh-cchhhhhhcCcEEE
Confidence 3579999999999995 556689999999999999988744 4455566889999999999988 88999988999999
Q ss_pred eccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCccc
Q 039322 79 GVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNIT 158 (708)
Q Consensus 79 ~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~ 158 (708)
+||+|+|..+....|.++..|-.||||+|++..+ |.....+.+|++|+|++|.+....-..+..+++|+.|.+++.+=+
T Consensus 132 NLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~L-PPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRT 210 (1255)
T KOG0444|consen 132 NLSYNNIETIPNSLFINLTDLLFLDLSNNRLEML-PPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRT 210 (1255)
T ss_pred EcccCccccCCchHHHhhHhHhhhccccchhhhc-CHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccch
Confidence 9999999955556678999999999999999955 456788999999999999986555556667788899999986543
Q ss_pred -ccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCC
Q 039322 159 -GGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENL 237 (708)
Q Consensus 159 -~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~ 237 (708)
..+|..+..+.+|..+|||.|.+. ..|+++.++++|+.|+|++|+|+ .+......-.+|++|+||+|+++ ..|+.+
T Consensus 211 l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~av 287 (1255)
T KOG0444|consen 211 LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAV 287 (1255)
T ss_pred hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHH
Confidence 467889999999999999999999 88999999999999999999999 55545555678999999999999 899999
Q ss_pred CccccceeecccCcccccC-CChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCccccccccc
Q 039322 238 GNLLKLHYLGLSNNQFVLE-LPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGIS 316 (708)
Q Consensus 238 ~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 316 (708)
+++++|+.|.+.+|+++.. +|..++++.+|+.+..++|.+. .+|+.++.++.|+.|.|+.|++. .+|.++.-++.|+
T Consensus 288 cKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~ 365 (1255)
T KOG0444|consen 288 CKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLK 365 (1255)
T ss_pred hhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcc
Confidence 9999999999999999744 6888999999999999999998 99999999999999999999998 8899999999999
Q ss_pred EEecCCCcCCCCCCC
Q 039322 317 VIDISDNQLQGPVPN 331 (708)
Q Consensus 317 ~l~l~~N~l~~~~~~ 331 (708)
.||+..|+---.+|.
T Consensus 366 vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 366 VLDLRENPNLVMPPK 380 (1255)
T ss_pred eeeccCCcCccCCCC
Confidence 999999987766554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=279.20 Aligned_cols=270 Identities=17% Similarity=0.221 Sum_probs=183.8
Q ss_pred HhccccccceeccccCccEEEEEe-----------------CCCcEEEEEEcCCCCCcchh----------HhHHHHHHH
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-----------------PSGQVVAIKKFHSPLPCDQI----------ADQKEFLIE 486 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-----------------~~~~~vavK~~~~~~~~~~~----------~~~~~~~~e 486 (708)
..++|++.++||+|+||.||+|.. ..++.||||.+......... ...+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999953 23567999998642110000 011234457
Q ss_pred HHHHHhccCCce-----eeEEEEEee--------CCeeEEEEEeccCCCHHHHhcccc---------------------c
Q 039322 487 VKALTEIRHRNI-----VKFYGFCSH--------ARHSFLVYELLERGSLAAILSSDT---------------------A 532 (708)
Q Consensus 487 ~~~l~~l~h~~i-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~---------------------~ 532 (708)
+.++.+++|.++ ++++++|.. ++..++||||+++|+|.++++... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778876554 677787753 356899999999999999986421 0
Q ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCc-cccccccccccCc
Q 039322 533 AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN-WTEFAGTYGYVAP 611 (708)
Q Consensus 533 ~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~y~aP 611 (708)
...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......... .....+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356788999999999999999999 9999999999999999999999999999765432211 1223447899999
Q ss_pred cccccCCC----------------------CcchhHHHHHHHHHHHHhCCC-CCCccccccccccccccccc---cccCC
Q 039322 612 ELAYTMKI----------------------TEKCDVYSFGVLVLEAIKGKH-PRDFLSLISSSSLNTDIALD---EILDP 665 (708)
Q Consensus 612 E~~~~~~~----------------------~~~~DvwslG~~l~elltg~~-p~~~~~~~~~~~~~~~~~~~---~~~~~ 665 (708)
|.+..... ..+.||||+||++|+|++|.. ||.................. .+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 98754321 124699999999999999886 66532211110000000000 11111
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCC---CCCCCHHHHHHHhhC
Q 039322 666 RLPPPSRSVQEKLISIMEVAFSCLNESP---ESRPTMKVVTQQVRI 708 (708)
Q Consensus 666 ~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~l~~ 708 (708)
.... ...........+++.+++.++| .+|+|++|+++|-++
T Consensus 460 ~~~~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f 503 (507)
T PLN03224 460 KYDF--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF 503 (507)
T ss_pred CCCc--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence 1111 1122233457788899999876 689999999998653
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=289.66 Aligned_cols=262 Identities=20% Similarity=0.221 Sum_probs=169.4
Q ss_pred HhccccccceeccccCccEEEEEeC-C----CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEE----
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP-S----GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGF---- 504 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~---- 504 (708)
..++|++.+.||+|+||.||+|... + +..||+|++.... ..+....| .+....+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 4578999999999999999999764 4 6899999876421 11111111 1111112222222111
Q ss_pred --EeeCCeeEEEEEeccCCCHHHHhcccccc-----------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 039322 505 --CSHARHSFLVYELLERGSLAAILSSDTAA-----------------QELGWSQRMNVIKGVADALSYLHHDCFPPIVH 565 (708)
Q Consensus 505 --~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH 565 (708)
...+...++|+||+.+++|.+++...... .......+..++.|++.||+|||++ +|+|
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiH 278 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVH 278 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 24556789999999999999998653210 0112344668999999999999999 9999
Q ss_pred ccCCCCCeeeCC-CCcEEEeecccccccCCCC-CccccccccccccCccccccC----------------------CCCc
Q 039322 566 QDISSKNLLLDL-EYEAHVADFGIAKFLKPES-SNWTEFAGTYGYVAPELAYTM----------------------KITE 621 (708)
Q Consensus 566 ~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~~~y~aPE~~~~~----------------------~~~~ 621 (708)
|||||+|||++. ++.+||+|||+|....... .......+++.|+|||.+... .++.
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 999999999986 5799999999998654322 223456788999999965322 1334
Q ss_pred chhHHHHHHHHHHHHhCCCCCCccccc-----cccccccccccccccCCCCCCCCc----hhHHHHHHHHHHHHhccCCC
Q 039322 622 KCDVYSFGVLVLEAIKGKHPRDFLSLI-----SSSSLNTDIALDEILDPRLPPPSR----SVQEKLISIMEVAFSCLNES 692 (708)
Q Consensus 622 ~~DvwslG~~l~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~d 692 (708)
++||||+||++|||+++..|++..... ...... .........+....... ..........+|+.+|+++|
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYD-LVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCc-HHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 569999999999999988775521100 000000 00001111111100000 00001123458999999999
Q ss_pred CCCCCCHHHHHHHhh
Q 039322 693 PESRPTMKVVTQQVR 707 (708)
Q Consensus 693 P~~RPs~~evl~~l~ 707 (708)
|++|||++|+++|-+
T Consensus 438 P~kR~ta~e~L~Hpf 452 (566)
T PLN03225 438 GRQRISAKAALAHPY 452 (566)
T ss_pred cccCCCHHHHhCCcC
Confidence 999999999999854
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=234.39 Aligned_cols=204 Identities=24% Similarity=0.406 Sum_probs=169.0
Q ss_pred HHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHH-HhccCCceeeEEEEEeeCCe
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKAL-TEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~l~~~~~~~~~ 510 (708)
...++..-...||+|+||.|-+.++ .+|+..|+|.++... +....++..+|+.+. +...+|.+|+++|...++..
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv---n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV---NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc---ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 3345566667799999999987754 479999999998654 345677888999974 45579999999999999999
Q ss_pred eEEEEEeccCCCHHHHhccc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccc
Q 039322 511 SFLVYELLERGSLAAILSSD-TAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA 589 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 589 (708)
.++.||.|.- ||+.+-+.- ..+..+++.-+-+||..+++||.|||++. .++|||+||+|||++.+|++|+||||.+
T Consensus 120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence 9999999965 887765432 23456889999999999999999999996 8999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccCcccccc----CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 039322 590 KFLKPESSNWTEFAGTYGYVAPELAYT----MKITEKCDVYSFGVLVLEAIKGKHPRD 643 (708)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~~l~elltg~~p~~ 643 (708)
....+ +-..+...|-..|||||.+.. ..|+.++||||||+.+.||.+++.||+
T Consensus 197 G~L~d-SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 197 GYLVD-SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred eeehh-hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 86653 233344567789999998753 368889999999999999999999987
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=280.94 Aligned_cols=245 Identities=25% Similarity=0.407 Sum_probs=188.6
Q ss_pred ccccceeccccCcc-EEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeEEEE
Q 039322 438 FDAQYCIGNGGHGS-VYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 438 ~~~~~~ig~G~~g~-vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
|.-.+++|.|+.|+ ||+|.. +|+.||||.+-. +-.....+|+..++.- +|||||++++.-.++...||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~-------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE-------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh-------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 44455789999986 699988 589999999754 2345677899998888 5999999999999999999999
Q ss_pred EeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC---C--CcEEEeecccc
Q 039322 516 ELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL---E--YEAHVADFGIA 589 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfg~a 589 (708)
|.|.. +|++++.... ......-...+.+..|+++|+++||+. +||||||||.|||++. + ..++|+|||++
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 99965 9999998742 111112245678899999999999998 9999999999999976 3 46899999999
Q ss_pred cccCCCCCcc---ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC
Q 039322 590 KFLKPESSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP 665 (708)
Q Consensus 590 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 665 (708)
.....+.... ....||-+|+|||++.....+.++||||+||++|+.++ |.+||.........-......+.
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~----- 733 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLV----- 733 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcccee-----
Confidence 9887665443 34678999999999999888889999999999999998 59999743221111000011111
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 666 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
.+.+.. ++ .-.+||.+|+++||..||+|.+|+.|
T Consensus 734 ~L~~~~----d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 734 HLEPLP----DC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred eeccCc----hH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 111111 11 45688999999999999999999976
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-34 Score=277.52 Aligned_cols=340 Identities=27% Similarity=0.380 Sum_probs=229.8
Q ss_pred CCCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEec
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGV 80 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l 80 (708)
|..|.+|++++|+++ ..|.+++.+..++.|+.++|+++..++.....+++..|++++|.+.. ++++++.+..|..|+.
T Consensus 67 L~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~e-l~~~i~~~~~l~dl~~ 144 (565)
T KOG0472|consen 67 LACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELKE-LPDSIGRLLDLEDLDA 144 (565)
T ss_pred ccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhccccceee-cCchHHHHhhhhhhhc
Confidence 346778888888888 46667788888888888888887444444455888888888888877 7777888888888888
Q ss_pred cCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccc-
Q 039322 81 SENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITG- 159 (708)
Q Consensus 81 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~- 159 (708)
.+|+++ ..|..+.++.+|..|++.+|+++..+++.+. ++.|++||..+|.+. ..|..++.+.+|..|+|..|.|..
T Consensus 145 ~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~l 221 (565)
T KOG0472|consen 145 TNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFL 221 (565)
T ss_pred cccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccC
Confidence 888888 6677777788888888888887766666555 666677766666665 334455666666666666666552
Q ss_pred ---------------------cCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCC
Q 039322 160 ---------------------GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVD 218 (708)
Q Consensus 160 ---------------------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~ 218 (708)
.......++++|.+|||++|+++ ..|..++-+.+|..|++++|.|+ .+|..++++ .
T Consensus 222 Pef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-h 298 (565)
T KOG0472|consen 222 PEFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-H 298 (565)
T ss_pred CCCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-e
Confidence 22222335566666666666666 55666666666666666666666 455566666 6
Q ss_pred CCeEeccCCccccc----------------------------------------------------------------CC
Q 039322 219 LEYLDLSANRFNNS----------------------------------------------------------------VP 234 (708)
Q Consensus 219 L~~L~l~~N~i~~~----------------------------------------------------------------~~ 234 (708)
|+.|-+.+|.+... +|
T Consensus 299 L~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VP 378 (565)
T KOG0472|consen 299 LKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVP 378 (565)
T ss_pred eeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCC
Confidence 66666666665320 00
Q ss_pred CCCCcccc---ceeecccCcccc-----------------------cCCChhhhhhcccchhhcccccCCCCCchhhcCc
Q 039322 235 ENLGNLLK---LHYLGLSNNQFV-----------------------LELPKELEKLVQLSELDASHNLFGGEIPFQICSL 288 (708)
Q Consensus 235 ~~~~~l~~---L~~L~l~~n~l~-----------------------~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~ 288 (708)
.....-.. ++..+++.|++. +.+|..++.+++|..|+|++|.+. ..|..+..+
T Consensus 379 dEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~l 457 (565)
T KOG0472|consen 379 DEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSL 457 (565)
T ss_pred HHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhh
Confidence 00000000 223333333332 135555666777777777777776 566667777
Q ss_pred ccCCceeccccccc-----------------------CCCCCcccccccccEEecCCCcCCCCCCCccccccCccccccc
Q 039322 289 KSLEKLNLSHNNLS-----------------------GSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKG 345 (708)
Q Consensus 289 ~~L~~L~l~~N~l~-----------------------~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~ 345 (708)
..|+.|+++.|++. ...+..+.+|.+|..||+.+|.++..+|..+...+++-+.++|
T Consensus 458 v~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~g 537 (565)
T KOG0472|consen 458 VRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDG 537 (565)
T ss_pred hhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecC
Confidence 77777777777664 2344457788999999999999999999999999999999999
Q ss_pred ccCc
Q 039322 346 NKGL 349 (708)
Q Consensus 346 n~~~ 349 (708)
||+.
T Consensus 538 Npfr 541 (565)
T KOG0472|consen 538 NPFR 541 (565)
T ss_pred CccC
Confidence 9975
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=256.18 Aligned_cols=261 Identities=24% Similarity=0.312 Sum_probs=198.6
Q ss_pred ccccccceeccccCccEEEEE-eCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-----C---CceeeEEEEEe
Q 039322 436 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-----H---RNIVKFYGFCS 506 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~l~~~~~ 506 (708)
++|-+.++||-|.|++||++. ....+.||+|+.+.. ..-.+..+.|+++|++++ | .+||++++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 689999999999999999994 456789999998862 344667889999999994 2 47999999996
Q ss_pred e----CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC----
Q 039322 507 H----ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE---- 578 (708)
Q Consensus 507 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---- 578 (708)
. +.+.|+|+|++ |.+|..++..... +.++...+++|++||..||.|||.+| ||||-||||+|||+..+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~ 228 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDP 228 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccch
Confidence 5 45899999998 5699999976654 45899999999999999999999998 99999999999998300
Q ss_pred --------------------------------------------------------------------------------
Q 039322 579 -------------------------------------------------------------------------------- 578 (708)
Q Consensus 579 -------------------------------------------------------------------------------- 578 (708)
T Consensus 229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~ 308 (590)
T KOG1290|consen 229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR 308 (590)
T ss_pred hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 039322 579 -------------------------------------------------------------------------------- 578 (708)
Q Consensus 579 -------------------------------------------------------------------------------- 578 (708)
T Consensus 309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~ 388 (590)
T KOG1290|consen 309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE 388 (590)
T ss_pred CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence
Q ss_pred --CcEEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-----
Q 039322 579 --YEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS----- 651 (708)
Q Consensus 579 --~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~----- 651 (708)
-.|||+|||-|+.+. ..++.-+.|..|+|||++.+..|+..+||||++|++|||+||...|+..+.....
T Consensus 389 ~di~vKIaDlGNACW~~---khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 389 CDIRVKIADLGNACWVH---KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred cceeEEEeeccchhhhh---hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 015666666666542 2345556788999999999999999999999999999999999999743221100
Q ss_pred ------------------------ccccccccccccCCCC-------CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHH
Q 039322 652 ------------------------SLNTDIALDEILDPRL-------PPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700 (708)
Q Consensus 652 ------------------------~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 700 (708)
..+....++.+..-++ ........+...++.+++.-|++.+|++||||.
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~ 545 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA 545 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence 0000001111111000 001123345667899999999999999999999
Q ss_pred HHHHHhhC
Q 039322 701 VVTQQVRI 708 (708)
Q Consensus 701 evl~~l~~ 708 (708)
+.++|-|+
T Consensus 546 ~cl~hPwL 553 (590)
T KOG1290|consen 546 QCLKHPWL 553 (590)
T ss_pred HHhcCccc
Confidence 99988653
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=235.33 Aligned_cols=254 Identities=20% Similarity=0.296 Sum_probs=194.1
Q ss_pred hccccccceeccccCccEEEE-EeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeC--Ce
Q 039322 435 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHA--RH 510 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~--~~ 510 (708)
.++|++.+.+|+|.|+.||.| ...+.+.++||+++. ...+.+.+|+.+++.+. ||||+.+++...++ ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 468999999999999999999 456788999999875 45778999999999997 99999999999775 46
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC-CcEEEeecccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE-YEAHVADFGIA 589 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a 589 (708)
+.+|+||+.+.+..... +.++...+..+..++..||.|+|+. ||+|||+||.|++++.. ..++|+|+|+|
T Consensus 110 paLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred chhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchH
Confidence 78999999998777665 3377788999999999999999999 99999999999999875 57999999999
Q ss_pred cccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-----------------
Q 039322 590 KFLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS----------------- 651 (708)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~----------------- 651 (708)
.++.+.... ...+.+..|..||.+.. ..++..-|+|||||++..|+..+.||=........
T Consensus 181 EFYHp~~eY-nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 181 EFYHPGKEY-NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred hhcCCCcee-eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 999866443 44566778899998765 45888999999999999999999998432111000
Q ss_pred ---ccccccccccccCCCCCCCCc------hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 652 ---SLNTDIALDEILDPRLPPPSR------SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 652 ---~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
...-+.....++......+.. ...-...+..+++.+.+.+|-.+|||++|...|
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 000111111111111111100 000011345677889999999999999998876
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=263.09 Aligned_cols=210 Identities=22% Similarity=0.323 Sum_probs=175.1
Q ss_pred HHHHHHHh---ccccccceeccccCccEEEE-EeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEE
Q 039322 428 YDEIVRAT---NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503 (708)
Q Consensus 428 ~~~~~~~~---~~~~~~~~ig~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~ 503 (708)
|..+.++. .-|...+.||-|+||.|.++ +..+...||+|.+++.. .-........+.|-.||..-..+-||++|.
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaD-Vl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKAD-VLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHH-HHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 44444443 35778888999999999999 45556789999998731 112233456788999999999999999999
Q ss_pred EEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEE
Q 039322 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHV 583 (708)
Q Consensus 504 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl 583 (708)
.|.+++.+|+||||++||++..+|.+.+- +.+...+.++..++.|+++.|+. |+|||||||+|||+|.+|++||
T Consensus 697 SFQDkdnLYFVMdYIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKL 770 (1034)
T KOG0608|consen 697 SFQDKDNLYFVMDYIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKL 770 (1034)
T ss_pred EeccCCceEEEEeccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceee
Confidence 99999999999999999999999976553 77888889999999999999999 9999999999999999999999
Q ss_pred eecccccccC---------CCCCc---------------------------------cccccccccccCccccccCCCCc
Q 039322 584 ADFGIAKFLK---------PESSN---------------------------------WTEFAGTYGYVAPELAYTMKITE 621 (708)
Q Consensus 584 ~Dfg~a~~~~---------~~~~~---------------------------------~~~~~~~~~y~aPE~~~~~~~~~ 621 (708)
.|||++..+. .++.. ....+||+.|+|||++....++.
T Consensus 771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q 850 (1034)
T KOG0608|consen 771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ 850 (1034)
T ss_pred eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence 9999986432 11000 01246899999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCc
Q 039322 622 KCDVYSFGVLVLEAIKGKHPRDF 644 (708)
Q Consensus 622 ~~DvwslG~~l~elltg~~p~~~ 644 (708)
..|.||.|++||||+.|+.||-.
T Consensus 851 ~cdwws~gvil~em~~g~~pf~~ 873 (1034)
T KOG0608|consen 851 LCDWWSVGVILYEMLVGQPPFLA 873 (1034)
T ss_pred cchhhHhhHHHHHHhhCCCCccC
Confidence 99999999999999999999964
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=235.85 Aligned_cols=212 Identities=33% Similarity=0.577 Sum_probs=184.3
Q ss_pred eccccCccEEEEEeCC-CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccCCC
Q 039322 444 IGNGGHGSVYRAELPS-GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGS 522 (708)
Q Consensus 444 ig~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~ 522 (708)
||+|.+|.||++.... ++.+++|++....... ..+.+.+|++.++.++|++++++++++......++++|++.+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 6899999999997754 8999999988632111 35679999999999999999999999999999999999999999
Q ss_pred HHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-CCcEEEeecccccccCCCCCcccc
Q 039322 523 LAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL-EYEAHVADFGIAKFLKPESSNWTE 601 (708)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~ 601 (708)
|.+++.... ..+++..++.++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+............
T Consensus 78 l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 78 LKDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred HHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence 999987542 3478999999999999999999999 9999999999999999 899999999999866544322344
Q ss_pred ccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHH
Q 039322 602 FAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLIS 680 (708)
Q Consensus 602 ~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 680 (708)
..+...|++||..... ..+.++|+|++|++++++ ..
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~~ 189 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------PE 189 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------HH
Confidence 5678899999998877 788899999999999998 35
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 681 IMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 681 l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
+.+++.+|++.+|++||++.++++++
T Consensus 190 ~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 190 LKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 88999999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=256.31 Aligned_cols=276 Identities=21% Similarity=0.210 Sum_probs=211.5
Q ss_pred cccCCCchHHHHHHHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc----
Q 039322 420 LNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR---- 494 (708)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---- 494 (708)
.+.++-+.+.-.+....+|.+....|+|-|++|.+|.. .-|..||||+++.. ..-.+.=+.|+++|++|+
T Consensus 416 dDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-----E~M~KtGl~EleiLkKL~~AD~ 490 (752)
T KOG0670|consen 416 DDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-----EVMHKTGLKELEILKKLNDADP 490 (752)
T ss_pred ccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-----hHHhhhhhHHHHHHHHhhccCc
Confidence 34445555554555678999999999999999999954 45789999999863 233455678999999995
Q ss_pred --CCceeeEEEEEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 039322 495 --HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKN 572 (708)
Q Consensus 495 --h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N 572 (708)
--|.++++-.|.+.+++|||+|.+.. +|.+.+++.+....+....+..++.|+.-||..|... ||+|.||||.|
T Consensus 491 Edk~Hclrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDN 566 (752)
T KOG0670|consen 491 EDKFHCLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDN 566 (752)
T ss_pred hhhhHHHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccc
Confidence 25899999999999999999998865 9999999888777789999999999999999999998 99999999999
Q ss_pred eeeCCCC-cEEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccc-----
Q 039322 573 LLLDLEY-EAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLS----- 646 (708)
Q Consensus 573 ill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~----- 646 (708)
||+.+.. .+||||||.|...... ..+....+-.|.|||.+.+-.|+...|+||.||+|||+.||+..|....
T Consensus 567 iLVNE~k~iLKLCDfGSA~~~~en--eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML 644 (752)
T KOG0670|consen 567 ILVNESKNILKLCDFGSASFASEN--EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML 644 (752)
T ss_pred eEeccCcceeeeccCccccccccc--cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence 9998875 4799999999876543 3344456778999999999999999999999999999999999886411
Q ss_pred --------ccc------------------------cccccccccccc--ccCCC------CC---CCCchhHHHHHHHHH
Q 039322 647 --------LIS------------------------SSSLNTDIALDE--ILDPR------LP---PPSRSVQEKLISIME 683 (708)
Q Consensus 647 --------~~~------------------------~~~~~~~~~~~~--~~~~~------~~---~~~~~~~~~~~~l~~ 683 (708)
.+. ............ .+.|. +. ..+.........|.+
T Consensus 645 rl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rd 724 (752)
T KOG0670|consen 645 RLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRD 724 (752)
T ss_pred HHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHH
Confidence 000 000000000000 00000 00 011122334567899
Q ss_pred HHHhccCCCCCCCCCHHHHHHHh
Q 039322 684 VAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 684 li~~cl~~dP~~RPs~~evl~~l 706 (708)
|+..|+..||++|.|..+.++|-
T Consensus 725 LLdkml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 725 LLDKMLILDPEKRITVNQALKHP 747 (752)
T ss_pred HHHHHhccChhhcCCHHHHhcCC
Confidence 99999999999999999999874
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=241.55 Aligned_cols=261 Identities=26% Similarity=0.362 Sum_probs=193.9
Q ss_pred cccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC-----Ce
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA-----RH 510 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~~ 510 (708)
+.+-.+.||-|+||.||.+++ ++|+.||.|++..- .......+.+.+|++++...+|.|++..++...-+ .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv--fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV--FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH--HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 344567799999999999955 58999999998642 23455678899999999999999999888776433 24
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.|.++|.|.. +|...+-.. +.++...+.-+++||.+||.|||+. +|.||||||.|.+++++..+||||||+|+
T Consensus 132 iYV~TELmQS-DLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHHh-hhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccc
Confidence 6788898865 888777544 4488899999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCC-ccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccccccc--------------
Q 039322 591 FLKPESS-NWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN-------------- 654 (708)
Q Consensus 591 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-------------- 654 (708)
..+.+.. ..+..+.|..|.|||.+.+.+ |+.+.||||.||++.|++..+..|...+.....+.+
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 8765543 345567899999999998754 889999999999999999988888643332111110
Q ss_pred -cccccccccCCCCCCCCc-------hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 655 -TDIALDEILDPRLPPPSR-------SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 655 -~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.+.....++......+.. ......-+-..+...++..||.+|.+.++.+.+.
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 011111122222221111 0001111234566789999999999999887654
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-32 Score=263.46 Aligned_cols=269 Identities=27% Similarity=0.419 Sum_probs=163.2
Q ss_pred CcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcc
Q 039322 50 MLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLS 129 (708)
Q Consensus 50 ~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~ 129 (708)
.|+.|++.+|.++. +|..++.+.+|..|++.+|.|. .+| .|..+..|.+|+++.|.|.-++.+....++++.+|||.
T Consensus 184 ~L~~ld~~~N~L~t-lP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLR 260 (565)
T KOG0472|consen 184 RLKHLDCNSNLLET-LPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLR 260 (565)
T ss_pred HHHhcccchhhhhc-CChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeecc
Confidence 34444444444443 4555555555555555555555 334 45555555555555555555555555555556666666
Q ss_pred cCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEeccccccccc-------------------------
Q 039322 130 RNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGE------------------------- 184 (708)
Q Consensus 130 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~------------------------- 184 (708)
+|+++ ..|..+..+.+|++||+++|.|+ ..|..++++ +|+.|-+.+|.++..
T Consensus 261 dNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dgl 337 (565)
T KOG0472|consen 261 DNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGL 337 (565)
T ss_pred ccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCC
Confidence 66655 23344445555556666666655 344455555 555555555554100
Q ss_pred ------------CCc-ccC---CCCC--------------------------CCEEEccCcccc----------------
Q 039322 185 ------------IPK-ELG---KLNS--------------------------LTELILRGNQFT---------------- 206 (708)
Q Consensus 185 ------------~~~-~~~---~l~~--------------------------L~~L~l~~n~l~---------------- 206 (708)
.+. .+. .+-+ +...+++.|++.
T Consensus 338 S~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l 417 (565)
T KOG0472|consen 338 SQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDL 417 (565)
T ss_pred CCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHH
Confidence 000 000 0000 122333333333
Q ss_pred -------ccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCC
Q 039322 207 -------GRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGG 279 (708)
Q Consensus 207 -------~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~ 279 (708)
+.+|..++.+++|..|+|++|.+. ..|..++.+..|+.|+++.|++. ..|.++-.+..++.+-.++|++..
T Consensus 418 ~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~ 495 (565)
T KOG0472|consen 418 VLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGS 495 (565)
T ss_pred HhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccc
Confidence 123334455667777777777776 56666777777777777777776 566666666666666667778876
Q ss_pred CCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCC
Q 039322 280 EIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQG 327 (708)
Q Consensus 280 ~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 327 (708)
+.+..+..|.+|..|||.+|.+. .+|..+.+|.+|++|+++||++.-
T Consensus 496 vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr~ 542 (565)
T KOG0472|consen 496 VDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFRQ 542 (565)
T ss_pred cChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccCC
Confidence 77777899999999999999998 788889999999999999999993
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=239.32 Aligned_cols=257 Identities=22% Similarity=0.291 Sum_probs=195.5
Q ss_pred ccccccceeccccCccEEEE-EeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC------
Q 039322 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA------ 508 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------ 508 (708)
.+|.-.+.+|.|.- .|..| +.-.++.||+|+...+ ..+....++..+|...+..++|+||++++.+|.-.
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p--f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP--FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCc--cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 56777778898888 56666 3346889999998765 34445567888999999999999999999999543
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
...|+|||+|.. +|...+.. .++-..+..+.+|+..|++|||+. ||+||||||+||++..+..+||.|||+
T Consensus 94 ~e~y~v~e~m~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 94 QEVYLVMELMDA-NLCQVILM-----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HhHHHHHHhhhh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence 357999999965 99888862 267788999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-----------------
Q 039322 589 AKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS----------------- 651 (708)
Q Consensus 589 a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~----------------- 651 (708)
|+....+ -..+..+.+..|.|||++.+..+.+.+||||.||++.||++|+.-|......+..
T Consensus 165 ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 165 ARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred hcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 9865543 3456678899999999999999999999999999999999999988642211000
Q ss_pred -------------ccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 652 -------------SLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 652 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
.+.....-+-+-|..++...+...-......+++.+|+..||++|-+++++++|
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000000000111111111111111112246788899999999999999999987
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-29 Score=261.49 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=203.2
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.+|+....+|.|.||.||+|+. .+++..|+|+++-. ...+.+-.++|+-+++..+|+||+.++|.+...+..|+.
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe----p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE----PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeecc----CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 6888999999999999999954 57899999998862 223466678899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
||||.+|+|++.-+... .+++.++..+.+...+|++|||+. |-+|||||-.||++++.|.+|++|||.+..+..
T Consensus 91 MEycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 99999999999876544 488899999999999999999999 999999999999999999999999999988876
Q ss_pred CCCccccccccccccCcccc---ccCCCCcchhHHHHHHHHHHHHhCCCC-CCccccccccccccccccccccCCCCCCC
Q 039322 595 ESSNWTEFAGTYGYVAPELA---YTMKITEKCDVYSFGVLVLEAIKGKHP-RDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~~l~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
.-.+.....||+.|||||+. ..+.|...+|||+.|+...|+---+.| |+... +.. .....+.-.++..
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-mr~----l~LmTkS~~qpp~--- 236 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-MRA----LFLMTKSGFQPPT--- 236 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-HHH----HHHhhccCCCCCc---
Confidence 66667788999999999975 356788999999999999999877776 22110 000 0001111111111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
....-.+...|.++++.|+.++|++||+++.+++|
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 11222344468899999999999999999988764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=250.54 Aligned_cols=201 Identities=24% Similarity=0.364 Sum_probs=170.4
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcc--hhHhH--HHHHHHHHHHHhcc---CCceeeEEEEEe
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCD--QIADQ--KEFLIEVKALTEIR---HRNIVKFYGFCS 506 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~--~~~~~e~~~l~~l~---h~~iv~l~~~~~ 506 (708)
..+|...+.+|+|+||.|+.|.++ +...|+||++.+..... +.+++ -.+-.|+.+|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 467899999999999999999765 45679999998742221 11111 24667999999997 999999999999
Q ss_pred eCCeeEEEEEeccCC-CHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEee
Q 039322 507 HARHSFLVYELLERG-SLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVAD 585 (708)
Q Consensus 507 ~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 585 (708)
+++.+|++||-...| +|.+++.... .+++++..-|++||+.|+++||++ ||||||||-+||.++.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 999999999976544 8999997554 489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCccccccccccccCccccccCCCC-cchhHHHHHHHHHHHHhCCCCCC
Q 039322 586 FGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKIT-EKCDVYSFGVLVLEAIKGKHPRD 643 (708)
Q Consensus 586 fg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~elltg~~p~~ 643 (708)
||.|..... ..+...+||..|.|||++.+.+|- ..-|||++|+++|.++..+.||.
T Consensus 714 fgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999976543 345678999999999999998864 46899999999999999988874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=224.26 Aligned_cols=250 Identities=20% Similarity=0.314 Sum_probs=184.1
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEE-EEeeCCee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYG-FCSHARHS 511 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~-~~~~~~~~ 511 (708)
.+.|.+.+.+|+|.||.+-+++++ +.+.+|+|.+..+. ...++|.+|...--.| .|.||+.-|+ .|+..+.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 467899999999999999999775 57789999998743 4567899998875556 4899998875 46677888
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC--CCCcEEEeecccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD--LEYEAHVADFGIA 589 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~a 589 (708)
+.++||++.|+|.+-+...+ +.+....+++.|+++|+.|||++ ++||||||.+|||+- +...+|+||||..
T Consensus 98 vF~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred EEeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccc
Confidence 89999999999998876544 78888999999999999999999 999999999999993 3357999999999
Q ss_pred cccCCCCCccccccccccccCccccccC-----CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC
Q 039322 590 KFLKPESSNWTEFAGTYGYVAPELAYTM-----KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD 664 (708)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 664 (708)
+..+. .....--+..|.|||..... ...+.+|||.||+++|.++||..||.- .+.....+...........
T Consensus 171 ~k~g~---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 171 RKVGT---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPYWEWEQWLKRKN 246 (378)
T ss_pred cccCc---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchHHHHHHHhcccC
Confidence 75442 22222345678999976532 356789999999999999999999972 2222222222222222222
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 039322 665 PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVT 703 (708)
Q Consensus 665 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 703 (708)
++.+.. ........+.+.++-+.++|++|--..++.
T Consensus 247 ~~~P~~---F~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 247 PALPKK---FNPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred ccCchh---hcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 222222 222233466777789999999995444443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=225.31 Aligned_cols=198 Identities=31% Similarity=0.521 Sum_probs=170.9
Q ss_pred ccccceeccccCccEEEEEeCC-CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEE
Q 039322 438 FDAQYCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYE 516 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 516 (708)
|...+.||+|++|.||+|...+ ++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++...+..++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEe
Confidence 4567889999999999997764 889999999864221 246788999999999999999999999999899999999
Q ss_pred eccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 039322 517 LLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596 (708)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 596 (708)
|+++++|.+++..... .+++..+..++.+++.++++||+. +++|+|++|+||+++.++.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 78 YCEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred ccCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 9999999999975432 178899999999999999999999 99999999999999999999999999998765432
Q ss_pred -CccccccccccccCcccc-ccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 039322 597 -SNWTEFAGTYGYVAPELA-YTMKITEKCDVYSFGVLVLEAIKGKHPRD 643 (708)
Q Consensus 597 -~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~elltg~~p~~ 643 (708)
.......++..|++||.. ....++.++|||++|+++++|++|+.||+
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 122344677889999998 66667889999999999999999999986
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=227.18 Aligned_cols=199 Identities=26% Similarity=0.399 Sum_probs=166.5
Q ss_pred HHHHHHhccccccceeccccCccEEEEEeC----CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEE
Q 039322 429 DEIVRATNDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYG 503 (708)
Q Consensus 429 ~~~~~~~~~~~~~~~ig~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~ 503 (708)
+.+....+.|...++||+|.|++||+|... ..+.||+|.+... .....+..|+++|..+. +.||+++.+
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t------s~p~ri~~El~~L~~~gG~~ni~~~~~ 102 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT------SSPSRILNELEMLYRLGGSDNIIKLNG 102 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc------cCchHHHHHHHHHHHhccchhhhcchh
Confidence 344555678999999999999999999543 4678999998753 34566889999999994 999999999
Q ss_pred EEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC-CcEE
Q 039322 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE-YEAH 582 (708)
Q Consensus 504 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~k 582 (708)
++..++..++|+||++.....++... ++..++..+++.+..||+++|++ |||||||||+|++.+.. +.-.
T Consensus 103 ~~rnnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~ 173 (418)
T KOG1167|consen 103 CFRNNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGV 173 (418)
T ss_pred hhccCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCce
Confidence 99999999999999999998888743 67899999999999999999999 99999999999999754 6779
Q ss_pred EeecccccccCCCC----------------------------------C----------ccccccccccccCcccccc-C
Q 039322 583 VADFGIAKFLKPES----------------------------------S----------NWTEFAGTYGYVAPELAYT-M 617 (708)
Q Consensus 583 l~Dfg~a~~~~~~~----------------------------------~----------~~~~~~~~~~y~aPE~~~~-~ 617 (708)
|+|||+|..++... . ......||++|.|||++.. .
T Consensus 174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~ 253 (418)
T KOG1167|consen 174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP 253 (418)
T ss_pred EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence 99999998321000 0 0113569999999998765 4
Q ss_pred CCCcchhHHHHHHHHHHHHhCCCCC
Q 039322 618 KITEKCDVYSFGVLVLEAIKGKHPR 642 (708)
Q Consensus 618 ~~~~~~DvwslG~~l~elltg~~p~ 642 (708)
..++++||||.|+++..+++++.||
T Consensus 254 ~QttaiDiws~GVI~Lslls~~~PF 278 (418)
T KOG1167|consen 254 RQTTAIDIWSAGVILLSLLSRRYPF 278 (418)
T ss_pred CcCCccceeeccceeehhhcccccc
Confidence 5788999999999999999999997
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=209.96 Aligned_cols=162 Identities=25% Similarity=0.291 Sum_probs=124.2
Q ss_pred CCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCccc
Q 039322 521 GSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWT 600 (708)
Q Consensus 521 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 600 (708)
|+|.++++..+ ..+++.+++.++.|++.||+|||++ + ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 68999997543 4589999999999999999999998 6 999999999999999 99998654322
Q ss_pred cccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC---CCCCCCCchhHHH
Q 039322 601 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD---PRLPPPSRSVQEK 677 (708)
Q Consensus 601 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 677 (708)
..|++.|+|||++.+..++.++|||||||++|||+||+.||....... .....+.. ...+.........
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~ 135 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-------AILEILLNGMPADDPRDRSNLESV 135 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-------HHHHHHHHHhccCCccccccHHHH
Confidence 257899999999999999999999999999999999999986432110 01111111 1101100111122
Q ss_pred HH--HHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 678 LI--SIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 678 ~~--~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. .+.+++.+||+.+|++||++.|++++++
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence 22 5889999999999999999999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-26 Score=265.19 Aligned_cols=199 Identities=17% Similarity=0.186 Sum_probs=141.4
Q ss_pred HhccC-CceeeEEEEE-------eeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 039322 491 TEIRH-RNIVKFYGFC-------SHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562 (708)
Q Consensus 491 ~~l~h-~~iv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ 562 (708)
+.++| +||++++++| .+.+..+.++||+ +++|.+++.... ..+++.+++.++.||++||+|||++ |
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 34455 5888888887 2334677888987 559999996432 4589999999999999999999999 9
Q ss_pred eEEccCCCCCeeeCCC-------------------CcEEEeecccccccCCCCC----------------cccccccccc
Q 039322 563 IVHQDISSKNLLLDLE-------------------YEAHVADFGIAKFLKPESS----------------NWTEFAGTYG 607 (708)
Q Consensus 563 ivH~dlk~~Nill~~~-------------------~~~kl~Dfg~a~~~~~~~~----------------~~~~~~~~~~ 607 (708)
|+||||||+|||++.. +.+|++|||+++....... ......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999653 4556666666653211000 0011347888
Q ss_pred ccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHh
Q 039322 608 YVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFS 687 (708)
Q Consensus 608 y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 687 (708)
|+|||++.+..++.++|||||||++|||++|..|+..... ....+.....++. ..........++.+
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----------~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 247 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----------TMSSLRHRVLPPQ---ILLNWPKEASFCLW 247 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----------HHHHHHHhhcChh---hhhcCHHHHHHHHH
Confidence 9999999999999999999999999999999888652110 0001100011110 01112234577889
Q ss_pred ccCCCCCCCCCHHHHHHHhhC
Q 039322 688 CLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 688 cl~~dP~~RPs~~evl~~l~~ 708 (708)
||+++|.+||+|.|+++|-+|
T Consensus 248 ~L~~~P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 248 LLHPEPSCRPSMSELLQSEFI 268 (793)
T ss_pred hCCCChhhCcChHHHhhchhh
Confidence 999999999999999987653
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-27 Score=253.44 Aligned_cols=222 Identities=30% Similarity=0.396 Sum_probs=147.3
Q ss_pred CCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEcc
Q 039322 122 NLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILR 201 (708)
Q Consensus 122 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 201 (708)
+|+++++++|+++.+. ..+..+.+|+.|+..+|+++ ..|..+..+.+|+.|++.+|.+. -+|....+++.|++|+|.
T Consensus 242 nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 242 NLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQ 318 (1081)
T ss_pred cceeeecchhhhhcch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeeh
Confidence 4444444444444333 33444444444444444443 33333344444444444444444 344445556666666666
Q ss_pred CccccccCCccc--------------------------CCCCCCCeEeccCCcccccCCCCCCccccceeecccCccccc
Q 039322 202 GNQFTGRLPPEI--------------------------GSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVL 255 (708)
Q Consensus 202 ~n~l~~~~~~~~--------------------------~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~ 255 (708)
.|+|. .+|+.+ ..++.|+.|++.+|.++...-..+.+..+|+.|+|++|+|..
T Consensus 319 ~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~ 397 (1081)
T KOG0618|consen 319 SNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNS 397 (1081)
T ss_pred hcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccccc
Confidence 66665 222211 012235556666666665555566777889999999999986
Q ss_pred CCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCC-CCCccc
Q 039322 256 ELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGP-VPNSTA 334 (708)
Q Consensus 256 ~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~-~~~~~~ 334 (708)
.....+.+++.|++|+||+|+++ .+|..+..++.|++|...+|++. ..| .+..++.|+.+|+|.|+++.. .|....
T Consensus 398 fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p 474 (1081)
T KOG0618|consen 398 FPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP 474 (1081)
T ss_pred CCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCC
Confidence 66677899999999999999998 67788899999999999999998 667 788899999999999999864 344444
Q ss_pred cccCcccccccccCcC
Q 039322 335 FRNAPVEALKGNKGLC 350 (708)
Q Consensus 335 ~~~~~~~~~~~n~~~c 350 (708)
.++++-+.++||+|.-
T Consensus 475 ~p~LkyLdlSGN~~l~ 490 (1081)
T KOG0618|consen 475 SPNLKYLDLSGNTRLV 490 (1081)
T ss_pred CcccceeeccCCcccc
Confidence 4788999999999744
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-27 Score=232.95 Aligned_cols=299 Identities=19% Similarity=0.165 Sum_probs=232.9
Q ss_pred CCcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccC-CccccccccccCCCCCCCEEE
Q 039322 49 PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNS-NNLTGNISEALGIYPNLTFID 127 (708)
Q Consensus 49 ~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~~~~~~~L~~L~ 127 (708)
+..+.+.|+.|.|+++++..|+.+.+|+.||||+|+|+.+.|++|..+++|.+|-+.+ |+|+.+..++|.++..|+.|.
T Consensus 67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL 146 (498)
T ss_pred CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence 4577888888888888888888999999999999999988899999998888877777 889989899999999999999
Q ss_pred cccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEeccccccc------------ccCCcccCCCCCC
Q 039322 128 LSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIV------------GEIPKELGKLNSL 195 (708)
Q Consensus 128 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~------------~~~~~~~~~l~~L 195 (708)
+.-|++..+..++|..+++|..|.+.+|.+..+....|..+..++.+.+..|.+- ...+..++.....
T Consensus 147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~ 226 (498)
T KOG4237|consen 147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCV 226 (498)
T ss_pred cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceec
Confidence 9889998888888889999999999999988666668888888999988888732 2234445555556
Q ss_pred CEEEccCccccccCCcccCCC-CCCCeEeccCCcccccCC-CCCCccccceeecccCcccccCCChhhhhhcccchhhcc
Q 039322 196 TELILRGNQFTGRLPPEIGSL-VDLEYLDLSANRFNNSVP-ENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDAS 273 (708)
Q Consensus 196 ~~L~l~~n~l~~~~~~~~~~~-~~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls 273 (708)
....+.++++..+.+..|... .++..=-.+.....+..| ..|..+++|+.|+|++|+|+.+.+.+|.++..+++|.|.
T Consensus 227 ~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~ 306 (498)
T KOG4237|consen 227 SPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLT 306 (498)
T ss_pred chHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcC
Confidence 666666777665555444322 222111112222333444 358889999999999999999999999999999999999
Q ss_pred cccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCCCccccccCccccccccc
Q 039322 274 HNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNK 347 (708)
Q Consensus 274 ~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~ 347 (708)
.|+|..+....|.++..|+.|+|.+|+|+...|.+|..+.+|..|++-.|++.|.+...+--.+++.-+..|||
T Consensus 307 ~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~ 380 (498)
T KOG4237|consen 307 RNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNP 380 (498)
T ss_pred cchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCC
Confidence 99998777788899999999999999999999999999999999999999999876554333333433444443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-27 Score=229.01 Aligned_cols=274 Identities=23% Similarity=0.228 Sum_probs=196.9
Q ss_pred EEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEccc-C
Q 039322 77 YFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSM-N 155 (708)
Q Consensus 77 ~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~-N 155 (708)
..+.++-.++ .+|..+. +.-.+++|..|.|+.+++.+|..+++|+.|||++|+|+.|.+.+|.++++|.+|-+.+ |
T Consensus 50 ~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N 126 (498)
T KOG4237|consen 50 IVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN 126 (498)
T ss_pred eEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence 4566666666 5555444 4566677777777777777777777777777777777777777777777776665555 7
Q ss_pred cccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcc------
Q 039322 156 NITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRF------ 229 (708)
Q Consensus 156 ~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i------ 229 (708)
+|+.+..+.|+++..|+.|.+.-|++.....+.|..+++|..|.+.+|.+..+-...|..+.+++.+++..|.+
T Consensus 127 kI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL 206 (498)
T KOG4237|consen 127 KITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNL 206 (498)
T ss_pred chhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccccc
Confidence 77776677777777777777777777766666777777777777777777744334677777777777777662
Q ss_pred ------------------------------cccCCCCCCc-cccce-eecccCcccccCCChhhhhhcccchhhcccccC
Q 039322 230 ------------------------------NNSVPENLGN-LLKLH-YLGLSNNQFVLELPKELEKLVQLSELDASHNLF 277 (708)
Q Consensus 230 ------------------------------~~~~~~~~~~-l~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i 277 (708)
..+.+..|.. +.++. .+....+....-...+|.++++|+.|+|++|+|
T Consensus 207 ~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i 286 (498)
T KOG4237|consen 207 PWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKI 286 (498)
T ss_pred chhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCcc
Confidence 1111111111 11111 122222233322335799999999999999999
Q ss_pred CCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCCCcc-ccccCcccccccccCcCCCC
Q 039322 278 GGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNST-AFRNAPVEALKGNKGLCGGV 353 (708)
Q Consensus 278 ~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~-~~~~~~~~~~~~n~~~c~~~ 353 (708)
+++-+..|.+...+++|+|..|+|.......|.++.+|+.|+|.+|++++..|... ....+..+.+-.|||.|+|-
T Consensus 287 ~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~ 363 (498)
T KOG4237|consen 287 TRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCR 363 (498)
T ss_pred chhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccc
Confidence 99999999999999999999999998888999999999999999999999877643 34567888899999999984
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-26 Score=246.26 Aligned_cols=333 Identities=28% Similarity=0.359 Sum_probs=200.4
Q ss_pred CcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCC-CCCcccccccCCCccCCCCccccCCCCccEEeccC
Q 039322 4 LSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLE-NPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSE 82 (708)
Q Consensus 4 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~ 82 (708)
|+.|||++|++. --|..+..+.+|+.|+++.|.|. ..|.+.. ..+|+.|.|..|.+.. +|.++..+.+|++||+++
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~~-lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQS-LPASISELKNLQYLDLSF 123 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhhc-CchhHHhhhcccccccch
Confidence 788899999888 57777888888888888888887 4454443 3678888888888776 788888888888888888
Q ss_pred CccccccCccCcCCCCCcE-----------------------------------------EEccCCccccccccccCCCC
Q 039322 83 NHFQGTIPKILRNCSSLIR-----------------------------------------VRLNSNNLTGNISEALGIYP 121 (708)
Q Consensus 83 n~i~~~~~~~~~~l~~L~~-----------------------------------------L~l~~n~i~~~~~~~~~~~~ 121 (708)
|++. ..|..+..+..+.. |+|++|.+.. -.+..+.
T Consensus 124 N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~~---~dls~~~ 199 (1081)
T KOG0618|consen 124 NHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTHQLDLRYNEMEV---LDLSNLA 199 (1081)
T ss_pred hccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhheeeecccchhhh---hhhhhcc
Confidence 8887 44433333333322 4444444331 1123333
Q ss_pred CCCEEEcccCcceeeCCCC------------------CCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccc
Q 039322 122 NLTFIDLSRNDFYGEISSN------------------WGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVG 183 (708)
Q Consensus 122 ~L~~L~l~~n~l~~~~~~~------------------~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~ 183 (708)
+|+.|..+.|++..+.-.. -..-.+|++++++.|+++. .|+++..+.+|+.|+..+|+++
T Consensus 200 ~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~- 277 (1081)
T KOG0618|consen 200 NLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV- 277 (1081)
T ss_pred chhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-
Confidence 3444444433332211000 0011345555555555552 3355555555555555555554
Q ss_pred cCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCC-C------------------------
Q 039322 184 EIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENL-G------------------------ 238 (708)
Q Consensus 184 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~-~------------------------ 238 (708)
.+|..+...++|+.|.+..|.++ .+|.....+++|++|+|..|+|.. .|+.+ .
T Consensus 278 ~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e 355 (1081)
T KOG0618|consen 278 ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPS-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEE 355 (1081)
T ss_pred hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccc-cchHHHhhhhHHHHHHhhhhccccccccccc
Confidence 45555555555666666666665 555556667777777777777763 22211 1
Q ss_pred -ccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccE
Q 039322 239 -NLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISV 317 (708)
Q Consensus 239 -~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 317 (708)
.++.|+.|.+.+|.++...-..+.++.+|+.|+|++|++.......+.+++.|++|+||||+++ .+|.....+..|++
T Consensus 356 ~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~t 434 (1081)
T KOG0618|consen 356 NNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHT 434 (1081)
T ss_pred hhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHH
Confidence 1223566666666666555555666666777777777666444455566666677777777776 55566666666777
Q ss_pred EecCCCcCCCCCCCccccccCcccccccccCc
Q 039322 318 IDISDNQLQGPVPNSTAFRNAPVEALKGNKGL 349 (708)
Q Consensus 318 l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~ 349 (708)
|...+|++...+ ....++.++.+.++.|...
T Consensus 435 L~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~ 465 (1081)
T KOG0618|consen 435 LRAHSNQLLSFP-ELAQLPQLKVLDLSCNNLS 465 (1081)
T ss_pred HhhcCCceeech-hhhhcCcceEEecccchhh
Confidence 777766666544 5556666777777766543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=232.18 Aligned_cols=263 Identities=26% Similarity=0.316 Sum_probs=165.4
Q ss_pred CcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEeccCC
Q 039322 4 LSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSEN 83 (708)
Q Consensus 4 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n 83 (708)
-..|+|+.|.++. .|..+. ++|+.|++++|+++. +|.. .++|+.|++++|.+++. |.. .++|+.|++++|
T Consensus 203 ~~~LdLs~~~Lts-LP~~l~--~~L~~L~L~~N~Lt~-LP~l--p~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~Ls~N 272 (788)
T PRK15387 203 NAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTS-LPAL--PPELRTLEVSGNQLTSL-PVL---PPGLLELSIFSN 272 (788)
T ss_pred CcEEEcCCCCCCc-CCcchh--cCCCEEEccCCcCCC-CCCC--CCCCcEEEecCCccCcc-cCc---ccccceeeccCC
Confidence 4578888888884 455553 478888888888874 4432 25777777777777763 332 356777777777
Q ss_pred ccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCc
Q 039322 84 HFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPR 163 (708)
Q Consensus 84 ~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~ 163 (708)
.++ .+|..+ ++|+.|+|++|+++.++. .+++|++|+|++|+++.+.. . ..+|+.|++++|+|+. +|.
T Consensus 273 ~L~-~Lp~lp---~~L~~L~Ls~N~Lt~LP~----~p~~L~~LdLS~N~L~~Lp~-l---p~~L~~L~Ls~N~L~~-LP~ 339 (788)
T PRK15387 273 PLT-HLPALP---SGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASLPA-L---PSELCKLWAYNNQLTS-LPT 339 (788)
T ss_pred chh-hhhhch---hhcCEEECcCCccccccc----cccccceeECCCCccccCCC-C---cccccccccccCcccc-ccc
Confidence 776 334322 456777777777775543 24567777777777765432 1 2356677777777764 332
Q ss_pred cccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccc
Q 039322 164 EIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKL 243 (708)
Q Consensus 164 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L 243 (708)
. ..+|+.|+|++|+|+. +|.. .++|+.|++++|+|+ .+|.. ..+|+.|+|++|+|++ .|.. .++|
T Consensus 340 l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L 404 (788)
T PRK15387 340 L---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LPVL---PSEL 404 (788)
T ss_pred c---ccccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCccc---ccccceEEecCCcccC-CCCc---ccCC
Confidence 1 1467777777777773 3432 246677777777777 34432 2457777777777773 3432 2456
Q ss_pred eeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcc
Q 039322 244 HYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCF 309 (708)
Q Consensus 244 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~ 309 (708)
+.|++++|+|+. +|..+ .+|+.|++++|+|+ .+|..+..+++|+.|+|++|+|++..+..+
T Consensus 405 ~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 405 KELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred CEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 777777777763 44322 35666777777776 556666677777777777777776555544
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-23 Score=245.19 Aligned_cols=331 Identities=23% Similarity=0.242 Sum_probs=188.8
Q ss_pred CCCCcEEECCCCc------ccccCCccccCCC-CCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCC
Q 039322 1 MRSLSILDLNQNQ------FKGVLPPSVSNLT-NLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGG 73 (708)
Q Consensus 1 l~~L~~L~l~~n~------i~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~ 73 (708)
|++|+.|.+..+. +....|+.|..++ +|+.|.+.++.++ .+|..+...+|+.|++++|.+.. ++.++..++
T Consensus 557 m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f~~~~L~~L~L~~s~l~~-L~~~~~~l~ 634 (1153)
T PLN03210 557 MRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNFRPENLVKLQMQGSKLEK-LWDGVHSLT 634 (1153)
T ss_pred CccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcCCccCCcEEECcCccccc-cccccccCC
Confidence 4556666665442 2222344455543 4666666666664 44555555666777777766655 455566666
Q ss_pred CccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcc
Q 039322 74 ALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVS 153 (708)
Q Consensus 74 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 153 (708)
+|++|+|+++.....+|. ++.+++|++|+|++|..-...+..+.++++|+.|++++|..-...|..+ ++++|+.|+++
T Consensus 635 ~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Ls 712 (1153)
T PLN03210 635 GLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLS 712 (1153)
T ss_pred CCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCC
Confidence 777777766543334443 6666677777776665433445566666677777776653222223222 56666777776
Q ss_pred cCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCcccc-------ccCCcccCCCCCCCeEeccC
Q 039322 154 MNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFT-------GRLPPEIGSLVDLEYLDLSA 226 (708)
Q Consensus 154 ~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-------~~~~~~~~~~~~L~~L~l~~ 226 (708)
+|......|.. ..+|++|++++|.++ .+|..+ .+++|++|.+.++... ...+..+...++|+.|+|++
T Consensus 713 gc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~ 787 (1153)
T PLN03210 713 GCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSD 787 (1153)
T ss_pred CCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCC
Confidence 66543333322 345666777777665 344333 3455555555543221 01111122235677777777
Q ss_pred CcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCC
Q 039322 227 NRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIP 306 (708)
Q Consensus 227 N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~ 306 (708)
|......|..++++++|+.|++++|...+.+|..+ .+++|+.|++++|......|.. .++|+.|+|++|.++ .+|
T Consensus 788 n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP 862 (1153)
T PLN03210 788 IPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVP 862 (1153)
T ss_pred CCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cCh
Confidence 76555667777777777777777764333455444 5667777777776543333332 356777777777776 566
Q ss_pred CcccccccccEEecCC-CcCCCCCCCccccccCccccccc
Q 039322 307 NCFEGIRGISVIDISD-NQLQGPVPNSTAFRNAPVEALKG 345 (708)
Q Consensus 307 ~~~~~l~~L~~l~l~~-N~l~~~~~~~~~~~~~~~~~~~~ 345 (708)
..+..+++|+.|++++ |.+.+.++....++.++.+.+.+
T Consensus 863 ~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~ 902 (1153)
T PLN03210 863 WWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSD 902 (1153)
T ss_pred HHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCC
Confidence 6777777777777777 45555544444455555555443
|
syringae 6; Provisional |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-23 Score=212.77 Aligned_cols=254 Identities=20% Similarity=0.257 Sum_probs=187.3
Q ss_pred cccccceeccccCccEEEEEeCCC--cEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc----CCceeeEEEEE-eeCC
Q 039322 437 DFDAQYCIGNGGHGSVYRAELPSG--QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR----HRNIVKFYGFC-SHAR 509 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~l~~~~-~~~~ 509 (708)
+|.+.+.||+|+||.||.+..... +.+|+|........ ....+..|..++..+. .+++..+++.. ..++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~----~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS----KPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC----CCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 899999999999999999976543 47888887652211 1125777888888886 36999999999 5777
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC-----CcEEEe
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE-----YEAHVA 584 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-----~~~kl~ 584 (708)
..|+||+.+ |.+|.++..... .+.++..+..+++.|++.+|+++|+. |++||||||.|+.+... ..+.+.
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEE
Confidence 889999977 679999886555 56799999999999999999999999 99999999999999765 468999
Q ss_pred eccccc--ccCCCCC-------c-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc
Q 039322 585 DFGIAK--FLKPESS-------N-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN 654 (708)
Q Consensus 585 Dfg~a~--~~~~~~~-------~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~ 654 (708)
|||+|+ .+..... . .....||.+|.+++...+...+++.|+||++.++.|+..|..||............
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 999998 3321111 0 12356999999999999999999999999999999999999998643321111000
Q ss_pred cccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 655 TDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
........... .....+. .+.++...+-..+..++|....+...+
T Consensus 250 ~~~~~~~~~~~----~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l 294 (322)
T KOG1164|consen 250 EKDPRKLLTDR----FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELL 294 (322)
T ss_pred HHHhhhhcccc----ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence 00111111110 1111222 344444455558899999998887765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=191.21 Aligned_cols=257 Identities=21% Similarity=0.299 Sum_probs=201.8
Q ss_pred hccccccceeccccCccEEEE-EeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccC-CceeeEEEEEeeCCeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH-RNIVKFYGFCSHARHSF 512 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~~~~ 512 (708)
.+.|...+.||.|+||.+|.| ...+|+.||||+-+.. ....++..|.++++.+++ ..|+.+.-+..+...-.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~------a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK------AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc------CCCcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 478999999999999999999 5678999999997653 234567889999999974 78889999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC---CcEEEeecccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE---YEAHVADFGIA 589 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a 589 (708)
+|||.+ |.+|.+.+.... +.++.++++-.|-|++.-++|+|.+ +++||||||+|.|+.-+ ..+.++|||+|
T Consensus 88 lVMdLL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeeecc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence 999988 679999987554 5689999999999999999999999 99999999999999654 56899999999
Q ss_pred cccCCCCCc-------cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 039322 590 KFLKPESSN-------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEI 662 (708)
Q Consensus 590 ~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 662 (708)
..+.+.... .....||.+|.+-....+...+.+.|+-|+|.++..+--|..||....+.. .....+.+
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t-----k~QKyEkI 236 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT-----KKQKYEKI 236 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh-----HHHHHHHH
Confidence 977543222 234578999999988888888999999999999999999999998654322 12223333
Q ss_pred cCCCCCCCC-chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 663 LDPRLPPPS-RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 663 ~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
...+...+. ..+...+.++.-.+..|-...-++-|...-+-+.++|
T Consensus 237 ~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 237 SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 333333222 1223334456777778888888888988777776654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-24 Score=197.39 Aligned_cols=249 Identities=19% Similarity=0.289 Sum_probs=187.4
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
.+.....+|.+...|..|+|++. |..+++|++.... ........|..|.-.++-+.||||++++|.|..+.+..++.
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~--~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVRE--VTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhhccCCCccccccccc-Ccchhhhhhhhhh--cchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 44556678999999999999995 6667788876421 11223456888888888889999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE-EccCCCCCeeeCCCCcEEEe--eccccccc
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIV-HQDISSKNLLLDLEYEAHVA--DFGIAKFL 592 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iv-H~dlk~~Nill~~~~~~kl~--Dfg~a~~~ 592 (708)
.||+.|+|+..++.... ...+-.+..+++.++|+|++|||+.. +++ ---+.+..+++|++.+++|+ |--++...
T Consensus 267 q~mp~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsfqe 343 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE 343 (448)
T ss_pred eeccchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeeeec
Confidence 99999999999987664 33577899999999999999999974 444 44689999999999888774 33222110
Q ss_pred CCCCCccccccccccccCccccccCCCC---cchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKIT---EKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
....-.+.|++||.++..+.+ +++|+|||++++||+.|.+.||...+.++.......+.++.-+.+..
T Consensus 344 -------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgi-- 414 (448)
T KOG0195|consen 344 -------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGI-- 414 (448)
T ss_pred -------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCc--
Confidence 112235889999998876544 47999999999999999999998766554444333333332222222
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+.+|+.-|++.||.+||.+..|+-.|+
T Consensus 415 --------s~hm~klm~icmnedpgkrpkfdmivpile 444 (448)
T KOG0195|consen 415 --------SRHMNKLMNICMNEDPGKRPKFDMIVPILE 444 (448)
T ss_pred --------cHHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence 234667788899999999999998876553
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-23 Score=227.58 Aligned_cols=263 Identities=25% Similarity=0.264 Sum_probs=208.9
Q ss_pred CCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEcc
Q 039322 26 TNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLN 105 (708)
Q Consensus 26 ~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 105 (708)
..-..|+|++|.++ .+|..+. ++|+.|.+++|+++. +|.. .++|++|++++|+|+ .+|.. .++|++|+|+
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~-~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls 270 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP-AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIF 270 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh-cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccC-cccCc---ccccceeecc
Confidence 34678999999998 4666554 489999999999998 4432 478999999999999 45542 4689999999
Q ss_pred CCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccC
Q 039322 106 SNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEI 185 (708)
Q Consensus 106 ~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 185 (708)
+|.++.++. .+.+|+.|++++|+++.+.. .+++|+.|+|++|+|+.+ |.. ..+|+.|++++|+|++ +
T Consensus 271 ~N~L~~Lp~----lp~~L~~L~Ls~N~Lt~LP~----~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~-L 337 (788)
T PRK15387 271 SNPLTHLPA----LPSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTS-L 337 (788)
T ss_pred CCchhhhhh----chhhcCEEECcCCccccccc----cccccceeECCCCccccC-CCC---cccccccccccCcccc-c
Confidence 999996543 23679999999999986543 357899999999999954 432 2468899999999984 4
Q ss_pred CcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhc
Q 039322 186 PKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLV 265 (708)
Q Consensus 186 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 265 (708)
|.. .++|+.|+|++|+|+ .+|.. ..+|+.|++++|+|+. +|... .+|+.|++++|+|+. +|.. .+
T Consensus 338 P~l---p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~-LP~l~---~~L~~LdLs~N~Lt~-LP~l---~s 402 (788)
T PRK15387 338 PTL---PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTS-LPALP---SGLKELIVSGNRLTS-LPVL---PS 402 (788)
T ss_pred ccc---ccccceEecCCCccC-CCCCC---Ccccceehhhcccccc-Ccccc---cccceEEecCCcccC-CCCc---cc
Confidence 532 258999999999999 45543 3578899999999994 55433 579999999999995 4443 35
Q ss_pred ccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCCC
Q 039322 266 QLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPN 331 (708)
Q Consensus 266 ~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 331 (708)
+|+.|++++|+|+. +|.. ..+|+.|++++|+|+ .+|..+..+++|+.|++++|++++..+.
T Consensus 403 ~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 403 ELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred CCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 79999999999984 5543 357889999999998 6788899999999999999999987554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=208.79 Aligned_cols=170 Identities=20% Similarity=0.206 Sum_probs=130.7
Q ss_pred HHHhccccccceeccccCccEEEEEeC--CCcEEEEEEcCCCCCc-chhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC
Q 039322 432 VRATNDFDAQYCIGNGGHGSVYRAELP--SGQVVAIKKFHSPLPC-DQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA 508 (708)
Q Consensus 432 ~~~~~~~~~~~~ig~G~~g~vy~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 508 (708)
....++|.+.+.||+|+||+||+|.+. +++.||||+....... ......+.|.+|++++++++|+|+++.+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345578999999999999999999654 5778899987532110 1123456799999999999999998533222
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccC-CCCCeeeCCCCcEEEeecc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDI-SSKNLLLDLEYEAHVADFG 587 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg 587 (708)
+..++||||++|++|... . . .. ...++.|+++||+|||++ ||+|||| ||+||+++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~--~----~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-R--P----HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHh-C--c----cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 457999999999999732 1 1 11 146789999999999999 9999999 9999999999999999999
Q ss_pred cccccCCCCCcc--------ccccccccccCccccccC
Q 039322 588 IAKFLKPESSNW--------TEFAGTYGYVAPELAYTM 617 (708)
Q Consensus 588 ~a~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~ 617 (708)
+|+.+....... +...++..|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999775443211 245578889999998653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=191.75 Aligned_cols=250 Identities=17% Similarity=0.239 Sum_probs=193.0
Q ss_pred ccccccceeccccCccEEEE-EeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCeeEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~l 513 (708)
-.|+++++||+|.||.++.| ..-+++.||||.-... .+..++..|.+.++.|. .++|..++.+...+.+-.+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk------S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK------SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc------CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 47999999999999999999 4568999999986542 23456778999999885 7999999988888889999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-----cEEEeeccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY-----EAHVADFGI 588 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfg~ 588 (708)
|+|.+ |.+|.|++.-++ ++++.+++..+|.|++.-++|+|++ .+|.|||||+|+|+...+ .+.++|||+
T Consensus 102 VidLL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhhh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 99988 679999987554 5699999999999999999999999 999999999999997653 489999999
Q ss_pred ccccCCCCCc-------cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 039322 589 AKFLKPESSN-------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDE 661 (708)
Q Consensus 589 a~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 661 (708)
|..+.++... .....||.+||+-....+.+.+++.|.-|+|-++..++-|..||....... .....+.
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t-----nK~kYeK 250 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT-----NKEKYEK 250 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc-----hHHHHHH
Confidence 9988755443 235679999999999999999999999999999999999999998654321 1222222
Q ss_pred ccCCCCCCC-CchhHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 039322 662 ILDPRLPPP-SRSVQEKLISIMEVAFSCLNESPESRPTMKVV 702 (708)
Q Consensus 662 ~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 702 (708)
+=+.+...+ ...+...+.++..-+.-.=..+-.+-|..+-+
T Consensus 251 IGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl 292 (449)
T KOG1165|consen 251 IGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL 292 (449)
T ss_pred hccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence 323222222 22233334445555445555566666765543
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.7e-22 Score=235.51 Aligned_cols=307 Identities=19% Similarity=0.204 Sum_probs=242.3
Q ss_pred CCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCC-CCCcccccccCCCccCCCCccccCCCCccEEec
Q 039322 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLE-NPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGV 80 (708)
Q Consensus 2 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l 80 (708)
++|+.|++.++.++. .|..| .+.+|++|+|++|++.. ++..+. .++|+.|++++|.....+| .++.+++|++|+|
T Consensus 589 ~~Lr~L~~~~~~l~~-lP~~f-~~~~L~~L~L~~s~l~~-L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L 664 (1153)
T PLN03210 589 PKLRLLRWDKYPLRC-MPSNF-RPENLVKLQMQGSKLEK-LWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKL 664 (1153)
T ss_pred cccEEEEecCCCCCC-CCCcC-CccCCcEEECcCccccc-cccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEe
Confidence 468999999999985 45556 57899999999999974 454443 4899999999987655566 4788899999999
Q ss_pred cCCccccccCccCcCCCCCcEEEccCC-ccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccc
Q 039322 81 SENHFQGTIPKILRNCSSLIRVRLNSN-NLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITG 159 (708)
Q Consensus 81 ~~n~i~~~~~~~~~~l~~L~~L~l~~n-~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 159 (708)
++|.....+|..+.++++|+.|++++| .++.++. .+ ++++|++|+|++|......+. ...+|+.|+|++|.++
T Consensus 665 ~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~-~i-~l~sL~~L~Lsgc~~L~~~p~---~~~nL~~L~L~~n~i~- 738 (1153)
T PLN03210 665 SDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPT-GI-NLKSLYRLNLSGCSRLKSFPD---ISTNISWLDLDETAIE- 738 (1153)
T ss_pred cCCCCccccchhhhccCCCCEEeCCCCCCcCccCC-cC-CCCCCCEEeCCCCCCcccccc---ccCCcCeeecCCCccc-
Confidence 998776788999999999999999997 4554443 33 789999999999865433332 2468999999999998
Q ss_pred cCCccccCCCCCCEEeccccccc-------ccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCccccc
Q 039322 160 GIPREIGNSSQLQALDLSLNHIV-------GEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNS 232 (708)
Q Consensus 160 ~~~~~~~~l~~L~~L~L~~n~l~-------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~ 232 (708)
..|..+ .+++|++|++.++... ...+..+...++|+.|+|++|...+.+|..+.++++|+.|+|++|..-+.
T Consensus 739 ~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~ 817 (1153)
T PLN03210 739 EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLET 817 (1153)
T ss_pred cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCe
Confidence 445544 5789999999875432 11122233457999999999987778999999999999999999754446
Q ss_pred CCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCccccc
Q 039322 233 VPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGI 312 (708)
Q Consensus 233 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l 312 (708)
+|..+ .+++|+.|++++|......|.. ..+|+.|+|++|.|+ .+|..+..+++|+.|++++|+--..+|..+..+
T Consensus 818 LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L 892 (1153)
T PLN03210 818 LPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKL 892 (1153)
T ss_pred eCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccc
Confidence 67655 7899999999998654455543 358999999999998 778889999999999999954334677788899
Q ss_pred ccccEEecCCCc
Q 039322 313 RGISVIDISDNQ 324 (708)
Q Consensus 313 ~~L~~l~l~~N~ 324 (708)
++|+.+++++|.
T Consensus 893 ~~L~~L~l~~C~ 904 (1153)
T PLN03210 893 KHLETVDFSDCG 904 (1153)
T ss_pred cCCCeeecCCCc
Confidence 999999999884
|
syringae 6; Provisional |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-23 Score=226.53 Aligned_cols=247 Identities=22% Similarity=0.267 Sum_probs=190.5
Q ss_pred cccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEE
Q 039322 437 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYE 516 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 516 (708)
++...+.+|.+.|=.|.+|++..|. |+||+|-+..........++-..|++ ....++||.+++..+-...+..|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6778889999999999999998886 99999977554444455555566666 566689999999998888888899999
Q ss_pred eccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc--ccCC
Q 039322 517 LLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK--FLKP 594 (708)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~--~~~~ 594 (708)
|..+ +|.|.+..+.. +...+.+.|+.|+..|+..+|+. ||+|||||.+|||++.-.-+.|+||..-+ +...
T Consensus 102 yvkh-nLyDRlSTRPF---L~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPF---LVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHhh-hhhhhhccchH---HHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 9977 99999976543 67788889999999999999999 99999999999999999999999997543 1111
Q ss_pred CCC-c----cccccccccccCccccccC-----------CCCcchhHHHHHHHHHHHHh-CCCCCCcccccccc---ccc
Q 039322 595 ESS-N----WTEFAGTYGYVAPELAYTM-----------KITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSS---SLN 654 (708)
Q Consensus 595 ~~~-~----~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~---~~~ 654 (708)
++. . +........|.|||.+... ..+++.||||+||+++|+++ |++||+..+..... ...
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~ 254 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD 254 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence 111 1 2334455789999976541 14568999999999999998 78899854433222 112
Q ss_pred cccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 655 TDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.+..++.+.|. .+++++..|++.||++|-++++.++.-
T Consensus 255 ~e~~Le~Ied~--------------~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 255 PEQLLEKIEDV--------------SLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred HHHHHHhCcCc--------------cHHHHHHHHHccCchhccCHHHHHHhh
Confidence 22223333332 478999999999999999999999863
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-20 Score=196.34 Aligned_cols=260 Identities=28% Similarity=0.410 Sum_probs=195.3
Q ss_pred ccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCC-ceeeEEEEEeeCCeeEEEEE
Q 039322 438 FDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHR-NIVKFYGFCSHARHSFLVYE 516 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~l~~~~~~~~~~~lv~e 516 (708)
|.....||.|+||.||++... ..+++|.+........ .....+.+|+.+++.+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS-KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch-hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 567788999999999999775 7899999886432221 2467799999999999988 79999999977777899999
Q ss_pred eccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-cEEEeecccccccCCC
Q 039322 517 LLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY-EAHVADFGIAKFLKPE 595 (708)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~ 595 (708)
++.++++.+++........++......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999997775443112478899999999999999999999 999999999999999988 7999999999865443
Q ss_pred CC------ccccccccccccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 039322 596 SS------NWTEFAGTYGYVAPELAYT---MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPR 666 (708)
Q Consensus 596 ~~------~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (708)
.. ......++..|+|||...+ .......|+||+|++++++++|..||....... ..............+.
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS-ATSQTLKIILELPTPS 234 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc-cHHHHHHHHHhcCCcc
Confidence 32 2356789999999999887 578889999999999999999999976433200 0000000000000000
Q ss_pred CCCCCch--hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039322 667 LPPPSRS--VQEKLISIMEVAFSCLNESPESRPTMKVVTQ 704 (708)
Q Consensus 667 ~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 704 (708)
....... .......+.+++.+|+..+|..|.++.+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 0000000 0112245778888999999999999887654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-22 Score=218.59 Aligned_cols=259 Identities=19% Similarity=0.242 Sum_probs=187.9
Q ss_pred cccceeccccCccEEEEE-eCCCcEEEEEEcCCCC-CcchhHh-HHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 439 DAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPL-PCDQIAD-QKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 439 ~~~~~ig~G~~g~vy~~~-~~~~~~vavK~~~~~~-~~~~~~~-~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
...+.+|.|++|.|+.+. ....+.++.|.++... ....... ...+..|+.+-..+.|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456679999999888773 3344445555544210 1111122 222677888888889999988888777766666669
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
|||++ +|..++... ..++..++..+++|+..|++|+|+. |+.|||+|++|++++.+|.+||+|||.+..+.-+
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 999998765 2478889999999999999999999 9999999999999999999999999999866544
Q ss_pred CC----ccccccccccccCccccccCCCCc-chhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 596 SS----NWTEFAGTYGYVAPELAYTMKITE-KCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 596 ~~----~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
.. ......|+..|+|||.+.+..|++ ..||||.|+++..|.+|+.||.......... .........+ ....+
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~~~~~~~~~~-~~~~~ 550 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--KTNNYSDQRN-IFEGP 550 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--hhhccccccc-cccCh
Confidence 33 234577999999999999999887 5899999999999999999987433211110 0000000000 00111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..-....+..-..++.++++.||.+|-|+++|++.=|
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W 587 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW 587 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence 1122233445678889999999999999999987644
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=216.07 Aligned_cols=264 Identities=27% Similarity=0.370 Sum_probs=169.7
Q ss_pred CCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccC
Q 039322 27 NLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNS 106 (708)
Q Consensus 27 ~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~ 106 (708)
+.++|++++++++. +|..+. ++|+.|++++|.+++ +|..+. .+|++|++++|+++ .+|..+. ++|+.|+|++
T Consensus 179 ~~~~L~L~~~~Lts-LP~~Ip-~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~ 250 (754)
T PRK15370 179 NKTELRLKILGLTT-IPACIP-EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI 250 (754)
T ss_pred CceEEEeCCCCcCc-CCcccc-cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence 45667777776653 343332 356666777776665 344333 46788888888877 4555443 4688888888
Q ss_pred CccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCC
Q 039322 107 NNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIP 186 (708)
Q Consensus 107 n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 186 (708)
|+++.++.. +. .+|+.|++++|+++.+ |..+. ++|+.|+|++|+|+. .|..+. ++|+.|++++|+++. +|
T Consensus 251 N~L~~LP~~-l~--s~L~~L~Ls~N~L~~L-P~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP 320 (754)
T PRK15370 251 NRITELPER-LP--SALQSLDLFHNKISCL-PENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LP 320 (754)
T ss_pred CccCcCChh-Hh--CCCCEEECcCCccCcc-ccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CC
Confidence 888755432 22 4688888888888754 33332 478888888888874 343332 467888888888873 44
Q ss_pred cccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcc
Q 039322 187 KELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQ 266 (708)
Q Consensus 187 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 266 (708)
..+ .++|+.|++++|.++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|+|+ .+|..+.. .
T Consensus 321 ~~l--~~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~~--s 389 (754)
T PRK15370 321 ETL--PPGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLPA--A 389 (754)
T ss_pred ccc--cccceeccccCCccc-cCChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHHH--H
Confidence 433 257888888888887 3555443 57888888888887 4555443 57888888888887 44554543 6
Q ss_pred cchhhcccccCCCCCchhh----cCcccCCceecccccccCCCCCcccccccccEEecCCCcCCC
Q 039322 267 LSELDASHNLFGGEIPFQI----CSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQG 327 (708)
Q Consensus 267 L~~L~ls~N~i~~~~~~~~----~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 327 (708)
|+.|++++|++. ..|..+ ..++.+..|++.+|+++. ..+.+|+.+ ++.+.+.|
T Consensus 390 L~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~g 446 (754)
T PRK15370 390 LQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQG 446 (754)
T ss_pred HHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccC
Confidence 888888888887 444433 334677788888888762 344455554 34444444
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-21 Score=217.41 Aligned_cols=264 Identities=24% Similarity=0.351 Sum_probs=203.4
Q ss_pred CCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEecc
Q 039322 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVS 81 (708)
Q Consensus 2 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~ 81 (708)
++...|+|++++++. .|..+ .++|+.|+|++|+|+. +|..+. ++|+.|++++|.+++ +|..+. .+|+.|+|+
T Consensus 178 ~~~~~L~L~~~~Lts-LP~~I--p~~L~~L~Ls~N~Lts-LP~~l~-~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 178 NNKTELRLKILGLTT-IPACI--PEQITTLILDNNELKS-LPENLQ-GNIKTLYANSNQLTS-IPATLP--DTIQEMELS 249 (754)
T ss_pred cCceEEEeCCCCcCc-CCccc--ccCCcEEEecCCCCCc-CChhhc-cCCCEEECCCCcccc-CChhhh--ccccEEECc
Confidence 457899999999996 45545 3579999999999984 555443 589999999999987 565554 479999999
Q ss_pred CCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccC
Q 039322 82 ENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGI 161 (708)
Q Consensus 82 ~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~ 161 (708)
+|+++ .+|..+. ++|+.|+|++|+|+.++. .+. ++|++|++++|+++.+.. .+ .++|+.|++++|.++. +
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~LP~-~l~--~sL~~L~Ls~N~Lt~LP~-~l--p~sL~~L~Ls~N~Lt~-L 319 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKISCLPE-NLP--EELRYLSVYDNSIRTLPA-HL--PSGITHLNVQSNSLTA-L 319 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccCcccc-ccC--CCCcEEECCCCccccCcc-cc--hhhHHHHHhcCCcccc-C
Confidence 99999 6676664 589999999999996543 332 589999999999986543 22 2579999999999985 4
Q ss_pred CccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccc
Q 039322 162 PREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLL 241 (708)
Q Consensus 162 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~ 241 (708)
|..+ .++|+.|++++|.++. +|..+. ++|+.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .
T Consensus 320 P~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~ 388 (754)
T PRK15370 320 PETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--A 388 (754)
T ss_pred Cccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--H
Confidence 4433 2689999999999984 565553 79999999999998 5666553 68999999999999 4555554 3
Q ss_pred cceeecccCcccccCCChhhh----hhcccchhhcccccCCCCCchhhcCcccCCceeccccccc
Q 039322 242 KLHYLGLSNNQFVLELPKELE----KLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS 302 (708)
Q Consensus 242 ~L~~L~l~~n~l~~~~~~~~~----~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 302 (708)
+|+.|++++|+|+ .+|..+. .++++..|++.+|++.. ..+.+|+.| ++.+.+.
T Consensus 389 sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~ 445 (754)
T PRK15370 389 ALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQ 445 (754)
T ss_pred HHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhccccc
Confidence 7999999999998 5565544 34788999999999972 234455555 4445444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.2e-21 Score=182.21 Aligned_cols=185 Identities=13% Similarity=0.143 Sum_probs=138.0
Q ss_pred CCCchHHHHHH--HhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHH------HHHHHHHHHHhcc
Q 039322 423 EGKLVYDEIVR--ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQK------EFLIEVKALTEIR 494 (708)
Q Consensus 423 ~~~~~~~~~~~--~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~~e~~~l~~l~ 494 (708)
+....|.++.. ..++|+..+++|+|+||.||.+.. ++..+|+|+++......+ ...+ .+.+|++.+.+++
T Consensus 16 ~~~~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~-~~~~~f~~g~~~e~Ea~~l~rL~ 93 (232)
T PRK10359 16 DNDNKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTE-RFLKSFVKGDYYENLIVQTDRVR 93 (232)
T ss_pred CCcccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchH-HHHHhhhhhHHHHHHHHHHHHHH
Confidence 33433444432 357899999999999999999866 577899999986443222 2222 2678999999999
Q ss_pred CCceeeEEEEEeeC--------CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEc
Q 039322 495 HRNIVKFYGFCSHA--------RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQ 566 (708)
Q Consensus 495 h~~iv~l~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~ 566 (708)
|++|..+.+++... ...++||||++|.+|.++.. ++. ....+++.++..+|+. |++||
T Consensus 94 ~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~ 159 (232)
T PRK10359 94 SEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSG 159 (232)
T ss_pred HCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccC
Confidence 99999999886643 35789999999999988732 222 2456999999999999 99999
Q ss_pred cCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHH
Q 039322 567 DISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAI 636 (708)
Q Consensus 567 dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell 636 (708)
|++|+||+++.++ ++++|||.......+... . .+.....+..++|+|+||+.+..+.
T Consensus 160 Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~-d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 160 DPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK-D-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCChHHEEEeCCC-EEEEECCCcccccchhhH-H-----------HHHHHhHhcccccccceeEeehHHH
Confidence 9999999999988 999999988754321111 1 1233344667899999999875543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=185.66 Aligned_cols=237 Identities=19% Similarity=0.252 Sum_probs=150.7
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc----------CCceeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR----------HRNIVKFYGF 504 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~----------h~~iv~l~~~ 504 (708)
..+...+.||.|+++.||.+++. +|+.+|+|++..+. .......+++.+|.-....+. |-.++-.++.
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 35667788999999999999664 58999999987654 233345667777765544422 2122222222
Q ss_pred Ee---------eC---Ce-----eEEEEEeccCCCHHHHhcc---ccc-ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 039322 505 CS---------HA---RH-----SFLVYELLERGSLAAILSS---DTA-AQELGWSQRMNVIKGVADALSYLHHDCFPPI 563 (708)
Q Consensus 505 ~~---------~~---~~-----~~lv~e~~~~g~L~~~l~~---~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i 563 (708)
.. .. .. .+++|+-+.+ +|.+++.. ... ...+....+..+..|+++.+++||+. |+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---Gl 166 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GL 166 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ce
Confidence 11 11 11 3678887754 88887642 111 11234455677789999999999999 99
Q ss_pred EEccCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccccccCccccccC--------CCCcchhHHHHHHHHHHH
Q 039322 564 VHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTM--------KITEKCDVYSFGVLVLEA 635 (708)
Q Consensus 564 vH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~DvwslG~~l~el 635 (708)
+|+||+|+|++++.+|.++|+||+.....+. .......+..|.|||..... .++.+.|.|++|+++|.|
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGT---RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTE---EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCc---eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999999999999999998875432 22223456889999976442 467899999999999999
Q ss_pred HhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCC
Q 039322 636 IKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESR 696 (708)
Q Consensus 636 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 696 (708)
++|..||+.......... .+ ..+.+.+..+..||..+++++|.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~------------~f----~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW------------DF----SRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG------------GG----TTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc------------cc----hhcCCcCHHHHHHHHHHccCCcccC
Confidence 999999985432111110 11 1122455678899999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=176.66 Aligned_cols=144 Identities=22% Similarity=0.202 Sum_probs=109.5
Q ss_pred cceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhH----------------------hHHHHHHHHHHHHhccCCce
Q 039322 441 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIA----------------------DQKEFLIEVKALTEIRHRNI 498 (708)
Q Consensus 441 ~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~~i 498 (708)
...||+|++|.||+|...+|+.||||+++......... .......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 45799999999999988789999999997642211100 01223459999999988776
Q ss_pred eeEEEEEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEccCCCCCeeeCC
Q 039322 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL-HHDCFPPIVHQDISSKNLLLDL 577 (708)
Q Consensus 499 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~~~~ivH~dlk~~Nill~~ 577 (708)
.....+... ..++||||++++++....... ..++..+...++.|++.+|+++ |+. ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 443333222 238999999998776543222 3478899999999999999999 688 999999999999998
Q ss_pred CCcEEEeecccccccC
Q 039322 578 EYEAHVADFGIAKFLK 593 (708)
Q Consensus 578 ~~~~kl~Dfg~a~~~~ 593 (708)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 5789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-19 Score=168.37 Aligned_cols=187 Identities=11% Similarity=0.042 Sum_probs=138.8
Q ss_pred cccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCeeEEEEEe
Q 039322 439 DAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARHSFLVYEL 517 (708)
Q Consensus 439 ~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~ 517 (708)
.....|++|+||+||.+.. .+.+++.+.+..............+.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998866 577888777764211111111235889999999995 5889999886 346899999
Q ss_pred ccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccC-CCCCeeeCCCCcEEEeecccccccCCCC
Q 039322 518 LERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDI-SSKNLLLDLEYEAHVADFGIAKFLKPES 596 (708)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~a~~~~~~~ 596 (708)
++|.+|.+.... ....++.|++.+++++|++ ||+|||| ||+||+++.++.++|+|||+|....+..
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999998754311 1235778999999999999 9999999 7999999999999999999998655433
Q ss_pred Cc-----cc--------cccccccccCccccccC-CCC-cchhHHHHHHHHHHHHhCCCCCC
Q 039322 597 SN-----WT--------EFAGTYGYVAPELAYTM-KIT-EKCDVYSFGVLVLEAIKGKHPRD 643 (708)
Q Consensus 597 ~~-----~~--------~~~~~~~y~aPE~~~~~-~~~-~~~DvwslG~~l~elltg~~p~~ 643 (708)
.. .. -...++.|++|+...-- ..+ .+.+.++-|+.+|.++|+..++.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 21 00 11245677777743321 233 56789999999999999999864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.2e-20 Score=193.70 Aligned_cols=209 Identities=27% Similarity=0.488 Sum_probs=159.9
Q ss_pred HHhccCCceeeEEEEEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EEccC
Q 039322 490 LTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI-VHQDI 568 (708)
Q Consensus 490 l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i-vH~dl 568 (708)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.... .++++.....+.++|+.||+|+|+- +| +|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 457889999999999999999999999999999999997633 5689999999999999999999987 44 89999
Q ss_pred CCCCeeeCCCCcEEEeecccccccCC--CCCccccccccccccCccccccCC-------CCcchhHHHHHHHHHHHHhCC
Q 039322 569 SSKNLLLDLEYEAHVADFGIAKFLKP--ESSNWTEFAGTYGYVAPELAYTMK-------ITEKCDVYSFGVLVLEAIKGK 639 (708)
Q Consensus 569 k~~Nill~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwslG~~l~elltg~ 639 (708)
++.|++++..+.+|++|||+...... ............-|.|||.+.... .+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999876642 111122233567899999987631 456799999999999999999
Q ss_pred CCCCccccccccccccccccccccC-CC--CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 640 HPRDFLSLISSSSLNTDIALDEILD-PR--LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 640 ~p~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.||+........ ++....+.+ +. +.+......+....+..++.+||..+|++||++++|-..++
T Consensus 156 ~~~~~~~~~~~~----~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~ 222 (484)
T KOG1023|consen 156 GPFDLRNLVEDP----DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLL 222 (484)
T ss_pred CccccccccCCh----HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence 999853321111 112222222 22 11111111133336889999999999999999999987664
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-19 Score=171.23 Aligned_cols=143 Identities=20% Similarity=0.204 Sum_probs=111.7
Q ss_pred cceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchh----------------------HhHHHHHHHHHHHHhccCCce
Q 039322 441 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQI----------------------ADQKEFLIEVKALTEIRHRNI 498 (708)
Q Consensus 441 ~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~~i 498 (708)
.+.||+|++|.||+|...+|+.||||+++........ .....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999998778999999999864321000 002234678999999999987
Q ss_pred eeEEEEEeeCCeeEEEEEeccCCCHHHH-hcccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEccCCCCCeeeC
Q 039322 499 VKFYGFCSHARHSFLVYELLERGSLAAI-LSSDTAAQELGWSQRMNVIKGVADALSYLHH-DCFPPIVHQDISSKNLLLD 576 (708)
Q Consensus 499 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~ 576 (708)
.....+.... .++||||++++++... +.. ..++..+...++.|++.++.++|+ . ||+||||||+||+++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 5544443332 4899999998855433 322 236788999999999999999999 8 999999999999999
Q ss_pred CCCcEEEeecccccccC
Q 039322 577 LEYEAHVADFGIAKFLK 593 (708)
Q Consensus 577 ~~~~~kl~Dfg~a~~~~ 593 (708)
++.++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 8999999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-21 Score=202.85 Aligned_cols=260 Identities=21% Similarity=0.229 Sum_probs=148.7
Q ss_pred CccccCCCCccEEeccCCccccc----cCccCcCCCCCcEEEccCCcccc------ccccccCCCCCCCEEEcccCccee
Q 039322 66 PHNVCRGGALQYFGVSENHFQGT----IPKILRNCSSLIRVRLNSNNLTG------NISEALGIYPNLTFIDLSRNDFYG 135 (708)
Q Consensus 66 ~~~~~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~l~~n~i~~------~~~~~~~~~~~L~~L~l~~n~l~~ 135 (708)
...+..+.+|+.|+++++.++.. ++..+...++|++|+++++.+.. ..+..+..+++|++|++++|.+..
T Consensus 16 ~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~ 95 (319)
T cd00116 16 TELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGP 95 (319)
T ss_pred HHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCCh
Confidence 34444555677777777766432 33445556667777777766652 223445566677777777777654
Q ss_pred eCCCCCCCCC---CCCEEEcccCcccc----cCCccccCC-CCCCEEeccccccccc----CCcccCCCCCCCEEEccCc
Q 039322 136 EISSNWGKCP---KLGTLNVSMNNITG----GIPREIGNS-SQLQALDLSLNHIVGE----IPKELGKLNSLTELILRGN 203 (708)
Q Consensus 136 ~~~~~~~~l~---~L~~L~L~~N~i~~----~~~~~~~~l-~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~l~~n 203 (708)
..+..+..+. +|++|++++|+++. .....+..+ ++|+.|+|++|.+++. ....+..+++|++|++++|
T Consensus 96 ~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n 175 (319)
T cd00116 96 DGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANN 175 (319)
T ss_pred hHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCC
Confidence 3333333333 37777777777652 222334455 6777777777776632 2234555567777777777
Q ss_pred ccccc----CCcccCCCCCCCeEeccCCcccccC----CCCCCccccceeecccCcccccCCChhhhh-----hcccchh
Q 039322 204 QFTGR----LPPEIGSLVDLEYLDLSANRFNNSV----PENLGNLLKLHYLGLSNNQFVLELPKELEK-----LVQLSEL 270 (708)
Q Consensus 204 ~l~~~----~~~~~~~~~~L~~L~l~~N~i~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-----l~~L~~L 270 (708)
.+++. ++..+..+++|++|++++|.+++.. ...+..+++|+.|++++|.+++.....+.. .+.|+.|
T Consensus 176 ~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L 255 (319)
T cd00116 176 GIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTL 255 (319)
T ss_pred CCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEE
Confidence 76631 2223444567777777777765332 223455667777777777776433333322 2577777
Q ss_pred hcccccCCCC----CchhhcCcccCCceecccccccCC----CCCccccc-ccccEEecCCCcC
Q 039322 271 DASHNLFGGE----IPFQICSLKSLEKLNLSHNNLSGS----IPNCFEGI-RGISVIDISDNQL 325 (708)
Q Consensus 271 ~ls~N~i~~~----~~~~~~~~~~L~~L~l~~N~l~~~----~~~~~~~l-~~L~~l~l~~N~l 325 (708)
++++|.+++. ....+..+++|+++++++|.++.. ....+... +.|+.+++.+|++
T Consensus 256 ~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 256 SLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred EccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 7777777531 223344556677777777777643 22233333 5666667666654
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-20 Score=195.50 Aligned_cols=227 Identities=26% Similarity=0.307 Sum_probs=179.6
Q ss_pred eeccccCccEEEEE----eCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCeeEEEEEe
Q 039322 443 CIGNGGHGSVYRAE----LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARHSFLVYEL 517 (708)
Q Consensus 443 ~ig~G~~g~vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~ 517 (708)
++|+|+||.|+.+. ...|..+|+|+.++...... .......|..++...+ ||.++++...+..+...+++++|
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~--~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVR--DRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccc--cccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence 37999999998773 23477899999887443222 1225666788888886 99999999999999999999999
Q ss_pred ccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCC
Q 039322 518 LERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS 597 (708)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 597 (708)
..+|.+...+.... .+++.....+...++-+++++|+. +++|||+|++||+++.+|++++.|||+++..-....
T Consensus 79 ~rgg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cccchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 99999988876544 367788888999999999999999 999999999999999999999999999986543322
Q ss_pred ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHH
Q 039322 598 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEK 677 (708)
Q Consensus 598 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (708)
.+||..|||||.+. ....++|.||||++++||+||..||.. +....+...++..+.. .
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~~~~p~~----l 210 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAELEMPRE----L 210 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhccCCchh----h
Confidence 28899999999988 467889999999999999999999872 3334444434433322 2
Q ss_pred HHHHHHHHHhccCCCCCCCCCH
Q 039322 678 LISIMEVAFSCLNESPESRPTM 699 (708)
Q Consensus 678 ~~~l~~li~~cl~~dP~~RPs~ 699 (708)
......++..++..+|..|--.
T Consensus 211 ~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 211 SAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hHHHHHHHHHHHhhCHHHHhcc
Confidence 2335666778888899888744
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-21 Score=203.32 Aligned_cols=277 Identities=23% Similarity=0.258 Sum_probs=166.1
Q ss_pred EEECCCCcccc-cCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEeccCCc
Q 039322 6 ILDLNQNQFKG-VLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENH 84 (708)
Q Consensus 6 ~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~ 84 (708)
.|+|..++++. -....|..+.+|++|+|+++.+....... ++..+...++|++|+++++.
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~-------------------i~~~l~~~~~l~~l~l~~~~ 62 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKA-------------------LASALRPQPSLKELCLSLNE 62 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHH-------------------HHHHHhhCCCceEEeccccc
Confidence 57888888873 33556677888999999999875321100 22223334445555555554
Q ss_pred cc------cccCccCcCCCCCcEEEccCCccccccccccCCCCC---CCEEEcccCccee----eCCCCCCCC-CCCCEE
Q 039322 85 FQ------GTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPN---LTFIDLSRNDFYG----EISSNWGKC-PKLGTL 150 (708)
Q Consensus 85 i~------~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~---L~~L~l~~n~l~~----~~~~~~~~l-~~L~~L 150 (708)
+. ..++..+.++++|++|++++|.+....+..+..+.+ |++|++++|+++. .....+..+ ++|+.|
T Consensus 63 ~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L 142 (319)
T cd00116 63 TGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKL 142 (319)
T ss_pred cCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEE
Confidence 44 122334555666777777666665444444433333 7777777776652 111223444 677777
Q ss_pred EcccCccccc----CCccccCCCCCCEEeccccccccc----CCcccCCCCCCCEEEccCcccccc----CCcccCCCCC
Q 039322 151 NVSMNNITGG----IPREIGNSSQLQALDLSLNHIVGE----IPKELGKLNSLTELILRGNQFTGR----LPPEIGSLVD 218 (708)
Q Consensus 151 ~L~~N~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~~~~ 218 (708)
++++|.+++. ....+..+++|++|+|++|.+++. ++..+..+++|++|++++|.+++. +...+..+++
T Consensus 143 ~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~ 222 (319)
T cd00116 143 VLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKS 222 (319)
T ss_pred EcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCC
Confidence 7777777621 233455566777777777777632 223344556778888877777532 2334566777
Q ss_pred CCeEeccCCcccccCCCCCC-----ccccceeecccCcccccC----CChhhhhhcccchhhcccccCCCC----Cchhh
Q 039322 219 LEYLDLSANRFNNSVPENLG-----NLLKLHYLGLSNNQFVLE----LPKELEKLVQLSELDASHNLFGGE----IPFQI 285 (708)
Q Consensus 219 L~~L~l~~N~i~~~~~~~~~-----~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~ls~N~i~~~----~~~~~ 285 (708)
|++|++++|.+++.....+. ..++|+.|++++|.++.. ....+..+++|+.+++++|.+++. ....+
T Consensus 223 L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~ 302 (319)
T cd00116 223 LEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESL 302 (319)
T ss_pred CCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHH
Confidence 88888888877743222221 236788888888887622 233455567788888888888754 23333
Q ss_pred cCc-ccCCceecccccc
Q 039322 286 CSL-KSLEKLNLSHNNL 301 (708)
Q Consensus 286 ~~~-~~L~~L~l~~N~l 301 (708)
... +.|+.|++.+|++
T Consensus 303 ~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 303 LEPGNELESLWVKDDSF 319 (319)
T ss_pred hhcCCchhhcccCCCCC
Confidence 344 6788888887764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.9e-21 Score=164.07 Aligned_cols=179 Identities=28% Similarity=0.414 Sum_probs=109.3
Q ss_pred CCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceee
Q 039322 167 NSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYL 246 (708)
Q Consensus 167 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L 246 (708)
.+.+++.|.|++|+++ ..|..+..+.+|+.|++.+|+++ .+|..++.+++|+.|+++-|++. ..|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 3444455555555554 34444455555555555555555 44455555555555555555554 455555555555555
Q ss_pred cccCccccc-CCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcC
Q 039322 247 GLSNNQFVL-ELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQL 325 (708)
Q Consensus 247 ~l~~n~l~~-~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l 325 (708)
||++|.+.. ..|..|-.+..|+.|+|+.|.+. ..|..++.+++|+.|.+..|.+. ..|..+..+..|++|++.+|++
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 555555532 35666666777777777777776 66666777777777777777776 6677777777777777777777
Q ss_pred CCCCCCccc---cccCcccccccccCcC
Q 039322 326 QGPVPNSTA---FRNAPVEALKGNKGLC 350 (708)
Q Consensus 326 ~~~~~~~~~---~~~~~~~~~~~n~~~c 350 (708)
+-.+|.... ...-+...++.|||.-
T Consensus 186 ~vlppel~~l~l~~~k~v~r~E~NPwv~ 213 (264)
T KOG0617|consen 186 TVLPPELANLDLVGNKQVMRMEENPWVN 213 (264)
T ss_pred eecChhhhhhhhhhhHHHHhhhhCCCCC
Confidence 776666443 2345666788888854
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.1e-19 Score=171.90 Aligned_cols=195 Identities=22% Similarity=0.326 Sum_probs=138.8
Q ss_pred cCCceeeEEEEEee---------------------------CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHH
Q 039322 494 RHRNIVKFYGFCSH---------------------------ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIK 546 (708)
Q Consensus 494 ~h~~iv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~ 546 (708)
+|||||++.++|.+ +...|+||...+. +|..++-.+. .+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence 59999999988742 2346899998866 9999986554 56677788999
Q ss_pred HHHHHHHHHHhCCCCCeEEccCCCCCeee--CCCC--cEEEeecccccccCC------CCCccccccccccccCcccccc
Q 039322 547 GVADALSYLHHDCFPPIVHQDISSKNLLL--DLEY--EAHVADFGIAKFLKP------ESSNWTEFAGTYGYVAPELAYT 616 (708)
Q Consensus 547 ~i~~~l~~Lh~~~~~~ivH~dlk~~Nill--~~~~--~~kl~Dfg~a~~~~~------~~~~~~~~~~~~~y~aPE~~~~ 616 (708)
|+.+|+.|||++ ||.|||+|++|||+ ++|+ ...|+|||++---+. -.+......|....||||....
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999 99999999999999 3343 468999998642111 1122334557788999998765
Q ss_pred CC-----C-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccC
Q 039322 617 MK-----I-TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLN 690 (708)
Q Consensus 617 ~~-----~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 690 (708)
.+ . -.|+|.|+.|.+.||+++...||...+.+... ...+....++..++.++ ..+.+++...++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~-------~r~Yqe~qLPalp~~vp---p~~rqlV~~lL~ 495 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD-------TRTYQESQLPALPSRVP---PVARQLVFDLLK 495 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec-------hhhhhhhhCCCCcccCC---hHHHHHHHHHhc
Confidence 32 1 23899999999999999999998742211111 11122233444333333 347788889999
Q ss_pred CCCCCCCCHHHHHHHh
Q 039322 691 ESPESRPTMKVVTQQV 706 (708)
Q Consensus 691 ~dP~~RPs~~evl~~l 706 (708)
.||.+||+..-..+.+
T Consensus 496 r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 496 RDPSKRVSPNIAANVL 511 (598)
T ss_pred CCccccCCccHHHhHH
Confidence 9999999876554443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-18 Score=192.93 Aligned_cols=199 Identities=24% Similarity=0.284 Sum_probs=161.6
Q ss_pred HHHHHhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc---CCceeeEEEEEe
Q 039322 430 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR---HRNIVKFYGFCS 506 (708)
Q Consensus 430 ~~~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~l~~~~~ 506 (708)
+.+...+.|.+.+.||+|+||+||.|...+|+.||+|+-+.+...+ |.-=.+++.+|+ -+.|..+..+..
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-------fYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-------FYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-------eeehHHHHHhhchhhhcchHHHHHHHc
Confidence 3344567899999999999999999988889999999977643221 111122333443 245566666667
Q ss_pred eCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-------CC
Q 039322 507 HARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL-------EY 579 (708)
Q Consensus 507 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-------~~ 579 (708)
..+..++|+||.+.|+|.+++... +.++|.-+..++.|+++.+++||.. +||||||||+|.++.. ..
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N~~---~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLINTN---KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred cCCcceeeeeccccccHHHhhccC---CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCccc
Confidence 778889999999999999999733 4489999999999999999999999 9999999999999943 24
Q ss_pred cEEEeecccccccC--CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 039322 580 EAHVADFGIAKFLK--PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641 (708)
Q Consensus 580 ~~kl~Dfg~a~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p 641 (708)
.++|+|||.|-.+. ++...+...++|-.+-.+|+..+..++.++|-|.++.+++-|+.|+.-
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 58999999987653 445567788899999999999999999999999999999999999876
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.6e-18 Score=160.55 Aligned_cols=138 Identities=20% Similarity=0.249 Sum_probs=105.5
Q ss_pred ccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-----cCCceeeEEEEEeeCC---
Q 039322 438 FDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-----RHRNIVKFYGFCSHAR--- 509 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~l~~~~~~~~--- 509 (708)
+.-...||+|++|.||. +++....+||++.... ....+.+.+|+++++.+ .||||++++|+++++.
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~----~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG----DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccc----cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 34456899999999996 4433334799886521 12456789999999999 5799999999998864
Q ss_pred e-eEEEEEe--ccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEccCCCCCeeeCC----CCcE
Q 039322 510 H-SFLVYEL--LERGSLAAILSSDTAAQELGWSQRMNVIKGVADAL-SYLHHDCFPPIVHQDISSKNLLLDL----EYEA 581 (708)
Q Consensus 510 ~-~~lv~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~Lh~~~~~~ivH~dlk~~Nill~~----~~~~ 581 (708)
. ..+|+|| +.+|+|.+++.... +++. ..++.+++.++ +|||++ +|+||||||+||+++. ++.+
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcE
Confidence 3 3378999 55789999996532 4444 35677888777 999999 9999999999999974 3479
Q ss_pred EEee-ccccc
Q 039322 582 HVAD-FGIAK 590 (708)
Q Consensus 582 kl~D-fg~a~ 590 (708)
+|+| ||...
T Consensus 149 ~LiDg~G~~~ 158 (210)
T PRK10345 149 VVCDNIGEST 158 (210)
T ss_pred EEEECCCCcc
Confidence 9999 55443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.4e-20 Score=159.79 Aligned_cols=184 Identities=30% Similarity=0.449 Sum_probs=139.9
Q ss_pred CCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCC
Q 039322 141 WGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLE 220 (708)
Q Consensus 141 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~ 220 (708)
+..+.+++.|.|++|+++ .+|..++.+.+|+.|++++|+|. .+|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 345667777888888887 56667788888888888888887 67777888888888888888888 7888888888888
Q ss_pred eEeccCCccc-ccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccc
Q 039322 221 YLDLSANRFN-NSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299 (708)
Q Consensus 221 ~L~l~~N~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N 299 (708)
.|||++|++. ...|..|..++.|+.|+|++|.+. ..|..++.+.+|+.|.+..|.+- ..|..++.+..|++|.+.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 8888888876 366777888888888888888887 67777888888888888888877 67788888888888888888
Q ss_pred cccCCCCCccccc---ccccEEecCCCcCCCCCC
Q 039322 300 NLSGSIPNCFEGI---RGISVIDISDNQLQGPVP 330 (708)
Q Consensus 300 ~l~~~~~~~~~~l---~~L~~l~l~~N~l~~~~~ 330 (708)
+++ .+|..+..+ .+-+.+.+.+|++...+.
T Consensus 184 rl~-vlppel~~l~l~~~k~v~r~E~NPwv~pIa 216 (264)
T KOG0617|consen 184 RLT-VLPPELANLDLVGNKQVMRMEENPWVNPIA 216 (264)
T ss_pred eee-ecChhhhhhhhhhhHHHHhhhhCCCCChHH
Confidence 888 444444432 223445566777765543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.6e-17 Score=161.16 Aligned_cols=147 Identities=20% Similarity=0.203 Sum_probs=113.1
Q ss_pred ccccccceeccccCccEEEEE--eCCCcEEEEEEcCCCCCcc-h-----------------h--HhHHHHHHHHHHHHhc
Q 039322 436 NDFDAQYCIGNGGHGSVYRAE--LPSGQVVAIKKFHSPLPCD-Q-----------------I--ADQKEFLIEVKALTEI 493 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~--~~~~~~vavK~~~~~~~~~-~-----------------~--~~~~~~~~e~~~l~~l 493 (708)
.-|.+.+.||+|++|.||+|. ..+|+.||+|+++...... . . .....+..|++.++++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357888999999999999997 5689999999987532110 0 0 0123467899999999
Q ss_pred cCC--ceeeEEEEEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEccCCC
Q 039322 494 RHR--NIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP-IVHQDISS 570 (708)
Q Consensus 494 ~h~--~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~-ivH~dlk~ 570 (708)
.+. .+++++++ ...++||||++++++..+.... ......+...++.|++.++++||+. | ++|||+||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 753 34555543 2348999999998887654222 2245566789999999999999999 9 99999999
Q ss_pred CCeeeCCCCcEEEeecccccccC
Q 039322 571 KNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 571 ~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
+||+++ ++.++|+|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 8899999999997544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-18 Score=178.11 Aligned_cols=176 Identities=23% Similarity=0.393 Sum_probs=139.0
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccc
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA 589 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 589 (708)
+.|+.|++|+..+|.+|+.........++.....++.|++.|++| + +.+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999877766778899999999999999999 5 8999999999999999999999999998
Q ss_pred cccCCCC------CccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccc
Q 039322 590 KFLKPES------SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEI 662 (708)
Q Consensus 590 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 662 (708)
....... ...+.-.||..||+||.+.+..|+.++||||||++++|++. =.-+++ ....+.++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-----------r~~t~~d~ 472 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-----------RIATLTDI 472 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-----------HHHhhhhh
Confidence 8665433 12345679999999999999999999999999999999997 223322 23344555
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 663 LDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
.+..+++.. ..+.+.+ ..++.+++++.|.+||++.++.-+
T Consensus 473 r~g~ip~~~--~~d~p~e-~~ll~~lls~~p~~RP~~~~~~~~ 512 (516)
T KOG1033|consen 473 RDGIIPPEF--LQDYPEE-YTLLQQLLSPSPEERPSAIEVALH 512 (516)
T ss_pred hcCCCChHH--hhcCcHH-HHHHHHhcCCCcccCchHHHHhhh
Confidence 555555322 2222222 356669999999999977776554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.6e-17 Score=156.53 Aligned_cols=138 Identities=18% Similarity=0.296 Sum_probs=115.6
Q ss_pred ceeccccCccEEEEEeCCCcEEEEEEcCCCCCcch----hHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEe
Q 039322 442 YCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQ----IADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYEL 517 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 517 (708)
+.||+|++|.||+|.. .|..|++|+......... ......+.+|++++..++|++++....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5689999999999987 677899998664322111 11235688899999999999998888888778888999999
Q ss_pred ccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 518 LERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++|++|.+++.... . .+..++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999985422 2 7889999999999999999 999999999999999 78999999999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-16 Score=153.79 Aligned_cols=148 Identities=19% Similarity=0.171 Sum_probs=114.1
Q ss_pred HHHHHhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchh------------------HhHHHHHHHHHHHH
Q 039322 430 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQI------------------ADQKEFLIEVKALT 491 (708)
Q Consensus 430 ~~~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~------------------~~~~~~~~e~~~l~ 491 (708)
++.+...-|.+.+.||+|+||.||+|..++|+.||||+++........ .....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 444444558888999999999999998888999999987653211000 01224677888899
Q ss_pred hccCC--ceeeEEEEEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCC
Q 039322 492 EIRHR--NIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDIS 569 (708)
Q Consensus 492 ~l~h~--~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk 569 (708)
++.|+ .++..++. ...++||||+++++|.+.... .....++.+++.++.++|+. |++||||+
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 88877 44555442 345899999999998765421 34567889999999999998 99999999
Q ss_pred CCCeeeCCCCcEEEeecccccccC
Q 039322 570 SKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 570 ~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
|+||++++++.++|+|||.+....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999997544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.3e-16 Score=172.52 Aligned_cols=142 Identities=18% Similarity=0.278 Sum_probs=114.1
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEE-cCCCCCcc---hhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKK-FHSPLPCD---QIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~-~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
...|...+.||+|+||.||+|.+... .+++|+ ..+..... .....+.+.+|+++++.++|++++....++..++.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34556788999999999999987544 344443 22211111 11234578899999999999999988888888778
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++||||+++++|.+++. ....++.++++++.+||+. +++|||+||+||++ .++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999999874 3567999999999999999 99999999999999 67899999999997
Q ss_pred cc
Q 039322 591 FL 592 (708)
Q Consensus 591 ~~ 592 (708)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 53
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.1e-16 Score=152.18 Aligned_cols=135 Identities=18% Similarity=0.317 Sum_probs=109.6
Q ss_pred eeccccCccEEEEEeCCCcEEEEEEcCCCCCcc----hhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEec
Q 039322 443 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCD----QIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELL 518 (708)
Q Consensus 443 ~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 518 (708)
.||+|++|.||+|.. +|..|++|+........ ......++.+|++++..++|+++.....++..++..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 57889999865422111 1123467889999999999887766666666777789999999
Q ss_pred cCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 519 ERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 519 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+|++|.+++.... . .++.+++.+|+++|+. |++|||++|.||+++ ++.++++|||.+...
T Consensus 80 ~g~~l~~~~~~~~-------~---~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN-------D---ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH-------H---HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999999875322 1 7899999999999999 999999999999999 899999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.3e-17 Score=176.06 Aligned_cols=206 Identities=24% Similarity=0.292 Sum_probs=137.9
Q ss_pred ccccccceeccccCccEEEEEeCC-CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.+|+.++.|..|+||.||..+++. .+++|+| +.++. -+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~---------lilRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN---------LILRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccc---------hhhhc--cccccCCccee---------------
Confidence 689999999999999999998763 5678884 33310 00000 22222334333
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|+=...++..+ .++.. .+.+++|+|+. ||+|||+||+|.+++.-|++|+.|||+++..-.
T Consensus 136 ------gDc~tllk~~g---~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ------GDCATLLKNIG---PLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ------chhhhhcccCC---CCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 34444443322 23322 27899999999 999999999999999999999999999874321
Q ss_pred CCC---------------ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccc
Q 039322 595 ESS---------------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIAL 659 (708)
Q Consensus 595 ~~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 659 (708)
... .....+||+.|.|||++....|...+|+|++|+++||++-|+.||..... ++.+
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp--------eelf 267 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------EELF 267 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH--------HHHH
Confidence 100 01235799999999999999999999999999999999999999874311 1111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCC
Q 039322 660 DEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRP 697 (708)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 697 (708)
..++......+.. ......+..+++.+.++.+|..|-
T Consensus 268 g~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 268 GQVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhc
Confidence 1111111111111 111123467788899999999986
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.8e-15 Score=136.04 Aligned_cols=135 Identities=19% Similarity=0.190 Sum_probs=114.3
Q ss_pred ccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccC--CceeeEEEEEeeCCeeEEEEEe
Q 039322 440 AQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH--RNIVKFYGFCSHARHSFLVYEL 517 (708)
Q Consensus 440 ~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~l~~~~~~~~~~~lv~e~ 517 (708)
+.+.||+|.++.||++...+ ..+++|.+..... ...+..|+.+++.++| ..+++++++...++..++++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 35679999999999998754 7899999875321 4578889999999976 5899999999888889999999
Q ss_pred ccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 518 LERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++++.+..+ +......++.+++++++++|....++++|+|++|+||+++..+.++++|||.+..
T Consensus 75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998777543 4466778899999999999986444799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.3e-15 Score=140.92 Aligned_cols=140 Identities=21% Similarity=0.216 Sum_probs=99.8
Q ss_pred cceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhH--------------------HHHHHHHHHHHhccCC--ce
Q 039322 441 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQ--------------------KEFLIEVKALTEIRHR--NI 498 (708)
Q Consensus 441 ~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~--------------------~~~~~e~~~l~~l~h~--~i 498 (708)
.+.||+|+||.||+|...+|+.||||+++........... .....|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999998878999999998753221110000 0113566666666543 34
Q ss_pred eeEEEEEeeCCeeEEEEEeccCCCHHH-HhcccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEccCCCCCeeeC
Q 039322 499 VKFYGFCSHARHSFLVYELLERGSLAA-ILSSDTAAQELGWSQRMNVIKGVADALSYLHH-DCFPPIVHQDISSKNLLLD 576 (708)
Q Consensus 499 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~ 576 (708)
.+.+++ ...++||||++++++.. .+.... .. .+...++.+++.++.++|. . +++|||+||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 555543 23589999999954321 111111 11 5678899999999999999 7 999999999999999
Q ss_pred CCCcEEEeecccccccC
Q 039322 577 LEYEAHVADFGIAKFLK 593 (708)
Q Consensus 577 ~~~~~kl~Dfg~a~~~~ 593 (708)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-16 Score=175.11 Aligned_cols=255 Identities=22% Similarity=0.268 Sum_probs=187.9
Q ss_pred ccccccceeccccCccEEEEEeC--CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCeeE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP--SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~ 512 (708)
..|...+.||+|+|+.|-..... ....+|+|.+.... ...........|..+-+.+. |+|+++.++...+++..+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 56777888999999999887543 24456666665432 22233445566777777776 999999999999999999
Q ss_pred EEEEeccCCCHHHHh-cccccccCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEccCCCCCeeeCCCC-cEEEeecccc
Q 039322 513 LVYELLERGSLAAIL-SSDTAAQELGWSQRMNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEY-EAHVADFGIA 589 (708)
Q Consensus 513 lv~e~~~~g~L~~~l-~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a 589 (708)
+++||..+|++.+.+ +... ...+....-.++.|+..++.|+| +. ++.|+|+||+|.+++..+ ..+++|||+|
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred cccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhh
Confidence 999999999999888 4332 13556777789999999999999 77 999999999999999999 9999999999
Q ss_pred cccCC-CCCc--cccccc-cccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC
Q 039322 590 KFLKP-ESSN--WTEFAG-TYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD 664 (708)
Q Consensus 590 ~~~~~-~~~~--~~~~~~-~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 664 (708)
..+.. .+.. .....| ++.|+|||...+. -..+..|+||.|+++.-+++|..|++...... .....+..
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-------~~~~~~~~ 245 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-------GRYSSWKS 245 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-------ccceeecc
Confidence 97765 3222 344567 9999999998874 45668999999999999999999987533211 11112222
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039322 665 PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQ 704 (708)
Q Consensus 665 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 704 (708)
.+.......+........++..+++..+|..|.+.+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 246 NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 2111111112222234567777899999999999888754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-14 Score=142.99 Aligned_cols=141 Identities=16% Similarity=0.249 Sum_probs=108.2
Q ss_pred cceec-cccCccEEEEEeCCCcEEEEEEcCCCCC-----c----chhHhHHHHHHHHHHHHhccCCce--eeEEEEEeeC
Q 039322 441 QYCIG-NGGHGSVYRAELPSGQVVAIKKFHSPLP-----C----DQIADQKEFLIEVKALTEIRHRNI--VKFYGFCSHA 508 (708)
Q Consensus 441 ~~~ig-~G~~g~vy~~~~~~~~~vavK~~~~~~~-----~----~~~~~~~~~~~e~~~l~~l~h~~i--v~l~~~~~~~ 508 (708)
...|| .|+.|+||.+... +..+|||.+..... . ........+.+|++++.+++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45688 8999999999875 77899998854210 0 011234678899999999998775 7777765443
Q ss_pred C----eeEEEEEeccC-CCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEE
Q 039322 509 R----HSFLVYELLER-GSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHV 583 (708)
Q Consensus 509 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl 583 (708)
. ..++|||+++| .+|.+++... .++.. .+.+++.++++||+. ||+||||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 6999888542 23433 357899999999999 9999999999999999999999
Q ss_pred eecccccccC
Q 039322 584 ADFGIAKFLK 593 (708)
Q Consensus 584 ~Dfg~a~~~~ 593 (708)
+|||.+....
T Consensus 184 IDfg~~~~~~ 193 (239)
T PRK01723 184 IDFDRGELRT 193 (239)
T ss_pred EECCCcccCC
Confidence 9999998643
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-15 Score=156.08 Aligned_cols=197 Identities=30% Similarity=0.441 Sum_probs=161.0
Q ss_pred EEcccCcceeeCCCCCC-CCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCcc
Q 039322 126 IDLSRNDFYGEISSNWG-KCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQ 204 (708)
Q Consensus 126 L~l~~n~l~~~~~~~~~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 204 (708)
|.|++-++.....+.+. .+..-...+|+.|++. .+|..+..+..|+.+.|..|.+. .+|.+++++..|+.|+|+.|+
T Consensus 55 l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~Nq 132 (722)
T KOG0532|consen 55 LLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQ 132 (722)
T ss_pred cccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccch
Confidence 44555555544444443 3445566788888887 67777788888888999999998 788888899999999999999
Q ss_pred ccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchh
Q 039322 205 FTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQ 284 (708)
Q Consensus 205 l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~ 284 (708)
++ .+|..++.+ -|+.|.+++|+++ .+|+.++.+++|..||.+.|.|. ..|..+.++.+|+.|.+..|.+. ..|.+
T Consensus 133 lS-~lp~~lC~l-pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~E 207 (722)
T KOG0532|consen 133 LS-HLPDGLCDL-PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEE 207 (722)
T ss_pred hh-cCChhhhcC-cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHH
Confidence 98 778777776 4889999999998 77888888889999999999998 67888999999999999999998 66777
Q ss_pred hcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCCC
Q 039322 285 ICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPN 331 (708)
Q Consensus 285 ~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 331 (708)
+..+| |..||++.|+++ .+|..|.+|..|++|-|.+|+++.++..
T Consensus 208 l~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAq 252 (722)
T KOG0532|consen 208 LCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQ 252 (722)
T ss_pred HhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChHH
Confidence 77666 899999999998 8899999999999999999999976543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.3e-13 Score=142.64 Aligned_cols=146 Identities=21% Similarity=0.255 Sum_probs=102.5
Q ss_pred cceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHh------------------------------------HHHHH
Q 039322 441 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIAD------------------------------------QKEFL 484 (708)
Q Consensus 441 ~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~------------------------------------~~~~~ 484 (708)
.+.||.|++|.||+|+.++|+.||||+.+......-..+ .-.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999876432110000 01245
Q ss_pred HHHHHHHhcc-----CCceeeEEEEEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHH-HHHHHHhC
Q 039322 485 IEVKALTEIR-----HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVAD-ALSYLHHD 558 (708)
Q Consensus 485 ~e~~~l~~l~-----h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~~Lh~~ 558 (708)
.|.+.+.+++ ++++.-..-+.......++||||++|++|.++...... .. ...+++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 5666655553 33332222222334457899999999999887643211 11 24456666666 47888988
Q ss_pred CCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 559 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|++|+|++|.||+++.++.++++|||++..+.+
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.2e-13 Score=132.54 Aligned_cols=201 Identities=20% Similarity=0.307 Sum_probs=139.3
Q ss_pred HHhccCCceeeEEEEEeeCC-----eeEEEEEeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 039322 490 LTEIRHRNIVKFYGFCSHAR-----HSFLVYELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563 (708)
Q Consensus 490 l~~l~h~~iv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i 563 (708)
+-++.|.|||++..|+.+.+ ...++.|||..|++.++|++.. ....+......+|+.||..||.|||+. .|.+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence 45567999999999986543 4678999999999999997543 234577888899999999999999985 6799
Q ss_pred EEccCCCCCeeeCCCCcEEEeecccccccCCC---C--CccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhC
Q 039322 564 VHQDISSKNLLLDLEYEAHVADFGIAKFLKPE---S--SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKG 638 (708)
Q Consensus 564 vH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~---~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg 638 (708)
+|+++..+-|++..+|-+|++----. ...+. . .......+-++|.+||.=.....+.++|||+||....||.-|
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999999998531111 11000 0 001123356899999986666677899999999999999987
Q ss_pred CCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 639 KHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 639 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
..--..... ...........+..- +.. .=..++..|++..|..||+|++++.|.
T Consensus 279 Eiq~tnseS----~~~~ee~ia~~i~~l-----en~-----lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 279 EIQSTNSES----KVEVEENIANVIIGL-----ENG-----LQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred eeccCCCcc----eeehhhhhhhheeec-----cCc-----cccCcCcccccCCCCCCcchhhhhcCc
Confidence 665221110 111111111111000 000 013566799999999999999998764
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.9e-13 Score=150.45 Aligned_cols=118 Identities=31% Similarity=0.534 Sum_probs=102.4
Q ss_pred cceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecC
Q 039322 242 KLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDIS 321 (708)
Q Consensus 242 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~ 321 (708)
.++.|+|++|.+++.+|..+..+++|+.|+|++|.+.+.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCCCCccc--cccCcccccccccCcCCCCCCCCCcc
Q 039322 322 DNQLQGPVPNSTA--FRNAPVEALKGNKGLCGGVKGMQPCK 360 (708)
Q Consensus 322 ~N~l~~~~~~~~~--~~~~~~~~~~~n~~~c~~~~~~~~~~ 360 (708)
+|.++|.+|.... +.....+.+.+|+..|+.+. ..+|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~-l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG-LRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC-CCCCc
Confidence 9999998886422 23455678999999998753 34563
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.4e-13 Score=145.74 Aligned_cols=197 Identities=34% Similarity=0.476 Sum_probs=103.5
Q ss_pred EEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCC-CCCEEEcccCcceeeCCCCCCCCCCCCEEEcccC
Q 039322 77 YFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYP-NLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMN 155 (708)
Q Consensus 77 ~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 155 (708)
.++++.|.+. .....+..++.++.|++.+|.++.+.+ ....+. +|+.|++++|++..+. ..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~i~~-~~~~~~~nL~~L~l~~N~i~~l~-~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITDIPP-LIGLLKSNLKELDLSDNKIESLP-SPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccccCcc-ccccchhhcccccccccchhhhh-hhhhccccccccccCCc
Confidence 4555555553 112223344556666666666664433 223332 5666666666665332 33455566666666666
Q ss_pred cccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCC
Q 039322 156 NITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPE 235 (708)
Q Consensus 156 ~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~ 235 (708)
++. ..+.....+++|+.|++++|+++ .+|........|++|.+++|.+. ..+..+..+.++..|.+.+|++. ..+.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 665 23333335556666666666665 34433333444666666666433 34444555556666666666655 2244
Q ss_pred CCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCc
Q 039322 236 NLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIP 282 (708)
Q Consensus 236 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~ 282 (708)
.+..+++++.|++++|.++.... +..+.+++.|++++|.+....+
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred hhccccccceecccccccccccc--ccccCccCEEeccCccccccch
Confidence 55555566666666666653322 5555666666666666654433
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.39 E-value=8.2e-15 Score=150.15 Aligned_cols=172 Identities=26% Similarity=0.380 Sum_probs=86.4
Q ss_pred CCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecc
Q 039322 98 SLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLS 177 (708)
Q Consensus 98 ~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 177 (708)
--...||+.|++..+ +..+..+..|+.+.|..|.+. .++..+..+..|+.|||+.|+++ ..|..+..++ |+.|-++
T Consensus 76 dt~~aDlsrNR~~el-p~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~s 151 (722)
T KOG0532|consen 76 DTVFADLSRNRFSEL-PEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVS 151 (722)
T ss_pred chhhhhccccccccC-chHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEe
Confidence 334455555555522 333344444555555555554 33444555555555555555555 3444444444 5555555
Q ss_pred cccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCC
Q 039322 178 LNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLEL 257 (708)
Q Consensus 178 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 257 (708)
+|+++ .+|..++.++.|..|+.+.|.+. .+|..++++.+|+.|.+..|++. ..|..+..| .|..||+|.|++. .+
T Consensus 152 NNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~i 226 (722)
T KOG0532|consen 152 NNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YL 226 (722)
T ss_pred cCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ec
Confidence 55555 44445555555555555555555 44444555555555555555554 333334433 3455555555555 44
Q ss_pred ChhhhhhcccchhhcccccCC
Q 039322 258 PKELEKLVQLSELDASHNLFG 278 (708)
Q Consensus 258 ~~~~~~l~~L~~L~ls~N~i~ 278 (708)
|-.|.+|..|+.|-|.+|+++
T Consensus 227 Pv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 227 PVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred chhhhhhhhheeeeeccCCCC
Confidence 555555555555555555554
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.5e-13 Score=142.91 Aligned_cols=263 Identities=29% Similarity=0.350 Sum_probs=180.9
Q ss_pred cccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCC-CCcEEEccCCccccccccccCCCCCCCEEEcccC
Q 039322 53 RPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCS-SLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRN 131 (708)
Q Consensus 53 ~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~-~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n 131 (708)
.+.++.|.+.. ....+..+..++.|++.+|.++ .++.....+. +|+.|++++|.+..++ ..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~l~-~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLP-SPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchhhhh-hhhhccccccccccCCc
Confidence 45666666533 2344445578899999999998 5556566664 8999999999998543 56788899999999999
Q ss_pred cceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCc
Q 039322 132 DFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPP 211 (708)
Q Consensus 132 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 211 (708)
++..+.+ ....+++|+.|++++|+++ .+|........|++|.+++|++. ..+..+..++++..+.+.+|++. ..+.
T Consensus 174 ~l~~l~~-~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLSDLPK-LLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhhhhhh-hhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 9985544 2337788999999999998 45555556667999999999655 45667888889999999999988 4467
Q ss_pred ccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccC
Q 039322 212 EIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSL 291 (708)
Q Consensus 212 ~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L 291 (708)
.+..++++++|++++|.++.... +..+.+|+.|++++|.+....+...........+ .. +.+. ..+........+
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~~~~~~~~~-~~-~~~~-~~~~~~~~~~~~ 324 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIALLLLLLELL-LN-LLLT-LKALELKLNSIL 324 (394)
T ss_pred hhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhccchhHHhh-hh-hhhh-cccccccccccc
Confidence 78888889999999999985443 8888999999999999986666554432222222 22 2222 222223333334
Q ss_pred CceecccccccCCCCCcccccccccEEecCCCcCCCC
Q 039322 292 EKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGP 328 (708)
Q Consensus 292 ~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 328 (708)
....+..+... ..+..+.....+..++...+.....
T Consensus 325 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (394)
T COG4886 325 LNNNILSNGET-SSPEALSILESLNNLWTLDNALDES 360 (394)
T ss_pred ccccccccccc-ccchhhcccccccCceecccccccc
Confidence 44455555554 4455555555566666665555543
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.8e-14 Score=139.69 Aligned_cols=234 Identities=26% Similarity=0.305 Sum_probs=147.4
Q ss_pred CcCCCCCcEEEccCCccc----cccccccCCCCCCCEEEcccCcc---eeeC-------CCCCCCCCCCCEEEcccCccc
Q 039322 93 LRNCSSLIRVRLNSNNLT----GNISEALGIYPNLTFIDLSRNDF---YGEI-------SSNWGKCPKLGTLNVSMNNIT 158 (708)
Q Consensus 93 ~~~l~~L~~L~l~~n~i~----~~~~~~~~~~~~L~~L~l~~n~l---~~~~-------~~~~~~l~~L~~L~L~~N~i~ 158 (708)
+..+..++.|+|++|.+. ......+.+.++|+..++|+=-- .... ..++...++|++|+||+|-+.
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G 105 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG 105 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence 334455666666666654 22334455555666666655211 1111 122344567777777777776
Q ss_pred ccCCccc----cCCCCCCEEecccccccccCC-------------cccCCCCCCCEEEccCccccccC----CcccCCCC
Q 039322 159 GGIPREI----GNSSQLQALDLSLNHIVGEIP-------------KELGKLNSLTELILRGNQFTGRL----PPEIGSLV 217 (708)
Q Consensus 159 ~~~~~~~----~~l~~L~~L~L~~n~l~~~~~-------------~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~~~ 217 (708)
...+..| ..+.+|+.|.|.+|.+..... .....-+.|+.++.++|++.... ...|...+
T Consensus 106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~ 185 (382)
T KOG1909|consen 106 PKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHP 185 (382)
T ss_pred ccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhcc
Confidence 4444433 345777777777777752111 12233478888888888887322 23466667
Q ss_pred CCCeEeccCCcccccCC----CCCCccccceeecccCcccccC----CChhhhhhcccchhhcccccCCCCCchhhc---
Q 039322 218 DLEYLDLSANRFNNSVP----ENLGNLLKLHYLGLSNNQFVLE----LPKELEKLVQLSELDASHNLFGGEIPFQIC--- 286 (708)
Q Consensus 218 ~L~~L~l~~N~i~~~~~----~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~--- 286 (708)
.|+.+.++.|.|..... ..|..+++|+.|||.+|-++.. ....++.+++|++|++++|.+.......+.
T Consensus 186 ~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al 265 (382)
T KOG1909|consen 186 TLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDAL 265 (382)
T ss_pred ccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHH
Confidence 88888888888863222 3467788888888888888643 334567778888888888888875554442
Q ss_pred --CcccCCceecccccccC----CCCCcccccccccEEecCCCcCC
Q 039322 287 --SLKSLEKLNLSHNNLSG----SIPNCFEGIRGISVIDISDNQLQ 326 (708)
Q Consensus 287 --~~~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~l~l~~N~l~ 326 (708)
..|+|+.|.+.+|.++. .+..++...+.|..|+|++|.+.
T Consensus 266 ~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 266 KESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred hccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 35788888888888873 22234445788888888888884
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.1e-14 Score=141.24 Aligned_cols=162 Identities=23% Similarity=0.273 Sum_probs=88.8
Q ss_pred ccCCCCccEEeccCCccccccCccC----cCCCCCcEEEccCCcccccc-------------ccccCCCCCCCEEEcccC
Q 039322 69 VCRGGALQYFGVSENHFQGTIPKIL----RNCSSLIRVRLNSNNLTGNI-------------SEALGIYPNLTFIDLSRN 131 (708)
Q Consensus 69 ~~~l~~L~~L~l~~n~i~~~~~~~~----~~l~~L~~L~l~~n~i~~~~-------------~~~~~~~~~L~~L~l~~n 131 (708)
+...++|++||||.|.+.-..+..| .++..|++|.|.+|.+.... ......-+.|+++...+|
T Consensus 88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rN 167 (382)
T KOG1909|consen 88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRN 167 (382)
T ss_pred HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecc
Confidence 3444577788888887775444443 44677778888877776221 122344556666777666
Q ss_pred cceeeCC----CCCCCCCCCCEEEcccCccccc----CCccccCCCCCCEEeccccccccc----CCcccCCCCCCCEEE
Q 039322 132 DFYGEIS----SNWGKCPKLGTLNVSMNNITGG----IPREIGNSSQLQALDLSLNHIVGE----IPKELGKLNSLTELI 199 (708)
Q Consensus 132 ~l~~~~~----~~~~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~ 199 (708)
++..... ..|...+.|+.+.++.|.|... ...+|..+++|+.|||++|-++.. +...++.+++|+.|+
T Consensus 168 rlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~ 247 (382)
T KOG1909|consen 168 RLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELN 247 (382)
T ss_pred ccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeec
Confidence 6643322 2234446666666666666522 223455666666666666666522 223445555666666
Q ss_pred ccCccccccCCccc-----CCCCCCCeEeccCCccc
Q 039322 200 LRGNQFTGRLPPEI-----GSLVDLEYLDLSANRFN 230 (708)
Q Consensus 200 l~~n~l~~~~~~~~-----~~~~~L~~L~l~~N~i~ 230 (708)
+++|.+...-..+| ...++|+.|.|.+|.|+
T Consensus 248 l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 248 LGDCLLENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred ccccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 66666553222221 12345555555555554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-12 Score=137.37 Aligned_cols=250 Identities=26% Similarity=0.268 Sum_probs=182.0
Q ss_pred ccccccceecc--ccCccEEEEEe---CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCC
Q 039322 436 NDFDAQYCIGN--GGHGSVYRAEL---PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHAR 509 (708)
Q Consensus 436 ~~~~~~~~ig~--G~~g~vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~ 509 (708)
..|.+...+|. |.+|.||.+.. .++..+|+|.-+.+... ......=.+|+...++++ |++.++.+..+...+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~--p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSP--PLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCC--ccccccccchhhcccccCccccccccCcccccCC
Confidence 34566677899 99999999955 46888999985543321 122333445666666664 999999889999999
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEccCCCCCeeeCCC-CcEEEe
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVAD----ALSYLHHDCFPPIVHQDISSKNLLLDLE-YEAHVA 584 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~ 584 (708)
..++-+|++. .++.++-+... ..++....+....+... |+.++|+. +++|-|+||.||+...+ ..++++
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred cceeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence 9999999985 58888776543 33567788888888888 99999999 99999999999999999 889999
Q ss_pred ecccccccCCCCCcccc-----ccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccc
Q 039322 585 DFGIAKFLKPESSNWTE-----FAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIAL 659 (708)
Q Consensus 585 Dfg~a~~~~~~~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 659 (708)
|||+...+.+..-.... ..+...|++||...+ .++..+|+|++|.+..+-.+|-.+.....- ......
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~~~ 338 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN------SSWSQL 338 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC------CCcccc
Confidence 99999877655432222 267889999998655 578899999999999999987766442100 000111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 660 DEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
+... .+.+.+.....++...+..+++.+|..|++++.+..+
T Consensus 339 r~~~-----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 339 RQGY-----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred cccc-----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 1111 1122232333455568889999999999999988754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.7e-12 Score=135.46 Aligned_cols=148 Identities=17% Similarity=0.213 Sum_probs=95.1
Q ss_pred hccccccceeccccCccEEEEEeCC-CcEEEEEEcCCCCCcc-------------------------h-h----HhHH--
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLPCD-------------------------Q-I----ADQK-- 481 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~-------------------------~-~----~~~~-- 481 (708)
..+|+. +.||+|++|.||+|+.++ |+.||||+.++..... . . +-.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456776 789999999999999887 9999999998643110 0 0 0011
Q ss_pred ----HHHHHHHHHHhcc----CCceeeEEEEE-eeCCeeEEEEEeccCCCHHHHh--cccc-cccCCCHHHHHHHHHHHH
Q 039322 482 ----EFLIEVKALTEIR----HRNIVKFYGFC-SHARHSFLVYELLERGSLAAIL--SSDT-AAQELGWSQRMNVIKGVA 549 (708)
Q Consensus 482 ----~~~~e~~~l~~l~----h~~iv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l--~~~~-~~~~l~~~~~~~i~~~i~ 549 (708)
.+.+|+..+.+++ +...+.+=.++ ......++||||++|+.+.++- ...+ ....+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 2344554444442 33323322222 2244578999999999998742 2211 01112222333333343
Q ss_pred HHHHHHHhCCCCCeEEccCCCCCeeeCCCC----cEEEeecccccccC
Q 039322 550 DALSYLHHDCFPPIVHQDISSKNLLLDLEY----EAHVADFGIAKFLK 593 (708)
Q Consensus 550 ~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a~~~~ 593 (708)
... |++|+|+||.||+++.++ .+++.|||++....
T Consensus 277 ------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 345 999999999999999988 99999999997654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.6e-13 Score=128.42 Aligned_cols=208 Identities=24% Similarity=0.220 Sum_probs=132.9
Q ss_pred ccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEeccC-CccccccCccCc
Q 039322 16 GVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSE-NHFQGTIPKILR 94 (708)
Q Consensus 16 ~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~~~ 94 (708)
...|..++-+++|+.+.+|++.-..+..-....|.|+.+.+.+..+... | .+-....+..+.-+. .-.+|.....+.
T Consensus 204 ~~l~f~l~~f~~l~~~~~s~~~~~~i~~~~~~kptl~t~~v~~s~~~~~-~-~l~pe~~~~D~~~~E~~t~~G~~~~~~d 281 (490)
T KOG1259|consen 204 NRLSFNLNAFRNLKTLKFSALSTENIVDIELLKPTLQTICVHNTTIQDV-P-SLLPETILADPSGSEPSTSNGSALVSAD 281 (490)
T ss_pred cccccchHHhhhhheeeeeccchhheeceeecCchhheeeeeccccccc-c-cccchhhhcCccCCCCCccCCceEEecc
Confidence 3456667888889999888886554433344457788777766554421 1 111112222222111 112222223333
Q ss_pred CCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEE
Q 039322 95 NCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQAL 174 (708)
Q Consensus 95 ~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 174 (708)
-...|++|||++|.|+. +.....-.|.++.|++|+|.|..+.. +..+++|+.|||++|.++ .....-..+.++++|
T Consensus 282 TWq~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~~v~n--La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIRTVQN--LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchhh-hhhhhhhccceeEEeccccceeeehh--hhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 44678888888888874 34456667788888888888875543 777888888888888887 344455567788888
Q ss_pred ecccccccccCCcccCCCCCCCEEEccCccccccCC-cccCCCCCCCeEeccCCcccc
Q 039322 175 DLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLP-PEIGSLVDLEYLDLSANRFNN 231 (708)
Q Consensus 175 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~~~~L~~L~l~~N~i~~ 231 (708)
.|+.|.|... ..++.+-+|..|++++|+|..... ..++++|-|+.+.|.+|.+.+
T Consensus 358 ~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 358 KLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred ehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 8888877632 346667788888888888873222 357788888888888888873
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.32 E-value=9.4e-14 Score=138.36 Aligned_cols=161 Identities=27% Similarity=0.203 Sum_probs=82.2
Q ss_pred cCCCCCcEEEccCCccccccc-cccCCCCCCCEEEcccCcceeeC--CCCCCCCCCCCEEEcccCcccccCCccc-cCCC
Q 039322 94 RNCSSLIRVRLNSNNLTGNIS-EALGIYPNLTFIDLSRNDFYGEI--SSNWGKCPKLGTLNVSMNNITGGIPREI-GNSS 169 (708)
Q Consensus 94 ~~l~~L~~L~l~~n~i~~~~~-~~~~~~~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~L~~N~i~~~~~~~~-~~l~ 169 (708)
+++.+|+.+.|.++.+..... .....+++++.|||+.|-++... ......+|+|+.|+|+.|++........ ..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 445666777777666652221 34455666677777766654322 2223456666666666666652222111 1345
Q ss_pred CCCEEecccccccccCC-cccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCC-CCCCccccceeec
Q 039322 170 QLQALDLSLNHIVGEIP-KELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVP-ENLGNLLKLHYLG 247 (708)
Q Consensus 170 ~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~ 247 (708)
+|+.|.|+.|.++.... ..+..+|+|+.|+|.+|............+..|++|||++|++-.... ...+.++.|+.|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 66666666666652111 123345666666666664222333334444556666666655542221 2234455555555
Q ss_pred ccCcccc
Q 039322 248 LSNNQFV 254 (708)
Q Consensus 248 l~~n~l~ 254 (708)
++.|.|.
T Consensus 278 ls~tgi~ 284 (505)
T KOG3207|consen 278 LSSTGIA 284 (505)
T ss_pred ccccCcc
Confidence 5555554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.1e-13 Score=127.16 Aligned_cols=223 Identities=26% Similarity=0.221 Sum_probs=156.2
Q ss_pred CCCCCEEEeeCce----eeeeCCCC--CCC---CCcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcC
Q 039322 25 LTNLKELVLLYNN----LSGFIPPS--LEN---PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRN 95 (708)
Q Consensus 25 l~~L~~L~L~~n~----i~~~~~~~--~~~---~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~ 95 (708)
..+|..|.+++.+ -+.++|.. |.. .+|..+.+++|.-.....-.. .=+.|+++.+.+..++. .|. +-.
T Consensus 181 ~~~l~~l~vs~~~~p~~~sni~~~~l~f~l~~f~~l~~~~~s~~~~~~i~~~~~-~kptl~t~~v~~s~~~~-~~~-l~p 257 (490)
T KOG1259|consen 181 CTQLVALVVTPVKDPIDRSNIIPNRLSFNLNAFRNLKTLKFSALSTENIVDIEL-LKPTLQTICVHNTTIQD-VPS-LLP 257 (490)
T ss_pred hhheeEEEecCCCCCCccccccccccccchHHhhhhheeeeeccchhheeceee-cCchhheeeeecccccc-ccc-ccc
Confidence 4567888887653 11222222 222 578888888876443221111 22788999998887773 222 222
Q ss_pred CCCCcEEEccCC-ccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEE
Q 039322 96 CSSLIRVRLNSN-NLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQAL 174 (708)
Q Consensus 96 l~~L~~L~l~~n-~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 174 (708)
...+..+.-+.- -.+|.........+-|++||||+|.|+.+ .....-+|.++.|++++|.|..+ ..++.+++|+.|
T Consensus 258 e~~~~D~~~~E~~t~~G~~~~~~dTWq~LtelDLS~N~I~~i-DESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~L 334 (490)
T KOG1259|consen 258 ETILADPSGSEPSTSNGSALVSADTWQELTELDLSGNLITQI-DESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLL 334 (490)
T ss_pred hhhhcCccCCCCCccCCceEEecchHhhhhhccccccchhhh-hhhhhhccceeEEeccccceeee--hhhhhcccceEe
Confidence 233333322222 12333344455667899999999999854 45667789999999999999844 348999999999
Q ss_pred ecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCC-CCCCccccceeecccCccc
Q 039322 175 DLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVP-ENLGNLLKLHYLGLSNNQF 253 (708)
Q Consensus 175 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~l~~n~l 253 (708)
||++|.++ ....+-..+.|+++|.|++|.|... ..+..+.+|..||+++|+|..... ..++++|.|+.|.|.+|.+
T Consensus 335 DLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl 411 (490)
T KOG1259|consen 335 DLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPL 411 (490)
T ss_pred ecccchhH-hhhhhHhhhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCc
Confidence 99999998 4555556788999999999999832 246778899999999999985433 4689999999999999999
Q ss_pred ccC
Q 039322 254 VLE 256 (708)
Q Consensus 254 ~~~ 256 (708)
.+.
T Consensus 412 ~~~ 414 (490)
T KOG1259|consen 412 AGS 414 (490)
T ss_pred ccc
Confidence 844
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.1e-13 Score=133.82 Aligned_cols=208 Identities=20% Similarity=0.190 Sum_probs=139.7
Q ss_pred CCCCccEEeccCCccccccC-ccCcCCCCCcEEEccCCcccc--ccccccCCCCCCCEEEcccCcceeeCCCC-CCCCCC
Q 039322 71 RGGALQYFGVSENHFQGTIP-KILRNCSSLIRVRLNSNNLTG--NISEALGIYPNLTFIDLSRNDFYGEISSN-WGKCPK 146 (708)
Q Consensus 71 ~l~~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~l~~n~i~~--~~~~~~~~~~~L~~L~l~~n~l~~~~~~~-~~~l~~ 146 (708)
++.+|+...|.++.+..... .....|++++.|||+.|-+.. ........+|+|+.|+|+.|++....... -..+++
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 45678888888877763322 346678888888888888763 33445677888999999998885332222 235678
Q ss_pred CCEEEcccCccccc-CCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCC--cccCCCCCCCeEe
Q 039322 147 LGTLNVSMNNITGG-IPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLP--PEIGSLVDLEYLD 223 (708)
Q Consensus 147 L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~~~~~~~L~~L~ 223 (708)
|+.|.|++|.++.- +......+|+|+.|+|..|..-.........+..|++|+|++|++. ..+ .....++.|+.|+
T Consensus 199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhh
Confidence 88899999988732 2223455688999999998532233333445678899999998887 333 3456788888899
Q ss_pred ccCCcccccCCCC------CCccccceeecccCcccccC-CChhhhhhcccchhhcccccCCC
Q 039322 224 LSANRFNNSVPEN------LGNLLKLHYLGLSNNQFVLE-LPKELEKLVQLSELDASHNLFGG 279 (708)
Q Consensus 224 l~~N~i~~~~~~~------~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~ls~N~i~~ 279 (708)
++.+.|....... ...+++|++|+++.|+|... .-..+..+++|+.|....|.+..
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 9998887532222 24567788888888887522 22345556667777777777663
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.4e-11 Score=110.73 Aligned_cols=141 Identities=21% Similarity=0.234 Sum_probs=100.9
Q ss_pred cceeccccCccEEEEEeCC-------CcEEEEEEcCCCCCc---------ch---------hHhHHHH----HHHHHHHH
Q 039322 441 QYCIGNGGHGSVYRAELPS-------GQVVAIKKFHSPLPC---------DQ---------IADQKEF----LIEVKALT 491 (708)
Q Consensus 441 ~~~ig~G~~g~vy~~~~~~-------~~~vavK~~~~~~~~---------~~---------~~~~~~~----~~e~~~l~ 491 (708)
...||.|.-+.||.|...+ +..+|||+.+..... .+ ....+.+ .+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999996543 478999998753210 00 0112233 38999999
Q ss_pred hccC--CceeeEEEEEeeCCeeEEEEEeccCCCHHH-HhcccccccCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEcc
Q 039322 492 EIRH--RNIVKFYGFCSHARHSFLVYELLERGSLAA-ILSSDTAAQELGWSQRMNVIKGVADALSYL-HHDCFPPIVHQD 567 (708)
Q Consensus 492 ~l~h--~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~~~~ivH~d 567 (708)
++.. -+++.++++ ...++||||+.++.+.. .++. ..++.++...+..+++.++..+ |+. |+||||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 9953 466777764 45679999997754322 2221 1244556778889999999998 788 999999
Q ss_pred CCCCCeeeCCCCcEEEeecccccccC
Q 039322 568 ISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 568 lk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
+++.||+++ ++.+.++|||.|...+
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999997 5789999999987554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.7e-11 Score=114.70 Aligned_cols=131 Identities=19% Similarity=0.162 Sum_probs=96.1
Q ss_pred cceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCce-eeEEEEEeeCCeeEEEEEecc
Q 039322 441 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI-VKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 441 ~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~l~~~~~~~~~~~lv~e~~~ 519 (708)
.+.++.|..+.||+++.. ++.|++|....... ....+..|+++++.+.+.++ ++++++. ....++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecC
Confidence 356899999999999875 77899999765321 12345678888888865444 4455443 234579999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC--FPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
|.++.+. . .....++.+++++++.||+.. ..+++|||++|.||+++ ++.++++|||.+..
T Consensus 75 G~~l~~~----~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE----D-------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc----c-------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9877643 0 112345678999999999982 11259999999999999 67899999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.6e-11 Score=126.44 Aligned_cols=168 Identities=19% Similarity=0.257 Sum_probs=127.7
Q ss_pred EeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEeccCCCHHHHhcccccccC
Q 039322 456 ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQE 535 (708)
Q Consensus 456 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 535 (708)
+..++.+|.|.+.+.... ...+...+.++.++.++||+|++++..++.+++.|+|+|-+. .|..+++.
T Consensus 33 ~k~~~~~vsVF~~~~~~~----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------ 100 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------ 100 (690)
T ss_pred eeccCCceEEEEEeCCCc----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------
Confidence 444688888888765321 334556778888999999999999999999999999999883 67777754
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccccccCccccc
Q 039322 536 LGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAY 615 (708)
Q Consensus 536 l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~ 615 (708)
++......-+.||+.||.|||+.+ +++|++|....|++++.|+.||++|.++......+.......--..|..|+.+.
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID 178 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC
Confidence 345667778999999999999775 999999999999999999999999998865443222111112223456666543
Q ss_pred cCCCCcchhHHHHHHHHHHHHhCC
Q 039322 616 TMKITEKCDVYSFGVLVLEAIKGK 639 (708)
Q Consensus 616 ~~~~~~~~DvwslG~~l~elltg~ 639 (708)
... -..|.|.|||+++|++.|.
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCcc
Confidence 322 3469999999999999983
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.8e-13 Score=142.82 Aligned_cols=195 Identities=30% Similarity=0.293 Sum_probs=88.2
Q ss_pred CCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEE
Q 039322 72 GGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLN 151 (708)
Q Consensus 72 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 151 (708)
+..++.+++..|.|. ..-..+..+.+|+.|++.+|+|..+.. .+..+++|++|++++|.|+.+.. +..++.|+.|+
T Consensus 71 l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~ 146 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELN 146 (414)
T ss_pred hHhHHhhccchhhhh-hhhcccccccceeeeeccccchhhccc-chhhhhcchheeccccccccccc--hhhccchhhhe
Confidence 344555555555555 222334555555556666555553322 14455555555555555544322 33444455555
Q ss_pred cccCcccccCCccccCCCCCCEEecccccccccCC-cccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCccc
Q 039322 152 VSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIP-KELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFN 230 (708)
Q Consensus 152 L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~ 230 (708)
+++|.|+.+ ..+..+.+|+.+++++|++....+ . ...+.+|+.+.+.+|.+... ..+..+..+..+++..|.++
T Consensus 147 l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 147 LSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred eccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccce
Confidence 555555522 334445555555555555553222 1 24444555555555555411 11222333333344555544
Q ss_pred ccCCCCCCccc--cceeecccCcccccCCChhhhhhcccchhhcccccCC
Q 039322 231 NSVPENLGNLL--KLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFG 278 (708)
Q Consensus 231 ~~~~~~~~~l~--~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~ 278 (708)
...+ +..+. +|+.+++++|++. ..+..+..+..+..|++++|++.
T Consensus 222 ~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 222 KLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred eccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccc
Confidence 2211 11111 1444555555444 22233344444444454444443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.4e-13 Score=142.49 Aligned_cols=244 Identities=26% Similarity=0.236 Sum_probs=174.0
Q ss_pred CCcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEc
Q 039322 49 PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDL 128 (708)
Q Consensus 49 ~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l 128 (708)
..+..+.++.|.+.. .-..++.+.+|..|++..|.|.. +...+..+++|++|+|++|.|+.+. .+..++.|+.|++
T Consensus 72 ~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l 147 (414)
T KOG0531|consen 72 TSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNL 147 (414)
T ss_pred HhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhhhee
Confidence 345555566666554 33446778889999999999984 3333778899999999999998654 4566777999999
Q ss_pred ccCcceeeCCCCCCCCCCCCEEEcccCcccccCC-ccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccc
Q 039322 129 SRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIP-REIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTG 207 (708)
Q Consensus 129 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 207 (708)
++|.|+.+. .+..+++|+.+++++|++....+ . ...+.+++.+.+.+|.+... ..+..+..+..+++..|.++.
T Consensus 148 ~~N~i~~~~--~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~ 222 (414)
T KOG0531|consen 148 SGNLISDIS--GLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISK 222 (414)
T ss_pred ccCcchhcc--CCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhccccccee
Confidence 999997553 45568899999999999985544 2 57788899999999988732 334455666667899999884
Q ss_pred cCCcccCCCCC--CCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCC---Cc
Q 039322 208 RLPPEIGSLVD--LEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGE---IP 282 (708)
Q Consensus 208 ~~~~~~~~~~~--L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~---~~ 282 (708)
..+ +..+.. |+.+++++|++. ..+..+..+.++..|++.+|++... ..+.....+..+....|.+... ..
T Consensus 223 ~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (414)
T KOG0531|consen 223 LEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQ 297 (414)
T ss_pred ccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhc
Confidence 333 223333 899999999998 4445677788999999999998732 3355566777788888887631 11
Q ss_pred hh-hcCcccCCceecccccccCCCC
Q 039322 283 FQ-ICSLKSLEKLNLSHNNLSGSIP 306 (708)
Q Consensus 283 ~~-~~~~~~L~~L~l~~N~l~~~~~ 306 (708)
.. ....+.+..+.+.+|++....+
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 298 EYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred cccccccccccccccccCccccccc
Confidence 11 3445667777777777765444
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.6e-10 Score=103.68 Aligned_cols=134 Identities=20% Similarity=0.341 Sum_probs=103.9
Q ss_pred eeccccCccEEEEEeCCCcEEEEEE-cCCCCCcchhH---hHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEec
Q 039322 443 CIGNGGHGSVYRAELPSGQVVAIKK-FHSPLPCDQIA---DQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELL 518 (708)
Q Consensus 443 ~ig~G~~g~vy~~~~~~~~~vavK~-~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 518 (708)
.+++|+-+.+|.+.+. |..+++|. +++...-.... ....-.+|++++.+++--.|...+-++.+++...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999774 44455554 23322222221 2456788999999998778877788888888899999999
Q ss_pred cCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 519 ERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 519 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
+|..|.+.+... ...++..+-.-+.-||.. ||+|||+.++||.+..++ +.++|||++.+
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888643 245666777778889999 999999999999998665 99999999974
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.22 E-value=6.6e-12 Score=114.95 Aligned_cols=125 Identities=34% Similarity=0.392 Sum_probs=42.3
Q ss_pred CCCCCCEEEccCccccccCCcccC-CCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhh-hhhcccc
Q 039322 191 KLNSLTELILRGNQFTGRLPPEIG-SLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKEL-EKLVQLS 268 (708)
Q Consensus 191 ~l~~L~~L~l~~n~l~~~~~~~~~-~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~ 268 (708)
+..++++|+|++|+|+. +. .++ .+.+|+.|+|++|.|+.. +.+..+++|+.|++++|+|+.. ...+ ..+++|+
T Consensus 17 n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--
T ss_pred ccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCcc-ccchHHhCCcCC
Confidence 34456777777777763 22 333 456777777777777633 2466677777777777777743 3333 4577777
Q ss_pred hhhcccccCCCC-CchhhcCcccCCceecccccccCCCCC----cccccccccEEecC
Q 039322 269 ELDASHNLFGGE-IPFQICSLKSLEKLNLSHNNLSGSIPN----CFEGIRGISVIDIS 321 (708)
Q Consensus 269 ~L~ls~N~i~~~-~~~~~~~~~~L~~L~l~~N~l~~~~~~----~~~~l~~L~~l~l~ 321 (708)
+|++++|+|.+. .-..+..+++|+.|+|.+|+++.. +. .+..+|+|+.||-.
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETTE
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCCE
Confidence 777777777652 224556677777788888877633 22 23456777766543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.19 E-value=9.7e-12 Score=113.85 Aligned_cols=106 Identities=30% Similarity=0.305 Sum_probs=23.3
Q ss_pred CCCCcEEEccCCccccccccccC-CCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccc-cCCCCCCE
Q 039322 96 CSSLIRVRLNSNNLTGNISEALG-IYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREI-GNSSQLQA 173 (708)
Q Consensus 96 l~~L~~L~l~~n~i~~~~~~~~~-~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~-~~l~~L~~ 173 (708)
..++++|+|++|.|+.+. .++ .+.+|+.|||++|+|+.+. .+..+++|+.|++++|+|+... ..+ ..+++|++
T Consensus 18 ~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~i~-~~l~~~lp~L~~ 92 (175)
T PF14580_consen 18 PVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISSIS-EGLDKNLPNLQE 92 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS---S-C-HHHHHH-TT--E
T ss_pred cccccccccccccccccc--chhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCccc-cchHHhCCcCCE
Confidence 344555555555555331 222 3445555555555554432 2444555555555555555322 122 23455555
Q ss_pred EecccccccccC-CcccCCCCCCCEEEccCcccc
Q 039322 174 LDLSLNHIVGEI-PKELGKLNSLTELILRGNQFT 206 (708)
Q Consensus 174 L~L~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~ 206 (708)
|+|++|+|.... -..+..+++|+.|+|.+|.++
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 555555554211 122334444444444444444
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.6e-11 Score=127.38 Aligned_cols=248 Identities=21% Similarity=0.214 Sum_probs=175.6
Q ss_pred HHhccccccceeccccCccEEEEEe--CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCC
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAEL--PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHAR 509 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~ 509 (708)
.-..+|..+..||.|.|+.|+.... .++..|++|........ ..+...-..|+-+...+ .|.++++.+..+..-+
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~--~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT--FASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccc--hHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3456888899999999999999843 46788999988764322 12223334566665555 4889999888888878
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC-CcEEEeeccc
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE-YEAHVADFGI 588 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~ 588 (708)
+.|+=-||+++++...... ....++...++++..|++.++.++|+. .++|+|++|+||++..+ +..+++|||.
T Consensus 340 ~~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred cccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccc
Confidence 8889999999998877662 224477788999999999999999998 99999999999999886 7889999999
Q ss_pred ccccCCCCCcccccccccccc--CccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 039322 589 AKFLKPESSNWTEFAGTYGYV--APELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPR 666 (708)
Q Consensus 589 a~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (708)
+..+.- .........++. +|+......+..+.|+||||.-+.|.++|..--+.. .....+..+.
T Consensus 414 ~t~~~~---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-----------~~~~~i~~~~ 479 (524)
T KOG0601|consen 414 WTRLAF---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-----------VQSLTIRSGD 479 (524)
T ss_pred ccccce---ecccccccccccccchhhccccccccccccccccccccccccCcccCccc-----------ccceeeeccc
Confidence 864221 111122233344 555556667888999999999999999876653210 1111112222
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 667 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.+...... ..+..+.+.+..++++.||.+.++..+.
T Consensus 480 ~p~~~~~~----~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 480 TPNLPGLK----LQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred ccCCCchH----HhhhhhhhhhcCCccccchhhhhhcccc
Confidence 22111111 3466677789999999999998876653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.6e-09 Score=108.30 Aligned_cols=255 Identities=19% Similarity=0.260 Sum_probs=159.7
Q ss_pred cccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEE-------eeCCe
Q 039322 439 DAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFC-------SHARH 510 (708)
Q Consensus 439 ~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~-------~~~~~ 510 (708)
...+.+|+|+.+.+|-.-. -...+.|+...+-... .. +.+..|... .||-+-.-+.|- .....
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~----~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAA----QA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchH----HH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 3466799999999996621 1224567777643221 11 123333433 455433322221 11223
Q ss_pred eEEEEEeccCC-CHHHHhc---ccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeec
Q 039322 511 SFLVYELLERG-SLAAILS---SDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADF 586 (708)
Q Consensus 511 ~~lv~e~~~~g-~L~~~l~---~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 586 (708)
..+.|..+.+- .+.+++. .++......|+..+++++.+|.+.+.||+. |.+-||+.++|+|+.+++.+.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcc
Confidence 56788877764 3333332 223344578999999999999999999999 9999999999999999999999986
Q ss_pred ccccccCCCCCccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhC-CCCCCccccccccccccc--cc
Q 039322 587 GIAKFLKPESSNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLVLEAIKG-KHPRDFLSLISSSSLNTD--IA 658 (708)
Q Consensus 587 g~a~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg-~~p~~~~~~~~~~~~~~~--~~ 658 (708)
+.-... ..+......+|...|++||... +...+...|.|.+|+++++++.| ++||...........-.+ ..
T Consensus 162 Dsfqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 162 DSFQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred cceeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 554433 3344456678999999999765 33456689999999999999985 999986543221111111 00
Q ss_pred -----c-ccccCCCCCCC-CchhHHHHHHHHHHHHhccCCC--CCCCCCHHHHHHHh
Q 039322 659 -----L-DEILDPRLPPP-SRSVQEKLISIMEVAFSCLNES--PESRPTMKVVTQQV 706 (708)
Q Consensus 659 -----~-~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~l 706 (708)
. .+.-.+..+++ ...+..-..++..+..+|+... |.-|||++.++..|
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl 297 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAAL 297 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Confidence 0 01111111111 1122222345666666888743 56899999887654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1e-09 Score=97.88 Aligned_cols=148 Identities=19% Similarity=0.267 Sum_probs=109.9
Q ss_pred ccceeccccCccEEEEEeCCCcEEEEEE-cCCCCCc---chhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 440 AQYCIGNGGHGSVYRAELPSGQVVAIKK-FHSPLPC---DQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 440 ~~~~ig~G~~g~vy~~~~~~~~~vavK~-~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
....+-||+-+.|+++.+. |+..+||. +.+...- +..-..++..+|++.+.++.--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5567899999999999884 77766764 3222111 11123567889999999998667766666777777778999
Q ss_pred EeccC-CCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC---cEEEeecccccc
Q 039322 516 ELLER-GSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY---EAHVADFGIAKF 591 (708)
Q Consensus 516 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~~ 591 (708)
||++| .++.+++....... ...+....++..|-+.+.-||.. +++||||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 47888886544322 22233378899999999999999 999999999999997665 358999999974
Q ss_pred c
Q 039322 592 L 592 (708)
Q Consensus 592 ~ 592 (708)
-
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.2e-10 Score=130.51 Aligned_cols=113 Identities=30% Similarity=0.447 Sum_probs=102.8
Q ss_pred CCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecc
Q 039322 218 DLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLS 297 (708)
Q Consensus 218 ~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~ 297 (708)
.++.|+|++|.+++..|..+..+++|+.|+|++|.+.+.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccc-ccccEEecCCCcCCCCCC
Q 039322 298 HNNLSGSIPNCFEGI-RGISVIDISDNQLQGPVP 330 (708)
Q Consensus 298 ~N~l~~~~~~~~~~l-~~L~~l~l~~N~l~~~~~ 330 (708)
+|++++.+|..+..+ ..+..+++.+|+..|..|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999888764 467789999998766443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.9e-10 Score=108.43 Aligned_cols=143 Identities=20% Similarity=0.273 Sum_probs=109.6
Q ss_pred ceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccC--CceeeEEEEEeeCC---eeEEEEE
Q 039322 442 YCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH--RNIVKFYGFCSHAR---HSFLVYE 516 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~l~~~~~~~~---~~~lv~e 516 (708)
+.+|.|..+.||++...+|+.+++|........ .....+..|.++++.+++ ..+.+++.+....+ ..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 568999999999998776789999997653211 134567889999999975 34677887776543 6689999
Q ss_pred eccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 039322 517 LLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC------------------------------------- 559 (708)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~------------------------------------- 559 (708)
|++|.++.+.+.. ..++..+...++.+++++++.||+..
T Consensus 81 ~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 81 RVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 9999888775531 23567778888888888888888531
Q ss_pred ----------------CCCeEEccCCCCCeeeCC--CCcEEEeecccccc
Q 039322 560 ----------------FPPIVHQDISSKNLLLDL--EYEAHVADFGIAKF 591 (708)
Q Consensus 560 ----------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~ 591 (708)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 146799999999999998 66789999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.4e-10 Score=84.56 Aligned_cols=59 Identities=31% Similarity=0.427 Sum_probs=28.6
Q ss_pred CCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCc
Q 039322 98 SLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNN 156 (708)
Q Consensus 98 ~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 156 (708)
+|++|++++|+|+.+.++.|..+++|++|++++|.++.+.+..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444444444444444444444444444444444444444444444444444
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.2e-10 Score=129.69 Aligned_cols=132 Identities=17% Similarity=0.216 Sum_probs=99.0
Q ss_pred cCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCC--ccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCc
Q 039322 23 SNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH--FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLI 100 (708)
Q Consensus 23 ~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~--~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~ 100 (708)
......+...+-+|++. .++.....+.|+.|-+..|. +.......|..++.|++|||++|.=.+.+|..+++|-+|+
T Consensus 520 ~~~~~~rr~s~~~~~~~-~~~~~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr 598 (889)
T KOG4658|consen 520 KSWNSVRRMSLMNNKIE-HIAGSSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR 598 (889)
T ss_pred cchhheeEEEEeccchh-hccCCCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence 34466788888888875 45666666778888888885 4554555577788888888888776668888888888888
Q ss_pred EEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCc
Q 039322 101 RVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNN 156 (708)
Q Consensus 101 ~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 156 (708)
.|+|+++.|. ..|..+.+++.|.+||+..+.-....++....+++|++|.+..-.
T Consensus 599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 8888888888 556678888888888888876554556666678888888877654
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.7e-10 Score=131.87 Aligned_cols=270 Identities=19% Similarity=0.209 Sum_probs=170.4
Q ss_pred CcEEECCCCcccccCCccccCCCCCCEEEeeCce--eeeeCCCCCC-CCCcccccccCCCccCCCCccccCCCCccEEec
Q 039322 4 LSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNN--LSGFIPPSLE-NPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGV 80 (708)
Q Consensus 4 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~--i~~~~~~~~~-~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l 80 (708)
.+...+-+|++..+... ...++|++|-+.+|. +..+....|. .|.|.+||+++|.-.+.+|..++.+-+|++|++
T Consensus 525 ~rr~s~~~~~~~~~~~~--~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L 602 (889)
T KOG4658|consen 525 VRRMSLMNNKIEHIAGS--SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDL 602 (889)
T ss_pred eeEEEEeccchhhccCC--CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccc
Confidence 45666677777743333 334479999999997 5433333343 489999999998888889999999999999999
Q ss_pred cCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcce--eeCCCCCCCCCCCCEEEcccCccc
Q 039322 81 SENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFY--GEISSNWGKCPKLGTLNVSMNNIT 158 (708)
Q Consensus 81 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~L~~N~i~ 158 (708)
+++.+. .+|..+++++.|.+|++..+.--...+.....+++|++|.+...... ...-..+..+.+|+.+..+.....
T Consensus 603 ~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~~ 681 (889)
T KOG4658|consen 603 SDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSVL 681 (889)
T ss_pred cCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchhH
Confidence 999999 88999999999999999998765556778888999999999876521 222223345555555555443321
Q ss_pred ccCCccccCCCCCC----EEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCC------CCCCCeEeccCCc
Q 039322 159 GGIPREIGNSSQLQ----ALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGS------LVDLEYLDLSANR 228 (708)
Q Consensus 159 ~~~~~~~~~l~~L~----~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~------~~~L~~L~l~~N~ 228 (708)
....+..+..|. .+.+.++... ..+..+..+.+|+.|.+.++.+.......+.. ++++..+.+.++.
T Consensus 682 --~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~ 758 (889)
T KOG4658|consen 682 --LLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCH 758 (889)
T ss_pred --hHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccc
Confidence 111222333332 3333333333 44556777888899988888876333322221 1122222222221
Q ss_pred ccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCC
Q 039322 229 FNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGE 280 (708)
Q Consensus 229 i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~ 280 (708)
.- ..+....-.++|+.|.+..++....+......+..++.+-+..+.+.+.
T Consensus 759 ~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l 809 (889)
T KOG4658|consen 759 ML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGL 809 (889)
T ss_pred cc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccc
Confidence 11 1122222346788888888777666666666666666655666666544
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.7e-10 Score=83.57 Aligned_cols=61 Identities=38% Similarity=0.507 Sum_probs=45.1
Q ss_pred CCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccc
Q 039322 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHI 181 (708)
Q Consensus 121 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l 181 (708)
|+|++|++++|+++.+.+..|.++++|++|++++|.|+.+.+..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4677777777777777777777777777777777777777777777777777777777764
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.9e-10 Score=126.99 Aligned_cols=251 Identities=21% Similarity=0.245 Sum_probs=168.2
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
..+++.+.+.+-+|.++.++-+.- ..|...++|+....-. -.....+....+-.+.-...+|.+++....+.-....+
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~-i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPK-IRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchh-hccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 346677778889999999988843 2344455554433110 00011122222222222234566666655555667789
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
++++|..+++|...++.... .+..-.......+..+.++||.. .+.|+|++|.|.+...++..+++|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence 99999999999999876552 34455566677788899999997 6899999999999999999999999843221
Q ss_pred CC---------------------CC----------CccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 039322 593 KP---------------------ES----------SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641 (708)
Q Consensus 593 ~~---------------------~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p 641 (708)
.. .. .......+|+.|.+||...+......+|.|+.|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 00 001235689999999999999999999999999999999999999
Q ss_pred CCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHH
Q 039322 642 RDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700 (708)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 700 (708)
|.... ....++.+.....+.+ ...........+++...+..+|.+|-.|.
T Consensus 1035 ~na~t--------pq~~f~ni~~~~~~~p-~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAET--------PQQIFENILNRDIPWP-EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcc--------hhhhhhccccCCCCCC-CCccccChhhhhhhhhhhccCchhccCcc
Confidence 87322 2233333333333322 22223334566777788889999998765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.4e-08 Score=94.76 Aligned_cols=130 Identities=24% Similarity=0.310 Sum_probs=84.0
Q ss_pred cEEEEEeCCCcEEEEEEcCCCCCc----------------------chhHhHHHHHHHHHHHHhccCC--ceeeEEEEEe
Q 039322 451 SVYRAELPSGQVVAIKKFHSPLPC----------------------DQIADQKEFLIEVKALTEIRHR--NIVKFYGFCS 506 (708)
Q Consensus 451 ~vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~~~e~~~l~~l~h~--~iv~l~~~~~ 506 (708)
.||.|...+|..+|+|..+..... ..........+|.+.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389998888999999998753111 0011234678899999999765 566666553
Q ss_pred eCCeeEEEEEecc--CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEEccCCCCCeeeCCCCcEEE
Q 039322 507 HARHSFLVYELLE--RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY-LHHDCFPPIVHQDISSKNLLLDLEYEAHV 583 (708)
Q Consensus 507 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-Lh~~~~~~ivH~dlk~~Nill~~~~~~kl 583 (708)
..++||||++ |..+..+.... ++......++.+++..+.. +|+. |++|||+.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 2369999999 54454433221 1123456677778875555 5677 99999999999999987 9999
Q ss_pred eecccccccC
Q 039322 584 ADFGIAKFLK 593 (708)
Q Consensus 584 ~Dfg~a~~~~ 593 (708)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.3e-08 Score=99.27 Aligned_cols=144 Identities=20% Similarity=0.149 Sum_probs=101.1
Q ss_pred eeccccCccEEEEEeCCCcEEEEEEcCCCCCcchh-------HhHHHHHHHHHHHHhccCCc--eeeEEEEEee-----C
Q 039322 443 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQI-------ADQKEFLIEVKALTEIRHRN--IVKFYGFCSH-----A 508 (708)
Q Consensus 443 ~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~--iv~l~~~~~~-----~ 508 (708)
.+-+.....|+++.. +|+.|.||........... .....+.+|.+.+.++...+ .+.++++.+. .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344444445777766 5788999977432100000 01124778999988885433 3455666643 2
Q ss_pred CeeEEEEEeccCC-CHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-------CCc
Q 039322 509 RHSFLVYELLERG-SLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL-------EYE 580 (708)
Q Consensus 509 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-------~~~ 580 (708)
...++|+|++++. +|.+++.... ....+......++.+++..+..||.. ||+|+|++++|||++. ++.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 3578999999986 8999875321 12345677889999999999999999 9999999999999975 467
Q ss_pred EEEeecccccc
Q 039322 581 AHVADFGIAKF 591 (708)
Q Consensus 581 ~kl~Dfg~a~~ 591 (708)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998864
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.8e-10 Score=109.44 Aligned_cols=207 Identities=19% Similarity=0.114 Sum_probs=110.8
Q ss_pred CCCCcEEEccCCccccccc-ccc-CCCCCCCEEEcccCccee--eCCCCCCCCCCCCEEEcccCcccccCCccccCCCCC
Q 039322 96 CSSLIRVRLNSNNLTGNIS-EAL-GIYPNLTFIDLSRNDFYG--EISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQL 171 (708)
Q Consensus 96 l~~L~~L~l~~n~i~~~~~-~~~-~~~~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L 171 (708)
...+.-|.+.++.|..+.. ..| .....++.|||.+|.|+. .+...+.++|.|+.|+|+.|.+.+.+...-....+|
T Consensus 44 ~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl 123 (418)
T KOG2982|consen 44 LRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNL 123 (418)
T ss_pred ccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccce
Confidence 3445556666666653321 122 334677788888887753 223345677888888888888775443322456778
Q ss_pred CEEecccccccccC-CcccCCCCCCCEEEccCccccccCC--cccCC-CCCCCeEeccCCcccccC--CCCCCcccccee
Q 039322 172 QALDLSLNHIVGEI-PKELGKLNSLTELILRGNQFTGRLP--PEIGS-LVDLEYLDLSANRFNNSV--PENLGNLLKLHY 245 (708)
Q Consensus 172 ~~L~L~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~--~~~~~-~~~L~~L~l~~N~i~~~~--~~~~~~l~~L~~ 245 (708)
++|-|.+..+.-.. ...+..+|.+++|+++.|.+..... +.... -+.+++|+...|...... ...-.-++++..
T Consensus 124 ~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~s 203 (418)
T KOG2982|consen 124 RVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNS 203 (418)
T ss_pred EEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchh
Confidence 88888777766322 2345567777788877774442111 11111 123444444433322100 000122345666
Q ss_pred ecccCcccccCC-ChhhhhhcccchhhcccccCCC-CCchhhcCcccCCceeccccccc
Q 039322 246 LGLSNNQFVLEL-PKELEKLVQLSELDASHNLFGG-EIPFQICSLKSLEKLNLSHNNLS 302 (708)
Q Consensus 246 L~l~~n~l~~~~-~~~~~~l~~L~~L~ls~N~i~~-~~~~~~~~~~~L~~L~l~~N~l~ 302 (708)
+.+..|.|.... ...+..++.+.-|+|+.|+|.+ ..-+++..++.|..|.+++|++.
T Consensus 204 v~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 204 VFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred eeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 666666664332 2234455555566666666654 22344556666666666666665
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.6e-08 Score=95.09 Aligned_cols=139 Identities=22% Similarity=0.189 Sum_probs=99.3
Q ss_pred ccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCc-----------------ch-hHhHHHHHHHHHHHHhccCC--c
Q 039322 438 FDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPC-----------------DQ-IADQKEFLIEVKALTEIRHR--N 497 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~-----------------~~-~~~~~~~~~e~~~l~~l~h~--~ 497 (708)
..++..||-|.-+.||.|..++|.++|||.=+....+ .+ ........+|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3456789999999999999999999999975432110 11 11234567899999999755 6
Q ss_pred eeeEEEEEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC
Q 039322 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL 577 (708)
Q Consensus 498 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~ 577 (708)
+++.+++- ..++||||++|--|...- ++......++..|..-+.-.-.. |+||||+.+-||++++
T Consensus 173 VP~P~~~n----RHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAWN----RHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCccccc----cceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 77777654 447999999986554321 12333444555555555544455 9999999999999999
Q ss_pred CCcEEEeecccccc
Q 039322 578 EYEAHVADFGIAKF 591 (708)
Q Consensus 578 ~~~~kl~Dfg~a~~ 591 (708)
||.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999976653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.4e-07 Score=97.15 Aligned_cols=170 Identities=18% Similarity=0.240 Sum_probs=127.4
Q ss_pred cCccEEEEE-eCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEe----eCCeeEEEEEeccCC-
Q 039322 448 GHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCS----HARHSFLVYELLERG- 521 (708)
Q Consensus 448 ~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~----~~~~~~lv~e~~~~g- 521 (708)
...+.|++. ..||..|++|+++.... .....-..-+++.+++.|+|+|++.++|. .+...++||+|.++.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~----~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRD----QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccc----cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 345789994 45899999999843211 11112234577899999999999999886 234678999999984
Q ss_pred CHHHHhcccc------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccc
Q 039322 522 SLAAILSSDT------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA 589 (708)
Q Consensus 522 ~L~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 589 (708)
+|.+...... .....++..+|.++.|++.||.++|+. |+..+-|.+++|+++.+..++|+..|..
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccce
Confidence 7877653222 223467899999999999999999999 9999999999999999889999988887
Q ss_pred cccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 039322 590 KFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641 (708)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p 641 (708)
.....+.. |-+. --.+-|.=.||.+++.|.||..-
T Consensus 441 Dvl~~d~~--------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 441 DVLQEDPT--------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred eeecCCCC--------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 76654431 0011 12356888999999999998554
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=8.1e-11 Score=124.34 Aligned_cols=183 Identities=23% Similarity=0.184 Sum_probs=112.2
Q ss_pred CCCCCCCCCCCEEEcccCcccccCCccccCC-CCCCEEeccccccc---ccCCc---ccCC---CCCCCEEEccCccccc
Q 039322 138 SSNWGKCPKLGTLNVSMNNITGGIPREIGNS-SQLQALDLSLNHIV---GEIPK---ELGK---LNSLTELILRGNQFTG 207 (708)
Q Consensus 138 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l-~~L~~L~L~~n~l~---~~~~~---~~~~---l~~L~~L~l~~n~l~~ 207 (708)
|-.+..+..|+.|.|.++.|.. ...+..+ ..|++|...+ .+. .++.. .+++ ...|.+.+.++|++.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~-Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICHN-SLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhhc-cHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence 4445566788888888888763 2333333 3455554332 221 11111 1221 135777777788777
Q ss_pred cCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcC
Q 039322 208 RLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICS 287 (708)
Q Consensus 208 ~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~ 287 (708)
....++.-++.|+.|+|++|+++... .+..+++|++|||+.|.+....--...++ +|..|.+++|.++.. ..+.+
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~lrnN~l~tL--~gie~ 252 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLNLRNNALTTL--RGIEN 252 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhh-hheeeeecccHHHhh--hhHHh
Confidence 55666666777888888888877433 67777788888888888773322223333 477788888877643 23556
Q ss_pred cccCCceecccccccCCCC-CcccccccccEEecCCCcCCCCC
Q 039322 288 LKSLEKLNLSHNNLSGSIP-NCFEGIRGISVIDISDNQLQGPV 329 (708)
Q Consensus 288 ~~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~ 329 (708)
+.+|+.||++.|-|.+-.- ..++.+..|+.|+|.||++.|-+
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 7777788888877764211 23456677777888888877653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.4e-07 Score=86.78 Aligned_cols=142 Identities=18% Similarity=0.124 Sum_probs=105.0
Q ss_pred eccccCccEEEEEeCCCcEEEEEEcCCCCCcch--hHhHHHHHHHHHHHHhccC--CceeeEEEEEeeC----CeeEEEE
Q 039322 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQ--IADQKEFLIEVKALTEIRH--RNIVKFYGFCSHA----RHSFLVY 515 (708)
Q Consensus 444 ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h--~~iv~l~~~~~~~----~~~~lv~ 515 (708)
-|+||-+.|++.... |+.+-+|.-..-..... ......|.+|...+.++.. -.++++..+.... -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 578899999998774 55788888652222111 1246789999999999953 2355555222221 2368999
Q ss_pred EeccCC-CHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc--EEEeeccccc
Q 039322 516 ELLERG-SLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE--AHVADFGIAK 590 (708)
Q Consensus 516 e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~ 590 (708)
|.+.+- +|.+++..... .+.+......++.+++.+++-||+. |+.|+|+.+.||+++.++. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 988753 89998855332 3457788889999999999999999 9999999999999986666 9999998765
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=4.8e-10 Score=118.63 Aligned_cols=179 Identities=24% Similarity=0.206 Sum_probs=105.2
Q ss_pred CccCcCCCCCcEEEccCCccccccccccCCC-CCCCEEEcccC--cce-------eeCCCCCCCCCCCCEEEcccCcccc
Q 039322 90 PKILRNCSSLIRVRLNSNNLTGNISEALGIY-PNLTFIDLSRN--DFY-------GEISSNWGKCPKLGTLNVSMNNITG 159 (708)
Q Consensus 90 ~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~-~~L~~L~l~~n--~l~-------~~~~~~~~~l~~L~~L~L~~N~i~~ 159 (708)
|-.+..+.+|+.|.|.++.|.. ...+..+ .+|++|...+- -+. +.....+.. ..|...+.+.|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~W-n~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPVW-NKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchhh-hhHhhhhcchhhHH-
Confidence 4445556677777777776652 1111111 23454444321 010 011111111 24666777777777
Q ss_pred cCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCc-ccCCCCCCCeEeccCCcccccCCCCCC
Q 039322 160 GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPP-EIGSLVDLEYLDLSANRFNNSVPENLG 238 (708)
Q Consensus 160 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~~~~L~~L~l~~N~i~~~~~~~~~ 238 (708)
....++.-++.|+.|+|++|+++... .+..+++|++|||++|.+. .+|. ....+ +|..|.|++|.++.. ..+.
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lrnN~l~tL--~gie 251 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLRNNALTTL--RGIE 251 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hheeeeecccHHHhh--hhHH
Confidence 45566777777888888888777432 5667777888888888777 4443 22233 377777777777632 2356
Q ss_pred ccccceeecccCcccccC-CChhhhhhcccchhhcccccCC
Q 039322 239 NLLKLHYLGLSNNQFVLE-LPKELEKLVQLSELDASHNLFG 278 (708)
Q Consensus 239 ~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~ls~N~i~ 278 (708)
++.+|+.||+++|-|.+. ....+..+..|+.|+|.+|++-
T Consensus 252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 677777778877777643 2234556667777777777775
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.1e-09 Score=102.99 Aligned_cols=231 Identities=21% Similarity=0.219 Sum_probs=136.1
Q ss_pred CCCCcEEEccCCccccc----cccccCCCCCCCEEEcccCccee----------eCCCCCCCCCCCCEEEcccCcccccC
Q 039322 96 CSSLIRVRLNSNNLTGN----ISEALGIYPNLTFIDLSRNDFYG----------EISSNWGKCPKLGTLNVSMNNITGGI 161 (708)
Q Consensus 96 l~~L~~L~l~~n~i~~~----~~~~~~~~~~L~~L~l~~n~l~~----------~~~~~~~~l~~L~~L~L~~N~i~~~~ 161 (708)
+..+..++||+|.|... ..+.+.+-.+|+..++++-.... ....++.++|+|+.++||+|.+....
T Consensus 29 ~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~~ 108 (388)
T COG5238 29 MDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEF 108 (388)
T ss_pred hcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCccc
Confidence 45566666666666522 22334445566666666532211 11223456778888888888777555
Q ss_pred Ccc----ccCCCCCCEEecccccccccCCccc-------------CCCCCCCEEEccCccccccCC----cccCCCCCCC
Q 039322 162 PRE----IGNSSQLQALDLSLNHIVGEIPKEL-------------GKLNSLTELILRGNQFTGRLP----PEIGSLVDLE 220 (708)
Q Consensus 162 ~~~----~~~l~~L~~L~L~~n~l~~~~~~~~-------------~~l~~L~~L~l~~n~l~~~~~----~~~~~~~~L~ 220 (708)
|.. ++..+.|++|.|++|.+......-+ ..-|.|++.+...|++..-.. ..+..-..|+
T Consensus 109 ~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs~~~~a~~l~sh~~lk 188 (388)
T COG5238 109 PEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGSKELSAALLESHENLK 188 (388)
T ss_pred chHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCcHHHHHHHHHhhcCce
Confidence 443 3455778888888887752211111 234788888888888872221 1233335788
Q ss_pred eEeccCCcccccCC-----CCCCccccceeecccCcccccCC----ChhhhhhcccchhhcccccCCCCCchhhc-----
Q 039322 221 YLDLSANRFNNSVP-----ENLGNLLKLHYLGLSNNQFVLEL----PKELEKLVQLSELDASHNLFGGEIPFQIC----- 286 (708)
Q Consensus 221 ~L~l~~N~i~~~~~-----~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~ls~N~i~~~~~~~~~----- 286 (708)
.+.+..|.|.-... ..+..+.+|+.|||..|-++... ...++.++.|++|.+..|-++......+.
T Consensus 189 ~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e 268 (388)
T COG5238 189 EVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNE 268 (388)
T ss_pred eEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhccccHHHHHHHhhh
Confidence 88888888763211 12355678888888888886432 33456677788888888888765443332
Q ss_pred -CcccCCceecccccccCCCCCc-----c--cccccccEEecCCCcCC
Q 039322 287 -SLKSLEKLNLSHNNLSGSIPNC-----F--EGIRGISVIDISDNQLQ 326 (708)
Q Consensus 287 -~~~~L~~L~l~~N~l~~~~~~~-----~--~~l~~L~~l~l~~N~l~ 326 (708)
..|+|..|.+..|...+..-.. | ..+|-|..|.+.+|++.
T Consensus 269 ~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~ 316 (388)
T COG5238 269 KFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIK 316 (388)
T ss_pred hcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcch
Confidence 3477788888888665422111 1 13455555555555554
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.68 E-value=3e-09 Score=101.30 Aligned_cols=207 Identities=17% Similarity=0.071 Sum_probs=110.6
Q ss_pred cCCCCCCEEEeeCceeeeeCCCC-CCC--CCcccccccCCCccCC--CCccccCCCCccEEeccCCccccccCccC-cCC
Q 039322 23 SNLTNLKELVLLYNNLSGFIPPS-LEN--PMLTRPGLDFNHFTSY--LPHNVCRGGALQYFGVSENHFQGTIPKIL-RNC 96 (708)
Q Consensus 23 ~~l~~L~~L~L~~n~i~~~~~~~-~~~--~~l~~l~l~~n~~~~~--~~~~~~~l~~L~~L~l~~n~i~~~~~~~~-~~l 96 (708)
..+.-+..|.+.++.|.++-... |.. ..++.|++.+|.|+.| +..-+..++.|++|+|+.|.+.. ..+++ ..+
T Consensus 42 ~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s-~I~~lp~p~ 120 (418)
T KOG2982|consen 42 SSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSS-DIKSLPLPL 120 (418)
T ss_pred ccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCC-ccccCcccc
Confidence 33444557777777776543221 221 4577888888888765 44555677888888888888873 33344 356
Q ss_pred CCCcEEEccCCccc-cccccccCCCCCCCEEEcccCcceeeC--CCCCCCC-CCCCEEEcccCccccc--CCccccCCCC
Q 039322 97 SSLIRVRLNSNNLT-GNISEALGIYPNLTFIDLSRNDFYGEI--SSNWGKC-PKLGTLNVSMNNITGG--IPREIGNSSQ 170 (708)
Q Consensus 97 ~~L~~L~l~~n~i~-~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~~~l-~~L~~L~L~~N~i~~~--~~~~~~~l~~ 170 (708)
.+|++|.|.+..+. .-....+..+|.++.|++|.|.+.... ....... +.+++|.+..|..... ....-.-+++
T Consensus 121 ~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpn 200 (418)
T KOG2982|consen 121 KNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPN 200 (418)
T ss_pred cceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhccc
Confidence 77888888777665 222334566777788888877543211 1111111 2344444444432210 0111122355
Q ss_pred CCEEecccccccccCC-cccCCCCCCCEEEccCccccccCC-cccCCCCCCCeEeccCCccc
Q 039322 171 LQALDLSLNHIVGEIP-KELGKLNSLTELILRGNQFTGRLP-PEIGSLVDLEYLDLSANRFN 230 (708)
Q Consensus 171 L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~~~~L~~L~l~~N~i~ 230 (708)
+..+-+..|.|+.... ..+..+|.+.-|+|+.|+|..... +.+.++++|.-|.+++|.+.
T Consensus 201 v~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 201 VNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred chheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 5556666665553222 223344555556666665552211 23455555555555555554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.5e-07 Score=99.53 Aligned_cols=145 Identities=21% Similarity=0.234 Sum_probs=97.4
Q ss_pred ceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHh------------------------------------HHHHHH
Q 039322 442 YCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIAD------------------------------------QKEFLI 485 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~------------------------------------~~~~~~ 485 (708)
+.|+.++-|.||+|++++|+.||||+.+......-..+ .-.+..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999999999999999887532110000 012444
Q ss_pred HHHHHHhcc-----CCceeeEEEEEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 039322 486 EVKALTEIR-----HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADA-LSYLHHDC 559 (708)
Q Consensus 486 e~~~l~~l~-----h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~-l~~Lh~~~ 559 (708)
|..-+.+++ .+.+.-..-|++......++|||++|-.+.+...... ...+. ..++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~---k~ia~~~~~~f~~q~~~d- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDR---KELAELLVRAFLRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCH---HHHHHHHHHHHHHHHHhc-
Confidence 555555553 3444433444445566789999999988888742222 11332 3333334433 2333334
Q ss_pred CCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 560 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|++|.|.+|.||+++.+|.+-+.|||+.....+
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999886653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=8.9e-09 Score=109.91 Aligned_cols=150 Identities=21% Similarity=0.278 Sum_probs=102.7
Q ss_pred HHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcc---------ccccccccccCccccc
Q 039322 545 IKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW---------TEFAGTYGYVAPELAY 615 (708)
Q Consensus 545 ~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~---------~~~~~~~~y~aPE~~~ 615 (708)
+.+++.|+.|+|... ++||+.|.|++|.++..+..||+.|+++.....+.... ........|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 344569999999884 99999999999999999999999999987554422211 1123467999999999
Q ss_pred cCCCCcchhHHHHHHHHHHHH-hCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCC
Q 039322 616 TMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPE 694 (708)
Q Consensus 616 ~~~~~~~~DvwslG~~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 694 (708)
+...+.++|+||+|+++|.+. .|+.-+...+......... . ..+-... ....+.+.++.+=+.+++..++.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~--~---~~~~~~~---~~s~~~p~el~~~l~k~l~~~~~ 254 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR--N---LLNAGAF---GYSNNLPSELRESLKKLLNGDSA 254 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh--c---ccccccc---cccccCcHHHHHHHHHHhcCCcc
Confidence 988889999999999999999 4665554322111000000 0 0000000 00122334577778899999999
Q ss_pred CCCCHHHHHH
Q 039322 695 SRPTMKVVTQ 704 (708)
Q Consensus 695 ~RPs~~evl~ 704 (708)
.||++.++..
T Consensus 255 ~rp~~~~l~~ 264 (700)
T KOG2137|consen 255 VRPTLDLLLS 264 (700)
T ss_pred cCcchhhhhc
Confidence 9998877654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 708 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-37 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-31 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-31 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-30 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-22 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-30 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 8e-22 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-28 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-26 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-14 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-14 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-14 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-05 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 1e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-05 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 4e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 708 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-106 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-84 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 6e-78 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 8e-65 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-12 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-08 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-90 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-80 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-74 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-72 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-52 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-47 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-43 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 6e-40 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-05 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-65 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 9e-63 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-59 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-57 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 6e-41 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-28 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-60 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-60 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-56 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-53 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-28 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-09 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 6e-60 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-59 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-59 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-56 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-52 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-43 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 9e-37 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-35 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-29 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-22 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-07 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-55 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-54 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 6e-51 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-48 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-46 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 7e-46 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-38 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-37 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 9e-22 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-52 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-52 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-52 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-51 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-50 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-49 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-48 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-48 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-46 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-40 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 7e-29 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-25 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-48 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 9e-48 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 6e-47 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-46 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-46 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 6e-46 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 6e-38 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-36 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-21 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-45 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 9e-45 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-43 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 6e-39 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-44 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-44 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-43 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-41 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-40 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-39 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-34 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-33 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 6e-29 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-25 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-41 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 7e-37 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-34 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-27 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-26 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-12 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-07 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-39 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-39 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-38 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 7e-38 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-36 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-33 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-38 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-32 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 7e-17 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 7e-13 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-06 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 7e-37 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-35 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-34 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-33 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-26 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 6e-25 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 9e-37 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-33 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 9e-33 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 5e-31 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-13 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-36 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 5e-36 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-28 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 6e-25 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 5e-22 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-35 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-30 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-24 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-18 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-16 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-12 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-05 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 5e-35 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 8e-34 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-32 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-25 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-22 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-13 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-34 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-31 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-31 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-30 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 8e-30 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-24 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 7e-21 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-19 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-34 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-31 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-29 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-24 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-23 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-13 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-34 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-32 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-29 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-28 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-23 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 5e-34 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 9e-34 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-33 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 8e-28 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 4e-25 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 5e-19 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-33 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 3e-33 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-32 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-32 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 5e-32 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 8e-32 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 8e-32 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 9e-32 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 9e-32 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-31 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-31 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 7e-31 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-30 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-30 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-30 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-28 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-27 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 4e-25 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 6e-18 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 7e-30 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 8e-30 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-29 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-29 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 3e-29 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 6e-29 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 6e-29 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 8e-29 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-26 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-25 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-24 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-20 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-28 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-28 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-28 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-28 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-28 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-28 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-28 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-28 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 3e-28 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-28 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-28 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-28 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 4e-28 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 5e-28 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 5e-28 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 6e-28 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 6e-28 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 9e-28 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-27 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-27 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-27 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-27 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-27 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-27 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-27 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-27 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-27 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-27 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-27 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-27 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-27 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 6e-27 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 7e-23 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-22 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-12 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-06 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 6e-27 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 7e-27 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 8e-27 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-22 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-22 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-19 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-13 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 7e-10 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 8e-27 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-25 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 9e-18 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-14 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-11 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 8e-27 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-26 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-26 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-22 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 9e-11 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-26 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-26 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-26 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-26 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-18 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-18 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-12 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 7e-11 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 6e-26 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 7e-26 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 9e-26 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-25 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-25 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-25 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-25 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-25 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 5e-25 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 6e-25 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 6e-25 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 9e-25 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-24 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-24 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-24 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-24 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-24 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 4e-24 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 4e-24 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-20 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-15 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-24 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-22 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 7e-17 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 5e-24 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-24 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 7e-24 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 7e-24 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 8e-24 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-23 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-23 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-23 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-23 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-23 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-23 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-20 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-18 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-16 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-15 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 5e-10 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 6e-05 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-23 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 6e-21 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-23 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-23 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-23 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-23 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-23 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 5e-23 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 5e-23 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 6e-23 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 7e-23 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 7e-23 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 8e-23 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 8e-23 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-22 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-22 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-22 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-18 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-14 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-06 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-22 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 8e-17 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 6e-14 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-13 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-22 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-22 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-22 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-20 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-20 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-11 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-22 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 4e-22 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 5e-22 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 5e-22 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 6e-22 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 6e-22 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 7e-22 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-21 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-21 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-21 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-21 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-21 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-21 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 6e-21 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 6e-21 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-16 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 4e-10 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 7e-21 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-20 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-20 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 7e-20 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-15 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-13 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-13 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-20 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 5e-20 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 5e-20 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 7e-20 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-19 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 9e-19 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-18 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-18 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-14 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 6e-11 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 5e-18 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 7e-18 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 8e-18 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-17 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-17 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-17 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-17 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 5e-15 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-08 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 7e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 4e-15 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-04 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 7e-17 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-13 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-11 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 7e-17 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 9e-17 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-15 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 9e-12 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-08 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-16 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-15 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-11 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-11 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 6e-10 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-16 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-16 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-16 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-16 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-16 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 5e-07 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 6e-07 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-05 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 4e-16 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-16 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-14 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-11 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-08 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-06 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 5e-16 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 6e-16 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 7e-16 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 9e-16 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 9e-16 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-15 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-15 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 4e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 4e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-11 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 6e-09 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 5e-15 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 6e-15 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 8e-15 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-14 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 5e-10 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-09 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-14 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-14 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-14 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-14 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-14 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 4e-14 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 6e-13 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 5e-12 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 5e-07 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-14 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 6e-14 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 7e-14 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 7e-14 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 9e-14 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-13 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-13 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-13 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-13 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-13 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-13 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 4e-13 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 5e-13 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 5e-13 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 5e-13 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 5e-13 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 9e-13 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-12 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-12 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-12 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-12 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-12 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-12 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-12 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-12 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 5e-12 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-11 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-11 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-11 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-05 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-05 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-11 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-11 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-11 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 9e-11 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-04 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 8e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 7e-07 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-10 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-09 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-06 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-10 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 5e-10 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 6e-08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 7e-06 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 5e-10 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 9e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-05 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 4e-06 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-09 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-09 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-08 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-04 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-09 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 4e-09 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 5e-09 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 5e-09 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 6e-09 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 7e-09 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 8e-09 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 8e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 9e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 3e-05 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-04 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-05 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 1e-08 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 5e-04 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 2e-08 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 2e-07 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 3e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 8e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-04 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-08 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-08 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-05 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-08 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-04 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-04 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 4e-08 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 4e-08 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 6e-08 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 7e-08 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-07 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 2e-07 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-07 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 3e-07 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 1e-05 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 3e-04 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 7e-07 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 5e-05 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 8e-04 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 9e-07 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 9e-07 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 4e-04 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-06 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 2e-06 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 9e-06 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 1e-05 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 3e-06 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 4e-06 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-05 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 4e-05 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 6e-05 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 1e-04 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 8e-04 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 1e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 339 bits (871), Expect = e-106
Identities = 106/355 (29%), Positives = 159/355 (44%), Gaps = 7/355 (1%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
+L L L N F G +PP++SN + L L L +N LSG IP SL + L L N
Sbjct: 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLN 452
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
+P + L+ + N G IP L NC++L + L++N LTG I + +G
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
NL + LS N F G I + G C L L+++ N G IP + S ++ N
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAAN 568
Query: 180 HIVGEIPKELGKLNSLTELILRGN--QFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENL 237
I G+ + E GN +F G ++ L ++++ +
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628
Query: 238 GNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLS 297
N + +L +S N +PKE+ + L L+ HN G IP ++ L+ L L+LS
Sbjct: 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLS 688
Query: 298 HNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGG 352
N L G IP + ++ ID+S+N L GP+P F P N GLCG
Sbjct: 689 SNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGY 743
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 4e-84
Identities = 107/360 (29%), Positives = 163/360 (45%), Gaps = 28/360 (7%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVS-NLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDF 58
++SL L L +N+F G +P +S L L L N+ G +PP + +L L
Sbjct: 268 LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS 327
Query: 59 NHFTSYLPHNV-CRGGALQYFGVSENHFQGTIPKILRNCS-SLIRVRLNSNNLTGNISEA 116
N+F+ LP + + L+ +S N F G +P+ L N S SL+ + L+SNN +G I
Sbjct: 328 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387
Query: 117 LGIYP--NLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQAL 174
L P L + L N F G+I C +L +L++S N ++G IP +G+ S+L+ L
Sbjct: 388 LCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDL 447
Query: 175 DLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVP 234
L LN + GEIP+EL + +L LIL N TG +P + + +L ++ LS NR +P
Sbjct: 448 KLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507
Query: 235 ENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKL 294
+ +G L L L LSNN F +P EL L LD + NLF G IP +
Sbjct: 508 KWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAA 567
Query: 295 NL----------------------SHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNS 332
N + G + + +I+ G +
Sbjct: 568 NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 6e-78
Identities = 92/339 (27%), Positives = 151/339 (44%), Gaps = 14/339 (4%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFT 62
S+ + N + S+ +LT L+ L L ++++G + + LT L N +
Sbjct: 54 SIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLS 113
Query: 63 SYLPHNVCRGG--ALQYFGVSENHFQGTIPK-ILRNCSSLIRVRLNSNNLTGNISEALGI 119
+ G L++ VS N +SL + L++N+++G +
Sbjct: 114 GPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVL 173
Query: 120 Y---PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDL 176
L + +S N G++ +C L L+VS NN + GIP +G+ S LQ LD+
Sbjct: 174 SDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDI 230
Query: 177 SLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPEN 236
S N + G+ + + L L + NQF G +PP L L+YL L+ N+F +P+
Sbjct: 231 SGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDF 288
Query: 237 L-GNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQ-ICSLKSLEKL 294
L G L L LS N F +P L L S N F GE+P + ++ L+ L
Sbjct: 289 LSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVL 348
Query: 295 NLSHNNLSGSIPNCFEGIRG-ISVIDISDNQLQGPVPNS 332
+LS N SG +P + + +D+S N GP+ +
Sbjct: 349 DLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 8e-65
Identities = 71/287 (24%), Positives = 129/287 (44%), Gaps = 13/287 (4%)
Query: 54 PGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNI 113
N S + ++ L+ +S +H G++ +SL + L+ N+L+G +
Sbjct: 58 SSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFK-CSASLTSLDLSRNSLSGPV 116
Query: 114 SEALGIY--PNLTFIDLSRNDFYGEISSNWG-KCPKLGTLNVSMNNITGGIPREI---GN 167
+ + L F+++S N + G K L L++S N+I+G
Sbjct: 117 TTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDG 176
Query: 168 SSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSAN 227
+L+ L +S N I G++ + + +L L + N F+ +P +G L++LD+S N
Sbjct: 177 CGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGN 233
Query: 228 RFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQIC- 286
+ + + +L L +S+NQFV +P L L L + N F GEIP +
Sbjct: 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSG 291
Query: 287 SLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNST 333
+ +L L+LS N+ G++P F + + +S N G +P T
Sbjct: 292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDT 338
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 1e-12
Identities = 22/103 (21%), Positives = 36/103 (34%), Gaps = 3/103 (2%)
Query: 236 NLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLN 295
+ + N + L L L L S++ G + SL L+
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106
Query: 296 LSHNNLSGSIPNCFE--GIRGISVIDISDNQLQGPVPNSTAFR 336
LS N+LSG + G+ +++S N L P S +
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLK 149
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-08
Identities = 19/74 (25%), Positives = 37/74 (50%), Gaps = 1/74 (1%)
Query: 264 LVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDN 323
+ + N+ + + SL LE L LS+++++GS+ F+ ++ +D+S N
Sbjct: 52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRN 110
Query: 324 QLQGPVPNSTAFRN 337
L GPV T+ +
Sbjct: 111 SLSGPVTTLTSLGS 124
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 2e-90
Identities = 94/288 (32%), Positives = 150/288 (52%), Gaps = 17/288 (5%)
Query: 428 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEV 487
E+ A+++F + +G GG G VY+ L G +VA+K+ Q + +F EV
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE--RTQ-GGELQFQTEV 78
Query: 488 KALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQE-LGWSQRMNVIK 546
+ ++ HRN+++ GFC LVY + GS+A+ L +Q L W +R +
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 547 GVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN-WTEFAGT 605
G A L+YLH C P I+H+D+ + N+LLD E+EA V DFG+AK + + ++ T GT
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 198
Query: 606 YGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN---------TD 656
G++APE T K +EK DV+ +GV++LE I G+ D L + + +
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 657 IALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTM-KVVT 703
L+ ++D L E++ +++VA C SP RP M +VV
Sbjct: 259 KKLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 257 bits (660), Expect = 2e-80
Identities = 97/318 (30%), Positives = 152/318 (47%), Gaps = 29/318 (9%)
Query: 400 KSDSGDRQSSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPS 459
S S N + + ++ ++ ATN+FD ++ IG+G G VY+ L
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 460 GQVVAIKKFHSPLPCDQIADQ--KEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYEL 517
G VA+K+ + Q +EF E++ L+ RH ++V GFC L+Y+
Sbjct: 63 GAKVALKR------RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY 116
Query: 518 LERGSLAAILS-SDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD 576
+E G+L L SD + W QR+ + G A L YLH I+H+D+ S N+LLD
Sbjct: 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLD 173
Query: 577 LEYEAHVADFGIAKFLKPESSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVL 633
+ + DFGI+K E T GT GY+ PE ++TEK DVYSFGV++
Sbjct: 174 ENFVPKITDFGISK-KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLF 232
Query: 634 EAIKGKH------PRDFLSLIS-SSSLNTDIALDEILDPRLP--PPSRSVQEKLISIMEV 684
E + + PR+ ++L + + + L++I+DP L S+++ +
Sbjct: 233 EVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK----FGDT 288
Query: 685 AFSCLNESPESRPTMKVV 702
A CL S E RP+M V
Sbjct: 289 AVKCLALSSEDRPSMGDV 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 2e-74
Identities = 85/292 (29%), Positives = 143/292 (48%), Gaps = 25/292 (8%)
Query: 428 YDEIVRATNDFDAQYC------IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQK 481
+ E+ TN+FD + +G GG G VY+ + VA+KK + + ++
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQ 75
Query: 482 EFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQR 541
+F E+K + + +H N+V+ GF S LVY + GSL LS L W R
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 542 MNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW-- 599
+ +G A+ +++LH + +H+DI S N+LLD + A ++DFG+A+ + +
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR-ASEKFAQTVM 191
Query: 600 -TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDF------LSLISSSS 652
+ GT Y+APE A +IT K D+YSFGV++LE I G D L I
Sbjct: 192 TSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI 250
Query: 653 LNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK-VVT 703
+ + +++ +D ++ + + + ++ VA CL+E RP +K V
Sbjct: 251 EDEEKTIEDYIDKKM---NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 1e-72
Identities = 75/357 (21%), Positives = 126/357 (35%), Gaps = 79/357 (22%)
Query: 7 LDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSG--FIPPSLENPMLTRPGLDFNHFTSY 64
D + GVL + + + L L NL IP SL N
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLAN---------------- 74
Query: 65 LPHNVCRGGALQYFGVS-ENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNL 123
LP+ L + + N+ G IP + + L + + N++G I + L L
Sbjct: 75 LPY-------LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 124 TFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQL-QALDLSLNHIV 182
+D S N G + + P L + N I+G IP G+ S+L ++ +S N +
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 183 GEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLK 242
G+IP LN L + L N G GS + + + L+ N
Sbjct: 188 GKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA------------ 234
Query: 243 LHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS 302
++ ++ K+L L+L +N +
Sbjct: 235 ------------------------------------FDLG-KVGLSKNLNGLDLRNNRIY 257
Query: 303 GSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKGMQPC 359
G++P ++ + +++S N L G +P + V A NK LCG + C
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS--PLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-52
Identities = 61/229 (26%), Positives = 95/229 (41%), Gaps = 27/229 (11%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
+ L L + G +P +S + L L YN LSG +PPS+ +
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS------------ 147
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRV-RLNSNNLTGNISEALGI 119
LP+ L N G IP + S L ++ N LTG I
Sbjct: 148 ----LPN-------LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA- 195
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
NL F+DLSRN G+ S +G ++++ N++ + ++G S L LDL N
Sbjct: 196 NLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNN 254
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANR 228
I G +P+ L +L L L + N G + P+ G+L + + N+
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-47
Identities = 53/198 (26%), Positives = 81/198 (40%), Gaps = 10/198 (5%)
Query: 139 SNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGE--IPKELGKLNSLT 196
S+W L T + G + + ++ LDLS ++ IP L L L
Sbjct: 25 SSW-----LPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79
Query: 197 ELILRG-NQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVL 255
L + G N G +PP I L L YL ++ + ++P+ L + L L S N
Sbjct: 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG 139
Query: 256 ELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSL-EKLNLSHNNLSGSIPNCFEGIRG 314
LP + L L + N G IP S L + +S N L+G IP F +
Sbjct: 140 TLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN- 198
Query: 315 ISVIDISDNQLQGPVPNS 332
++ +D+S N L+G
Sbjct: 199 LAFVDLSRNMLEGDASVL 216
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 58/214 (27%), Positives = 87/214 (40%), Gaps = 29/214 (13%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
+++L LD + N G LPPS+S+L NL + N +SG IP S + L
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL-------- 175
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
+S N G IP N +L V L+ N L G+ S G
Sbjct: 176 ---------------FTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGS 219
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
N I L++N ++ G L L++ N I G +P+ + L +L++S N
Sbjct: 220 DKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFT--GRLPP 211
++ GEIP+ G L N+ LP
Sbjct: 279 NLCGEIPQG-GNLQRFDVSAYANNKCLCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-40
Identities = 44/180 (24%), Positives = 79/180 (43%), Gaps = 8/180 (4%)
Query: 161 IPREIGNSSQLQ----ALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGR--LPPEIG 214
I +++GN + L D +G + + + L L G +P +
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 215 SLVDLEYLDLS-ANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDAS 273
+L L +L + N +P + L +LHYL +++ +P L ++ L LD S
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 274 HNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRG-ISVIDISDNQLQGPVPNS 332
+N G +P I SL +L + N +SG+IP+ + + + IS N+L G +P +
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 3e-05
Identities = 20/85 (23%), Positives = 35/85 (41%), Gaps = 7/85 (8%)
Query: 255 LELPKELEKLVQLS----ELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGS--IPNC 308
L++ K+L LS D + + G + + L+LS NL IP+
Sbjct: 12 LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSS 71
Query: 309 FEGIRGISVIDISD-NQLQGPVPNS 332
+ ++ + I N L GP+P +
Sbjct: 72 LANLPYLNFLYIGGINNLVGPIPPA 96
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 3e-65
Identities = 68/304 (22%), Positives = 120/304 (39%), Gaps = 45/304 (14%)
Query: 428 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEV 487
+ + + G G V++A+L + VA+K F Q + EV
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPI-----QDKQSWQNEYEV 69
Query: 488 KALTEIRHRNIVKFYGFCSHARHS----FLVYELLERGSLAAILSSDTAAQELGWSQRMN 543
+L ++H NI++F G +L+ E+GSL+ L ++ + W++ +
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCH 125
Query: 544 VIKGVADALSYLHHDCF-------PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596
+ + +A L+YLH D P I H+DI SKN+LL A +ADFG+A +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 597 SNW--TEFAGTYGYVAPELA-----YTMKITEKCDVYSFGVLVLEAIKGKHPRDFLS--- 646
S GT Y+APE+ + + D+Y+ G+++ E D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 647 -LISSSSLNTDIALDEI--------LDPRLPP--PSRSVQEKLISIMEVAFSCLNESPES 695
L + +L+++ P L + L +E C + E+
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE---ECWDHDAEA 302
Query: 696 RPTM 699
R +
Sbjct: 303 RLSA 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 9e-63
Identities = 55/365 (15%), Positives = 115/365 (31%), Gaps = 39/365 (10%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPG----- 55
++ L+ +++ LP + L ++ + + N + L
Sbjct: 248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKI 307
Query: 56 ----LDFNHFTSY-LPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLT 110
+ +N+ ++ + ++ + L N +G +P + L + L N +T
Sbjct: 308 QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASLNLAYNQIT 366
Query: 111 GNISEALGIYPNLTFIDLSRNDFYG-EISSNWGKCPKLGTLNVSMNNITG-------GIP 162
+ G + + + N + + ++ S N I +
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
Query: 163 REIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTG-------RLPPEIGS 215
+ +++LS N I + + L+ + L GN T +
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486
Query: 216 LVDLEYLDLSANRFNNSVPENL--GNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDAS 273
L +DL N+ + ++ L L + LS N F + P + L
Sbjct: 487 TYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLKGFGIR 544
Query: 274 HNL------FGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQG 327
+ E P I SL +L + N++ + ISV+DI DN
Sbjct: 545 NQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNIS 601
Query: 328 PVPNS 332
+
Sbjct: 602 IDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-59
Identities = 62/335 (18%), Positives = 114/335 (34%), Gaps = 36/335 (10%)
Query: 1 MRSLSILDLNQNQFKGV-LPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDF 58
+ I+ + N K + S+ + L L LYN L G P+ + L L +
Sbjct: 304 GEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAY 362
Query: 59 NHFTSYLPHNVCRG-GALQYFGVSENHFQGTIPKIL--RNCSSLIRVRLNSNNLTG---- 111
N T +P N C ++ + N + IP I ++ S + + + N +
Sbjct: 363 NQITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGK 420
Query: 112 ---NISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITG-------GI 161
+ N++ I+LS N + L ++N+ N +T
Sbjct: 421 NFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDE 480
Query: 162 PREIGNSSQLQALDLSLNHIVGEIPKEL--GKLNSLTELILRGNQFTGRLPPEIGSLVDL 219
N+ L ++DL N + + + L L + L N F+ P + + L
Sbjct: 481 NENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538
Query: 220 EYL------DLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDAS 273
+ D NR PE + L L + +N ++ +++ +S LD
Sbjct: 539 KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIK 595
Query: 274 HNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNC 308
N +C L ++ I C
Sbjct: 596 DNPNISIDLSYVCPYIEAGMYMLFYDKTQ-DIRGC 629
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-57
Identities = 55/348 (15%), Positives = 119/348 (34%), Gaps = 38/348 (10%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
++ L L G +P ++ LT L+ L L +
Sbjct: 80 NGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFG-------------- 125
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKIL--RNCSSLIRVRLNSNNLTGNISEALG 118
P + + + H+Q T + S LI+ +NS+ +I ++
Sbjct: 126 -----PKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180
Query: 119 IYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSL 178
I T I N+ +S + KL + + E + +
Sbjct: 181 ITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEY 234
Query: 179 NHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRF--------N 230
+ L LT++ + +LP + +L +++ ++++ NR +
Sbjct: 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDD 294
Query: 231 NSVPENLGNLLKLHYLGLSNNQF-VLELPKELEKLVQLSELDASHNLFGGEIPFQICSLK 289
+ K+ + + N + L+K+ +L L+ +N G++P S
Sbjct: 295 WQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEI 353
Query: 290 SLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRN 337
L LNL++N ++ N + + + N+L+ +PN ++
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKS 400
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-41
Identities = 32/255 (12%), Positives = 70/255 (27%), Gaps = 21/255 (8%)
Query: 93 LRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYG----EISSNWGKCPKLG 148
L + + + L +G + +A+G L + L +
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 149 TLNVSMNNITGGIPREIG--NSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFT 206
+ + S L ++ + I K T++ N T
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 207 GRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQ 266
+ + L L + + F Y + + L
Sbjct: 197 F-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----EDLKWDNLKD 250
Query: 267 LSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNL--------SGSIPNCFEGIRGISVI 318
L++++ + ++P + +L ++ +N++ N I +I
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310
Query: 319 DISDNQLQ-GPVPNS 332
I N L+ PV S
Sbjct: 311 YIGYNNLKTFPVETS 325
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-28
Identities = 25/241 (10%), Positives = 75/241 (31%), Gaps = 33/241 (13%)
Query: 117 LGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDL 176
I+ L + S+ F + +NW N ++ + ++ ++ L L
Sbjct: 36 KEIWDALNGKNWSQQGFGTQPGANW-------NFNKELDMWGAQPGVSLNSNGRVTGLSL 88
Query: 177 SLNHIVGEIPKELGKLNSLTELILRGNQFTG----RLPPEIGSLVDLEYLDLSANRFNNS 232
G +P +G+L L L L + P I + + E + +
Sbjct: 89 EGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKT 148
Query: 233 VPENLG--NLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKS 290
+ + L ++++ + K ++ +++ N + + L
Sbjct: 149 FVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTK 207
Query: 291 LEKLNLSHNNLSG-------------------SIPNCFEGIRGISVIDISDNQLQGPVPN 331
L + + ++ + ++ ++ ++ +++ + +P
Sbjct: 208 LRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267
Query: 332 S 332
Sbjct: 268 F 268
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 1e-60
Identities = 74/360 (20%), Positives = 124/360 (34%), Gaps = 17/360 (4%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNH 60
++++L+L NQ + + + + + L L + +N +S P + PML L N
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
+ L + N Q +LI + L+ N L+
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144
Query: 121 PNLTFIDLSRNDFYGEISS--NWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSL 178
NL + LS N S + L L +S N I P +L L L+
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN 204
Query: 179 NHIVGEIPKELG---KLNSLTELILRGNQFTGRLPPEIGSL--VDLEYLDLSANRFNNSV 233
+ + ++L S+ L L +Q + L +L LDLS N N
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264
Query: 234 PENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEI---------PFQ 284
++ L +L Y L N L L + L+ + I F
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324
Query: 285 ICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALK 344
LK LE LN+ N++ G N F G+ + + +S++ + F + L
Sbjct: 325 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 3e-60
Identities = 72/363 (19%), Positives = 118/363 (32%), Gaps = 26/363 (7%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYN---------NLSGFIPPSLEN-PM 50
+ L L N + + S+ L N++ L L + +L S +
Sbjct: 271 LPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKC 330
Query: 51 LTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGT--IPKILRNC--SSLIRVRLNS 106
L ++ N + L+Y +S + + + S L + L
Sbjct: 331 LEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTK 390
Query: 107 NNLTGNISEALGIYPNLTFIDLSRNDFYGEISSN-WGKCPKLGTLNVSMNNITGGIPREI 165
N ++ S+A +L +DL N+ E++ W + + +S N
Sbjct: 391 NKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSF 450
Query: 166 GNSSQLQALDLSLNHI--VGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLD 223
LQ L L + V P L +LT L L N + L LE LD
Sbjct: 451 ALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILD 510
Query: 224 LSANR--------FNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHN 275
L N L L LH L L +N F + + L +L +D N
Sbjct: 511 LQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLN 570
Query: 276 LFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGI-RGISVIDISDNQLQGPVPNSTA 334
+ SL+ LNL N ++ F R ++ +D+ N +
Sbjct: 571 NLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAW 630
Query: 335 FRN 337
F N
Sbjct: 631 FVN 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 6e-56
Identities = 66/358 (18%), Positives = 121/358 (33%), Gaps = 22/358 (6%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
+ L +L+L N+ + + + TNL EL L+ N++ L L N
Sbjct: 72 LPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHN 131
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILR--NCSSLIRVRLNSNNLTGNISEAL 117
+S + LQ +S N Q + L SSL ++ L+SN +
Sbjct: 132 GLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191
Query: 118 GIYPNLTFIDLSRNDFYGEISSNWG---KCPKLGTLNVSMNNITGGIPREIGN--SSQLQ 172
L + L+ ++ + L++S + ++ + L
Sbjct: 192 HAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLT 251
Query: 173 ALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNS 232
LDLS N++ L L L N + L ++ YL+L + S
Sbjct: 252 MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQS 311
Query: 233 VPEN---------LGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIP- 282
+ L L +L + +N L+ L L S++
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371
Query: 283 ---FQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRN 337
F + L LNL+ N +S + F + + V+D+ N++ + +R
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ-EWRG 428
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 3e-53
Identities = 72/348 (20%), Positives = 122/348 (35%), Gaps = 22/348 (6%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHF 61
S + D + + V P + TN+ L L +N L + LT + FN
Sbjct: 5 SHEVADCSHLKLTQV-PDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 62 TSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
+ L +C+ L+ + N K C++L + L SN++ +
Sbjct: 62 SK-LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIG--NSSQLQALDLSL 178
NL +DLS N + L L +S N I E+ +S L+ L+LS
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 179 NHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIG---SLVDLEYLDLSANRFNNSVPE 235
N I P + L L L Q L ++ + + L LS ++ + +
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 236 NLGNL--LKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEK 293
L L L LS N + L QL +N + L ++
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300
Query: 294 LNLSHN---------NLSGSIPNCFEGIRGISVIDISDNQLQGPVPNS 332
LNL + +L F+ ++ + +++ DN + G N
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNM 348
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-28
Identities = 37/170 (21%), Positives = 60/170 (35%), Gaps = 3/170 (1%)
Query: 168 SSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSAN 227
+ + D S + ++P +L ++T L L NQ L LD+ N
Sbjct: 3 TVSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 228 RFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICS 287
+ PE L L L L +N+ K L+EL N
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 288 LKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRN 337
K+L L+LSHN LS + + + + +S+N++Q
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFA 169
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 27/116 (23%), Positives = 39/116 (33%), Gaps = 4/116 (3%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
+ L IL+L N F + +L LK + L NNL+ N L L N
Sbjct: 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594
Query: 60 HFTSYLPHNVCRGG--ALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNI 113
TS + V L + N F T I + + N L+ +
Sbjct: 595 LITS-VEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 6e-60
Identities = 69/263 (26%), Positives = 127/263 (48%), Gaps = 22/263 (8%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
+G G G V +A+ + VAIK+ S +++K F++E++ L+ + H NIVK YG
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESE------SERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563
C + LV E E GSL +L + M+ + ++YLH +
Sbjct: 69 ACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 564 VHQDISSKNLLLDLEYE-AHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEK 622
+H+D+ NLLL + DFG A ++ ++ T G+ ++APE+ +EK
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 623 CDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIM 682
CDV+S+G+++ E I + P D + + + + + PP +++ + + S+M
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAF------RIMWAVHNGTRPPLIKNLPKPIESLM 237
Query: 683 EVAFSCLNESPESRPTMKVVTQQ 705
C ++ P RP+M+ + +
Sbjct: 238 T---RCWSKDPSQRPSMEEIVKI 257
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-59
Identities = 80/262 (30%), Positives = 125/262 (47%), Gaps = 14/262 (5%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
IG G G+V+RAE G VA+K + EFL EV + +RH NIV F G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERV--NEFLREVAIMKRLRHPNIVLFMG 101
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563
+ + +V E L RGSL +L A ++L +R+++ VA ++YLH+ PPI
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKC 623
VH+++ S NLL+D +Y V DFG+++ + AGT ++APE+ EK
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 624 DVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIME 683
DVYSFGV++ E + P L+ + + R++ ++ +I+E
Sbjct: 221 DVYSFGVILWELATLQQPWGNLN-------PAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273
Query: 684 VAFSCLNESPESRPTMKVVTQQ 705
C P RP+ +
Sbjct: 274 ---GCWTNEPWKRPSFATIMDL 292
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-59
Identities = 72/270 (26%), Positives = 114/270 (42%), Gaps = 25/270 (9%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
IG GG G VYRA G VA+K D + E K ++H NI+ G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563
C + LV E G L +LS + + +N +A ++YLH + PI
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 564 VHQDISSKNLLLDLEYEAH--------VADFGIAKFLKPESSNWTEFAGTYGYVAPELAY 615
+H+D+ S N+L+ + E + DFG+A+ + AG Y ++APE+
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAAGAYAWMAPEVIR 187
Query: 616 TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQ 675
++ DV+S+GVL+ E + G+ P + +A ++ P +
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGID-------GLAVAYGVAMNKLALPIPSTCP 240
Query: 676 EKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
E +ME C N P SRP+ + Q
Sbjct: 241 EPFAKLME---DCWNPDPHSRPSFTNILDQ 267
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 205 bits (522), Expect = 4e-56
Identities = 59/381 (15%), Positives = 119/381 (31%), Gaps = 42/381 (11%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGF---------IPPSLEN-PM 50
++ L+ ++L LP + +L L+ L + N + + P
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549
Query: 51 LTRPGLDFNHFTSYLPHNVCRGG--ALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNN 108
+ + +N+ P + L N + L ++L+ N
Sbjct: 550 IQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQ 606
Query: 109 LTGNISEALGIYPNLTFIDLSRNDFYG-EISSNWGKCPKLGTLNVSMNNITG-----GIP 162
+ + + + S N N +G+++ S N I
Sbjct: 607 IEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCS 666
Query: 163 REIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFT-------GRLPPEIGS 215
+ + LS N I + + ++ +IL N T +
Sbjct: 667 MDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKN 726
Query: 216 LVDLEYLDLSANRFNNSVPENL--GNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDAS 273
L +DL N+ S+ ++ L L + +S N F P + QL
Sbjct: 727 TYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIR 784
Query: 274 HNLFG------GEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQL-Q 326
H + P I + SL +L + N++ + + + ++DI+DN
Sbjct: 785 HQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDE--KLTPQLYILDIADNPNIS 841
Query: 327 GPVPNSTAFRNAPVEALKGNK 347
V + + A + L +K
Sbjct: 842 IDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 4e-52
Identities = 63/351 (17%), Positives = 115/351 (32%), Gaps = 30/351 (8%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPP-SLENPMLTRPGLDFN 59
++ L L KG +P ++ LT LK L ++ + E +
Sbjct: 322 NGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKH 381
Query: 60 HFTSYLPHNVCRGG-ALQYFGVSENHFQ-----GTIPKILRNCSSLIRVRLNSNNLTGNI 113
+ L + ++ I K R ++ +N +T I
Sbjct: 382 RIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-I 440
Query: 114 SEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQA 173
S+A+ L I + + F + N N L
Sbjct: 441 SKAIQRLTKLQIIYFANSPFTYDN-----IAVDWEDANSDYAKQYENEELSWSNLKDLTD 495
Query: 174 LDLSLNHIVGEIPKELGKLNSLTELILRGNQFTG---------RLPPEIGSLVDLEYLDL 224
++L + ++P L L L L + N+ RL + + ++ +
Sbjct: 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYM 555
Query: 225 SANRFNNSVPE-NLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPF 283
N +L ++KL L +N+ + + V+L++L +N EIP
Sbjct: 556 GYNNLEEFPASASLQKMVKLGLLDCVHNK--VRHLEAFGTNVKLTDLKLDYNQI-EEIPE 612
Query: 284 QICS-LKSLEKLNLSHNNLSGSIPNCFE--GIRGISVIDISDNQLQGPVPN 331
C+ +E L SHN L IPN F + + +D S N++ N
Sbjct: 613 DFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRN 662
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 4e-43
Identities = 55/344 (15%), Positives = 107/344 (31%), Gaps = 28/344 (8%)
Query: 12 NQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVC 70
+ + + N + L L G +P ++ L + T
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 71 RGGALQYFGVSENHFQGTIPKILR------NCSSLIRVRLNSNNLTGNISEALGIYPNLT 124
++ + K+ N S L++ +N N I + I T
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428
Query: 125 FIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGE 184
I N IS + KL + + + T + + +
Sbjct: 429 QIGNLTNRI-TFISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAKQYEN 482
Query: 185 IPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFN---------NSVPE 235
L LT++ L +LP + L +L+ L+++ NR + +
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLAD 542
Query: 236 NLGNLLKLHYLGLSNNQFVLELPKE--LEKLVQLSELDASHNLFGGEIPFQICSLKSLEK 293
+ K+ + N E P L+K+V+L LD HN + + L
Sbjct: 543 DEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKV-RHLEA-FGTNVKLTD 599
Query: 294 LNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRN 337
L L +N + + + + S N+L+ +PN ++
Sbjct: 600 LKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKS 642
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-37
Identities = 41/359 (11%), Positives = 109/359 (30%), Gaps = 48/359 (13%)
Query: 18 LPPSVSNLTNLKELVLLYNNLSGF-------IPPSLENPMLTRPGLDFNHFTSYLPHNVC 70
L + + + K L ++ L G + + + + + + ++
Sbjct: 261 LKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLD 320
Query: 71 RGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSR 130
G + ++ +G +P + + L + +++ T + + +
Sbjct: 321 NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380
Query: 131 NDFYGEISSNWGKCP-KLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVG------ 183
+ + +L ++ + I E+ + + L I
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRIT 438
Query: 184 EIPKELGKLNSLTELILRGNQFTG-------------------RLPPEIGSLVDLEYLDL 224
I K + +L L + + FT +L DL ++L
Sbjct: 439 FISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL 498
Query: 225 SANRFNNSVPENLGNLLKLHYLGLSNNQFV---------LELPKELEKLVQLSELDASHN 275
+P+ L +L +L L ++ N+ + L + + ++ +N
Sbjct: 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYN 558
Query: 276 LFGG-EIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNST 333
+ + L L+ HN + + F ++ + + NQ++ +P
Sbjct: 559 NLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEE-IPEDF 614
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-35
Identities = 38/275 (13%), Positives = 81/275 (29%), Gaps = 22/275 (8%)
Query: 78 FGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEI 137
F + + L N + + L G + +A+G L + +
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 138 SSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQ-LQALDLSLNHI-----VGEIPKELGK 191
+ + I + + Q L DL + I + I K+
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI 423
Query: 192 LNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNN 251
T++ N+ T + I L L+ + + + F Y N
Sbjct: 424 SLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN 482
Query: 252 QFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSG-------- 303
L L++++ + ++P + L L+ LN++ N
Sbjct: 483 -----EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW 537
Query: 304 -SIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRN 337
+ + + I + + N L+ P S + +
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQK 571
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-29
Identities = 30/242 (12%), Positives = 70/242 (28%), Gaps = 14/242 (5%)
Query: 107 NNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIG 166
+ L +T + L+ G + G+ +L L+ ++ T
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 167 NSSQLQALDLSLNHIVGEIPKE-LGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLS 225
+ + I K L L L + PE+ + + L
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLK 426
Query: 226 ANRFNN------SVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGG 279
+ N + + + L KL + +N+ F V + ++ +
Sbjct: 427 DTQIGNLTNRITFISKAIQRLTKLQIIYFANSPF-----TYDNIAVDWEDANSDYAKQYE 481
Query: 280 EIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAP 339
+LK L + L + +P+ + + ++I+ N+ +
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA 541
Query: 340 VE 341
+
Sbjct: 542 DD 543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 27/256 (10%), Positives = 79/256 (30%), Gaps = 27/256 (10%)
Query: 102 VRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGI 161
V + I + + +D +Y +N N ++
Sbjct: 257 VPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNF-NKELDMWGDQP 315
Query: 162 PREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEY 221
++ N+ ++ L L+ G +P +G+L L L + T + +
Sbjct: 316 GVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDM 375
Query: 222 LDLSANRFNNSVPEN-LGNLLKLHYLGLSNNQF-----VLELPKELEKLVQLSELDASHN 275
+ +R + L +L+ L + + + K+ ++ +++ N
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTN 435
Query: 276 LFGGEIPFQICSLKSLEKLNLSHNNLSG-------------------SIPNCFEGIRGIS 316
I I L L+ + +++ + + + ++ ++
Sbjct: 436 RITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLT 494
Query: 317 VIDISDNQLQGPVPNS 332
+++ + +P+
Sbjct: 495 DVELYNCPNMTQLPDF 510
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 17/153 (11%), Positives = 50/153 (32%), Gaps = 1/153 (0%)
Query: 191 KLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSN 250
KL + ++ + + E LD R+ + N + L +
Sbjct: 250 KLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKEL 308
Query: 251 NQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFE 310
+ + + +L+ +++ L + G +P I L L+ L+ ++ + S +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 311 GIRGISVIDISDNQLQGPVPNSTAFRNAPVEAL 343
+ + ++++ + +
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLS 401
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 1e-55
Identities = 73/273 (26%), Positives = 119/273 (43%), Gaps = 27/273 (9%)
Query: 444 IGNGGHGSVYRAELPS-GQVVAIKKFHSPLPCDQIADQ---KEFLIEVKALTEIRHRNIV 499
IG GG G V++ L VVAIK + +EF EV ++ + H NIV
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
K YG + +V E + G L L A + WS ++ ++ +A + Y+ +
Sbjct: 87 KLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN-Q 141
Query: 560 FPPIVHQDISSKNLLLDLEYE-----AHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
PPIVH+D+ S N+ L E A VADFG+++ + + G + ++APE
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---SVHSVSGLLGNFQWMAPETI 198
Query: 615 YTMKI--TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672
+ TEK D YSF +++ + G+ P D S +N R P
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL----RPTIPE- 253
Query: 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
+L +++E C + P+ RP + ++
Sbjct: 254 DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKE 283
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-54
Identities = 68/342 (19%), Positives = 115/342 (33%), Gaps = 23/342 (6%)
Query: 1 MRSLSILDLNQNQFKG---VLPPSVSNLTNLKELVLLYNNLS------GFIPPSLEN-PM 50
+ L + L +F+ + S L L L + L+ I
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283
Query: 51 LTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLT 110
++ L + G Q+ + F L++ L +
Sbjct: 284 VSSFSLVSVTIERVKDFSYNFG--WQHLELVNCKFGQFPTLKLKSLKRL-----TFTSNK 336
Query: 111 GNISEALGIYPNLTFIDLSRND--FYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNS 168
G + + P+L F+DLSRN F G S + L L++S N + +
Sbjct: 337 GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGL 395
Query: 169 SQLQALDLSLNHIVGEIPKE-LGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSAN 227
QL+ LD +++ L +L L + L LE L ++ N
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455
Query: 228 RFNNSV-PENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQIC 286
F + P+ L L +L LS Q P L L L+ SHN F F
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 515
Query: 287 SLKSLEKLNLSHNNLSGSIPNCFEGI-RGISVIDISDNQLQG 327
L SL+ L+ S N++ S + ++ ++++ N
Sbjct: 516 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 6e-51
Identities = 66/345 (19%), Positives = 113/345 (32%), Gaps = 23/345 (6%)
Query: 3 SLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIP---------PSLENPMLT 52
L L L N + + L L+ L+ L N +
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 53 RPGLDFNHFTSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTG 111
L + + ++ + F + + + L +
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQ 318
Query: 112 NISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNIT--GGIPREIGNSS 169
+ L LTF + + E+ P L L++S N ++ G + ++
Sbjct: 319 FPTLKLKSLKRLTFTSNKGGNAFSEVD-----LPSLEFLDLSRNGLSFKGCCSQSDFGTT 373
Query: 170 QLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSANR 228
L+ LDLS N ++ + L L L + + + SL +L YLD+S
Sbjct: 374 SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432
Query: 229 FNNSVPENLGNLLKLHYLGLSNNQFV-LELPKELEKLVQLSELDASHNLFGGEIPFQICS 287
+ L L L ++ N F LP +L L+ LD S P S
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 288 LKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNS 332
L SL+ LN+SHNN ++ + + V+D S N +
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 537
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-48
Identities = 63/328 (19%), Positives = 117/328 (35%), Gaps = 17/328 (5%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
+ ++S L + V S + L L+ F L++ L F
Sbjct: 281 LTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKS----LKRLTFTS 334
Query: 61 FTSYLPHNVCRGGALQYFGVSENH--FQGTIPKILRNCSSLIRVRLNSNNLTGNISEALG 118
+ +L++ +S N F+G + +SL + L+ N + S LG
Sbjct: 335 NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG 394
Query: 119 IYPNLTFIDLSRNDFYGEIS-SNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLS 177
+ L +D ++ S + L L++S + S L+ L ++
Sbjct: 395 L-EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453
Query: 178 LNHIVGEIPKE-LGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPEN 236
N + +L +LT L L Q P SL L+ L++S N F +
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 513
Query: 237 LGNLLKLHYLGLSNNQFVLELPKELEKLV-QLSELDASHNLFGGEIPFQ--ICSLKSLEK 293
L L L S N + +EL+ L+ L+ + N F Q + +K +
Sbjct: 514 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQ 573
Query: 294 LNLSHNNLSGSIPNCFEGIRGISVIDIS 321
L + + + P +G+ V+ ++
Sbjct: 574 LLVEVERMECATP---SDKQGMPVLSLN 598
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-46
Identities = 63/373 (16%), Positives = 110/373 (29%), Gaps = 60/373 (16%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
S LDL+ N + + S + L+ L L + + ++
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS------------ 74
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
L H L ++ N Q SSL ++ NL + +G
Sbjct: 75 ----LSH-------LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123
Query: 121 PNLTFIDLSRNDF-YGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQA----LD 175
L ++++ N ++ + L L++S N I ++ Q+ LD
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 176 LSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPE-IGSLVDLEYLDLSANRFNN--- 231
LSLN + P ++ L +L LR N + + I L LE L F N
Sbjct: 184 LSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
Query: 232 ------SVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQI 285
S E L NL + + ++ ++ L +S F
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY 302
Query: 286 CSLKSLEKLNLSHNNLS-------------------GSIPNCFEGIRGISVIDISDNQLQ 326
+ L L + G + + +D+S N L
Sbjct: 303 NF--GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS 360
Query: 327 GPVPNSTAFRNAP 339
S +
Sbjct: 361 FKGCCSQSDFGTT 373
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 7e-46
Identities = 60/357 (16%), Positives = 115/357 (32%), Gaps = 28/357 (7%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
+ LS L L N + + + S L++L++LV + NL+ + + L + N
Sbjct: 75 LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134
Query: 60 HFTSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSL----IRVRLNSNNLTGNIS 114
S+ L++ +S N Q LR + + + L+ N +
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194
Query: 115 EALGIYPNLTFIDLSRNDFYGEISSNW-GKCPKLGTLNVSMN------NITGGIPREIGN 167
A L + L N + L + + N+ +
Sbjct: 195 GAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG 253
Query: 168 SSQLQALDLSLNHI---VGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDL 224
L + L ++ + +I L +++ L + ++L+L
Sbjct: 254 LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLEL 311
Query: 225 SANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHN--LFGGEIP 282
+F L +L +L + L L LD S N F G
Sbjct: 312 VNCKFGQFPTLKLKSLKRLTFTSNKGG-----NAFSEVDLPSLEFLDLSRNGLSFKGCCS 366
Query: 283 FQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAP 339
SL+ L+LS N + + + F G+ + +D + L+ S F +
Sbjct: 367 QSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS-VFLSLR 421
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-38
Identities = 56/234 (23%), Positives = 91/234 (38%), Gaps = 10/234 (4%)
Query: 100 IRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITG 159
I + N I + + + +DLS N S ++ P+L L++S I
Sbjct: 10 ITYQCMELNFY-KIPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 160 GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDL 219
+ S L L L+ N I L+SL +L+ IG L L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 220 EYLDLSANRFNN-SVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLS----ELDASH 274
+ L+++ N + +PE NL L +L LS+N+ +L L Q+ LD S
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 275 NLFGGEIPFQICSLKSLEKLNLSHNNLSGSIP-NCFEGIRGISVIDISDNQLQG 327
N I L KL L +N S ++ C +G+ G+ V + + +
Sbjct: 187 NPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-37
Identities = 51/218 (23%), Positives = 82/218 (37%), Gaps = 10/218 (4%)
Query: 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNH 180
PN+T+ +FY +I N L++S N + + +LQ LDLS
Sbjct: 8 PNITY-QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63
Query: 181 IVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNL 240
I L+ L+ LIL GN L L+ L + +G+L
Sbjct: 64 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123
Query: 241 LKLHYLGLSNNQF-VLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLE----KLN 295
L L +++N +LP+ L L LD S N + L + L+
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 296 LSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNST 333
LS N ++ P F+ IR + + + +N V +
Sbjct: 184 LSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTC 220
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-22
Identities = 33/182 (18%), Positives = 69/182 (37%), Gaps = 6/182 (3%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSL--ENPMLTRPGLDF 58
+R+L LD++ + + L++L+ L + N+ P + E LT L
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 59 NHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALG 118
P +LQ +S N+F + +SL + + N++ + + L
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 539
Query: 119 -IYPNLTFIDLSRNDFYGEISSNW--GKCPKLGTLNVSMNNITGGIPREIGNSSQLQALD 175
+L F++L++NDF L V + + P + + +L+
Sbjct: 540 HFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLN 598
Query: 176 LS 177
++
Sbjct: 599 IT 600
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-52
Identities = 67/277 (24%), Positives = 113/277 (40%), Gaps = 33/277 (11%)
Query: 444 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G G G + +G+V+ +K+ Q+ FL EVK + + H N++KF
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDE----ETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
G + + E ++ G+L I+ S + WSQR++ K +A ++YLH
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFL--------------KPESSNWTEFAGTYGY 608
I+H+D++S N L+ VADFG+A+ + KP+ G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 609 VAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668
+APE+ EK DV+SFG+++ E I + D L+
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY-----LPRTMDFGLNVRGFLDRY 243
Query: 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
P + I C + PE RP+ +
Sbjct: 244 CPP-NCPPSFFPIT---VRCCDLDPEKRPSFVKLEHW 276
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 3e-52
Identities = 52/267 (19%), Positives = 101/267 (37%), Gaps = 25/267 (9%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
+ G +++ G + +K + + ++F E L H N++ G
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKS--RDFNEECPRLRIFSHPNVLPVLG 74
Query: 504 FCSH--ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFP 561
C A H L+ + GSL +L T + SQ + +A +++LH P
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHT-LEP 132
Query: 562 PIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL---AYTMK 618
I ++S+++++D + A ++ + + +VAPE
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----PGRMYAPAWVAPEALQKKPEDT 187
Query: 619 ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKL 678
D++SF VL+ E + + P LS N +I + L+ P + +
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFADLS-------NMEIGMKVALEGLRPTIPPGISPHV 240
Query: 679 ISIMEVAFSCLNESPESRPTMKVVTQQ 705
+M+ C+NE P RP ++
Sbjct: 241 SKLMK---ICMNEDPAKRPKFDMIVPI 264
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 4e-52
Identities = 64/317 (20%), Positives = 110/317 (34%), Gaps = 54/317 (17%)
Query: 428 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEV 487
E ++ IG G +G+VY+ L + VA+K F +++ F+ E
Sbjct: 5 ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-------NRQNFINEK 56
Query: 488 K--ALTEIRHRNIVKFYGFCSHARHS-----FLVYELLERGSLAAILSSDTAAQELGWSQ 540
+ + H NI +F LV E GSL LS T W
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVS 112
Query: 541 RMNVIKGVADALSYLHHD------CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594
+ V L+YLH + P I H+D++S+N+L+ + ++DFG++ L
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 595 ESSNWTEF--------AGTYGYVAPE-------LAYTMKITEKCDVYSFGVLVLEAIKGK 639
GT Y+APE L ++ D+Y+ G++ E
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 640 HPR--------------DFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVA 685
+ + + E P+ P + + S+ E
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 686 FSCLNESPESRPTMKVV 702
C ++ E+R T +
Sbjct: 293 EDCWDQDAEARLTAQXA 309
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 3e-51
Identities = 66/345 (19%), Positives = 116/345 (33%), Gaps = 12/345 (3%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNH 60
S L+ + N + + S L NL L L + + ++ L L N
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92
Query: 61 FTSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
+ G AL++ + L N +L + L SN+++
Sbjct: 93 LIF-MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLG--TLNVSMNNITGGIPREIGNSSQLQALDLS 177
L +D N + + + +LN++ N+I G I +S+ Q+L+
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFG 210
Query: 178 LNHIVGEIPKELG--KLNSLTELILRGNQFTG--RLPPEIGSLVDLEYLDLSANRFNNSV 233
+ I K L + SL E + +E ++L + F N
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270
Query: 234 PENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEK 293
L L L+ ELP L L L +L S N F + SL
Sbjct: 271 SNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329
Query: 294 LNLSHNNLSGSI-PNCFEGIRGISVIDISDNQLQGPVPNSTAFRN 337
L++ N + C E + + +D+S + ++ + RN
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 4e-50
Identities = 70/350 (20%), Positives = 125/350 (35%), Gaps = 12/350 (3%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
++L L L N + P LK L N + + + T L+ N
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLN 187
Query: 60 H-FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCS--SLIRVRLNSNNLTGNISEA 116
+ + Q I K L+N + SL +
Sbjct: 188 GNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247
Query: 117 LGIYP--NLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQAL 174
++ I+L ++ F+ S+ + L L+++ +++ +P + S L+ L
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKL 306
Query: 175 DLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPE-IGSLVDLEYLDLSANRFNNS- 232
LS N SLT L ++GN L + +L +L LDLS + S
Sbjct: 307 VLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSD 366
Query: 233 -VPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPF-QICSLKS 290
L NL L L LS N+ + + ++ QL LD + + +L
Sbjct: 367 CCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHL 426
Query: 291 LEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQG-PVPNSTAFRNAP 339
L+ LNLSH+ L S F+G+ + +++ N + + + +
Sbjct: 427 LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG 476
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-49
Identities = 70/342 (20%), Positives = 122/342 (35%), Gaps = 14/342 (4%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN---PMLTRPGLDFN 59
+ L+LN N G + P + + L I L+N L +
Sbjct: 180 TNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 60 HFTSYLPH--NVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEAL 117
P +++ + +++F S L + L + +L+ + L
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGL 297
Query: 118 GIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPRE-IGNSSQLQALDL 176
L + LS N F + P L L++ N + + N L+ LDL
Sbjct: 298 VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDL 357
Query: 177 SLNHI--VGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVP 234
S + I +L L+ L L L N+ LE LDL+ R
Sbjct: 358 SHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDA 417
Query: 235 EN-LGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQ---ICSLKS 290
++ NL L L LS++ + + + L L L+ N F + + +L
Sbjct: 418 QSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR 477
Query: 291 LEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNS 332
LE L LS +LS + F ++ ++ +D+S N+L +
Sbjct: 478 LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-48
Identities = 76/371 (20%), Positives = 128/371 (34%), Gaps = 37/371 (9%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
+ +L+ LDL + Q + + + L LVL N L +L L
Sbjct: 56 LINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQT 115
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
+S + L+ + NH L + +N + E +
Sbjct: 116 GISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSS 175
Query: 120 YPNLTFI--DLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSS-------- 169
T + +L+ ND I +LN I + + NS+
Sbjct: 176 LQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGT 234
Query: 170 --------------------QLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRL 209
+++++L ++ + L EL L + L
Sbjct: 235 FEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-EL 293
Query: 210 PPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKE-LEKLVQLS 268
P + L L+ L LSAN+F N + N L +L + N LEL LE L L
Sbjct: 294 PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLR 353
Query: 269 ELDASHN--LFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
ELD SH+ Q+ +L L+ LNLS+N F+ + ++D++ +L+
Sbjct: 354 ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413
Query: 327 GPVPNSTAFRN 337
S F+N
Sbjct: 414 VKDAQS-PFQN 423
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 6e-48
Identities = 68/337 (20%), Positives = 118/337 (35%), Gaps = 12/337 (3%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNL--TNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLD 57
++SL + + + P L +++ + L + + L L
Sbjct: 227 IQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLT 286
Query: 58 FNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNI-SEA 116
H + LP + L+ +S N F+ N SL + + N + +
Sbjct: 287 ATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345
Query: 117 LGIYPNLTFIDLSRNDFY--GEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQAL 174
L NL +DLS +D + L +LN+S N QL+ L
Sbjct: 346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL 405
Query: 175 DLSLNHIVGEIPKE-LGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRF---N 230
DL+ + + + L+ L L L + L L++L+L N F N
Sbjct: 406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGN 465
Query: 231 NSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKS 290
+L L +L L LS L ++ +D SHN + LK
Sbjct: 466 IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525
Query: 291 LEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQG 327
+ LNL+ N++S +P+ + I++ N L
Sbjct: 526 IY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-46
Identities = 69/343 (20%), Positives = 132/343 (38%), Gaps = 16/343 (4%)
Query: 3 SLSILDLNQNQFKGVLPPSVSN--LTNLKELVLLYNNLSGFIP---PSLENPMLTRPGLD 57
L+ Q V+ + N + +L + P L + L
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ 262
Query: 58 FNHFTSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEA 116
++F + + N LQ ++ H +P L S+L ++ L++N +
Sbjct: 263 KHYFFN-ISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQIS 320
Query: 117 LGIYPNLTFIDLSRNDFYGEISSNW-GKCPKLGTLNVSMNNIT--GGIPREIGNSSQLQA 173
+P+LT + + N E+ + L L++S ++I ++ N S LQ+
Sbjct: 321 ASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQS 380
Query: 174 LDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSANRFNNS 232
L+LS N + + + L L L + + +L L+ L+LS + + S
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440
Query: 233 VPENLGNLLKLHYLGLSNNQFV---LELPKELEKLVQLSELDASHNLFGGEIPFQICSLK 289
+ L L +L L N F ++ L+ L +L L S SLK
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLK 500
Query: 290 SLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNS 332
+ ++LSHN L+ S ++GI ++++ N + +P+
Sbjct: 501 MMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSL 542
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-40
Identities = 79/334 (23%), Positives = 123/334 (36%), Gaps = 21/334 (6%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
L LDL LP + L+ LK+LVL N S N P LT + N
Sbjct: 277 FSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGN 335
Query: 60 HFTSYLPHNVCRG-GALQYFGVSENHFQ--GTIPKILRNCSSLIRVRLNSNNLTGNISEA 116
L L+ +S + + LRN S L + L+ N +EA
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395
Query: 117 LGIYPNLTFIDLSRNDFYGEIS-SNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALD 175
P L +DL+ + + S + L LN+S + + + LQ L+
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455
Query: 176 LSLNHIVGEIPKE---LGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNS 232
L NH ++ L L L L+L + SL + ++DLS NR +S
Sbjct: 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSS 515
Query: 233 VPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQ-ICSLKSL 291
E L +L + YL L++N + LP L L Q ++ N P CS
Sbjct: 516 SIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQN------PLDCTCSNIYF 568
Query: 292 EKLNLSHNNLSGSIPN--CF--EGIRGISVIDIS 321
+ + + C +RG+ + D++
Sbjct: 569 LEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVT 602
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-29
Identities = 36/235 (15%), Positives = 70/235 (29%), Gaps = 8/235 (3%)
Query: 102 VRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGI 161
+ L I L + ++ S N ++ + + L L+++ I
Sbjct: 17 YNCENLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 162 PREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEY 221
+ +L L L+ N ++ L +L L + + + LE
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 222 LDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLS--ELDASHNLFGG 279
L L +N ++ KL L NN +++ L Q + L+ + N
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-A 192
Query: 280 EIPFQICSLKSLEKLNLSHNNLSGSIPN--CFEGIRGISVIDISDNQLQGPVPNS 332
I + LN I I+ + + D + P
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 38/215 (17%), Positives = 67/215 (31%), Gaps = 5/215 (2%)
Query: 149 TLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGR 208
T N + IP + NS + L+ S N + +L +LT L L Q
Sbjct: 16 TYNCENLGLNE-IPGTLPNS--TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 209 LPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLS 268
S L+ L L+AN L L +L L L
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 269 ELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVI--DISDNQLQ 326
L N + + L+ L+ +N + ++ + + +++ N +
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 327 GPVPNSTAFRNAPVEALKGNKGLCGGVKGMQPCKV 361
G P + G + L KG++ +
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTI 227
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 3e-48
Identities = 67/296 (22%), Positives = 121/296 (40%), Gaps = 49/296 (16%)
Query: 443 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVK--ALTEIRHRNIVK 500
C+G G +G V+R G+ VA+K F S D+K + E + +RH NI+
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILG 66
Query: 501 FYGFCSHARHS----FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
F +RHS +L+ E GSL L L + ++ +A L++LH
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLH 122
Query: 557 HDCF-----PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS----NWTEFAGTYG 607
+ F P I H+D+ SKN+L+ + +AD G+A ++ GT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 608 YVAPEL------AYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLIS---SSSLNTDIA 658
Y+APE+ ++ D+++FG+++ E + + + D +
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242
Query: 659 LDEILD--------PRLPP--PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQ 704
+++ P +P S L +M+ C ++P +R T + +
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKK 295
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 9e-48
Identities = 56/277 (20%), Positives = 103/277 (37%), Gaps = 36/277 (12%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
IG G G VY G+V AI+ + K F EV A + RH N+V F G
Sbjct: 41 IGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQL--KAFKREVMAYRQTRHENVVLFMG 96
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563
C H ++ L + +L +++ A L ++ + + + + YLH I
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHA---KGI 151
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAK-----FLKPESSNWTEFAGTYGYVAPELAYTMK 618
+H+D+ SKN+ D + + DFG+ G ++APE+ +
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 619 I---------TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEIL-DPRLP 668
++ DV++ G + E + P F + + + ++ +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWP--F------KTQPAEAIIWQMGTGMKPN 262
Query: 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
+ +++ I+ C E RPT +
Sbjct: 263 LSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDM 296
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 6e-47
Identities = 64/271 (23%), Positives = 125/271 (46%), Gaps = 29/271 (10%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
IG+G G+VY+ + G V A+K + P Q + F EV L + RH NI+ F G
Sbjct: 32 IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 87
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563
+ + + + +V + E SL L + + + +++ + A + YLH I
Sbjct: 88 YSTAPQLA-IVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAKFLK--PESSNWTEFAGTYGYVAPEL---AYTMK 618
+H+D+ S N+ L + + DFG+A S + + +G+ ++APE+ +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 619 ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEI----LDPRLPPPSRSV 674
+ + DVY+FG+++ E + G+ P ++ N D ++ + L P L +
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNIN-------NRDQIIEMVGRGSLSPDLSKVRSNC 254
Query: 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
+++ +M CL + + RP+ + +
Sbjct: 255 PKRMKRLMA---ECLKKKRDERPSFPRILAE 282
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-46
Identities = 68/290 (23%), Positives = 115/290 (39%), Gaps = 47/290 (16%)
Query: 443 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G +G V+ + G+ VA+K F + ++ + +E E+ +RH NI+ F
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRE--TEIYQTVLMRHENILGFI 97
Query: 503 GFCSHARHS----FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
S +L+ + E GSL L S T L + + L +LH +
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTE 153
Query: 559 CF-----PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW----TEFAGTYGYV 609
F P I H+D+ SKN+L+ +AD G+A +++ GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 610 APE-LAYTMKI-----TEKCDVYSFGVLVL-EAIKGKHPRDFLS---LISSSSLNTDIAL 659
PE L ++ D+YSFG L+L E + + L + +D +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFG-LILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 660 DEILD--------PRLPP--PSRSVQEKLISIMEVAFSCLNESPESRPTM 699
+++ + P P S ++ +M C +P SR T
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMT---ECWAHNPASRLTA 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-46
Identities = 51/318 (16%), Positives = 100/318 (31%), Gaps = 20/318 (6%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
L + L P L+ + N +
Sbjct: 11 SSGRENLYFQGSTA---LRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRA 67
Query: 61 FTSYLPHNV--CRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALG 118
+ + + P S L + +++ L + + +
Sbjct: 68 LKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQ 124
Query: 119 IYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSS--------- 169
+ L + L+RN + ++ +L L++ +P + ++
Sbjct: 125 QFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLV 183
Query: 170 QLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRF 229
LQ+L L I +P + L +L L +R + + L P I L LE LDL
Sbjct: 184 NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTA 241
Query: 230 NNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLK 289
+ P G L L L + +L LP ++ +L QL +LD + +P I L
Sbjct: 242 LRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLP 301
Query: 290 SLEKLNLSHNNLSGSIPN 307
+ + + + + +
Sbjct: 302 ANCIILVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 50/300 (16%), Positives = 90/300 (30%), Gaps = 22/300 (7%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN---PMLTRPGLD 57
+ D N+ N N + L LE+ P L
Sbjct: 35 WQRHYNADRNRWHSAWRQA----NSNNPQIETRTGRALKA-TADLLEDATQPGRVALELR 89
Query: 58 FNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEAL 117
P R LQ+ + +P ++ + L + L N L + ++
Sbjct: 90 SVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASI 146
Query: 118 GIYPNLTFIDLSRND---------FYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNS 168
L + + + S L +L + I +P I N
Sbjct: 147 ASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANL 205
Query: 169 SQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANR 228
L++L + + + + + L L EL LRG PP G L+ L L
Sbjct: 206 QNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCS 264
Query: 229 FNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSL 288
++P ++ L +L L L + LP + +L + +L + +
Sbjct: 265 NLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 46/254 (18%), Positives = 87/254 (34%), Gaps = 17/254 (6%)
Query: 90 PKILRNCSSLIRVRLNSNNLTGNISEALGI--YPNLTFIDLSRNDFYGEISSNWGKCPKL 147
N ++ L ++ L P ++L + + L
Sbjct: 49 AWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHL 106
Query: 148 GTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTG 207
+ + + +P + + L+ L L+ N + +P + LN L EL +R
Sbjct: 107 QHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT 164
Query: 208 RLPPEIGS---------LVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELP 258
LP + S LV+L+ L L S+P ++ NL L L + N+ L
Sbjct: 165 ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALG 222
Query: 259 KELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVI 318
+ L +L ELD P L++L L + ++P + + +
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL 282
Query: 319 DISDNQLQGPVPNS 332
D+ +P+
Sbjct: 283 DLRGCVNLSRLPSL 296
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 27/205 (13%), Positives = 54/205 (26%), Gaps = 36/205 (17%)
Query: 159 GGIPREIGNSSQLQALDLSLNHIVGEIPKELGKL--------------------NSLTEL 198
G +SS + L + + L + N+
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 199 ILRGNQFTGRLPPEIGSLVD--LEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLE 256
G + L+L + P+ L L ++ + + E
Sbjct: 62 TRTGRALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-E 118
Query: 257 LPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGIS 316
LP +++ L L + N +P I SL L +L++ +P
Sbjct: 119 LPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 317 VI---------DISDNQLQGPVPNS 332
+ ++ +P S
Sbjct: 178 EHQGLVNLQSLRLEWTGIRS-LPAS 201
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 63/291 (21%), Positives = 113/291 (38%), Gaps = 49/291 (16%)
Query: 443 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIE--VKALTEIRHRNIVK 500
IG G G V+R + G+ VA+K F S +++ + E + +RH NI+
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILG 100
Query: 501 FYGFCSHARHS----FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
F + + +LV + E GSL L+ T + + + A L++LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLH 156
Query: 557 HDCF-----PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS----NWTEFAGTYG 607
+ P I H+D+ SKN+L+ +AD G+A + GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 608 YVAPEL------AYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLS---LISSSSLNTDIA 658
Y+APE+ + ++ D+Y+ G++ E + L + +D +
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 659 LDEILD--------PRLPPPSRS--VQEKLISIMEVAFSCLNESPESRPTM 699
++E+ P +P +S + IM C + +R T
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTA 324
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 9e-45
Identities = 65/326 (19%), Positives = 134/326 (41%), Gaps = 22/326 (6%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
+ S++ L + + + + LTNL+ L L N ++ I P LT + N
Sbjct: 43 LESITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNK 99
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
T + L+ ++E++ P L N + + + L +N+ ++S L
Sbjct: 100 ITD--ISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNM 154
Query: 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNH 180
L ++ ++ + + + L +L+++ N I P + + + L +N
Sbjct: 155 TGLNYLTVTESKV--KDVTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQ 210
Query: 181 IVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNL 240
I P + + L L + N+ T + +L L +L++ N+ ++ + +L
Sbjct: 211 ITDITP--VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDL 264
Query: 241 LKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNN 300
KL L + +NQ + L L QL+ L ++N G E I L +L L LS N+
Sbjct: 265 TKLKMLNVGSNQ--ISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
Query: 301 LSGSIPNCFEGIRGISVIDISDNQLQ 326
++ P + + D ++ ++
Sbjct: 323 ITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-43
Identities = 65/328 (19%), Positives = 119/328 (36%), Gaps = 24/328 (7%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
+ L + + L ++ +LV+ ++ +E L L+ N
Sbjct: 21 LAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVASI--QGIEYLTNLEYLNLNGN 76
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
T P + L + N T L+N ++L + LN +N++ L
Sbjct: 77 QITDISPLSNLV--KLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISD--ISPLAN 130
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
+ ++L N ++S L L V+ + + P I N + L +L L+ N
Sbjct: 131 LTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
I P L L SL NQ T + ++ L L + N+ + L N
Sbjct: 188 QIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDL--SPLAN 241
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
L +L +L + NQ + ++ L +L L+ N +L L L L++N
Sbjct: 242 LSQLTWLEIGTNQ--ISDINAVKDLTKLKMLNVGSNQISDISVLN--NLSQLNSLFLNNN 297
Query: 300 NLSGSIPNCFEGIRGISVIDISDNQLQG 327
L G+ ++ + +S N +
Sbjct: 298 QLGNEDMEVIGGLTNLTTLFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-39
Identities = 64/330 (19%), Positives = 122/330 (36%), Gaps = 26/330 (7%)
Query: 4 LSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPS-LENPMLTRPGLDFNHFT 62
+ L + P ++L VL +++ + LE+ +T+ +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQEELES--ITKLVVAGEKVA 57
Query: 63 SYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPN 122
S L+Y ++ N P L N L + + +N +T AL N
Sbjct: 58 SIQGIEYLTN--LEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 123 LTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIV 182
L + L+ ++ S K+ +LN+ N+ + + N + L L ++ + +
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVK 168
Query: 183 GEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLK 242
P + L L L L NQ + SL L Y N+ + + N+ +
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDI--TPVANMTR 222
Query: 243 LHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS 302
L+ L + NN+ + L L QL+ L+ N + L L+ LN+ N +S
Sbjct: 223 LNSLKIGNNK--ITDLSPLANLSQLTWLEIGTNQISDINAVK--DLTKLKMLNVGSNQIS 278
Query: 303 GSIPNCFEGIRGISVIDISDNQLQGPVPNS 332
I + ++ + +++NQL
Sbjct: 279 -DISV-LNNLSQLNSLFLNNNQLGNEDMEV 306
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-44
Identities = 56/327 (17%), Positives = 101/327 (30%), Gaps = 35/327 (10%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFT 62
++ L L N+ + L ++ ++ ++ +
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLSIIRCQLK 320
Query: 63 SYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPN 122
P + + L + L N + IS P+
Sbjct: 321 Q-------------------------FPTL--DLPFLKSLTLTMNKGS--ISFKKVALPS 351
Query: 123 LTFIDLSRNDFY--GEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNH 180
L+++DLSRN G S + L L++S N + +LQ LD +
Sbjct: 352 LSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHST 410
Query: 181 IVGEIPKE-LGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPEN-LG 238
+ L L L + L L L ++ N F ++ N
Sbjct: 411 LKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470
Query: 239 NLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSH 298
N L +L LS Q + L +L L+ SHN L SL L+ S
Sbjct: 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSF 530
Query: 299 NNLSGSIPNCFEGIRGISVIDISDNQL 325
N + S + ++ ++++N +
Sbjct: 531 NRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-43
Identities = 64/344 (18%), Positives = 108/344 (31%), Gaps = 22/344 (6%)
Query: 3 SLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGF---------IPPSLENPMLT 52
L L L N + + NL L L+ I L + +
Sbjct: 205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID 264
Query: 53 RPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGN 112
L + + S + ++ + + + + L
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQF 322
Query: 113 ISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPR--EIGNSSQ 170
+ L P L + L+ N G IS P L L++S N ++ ++
Sbjct: 323 PTLDL---PFLKSLTLTMN--KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNS 377
Query: 171 LQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPE-IGSLVDLEYLDLSANRF 229
L+ LDLS N + + L L L + + SL L YLD+S
Sbjct: 378 LRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNT 436
Query: 230 NNSVPENLGNLLKLHYLGLSNNQFVLELPKE-LEKLVQLSELDASHNLFGGEIPFQICSL 288
L L+ L ++ N F L+ LD S +L
Sbjct: 437 KIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL 496
Query: 289 KSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNS 332
L+ LN+SHNNL + + + +S +D S N+++
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-41
Identities = 69/357 (19%), Positives = 131/357 (36%), Gaps = 28/357 (7%)
Query: 1 MRSLSILDLNQNQFKGV-LPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPG---- 55
+ +L L++ N LP SNLTNL + L YN + L+
Sbjct: 127 LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSL 186
Query: 56 -LDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPK-ILRNCSSLIRVRLNSNNLTGNI 113
+ N + +G L + N I K L+N + L RL
Sbjct: 187 DMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER 245
Query: 114 S------EALGIYPNLTF--IDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREI 165
+ + ++T L+ + + + + + ++++ +I ++
Sbjct: 246 NLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDV 303
Query: 166 GNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLS 225
+ Q+L + + + P L L L L N+ + + + +L L YLDLS
Sbjct: 304 PKHFKWQSLSIIRCQL-KQFPT--LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLS 358
Query: 226 ANRFNNSVPENLGNL--LKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPF 283
N + S + +L L +L LS N ++ + L +L LD H+ F
Sbjct: 359 RNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEF 417
Query: 284 Q-ICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAP 339
SL+ L L++S+ N F G+ ++ + ++ N + ++ F N
Sbjct: 418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN-VFANTT 473
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-40
Identities = 64/353 (18%), Positives = 115/353 (32%), Gaps = 23/353 (6%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNH 60
S +DL+ N K + S SN + L+ L L + + L+ L N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTG-NISEALGI 119
S+ P + +L+ E + +L ++ + N + +
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 120 YPNLTFIDLSRNDF----YGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALD 175
NL +DLS N ++ +L++S+N I I + +L L
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELT 210
Query: 176 LSLNHIVGEIPKELGK-LNSLTELILRGNQFTG-----RLPPEI-GSLVDL--EYLDLSA 226
L N I K + L L L +F P I L D+ + L+
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270
Query: 227 NRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQIC 286
+ L + + L+ ++ +++ K + L + P
Sbjct: 271 TNDFSDDIVKFHCLANVSAMSLAGVS--IKYLEDVPKHFKWQSLSIIRCQL-KQFPTL-- 325
Query: 287 SLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAP 339
L L+ L L+ N SI + +S +D+S N L S +
Sbjct: 326 DLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTN 376
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-39
Identities = 71/356 (19%), Positives = 117/356 (32%), Gaps = 28/356 (7%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
L LDL++ + + + + L +L L+L N + F P S L
Sbjct: 55 FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET 114
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQG-TIPKILRNCSSLIRVRLNSNNLTGNISEALG 118
S + + L+ V+ N +P N ++L+ V L+ N + L
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174
Query: 119 IYPNLTF----IDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNS-SQLQA 173
+D+S N I + KL L + N + I + + + L
Sbjct: 175 FLRENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHV 233
Query: 174 LDLSLNHIVGEI------PKELGKLNSLTELILR--GNQFTGRLPPEIGSLVDLEYLDLS 225
L L E P + L +T R + L ++ + L+
Sbjct: 234 HRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLA 293
Query: 226 ANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQI 285
E++ K L + Q + P L L L + N G I F+
Sbjct: 294 GVSIKY--LEDVPKHFKWQSLSIIRCQL-KQFPT--LDLPFLKSLTLTMNK--GSISFKK 346
Query: 286 CSLKSLEKLNLSHNNLSGSIPNCFEGIRGIS--VIDISDNQLQGPVPNSTAFRNAP 339
+L SL L+LS N LS S + + S +D+S N S F
Sbjct: 347 VALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM---SANFMGLE 399
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-34
Identities = 50/257 (19%), Positives = 81/257 (31%), Gaps = 9/257 (3%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
L + + Q K +L LK L L N S + P L+ L N
Sbjct: 306 HFKWQSLSIIRCQLKQF---PTLDLPFLKSLTLTMNKGS-ISFKKVALPSLSYLDLSRNA 361
Query: 61 FTSYLPHNVCRGG--ALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNIS-EAL 117
+ + G +L++ +S N + L + + L A
Sbjct: 362 LSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAF 420
Query: 118 GIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREI-GNSSQLQALDL 176
L ++D+S + + + L TL ++ N+ + N++ L LDL
Sbjct: 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL 480
Query: 177 SLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPEN 236
S + L+ L L + N L L LD S NR S
Sbjct: 481 SKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540
Query: 237 LGNLLKLHYLGLSNNQF 253
L + L+NN
Sbjct: 541 QHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 5e-33
Identities = 55/336 (16%), Positives = 105/336 (31%), Gaps = 44/336 (13%)
Query: 16 GVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGAL 75
G L P + + N+ + LS +P + +S
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLSK-VPDDI--------------PSS-----------T 34
Query: 76 QYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYG 135
+ +S N + N S L + L+ + +A +L+ + L+ N
Sbjct: 35 KNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS 94
Query: 136 EISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVG-EIPKELGKLNS 194
++ L L + IG L+ L+++ N I ++P L +
Sbjct: 95 FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTN 154
Query: 195 LTELILRGNQFTGRLPPEI-----GSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLS 249
L + L N + + LD+S N + + + +KLH L L
Sbjct: 155 LVHVDLSYNYIQT-ITVNDLQFLRENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLR 212
Query: 250 NNQFVLELPKE-LEKLVQLSELDASHNLFGGEIPFQICSLKSLEKL--------NLSHNN 300
N + K L+ L L F E +I +E L L++ N
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272
Query: 301 LSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFR 336
F + +S + ++ ++ F+
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFK 308
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-29
Identities = 52/235 (22%), Positives = 90/235 (38%), Gaps = 17/235 (7%)
Query: 111 GNISEALGIYPNLTFIDLSRNDFY---GEISSNWGKCPKLGTLNVSMNNITGGIPREIGN 167
G+++ + + PN+T+ +I S+ +++S N + N
Sbjct: 2 GSLNPCIEVVPNITY-QCMDQKLSKVPDDIPSS------TKNIDLSFNPLKILKSYSFSN 54
Query: 168 SSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSAN 227
S+LQ LDLS I K L+ L+ LIL GN P L LE L
Sbjct: 55 FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET 114
Query: 228 RFNNSVPENLGNLLKLHYLGLSNNQF-VLELPKELEKLVQLSELDASHNLFGGEIPFQIC 286
+ + +G L+ L L +++N +LP L L +D S+N +
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174
Query: 287 SLK----SLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRN 337
L+ L++S N + F+GI+ + + + N + T +N
Sbjct: 175 FLRENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIM-KTCLQN 227
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-25
Identities = 47/210 (22%), Positives = 71/210 (33%), Gaps = 4/210 (1%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNL--TNLKELVLLYNNLSGFIPPSLENPMLTRPGLDF 58
+ SLS LDL++N S S+L +L+ L L +N + L
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQH 408
Query: 59 NHFTSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNI-SEA 116
+ + L Y +S + + I +SL +++ N+ N S
Sbjct: 409 STLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV 468
Query: 117 LGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDL 176
NLTF+DLS+ + +L LN+S NN+ L LD
Sbjct: 469 FANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDC 528
Query: 177 SLNHIVGEIPKELGKLNSLTELILRGNQFT 206
S N I SL L N
Sbjct: 529 SFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-39
Identities = 78/330 (23%), Positives = 126/330 (38%), Gaps = 26/330 (7%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
+ ++ L ++ K V L NL ++ N L+ I P L ++ N
Sbjct: 45 LDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQ 101
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
P L + N P L+N ++L R+ L+SN ++ AL
Sbjct: 102 IADITPLANLT--NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGL 155
Query: 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNH 180
+L + L L++S N ++ + + L++L + N
Sbjct: 156 TSLQQLSFGNQV---TDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQ 210
Query: 181 IVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNL 240
I P LG L +L EL L GNQ + SL +L LDL+ N+ +N L L
Sbjct: 211 ISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL--APLSGL 264
Query: 241 LKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNN 300
KL L L NQ + L L L+ L+ + N P I +LK+L L L NN
Sbjct: 265 TKLTELKLGANQ--ISNISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNN 320
Query: 301 LSGSIPNCFEGIRGISVIDISDNQLQGPVP 330
+S P + + + +N++
Sbjct: 321 ISDISP--VSSLTKLQRLFFYNNKVSDVSS 348
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-39
Identities = 80/331 (24%), Positives = 129/331 (38%), Gaps = 28/331 (8%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
+ +L+ ++ + NQ + + NLT L ++++ N ++ P L N LT L N
Sbjct: 67 LNNLTQINFSNNQLTDI--TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 122
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
T + L +S N L +SL ++ N +T + L
Sbjct: 123 QITD--IDPLKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSF-GNQVTD--LKPLAN 175
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
L +D+S N S K L +L + N I+ P +G + L L L+ N
Sbjct: 176 LTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGN 231
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
+ L L +LT+L L NQ + + L L L L AN+ +N L
Sbjct: 232 QLKD--IGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNI--SPLAG 285
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
L L L L+ NQ LE + L L+ L N P + SL L++L +N
Sbjct: 286 LTALTNLELNENQ--LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNN 341
Query: 300 NLSGSIPNCFEGIRGISVIDISDNQLQGPVP 330
+S + + I+ + NQ+ P
Sbjct: 342 KVSD--VSSLANLTNINWLSAGHNQISDLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-38
Identities = 77/330 (23%), Positives = 125/330 (37%), Gaps = 28/330 (8%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
+ +L+ L L NQ + + NLTNL L L N +S I L + N
Sbjct: 111 LTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLSFG-NQ 166
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
T P L+ +S N + +L ++L + +N ++ LGI
Sbjct: 167 VTDLKPLANLT--TLERLDISSNKV--SDISVLAKLTNLESLIATNNQISD--ITPLGIL 220
Query: 121 PNLTFIDLSRNDFYGEIS--SNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSL 178
NL + L+ N ++ L L+++ N I+ P + ++L L L
Sbjct: 221 TNLDELSLNGN----QLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 274
Query: 179 NHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLG 238
N I P L L +LT L L NQ I +L +L YL L N ++ +
Sbjct: 275 NQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDI--SPVS 328
Query: 239 NLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSH 298
+L KL L NN+ + L L ++ L A HN P +L + +L L+
Sbjct: 329 SLTKLQRLFFYNNK--VSDVSSLANLTNINWLSAGHNQISDLTPLA--NLTRITQLGLND 384
Query: 299 NNLSGSIPNCFEGIRGISVIDISDNQLQGP 328
+ + N + + + L P
Sbjct: 385 QAWTNAPVNYKANVSIPNTVKNVTGALIAP 414
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-38
Identities = 76/333 (22%), Positives = 125/333 (37%), Gaps = 32/333 (9%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
+ L + + ++L + L + +E LT+ N
Sbjct: 23 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNN 78
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
T P L ++ N P L N ++L + L +N +T + L
Sbjct: 79 QLTDITPLKNLT--KLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD--IDPLKN 132
Query: 120 YPNLTFIDLSRNDFYGEIS--SNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLS 177
NL ++LS N IS S L L+ N +T P + N + L+ LD+S
Sbjct: 133 LTNLNRLELSSN----TISDISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDIS 185
Query: 178 LNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENL 237
N + L KL +L LI NQ + +G L +L+ L L+ N+ + L
Sbjct: 186 SNKV--SDISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKD--IGTL 239
Query: 238 GNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLS 297
+L L L L+NNQ + L L +L+EL N P + L +L L L+
Sbjct: 240 ASLTNLTDLDLANNQ--ISNLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELN 295
Query: 298 HNNLSGSIPNCFEGIRGISVIDISDNQLQGPVP 330
N L P ++ ++ + + N + P
Sbjct: 296 ENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-36
Identities = 73/327 (22%), Positives = 122/327 (37%), Gaps = 28/327 (8%)
Query: 5 SILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPS-LENPMLTRPGLDFNHFTS 63
S + + L + VL N++ + + L+ +T D S
Sbjct: 5 SATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVSQTDLDQ--VTTLQADRLGIKS 60
Query: 64 YLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNL 123
V L S N P L+N + L+ + +N+N + L NL
Sbjct: 61 --IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNL 114
Query: 124 TFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVG 183
T + L N L L +S N I+ + + LQ L N +
Sbjct: 115 TGLTLFNNQI--TDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTD 169
Query: 184 EIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKL 243
P L L +L L + N+ + + L +LE L + N+ ++ LG L L
Sbjct: 170 LKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDI--TPLGILTNL 223
Query: 244 HYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSG 303
L L+ NQ L+ L L L++LD ++N P L L +L L N +S
Sbjct: 224 DELSLNGNQ--LKDIGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISN 279
Query: 304 SIPNCFEGIRGISVIDISDNQLQGPVP 330
P G+ ++ +++++NQL+ P
Sbjct: 280 ISP--LAGLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-33
Identities = 55/306 (17%), Positives = 105/306 (34%), Gaps = 20/306 (6%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
+ +L LD++ N+ ++ LTNL+ L+ N +S P L L+ N
Sbjct: 176 LTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLG-ILTNLDELSLNGNQ 232
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
+ L ++ N P L + L ++L +N ++ L
Sbjct: 233 LKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGL 286
Query: 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNH 180
LT ++L+ N S L L + NNI+ P + + ++LQ L N
Sbjct: 287 TALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNK 342
Query: 181 IVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNL 240
+ L L ++ L NQ + + +L + L L+ + N+ N+
Sbjct: 343 V--SDVSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKANV 398
Query: 241 LKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNN 300
+ + + P + +E D + NL + +
Sbjct: 399 SIPNTVKNVTGALI--APATISDGGSYTEPDITWNLP-SYTNEVSYTFSQPVTIGKGTTT 455
Query: 301 LSGSIP 306
SG++
Sbjct: 456 FSGTVT 461
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-38
Identities = 68/353 (19%), Positives = 123/353 (34%), Gaps = 24/353 (6%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
+ + I+ + + + + + ++ L L + + + + + FN
Sbjct: 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 103
Query: 60 HFTSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALG 118
LP +V + L + N I N L + +++NNL +
Sbjct: 104 AIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ 162
Query: 119 IYPNLTFIDLSRNDFYGEISS-NWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLS 177
+L + LS N ++ + P L NVS N ++ + ++ LD S
Sbjct: 163 ATTSLQNLQLSSN----RLTHVDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDAS 213
Query: 178 LNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENL 237
N I + + LT L L+ N T + + L +DLS N +
Sbjct: 214 HNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPF 268
Query: 238 GNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLS 297
+ +L L +SNN+ V L + + L LD SHN + LE L L
Sbjct: 269 VKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLD 326
Query: 298 HNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLC 350
HN++ ++ + + +S N FRN A+ C
Sbjct: 327 HNSIV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 55/328 (16%), Positives = 109/328 (33%), Gaps = 22/328 (6%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHF 61
+ ++ L N K + + + L++ + L+
Sbjct: 22 VFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI 81
Query: 62 TSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
+ +Q + N + P + +N L + L N+L+
Sbjct: 82 EE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNT 140
Query: 121 PNLTFIDLSRNDFYGEISSN-WGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
P LT + +S N+ I + + L L +S N +T + + L ++S N
Sbjct: 141 PKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYN 196
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
+ L ++ EL N + V+L L L N + L N
Sbjct: 197 LL-----STLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAWLLN 246
Query: 240 LLKLHYLGLSNNQFVLELPKE-LEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSH 298
L + LS N+ ++ K+ +L L S+N + + +L+ L+LSH
Sbjct: 247 YPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSH 304
Query: 299 NNLSGSIPNCFEGIRGISVIDISDNQLQ 326
N+L + + + + N +
Sbjct: 305 NHLL-HVERNQPQFDRLENLYLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 7e-17
Identities = 28/163 (17%), Positives = 59/163 (36%), Gaps = 6/163 (3%)
Query: 168 SSQLQALDLSLNHIVGEIPK--ELGKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDL 224
D+ ++ ++ E LN+ + + + +LP + S +E L+L
Sbjct: 18 QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNL 76
Query: 225 SANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQ 284
+ + + L + N P + + L+ L N +P
Sbjct: 77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRG 135
Query: 285 I-CSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
I + L L++S+NNL + F+ + + +S N+L
Sbjct: 136 IFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 22/144 (15%), Positives = 49/144 (34%), Gaps = 4/144 (2%)
Query: 185 IPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLH 244
I L ++ + E +L + + + + L + ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 245 YLGLSNNQFVLELPKE-LEKLVQLSELDASHNLFGGEIPFQI-CSLKSLEKLNLSHNNLS 302
L L++ Q E+ + +L N +P + ++ L L L N+LS
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTVLVLERNDLS 130
Query: 303 GSIPNCFEGIRGISVIDISDNQLQ 326
F ++ + +S+N L+
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE 154
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 12/95 (12%), Positives = 28/95 (29%)
Query: 231 NSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKS 290
+ NL + + + + E L + ++ + S +
Sbjct: 11 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 70
Query: 291 LEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQL 325
+E LNL+ + F I + + N +
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI 105
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 44/253 (17%), Positives = 97/253 (38%), Gaps = 15/253 (5%)
Query: 75 LQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFY 134
+ V+++ + + + ++ ++ + L+ N L+ + L + L ++LS N Y
Sbjct: 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 135 GEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNS 194
+ + L TL+++ N + E+ ++ L + N+I +
Sbjct: 72 E--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCSR--GQG 121
Query: 195 LTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNN-SVPENLGNLLKLHYLGLSNNQF 253
+ L N+ T + G ++YLDL N + + E + L +L L N
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 254 VLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIR 313
++ ++ +L LD S N + + S + ++L +N L I +
Sbjct: 182 Y-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237
Query: 314 GISVIDISDNQLQ 326
+ D+ N
Sbjct: 238 NLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 54/298 (18%), Positives = 102/298 (34%), Gaps = 17/298 (5%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
I + + K L + N+KEL L N LS L L L N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
++ L+ ++ N+ Q + S+ + +NN++ +S + G
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNIS-RVSCSRG- 119
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITG-GIPREIGNSSQLQALDLSL 178
I L+ N + G ++ L++ +N I +S L+ L+L
Sbjct: 120 -QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 179 NHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLG 238
N I ++ ++ L L L N+ + PE S + ++ L N+ + + L
Sbjct: 179 NFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-VLIEKALR 234
Query: 239 NLLKLHYLGLSNNQFV-LELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLN 295
L + L N F L K ++ + + C++ +L
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 50/238 (21%), Positives = 102/238 (42%), Gaps = 14/238 (5%)
Query: 89 IPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLG 148
I +I +N + ++ ++L ++ N+ +DLS N +++ KL
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 149 TLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGR 208
LN+S N + ++ + S L+ LDL+ N++ +EL S+ L N + R
Sbjct: 62 LLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-R 113
Query: 209 LPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFV-LELPKELEKLVQL 267
+ G + + L+ N+ + G ++ YL L N+ + + L
Sbjct: 114 VSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 268 SELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQL 325
L+ +N ++ Q+ L+ L+LS N L+ + F+ G++ I + +N+L
Sbjct: 172 EHLNLQYNFI-YDVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 52/303 (17%), Positives = 103/303 (33%), Gaps = 39/303 (12%)
Query: 24 NLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSEN 83
N K + ++L + ++ + ++ +S N
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQS----------------AWN-------VKELDLSGN 44
Query: 84 HFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGK 143
L + L + L+SN L + L L +DL+ N
Sbjct: 45 PLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLV 97
Query: 144 CPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGN 203
P + TL+ + NNI+ + G + + L+ N I + G + + L L+ N
Sbjct: 98 GPSIETLHAANNNIS-RVSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN 154
Query: 204 QFTG-RLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELE 262
+ S LE+L+L N V + KL L LS+N+ + E +
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFI-YDVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQ 211
Query: 263 KLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS-GSIPNCFEGIRGISVIDIS 321
++ + +N I + ++LE +L N G++ + F + + +
Sbjct: 212 SAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
Query: 322 DNQ 324
+
Sbjct: 271 TVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 29/167 (17%), Positives = 64/167 (38%), Gaps = 10/167 (5%)
Query: 160 GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDL 219
I N ++ + ++ + + + ++ EL L GN + ++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 220 EYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGG 279
E L+LS+N +L +L L L L+NN +EL + L A++N
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-S 112
Query: 280 EIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
+ + + + L++N ++ + +D+ N++
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 27/183 (14%), Positives = 59/183 (32%), Gaps = 11/183 (6%)
Query: 145 PKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQ 204
+ V+ +++ + ++ ++ LDLS N + +L L L L N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 205 FTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKL 264
++ SL L LDL+ N + L + L +NN +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSR--G 119
Query: 265 VQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSG-SIPNCFEGIRGISVIDISDN 323
+ ++N ++ L+L N + + + +++ N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 324 QLQ 326
+
Sbjct: 180 FIY 182
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-37
Identities = 64/338 (18%), Positives = 108/338 (31%), Gaps = 53/338 (15%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN------------- 48
L + + +P N+ + E ++ PP
Sbjct: 11 TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69
Query: 49 -PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSN 107
L+ +S LP L+ S N +P++ ++ SL+ N
Sbjct: 70 DRQAHELELNNLGLSS-LPELP---PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 124
Query: 108 NLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGN 167
L+ P L ++ +S N E L ++V N++ +P +
Sbjct: 125 ALSDLP-------PLLEYLGVSNNQL--EKLPELQNSSFLKIIDVDNNSLK-KLPDLPPS 174
Query: 168 SSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSAN 227
L+ + N + E+P EL L LT + N +LP S LE + N
Sbjct: 175 ---LEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNN 225
Query: 228 RFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICS 287
L NL L + NN LP L L+ N ++P S
Sbjct: 226 IL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVRDNYL-TDLPELPQS 278
Query: 288 LKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQL 325
L L+ + LS PN + ++ S N++
Sbjct: 279 LTFLDVSENIFSGLSELPPN-------LYYLNASSNEI 309
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-33
Identities = 69/328 (21%), Positives = 124/328 (37%), Gaps = 46/328 (14%)
Query: 18 LPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNV------- 69
+ P + T L+E + +NL+ +P EN T ++ + P
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 70 ------CRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNL 123
C ++ ++P++ + SL + N+LT + E +L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSL 116
Query: 124 TFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVG 183
+ + P L L VS N + +P E+ NSS L+ +D+ N +
Sbjct: 117 LVDNNNLKALSDLP-------PLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK- 166
Query: 184 EIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKL 243
++P SL + NQ PE+ +L L + N +P+ +L +
Sbjct: 167 KLPDLPP---SLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSL-KKLPDLPLSLESI 220
Query: 244 HYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSG 303
NN LE EL+ L L+ + A +NL +P SL++ LN+ N L+
Sbjct: 221 V---AGNNI--LEELPELQNLPFLTTIYADNNLL-KTLPDLPPSLEA---LNVRDNYLT- 270
Query: 304 SIPNCFEGIRGISVIDISDNQLQGPVPN 331
+P + + + V + + L PN
Sbjct: 271 DLPELPQSLTFLDVSENIFSGLSELPPN 298
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-33
Identities = 69/303 (22%), Positives = 112/303 (36%), Gaps = 44/303 (14%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
+ L+ + + N K LP +L+ +V N L P L+N P LT D N
Sbjct: 194 LPFLTAIYADNNSLK-KLPDL---PLSLESIVAGNNILE--ELPELQNLPFLTTIYADNN 247
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
+ LP L+ V +N+ +P++ ++ + L + L+
Sbjct: 248 LLKT-LPDLPPS---LEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELP------ 296
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
PNL +++ S N+ + P L LNVS N + +P L+ L S N
Sbjct: 297 -PNLYYLNASSNEI-RSLCDLP---PSLEELNVSNNKLIE-LPALPPR---LERLIASFN 347
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
H+ E+P+ +L +L + N P S+ DL N VPE N
Sbjct: 348 HLA-EVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLR-----MNSHLAEVPELPQN 397
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
L +LH + N E P E + +L + F + LE H+
Sbjct: 398 LKQLH---VETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHH 450
Query: 300 NLS 302
+
Sbjct: 451 HHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-31
Identities = 67/324 (20%), Positives = 118/324 (36%), Gaps = 46/324 (14%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFT 62
L L ++ NQ + + P + N + LK + + N+L +P + L N
Sbjct: 132 LLEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLK-KLPDLPPS--LEFIAAGNNQLE 186
Query: 63 SYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPN 122
LP + L N + +P + + S++ +N L + E L P
Sbjct: 187 E-LP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESIV---AGNNILE-ELPE-LQNLPF 238
Query: 123 LTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIV 182
LT I N + + P L LNV N +T +P + + L + + +
Sbjct: 239 LTTIYADNN----LLKTLPDLPPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLS 293
Query: 183 GEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLK 242
P +L L N+ L SL E L++S N+ +P L +
Sbjct: 294 ELPP-------NLYYLNASSNEIR-SLCDLPPSL---EELNVSNNKLI-ELPALPPRLER 341
Query: 243 LHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS 302
L S N E+P+ + L +L +N E P S++ +L N+
Sbjct: 342 LI---ASFNHLA-EVPELPQNL---KQLHVEYNPLR-EFPDIPESVE-----DLRMNSHL 388
Query: 303 GSIPNCFEGIRGISVIDISDNQLQ 326
+P E + + + + N L+
Sbjct: 389 AEVP---ELPQNLKQLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 46/229 (20%), Positives = 75/229 (32%), Gaps = 32/229 (13%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFT 62
SL L++ N LP +LT L +++ LS PP+L L N
Sbjct: 258 SLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSEL-PPNLYY--LN---ASSNEIR 310
Query: 63 SYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPN 122
S L +L+ VS N +P + LI + N+L + E N
Sbjct: 311 S-LCDLP---PSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQ---N 358
Query: 123 LTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIV 182
L + + N E L MN+ +P N L+ L + N +
Sbjct: 359 LKQLHVEYNPLR-EFPDIPESVEDL-----RMNSHLAEVPELPQN---LKQLHVETNPLR 409
Query: 183 GEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNN 231
E P S+ +L + + + LE + ++
Sbjct: 410 -EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHHH 454
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 59/265 (22%), Positives = 106/265 (40%), Gaps = 30/265 (11%)
Query: 443 CIGNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
IG G +VY+ + + VA + L + + F E + L ++H NIV+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER---QRFKEEAEMLKGLQHPNIVR 89
Query: 501 FYG----FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
FY + LV EL+ G+L L + + + + + L +LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 557 HDCFPPIVHQDISSKNLLLDLEY-EAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAY 615
PPI+H+D+ N+ + + D G+A + +S GT ++APE+ Y
Sbjct: 147 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAPEM-Y 202
Query: 616 TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQ 675
K E DVY+FG+ +LE ++P S + + + P S
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSEYP--------YSECQNAAQIYRRVTSGVKPASF--- 251
Query: 676 EKLISIMEVAF--SCLNESPESRPT 698
+K+ C+ ++ + R +
Sbjct: 252 DKVAIPEVKEIIEGCIRQNKDERYS 276
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 5e-36
Identities = 70/324 (21%), Positives = 112/324 (34%), Gaps = 46/324 (14%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHF 61
++L++ ++ LP + ++ LV+ NNL+ +P L + N
Sbjct: 40 NGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPE--LRTLEVSGNQL 93
Query: 62 TSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYP 121
TS LP L F H +P + L + N LT ++
Sbjct: 94 TS-LPVLPPGLLELSIFSNPLTH----LPALPSGLCKL---WIFGNQLT-SLPVLPP--- 141
Query: 122 NLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHI 181
L + +S N +++S +L L N +T +P LQ L +S N +
Sbjct: 142 GLQELSVSDN----QLASLPALPSELCKLWAYNNQLT-SLPMLPSG---LQELSVSDNQL 193
Query: 182 VGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLL 241
+P L +L N+ T LP L+ L +S NR S+P L
Sbjct: 194 A-SLPTLPS---ELYKLWAYNNRLT-SLPALPSG---LKELIVSGNRL-TSLPVLPSELK 244
Query: 242 KLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNL 301
+L +S N+ LP L L N +P + L S +NL N L
Sbjct: 245 ELM---VSGNRLT-SLPMLPS---GLLSLSVYRNQL-TRLPESLIHLSSETTVNLEGNPL 296
Query: 302 SGSIPNCFEGIRGISVIDISDNQL 325
S R I+ +
Sbjct: 297 S-ERTLQAL--REITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 59/295 (20%), Positives = 99/295 (33%), Gaps = 37/295 (12%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFT 62
L L+++ NQ LP L L +L +P L L + N T
Sbjct: 82 ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPA-LPSGLCK--LW---IFGNQLT 134
Query: 63 SYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPN 122
S LP LQ VS+N ++P + L +N LT ++
Sbjct: 135 S-LPVLP---PGLQELSVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPMLPS---G 182
Query: 123 LTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIV 182
L + +S N + + +L L N +T +P L+ L +S N +
Sbjct: 183 LQELSVSDNQL-ASLPTLPS---ELYKLWAYNNRLT-SLPALPSG---LKELIVSGNRL- 233
Query: 183 GEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLK 242
+P L EL++ GN+ T LP L L + N+ +PE+L +L
Sbjct: 234 TSLPVLPS---ELKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQL-TRLPESLIHLSS 285
Query: 243 LHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLS 297
+ L N E + + + + + + L +
Sbjct: 286 ETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAA 339
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 6e-25
Identities = 45/183 (24%), Positives = 68/183 (37%), Gaps = 27/183 (14%)
Query: 144 CPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGN 203
LNV + +T +P + + L + N++ +P + L L + GN
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPE---LRTLEVSGN 91
Query: 204 QFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEK 263
Q T LP L++L +P L KL + NQ LP
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNP----LTHLPALPSGLCKLW---IFGNQLT-SLPVLPP- 141
Query: 264 LVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDN 323
L EL S N +P L KL +N L+ S+P G++ + +SDN
Sbjct: 142 --GLQELSVSDNQL-ASLPALPSELC---KLWAYNNQLT-SLPMLPSGLQ---ELSVSDN 191
Query: 324 QLQ 326
QL
Sbjct: 192 QLA 194
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 5e-22
Identities = 56/308 (18%), Positives = 98/308 (31%), Gaps = 33/308 (10%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFT 62
L L + NQ LP L+EL + N L+ +P L + N T
Sbjct: 122 GLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALPSE--LCKLWAYNNQLT 174
Query: 63 SYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPN 122
S LP LQ VS+N ++P + S L ++ +N LT ++
Sbjct: 175 S-LPMLP---SGLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLT-SLPALPS---G 222
Query: 123 LTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIV 182
L + +S N ++S +L L VS N +T +P L +L + N +
Sbjct: 223 LKELIVSGN----RLTSLPVLPSELKELMVSGNRLTS-LPMLPSG---LLSLSVYRNQLT 274
Query: 183 GEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLK 242
+P+ L L+S T + L GN + + ++ + +
Sbjct: 275 -RLPESLIHLSSETTVNLEGNPLS-ERTLQALR--EITSAPGYSGPIIRFDMAGASAPRE 330
Query: 243 LHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS 302
L L+ +P + + S + +
Sbjct: 331 TRALHLAAAD--WLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKDAGFK 388
Query: 303 GSIPNCFE 310
I +
Sbjct: 389 AQISSWLA 396
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-35
Identities = 68/352 (19%), Positives = 122/352 (34%), Gaps = 22/352 (6%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
+ + I+ + + + + + ++ L L + + + + + FN
Sbjct: 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 109
Query: 60 HFTSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALG 118
LP +V + L + N I N L + +++NNL +
Sbjct: 110 AIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ 168
Query: 119 IYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSL 178
+L + LS N + + P L NVS N ++ + ++ LD S
Sbjct: 169 ATTSLQNLQLSSNRL-THVDLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELDASH 220
Query: 179 NHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLG 238
N I + + LT L L+ N T + + L +DLS N +
Sbjct: 221 NSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFV 275
Query: 239 NLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSH 298
+ +L L +SNN+ V L + + L LD SHN + LE L L H
Sbjct: 276 KMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDH 333
Query: 299 NNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLC 350
N++ ++ + + +S N FRN A+ C
Sbjct: 334 NSIV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHC 381
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 4e-30
Identities = 55/324 (16%), Positives = 108/324 (33%), Gaps = 22/324 (6%)
Query: 7 LDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYL 65
+ ++ L N K + + + L++ + L+ +
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-I 90
Query: 66 PHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLT 124
+Q + N + P + +N L + L N+L+ P LT
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 150
Query: 125 FIDLSRNDFYGEISSNW-GKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVG 183
+ +S N+ I + L L +S N +T + + L ++S N +
Sbjct: 151 TLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-- 204
Query: 184 EIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKL 243
L ++ EL N + V+L L L N + L N L
Sbjct: 205 ---STLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAWLLNYPGL 256
Query: 244 HYLGLSNNQFVLELPKE-LEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS 302
+ LS N+ ++ K+ +L L S+N + + +L+ L+LSHN+L
Sbjct: 257 VEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL 314
Query: 303 GSIPNCFEGIRGISVIDISDNQLQ 326
+ + + + N +
Sbjct: 315 -HVERNQPQFDRLENLYLDHNSIV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 57/275 (20%), Positives = 109/275 (39%), Gaps = 21/275 (7%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
L+ L ++ N + + + T+L+ L L N L+ + + L + +N
Sbjct: 146 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPS--LFHANVSYNL 203
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
++ L + A++ S N + L ++L NNLT + + L Y
Sbjct: 204 LST-LAIPI----AVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT-DTA-WLLNY 253
Query: 121 PNLTFIDLSRNDFYGEISSN-WGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
P L +DLS N+ +I + + K +L L +S N + + L+ LDLS N
Sbjct: 254 PGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHN 311
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
H++ + + + + L L L N L + L+ L LS N ++ + L
Sbjct: 312 HLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWDCNSLRAL-- 365
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASH 274
+ + + ++ +LE + E D +
Sbjct: 366 FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPY 400
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 4e-18
Identities = 34/183 (18%), Positives = 63/183 (34%), Gaps = 13/183 (7%)
Query: 150 LNVSMNNITGGIPR--EIGNSSQLQALDLSLNHIVGEIPKE-LGKLNSLTELILRGNQFT 206
+V ++ T + E + + + + + ++P L + L L Q
Sbjct: 30 YDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE 88
Query: 207 GRLPPEI-GSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKEL-EKL 264
+ ++ L + N P N+ L L L N LP+ +
Sbjct: 89 -EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNT 146
Query: 265 VQLSELDASHNLFGGEIPFQI-CSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDN 323
+L+ L S+N I + SL+ L LS N L+ + I + ++S N
Sbjct: 147 PKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYN 202
Query: 324 QLQ 326
L
Sbjct: 203 LLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 2e-16
Identities = 28/163 (17%), Positives = 59/163 (36%), Gaps = 6/163 (3%)
Query: 168 SSQLQALDLSLNHIVGEIPK--ELGKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDL 224
D+ ++ ++ E LN+ + + + +LP + S +E L+L
Sbjct: 24 QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNL 82
Query: 225 SANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQ 284
+ + + L + N P + + L+ L N +P
Sbjct: 83 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRG 141
Query: 285 I-CSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
I + L L++S+NNL + F+ + + +S N+L
Sbjct: 142 IFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 184
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 5e-12
Identities = 22/145 (15%), Positives = 49/145 (33%), Gaps = 4/145 (2%)
Query: 184 EIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKL 243
I L ++ + E +L + + + + L + ++
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 244 HYLGLSNNQFVLELPKE-LEKLVQLSELDASHNLFGGEIPFQI-CSLKSLEKLNLSHNNL 301
L L++ Q E+ + +L N +P + ++ L L L N+L
Sbjct: 78 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTVLVLERNDL 135
Query: 302 SGSIPNCFEGIRGISVIDISDNQLQ 326
S F ++ + +S+N L+
Sbjct: 136 SSLPRGIFHNTPKLTTLSMSNNNLE 160
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 13/96 (13%), Positives = 31/96 (32%), Gaps = 2/96 (2%)
Query: 231 NSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQI-CSLK 289
+ NL + + + + E L + ++ ++P + S +
Sbjct: 17 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFR 75
Query: 290 SLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQL 325
+E LNL+ + F I + + N +
Sbjct: 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI 111
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-35
Identities = 52/360 (14%), Positives = 117/360 (32%), Gaps = 41/360 (11%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
++ LDL+ N + ++ T L+ L L N L L L+ N+
Sbjct: 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNY 91
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
+ G +++ + N+ + ++ L +N +T G
Sbjct: 92 VQE-----LLVGPSIETLHAANNNISRVSCSRGQGKKNI---YLANNKITMLRDLDEGCR 143
Query: 121 PNLTFIDLSRNDFYG-EISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
+ ++DL N+ + L LN+ N I + ++ ++L+ LDLS N
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSN 201
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFN-NSVPENLG 238
+ + E +T + LR N+ + + +LE+ DL N F+ ++ +
Sbjct: 202 KLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259
Query: 239 NLLKLHYLGLSNNQFVLELPKE----------------------LEKLVQLSELDASHNL 276
++ + + + +E ++L+ L + +
Sbjct: 260 KNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLS 319
Query: 277 FGG----EIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNS 332
G + + + +++ I + ++ L V N
Sbjct: 320 GQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNG 379
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-34
Identities = 62/327 (18%), Positives = 114/327 (34%), Gaps = 39/327 (11%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
I + + K L + N+KEL L N LS L T+
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAP--FTK------- 59
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
L+ +S N T+ L + S+L + LN+N + L +
Sbjct: 60 --------------LELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVG 98
Query: 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNH 180
P++ + + N+ +S + G + ++ N IT + G S++Q LDL LN
Sbjct: 99 PSIETLHAANNNI-SRVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 181 IVG-EIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
I + ++L L L+ N + ++ L+ LDLS+N+ + +
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL-AFMGPEFQS 212
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
+ ++ L NN+ V + K L L D N F + K+ ++
Sbjct: 213 AAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQ 270
Query: 300 NLSGSIPNCFEGIRGISVIDISDNQLQ 326
+ E ++ +
Sbjct: 271 TVKKLTGQNEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-32
Identities = 50/239 (20%), Positives = 102/239 (42%), Gaps = 14/239 (5%)
Query: 89 IPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLG 148
I +I +N + ++ ++L ++ N+ +DLS N +++ KL
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 149 TLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGR 208
LN+S N + ++ + S L+ LDL+ N++ +EL S+ L N + R
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-R 113
Query: 209 LPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFV-LELPKELEKLVQL 267
+ G + + L+ N+ + G ++ YL L N+ + + L
Sbjct: 114 VSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 268 SELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
L+ +N ++ Q+ L+ L+LS N L+ + F+ G++ I + +N+L
Sbjct: 172 EHLNLQYNFI-YDVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 29/167 (17%), Positives = 64/167 (38%), Gaps = 10/167 (5%)
Query: 160 GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDL 219
I N ++ + ++ + + + ++ EL L GN + ++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 220 EYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGG 279
E L+LS+N +L +L L L L+NN +EL + L A++N
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-S 112
Query: 280 EIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
+ + + + L++N ++ + +D+ N++
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 42/373 (11%), Positives = 103/373 (27%), Gaps = 40/373 (10%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
+ +L LDLN N + + +++ L NN+S + L N
Sbjct: 79 LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQG--KKNIYLANNK 131
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQG-TIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
T + +QY + N ++ + +L + L N + ++ +
Sbjct: 132 ITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVF 190
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
L +DLS N + + + +++ N + I + + S L+ DL N
Sbjct: 191 -AKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGN 247
Query: 180 HIV-GEIPKELGKLNSLTELILRGNQFTGRLPPE-------------------IGSLVDL 219
G + K + + + + E L
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL 307
Query: 220 EYLDLSANRFNN-------SVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDA 272
L + + + N + + Q+ + + + L+
Sbjct: 308 IALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQ 367
Query: 273 SHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNS 332
++ + L+ + + E + ++ + +
Sbjct: 368 KKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPLQLLRAIVKRYEEMYVEQ 426
Query: 333 TAFRNAPVEALKG 345
+ +N +
Sbjct: 427 QSVQNNAIRDWDM 439
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 26/259 (10%), Positives = 62/259 (23%), Gaps = 9/259 (3%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
++ + L N+ ++ ++ NL+ L N + +
Sbjct: 213 AAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGN----ISEA 116
N + +L R + G+ +
Sbjct: 272 VKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECE 331
Query: 117 LGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDL 176
ID + + I + TL + + ++L
Sbjct: 332 RENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQ 391
Query: 177 SLNHIVGEIPKELGKLNSLTELILRGNQFTGRL-PPEIGSLVDLEYLDLSANRFNNSVPE 235
+ E+ + + L L ++ + + D+ ++ E
Sbjct: 392 QAVGQI-ELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEE 450
Query: 236 N--LGNLLKLHYLGLSNNQ 252
N L L L L++
Sbjct: 451 NARLKKLNGEADLALASAN 469
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-34
Identities = 64/340 (18%), Positives = 111/340 (32%), Gaps = 25/340 (7%)
Query: 3 SLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLY------NNLSGFIPPSLEN-PMLTRP 54
L L L N + + L L+ L+ NL F +LE LT
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 55 GLDFNH---FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTG 111
+ + + + F + + + L +
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQ 318
Query: 112 NISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNIT--GGIPREIGNSS 169
+ L +L + + N S P L L++S N ++ G + ++
Sbjct: 319 FPTLKL---KSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373
Query: 170 QLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI--GSLVDLEYLDLSAN 227
L+ LDLS N ++ + L L L + + ++ SL +L YLD+S
Sbjct: 374 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHT 431
Query: 228 RFNNSVPENLGNLLKLHYLGLSNNQFVLELPKE-LEKLVQLSELDASHNLFGGEIPFQIC 286
+ L L L ++ N F + +L L+ LD S P
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 287 SLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
SL SL+ LN++ N L F+ + + I + N
Sbjct: 492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-31
Identities = 66/372 (17%), Positives = 113/372 (30%), Gaps = 60/372 (16%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHF 61
S LDL+ N + + S + L+ L L + I +
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGA-----------YQSL 75
Query: 62 TSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYP 121
+ L ++ N Q SSL ++ NL + +G
Sbjct: 76 SH-----------LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124
Query: 122 NLTFIDLSRNDF-YGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQA----LDL 176
L ++++ N ++ + L L++S N I ++ Q+ LDL
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 177 SLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPE-IGSLVDLEYLDLSANRFNN---- 231
SLN + I K L +L LR N + + I L LE L F N
Sbjct: 185 SLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243
Query: 232 -----SVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHN----------- 275
S E L NL + + ++ ++ L +S
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 303
Query: 276 --------LFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQG 327
+ F LKSL++L + N + + + +D+S N L
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSF 361
Query: 328 PVPNSTAFRNAP 339
S +
Sbjct: 362 KGCCSQSDFGTT 373
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-31
Identities = 70/345 (20%), Positives = 116/345 (33%), Gaps = 28/345 (8%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
L +LDL++ + + + + +L++L L+L N + + L +
Sbjct: 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQ-GTIPKILRNCSSLIRVRLNSNNLTGNISEALG 118
+ S + L+ V+ N Q +P+ N ++L + L+SN + L
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 119 IYPNLTF----IDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPRE-IGNSSQLQA 173
+ + +DLS N I K +L L + N + + + I + L+
Sbjct: 171 VLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEV 229
Query: 174 LDLSLNHIVGEIPKE------LGKLNSLTELILRGNQFTGRLPPEIGS---LVDLEYLDL 224
L L E E L L +LT R L I L ++ L
Sbjct: 230 HRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSL 289
Query: 225 SANRFNNSVPE-NLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPF 283
+ L + QF KL L L + N G
Sbjct: 290 VSVTIERVKDFSYNFGWQHLELVNCKFGQF------PTLKLKSLKRLTFTSNKGGNAFSE 343
Query: 284 QICSLKSLEKLNLSHNNLS--GSIPNCFEGIRGISVIDISDNQLQ 326
L SLE L+LS N LS G G + +D+S N +
Sbjct: 344 V--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-30
Identities = 65/324 (20%), Positives = 110/324 (33%), Gaps = 28/324 (8%)
Query: 1 MRSLSILDLNQNQFKG---VLPPSVSNLTNLKELVLLYNNLSGFIPPSLENP-------M 50
+ L + L +F+ + S L L L + L+ +
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283
Query: 51 LTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLT 110
++ L + G Q+ + F L++ L ++N
Sbjct: 284 VSSFSLVSVTIERVKDFSYNFG--WQHLELVNCKFGQFPTLKLKSLKRLT----FTSNKG 337
Query: 111 GNISEALGIYPNLTFIDLSRND--FYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNS 168
GN + + P+L F+DLSRN F G S + L L++S N + +
Sbjct: 338 GNAFSEVDL-PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGL 395
Query: 169 SQLQALDLSLNHIVGEIPKE--LGKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLS 225
QL+ LD +++ ++ + L +L L + I L LE L ++
Sbjct: 396 EQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMA 453
Query: 226 ANRFNNSVPEN-LGNLLKLHYLGLSNNQFVLELPKE-LEKLVQLSELDASHNLFGGEIPF 283
N F + + L L +L LS Q +L L L L+ + N
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDG 512
Query: 284 QICSLKSLEKLNLSHNNLSGSIPN 307
L SL+K+ L N S P
Sbjct: 513 IFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 8e-30
Identities = 76/354 (21%), Positives = 124/354 (35%), Gaps = 32/354 (9%)
Query: 1 MRSLSILDLNQNQFKGV-LPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-----PMLTRP 54
+++L L++ N + LP SNLTNL+ L L N + L +
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 55 GLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPK-ILRNCSSLIRVRL------NSN 107
L N + + L + N + K ++ + L RL N
Sbjct: 183 DLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241
Query: 108 NLTGNISEALGIYPNLTFI--DLSRNDFYG-EISSNWGKCPKLGTLNVSMNNITGGIPRE 164
NL AL NLT L+ D+Y +I + + + ++ I +
Sbjct: 242 NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDF 300
Query: 165 IGNSS--QLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYL 222
N L+ ++ KL SL L N+ L LE+L
Sbjct: 301 SYNFGWQHLELVNCKFGQF------PTLKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFL 352
Query: 223 DLSANRFN--NSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGE 280
DLS N + ++ L YL LS N + + L QL LD H+
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQM 411
Query: 281 IPFQI-CSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNST 333
F + SL++L L++SH + + F G+ + V+ ++ N Q
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 54/232 (23%), Positives = 88/232 (37%), Gaps = 10/232 (4%)
Query: 102 VRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGI 161
+ N + + +DLS N S ++ P+L L++S I
Sbjct: 12 YQCMELNFY---KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68
Query: 162 PREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEY 221
+ S L L L+ N I L+SL +L+ IG L L+
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 222 LDLSANRFNN-SVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLS----ELDASHNL 276
L+++ N + +PE NL L +L LS+N+ +L L Q+ LD S N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 277 FGGEIPFQICSLKSLEKLNLSHNNLSGSIP-NCFEGIRGISVIDISDNQLQG 327
I L KL L +N S ++ C +G+ G+ V + + +
Sbjct: 189 M-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-21
Identities = 39/184 (21%), Positives = 62/184 (33%), Gaps = 10/184 (5%)
Query: 149 TLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGR 208
T N IP + S + LDLS N + L L L +
Sbjct: 11 TYQCMELNFYK-IPDNLPFS--TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-T 66
Query: 209 LPPE-IGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQL 267
+ SL L L L+ N + L L L + L L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 268 SELDASHN-LFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISV----IDISD 322
EL+ +HN + ++P +L +LE L+LS N + + + + +D+S
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 323 NQLQ 326
N +
Sbjct: 187 NPMN 190
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 38/159 (23%), Positives = 59/159 (37%), Gaps = 7/159 (4%)
Query: 175 DLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVP 234
+L+ I +P S L L N S +L+ LDLS
Sbjct: 16 ELNFYKIPDNLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 235 ENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKL 294
+L L L L+ N L L +L A F I LK+L++L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 295 NLSHNNL-SGSIPNCFEGIRGISVIDISDNQLQGPVPNS 332
N++HN + S +P F + + +D+S N++Q
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-34
Identities = 63/355 (17%), Positives = 116/355 (32%), Gaps = 31/355 (8%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSL--ENPMLTRPGLDF 58
+ + L L+ N + V S L L+ L L I P L L
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 59 NHFTSYLPHNVCRG-GALQYFGVSENHFQGTI--PKILRNCSSLIRVRLNSNNLTG-NIS 114
+ L + +G L + + RN +L R+ L+ N + +
Sbjct: 83 SKIYF-LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141
Query: 115 EALGIYPNLTFIDLSRNDFYGEISSN---WGKCPKLGTLNVSMNNITGGIPREIGNSSQ- 170
+ G +L ID S N + + + + L +++ N++ + + G
Sbjct: 142 PSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200
Query: 171 -----LQALDLSLNHIVGEIPK------------ELGKLNSLTELILRGNQFTGRLPPEI 213
L+ LD+S N +I L + + +
Sbjct: 201 FRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTF 260
Query: 214 GSLVD--LEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELD 271
L + +LDLS + L L L L+ N+ + L L L+
Sbjct: 261 AGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLN 320
Query: 272 ASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
S+NL G L + ++L N+++ F+ + + +D+ DN L
Sbjct: 321 LSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-31
Identities = 76/354 (21%), Positives = 122/354 (34%), Gaps = 37/354 (10%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSL---ENPMLTRPGLD 57
+ +L ILDL ++ + P + L +L EL L + LS + LTR L
Sbjct: 72 LPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLS 131
Query: 58 FNHFTSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCS--SLIRVRLNSNNLTGNIS 114
N S H +L+ S N L +L L +N+L +S
Sbjct: 132 KNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVS 191
Query: 115 EALGIYPN------LTFIDLSRNDFYGEISSN------------WGKCPKLGTLNVSMNN 156
G N L +D+S N + +I+ N + +N
Sbjct: 192 VDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251
Query: 157 ITGGIPREI---GNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI 213
I + S ++ LDLS + + L L L L N+
Sbjct: 252 IKD-PDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAF 310
Query: 214 GSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDAS 273
L +L+ L+LS N N L K+ Y+ L N + + + L +L LD
Sbjct: 311 YGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLR 370
Query: 274 HNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQG 327
N I + S+ + LS N L ++I +S+N+L+
Sbjct: 371 DNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTA----NLIHLSENRLEN 415
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-29
Identities = 71/355 (20%), Positives = 127/355 (35%), Gaps = 39/355 (10%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTN------LKELVLLYNNLSGFIPPSLEN------ 48
++LS L N + N L+ L + N + I + N
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232
Query: 49 -------PMLTRPGLDFNHFTSYLPHNVCRGGA---LQYFGVSENHFQGTIPKILRNCSS 98
+ G F++ N G A +++ +S ++
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKD-PDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKD 291
Query: 99 LIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNIT 158
L + L N + EA NL ++LS N SSN+ PK+ +++ N+I
Sbjct: 292 LKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA 351
Query: 159 GGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVD 218
+ +LQ LDL N + + + S+ ++ L GN+ LP +
Sbjct: 352 IIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-TLPKINLTA-- 403
Query: 219 LEYLDLSANRFNN-SVPENLGNLLKLHYLGLSNNQFV-LELPKELEKLVQLSELDASHNL 276
+ LS NR N + L + L L L+ N+F + + L +L N+
Sbjct: 404 -NLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENM 462
Query: 277 FGGEIPFQICS-----LKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
++C L L+ L L+HN L+ P F + + + ++ N+L
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-24
Identities = 51/273 (18%), Positives = 91/273 (33%), Gaps = 27/273 (9%)
Query: 80 VSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISS 139
++ F + ++ + ++ R+ L+ N + + + L ++L I
Sbjct: 8 IAFYRFCN-LTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 140 NW-GKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEI--PKELGKLNSLT 196
P L L++ + I P L L L + + L +LT
Sbjct: 67 EAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126
Query: 197 ELILRGNQFTG-RLPPEIGSLVDLEYLDLSANRFNNSVPENLGNL--LKLHYLGLSNNQF 253
L L NQ L P G L L+ +D S+N+ L L L + L+ N
Sbjct: 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSL 186
Query: 254 VLELPKELEKL------VQLSELDASHNLFGGEIP------------FQICSLKSLEKLN 295
+ + K + L LD S N + +I F + +
Sbjct: 187 YSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAG 246
Query: 296 LSHNNLSGSIPNCFEGIRGISV--IDISDNQLQ 326
+N+ N F G+ SV +D+S +
Sbjct: 247 FGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF 279
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 75/352 (21%), Positives = 124/352 (35%), Gaps = 36/352 (10%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
++ L +L+L N+ + + L NL+ L L YN L + P + L N
Sbjct: 289 LKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 60 HFTSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALG 118
H + + LQ + +N + S+ + L+ N L L
Sbjct: 349 HIAI-IQDQTFKFLEKLQTLDLRDNALTT-----IHFIPSIPDIFLSGNKLVTLPKINL- 401
Query: 119 IYPNLTFIDLSRNDFYG-EISSNWGKCPKLGTLNVSMNNITGGIPREI-GNSSQLQALDL 176
I LS N +I + P L L ++ N + + + L+ L L
Sbjct: 402 ---TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFL 458
Query: 177 SLNHIVGEIPKEL-----GKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSANRFN 230
N + EL L+ L L L N LPP + L L L L++NR
Sbjct: 459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLT 517
Query: 231 NSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKS 290
+L L+ L +S NQ + P LS LD +HN F C L +
Sbjct: 518 VLSHNDLPANLE--ILDISRNQLLAPNPDVFVS---LSVLDITHNKF-----ICECELST 567
Query: 291 L-EKLNLSHNNLSGSIPNCF----EGIRGISVIDISDNQLQGPVPNSTAFRN 337
LN ++ ++G + + + G+S+ +S + +
Sbjct: 568 FINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFS 619
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 1e-13
Identities = 26/128 (20%), Positives = 45/128 (35%), Gaps = 10/128 (7%)
Query: 213 IGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDA 272
G + + +L+ VP+ L +L LS N L QL L+
Sbjct: 5 DGRIAFYRFCNLT------QVPQVLNTTERLL---LSFNYIRTVTASSFPFLEQLQLLEL 55
Query: 273 SHNLFGGEIPFQIC-SLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPN 331
I + +L +L L+L + + P+ F+G+ + + + L V
Sbjct: 56 GSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLK 115
Query: 332 STAFRNAP 339
FRN
Sbjct: 116 DGYFRNLK 123
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-34
Identities = 68/352 (19%), Positives = 120/352 (34%), Gaps = 38/352 (10%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPS------------LEN 48
+R + L L+ ++ +L L++++ L L NL+ F L
Sbjct: 171 IRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF 230
Query: 49 PMLTRPGLDFNHFTSYLPHNV---------CRGGALQYFGVSENHFQGTIPKILRNCSSL 99
FN L + + C L F SE+ + K+ ++
Sbjct: 231 RGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV--ETVTI 288
Query: 100 IRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITG 159
R+ + L ++S + + I + + + S L L++S N +
Sbjct: 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVE 348
Query: 160 GIPRE---IGNSSQLQALDLSLNHI--VGEIPKELGKLNSLTELILRGNQFTGRLPPEIG 214
+ G LQ L LS NH+ + + + L L +LT L + N F +P
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQ 407
Query: 215 SLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASH 274
+ +L+LS+ V + L L +SNN L +L EL S
Sbjct: 408 WPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLP---RLQELYISR 460
Query: 275 NLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
N +P L + +S N L F+ + + I + N
Sbjct: 461 NKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-32
Identities = 55/352 (15%), Positives = 118/352 (33%), Gaps = 27/352 (7%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSL--ENPMLTRPGLDF 58
+ SL LDL+ N + L++LK L L+ N SL L +
Sbjct: 73 LGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGN 132
Query: 59 NHFTSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEAL 117
S + G +L + + + L++ + + L+ + +
Sbjct: 133 VETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFA 192
Query: 118 GIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITG----------GIPREIGN 167
I ++ +++L + S + + + R I
Sbjct: 193 DILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILE 252
Query: 168 SSQLQALDLSLNHIVG------EIPKELGKLN--SLTELILRGNQFTGRLPPEIGSLVDL 219
S+++ D +LN + ++ ELGK+ ++ L + L L +
Sbjct: 253 LSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKV 312
Query: 220 EYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQF---VLELPKELEKLVQLSELDASHNL 276
+ + + ++ +L L +L LS N L+ L L S N
Sbjct: 313 KRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNH 372
Query: 277 FG--GEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
+ + +LK+L L++S N +P+ + + +++S ++
Sbjct: 373 LRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-29
Identities = 54/363 (14%), Positives = 119/363 (32%), Gaps = 30/363 (8%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSL--ENPMLTRPGLDFN 59
++ LDL+ N+ + + NL+ L+L + ++ I L L N
Sbjct: 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDN 84
Query: 60 HFTSYLPHNVCRG-GALQYFGVSENHFQG-TIPKILRNCSSLIRVRLNSNNLTGNISE-A 116
H +S L + +L+Y + N +Q + + N ++L +R+ + I
Sbjct: 85 HLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRID 143
Query: 117 LGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDL 176
+L +++ S + + L + ++ + S ++ L+L
Sbjct: 144 FAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLEL 203
Query: 177 SLNHIVGEIPKELGKLNSLTELILRGNQFTG----------RLPPEIGSLVDLEYLDLSA 226
++ L + + + + +L I L ++E+ D +
Sbjct: 204 RDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTL 263
Query: 227 NRFNNSVPENLG--------NLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFG 278
N + P + + L + +L L ++ + ++
Sbjct: 264 NGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF 323
Query: 279 GEIPFQICS-LKSLEKLNLSHNNLSGSI---PNCFEGIRGISVIDISDNQLQGPVPNSTA 334
+P LKSLE L+LS N + C + + +S N L+
Sbjct: 324 -LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382
Query: 335 FRN 337
Sbjct: 383 LLT 385
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-28
Identities = 53/358 (14%), Positives = 122/358 (34%), Gaps = 26/358 (7%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHF 61
+ + D F + P ++ +K L L +N ++ L L L +
Sbjct: 6 ASGVCDGRSRSFTSI-PSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62
Query: 62 TSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTG-NISEALGI 119
+ + + G+L++ +S+NH SSL + L N ++
Sbjct: 63 NT-IEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121
Query: 120 YPNLTFIDLSRNDFYGEISSNW-GKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSL 178
NL + + + + EI L L + ++ + + + + L L L
Sbjct: 122 LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHL 181
Query: 179 NHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLG 238
+ + L+S+ L LR + + A R + E+
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241
Query: 239 NLLKLHYLGLSNNQFVL----------------ELPKELEKL--VQLSELDASHNLFGGE 280
LLKL L ++ ++ EL K+ V + L +
Sbjct: 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYD 301
Query: 281 IPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNA 338
+ L+ ++++ + ++ + + + ++ + +D+S+N + ++A + A
Sbjct: 302 LSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 45/241 (18%), Positives = 80/241 (33%), Gaps = 7/241 (2%)
Query: 95 NCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSM 154
+C + S + T S G+ + +DLS N + C L L +
Sbjct: 3 SCDASGVCDGRSRSFT---SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 155 NNITGGIPREI-GNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTG-RLPPE 212
+ I I + + L+ LDLS NH+ G L+SL L L GN + +
Sbjct: 60 SRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 213 IGSLVDLEYLDLSANRFNNSVPEN-LGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELD 271
+L +L+ L + + + L L+ L + + L+ + + L
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 272 ASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPN 331
+ + L S+ L L NL+ + S + +
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238
Query: 332 S 332
S
Sbjct: 239 S 239
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 61/293 (20%), Positives = 122/293 (41%), Gaps = 44/293 (15%)
Query: 433 RATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALT 491
R DF+ C+G GG G V+ A+ AIK+ P ++ +++ + EVKAL
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP---NRELAREKVMREVKALA 58
Query: 492 EIRHRNIVKFYGFC------------SHARHSFLVYELLERGSLAAILSSDTAAQELGWS 539
++ H IV+++ S + ++ +L + +L ++ +E S
Sbjct: 59 KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 540 QRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK------ 593
+++ +A+A+ +LH ++H+D+ N+ ++ V DFG+ +
Sbjct: 119 VCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 594 ------PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSL 647
P + T GT Y++PE + + K D++S G+++ E + +P F +
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP--FSTQ 230
Query: 648 ISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
+ TD+ + P L + ++ L+ SP RP
Sbjct: 231 MERVRTLTDVRNLKF--PPLFTQKYPCEYVMVQ------DMLSPSPMERPEAI 275
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-34
Identities = 55/287 (19%), Positives = 111/287 (38%), Gaps = 50/287 (17%)
Query: 433 RATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALT 491
R DF IG+GG G V++A+ G+ IK+ + ++ EVKAL
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY--------NNEKAEREVKALA 59
Query: 492 EIRHRNIVKFYGF----------------CSHARHSFLVYELLERGSLAAILSSDTAAQE 535
++ H NIV + G S + F+ E ++G+L + ++
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EK 118
Query: 536 LGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595
L + + + + + Y+H ++++D+ N+ L + + DFG+ LK +
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 596 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLE-AIKGKHPRDFLSLISSSSLN 654
GT Y++PE + ++ D+Y+ G+++ E + +
Sbjct: 176 GKRTR-SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT----- 229
Query: 655 TDIALDEILDPRLPPP-SRSVQEKLISIMEVAFSCLNESPESRPTMK 700
++ D + + + L+ L++ PE RP
Sbjct: 230 ------DLRDGIISDIFDKKEKT-LLQ------KLLSKKPEDRPNTS 263
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-33
Identities = 69/330 (20%), Positives = 122/330 (36%), Gaps = 33/330 (10%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNH 60
+LDL +N+ K + ++ +L+EL L N +S P + N L GL N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 61 FTSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
+P V G L +SEN + + ++ +L + + N+L A
Sbjct: 92 LKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSG 150
Query: 120 YPNLTFIDLSRNDFYGEISSNW-GKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSL 178
+L + L + + I + L L + NI +L+ L++S
Sbjct: 151 LNSLEQLTLEKCNL-TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209
Query: 179 NHIVGEIPKELGKLNSLTELILRGNQFTGRLPPE-IGSLVDLEYLDLSANRFNNSVPENL 237
+ + +LT L + T +P + LV L +L+LS N + L
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSML 268
Query: 238 GNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLS 297
LL+L + L Q L+ ++ F G L L LN+S
Sbjct: 269 HELLRLQEIQLVGGQ--------------LAVVEP--YAFRG--------LNYLRVLNVS 304
Query: 298 HNNLSGSIP-NCFEGIRGISVIDISDNQLQ 326
N L+ ++ + F + + + + N L
Sbjct: 305 GNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-28
Identities = 49/247 (19%), Positives = 91/247 (36%), Gaps = 10/247 (4%)
Query: 97 SSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSN-WGKCPKLGTLNVSMN 155
+ + L N + + +P+L ++L+ N + + L TL + N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSN 90
Query: 156 NITGGIPREI-GNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI- 213
+ IP + S L LD+S N IV + L +L L + N +
Sbjct: 91 RLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAF 148
Query: 214 GSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDAS 273
L LE L L + E L +L L L L + ++L +L L+ S
Sbjct: 149 SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEIS 208
Query: 274 HNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIP-NCFEGIRGISVIDISDNQLQGPVPNS 332
H + + +L L+++H NL+ ++P + + +++S N + + S
Sbjct: 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIST-IEGS 266
Query: 333 TAFRNAP 339
Sbjct: 267 -MLHELL 272
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-25
Identities = 56/262 (21%), Positives = 109/262 (41%), Gaps = 15/262 (5%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSL--ENPMLTRPGLDF 58
+ +L L L N+ K + + L+NL +L + N + + + + L +
Sbjct: 79 LFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGD 137
Query: 59 NHFTSYLPHNVCRG-GALQYFGVSENHFQGTIPK-ILRNCSSLIRVRLNSNNLTGNISEA 116
N + H G +L+ + + + +IP L + LI +RL N+ +
Sbjct: 138 NDLVY-ISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYS 195
Query: 117 LGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPRE-IGNSSQLQALD 175
L +++S + ++ N L +L+++ N+T +P + + L+ L+
Sbjct: 196 FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLN 254
Query: 176 LSLNHIVGEIPKE-LGKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSANRFNNSV 233
LS N I I L +L L E+ L G Q + P L L L++S N+ ++
Sbjct: 255 LSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQL-TTL 311
Query: 234 PENL-GNLLKLHYLGLSNNQFV 254
E++ ++ L L L +N
Sbjct: 312 EESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-19
Identities = 46/171 (26%), Positives = 67/171 (39%), Gaps = 12/171 (7%)
Query: 161 IPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVDL 219
+P I ++ + LDL N I E L EL L N + + P +L +L
Sbjct: 26 VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNL 82
Query: 220 EYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGG 279
L L +NR L L L +S N+ V+ L + L L L+ N
Sbjct: 83 RTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL-V 141
Query: 280 EIP---FQICSLKSLEKLNLSHNNLSGSIP-NCFEGIRGISVIDISDNQLQ 326
I F L SLE+L L NL+ SIP + G+ V+ + +
Sbjct: 142 YISHRAFS--GLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN 189
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 70/272 (25%), Positives = 118/272 (43%), Gaps = 40/272 (14%)
Query: 437 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI-EVKALTEIR 494
F IG G G V++ + + +VVAIK + ++ D+ E + E+ L++
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI----IDLEEAEDEIEDIQQEITVLSQCD 78
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
+ K+YG +++ E L GS +L L +Q +++ + L Y
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDY 134
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
LH + +H+DI + N+LL E +ADFG+A L F GT ++APE+
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGK------HPRDFLSLISSSSLNTDIALDEILDPRLP 668
K D++S G+ +E +G+ HP L LI P+
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI----------------PKNN 235
Query: 669 PPSRSVQEKLISIME--VAFSCLNESPESRPT 698
PP +++ ++ V +CLN+ P RPT
Sbjct: 236 PP--TLEGNYSKPLKEFVE-ACLNKEPSFRPT 264
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-33
Identities = 67/276 (24%), Positives = 113/276 (40%), Gaps = 43/276 (15%)
Query: 444 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G G V+ L + VA+K LP D +FL E + L + H NIV+
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK---AKFLQEARILKQYSHPNIVRLI 178
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
G C+ + ++V EL++ G L ++ L + ++ A + YL C
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKCC-- 234
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN-----------WTEFAGTYGYVAP 611
+H+D++++N L+ + ++DFG+++ WT AP
Sbjct: 235 -IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT---------AP 284
Query: 612 ELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDP-RLPP 669
E + + + DV+SFG+L+ E G P LS N + + RLP
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS-------NQQT-REFVEKGGRLPC 336
Query: 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
P + + +ME C P RP+ + Q+
Sbjct: 337 P-ELCPDAVFRLME---QCWAYEPGQRPSFSTIYQE 368
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 64/324 (19%), Positives = 122/324 (37%), Gaps = 41/324 (12%)
Query: 404 GDRQSSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAE-LPSGQV 462
G + + G + L F+G ++ + +G GG V E L G
Sbjct: 2 GSSHHHHHHSSGREN-LYFQGH----MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHF 56
Query: 463 VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS----FLVYELL 518
A+K+ + C + D++E E H NI++ +C R + +L+
Sbjct: 57 YALKR----ILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112
Query: 519 ERGSLAAILSSDTAAQE-LGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL 577
+RG+L + L Q + ++ G+ L +H H+D+ N+LL
Sbjct: 113 KRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGD 169
Query: 578 EYEAHVADFGIAKFLKPESSN---------WTEFAGTYGYVAPEL----AYTMKITEKCD 624
E + + D G W T Y APEL ++ + I E+ D
Sbjct: 170 EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV-IDERTD 228
Query: 625 VYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEV 684
V+S G ++ + G+ P + + +++ P+ P S ++ + L++ M
Sbjct: 229 VWSLGCVLYAMMFGEGP--YDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQ-LLNSM-- 283
Query: 685 AFSCLNESPESRPTMKVVTQQVRI 708
+ P RP + ++ Q+
Sbjct: 284 ----MTVDPHQRPHIPLLLSQLEA 303
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 71/313 (22%), Positives = 123/313 (39%), Gaps = 44/313 (14%)
Query: 400 KSDSGDRQSSNQNPHGLFSILNFEGKLVYDEIVRATN---DFDAQYCIGNGGHGSVYRA- 455
SG + + + + K +V + D+ IG G G V A
Sbjct: 6 HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR 65
Query: 456 ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL-- 513
E SG+ VA+K + + ++ EV + + +H N+V+ Y S+ L
Sbjct: 66 EKHSGRQVAVKM----MDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK--SYLVGEELWV 119
Query: 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNL 573
+ E L+ G+L I+S L Q V + V AL+YLH ++H+DI S ++
Sbjct: 120 LMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSI 172
Query: 574 LLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVL 633
LL L+ ++DFG + + GT ++APE+ + D++S G++V+
Sbjct: 173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVI 232
Query: 634 EAIKGK------HPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAF- 686
E + G+ P + + PPP K+ ++ F
Sbjct: 233 EMVDGEPPYFSDSPVQAMKRL----------------RDSPPPKLKNSHKVSPVLR-DFL 275
Query: 687 -SCLNESPESRPT 698
L P+ R T
Sbjct: 276 ERMLVRDPQERAT 288
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 60/273 (21%), Positives = 103/273 (37%), Gaps = 35/273 (12%)
Query: 435 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI 493
+ Q +G G G V+R + +G A+K ++ + + E+ A +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK---------KVRLEVFRVEELVACAGL 107
Query: 494 RHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALS 553
IV YG + ELLE GSL ++ E + + + + L
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLE 164
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLE-YEAHVADFGIAKFLKPESSNWTE-----FAGTYG 607
YLH I+H D+ + N+LL + A + DFG A L+P+ + GT
Sbjct: 165 YLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 608 YVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667
++APE+ K D++S ++L + G HP + +I
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW--------TQYFRGPLCLKI--ASE 271
Query: 668 PPPSRSVQEKLISIMEVAF--SCLNESPESRPT 698
PPP R + + + L + P R +
Sbjct: 272 PPPIREIPPSC-APLTAQAIQEGLRKEPVHRAS 303
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 65/271 (23%), Positives = 113/271 (41%), Gaps = 22/271 (8%)
Query: 436 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKE---FLIEVKALT 491
+F + IG G VYRA L G VA+KK + + D K + E+ L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKK----VQIFDLMDAKARADCIKEIDLLK 87
Query: 492 EIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQE-LGWSQRMNVIKGVAD 550
++ H N++K+Y +V EL + G L+ ++ + + +
Sbjct: 88 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVA 610
AL ++H ++H+DI N+ + + D G+ +F +++ GT Y++
Sbjct: 148 ALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 204
Query: 611 PELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLS-LISSSSLNTDIALDEILDPRLPP 669
PE + K D++S G L+ E + P F ++ SL I + P LP
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKIEQCDY--PPLPS 260
Query: 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
S E+L ++ C+N PE RP +
Sbjct: 261 DHYS--EELRQLVN---MCINPDPEKRPDVT 286
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 76/283 (26%), Positives = 122/283 (43%), Gaps = 40/283 (14%)
Query: 428 YDEIVRATN---DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEF 483
DE FD +G G +GSVY+A +GQ+VAIK+ +D +E
Sbjct: 18 LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ------VPVESDLQEI 71
Query: 484 LIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMN 543
+ E+ + + ++VK+YG ++V E GS++ I+ + L +
Sbjct: 72 IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIAT 129
Query: 544 VIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFA 603
+++ L YLH +H+DI + N+LL+ E A +ADFG+A L +
Sbjct: 130 ILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI 186
Query: 604 GTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGK------HPRDFLSLISSSSLNTDI 657
GT ++APE+ + D++S G+ +E +GK HP + +I
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI--------- 237
Query: 658 ALDEILDPRLPPPSRSVQEKLISIMEVAF--SCLNESPESRPT 698
P PPP+ E S F CL +SPE R T
Sbjct: 238 -------PTNPPPTFRKPELW-SDNFTDFVKQCLVKSPEQRAT 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-32
Identities = 65/287 (22%), Positives = 116/287 (40%), Gaps = 51/287 (17%)
Query: 437 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RH 495
F + +G+G G++ + + VA+K+ C AD+ EV+ L E H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI--LPECFSFADR-----EVQLLRESDEH 77
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLA-AILSSDTAAQELGWSQRMNVIKGVADALSY 554
N+++++ + ++ EL +L + D A L + + +++ L++
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL---EPITLLQQTTSGLAH 133
Query: 555 LHHDCFPPIVHQDISSKNLLL-----DLEYEAHVADFGIAKFLKPESS---NWTEFAGTY 606
LH IVH+D+ N+L+ + +A ++DFG+ K L + GT
Sbjct: 134 LHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 607 GYVAPEL---AYTMKITEKCDVYSFGVLVLEAI-KGKHP------RDFLSLISSSSLNTD 656
G++APE+ T D++S G + I +G HP R L+ + S
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS---- 246
Query: 657 IALDEILDPRLPPPSRSVQEK-LISIMEVAFSCLNESPESRPTMKVV 702
LD P V + LI + P+ RP+ K V
Sbjct: 247 ------LDCLHPEKHEDVIARELIE------KMIAMDPQKRPSAKHV 281
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-32
Identities = 65/272 (23%), Positives = 114/272 (41%), Gaps = 25/272 (9%)
Query: 436 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
D++ Y IG G +G + G+++ K+ A+++ + EV L E++
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVSEVNLLRELK 63
Query: 495 HRNIVKFYG--FCSHARHSFLVYELLERGSLAAILSSDTAAQE-LGWSQRMNVIKGVADA 551
H NIV++Y ++V E E G LA++++ T ++ L + V+ + A
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 552 LSYLH--HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYV 609
L H D ++H+D+ N+ LD + + DFG+A+ L ++S F GT Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 610 APELAYTMKITEKCDVYSFGVLVLEAIKGKHP---RDFLSLISSSSLNTDIALDEILDPR 666
+PE M EK D++S G L+ E P L I + +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK-----------IREGK 232
Query: 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
++L I+ LN RP+
Sbjct: 233 FRRIPYRYSDELNEIIT---RMLNLKDYHRPS 261
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 71/275 (25%), Positives = 117/275 (42%), Gaps = 41/275 (14%)
Query: 435 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI 493
+ IG G G+VY A ++ +GQ VAI++ + Q ++ + E+ + E
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQ----MNLQQQPKKELIINEILVMREN 74
Query: 494 RHRNIVKFYGFCSHARHSFL--VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADA 551
++ NIV + S+ L V E L GSL +++ + Q V + A
Sbjct: 75 KNPNIVNYLD--SYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQA 128
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAP 611
L +LH + ++H+DI S N+LL ++ + DFG + PE S + GT ++AP
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 612 ELAYTMKITEKCDVYSFGVLVLEAIKGK------HPRDFLSLISSSSLNTDIALDEILDP 665
E+ K D++S G++ +E I+G+ +P L LI
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI----------------A 229
Query: 666 RLPPPSRSVQEKLISIMEVAF--SCLNESPESRPT 698
P EKL S + F CL E R +
Sbjct: 230 TNGTPELQNPEKL-SAIFRDFLNRCLEMDVEKRGS 263
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 59/269 (21%), Positives = 104/269 (38%), Gaps = 28/269 (10%)
Query: 436 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
+ IG G G + G+ IK+ + +++E EV L ++
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI--NISRMSSKEREESRREVAVLANMK 81
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAA--QELGWSQRMNVIKGVADAL 552
H NIV++ ++V + E G L +++ QE Q ++ + AL
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE---DQILDWFVQICLAL 138
Query: 553 SYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE 612
++H I+H+DI S+N+ L + + DFGIA+ L GT Y++PE
Sbjct: 139 KHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 613 LAYTMKITEKCDVYSFGVLVLEAIKGKHP---RDFLSLISSSSLNTDIALDEILDPRLPP 669
+ K D+++ G ++ E KH +L+ I+ PP
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK-----------IISGSFPP 244
Query: 670 PSRSVQEKLISIMEVAFSCLNESPESRPT 698
S L S++ +P RP+
Sbjct: 245 VSLHYSYDLRSLVS---QLFKRNPRDRPS 270
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 70/257 (27%), Positives = 112/257 (43%), Gaps = 18/257 (7%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G GG +VY AE VAIK P + ++ F EV +++ H+NIV
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSSQLSHQNIVSMI 77
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
+LV E +E +L+ + S L +N + D + + H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM---R 131
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFA-GTYGYVAPELAYTMKITE 621
IVH+DI +N+L+D + DFGIAK L S T GT Y +PE A E
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 622 KCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKL-IS 680
D+YS G+++ E + G+ P + + +S IA+ I D +P + V++ + S
Sbjct: 192 CTDIYSIGIVLYEMLVGEPPFNGETAVS-------IAIKHIQDS-VPNVTTDVRKDIPQS 243
Query: 681 IMEVAFSCLNESPESRP 697
+ V + +R
Sbjct: 244 LSNVILRATEKDKANRY 260
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 65/288 (22%), Positives = 127/288 (44%), Gaps = 43/288 (14%)
Query: 428 YDEIVRATN---DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEF 483
Y+ + R + ++ +G+G G VY+A +G + A K + + +++
Sbjct: 8 YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKV----IETKSEEELEDY 63
Query: 484 LIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMN 543
++E++ L H IVK G H +++ E G++ AI+ + L Q
Sbjct: 64 IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQV 121
Query: 544 VIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFA 603
V + + +AL++LH I+H+D+ + N+L+ LE + +ADFG++ F
Sbjct: 122 VCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI 178
Query: 604 GTYGYVAPELAYTMKITE-----KCDVYSFGVLVLEAIKGK------HPRDFLSLISSSS 652
GT ++APE+ + + K D++S G+ ++E + + +P L I
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI---- 234
Query: 653 LNTDIALDEILDPRLPPPSRSVQEKLISIMEVAF--SCLNESPESRPT 698
+ PP+ K S+ F L+++PE+RP+
Sbjct: 235 ------------AKSDPPTLLTPSKW-SVEFRDFLKIALDKNPETRPS 269
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 65/264 (24%), Positives = 112/264 (42%), Gaps = 28/264 (10%)
Query: 443 CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKF 501
+G G +G VY +L + +AIK+ +P + E+ ++H+NIV++
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKE----IPERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 502 YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFP 561
G S + E + GSL+A+L S + K + + L YLH +
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ-- 142
Query: 562 PIVHQDISSKNLLLDLEYEAHV--ADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKI 619
IVH+DI N+L++ Y + +DFG +K L + F GT Y+APE+
Sbjct: 143 -IVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 620 --TEKCDVYSFGVLVLEAIKGKHP-RDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQE 676
+ D++S G ++E GK P + + A+ ++ ++ P + E
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--------AMFKVGMFKVHPE---IPE 249
Query: 677 KLISIMEVAF--SCLNESPESRPT 698
+ S AF C P+ R
Sbjct: 250 SM-SAEAKAFILKCFEPDPDKRAC 272
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-30
Identities = 66/326 (20%), Positives = 106/326 (32%), Gaps = 36/326 (11%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
+ L+ L N + +S TNL L N L+ LT D N
Sbjct: 63 LTGLTKLICTSNNITTL---DLSQNTNLTYLACDSNKLTNL--DVTPLTKLTYLNCDTNK 117
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
T L + L Y + N I + + + L + + N + +
Sbjct: 118 LTK-LDVSQNP--LLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKL--DVTPQ 169
Query: 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNH 180
LT +D S N + + L LN NNIT + + + QL LD S N
Sbjct: 170 TQLTTLDCSFNKI---TELDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNK 223
Query: 181 IVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNL 240
+ EI + L LT N T L + +L L L +L +
Sbjct: 224 LT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEI---DLTHN 274
Query: 241 LKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNN 300
+L Y + + EL ++ QL LD E+ L L L++
Sbjct: 275 TQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGI-TELDLS--QNPKLVYLYLNNTE 329
Query: 301 LSGSIPNCFEGIRGISVIDISDNQLQ 326
L+ + + + + +Q
Sbjct: 330 LT-ELD--VSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-28
Identities = 54/327 (16%), Positives = 110/327 (33%), Gaps = 37/327 (11%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
+L+ L + N+ + V+ LT L L N L+ +NP+LT N
Sbjct: 84 NTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTKL--DVSQNPLLTYLNCARNT 138
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
T + + L N + + + L + + N +T +
Sbjct: 139 LTE-IDVSHNT--QLTELDCHLN--KKITKLDVTPQTQLTTLDCSFNKIT---ELDVSQN 190
Query: 121 PNLTFIDLSRNDFYGEISS-NWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
L ++ N I+ + + +L L+ S N +T I + +QL D S+N
Sbjct: 191 KLLNRLNCDTN----NITKLDLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVN 243
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
+ E+ + L+ LT L + + L Y ++ +
Sbjct: 244 PL-TELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGC--RKIKELDVTH 295
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299
+L+ L EL L + +L L ++ E+ + L+ L+ +
Sbjct: 296 NTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL-TELD--VSHNTKLKSLSCVNA 349
Query: 300 NLSGSIPNCFEGIRGISVIDISDNQLQ 326
++ + I ++ ++ Q
Sbjct: 350 HIQ-DFSS-VGKIPALNNNFEAEGQTI 374
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-27
Identities = 56/341 (16%), Positives = 116/341 (34%), Gaps = 48/341 (14%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHF 61
S + S L L L ++++ + + LT+ N+
Sbjct: 21 ASEVAAAFEMQATDTI---SEEQLATLTSLDCHNSSITD-MTGIEKLTGLTKLICTSNNI 76
Query: 62 TSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYP 121
T+ ++ + L Y N + + + L + ++N LT + P
Sbjct: 77 TTL---DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNP 127
Query: 122 NLTFIDLSRNDFYGEISS-NWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNH 180
LT+++ +RN ++ + +L L+ +N + + +QL LD S N
Sbjct: 128 LLTYLNCARN----TLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNK 181
Query: 181 IVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNL 240
I E+ + + L L N T ++ + L +LD S+N+ ++ L
Sbjct: 182 IT-ELD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLTEI---DVTPL 232
Query: 241 LKLHYLGLSNNQFV---LELPKELEKLV----QLSELDASHNL---------FGGEIPFQ 284
+L Y S N + +L L L E+D +HN
Sbjct: 233 TQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELD 292
Query: 285 ICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQL 325
+ L L+ ++ + + + +++ +L
Sbjct: 293 VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL 330
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-25
Identities = 57/326 (17%), Positives = 100/326 (30%), Gaps = 48/326 (14%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
L+ L+ +N + VS+ T L EL N LT FN
Sbjct: 126 NPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKIT-KLDVTPQTQLTTLDCSFNK 181
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
T +V + L N+ + L L + +SN LT I +
Sbjct: 182 ITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPL 232
Query: 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNH 180
LT+ D S N + KL TL+ ++ EI + Q +
Sbjct: 233 TQLTYFDCSVNPL---TELDVSTLSKLTTLHCIQTDLL-----EIDLTHNTQLIYFQAEG 284
Query: 181 IVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNL 240
++ L L + T L + L YL L+ ++ +
Sbjct: 285 CRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE---LDVSHN 338
Query: 241 LKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNN 300
KL L N + + K+ L+ + ++ K L++N+
Sbjct: 339 TKLKSLSCVNAHI-QDFS-SVGKIPALNNNFEAEG-----------QTITMPKETLTNNS 385
Query: 301 LSGSIPNCFEGIRGISVIDISDNQLQ 326
L+ ++ ++D N +
Sbjct: 386 LTIAVSP--------DLLDQFGNPMN 403
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-18
Identities = 38/205 (18%), Positives = 76/205 (37%), Gaps = 19/205 (9%)
Query: 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNH 180
N + + + + + L +L+ ++IT + I + L L + N+
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN 75
Query: 181 IVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNL 240
I + L + +LT L N+ T L + L L YL+ N+ ++
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKL---DVSQN 126
Query: 241 LKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNN 300
L YL + N E+ + QL+ELD N ++ L L+ S N
Sbjct: 127 PLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDV--TPQTQLTTLDCSFNK 181
Query: 301 LSGSIPNCFEGIRGISVIDISDNQL 325
++ + + ++ ++ N +
Sbjct: 182 IT-ELD--VSQNKLLNRLNCDTNNI 203
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 72/296 (24%), Positives = 124/296 (41%), Gaps = 62/296 (20%)
Query: 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI-EVKALTEI 493
+D++ Q IG+G V A P + VAIK+ + ++ + L+ E++A+++
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKR----INLEKCQTSMDELLKEIQAMSQC 70
Query: 494 RHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMN------VIKG 547
H NIV +Y +LV +LL GS+ I+ A+ S ++ +++
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKH-IVAKGEHKSGVLDESTIATILRE 129
Query: 548 VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTE-----F 602
V + L YLH + +H+D+ + N+LL + +ADFG++ FL F
Sbjct: 130 VLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 603 AGTYGYVAPEL-----AYTMKITEKCDVYSFGVLVLEAIKGK------HPRDFLSLISSS 651
GT ++APE+ Y K D++SFG+ +E G P L L
Sbjct: 187 VGTPCWMAPEVMEQVRGY----DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT--- 239
Query: 652 SLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFS---------CLNESPESRPT 698
+ PPS + +++ + CL + PE RPT
Sbjct: 240 -------------LQNDPPSLETGVQDKEMLK-KYGKSFRKMISLCLQKDPEKRPT 281
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 72/281 (25%), Positives = 121/281 (43%), Gaps = 36/281 (12%)
Query: 435 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI 493
F+ +GNG +G VY+ + +GQ+ AIK + D +++E E+ L +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGD---EEEEIKQEINMLKKY 77
Query: 494 -RHRNIVKFYG------FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIK 546
HRNI +YG +LV E GS+ ++ + T L + +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICR 136
Query: 547 GVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTY 606
+ LS+LH ++H+DI +N+LL E + DFG++ L F GT
Sbjct: 137 EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 193
Query: 607 GYVAPELAYTMKITE-----KCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDE 661
++APE+ + + K D++S G+ +E +G P ++ AL
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL--------CDMHPMRALFL 245
Query: 662 ILDPRLPPPSRSVQEKLISIMEVAF--SCLNESPESRPTMK 700
I PR P P ++ K S +F SCL ++ RP +
Sbjct: 246 I--PRNPAP--RLKSKKWSKKFQSFIESCLVKNHSQRPATE 282
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 72/302 (23%), Positives = 114/302 (37%), Gaps = 59/302 (19%)
Query: 433 RATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALT 491
R +DF+ +G G G V +A + AIKK + + L EV L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK----IRHTE-EKLSTILSEVMLLA 57
Query: 492 EIRHRNIVKFYGFCSHARHS-------------FLVYELLERGSLA-AILSSDTAAQELG 537
+ H+ +V++Y R+ F+ E E G+L I S + Q
Sbjct: 58 SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR-- 115
Query: 538 WSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK---- 593
+ + + + +ALSY+H I+H+D+ N+ +D + DFG+AK +
Sbjct: 116 -DEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 594 ----------PESSNWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLVLE----AIKG 638
S N T GT YVA E L T EK D+YS G++ E G
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTG 231
Query: 639 KHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
+ L + S S+ P V++K+I ++ P RP
Sbjct: 232 MERVNILKKLRSVSIE--------FPPDFDDNKMKVEKKIIR------LLIDHDPNKRPG 277
Query: 699 MK 700
+
Sbjct: 278 AR 279
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 56/237 (23%), Positives = 101/237 (42%), Gaps = 16/237 (6%)
Query: 444 IGNGGHGSVYRAELPS-GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G GG G VY AE ++VA+K L D + + E + ++ ++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVF-RTRMQREARTAGRLQEPHVVPIH 100
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
F ++ L+ LAA+L L + + +++ + AL H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA---G 154
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTE---FAGTYGYVAPELAYTMKI 619
H+D+ +N+L+ + A++ DFGIA T+ GT Y+APE
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 620 TEKCDVYSFGVLVLEAIKGKHP--RDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674
T + D+Y+ ++ E + G P D LS++ + +N I + P +P +V
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQGDQLSVM-GAHINQAIPRPSTVRPGIPVAFDAV 268
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 67/267 (25%), Positives = 116/267 (43%), Gaps = 43/267 (16%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
IG+G G V+ + VAIK +++F+ E + + ++ H +V+ YG
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563
C LV E +E G L+ L + + + V + ++YL C
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEACV--- 125
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAKFLKPE----SSN------WTEFAGTYGYVAPEL 613
+H+D++++N L+ V+DFG+ +F+ + S+ W +PE+
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA---------SPEV 176
Query: 614 AYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDP-RLPPPS 671
+ + K DV+SFGVL+ E +GK P + S N+++ +++I RL P
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEV-VEDISTGFRLYKP- 227
Query: 672 RSVQEKLISIMEVAFSCLNESPESRPT 698
R + IM C E PE RP
Sbjct: 228 RLASTHVYQIMN---HCWRERPEDRPA 251
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 47/272 (17%)
Query: 444 IGNGGHGSVYRAEL--PSGQV-VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
+G G GSV + Q+ VAIK + AD +E + E + + ++ + IV+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLK---QGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
G C LV E+ G L L +E+ S ++ V+ + YL F
Sbjct: 75 LIGVCQAEAL-MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN------------WTEFAGTYGY 608
VH+D++++N+LL + A ++DFG++K L + S W
Sbjct: 132 ---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-------- 180
Query: 609 VAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDP-R 666
APE K + + DV+S+GV + EA+ G+ P + ++ + I R
Sbjct: 181 -APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-------GPEV-MAFIEQGKR 231
Query: 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
+ P E L ++M C E RP
Sbjct: 232 MECPPECPPE-LYALM---SDCWIYKWEDRPD 259
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 70/267 (26%), Positives = 122/267 (45%), Gaps = 43/267 (16%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
+G+G G V + VA+K + EF E + + ++ H +VKFYG
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563
CS ++V E + G L L S + L SQ + + V + +++L F
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQF--- 125
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAKFLKPE----SSN------WTEFAGTYGYVAPEL 613
+H+D++++N L+D + V+DFG+ +++ + S W+ APE+
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS---------APEV 176
Query: 614 AYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDP-RLPPPS 671
+ K + K DV++FG+L+ E GK P D + N+++ + ++ RL P
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-------NSEV-VLKVSQGHRLYRP- 227
Query: 672 RSVQEKLISIMEVAFSCLNESPESRPT 698
+ + IM SC +E PE RPT
Sbjct: 228 HLASDTIYQIMY---SCWHELPEKRPT 251
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-29
Identities = 53/242 (21%), Positives = 84/242 (34%), Gaps = 31/242 (12%)
Query: 89 IPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLG 148
N N + E L + + L+R + + N P++
Sbjct: 29 YFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNL-SSLPDNLP--PQIT 83
Query: 149 TLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGR 208
L ++ N + +P + L+ LD N + +P+ SL L + NQ T
Sbjct: 84 VLEITQNALIS-LPELPAS---LEYLDACDNRLS-TLPELPA---SLKHLDVDNNQLT-M 134
Query: 209 LPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLS 268
LP L EY++ N+ +PE +L L + NNQ LP+ E L
Sbjct: 135 LPELPALL---EYINADNNQLT-MLPELPTSLEVLS---VRNNQLT-FLPELPE---SLE 183
Query: 269 ELDASHNLFGGEIPFQICSLKSLEK----LNLSHNNLSGSIPNCFEGIRGISVIDISDNQ 324
LD S NL +P E+ N ++ IP + I + DN
Sbjct: 184 ALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNP 241
Query: 325 LQ 326
L
Sbjct: 242 LS 243
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-26
Identities = 52/262 (19%), Positives = 93/262 (35%), Gaps = 33/262 (12%)
Query: 48 NPMLTRPGLDFNHFTSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNC--SSLIRVRL 104
N + F + S + + + + + +L+ C + ++L
Sbjct: 8 NNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGEN-RNEAVSLLKECLINQFSELQL 66
Query: 105 NSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPRE 164
N NL+ ++ + L P +T +++++N + L L+ N ++ +P
Sbjct: 67 NRLNLS-SLPDNLP--PQITVLEITQNAL-ISLPELPAS---LEYLDACDNRLST-LPEL 118
Query: 165 IGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDL 224
+ L+ LD+ N + +P+ L + NQ T LP SL E L +
Sbjct: 119 PAS---LKHLDVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPTSL---EVLSV 167
Query: 225 SANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSE----LDASHNLFGGE 280
N+ +PE +L L +S N LP + E N
Sbjct: 168 RNNQLT-FLPELPESLEALD---VSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-H 221
Query: 281 IPFQICSLKSLEKLNLSHNNLS 302
IP I SL + L N LS
Sbjct: 222 IPENILSLDPTCTIILEDNPLS 243
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 53/290 (18%), Positives = 97/290 (33%), Gaps = 39/290 (13%)
Query: 21 SVSNLTNLKELVLLYNNLSGFIPPSLENPM-----LTRPGLDFNHFTSYLPHNVCRGGAL 75
++N +L + YN +SG + PG + N S L C
Sbjct: 6 PINNNFSLSQN-SFYNTISG-TYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQF 61
Query: 76 QYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYG 135
++ + ++P L + + + N L ++ E +L ++D N
Sbjct: 62 SELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPA---SLEYLDACDN---- 110
Query: 136 EISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSL 195
+S+ L L+V N +T +P L+ ++ N + +P+ SL
Sbjct: 111 RLSTLPELPASLKHLDVDNNQLTM-LPELPAL---LEYINADNNQLT-MLPELPT---SL 162
Query: 196 TELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKL----HYLGLSNN 251
L +R NQ T LP SL E LD+S N S+P + N
Sbjct: 163 EVLSVRNNQLT-FLPELPESL---EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCREN 217
Query: 252 QFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNL 301
+ +P+ + L + N + S ++ +
Sbjct: 218 RIT-HIPENILSLDPTCTIILEDNPL-SSRIRESLSQQTAQPDYHGPRIY 265
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 53/281 (18%), Positives = 94/281 (33%), Gaps = 54/281 (19%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
++ N+N+ +L + EL L NLS +P +L P +T + N
Sbjct: 36 WEKQALPGENRNEAVSLLKEC--LINQFSELQLNRLNLS-SLPDNL-PPQITVLEITQNA 91
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
S LP +L+Y +N T+P++ + L +++N LT + E
Sbjct: 92 LIS-LPELP---ASLEYLDACDNRLS-TLPELPASLKHL---DVDNNQLT-MLPELPA-- 140
Query: 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNH 180
L +N N +T +P + L+ L + N
Sbjct: 141 -------------------------LLEYINADNNQLT-MLPELPTS---LEVLSVRNNQ 171
Query: 181 IVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLE----YLDLSANRFNNSVPEN 236
+ +P+ SL L + N LP E + NR +PEN
Sbjct: 172 L-TFLPELPE---SLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRI-THIPEN 225
Query: 237 LGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLF 277
+ +L + L +N + + L + + F
Sbjct: 226 ILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 1e-20
Identities = 48/281 (17%), Positives = 91/281 (32%), Gaps = 30/281 (10%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
+ S L LN+ LP ++ + L + N L +P + L N
Sbjct: 58 INQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPAS--LEYLDACDNR 111
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
++ LP +L++ V N +P++ + ++N LT + E
Sbjct: 112 LST-LPELP---ASLKHLDVDNNQLT-MLPELPALLEYI---NADNNQLT-MLPELPT-- 160
Query: 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQ----ALDL 176
+L + + N + L L+VS N + +P + +
Sbjct: 161 -SLEVLSVRNNQL-TFLPE---LPESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRC 214
Query: 177 SLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPEN 236
N I IP+ + L+ +IL N + R+ + D R S+ +
Sbjct: 215 RENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQP--DYHGPRIYFSMSDG 271
Query: 237 LGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLF 277
N L F ++ ++ E + N F
Sbjct: 272 QQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTF 312
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 63/264 (23%), Positives = 113/264 (42%), Gaps = 27/264 (10%)
Query: 444 IGNGGHGSVYRAE---LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
+G GG V+ A + VA+K + L D + F E + + H IV
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVA 76
Query: 501 FY--GF--CSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
Y G ++V E ++ +L I+ ++ + + + VI AL++ H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH 133
Query: 557 HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFA---GTYGYVAPEL 613
+ I+H+D+ N+++ V DFGIA+ + ++ T+ A GT Y++PE
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 614 AYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673
A + + DVYS G ++ E + G+ P S +S +A + + PPS
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVRED-PIPPSAR 242
Query: 674 VQEKLISIMEVAFSCLNESPESRP 697
+ + V L ++PE+R
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRY 266
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 73/272 (26%), Positives = 122/272 (44%), Gaps = 39/272 (14%)
Query: 438 FDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI-EVKALTEIRH 495
F IG+G G+VY A ++ + +VVAIKK Q ++ + +I EV+ L ++RH
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKM--SYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
N +++ G ++LV E GS + +L + + L + V G L+YL
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAY 615
H ++H+D+ + N+LL + DFG A + P +S F GT ++APE+
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVIL 223
Query: 616 TMKITE---KCDVYSFGVLVLEAIKGK------HPRDFLSLISSSSLNTDIALDEILDPR 666
M + K DV+S G+ +E + K + L I+ + P
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-----------SPA 272
Query: 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
L S E + ++ CL + P+ RPT
Sbjct: 273 LQSGHWS--EYFRNFVDS---CLQKIPQDRPT 299
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 68/289 (23%), Positives = 108/289 (37%), Gaps = 49/289 (16%)
Query: 444 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI 498
+G G GSV +G +VA+K+ L Q++F E++ L + I
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQ----LQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 499 VKFYGFCSHARHS--FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
VK+ G LV E L G L L L S+ + + + YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLG 144
Query: 557 HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS------------NWTEFAG 604
VH+D++++N+L++ E +ADFG+AK L + W
Sbjct: 145 SRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY---- 197
Query: 605 TYGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNT--DIALDE 661
APE + + DV+SFGV++ E + AL
Sbjct: 198 -----APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 662 ILDP-----RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
+L+ RLP P E + +M+ C SP+ RP+ + Q
Sbjct: 253 LLELLEEGQRLPAPPACPAE-VHELMK---LCWAPSPQDRPSFSALGPQ 297
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 55/263 (20%), Positives = 98/263 (37%), Gaps = 44/263 (16%)
Query: 443 CIGNGGHGSVYRAE---LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
CI +GG G +Y A + +G+ V +K D A Q + E + L E+ H +IV
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSG--DAEA-QAMAMAERQFLAEVVHPSIV 142
Query: 500 KFYGFCSHARHS-----FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
+ + F H ++V E + SL Q+L ++ + + + ALSY
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSY 197
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
LH +V+ D+ +N++L E + + D G + GT G+ APE+
Sbjct: 198 LHSI---GLVYNDLKPENIMLT-EEQLKLIDLGAVSRINSFGY----LYGTPGFQAPEIV 249
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674
T T D+Y+ G + R+ D ++ + +
Sbjct: 250 RT-GPTVATDIYTVGRTLAALTLDLPTRN--------GRYVDGLPEDDPVLKTYDSYGRL 300
Query: 675 QEKLISIMEVAFSCLNESPESRP 697
+ ++ P R
Sbjct: 301 LRR----------AIDPDPRQRF 313
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 57/276 (20%), Positives = 96/276 (34%), Gaps = 41/276 (14%)
Query: 433 RATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALT 491
F +G+G +G V++ G++ A+K+ S P D+ L EV +
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR--SMSPFRGPKDRARKLAEVGSHE 111
Query: 492 EI-RHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVAD 550
++ +H V+ +L EL SL + L +Q ++
Sbjct: 112 KVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWG--ASLPEAQVWGYLRDTLL 168
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVA 610
AL++LH +VH D+ N+ L + DFG+ L + G Y+A
Sbjct: 169 ALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDPRYMA 224
Query: 611 PEL---AYTMKITEKCDVYSFGVLVLEAIKGKHP----RDFLSLISSSSLNTDIALDEIL 663
PEL +Y DV+S G+ +LE + L L
Sbjct: 225 PELLQGSY----GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQG-----------YL 269
Query: 664 DPRLPPP-SRSVQEKLISIMEVAFSCLNESPESRPT 698
P S ++ ++ L P+ R T
Sbjct: 270 PPEFTAGLSSELRS-VLV------MMLEPDPKLRAT 298
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 68/260 (26%), Positives = 117/260 (45%), Gaps = 29/260 (11%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
+G G G V + VAIK + EF+ E K + + H +V+ YG
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563
C+ R F++ E + G L L Q + + K V +A+ YL F
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQF--- 141
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT---YGYVAPELAYTMKIT 620
+H+D++++N L++ + V+DFG+++++ +T G+ + PE+ K +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 621 EKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDP-RLPPPSRSVQEKL 678
K D+++FGVL+ E GK P + + N++ + I RL P EK+
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFT-------NSET-AEHIAQGLRLYRP-HLASEKV 250
Query: 679 ISIMEVAFSCLNESPESRPT 698
+IM SC +E + RPT
Sbjct: 251 YTIMY---SCWHEKADERPT 267
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 66/264 (25%), Positives = 110/264 (41%), Gaps = 41/264 (15%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
IG G G V + G VA+K A + FL E +T++RH N+V+ G
Sbjct: 29 IGKGEFGDVMLGDY-RGNKVAVKC------IKNDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 504 FCSHARHS-FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
+ ++V E + +GSL L S LG + V +A+ YL + F
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNF-- 138
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN------WTEFAGTYGYVAPELAYT 616
VH+D++++N+L+ + A V+DFG+ K WT APE
Sbjct: 139 -VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEALRE 188
Query: 617 MKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDP-RLPPPSRSV 674
K + K DV+SFG+L+ E G+ P + D+ + + ++ P
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDV-VPRVEKGYKMDAP-DGC 239
Query: 675 QEKLISIMEVAFSCLNESPESRPT 698
+ +M+ +C + RP+
Sbjct: 240 PPAVYEVMK---NCWHLDAAMRPS 260
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 70/281 (24%), Positives = 125/281 (44%), Gaps = 29/281 (10%)
Query: 430 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV-VAIKKFHSPLPCDQIADQKEFLIEVK 488
E+ R D ++ +G G +G VY + VA+K L D + + +EFL E
Sbjct: 216 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT----LKEDTM-EVEEFLKEAA 268
Query: 489 ALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGV 548
+ EI+H N+V+ G C+ +++ E + G+L L QE+ + + +
Sbjct: 269 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQI 327
Query: 549 ADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT--- 605
+ A+ YL F +H++++++N L+ + VADFG+++ + +T AG
Sbjct: 328 SSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFP 382
Query: 606 YGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILD 664
+ APE K + K DV++FGVL+ E G P + + + D
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYELLEKD 435
Query: 665 PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
R+ P EK+ +M +C +P RP+ + Q
Sbjct: 436 YRMERP-EGCPEKVYELM---RACWQWNPSDRPSFAEIHQA 472
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 61/289 (21%), Positives = 113/289 (39%), Gaps = 48/289 (16%)
Query: 444 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI 498
+G G G V +G+ VA+K P + E++ L + H NI
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK---PESGGNHIADLKKEIEILRNLYHENI 85
Query: 499 VKFYGFCSHARHS--FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
VK+ G C+ + L+ E L GSL L + ++ Q++ + + YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLG 143
Query: 557 HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN------------WTEFAG 604
+ VH+D++++N+L++ E++ + DFG+ K ++ + W
Sbjct: 144 SRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY---- 196
Query: 605 TYGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNT--DIALDE 661
APE K DV+SFGV + E + ++L T + +
Sbjct: 197 -----APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 662 ILDP-----RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
+++ RLP P E + +M C P +R + + + +
Sbjct: 252 LVNTLKEGKRLPCPPNCPDE-VYQLMR---KCWEFQPSNRTSFQNLIEG 296
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 64/272 (23%), Positives = 117/272 (43%), Gaps = 47/272 (17%)
Query: 444 IGNGGHGSVYRAELPSGQV---VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
+G+G G+V + +V VA+K + + A + E L E + ++ + IV+
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
G C LV E+ E G L L + + + + ++ V+ + YL F
Sbjct: 83 MIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN------------WTEFAGTYGY 608
VH+D++++N+LL ++ A ++DFG++K L+ + + W
Sbjct: 139 ---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-------- 187
Query: 609 VAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDP-R 666
APE K + K DV+SFGVL+ EA G+ P + +++ + R
Sbjct: 188 -APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEV-TAMLEKGER 238
Query: 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
+ P+ +E + +M C E+RP
Sbjct: 239 MGCPAGCPRE-MYDLM---NLCWTYDVENRPG 266
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 72/274 (26%), Positives = 107/274 (39%), Gaps = 47/274 (17%)
Query: 444 IGNGGHGSVYRAEL--PSGQV--VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
+G+G G V R E PSG+ VA+K P Q +F+ EV A+ + HRN++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLK-PDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
+ YG +V EL GSL L VA+ + YL
Sbjct: 85 RLYGVVL-TPPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN------------WTEFAGTYG 607
F +H+D++++NLLL + DFG+ + L + W
Sbjct: 142 F---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC------- 191
Query: 608 YVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDP- 665
APE T + D + FGV + E G+ P L+ + I L +I
Sbjct: 192 --APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQI-LHKIDKEG 241
Query: 666 -RLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
RLP P + + ++M C PE RPT
Sbjct: 242 ERLPRPEDC-PQDIYNVMV---QCWAHKPEDRPT 271
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 66/273 (24%), Positives = 114/273 (41%), Gaps = 47/273 (17%)
Query: 444 IGNGGHGSVYRAELPSG----QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
IG+G G V L VAIK +++FL E + + H NI+
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
+ G + R + +V E +E GSL L + + Q + +++GV + YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN------------WTEFAGTYG 607
+ VH+D++++N+L+D V+DFG+++ L+ + WT
Sbjct: 172 Y---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT------- 221
Query: 608 YVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILD-P 665
APE + DV+SFGV++ E + G+ P ++ N D+ + + +
Sbjct: 222 --APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT-------NRDV-ISSVEEGY 271
Query: 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
RLP P L +M C ++ RP
Sbjct: 272 RLPAP-MGCPHALHQLM---LDCWHKDRAQRPR 300
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-28
Identities = 68/290 (23%), Positives = 121/290 (41%), Gaps = 50/290 (17%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFY 502
+G G G+V G+ VA+K+ + IA E+K LTE H N++++Y
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRM--LIDFCDIALM-----EIKLLTESDDHPNVIRYY 75
Query: 503 GFCSHARHSFLVYELLERGSLAAIL----SSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
+ R ++ EL +L ++ SD + +++++ +A +++LH
Sbjct: 76 CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134
Query: 559 CFPPIVHQDISSKNLLLDLEYEAH-------------VADFGIAKFLKPESSNWT----E 601
I+H+D+ +N+L+ ++DFG+ K L S++
Sbjct: 135 K---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 602 FAGTYGYVAPEL-------AYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSL 653
+GT G+ APEL ++T D++S G + + KGKHP S+ +
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 654 NTDIALDEILDPRLPPPSRSVQEK-LISIMEVAFSCLNESPESRPTMKVV 702
+LDE+ L S + LIS ++ P RPT V
Sbjct: 252 RGIFSLDEM--KCLHDRSLIAEATDLIS------QMIDHDPLKRPTAMKV 293
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 48/310 (15%), Positives = 97/310 (31%), Gaps = 52/310 (16%)
Query: 435 TNDFDAQYCIGNGGH--GSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALT 491
++ IG G +V A P+G+ V +++ L E+
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI--NLEACSNEMVTFLQGELHVSK 81
Query: 492 EIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADA 551
H NIV + ++V + GS ++ + + +++GV A
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT-HFMDGMNELAIAYILQGVLKA 140
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL-------KPESSNWTEFAG 604
L Y+HH VH+ + + ++L+ ++ + +++ + +
Sbjct: 141 LDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 605 TYGYVAPELAYTMKI--TEKCDVYSFGVLVLEAIKGK------HPRDFLSLISSS---SL 653
+++PE+ K D+YS G+ E G L + L
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257
Query: 654 NTDIALDEILDPRLPPPSRSVQEKLISIMEVA----------------FS---------C 688
+ P S + S+ FS C
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317
Query: 689 LNESPESRPT 698
L +P++RP+
Sbjct: 318 LQRNPDARPS 327
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-28
Identities = 72/272 (26%), Positives = 118/272 (43%), Gaps = 37/272 (13%)
Query: 443 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G G G V+ VAIK + FL E + + ++RH +V+ Y
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
S ++V E + +GSL L +T + L Q +++ +A ++Y+ +
Sbjct: 246 AVVSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMNY-- 301
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT---YGYVAPELAYTMKI 619
VH+D+ + N+L+ VADFG+A+ + E + +T G + APE A +
Sbjct: 302 -VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 620 TEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDP-----RLPPPSRS 673
T K DV+SFG+L+ E KG+ P + E+LD R+P P
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCP-PE 405
Query: 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
E L +M C + PE RPT + +
Sbjct: 406 CPESLHDLM---CQCWRKEPEERPTFEYLQAF 434
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 61/277 (22%), Positives = 111/277 (40%), Gaps = 42/277 (15%)
Query: 443 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN--IVK 500
IG+GG V++ Q+ AIK L + E+ L +++ + I++
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH-HDC 559
Y + ++ ++V E L + L + +R + K + +A+ +H H
Sbjct: 93 LYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQHG- 147
Query: 560 FPPIVHQDISSKNLLLDLEYEAHV--ADFGIAKFLKPESSNW--TEFAGTYGYVAPEL-- 613
IVH D+ N L+ + + DFGIA ++P++++ GT Y+ PE
Sbjct: 148 ---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 614 ---------AYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD 664
KI+ K DV+S G ++ GK P F +N L I+D
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--F-----QQIINQISKLHAIID 254
Query: 665 PRLPPPS-RSVQEKLISIMEVAFSCLNESPESRPTMK 700
P ++ L +++ CL P+ R ++
Sbjct: 255 PNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIP 288
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 62/273 (22%), Positives = 103/273 (37%), Gaps = 48/273 (17%)
Query: 444 IGNGGHGSVYRAEL--PSGQV---VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI 498
+G+G G+VY+ +V VAIK+ KE L E + + + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPHV 79
Query: 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
+ G C L+ +L+ G L + +G +N +A ++YL
Sbjct: 80 CRLLGICL-TSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS-----------NWTEFAGTYG 607
VH+D++++N+L+ + DFG+AK L E W
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM------- 186
Query: 608 YVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDP- 665
A E T + DV+S+GV V E + G P D + ++I +
Sbjct: 187 --ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------ASEI-SSILEKGE 236
Query: 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
RLP P + + IM C +SRP
Sbjct: 237 RLPQPPICTID-VYMIM---RKCWMIDADSRPK 265
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-28
Identities = 70/274 (25%), Positives = 117/274 (42%), Gaps = 48/274 (17%)
Query: 444 IGNGGHGSVYRAEL--PSGQV---VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI 498
IG G G VY+ L SG+ VAIK + +FL E + + H NI
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
++ G S + ++ E +E G+L L E Q + +++G+A + YL +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN------------WTEFAGTY 606
+ VH+D++++N+L++ V+DFG+++ L+ + WT
Sbjct: 167 NY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT------ 217
Query: 607 GYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILD- 664
APE K T DV+SFG+++ E + G+ P LS N ++ + I D
Sbjct: 218 ---APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHEV-MKAINDG 266
Query: 665 PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
RLP P + +M C + RP
Sbjct: 267 FRLPTP-MDCPSAIYQLMM---QCWQQERARRPK 296
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 63/267 (23%), Positives = 105/267 (39%), Gaps = 15/267 (5%)
Query: 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
+DF+ +G G G V++ PSG V+A K H + + A + + + E++ L E
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECN 89
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
IV FYG + E ++ GSL +L E V V L+Y
Sbjct: 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTY 146
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
L I+H+D+ N+L++ E + DFG++ L S F GT Y++PE
Sbjct: 147 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERL 202
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGKHP----RDFLSLISSSSLNTDIALDEILDPRLPPP 670
+ + D++S G+ ++E G++P + A + PR P
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 671 SRSVQEKLISIMEVAFSCLNESPESRP 697
+ F L+ P
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPP 289
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-27
Identities = 69/277 (24%), Positives = 113/277 (40%), Gaps = 51/277 (18%)
Query: 443 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G G V + G VA+K + D A + FL E +T++RH N+V+
Sbjct: 200 TIGKGEFGDVMLGDY-RGNKVAVKC----IKND--ATAQAFLAEASVMTQLRHSNLVQLL 252
Query: 503 GFCSHARHSF-LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFP 561
G + +V E + +GSL L S LG + V +A+ YL + F
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 310
Query: 562 PIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN------WTEFAGTYGYVAPELAY 615
VH+D++++N+L+ + A V+DFG+ K WT APE
Sbjct: 311 --VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEALR 359
Query: 616 TMKITEKCDVYSFGVLVLEAI-KGKHP------RDFLSLISSSSLNTDIALDEILDPRLP 668
K + K DV+SFG+L+ E G+ P +D + + ++
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-------------GYKMD 406
Query: 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
P + +M +C + +RPT + +Q
Sbjct: 407 AP-DGCPPAVYDVM---KNCWHLDAATRPTFLQLREQ 439
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-27
Identities = 63/261 (24%), Positives = 117/261 (44%), Gaps = 29/261 (11%)
Query: 443 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G G G V+ A VA+K + FL E + ++H +VK +
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-----SVEAFLAEANVMKTLQHDKLVKLH 249
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
+ +++ E + +GSL L SD + + ++ +A+ ++++ +
Sbjct: 250 AVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNY-- 305
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYV---APELAYTMKI 619
+H+D+ + N+L+ +ADFG+A+ + E + +T G + APE
Sbjct: 306 -IHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 620 TEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDP-RLPPPSRSVQEK 677
T K DV+SFG+L++E + G+ P +S N ++ + + R+P P + E+
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGMS-------NPEV-IRALERGYRMPRP-ENCPEE 413
Query: 678 LISIMEVAFSCLNESPESRPT 698
L +IM C PE RPT
Sbjct: 414 LYNIM---MRCWKNRPEERPT 431
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 71/272 (26%), Positives = 117/272 (43%), Gaps = 37/272 (13%)
Query: 443 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G G G V+ VAIK + FL E + + ++RH +V+ Y
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLY 328
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
S ++V E + +GSL L + + L Q +++ +A ++Y+ +
Sbjct: 329 AVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY-- 384
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT---YGYVAPELAYTMKI 619
VH+D+ + N+L+ VADFG+A+ + E + +T G + APE A +
Sbjct: 385 -VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 620 TEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDP-----RLPPPSRS 673
T K DV+SFG+L+ E KG+ P + E+LD R+P P
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCP-PE 488
Query: 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
E L +M C + PE RPT + +
Sbjct: 489 CPESLHDLM---CQCWRKEPEERPTFEYLQAF 517
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-27
Identities = 66/263 (25%), Positives = 115/263 (43%), Gaps = 29/263 (11%)
Query: 444 IGNGGHGSVYRAEL--PSGQV-VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
+G G GSV + Q+ VAIK + AD +E + E + + ++ + IV+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLK---QGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
G C LV E+ G L L +E+ S ++ V+ + YL F
Sbjct: 401 LIGVCQAEAL-MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT---YGYVAPELAYTM 617
VH++++++N+LL + A ++DFG++K L + S +T + + APE
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 618 KITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDP-RLPPPSRSVQ 675
K + + DV+S+GV + EA+ G+ P + ++ + I R+ P
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKPYKKMK-------GPEV-MAFIEQGKRMECPPECPP 566
Query: 676 EKLISIMEVAFSCLNESPESRPT 698
E L ++M C E RP
Sbjct: 567 E-LYALM---SDCWIYKWEDRPD 585
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 65/290 (22%), Positives = 112/290 (38%), Gaps = 50/290 (17%)
Query: 444 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI 498
+G G GSV +G+VVA+KK L ++F E++ L ++H NI
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 499 VKFYGFCSHARHS--FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
VK+ G C A L+ E L GSL L + + + + + + YL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG 131
Query: 557 HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN------------WTEFAG 604
+ +H+D++++N+L++ E + DFG+ K L + W
Sbjct: 132 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY---- 184
Query: 605 TYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNT----DIALD 660
APE K + DV+SFGV++ E + + +
Sbjct: 185 -----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 661 EILDP-----RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
+++ RLP P E + IM C N + RP+ + + +
Sbjct: 240 HLIELLKNNGRLPRPDGCPDE-IYMIMT---ECWNNNVNQRPSFRDLALR 285
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 63/268 (23%), Positives = 115/268 (42%), Gaps = 43/268 (16%)
Query: 444 IGNGGHGSVYRAELPSGQV-VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G G +G VY + VA+K + + +EFL E + EI+H N+V+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
G C+ +++ E + G+L L QE+ + + ++ A+ YL F
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNF-- 132
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE----SSN------WTEFAGTYGYVAPE 612
+H+D++++N L+ + VADFG+++ + + + WT APE
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT---------APE 182
Query: 613 LAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDP-RLPPP 670
K + K DV++FGVL+ E G P + + + + + R+ P
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQV-YELLEKDYRMERP 234
Query: 671 SRSVQEKLISIMEVAFSCLNESPESRPT 698
EK+ +M +C +P RP+
Sbjct: 235 -EGCPEKVYELMR---ACWQWNPSDRPS 258
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 61/284 (21%), Positives = 110/284 (38%), Gaps = 50/284 (17%)
Query: 444 IGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI 498
+G G G V +G++VA+K + + E+ L + H +I
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---ADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 499 VKFYGFCSHARHS--FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
+K+ G C A + LV E + GSL L +G +Q + + + + ++YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLH 151
Query: 557 HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN------------WTEFAG 604
+ +H+D++++N+LLD + + DFG+AK + W
Sbjct: 152 AQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY---- 204
Query: 605 TYGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNT--DIALDE 661
APE K DV+SFGV + E + + + + +
Sbjct: 205 -----APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 662 ILDP-----RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
+ + RLP P + E + +M+ +C RPT +
Sbjct: 260 LTELLERGERLPRPDKCPAE-VYHLMK---NCWETEASFRPTFE 299
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 61/293 (20%), Positives = 108/293 (36%), Gaps = 54/293 (18%)
Query: 433 RATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALT 491
R T +F IG+G GSV++ + G + AIK+ S P D++ L EV A
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR--SKKPLAGSVDEQNALREVYAHA 65
Query: 492 EI-RHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQE-LGWSQRMNVIKGVA 549
+ +H ++V+++ + H + E GSLA +S + ++ +++ V
Sbjct: 66 VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 550 DALSYLHHDCFPPIVHQDISSKNLLLD-------------------LEYEAHVADFGIAK 590
L Y+H +VH DI N+ + + + D G
Sbjct: 126 RGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 591 FLKPESSNWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSL-- 647
+ S+ G ++A E L K D+++ + V+ A +
Sbjct: 183 RI----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH 238
Query: 648 -ISSSSLNTDIALDEILDPRLPPP-SRSVQEKLISIMEVAFSCLNESPESRPT 698
I L PR+P S+ E L+ ++ PE RP+
Sbjct: 239 EIRQGRL-----------PRIPQVLSQEFTE-LLK------VMIHPDPERRPS 273
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 61/277 (22%), Positives = 110/277 (39%), Gaps = 42/277 (15%)
Query: 443 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH--RNIVK 500
IG+GG V++ Q+ AIK L + E+ L +++ I++
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH-HDC 559
Y + ++ ++V E L + L + +R + K + +A+ +H H
Sbjct: 74 LYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQHG- 128
Query: 560 FPPIVHQDISSKNLLLDLEYEAHV--ADFGIAKFLKPESSNW--TEFAGTYGYVAPEL-- 613
IVH D+ N L+ + + DFGIA ++P++++ GT Y+ PE
Sbjct: 129 ---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 614 ---------AYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD 664
KI+ K DV+S G ++ GK P F +N L I+D
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--F-----QQIINQISKLHAIID 235
Query: 665 PRLPPP-SRSVQEKLISIMEVAFSCLNESPESRPTMK 700
P ++ L +++ CL P+ R ++
Sbjct: 236 PNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIP 269
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 54/279 (19%), Positives = 104/279 (37%), Gaps = 56/279 (20%)
Query: 444 IGNGGHGSVYRAEL--------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
+G G +++ V +K L + F ++++ H
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKV----LDKAHRNYSESFFEAASMMSKLSH 71
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
+++V YG C + LV E ++ GSL L + + ++ V K +A A+ +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFL 129
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAH--------VADFGIAKFLKPESS-----NWTEF 602
+ +H ++ +KN+LL E + ++D GI+ + P+ W
Sbjct: 130 EENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV-- 184
Query: 603 AGTYGYVAPE-LAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALD 660
PE + + D +SFG + E G P L + L
Sbjct: 185 -------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-------SQRK-LQ 229
Query: 661 EILDP-RLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
D +LP P +L +++ +C++ P+ RP+
Sbjct: 230 FYEDRHQLPAPK---AAELANLIN---NCMDYEPDHRPS 262
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 58/296 (19%), Positives = 111/296 (37%), Gaps = 53/296 (17%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI-EVKALTEIRHRNIVKF 501
+G G +V+R +G + AIK F++ + + E + L ++ H+NIVK
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 502 YGF--CSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
+ + RH L+ E GSL +L + A L S+ + V++ V +++L +
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 560 FPPIVHQDISSKNLLLDLEYEAH----VADFGIAKFLKPESSNWTEFAGTYGYVAPEL-- 613
IVH++I N++ + + + DFG A+ L+ + GT Y+ P++
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLYGTEEYLHPDMYE 188
Query: 614 ------AYTMKITEKCDVYSFGVLVLEA-----------------------IKGKHPRDF 644
+ K D++S GV A I GK
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 645 LSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
+ + + D + D + L + + +++ + L E
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI------LEADQEKCWGFD 298
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 65/290 (22%), Positives = 112/290 (38%), Gaps = 50/290 (17%)
Query: 444 IGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI 498
+G G GSV +G+VVA+KK L ++F E++ L ++H NI
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 499 VKFYGFCSHARHS--FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
VK+ G C A L+ E L GSL L + + + + + + YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG 162
Query: 557 HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN------------WTEFAG 604
+ +H+D++++N+L++ E + DFG+ K L + W
Sbjct: 163 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY---- 215
Query: 605 TYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNT----DIALD 660
APE K + DV+SFGV++ E + + +
Sbjct: 216 -----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270
Query: 661 EILDP-----RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
+++ RLP P E + IM C N + RP+ + + +
Sbjct: 271 HLIELLKNNGRLPRPDGCPDE-IYMIMT---ECWNNNVNQRPSFRDLALR 316
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 63/328 (19%), Positives = 102/328 (31%), Gaps = 57/328 (17%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHF 61
++LDL N + L +L LVL+ N +S + L + + NH
Sbjct: 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114
Query: 62 TSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYP 121
+ N SSL+ +R++ N +
Sbjct: 115 VE----------------IPPNLP-----------SSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 122 NLTFIDLSRNDFY-GEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNH 180
N+ I++ N KL L +S +T GIP+ L L L N
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNK 204
Query: 181 IVGEIPKE-LGKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSANRFNNSVPENLG 238
I I E L + + L L L NQ + L L L L N+ + VP L
Sbjct: 205 IQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKL-SRVPAGLP 261
Query: 239 NLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSH 298
+L L + L N ++++ N F ++L +
Sbjct: 262 DLKLLQVVYLHTN--------------NITKVGV--NDFCPVGFGV--KRAYYNGISLFN 303
Query: 299 NNLSGSI--PNCFEGIRGISVIDISDNQ 324
N + P F + I + +
Sbjct: 304 NPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 59/240 (24%), Positives = 99/240 (41%), Gaps = 21/240 (8%)
Query: 94 RNCS-SLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSN-WGKCPKLGTLN 151
C L V+ + L + I P+ T +DL ND E+ + + L L
Sbjct: 29 FGCHCHLRVVQCSDLGLK---AVPKEISPDTTLLDLQNNDI-SELRKDDFKGLQHLYALV 84
Query: 152 VSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPP 211
+ N I+ + +LQ L +S NH+V EIP L +SL EL + N+ ++P
Sbjct: 85 LVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPK 140
Query: 212 EI-GSLVDLEYLDLSANRFNNS-VPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSE 269
+ L ++ +++ N NS + LKL+YL +S + +PK+L L+E
Sbjct: 141 GVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNE 197
Query: 270 LDASHNLFGGEIP---FQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
L HN I L +L L HN + + + + + +N+L
Sbjct: 198 LHLDHNKIQ-AIELEDLL--RYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 54/238 (22%), Positives = 97/238 (40%), Gaps = 22/238 (9%)
Query: 97 SSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKC----PKLGTLNV 152
+ L +N+++ + +L + L N +IS K KL L +
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNN----KISKIHEKAFSPLRKLQKLYI 109
Query: 153 SMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKE-LGKLNSLTELILRGNQFT-GRLP 210
S N++ IP + S L L + N I ++PK L ++ + + GN
Sbjct: 110 SKNHLVE-IPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFE 165
Query: 211 PEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKE-LEKLVQLSE 269
P + L YL +S + +P++L L+ L L +N+ + E L + +L
Sbjct: 166 PGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYR 221
Query: 270 LDASHNLFGGEIPFQICS-LKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
L HN I S L +L +L+L +N LS +P ++ + V+ + N +
Sbjct: 222 LGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 36/144 (25%), Positives = 55/144 (38%), Gaps = 6/144 (4%)
Query: 194 SLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQF 253
L + +P EI D LDL N + ++ L L+ L L NN+
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 254 VLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIR 313
K L +L +L S N EIP + SL +L + N + F G+R
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 314 GISVIDISDNQLQGPVPNSTAFRN 337
++ I++ N L+ AF
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDG 171
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 28/135 (20%), Positives = 43/135 (31%), Gaps = 24/135 (17%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
L L L NQ + + S+S L L+EL L N LS +P L + +L L N
Sbjct: 216 YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTN 274
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLT-GNISEAL- 117
+ T V N F + + L +N + + A
Sbjct: 275 NITK----------------VGVNDFCPV--GFGVKRAYYNGISLFNNPVPYWEVQPATF 316
Query: 118 -GIYPNLTFIDLSRN 131
+ + I
Sbjct: 317 RCV-TDRLAIQFGNY 330
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 6e-27
Identities = 60/261 (22%), Positives = 118/261 (45%), Gaps = 29/261 (11%)
Query: 443 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G G G V+ VA+K FL E + +++H+ +V+ Y
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
+ +++ E +E GSL L + + +L ++ +++ +A+ ++++ +
Sbjct: 75 AVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNY-- 130
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT---YGYVAPELAYTMKI 619
+H+D+ + N+L+ +ADFG+A+ + E + +T G + APE
Sbjct: 131 -IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 620 TEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDP-RLPPPSRSVQEK 677
T K DV+SFG+L+ E + G+ P ++ N ++ + + R+ P + E+
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEV-IQNLERGYRMVRP-DNCPEE 238
Query: 678 LISIMEVAFSCLNESPESRPT 698
L +M C E PE RPT
Sbjct: 239 LYQLM---RLCWKERPEDRPT 256
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 42/236 (17%), Positives = 75/236 (31%), Gaps = 34/236 (14%)
Query: 430 EIVRATNDFDAQYCIGNGGHGSVYRAE------LPSGQVVAIKKFHSPLPCDQIADQKEF 483
E + + +G G VY A + Q +K P EF
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP-------WEF 111
Query: 484 LIEVKALTEIR---HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQ 540
I + + ++ +KFY S LV EL G+L ++ E Q
Sbjct: 112 YIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 541 --RMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAH-----------VADFG 587
++ + + +H I+H DI N +L + + D G
Sbjct: 172 GLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228
Query: 588 IAKFLK--PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
+ +K P+ + +T T G+ E+ + D + V + G +
Sbjct: 229 QSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 72/312 (23%), Positives = 111/312 (35%), Gaps = 48/312 (15%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNH 60
++LDL N+ + NL NL L+L+ N +S P + L R L N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPK-ILRNCSSLIRVRLNSNNLTGNISEALGI 119
LP + + LQ V EN + K + + +I V L +N L + GI
Sbjct: 112 LKE-LPEKMPKT--LQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK-----SSGI 162
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
N F + KL + ++ NIT IP+ G L L L N
Sbjct: 163 -ENGAFQGM----------------KKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGN 202
Query: 180 HIVGEIPKE-LGKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSANRFNNSVPENL 237
I ++ L LN+L +L L N + + + L L L+ N+ VP L
Sbjct: 203 KI-TKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKL-VKVPGGL 259
Query: 238 GNLLKLHYLGLSNNQF------VLELPKELEKLVQLSELDASHN-LFGGEIP---FQICS 287
+ + + L NN P K S + N + EI F+
Sbjct: 260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR--C 317
Query: 288 LKSLEKLNLSHN 299
+ + L +
Sbjct: 318 VYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 51/241 (21%), Positives = 97/241 (40%), Gaps = 22/241 (9%)
Query: 94 RNCS-SLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNW-GKCPKLGTLN 151
C L V+ + L + + + P+ +DL N EI L TL
Sbjct: 27 FRCQCHLRVVQCSDLGLE-KVPK--DLPPDTALLDLQNNKI-TEIKDGDFKNLKNLHTLI 82
Query: 152 VSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPP 211
+ N I+ P +L+ L LS N + E+P+++ +L EL + N+ T ++
Sbjct: 83 LINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRK 138
Query: 212 EI-GSLVDLEYLDLSANRFNNSV--PENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLS 268
+ L + ++L N +S + KL Y+ +++ +P+ L L+
Sbjct: 139 SVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLT 195
Query: 269 ELDASHNLFGGEIP---FQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQL 325
EL N ++ + L +L KL LS N++S + + +++N+L
Sbjct: 196 ELHLDGNKIT-KVDAASLK--GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252
Query: 326 Q 326
Sbjct: 253 V 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 56/270 (20%), Positives = 96/270 (35%), Gaps = 21/270 (7%)
Query: 81 SENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSN 140
N +N +L + L +N ++ A L + LS+N E+
Sbjct: 60 QNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEK 118
Query: 141 WGKCPK-LGTLNVSMNNITGGIPREI-GNSSQLQALDLSLNHI-VGEIPKE-LGKLNSLT 196
PK L L V N IT + + + +Q+ ++L N + I + L+
Sbjct: 119 ---MPKTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS 174
Query: 197 ELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLE 256
+ + T +P G L L L N+ +L L L LGLS N
Sbjct: 175 YIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 231
Query: 257 LPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPN-------CF 309
L L EL ++N ++P + K ++ + L +NN+S +I +
Sbjct: 232 DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYN 289
Query: 310 EGIRGISVIDISDNQLQGPVPNSTAFRNAP 339
S + + N +Q + FR
Sbjct: 290 TKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 41/194 (21%), Positives = 68/194 (35%), Gaps = 12/194 (6%)
Query: 149 TLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGR 208
L++ N IT + N L L L N I P L L L L NQ
Sbjct: 56 LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-E 114
Query: 209 LPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLEL--PKELEKLVQ 266
LP L+ L + N L ++ + L N + + +
Sbjct: 115 LPE--KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 172
Query: 267 LSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIP-NCFEGIRGISVIDISDNQL 325
LS + + IP + SL +L+L N ++ + +G+ ++ + +S N +
Sbjct: 173 LSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSI 228
Query: 326 QGPVPNSTAFRNAP 339
V N + N P
Sbjct: 229 SA-VDNG-SLANTP 240
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 35/146 (23%), Positives = 62/146 (42%), Gaps = 6/146 (4%)
Query: 194 SLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQF 253
L + ++P ++ D LDL N+ + NL LH L L NN+
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 254 VLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIR 313
P LV+L L S N E+P ++ K+L++L + N ++ + F G+
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLN 145
Query: 314 GISVIDISDNQLQGPVPNSTAFRNAP 339
+ V+++ N L+ + AF+
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMK 171
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 29/205 (14%), Positives = 55/205 (26%), Gaps = 47/205 (22%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
M+ LS + + + P + +L EL L N ++ + +
Sbjct: 170 MKKLSYIRIADTNITTI-PQGL--PPSLTELHLDGNKIT-KVDAA-----------SLKG 214
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
+ L G+S N L N L + LN+N L + L +
Sbjct: 215 LNN-----------LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 262
Query: 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNH 180
+ + L N + + + P + + L N
Sbjct: 263 KYIQVVYLHNN--------------NISAIGSN----DFCPPGYNTKKASYSGVSLFSNP 304
Query: 181 I-VGEIPKEL-GKLNSLTELILRGN 203
+ EI + + L
Sbjct: 305 VQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-27
Identities = 73/365 (20%), Positives = 127/365 (34%), Gaps = 48/365 (13%)
Query: 1 MRSLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPPSL--ENPMLTRPGLD 57
++ L L + Q V+ + L++L L L YN + L L
Sbjct: 53 LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLT 111
Query: 58 FNHFTS-YLPHNVCRG-GALQYFGVSENHFQGTIPKIL-RNCSSLIRVRLNSN------- 107
+ L N + +L+ + +N+ + P N + L N
Sbjct: 112 QCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICE 171
Query: 108 ----NLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPR 163
N G L + T D++ E N K + TL++S N + +
Sbjct: 172 EDLLNFQGKHFTLLRLSSI-TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAK 230
Query: 164 EI---GNSSQLQALDLSLNHIVGE-----IPKELGKL-------NSLTELILRGNQFTGR 208
+++Q+L LS ++ +G K+ + + L ++
Sbjct: 231 RFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-A 289
Query: 209 LPPEI-GSLVDLEYLDLSANRFNNSVPEN-LGNLLKLHYLGLSNNQFVLELPKEL-EKLV 265
L + DLE L L+ N N + +N L L L LS N + + E L
Sbjct: 290 LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLD 347
Query: 266 QLSELDASHNLFGGEIP---FQICSLKSLEKLNLSHNNLSGSIP-NCFEGIRGISVIDIS 321
+L LD S+N + F L +L++L L N L S+P F+ + + I +
Sbjct: 348 KLEVLDLSYNHIR-ALGDQSFL--GLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLH 403
Query: 322 DNQLQ 326
N
Sbjct: 404 TNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-25
Identities = 62/364 (17%), Positives = 132/364 (36%), Gaps = 50/364 (13%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSL--ENPMLTRPGLDFNH 60
++ +DL+ N + S S L +L+ L + I + L LD+N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 61 FTSYLPHNVCRG-GALQYFGVSENHFQGTI--PKILRNCSSLIRVRLNSNNLT----GNI 113
F L G L+ +++ + G + + +SL + L NN+ +
Sbjct: 91 FLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 114 SEALGIYPNLTFIDLSRN--------DFYGEISSN--WGKCPKLGTLNVSMNNITGGIPR 163
+ +DL+ N D + + + +++ +
Sbjct: 150 FLNM---RRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCG 206
Query: 164 EIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELI-----LRGNQFTGRLPPEIGSLVD 218
++ + LDLS N + K + T++ N + +
Sbjct: 207 NPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDN 266
Query: 219 ----------LEYLDLSANRFNNSVPENL-GNLLKLHYLGLSNNQFVLELPKE-LEKLVQ 266
++ DLS ++ ++ +++ + L L L+ N+ ++ L
Sbjct: 267 FTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTH 324
Query: 267 LSELDASHNLFGGEIP---FQICSLKSLEKLNLSHNNLSGSIPNC-FEGIRGISVIDISD 322
L +L+ S N G I F+ +L LE L+LS+N++ ++ + F G+ + + +
Sbjct: 325 LLKLNLSQNFL-GSIDSRMFE--NLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDT 380
Query: 323 NQLQ 326
NQL+
Sbjct: 381 NQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 9e-18
Identities = 47/270 (17%), Positives = 95/270 (35%), Gaps = 36/270 (13%)
Query: 88 TIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSN-WGKCPK 146
+P++ + + + L+ N++ + +L F+ + + I +N +
Sbjct: 24 QVPELPAHVNYV---DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 147 LGTLNVSMNNITGGIPREI-GNSSQLQALDLSLNHI-VGEIPKEL-GKLNSLTELILRGN 203
L L + N + + L+ L L+ ++ + L SL L+LR N
Sbjct: 81 LIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139
Query: 204 QFTGRLPPEI--GSLVDLEYLDLSANRFNNSVPENLGNLLKLH--YLGLSNNQ------- 252
++ P ++ LDL+ N+ + E+L N H L LS+
Sbjct: 140 NIK-KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEY 198
Query: 253 -FVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKL-------------NLSH 298
E K ++ LD S N F + + + K+ + H
Sbjct: 199 WLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGH 258
Query: 299 NNLSGSIPNCFEGIR--GISVIDISDNQLQ 326
N F+G+ G+ D+S +++
Sbjct: 259 TNFKDPDNFTFKGLEASGVKTCDLSKSKIF 288
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 34/206 (16%), Positives = 63/206 (30%), Gaps = 28/206 (13%)
Query: 149 TLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKEL-GKLNSLTELILRGNQFTG 207
+++S+N+I LQ L + I L+SL L L NQF
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL- 92
Query: 208 RLPPEI-GSLVDLEYLDLSANRFNNS-VPENL-GNLLKLHYLGLSNNQFVLELPKELEKL 264
+L L +LE L L+ + + + N L L L L +N
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN------------ 140
Query: 265 VQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQ 324
+ ++ + F +++ L+L+ N + +G + +
Sbjct: 141 --IKKIQ-PASFF--------LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189
Query: 325 LQGPVPNSTAFRNAPVEALKGNKGLC 350
+ N N +
Sbjct: 190 ITLQDMNEYWLGWEKCGNPFKNTSIT 215
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 28/125 (22%), Positives = 52/125 (41%), Gaps = 6/125 (4%)
Query: 217 VDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKEL-EKLVQLSELDASHN 275
+ Y+DLS N + L L +L + L + L L L +N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 276 LFGGEIPFQI-CSLKSLEKLNLSHNNLSGSI--PNCFEGIRGISVIDISDNQLQGPVPNS 332
F ++ L +LE L L+ NL G++ N F+ + + ++ + DN ++ + +
Sbjct: 90 QF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK-IQPA 147
Query: 333 TAFRN 337
+ F N
Sbjct: 148 SFFLN 152
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 8e-27
Identities = 63/287 (21%), Positives = 107/287 (37%), Gaps = 43/287 (14%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKF 501
+ GG VY A+ + SG+ A+K+ L ++ + + EV + ++ H NIV+F
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKR----LLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 502 YGFCSHARHS-------FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
S + FL+ L +G L L + L + + A+ +
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN------------WTEF 602
+H PPI+H+D+ +NLLL + + DFG A +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 603 AGTYGYVAPELAYTMK---ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIAL 659
T Y PE+ I EK D+++ G ++ +HP + + L I
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE-----DGAKLR--IVN 263
Query: 660 DEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706
+ P LI M L +PE R ++ V Q+
Sbjct: 264 GKYSIPPHDTQYTVFH-SLIRAM------LQVNPEERLSIAEVVHQL 303
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 59/277 (21%), Positives = 112/277 (40%), Gaps = 42/277 (15%)
Query: 443 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQI--ADQKEFLIEVKALTEIRH--RNI 498
IG+GG V++ Q+ AIK + ++ + E+ L +++ I
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKY----VNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH-H 557
++ Y + ++ ++V E L + L + +R + K + +A+ +H H
Sbjct: 119 IRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQH 174
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTE--FAGTYGYVAPEL-- 613
IVH D+ N L+ + + DFGIA ++P++++ + G Y+ PE
Sbjct: 175 G----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 614 ---------AYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD 664
KI+ K DV+S G ++ GK P F +N L I+D
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--F-----QQIINQISKLHAIID 282
Query: 665 PRLPPP-SRSVQEKLISIMEVAFSCLNESPESRPTMK 700
P ++ L +++ CL P+ R ++
Sbjct: 283 PNHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIP 316
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 59/239 (24%), Positives = 98/239 (41%), Gaps = 17/239 (7%)
Query: 96 CSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMN 155
CS +R NS LT S GI + T ++L N + K +L L++S N
Sbjct: 7 CSGT-EIRCNSKGLT---SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSN 62
Query: 156 NITGG--IPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPE- 212
++ + ++ L+ LDLS N ++ + L L L + + ++
Sbjct: 63 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFS 120
Query: 213 -IGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKE-LEKLVQLSEL 270
SL +L YLD+S + L L L ++ N F + +L L+ L
Sbjct: 121 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 180
Query: 271 DASHNLFGGEIP---FQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
D S ++ F SL SL+ LN+SHNN ++ + + V+D S N +
Sbjct: 181 DLSQCQLE-QLSPTAFN--SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 57/258 (22%), Positives = 88/258 (34%), Gaps = 33/258 (12%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFT 62
S + L+L N+ + + LT L +L L N LS S + T
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS--------- 79
Query: 63 SYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISE--ALGIY 120
L+Y +S N T+ L + +NL +SE
Sbjct: 80 ------------LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSL 125
Query: 121 PNLTFIDLSRNDFYGEISSNW-GKCPKLGTLNVSMNNITGGIPREI-GNSSQLQALDLSL 178
NL ++D+S + L L ++ N+ +I L LDLS
Sbjct: 126 RNLIYLDISHTHT-RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 179 NHIVGEIPKE-LGKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSANRFNNSVPEN 236
+ ++ L+SL L + N F L L L+ LD S N S +
Sbjct: 185 CQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 242
Query: 237 LGNLLK-LHYLGLSNNQF 253
L + L +L L+ N F
Sbjct: 243 LQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 46/209 (22%), Positives = 67/209 (32%), Gaps = 52/209 (24%)
Query: 1 MRSLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFN 59
+ L LD + K + SV +L NL L + + + + FN
Sbjct: 100 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGI-----------FN 147
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTI-PKILRNCSSLIRVRLNSNNLTGNISEALG 118
+S L+ ++ N FQ P I +L + L+ L +
Sbjct: 148 GLSS-----------LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QL----- 190
Query: 119 IYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSL 178
F L L LN+S NN + LQ LD SL
Sbjct: 191 --SPTAFNSL----------------SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 232
Query: 179 NHIVGEIPKEL--GKLNSLTELILRGNQF 205
NHI+ K+ +SL L L N F
Sbjct: 233 NHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 66/273 (24%), Positives = 117/273 (42%), Gaps = 47/273 (17%)
Query: 444 IGNGGHGSVYRAELPSG----QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
+G G G V L VAIK Q +++FL E + + H NI+
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ---RRDFLGEASIMGQFDHPNII 109
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
+ G + ++ +V E +E GSL + L A + Q + +++G+A + YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN------------WTEFAGTYG 607
+ VH+D++++N+L++ V+DFG+ + L+ + WT
Sbjct: 168 Y---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT------- 217
Query: 608 YVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILD-P 665
+PE K T DV+S+G+++ E + G+ P +S N D+ + + +
Sbjct: 218 --SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-------NQDV-IKAVDEGY 267
Query: 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
RLPPP L +M C + +RP
Sbjct: 268 RLPPP-MDCPAALYQLM---LDCWQKDRNNRPK 296
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 69/281 (24%), Positives = 113/281 (40%), Gaps = 41/281 (14%)
Query: 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVK-ALTEI 493
D IG G +GSV + PSGQ++A+K+ S + +QK+ L+++ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSS 78
Query: 494 RHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRM--NVIKGVADA 551
IV+FYG ++ EL+ S + + + + + A
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAP 611
L++L + I+H+DI N+LLD + DFGI+ L +S T AG Y+AP
Sbjct: 138 LNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAP 194
Query: 612 E----LAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDI-ALDEILDPR 666
E A + DV+S G+ + E G+ P N+ L ++ +
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY--------PKWNSVFDQLTQV--VK 244
Query: 667 LPPPSRSVQEKLISIMEVAFS---------CLNESPESRPT 698
PP +L + E FS CL + RP
Sbjct: 245 GDPP------QLSNSEEREFSPSFINFVNLCLTKDESKRPK 279
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 58/302 (19%), Positives = 113/302 (37%), Gaps = 53/302 (17%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI-EVKALTEIRHRNIVKF 501
+G G +V+R +G + AIK F++ + + E + L ++ H+NIVK
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 502 YGF--CSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
+ + RH L+ E GSL +L + A L S+ + V++ V +++L +
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 560 FPPIVHQDISSKNLLLDLEYEAH----VADFGIAKFLKPESSNWTEFAGTYGYVAPEL-- 613
IVH++I N++ + + + DFG A+ L+ + + GT Y+ P++
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLYGTEEYLHPDMYE 188
Query: 614 ------AYTMKITEKCDVYSFGVLVLEA-----------------------IKGKHPRDF 644
+ K D++S GV A I GK
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 645 LSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQ 704
+ + + D + D + L + + +++ + L E
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI------LEADQEKCWGFDQFFA 302
Query: 705 QV 706
+
Sbjct: 303 ET 304
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-26
Identities = 66/373 (17%), Positives = 125/373 (33%), Gaps = 52/373 (13%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPS--------------- 45
M L L L+ + +++L K L++L P
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173
Query: 46 --------LENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQG---------- 87
L+ + T L+ ++ L N C + N
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT 233
Query: 88 --TIPKILR--NCSSLIRVRLNSNNLTGNISEALGIYPN-----LTFIDLSRNDFYGEIS 138
+ +IL+ +++ +++ L G + Y L+ + + F S
Sbjct: 234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQS 293
Query: 139 SNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTEL 198
+ + N +++ S LD S N + + + G L L L
Sbjct: 294 YIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETL 353
Query: 199 ILRGNQFTGRLPPEIG---SLVDLEYLDLSANRFNNSVPENL-GNLLKLHYLGLSNNQFV 254
IL+ NQ L + L+ LD+S N + + L L +S+N
Sbjct: 354 ILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412
Query: 255 LELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNC-FEGIR 313
+ + L ++ LD N IP Q+ L++L++LN++ N L S+P+ F+ +
Sbjct: 413 DTIFRCL--PPRIKVLDLHSNKI-KSIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLT 468
Query: 314 GISVIDISDNQLQ 326
+ I + N
Sbjct: 469 SLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 3e-18
Identities = 56/354 (15%), Positives = 113/354 (31%), Gaps = 25/354 (7%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPM--LTRPGLDF 58
+ L LDL+ N+ + S NLK L L +N M L GL
Sbjct: 68 NQELEYLDLSHNKLVKI---SCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLST 124
Query: 59 NHFTSYLPHNVCRGGALQYF-GVSENHFQGTIPKILRNC--SSLIRVRLNSNNLTGNISE 115
H + + + E + + P+ L++ SL V + +
Sbjct: 125 THLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDV 184
Query: 116 ALGIYPNLTFIDLSRNDFYGEIS------SNWGKCPKLGTLNVSMNNITGGIPREIGN-- 167
++ NL ++ + S + PKL L ++ T I
Sbjct: 185 SVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV 244
Query: 168 -SSQLQALDLSLNHIVGEIPKELG-----KLNSLTELILRGNQFTGRLPPEIGSLVDLEY 221
+ + +S + G++ L +L+ + + F ++
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304
Query: 222 LDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFG--G 279
+ + + + +L SNN + + L +L L N
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELS 364
Query: 280 EIPFQICSLKSLEKLNLSHNNLSGSIP-NCFEGIRGISVIDISDNQLQGPVPNS 332
+I +KSL++L++S N++S + + +++S N L +
Sbjct: 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 3e-18
Identities = 54/359 (15%), Positives = 119/359 (33%), Gaps = 30/359 (8%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSL--ENPMLTRPGLDFN 59
+ +IL+++QN + + +L+ L+ L++ +N + + S+ N L L N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLSHN 79
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQG-TIPKILRNCSSLIRVRLNSNNLTGNISEALG 118
+ + L++ +S N F I K N S L + L++ +L ++
Sbjct: 80 KLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE---KSSVL 133
Query: 119 IYPNLTFIDLSRNDFYGEISSNWGKC-PKLGTLNVSMNNITGGIPREIGNSSQLQALDLS 177
+L + + T ++ + T I + S +L
Sbjct: 134 PIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLE 193
Query: 178 LNHIVG-----------EIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVD---LEYLD 223
L++I I +L L+ L L + T I LV + Y
Sbjct: 194 LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253
Query: 224 LSANRFNNSVPENLG-----NLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFG 278
+S + + +L L + ++ F E ++ + + +
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313
Query: 279 GEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRN 337
+ L+ S+N L+ ++ + + + + NQL+ +
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQ 372
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 39/193 (20%), Positives = 70/193 (36%), Gaps = 8/193 (4%)
Query: 118 GIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLS 177
+ T +++S+N +S+ KL L +S N I + +L+ LDLS
Sbjct: 18 DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS 77
Query: 178 LNHIVGEIPKELGKLNSLTELILRGNQFTGRLPP--EIGSLVDLEYLDLSANRFNNSVPE 235
N + +I +L L L N F LP E G++ L++L LS S
Sbjct: 78 HNKL-VKIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVL 133
Query: 236 NLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLN 295
+ +L L + + + + E L + + I + N
Sbjct: 134 PIAHLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN 191
Query: 296 LSHNNLSGSIPNC 308
L +N+ + +
Sbjct: 192 LELSNIKCVLEDN 204
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 36/143 (25%), Positives = 56/143 (39%), Gaps = 8/143 (5%)
Query: 185 IPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLH 244
+PK+L + T L + N + +I SL L L +S NR +L
Sbjct: 15 VPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72
Query: 245 YLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQ--ICSLKSLEKLNLSHNNLS 302
YL LS+N+ V ++ V L LD S N F +P ++ L+ L LS +L
Sbjct: 73 YLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAF-DALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 303 GSIPNCFEGIRGISVIDISDNQL 325
S + V+ +
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETY 151
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 6e-26
Identities = 31/292 (10%), Positives = 66/292 (22%), Gaps = 52/292 (17%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+ G V+ ++ + A+K F + ++ + A + + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSR-SELERLHEATFAAARLLGESPEEAR 128
Query: 503 GFCSHAR--------------------------HSFLVYELLERGSLAAILSS----DTA 532
+ L+ L + S+
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187
Query: 533 AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592
+ G + + + L +VH + NL + + + D
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL--- 241
Query: 593 KPESSNWTEFAGTYGYVAPEL--AYTMKITEKCDVYSFGVLVLEAIKGKHP----RDFLS 646
+ + Y E A T T + + G+ + P +
Sbjct: 242 WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 647 LISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
D + P V+ LI LN R
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPDFVKT-LIG------RFLNFDRRRRLL 346
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 60/272 (22%), Positives = 104/272 (38%), Gaps = 48/272 (17%)
Query: 444 IGNGGHGSVYRAEL--PSGQV--VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
+G G G VY G+ VA+K + ++++F+ E + + H +IV
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 500 KFYGFCSHARHS-FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
K G +++ EL G L L + L + + A++YL
Sbjct: 77 KLIGIIE--EEPTWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN----------WTEFAGTYGY 608
VH+DI+ +N+L+ + DFG++++++ E W
Sbjct: 133 NC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM-------- 181
Query: 609 VAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDP-R 666
+PE + T DV+ F V + E + GK P +L N D+ + + R
Sbjct: 182 -SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-------NKDV-IGVLEKGDR 232
Query: 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
LP P L ++M C + P RP
Sbjct: 233 LPKP-DLCPPVLYTLMT---RCWDYDPSDRPR 260
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 62/273 (22%), Positives = 103/273 (37%), Gaps = 48/273 (17%)
Query: 444 IGNGGHGSVYRAEL--PSGQV---VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI 498
+G+G G+VY+ +V VAIK+ KE L E + + + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPHV 79
Query: 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
+ G C L+ +L+ G L + +G +N +A ++YL
Sbjct: 80 CRLLGICL-TSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS-----------NWTEFAGTYG 607
VH+D++++N+L+ + DFG+AK L E W
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM------- 186
Query: 608 YVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDP- 665
A E T + DV+S+GV V E + G P D + ++I +
Sbjct: 187 --ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------ASEI-SSILEKGE 236
Query: 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
RLP P + + IM C +SRP
Sbjct: 237 RLPQPPICTID-VYMIM---VKCWMIDADSRPK 265
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 59/276 (21%), Positives = 103/276 (37%), Gaps = 36/276 (13%)
Query: 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKAL-TEI 493
ND + +G+G G V++ +G V+A+K+ + K L+++ +
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG---NKEENKRILMDLDVVLKSH 81
Query: 494 RHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALS 553
IV+ +G F+ EL+ + E + + AL
Sbjct: 82 DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE---RILGKMTVAIVKALY 138
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL 613
YL ++H+D+ N+LLD + + DFGI+ L + AG Y+APE
Sbjct: 139 YLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPER 195
Query: 614 AYTMKITE-----KCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDI-ALDEILD--- 664
T+ + DV+S G+ ++E G+ P + TD L ++L
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFPY--------KNCKTDFEVLTKVLQEEP 247
Query: 665 PRLPPPSRSVQE--KLISIMEVAFSCLNESPESRPT 698
P LP + + CL + RP
Sbjct: 248 PLLPGHMGFSGDFQSFVK------DCLTKDHRKRPK 277
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 32/212 (15%)
Query: 435 TNDFDAQYC----IGNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPCDQIADQKEFLIEVK 488
F +Y +G G V R ++ +GQ A + L + E +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EAR 62
Query: 489 ALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSL------AAILSSDTAAQELGWSQRM 542
++H NIV+ + S H +L+++L+ G L S A+
Sbjct: 63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS--------- 113
Query: 543 NVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAH---VADFGIAKFLKPESSN 598
+ I+ + +A+ + H +VH+++ +NLLL + + +ADFG+A ++ E
Sbjct: 114 HCIQQILEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169
Query: 599 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGV 630
W FAGT GY++PE+ + D+++ GV
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGV 201
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 64/286 (22%), Positives = 99/286 (34%), Gaps = 43/286 (15%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI-EVKALTEIRHRNIVKF 501
+G GG G V R +G+ VAIK+ + +E E++ + ++ H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQ----ELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 502 Y------GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
+ L E E G L L+ L ++ ++ AL YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAH---VADFGIAKFLKPESSNWTEFAGTYGYVAPE 612
H + I+H+D+ +N++L + + D G AK L F GT Y+APE
Sbjct: 138 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE-FVGTLQYLAPE 193
Query: 613 LAYTMKITEKCDVYSFGVLVLEAIKGKHP-----------------RDFLSLISSSSLNT 655
L K T D +SFG L E I G P + ++
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA 253
Query: 656 DIALDEILDP-RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
+ P L E+ + M L R T
Sbjct: 254 VKFSSVLPTPNHLSGILAGKLERWLQCM------LMWHQRQRGTDP 293
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 41/204 (20%), Positives = 78/204 (38%), Gaps = 29/204 (14%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPCDQIADQKEFLIEVKALTEIRHRNIVKF 501
IG G V R +GQ A+K + ++ E ++H +IV+
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 502 YGFCSHARHSFLVYELL----------ERGSLAAILSSDTAAQELGWSQRMNVIKGVADA 551
S ++V+E + +R + S A+ + ++ + +A
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS---------HYMRQILEA 142
Query: 552 LSYLH-HDCFPPIVHQDISSKNLLLDLEYEAH---VADFGIAKFLKPESSNWTEFAGTYG 607
L Y H ++ I+H+D+ +LL + + + FG+A L GT
Sbjct: 143 LRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPH 198
Query: 608 YVAPELAYTMKITEKCDVYSFGVL 631
++APE+ + DV+ GV+
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVI 222
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 36/214 (16%)
Query: 433 RATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEV 487
T + + G+G V+ + +G++ A+K E+
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK----SPAFRDSSLENEI 57
Query: 488 KALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSL-AAILS------SDTAAQELGWSQ 540
L +I+H NIV H +LV +L+ G L IL D +
Sbjct: 58 AVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS-------- 109
Query: 541 RMNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLL-DLEYEAHV--ADFGIAKFLKPES 596
VI+ V A+ YLH + IVH+D+ +NLL E + + DFG++K +
Sbjct: 110 --LVIQQVLSAVKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163
Query: 597 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGV 630
+ GT GYVAPE+ ++ D +S GV
Sbjct: 164 --MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGV 195
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 53/221 (23%), Positives = 91/221 (41%), Gaps = 36/221 (16%)
Query: 433 RATNDFDAQY----CIGNGGHGSVYRA-ELPSGQVVAIK-----KFHSPLPCDQIADQKE 482
+T+ F Y +G G V R P+ + A+K S + ++
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 483 FLIEVKALTEI-RHRNIVKFYGFCSHARHSFLVYELLERGSL------AAILSSDTAAQE 535
L EV L ++ H NI++ FLV++L+++G L LS
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-- 127
Query: 536 LGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595
+++ + + + LH IVH+D+ +N+LLD + + DFG + L P
Sbjct: 128 -------KIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 596 SSNWTEFAGTYGYVAPE-LAYTMKI-----TEKCDVYSFGV 630
E GT Y+APE + +M ++ D++S GV
Sbjct: 178 EK-LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 67/216 (31%), Positives = 99/216 (45%), Gaps = 28/216 (12%)
Query: 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQI--ADQKEFLI-EVKALT 491
DF+ +G G G+VY A E S ++A+K Q+ A + L EV+ +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK----AQLEKAGVEHQLRREVEIQS 64
Query: 492 EIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSS------DTAAQELGWSQRMNVI 545
+RH NI++ YG+ A +L+ E G++ L A I
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT---------YI 115
Query: 546 KGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT 605
+A+ALSY H ++H+DI +NLLL E +ADFG + SS T+ GT
Sbjct: 116 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTDLCGT 170
Query: 606 YGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
Y+ PE+ EK D++S GVL E + GK P
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 27/258 (10%), Positives = 63/258 (24%), Gaps = 46/258 (17%)
Query: 443 CIGNGGHGSVYRAE---LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
G ++A L + VA+ +E L L+ I +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPD-DVLQETLSRTLRLSRIDKPGVA 94
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
+ +V E + GSL + + ++ +A A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHRA- 148
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKI 619
+ + + ++ + +A +
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYP--------------------ATMPDA------- 179
Query: 620 TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLI 679
+ D+ G + + + P L + + + + P+ ++
Sbjct: 180 NPQDDIRGIGASLYALLVNRWP-----LPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234
Query: 680 SIMEVAFSCLNESPESRP 697
I VA + R
Sbjct: 235 QISAVAARSVQGDGGIRS 252
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 67/271 (24%), Positives = 110/271 (40%), Gaps = 46/271 (16%)
Query: 444 IGNGGHGSVYRAEL--PSGQV--VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
IG G G V++ P VAIK C + +++FL E + + H +IV
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
K G + +++ EL G L + L L + + ++ AL+YL
Sbjct: 80 KLIGVITENPV-WIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR 136
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE----SSN------WTEFAGTYGYV 609
F VH+DI+++N+L+ + DFG++++++ +S W
Sbjct: 137 F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM--------- 184
Query: 610 APELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILD-PRL 667
APE + T DV+ FGV + E + G P + N D+ + I + RL
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDV-IGRIENGERL 236
Query: 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
P P + L S+M C P RP
Sbjct: 237 PMP-PNCPPTLYSLMT---KCWAYDPSRRPR 263
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 61/286 (21%), Positives = 118/286 (41%), Gaps = 55/286 (19%)
Query: 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVK-ALTEI 493
+D + +G G +G V + +PSGQ++A+K+ + + +QK L+++ ++ +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---NSQEQKRLLMDLDISMRTV 63
Query: 494 RHRNIVKFYGFCSHARHSFL----VYELLE--RGSLAAILSSDTAAQELGWSQRMN---- 543
V FYG + V+ +E SL Q + Q +
Sbjct: 64 DCPFTVTFYG-------ALFREGDVWICMELMDTSLDKFY-----KQVIDKGQTIPEDIL 111
Query: 544 --VIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTE 601
+ + AL +LH ++H+D+ N+L++ + + DFGI+ +L +
Sbjct: 112 GKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDI 168
Query: 602 FAGTYGYVAPE--------LAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL 653
AG Y+APE Y++ K D++S G+ ++E + P + S +
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFP--YDSWGTPFQQ 222
Query: 654 NTDIALDEILDPRLPPPSRSVQ-EKLISIMEVAFSCLNESPESRPT 698
+ + P+LP S + S CL ++ + RPT
Sbjct: 223 LKQVVEEP--SPQLPADKFSAEFVDFTS------QCLKKNSKERPT 260
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 62/266 (23%), Positives = 111/266 (41%), Gaps = 28/266 (10%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQK---EFLIEVKALTEIRHRNIV 499
+G GG + + + +V A K +P + + +E+ + H+++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHVV 78
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
F+GF F+V EL R SL + A E + ++ + YLH +
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE---PEARYYLRQIVLGCQYLHRNR 135
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKI 619
++H+D+ NL L+ + E + DFG+A ++ + GT Y+APE+
Sbjct: 136 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 620 TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPR-LPPPSRSVQEKL 678
+ + DV+S G ++ + GK P + L I +E P+ + P + S L
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCL---KETYLRIKKNEYSIPKHINPVAAS----L 245
Query: 679 ISIMEVAFSCLNESPESRPTMKVVTQ 704
I M L P +RPT+ +
Sbjct: 246 IQKM------LQTDPTARPTINELLN 265
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 33/212 (15%)
Query: 435 TNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPCDQIADQKEFLIEVK 488
+ F Y + G G V R +G A K + L D ++ E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR---DFQKLEREAR 57
Query: 489 ALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSL------AAILSSDTAAQELGWSQRM 542
+++H NIV+ + +LV++L+ G L S A+
Sbjct: 58 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS--------- 108
Query: 543 NVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYE-AHV--ADFGIAKFLKPESSN 598
+ I+ + ++++Y H + IVH+++ +NLLL + + A V ADFG+A + +
Sbjct: 109 HCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA- 163
Query: 599 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGV 630
W FAGT GY++PE+ ++ D+++ GV
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 195
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 435 TNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPCDQIADQKEFLIEVK 488
F +Y I G G G V + + + Q A+K + + + EV+
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVE 73
Query: 489 ALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSL-AAILS----SDTAAQELGWSQRMN 543
L ++ H NI+K + + ++V EL G L I+ S+ A +
Sbjct: 74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI------- 126
Query: 544 VIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAH---VADFGIAKFLKPESSNWT 600
IK V ++Y+H IVH+D+ +N+LL+ + + + DFG++ + +
Sbjct: 127 -IKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MK 181
Query: 601 EFAGTYGYVAPEL---AYTMKITEKCDVYSFGV 630
+ GT Y+APE+ Y EKCDV+S GV
Sbjct: 182 DRIGTAYYIAPEVLRGTY----DEKCDVWSAGV 210
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-24
Identities = 57/224 (25%), Positives = 86/224 (38%), Gaps = 37/224 (16%)
Query: 431 IVRATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIK---------KFHSPLPCDQ 476
+ + Y G+G +G V E AIK +S +
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 477 IADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSL------AAILSSD 530
+E E+ L + H NI+K + ++ +LV E E G L
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 531 TAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL---DLEYEAHVADFG 587
AA N++K + + YLH IVH+DI +N+LL + + DFG
Sbjct: 147 DAA---------NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 588 IAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVL 631
++ F + GT Y+APE K EKCDV+S GV+
Sbjct: 195 LSSFFSK-DYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVI 236
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 4e-24
Identities = 53/242 (21%), Positives = 88/242 (36%), Gaps = 20/242 (8%)
Query: 93 LRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISS--NWGKCPKLGTL 150
+ I+ L ++T ++ ++ I + + +I S P + L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNS----DIKSVQGIQYLPNVTKL 70
Query: 151 NVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLP 210
++ N +T P + N L L L N I ++ L L L L L N + +
Sbjct: 71 FLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DIN 125
Query: 211 PEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSEL 270
+ L LE L L N+ + L L KL L L +NQ + L L +L L
Sbjct: 126 G-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQ--ISDIVPLAGLTKLQNL 180
Query: 271 DASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVP 330
S N ++ + LK+L+ L L N + + + +D L P
Sbjct: 181 YLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI 238
Query: 331 NS 332
S
Sbjct: 239 IS 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 95.6 bits (237), Expect = 1e-20
Identities = 57/321 (17%), Positives = 107/321 (33%), Gaps = 51/321 (15%)
Query: 7 LDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLP 66
K + P + L +++ + N S
Sbjct: 4 TITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--------------QNELNS--- 44
Query: 67 HNVCRGGALQYFGVSENHFQGTIPKI--LRNCSSLIRVRLNSNNLTGNISEALGIYPNLT 124
+ + + I + ++ ++ ++ LN N LT +I L NL
Sbjct: 45 --------IDQIIANNSD----IKSVQGIQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLG 90
Query: 125 FIDLSRNDFYGEIS--SNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIV 182
++ L N +I S+ KL +L++ N I+ + + QL++L L N I
Sbjct: 91 WLFLDEN----KIKDLSSLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKI- 143
Query: 183 GEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLK 242
L +L L L L NQ + + P + L L+ L LS N ++ L L
Sbjct: 144 -TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISD--LRALAGLKN 198
Query: 243 LHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS 302
L L L + + + + LV + + + P I EK N+ +
Sbjct: 199 LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 256
Query: 303 GSIPNCFEGIRGISVIDISDN 323
+ F + +++
Sbjct: 257 FTNEVSFIFYQPVTIGKAKAR 277
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 79.4 bits (195), Expect = 1e-15
Identities = 51/278 (18%), Positives = 92/278 (33%), Gaps = 67/278 (24%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
+ S+ + N + K V + L N+ +L L N L+ P
Sbjct: 42 LNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP----------------- 82
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
L N +L + L+ N + ++ +L
Sbjct: 83 --------------------------------LTNLKNLGWLFLDENKIK-DL-SSLKDL 108
Query: 121 PNLTFIDLSRNDFYGEIS--SNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSL 178
L + L N IS + P+L +L + N IT + ++L L L
Sbjct: 109 KKLKSLSLEHN----GISDINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLED 162
Query: 179 NHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLG 238
N I +I L L L L L N + L + L +L+ L+L + N +
Sbjct: 163 NQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQS 218
Query: 239 NLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNL 276
NL+ + + ++ L P+ + + + +L
Sbjct: 219 NLVVPNTVKNTDGS--LVTPEIISDDGDYEKPNVKWHL 254
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-24
Identities = 64/242 (26%), Positives = 95/242 (39%), Gaps = 25/242 (10%)
Query: 96 CSS-LIRVRLNSNNLTGNISEAL--GIYPNLTFIDLSRNDFYGEISSNW-GKCPKLGTLN 151
CS+ +V NL + GI N ++L N I N L L
Sbjct: 41 CSNQFSKVICVRKNLR-----EVPDGISTNTRLLNLHENQI-QIIKVNSFKHLRHLEILQ 94
Query: 152 VSMNNITGGIPREI-GNSSQLQALDLSLNHIVGEIPKE-LGKLNSLTELILRGNQFTGRL 209
+S N+I I + L L+L N + IP L+ L EL LR N +
Sbjct: 95 LSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SI 151
Query: 210 PPEI-GSLVDLEYLDLSANRFNNSVPEN-LGNLLKLHYLGLSNNQFVLELPKELEKLVQL 267
P + L LDL + + + E L L YL L+ E+P L L++L
Sbjct: 152 PSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKL 209
Query: 268 SELDASHNLFGGEIP---FQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQ 324
ELD S N I FQ L L+KL + + + N F+ ++ + I+++ N
Sbjct: 210 DELDLSGNHL-SAIRPGSFQ--GLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN 266
Query: 325 LQ 326
L
Sbjct: 267 LT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-22
Identities = 63/340 (18%), Positives = 112/340 (32%), Gaps = 66/340 (19%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHF 61
+ +L+L++NQ + + S +L +L+ L L N++ I
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIE------------------ 104
Query: 62 TSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYP 121
++L + L N LT + A
Sbjct: 105 ----------------------------IGAFNGLANLNTLELFDNRLTTIPNGAFVYLS 136
Query: 122 NLTFIDLSRNDFYGEISSN-WGKCPKLGTLNVSMNNITGGIPREI-GNSSQLQALDLSLN 179
L + L N I S + + P L L++ I S L+ L+L++
Sbjct: 137 KLKELWLRNNPI-ESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMC 195
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSANRFNNSVPENLG 238
++ EIP L L L EL L GN + + P L+ L+ L + ++
Sbjct: 196 NLR-EIP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFD 252
Query: 239 NLLKLHYLGLSNNQFVLELPKE-LEKLVQLSELDASHNLFGGEIPFQ-ICSLKSL-EKLN 295
NL L + L++N LP + L L + HN P+ C + L +
Sbjct: 253 NLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN------PWNCNCDILWLSWWIK 305
Query: 296 LSHNNLSGSIPNCF--EGIRGISVIDISDNQLQGPVPNST 333
+ + C ++G + ++ N P
Sbjct: 306 DMAPSNTACCARCNTPPNLKGRYIGELDQNYFTCYAPVIV 345
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 7e-17
Identities = 49/199 (24%), Positives = 73/199 (36%), Gaps = 18/199 (9%)
Query: 145 PKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQ 204
+ + N+ +P I S+ + L+L N I L L L L N
Sbjct: 43 NQFSKVICVRKNLRE-VPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 205 FTGRLPPEI-GSLVDLEYLDLSANRFNNSVPEN-LGNLLKLHYLGLSNNQFVLELPKEL- 261
+ L +L L+L NR ++P L KL L L NN +P
Sbjct: 100 IR-TIEIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAF 156
Query: 262 EKLVQLSELDASHNLFGGEIP---FQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVI 318
++ L LD I F+ L +L LNL+ NL IPN + + +
Sbjct: 157 NRIPSLRRLDLGELKRLSYISEGAFE--GLSNLRYLNLAMCNLR-EIPN-LTPLIKLDEL 212
Query: 319 DISDNQLQGPVPNSTAFRN 337
D+S N L P +F+
Sbjct: 213 DLSGNHLSAIRPG--SFQG 229
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 64/273 (23%), Positives = 102/273 (37%), Gaps = 48/273 (17%)
Query: 444 IGNGGHGSVYRAEL-PSGQ----VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI 498
+G+G G+V++ P G+ V IK + + A+ + H +I
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIE---DKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
V+ G C LV + L GSL + LG +N +A + YL
Sbjct: 78 VRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS-----------NWTEFAGTYG 607
VH++++++N+LL + VADFG+A L P+ W
Sbjct: 135 GM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM------- 184
Query: 608 YVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILD-P 665
A E + K T + DV+S+GV V E + G P L ++ D +
Sbjct: 185 --ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-------LAEV-PDLLEKGE 234
Query: 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
RL P + + +M C RPT
Sbjct: 235 RLAQPQICTID-VYMVM---VKCWMIDENIRPT 263
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-24
Identities = 56/228 (24%), Positives = 89/228 (39%), Gaps = 35/228 (15%)
Query: 426 LVYDEIVRATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFH----SPLPCDQ 476
L D+ +Y + G+G G V A E + + VAI+ + +
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSARE 180
Query: 477 IADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSL------AAILSSD 530
E++ L ++ H I+K F A ++V EL+E G L L
Sbjct: 181 ADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEA 239
Query: 531 TAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAH---VADFG 587
T + A+ YLH + I+H+D+ +N+LL + E + DFG
Sbjct: 240 TCK---------LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 287
Query: 588 IAKFLKPESSNWTEFAGTYGYVAPE-LAYTMKI--TEKCDVYSFGVLV 632
+K L E+S GT Y+APE L D +S GV++
Sbjct: 288 HSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 50/218 (22%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 429 DEIVRATNDFDAQY----CIGNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPCDQIADQKE 482
+ ++ A+ F Y +G G V R +G A K + L +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 483 FLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSL------AAILSSDTAAQEL 536
E + +++H NIV+ + +LV++L+ G L S A+
Sbjct: 78 ---EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS--- 131
Query: 537 GWSQRMNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAH---VADFGIAKFL 592
+ I+ + ++++Y H + IVH+++ +NLLL + + +ADFG+A +
Sbjct: 132 ------HCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181
Query: 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGV 630
+ W FAGT GY++PE+ ++ D+++ GV
Sbjct: 182 NDSEA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 62/266 (23%), Positives = 111/266 (41%), Gaps = 28/266 (10%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQK---EFLIEVKALTEIRHRNIV 499
+G GG + + + +V A K +P + + +E+ + H+++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
F+GF F+V EL R SL + A E + ++ + YLH +
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE---PEARYYLRQIVLGCQYLHRNR 161
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKI 619
++H+D+ NL L+ + E + DFG+A ++ + GT Y+APE+
Sbjct: 162 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 620 TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPR-LPPPSRSVQEKL 678
+ + DV+S G ++ + GK P + L I +E P+ + P + S L
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETSCL---KETYLRIKKNEYSIPKHINPVAAS----L 271
Query: 679 ISIMEVAFSCLNESPESRPTMKVVTQ 704
I M L P +RPT+ +
Sbjct: 272 IQKM------LQTDPTARPTINELLN 291
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 55/284 (19%)
Query: 444 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCD-QIADQKEFLIEVKALTEIRHR 496
+G+G G VY ++ PS VA+K LP D+ +FL+E +++ H+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 497 NIVKFYGFCSHARHSFLVYELLERGSLAAIL----SSDTAAQELGWSQRMNVIKGVADAL 552
NIV+ G + F++ EL+ G L + L + L ++V + +A
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 553 SYLHHDCFPPIVHQDISSKNLLLDLEYEAHV---ADFGIAKFLKPESSNWTEFAGTYGYV 609
YL + F +H+DI+++N LL V DFG+A+ + +++ G +
Sbjct: 154 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRASYYR-KGGCAML 207
Query: 610 -----APE-LAYTMKITEKCDVYSFGVLVLEAI-KGKHP------RDFLSLISSSSLNTD 656
PE T K D +SFGVL+ E G P ++ L ++S
Sbjct: 208 PVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---- 262
Query: 657 IALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
R+ PP ++ + IM C PE RP
Sbjct: 263 ---------RMDPP-KNCPGPVYRIMT---QCWQHQPEDRPNFA 293
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 71/293 (24%), Positives = 110/293 (37%), Gaps = 52/293 (17%)
Query: 431 IVRATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPCDQIADQKEFL 484
I Y G+G +G V + + AIK + + + + L
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST---SSNSKLL 84
Query: 485 IEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSL------AAILSSDTAAQELGW 538
EV L + H NI+K Y F R+ +LV E + G L + AA
Sbjct: 85 EEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA----- 139
Query: 539 SQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAH---VADFGIAKFLKPE 595
+IK V ++YLH IVH+D+ +NLLL+ + + + DFG++ +
Sbjct: 140 ----VIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN- 191
Query: 596 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNT 655
E GT Y+APE+ K EKCDV+S GV++ + G P F
Sbjct: 192 QKKMKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP--F------GGQTD 242
Query: 656 DIALDEILD-----PRLPPPSRSVQEK-LISIMEVAFSCLNESPESRPTMKVV 702
L ++ + S K LI M L + R + +
Sbjct: 243 QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQM------LQFDSQRRISAQQA 289
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-23
Identities = 38/294 (12%), Positives = 83/294 (28%), Gaps = 59/294 (20%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSP--LPCDQIADQKEFLIEVKALTEIRH----- 495
+G + A +G+ + + P + I KE ++ ++ L I++
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 496 --------------RNIVKFYGFCSHARHSFLVYELL-------ERGSLAAILSSDTAAQ 534
K R +++ + +L S ++
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 535 E-LGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593
+ L R+ + V L+ LHH +VH + +++LD + F +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--R 260
Query: 594 PESSNWTEFAGTYG---YVAPELAY-----TMKITEKCDVYSFGVLVLEAIKGKHPRDFL 645
+S + + A + +T D ++ G+ + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--N- 317
Query: 646 SLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTM 699
+ + +P P R+ L+ L E R
Sbjct: 318 ---TDDAALGGSEWIFRSCKNIPQPVRA----LLE------GFLRYPKEDRLLP 358
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 35/220 (15%)
Query: 433 RATNDFDAQY----CIGNGGHGSVYRA-ELPSGQVVAIK---KFHSPLPCDQIADQKEFL 484
A +F +Y IG G V R +G A+K L +Q+ + +E
Sbjct: 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146
Query: 485 I-EVKALTEIR-HRNIVKFYGFCSHARHSFLVYELLERGSL------AAILSSDTAAQEL 536
E L ++ H +I+ + FLV++L+ +G L LS
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR--- 203
Query: 537 GWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596
++++ + +A+S+LH + IVH+D+ +N+LLD + ++DFG + L+P
Sbjct: 204 ------SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254
Query: 597 SNWTEFAGTYGYVAPE-LAYTMKITEK-----CDVYSFGV 630
E GT GY+APE L +M T D+++ GV
Sbjct: 255 K-LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 55/259 (21%), Positives = 93/259 (35%), Gaps = 54/259 (20%)
Query: 423 EGKLVYDEIVRATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPCDQ 476
G+ + + +Y + G G +G V A E + + AIK + + +
Sbjct: 9 SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68
Query: 477 IADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSL------------- 523
D + EV+ + ++ H NI + Y ++ LV EL G L
Sbjct: 69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128
Query: 524 ----------------------AAILSSDTAAQELGWSQRM--NVIKGVADALSYLHHDC 559
+ + + +++ N+++ + AL YLH+
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ- 187
Query: 560 FPPIVHQDISSKNLLLDLEYEAHV--ADFGIAKFLKP----ESSNWTEFAGTYGYVAPEL 613
I H+DI +N L + DFG++K E T AGT +VAPE+
Sbjct: 188 --GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV 245
Query: 614 --AYTMKITEKCDVYSFGV 630
KCD +S GV
Sbjct: 246 LNTTNESYGPKCDAWSAGV 264
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 74/293 (25%), Positives = 119/293 (40%), Gaps = 51/293 (17%)
Query: 431 IVRATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPCDQIADQKEFL 484
+ +T F +Y G G G V + +GQ A+K + D++ L
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKT--DKESLL 74
Query: 485 IEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSL------AAILSSDTAAQELGW 538
EV+ L ++ H NI+K Y F + +LV E+ G L S AA
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA----- 129
Query: 539 SQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL-DLEYEAHV--ADFGIAKFLKPE 595
+I+ V ++Y+H + IVH+D+ +NLLL +A++ DFG++ +
Sbjct: 130 ----RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA- 181
Query: 596 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP------RDFLSLIS 649
S + GT Y+APE+ EKCDV+S GV++ + G P D L +
Sbjct: 182 SKKMKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE 240
Query: 650 SSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVV 702
+ P+ S S ++ LI M L P R + +
Sbjct: 241 KGKYTFE-------LPQWKKVSESAKD-LIRKM------LTYVPSMRISARDA 279
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 53/267 (19%), Positives = 85/267 (31%), Gaps = 41/267 (15%)
Query: 3 SLSILDLNQNQFKGVLPPSVS---NLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFN 59
SL L + + + ++ L+EL L ++G PP L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGP------- 121
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKI--LRNCS--SLIRVRLNSNNLTGNISE 115
L + + + L+ L + + + E
Sbjct: 122 --------------DLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCE 167
Query: 116 ALGIYPNLTFIDLSRNDFYGEISSNWGKC----PKLGTLNVSMNNIT---GGIPREIGNS 168
+ ++P L+ +DLS N GE C P L L + + G
Sbjct: 168 QVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR 227
Query: 169 SQLQALDLSLNHIVGEIPKEL-GKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSAN 227
QLQ LDLS N + + L L L ++P + + L LDLS N
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYN 284
Query: 228 RFNNSVPENLGNLLKLHYLGLSNNQFV 254
R + P L ++ L L N F+
Sbjct: 285 RL-DRNPSPDE-LPQVGNLSLKGNPFL 309
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 46/251 (18%), Positives = 80/251 (31%), Gaps = 45/251 (17%)
Query: 93 LRNCSSLIRVRLNSNNLTGNISEALGIY--PNLTFIDLSRNDFYGEISSNWG----KCPK 146
+ S L + L + +TG L P+L ++L + + P
Sbjct: 91 VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG 150
Query: 147 LGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKE----LGKLNSLTELILRG 202
L L+++ + ++ L LDLS N +GE K +L L LR
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210
Query: 203 NQFTGRLPPEIGSLVD----LEYLDLSANRFNNSVPENLGNLL-KLHYLGLSNNQFVLEL 257
+L L+ LDLS N ++ + +L+ L LS ++
Sbjct: 211 AGME-TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QV 268
Query: 258 PKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISV 317
PK L L+LS+N L P+ + + +
Sbjct: 269 PK--------------------------GLPAKLSVLDLSYNRLD-RNPS-PDELPQVGN 300
Query: 318 IDISDNQLQGP 328
+ + N
Sbjct: 301 LSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 44/248 (17%), Positives = 75/248 (30%), Gaps = 22/248 (8%)
Query: 93 LRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNV 152
NC V L + L +D + +L
Sbjct: 27 AFNCLGAADVELYGGGR--------SLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAA 78
Query: 153 SMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKL--NSLTELILRGNQFTGRLP 210
+ + + S LQ L L + G P L + L L LR + R
Sbjct: 79 RIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDA 138
Query: 211 --PEIGSLV--DLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKE----LE 262
E+ + L+ L ++ N E + L L LS+N + E
Sbjct: 139 WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198
Query: 263 KLVQLSELDASHNLF---GGEIPFQICSLKSLEKLNLSHNNLSGSIPN-CFEGIRGISVI 318
K L L + G + L+ L+LSHN+L + + ++ +
Sbjct: 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSL 258
Query: 319 DISDNQLQ 326
++S L+
Sbjct: 259 NLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 41/186 (22%), Positives = 67/186 (36%), Gaps = 16/186 (8%)
Query: 164 EIGNSSQLQALDLSLNHIVGEIPKELGKL---NSLTELILRGNQFTGRLPPEIGSLV--D 218
+I S L+ L + I I ++ + L EL L + TG PP + D
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPD 122
Query: 219 LEYLDLSANRFNN--SVPENLGNLLK--LHYLGLSNNQFVLELPKELEKLVQLSELDASH 274
L L+L + + L LK L L ++ + +++ LS LD S
Sbjct: 123 LNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSD 182
Query: 275 NLFGGEIPF--QIC--SLKSLEKLNLSHNN---LSGSIPNCFEGIRGISVIDISDNQLQG 327
N GE +C +L+ L L + SG + +D+S N L+
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242
Query: 328 PVPNST 333
+
Sbjct: 243 AAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 38/208 (18%), Positives = 58/208 (27%), Gaps = 50/208 (24%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFT 62
L +L + Q V L L L N G
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG------------------- 190
Query: 63 SYLPHNVCRGG--ALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
L +C LQ + +G S
Sbjct: 191 --LISALCPLKFPTLQVLALRNAGM---------------------ETPSGVCSALAAAR 227
Query: 121 PNLTFIDLSRNDFYGEI-SSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
L +DLS N + + +L +LN+S + +P+ + ++L LDLS N
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYN 284
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTG 207
+ P L + L L+GN F
Sbjct: 285 RL-DRNPSPDE-LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 30/166 (18%), Positives = 56/166 (33%), Gaps = 10/166 (6%)
Query: 189 LGKLNSLTELILRGNQFTGRLP-PEIGSLVDLEYLDLSANRFNNSVPENLGNLL---KLH 244
G SL L+ R + +I + L+ L + A R + + +L L
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 245 YLGLSNNQFVLELPKELEKLV--QLSELDASHNLFGGEIPF----QICSLKSLEKLNLSH 298
L L N + P L + L+ L+ + + + Q L+ L+++
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 299 NNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALK 344
+ +S +D+SDN G +A L+
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 21/119 (17%), Positives = 31/119 (26%), Gaps = 16/119 (13%)
Query: 1 MRSLSILDLNQNQFK---GVLPPSVSNLTNLKELVLLYNNLSGFIPPS--LENPMLTRPG 55
+L +L L + GV + L+ L L +N+L L
Sbjct: 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLN 259
Query: 56 LDFNHFTS---YLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTG 111
L F LP L +S N P + + L N
Sbjct: 260 LSFTGLKQVPKGLPAK------LSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFLD 310
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 48/234 (20%), Positives = 90/234 (38%), Gaps = 18/234 (7%)
Query: 93 LRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNV 152
++ I++ +N+T + +T + L L +
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLEL 70
Query: 153 SMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPE 212
N IT P + N +++ L+LS N + + + L S+ L L Q T
Sbjct: 71 KDNQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD--VTP 124
Query: 213 IGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDA 272
+ L +L+ L L N+ N L L L YL + N Q + L L +L+ L A
Sbjct: 125 LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQ--VSDLTPLANLSKLTTLKA 180
Query: 273 SHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
N +I + SL +L +++L +N +S P + ++ +++ +
Sbjct: 181 DDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 49/242 (20%), Positives = 90/242 (37%), Gaps = 20/242 (8%)
Query: 93 LRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEIS--SNWGKCPKLGTL 150
+ + + +T I E + NL ++L N +I+ + K+ L
Sbjct: 37 QADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDN----QITDLAPLKNLTKITEL 90
Query: 151 NVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLP 210
+S N + I ++ LDL+ I P L L++L L L NQ T +
Sbjct: 91 ELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NIS 145
Query: 211 PEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSEL 270
P + L +L+YL + + ++ L NL KL L +N+ + L L L E+
Sbjct: 146 P-LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNK--ISDISPLASLPNLIEV 200
Query: 271 DASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVP 330
+N P + +L + L++ ++ + +V+ P
Sbjct: 201 HLKNNQISDVSPLA--NTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPAT 258
Query: 331 NS 332
S
Sbjct: 259 IS 260
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 53/305 (17%), Positives = 107/305 (35%), Gaps = 49/305 (16%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
+ + + ++ + ++L + L ++ ++E +
Sbjct: 18 LANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVT-----TIEG---------VQY 61
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
+ L + +N P L+N + + + L+ N L N+ A+
Sbjct: 62 LNN-----------LIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NV-SAIAGL 106
Query: 121 PNLTFIDLSRNDFYGEIS--SNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSL 178
++ +DL+ +I+ + L L + +N IT P + + LQ L +
Sbjct: 107 QSIKTLDLTST----QITDVTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGN 160
Query: 179 NHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLG 238
+ P L L+ LT L N+ + + P + SL +L + L N+ ++ L
Sbjct: 161 AQVSDLTP--LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDV--SPLA 214
Query: 239 NLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEI-PFQICSLKSLEKLNLS 297
N L + L+N + LV + + G I P I + NL+
Sbjct: 215 NTSNLFIVTLTNQTITNQPVFYNNNLVVPNVV---KGPSGAPIAPATISDNGTYASPNLT 271
Query: 298 HNNLS 302
N S
Sbjct: 272 WNLTS 276
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 33/212 (15%)
Query: 433 RATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEV 487
+ + + G G VYR + + + A+K + D+K E+
Sbjct: 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL------KKTVDKKIVRTEI 99
Query: 488 KALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSL------AAILSSDTAAQELGWSQR 541
L + H NI+K LV EL+ G L S AA
Sbjct: 100 GVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA-------- 151
Query: 542 MNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL-DLEYEAHV--ADFGIAKFLKPESSN 598
+ +K + +A++YLH + IVH+D+ +NLL +A + ADFG++K ++ +
Sbjct: 152 -DAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL- 206
Query: 599 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGV 630
GT GY APE+ + D++S G+
Sbjct: 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 53/222 (23%), Positives = 85/222 (38%), Gaps = 38/222 (17%)
Query: 427 VYDEIVRATNDFDAQY----CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQK 481
+ ++ R + F Y IG G + R + A+K I K
Sbjct: 9 IVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK---------IIDKSK 59
Query: 482 EFLI-EVKAL-TEIRHRNIVKFYGFCSHARHSFLVYELLERGSL-AAILS----SDTAAQ 534
E++ L +H NI+ ++ ++V EL++ G L IL S+ A
Sbjct: 60 RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS 119
Query: 535 ELGWSQRMNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAH----VADFGIA 589
V+ + + YLH +VH+D+ N+L E + DFG A
Sbjct: 120 A--------VLFTITKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFA 167
Query: 590 KFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVL 631
K L+ E+ T +VAPE+ CD++S GVL
Sbjct: 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVL 209
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 51/335 (15%), Positives = 113/335 (33%), Gaps = 83/335 (24%)
Query: 433 RATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIK------------------KFHSPLP 473
R DF+ C+G GG G V+ A+ AIK K + L
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 474 CDQIADQKEFLI------------------------------------EVKALTEIRHRN 497
I + +++ + +N
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH 557
V S + ++ +L + +L ++ + ++ +++ +A+A+ +LH
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK------------PESSNWTEFAGT 605
++H+D+ N+ ++ V DFG+ + P + T GT
Sbjct: 183 KG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 606 YGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDP 665
Y++PE + + K D++S G+++ E + + S+ + + ++ +
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YSF-------STQMERVRIITDVRNL 289
Query: 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
+ P + +++ L+ SP RP
Sbjct: 290 KFPLLFTQKYPQEHMMVQ---DMLSPSPTERPEAT 321
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 49/221 (22%), Positives = 88/221 (39%), Gaps = 23/221 (10%)
Query: 421 NFEGKLVYDEIVRATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCD 475
+ K V + Y I G+G G V+R E +G+V K +
Sbjct: 32 DIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF----INTP 87
Query: 476 QIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSL-AAILSSDTAAQ 534
D+ E+ + ++ H ++ + L+ E L G L I + D
Sbjct: 88 YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS 147
Query: 535 ELGWSQRMNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAKF 591
E ++ +N ++ + L ++H H IVH DI +N++ + + + V DFG+A
Sbjct: 148 E---AEVINYMRQACEGLKHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGLATK 200
Query: 592 LKPESSNWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVL 631
L P+ T + APE + + D+++ GVL
Sbjct: 201 LNPDEIVKVTT-ATAEFAAPEIVDREP-VGFYTDMWAIGVL 239
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 70/284 (24%), Positives = 115/284 (40%), Gaps = 55/284 (19%)
Query: 444 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCD-QIADQKEFLIEVKALTEIRHR 496
+G+G G VY ++ PS VA+K LP D+ +FL+E +++ H+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 497 NIVKFYGFCSHARHSFLVYELLERGSLAAILSS----DTAAQELGWSQRMNVIKGVADAL 552
NIV+ G + F++ EL+ G L + L + L ++V + +A
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 553 SYLHHDCFPPIVHQDISSKNLLLDLEYEAHV---ADFGIAKFLKPESSNWTEFAGTYGYV 609
YL + F +H+DI+++N LL V DFG+A+ + + + G +
Sbjct: 195 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRAGYYR-KGGCAML 248
Query: 610 -----APE-LAYTMKITEKCDVYSFGVLVLEAI-KGKHP------RDFLSLISSSSLNTD 656
PE T K D +SFGVL+ E G P ++ L ++S
Sbjct: 249 PVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG---- 303
Query: 657 IALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
R+ PP ++ + IM C PE RP
Sbjct: 304 ---------RMDPP-KNCPGPVYRIMT---QCWQHQPEDRPNFA 334
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-23
Identities = 66/342 (19%), Positives = 107/342 (31%), Gaps = 66/342 (19%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHF 61
+ L+L +N + + + +L +L+ L L N++ I
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIE------------------ 115
Query: 62 TSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYP 121
+SL + L N LT S A
Sbjct: 116 ----------------------------VGAFNGLASLNTLELFDNWLTVIPSGAFEYLS 147
Query: 122 NLTFIDLSRNDFYGEISSN-WGKCPKLGTLNVSMNNITGGIPREI-GNSSQLQALDLSLN 179
L + L N I S + + P L L++ I L+ L+L +
Sbjct: 148 KLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMC 206
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPE-IGSLVDLEYLDLSANRFNNSVPENLG 238
+I ++P L L L EL + GN F + P L L+ L + ++ +
Sbjct: 207 NIK-DMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFD 263
Query: 239 NLLKLHYLGLSNNQFVLELPKE-LEKLVQLSELDASHNLFGGEIPFQ-ICSLKSL-EKLN 295
L L L L++N LP + L L EL HN P+ C + L L
Sbjct: 264 GLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN------PWNCDCDILWLAWWLR 316
Query: 296 LSHNNLSGSIPNCF--EGIRGISVIDISDNQLQGPVPNSTAF 335
S C +RG ++++ Q P
Sbjct: 317 EYIPTNSTCCGRCHAPMHMRGRYLVEVDQASFQCSAPFIMDA 358
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 5e-23
Identities = 52/216 (24%), Positives = 83/216 (38%), Gaps = 40/216 (18%)
Query: 433 RATNDFDAQYCIGN----GGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEV 487
D + Y + N G G V A + + A KK +P + D F E+
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKK----IPKYFVEDVDRFKQEI 57
Query: 488 KALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSL------AAILSSDTAAQELGWSQR 541
+ + + H NI++ Y +LV EL G L + AA
Sbjct: 58 EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-------- 109
Query: 542 MNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAH---VADFGIAKFLKPESS 597
++K V A++Y H + + H+D+ +N L + + DFG+A KP
Sbjct: 110 -RIMKDVLSAVAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP-GK 163
Query: 598 NWTEFAGTYGYVAPEL---AYTMKITEKCDVYSFGV 630
GT YV+P++ Y +CD +S GV
Sbjct: 164 MMRTKVGTPYYVSPQVLEGLY----GPECDEWSAGV 195
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 54/201 (26%), Positives = 82/201 (40%), Gaps = 34/201 (16%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI--EVKALTEIR-HRNIV 499
+G G + S Q A+K I+ + E E+ AL H NIV
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVK---------IISKRMEANTQKEITALKLCEGHPNIV 69
Query: 500 KFYGFCSHARHSFLVYELLERGSL-AAILSSDT-----AAQELGWSQRMNVIKGVADALS 553
K + H+FLV ELL G L I A+ +++ + A+S
Sbjct: 70 KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY---------IMRKLVSAVS 120
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLEYEAH---VADFGIAKFLKPESSNWTEFAGTYGYVA 610
++H +VH+D+ +NLL E + + DFG A+ P++ T Y A
Sbjct: 121 HMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177
Query: 611 PELAYTMKITEKCDVYSFGVL 631
PEL E CD++S GV+
Sbjct: 178 PELLNQNGYDESCDLWSLGVI 198
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 53/204 (25%), Positives = 80/204 (39%), Gaps = 31/204 (15%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFH----SPLPCDQIADQKEFLIEVKALTEIRHRNI 498
+G+G G V A E + + VAIK + + E++ L ++ H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 499 VKFYGFCSHARHSFLVYELLERGSL------AAILSSDTAAQELGWSQRMNVIKGVADAL 552
+K F A ++V EL+E G L L T + A+
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK---------LYFYQMLLAV 127
Query: 553 SYLHHDCFPPIVHQDISSKNLLLDLEYEAH---VADFGIAKFLKPESSNWTEFAGTYGYV 609
YLH + I+H+D+ +N+LL + E + DFG +K L S GT Y+
Sbjct: 128 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYL 183
Query: 610 APE-LAYTMKI--TEKCDVYSFGV 630
APE L D +S GV
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGV 207
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 45/200 (22%), Positives = 86/200 (43%), Gaps = 17/200 (8%)
Query: 437 DFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
+G G G V++ E +G +A K + + D++E E+ + ++ H
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKI----IKTRGMKDKEEVKNEISVMNQLDH 145
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSL-AAILSSDTAAQELGWSQRMNVIKGVADALSY 554
N+++ Y LV E ++ G L I+ E + +K + + + +
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTE---LDTILFMKQICEGIRH 202
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAKFLKPESSNWTEFAGTYGYVAPE 612
+H I+H D+ +N+L + DFG+A+ KP F GT ++APE
Sbjct: 203 MHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPE 258
Query: 613 -LAYTMKITEKCDVYSFGVL 631
+ Y ++ D++S GV+
Sbjct: 259 VVNYD-FVSFPTDMWSVGVI 277
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 8e-23
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 23/215 (10%)
Query: 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKK-FHSPLPCDQIADQKEFLIEVKALTEI 493
DF +G G VYRA + +G VAIK + + + EVK ++
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR--VQNEVKIHCQL 68
Query: 494 RHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSS-------DTAAQELGWSQRMNVIK 546
+H +I++ Y + + + +LV E+ G + L + + A + +
Sbjct: 69 KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR---------HFMH 119
Query: 547 GVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTY 606
+ + YLH I+H+D++ NLLL +ADFG+A LK GT
Sbjct: 120 QIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTP 176
Query: 607 GYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
Y++PE+A + DV+S G + + G+ P
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 8e-23
Identities = 67/267 (25%), Positives = 110/267 (41%), Gaps = 33/267 (12%)
Query: 444 IGNGGHGSVYRAELPSG----QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
IG G G VY L A+K + I + +FL E + + H N++
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 500 KFYGFCSHARHS-FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
G C + S +V ++ G L + ++T + VA + +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYV-----APEL 613
F VH+D++++N +LD ++ VADFG+A+ + + + T + A E
Sbjct: 212 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEFDSVHNKTGAKLPVKWMALES 267
Query: 614 AYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILD-PRLPPPS 671
T K T K DV+SFGVL+ E + +G P ++ DI +L RL P
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDI-TVYLLQGRRLLQP- 318
Query: 672 RSVQEKLISIMEVAFSCLNESPESRPT 698
+ L +M C + E RP+
Sbjct: 319 EYCPDPLYEVML---KCWHPKAEMRPS 342
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIAD---QKEFLIEVKALT 491
+DFD +G G G+VY A E + ++A+K L Q+ + + E++ +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKV----LFKSQLEKEGVEHQLRREIEIQS 69
Query: 492 EIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMN------VI 545
+RH NI++ Y + + +L+ E RG L L R + +
Sbjct: 70 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK---------HGRFDEQRSATFM 120
Query: 546 KGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT 605
+ +ADAL Y H ++H+DI +NLL+ + E +ADFG + P T GT
Sbjct: 121 EELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRT-MCGT 175
Query: 606 YGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
Y+ PE+ EK D++ GVL E + G P
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 32/217 (14%)
Query: 429 DEIVRATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPCDQIADQKE 482
E + F +Y I G G G V + + + Q A+K + + D
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK---DTST 67
Query: 483 FLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSL------AAILSSDTAAQEL 536
L EV+ L ++ H NI+K + + ++V EL G L S AA
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--- 124
Query: 537 GWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL-DLEYEAH--VADFGIAKFLK 593
+IK V ++Y+H IVH+D+ +N+LL E + + DFG++ +
Sbjct: 125 ------RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGV 630
++ + GT Y+APE+ EKCDV+S GV
Sbjct: 176 Q-NTKMKDRIGTAYYIAPEV-LRGTYDEKCDVWSAGV 210
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-22
Identities = 30/159 (18%), Positives = 61/159 (38%), Gaps = 7/159 (4%)
Query: 145 PKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQ 204
L + ++ N+T I + ++ L ++ H + L++L L + G
Sbjct: 44 NSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKD 99
Query: 205 FTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKL 264
T P + L L LD+S + ++S+ + L K++ + LS N + L+ L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG-AITDIMPLKTL 158
Query: 265 VQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSG 303
+L L+ + + L +L + G
Sbjct: 159 PELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-18
Identities = 29/156 (18%), Positives = 56/156 (35%), Gaps = 8/156 (5%)
Query: 170 QLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRF 229
L + ++NSLT + L T L I +++ L ++
Sbjct: 24 AYLNGLLGQSST---ANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHA 78
Query: 230 NNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLK 289
N + L L L + + L L L+ LD SH+ I +I +L
Sbjct: 79 TNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136
Query: 290 SLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQL 325
+ ++LS+N I + + + ++I + +
Sbjct: 137 KVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 29/206 (14%), Positives = 72/206 (34%), Gaps = 33/206 (16%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHF 61
++ L Q+ + + + +L + L N++ L +
Sbjct: 23 KAYLNGLLGQSS---TANITEAQMNSLTYITLANINVT-----DLTG---------IEYA 65
Query: 62 TSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYP 121
+ ++ ++ H P + S+L R+R+ ++T + L
Sbjct: 66 HN-----------IKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLT 112
Query: 122 NLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHI 181
+LT +D+S + I + PK+ ++++S N I + +L++L++ + +
Sbjct: 113 SLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGV 171
Query: 182 VGEIPKELGKLNSLTELILRGNQFTG 207
+ L +L G
Sbjct: 172 HDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 17/131 (12%), Positives = 39/131 (29%), Gaps = 26/131 (19%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
+ +L L + P++S LT+L L + ++ I + L +
Sbjct: 87 LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT--LPK------- 137
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
+ +S N T L+ L + + + + + + +
Sbjct: 138 --------------VNSIDLSYNG-AITDIMPLKTLPELKSLNIQFDGVH-DYR-GIEDF 180
Query: 121 PNLTFIDLSRN 131
P L +
Sbjct: 181 PKLNQLYAFSQ 191
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 52/233 (22%), Positives = 83/233 (35%), Gaps = 18/233 (7%)
Query: 102 VRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGI 161
L + GI I L N ++++ C L L + N +
Sbjct: 16 TSCPQQGLQ-AVPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 162 PREIGNSSQLQALDLSLNHIVGEIPKE-LGKLNSLTELILRGNQFTGRLPPEI-GSLVDL 219
+ L+ LDLS N + + L L L L L P + L L
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAAL 131
Query: 220 EYLDLSANRFNNSVPEN-LGNLLKLHYLGLSNNQFVLELPKE-LEKLVQLSELDASHNLF 277
+YL L N ++P++ +L L +L L N+ +P+ L L L N
Sbjct: 132 QYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRV 189
Query: 278 GGEIP---FQICSLKSLEKLNLSHNNLSGSIP-NCFEGIRGISVIDISDNQLQ 326
+ F+ L L L L NNLS ++P +R + + ++DN
Sbjct: 190 A-HVHPHAFR--DLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 8e-17
Identities = 53/258 (20%), Positives = 84/258 (32%), Gaps = 56/258 (21%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHF 61
+ + L+ N+ V S NL L L N L+ I + F
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAA-----------FTGL 79
Query: 62 TSYLPHNVCRGGALQYFGVSENHFQGTIPK-ILRNCSSLIRVRLNSNNLTGNISEALGIY 120
L+ +S+N ++ L + L+ L
Sbjct: 80 AL-----------LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ---------- 118
Query: 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREI-GNSSQLQALDLSLN 179
+L F G L L + N + +P + + L L L N
Sbjct: 119 ------ELGPGLFRG--------LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGN 163
Query: 180 HIVGEIPKE-LGKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSANRFNNSVPEN- 236
I +P+ L+SL L+L N+ + P L L L L AN +++P
Sbjct: 164 RIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNL-SALPTEA 220
Query: 237 LGNLLKLHYLGLSNNQFV 254
L L L YL L++N +V
Sbjct: 221 LAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 48/231 (20%), Positives = 75/231 (32%), Gaps = 54/231 (23%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
R+L+IL L+ N + + + L L++L L N + P+ F+
Sbjct: 55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPAT-----------FHG 103
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPK-ILRNCSSLIRVRLNSNNLTGNISEALGI 119
L + Q + + R ++L + L N L +
Sbjct: 104 LGR-----------LHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-AL------ 144
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREI-GNSSQLQALDLSL 178
P+ TF DL L L + N I+ +P L L L
Sbjct: 145 -PDDTFRDL----------------GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQ 186
Query: 179 NHIVGEIPKE-LGKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSAN 227
N + + L L L L N + LP E L L+YL L+ N
Sbjct: 187 NRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 32/160 (20%), Positives = 60/160 (37%), Gaps = 15/160 (9%)
Query: 184 EIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSANRFNNSVPENLGNLLK 242
+P + + + L GN+ + +P + +L L L +N L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 243 LHYLGLSNNQFVLELPKE-LEKLVQLSELDASHNLFGGEIP---FQICSLKSLEKLNLSH 298
L L LS+N + + L +L L E+ F+ L +L+ L L
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFR--GLAALQYLYLQD 138
Query: 299 NNLSGSIP-NCFEGIRGISVIDISDNQLQGPVPNSTAFRN 337
N L ++P + F + ++ + + N++ AFR
Sbjct: 139 NALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPER--AFRG 175
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 47/247 (19%), Positives = 90/247 (36%), Gaps = 31/247 (12%)
Query: 400 KSDSGDRQSSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCI----GNGGHGSVYRA 455
+ R + + + + + + + Y I G G G V+R
Sbjct: 117 EQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV 176
Query: 456 -ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514
E +G A K + +D++ E++ ++ +RH +V + ++
Sbjct: 177 TERATGNNFAAKF----VMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232
Query: 515 YELLERGSL-------AAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQD 567
YE + G L +S D A ++ V L ++H + VH D
Sbjct: 233 YEFMSGGELFEKVADEHNKMSEDEAV---------EYMRQVCKGLCHMHEN---NYVHLD 280
Query: 568 ISSKNLLLDLEYEAHV--ADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDV 625
+ +N++ + + DFG+ L P + GT + APE+A + D+
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDP-KQSVKVTTGTAEFAAPEVAEGKPVGYYTDM 339
Query: 626 YSFGVLV 632
+S GVL
Sbjct: 340 WSVGVLS 346
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 68/267 (25%), Positives = 111/267 (41%), Gaps = 33/267 (12%)
Query: 444 IGNGGHGSVYRAELPSG----QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
IG G G VY L A+K + I + +FL E + + H N++
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD---IGEVSQFLTEGIIMKDFSHPNVL 89
Query: 500 KFYGFCSHARHS-FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
G C + S +V ++ G L + ++T + VA + YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYV-----APEL 613
F VH+D++++N +LD ++ VADFG+A+ + + ++ T + A E
Sbjct: 148 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWMALES 203
Query: 614 AYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILD-PRLPPPS 671
T K T K DV+SFGVL+ E + +G P ++ DI +L RL P
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDI-TVYLLQGRRLLQP- 254
Query: 672 RSVQEKLISIMEVAFSCLNESPESRPT 698
+ L +M C + E RP+
Sbjct: 255 EYCPDPLYEVML---KCWHPKAEMRPS 278
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 57/312 (18%), Positives = 102/312 (32%), Gaps = 64/312 (20%)
Query: 3 SLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHF 61
++ LDL+ N+ + S NL+ LVL N ++ I F+
Sbjct: 53 AVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDS-----------FSSL 99
Query: 62 TSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYP 121
S L++ +S N+ + SSL + L N +
Sbjct: 100 GS-----------LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-------TLGE 141
Query: 122 NLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREI-GNSSQLQALDLSLNH 180
F L KL L V + I R+ + L+ L++ +
Sbjct: 142 TSLFSHL----------------TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185
Query: 181 IVGEIPKE-LGKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSANRFNNS------ 232
+ + L + +++ LIL Q L +E L+L +
Sbjct: 186 LQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELS 243
Query: 233 --VPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQIC-SLK 289
+L + +++ ++ K L ++ L EL+ S N +P I L
Sbjct: 244 TGETNSLIKKFTFRNVKITDESL-FQVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLT 301
Query: 290 SLEKLNLSHNNL 301
SL+K+ L N
Sbjct: 302 SLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 41/244 (16%), Positives = 91/244 (37%), Gaps = 17/244 (6%)
Query: 97 SSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNW-GKCPKLGTLNVSMN 155
++ + L++N +T + L NL + L+ N I + L L++S N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYN 110
Query: 156 NITGGIPREI-GNSSQLQALDLSLNHIVGEIPKE--LGKLNSLTELILRGNQFTGRLPPE 212
++ + S L L+L N + + L L L + ++ +
Sbjct: 111 YLSN-LSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168
Query: 213 I-GSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELD 271
L LE L++ A+ + P++L ++ + +L L Q +L L ++ + L+
Sbjct: 169 DFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLE 228
Query: 272 ASHNLFGGEIPFQICS--------LKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDN 323
++ + + + ++ +L + I G+ ++ S N
Sbjct: 229 LRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRN 287
Query: 324 QLQG 327
QL+
Sbjct: 288 QLKS 291
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 40/234 (17%), Positives = 81/234 (34%), Gaps = 24/234 (10%)
Query: 2 RSLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPPSL--ENPMLTRPGLDF 58
SL LDL+ N L S L++L L LL N SL L +
Sbjct: 100 GSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN 158
Query: 59 NHFTSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEAL 117
+ + G L+ + + Q PK L++ ++ + L+ + +
Sbjct: 159 MDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFV 218
Query: 118 GIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLS 177
+ ++ ++L D + ++ G + + + ++
Sbjct: 219 DVTSSVECLELRDTDLD----------------TFHFSELSTGETNSLIKKFTFRNVKIT 262
Query: 178 LNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSANRFN 230
+ ++ K L +++ L EL NQ +P I L L+ + L N ++
Sbjct: 263 DESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 25/142 (17%), Positives = 49/142 (34%), Gaps = 14/142 (9%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPP-------SLENPMLTR 53
+ L L+++ + + P S+ ++ N+ L+L + S+E L
Sbjct: 173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRD 231
Query: 54 PGLDFNHFTSYLPHNVCRG----GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNL 109
LD HF+ L + +++ + K+L S L+ + + N L
Sbjct: 232 TDLDTFHFSE-LSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289
Query: 110 TGNISEALGIYPNLTFIDLSRN 131
+L I L N
Sbjct: 290 KSVPDGIFDRLTSLQKIWLHTN 311
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 64/282 (22%), Positives = 103/282 (36%), Gaps = 35/282 (12%)
Query: 430 EIVRATNDFDAQYCIGNGGHGSVYRAELPSG----QVVAIKKFHSPLPCDQIADQKEFLI 485
I + IG G G VY E AIK ++ + FL
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLR 71
Query: 486 EVKALTEIRHRNIVKFYGFCSHAR-HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNV 544
E + + H N++ G ++ + G L + S + ++
Sbjct: 72 EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISF 129
Query: 545 IKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAG 604
VA + YL F VH+D++++N +LD + VADFG+A+ + +
Sbjct: 130 GLQVARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARDI--LDREYYSVQQ 184
Query: 605 TYG------YVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDI 657
+ A E T + T K DV+SFGVL+ E + +G P + D+
Sbjct: 185 HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-------PFDL 237
Query: 658 ALDEILD-PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
+ RLP P + L +M+ C P RPT
Sbjct: 238 -THFLAQGRRLPQP-EYCPDSLYQVMQ---QCWEADPAVRPT 274
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 72/288 (25%), Positives = 124/288 (43%), Gaps = 59/288 (20%)
Query: 444 IGNGGHGSVYRAELPSG------QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G G G V+ AE + +VA+K L + +++F E + LT ++H++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKA----LKEASESARQDFQREAELLTMLQHQH 104
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAIL------------SSDTAAQELGWSQRMNVI 545
IV+F+G C+ R +V+E + G L L D A LG Q + V
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 546 KGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGT 605
VA + YL F VH+D++++N L+ + DFG+++ + S+++ G
Sbjct: 165 SQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDI--YSTDYYR-VGG 218
Query: 606 YGYV-----APE-LAYTMKITEKCDVYSFGVLVLEAI-KGKHP------RDFLSLISSSS 652
+ PE + Y K T + DV+SFGV++ E GK P + + I+
Sbjct: 219 RTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277
Query: 653 LNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
L P R+ ++ +IM C P+ R ++K
Sbjct: 278 -------------ELERP-RACPPEVYAIMR---GCWQREPQQRHSIK 308
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 72/289 (24%), Positives = 122/289 (42%), Gaps = 60/289 (20%)
Query: 444 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G G G V+ AE +VA+K L +A +K+F E + LT ++H +
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKA----LKDPTLAARKDFQREAELLTNLQHEH 78
Query: 498 IVKFYGFCSHARHSFLVYELLERGSL-------------AAILSSDTAAQELGWSQRMNV 544
IVKFYG C +V+E ++ G L A ELG SQ +++
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 545 IKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAG 604
+A + YL F VH+D++++N L+ + DFG+++ + S+++ G
Sbjct: 139 ASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDV--YSTDYYR-VG 192
Query: 605 TYGYV-----APE-LAYTMKITEKCDVYSFGVLVLEAI-KGKHP------RDFLSLISSS 651
+ + PE + Y K T + DV+SFGV++ E GK P + + I+
Sbjct: 193 GHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 251
Query: 652 SLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
L P R +++ +M C P+ R +K
Sbjct: 252 R-------------VLERP-RVCPKEVYDVML---GCWQREPQQRLNIK 283
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 5e-22
Identities = 66/266 (24%), Positives = 112/266 (42%), Gaps = 36/266 (13%)
Query: 444 IGNGGHGSVYRAEL--PSGQV--VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
IG G G V++ P VAIK C + +++FL E + + H +IV
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 500 KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC 559
K G + +++ EL G L + L L + + ++ AL+YL
Sbjct: 455 KLIGVIT-ENPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR 511
Query: 560 FPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYV-----APELA 614
F VH+DI+++N+L+ + DFG++++++ + + + G + APE
Sbjct: 512 F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKLPIKWMAPESI 564
Query: 615 YTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILD-PRLPPPSR 672
+ T DV+ FGV + E + G P + N D+ + I + RLP P
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDV-IGRIENGERLPMP-P 615
Query: 673 SVQEKLISIMEVAFSCLNESPESRPT 698
+ L S+M C P RP
Sbjct: 616 NCPPTLYSLMT---KCWAYDPSRRPR 638
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 6e-22
Identities = 41/298 (13%), Positives = 88/298 (29%), Gaps = 64/298 (21%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIK--KFHSPLPCDQIADQKEFLIEVKALTEIR------ 494
+G + A + +G+ + F P + I KE ++ ++ L I+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 495 ----------------HRNIVKFYGFCSH--ARHSFLVYELLE--RGSLAAILSSDTAAQ 534
+ +++ F +Y ++ + +L S ++
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 535 E-LGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593
+ L R+ + V L+ LHH +VH + +++LD + F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 254
Query: 594 PESSNWTEFAGTYGYVAPEL-----------AYTMKITEKCDVYSFGVLVLEAIKGKHPR 642
+ + G+ PEL +T D ++ G+++ P
Sbjct: 255 -RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP- 312
Query: 643 DFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
+ + +P P R+ L+ L E R
Sbjct: 313 -I----TKDAALGGSEWIFRSCKNIPQPVRA----LLE------GFLRYPKEDRLLPL 355
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 6e-22
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 435 TNDFDAQYC----IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI-EVK 488
D + +G+G G V+ E SG IK + D+ E + E++
Sbjct: 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKT----INKDRSQVPMEQIEAEIE 72
Query: 489 ALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSL-AAILSSDTAAQELGWSQRMNVIKG 547
L + H NI+K + + ++V E E G L I+S+ + L ++K
Sbjct: 73 VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132
Query: 548 VADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAH---VADFGIAKFLKPESSNWTEFA 603
+ +AL+Y H +VH+D+ +N+L + DFG+A+ K + T A
Sbjct: 133 MMNALAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEHSTNAA 187
Query: 604 GTYGYVAPE-LAYTMKITEKCDVYSFGV 630
GT Y+APE +T KCD++S GV
Sbjct: 188 GTALYMAPEVFKR--DVTFKCDIWSAGV 213
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 58/288 (20%), Positives = 110/288 (38%), Gaps = 63/288 (21%)
Query: 444 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G G G VY VAIK + + ++ EFL E + E +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 89
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAIL-------SSDTAAQELGWSQRMNVIKGVAD 550
+V+ G S + + ++ EL+ RG L + L +++ S+ + + +AD
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL------KPESSN-----W 599
++YL+ + F VH+D++++N ++ ++ + DFG+ + + + W
Sbjct: 150 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206
Query: 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLE-AIKGKHP------RDFLSLISSSS 652
+PE T DV+SFGV++ E A + P L +
Sbjct: 207 M---------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 257
Query: 653 LNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
L P + + L +M C +P+ RP+
Sbjct: 258 -------------LLDKP-DNCPDMLFELMR---MCWQYNPKMRPSFL 288
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 61/287 (21%), Positives = 104/287 (36%), Gaps = 65/287 (22%)
Query: 444 IGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
+G G GSV L + VA+K + + +EFL E + + H N++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR--EIEEFLSEAACMKDFSHPNVI 99
Query: 500 KFYGFCS-----HARHSFLVYELLERGSLAAIL---SSDTAAQELGWSQRMNVIKGVADA 551
+ G C ++ ++ G L L +T + + + + +A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN------------- 598
+ YL + F +H+D++++N +L + VADFG++K + S +
Sbjct: 160 MEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKI--YSGDYYRQGRIAKMPVK 214
Query: 599 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHP------RDFLSLISSS 651
W A E T K DV++FGV + E +G P + +
Sbjct: 215 WI---------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265
Query: 652 SLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
RL P ++L IM SC P RPT
Sbjct: 266 H-------------RLKQP-EDCLDELYEIMY---SCWRTDPLDRPT 295
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 47/213 (22%), Positives = 81/213 (38%), Gaps = 33/213 (15%)
Query: 435 TNDFDAQY-----CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVK 488
Y +G G +G V +GQ A+K + D + EV
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK---------LLYDSPKARQEVD 73
Query: 489 ALTEI-RHRNIVKFYGFCSHARHS----FLVYELLERGSLAAILSSDTAAQELGWSQRM- 542
+ +IV + H ++ E +E G L S + +++R
Sbjct: 74 HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL---FSRIQERGDQAFTEREA 130
Query: 543 -NVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAH---VADFGIAKFLKPESSN 598
+++ + A+ +LH I H+D+ +NLL + + + DFG AK +
Sbjct: 131 AEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-- 185
Query: 599 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVL 631
T YVAPE+ K + CD++S GV+
Sbjct: 186 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 62/283 (21%), Positives = 109/283 (38%), Gaps = 56/283 (19%)
Query: 444 IGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
+G G GSV A+L S VA+K + + D +EFL E + E H ++
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS--DIEEFLREAACMKEFDHPHVA 88
Query: 500 KFYGFCS------HARHSFLVYELLERGSLAAIL---SSDTAAQELGWSQRMNVIKGVAD 550
K G ++ ++ G L A L L + + +A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN------------ 598
+ YL F +H+D++++N +L + VADFG+++ + S +
Sbjct: 149 GMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKI--YSGDYYRQGCASKLPV 203
Query: 599 -WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTD 656
W A E T DV++FGV + E + +G+ P + N +
Sbjct: 204 KWL---------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-------NAE 247
Query: 657 IALDEILD-PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
I + ++ RL P E++ +M C + P+ RP+
Sbjct: 248 I-YNYLIGGNRLKQP-PECMEEVYDLMY---QCWSADPKQRPS 285
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 24/211 (11%)
Query: 435 TNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFH--SPLPCDQIADQKEFLIEV 487
+ Y I G+G V + E +G A K + ++E EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 488 KALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQR--MNVI 545
L ++ H NI+ + + L+ EL+ G L D AQ+ S+ + I
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL-----FDFLAQKESLSEEEATSFI 121
Query: 546 KGVADALSYLHHDCFPPIVHQDISSKNLLL-DLEYEAH---VADFGIAKFLKPESSNWTE 601
K + D ++YLH I H D+ +N++L D + DFG+A ++ +
Sbjct: 122 KQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKN 177
Query: 602 FAGTYGYVAPE-LAYTMKITEKCDVYSFGVL 631
GT +VAPE + Y + + D++S GV+
Sbjct: 178 IFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 207
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 28/202 (13%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIK--KFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
+G+G V + + +G+ A K K + ++E EV L EIRH NI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 501 FYGFCSHARHSFLVYELLERGSL------AAILSSDTAAQELGWSQRMNVIKGVADALSY 554
+ + L+ EL+ G L L+ D A +K + D + Y
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT---------QFLKQILDGVHY 123
Query: 555 LHHDCFPPIVHQDISSKNLLL-DLEYEAH---VADFGIAKFLKPESSNWTEFAGTYGYVA 610
LH I H D+ +N++L D + DFGIA ++ + + GT +VA
Sbjct: 124 LHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVA 179
Query: 611 PE-LAYTMKITEKCDVYSFGVL 631
PE + Y + + D++S GV+
Sbjct: 180 PEIVNYE-PLGLEADMWSIGVI 200
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-21
Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 24/211 (11%)
Query: 435 TNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPCDQIADQKEFLI-EV 487
+ Y I G+G V + E +G A K + +E + EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 488 KALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQR--MNVI 545
L ++ H N++ + + L+ EL+ G L D AQ+ S+ + I
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL-----FDFLAQKESLSEEEATSFI 121
Query: 546 KGVADALSYLHHDCFPPIVHQDISSKNLLL-DLEYEAH---VADFGIAKFLKPESSNWTE 601
K + D ++YLH I H D+ +N++L D + DFG+A ++ +
Sbjct: 122 KQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKN 177
Query: 602 FAGTYGYVAPE-LAYTMKITEKCDVYSFGVL 631
GT +VAPE + Y + + D++S GV+
Sbjct: 178 IFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 207
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 6e-21
Identities = 40/227 (17%), Positives = 87/227 (38%), Gaps = 27/227 (11%)
Query: 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIK-------------KFHSPLPCDQIADQKE 482
ND+ + G + E + A+K + + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 483 FLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRM 542
F E++ +T+I++ + G ++ +++YE +E S+ + ++ +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFI 148
Query: 543 ------NVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596
+IK V ++ SY+H+ I H+D+ N+L+D ++DFG ++++
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM--VD 204
Query: 597 SNWTEFAGTYGYVAPELAYTMKIT--EKCDVYSFGVLVLEAIKGKHP 641
GTY ++ PE K D++S G+ + P
Sbjct: 205 KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-21
Identities = 53/248 (21%), Positives = 86/248 (34%), Gaps = 32/248 (12%)
Query: 93 LRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISS--NWGKCPKLGTL 150
+ I+ L ++T ++ ++ I + + +I S P + L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNS----DIKSVQGIQYLPNVTKL 73
Query: 151 NVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLP 210
++ N +T P + N L L L N + ++ L L L L L N + +
Sbjct: 74 FLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DIN 128
Query: 211 PEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSEL 270
+ L LE L L N+ + L L KL L L +NQ + L L +L L
Sbjct: 129 G-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQ--ISDIVPLAGLTKLQNL 183
Query: 271 DASHNLFGGEIPFQICS------LKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQ 324
S N I LK+L+ L L N + + + +D
Sbjct: 184 YLSKN--------HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 235
Query: 325 LQGPVPNS 332
L P S
Sbjct: 236 LVTPEIIS 243
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 54/284 (19%), Positives = 99/284 (34%), Gaps = 49/284 (17%)
Query: 23 SNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSE 82
+ L +++ + N S + +
Sbjct: 21 DAFAETIKDNLKKKSVTDAVT--------------QNELNS-----------IDQIIANN 55
Query: 83 NHFQGTIPKI--LRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEIS-- 138
+ I + ++ ++ ++ LN N LT +I L NL ++ L N ++
Sbjct: 56 SD----IKSVQGIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDEN----KVKDL 105
Query: 139 SNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTEL 198
S+ KL +L++ N I+ I + + QL++L L N I L +L L L
Sbjct: 106 SSLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTL 161
Query: 199 ILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELP 258
L NQ + + P + L L+ L LS N ++ L L L L L + + + +
Sbjct: 162 SLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPI 217
Query: 259 KELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS 302
LV + + + P I EK N+ +
Sbjct: 218 NHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 48/278 (17%), Positives = 90/278 (32%), Gaps = 89/278 (32%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
+ +++ L LN N+ + P ++NL NL L L N + L +
Sbjct: 67 LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-----DLSS------------ 107
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
L++ L + L N ++ +I L
Sbjct: 108 --------------------------------LKDLKKLKSLSLEHNGIS-DI-NGLVHL 133
Query: 121 PNLTFIDLSRNDFYGEIS--SNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSL 178
P L + L N +I+ + + KL TL++ N I+ D+
Sbjct: 134 PQLESLYLGNN----KITDITVLSRLTKLDTLSLEDNQIS----------------DIV- 172
Query: 179 NHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLG 238
L L L L L N + L + L +L+ L+L + N +
Sbjct: 173 ---------PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQS 221
Query: 239 NLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNL 276
NL+ + + ++ V P+ + + + +L
Sbjct: 222 NLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHL 257
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 50/219 (22%), Positives = 86/219 (39%), Gaps = 34/219 (15%)
Query: 432 VRATNDFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFH-SPLPCDQIADQKEFLI 485
V + D Y G+G V + E +G A K + +E +
Sbjct: 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 486 -EVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSL------AAILSSDTAAQELGW 538
EV L EI+H N++ + + L+ EL+ G L L+ + A
Sbjct: 63 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT----- 117
Query: 539 SQRMNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLL-DLEYEAH---VADFGIAKFLK 593
+K + + + YLH I H D+ +N++L D + DFG+A +
Sbjct: 118 ----EFLKQILNGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 594 PESSNWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVL 631
+ + GT +VAPE + Y + + D++S GV+
Sbjct: 170 FGNE-FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVI 206
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 48/222 (21%), Positives = 87/222 (39%), Gaps = 39/222 (17%)
Query: 431 IVRATNDFDAQYCI-----GNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIA--DQKE 482
++ +F+ Y + G G V + +GQ A K L + + E
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKF----LKKRRRGQDCRAE 74
Query: 483 FLIEVKALTEIRHR-NIVKFYGFCSHARHSFLVYELLERGSL--------AAILSSDTAA 533
L E+ L + ++ + + L+ E G + A ++S +
Sbjct: 75 ILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI 134
Query: 534 QELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAH---VADFGIAK 590
+IK + + + YLH + IVH D+ +N+LL Y + DFG+++
Sbjct: 135 ---------RLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182
Query: 591 FLKPESSNWTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVL 631
+ E GT Y+APE L Y IT D+++ G++
Sbjct: 183 KIGHACE-LREIMGTPEYLAPEILNYD-PITTATDMWNIGII 222
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 1e-20
Identities = 66/346 (19%), Positives = 113/346 (32%), Gaps = 26/346 (7%)
Query: 3 SLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDF--N 59
SL LDL+ N F + NLT L L L + + L+ LD
Sbjct: 122 SLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSY 181
Query: 60 HFTSYLPHNVCRGGA--LQYFGVSENHFQGTIPKILRNCSSL--IRVRLNSNNLTGNISE 115
H ++ L + F + + L ++LN N ++
Sbjct: 182 HIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF 241
Query: 116 ALGIYPNLTF-------IDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNS 168
+ T I+ + W + + LN+ IT I RE
Sbjct: 242 LSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP--VEYLNIYNLTITERIDREEFTY 299
Query: 169 S-----QLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLD 223
S L + + + +L + S +L+
Sbjct: 300 SETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLN 359
Query: 224 LSANRFNNSVPENLGNLLKLHYLGLSNNQF--VLELPKELEKLVQLSELDASHNLFGGEI 281
+ N F +SV + L +L L L N ++ + + L LD S N
Sbjct: 360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHA 419
Query: 282 PFQICSL-KSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
+ C+ +S+ LNLS N L+GS+ C + V+D+ +N++
Sbjct: 420 YDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM 463
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 7e-20
Identities = 60/368 (16%), Positives = 124/368 (33%), Gaps = 50/368 (13%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNL-TNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFN 59
+ L+ L L+ +F+ + V++L + L L+ ++ G SL+ P T L F+
Sbjct: 145 LTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFH 204
Query: 60 --------------------------------HFTSYLPHNVCRGGALQYFGVSENHFQG 87
++L L
Sbjct: 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWK 264
Query: 88 TIPKILRN--CSSLIRVRLNSNNLTGNISEALGIY-----PNLTFIDLSRNDFYGEISSN 140
K+ + + + + + +T I Y +L + F +
Sbjct: 265 CSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEAL 324
Query: 141 WGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELIL 200
+ ++ +S+++ + S L+ + N + + L L LIL
Sbjct: 325 YSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL 384
Query: 201 RGNQFTGRLPPEIGSLVDLEYL---DLSANRFNNSVPENLGNLL-KLHYLGLSNNQFVLE 256
+ N ++ L D+S N N+ + + L LS+N
Sbjct: 385 QRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443
Query: 257 LPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPN-CFEGIRGI 315
+ + L ++ LD +N IP + L++L++LN++ N L S+P+ F+ + +
Sbjct: 444 VFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSL 499
Query: 316 SVIDISDN 323
I + DN
Sbjct: 500 QYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 3e-15
Identities = 53/345 (15%), Positives = 117/345 (33%), Gaps = 28/345 (8%)
Query: 3 SLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPPSL--ENPMLTRPGLDFN 59
L L+QN L S L+ L+ L L +N + + + N L + N
Sbjct: 53 RTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHN 110
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIP--KILRNCSSLIRVRLNSNNLT-GNISEA 116
+ + +L++ +S N F +P K N + L + L++ ++
Sbjct: 111 RLQNISCCPM---ASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPV 166
Query: 117 LGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNIT---GGIPREIGNSSQLQA 173
++ + +DL G + + + P L++ + + + + LQ
Sbjct: 167 AHLHLSCILLDLVSYHIKGGETESL-QIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQL 225
Query: 174 LDLSLNHI----VGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLV---DLEYLDLSA 226
++ LN + EL + +L + L+ + T + ++ +EYL++
Sbjct: 226 SNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYN 285
Query: 227 NRFNNSVPENLGN-----LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEI 281
+ L L + N F+ +++ S +
Sbjct: 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIH 345
Query: 282 PFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
S S LN + N + S+ ++ + + + N L+
Sbjct: 346 MVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 1e-13
Identities = 37/289 (12%), Positives = 89/289 (30%), Gaps = 41/289 (14%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGF------IPPSLENPMLTRPGL 56
LS + LN + ++ L + ++ + + +
Sbjct: 224 QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283
Query: 57 DFNHFTS-----YLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTG 111
T ++ +L V F + + + + L+ ++
Sbjct: 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343
Query: 112 NISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQL 171
+ TF++ ++N F + +L TL + N + + + +
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNM 402
Query: 172 QALDLSLNHIVG----------EIPKELGKLN----------------SLTELILRGNQF 205
+L+ + + + LN + L L N+
Sbjct: 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRI 462
Query: 206 TGRLPPEIGSLVDLEYLDLSANRFNNSVPEN-LGNLLKLHYLGLSNNQF 253
+P ++ L L+ L++++N+ SVP+ L L Y+ L +N +
Sbjct: 463 M-SIPKDVTHLQALQELNVASNQL-KSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 5e-13
Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 11/154 (7%)
Query: 161 IPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVDL 219
+P+++ + +AL LS N I ++ L+ L L L N+ L + DL
Sbjct: 46 VPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDL 102
Query: 220 EYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQF-VLELPKELEKLVQLSELDASHNLFG 278
EYLD+S NR ++ + L +L LS N F VL + KE L +L+ L S F
Sbjct: 103 EYLDVSHNRL-QNIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKF- 158
Query: 279 GEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGI 312
++ + L + + +S I
Sbjct: 159 RQLDL--LPVAHLHLSCILLDLVSYHIKGGETES 190
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 48/211 (22%), Positives = 81/211 (38%), Gaps = 36/211 (17%)
Query: 437 DFDAQYCI----GNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALT 491
+ +Y I G G G V+R E S + K + DQ E+ L
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVLVKKEISILN 56
Query: 492 EIRHRNIVKFYGFCSHARHSFLVYELLERGSL-------AAILSSDTAAQELGWSQRMNV 544
RHRNI+ + +++E + + A L+ +
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV---------SY 107
Query: 545 IKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAKFLKPESSNWTE 601
+ V +AL +LH H+ I H DI +N++ + + +FG A+ LKP +
Sbjct: 108 VHQVCEALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163
Query: 602 FAGTYGYVAPE-LAYTMKITEKCDVYSFGVL 631
F Y APE + + ++ D++S G L
Sbjct: 164 F-TAPEYYAPEVHQHDV-VSTATDMWSLGTL 192
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 5e-20
Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 27/199 (13%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKF 501
+G G +G V + + + A+K + D + EV+ + +IV+
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALK---------MLQDCPKARREVELHWRASQCPHIVRI 120
Query: 502 YGFC----SHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRM--NVIKGVADALSYL 555
+ + +V E L+ G L S + +++R ++K + +A+ YL
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAH---VADFGIAKFLKPESSNWTEFAGTYGYVAPE 612
H I H+D+ +NLL + + DFG AK +S T T YVAPE
Sbjct: 178 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPE 233
Query: 613 LAYTMKITEKCDVYSFGVL 631
+ K + CD++S GV+
Sbjct: 234 VLGPEKYDKSCDMWSLGVI 252
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 49/225 (21%), Positives = 88/225 (39%), Gaps = 44/225 (19%)
Query: 435 TNDFDAQY-----CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVK 488
+ F+ Y +G G H V L + Q A+K + + EV+
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKI----IEKQPGHIRSRVFREVE 62
Query: 489 ALTEIR-HRNIVKFYGFCSHARHSFLVYELLERGSL-AAILSSDT-----AAQELGWSQR 541
L + + HRN+++ F +LV+E + GS+ + I A+
Sbjct: 63 MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV------- 115
Query: 542 MNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAH---VADFGIAKFLKP---- 594
V++ VA AL +LH I H+D+ +N+L + + + DF + +K
Sbjct: 116 --VVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170
Query: 595 ---ESSNWTEFAGTYGYVAPE-----LAYTMKITEKCDVYSFGVL 631
+ G+ Y+APE ++CD++S GV+
Sbjct: 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 60/300 (20%), Positives = 110/300 (36%), Gaps = 81/300 (27%)
Query: 444 IGNGGHGSVYRAEL------PSGQVVAIK--KFHSPLPCDQIADQKEFLIEVKALTEIRH 495
+G G VY+ L Q VAIK K + P ++EF E ++H
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP-----LREEFRHEAMLRARLQH 71
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSL-------------AAILSSDTAAQELGWSQRM 542
N+V G + + +++ G L + T L +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 543 NVIKGVADALSYL--HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN-- 598
+++ +A + YL HH +VH+D++++N+L+ + ++D G+ + + +++
Sbjct: 132 HLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREV--YAADYY 184
Query: 599 -----------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHP----- 641
W APE K + D++S+GV++ E G P
Sbjct: 185 KLLGNSLLPIRWM---------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 235
Query: 642 -RDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
+D + +I + LP P + ++M C NE P RP K
Sbjct: 236 NQDVVEMIRNRQ-------------VLPCP-DDCPAWVYALMI---ECWNEFPSRRPRFK 278
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 68/298 (22%), Positives = 116/298 (38%), Gaps = 72/298 (24%)
Query: 444 IGNGGHGSVYRAEL---PSGQVVAIK---KFHSPLPCDQIADQKEFLIEVKALTEI-RHR 496
IG G G V +A + AIK ++ S D ++F E++ L ++ H
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK------DDHRDFAGELEVLCKLGHHP 86
Query: 497 NIVKFYGFCSHARHSFLVYELLERGSL-------------AAILSSDTAAQELGWSQRMN 543
NI+ G C H + +L E G+L A +++ A L Q ++
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 544 VIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK----FLKPESSN- 598
VA + YL F +H+D++++N+L+ Y A +ADFG+++ ++K
Sbjct: 147 FAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 203
Query: 599 ---WTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLVLEAI-KGKHP------RDFLSL 647
W A E L Y+ T DV+S+GVL+ E + G P +
Sbjct: 204 PVRWM---------AIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253
Query: 648 ISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
+ RL P + +++ +M C E P RP+ +
Sbjct: 254 LPQGY-------------RLEKP-LNCDDEVYDLM---RQCWREKPYERPSFAQILVS 294
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 9e-19
Identities = 61/292 (20%), Positives = 109/292 (37%), Gaps = 69/292 (23%)
Query: 444 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHR 496
+G G G V A + VA+K +++ + E+K ++ + +H
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLGQHE 110
Query: 497 NIVKFYGFCSHARHSFLVYELLERGSLAAIL-----------SSDTAAQELGWSQRMNVI 545
NIV G C+H ++ E G L L + A ++
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 546 KGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES-----SN-- 598
VA +++L +H+D++++N+LL + A + DFG+A+ + +S N
Sbjct: 171 SQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 599 ----WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHP-------RDFLS 646
W APE + T + DV+S+G+L+ E G +P F
Sbjct: 228 LPVKWM---------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278
Query: 647 LISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
L+ ++ P + + SIM+ +C P RPT
Sbjct: 279 LVKDGY-------------QMAQP-AFAPKNIYSIMQ---ACWALEPTHRPT 313
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 61/298 (20%), Positives = 112/298 (37%), Gaps = 74/298 (24%)
Query: 444 IGNGGHGSVYRAELP--------SGQVVAIKKFHSPLPCD-QIADQKEFLIEVKALTEI- 493
+G G G V AE VA+K L D D + + E++ + I
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM----LKDDATEKDLSDLVSEMEMMKMIG 98
Query: 494 RHRNIVKFYGFCSHARHSFLVYELLERGSL-------------AAILSSDTAAQELGWSQ 540
+H+NI+ G C+ +++ E +G+L + + +++ +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 541 RMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE----- 595
++ +A + YL +H+D++++N+L+ +ADFG+A+ +
Sbjct: 159 LVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 596 SSN------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHP------R 642
++N W APE + T + DV+SFGVL+ E G P
Sbjct: 216 TTNGRLPVKWM---------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266
Query: 643 DFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
+ L+ R+ P + +L +M C + P RPT K
Sbjct: 267 ELFKLLKEGH-------------RMDKP-ANCTNELYMMMR---DCWHAVPSQRPTFK 307
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-18
Identities = 63/374 (16%), Positives = 109/374 (29%), Gaps = 71/374 (18%)
Query: 2 RSLSILDLNQNQFK-GVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
+ LD+ + + L + + L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTE---------------ARCKD 47
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQG----TIPKILRNCS-SLIRVRLNSNNLT----G 111
+S L N L + N + + L+ S + ++ L + LT G
Sbjct: 48 ISSALRVNPA----LAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 103
Query: 112 NISEALGIYPNLTFIDLSRNDFYGE----ISSNWGK-CPKLGTLNVSMNNITGGIPREIG 166
+S L P L + LS N + +L L + +++ +
Sbjct: 104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163
Query: 167 ----NSSQLQALDLSLNHI----VGEIPKELGKLN-SLTELILRGNQFTGR----LPPEI 213
+ L +S N I V + + L L L L T L +
Sbjct: 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 223
Query: 214 GSLVDLEYLDLSANRFNNSVPENLGNLLK-----LHYLGLSNNQF----VLELPKELEKL 264
S L L L +N+ + L L L L + +L + L
Sbjct: 224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK 283
Query: 265 VQLSELDASHNLFGGEIPFQICSL-----KSLEKLNLSHNNLSGSIPNCFEGI------- 312
L EL + N G E +C LE L + + + C
Sbjct: 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT---AACCSHFSSVLAQN 340
Query: 313 RGISVIDISDNQLQ 326
R + + IS+N+L+
Sbjct: 341 RFLLELQISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 65/350 (18%), Positives = 116/350 (33%), Gaps = 74/350 (21%)
Query: 3 SLSILDLNQNQFK----GVLPPSVSNLTNLKELVLLYNNLSG----FIPPSLENPM--LT 52
+ L L GVL ++ L L+EL L N L + L +P L
Sbjct: 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145
Query: 53 RPGLDFNHFT--------SYLPHNVCRGGALQYFGVSENHFQGT----IPKILR-NCSSL 99
+ L++ + S L + VS N + + L+ + L
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPD----FKELTVSNNDINEAGVRVLCQGLKDSPCQL 201
Query: 100 IRVRLNSNNLT----GNISEALGIYPNLTFIDLSRNDFYGE----ISSNWGKC-PKLGTL 150
++L S +T ++ + +L + L N + +L TL
Sbjct: 202 EALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL 261
Query: 151 NVSMNNIT----GGIPREIGNSSQLQALDLSLNHI----VGEIPKELGKLN-SLTELILR 201
+ IT G + R + L+ L L+ N + + + L + L L ++
Sbjct: 262 WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321
Query: 202 GNQFTGRLPPEIGSLVD----LEYLDLSANRFNNSVPENLGNLLK-----LHYLGLSNNQ 252
FT S++ L L +S NR ++ L L L L L++
Sbjct: 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381
Query: 253 FVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS 302
+S+ S + + + SL +L+LS+N L
Sbjct: 382 --------------VSDSSCSS------LAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-11
Identities = 37/182 (20%), Positives = 59/182 (32%), Gaps = 23/182 (12%)
Query: 168 SSQLQALDLSLNHIVGEIPKELGKLNS-LTELILRGNQFTGR----LPPEIGSLVDLEYL 222
S +Q+LD+ + EL L + L T + + L L
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 223 DLSANRFNNSVPENLGNLLK-----LHYLGLSNNQF----VLELPKELEKLVQLSELDAS 273
+L +N + + L+ + L L N L L L L EL S
Sbjct: 62 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121
Query: 274 HNLFGGEIPFQICSL-----KSLEKLNLSHNNLS----GSIPNCFEGIRGISVIDISDNQ 324
NL G +C LEKL L + +LS + + + +S+N
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181
Query: 325 LQ 326
+
Sbjct: 182 IN 183
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 62/296 (20%), Positives = 108/296 (36%), Gaps = 74/296 (25%)
Query: 444 IGNGGHGSVYRAELP--------SGQVVAIKKFHSPLPCD-QIADQKEFLIEVKALTEI- 493
+G G G V AE VA+K L D D + + E++ + I
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM----LKSDATEKDLSDLISEMEMMKMIG 132
Query: 494 RHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKG------ 547
+H+NI+ G C+ +++ E +G+L L + + +
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 548 -------VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE----- 595
VA + YL +H+D++++N+L+ + +ADFG+A+ +
Sbjct: 193 LVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 596 SSN------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHP------R 642
++N W APE + T + DV+SFGVL+ E G P
Sbjct: 250 TTNGRLPVKWM---------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300
Query: 643 DFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
+ L+ R+ P + +L +M C + P RPT
Sbjct: 301 ELFKLLKEGH-------------RMDKP-SNCTNELYMMMR---DCWHAVPSQRPT 339
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 61/308 (19%), Positives = 115/308 (37%), Gaps = 89/308 (28%)
Query: 444 IGNGGHGSVYRAELPSG------QVVAIK---KFHSPLPCDQIADQKEFLIEVKALTEIR 494
IG G G V++A P +VA+K + S Q +F E + E
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA------DMQADFQREAALMAEFD 108
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSL---------------------AAILSSDTAA 533
+ NIVK G C+ + L++E + G L S
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 534 QELGWSQRMNVIKGVADALSYL--HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591
L ++++ + + VA ++YL VH+D++++N L+ +ADFG+++
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 592 L------KPESSN-----WTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLVLEAI-KG 638
+ K + ++ W PE + Y + T + DV+++GV++ E G
Sbjct: 224 IYSADYYKADGNDAIPIRWM---------PPESIFYN-RYTTESDVWAYGVVLWEIFSYG 273
Query: 639 KHP------RDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNES 692
P + + + + L P + +L ++M C ++
Sbjct: 274 LQPYYGMAHEEVIYYVRDGN-------------ILACP-ENCPLELYNLMR---LCWSKL 316
Query: 693 PESRPTMK 700
P RP+
Sbjct: 317 PADRPSFC 324
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 59/302 (19%), Positives = 111/302 (36%), Gaps = 82/302 (27%)
Query: 444 IGNGGHGSVYRAEL--------PSGQVVAIK---KFHSPLPCDQIADQKEFLIEVKALTE 492
+G G G V AE VA+K + D + + E++ +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE------KDLSDLVSEMEMMKM 142
Query: 493 I-RHRNIVKFYGFCSHARHSFLVYELLERGSL-------------AAILSSDTAAQELGW 538
I +H+NI+ G C+ +++ E +G+L + + +++ +
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 539 SQRMNVIKGVADALSYL--HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE- 595
++ +A + YL +H+D++++N+L+ +ADFG+A+ +
Sbjct: 203 KDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 596 ----SSN------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHP--- 641
++N W APE + T + DV+SFGVL+ E G P
Sbjct: 258 YYKKTTNGRLPVKWM---------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308
Query: 642 ---RDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
+ L+ R+ P + +L +M C + P RPT
Sbjct: 309 IPVEELFKLLKEGH-------------RMDKP-ANCTNELYMMMR---DCWHAVPSQRPT 351
Query: 699 MK 700
K
Sbjct: 352 FK 353
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 65/313 (20%), Positives = 115/313 (36%), Gaps = 89/313 (28%)
Query: 444 IGNGGHGSVYRAEL------PSGQVVAIK---KFHSPLPCDQIADQKEFLIEVKALTEIR 494
+G G G V +A VA+K + SP ++ ++ L E L ++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP------SELRDLLSEFNVLKQVN 84
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSLAAIL--SSDTAAQELGWSQRMNVIKG----- 547
H +++K YG CS L+ E + GSL L S LG N
Sbjct: 85 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 548 --------------VADALSYL--HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591
++ + YL +VH+D++++N+L+ + ++DFG+++
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 592 LKPE-----SSN------WTEFAGTYGYVAPE-LAYTMKITEKCDVYSFGVLVLEAI--- 636
+ E S W A E L T + DV+SFGVL+ E +
Sbjct: 200 VYEEDSYVKRSQGRIPVKWM---------AIESLFDH-IYTTQSDVWSFGVLLWEIVTLG 249
Query: 637 ----KGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNES 692
G P +L+ + R+ P + E++ +M C +
Sbjct: 250 GNPYPGIPPERLFNLLKTGH-------------RMERP-DNCSEEMYRLML---QCWKQE 292
Query: 693 PESRPTMKVVTQQ 705
P+ RP +++
Sbjct: 293 PDKRPVFADISKD 305
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 60/298 (20%), Positives = 106/298 (35%), Gaps = 73/298 (24%)
Query: 444 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHR 496
+G G G V A + VA+K P + +++ + E+K L+ + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87
Query: 497 NIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKG--------- 547
NIV G C+ + ++ E G L L + + +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 548 ------VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE-----S 596
VA +++L +H+D++++N+LL + DFG+A+ +K +
Sbjct: 148 LSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 597 SN------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHP-------R 642
N W APE + T + DV+S+G+ + E G P
Sbjct: 205 GNARLPVKWM---------APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 643 DFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
F +I R+ P ++ IM+ +C + P RPT K
Sbjct: 256 KFYKMIKEGF-------------RMLSP-EHAPAEMYDIMK---TCWDADPLKRPTFK 296
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 65/266 (24%), Positives = 105/266 (39%), Gaps = 37/266 (13%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLI--EVKALTEIRHRNIVK 500
IG G V A + +G+ VAIK + Q+ + EV+ + + H NIVK
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKI----IDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
+ + +L+ E G + L + +E + + + + A+ Y H
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE---KEARSKFRQIVSAVQYCHQKR- 134
Query: 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL----AYT 616
IVH+D+ ++NLLLD + +ADFG + F G Y APEL Y
Sbjct: 135 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYAAPELFQGKKYD 191
Query: 617 MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR-SVQ 675
+ DV+S GV++ + G P D N + +L + P S
Sbjct: 192 GP---EVDVWSLGVILYTLVSGSLPFD--------GQNLKELRERVLRGKYRIPFYMSTD 240
Query: 676 -EKLISIMEVAFSCLNESPESRPTMK 700
E L+ L +P R T++
Sbjct: 241 CENLLKRF------LVLNPIKRGTLE 260
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 48/213 (22%), Positives = 84/213 (39%), Gaps = 21/213 (9%)
Query: 93 LRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEIS--SNWGKCPKLGTL 150
+ S + +++N+ ++ + + NL + LS N +IS S KL L
Sbjct: 37 QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHN----QISDLSPLKDLTKLEEL 90
Query: 151 NVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLP 210
+V+ N + + S+ L L L N + L L +L L +R N+ +
Sbjct: 91 SVNRNRLKN-L--NGIPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIV 144
Query: 211 PEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSEL 270
+G L LE LDL N N L L K++++ L+ + V E K +L + +
Sbjct: 145 M-LGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTV 201
Query: 271 DASHNLFGGEI-PFQICSLKSLEKLNLSHNNLS 302
+ G I P+ I + S +
Sbjct: 202 ---KDPDGRWISPYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 40/187 (21%), Positives = 70/187 (37%), Gaps = 15/187 (8%)
Query: 139 SNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTEL 198
N+ ++T + S +Q + ++I + + +L EL
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKEL 68
Query: 199 ILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELP 258
L NQ + L P + L LE L ++ NR N + L L L NN+ L
Sbjct: 69 HLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKN--LNGI-PSACLSRLFLDNNE--LRDT 121
Query: 259 KELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVI 318
L L L L +N I + L LE L+L N ++ + ++ ++ I
Sbjct: 122 DSLIHLKNLEILSIRNNKL-KSIVM-LGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWI 177
Query: 319 DISDNQL 325
D++ +
Sbjct: 178 DLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 39/278 (14%), Positives = 81/278 (29%), Gaps = 90/278 (32%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
+ + + + + + + + TNLKEL L +N +S L
Sbjct: 40 LSGVQNFNGDNSNIQSL--AGMQFFTNLKELHLSHNQIS-----DLSP------------ 80
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
L++ + L + +N N L N++
Sbjct: 81 --------------------------------LKDLTKLEELSVNRNRLK-NLNGIPS-- 105
Query: 121 PNLTFIDLSRNDFYGEIS--SNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSL 178
L+ + L N E+ + L L++ N + +
Sbjct: 106 ACLSRLFLDNN----ELRDTDSLIHLKNLEILSIRNNKLK----------------SIV- 144
Query: 179 NHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLG 238
LG L+ L L L GN+ T + L + ++DL+ + N +
Sbjct: 145 ---------MLGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWIDLTGQKCVNEPVKYQP 193
Query: 239 NLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNL 276
L + + + +++ P + + L
Sbjct: 194 ELYITNTVKDPDGRWI--SPYYISNGGSYVDGCVLWEL 229
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 59/295 (20%), Positives = 104/295 (35%), Gaps = 72/295 (24%)
Query: 444 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHR 496
+G G G V A+ + + VA+K ++ + + E+K L I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91
Query: 497 NIVKFYGFCSHA-RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKG-------- 547
N+V G C+ ++ E + G+L+ L S ++ K
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 548 -----VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS----- 597
VA + +L +H+D++++N+LL + + DFG+A+ + +
Sbjct: 152 CYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 598 ------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHP-------RD 643
W APE + T + DV+SFGVL+ E G P +
Sbjct: 209 DARLPLKWM---------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 644 FLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
F + + R+ P ++ M C + P RPT
Sbjct: 260 FCRRLKEGT-------------RMRAP-DYTTPEMYQTML---DCWHGEPSQRPT 297
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 57/313 (18%), Positives = 108/313 (34%), Gaps = 62/313 (19%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHF 61
R+ L + + + + S +L+++ + N++ I + F++
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV-----------FSNL 78
Query: 62 TSYLPHNVCRGGALQYFGVSE-NHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
L + + N+ P+ +N +L + +++ + ++ + I+
Sbjct: 79 PK-----------LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIH 126
Query: 121 -PNLTFIDLSRNDFYGEISSNW--GKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLS 177
+D+ N I N G + L ++ N I I N +QL L+LS
Sbjct: 127 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLS 185
Query: 178 LNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENL 237
N N+L E L + F G LD+S R ++ L
Sbjct: 186 DN-------------NNLEE--LPNDVFHG--------ASGPVILDISRTRIHSLPSYGL 222
Query: 238 GNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLS 297
NL KL N + +LP LEKLV L E ++ P C+ + +
Sbjct: 223 ENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTY-------PSHCCAFANWRRQISE 271
Query: 298 HNNLSGSIPNCFE 310
+ + E
Sbjct: 272 LHPICNKSILRQE 284
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 40/237 (16%), Positives = 83/237 (35%), Gaps = 16/237 (6%)
Query: 96 CSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSN-WGKCPKLGTLNVSM 154
CS+ + + +T + N + I + L + +S
Sbjct: 9 CSNRV-FLCQESKVT---EIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQ 63
Query: 155 NNITGGIPREI-GNSSQLQALDLS-LNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPE 212
N++ I ++ N +L + + N+++ P+ L +L L++ LP
Sbjct: 64 NDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDV 122
Query: 213 I-GSLVDLEYLDLSANRFNNSVPENL--GNLLKLHYLGLSNNQFVLELPKELEKLVQLSE 269
+ LD+ N +++ N G + L L+ N E+ QL E
Sbjct: 123 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDE 181
Query: 270 LDASHNLFGGEIPFQICS-LKSLEKLNLSHNNLSGSIP-NCFEGIRGISVIDISDNQ 324
L+ S N E+P + L++S + S+P E ++ + + +
Sbjct: 182 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 17/134 (12%), Positives = 42/134 (31%), Gaps = 27/134 (20%)
Query: 194 SLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQF 253
S + + ++ T +P ++ + L + L + +S N
Sbjct: 10 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND- 65
Query: 254 VLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIP-NCFEGI 312
L ++A ++F L L ++ + N I F+ +
Sbjct: 66 ------------VLEVIEA--DVFSN--------LPKLHEIRIEKANNLLYINPEAFQNL 103
Query: 313 RGISVIDISDNQLQ 326
+ + IS+ ++
Sbjct: 104 PNLQYLLISNTGIK 117
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 83.7 bits (206), Expect = 7e-17
Identities = 45/224 (20%), Positives = 73/224 (32%), Gaps = 10/224 (4%)
Query: 80 VSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISS 139
V + L R L+ T SE L L ++ + + +
Sbjct: 332 VLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSE-LESCKELQELEP---ENKWCLLT 387
Query: 140 NWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELI 199
L L + + + + LD + + E + + L
Sbjct: 388 IILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLH 447
Query: 200 LRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPK 259
L T + + L+ + +LDLS NR ++P L L L L S+N LE
Sbjct: 448 LAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNA--LENVD 502
Query: 260 ELEKLVQLSELDASHNLFGG-EIPFQICSLKSLEKLNLSHNNLS 302
+ L +L EL +N + S L LNL N+L
Sbjct: 503 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 72.5 bits (177), Expect = 2e-13
Identities = 47/274 (17%), Positives = 91/274 (33%), Gaps = 19/274 (6%)
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEA--- 116
F+ L G L + + P S + L + +L + +
Sbjct: 260 CFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFR 319
Query: 117 -LGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALD 175
+ + + D + +L +S+ T + E+ + +LQ L+
Sbjct: 320 VIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTV-LQSELESCKELQELE 378
Query: 176 LSLNHIVGEI---PKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNS 232
+ I + L L E + + P L DL L
Sbjct: 379 PENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFL------LE 432
Query: 233 VPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLE 292
+ L L++ L + LE+L+ ++ LD SHN +P + +L+ LE
Sbjct: 433 NSVLKMEYADVRVLHLAHKD--LTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLE 489
Query: 293 KLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
L S N L ++ + + + + +N+LQ
Sbjct: 490 VLQASDNALE-NVDG-VANLPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 40/227 (17%), Positives = 70/227 (30%), Gaps = 16/227 (7%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYN-NLSGFIPPSLENPMLTRPGLDFNHF 61
L +L+ + VL + + L+EL L I L +F
Sbjct: 350 QLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYF 408
Query: 62 TSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYP 121
++ + R Y + F + + + + L +LT + L
Sbjct: 409 STLKAVDPMR---AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VL-CHLEQLL 463
Query: 122 NLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHI 181
+T +DLS N + L L S N + + + N +LQ L L N +
Sbjct: 464 LVTHLDLSHNRL-RALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRL 520
Query: 182 VG-EIPKELGKLNSLTELILRGNQFTGRLPPEIGSLV----DLEYLD 223
+ L L L L+GN + L + +
Sbjct: 521 QQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLPSVSSIL 566
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 61/285 (21%), Positives = 108/285 (37%), Gaps = 66/285 (23%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIK-----KFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G+G G V+ A + V +K K + K L E+ L+ + H N
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILSRVEHAN 90
Query: 498 IVKFYGFCSHARHSFLVYE-----------LLERGSLAAILSSDTAAQELGWSQRMNVIK 546
I+K + LV E + L L+S Q
Sbjct: 91 IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ------------ 138
Query: 547 GVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTY 606
+ A+ YL I+H+DI +N+++ ++ + DFG A +L+ +T F GT
Sbjct: 139 -LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTI 193
Query: 607 GYVAPEL----AYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEI 662
Y APE+ Y + +++S GV + + ++P L+E
Sbjct: 194 EYCAPEVLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFC--------------ELEET 236
Query: 663 LDPRLPPP---SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQ 704
++ + PP S+ + L+S + L PE R T++ +
Sbjct: 237 VEAAIHPPYLVSKEL-MSLVSGL------LQPVPERRTTLEKLVT 274
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 9e-17
Identities = 49/299 (16%), Positives = 88/299 (29%), Gaps = 69/299 (23%)
Query: 89 IPKILRNCSSLIRVRLNSNNLTGN----ISEALGIYPNLTFIDLSRNDFYGEISSNWG-- 142
+ +L S+ + L+ N + +SE + +L + S F G +
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI-FTGRVKDEIPEA 82
Query: 143 ---------KCPKLGTLNVSMNNITG----GIPREIGNSSQLQALDLSLNHI-------- 181
KCPKL T+ +S N + + + L+ L L N +
Sbjct: 83 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 142
Query: 182 -----VGEIPKELGKLNSLTELILRGNQFTGR----LPPEIGSLVDLEYLDLSANRFNNS 232
+ K+ L +I N+ S L + + N
Sbjct: 143 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 202
Query: 233 -VPENLGNLLK----LHYLGLSNNQF----VLELPKELEKLVQLSELDASHNLFGGE--- 280
+ L L L L L +N F L L+ L EL + L
Sbjct: 203 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 262
Query: 281 ---IPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGIS-----------VIDISDNQL 325
F L+ L L +N + + +R + ++++ N+
Sbjct: 263 AVVDAFSKLENIGLQTLRLQYNEIEL------DAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 53/359 (14%), Positives = 108/359 (30%), Gaps = 67/359 (18%)
Query: 2 RSLSILDLNQNQF--KGV--LPPSVSNLTNLKELVLLYNNLSG----FIPPSLE-NPMLT 52
S+ L + + + + ++KE+VL N + ++ ++ L
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 53 RPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGN 112
+F+ + + + + L C L VRL+ N
Sbjct: 64 I--AEFSDIFTGRVKDEIPEAL------------RLLLQALLKCPKLHTVRLSDNAFGPT 109
Query: 113 ----ISEALGIYPNLTFIDLSRNDF-------------YGEISSNWGKCPKLGTLNVSMN 155
+ + L + L + L N ++ P L ++ N
Sbjct: 110 AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 169
Query: 156 NITGG----IPREIGNSSQLQALDLSLNHI-----VGEIPKELGKLNSLTELILRGNQFT 206
+ G + + L + + N I + + L L L L+ N FT
Sbjct: 170 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229
Query: 207 GR----LPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLK------LHYLGLSNNQF--- 253
L + S +L L L+ + + + L L L N+
Sbjct: 230 HLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELD 289
Query: 254 -VLELPKEL-EKLVQLSELDASHNLFG--GEIPFQICS-LKSLEKLNLSHNNLSGSIPN 307
V L + EK+ L L+ + N F ++ +I + + L + + +
Sbjct: 290 AVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTD 348
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 42/224 (18%), Positives = 69/224 (30%), Gaps = 45/224 (20%)
Query: 165 IGNSSQLQALDLSLNHI----VGEIPKELGKLNSLTELILRGNQFTGR----LPPEIGSL 216
+ S ++ L L+ I + L + +S+ E++L GN L I S
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 217 VDLEYLDLSANRFNNSVPEN----------LGNLLKLHYLGLSNNQF----VLELPKELE 262
DLE + S E L KLH + LS+N F L L
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 263 KLVQLSELDASHNLFGGE-------------IPFQICSLKSLEKLNLSHNNLSG----SI 305
K L L +N G + + + + L + N L
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179
Query: 306 PNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGL 349
F+ R + + + N + + +E L + L
Sbjct: 180 AKTFQSHRLLHTVKMVQNGI-----RPEGIEHLLLEGLAYCQEL 218
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 52/295 (17%), Positives = 89/295 (30%), Gaps = 64/295 (21%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTN-LKELVLLYNNLSGFIPPSLENPMLTRPGLDFN 59
L L L+ N P + + + L+EL + + P L N
Sbjct: 121 HTPLEHLYLHNNGLG---PQAGAKIARALQELAVNKK--------AKNAPPLRSIICGRN 169
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLT-----GNIS 114
+ G + + K ++ L V++ N + +
Sbjct: 170 RLEN--------GSM-KEWA-----------KTFQSHRLLHTVKMVQNGIRPEGIEHLLL 209
Query: 115 EALGIYPNLTFIDLSRNDFYGE----ISSNWGKCPKLGTLNVSMNNITG-GIPR-----E 164
E L L +DL N F ++ P L L ++ ++ G
Sbjct: 210 EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS 269
Query: 165 IGNSSQLQALDLSLNHIVGEIPKELG-----KLNSLTELILRGNQFT--GRLPPEI---- 213
+ LQ L L N I + + L K+ L L L GN+F+ + EI
Sbjct: 270 KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVF 329
Query: 214 -----GSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEK 263
G L +L+ ++ + E + + EL EL K
Sbjct: 330 STRGRGELDELDDMEELTDEEEEDEEEEAESQSPEPETSEEEKE-DKELADELSK 383
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 46/172 (26%), Positives = 69/172 (40%), Gaps = 19/172 (11%)
Query: 160 GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDL 219
+P++ L LS N + L LT+L L + T G+L L
Sbjct: 28 DLPKD------TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK--LQVDGTLPVL 79
Query: 220 EYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKEL-EKLVQLSELDASHNLFG 278
LDLS N+ S+P L L L +S N+ LP L +L EL N
Sbjct: 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK 137
Query: 279 GEIP---FQICSLKSLEKLNLSHNNLSGSIP-NCFEGIRGISVIDISDNQLQ 326
+P LEKL+L++NNL+ +P G+ + + + +N L
Sbjct: 138 -TLPPGLLT--PTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 52/184 (28%), Positives = 70/184 (38%), Gaps = 14/184 (7%)
Query: 97 SSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISS--NWGKCPKLGTLNVSM 154
+ L+ N L L Y LT ++L R E++ G P LGTL++S
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA----ELTKLQVDGTLPVLGTLDLSH 86
Query: 155 NNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI- 213
N + +P L LD+S N + L L L EL L+GN+ LPP +
Sbjct: 87 NQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLL 144
Query: 214 GSLVDLEYLDLSANRFNNSVPENL-GNLLKLHYLGLSNNQFVLE-LPKELEKLVQLSELD 271
LE L L+ N +P L L L L L N L +PK L
Sbjct: 145 TPTPKLEKLSLANNNL-TELPAGLLNGLENLDTLLLQENS--LYTIPKGFFGSHLLPFAF 201
Query: 272 ASHN 275
N
Sbjct: 202 LHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 35/136 (25%), Positives = 55/136 (40%), Gaps = 8/136 (5%)
Query: 192 LNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNN 251
+ S E+ T LPP++ D L LS N L +L L L
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 252 QFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIP-NCFE 310
+ L + L L LD SHN +P +L +L L++S N L+ S+P
Sbjct: 66 E--LTKLQVDGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALR 121
Query: 311 GIRGISVIDISDNQLQ 326
G+ + + + N+L+
Sbjct: 122 GLGELQELYLKGNELK 137
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 48/202 (23%), Positives = 66/202 (32%), Gaps = 29/202 (14%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFT 62
+IL L++N ++ T L +L L L+ + P+L L N
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPVLGTLDLSHNQLQ 90
Query: 63 SYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPN 122
S LP AL VS N LR L + L N L L P
Sbjct: 91 S-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-----TL---PP 141
Query: 123 LTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREI-GNSSQLQALDLSLNHI 181
PKL L+++ NN+T +P + L L L N +
Sbjct: 142 GLLTPT----------------PKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSL 184
Query: 182 VGEIPKELGKLNSLTELILRGN 203
IPK + L L GN
Sbjct: 185 YT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 33/137 (24%), Positives = 52/137 (37%), Gaps = 13/137 (9%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPP----SLENPMLTRPGL 56
+ L LDL+ NQ + LP L L L + +N L+ +P L L L
Sbjct: 76 LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGE--LQELYL 131
Query: 57 DFNHFTSYLPHNVCRG-GALQYFGVSENHFQGTIPK-ILRNCSSLIRVRLNSNNLTGNIS 114
N + LP + L+ ++ N+ +P +L +L + L N+L I
Sbjct: 132 KGNELKT-LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIP 188
Query: 115 EALGIYPNLTFIDLSRN 131
+ L F L N
Sbjct: 189 KGFFGSHLLPFAFLHGN 205
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 62/313 (19%), Positives = 112/313 (35%), Gaps = 88/313 (28%)
Query: 444 IGNGGHGSVYRAEL------PSGQVVAIK---KFHSPLPCDQIADQKEFLIEVKALTEI- 493
+G+G G V A VA+K + ++++ + E+K +T++
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS------SEREALMSELKMMTQLG 106
Query: 494 RHRNIVKFYGFCSHARHSFLVYELLERGSL--------------------AAILSSDTAA 533
H NIV G C+ + +L++E G L L +
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 534 QELGWSQRMNVIKGVADALSYL--HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591
L + + VA + +L VH+D++++N+L+ + DFG+A+
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 592 LKPE-----SSN------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGK 639
+ + N W APE + T K DV+S+G+L+ E G
Sbjct: 222 IMSDSNYVVRGNARLPVKWM---------APESLFEGIYTIKSDVWSYGILLWEIFSLGV 272
Query: 640 HP-------RDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNES 692
+P +F LI + ++ P E++ IM+ SC
Sbjct: 273 NPYPGIPVDANFYKLIQNGF-------------KMDQP-FYATEEIYIIMQ---SCWAFD 315
Query: 693 PESRPTMKVVTQQ 705
RP+ +T
Sbjct: 316 SRKRPSFPNLTSF 328
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEF-----LIEVKALTEIRHRN 497
+G G +G V + +G++VAIKKF +D + + E+K L ++RH N
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFL-------ESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH 557
+V C + +LV+E ++ ++ L + L + + + + + + H
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL---- 613
I+H+DI +N+L+ + DFG A+ L + + T Y APEL
Sbjct: 143 HN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGD 199
Query: 614 -AYTMKITEKCDVYSFGVLVLEAIKGK 639
Y + DV++ G LV E G+
Sbjct: 200 VKYGKAV----DVWAIGCLVTEMFMGE 222
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 51/220 (23%), Positives = 80/220 (36%), Gaps = 45/220 (20%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEF----LIEVKALTEIRHRNI 498
G G G+V E +G VAIKK + F L ++ L + H NI
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKK---------VIQDPRFRNRELQIMQDLAVLHHPNI 81
Query: 499 VK-FYGFCSHARHSF------LVYELLERGSLAAILSSDTAAQELGWSQRMNV--IKG-- 547
V+ F + +V E + +L + IK
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR-----QVAPPPILIKVFL 135
Query: 548 --VADALSYLHHDCFPPIVHQDISSKNLLLDLE-YEAHVADFGIAKFLKPESSNWTEFAG 604
+ ++ LH + H+DI N+L++ + DFG AK L P N +
Sbjct: 136 FQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-VAYIC 193
Query: 605 TYGYVAPEL-----AYTMKITEKCDVYSFGVLVLEAIKGK 639
+ Y APEL YT + D++S G + E + G+
Sbjct: 194 SRYYRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGE 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 48/203 (23%), Positives = 87/203 (42%), Gaps = 19/203 (9%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG+G G V A + + VAIKK P K E+ + + H+NI+
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 503 ------GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
+ +LV EL++ +L ++ EL + ++ + + +LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 181
Query: 557 HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYT 616
I+H+D+ N+++ + + DFG+A+ S T + T Y APE+
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 237
Query: 617 MKITEKCDVYSFGVLVLEAIKGK 639
M E D++S G ++ E ++ K
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHK 260
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 45/177 (25%), Positives = 75/177 (42%), Gaps = 18/177 (10%)
Query: 161 IPREIGNSSQLQALDLSLNHIVGEIPKE--LGKLNSLTELILRGNQFTGRLPPEI-GSLV 217
+P+ + S LDLS N++ + E +L +L L+L N + E +
Sbjct: 33 VPQSL--PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 218 DLEYLDLSANRFNNSVPEN-LGNLLKLHYLGLSNNQFVLELPKE-LEKLVQLSELDASHN 275
+L YLDLS+N + ++ E +L L L L NN V + + E + QL +L S N
Sbjct: 89 NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146
Query: 276 LFGGEIPFQI----CSLKSLEKLNLSHNNLSGSIPNCFEGIRGISV--IDISDNQLQ 326
P ++ L L L+LS N L + + + + +N L+
Sbjct: 147 QIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 37/185 (20%), Positives = 66/185 (35%), Gaps = 31/185 (16%)
Query: 2 RSLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPP----SLENPMLTRPGL 56
++LDL+ N + + LTNL L+L +N+L+ FI + N L L
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPN--LRYLDL 95
Query: 57 DFNHFTSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISE 115
NH + L + AL+ + NH + + L ++ L+ N ++
Sbjct: 96 SSNHLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RF-- 151
Query: 116 ALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALD 175
P + K PKL L++S N + ++
Sbjct: 152 -----PVELI-------------KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193
Query: 176 LSLNH 180
L L++
Sbjct: 194 LYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 27/135 (20%), Positives = 47/135 (34%), Gaps = 8/135 (5%)
Query: 1 MRSLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDF 58
+ +L L L+ N + + NL+ L L N+L + L L
Sbjct: 63 LTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYN 121
Query: 59 NHFTSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVR---LNSNNLTGNIS 114
NH + N LQ +S+N +++++ + L ++ L+SN L
Sbjct: 122 NHIVV-VDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPL 180
Query: 115 EALGIYPNLTFIDLS 129
L P L
Sbjct: 181 TDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 25/119 (21%), Positives = 50/119 (42%), Gaps = 12/119 (10%)
Query: 1 MRSLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPP-SLEN-PMLTRPGLD 57
+ +L LDL+ N L + S+L L+ L+L N++ + + E+ L + L
Sbjct: 87 VPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLS 144
Query: 58 FNHFTSYLPHNVCRGG----ALQYFGVSENHFQGTIPKILRNCSSLIR--VRLNSNNLT 110
N + P + + G L +S N + L+ + ++ + L++N L
Sbjct: 145 QNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 9/171 (5%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G +G V++ +GQ+VAIKKF D +K L E++ L +++H N+V
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFL--ESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
R LV+E + ++ L D + + ++ A+++ H
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKHN--- 122
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL 613
+H+D+ +N+L+ + DFG A+ L S + + T Y +PEL
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 53/215 (24%), Positives = 87/215 (40%), Gaps = 14/215 (6%)
Query: 118 GIYPNLTFIDLSRNDFYGEISSN-WGKCPKLGTLNVSMNNITGGIPREI-GNSSQLQALD 175
+ + +DLS N + S + P+L L++S I I + S L L
Sbjct: 25 NLPFSTKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLI 82
Query: 176 LSLNHIVGEIPKEL-GKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSANRFNN-S 232
L+ N I + L+SL +L+ L G L L+ L+++ N +
Sbjct: 83 LTGNPI-QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFK 140
Query: 233 VPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFG---GEIPFQICSLK 289
+PE NL L +L LS+N+ +L L Q+ L+ S +L I
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI 200
Query: 290 SLEKLNLSHNNLSGSIP-NCFEGIRGISVIDISDN 323
L++L L N L S+P F+ + + I + N
Sbjct: 201 RLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 50/237 (21%), Positives = 74/237 (31%), Gaps = 43/237 (18%)
Query: 3 SLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHF 61
S LDL+ N + L + L+ L L + I +
Sbjct: 29 STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGA-----------YQSL 75
Query: 62 TSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYP 121
+ L ++ N Q SSL ++ NL + +G
Sbjct: 76 SH-----------LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124
Query: 122 NLTFIDLSRNDFYGEISS--NWG---KCPKLGTLNVSMNNITGGIPREI-GNSSQLQA-- 173
L ++++ N I S L L++S N I I Q+
Sbjct: 125 TLKELNVAHNL----IQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLN 179
Query: 174 --LDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSAN 227
LDLSLN + I K L EL L NQ +P I L L+ + L N
Sbjct: 180 LSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 39/209 (18%), Positives = 78/209 (37%), Gaps = 33/209 (15%)
Query: 2 RSLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPP----SLENPMLTRPGL 56
L +LDL++ + + + +L++L L+L N + + L + L +
Sbjct: 52 PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSS--LQKLVA 107
Query: 57 DFNHFTSYLPHNVCRG-GALQYFGVSENHFQG-TIPKILRNCSSLIRVRLNSNNLTGNIS 114
+ S L + L+ V+ N Q +P+ N ++L + L+SN +
Sbjct: 108 VETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166
Query: 115 EALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQAL 174
L + + ++LS L++S+N + I +L+ L
Sbjct: 167 TDLRVLHQMPLLNLS--------------------LDLSLNPMN-FIQPGAFKEIRLKEL 205
Query: 175 DLSLNHIVGEIPKELGKLNSLTELILRGN 203
L N + +L SL ++ L N
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 29/140 (20%), Positives = 45/140 (32%), Gaps = 13/140 (9%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPP----SLENPMLTRPGLDF 58
SL L + + + +L LKEL + +N + F P +L N L L
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN--LEHLDLSS 158
Query: 59 NHFTSYLPHNVCRG-GALQYFGV----SENHFQGTIPKILRNCSSLIRVRLNSNNLTGNI 113
N S + R + + S N I L + L++N L
Sbjct: 159 NKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVP 216
Query: 114 SEALGIYPNLTFIDLSRNDF 133
+L I L N +
Sbjct: 217 DGIFDRLTSLQKIWLHTNPW 236
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 27/123 (21%), Positives = 47/123 (38%), Gaps = 5/123 (4%)
Query: 217 VDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNL 276
+ LDLS N + + + +L L LS + + L LS L + N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 277 FGGEIPFQICS-LKSLEKLNLSHNNLSGSIP-NCFEGIRGISVIDISDNQLQGPVPNSTA 334
+ S L SL+KL NL+ S+ ++ + ++++ N +Q
Sbjct: 88 I-QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQS-FKLPEY 144
Query: 335 FRN 337
F N
Sbjct: 145 FSN 147
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 39/214 (18%)
Query: 444 IGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IGNG G VY+A+L SG++VAIKK D++ E++ + ++ H NIV+
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVL--------QDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 503 GFCSHARHSF------LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKG----VADAL 552
F + LV + + A Q L + +K + +L
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP----VIYVKLYMYQLFRSL 169
Query: 553 SYLH-HDCFPPIVHQDISSKNLLLDLE-YEAHVADFGIAKFLKPESSNWTEFAGTYGYVA 610
+Y+H I H+DI +NLLLD + + DFG AK L N + + Y A
Sbjct: 170 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRA 224
Query: 611 PEL-----AYTMKITEKCDVYSFGVLVLEAIKGK 639
PEL YT I DV+S G ++ E + G+
Sbjct: 225 PELIFGATDYTSSI----DVWSAGCVLAELLLGQ 254
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 435 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI 493
+ +G+G +G+V A + +G VAIKK + P K E++ L +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHM 81
Query: 494 RHRNIVKFY------GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKG 547
RH N++ +LV + L ++ ++LG + ++
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKH----EKLGEDRIQFLVYQ 136
Query: 548 VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG 607
+ L Y+H I+H+D+ NL ++ + E + DFG+A + S T + T
Sbjct: 137 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMTGYVVTRW 190
Query: 608 YVAPELAYT-MKITEKCDVYSFGVLVLEAIKGK 639
Y APE+ M+ T+ D++S G ++ E I GK
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-16
Identities = 54/226 (23%), Positives = 85/226 (37%), Gaps = 44/226 (19%)
Query: 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEF---LIEVKALT 491
DF +G G +V A EL + + AIK L I + + E ++
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKI----LEKRHIIKENKVPYVTRERDVMS 85
Query: 492 EIRHRNIVKFYGFCSHARHSFLVYELLERGSL------AAILSSDTA----AQELGWSQR 541
+ H VK Y + + G L A+
Sbjct: 86 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE------- 138
Query: 542 MNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAKFLKPESSN 598
+ AL YLH I+H+D+ +N+LL+ + H+ DFG AK L PES
Sbjct: 139 ------IVSALEYLHGKG----IIHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQ 186
Query: 599 ---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
+ F GT YV+PEL + D+++ G ++ + + G P
Sbjct: 187 ARANS-FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 65/282 (23%), Positives = 102/282 (36%), Gaps = 66/282 (23%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIK---KFHSPLPCDQIADQKEFLIEVKALTEIR----H 495
+G GG G+V+ L VAIK + + L ++D +EV L ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPR-NRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQEL----GWSQRM------NVI 545
+++ + LV E Q+L +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPA------------QDLFDYITEKGPLGEGPSRCFF 145
Query: 546 KGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY-EAHVADFGIAKFLKPESSNWTEFAG 604
V A+ + H +VH+DI +N+L+DL A + DFG L +T+F G
Sbjct: 146 GQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDFDG 200
Query: 605 TYGYVAPEL----AYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALD 660
T Y PE Y V+S G+L+ + + G P +
Sbjct: 201 TRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIPFE------------RD--Q 243
Query: 661 EILDPRLPPPSR-SVQ-EKLISIMEVAFSCLNESPESRPTMK 700
EIL+ L P+ S LI CL P SRP+++
Sbjct: 244 EILEAELHFPAHVSPDCCALIR------RCLAPKPSSRPSLE 279
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 19/212 (8%)
Query: 435 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI 493
+ IG+G G V A + + VAIKK P K E+ + +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCV 81
Query: 494 RHRNIVKFY------GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKG 547
H+NI+ + ++V EL++ +L ++ EL + ++
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQ 135
Query: 548 VADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYG 607
+ + +LH I+H+D+ N+++ + + DFG+A+ S T + T
Sbjct: 136 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRY 191
Query: 608 YVAPELAYTMKITEKCDVYSFGVLVLEAIKGK 639
Y APE+ M E D++S G ++ E IKG
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 65/266 (24%), Positives = 103/266 (38%), Gaps = 47/266 (17%)
Query: 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIK---KFHSPLPCDQIADQKEF---LIEVK 488
+ F+ IG G G V + + ++ A+K K + ++ E E++
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK-------QKCVERNEVRNVFKELQ 67
Query: 489 ALTEIRHRNIVK-FYGFCSHARHSFLVYELLERGSL------AAILSSDTA---AQELGW 538
+ + H +V +Y F F+V +LL G L +T EL
Sbjct: 68 IMQGLEHPFLVNLWYSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL-- 124
Query: 539 SQRMNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS 597
AL YL I+H+D+ N+LLD H+ DF IA L E+
Sbjct: 125 ----------VMALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
Query: 598 NWTEFAGTYGYVAPELAYTMKI---TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN 654
T AGT Y+APE+ + K + D +S GV E ++G+ P S SS +
Sbjct: 171 ITT-MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229
Query: 655 TDIALDEILDPR-LPPPSRSVQEKLI 679
+ P S+ +KL+
Sbjct: 230 HTFETTVVTYPSAWSQEMVSLLKKLL 255
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 66/282 (23%), Positives = 107/282 (37%), Gaps = 68/282 (24%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLI------EVKALTEIRHR 496
+G+GG GSVY + VAIK + D+I+D E EV L ++
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKH----VEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 497 --NIVKFYGFCSHARHSFLVYE-----------LLERGSLAAILSSDTAAQELGWSQRMN 543
+++ + L+ E + ERG+L L+ Q
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ--------- 157
Query: 544 VIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY-EAHVADFGIAKFLKPESSNWTEF 602
V +A+ + H+ ++H+DI +N+L+DL E + DFG LK + +T+F
Sbjct: 158 ----VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDF 208
Query: 603 AGTYGYVAPEL----AYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIA 658
GT Y PE Y + V+S G+L+ + + G P + I +
Sbjct: 209 DGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF---- 261
Query: 659 LDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
R+ + LI CL P RPT +
Sbjct: 262 ----FRQRVSSECQH----LIR------WCLALRPSDRPTFE 289
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 65/254 (25%), Positives = 106/254 (41%), Gaps = 42/254 (16%)
Query: 403 SGDRQSSNQNPHGLFSILNFEGKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQV 462
+G + + +P+ + +L +GK + + IGNG G V++A+L
Sbjct: 11 NGVKLNPLDDPNKVIKVLASDGKTGEQREIA----YTNCKVIGNGSFGVVFQAKLVESDE 66
Query: 463 VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK-FYGFCSHARHS-----FLVYE 516
VAIKK D++ E++ + ++H N+V F S+ LV E
Sbjct: 67 VAIKKVLQ--------DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118
Query: 517 LLERGSLAAILSSDTAAQELGWSQRMNVIKG----VADALSYLH-HDCFPPIVHQDISSK 571
+ A Q + M +IK + +L+Y+H I H+DI +
Sbjct: 119 YVPETVYRASRHYAKLKQTMP----MLLIKLYMYQLLRSLAYIHSIG----ICHRDIKPQ 170
Query: 572 NLLLDLE-YEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL-----AYTMKITEKCDV 625
NLLLD + DFG AK L N + + Y APEL YT I D+
Sbjct: 171 NLLLDPPSGVLKLIDFGSAKILIAGEPN-VSYICSRYYRAPELIFGATNYTTNI----DI 225
Query: 626 YSFGVLVLEAIKGK 639
+S G ++ E ++G+
Sbjct: 226 WSTGCVMAELMQGQ 239
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-15
Identities = 45/256 (17%), Positives = 88/256 (34%), Gaps = 38/256 (14%)
Query: 66 PHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTF 125
C + F V+ Q IP + + ++L +L S A PN++
Sbjct: 4 SSPPCECHQEEDFRVTCKDIQ-RIPSLPPS---TQTLKLIETHLRTIPSHAFSNLPNISR 59
Query: 126 IDLSRNDFYGEISSNW-GKCPKLGTLNVSMNNITGGIPREI-GNSSQLQALDLSLNHIVG 183
I +S + ++ S+ K+ + + I + L+ L + +
Sbjct: 60 IYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK- 118
Query: 184 EIPKE--LGKLNSLTELILRGNQFTGRLPPEI--GSLVDLEYLDLSANRFNNSVPENLGN 239
P + + L + N + +P G + L L N F SV N
Sbjct: 119 MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFN 177
Query: 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKS-LEKLNLSH 298
KL + L+ N+ L+ +D + FGG + S L++S
Sbjct: 178 GTKLDAVYLNKNK-------------YLTVIDK--DAFGG--------VYSGPSLLDVSQ 214
Query: 299 NNLSGSIP-NCFEGIR 313
+++ ++P E ++
Sbjct: 215 TSVT-ALPSKGLEHLK 229
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 37/228 (16%), Positives = 75/228 (32%), Gaps = 34/228 (14%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHF 61
S L L + + + + SNL N+ + + + + F +
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHS-----------FYNL 79
Query: 62 TSYLPHNVCRGGALQYFGVSENHFQGTIPK-ILRNCSSLIRVRLNSNNLTGNISEALGIY 120
+ + + + I L+ L + + + L + +Y
Sbjct: 80 SK-----------VTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVY 127
Query: 121 --PNLTFIDLSRNDFYGEISSN--WGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDL 176
++++ N + I N G C + TL + N T + N ++L A+ L
Sbjct: 128 STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYL 186
Query: 177 SLNHIVGEIPKEL--GKLNSLTELILRGNQFTGRLPPEIGSLVDLEYL 222
+ N + I K+ G + + L + T LP L L+ L
Sbjct: 187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPS--KGLEHLKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 32/166 (19%), Positives = 66/166 (39%), Gaps = 13/166 (7%)
Query: 194 SLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSANRFNNSVPENL-GNLLKLHYLGLSNN 251
S L L +P +L ++ + +S + + + NL K+ ++ + N
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 252 QFVLELPKE-LEKLVQLSELDASHNLFGGEIP--FQICSLKSLEKLNLSHNNLSGSIP-N 307
+ + + + L++L L L + P ++ S L ++ N SIP N
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 308 CFEGIRGISV-IDISDNQLQGPVPNSTAFRNAPVEAL--KGNKGLC 350
F+G+ ++ + + +N V AF ++A+ NK L
Sbjct: 150 AFQGLCNETLTLKLYNNGFTS-VQGY-AFNGTKLDAVYLNKNKYLT 193
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 31/210 (14%), Positives = 65/210 (30%), Gaps = 34/210 (16%)
Query: 1 MRSLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFN 59
+ ++S + ++ + L NL+ + + + +I P
Sbjct: 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDA-----------LK 102
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKI--LRNCSSLIRVRLNSNNLTGNISEAL 117
L++ G+ + P + + + + + N +I
Sbjct: 103 ELPL-----------LKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 118 --GIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREI--GNSSQLQA 173
G+ + L N F + KL + ++ N I ++ G S
Sbjct: 151 FQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL 209
Query: 174 LDLSLNHIVGEIPKELGKLNSLTELILRGN 203
LD+S + +P + L L ELI R
Sbjct: 210 LDVSQTSVT-ALPSKG--LEHLKELIARNT 236
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G+G +GSV A + SG+ VAIKK P K E+ L ++H N++
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 503 G-FCSHARHS-----FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH 556
F + +LV ++ L I+ + + ++ + L Y+H
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIH 143
Query: 557 HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYT 616
+VH+D+ NL ++ + E + DFG+A + + T + T Y APE+ +
Sbjct: 144 S---AGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYRAPEVILS 197
Query: 617 -MKITEKCDVYSFGVLVLEAIKGK 639
M + D++S G ++ E + GK
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 443 CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKF 501
+G+G +GSV A + +G VA+KK P I K E++ L ++H N++
Sbjct: 36 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGL 93
Query: 502 YGFC--SHARHSF----LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
+ + F LV L+ L I+ Q+L +I + L Y+
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKC----QKLTDDHVQFLIYQILRGLKYI 148
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAY 615
H I+H+D+ NL ++ + E + DFG+A + + T + T Y APE+
Sbjct: 149 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVATRWYRAPEIML 202
Query: 616 T-MKITEKCDVYSFGVLVLEAIKGK 639
M + D++S G ++ E + G+
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 8e-15
Identities = 46/179 (25%), Positives = 77/179 (43%), Gaps = 30/179 (16%)
Query: 160 GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVD 218
IP + + LDL N + K +L L L L N+ LP I L +
Sbjct: 34 NIP------ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKN 86
Query: 219 LEYLDLSANRFNNSVPENL-GNLLKLHYLGLSNNQFVLELPKEL-EKLVQLSELDASHNL 276
LE L ++ N+ ++P + L+ L L L NQ LP + + L +L+ L +N
Sbjct: 87 LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYN- 143
Query: 277 FGGEIPFQICS--------LKSLEKLNLSHNNLSGSIP-NCFEGIRGISVIDISDNQLQ 326
++ S L SL++L L +N L +P F+ + + + + +NQL+
Sbjct: 144 -------ELQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK 194
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 10/179 (5%)
Query: 150 LNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKEL-GKLNSLTELILRGNQFTGR 208
L++ N ++ + ++L+ L L+ N + +P + +L +L L + N+
Sbjct: 42 LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-A 99
Query: 209 LPPEI-GSLVDLEYLDLSANRFNNSVPENL-GNLLKLHYLGLSNNQFVLELPKEL-EKLV 265
LP + LV+L L L N+ S+P + +L KL YL L N+ LPK + +KL
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLT 157
Query: 266 QLSELDASHNLFGGEIPFQIC-SLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDN 323
L EL +N +P L L+ L L +N L F+ + + ++ + +N
Sbjct: 158 SLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 36/137 (26%), Positives = 54/137 (39%), Gaps = 11/137 (8%)
Query: 1 MRSLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPP----SLENPMLTRPG 55
+++L L + N+ + LP V L NL EL L N L +PP SL LT
Sbjct: 84 LKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTK--LTYLS 139
Query: 56 LDFNHFTSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNIS 114
L +N S LP V +L+ + N + + L ++L++N L
Sbjct: 140 LGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPE 198
Query: 115 EALGIYPNLTFIDLSRN 131
A L + L N
Sbjct: 199 GAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 44/208 (21%), Positives = 71/208 (34%), Gaps = 37/208 (17%)
Query: 3 SLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPP----SLENPMLTRPGLD 57
LDL N+ LP LT L+ L L N L +P L+N L +
Sbjct: 38 DTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN--LETLWVT 93
Query: 58 FNHFTSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEA 116
N + LP V L + N + P++ + + L + L N L ++ +
Sbjct: 94 DNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPK- 150
Query: 117 LGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNS-SQLQALD 175
G++ LT L L + N + +P + ++L+ L
Sbjct: 151 -GVFDKLT---------------------SLKELRLYNNQLK-RVPEGAFDKLTELKTLK 187
Query: 176 LSLNHIVGEIPKELGKLNSLTELILRGN 203
L N + L L L L+ N
Sbjct: 188 LDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKE-----FLIEVKALTEIRHRNI 498
IG G +G VY+A+ G+ A+KK + + E + E+ L E++H NI
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIR-------LEKEDEGIPSTTIREISILKELKHSNI 62
Query: 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
VK Y + LV+E L++ L +L D L + + + + ++Y H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL----- 613
++H+D+ +NLL++ E E +ADFG+A+ +T T Y AP++
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 614 AYTMKITEKCDVYSFGVLVLEAIKGK 639
Y+ I D++S G + E + G
Sbjct: 177 KYSTTI----DIWSVGCIFAEMVNGT 198
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 29/210 (13%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G +G V A + + VAIKK P + + L E+K L RH NI+
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 503 G-FCSHARHSF----LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH 557
+ +V +L+E L +L + Q L + + L Y+H
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS 146
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN---WTEFAGTYGYVAPEL- 613
++H+D+ NLLL+ + + DFG+A+ P+ + TE+ T Y APE+
Sbjct: 147 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 614 ----AYTMKITEKCDVYSFGVLVLEAIKGK 639
YT I D++S G ++ E + +
Sbjct: 204 LNSKGYTKSI----DIWSVGCILAEMLSNR 229
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 62/282 (21%), Positives = 109/282 (38%), Gaps = 52/282 (18%)
Query: 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEF---LIEVKALT 491
+ F +G GG G V+ ++ +G++ A KK L ++ +K + ++E K L
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKK----LNKKRLKKRKGYQGAMVEKKILA 240
Query: 492 EIRHRNIVK-FYGFCSHARHSF---------LVYELLERGSLAAILSSDTA---AQELGW 538
++ R IV Y F + + Y + A +
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ--- 297
Query: 539 SQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAKFLKPES 596
+ L +LH I+++D+ +N+LLD + +V +D G+A LK
Sbjct: 298 ---------IVSGLEHLHQRN---IIYRDLKPENVLLD--DDGNVRISDLGLAVELKAGQ 343
Query: 597 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP-RDFLSLISSSSLNT 655
+ +AGT G++APEL + D ++ GV + E I + P R + + L
Sbjct: 344 TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ 403
Query: 656 DIALDEILDPR-LPPPSRSVQEKLISIMEVAFSCLNESPESR 696
+ + P P S+ E L L + PE R
Sbjct: 404 RVLEQAVTYPDKFSPASKDFCEAL----------LQKDPEKR 435
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 52/243 (21%), Positives = 90/243 (37%), Gaps = 42/243 (17%)
Query: 423 EGKLVYDEIVRATNDFDAQY----CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIA 478
+G+ +++ + + Y I +G +G+V G VAIK+ + + +
Sbjct: 5 KGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTV 64
Query: 479 -------DQKEFLIEVKALTEIRHRNIVKFYG-FCSHARHSF----LVYELLERGSLAAI 526
K L E++ L H NI+ F + LV EL+ LA +
Sbjct: 65 NILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQV 123
Query: 527 LSSDTAAQELGWSQRMNVI-----KGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEA 581
+ Q + G L LH +VH+D+ N+LL +
Sbjct: 124 IHDQRIVIS---PQHIQYFMYHILLG----LHVLHE---AGVVHRDLHPGNILLADNNDI 173
Query: 582 HVADFGIAKFLKPESSNWTEFAGTYGYVAPEL-----AYTMKITEKCDVYSFGVLVLEAI 636
+ DF +A+ +N T + Y APEL +T + D++S G ++ E
Sbjct: 174 TICDFNLAR-EDTADANKTHYVTHRWYRAPELVMQFKGFTKLV----DMWSAGCVMAEMF 228
Query: 637 KGK 639
K
Sbjct: 229 NRK 231
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 51/223 (22%), Positives = 83/223 (37%), Gaps = 51/223 (22%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIK------------KFHSPLPCDQIADQKEFLI----- 485
IG G +G V A A+K P P +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 486 -----EVKALTEIRHRNIVKFYGFCSHA--RHSFLVYELLERGSLAAI-----LSSDTA- 532
E+ L ++ H N+VK H ++V+EL+ +G + + LS D A
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 533 --AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590
Q+L + YLH+ I+H+DI NLL+ + +ADFG++
Sbjct: 141 FYFQDL------------IKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 591 FLKPESSNWTEFAGTYGYVAPELAYTMKIT---EKCDVYSFGV 630
K + + GT ++APE + + DV++ GV
Sbjct: 186 EFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 41/252 (16%), Positives = 87/252 (34%), Gaps = 41/252 (16%)
Query: 92 ILRNCSSLIRVRLNSNNLT----GNISEALGIYP-NLTFIDLSRNDFYGE----ISSNWG 142
+S+ + L+ N+L + + L P N+T ++LS N + +
Sbjct: 46 FANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLA 105
Query: 143 KCP-KLGTLNVSMNNITGGIPREIG-----NSSQLQALDLSLNHI----VGEIPKELGKL 192
P + L++ N+ + E + + +L+L N + E+ + L +
Sbjct: 106 AIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAI 165
Query: 193 N-SLTELILRGNQFTGRLPPEIGSLVD-----LEYLDLSANRFNNSVPENLGNLLK---- 242
++ L LRGN + E+ + + LDLSAN L +
Sbjct: 166 PANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPN 225
Query: 243 -LHYLGLSNNQF----VLELPKELEKLVQLSELDASHNLFGGEIPFQICSL-------KS 290
+ L L N + L + L L + +++ Q +L +
Sbjct: 226 HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQK 285
Query: 291 LEKLNLSHNNLS 302
+ ++ + +
Sbjct: 286 IILVDKNGKEIH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 56/288 (19%), Positives = 107/288 (37%), Gaps = 47/288 (16%)
Query: 106 SNNLTGN-----ISEALGIYPNLTFIDLSRNDFYGE----ISSNWGKCP-KLGTLNVSMN 155
+ LT + + E I +T +DLS N+ Y + + P + +LN+S N
Sbjct: 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGN 61
Query: 156 NITGGIPREIG-----NSSQLQALDLSLNHI----VGEIPKELGKLN-SLTELILRGNQF 205
++ E+ + + +L+LS N + E+ K L + ++T L L N F
Sbjct: 62 SLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF 121
Query: 206 TGRLPPEIGSLV-----DLEYLDLSANRFNNSVPENLGNLLK-----LHYLGLSNNQF-- 253
+ + E + L+L N + L +L ++ L L N
Sbjct: 122 SSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181
Query: 254 --VLELPKELEKL-VQLSELDASHNLFGGEIPFQICSL-----KSLEKLNLSHNNLSGS- 304
EL K L + ++ LD S NL G + ++ + + LNL N L G
Sbjct: 182 KNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241
Query: 305 ---IPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGL 349
+ + ++ + + + + ++ S A A + +
Sbjct: 242 LENLKLLKDSLKHLQTVYLDYDIVKNM---SKEQCKALGAAFPNIQKI 286
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 47/284 (16%), Positives = 96/284 (33%), Gaps = 49/284 (17%)
Query: 65 LPHNVCRGGALQYFGVSENHFQGT----IPKILR-NCSSLIRVRLNSNNLTGN----ISE 115
+ + +S N + +IL +++ + L+ N L+ + +
Sbjct: 46 FANTPAS---VTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102
Query: 116 ALGIYP-NLTFIDLSRNDFYGE----ISSNWGKCPK-LGTLNVSMNNITGGIPREIG--- 166
L P +T +DL NDF + + P + +LN+ N++ E+
Sbjct: 103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162
Query: 167 --NSSQLQALDLSLNHI----VGEIPKELGKLN-SLTELILRGNQFTGRLPPEIGSLV-- 217
+ + +L+L N++ E+ K L + S+T L L N + E+ +
Sbjct: 163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS 222
Query: 218 ---DLEYLDLSANRFNNSVPENLGNLLK----LHYLGLSNNQF-------VLELPKELEK 263
+ L+L N + ENL L L + L + L
Sbjct: 223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPN 282
Query: 264 LVQLSELDASHNLFGGEIPFQICSL-----KSLEKLNLSHNNLS 302
+ ++ +D + I +L + +L + L
Sbjct: 283 IQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLI 326
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 44/318 (13%), Positives = 95/318 (29%), Gaps = 83/318 (26%)
Query: 2 RSLSILDLNQNQF--KGVLPPS---VSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGL 56
+++ L+L+ N K + + L L +N+ S
Sbjct: 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS----------------- 122
Query: 57 DFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGN---- 112
+ +S A +S+ + L N+L
Sbjct: 123 --SKSSSEF------KQAFS-----------------NLPASITSLNLRGNDLGIKSSDE 157
Query: 113 ISEALGIYP-NLTFIDLSRNDFYGE----ISSNWGKCPK-LGTLNVSMNNITGGIPREIG 166
+ + L P N+ ++L N+ + ++ P + +L++S N + E+
Sbjct: 158 LIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELA 217
Query: 167 -----NSSQLQALDLSLNHIVGEIPKELGKL----NSLTELILRGNQFTGRLPPEIGSLV 217
+ + +L+L LN + G + L L L + L + + +L
Sbjct: 218 YIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALG 277
Query: 218 D-------LEYLDLSANRFNNSVPENLGNLLK-----LHYLGLSNN-----QFVLELPKE 260
+ +D + + S + NL++ L N Q ++
Sbjct: 278 AAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIED 337
Query: 261 LEKLVQLSELDASHNLFG 278
L +L E +
Sbjct: 338 LNIPDELRESIQTCKPLL 355
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 56/235 (23%), Positives = 93/235 (39%), Gaps = 46/235 (19%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G GG+G V+ A + + VAIKK + K L E+K + + H NIVK +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKK----IVLTDPQSVKHALREIKIIRRLDHDNIVKVF 74
Query: 503 ----------GFCSHARHSF----LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGV 548
+ +V E +E LA +L L + +
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQL 129
Query: 549 ADALSYLHHDCFPPIVHQDISSKNLLLDLE-YEAHVADFGIAKFLKPESSN---WTEFAG 604
L Y+H ++H+D+ NL ++ E + DFG+A+ + P S+ +E
Sbjct: 130 LRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 605 TYGYVAPEL-----AYTMKITEKCDVYSFGVLVLEAI------KGKHPRDFLSLI 648
T Y +P L YT I D+++ G + E + G H + + LI
Sbjct: 187 TKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 6e-14
Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKE-----FLIEVKALTEIRHRNI 498
+G G +G VY+A+ G++VA+K+ + + E + E+ L E+ H NI
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIR-------LDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
V R LV+E +E+ L +L D L SQ + + +++ H
Sbjct: 82 VSLIDVIHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL----- 613
I+H+D+ +NLL++ + +ADFG+A+ ++T T Y AP++
Sbjct: 139 R---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 614 AYTMKITEKCDVYSFGVLVLEAIKGK 639
Y+ + D++S G + E I GK
Sbjct: 196 KYSTSV----DIWSIGCIFAEMITGK 217
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 7e-14
Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 41/224 (18%)
Query: 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEF---LIEVKALT 491
N F +G GG G V ++ +G++ A KK L +I +K L E + L
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKK----LEKKRIKKRKGEAMALNEKQILE 239
Query: 492 EIRHRNIVK-FYGFCSHARHSFLVYELLERGSL--------AAILSSDTA---AQELGWS 539
++ R +V Y + + LV L+ G L A A A E
Sbjct: 240 KVNSRFVVSLAYAYETKD-ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE---- 294
Query: 540 QRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAKFLKPESS 597
+ L LH + IV++D+ +N+LLD H+ +D G+A + +
Sbjct: 295 --------ICCGLEDLHRER---IVYRDLKPENILLD--DHGHIRISDLGLAVHVPEGQT 341
Query: 598 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
GT GY+APE+ + T D ++ G L+ E I G+ P
Sbjct: 342 IKG-RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 7e-14
Identities = 47/209 (22%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKE-----FLIEVKALTEIRHRN 497
IG G +G+V++A + ++VA+K+ + D E L E+ L E++H+N
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVR-------LDDDDEGVPSSALREICLLKELKHKN 62
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH 557
IV+ + + LV+E ++ L D+ +L + + + L + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL---- 613
++H+D+ +NLL++ E +A+FG+A+ ++ T Y P++
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 614 -AYTMKITEKCDVYSFGVLVLEAIKGKHP 641
Y+ I D++S G + E P
Sbjct: 177 KLYSTSI----DMWSAGCIFAELANAGRP 201
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 9e-14
Identities = 49/211 (23%), Positives = 93/211 (44%), Gaps = 32/211 (15%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKE-----FLIEVKALTEIRHRN 497
+GNG + +VY+ +G VA+K+ D +E + E+ + E++H N
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVK--------LDSEEGTPSTAIREISLMKELKHEN 64
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA----DALS 553
IV+ Y LV+E ++ L + +N++K L+
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDN-DLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL 613
+ H + I+H+D+ +NLL++ + + DFG+A+ + ++ T Y AP++
Sbjct: 123 FCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDV 179
Query: 614 -----AYTMKITEKCDVYSFGVLVLEAIKGK 639
Y+ I D++S G ++ E I GK
Sbjct: 180 LMGSRTYSTSI----DIWSCGCILAEMITGK 206
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 44/212 (20%), Positives = 88/212 (41%), Gaps = 34/212 (16%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKE-----FLIEVKALTEIRHRN 497
+G G +G VY+A + + + VAIK+ + ++E + EV L E++HRN
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIR-------LEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH 557
I++ H L++E E L + ++ + + + + +++ H
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAH-----VADFGIAKFLKPESSNWTEFAGTYGYVAPE 612
+H+D+ +NLLL + + + DFG+A+ +T T Y PE
Sbjct: 151 RR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPE 207
Query: 613 L-----AYTMKITEKCDVYSFGVLVLEAIKGK 639
+ Y+ + D++S + E +
Sbjct: 208 ILLGSRHYSTSV----DIWSIACIWAEMLMKT 235
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 45/207 (21%), Positives = 88/207 (42%), Gaps = 29/207 (14%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKE-----FLIEVKALTEIRHRN 497
+G G + +VY+ + +VA+K+ + +E + EV L +++H N
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIR--------LEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH 557
IV + + LV+E L++ L L D + + + L+Y H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL---- 613
++H+D+ +NLL++ E +ADFG+A+ + + T Y P++
Sbjct: 119 QK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS 175
Query: 614 -AYTMKITEKCDVYSFGVLVLEAIKGK 639
Y+ +I D++ G + E G+
Sbjct: 176 TDYSTQI----DMWGVGCIFYEMATGR 198
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 63/241 (26%), Positives = 102/241 (42%), Gaps = 42/241 (17%)
Query: 435 TNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI 493
++DF + +G G +G V A P+G++VAIKK P D+ L E+K L
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHF 66
Query: 494 RHRNIVKFYG-FCSHARHSF----LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGV 548
+H NI+ + + +F ++ EL++ L ++S+ Q L I
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST----QMLSDDHIQYFIYQT 121
Query: 549 ADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA----------KFLKPESSN 598
A+ LH ++H+D+ NLL++ + V DFG+A + S
Sbjct: 122 LRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 599 WTEFAGTYGYVAPEL-----AYTMKITEKCDVYSFGVLVLEAI------KGKHPRDFLSL 647
EF T Y APE+ Y+ + DV+S G ++ E G+ R L L
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRRPIFPGRDYRHQLLL 234
Query: 648 I 648
I
Sbjct: 235 I 235
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 31/200 (15%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEF--------LIEVKALTEIR 494
+G G +VY+A + + Q+VAIKK + + E L E+K L E+
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIK-------LGHRSEAKDGINRTALREIKLLQELS 70
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
H NI+ H + LV++ +E L I+ + L S + L Y
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL- 613
LH I+H+D+ NLLLD +ADFG+AK + +T T Y APEL
Sbjct: 128 LHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 184
Query: 614 ----AYTMKITEKCDVYSFG 629
Y + + D+++ G
Sbjct: 185 FGARMYGVGV----DMWAVG 200
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 47/210 (22%), Positives = 87/210 (41%), Gaps = 39/210 (18%)
Query: 444 IGNGGHGSVYRA---ELPSGQVVAIKKFHSP-LPCDQIADQKEFLIEVKALTEIRHRNIV 499
+G G +G VY+A + + A+K+ + E+ L E++H N++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-------EIALLRELKHPNVI 81
Query: 500 KFYG-FCSHARHS-FLVYELLERGSLAAILSSDTAAQELGWSQRMN--VIKGVA----DA 551
F SHA +L+++ E L I+ A++ ++ ++K + D
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEAH----VADFGIAKFLKPESSNWTEFAG--- 604
+ YLH + ++H+D+ N+L+ E +AD G A+ +
Sbjct: 141 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 605 TYGYVAPEL-----AYTMKITEKCDVYSFG 629
T+ Y APEL YT I D+++ G
Sbjct: 198 TFWYRAPELLLGARHYTKAI----DIWAIG 223
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 26/198 (13%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIK-----KFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G G G V E +G VA+K K S +I E++ L RH +
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR------EIQNLKLFRHPH 72
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH 557
I+K Y S F+V E + G L + +E + + + + A+ Y H
Sbjct: 73 IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE---MEARRLFQQILSAVDYCHR 129
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL---- 613
+VH+D+ +N+LLD A +ADFG++ + T G+ Y APE+
Sbjct: 130 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGR 185
Query: 614 AYTMKITEKCDVYSFGVL 631
Y + D++S GV+
Sbjct: 186 LYA---GPEVDIWSCGVI 200
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 56/230 (24%), Positives = 98/230 (42%), Gaps = 40/230 (17%)
Query: 433 RATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKE-FLI----E 486
+ ++ IG G G V++A +GQ VA+KK + ++KE F I E
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-------MENEKEGFPITALRE 66
Query: 487 VKALTEIRHRNIVKFYGFCSHARHS--------FLVYELLERGSLAAILSSDTAAQELGW 538
+K L ++H N+V C +LV++ E LA +L +
Sbjct: 67 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLVKFTL 123
Query: 539 SQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA-KFLKPESS 597
S+ V++ + + L Y+H + I+H+D+ + N+L+ + +ADFG+A F ++S
Sbjct: 124 SEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 598 NWTEFAG---TYGYVAPEL-----AYTMKITEKCDVYSFGVLVLEAIKGK 639
+ T Y PEL Y I D++ G ++ E
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS 226
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 5e-13
Identities = 65/276 (23%), Positives = 103/276 (37%), Gaps = 52/276 (18%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLI-EVKALTEIRHRNIVKF 501
+G G +G V A + + VA+K + + D E + E+ + H N+VKF
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKI----VDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 502 YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMN----------VIKGVADA 551
YG +L E G L + D M ++ GV
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPD---------IGMPEPDAQRFFHQLMAGV--- 118
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW---TEFAGTYGY 608
YLH I H+DI +NLLLD ++DFG+A + + GT Y
Sbjct: 119 -VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPY 173
Query: 609 VAPEL----AYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD 664
VAPEL + E DV+S G+++ + G+ P + S +D +
Sbjct: 174 VAPELLKRREFH---AEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWKEKKTYL 228
Query: 665 PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
+ L+ + L E+P +R T+
Sbjct: 229 NPWKKIDSAPL-ALLHKI------LVENPSARITIP 257
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 46/208 (22%), Positives = 80/208 (38%), Gaps = 40/208 (19%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLI----EVKALTEIRHRNI 498
+G G +G V + A+K L ++ E++ L +RH+N+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKI----LKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 499 VKFYGFCSHA--RHSFLVYELLERGS---LAAI----LSSDTAA---QELGWSQRMNVIK 546
++ + + ++V E G L ++ A +L
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL---------- 118
Query: 547 GVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWT--EFAG 604
D L YLH IVH+DI NLLL ++ G+A+ L P +++ T G
Sbjct: 119 --IDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQG 173
Query: 605 TYGYVAPELAYTMKITE--KCDVYSFGV 630
+ + PE+A + K D++S GV
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGV 201
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 52/223 (23%), Positives = 88/223 (39%), Gaps = 43/223 (19%)
Query: 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEF---LIEVKALT 491
+ FD +G G G V + SG A+K L ++ K+ L E + L
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI----LDKQKVVKLKQIEHTLNEKRILQ 96
Query: 492 EIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDT----------AAQELGWSQR 541
+ +VK + ++V E + G + + L AAQ
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ------- 149
Query: 542 MNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAKFLKPESSN 598
+ YLH D ++++D+ +NLL+D + ++ DFG AK + +
Sbjct: 150 ------IVLTFEYLHSLD----LIYRDLKPENLLID--QQGYIQVTDFGFAK--RVKGRT 195
Query: 599 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
WT GT +APE+ + + D ++ GVL+ E G P
Sbjct: 196 WT-LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 53/232 (22%), Positives = 86/232 (37%), Gaps = 49/232 (21%)
Query: 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKE---FLIEVKALT 491
+DF+ IG G V ++ +GQV A+K + + + E F E L
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKI----MNKWDMLKRGEVSCFREERDVLV 116
Query: 492 EIRHRNIVK-FYGFCSHARHSFLVYELLERGSL-------AAILSSDTA---AQELGWSQ 540
R I + + F + +LV E G L + ++ A E+
Sbjct: 117 NGDRRWITQLHFAFQD-ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI---- 171
Query: 541 RMNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAKFLKPESS 597
A+ +H VH+DI N+LLD H+ ADFG L+ + +
Sbjct: 172 --------VMAIDSVHRLG----YVHRDIKPDNILLD--RCGHIRLADFGSCLKLRADGT 217
Query: 598 NWTE-FAGTYGYVAPELAYTMKITEK-------CDVYSFGVLVLEAIKGKHP 641
+ GT Y++PE+ + CD ++ GV E G+ P
Sbjct: 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 28/218 (12%)
Query: 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEF---LIEVKALT 491
NDF IG GG G VY +G++ A+K L +I ++ L E L+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC----LDKKRIKMKQGETLALNERIMLS 244
Query: 492 EI---RHRNIVK-FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNV-IK 546
+ IV Y F + + +L+ G L LS E M
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHGVFSE----ADMRFYAA 299
Query: 547 GVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAKFLKPESSNWTEFAG 604
+ L ++H+ +V++D+ N+LLD HV +D G+A + G
Sbjct: 300 EIILGLEHMHNRF---VVYRDLKPANILLD--EHGHVRISDLGLACDF-SKKKPHA-SVG 352
Query: 605 TYGYVAPE-LAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
T+GY+APE L + D +S G ++ + ++G P
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 52/256 (20%), Positives = 85/256 (33%), Gaps = 67/256 (26%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK-- 500
+G G G V ++ SG+ A+KK D + E+ + + H NI+K
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQ--------DPRYKNRELDIMKVLDHVNIIKLV 66
Query: 501 --FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMN--------------- 543
FY + + ++ + +
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 544 VIKGVAD-------------------ALSYLHHDCFPPIVHQDISSKNLLLDLE-YEAHV 583
V+K A+ ++H I H+DI +NLL++ + +
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKL 183
Query: 584 ADFGIAKFLKPESSNWTEFAGTYGYVAPEL-----AYTMKITEKCDVYSFGVLVLEAI-- 636
DFG AK L P + + + Y APEL YT I D++S G + E I
Sbjct: 184 CDFGSAKKLIPSEPS-VAYICSRFYRAPELMLGATEYTPSI----DLWSIGCVFGELILG 238
Query: 637 ----KGKHPRDFLSLI 648
G+ D L I
Sbjct: 239 KPLFSGETSIDQLVRI 254
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 68/278 (24%), Positives = 114/278 (41%), Gaps = 51/278 (18%)
Query: 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEF---LIEVKALT 491
N+F+ +G G G V + +G+ A+K L + I + E L E + L
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI----LKKEVIVAKDEVAHTLTENRVLQ 203
Query: 492 EIRHRNIVK-FYGFCSHARHSFLVYELLERGSL------AAILSSDTA---AQELGWSQR 541
RH + Y F +H V E G L + S D A E
Sbjct: 204 NSRHPFLTALKYSFQTHD-RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE------ 256
Query: 542 MNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAK-FLKPESSN 598
+ AL YLH + +V++D+ +NL+LD + H+ DFG+ K +K ++
Sbjct: 257 ------IVSALDYLHSEK--NVVYRDLKLENLMLD--KDGHIKITDFGLCKEGIKDGATM 306
Query: 599 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIA 658
T F GT Y+APE+ D + GV++ E + G+ P F + + +
Sbjct: 307 KT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--F------YNQDHEKL 357
Query: 659 LDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESR 696
+ IL + P R++ + S++ L + P+ R
Sbjct: 358 FELILMEEIRFP-RTLGPEAKSLLS---GLLKKDPKQR 391
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 44/210 (20%), Positives = 81/210 (38%), Gaps = 35/210 (16%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKF 501
+G G + V+ A + + + V +K +K+ E+K L +R NI+
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLRGGPNIITL 96
Query: 502 YGFCSHARHSF---LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH-H 557
S LV+E + + Q L + + AL Y H
Sbjct: 97 AD-IVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM 149
Query: 558 DCFPPIVHQDISSKNLLLDLEY-EAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL--- 613
I+H+D+ N+++D E+ + + D+G+A+F P + + + PEL
Sbjct: 150 G----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVD 204
Query: 614 --AYTMKITEKCDVYSFGVLVLEAIKGKHP 641
Y + D++S G ++ I K P
Sbjct: 205 YQMYDYSL----DMWSLGCMLASMIFRKEP 230
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 53/205 (25%), Positives = 77/205 (37%), Gaps = 44/205 (21%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLI--EVKALTEIRHRNIVK 500
IG+G G + ++VA+K + D+ + E+ +RH NIV+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKY----IERGAAIDEN---VQREIINHRSLRHPNIVR 80
Query: 501 FYGFCSHARHSFLVYELLERGSL------AAILSSDTAA---QELGWSQRMNVIKGVADA 551
F H ++ E G L A S D A Q+L
Sbjct: 81 FKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL------------LSG 128
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEAH--VADFGIAKFLKPESSNWTEFAGTYGYV 609
+SY H I H+D+ +N LLD + DFG +K S + GT Y+
Sbjct: 129 VSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYI 184
Query: 610 APEL----AYTMKITEKCDVYSFGV 630
APE+ Y K DV+S GV
Sbjct: 185 APEVLLRQEYDGK---IADVWSCGV 206
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 52/227 (22%), Positives = 86/227 (37%), Gaps = 44/227 (19%)
Query: 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKE---FLIEVKALT 491
D++ IG G G V + +V A+K ++ + + F E +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK----FEMIKRSDSAFFWEERDIMA 124
Query: 492 EIRHRNIVK-FYGFCSHARHSFLVYELLERGSLAAILSS-----DTA---AQELGWSQRM 542
+V+ FY F R+ ++V E + G L ++S+ A E
Sbjct: 125 FANSPWVVQLFYAFQD-DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAE------- 176
Query: 543 NVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAKFLKPESSNW 599
V AL +H +H+D+ N+LLD H+ ADFG + E
Sbjct: 177 -----VVLALDAIHSMG----FIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKEGMVR 225
Query: 600 TE-FAGTYGYVAPEL----AYTMKITEKCDVYSFGVLVLEAIKGKHP 641
+ GT Y++PE+ +CD +S GV + E + G P
Sbjct: 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 55/231 (23%), Positives = 88/231 (38%), Gaps = 49/231 (21%)
Query: 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKE---FLIEVKALT 491
DF+ IG G G V +L + +V A+K L ++ + E F E L
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKI----LNKWEMLKRAETACFREERDVLV 129
Query: 492 EIRHRNIVK-FYGFCSHARHSFLVYELLERGSLAAILSSDT-----------AAQELGWS 539
+ I Y F + +LV + G L +LS A+
Sbjct: 130 NGDSKWITTLHYAFQD-DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE----- 183
Query: 540 QRMNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAKFLKPES 596
+ A+ +H VH+DI N+L+D H+ ADFG L +
Sbjct: 184 --------MVIAIDSVHQLH----YVHRDIKPDNILMD--MNGHIRLADFGSCLKLMEDG 229
Query: 597 SNWTE-FAGTYGYVAPELAYTMKITEK-----CDVYSFGVLVLEAIKGKHP 641
+ + GT Y++PE+ M+ + CD +S GV + E + G+ P
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 55/206 (26%), Positives = 80/206 (38%), Gaps = 43/206 (20%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLI-EVKALTEIRHRNIVKF 501
+G G +G V A + + VA+K + + D E + E+ + H N+VKF
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKI----VDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 502 YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMN----------VIKGVADA 551
YG +L E G L + D M ++ GV
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPD---------IGMPEPDAQRFFHQLMAGV--- 118
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW---TEFAGTYGY 608
YLH I H+DI +NLLLD ++DFG+A + + GT Y
Sbjct: 119 -VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPY 173
Query: 609 VAPEL----AYTMKITEKCDVYSFGV 630
VAPEL + E DV+S G+
Sbjct: 174 VAPELLKRREFH---AEPVDVWSCGI 196
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 40/200 (20%), Positives = 76/200 (38%), Gaps = 50/200 (25%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKF 501
+G G +G V + + + A+K + D + EV+ + +IV+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALK---------MLQDCPKARREVELHWRASQCPHIVRI 76
Query: 502 YGFC----SHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRM--NVIKGVADALSYL 555
+ + +V E L+ G L S + +++R ++K + +A+ YL
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 556 H-HDCFPPIVHQDISSKNLLLDLEYEAH---VADFGIAKFLKPESSNWTEFAGTYGYVAP 611
H + I H+D+ +NLL + + DFG A E+ Y
Sbjct: 134 HSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFA----KET-----TGEKYD---- 176
Query: 612 ELAYTMKITEKCDVYSFGVL 631
+ CD++S GV+
Sbjct: 177 ---------KSCDMWSLGVI 187
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 49/225 (21%), Positives = 83/225 (36%), Gaps = 53/225 (23%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G +G V A + +VVAIKK + + D K L E+ L + H ++VK
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVF--EDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 503 G-FCSHARHSF----LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH- 556
F +V E+ + + + L ++ + + Y+H
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADS-DFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHS 174
Query: 557 HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTY---------- 606
I+H+D+ N L++ + V DFG+A+ + + ++ +
Sbjct: 175 AG----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 607 -----------GYV------APEL-----AYTMKITEKCDVYSFG 629
G+V APEL YT I DV+S G
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI----DVWSIG 271
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 50/198 (25%), Positives = 83/198 (41%), Gaps = 26/198 (13%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIK-----KFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G G G V + +G VA+K K S +I E++ L RH +
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR------EIQNLKLFRHPH 77
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH 557
I+K Y S F+V E + G L + + E + + + + + Y H
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE---KESRRLFQQILSGVDYCHR 134
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL---- 613
+VH+D+ +N+LLD A +ADFG++ + T G+ Y APE+
Sbjct: 135 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGR 190
Query: 614 AYTMKITEKCDVYSFGVL 631
Y + D++S GV+
Sbjct: 191 LYA---GPEVDIWSSGVI 205
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 49/177 (27%), Positives = 74/177 (41%), Gaps = 30/177 (16%)
Query: 160 GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVD 218
GIP + + LDL + L LT L L NQ L + L +
Sbjct: 32 GIPADT------EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTE 84
Query: 219 LEYLDLSANRFNNSVPENL-GNLLKLHYLGLSNNQFVLELPKEL-EKLVQLSELDASHNL 276
L L L+ N+ S+P + +L +L L L NQ LP + ++L +L EL + N
Sbjct: 85 LGTLGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTN- 141
Query: 277 FGGEIPFQICS--------LKSLEKLNLSHNNLSGSIP-NCFEGIRGISVIDISDNQ 324
Q+ S L +L+ L+LS N L S+P F+ + + I + NQ
Sbjct: 142 -------QLQSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 30/113 (26%), Positives = 38/113 (33%), Gaps = 11/113 (9%)
Query: 1 MRSLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPP----SLENPMLTRPG 55
+ L L L NQ LP V +LT L +L L N L +P L L
Sbjct: 82 LTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTK--LKELR 137
Query: 56 LDFNHFTSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSN 107
L+ N S +P LQ +S N Q L + L N
Sbjct: 138 LNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 36/137 (26%), Positives = 54/137 (39%), Gaps = 11/137 (8%)
Query: 1 MRSLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGF---IPPSLENPMLTRPGL 56
+ L+ L+L+ NQ + L V +LT L L L N L+ + L L + L
Sbjct: 58 LTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQ--LDKLYL 114
Query: 57 DFNHFTSYLPHNVCRG-GALQYFGVSENHFQGTIPK-ILRNCSSLIRVRLNSNNLTGNIS 114
N S LP V L+ ++ N Q +IP ++L + L++N L
Sbjct: 115 GGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPH 172
Query: 115 EALGIYPNLTFIDLSRN 131
A L I L N
Sbjct: 173 GAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 43/204 (21%), Positives = 65/204 (31%), Gaps = 52/204 (25%)
Query: 52 TRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTG 111
+ L + L + + N Q + + + L + L +N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 112 NISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQL 171
S LG++ +LT +L L + N QL
Sbjct: 97 --SLPLGVFDHLT---------------------QLDKLYLGGN--------------QL 119
Query: 172 QALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSANRFN 230
++L +L L EL L NQ +P L +L+ L LS N+
Sbjct: 120 KSLP----------SGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQL- 167
Query: 231 NSVPEN-LGNLLKLHYLGLSNNQF 253
SVP L KL + L NQF
Sbjct: 168 QSVPHGAFDRLGKLQTITLFGNQF 191
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 53/228 (23%)
Query: 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEF---LIEVKALT 491
DF +G G G V+ +G+ A+K L + + K+ E L+
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV----LKKEIVVRLKQVEHTNDERLMLS 61
Query: 492 EIRHRNIVKFYGFCSHARHSFLVYELLERGSL------AAILSSDTA----AQELGWSQR 541
+ H I++ +G A+ F++ + +E G L + + A A+
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE------- 114
Query: 542 MNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAKFLKPESSN 598
V AL YLH D I+++D+ +N+LLD H+ DFG AK
Sbjct: 115 ------VCLALEYLHSKD----IIYRDLKPENILLD--KNGHIKITDFGFAK--YVPDVT 160
Query: 599 WTEFAGTYGYVAPELAYTMKITEK-----CDVYSFGVLVLEAIKGKHP 641
+T GT Y+APE+ ++ K D +SFG+L+ E + G P
Sbjct: 161 YT-LCGTPDYIAPEV-----VSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 47/207 (22%), Positives = 80/207 (38%), Gaps = 45/207 (21%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIK-----KFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497
+G G G V A + Q VA+K ++ E+ L +RH +
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER------EISYLKLLRHPH 70
Query: 498 IVKFYGFCSHARHSFLVYE---------LLERGSLAAILSSDTAAQELGWSQRMNVIKGV 548
I+K Y + +V E ++E+ ++ D + +
Sbjct: 71 IIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKR----MTEDEG---------RRFFQQI 117
Query: 549 ADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGY 608
A+ Y H IVH+D+ +NLLLD +ADFG++ + + T G+ Y
Sbjct: 118 ICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNY 173
Query: 609 VAPEL----AYTMKITEKCDVYSFGVL 631
APE+ Y + DV+S G++
Sbjct: 174 AAPEVINGKLYA---GPEVDVWSCGIV 197
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 46/229 (20%), Positives = 87/229 (37%), Gaps = 54/229 (23%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIK------KFHSPLPCDQIADQKEFLIEVKALTEIR-- 494
+G G +V+ A+ + + VA+K + + E+K L +
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-----------EAAEDEIKLLQRVNDA 75
Query: 495 ---------HRNIVKFYGFCSH----ARHSFLVYELLERGSLAAILSSDTAAQELGWSQR 541
+I+K +H H +V+E+L +L A++ + G
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY---EHRGIP-- 129
Query: 542 MNVIKGVA----DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAH------VADFGIAKF 591
+ +K ++ L Y+H C I+H DI +N+L+++ +AD G A +
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 592 LKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKH 640
++T T Y +PE+ D++S L+ E I G
Sbjct: 188 ---YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 52/224 (23%), Positives = 84/224 (37%), Gaps = 56/224 (25%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G +G VY A + + + VAIKK + + + D K L E+ L ++ I++ Y
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 503 G-FCSHARHSF----LVYELLERGSLAAILSSDTAAQELGWSQRM-----NVIKGVADAL 552
F +V E+ + L + + L + + N++ G
Sbjct: 92 DLIIPDDLLKFDELYIVLEIADS-DLKKLFKTP---IFLT-EEHIKTILYNLLLG----E 142
Query: 553 SYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA----------------------K 590
+++H I+H+D+ N LL+ + V DFG+A
Sbjct: 143 NFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 591 FLKPESSNWTEFAGTYGYVAPEL-----AYTMKITEKCDVYSFG 629
K T T Y APEL YT I D++S G
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTG 239
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 43/143 (30%), Positives = 56/143 (39%), Gaps = 12/143 (8%)
Query: 160 GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVD 218
GIP + Q L L N I P L +L EL L NQ LP + SL
Sbjct: 37 GIP------TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89
Query: 219 LEYLDLSANRFNNSVPENL-GNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLF 277
L LDL N+ +P + L+ L L + N+ ELP+ +E+L L+ L N
Sbjct: 90 LTVLDLGTNQL-TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
Query: 278 GGEIPFQICSLKSLEKLNLSHNN 300
L SL L N
Sbjct: 148 KSIPHGAFDRLSSLTHAYL-FGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 35/137 (25%), Positives = 58/137 (42%), Gaps = 23/137 (16%)
Query: 210 PPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKEL-EKLVQLS 268
P I + + L L N+ P +L+ L L L +NQ LP + + L QL+
Sbjct: 35 PAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLT 91
Query: 269 ELDASHNLFGGEIPFQICSLKS--------LEKLNLSHNNLSGSIPNCFEGIRGISVIDI 320
LD N Q+ L S L++L + N L+ +P E + ++ + +
Sbjct: 92 VLDLGTN--------QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLAL 142
Query: 321 SDNQLQGPVPNSTAFRN 337
NQL+ +P+ AF
Sbjct: 143 DQNQLKS-IPHG-AFDR 157
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 38/130 (29%), Positives = 51/130 (39%), Gaps = 8/130 (6%)
Query: 6 ILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGF---IPPSLENPMLTRPGLDFNHFT 62
IL L+ NQ + P +L NLKEL L N L + SL LT L N T
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ--LTVLDLGTNQLT 101
Query: 63 SYLPHNVC-RGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYP 121
LP V R L+ + N +P+ + + L + L+ N L A
Sbjct: 102 V-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159
Query: 122 NLTFIDLSRN 131
+LT L N
Sbjct: 160 SLTHAYLFGN 169
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 73/283 (25%), Positives = 113/283 (39%), Gaps = 62/283 (21%)
Query: 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEF---LIEVKALT 491
NDFD +G G G V +G+ A+K L + I + E + E + L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKI----LRKEVIIAKDEVAHTVTESRVLQ 60
Query: 492 EIRHRNIVK-FYGFCSHARHSFLVYELLERGSL------AAILSSDTA---AQELGWSQR 541
RH + Y F +H V E G L + + + A E
Sbjct: 61 NTRHPFLTALKYAFQTHD-RLCFVMEYANGGELFFHLSRERVFTEERARFYGAE------ 113
Query: 542 MNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAK-FLKPESS 597
+ AL YLH D +V++DI +NL+LD + H+ DFG+ K + ++
Sbjct: 114 ------IVSALEYLHSRD----VVYRDIKLENLMLD--KDGHIKITDFGLCKEGISDGAT 161
Query: 598 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP---RDFLSLISSSSLN 654
T F GT Y+APE+ D + GV++ E + G+ P +D L
Sbjct: 162 MKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL---- 216
Query: 655 TDIALDEILDPR-LPPPSRSVQEKLISIMEVAFSCLNESPESR 696
I ++EI PR L P ++S+ L L + P+ R
Sbjct: 217 --ILMEEIRFPRTLSPEAKSLLAGL----------LKKDPKQR 247
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 39/137 (28%), Positives = 59/137 (43%), Gaps = 14/137 (10%)
Query: 194 SLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSANRFNNSVPENL-GNLLKLHYLGLSNN 251
++TE+ L N +PP L +DLS N+ + + + L L+ L L N
Sbjct: 33 TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 252 QFVLELPKEL-EKLVQLSELDASHNLFGGEIP---FQICSLKSLEKLNLSHNNLSGSIPN 307
+ ELPK L E L L L + N + FQ L +L L+L N L +I
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQ--DLHNLNLLSLYDNKLQ-TIAK 145
Query: 308 -CFEGIRGISVIDISDN 323
F +R I + ++ N
Sbjct: 146 GTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 30/115 (26%), Positives = 51/115 (44%), Gaps = 10/115 (8%)
Query: 217 VDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKEL-EKLVQLSELDASHN 275
+ + L N P KL + LSNNQ EL + + L L+ L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 276 LFGGEIP---FQICSLKSLEKLNLSHNNLSGSIPN-CFEGIRGISVIDISDNQLQ 326
E+P F+ L SL+ L L+ N ++ + F+ + ++++ + DN+LQ
Sbjct: 91 KIT-ELPKSLFE--GLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 35/140 (25%), Positives = 55/140 (39%), Gaps = 8/140 (5%)
Query: 118 GIYPNLTFIDLSRNDFYGEISSN-WGKCPKLGTLNVSMNNITGGIPREI-GNSSQLQALD 175
+ +T I L +N I + KL +++S N I+ + + L +L
Sbjct: 29 NLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLV 86
Query: 176 LSLNHIVGEIPKEL-GKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSANRFNNSV 233
L N I E+PK L L SL L+L N+ L + L +L L L N+
Sbjct: 87 LYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIA 144
Query: 234 PENLGNLLKLHYLGLSNNQF 253
L + + L+ N F
Sbjct: 145 KGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 30/132 (22%), Positives = 51/132 (38%), Gaps = 13/132 (9%)
Query: 7 LDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPP----SLENPMLTRPGLDFNHF 61
+ L QN K V+PP S L+ + L N +S + P L + L L N
Sbjct: 37 IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS--LNSLVLYGNKI 92
Query: 62 TSYLPHNVCRG-GALQYFGVSENHFQGTIPK-ILRNCSSLIRVRLNSNNLTGNISEALGI 119
T LP ++ G +LQ ++ N + ++ +L + L N L
Sbjct: 93 TE-LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150
Query: 120 YPNLTFIDLSRN 131
+ + L++N
Sbjct: 151 LRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 24/112 (21%), Positives = 40/112 (35%), Gaps = 11/112 (9%)
Query: 2 RSLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPP----SLENPMLTRPGL 56
+ L +DL+ NQ L P L +L LVL N ++ +P L + L L
Sbjct: 56 KKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFS--LQLLLL 111
Query: 57 DFNHFTSYLPHNVCRG-GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSN 107
+ N L + + L + +N Q ++ + L N
Sbjct: 112 NANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 29/120 (24%), Positives = 41/120 (34%), Gaps = 14/120 (11%)
Query: 93 LRNCSSLIRVRLNSNNLT--GNISEALGIYPNLTFIDLSRNDFYGEISS--NWGKCPKLG 148
N + L + N+ L ID S N EI + +L
Sbjct: 15 YTNAVRDRELDLRGYKIPVIENLGATL---DQFDAIDFSDN----EIRKLDGFPLLRRLK 67
Query: 149 TLNVSMNNITGGIPREIGNSSQLQALDLSLNHI--VGEIPKELGKLNSLTELILRGNQFT 206
TL V+ N I L L L+ N + +G++ L L SLT L + N T
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 29/128 (22%), Positives = 51/128 (39%), Gaps = 8/128 (6%)
Query: 174 LDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSV 233
+ L+ I + + EL LRG + + +L + +D S N
Sbjct: 2 VKLTAELI-EQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RK 56
Query: 234 PENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFG--GEIPFQICSLKSL 291
+ L +L L ++NN+ + L L+EL ++N G++ + SLKSL
Sbjct: 57 LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSL 115
Query: 292 EKLNLSHN 299
L + N
Sbjct: 116 TYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 19/108 (17%), Positives = 43/108 (39%), Gaps = 11/108 (10%)
Query: 222 LDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKEL-EKLVQLSELDASHNLFGGE 280
+ L+A + N ++ L L + + + + L L Q +D S N E
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYK--IPVIENLGATLDQFDAIDFSDN----E 53
Query: 281 IPF--QICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
I L+ L+ L +++N + + + ++ + +++N L
Sbjct: 54 IRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 3e-10
Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 29/165 (17%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI--------EVKALTEIR 494
IG G +G+VY+A + SG VA+K + + EV L +
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVR-------VPNGGGGGGGLPISTVREVALLRRLE 69
Query: 495 ---HRNIVKFYGFCSHARHS-----FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIK 546
H N+V+ C+ +R LV+E +++ L L L ++++
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD-KAPPPGLPAETIKDLMR 127
Query: 547 GVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591
L +LH +C IVH+D+ +N+L+ +ADFG+A+
Sbjct: 128 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 61.1 bits (147), Expect = 5e-10
Identities = 34/216 (15%), Positives = 71/216 (32%), Gaps = 36/216 (16%)
Query: 105 NSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPRE 164
+ +++ I E + + + DF + S W + L +
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEIS-WIEQVDLSPV-------------- 167
Query: 165 IGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGS--LVDLEYL 222
+ L L + + + K +L L + + +I L +LE L
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKK---PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKL 224
Query: 223 DLSANRFN---NSVPENLGNLL------KLHYLGLSNNQFVLELPKEL---EKLVQLSEL 270
L + + L L +LG+ + + + + + L QL +
Sbjct: 225 VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETM 284
Query: 271 DASHNLFGGE----IPFQICSLKSLEKLNLSHNNLS 302
D S + E + + +K L+ +N+ +N LS
Sbjct: 285 DISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 54.2 bits (129), Expect = 6e-08
Identities = 27/189 (14%), Positives = 56/189 (29%), Gaps = 37/189 (19%)
Query: 106 SNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREI 165
S ++S L P L + + + +S P L +L + + + +I
Sbjct: 157 SWIEQVDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDI 213
Query: 166 GNS--SQLQALDLSL---NHIVGEIPKEL------GKLNSLTELILRGNQFTGRLPPEIG 214
S L+ L L + ++ + +L L + + +
Sbjct: 214 LGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL 273
Query: 215 S---LVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELD 271
L LE +D+SA + L ++K+ L ++
Sbjct: 274 ESDILPQLETMDISAGVLTDEGAR--------------------LLLDHVDKIKHLKFIN 313
Query: 272 ASHNLFGGE 280
+N E
Sbjct: 314 MKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 7e-06
Identities = 27/210 (12%), Positives = 70/210 (33%), Gaps = 26/210 (12%)
Query: 84 HFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSN--W 141
Q + +L L +++ N N+S PNL +++ + +
Sbjct: 159 IEQVDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILG 215
Query: 142 GKCPKLGTLNVSM--NNITGGIPREI-------GNSSQLQALDLSLNHIVGEIPKELGK- 191
P L L + + + + L+ L + + + +
Sbjct: 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLES 275
Query: 192 --LNSLTELILRGNQFTGR----LPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHY 245
L L + + T L + + L+++++ N ++ + + L L +
Sbjct: 276 DILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMK- 334
Query: 246 LGLSNNQFVLELPKELEKLVQLSELDASHN 275
+ +S++Q + ++EL+ H+
Sbjct: 335 IDVSDSQ----EYDDDYSYPMITELEHHHH 360
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 5e-10
Identities = 64/259 (24%), Positives = 106/259 (40%), Gaps = 60/259 (23%)
Query: 436 NDFDAQYCIGNGGHGSVYRAELP----SGQVVAIK---KFHSPLPCDQIA--DQKEFLIE 486
+ F+ +G G G V+ + + Q+ A+K K + D+ +E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-------ATLKVRDRVRTKME 76
Query: 487 VKALTEIRHRNIVK-FYGFCSHARHSFLVYELLERGSL------AAILSSDTA---AQEL 536
L E+ H IVK Y F + + +L+ + L G L + + + EL
Sbjct: 77 RDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 135
Query: 537 GWSQRMNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAK-FL 592
A AL +LH I+++D+ +N+LLD E H+ DFG++K +
Sbjct: 136 ------------ALALDHLHSLG----IIYRDLKPENILLD--EEGHIKLTDFGLSKESI 177
Query: 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS 652
E ++ F GT Y+APE+ T+ D +SFGVL+ E + G P F
Sbjct: 178 DHEKKAYS-FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP--F------QG 228
Query: 653 LNTDIALDEIL--DPRLPP 669
+ + IL +P
Sbjct: 229 KDRKETMTMILKAKLGMPQ 247
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-09
Identities = 32/120 (26%), Positives = 49/120 (40%), Gaps = 10/120 (8%)
Query: 92 ILRNCSSLIRVRL-NSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISS--NWGKCPKLG 148
R S + + L NS + G + + L F+ ++S N K KL
Sbjct: 12 RNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVG----LTSIANLPKLNKLK 67
Query: 149 TLNVSMNNITGGIPREIGNSSQLQALDLSLNHI--VGEIPKELGKLNSLTELILRGNQFT 206
L +S N ++GG+ L L+LS N I + I + L KL +L L L + T
Sbjct: 68 KLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-09
Identities = 31/119 (26%), Positives = 50/119 (42%), Gaps = 6/119 (5%)
Query: 185 IPKELGK--LNSLTELILRGNQFT-GRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLL 241
I EL + + EL+L ++ G+L +LE+L + NL L
Sbjct: 7 IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL--TSIANLPKLN 64
Query: 242 KLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGG-EIPFQICSLKSLEKLNLSHN 299
KL L LS+N+ L EK L+ L+ S N + L++L+ L+L +
Sbjct: 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-07
Identities = 32/133 (24%), Positives = 51/133 (38%), Gaps = 13/133 (9%)
Query: 143 KCPKLGTLNVSMNNITGGIPREIGNS-SQLQALDLSLNHIVGEIPKELGKLNSLTELILR 201
+ L + + G + + +L+ L + I L KLN L +L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 202 GNQFTGRLPPEIGSLVDLEYLDLSANRFNN-SVPENLGNLLKLHYLGLSNN--------- 251
N+ +G L +L +L+LS N+ + S E L L L L L N
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYR 132
Query: 252 QFVLELPKELEKL 264
+ V +L +L L
Sbjct: 133 ENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 23/112 (20%), Positives = 46/112 (41%), Gaps = 12/112 (10%)
Query: 239 NLLKLHYLGLSNNQF-VLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLS 297
+ L L N++ +L ++ +L L + I + L L+KL LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72
Query: 298 HNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGL 349
N +SG + E ++ +++S N+++ + +E LK + L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL---------STIEPLKKLENL 115
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 30/170 (17%), Positives = 60/170 (35%), Gaps = 33/170 (19%)
Query: 161 IPREIGNSSQLQALDLSLNHIVGEIPK-ELGKLNSLTELILRGNQFTGRLPPEI-GSLVD 218
IP I L L+ N KL L ++ N+ T +
Sbjct: 26 IPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82
Query: 219 LEYLDLSANRFNNSVPENL-GNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLF 277
+ + L++NR +V + L L L L +N+ ++ + ++ F
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNR--------------ITCV--GNDSF 125
Query: 278 GGEIPFQICSLKSLEKLNLSHNNLSGSIPN-CFEGIRGISVIDISDNQLQ 326
G L S+ L+L N ++ ++ F+ + +S +++ N
Sbjct: 126 IG--------LSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 36/141 (25%), Positives = 57/141 (40%), Gaps = 9/141 (6%)
Query: 118 GIYPNLTFIDLSRNDFYG-EISSNWGKCPKLGTLNVSMNNITGGIPREIGNS-SQLQALD 175
I + L+ N+F E + + K P+L +N S N IT I S + +
Sbjct: 29 HIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEIL 87
Query: 176 LSLNHIVGEIPKEL-GKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSANRFNNSV 233
L+ N + + ++ L SL L+LR N+ T + + L + L L N+ +V
Sbjct: 88 LTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI-TTV 144
Query: 234 PEN-LGNLLKLHYLGLSNNQF 253
L L L L N F
Sbjct: 145 APGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 19/113 (16%), Positives = 41/113 (36%), Gaps = 13/113 (11%)
Query: 2 RSLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPP----SLENPMLTRPGL 56
L ++ + N+ + + + E++L N L + LE+ L L
Sbjct: 57 PQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLES--LKTLML 112
Query: 57 DFNHFTSYLPHNVCRG-GALQYFGVSENHFQGTIPK-ILRNCSSLIRVRLNSN 107
N T + ++ G +++ + +N T+ SL + L +N
Sbjct: 113 RSNRITC-VGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 37/178 (20%)
Query: 146 KLGTLNVSMNNIT--GGIPREIGNSSQLQALDLSLNHIVGEIPKELG---KLNSLTELIL 200
+ + + ++I GI ++ L L N + ++ +L +LT LIL
Sbjct: 42 SIDQIIANNSDIKSVQGIQY----LPNVRYLALGGNKL-----HDISALKELTNLTYLIL 92
Query: 201 RGNQFTGRLPPEI-GSLVDLEYLDLSANRFNNSVPENLGNLL-KLHYLGLSNNQFVLELP 258
GNQ LP + L +L+ L L N+ S+P+ + + L L YL L++NQ LP
Sbjct: 93 TGNQLQ-SLPNGVFDKLTNLKELVLVENQL-QSLPDGVFDKLTNLTYLNLAHNQLQ-SLP 149
Query: 259 KEL-EKLVQLSELDASHNLFGGEIPFQICS--------LKSLEKLNLSHNNLSGSIPN 307
K + +KL L+ELD S+N Q+ S L L+ L L N L S+P+
Sbjct: 150 KGVFDKLTNLTELDLSYN--------QLQSLPEGVFDKLTQLKDLRLYQNQLK-SVPD 198
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-09
Identities = 31/106 (29%), Positives = 43/106 (40%), Gaps = 9/106 (8%)
Query: 105 NSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISS--NWGKCPKLGTLNVSMNNITGGIP 162
N + G I + NL F+ L + S N K PKL L +S N I GG+
Sbjct: 33 NCKSNDGKIEGLTAEFVNLEFLSLINVG----LISVSNLPKLPKLKKLELSENRIFGGLD 88
Query: 163 REIGNSSQLQALDLSLNHI--VGEIPKELGKLNSLTELILRGNQFT 206
L L+LS N + + + + L KL L L L + T
Sbjct: 89 MLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 30/111 (27%), Positives = 47/111 (42%), Gaps = 6/111 (5%)
Query: 192 LNSLTELILRGNQFT-GRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSN 250
++ EL+L + G++ V+LE+L L NL L KL L LS
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL--ISVSNLPKLPKLKKLELSE 80
Query: 251 NQFVLELPKELEKLVQLSELDASHNLFG--GEIPFQICSLKSLEKLNLSHN 299
N+ L EKL L+ L+ S N + + L+ L+ L+L +
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 33/137 (24%), Positives = 50/137 (36%), Gaps = 7/137 (5%)
Query: 140 NWGKCPKLGTLNVSMNNITGGIPREIGNS-SQLQALDLSLNHIVGEIPKELGKLNSLTEL 198
+ L + G + L+ L L ++ + L KL L +L
Sbjct: 19 RNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKL 76
Query: 199 ILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNN-SVPENLGNLLKLHYLGLSNNQFVLEL 257
L N+ G L L +L +L+LS N+ + S E L L L L L N +
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLN 136
Query: 258 ---PKELEKLVQLSELD 271
+ L QL+ LD
Sbjct: 137 DYRESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 19/89 (21%), Positives = 35/89 (39%), Gaps = 3/89 (3%)
Query: 239 NLLKLHYLGLSNNQFVLELPKEL-EKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLS 297
+ L L N + + L + V L L + L L+KL LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP--KLPKLKKLELS 79
Query: 298 HNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
N + G + E + ++ +++S N+L+
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 55/342 (16%), Positives = 97/342 (28%), Gaps = 116/342 (33%)
Query: 444 IGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHR 496
+G G G V A+ + + VA+K + + + E+K L I H
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS---EHRALMSELKILIHIGHHL 86
Query: 497 NIVKFYGFCSHARHS-FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKG-------- 547
N+V G C+ ++ E + G+L+ L S ++ +G
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 548 ----------------------------VADALSYLHHDCFPPIVHQD------------ 567
+ + +
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 568 --ISSKNL----------LLDLEYEAHVADFGIAKFLKPESSN-----------WTEFAG 604
++S+ LL + + DFG+A+ + + W
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM---- 262
Query: 605 TYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHP-------RDFLSLISSSSLNTD 656
APE + T + DV+SFGVL+ E G P +F + +
Sbjct: 263 -----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---- 313
Query: 657 IALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPT 698
R+ P + E + M C + P RPT
Sbjct: 314 ---------RMRAPDYTTPE-MYQTML---DCWHGEPSQRPT 342
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-09
Identities = 69/283 (24%), Positives = 105/283 (37%), Gaps = 61/283 (21%)
Query: 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIK---KFHSPLPCDQIADQKEF---LIEVK 488
DF +G G G V+ AE + Q AIK K D + + ++E +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK-------DVVLMDDDVECTMVEKR 69
Query: 489 AL-TEIRHRNIVK-FYGFCSHARHSFLVYELLERGSL------AAILSSDTA---AQELG 537
L H + F F + F V E L G L A A E
Sbjct: 70 VLSLAWEHPFLTHMFCTFQTKENL-FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE-- 126
Query: 538 WSQRMNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAK-FLK 593
+ L +LH IV++D+ N+LLD + H+ ADFG+ K +
Sbjct: 127 ----------IILGLQFLHSKG----IVYRDLKLDNILLD--KDGHIKIADFGMCKENML 170
Query: 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL 653
++ T F GT Y+APE+ K D +SFGVL+ E + G+ P F
Sbjct: 171 GDAKTNT-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP--F------HGQ 221
Query: 654 NTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESR 696
+ + I P R ++++ ++ PE R
Sbjct: 222 DEEELFHSIRMDNPFYP-RWLEKEAKDLLV---KLFVREPEKR 260
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 5e-09
Identities = 49/227 (21%), Positives = 92/227 (40%), Gaps = 38/227 (16%)
Query: 433 RATNDFDAQYCIGNGGHGSVYRA--ELPSGQVVAIKKFHSPLPCDQIADQKE-----FLI 485
RA ++ IG G +G V++A G+ VA+K+ + +E +
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-------VQTGEEGMPLSTIR 60
Query: 486 EVKALTEIR---HRNIVK----FYGFCSHARHS-FLVYELLERGSLAAILSSDTAAQELG 537
EV L + H N+V+ + LV+E +++ L L +
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK-VPEPGVP 118
Query: 538 WSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK-FLKPES 596
+++ + L +LH +VH+D+ +N+L+ + +ADFG+A+ +
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173
Query: 597 SNWTEFAGTYGYVAPEL----AYTMKITEKCDVYSFGVLVLEAIKGK 639
T T Y APE+ +Y + D++S G + E + K
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 5e-09
Identities = 65/260 (25%), Positives = 108/260 (41%), Gaps = 60/260 (23%)
Query: 436 NDFDAQYCIGNGGHGSVYRAELP----SGQVVAIK---KFHSPLPCDQIADQKEF---LI 485
F+ +G GG+G V++ +G++ A+K K + + K+
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI------VRNAKDTAHTKA 70
Query: 486 EVKALTEIRHRNIVK-FYGFCSHARHSFLVYELLERGSL------AAILSSDTA---AQE 535
E L E++H IV Y F + + +L+ E L G L I DTA E
Sbjct: 71 ERNILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFMEDTACFYLAE 129
Query: 536 LGWSQRMNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAK-F 591
++ AL +LH I+++D+ +N++L+ ++ HV DFG+ K
Sbjct: 130 ------------ISMALGHLHQKG----IIYRDLKPENIMLN--HQGHVKLTDFGLCKES 171
Query: 592 LKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS 651
+ + T F GT Y+APE+ D +S G L+ + + G P F +
Sbjct: 172 IHDGTVTHT-FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP--F------T 222
Query: 652 SLNTDIALDEIL--DPRLPP 669
N +D+IL LPP
Sbjct: 223 GENRKKTIDKILKCKLNLPP 242
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 68/269 (25%), Positives = 99/269 (36%), Gaps = 81/269 (30%)
Query: 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
+DF IG G G V A A+K QK+ +++ K E +
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL-----------QKKAILKKK---EEK 83
Query: 495 H----RNIVKFYGFCSHARHSFLV------------Y---------ELLERGSLAAILSS 529
H RN+ + +H FLV Y EL
Sbjct: 84 HIMSERNV-----LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE 138
Query: 530 DTA---AQELGWSQRMNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHV-- 583
A A E +A AL YLH + IV++D+ +N+LLD + H+
Sbjct: 139 PRARFYAAE------------IASALGYLHSLN----IVYRDLKPENILLD--SQGHIVL 180
Query: 584 ADFGIAK-FLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPR 642
DFG+ K ++ S+ T F GT Y+APE+ + D + G ++ E + G P
Sbjct: 181 TDFGLCKENIEHNSTTST-FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP- 238
Query: 643 DFLSLISSSSLNTDIALDEIL--DPRLPP 669
F S NT D IL +L P
Sbjct: 239 -F------YSRNTAEMYDNILNKPLQLKP 260
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 7e-09
Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 22/154 (14%)
Query: 551 ALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAK-FLKPESSNWTEFAGTY 606
AL+YLH I+++D+ N+LLD E H+ D+G+ K L+P + T F GT
Sbjct: 122 ALNYLHERG----IIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTST-FCGTP 174
Query: 607 GYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL---NTDIALDEIL 663
Y+APE+ D ++ GVL+ E + G+ P F + SS + D IL
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP--FDIVGSSDNPDQNTEDYLFQVIL 232
Query: 664 DPRLP-PPSRSVQEKLISIMEVAFSCLNESPESR 696
+ ++ P S SV+ S+++ S LN+ P+ R
Sbjct: 233 EKQIRIPRSLSVKAA--SVLK---SFLNKDPKER 261
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 57/245 (23%), Positives = 99/245 (40%), Gaps = 58/245 (23%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKF 501
+G G +G V+++ + +G+VVA+KK D + E+ LTE+ H NIV
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAF--QNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 502 Y------GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
R +LV++ +E L A++ + L + V+ + + YL
Sbjct: 75 LNVLRADND----RDVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYL 125
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA---------------------KFLKP 594
H ++H+D+ N+LL+ E VADFG++ +
Sbjct: 126 HS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 595 ESSNWTEFAGTYGYVAPEL-----AYTMKITEKCDVYSFGVLVLEAI------KGKHPRD 643
+ T++ T Y APE+ YT I D++S G ++ E + G +
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCILGEILCGKPIFPGSSTMN 238
Query: 644 FLSLI 648
L I
Sbjct: 239 QLERI 243
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 60/285 (21%), Positives = 109/285 (38%), Gaps = 65/285 (22%)
Query: 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEF---LIEVKALT 491
DF+ +G G G V +E + ++ A+K L D + + ++E + L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKI----LKKDVVIQDDDVECTMVEKRVLA 396
Query: 492 EI-RHRNIVK-FYGFCSHARHSFLVYELLERGSL------AAILSSDTA---AQELGWSQ 540
+ + + F + R + V E + G L A A E
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRL-YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE----- 450
Query: 541 RMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAK-FLKPESS 597
+A L +L I+++D+ N++LD E H+ ADFG+ K + +
Sbjct: 451 -------IAIGLFFLQSK---GIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVT 498
Query: 598 NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDI 657
T F GT Y+APE+ + D ++FGVL+ E + G+ P F + D
Sbjct: 499 TKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP--F------EGEDEDE 549
Query: 658 ALDEILD-----PR-LPPPSRSVQEKLISIMEVAFSCLNESPESR 696
I++ P+ + + ++ + L + + P R
Sbjct: 550 LFQSIMEHNVAYPKSMSKEAVAICKGL----------MTKHPGKR 584
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 9e-09
Identities = 25/125 (20%), Positives = 48/125 (38%), Gaps = 22/125 (17%)
Query: 187 KELGKLNSLTELILRGNQFTG--RLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLH 244
++ ++ L ++ + +L ++L LS N +L + L
Sbjct: 17 RKSVVATEAEKVEL-HGMIPPIEKMDATLSTLKACKHLALSTNNI--EKISSLSGMENLR 73
Query: 245 YLGLSNNQFVLELPKELEKLVQ-LSELDASHNLFGGEIPFQICS------LKSLEKLNLS 297
L L N ++ + L+ + L EL S+N QI S L +L L +S
Sbjct: 74 ILSLGRNL--IKKIENLDAVADTLEELWISYN--------QIASLSGIEKLVNLRVLYMS 123
Query: 298 HNNLS 302
+N ++
Sbjct: 124 NNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 32/149 (21%), Positives = 49/149 (32%), Gaps = 42/149 (28%)
Query: 89 IPKI--LRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEIS--SNWGKC 144
I KI L +L + L N + I + L + +S N +I+ S K
Sbjct: 60 IEKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYN----QIASLSGIEKL 114
Query: 145 PKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQ 204
L L +S N IT + I +L L+ L +L+L GN
Sbjct: 115 VNLRVLYMSNNKIT------------------NWGEI-----DKLAALDKLEDLLLAGNP 151
Query: 205 FTGRLPPE----------IGSLVDLEYLD 223
+ L +L+ LD
Sbjct: 152 LYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 18/93 (19%), Positives = 32/93 (34%), Gaps = 4/93 (4%)
Query: 235 ENLGNLLKLHYLGLSNNQFVLE-LPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEK 293
+ + L +E + L L L S N +I + +++L
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRI 74
Query: 294 LNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326
L+L N + I N + + IS NQ+
Sbjct: 75 LSLGRNLIK-KIENLDAVADTLEELWISYNQIA 106
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 32/159 (20%)
Query: 551 ALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAK-FLKPESSNWTEFAGTY 606
AL+YLH I+++D+ N+LLD E H+ D+G+ K L+P + T F GT
Sbjct: 165 ALNYLHERG----IIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTST-FCGTP 217
Query: 607 GYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTD--------IA 658
Y+APE+ D ++ GVL+ E + G+ P F + SS + + + I
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP--FDIVGSSDNPDQNTEDYLFQVIL 275
Query: 659 LDEILDPR-LPPPSRSVQEKLISIMEVAFSCLNESPESR 696
+I PR L + SV + LN+ P+ R
Sbjct: 276 EKQIRIPRSLSVKAASVLKSF----------LNKDPKER 304
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 1e-08
Identities = 75/560 (13%), Positives = 153/560 (27%), Gaps = 169/560 (30%)
Query: 125 FIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGE 184
F++ Y + S + ++ M R ++ ++S +
Sbjct: 82 FVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQ--RDRLYNDNQVFAKYNVSRLQPYLK 139
Query: 185 IPKELGKLNSLTELILRGNQFTGRLPPEIG--SLVDLEYLDLSA-NRFNNSVPENLGNLL 241
+ + L +L +++ G G G + L + + +
Sbjct: 140 LRQALLELRPAKNVLIDG--VLG-----SGKTWVALDVCLSYKVQCKMDFKI-------- 184
Query: 242 KLHYLGLSNNQFVLELPKELEKL-VQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNN 300
+L L N + + L+KL Q+ S + I +I S+++ + L
Sbjct: 185 --FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP 242
Query: 301 LSGSIPNC---------------FEG-------IRGISVIDISDNQLQGPVP---NSTAF 335
NC F R V D + +S
Sbjct: 243 Y----ENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTL 298
Query: 336 RNA-----------------PVEALKGNKGLCGGVKGMQPCKVFLSHKQNSR-------- 370
P E L N + + L+ N +
Sbjct: 299 TPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAES--IRDGLATWDNWKHVNCDKLT 356
Query: 371 --VKWF--AIVFPVLGALFLSMALIAIFILRKRKSDSGDRQSSNQNPHGLFSILNFEGKL 426
++ + +F ++ +F S++ P L S++ F+ +
Sbjct: 357 TIIESSLNVLEPAEYRKMFDRLS---VF-----------PPSAHI-PTILLSLIWFD--V 399
Query: 427 VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIE 486
+ +++ N + S +PS + E ++
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTIS--IPSIYL-------------------ELKVK 438
Query: 487 VKALTEIRHRNIVKFY----GFCSHAR---------HSFLVY-----ELLERGSLAAILS 528
++ + HR+IV Y F S +S + + E ER +L ++
Sbjct: 439 LENEYAL-HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVF 497
Query: 529 SDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE-YEAHVAD-- 585
D + ++ K + HD I N L L+ Y+ ++ D
Sbjct: 498 LD-----FRFLEQ----K--------IRHDSTAWNASGSIL--NTLQQLKFYKPYICDND 538
Query: 586 -------FGIAKFLKPESSN 598
I FL N
Sbjct: 539 PKYERLVNAILDFLPKIEEN 558
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 2e-08
Identities = 81/608 (13%), Positives = 185/608 (30%), Gaps = 159/608 (26%)
Query: 175 DLSLNHIVGEIPKELGKLNSLTELILRGNQFTG--RLPPEIGSLVDLEYLDLSANRFNNS 232
+ + ++PK + + +I+ + +G RL ++
Sbjct: 32 NFDCKDVQ-DMPKSILSKEEIDHIIMSKDAVSGTLRL------------FWTLLSKQEEM 78
Query: 233 VPENLGNLLKLHYLGLSNNQFVLE------LPKELEKLVQLSELDASHN---LFGGEIPF 283
V + + +L+++Y +F++ + + + + D +N +F +
Sbjct: 79 VQKFVEEVLRINY------KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVF---AKY 129
Query: 284 QICSLKSLEKLNLSHNNLSGSIPNCF---EGIRGI--SVIDIS---DNQLQGPVPN---- 331
+ L+ KL L P +G+ G + + + ++Q +
Sbjct: 130 NVSRLQPYLKL---RQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW 186
Query: 332 -STAFRNAPVEALKGNKGLCGGVKGMQPCKVFLSHKQNSRVKWFAIVFPVLGALFLSM-- 388
+ N+P L+ + L + H N +++ + L L S
Sbjct: 187 LNLKNCNSPETVLEMLQKLL--YQIDPNWTSRSDHSSNIKLR-IHSIQAELRRLLKSKPY 243
Query: 389 --ALIAIFILR---------------K-----RKSDSGDRQSSNQNPHGLFSILNFEGKL 426
L+ +L K R D S+ H S+ + L
Sbjct: 244 ENCLL---VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTH--ISLDHHSMTL 298
Query: 427 VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIE 486
DE +Y +LP +V+ +P IA E + +
Sbjct: 299 TPDE----VKSLLLKYL-------DCRPQDLPR-EVLTT----NPRRLSIIA---ESIRD 339
Query: 487 VKALTE-IRHRNIVKFYGFCSHARHSFL----------VYELLERGSLAAILSSDT--AA 533
A + +H N K + S L +++ L ++
Sbjct: 340 GLATWDNWKHVNCDKL----TTIIESSLNVLEPAEYRKMFDRL------SVFPPSAHIPT 389
Query: 534 QELG--WSQR--------MN-------VIKGVADALSYLHHDCFPPIVHQDISSKNLLLD 576
L W +N V K ++ + ++ ++ K L+
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS------IYLELKVK---LE 440
Query: 577 LEYEAHVADFGIAKFLKPESSNWTEFAGTY--GYVAPELAYTMKITEKCDVYS-FGVLVL 633
EY H + + P++ + + Y Y + + +K E + + F ++ L
Sbjct: 441 NEYALH--RSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL 498
Query: 634 EA--IKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSC--- 688
+ ++ K D + +S S+ + + P + + + +I++
Sbjct: 499 DFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEEN 558
Query: 689 LNESPESR 696
L S +
Sbjct: 559 LICSKYTD 566
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 3e-05
Identities = 61/440 (13%), Positives = 128/440 (29%), Gaps = 116/440 (26%)
Query: 63 SYLPHNVCRGGALQ---YFGV-----SENHFQGTIPKILRN------------CSSLIRV 102
+++ +VC +Q F + + T+ ++L+ +
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223
Query: 103 RLNSNNLTGNISEALGI--YPN-LTFIDLSRNDFYGEISSNW------GKCPKLGT---L 150
+L +++ + L Y N L + + + C L T
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLL--------NVQNAKAWNAFNLSCKILLTTRFK 275
Query: 151 NV--SMNNITGGIPREIGNSSQL---QALDL---SLNHIVGEIPKELGKLNSLT-ELILR 201
V ++ T +S L + L L+ ++P+E+ N +I
Sbjct: 276 QVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII-- 333
Query: 202 GNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNL----LKLHYLGLSNNQFVLE- 256
+ + D + ++ ++ + +L L + + LS V
Sbjct: 334 -----AESIRDGLATWD-NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLS----VFPP 383
Query: 257 ---LP-KELEKL-VQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEG 311
+P L + + + D + SL + + SIP+ +
Sbjct: 384 SAHIPTILLSLIWFDVIKSDV-------MVVVNKLHKYSL--VEKQPKESTISIPSIY-- 432
Query: 312 IRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKGMQPC-KVFLSH----- 365
++ L+ + N A + V+ K + F SH
Sbjct: 433 ------LE-----LKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHL 481
Query: 366 KQNSRVKWFAIVFPVLGALFLSMALIAIFILRK-RKSDSGDRQSSNQNPHGLFSILNF-- 422
K + + F +FL F+ +K R + S + L F
Sbjct: 482 KNIEHPERMTL-FR---MVFLDFR----FLEQKIRHDSTAWNASGSILN--TLQQLKFYK 531
Query: 423 ----EGKLVYDEIVRATNDF 438
+ Y+ +V A DF
Sbjct: 532 PYICDNDPKYERLVNAILDF 551
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 38/176 (21%), Positives = 62/176 (35%), Gaps = 16/176 (9%)
Query: 88 TIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSR-----NDFYGEISSNWG 142
T+ IL CS L + L L+ I L NL ++LS + S+
Sbjct: 109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS-- 166
Query: 143 KCPKLGTLNVS-MNNIT-GGIPREIG-NSSQLQALDLS-LNHIVGE--IPKELGKLNSLT 196
C +L LN+S + T + + S + L+LS + + + + + +L
Sbjct: 167 -CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 225
Query: 197 ELILRG-NQFTGRLPPEIGSLVDLEYLDLSA-NRFNNSVPENLGNLLKLHYLGLSN 250
L L E L L++L LS LG + L L +
Sbjct: 226 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 39/217 (17%), Positives = 76/217 (35%), Gaps = 11/217 (5%)
Query: 93 LRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEIS-SNWGKCPKLGTLN 151
R S + + G + I + + + ++ ++
Sbjct: 40 YRLASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMD 99
Query: 152 VSMNNIT-GGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRG-NQFTGRL 209
+S + I + + S+LQ L L + I L K ++L L L G + F+
Sbjct: 100 LSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA 159
Query: 210 PPEIGS-LVDLEYLDLSANRF--NNSVPENLGNLLK-LHYLGLSNNQFVLE---LPKELE 262
+ S L+ L+LS V + ++ + + L LS + L+ L +
Sbjct: 160 LQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVR 219
Query: 263 KLVQLSELDASH-NLFGGEIPFQICSLKSLEKLNLSH 298
+ L LD S + + + L L+ L+LS
Sbjct: 220 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSR 256
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 40/296 (13%), Positives = 83/296 (28%), Gaps = 60/296 (20%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNL--------TNLKELVLLYNNLSG----FIPPSLEN 48
+ SL L+L + P + + L E+ L L + P
Sbjct: 71 LSSLRQLNLAGVRMT---PVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLR 127
Query: 49 PMLTRPGLDFNHFT--------SYLPHNVCRGGALQYFGVSENHFQGT----IPKILRNC 96
+ GL N L H+ C+ + +S N + + L
Sbjct: 128 --ARKLGLQLNSLGPEACKDLRDLLLHDQCQ---ITTLRLSNNPLTAAGVAVLMEGLAGN 182
Query: 97 SSLIRVRLNSNNLTGN----ISEALGIYPNLTFIDLSRNDFYGE----ISSNWGKCPKLG 148
+S+ + L L ++ L L ++++ N ++ + P L
Sbjct: 183 TSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLE 242
Query: 149 TLNVSMNNIT-------GGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILR 201
L++ N ++ + +++ + L ++ R
Sbjct: 243 LLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEV-------QR 295
Query: 202 GNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLK----LHYLGLSNNQF 253
R + ++L DL +R P LL+ + L
Sbjct: 296 NLNSWDRA--RVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSS 349
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 29/240 (12%), Positives = 66/240 (27%), Gaps = 40/240 (16%)
Query: 91 KILRNCSSLIRVRLNSNNLTGN----ISEALGIYP-NLTFIDLSRNDFYGE----ISSNW 141
+ L L N+L + + L +T + LS N +
Sbjct: 123 PVFLRARKL---GLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGL 179
Query: 142 GKCPKLGTLNVSMNNIT--GG--IPREIGNSSQLQALDLSLNHI----VGEIPKELGKLN 193
+ L++ + G + ++ + QLQ L+++ N + + +
Sbjct: 180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHP 239
Query: 194 SLTELILRGNQFT-------GRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYL 246
SL L L N+ + L + + L + +
Sbjct: 240 SLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQR---- 295
Query: 247 GLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSL----KSLEKLNLSHNNLS 302
N +++ ++L D + P++ L + L +
Sbjct: 296 ---NLNSWDRA--RVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 35/179 (19%), Positives = 62/179 (34%), Gaps = 23/179 (12%)
Query: 147 LGTLNVSMNNITGGIPREIG-----NSSQLQALDLSLNHIVGEIPKELGK-LNSLTELIL 200
L LN++ +T + L ++L+ + + L +L L
Sbjct: 74 LRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGL 133
Query: 201 RGNQFTGRLPPEIGSL-----VDLEYLDLSANRFNNSVPENLGNLLK----LHYLGLSNN 251
+ N ++ L + L LS N + L L + +L L +
Sbjct: 134 QLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHT 193
Query: 252 QF----VLELPKELEKLVQLSELDASHNLFGGEIPFQICSL----KSLEKLNLSHNNLS 302
+ L +L++ QL EL+ ++N G + SLE L+L N LS
Sbjct: 194 GLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 19/97 (19%), Positives = 30/97 (30%), Gaps = 4/97 (4%)
Query: 161 IPREIGNSSQLQALDLSLNHIVGEIPKE-LGKLNSLTELILRGNQFTGRLPPEIGS-LVD 218
+ + L L + + + L L L L + + + P+
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 219 LEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVL 255
L L+LS N S+ L L L LS N
Sbjct: 82 LSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 22/93 (23%), Positives = 34/93 (36%), Gaps = 2/93 (2%)
Query: 184 EIPKELGKLNSLTELILRGNQFTGRLPPE-IGSLVDLEYLDLSANRFNNSVPENLGNLLK 242
+ L +LTEL + Q L + L +L L + + P+ +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 243 LHYLGLSNNQFVLELPKELEKLVQLSELDASHN 275
L L LS N L + + + L EL S N
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 8e-06
Identities = 19/104 (18%), Positives = 34/104 (32%), Gaps = 5/104 (4%)
Query: 250 NNQFVLELPKELEKLVQLSELDASHNLFGGEIP---FQICSLKSLEKLNLSHNNLSGSIP 306
L+ L L+EL + + + L L L + + L P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLR--GLGELRNLTIVKSGLRFVAP 73
Query: 307 NCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLC 350
+ F +S +++S N L+ + + L GN C
Sbjct: 74 DAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 23/89 (25%), Positives = 36/89 (40%), Gaps = 5/89 (5%)
Query: 1 MRSLSILDLNQNQFKGVLPP-SVSNLTNLKELVLLYNNLSGFIPPS--LENPMLTRPGLD 57
+L+ L + Q L + L L+ L ++ + L F+ P P L+R L
Sbjct: 30 AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLS 88
Query: 58 FNHFTSYLPHNVCRGGALQYFGVSENHFQ 86
FN S L +G +LQ +S N
Sbjct: 89 FNALES-LSWKTVQGLSLQELVLSGNPLH 116
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 50/215 (23%), Positives = 82/215 (38%), Gaps = 40/215 (18%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIK------KFHSPLPCDQIADQKEFLIEVKALTEIRHR 496
IG G G V +A + VAIK F +Q IEV+ L +
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL-----NQA------QIEVRLLELMNKH 110
Query: 497 ------NIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA- 549
IV H LV+E+L +L +L + G S +N+ + A
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNT---NFRGVS--LNLTRKFAQ 164
Query: 550 ---DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAH--VADFGIAKFLKPESSNWTEFAG 604
AL +L I+H D+ +N+LL + + DFG + ++
Sbjct: 165 QMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---LGQRIYQYIQ 220
Query: 605 TYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGK 639
+ Y +PE+ M D++S G +++E G+
Sbjct: 221 SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 28/95 (29%), Positives = 38/95 (40%), Gaps = 11/95 (11%)
Query: 160 GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVD 218
GIPR++ L L N +PKEL LT + L N+ + L + ++
Sbjct: 28 GIPRDV------TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79
Query: 219 LEYLDLSANRFNNSVPENL-GNLLKLHYLGLSNNQ 252
L L LS NR +P L L L L N
Sbjct: 80 LLTLILSYNRL-RCIPPRTFDGLKSLRLLSLHGND 113
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 32/122 (26%), Positives = 51/122 (41%), Gaps = 29/122 (23%)
Query: 217 VDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNL 276
D+ L L N+F VP+ L N L + LSNN+ + L S+
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNR--------ISTL--------SNQS 73
Query: 277 FGGEIPFQICSLKSLEKLNLSHNNLSGSIPN-CFEGIRGISVIDISDNQLQGPVPNSTAF 335
F ++ L L LS+N L IP F+G++ + ++ + N + VP AF
Sbjct: 74 FS--------NMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISV-VPEG-AF 122
Query: 336 RN 337
+
Sbjct: 123 ND 124
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 25/109 (22%), Positives = 43/109 (39%), Gaps = 27/109 (24%)
Query: 1 MRSLSILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFN 59
+ L+++DL+ N+ L SN+T L L+L YN L IPP F+
Sbjct: 53 YKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRC-IPPRT-----------FD 99
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPK-ILRNCSSLIRVRLNSN 107
S L+ + N +P+ + S+L + + +N
Sbjct: 100 GLKS-----------LRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 49/147 (33%), Positives = 68/147 (46%), Gaps = 19/147 (12%)
Query: 160 GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVD 218
GIP +Q LDL N + +L SLT+L L GN+ LP + L
Sbjct: 25 GIP------AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 219 LEYLDLSANRFNNSVPENL-GNLLKLHYLGLSNNQFVLELPKEL-EKLVQLSELDASHNL 276
L YL+LS N+ S+P + L +L L L+ NQ LP + +KL QL +L N
Sbjct: 78 LTYLNLSTNQL-QSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQ 135
Query: 277 FGGEIP---FQICSLKSLEKLNLSHNN 300
+P F L SL+ + L H+N
Sbjct: 136 LKS-VPDGVFD--RLTSLQYIWL-HDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 37/138 (26%), Positives = 56/138 (40%), Gaps = 24/138 (17%)
Query: 210 PPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKEL-EKLVQLS 268
P I YLDL N + L L L L N+ LP + KL L+
Sbjct: 23 PTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLT 79
Query: 269 ELDASHNLFGGEIPFQICSLKS--------LEKLNLSHNNLSGSIPN-CFEGIRGISVID 319
L+ S N Q+ SL + L++L L+ N L S+P+ F+ + + +
Sbjct: 80 YLNLSTN--------QLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLR 130
Query: 320 ISDNQLQGPVPNSTAFRN 337
+ NQL+ VP+ F
Sbjct: 131 LYQNQLKS-VPDG-VFDR 146
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 32/114 (28%), Positives = 50/114 (43%), Gaps = 13/114 (11%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSN-LTNLKELVLLYNNLSGFIPP----SLENPMLTRPG 55
+ SL+ L L N+ + LP V N LT+L L L N L +P L L
Sbjct: 51 LTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQS-LPNGVFDKLTQ--LKELA 106
Query: 56 LDFNHFTSYLPHNVC-RGGALQYFGVSENHFQGTIPK-ILRNCSSLIRVRLNSN 107
L+ N S LP V + L+ + +N + ++P + +SL + L+ N
Sbjct: 107 LNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 48/217 (22%), Positives = 87/217 (40%), Gaps = 46/217 (21%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIK------KFHSPLPCDQIADQKEFLIEVKALTEIRHR 496
IG G G V +A Q VA+K +FH Q E++ L +R +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH-----RQA------AEEIRILEHLRKQ 153
Query: 497 ------NIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA- 549
N++ + H + +ELL +L ++ + + G+S + +++ A
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKN---KFQGFS--LPLVRKFAH 207
Query: 550 ---DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAH--VADFGIAKFLKPESSNW--TEF 602
L LH I+H D+ +N+LL + + V DFG + + + + F
Sbjct: 208 SILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF 264
Query: 603 AGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGK 639
Y APE+ + D++S G ++ E + G
Sbjct: 265 -----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 39/173 (22%), Positives = 65/173 (37%), Gaps = 39/173 (22%)
Query: 444 IGNGGHGSVYRAE---------LPSGQVVAIK--KFHSPLPCD----QIADQKEFLIEVK 488
G +Y A P Q ++K L + Q A + + + K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 489 ALTEIRHRNIVKFYGFCSH-ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNV-IK 546
L I GF H ++ FLV L R SL + L S + + +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALD---------VSPKHVLSER 159
Query: 547 GVA-------DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAK 590
V DAL +LH + + VH +++++N+ +D E ++ V A +G A
Sbjct: 160 SVLQVACRLLDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 59/286 (20%), Positives = 107/286 (37%), Gaps = 67/286 (23%)
Query: 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEF---LIEVKALT 491
DF+ +G G G V +E + ++ A+K L D + + ++E + L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKI----LKKDVVIQDDDVECTMVEKRVLA 75
Query: 492 EI-RHRNIVK-FYGFCSHARHSFLVYELLERGSL------AAILSSDTA---AQELGWSQ 540
+ + + F + R + V E + G L A A E
Sbjct: 76 LPGKPPFLTQLHSCFQTMDRL-YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE----- 129
Query: 541 RMNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAK-FLKPES 596
+A L +L I+++D+ N++LD E H+ ADFG+ K +
Sbjct: 130 -------IAIGLFFLQSKG----IIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGV 176
Query: 597 SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTD 656
+ T F GT Y+APE+ + D ++FGVL+ E + G+ P F + D
Sbjct: 177 TTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP--F------EGEDED 227
Query: 657 IALDEILD------PRLPPPSRSVQEKLISIMEVAFSCLNESPESR 696
I++ + + ++ + L + + P R
Sbjct: 228 ELFQSIMEHNVAYPKSMSKEAVAICKGL----------MTKHPGKR 263
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 41/156 (26%), Positives = 66/156 (42%), Gaps = 35/156 (22%)
Query: 551 ALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAK-FLKPESSNWTEFAGTY 606
AL +LH I+++D+ N+LLD +E H ADFG+ K + + T F GT
Sbjct: 136 ALMFLHDKG----IIYRDLKLDNVLLD--HEGHCKLADFGMCKEGICNGVTTAT-FCGTP 188
Query: 607 GYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD-- 664
Y+APE+ M D ++ GVL+ E + G P F + N D + IL+
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP--F------EAENEDDLFEAILNDE 240
Query: 665 ----PRLPPPSRSVQEKLISIMEVAFSCLNESPESR 696
L + + + + ++P R
Sbjct: 241 VVYPTWLHEDATGILKSF----------MTKNPTMR 266
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 41/181 (22%), Positives = 74/181 (40%), Gaps = 39/181 (21%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIK---------KFHSPLPCD----QIADQKEFLIEVKAL 490
IG GG G +Y A++ S + V + PL + Q A + E + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 491 TEIRHRNIVKFYGFCSH----ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIK 546
++++ + K++G H + F++ + L I ++ ++R + K
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEAN--------AKRFS-RK 152
Query: 547 GVA-------DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAKFLKPESS 597
V D L Y+H + VH DI + NLLL+ + V D+G+A PE
Sbjct: 153 TVLQLSLRILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209
Query: 598 N 598
+
Sbjct: 210 H 210
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 38/171 (22%), Positives = 64/171 (37%), Gaps = 38/171 (22%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIK------KFHSPLPCD----QIADQKEFLIEVKALTE 492
IG+GG G +Y A + A + + PL + Q +K+ + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 493 IRHRNIVKFYGFCSHA----RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGV 548
+ + I FYG + F+V E L L I + V
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISG---------QNGTFK-KSTV 153
Query: 549 A-------DALSYLHHDCFPPIVHQDISSKNLLLDLEYE--AHVADFGIAK 590
D L Y+H + + VH DI + NLLL + ++AD+G++
Sbjct: 154 LQLGIRMLDVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 57/261 (21%), Positives = 97/261 (37%), Gaps = 54/261 (20%)
Query: 436 NDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKA-- 489
+F+ +G G +G V+ +G++ A+K I + + +
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK----ATIVQKAKTTEHTRTER 109
Query: 490 --LTEIRHRN-IVK-FYGFCSHARHSFLVYELLERGSL------AAILSSDTA---AQEL 536
L IR +V Y F + + L+ + + G L + E+
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 168
Query: 537 GWSQRMNVIKGVADALSYLH-HDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAK-FL 592
AL +LH I+++DI +N+LLD HV DFG++K F+
Sbjct: 169 ------------VLALEHLHKLG----IIYRDIKLENILLD--SNGHVVLTDFGLSKEFV 210
Query: 593 KPESSNWTEFAGTYGYVAPELAYTMKI--TEKCDVYSFGVLVLEAIKGKHPRDFLSLISS 650
E+ +F GT Y+AP++ + D +S GVL+ E + G P F
Sbjct: 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTV--DG 266
Query: 651 SSLNTDIALDEIL--DPRLPP 669
+ IL +P P
Sbjct: 267 EKNSQAEISRRILKSEPPYPQ 287
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 39/233 (16%), Positives = 67/233 (28%), Gaps = 26/233 (11%)
Query: 93 LRNCSSLIRVRLNSNNLTGNISEALGI----YPNLTFIDLSR----NDFYGEISSNWGKC 144
L+ L + G + + Y L I L R +D I+ +
Sbjct: 73 LKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKS---F 129
Query: 145 PKLGTLNVS-MNNIT-GGIPREIGNSSQLQALDLSLNHIVGEIPKELGKL----NSLTEL 198
L +S + G+ L+ LDL + + L SL L
Sbjct: 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSL 189
Query: 199 ILRG--NQFTGR-LPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLS------ 249
+ ++ + L + +L+ L L+ + L +L LG
Sbjct: 190 NISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEV 249
Query: 250 NNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS 302
L L +L L + +P L LNLS+ +
Sbjct: 250 RPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQ 302
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 49/311 (15%), Positives = 93/311 (29%), Gaps = 55/311 (17%)
Query: 22 VSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVS 81
+ NLKEL L +++ L HF L +S
Sbjct: 152 AATCRNLKELDLRESDVDDVSGHWLS------------HFPDTYTS-------LVSLNIS 192
Query: 82 ENHFQGT---IPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLS------RND 132
+ + + +++ C +L ++LN ++ L P L + R D
Sbjct: 193 CLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPD 252
Query: 133 FYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGE-IPKELGK 191
Y +S C +L L+ + + +P S+L L+LS + + K L +
Sbjct: 253 VYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQ 312
Query: 192 LNSLTELILRGNQFTGRLPPEIGS-LVDLEYLDLSANRFNNSVPEN----------LGNL 240
L L + + + S DL L + + P
Sbjct: 313 CPKLQRLWVL-DYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGC 371
Query: 241 LKLHYLGLSNNQF----VLELPKELEKLVQLSELDASHNLFGGEIPFQI---------CS 287
KL + Q ++ + + + + L + +
Sbjct: 372 PKLESVLYFCRQMTNAALITIARNRPNMTRFR-LCIIEPKAPDYLTLEPLDIGFGAIVEH 430
Query: 288 LKSLEKLNLSH 298
K L +L+LS
Sbjct: 431 CKDLRRLSLSG 441
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 50/323 (15%), Positives = 93/323 (28%), Gaps = 36/323 (11%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNN-------LSGFIPPSLENPMLTRP 54
+L L LN+ L + L+EL SG L
Sbjct: 211 PNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCL 270
Query: 55 GLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGT-IPKILRNCSSLIRVRLNSNNLTGNI 113
++ +YLP L +S Q + K+L C L R+ + + +
Sbjct: 271 SGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWV-LDYIEDAG 329
Query: 114 SEALGIY-PNLTFIDLSRNDFYGEISSNW----------GKCPKLGTLNVSMNNITGGIP 162
E L +L + + ++ + + CPKL ++ +T
Sbjct: 330 LEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAAL 389
Query: 163 REIG-NSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEY 221
I N + L + L L+ I+ + DL
Sbjct: 390 ITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCK-------------DLRR 436
Query: 222 LDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLE-LPKELEKLVQLSELDASH-NLFGG 279
L LS + K+ L ++ + L L +L+
Sbjct: 437 LSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDK 496
Query: 280 EIPFQICSLKSLEKLNLSHNNLS 302
+ L+++ L +S ++S
Sbjct: 497 ALLANASKLETMRSLWMSSCSVS 519
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 7e-07
Identities = 31/116 (26%), Positives = 45/116 (38%), Gaps = 23/116 (19%)
Query: 196 TELILRGNQFTGRLPPE--IGSLVDLEYLDLSANRFNNSVPENL-GNLLKLHYLGLSNNQ 252
TEL+L N+ R+ + G L L L+L N+ + N + L L N+
Sbjct: 32 TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENK 89
Query: 253 FVLELPKEL-EKLVQLSELDASHNLFGGEIPFQICS--------LKSLEKLNLSHN 299
E+ ++ L QL L+ N QI L SL LNL+ N
Sbjct: 90 IK-EISNKMFLGLHQLKTLNLYDN--------QISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 25/109 (22%), Positives = 44/109 (40%), Gaps = 9/109 (8%)
Query: 150 LNVSMNNITGGIPREIGNS-SQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGR 208
L ++ N + + L L+L N + G P + + EL L N+
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-E 92
Query: 209 LPPEI-GSLVDLEYLDLSANRFNNSVPENLG---NLLKLHYLGLSNNQF 253
+ ++ L L+ L+L N+ + V G +L L L L++N F
Sbjct: 93 ISNKMFLGLHQLKTLNLYDNQI-SCVMP--GSFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 23/109 (21%), Positives = 41/109 (37%), Gaps = 12/109 (11%)
Query: 6 ILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPP----SLENPMLTRPGLDFNH 60
L LN N+ + + L +L +L L N L+G I P + + L N
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASH--IQELQLGENK 89
Query: 61 FTSYLPHNVCRG-GALQYFGVSENHFQGTIPK-ILRNCSSLIRVRLNSN 107
+ + + G L+ + +N + + +SL + L SN
Sbjct: 90 IKE-ISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 50.7 bits (120), Expect = 9e-07
Identities = 29/214 (13%), Positives = 49/214 (22%), Gaps = 42/214 (19%)
Query: 434 ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLP----CDQIADQKEFLIEVKA 489
T IG G G V++ VAIK P +E L E+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 490 LTEI---------RHRNIVKFYGF--CSHARHSFLVYELL----ERGSLAAILSSDTAAQ 534
E+ R + + L+ +GS Q
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 535 --------------------ELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLL 574
+ +++ + +L+ H+D+ N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVL 194
Query: 575 LDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGY 608
L + K S Y
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTL 228
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 9e-07
Identities = 30/95 (31%), Positives = 38/95 (40%), Gaps = 10/95 (10%)
Query: 160 GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVD 218
GIP S L+L N + KL LT+L L NQ LP + L
Sbjct: 25 GIP------SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77
Query: 219 LEYLDLSANRFNNSVPENL-GNLLKLHYLGLSNNQ 252
L L L N+ S+P + L +L L L NQ
Sbjct: 78 LTILYLHENKL-QSLPNGVFDKLTQLKELALDTNQ 111
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 29/108 (26%), Positives = 45/108 (41%), Gaps = 11/108 (10%)
Query: 6 ILDLNQNQFKGVLPPSV-SNLTNLKELVLLYNNLSGFIPP----SLENPMLTRPGLDFNH 60
L+L N+ + LP V LT L +L L N + +P L LT L N
Sbjct: 32 RLELESNKLQS-LPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK--LTILYLHENK 87
Query: 61 FTSYLPHNVC-RGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSN 107
S LP+ V + L+ + N + I +SL ++ L++N
Sbjct: 88 LQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 49/277 (17%), Positives = 88/277 (31%), Gaps = 78/277 (28%)
Query: 431 IVRATNDFDAQYCI----GNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLI 485
+V+ + F+ +Y + G G +V+ + + + VA+K S + A L
Sbjct: 28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-----LD 82
Query: 486 EVKALTEIRHRNIV-KFYGFCSHARHSF-----------LVYELLERGSLAAILSSDTAA 533
E++ L +R+ + F +V+E+L L + +
Sbjct: 83 EIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIK-SNY 140
Query: 534 QELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE--------------- 578
Q L +I+ V L YLH C I+H DI +N+LL +
Sbjct: 141 QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198
Query: 579 ----------------------------------YEAHVADFGIAKFLKPESSNWTEFAG 604
+ +AD G A ++ TE
Sbjct: 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TEDIQ 255
Query: 605 TYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
T Y + E+ D++S + E G +
Sbjct: 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL 292
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 48/339 (14%), Positives = 96/339 (28%), Gaps = 42/339 (12%)
Query: 2 RSLSILDLNQNQFKGV----LPPSVSNLTNLKELVLLYN---NLSGFIPPSLENPMLTRP 54
SL +L+ +F + L N +L + + L GF +
Sbjct: 192 TSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGG 251
Query: 55 GLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRL-NSNNLTGNI 113
L+ + N+ L G+S +P + + + ++ L + T +
Sbjct: 252 SLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDH 310
Query: 114 SEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIG------- 166
+ PNL ++ + C +L L + G+ E G
Sbjct: 311 CTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGL 370
Query: 167 -----NSSQLQALDLSLNHI----VGEIPKELGKLNSLTELILRGNQFTGRLPPEIG--- 214
+L+ + + ++ I + I L L ++L + LP + G
Sbjct: 371 IALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRS 430
Query: 215 ---SLVDLEYLDLSAN--RFNNSVPENLGNLLK-LHYLGLSNNQF----VLELPKELEKL 264
L + +G + ++ L ++E
Sbjct: 431 LLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEF---SRGC 487
Query: 265 VQLSELDASHNLFGGEIPFQIC-SLKSLEKLNLSHNNLS 302
L +L+ F L SL L + S
Sbjct: 488 PNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 40/280 (14%), Positives = 86/280 (30%), Gaps = 40/280 (14%)
Query: 83 NHFQGTIPKILRNCSSLIRVRLNSNNLT--GNISEALGIYPNLTFIDLSRNDFYGE--IS 138
+ + +I N L V ++ A +L + L + + +
Sbjct: 98 GYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLL 157
Query: 139 SNWGKCPKLGTLNVSMNNITGGIPREIG----NSSQLQALDLSLNHIVGEIPKELGKL-- 192
S C K+ TL + ++ + + + +++ L+ L+ + PK+L +
Sbjct: 158 SIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR 217
Query: 193 --NSLTELILRGNQFT--GRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGL 248
SL + + + +L + L+ + NL KL LGL
Sbjct: 218 NCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGL 277
Query: 249 SNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICS--------------------- 287
S E+P Q+ +LD + L E +
Sbjct: 278 SYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEV 336
Query: 288 ----LKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDN 323
K L++L + + + + +I ++
Sbjct: 337 LAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG 376
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 54/341 (15%), Positives = 99/341 (29%), Gaps = 43/341 (12%)
Query: 2 RSLSILDLNQNQFKGVLPPSVS----NLTNLKELVLLYNNLSGFIPPSLE-----NPMLT 52
R + L + ++ F + + T+L+ L + P LE L
Sbjct: 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLV 223
Query: 53 RPGLDFNHFTSYLPHNVCRGGA-LQYFGVSENHFQGTIPKILRNCSSLIRV-RLNSNNLT 110
+ F + A L+ F + +P+ N ++ RL + +
Sbjct: 224 S--VKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG 281
Query: 111 GNISEALGIY-PNLTFIDLSRNDFYGEIS-SNWGKCPKLGTLNVSMNNIT-GGIPREIGN 167
N L + + +DL E + KCP L L N I G+
Sbjct: 282 PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQY 340
Query: 168 SSQLQALDLSLNHIVGEIPKELGKLN------------SLTELILRGNQFTGR----LPP 211
QL+ L + + E G ++ L + + + T +
Sbjct: 341 CKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGT 400
Query: 212 EIGSLVDLEYLDLSANR------FNNSVPENLGNLLKLHYLGLSNNQFVL---ELPKELE 262
+ +L D + L +N V L KL Q L L +
Sbjct: 401 YLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQ 460
Query: 263 KLVQLSELDASHNLFGGEIPFQIC-SLKSLEKLNLSHNNLS 302
+ + + E + +L+KL + S
Sbjct: 461 YSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS 501
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 23/140 (16%), Positives = 44/140 (31%), Gaps = 19/140 (13%)
Query: 88 TIPKILRNCSSLIRVRLNSNNLTGN-----ISEALGIYPNLTFIDLSRNDFYGEISSNWG 142
T+ +I N L V LN+ +EAL + + ++
Sbjct: 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALA 86
Query: 143 KC----PKLGTLNVSMNNITGGIPREIGNS----SQLQALDLSLNH--IVGEIPKELGKL 192
+ L +LNV N I+G + + + L L + + + E+ +
Sbjct: 87 EMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANM 146
Query: 193 ----NSLTELILRGNQFTGR 208
+L + Q R
Sbjct: 147 LEKNTTLLKFGYHFTQQGPR 166
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 40/160 (25%), Positives = 56/160 (35%), Gaps = 31/160 (19%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G G ++ L + Q VAIK Q+ D+ K L I Y
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTY---KLLAGCTG--IPNVY 72
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA-------DALSYL 555
F H+ LV +LL SL +L R +K VA + +
Sbjct: 73 YFGQEGLHNVLVIDLLGP-SLEDLLD---------LCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEA-----HVADFGIAK 590
H V++DI N L+ +V DFG+ K
Sbjct: 123 HEKSL---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 37/159 (23%), Positives = 63/159 (39%), Gaps = 31/159 (19%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH-RNIVKF 501
IG+G G +Y + +G+ VAIK Q+ IE K ++ I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL------HIESKIYKMMQGGVGIPTI 70
Query: 502 YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA-------DALSY 554
+ ++ +V ELL SL + + + R +K V + Y
Sbjct: 71 RWCGAEGDYNVMVMELLGP-SLEDLFN---------FCSRKFSLKTVLLLADQMISRIEY 120
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAH---VADFGIAK 590
+H F +H+D+ N L+ L + + + DFG+AK
Sbjct: 121 IHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 35/160 (21%), Positives = 58/160 (36%), Gaps = 31/160 (19%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G G + + L + + VAIK Q+ + F K L I + Y
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFY---KQLGSGDG--IPQVY 71
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA-------DALSYL 555
F +++ +V ELL SL + R +K V + Y+
Sbjct: 72 YFGPCGKYNAMVLELLGP-SLEDLFD---------LCDRTFSLKTVLMIAIQLISRMEYV 121
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEA-----HVADFGIAK 590
H +++D+ +N L+ H+ DF +AK
Sbjct: 122 HSKNL---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 42/184 (22%), Positives = 71/184 (38%), Gaps = 38/184 (20%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKF 501
IG+G G +Y + + + VAIK + Q+ L E K ++ I
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL------LYESKIYRILQGGTGIPNV 68
Query: 502 YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA-------DALSY 554
F ++ LV +LL SL + + + R +K V + + +
Sbjct: 69 RWFGVEGDYNVLVMDLLGP-SLEDLFN---------FCSRKLSLKTVLMLADQMINRVEF 118
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAH---VADFGIAKFLKPESSNW-------TEFAG 604
+H F +H+DI N L+ L A+ + DFG+AK + S++ G
Sbjct: 119 VHSKSF---LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 605 TYGY 608
T Y
Sbjct: 176 TARY 179
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 33/96 (34%), Positives = 41/96 (42%), Gaps = 14/96 (14%)
Query: 160 GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVD 218
GIP + Q L L N I P +L LT L L NQ T LP + L
Sbjct: 27 GIP------TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79
Query: 219 LEYLDLSANRFNNSVPENLG---NLLKLHYLGLSNN 251
L L L+ N+ S+P G NL L ++ L NN
Sbjct: 80 LTQLSLNDNQL-KSIPR--GAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 8e-04
Identities = 20/61 (32%), Positives = 29/61 (47%), Gaps = 4/61 (6%)
Query: 194 SLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSANRFNNSVPENL-GNLLKLHYLGLSNN 251
+ L L NQ T +L P + L L LDL N+ +P + L +L L L++N
Sbjct: 31 TTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDN 88
Query: 252 Q 252
Q
Sbjct: 89 Q 89
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 1e-04
Identities = 30/96 (31%), Positives = 41/96 (42%), Gaps = 14/96 (14%)
Query: 160 GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVD 218
GIP + Q L L+ N I P L +L +L N+ T +P + L
Sbjct: 30 GIP------TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82
Query: 219 LEYLDLSANRFNNSVPENLG---NLLKLHYLGLSNN 251
L LDL+ N S+P G NL L ++ L NN
Sbjct: 83 LTQLDLNDNHL-KSIPR--GAFDNLKSLTHIYLYNN 115
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 708 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.98 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.89 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.84 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.83 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.83 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.83 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.8 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.8 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.72 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.6 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.58 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.57 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.55 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.53 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.46 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.46 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.43 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.36 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.34 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.34 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.26 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.25 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.25 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.03 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.99 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.85 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.69 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.52 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.51 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.46 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.33 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.32 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.31 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.31 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.29 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.19 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.1 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.1 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.94 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.89 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.86 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.69 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.59 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.53 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.51 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.33 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.22 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.12 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.07 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.04 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.97 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.91 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.91 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.82 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.66 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.52 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.5 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.94 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.58 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 92.0 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 91.8 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.59 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.25 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 90.4 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.2 | |
| 2lz0_A | 100 | Uncharacterized protein; hypothetical leucine rich | 84.01 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=433.26 Aligned_cols=254 Identities=26% Similarity=0.439 Sum_probs=209.0
Q ss_pred ccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
++|.+.+.||+|+||.||+|.+. +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 67889999999999999999763 4778999999752 2345678999999999999999999999999999
Q ss_pred eeEEEEEeccCCCHHHHhcccc----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC
Q 039322 510 HSFLVYELLERGSLAAILSSDT----------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY 579 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~ 579 (708)
..++|||||++|+|.++++..+ ....++|.++..++.|||+||+|||++ +|+||||||+|||+++++
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCC
Confidence 9999999999999999997643 234689999999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccc
Q 039322 580 EAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTD 656 (708)
Q Consensus 580 ~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 656 (708)
.+||+|||+|+........ .....||+.|||||++.+..++.++|||||||++|||+| |+.||..... .
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~ 237 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------N 237 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------H
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 9999999999866543322 223568999999999999999999999999999999999 9999974322 1
Q ss_pred cccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 657 IALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+..+...+.+... +.++.+++.+||+.||++||||+||.+.|+
T Consensus 238 ~~~~~i~~~~~~~~p~~~---~~~~~~li~~cl~~dP~~RPs~~~i~~~L~ 285 (299)
T 4asz_A 238 EVIECITQGRVLQRPRTC---PQEVYELMLGCWQREPHMRKNIKGIHTLLQ 285 (299)
T ss_dssp HHHHHHHHTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 222223333222222222 335888999999999999999999988774
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=433.19 Aligned_cols=255 Identities=21% Similarity=0.336 Sum_probs=210.2
Q ss_pred ccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
.++++.+.||+|+||.||+|.+. +++.||||+++... .....++|.+|+.++++++|||||+++|+|.+++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 56778889999999999999762 46789999997532 2234678999999999999999999999999999
Q ss_pred eeEEEEEeccCCCHHHHhcccc-------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC
Q 039322 510 HSFLVYELLERGSLAAILSSDT-------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD 576 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~ 576 (708)
..++|||||++|+|.++|.... ....++|.++.+++.|||+||+|||++ +||||||||+|||++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEEC
Confidence 9999999999999999996532 124589999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccc
Q 039322 577 LEYEAHVADFGIAKFLKPESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSL 653 (708)
Q Consensus 577 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~ 653 (708)
+++.+||+|||+|+.....+. ......||++|||||++.++.++.++|||||||++|||+| |+.||.....
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------ 253 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------ 253 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH------
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH------
Confidence 999999999999986643322 2344678999999999999999999999999999999998 8999974322
Q ss_pred ccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 NTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+..+...+.+..+ +..+.+++.+||+.||++||||+||+++|+
T Consensus 254 --~~~~~~i~~~~~~~~p~~~---~~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 254 --QDVVEMIRNRQVLPCPDDC---PAWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp --HHHHHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --HHHHHHHHcCCCCCCcccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 2222333333333222222 345888999999999999999999999986
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-53 Score=434.39 Aligned_cols=254 Identities=27% Similarity=0.449 Sum_probs=203.3
Q ss_pred ccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
++|.+.+.||+|+||.||+|++. +++.||||+++.. .....++|.+|++++++++|||||+++|+|.+++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 57888999999999999999764 4788999999752 3345678999999999999999999999999999
Q ss_pred eeEEEEEeccCCCHHHHhccccc------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC
Q 039322 510 HSFLVYELLERGSLAAILSSDTA------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL 577 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~ 577 (708)
..++|||||++|+|.++++.... ..+++|.+++.|+.|||+||+|||++ +||||||||+|||+++
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECC
Confidence 99999999999999999976532 24589999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccc
Q 039322 578 EYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLN 654 (708)
Q Consensus 578 ~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~ 654 (708)
++.+||+|||+|+........ .....||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~------- 266 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------- 266 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-------
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-------
Confidence 999999999999876443322 234678999999999999999999999999999999999 9999974322
Q ss_pred cccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 655 TDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+......+.+.. .+.++.+|+.+||++||++||||+||+++|+
T Consensus 267 -~~~~~~i~~g~~~~~p~~---~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 315 (329)
T 4aoj_A 267 -TEAIDCITQGRELERPRA---CPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315 (329)
T ss_dssp -HHHHHHHHHTCCCCCCTT---CCHHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred -HHHHHHHHcCCCCCCccc---ccHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 111222222221111122 2335888999999999999999999999885
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=436.53 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=207.8
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|.. .+|+.||||++.+... .....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 7899999999999999999965 5799999999976432 234567899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
||||+||+|.+++...+ ...+++.+++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+....
T Consensus 102 mEy~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EeCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999997543 23478999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
........+||+.|+|||++.+..++.++||||+||++|||+||+.||..... ...+..+.....++.+..
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~~~~~~~~- 248 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--------KNLVLKIISGSFPPVSLH- 248 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCCCCCCTT-
T ss_pred CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHcCCCCCCCcc-
Confidence 33334556799999999999999999999999999999999999999974321 222233333333322222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.++.++|.+||++||++|||++|+++|-+
T Consensus 249 --~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 249 --YSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279 (350)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred --CCHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence 2335788999999999999999999998743
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=425.12 Aligned_cols=256 Identities=23% Similarity=0.362 Sum_probs=200.9
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
+++.+.+.||+|+||+||+|.+++ .||||+++... ......+.|.+|++++++++|||||+++|++.+ +..++||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 678889999999999999998753 59999987532 233456789999999999999999999998865 5689999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
|||++|+|.++++... ..+++.++..|+.|||.||+|||++ +||||||||+|||+++++.+||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp ECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999997543 4589999999999999999999999 9999999999999999999999999999866433
Q ss_pred C--CccccccccccccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 596 S--SNWTEFAGTYGYVAPELAYT---MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 596 ~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
. .......||+.|||||++.+ +.++.++|||||||++|||+||+.||......... ..........+..+..
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~---~~~~~~~~~~p~~~~~ 262 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI---IFMVGRGYASPDLSKL 262 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH---HHHHHTTCCCCCSTTS
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH---HHHHhcCCCCCCcccc
Confidence 2 22345689999999999864 45899999999999999999999999743211000 0001111122222211
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+..+.+++.+||+.||++||||+||+++|+
T Consensus 263 ---~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 263 ---YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred ---cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 1223346889999999999999999999998875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=433.70 Aligned_cols=253 Identities=27% Similarity=0.403 Sum_probs=211.8
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
..|+..+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++|++++|||||+++++|.+++..|+|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~----~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGG----GCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecC----chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 5699999999999999999966 47999999998652 122345688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
||||+||+|.+++... .+++.++..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 150 mEy~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 150 MEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp ECCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 9999999999999643 489999999999999999999999 999999999999999999999999999998776
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
........+||+.|+|||++.+..|+.++||||+||++|||++|+.||...... ..+..+.+. .++.....
T Consensus 223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~-~~~~~~~~ 293 (346)
T 4fih_A 223 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDN-LPPRLKNL 293 (346)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHS-SCCCCSCG
T ss_pred CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHcC-CCCCCCcc
Confidence 656667789999999999999999999999999999999999999999743221 111111111 11111122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
...+.++.+++.+||++||++|||++|+++|-++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~ 327 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 2233468899999999999999999999988553
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=421.76 Aligned_cols=249 Identities=21% Similarity=0.300 Sum_probs=207.8
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||+||+|.. .+|+.||||++.+.. .......+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~-~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH-IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHH-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 6799999999999999999965 579999999987521 01122356799999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
||||+||+|.+++...+ .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 111 mEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999997543 489999999999999999999999 999999999999999999999999999997754
Q ss_pred CCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 595 ESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 595 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
... .....+||+.|+|||++.+..++.++||||+||++|||+||+.||..... ......+....+..+..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~~~~~p~~ 256 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------GLIFAKIIKLEYDFPEK 256 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCCCTT
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCcc
Confidence 332 34567899999999999999999999999999999999999999974321 22222333333322221
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVT 703 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 703 (708)
.+.++.++|.+|+++||++|||++|+.
T Consensus 257 ----~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 257 ----FFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ----CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ----cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 123578899999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-52 Score=434.77 Aligned_cols=252 Identities=26% Similarity=0.384 Sum_probs=210.9
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+.|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++|++++|||||+++++|.+++..|+|
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT----CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 5699999999999999999965 469999999997532 12345688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
||||+||+|.++++.. .+++.++..++.||+.||+|||++ |||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 227 mEy~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 227 MEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp EECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred EeCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 9999999999999643 389999999999999999999999 999999999999999999999999999998776
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
........+||+.|||||++.+..|+.++||||+||++|||++|+.||......... ........+.+.. .
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-----~~i~~~~~~~~~~----~ 370 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-----KMIRDNLPPRLKN----L 370 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHHSCCCCCSC----T
T ss_pred CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-----HHHHcCCCCCCcc----c
Confidence 666667789999999999999999999999999999999999999999743221110 0011111111111 1
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....++.+||.+||++||++|||++|+++|-+
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~ 403 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 403 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHH
Confidence 122345788999999999999999999998854
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=409.54 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=193.8
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|.. .+|+.||||++++... ......+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVL-AKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHc-CCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 6899999999999999999975 4699999999976322 1223456799999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+ +|+|.+++...+ .+++.++..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EeCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9999 679999997543 489999999999999999999999 999999999999999999999999999986653
Q ss_pred CCCccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
. .......||+.|+|||++.+..+ +.++||||+||++|||+||+.||+.... ......+.......+..
T Consensus 165 ~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--------~~~~~~i~~~~~~~p~~- 234 (275)
T 3hyh_A 165 G-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--------PVLFKNISNGVYTLPKF- 234 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCCCTT-
T ss_pred C-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCCCCCCC-
Confidence 3 33345789999999999988776 5799999999999999999999974321 11222222222222211
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.++.+++.+||++||++|||++|+++|-+
T Consensus 235 ---~s~~~~~li~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 235 ---LSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp ---SCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence 1235788999999999999999999999754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=410.73 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=200.5
Q ss_pred ccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee----CCeeE
Q 039322 438 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH----ARHSF 512 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----~~~~~ 512 (708)
|++.+.||+|+||.||+|.+ .+++.||+|++.... ......+.|.+|++++++++|||||+++++|.. ++..|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 36677899999999999965 468899999987532 123456789999999999999999999999865 35689
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEccCCCCCeeeCC-CCcEEEeecccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP--IVHQDISSKNLLLDL-EYEAHVADFGIA 589 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~-~~~~kl~Dfg~a 589 (708)
+|||||++|+|.+++... ..+++..+..++.||+.||+|||++ + |+||||||+|||++. ++.+||+|||+|
T Consensus 106 lvmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 999999999999999754 3489999999999999999999998 6 999999999999984 799999999999
Q ss_pred cccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 039322 590 KFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
+... .......+||+.|||||++.+ +++.++|||||||++|||+||+.||..... .......+.....+.
T Consensus 180 ~~~~--~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-------~~~~~~~i~~~~~~~ 249 (290)
T 3fpq_A 180 TLKR--ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGVKPA 249 (290)
T ss_dssp GGCC--TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTTCCCG
T ss_pred EeCC--CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-------HHHHHHHHHcCCCCC
Confidence 8543 233456789999999998865 699999999999999999999999963221 111112222221111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
......+.++.+++.+||++||++|||++|+++|-++
T Consensus 250 --~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~ 286 (290)
T 3fpq_A 250 --SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp --GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 1111122357899999999999999999999998653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=422.30 Aligned_cols=249 Identities=24% Similarity=0.277 Sum_probs=201.3
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.+.|++.+.||+|+||.||+|.+ .+|+.||||+++.... ..+|++++++++|||||++++++.+++..|+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 36788899999999999999975 4699999999976321 2369999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-cEEEeeccccccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY-EAHVADFGIAKFL 592 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~ 592 (708)
|||||+||+|.++++..+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+..
T Consensus 128 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp EECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred EEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 999999999999997543 489999999999999999999999 999999999999999987 6999999999877
Q ss_pred CCCCCc-----cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 039322 593 KPESSN-----WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 593 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
...... ....+||+.|||||++.+..++.++||||+||++|||+||+.||...... .....+.....
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~i~~~~~ 273 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG--------PLCLKIASEPP 273 (336)
T ss_dssp ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS--------CCHHHHHHSCC
T ss_pred cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHHHHcCCC
Confidence 543321 12357999999999999999999999999999999999999999743211 11111111111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+. .......+..+.++|.+||++||++|||+.|+++++.
T Consensus 274 ~~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~ 312 (336)
T 4g3f_A 274 PI-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312 (336)
T ss_dssp GG-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred Cc-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 00 0011122345788999999999999999999998864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-52 Score=417.57 Aligned_cols=252 Identities=24% Similarity=0.322 Sum_probs=201.9
Q ss_pred ccccccceeccccCccEEEEEeC----CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
++|++.+.||+|+||+||+|+.. +++.||||++++... .......+.+|++++++++|||||++++++.+++..
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL--KVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEE--EEEECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHc--ChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 67999999999999999999652 478999999976321 112344688899999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
|+|||||+||+|.+++...+ .+++.++..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999997543 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 592 LKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
............||+.|+|||++.+..++.++||||+||++|||+||+.||..... ......+.......+.
T Consensus 176 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~~~~p~ 247 (304)
T 3ubd_A 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--------KETMTMILKAKLGMPQ 247 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCT
T ss_pred ccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--------HHHHHHHHcCCCCCCC
Confidence 65555555667899999999999999999999999999999999999999974322 2222233333332222
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPT-----MKVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~ 707 (708)
. .+.++.+++.+||++||++||| ++|+++|-+
T Consensus 248 ~----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~ 284 (304)
T 3ubd_A 248 F----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284 (304)
T ss_dssp T----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred c----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence 1 2235788999999999999998 478888754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-51 Score=421.00 Aligned_cols=263 Identities=21% Similarity=0.340 Sum_probs=210.9
Q ss_pred HHHHHHhccccccceeccccCccEEEEEeCC------CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccC-CceeeE
Q 039322 429 DEIVRATNDFDAQYCIGNGGHGSVYRAELPS------GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH-RNIVKF 501 (708)
Q Consensus 429 ~~~~~~~~~~~~~~~ig~G~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l 501 (708)
++++...++|++.+.||+|+||.||+|.+.. ++.||||+++... .....+.|.+|++++++++| ||||++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3445556889999999999999999997532 3579999997642 23456789999999999975 899999
Q ss_pred EEEEeeC-CeeEEEEEeccCCCHHHHhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcc
Q 039322 502 YGFCSHA-RHSFLVYELLERGSLAAILSSDTA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQD 567 (708)
Q Consensus 502 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~d 567 (708)
+|+|.++ +..++|||||++|+|.++|+.... ...+++.++..++.|||+||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999765 578999999999999999975432 24489999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCc
Q 039322 568 ISSKNLLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDF 644 (708)
Q Consensus 568 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~ 644 (708)
|||+|||+++++.+||+|||+|+....+... .....||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544332 234678999999999999999999999999999999998 9999974
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 645 LSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.... ......+.++...+.+... +.++.+++.+||+.||++||||+||+++|+
T Consensus 291 ~~~~-------~~~~~~i~~g~~~~~p~~~---~~~~~~li~~c~~~dP~~RPt~~eil~~L~ 343 (353)
T 4ase_A 291 VKID-------EEFCRRLKEGTRMRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLG 343 (353)
T ss_dssp CCCS-------HHHHHHHHHTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHH-------HHHHHHHHcCCCCCCCccC---CHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 3211 1111111111111111222 235788999999999999999999999974
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=409.42 Aligned_cols=262 Identities=23% Similarity=0.294 Sum_probs=198.3
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC----ee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR----HS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----~~ 511 (708)
.+|.+.+.||+|+||+||+|.+ +|+.||||+++.. ......+..|+..+.+++|||||+++|++.+++ ..
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~-----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc-----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 5788899999999999999988 5899999998642 122223344666677889999999999998754 57
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEccCCCCCeeeCCCCcEEEeec
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD-----CFPPIVHQDISSKNLLLDLEYEAHVADF 586 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Df 586 (708)
|+|||||++|+|.++++.. .++++.+.+++.|++.||+|||++ +.++|+||||||+|||++.++.+||+||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 9999999999999999754 389999999999999999999976 2458999999999999999999999999
Q ss_pred ccccccCCCCCc----cccccccccccCccccccC------CCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-----
Q 039322 587 GIAKFLKPESSN----WTEFAGTYGYVAPELAYTM------KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS----- 651 (708)
Q Consensus 587 g~a~~~~~~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~----- 651 (708)
|+|+........ .....||+.|+|||++.+. .++.++|||||||++|||+||+.||.........
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 999876544322 2345799999999998764 3677999999999999999998887532211100
Q ss_pred --ccccccccccccCCCCCCCC-c--hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 652 --SLNTDIALDEILDPRLPPPS-R--SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 652 --~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..........+......+.. . ...+.+..+.+|+.+||+.||++||||+||++.|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 293 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 00001111122222222211 1 12244567889999999999999999999999874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=404.21 Aligned_cols=253 Identities=22% Similarity=0.406 Sum_probs=196.4
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC-----
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR----- 509 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 509 (708)
++|++.+.||+|+||.||+|.. .+|+.||||+++... .....+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 5799999999999999999965 479999999987532 2334578999999999999999999999987644
Q ss_pred -------eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEE
Q 039322 510 -------HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAH 582 (708)
Q Consensus 510 -------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 582 (708)
..|+|||||++|+|.+++.........++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence 3689999999999999998766555567788999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCc------------cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccc
Q 039322 583 VADFGIAKFLKPESSN------------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISS 650 (708)
Q Consensus 583 l~Dfg~a~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~ 650 (708)
|+|||+|+........ ....+||+.|||||++.+..++.++||||+||++|||++ ||....
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~---- 231 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---- 231 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----
Confidence 9999999876543221 233579999999999999999999999999999999996 765211
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 651 SSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+..+.+...+ ...........+++.+||++||++|||+.|+++|-+
T Consensus 232 ---~~~~~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~ 282 (299)
T 4g31_A 232 ---ERVRTLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAV 282 (299)
T ss_dssp ---HHHHHHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred ---HHHHHHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 011112222232322 223333445678999999999999999999998743
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=398.15 Aligned_cols=263 Identities=25% Similarity=0.360 Sum_probs=202.2
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee------C
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH------A 508 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~------~ 508 (708)
++|++.+.||+|+||.||+|.+ .+|+.||||++++.. ......+.+.+|+++|++++|||||++++++.. .
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc--cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 5799999999999999999965 579999999997643 223456778999999999999999999999764 3
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
+..|+|||||+ |+|.+++...+ .+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 57899999996 68999997543 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC----CCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc---------
Q 039322 589 AKFLKPE----SSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN--------- 654 (708)
Q Consensus 589 a~~~~~~----~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~--------- 654 (708)
|+.+... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||............
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9866432 2233457899999999998775 4689999999999999999999999743211100000
Q ss_pred ------ccccccc---ccCCCCCCCCc-hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 655 ------TDIALDE---ILDPRLPPPSR-SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 655 ------~~~~~~~---~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....... ...+..+.+.. .......++.+|+.+||.+||++|||++|+++|-+
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 347 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF 347 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence 0000000 00011110000 00111245778999999999999999999999855
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=432.02 Aligned_cols=359 Identities=36% Similarity=0.572 Sum_probs=300.5
Q ss_pred CCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCC-------------------------CCCCC-C-Ccccc
Q 039322 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIP-------------------------PSLEN-P-MLTRP 54 (708)
Q Consensus 2 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-------------------------~~~~~-~-~l~~l 54 (708)
++|++|+|++|++++..|..|.++++|++|+|++|.+.+.+| ..+.. + +|+.|
T Consensus 294 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L 373 (768)
T 3rgz_A 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTL 373 (768)
T ss_dssp TTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEE
T ss_pred CcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEE
Confidence 455666666666655555555555555555555555554444 33322 2 45555
Q ss_pred cccCCCccCCCCccccC--CCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCc
Q 039322 55 GLDFNHFTSYLPHNVCR--GGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRND 132 (708)
Q Consensus 55 ~l~~n~~~~~~~~~~~~--l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~ 132 (708)
++++|.+.+..+..+.. +++|++|++++|.+++.+|..+.++++|++|+|++|.+++..+..|..+++|++|++++|+
T Consensus 374 ~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~ 453 (768)
T 3rgz_A 374 DLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM 453 (768)
T ss_dssp ECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred EccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCc
Confidence 55555555555555544 5678888888888888888888888999999999999988888888999999999999999
Q ss_pred ceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcc
Q 039322 133 FYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPE 212 (708)
Q Consensus 133 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 212 (708)
+.+..+..+..+++|+.|+|++|++++..|..|..+++|++|+|++|++++.+|..++.+++|+.|+|++|++++.+|..
T Consensus 454 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 533 (768)
T 3rgz_A 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE 533 (768)
T ss_dssp CCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGG
T ss_pred ccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHH
Confidence 98888888889999999999999999888999999999999999999999899999999999999999999999999999
Q ss_pred cCCCCCCCeEeccCCcccccCCCC--------------------------------------------------------
Q 039322 213 IGSLVDLEYLDLSANRFNNSVPEN-------------------------------------------------------- 236 (708)
Q Consensus 213 ~~~~~~L~~L~l~~N~i~~~~~~~-------------------------------------------------------- 236 (708)
+..+++|++|+|++|++++..|..
T Consensus 534 l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 613 (768)
T 3rgz_A 534 LGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPC 613 (768)
T ss_dssp GGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCS
T ss_pred HcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhcccccccc
Confidence 999999999999999988665542
Q ss_pred --------------CCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceeccccccc
Q 039322 237 --------------LGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS 302 (708)
Q Consensus 237 --------------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 302 (708)
+..+++|+.|+|++|++++.+|..|..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|+++
T Consensus 614 ~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~ 693 (768)
T 3rgz_A 614 NITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLD 693 (768)
T ss_dssp CTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCE
T ss_pred ccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCccc
Confidence 344678999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcccccccccEEecCCCcCCCCCCCccccccCcccccccccCcCCCCCCCCCcccc
Q 039322 303 GSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKGMQPCKVF 362 (708)
Q Consensus 303 ~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~~~~~~~~ 362 (708)
+.+|..+..+++|+.||+++|+++|.+|....+..+...++.|||+.||.|.. +|+..
T Consensus 694 g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~--~C~~~ 751 (768)
T 3rgz_A 694 GRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP--RCDPS 751 (768)
T ss_dssp ECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC--CCCSC
T ss_pred CcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc--CCCCC
Confidence 99999999999999999999999999999988999999999999999998754 67543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=388.54 Aligned_cols=201 Identities=25% Similarity=0.366 Sum_probs=171.9
Q ss_pred HHHHHHHhccccccceeccccCccEEEEEeC----CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEE
Q 039322 428 YDEIVRATNDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFY 502 (708)
Q Consensus 428 ~~~~~~~~~~~~~~~~ig~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~ 502 (708)
|+.+....+.|++.+.||+|+||+||+|+.+ .++.||||.+.+. ....++.+|+++++.+ +||||++++
T Consensus 13 ~~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~------~~~~~~~~E~~~l~~~~~h~nIv~l~ 86 (361)
T 4f9c_A 13 YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT------SHPIRIAAELQCLTVAGGQDNVMGVK 86 (361)
T ss_dssp HHHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT------SCHHHHHHHHHHHHHTCSBTTBCCCS
T ss_pred HHhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc------cCHHHHHHHHHHHHHhcCCCCCceEE
Confidence 3344455678999999999999999999642 4678999998653 2345678899999998 699999999
Q ss_pred EEEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC-CcE
Q 039322 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE-YEA 581 (708)
Q Consensus 503 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~ 581 (708)
+++.++++.|+||||+++|+|.+++. .+++.++..++.|++.||+|||++ ||+||||||+|||++.+ +.+
T Consensus 87 ~~~~~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~ 157 (361)
T 4f9c_A 87 YCFRKNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKY 157 (361)
T ss_dssp EEEEETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEE
T ss_pred EEEEECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeE
Confidence 99999999999999999999999983 388999999999999999999999 99999999999999877 799
Q ss_pred EEeecccccccCCCCC----------------------------ccccccccccccCccccccC-CCCcchhHHHHHHHH
Q 039322 582 HVADFGIAKFLKPESS----------------------------NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLV 632 (708)
Q Consensus 582 kl~Dfg~a~~~~~~~~----------------------------~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l 632 (708)
||+|||+|+....... .....+||+.|+|||++.+. .++.++||||+||++
T Consensus 158 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il 237 (361)
T 4f9c_A 158 ALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF 237 (361)
T ss_dssp EECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred EECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHH
Confidence 9999999986543211 12335799999999998775 488999999999999
Q ss_pred HHHHhCCCCCC
Q 039322 633 LEAIKGKHPRD 643 (708)
Q Consensus 633 ~elltg~~p~~ 643 (708)
|||+||+.||.
T Consensus 238 ~ell~G~~Pf~ 248 (361)
T 4f9c_A 238 LSLLSGRYPFY 248 (361)
T ss_dssp HHHHHTCSSSS
T ss_pred HHHHHCCCCCC
Confidence 99999999995
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=409.06 Aligned_cols=256 Identities=20% Similarity=0.320 Sum_probs=214.5
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|+++|+.++|||||+++++|.+++..|+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc----chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 36899999999999999999965 47999999998763 33456788999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC--CcEEEeecccccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE--YEAHVADFGIAKF 591 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~a~~ 591 (708)
|||||+||+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 232 v~E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEeecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 999999999999996433 3589999999999999999999999 99999999999999865 8999999999998
Q ss_pred cCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 592 LKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
+.+. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...+..+.......+.
T Consensus 307 ~~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~ 377 (573)
T 3uto_A 307 LDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKSCDWNMDD 377 (573)
T ss_dssp CCTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHTTCCCCCS
T ss_pred ccCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHhCCCCCCc
Confidence 7643 334556899999999999999999999999999999999999999974321 2233333333333332
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.........+.+||.+||++||++|||++|+++|=++
T Consensus 378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~ 414 (573)
T 3uto_A 378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414 (573)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCc
Confidence 3333334567899999999999999999999998553
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=401.50 Aligned_cols=255 Identities=20% Similarity=0.229 Sum_probs=201.8
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHH---HHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFL---IEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~---~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
.++|++.++||+|+||.||+|.. .+|+.||||++.+... ........+. .++.+++.++|||||+++++|.+++.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i-~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHc-chhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 37899999999999999999965 4699999999865210 0011122233 34566777899999999999999999
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.|+|||||+||+|.+++...+ .+++..++.++.||+.||+|||++ |||||||||+|||++.+|++||+|||+|+
T Consensus 267 lylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999997543 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 039322 591 FLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
..... .....+||+.|+|||++.. ..++.++||||+||++|||++|+.||....... .......+.......
T Consensus 341 ~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-----~~~i~~~i~~~~~~~ 413 (689)
T 3v5w_A 341 DFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLTMAVEL 413 (689)
T ss_dssp ECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-----HHHHHHHHHHCCCCC
T ss_pred ecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhhcCCCCCC
Confidence 76543 2345689999999999875 579999999999999999999999997432111 111112222222222
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPT-----MKVVTQQVR 707 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~ 707 (708)
+.. .+.++.+||.+||++||++|++ ++||++|-+
T Consensus 414 p~~----~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 414 PDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp CTT----SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred Ccc----CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence 211 2235788999999999999998 799988754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=371.30 Aligned_cols=279 Identities=33% Similarity=0.611 Sum_probs=228.1
Q ss_pred CCchHHHHHHHhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEE
Q 039322 424 GKLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503 (708)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~ 503 (708)
..+++.++....++|++.+.||+|+||.||+|...+|+.||||++..... ......+.+|++++++++||||+++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT---QGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC---chHHHHHHHHHHHHHhccCCCccceEE
Confidence 35678899999999999999999999999999888899999999976321 112336889999999999999999999
Q ss_pred EEeeCCeeEEEEEeccCCCHHHHhccccc-ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEE
Q 039322 504 FCSHARHSFLVYELLERGSLAAILSSDTA-AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAH 582 (708)
Q Consensus 504 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 582 (708)
++..++..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+++.+||+||||||+||+++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999976542 34589999999999999999999998777999999999999999999999
Q ss_pred EeecccccccCCCCCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc---------c
Q 039322 583 VADFGIAKFLKPESSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS---------S 652 (708)
Q Consensus 583 l~Dfg~a~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~---------~ 652 (708)
|+|||++......... .....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||+........ .
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 9999999876543332 34456899999999998888999999999999999999999999632211111 1
Q ss_pred cccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 653 LNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...........+..... .........+.+++.+||+.||++|||++||+++|+
T Consensus 255 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQG--NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TTSSCCSTTSSCTTCTT--SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HhhchhhhhhcChhhcc--ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 11122223333333322 234556678999999999999999999999999986
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=364.42 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=209.7
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++..++..++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGG----GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecc----cccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 36899999999999999999964 57899999998642 22335678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++... .+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus 95 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999999654 389999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
..........||+.|+|||++.+..++.++||||+|+++|||++|+.||.......... .......+....
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----~~~~~~~~~~~~---- 238 (297)
T 3fxz_A 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-----LIATNGTPELQN---- 238 (297)
T ss_dssp STTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHHHCSCCCSC----
T ss_pred CcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhCCCCCCCC----
Confidence 65555566789999999999999999999999999999999999999996432111000 000000111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+.+++.+||+.||++|||++|+++|-+
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~ 272 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF 272 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 1122345789999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=367.05 Aligned_cols=260 Identities=31% Similarity=0.451 Sum_probs=203.7
Q ss_pred HHHHHhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 430 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 430 ~~~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
++....++|++.+.||+|+||.||+|.. +|+.||||++.... ......+.+.+|++++++++||||+++++++..++
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQD--FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCC--CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 3334467999999999999999999987 58899999997643 22345678999999999999999999999999999
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEccCCCCCeeeCCCCcEEEeecc
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP--IVHQDISSKNLLLDLEYEAHVADFG 587 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfg 587 (708)
..++||||+++|+|.+++........+++..++.++.|++.||+|||++ | |+||||||+||+++.++.+||+|||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg 184 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFG 184 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCC
Confidence 9999999999999999998765445589999999999999999999999 8 9999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc--cCC
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEI--LDP 665 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 665 (708)
+++.............||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ...... ...
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--------~~~~~~~~~~~ 256 (309)
T 3p86_A 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--------QVVAAVGFKCK 256 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--------HHHHHHHHSCC
T ss_pred CCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhcCC
Confidence 9986554433445567999999999999999999999999999999999999999743221 111111 111
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 666 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+. .....+.+++.+||+.||++|||++|+++.|+
T Consensus 257 ~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~ 294 (309)
T 3p86_A 257 RLEIPR----NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294 (309)
T ss_dssp CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 111111 12235889999999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=365.65 Aligned_cols=271 Identities=33% Similarity=0.542 Sum_probs=220.3
Q ss_pred HHHHHHHhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee
Q 039322 428 YDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH 507 (708)
Q Consensus 428 ~~~~~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 507 (708)
+.++..++++|+..+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++||||+++++++.+
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES----SQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC----SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 344555678999999999999999999998889999999987532 2346779999999999999999999999999
Q ss_pred CCeeEEEEEeccCCCHHHHhccccc-ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeec
Q 039322 508 ARHSFLVYELLERGSLAAILSSDTA-AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADF 586 (708)
Q Consensus 508 ~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 586 (708)
++..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999975442 23589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc-------cccc
Q 039322 587 GIAKFLKPESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL-------NTDI 657 (708)
Q Consensus 587 g~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-------~~~~ 657 (708)
|++........ ......|++.|+|||++.+..++.++||||||+++|||++|+.||........... ....
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 99986543222 23345689999999999988999999999999999999999999874322111100 0011
Q ss_pred ccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 ALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......++.... ......+..+.+++.+||+.||++|||++|++++|+
T Consensus 264 ~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 264 QLEQIVDPNLAD--KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp CCCSSSSSSCTT--CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cHHHhcChhhcc--ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 122233333322 223456678999999999999999999999999985
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=363.28 Aligned_cols=264 Identities=25% Similarity=0.364 Sum_probs=215.4
Q ss_pred CCchHHHHHHHhcc----------ccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHh
Q 039322 424 GKLVYDEIVRATND----------FDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTE 492 (708)
Q Consensus 424 ~~~~~~~~~~~~~~----------~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~ 492 (708)
+.++++++..+++. |+..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~ 98 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRD 98 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCSHHHHHHHHHHHTT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc----hhHHHHHHHHHHHHHh
Confidence 45677887777754 777789999999999999765 79999999987532 2345678899999999
Q ss_pred ccCCceeeEEEEEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 039322 493 IRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKN 572 (708)
Q Consensus 493 l~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N 572 (708)
++||||+++++++..++..++||||+++|+|.+++... .+++..+..++.|++.||+|||++ |++||||||+|
T Consensus 99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~N 171 (321)
T 2c30_A 99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDS 171 (321)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHH
Confidence 99999999999999999999999999999999998643 489999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc
Q 039322 573 LLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS 652 (708)
Q Consensus 573 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~ 652 (708)
|+++.++.+||+|||++..............||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 172 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~-- 249 (321)
T 2c30_A 172 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-- 249 (321)
T ss_dssp EEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--
T ss_pred EEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 999999999999999998776554445566899999999999998999999999999999999999999874321110
Q ss_pred cccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 653 LNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.........+... ........+.+++.+||+.||++|||++|++++-+
T Consensus 250 ---~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 250 ---MKRLRDSPPPKLK----NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp ---HHHHHHSSCCCCT----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred ---HHHHhcCCCCCcC----ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0011111111111 11122345788999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=363.98 Aligned_cols=253 Identities=24% Similarity=0.364 Sum_probs=210.2
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|.+ .+|+.||||++.... ......+.+.+|+++++.++||||+++++++..++..++
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ--LNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 47899999999999999999976 679999999987532 123456778899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++...+ .+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus 92 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999999996543 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccccccccccccCccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKIT-EKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
.. .......||+.|+|||++.+..++ .++||||+||++|+|++|+.||+.... ......+.......+..
T Consensus 166 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~~p~~ 236 (328)
T 3fe3_A 166 VG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--------KELRERVLRGKYRIPFY 236 (328)
T ss_dssp SS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCTT
T ss_pred CC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCCC
Confidence 43 334556799999999999887765 789999999999999999999974321 11222222222222211
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
....+.+++.+||+.||++|||++|+++|-++
T Consensus 237 ----~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 268 (328)
T 3fe3_A 237 ----MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268 (328)
T ss_dssp ----SCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred ----CCHHHHHHHHHHCCCChhHCcCHHHHhcCHhh
Confidence 12347789999999999999999999987553
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=403.19 Aligned_cols=348 Identities=34% Similarity=0.532 Sum_probs=238.6
Q ss_pred CCCCcEEECCCCcccccCCccccCC-CCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCcc-ccCCCCccE
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNL-TNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHN-VCRGGALQY 77 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l-~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~-~~~l~~L~~ 77 (708)
+++|++|+|++|++++..|..+.++ ++|++|+|++|.+.+.+|..+.. ++|+.|++++|.+.+.+|.. +..+++|++
T Consensus 268 l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~ 347 (768)
T 3rgz_A 268 LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKV 347 (768)
T ss_dssp CTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCE
T ss_pred cCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCE
Confidence 5789999999999998888888775 99999999999999999988866 88999999999998667765 888888888
Q ss_pred EeccCCccccccCccCcCCC-CCcEEEccCCccc--------------------------cccccccCCCCCCCEEEccc
Q 039322 78 FGVSENHFQGTIPKILRNCS-SLIRVRLNSNNLT--------------------------GNISEALGIYPNLTFIDLSR 130 (708)
Q Consensus 78 L~l~~n~i~~~~~~~~~~l~-~L~~L~l~~n~i~--------------------------~~~~~~~~~~~~L~~L~l~~ 130 (708)
|++++|.+++.+|..+.+++ +|++|++++|+++ +..+..|..+++|++|++++
T Consensus 348 L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~ 427 (768)
T 3rgz_A 348 LDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSF 427 (768)
T ss_dssp EECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCS
T ss_pred EeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcC
Confidence 88888888877777766654 5555555555554 44455555555555555555
Q ss_pred CcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCC
Q 039322 131 NDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLP 210 (708)
Q Consensus 131 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 210 (708)
|++++..+..|..+++|+.|+|++|.+++..|..|..+++|++|+|++|++++..|..+.++++|++|+|++|++++..|
T Consensus 428 N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 507 (768)
T 3rgz_A 428 NYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507 (768)
T ss_dssp SEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCC
T ss_pred CcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCC
Confidence 55555555555555666666666666655555566666666666666666665566666666666666666666666666
Q ss_pred cccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhh----------------------------
Q 039322 211 PEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELE---------------------------- 262 (708)
Q Consensus 211 ~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~---------------------------- 262 (708)
..+..+++|++|+|++|++++..|..+..+++|+.|++++|++++.+|..+.
T Consensus 508 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (768)
T 3rgz_A 508 KWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKEC 587 (768)
T ss_dssp GGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTC
T ss_pred hHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccc
Confidence 6666666666666666666666666666666666666666666555444321
Q ss_pred ------------------------------------------hhcccchhhcccccCCCCCchhhcCcccCCceeccccc
Q 039322 263 ------------------------------------------KLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNN 300 (708)
Q Consensus 263 ------------------------------------------~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~ 300 (708)
.+++|+.|||++|++++.+|..+..+++|+.|+|++|+
T Consensus 588 ~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~ 667 (768)
T 3rgz_A 588 HGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667 (768)
T ss_dssp CSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCc
Confidence 23455666666666666666666667777777777777
Q ss_pred ccCCCCCcccccccccEEecCCCcCCCCCCC-ccccccCcccccccccC
Q 039322 301 LSGSIPNCFEGIRGISVIDISDNQLQGPVPN-STAFRNAPVEALKGNKG 348 (708)
Q Consensus 301 l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~~ 348 (708)
+++.+|..+..+++|+.|||++|+++|.+|. ...+..++.+.+++|+.
T Consensus 668 l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l 716 (768)
T 3rgz_A 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL 716 (768)
T ss_dssp CCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEE
T ss_pred cCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcc
Confidence 7777777777777777777777777766654 34455666666666653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=374.67 Aligned_cols=259 Identities=22% Similarity=0.288 Sum_probs=212.5
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
..++|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+.+|++++++++||||+++++++.+++..+
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK--LSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCS--CHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 457899999999999999999964 578999999987632 23345677999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC---CCCcEEEeecccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD---LEYEAHVADFGIA 589 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a 589 (708)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||++ ||+||||||+||+++ .++.+||+|||++
T Consensus 87 lv~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EEECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 9999999999999987543 489999999999999999999999 999999999999998 4678999999999
Q ss_pred cccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 039322 590 KFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
..............||+.|+|||++.+..++.++||||+||++|+|++|..||..... ......+.......
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~ 232 (444)
T 3soa_A 161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--------HRLYQQIKAGAYDF 232 (444)
T ss_dssp BCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCCCC
T ss_pred EEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHhCCCCC
Confidence 8776555555567899999999999998999999999999999999999999964221 11222222222222
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
+...+...+..+.+++.+||+.||++|||++|+++|-+|
T Consensus 233 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~ 271 (444)
T 3soa_A 233 PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271 (444)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTT
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 222222233468899999999999999999999998654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=365.70 Aligned_cols=259 Identities=21% Similarity=0.268 Sum_probs=213.0
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcch--hHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQ--IADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
.+.|++.+.||+|+||.||+|... +|+.||+|++++...... ....+.+.+|+.++++++||||+++++++.+++..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999664 689999999976432211 12356789999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC----cEEEeecc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY----EAHVADFG 587 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg 587 (708)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 9999999999999999654 3489999999999999999999999 999999999999998877 79999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
++...... .......||+.|+|||++.+..++.++||||+|+++|+|++|..||.... .......+.....
T Consensus 165 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~--------~~~~~~~i~~~~~ 235 (361)
T 2yab_A 165 LAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANITAVSY 235 (361)
T ss_dssp SCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTTCC
T ss_pred CceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcCC
Confidence 99876543 23345679999999999998899999999999999999999999997422 1222233333333
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
..+...+......+.++|.+||.+||++|||++|+++|-++
T Consensus 236 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 276 (361)
T 2yab_A 236 DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (361)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCc
Confidence 32222222334568899999999999999999999998654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=362.42 Aligned_cols=254 Identities=22% Similarity=0.285 Sum_probs=212.2
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +++.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 478999999999999999999654 6889999998752 2345678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC--CCcEEEeecccccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL--EYEAHVADFGIAKF 591 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~ 591 (708)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||++ ||+||||||+||+++. ++.+||+|||++..
T Consensus 79 v~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 79 IFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 999999999999996543 3589999999999999999999999 9999999999999987 78999999999987
Q ss_pred cCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 592 LKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
.... .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.... .......+.......+.
T Consensus 154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~~~~ 224 (321)
T 1tki_A 154 LKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNAEYTFDE 224 (321)
T ss_dssp CCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCCCCH
T ss_pred CCCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHcCCCCCCh
Confidence 6543 33455678999999999998888999999999999999999999997422 12222333333333332
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+..+.+++.+||+.||++|||++|+++|-+
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 222233456889999999999999999999999865
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=355.30 Aligned_cols=254 Identities=27% Similarity=0.435 Sum_probs=206.7
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+.. ......+.+.+|++++++++||||+++++++.+++..++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 37899999999999999999966 4689999999865 234567789999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 85 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp EEECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 999999999999997643 4589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCcc--------------ccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc-cccccc
Q 039322 594 PESSNW--------------TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS-LNTDIA 658 (708)
Q Consensus 594 ~~~~~~--------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-~~~~~~ 658 (708)
...... ....||+.|+|||++.+..++.++||||||+++|||++|..||.......... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 239 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence 332211 14568999999999999999999999999999999999999986432211110 000111
Q ss_pred cccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 659 LDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+.. +..+.+++.+||+.||++|||++|+++.|+
T Consensus 240 ~~~~~~~~~----------~~~l~~li~~~l~~dP~~Rps~~~l~~~L~ 278 (310)
T 3s95_A 240 LDRYCPPNC----------PPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278 (310)
T ss_dssp HHHTCCTTC----------CTTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccccCCCCC----------CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 111111111 124788999999999999999999998875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=352.98 Aligned_cols=276 Identities=30% Similarity=0.513 Sum_probs=225.1
Q ss_pred CCchHHHHHHHhcccccc------ceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCc
Q 039322 424 GKLVYDEIVRATNDFDAQ------YCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN 497 (708)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~------~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 497 (708)
..++++++..++++|... +.||+|+||.||+|.. +++.||||++............+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 356889999999999877 8999999999999987 588999999976443333445678999999999999999
Q ss_pred eeeEEEEEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC
Q 039322 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL 577 (708)
Q Consensus 498 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~ 577 (708)
|+++++++.+++..++||||+++|+|.+++........+++..++.++.|++.||+|||++ |++||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 9999999999999999999999999999997655556689999999999999999999999 9999999999999999
Q ss_pred CCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc--
Q 039322 578 EYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL-- 653 (708)
Q Consensus 578 ~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-- 653 (708)
++.+||+|||++......... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||+..........
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 999999999999866543222 233568999999998765 588999999999999999999999975332111000
Q ss_pred ----ccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 ----NTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+....++.+... .......+.+++.+||+.||++|||+++++++|+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~ 302 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKMNDA---DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302 (307)
T ss_dssp HHHHTTSCCHHHHSCSSCSCC---CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHhhhhhhhhhhhcccccccc---chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 01112233344443332 3345567889999999999999999999999885
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=364.58 Aligned_cols=256 Identities=21% Similarity=0.376 Sum_probs=208.4
Q ss_pred hccccccceeccccCccEEEEEe--------CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL--------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFC 505 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~ 505 (708)
.++|++.+.||+|+||.||+|.. .++..||||+++.. ......+.+.+|+++++++ +||||+++++++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT---CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC---cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 37899999999999999999965 23567999999764 2334567899999999999 899999999999
Q ss_pred eeCCeeEEEEEeccCCCHHHHhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 039322 506 SHARHSFLVYELLERGSLAAILSSDTA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKN 572 (708)
Q Consensus 506 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N 572 (708)
..++..|+||||+++|+|.+++..... ...+++.+++.++.||+.||+|||++ ||+||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchhh
Confidence 999999999999999999999976432 23579999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccc
Q 039322 573 LLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLIS 649 (708)
Q Consensus 573 ill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~ 649 (708)
|+++.++.+||+|||+++........ .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-- 311 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-- 311 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 99999999999999999866543322 233456789999999999999999999999999999999 9999874321
Q ss_pred ccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 650 SSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+........+. .....+.+++.+||+.||++|||++|++++|+
T Consensus 312 ------~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 360 (370)
T 2psq_A 312 ------EELFKLLKEGHRMDKPA---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360 (370)
T ss_dssp ------GGHHHHHHTTCCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ------HHHHHHHhcCCCCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111122221111111 12235888999999999999999999999885
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=360.87 Aligned_cols=254 Identities=23% Similarity=0.277 Sum_probs=209.4
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|..+ +|+.||+|++++... ........+.+|++++++++||||+++++++...+..++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 378999999999999999999664 689999999865210 012235678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus 83 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999999654 3489999999999999999999999 99999999999999999999999999998655
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
..........||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ......+.......+..
T Consensus 157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~p~~- 227 (337)
T 1o6l_A 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEEIRFPRT- 227 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCTT-
T ss_pred cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCCC-
Confidence 444455667899999999999998999999999999999999999999964221 11112222222222211
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRP-----TMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~ 707 (708)
....+.+++.+||++||++|| +++|+++|-+
T Consensus 228 ---~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 228 ---LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp ---SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred ---CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 123578899999999999999 9999998754
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=385.37 Aligned_cols=351 Identities=21% Similarity=0.171 Sum_probs=251.8
Q ss_pred CCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEec
Q 039322 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGV 80 (708)
Q Consensus 2 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l 80 (708)
++|++|+|++|+++++.+..|+++++|++|+|++|.+++..|..|.. ++|+.|++++|.+.+..|..|..+++|++|++
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 34566666666666666656666666666666666666555555543 55666666666666655666666666666666
Q ss_pred cCCccccccCccCcCCCCCcEEEccCCccccc-cccccCCCCCCCEEEcccCcceeeCCCCC------------------
Q 039322 81 SENHFQGTIPKILRNCSSLIRVRLNSNNLTGN-ISEALGIYPNLTFIDLSRNDFYGEISSNW------------------ 141 (708)
Q Consensus 81 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~-~~~~~~~~~~L~~L~l~~n~l~~~~~~~~------------------ 141 (708)
++|.+++..+..++++++|++|++++|.++++ .+..|.++++|++|++++|+++++.+..|
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence 66666555545566666666666666665542 24555556666666655555544332211
Q ss_pred --------------------------------------------------------------------------------
Q 039322 142 -------------------------------------------------------------------------------- 141 (708)
Q Consensus 142 -------------------------------------------------------------------------------- 141 (708)
T Consensus 192 ~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~ 271 (606)
T 3vq2_A 192 PIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYT 271 (606)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCC
T ss_pred CcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecccc
Confidence
Q ss_pred ---------------------------------------------------------------------------CCCCC
Q 039322 142 ---------------------------------------------------------------------------GKCPK 146 (708)
Q Consensus 142 ---------------------------------------------------------------------------~~l~~ 146 (708)
..+++
T Consensus 272 ~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~ 351 (606)
T 3vq2_A 272 NDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPS 351 (606)
T ss_dssp TTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCCTT
T ss_pred ccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhccCCC
Confidence 12334
Q ss_pred CCEEEcccCccccc--CCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCC-cccCCCCCCCeEe
Q 039322 147 LGTLNVSMNNITGG--IPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLP-PEIGSLVDLEYLD 223 (708)
Q Consensus 147 L~~L~L~~N~i~~~--~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~~~~L~~L~ 223 (708)
|++|++++|.+++. .+..+..+++|++|++++|.+++ .+..+..+++|++|++++|++.+..+ ..+..+++|++|+
T Consensus 352 L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 430 (606)
T 3vq2_A 352 LSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLD 430 (606)
T ss_dssp CCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEE
T ss_pred CCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEE
Confidence 44455555555433 24555666666666666666663 44667788888888888888887666 5788888999999
Q ss_pred ccCCcccccCCCCCCccccceeecccCccccc-CCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceeccccccc
Q 039322 224 LSANRFNNSVPENLGNLLKLHYLGLSNNQFVL-ELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS 302 (708)
Q Consensus 224 l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 302 (708)
+++|++++..|..+..+++|+.|++++|++++ ..|..|..+++|+.|++++|.+++..|..+..+++|+.|++++|+++
T Consensus 431 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 510 (606)
T 3vq2_A 431 ISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLL 510 (606)
T ss_dssp CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred CcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCC
Confidence 99999988888889999999999999999987 46888999999999999999999888888999999999999999999
Q ss_pred CCCCCcccccccccEEecCCCcCCCCCCCccccc-cCcccccccccCcCCCC
Q 039322 303 GSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFR-NAPVEALKGNKGLCGGV 353 (708)
Q Consensus 303 ~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~~~~~~~~~n~~~c~~~ 353 (708)
+..|..+..+++|+.|++++|+++..++....++ .++.+.+.+|||.|+|+
T Consensus 511 ~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 511 FLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp CEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 8889999999999999999999997666656665 48999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=357.82 Aligned_cols=259 Identities=20% Similarity=0.276 Sum_probs=209.8
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcch--hHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQ--IADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
.+.|++.+.||+|+||.||+|... +|+.||+|++........ ....+.+.+|++++++++||||+++++++..++..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 367999999999999999999664 689999999876332111 12367799999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC----cEEEeecc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY----EAHVADFG 587 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg 587 (708)
++||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999999654 3489999999999999999999999 999999999999999887 79999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
++....... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||..... ......+.....
T Consensus 164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~~~~~~~ 234 (326)
T 2y0a_A 164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANVSAVNY 234 (326)
T ss_dssp TCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHHTCC
T ss_pred CCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHHHhcCC
Confidence 998765332 33456799999999999988999999999999999999999999864221 111111111111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
..+.......+..+.+++.+||+.||++|||++|+++|-++
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 275 (326)
T 2y0a_A 235 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275 (326)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence 11111112233467899999999999999999999998653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=363.41 Aligned_cols=261 Identities=19% Similarity=0.234 Sum_probs=210.3
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCC-cchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLP-CDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
.+.|++.+.||+|+||.||+|.. .+|+.||||++..... .......+.+.+|++++++++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 36799999999999999999965 4689999999853100 000113567899999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc---EEEeeccc
Q 039322 513 LVYELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE---AHVADFGI 588 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~ 588 (708)
+||||+++|+|.+++.... ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998886543 233589999999999999999999999 9999999999999987655 99999999
Q ss_pred ccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 039322 589 AKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 589 a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
+..............||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ......+......
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGIIKGKYK 250 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHHHTCCC
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHHcCCCC
Confidence 9877655444456679999999999999889999999999999999999999997421 1112222222222
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+...+..+.+++.+||+.||++|||+.|+++|-+
T Consensus 251 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 289 (351)
T 3c0i_A 251 MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPW 289 (351)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence 222222223456889999999999999999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=353.03 Aligned_cols=265 Identities=21% Similarity=0.276 Sum_probs=204.7
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.++|++.+.||+|+||.||+|...+|+.||+|++.... ........+.+|++++++++||||+++++++.+++..++|
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA--EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccc--ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 47899999999999999999988889999999997532 2223356788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++ +|.+++.... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 98 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 999985 8888886543 4589999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc-------------ccccccc
Q 039322 595 ESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL-------------NTDIALD 660 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-------------~~~~~~~ 660 (708)
.........+|+.|+|||++.+ ..++.++||||+|+++|+|++|+.||........... .......
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 5455556678999999999876 5689999999999999999999999974322110000 0000000
Q ss_pred cccCCCCCCCC-ch----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 661 EILDPRLPPPS-RS----VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 661 ~~~~~~~~~~~-~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.+....... .. ......++.+++.+||+.||++|||++|+++|-+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 303 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 00000000000 00 0111245789999999999999999999999754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=362.71 Aligned_cols=257 Identities=22% Similarity=0.319 Sum_probs=210.5
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
..++|++.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+.+|++++++++||||+++++++.+++..+
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 357899999999999999999965 4689999999975322 2345677899999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC---cEEEeecccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY---EAHVADFGIA 589 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a 589 (708)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus 105 lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EEECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 9999999999999986543 489999999999999999999999 999999999999998654 5999999999
Q ss_pred cccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 039322 590 KFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ......+.......
T Consensus 179 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~~~~i~~~~~~~ 249 (362)
T 2bdw_A 179 IEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQIKAGAYDY 249 (362)
T ss_dssp BCCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCC
T ss_pred eEecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCCCCC
Confidence 876533 233456799999999999998999999999999999999999999864221 11122222222222
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+...+...+..+.+++.+||+.||++|||+.|+++|-+
T Consensus 250 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 22222233456889999999999999999999998754
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=395.65 Aligned_cols=349 Identities=23% Similarity=0.211 Sum_probs=205.1
Q ss_pred CCCcEEECCCC-cccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCcc--ccCCCCccE
Q 039322 2 RSLSILDLNQN-QFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHN--VCRGGALQY 77 (708)
Q Consensus 2 ~~L~~L~l~~n-~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~--~~~l~~L~~ 77 (708)
++|++|||++| .+..+.+.+|.++++|++|+|++|.+.+..|..|.. ++|+.|++++|.+.+..+.. +..+++|++
T Consensus 48 ~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~ 127 (844)
T 3j0a_A 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127 (844)
T ss_dssp CSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCE
T ss_pred ccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCE
Confidence 44555555555 223333555566666666666666665555555544 55666666666665543333 555666666
Q ss_pred EeccCCccccccC-ccCcCCCCCcEEEccCCccccccccccCC-------------------------------------
Q 039322 78 FGVSENHFQGTIP-KILRNCSSLIRVRLNSNNLTGNISEALGI------------------------------------- 119 (708)
Q Consensus 78 L~l~~n~i~~~~~-~~~~~l~~L~~L~l~~n~i~~~~~~~~~~------------------------------------- 119 (708)
|+|++|.+++..+ ..|+++++|++|+|++|.++++.+..|..
T Consensus 128 L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~ 207 (844)
T 3j0a_A 128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE 207 (844)
T ss_dssp EEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBS
T ss_pred EECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCcee
Confidence 6666666654433 34556666666666665554322211110
Q ss_pred ---------------------------------------------------------CCCCCEEEcccCcceeeCCCCCC
Q 039322 120 ---------------------------------------------------------YPNLTFIDLSRNDFYGEISSNWG 142 (708)
Q Consensus 120 ---------------------------------------------------------~~~L~~L~l~~n~l~~~~~~~~~ 142 (708)
.++|++|++++|.+.++.+..|.
T Consensus 208 ~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~ 287 (844)
T 3j0a_A 208 ILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFE 287 (844)
T ss_dssp EEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSS
T ss_pred EEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhh
Confidence 13455555555555555555666
Q ss_pred CCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeE
Q 039322 143 KCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYL 222 (708)
Q Consensus 143 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L 222 (708)
.+++|+.|+|++|+|+...+..|..+++|++|+|++|++++..+..|..+++|+.|++++|.+++..+..|..+++|++|
T Consensus 288 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 367 (844)
T 3j0a_A 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTL 367 (844)
T ss_dssp SCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEE
T ss_pred cCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEE
Confidence 66666666666666666666666666667777777666665556666666667777777666665555566666666666
Q ss_pred eccCCcccccCC------------------C----------------------CCCccccceeecccCcccccCC-----
Q 039322 223 DLSANRFNNSVP------------------E----------------------NLGNLLKLHYLGLSNNQFVLEL----- 257 (708)
Q Consensus 223 ~l~~N~i~~~~~------------------~----------------------~~~~l~~L~~L~l~~n~l~~~~----- 257 (708)
+|++|.+++... . .+.++++|+.|+|++|++++..
T Consensus 368 ~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 447 (844)
T 3j0a_A 368 DLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTP 447 (844)
T ss_dssp EEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSS
T ss_pred ECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCccccccccccc
Confidence 666666553110 0 0113445555555555554221
Q ss_pred -------------------------ChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCccccc
Q 039322 258 -------------------------PKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGI 312 (708)
Q Consensus 258 -------------------------~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l 312 (708)
+..|.++++|+.|+|++|.+++..+..+..+++|+.|+|++|++++..+..+.
T Consensus 448 ~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-- 525 (844)
T 3j0a_A 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-- 525 (844)
T ss_dssp CSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--
T ss_pred ccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--
Confidence 23345556666666666666666666666666666666666666655555554
Q ss_pred ccccEEecCCCcCCCCCCCccccccCcccccccccCcCCCCC
Q 039322 313 RGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVK 354 (708)
Q Consensus 313 ~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~ 354 (708)
++|+.|++++|++++..|.. +..+..+.+.+|||.|+|+.
T Consensus 526 ~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 526 ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSSC
T ss_pred ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCccccccc
Confidence 56666666666666665543 56788899999999999863
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=356.05 Aligned_cols=254 Identities=23% Similarity=0.404 Sum_probs=204.5
Q ss_pred hccccccceeccccCccEEEEEeC----CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
.++|++.+.||+|+||.||+|... .+..||||+++... .....+.+.+|++++++++||||+++++++.+++.
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 368899999999999999999763 34569999997632 23456789999999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++.
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred cEEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 999999999999999996543 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc---cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC
Q 039322 591 FLKPESSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPR 666 (708)
Q Consensus 591 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (708)
........ .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+....
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~~~~~~~ 271 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------RDVISSVEEGY 271 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHHTTC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHcCC
Confidence 76543322 122345778999999998899999999999999999999 9999864322 11111121111
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 667 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+... ..+..+.+++.+||+.||++|||++|+++.|+
T Consensus 272 ~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~ 309 (325)
T 3kul_A 272 RLPAPM---GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309 (325)
T ss_dssp CCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCC---CcCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 111111 12235889999999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=364.29 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=204.2
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~ 512 (708)
.++|++.+.||+|+||.||+|..+ +|+.||||++++.. .......+.+..|.++++.+ +||||+++++++.+++..|
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~-~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV-ILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-HHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHH-hcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 478999999999999999999754 68999999987521 01123456788999999988 6999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999999654 3489999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
...........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+..
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~p~~ 246 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILNDEVVYPTW 246 (353)
T ss_dssp CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCTT
T ss_pred ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCCC
Confidence 4444445567899999999999988899999999999999999999999974321 22223333333322221
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTM------KVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~l~ 707 (708)
....+.+++.+||++||++||++ +|+++|-+
T Consensus 247 ----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~ 283 (353)
T 3txo_A 247 ----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283 (353)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG
T ss_pred ----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCc
Confidence 12347789999999999999998 88888754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=364.88 Aligned_cols=262 Identities=23% Similarity=0.315 Sum_probs=208.0
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~ 512 (708)
.++|++.+.||+|+||.||+|+.+ +++.||+|++++.... .....+.+..|..++.++ +||||+++++++.+++..+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 478999999999999999999764 5889999999763211 122345678899999887 8999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 130 lV~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999999754 3489999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc-ccccccccccCCCCCCCC
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL-NTDIALDEILDPRLPPPS 671 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 671 (708)
...........||+.|+|||++.+..++.++||||+||++|||++|+.||+.......... ........+.......+.
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 283 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 283 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence 4444455667899999999999999999999999999999999999999974322111111 111122222223322222
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTM------KVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~l~ 707 (708)
. ....+.+++.+||++||++||++ +|+++|-+
T Consensus 284 ~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf 321 (396)
T 4dc2_A 284 S----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321 (396)
T ss_dssp T----SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred c----CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence 1 22357889999999999999985 78887754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=356.96 Aligned_cols=255 Identities=22% Similarity=0.313 Sum_probs=198.1
Q ss_pred hccccccceeccccCccEEEEEe----CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
.++|++.+.||+|+||.||+|.. .+|+.||+|++++............+.+|++++++++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 37899999999999999999976 47899999999874322233445678899999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999996543 488999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 591 FLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
.............||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.......+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~~p 241 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKTIDKILKCKLNLP 241 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCCCCC
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCCCCCC
Confidence 654444444556799999999999988899999999999999999999999974321 111222222222222
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRP-----TMKVVTQQVR 707 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~ 707 (708)
.. ....+.+++.+||+.||++|| +++|+++|-+
T Consensus 242 ~~----~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 242 PY----LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp TT----SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred CC----CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 11 123578899999999999999 7889988754
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=382.94 Aligned_cols=351 Identities=21% Similarity=0.243 Sum_probs=308.5
Q ss_pred CCCCcEEECCCCcccccCCccccCCCCCC--EEEeeCceeeeeCCCCCCCC-----------------------------
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLK--ELVLLYNNLSGFIPPSLENP----------------------------- 49 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~--~L~L~~n~i~~~~~~~~~~~----------------------------- 49 (708)
+++|++|+|++|+++.+.+..|..+++|+ +|++++|.+.+..|..+...
T Consensus 152 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~ 231 (606)
T 3t6q_A 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLW 231 (606)
T ss_dssp CTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEE
T ss_pred CcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhhee
Confidence 35667777777777766666677777777 67777777776666555432
Q ss_pred -----------------------CcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccC
Q 039322 50 -----------------------MLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNS 106 (708)
Q Consensus 50 -----------------------~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~ 106 (708)
+|+.|++++|.+.+..+..+..+++|++|++++|.++ .+|..+.++++|++|++++
T Consensus 232 ~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~ 310 (606)
T 3t6q_A 232 LGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310 (606)
T ss_dssp CCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTT
T ss_pred chhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECcc
Confidence 5677788888888878888999999999999999999 7788899999999999999
Q ss_pred CccccccccccCCCCCCCEEEcccCccee-eCCCCCCCCCCCCEEEcccCcccccC--CccccCCCCCCEEecccccccc
Q 039322 107 NNLTGNISEALGIYPNLTFIDLSRNDFYG-EISSNWGKCPKLGTLNVSMNNITGGI--PREIGNSSQLQALDLSLNHIVG 183 (708)
Q Consensus 107 n~i~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~L~~n~l~~ 183 (708)
|.++++.+..+..+++|++|++++|.+.+ +.+..+..+++|++|++++|.+++.. +..+..+++|++|++++|++.+
T Consensus 311 n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 390 (606)
T 3t6q_A 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS 390 (606)
T ss_dssp CCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEE
T ss_pred CCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCc
Confidence 99999989999999999999999999874 55566899999999999999999766 7789999999999999999998
Q ss_pred cCCcccCCCCCCCEEEccCccccccCCcc-cCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccC---CCh
Q 039322 184 EIPKELGKLNSLTELILRGNQFTGRLPPE-IGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLE---LPK 259 (708)
Q Consensus 184 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~ 259 (708)
..+..+..+++|++|++++|++++..+.. +..+++|++|++++|.+++..+..+..+++|+.|++++|++++. .+.
T Consensus 391 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 470 (606)
T 3t6q_A 391 LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTN 470 (606)
T ss_dssp ECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSC
T ss_pred CCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccch
Confidence 88899999999999999999999776544 89999999999999999988899999999999999999999862 346
Q ss_pred hhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCCC-ccccccC
Q 039322 260 ELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPN-STAFRNA 338 (708)
Q Consensus 260 ~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~~ 338 (708)
.+..+++|+.|++++|.+++..|..+..+++|+.|++++|++++..|..+..++.| .|++++|++++.+|. ...++.+
T Consensus 471 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L 549 (606)
T 3t6q_A 471 SLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQ 549 (606)
T ss_dssp GGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTS
T ss_pred hhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCC
Confidence 79999999999999999998889999999999999999999999999999999999 999999999998776 3567889
Q ss_pred cccccccccCcCCCC
Q 039322 339 PVEALKGNKGLCGGV 353 (708)
Q Consensus 339 ~~~~~~~n~~~c~~~ 353 (708)
+.+.+.+|||.|+|+
T Consensus 550 ~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 550 RTINLRQNPLDCTCS 564 (606)
T ss_dssp SEEECTTCCEECSGG
T ss_pred CEEeCCCCCccccCC
Confidence 999999999999885
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=346.01 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=207.5
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.++|++.+.||+|+||.||+|...++..||+|+++... ...+++.+|++++++++||||+++++++.+++..++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-----MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-----BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-----CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 47899999999999999999998888899999997532 2346789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EEccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 99999999999996543 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 595 ESSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 595 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
.... .....+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||+..... .....+........+.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~ 228 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--------EVVLKVSQGHRLYRPH 228 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTCCCCCCT
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--------HHHHHHHcCCCCCCCC
Confidence 3222 223445678999999998889999999999999999999 99998743221 1111111111111111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. +..+.+++.+||+.||++|||++|++++|+
T Consensus 229 ~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 260 (268)
T 3sxs_A 229 LA---SDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260 (268)
T ss_dssp TS---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHG
T ss_pred cC---hHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11 235888999999999999999999999985
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=347.41 Aligned_cols=251 Identities=24% Similarity=0.404 Sum_probs=206.9
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-----cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 6899999999999999999998889999999998632 23467899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp ECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999996543 3589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CC-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 596 SS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 596 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
.. ......+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||..... ......+........+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~ 231 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFRLYKPRL 231 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCCCCCCTT
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhcCccCCCCCc
Confidence 21 1233456778999999998899999999999999999999 9999874322 111111111111111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+.+++.+||+.||++|||++|++++|+
T Consensus 232 ---~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~ 262 (269)
T 4hcu_A 232 ---ASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 262 (269)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---CCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 1235788999999999999999999999985
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=352.00 Aligned_cols=264 Identities=21% Similarity=0.292 Sum_probs=209.8
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC--eeE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR--HSF 512 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--~~~ 512 (708)
++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+.+|++++++++||||+++++++...+ ..+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS---FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG---GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc---ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 68999999999999999999765 58999999987521 2234567889999999999999999999998765 789
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee----CCCCcEEEeeccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL----DLEYEAHVADFGI 588 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~ 588 (708)
+||||+++|+|.+++........+++..++.++.|++.||+|||++ ||+||||||+||++ +.++.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 9999999999999998766555589999999999999999999999 99999999999999 7778899999999
Q ss_pred ccccCCCCCccccccccccccCccccc--------cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccc----
Q 039322 589 AKFLKPESSNWTEFAGTYGYVAPELAY--------TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTD---- 656 (708)
Q Consensus 589 a~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~---- 656 (708)
++...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||..............
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 98765443 334567899999999876 46788999999999999999999999863221100000000
Q ss_pred -------cccc------cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 657 -------IALD------EILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 657 -------~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.... ....+.++............+.+++.+||+.||++|||++|++++.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 0000 0011122332333455666788999999999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=355.95 Aligned_cols=263 Identities=24% Similarity=0.359 Sum_probs=203.9
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC----e
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR----H 510 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----~ 510 (708)
.++|++.+.||+|+||.||+|... ++.||||++... ......+..|+.++++++||||+++++++..+. .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 378999999999999999999875 889999998642 233455667899999999999999999998754 4
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCeEEccCCCCCeeeCCCCcEEE
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD-------CFPPIVHQDISSKNLLLDLEYEAHV 583 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-------~~~~ivH~dlk~~Nill~~~~~~kl 583 (708)
.++||||+++|+|.+++... .+++..++.++.|++.||+|||+. +.++|+||||||+||+++.++.+||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 69999999999999999653 389999999999999999999986 2348999999999999999999999
Q ss_pred eecccccccCCCCCc--cccccccccccCccccccC-----CCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc---
Q 039322 584 ADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTM-----KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL--- 653 (708)
Q Consensus 584 ~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~--- 653 (708)
+|||+++........ .....||+.|+|||++.+. .++.++|||||||++|||+||+.||...........
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999876543322 2345789999999998763 456688999999999999999999874322110000
Q ss_pred -----ccccccccccCCCCCCCC-c--hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 -----NTDIALDEILDPRLPPPS-R--SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 -----~~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...............+.. . .....+..+.+++.+||+.||++|||++|+++.|+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 314 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 001111111111111111 1 12234556899999999999999999999999885
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=351.90 Aligned_cols=258 Identities=26% Similarity=0.374 Sum_probs=203.4
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|.. .+++.||+|.+..... ......+.+.+|++++++++||||+++++++..++..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 36899999999999999999965 4689999999865322 233456789999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++.... .+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999997543 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC-C
Q 039322 594 PESS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP-S 671 (708)
Q Consensus 594 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 671 (708)
.... ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||+...... .... ......+.. .
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-------~~~~-~~~~~~~~~~~ 234 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-------IAIK-HIQDSVPNVTT 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH-------HHHH-HHSSCCCCHHH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHH-HhhccCCCcch
Confidence 4322 2334568999999999999999999999999999999999999997432211 0011 111111110 0
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRP-TMKVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~l~ 707 (708)
......+..+.+++.+||++||++|| +++++.+.|+
T Consensus 235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 01112234688999999999999999 8888887764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=356.70 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=189.7
Q ss_pred cceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCeeEEEEEec
Q 039322 441 QYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARHSFLVYELL 518 (708)
Q Consensus 441 ~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~ 518 (708)
.+.||+|+||.||+|... +++.||||++.. .....+.+|+++++.+. ||||+++++++.+++..++||||+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-------~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 88 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK-------RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL 88 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG-------GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh-------hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence 378999999999999664 689999999864 23566788999999997 999999999999999999999999
Q ss_pred cCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC---cEEEeecccccccCCC
Q 039322 519 ERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY---EAHVADFGIAKFLKPE 595 (708)
Q Consensus 519 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~~~~~~ 595 (708)
++|+|.+++... ..+++.+++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++......
T Consensus 89 ~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 89 NGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 999999999764 3489999999999999999999999 999999999999998765 8999999999877655
Q ss_pred CCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhH
Q 039322 596 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQ 675 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (708)
........+|+.|+|||++.+..++.++||||+|+++|+|++|+.||........ ..........+...........+.
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~i~~~~~~~~~~~~~ 241 (325)
T 3kn6_A 163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVEIMKKIKKGDFSFEGEAWK 241 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTTTCCCCCSHHHH
T ss_pred CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHHHHHHHHcCCCCCCccccc
Confidence 5555667789999999999999999999999999999999999999974322110 111122334444555544444444
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 676 EKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 676 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
..+..+.+++.+||+.||++|||++|+++|-++
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~ 274 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWL 274 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGG
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhcChhh
Confidence 455678999999999999999999999987553
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=356.04 Aligned_cols=254 Identities=20% Similarity=0.375 Sum_probs=206.5
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR---- 509 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~---- 509 (708)
.++|++.+.||+|+||.||+|... +|+.||||+++... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 478999999999999999999765 79999999997532 2234678999999999999999999999986543
Q ss_pred -----------------------------------------------------eeEEEEEeccCCCHHHHhcccccccCC
Q 039322 510 -----------------------------------------------------HSFLVYELLERGSLAAILSSDTAAQEL 536 (708)
Q Consensus 510 -----------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l 536 (708)
..++||||+++|+|.+++.........
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 379999999999999999877666667
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCC------------ccccccc
Q 039322 537 GWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS------------NWTEFAG 604 (708)
Q Consensus 537 ~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~~ 604 (708)
++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++........ ......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 8888999999999999999999 999999999999999999999999999987754421 1233568
Q ss_pred cccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHH
Q 039322 605 TYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEV 684 (708)
Q Consensus 605 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 684 (708)
|+.|+|||++.+..++.++||||+|+++|||++|..|+... ............ +.........+.++
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----------~~~~~~~~~~~~---~~~~~~~~~~~~~l 305 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----------VRIITDVRNLKF---PLLFTQKYPQEHMM 305 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----------HHHHHHHHTTCC---CHHHHHHCHHHHHH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----------HHHHHHhhccCC---CcccccCChhHHHH
Confidence 99999999999989999999999999999999998875311 111111122221 12233444567899
Q ss_pred HHhccCCCCCCCCCHHHHHHHhh
Q 039322 685 AFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 685 i~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+.+||+.||++|||++|++++-+
T Consensus 306 i~~~l~~~p~~Rps~~~~l~~~~ 328 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIENAI 328 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHHSTT
T ss_pred HHHHccCCCCcCCCHHHHhhchh
Confidence 99999999999999999999754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=360.93 Aligned_cols=256 Identities=19% Similarity=0.283 Sum_probs=208.4
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|.. .+|+.||+|++... .......+.+|++++++++||||+++++++.+++..++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc----chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 36899999999999999999965 46899999998753 22345678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC--CCcEEEeecccccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL--EYEAHVADFGIAKF 591 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~ 591 (708)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ ||+||||||+||+++. ++.+||+|||++..
T Consensus 126 v~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEeccccee
Confidence 999999999999996543 3589999999999999999999999 9999999999999974 47799999999987
Q ss_pred cCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 592 LKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.........
T Consensus 201 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------~~~~~i~~~~~~~~~ 271 (387)
T 1kob_A 201 LNPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--------ETLQNVKRCDWEFDE 271 (387)
T ss_dssp CCTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHHCCCCCCS
T ss_pred cCCCc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCc
Confidence 65432 334557999999999999989999999999999999999999999743211 111111111111111
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.........+.+++.+||+.||++|||++|+++|-++
T Consensus 272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (387)
T 1kob_A 272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 308 (387)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccc
Confidence 1111223458899999999999999999999998553
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=351.84 Aligned_cols=254 Identities=25% Similarity=0.396 Sum_probs=198.0
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHh--ccCCceeeEEEEEeeC----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTE--IRHRNIVKFYGFCSHA---- 508 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~l~~~~~~~---- 508 (708)
.++|++.+.||+|+||.||+|.. +++.||||++.. .....+..|.+++.. ++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~-------~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS-------RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG-------GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc-------ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 47899999999999999999987 689999999864 234556667777666 7899999999987543
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEccCCCCCeeeCCCCc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH--------HDCFPPIVHQDISSKNLLLDLEYE 580 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--------~~~~~~ivH~dlk~~Nill~~~~~ 580 (708)
...++||||+++|+|.++++.. .+++..++.++.|++.||+||| +. +|+||||||+||+++.++.
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSC
T ss_pred ceeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCC
Confidence 4689999999999999999543 4899999999999999999999 77 9999999999999999999
Q ss_pred EEEeecccccccCCCCCc----cccccccccccCccccccC------CCCcchhHHHHHHHHHHHHhC----------CC
Q 039322 581 AHVADFGIAKFLKPESSN----WTEFAGTYGYVAPELAYTM------KITEKCDVYSFGVLVLEAIKG----------KH 640 (708)
Q Consensus 581 ~kl~Dfg~a~~~~~~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~~l~elltg----------~~ 640 (708)
+||+|||+++........ .....||+.|+|||++.+. .++.++||||||+++|||++| +.
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 999999999866543332 2234789999999998876 455789999999999999999 67
Q ss_pred CCCcccccccccccccccccc--ccCCCCCCCC--chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 641 PRDFLSLISSSSLNTDIALDE--ILDPRLPPPS--RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 641 p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
||........ ....... ..+...+..+ .........+.+++.+||+.||++|||++|+++.|+
T Consensus 232 pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 298 (301)
T 3q4u_A 232 PFYDVVPNDP----SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298 (301)
T ss_dssp TTTTTSCSSC----CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred cccccCCCCc----chhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence 7643211100 0001111 1111111111 122345667999999999999999999999999885
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=356.33 Aligned_cols=261 Identities=23% Similarity=0.321 Sum_probs=208.8
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~l 513 (708)
++|++.+.||+|+||.||+|..+ +++.||+|++++... ......+.+.+|..+++++ +||||+++++++.+++..++
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS-CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh-cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 68999999999999999999764 688999999976322 2234456788999999988 89999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999999654 3489999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc-cccccccccccCCCCCCCCc
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS-LNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 672 (708)
..........||+.|+|||++.+..++.++||||+||++|||++|+.||.......... .........+.......+..
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 241 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence 44444556789999999999999899999999999999999999999997432211110 01111112222222222211
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTM------KVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~l~ 707 (708)
....+.+++.+||+.||++||++ +|+++|-+
T Consensus 242 ----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~ 278 (345)
T 3a8x_A 242 ----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278 (345)
T ss_dssp ----SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred ----CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence 22357889999999999999995 78887643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=364.15 Aligned_cols=253 Identities=24% Similarity=0.400 Sum_probs=205.9
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+.+|++++++++||||+++++++..++..++
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS---CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 478999999999999999999775 78999999987532 22345678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 190 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 999999999999997543 3589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCcc--ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCC
Q 039322 594 PESSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP-RLPP 669 (708)
Q Consensus 594 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 669 (708)
...... ....+++.|+|||.+.++.++.++||||||+++|||+| |..||...... .....+... +.+.
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~ 336 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--------QTREFVEKGGRLPC 336 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--------HHHHHHHTTCCCCC
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCC
Confidence 321111 12235778999999998899999999999999999998 99998743221 111111111 1111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+ .. .+..+.+++.+||+.||++|||++++++.|+
T Consensus 337 ~-~~---~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 370 (377)
T 3cbl_A 337 P-EL---CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370 (377)
T ss_dssp C-TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C-CC---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 1 11 1235788999999999999999999999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=356.79 Aligned_cols=252 Identities=21% Similarity=0.295 Sum_probs=203.9
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|.+.+.||+|+||.||+|.. .+++.||+|++..... ........+.+|+++++.++||||+++++++..++..++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL-KKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc-cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 37899999999999999999975 5789999999864210 011123578899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+ +|+|.+++... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus 87 v~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 99999 67999988654 3489999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
.. .......||+.|+|||++.+..+ +.++||||+|+++|+|++|+.||+.... ......+.......+..
T Consensus 160 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~~~~i~~~~~~~p~~ 230 (336)
T 3h4j_B 160 DG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI--------PNLFKKVNSCVYVMPDF 230 (336)
T ss_dssp TS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS--------TTCBCCCCSSCCCCCTT
T ss_pred CC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHcCCCCCccc
Confidence 43 23345679999999999988775 6899999999999999999999974221 11111111111111111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+..+.+++.+||+.||++|||++|+++|-+
T Consensus 231 ----~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 231 ----LSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp ----SCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred ----CCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 1235788999999999999999999998754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=358.54 Aligned_cols=256 Identities=24% Similarity=0.317 Sum_probs=207.3
Q ss_pred HHhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCe
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARH 510 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 510 (708)
...++|++.+.||+|+||.||+|..+ +|+.||+|++++... ......+.+..|.++++.+ +||||+++++++.+++.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh-hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34589999999999999999999764 688999999875210 0112355678899999887 89999999999999999
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 99999999999999999754 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 591 FLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
.............||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~p 238 (345)
T 1xjd_A 167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMDNPFYP 238 (345)
T ss_dssp CCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCC
T ss_pred hcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHhCCCCCC
Confidence 654444445567899999999999998999999999999999999999999974321 111122221121111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHHhh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMK-VVTQQVR 707 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~l~ 707 (708)
.. ....+.+++.+||+.||++||++. |+++|-+
T Consensus 239 ~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~ 272 (345)
T 1xjd_A 239 RW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272 (345)
T ss_dssp TT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred cc----cCHHHHHHHHHHhcCCHhHcCCChHHHHcCcc
Confidence 11 123578899999999999999998 8877643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=360.84 Aligned_cols=253 Identities=23% Similarity=0.443 Sum_probs=195.2
Q ss_pred hccccccceeccccCccEEEEEeC----CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
..+|++.+.||+|+||.||+|... ++..||||+++... .....+.+.+|++++++++||||+++++++.+++.
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 368999999999999999999764 57789999997632 23456789999999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 999999999999999997543 4589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcc---ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-
Q 039322 591 FLKPESSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP- 665 (708)
Q Consensus 591 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 665 (708)
......... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .....+...
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--------~~~~~i~~~~ 267 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------DVIKAVDEGY 267 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--------HHHHHHHTTE
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCC
Confidence 765432221 22335678999999999999999999999999999998 99998643211 111111111
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 666 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+.+. ..+..+.+++.+||+.||++||+++||++.|+
T Consensus 268 ~~~~~~----~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~ 305 (373)
T 2qol_A 268 RLPPPM----DCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305 (373)
T ss_dssp ECCCCT----TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCc----cccHHHHHHHHHHhCcChhhCcCHHHHHHHHH
Confidence 111111 12345889999999999999999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=350.88 Aligned_cols=256 Identities=22% Similarity=0.323 Sum_probs=199.7
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcch----------------------hHhHHHHHHHHHHHH
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQ----------------------IADQKEFLIEVKALT 491 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~----------------------~~~~~~~~~e~~~l~ 491 (708)
.++|++.+.||+|+||.||+|.. .+++.||||++........ ....+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 37899999999999999999965 4688999999875321110 112356889999999
Q ss_pred hccCCceeeEEEEEee--CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCC
Q 039322 492 EIRHRNIVKFYGFCSH--ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDIS 569 (708)
Q Consensus 492 ~l~h~~iv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk 569 (708)
+++||||+++++++.+ .+..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||++ ||+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 9999999999999987 5688999999999999886543 3489999999999999999999999 99999999
Q ss_pred CCCeeeCCCCcEEEeecccccccCCCCCccccccccccccCccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCccc
Q 039322 570 SKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMK---ITEKCDVYSFGVLVLEAIKGKHPRDFLS 646 (708)
Q Consensus 570 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~~l~elltg~~p~~~~~ 646 (708)
|+||+++.++.+||+|||++..............||+.|+|||.+.+.. .+.++||||||+++|+|++|+.||....
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999999987765544445667999999999987655 3778999999999999999999997432
Q ss_pred cccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 647 LISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
... ....+.......+. ....+..+.+++.+||+.||++|||++|+++|-+
T Consensus 245 ~~~--------~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 245 IMC--------LHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp HHH--------HHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred HHH--------HHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 111 01111111111110 0011235889999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=353.96 Aligned_cols=256 Identities=24% Similarity=0.331 Sum_probs=204.2
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc---ccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 378999999999999999999654 78999999986532 12234668899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++.... .+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++..+.
T Consensus 83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 999999999999996543 489999999999999999999999 99999999999999999999999999998654
Q ss_pred CCC--CccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 594 PES--SNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 594 ~~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
... .......||+.|+|||++.+..+ +.++||||+|+++|+|++|+.||+..... ......+........
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~~~ 229 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-------CQEYSDWKEKKTYLN 229 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT-------SHHHHHHHTTCTTST
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH-------HHHHHHHhcccccCC
Confidence 322 22345678999999999987775 67899999999999999999999743211 011111111111111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
........+.+++.+||+.||++|||++|++++-++
T Consensus 230 --~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 265 (323)
T 3tki_A 230 --PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265 (323)
T ss_dssp --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred --ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 111223457789999999999999999999987653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=350.52 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=207.0
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +|+.||+|++++.. .......+.+.+|..+++.++||||+++++++.+.+..++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI-VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 378999999999999999999664 69999999987521 0111235678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++.... .+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp EECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999997543 489999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
. ......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ......+.......+..
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~~p~~- 225 (318)
T 1fot_A 158 D---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNAELRFPPF- 225 (318)
T ss_dssp S---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHCCCCCCTT-
T ss_pred C---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCCC-
Confidence 3 22345789999999999999999999999999999999999999964221 11222222222222211
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRP-----TMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~ 707 (708)
....+.+++.+|++.||++|| +++|+++|-+
T Consensus 226 ---~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 226 ---FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261 (318)
T ss_dssp ---SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred ---CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence 123578899999999999999 8999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=345.48 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=193.4
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.++|++.+.||+|+||.||+|... ++.||||+++...........+.+.+|+++++.++||||+++++++..++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 368999999999999999999874 8899999987643333234457899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC--------CCcEEEeec
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL--------EYEAHVADF 586 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--------~~~~kl~Df 586 (708)
|||+++++|.+++.. ..+++..++.++.|++.||+|||++...+++||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999999864 34899999999999999999999992112999999999999986 678999999
Q ss_pred ccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 039322 587 GIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPR 666 (708)
Q Consensus 587 g~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (708)
|++....... .....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||....... .........
T Consensus 161 g~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~ 230 (271)
T 3dtc_A 161 GLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA--------VAYGVAMNK 230 (271)
T ss_dssp CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH--------HHHHHHTSC
T ss_pred Cccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHhhhcCC
Confidence 9998654332 234578999999999999889999999999999999999999997432111 111111111
Q ss_pred CC-CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 667 LP-PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 667 ~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. +... ..+..+.+++.+||+.||++|||++|++++|+
T Consensus 231 ~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~ 269 (271)
T 3dtc_A 231 LALPIPS---TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269 (271)
T ss_dssp CCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCc---ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence 11 1111 11235889999999999999999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=350.02 Aligned_cols=264 Identities=23% Similarity=0.329 Sum_probs=201.6
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
++|++.+.||+|+||.||+|...+|+.||+|++.... ......+.+.+|++++++++||||+++++++..++..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSS--GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccc--cccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 5789999999999999999988889999999997532 22223467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++ +|.+++.... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++......
T Consensus 80 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp ECCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 99986 9999886543 4589999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc----------ccccccc--cc
Q 039322 596 SSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL----------NTDIALD--EI 662 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~----------~~~~~~~--~~ 662 (708)
........+|+.|+|||++.+. .++.++||||+|+++|||++|+.||........... ....... ..
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 4444556789999999998764 589999999999999999999999974321100000 0000000 00
Q ss_pred cCCCCCC----C-CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 663 LDPRLPP----P-SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 663 ~~~~~~~----~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.++.... + ..........+.+++.+||+.||++|||++|+++|-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 283 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 0111100 0 0000112345789999999999999999999998855
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=356.84 Aligned_cols=254 Identities=23% Similarity=0.322 Sum_probs=193.2
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +++.||||+++.. ...+.+.+|++++++++||||+++++++..++..++
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT------VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc------hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 477999999999999999999765 5889999999753 234568889999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC---CCcEEEeeccccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL---EYEAHVADFGIAK 590 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~ 590 (708)
||||+++|+|.+++.... .+++.+++.++.|++.||+|||++ ||+||||||+||+++. ++.+||+|||+++
T Consensus 126 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp EECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 999999999999996543 489999999999999999999999 9999999999999975 8899999999998
Q ss_pred ccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 591 FLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......+........
T Consensus 200 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~i~~~~~~~~ 271 (349)
T 2w4o_A 200 IVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG-------DQFMFRRILNCEYYFI 271 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC-------HHHHHHHHHTTCCCCC
T ss_pred ccCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc-------cHHHHHHHHhCCCccC
Confidence 65432 223456789999999999998999999999999999999999999863221 1112222222222222
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
..........+.+++.+||+.||++|||+.|+++|-++
T Consensus 272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 309 (349)
T 2w4o_A 272 SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309 (349)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 11222234468899999999999999999999998553
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=345.98 Aligned_cols=252 Identities=23% Similarity=0.415 Sum_probs=204.3
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.++|++.+.||+|+||.||+|...++..||+|++.... ...+++.+|++++++++||||+++++++.+++..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-----CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 47899999999999999999998888899999998632 2346789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... ..+++.+++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 98 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 98 TEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp ECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999997533 4589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCC-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 595 ESS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 595 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
... ......+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||...... .....+........+.
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~ 244 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQGLRLYRPH 244 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTCCCCCCT
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--------HHHHHHhcccCCCCCC
Confidence 211 1223446788999999998899999999999999999998 99998743221 1111111111111111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. ...+.+++.+||+.||++|||++|++++|+
T Consensus 245 ~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 276 (283)
T 3gen_A 245 LA---SEKVYTIMYSCWHEKADERPTFKILLSNIL 276 (283)
T ss_dssp TC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred cC---CHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 11 235888999999999999999999999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=358.84 Aligned_cols=251 Identities=21% Similarity=0.280 Sum_probs=200.7
Q ss_pred cccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEe
Q 039322 439 DAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYEL 517 (708)
Q Consensus 439 ~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 517 (708)
...+.||+|+||.||+|.. .+|+.||+|+++.. .....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR----GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc----ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 3466899999999999965 56899999998763 234567899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee--CCCCcEEEeecccccccCCC
Q 039322 518 LERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL--DLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 518 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfg~a~~~~~~ 595 (708)
+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.....
T Consensus 168 ~~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 168 VDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp CTTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 99999999886433 3589999999999999999999999 99999999999999 56789999999999876543
Q ss_pred CCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhH
Q 039322 596 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQ 675 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (708)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+.....
T Consensus 243 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~~ 313 (373)
T 2x4f_A 243 E-KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--------AETLNNILACRWDLEDEEFQ 313 (373)
T ss_dssp C-BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCCSCSGGGT
T ss_pred c-ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhccCCCChhhhc
Confidence 2 33445799999999999988899999999999999999999999974321 11222222222222222222
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 676 EKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 676 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+.+++.+||+.||++|||++|+++|-+
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence 23446889999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=358.32 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=206.0
Q ss_pred hccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA 508 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 508 (708)
.++|++.+.||+|+||.||+|... +++.||||+++... .......+.+|+.++++++||||+++++++..+
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc---ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 368999999999999999999743 46789999997532 234456788999999999999999999999999
Q ss_pred CeeEEEEEeccCCCHHHHhcccc----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC---cE
Q 039322 509 RHSFLVYELLERGSLAAILSSDT----AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY---EA 581 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~ 581 (708)
+..++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||++ ||+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999997543 123589999999999999999999999 999999999999999555 59
Q ss_pred EEeecccccccCCCC--CccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccc
Q 039322 582 HVADFGIAKFLKPES--SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIA 658 (708)
Q Consensus 582 kl~Dfg~a~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 658 (708)
||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ...
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~~ 295 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEV 295 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHH
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHH
Confidence 999999997543221 22234567899999999999999999999999999999998 9999874321 111
Q ss_pred cccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 659 LDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+............ +..+.+++.+||+.||++|||++|++++|+
T Consensus 296 ~~~i~~~~~~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~eil~~l~ 341 (367)
T 3l9p_A 296 LEFVTSGGRMDPPKNC---PGPVYRIMTQCWQHQPEDRPNFAIILERIE 341 (367)
T ss_dssp HHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHcCCCCCCCccC---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 2222222211111111 235788999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=357.58 Aligned_cols=256 Identities=22% Similarity=0.367 Sum_probs=208.7
Q ss_pred hccccccceeccccCccEEEEEeC--------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP--------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFC 505 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~ 505 (708)
.++|.+.+.||+|+||.||+|... .++.||||+++... .....+.+.+|+++++++ +||||+++++++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc---CHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 478999999999999999999642 34579999997642 234567899999999999 899999999999
Q ss_pred eeCCeeEEEEEeccCCCHHHHhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 039322 506 SHARHSFLVYELLERGSLAAILSSDTA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKN 572 (708)
Q Consensus 506 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N 572 (708)
..++..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 999999999999999999999976432 24589999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccc
Q 039322 573 LLLDLEYEAHVADFGIAKFLKPESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLIS 649 (708)
Q Consensus 573 ill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~ 649 (708)
|+++.++.+||+|||+++....... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-- 299 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 299 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999987654332 2234557889999999999999999999999999999999 9999874321
Q ss_pred ccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 650 SSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+........+.. ....+.+++.+||+.||++|||++|++++|+
T Consensus 300 ------~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 348 (382)
T 3tt0_A 300 ------EELFKLLKEGHRMDKPSN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348 (382)
T ss_dssp ------HHHHHHHHTTCCCCCCSS---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ------HHHHHHHHcCCCCCCCcc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111111111111111111 1235888999999999999999999999885
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=344.25 Aligned_cols=264 Identities=19% Similarity=0.258 Sum_probs=203.2
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|... +++.||+|++..... .......+.+|++++++++||||+++++++.+++..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 57999999999999999999664 689999999976432 223456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++ ++.+++.... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred EecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 999986 6666554322 4589999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccc-----------cccccccccccc
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISS-----------SSLNTDIALDEI 662 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-----------~~~~~~~~~~~~ 662 (708)
.........+|+.|+|||++.+.. ++.++||||+|+++|||++|+.||........ ............
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 555556678899999999988766 79999999999999999999888532111000 000000000000
Q ss_pred cCC-------CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 663 LDP-------RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 663 ~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+. ...............+.+++.+||+.||++|||++|+++|-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 285 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence 000 000000011122345789999999999999999999999854
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=368.89 Aligned_cols=352 Identities=18% Similarity=0.158 Sum_probs=234.8
Q ss_pred CCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeee-CCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEe
Q 039322 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGF-IPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFG 79 (708)
Q Consensus 2 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~ 79 (708)
++|++|+|++|+|+++.+..|+++++|++|+|++|.+.+. .+..+.. ++|+.|++++|.+.+..|..+..+++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 5789999999999998899999999999999999988644 4556655 8899999999999988899999999999999
Q ss_pred ccCCccccccCcc--CcCCCCCcEEEccCCccccccccc-cCCCCCCCEEEcccCcceeeCCCCCCCC--CCCCEEEccc
Q 039322 80 VSENHFQGTIPKI--LRNCSSLIRVRLNSNNLTGNISEA-LGIYPNLTFIDLSRNDFYGEISSNWGKC--PKLGTLNVSM 154 (708)
Q Consensus 80 l~~n~i~~~~~~~--~~~l~~L~~L~l~~n~i~~~~~~~-~~~~~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~L~~ 154 (708)
+++|.+++..+.. |.++++|++|+|++|+++++.+.. |..+++|++|++++|+++++.+..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 9999998755444 889999999999999999887665 8899999999999999988888888766 6788888888
Q ss_pred CcccccCCcc--------ccCCCCCCEEecccccccccCCcccCCC---CCCCEEEccCcccccc----------CCccc
Q 039322 155 NNITGGIPRE--------IGNSSQLQALDLSLNHIVGEIPKELGKL---NSLTELILRGNQFTGR----------LPPEI 213 (708)
Q Consensus 155 N~i~~~~~~~--------~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~l~~n~l~~~----------~~~~~ 213 (708)
|.+....+.. +..+++|++|++++|++++..+..+... ++|+.|++++|.+.+. .+..+
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~ 269 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTT
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCccccc
Confidence 8887655443 2355788888888888876555443322 4455555554433211 01111
Q ss_pred CC--CCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccC
Q 039322 214 GS--LVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSL 291 (708)
Q Consensus 214 ~~--~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L 291 (708)
.. .++|++|++++|.+++..|..+..+++|+.|++++|++++..+..|.++++|+.|+|++|.+++..+..+..+++|
T Consensus 270 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 349 (455)
T 3v47_A 270 KGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKL 349 (455)
T ss_dssp GGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTC
T ss_pred ccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccC
Confidence 11 1345555555555555455555555555555555555554445555555555555555555554444455555555
Q ss_pred CceecccccccCCCCCcccccccccEEecCCCcCCCCCCCc-cccccCcccccccccCcCCCC
Q 039322 292 EKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNS-TAFRNAPVEALKGNKGLCGGV 353 (708)
Q Consensus 292 ~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~ 353 (708)
+.|++++|++++..|..+..+++|+.|++++|++++.++.. ..++.++.+.+.+|++.|+|+
T Consensus 350 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 350 EVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 55555555555444555555555555555555555444332 234445555555555555554
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=353.93 Aligned_cols=250 Identities=20% Similarity=0.245 Sum_probs=207.4
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|... +|+.||+|++.+.. .......+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK-VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHH-hccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 78999999999999999999764 68999999986421 01112356788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... .+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999997543 489999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+..
T Consensus 194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~p~~-- 260 (350)
T 1rdq_E 194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGKVRFPSH-- 260 (350)
T ss_dssp C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCTT--
T ss_pred C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHHHHcCCCCCCCC--
Confidence 2 2346799999999999998999999999999999999999999974221 12222222222222211
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPT-----MKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~ 707 (708)
....+.+++.+||+.||++||+ ++|+++|-+
T Consensus 261 --~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 261 --FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp --CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred --CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 1235789999999999999998 999988754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=355.31 Aligned_cols=259 Identities=22% Similarity=0.390 Sum_probs=209.6
Q ss_pred HHHhccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEE
Q 039322 432 VRATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFC 505 (708)
Q Consensus 432 ~~~~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~ 505 (708)
....++|++.+.||+|+||.||+|... +++.||||+++... .....+.+.+|++++++++||||+++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344589999999999999999999764 34789999997632 234467899999999999999999999999
Q ss_pred eeCCeeEEEEEeccCCCHHHHhccccc---------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 039322 506 SHARHSFLVYELLERGSLAAILSSDTA---------------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIV 564 (708)
Q Consensus 506 ~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~iv 564 (708)
.+++..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||++ ||+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 999999999999999999999976431 14689999999999999999999999 999
Q ss_pred EccCCCCCeeeCCCCcEEEeecccccccCCCCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCC
Q 039322 565 HQDISSKNLLLDLEYEAHVADFGIAKFLKPESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHP 641 (708)
Q Consensus 565 H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p 641 (708)
||||||+||+++.++.+||+|||++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999986543221 2234567889999999998899999999999999999999 9999
Q ss_pred CCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 642 RDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
|..... ......+.+......+.. .+..+.+++.+||+.||++|||++|++++|+
T Consensus 277 ~~~~~~--------~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~ 331 (343)
T 1luf_A 277 YYGMAH--------EEVIYYVRDGNILACPEN---CPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331 (343)
T ss_dssp TTTSCH--------HHHHHHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCh--------HHHHHHHhCCCcCCCCCC---CCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence 874321 111222222222221111 2235889999999999999999999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=355.86 Aligned_cols=254 Identities=20% Similarity=0.289 Sum_probs=208.1
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~ 512 (708)
.++|++.+.||+|+||.||+|..+ +|+.||+|++++... ......+.+..|.+++..+ +||+|+++++++.+.+..|
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH-HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 478999999999999999999765 478999999875210 0112356788899999988 7999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++...
T Consensus 98 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999997543 489999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+..
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~p~~ 243 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHNVAYPKS 243 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCTT
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhCCCCCCCC
Confidence 4444445567899999999999999999999999999999999999999974221 12222233222222211
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPT-----MKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~ 707 (708)
....+.+++.+||++||++||+ ++|+++|-+
T Consensus 244 ----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~ 279 (353)
T 2i0e_A 244 ----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279 (353)
T ss_dssp ----SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred ----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence 2235788999999999999995 688887743
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=359.90 Aligned_cols=264 Identities=20% Similarity=0.344 Sum_probs=208.9
Q ss_pred HHHHHHHhccccccceeccccCccEEEEEe------CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceee
Q 039322 428 YDEIVRATNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVK 500 (708)
Q Consensus 428 ~~~~~~~~~~~~~~~~ig~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~ 500 (708)
..++....++|++.+.||+|+||.||+|.+ .+++.||||+++... .....+.+.+|+++++++ +||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC---CHHHHHHHHHHHHHHHhhcCCcceee
Confidence 344555678999999999999999999963 346789999997632 234457799999999999 7899999
Q ss_pred EEEEEeeCC-eeEEEEEeccCCCHHHHhccccc-----------------------------------------------
Q 039322 501 FYGFCSHAR-HSFLVYELLERGSLAAILSSDTA----------------------------------------------- 532 (708)
Q Consensus 501 l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------- 532 (708)
+++++.+++ ..++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998765 48999999999999999976532
Q ss_pred ----------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 039322 533 ----------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES 596 (708)
Q Consensus 533 ----------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 596 (708)
...+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 11288999999999999999999999 99999999999999999999999999998664433
Q ss_pred C--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 597 S--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 597 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
. ......+|+.|+|||++.+..++.++||||||+++|||+| |+.||....... .....+........+..
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~ 320 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCRRLKEGTRMRAPDY 320 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-------HHHHHHHHTCCCCCCTT
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-------HHHHHHHcCCCCCCCCC
Confidence 2 2334568899999999999999999999999999999998 999987432110 01111111111111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+.+++.+||+.||++|||++|++++|+
T Consensus 321 ---~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 351 (359)
T 3vhe_A 321 ---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351 (359)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---CCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 1235788999999999999999999999985
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=355.78 Aligned_cols=256 Identities=24% Similarity=0.357 Sum_probs=205.3
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +++.||+|++.+.. .........+.+|++++++++||||+++++++.+++..++
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~-~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQK-CVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhh-cccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 378999999999999999999654 68899999986421 0112235678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+.+|+|.+++.... .+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus 93 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999997543 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccccccccccccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 594 PESSNWTEFAGTYGYVAPELAYT---MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .......+.......+
T Consensus 167 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~~p 240 (384)
T 4fr4_A 167 RE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-----SKEIVHTFETTVVTYP 240 (384)
T ss_dssp TT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-----HHHHHHHHHHCCCCCC
T ss_pred CC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHHhhcccCCC
Confidence 33 33456689999999999864 458899999999999999999999997422111 1111111111111111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHhh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPT-MKVVTQQVR 707 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~l~ 707 (708)
.. ....+.+++.+||+.||++||+ ++++.+|-+
T Consensus 241 ~~----~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~ 274 (384)
T 4fr4_A 241 SA----WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274 (384)
T ss_dssp TT----SCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGG
T ss_pred Cc----CCHHHHHHHHHHhcCCHhHhcccHHHHHcChh
Confidence 11 1235789999999999999998 888877643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=347.99 Aligned_cols=261 Identities=23% Similarity=0.356 Sum_probs=202.2
Q ss_pred hccccccceeccccCccEEEEEe-----CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC-
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA- 508 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~- 508 (708)
.++|++.+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 37899999999999999999973 36889999998753 334567899999999999999999999998654
Q ss_pred -CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecc
Q 039322 509 -RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFG 587 (708)
Q Consensus 509 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 587 (708)
...++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CCceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCc
Confidence 56899999999999999997654 3489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCc---cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccc----cccc----cc
Q 039322 588 IAKFLKPESSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISS----SSLN----TD 656 (708)
Q Consensus 588 ~a~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~----~~~~----~~ 656 (708)
++......... .....++..|+|||.+.+..++.++||||||+++|||+||..||........ .... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 99876543322 2334567789999999999999999999999999999999999864321100 0000 00
Q ss_pred cccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 657 IALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
............+.+.. .+..+.+++.+||+.||++|||++|+++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~el~~~L~ 287 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDG---CPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287 (295)
T ss_dssp HHHHHHHTTCCCCCCTT---CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHhccCcCCCCcC---cCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 11111111111111111 2235888999999999999999999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=349.57 Aligned_cols=259 Identities=20% Similarity=0.270 Sum_probs=210.6
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcch--hHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQ--IADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
.++|++.+.||+|+||.||+|... +|+.||+|.+........ ....+.+.+|++++++++||||+++++++.+++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 478999999999999999999764 689999999876432211 12367799999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC----cEEEeecc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY----EAHVADFG 587 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg 587 (708)
++||||+++++|.+++... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 9999999999999999754 3478999999999999999999999 999999999999999887 79999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.....
T Consensus 165 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANITSVSY 235 (321)
T ss_dssp TCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHTTCC
T ss_pred cceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhccc
Confidence 998765432 23455789999999999988999999999999999999999999864221 112222222222
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
..+.......+..+.+++.+||+.||++|||++|+++|-++
T Consensus 236 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~ 276 (321)
T 2a2a_A 236 DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (321)
T ss_dssp CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 22211112223468899999999999999999999998653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=342.62 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=185.9
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... .......+.+.+|++++++++||||+++++++.+.+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA-MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh-hhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 47899999999999999999975 578999999986411 0011224678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++++|.+++.... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999997543 4589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
..........+++.|+|||.+.+..++.++||||+|+++|||++|+.||...... .............+..
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~- 234 (278)
T 3cok_A 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK--------NTLNKVVLADYEMPSF- 234 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSSCCCCCTT-
T ss_pred CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH--------HHHHHHhhcccCCccc-
Confidence 4444444567899999999999888999999999999999999999998743211 1111111111111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+.+++.+||+.||++|||++|+++|-+
T Consensus 235 ---~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 265 (278)
T 3cok_A 235 ---LSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265 (278)
T ss_dssp ---SCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred ---cCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence 1235789999999999999999999998754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=369.05 Aligned_cols=258 Identities=21% Similarity=0.285 Sum_probs=207.0
Q ss_pred HHHHHhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC
Q 039322 430 EIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA 508 (708)
Q Consensus 430 ~~~~~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 508 (708)
++....++|++.+.||+|+||.||+|..+ +++.||+|++++.. .......+.+.+|+++++.++||||+++++++.++
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~-~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE-MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-HHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhh-hhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 44455689999999999999999999765 58899999986410 00011233578899999999999999999999999
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
+..|+||||+++|+|.+++... .+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence 9999999999999999999643 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC-ccccccccccccCccccccCC----CCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 039322 589 AKFLKPESS-NWTEFAGTYGYVAPELAYTMK----ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEIL 663 (708)
Q Consensus 589 a~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 663 (708)
|........ ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ......++
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~ 286 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIM 286 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--------hhHHHHHH
Confidence 987654332 223567999999999987655 77899999999999999999999974321 11112222
Q ss_pred CC----CCCCCCchhHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHhh
Q 039322 664 DP----RLPPPSRSVQEKLISIMEVAFSCLNESPES--RPTMKVVTQQVR 707 (708)
Q Consensus 664 ~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l~ 707 (708)
.. .++... .....+.++|.+|++.+|++ ||+++|+++|-+
T Consensus 287 ~~~~~~~~p~~~----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 287 NHKNSLTFPDDN----DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp THHHHCCCCTTC----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred hccccccCCCcc----cccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 11 111111 11235788999999999999 999999999865
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=357.31 Aligned_cols=255 Identities=21% Similarity=0.278 Sum_probs=205.5
Q ss_pred HhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCee
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~ 511 (708)
..++|++.+.||+|+||.||+|..+ +|+.||||++.+... ...+|++++.++ +||||+++++++.+++..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 3578999999999999999999664 688999999976321 234578888888 799999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC----CcEEEeecc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE----YEAHVADFG 587 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg 587 (708)
|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++ ||+||||||+||++..+ +.+||+|||
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 99999999999999996543 489999999999999999999999 99999999999998543 359999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
++..............||+.|+|||++.+..++.++||||+||++|||++|+.||..... .........+.....
T Consensus 166 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~~~~i~~~~~ 240 (342)
T 2qr7_A 166 FAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-----DTPEEILARIGSGKF 240 (342)
T ss_dssp TCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-----SCHHHHHHHHHHCCC
T ss_pred CcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-----CCHHHHHHHHccCCc
Confidence 998776555555567889999999999887889999999999999999999999974211 111122222222232
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+......+.+++.+||+.||++|||++|+++|-+
T Consensus 241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 2222222223446889999999999999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=347.17 Aligned_cols=256 Identities=21% Similarity=0.381 Sum_probs=207.9
Q ss_pred hccccccceeccccCccEEEEEe------CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA 508 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 508 (708)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+.+|++++++++||||+++++++.++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA---SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 47899999999999999999965 245789999997532 234567899999999999999999999999999
Q ss_pred CeeEEEEEeccCCCHHHHhccccc---------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTA---------------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQD 567 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~d 567 (708)
+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||++ |++|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence 999999999999999999976432 13478999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCc
Q 039322 568 ISSKNLLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDF 644 (708)
Q Consensus 568 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~ 644 (708)
|||+||+++.++.+||+|||++......... .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876543322 233456788999999998889999999999999999999 9999874
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 645 LSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
... ......+.......... ..+..+.+++.+||+.||++|||++|++++|+
T Consensus 256 ~~~--------~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~ 307 (314)
T 2ivs_A 256 IPP--------ERLFNLLKTGHRMERPD---NCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307 (314)
T ss_dssp CCG--------GGHHHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCH--------HHHHHHhhcCCcCCCCc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 322 11111111111111111 12335889999999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=363.86 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=207.5
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|.+.+.||+|+||.||+|... +|+.||||++.... .........+.+|+++++.++||||+++++++..++..++|
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQK-IRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHH-HHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh-ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 68999999999999999999764 79999999986421 01112356789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999999754 3489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
. .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||+.... ......+.+.....+...
T Consensus 169 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~p~~~ 239 (476)
T 2y94_A 169 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--------PTLFKKICDGIFYTPQYL 239 (476)
T ss_dssp T-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--------HHHHHHHHTTCCCCCTTC
T ss_pred c-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhcCCcCCCccC
Confidence 3 33345679999999999988765 6799999999999999999999974321 122223333332222111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+.+++.+||+.||++|||++|+++|-+
T Consensus 240 ----s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 240 ----NPSVISLLKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp ----CHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred ----CHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence 234788999999999999999999998743
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=342.60 Aligned_cols=256 Identities=22% Similarity=0.325 Sum_probs=207.2
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK--LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeeccc--CCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 47899999999999999999965 468999999986532 123445778899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc---EEEeeccccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE---AHVADFGIAK 590 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~a~ 590 (708)
||||+++|+|.+++... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++. +||+|||++.
T Consensus 83 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 99999999999988654 3489999999999999999999999 9999999999999987655 9999999998
Q ss_pred ccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 591 FLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
..... .......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||..... ......+.......+
T Consensus 157 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~ 227 (284)
T 3kk8_A 157 EVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQIKAGAYDYP 227 (284)
T ss_dssp ECCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCCC
T ss_pred EcccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--------hHHHHHHHhccccCC
Confidence 66533 233456789999999999999999999999999999999999999864321 111111111111111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..........+.+++.+||+.||++|||++|+++|-+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 228 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 1111122345889999999999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.93 Aligned_cols=266 Identities=24% Similarity=0.277 Sum_probs=206.2
Q ss_pred HHHHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCC-cchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC
Q 039322 431 IVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLP-CDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA 508 (708)
Q Consensus 431 ~~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 508 (708)
+....++|++.+.||+|+||.||+|.. .+++.||+|++..... .......+.+.+|++++++++||||+++++++.++
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345668999999999999999999965 5688999999864210 01123457899999999999999999999999999
Q ss_pred CeeEEEEEeccCCCHHHHhccccc-------------------------------------ccCCCHHHHHHHHHHHHHH
Q 039322 509 RHSFLVYELLERGSLAAILSSDTA-------------------------------------AQELGWSQRMNVIKGVADA 551 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~i~~~ 551 (708)
+..++||||+++|+|.+++..... ...+++..++.++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999852110 1123577888999999999
Q ss_pred HHHHHhCCCCCeEEccCCCCCeeeCCCC--cEEEeecccccccCCCCC----ccccccccccccCcccccc--CCCCcch
Q 039322 552 LSYLHHDCFPPIVHQDISSKNLLLDLEY--EAHVADFGIAKFLKPESS----NWTEFAGTYGYVAPELAYT--MKITEKC 623 (708)
Q Consensus 552 l~~Lh~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfg~a~~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~ 623 (708)
|+|||++ +|+||||||+||+++.++ .+||+|||++..+..... ......||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998776 899999999986543221 2345678999999999865 6688999
Q ss_pred hHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 039322 624 DVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVT 703 (708)
Q Consensus 624 DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 703 (708)
||||||+++|||++|+.||..... ......+..................+.+++.+||+.||++|||+.|++
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 329 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVND--------ADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 999999999999999999974322 122222222332222222222345688999999999999999999999
Q ss_pred HHhh
Q 039322 704 QQVR 707 (708)
Q Consensus 704 ~~l~ 707 (708)
+|-+
T Consensus 330 ~hp~ 333 (345)
T 3hko_A 330 QHPW 333 (345)
T ss_dssp HSHH
T ss_pred cChh
Confidence 9754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=341.87 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=207.6
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF----VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG----CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc----cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 478999999999999999999654 57789999987532 2346778999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee---CCCCcEEEeeccccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL---DLEYEAHVADFGIAK 590 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~ 590 (708)
||||+++++|.+++... ..+++..++.++.|++.||+|||++ |++||||||+||++ +.++.+||+|||++.
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 84 VMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 99999999999998654 3489999999999999999999999 99999999999999 788999999999998
Q ss_pred ccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 591 FLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
...... ......+++.|+|||.+.+. ++.++||||+|+++|+|++|+.||..... ......+.......+
T Consensus 158 ~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~ 227 (277)
T 3f3z_A 158 RFKPGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD--------SEVMLKIREGTFTFP 227 (277)
T ss_dssp ECCTTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCC
T ss_pred eccCcc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCCCCCC
Confidence 765433 33456789999999987654 89999999999999999999999874321 122222222233222
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+..+.+++.+||+.||++|||+.|+++|-+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 228 EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEW 264 (277)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 2222233456889999999999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=351.55 Aligned_cols=262 Identities=23% Similarity=0.372 Sum_probs=211.0
Q ss_pred HHHHHHhccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEE
Q 039322 429 DEIVRATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502 (708)
Q Consensus 429 ~~~~~~~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~ 502 (708)
+++....++|++.+.||+|+||.||+|... +++.||+|.+.... .......+.+|++++++++||||++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344455689999999999999999999654 36789999997532 234566799999999999999999999
Q ss_pred EEEeeCCeeEEEEEeccCCCHHHHhccccc-------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee
Q 039322 503 GFCSHARHSFLVYELLERGSLAAILSSDTA-------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL 575 (708)
Q Consensus 503 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill 575 (708)
+++.+++..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ ||+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence 999999999999999999999999975432 13468999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccc
Q 039322 576 DLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSS 652 (708)
Q Consensus 576 ~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~ 652 (708)
+.++.+||+|||++......... .....+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||.....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 246 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----- 246 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-----
Confidence 99999999999999865433221 223456889999999998889999999999999999999 8999874321
Q ss_pred cccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 653 LNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+........... .+..+.+++.+||+.||++|||+.|++++|+
T Consensus 247 ---~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~ 295 (322)
T 1p4o_A 247 ---EQVLRFVMEGGLLDKPDN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295 (322)
T ss_dssp ---HHHHHHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred ---HHHHHHHHcCCcCCCCCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 111222222222211111 2235788999999999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=356.62 Aligned_cols=267 Identities=16% Similarity=0.226 Sum_probs=205.2
Q ss_pred hccccccceeccc--cCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 435 TNDFDAQYCIGNG--GHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 435 ~~~~~~~~~ig~G--~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
.++|++.+.||+| +||.||+|... +|+.||||++.... ......+.+.+|++++++++||||+++++++.+++..
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA--CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc--cChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 4789999999999 99999999765 79999999997532 1234567788999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 999999999999999976532 3489999999999999999999999 999999999999999999999999998865
Q ss_pred cCCCC-------CccccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 039322 592 LKPES-------SNWTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEI 662 (708)
Q Consensus 592 ~~~~~-------~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 662 (708)
..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....................
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 42211 11233478899999999887 5789999999999999999999999974322110000000000000
Q ss_pred cCCCC----------------------------------CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 663 LDPRL----------------------------------PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 663 ~~~~~----------------------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+... .+...........+.+++.+||+.||++|||++|+++|-+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 00000 0000011122346889999999999999999999998744
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=339.93 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=193.7
Q ss_pred hccccccceeccccCccEEEEEeCC----CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
.++|++.+.||+|+||.||+|.... +..||+|.+.... .....+.+.+|+.++++++||||+++++++. ++.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 4789999999999999999997642 4579999987532 2345678999999999999999999999984 467
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence 899999999999999997543 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCC
Q 039322 591 FLKPESSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 591 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
........ .....+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ......+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~--------~~~~~~i~~~~~~ 236 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRIENGERL 236 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHHHHTTCCC
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH--------HHHHHHHHcCCCC
Confidence 76543222 233456789999999998899999999999999999997 9999874321 1111222222111
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+.+. ..+..+.+++.+||+.||++|||+.|++++|+
T Consensus 237 ~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 272 (281)
T 1mp8_A 237 PMPP---NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 272 (281)
T ss_dssp CCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCC---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1111 12335788999999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=354.99 Aligned_cols=253 Identities=23% Similarity=0.280 Sum_probs=197.4
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHH-HHhccCCceeeEEEEEeeCCeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKA-LTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
.++|++.+.||+|+||.||+|+.+ +++.||+|++++.... .......+..|..+ ++.++||||+++++++.+.+..|
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL-KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 378999999999999999999764 5889999999763211 12234556677776 57789999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++..
T Consensus 116 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999997543 488999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+..
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~ 261 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNKPLQLKPN 261 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHHHHHHHHSCCCCCSS
T ss_pred ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhcccCCCCC
Confidence 4444445567899999999999999999999999999999999999999974321 12222222222222211
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHH----HHHHHh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMK----VVTQQV 706 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~----evl~~l 706 (708)
....+.+++.+||++||++||++. |+.+|-
T Consensus 262 ----~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~ 295 (373)
T 2r5t_A 262 ----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV 295 (373)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSG
T ss_pred ----CCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCc
Confidence 123578899999999999999974 565553
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=352.43 Aligned_cols=257 Identities=22% Similarity=0.362 Sum_probs=205.1
Q ss_pred HhccccccceeccccCccEEEEEe------CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEe
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCS 506 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~ 506 (708)
..++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+++++++ +||||+++++++.
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 457899999999999999999975 245689999997532 223456799999999999 8999999999999
Q ss_pred eCCeeEEEEEeccCCCHHHHhcccccc--------------------cCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEc
Q 039322 507 HARHSFLVYELLERGSLAAILSSDTAA--------------------QELGWSQRMNVIKGVADALSYLHHDCFPPIVHQ 566 (708)
Q Consensus 507 ~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~ 566 (708)
.++..++||||+++|+|.+++...... ..+++..++.++.|++.||+|||++ ||+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 999999999999999999999765421 3479999999999999999999999 99999
Q ss_pred cCCCCCeeeCCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 039322 567 DISSKNLLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRD 643 (708)
Q Consensus 567 dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~ 643 (708)
||||+||+++.++.+||+|||++......... .....+++.|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999866543322 234557889999999998899999999999999999998 999987
Q ss_pred ccccccccccccccccccccCCCC-CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 644 FLSLISSSSLNTDIALDEILDPRL-PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..... ........... ...+.. .+..+.+++.+||+.||++|||++|++++|+
T Consensus 277 ~~~~~--------~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 277 GIPVD--------ANFYKLIQNGFKMDQPFY---ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp TCCCS--------HHHHHHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCCcH--------HHHHHHHhcCCCCCCCCC---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 43211 11111111111 111111 1335888999999999999999999999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=350.00 Aligned_cols=266 Identities=21% Similarity=0.310 Sum_probs=192.1
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +|+.||+|+++.... ....+.+.+|++++++++||||+++++++..++..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST---TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc---cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 468999999999999999999764 689999999875321 1234568899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccc---cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 514 VYELLERGSLAAILSSDT---AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
||||++ |+|.+++.... ....+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++.
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccce
Confidence 999998 59999986532 123489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc----------ccccc
Q 039322 591 FLKPESSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN----------TDIAL 659 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~----------~~~~~ 659 (708)
.............+|+.|+|||++.+. .++.++||||+||++|||++|+.||............ .....
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 776544444556789999999998764 5899999999999999999999999743221000000 00000
Q ss_pred cc--ccCCCCCCC-Cchh---------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 660 DE--ILDPRLPPP-SRSV---------QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 660 ~~--~~~~~~~~~-~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. ...+..... .... ......+.+++.+||+.||++|||++|+++|-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 296 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence 00 000000000 0000 011236889999999999999999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.79 Aligned_cols=250 Identities=22% Similarity=0.265 Sum_probs=198.0
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~l 513 (708)
++|++.+.||+|+||+||+|... +|+.||||++..... .......+..|+..+.++ +||||+++++++.+++..++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR--GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC--SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc--ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 68999999999999999999765 799999999875432 223445566666666655 89999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+ +++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 135 v~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 669999886543 4589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
... ......||+.|+|||++.+ .++.++||||||+++|||++|..|+..... ...+.....++ ..
T Consensus 209 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~~~~~~~~~~--~~ 273 (311)
T 3p1a_A 209 TAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQLRQGYLPP--EF 273 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------HHHHTTTCCCH--HH
T ss_pred cCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHHHhccCCCc--cc
Confidence 332 2344568999999998876 789999999999999999999776543211 11111111111 11
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.......+.+++.+||+.||++|||++|++++-++
T Consensus 274 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (311)
T 3p1a_A 274 TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308 (311)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccc
Confidence 11223568899999999999999999999998653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=353.42 Aligned_cols=259 Identities=22% Similarity=0.352 Sum_probs=206.4
Q ss_pred HHhccccccceeccccCccEEEEEeCC------CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEE
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAELPS------GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFC 505 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~ 505 (708)
...++|++.+.||+|+||.||+|.... ++.||+|.+.... .....+.+.+|+++++++ +||||+++++++
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345789999999999999999997532 2479999997632 234567899999999999 899999999999
Q ss_pred eeCCeeEEEEEeccCCCHHHHhccccc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCee
Q 039322 506 SHARHSFLVYELLERGSLAAILSSDTA-----------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLL 574 (708)
Q Consensus 506 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil 574 (708)
.+++..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ ||+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 999999999999999999999975431 23579999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccc
Q 039322 575 LDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSS 651 (708)
Q Consensus 575 l~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~ 651 (708)
++.++.+||+|||++......... .....+++.|+|||.+.+..++.++||||||+++|||+| |..||........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~- 275 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK- 275 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence 999999999999999866443322 233456789999999998899999999999999999998 9999874221100
Q ss_pred ccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 652 SLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
............. + .. .+..+.+++.+||+.||++|||++|++++|+
T Consensus 276 ---~~~~~~~~~~~~~--~-~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 322 (333)
T 2i1m_A 276 ---FYKLVKDGYQMAQ--P-AF---APKNIYSIMQACWALEPTHRPTFQQICSFLQ 322 (333)
T ss_dssp ---HHHHHHHTCCCCC--C-TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---HHHHHhcCCCCCC--C-CC---CCHHHHHHHHHHhccChhhCcCHHHHHHHHH
Confidence 0000111111111 1 11 1235788999999999999999999999885
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=366.69 Aligned_cols=252 Identities=22% Similarity=0.421 Sum_probs=206.0
Q ss_pred HhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
..++|++.+.||+|+||.||+|..++++.||||+++... ...+.|.+|++++++++||||+++++++. .+..++
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 457899999999999999999998888999999997632 24678999999999999999999999986 567899
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 260 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp EECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 999999999999997543 23578999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCC
Q 039322 594 PESSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP-RLPPP 670 (708)
Q Consensus 594 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 670 (708)
..... .....++..|+|||++....++.++||||||+++|||+| |+.||...... .....+... +.+.+
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~~~~~ 407 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--------EVIRALERGYRMPRP 407 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHHHHHHTCCCCCC
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCC
Confidence 32111 122345788999999998899999999999999999999 99999743221 111111111 11111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. .+..+.+++.+||+.||++|||+++|++.|+
T Consensus 408 -~~---~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~ 440 (454)
T 1qcf_A 408 -EN---CPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440 (454)
T ss_dssp -TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -CC---CCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 11 2335888999999999999999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=367.78 Aligned_cols=254 Identities=22% Similarity=0.271 Sum_probs=198.4
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... ........+.+|+++++.++||||+++++++...+..++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-C-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh-hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 47899999999999999999965 5689999999864210 112234567889999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH-DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+ + ||+||||||+|||++.++.+||+|||+|+..
T Consensus 226 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999996543 48999999999999999999998 7 9999999999999999999999999999865
Q ss_pred CCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+..
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~p~~ 371 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEEIRFPRT 371 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCTT
T ss_pred cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHHhCCCCCCcc
Confidence 5444455567899999999999999999999999999999999999999964321 11112222222221111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRP-----TMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~ 707 (708)
....+.+++.+||++||++|| +++|+++|-+
T Consensus 372 ----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 372 ----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp ----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred ----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence 123578899999999999999 9999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=361.11 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=202.6
Q ss_pred HhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC-eeE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR-HSF 512 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-~~~ 512 (708)
..++|++.+.||+|+||.||+|... |+.||||+++... ..+.|.+|++++++++||||+++++++...+ ..+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 3478999999999999999999885 7899999998632 3567999999999999999999999987765 789
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 264 iv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 99999999999999976432 3378999999999999999999999 9999999999999999999999999999854
Q ss_pred CCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
... .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... .....+......+.+
T Consensus 340 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~~~~p 408 (450)
T 1k9a_A 340 SST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPRVEKGYKMDAP 408 (450)
T ss_dssp C---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--------THHHHHHTTCCCCCC
T ss_pred ccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCC
Confidence 322 223356889999999999999999999999999999998 99998743221 111112121111111
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. .+..+.+++.+||+.||++|||++++++.|+
T Consensus 409 ~~---~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~ 441 (450)
T 1k9a_A 409 DG---CPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441 (450)
T ss_dssp TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred Cc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 11 2345888999999999999999999998874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=352.35 Aligned_cols=256 Identities=22% Similarity=0.344 Sum_probs=197.7
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe---
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH--- 510 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~--- 510 (708)
.++|++.+.||+|+||.||+|.. .+++.||||+++.... ........+.+|++++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT-TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc-CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 37899999999999999999975 5789999999986432 233446688999999999999999999999876543
Q ss_pred -eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccc
Q 039322 511 -SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA 589 (708)
Q Consensus 511 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 589 (708)
.++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 499999999999999997543 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc---cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 039322 590 KFLKPESSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPR 666 (708)
Q Consensus 590 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (708)
......... .....|++.|+|||++.+..++.++||||||+++|||++|+.||...... ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--------~~~~~~~~~~ 235 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--------SVAYQHVRED 235 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHhcCC
Confidence 866543222 23456899999999999989999999999999999999999999743211 1111111111
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 667 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
..++.......+..+.+++.+||+.||++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 236 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 111111111223468899999999999999988887765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=343.31 Aligned_cols=251 Identities=27% Similarity=0.455 Sum_probs=196.4
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
++|++.+.||+|+||.||+|... ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE------SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST------THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh------hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 68999999999999999999874 788999998642 345779999999999999999999998874 478999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc-EEEeecccccccCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE-AHVADFGIAKFLKP 594 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfg~a~~~~~ 594 (708)
||+++|+|.+++........+++..++.++.|+++||+|||+.+..||+||||||+||+++.++. +||+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999999987665556889999999999999999999932229999999999999998886 79999999975542
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
. .....|++.|+|||++.+..++.++||||||+++|||++|+.||+...... ............++...
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~-- 227 (307)
T 2eva_A 159 H---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA------FRIMWAVHNGTRPPLIK-- 227 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH------HHHHHHHHTTCCCCCBT--
T ss_pred c---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH------HHHHHHHhcCCCCCccc--
Confidence 2 234468999999999999899999999999999999999999997432110 00011111111111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+..+.+++.+||+.||++|||++|+++.|+
T Consensus 228 -~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 259 (307)
T 2eva_A 228 -NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259 (307)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 12235788999999999999999999999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=346.04 Aligned_cols=264 Identities=22% Similarity=0.316 Sum_probs=200.7
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+.+|++++++++||||+++++++..++..++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 68999999999999999999764 58999999987642 2334467788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++.... .+++..+..++.|++.||+|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp EECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999999886543 489999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccc-------------cccc
Q 039322 595 ESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTD-------------IALD 660 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~-------------~~~~ 660 (708)
.........+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.............. ....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 5445556678999999998876 5679999999999999999999999975332110000000 0000
Q ss_pred cccCCCCCCCCc------hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 661 EILDPRLPPPSR------SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 661 ~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+.+.. ........+.+++.+||+.||++|||++|+++|-+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 287 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence 000001111000 00122345789999999999999999999998754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=350.17 Aligned_cols=266 Identities=23% Similarity=0.361 Sum_probs=212.7
Q ss_pred hHHHHHHHhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcch----hHhHHHHHHHHHHHHhc-cCCceee
Q 039322 427 VYDEIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQ----IADQKEFLIEVKALTEI-RHRNIVK 500 (708)
Q Consensus 427 ~~~~~~~~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~ 500 (708)
.+.......++|++.+.||+|+||.||+|... +|+.||||+++....... ....+.+.+|+.+++++ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 44445556688999999999999999999774 799999999876432211 12246788999999999 7999999
Q ss_pred EEEEEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc
Q 039322 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE 580 (708)
Q Consensus 501 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 580 (708)
+++++...+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. |++||||||+||+++.++.
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 999999999999999999999999999643 3489999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCccccccccccccCcccccc------CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc
Q 039322 581 AHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYT------MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN 654 (708)
Q Consensus 581 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~ 654 (708)
+||+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.....
T Consensus 239 ikl~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------- 310 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ------- 310 (365)
T ss_dssp EEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------
T ss_pred EEEEecCcccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-------
Confidence 9999999998765432 3345679999999998863 3578899999999999999999999864221
Q ss_pred cccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 655 TDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+...........+......+.+++.+||+.||++|||++|+++|-+
T Consensus 311 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 362 (365)
T 2y7j_A 311 -ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPF 362 (365)
T ss_dssp -HHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred -HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 1111222222222211111122345889999999999999999999999865
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=341.18 Aligned_cols=253 Identities=27% Similarity=0.417 Sum_probs=202.6
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
+.++|++.+.||+|+||.||+|.. .+++.||+|++.... .........+.+|++++++++||||+++++++.+++..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc-cchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 347899999999999999999965 467799999986411 011122567889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999999999999654 3489999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
.. .......+++.|+|||.+.+..++.++||||+|+++|+|++|+.||...... .....+.......+..
T Consensus 160 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~ 229 (279)
T 3fdn_A 160 PS--SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKRISRVEFTFPDF 229 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCCCCTT
T ss_pred Cc--ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--------HHHHHHHhCCCCCCCc
Confidence 32 2234557899999999999988999999999999999999999999743211 1111111111111111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+.+++.+||+.||++|||++|+++|-+
T Consensus 230 ----~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 230 ----VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp ----SCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred ----CCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 1235788999999999999999999999865
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.14 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=209.8
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|.+.+.||+|+||.||+|... +++.||+|++..... ......+.+.+|++++++++||||+++++++.+++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 378999999999999999999765 588999999865322 123456788999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++++|.+++... ..+++.+++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999988653 3489999999999999999999999 99999999999999999999999999998766
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
..........+++.|+|||.+.+..++.++||||+|+++|+|++|+.||+..... .....+.......+..
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~- 237 (294)
T 2rku_A 167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------ETYLRIKKNEYSIPKH- 237 (294)
T ss_dssp STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTCCCCCTT-
T ss_pred cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhhccCCCccc-
Confidence 5444455567899999999999888999999999999999999999999743211 1111111222211111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+.+++.+||+.||++|||++|++++-+
T Consensus 238 ---~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 238 ---INPVAASLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred ---cCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 1235788999999999999999999998743
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=373.89 Aligned_cols=350 Identities=22% Similarity=0.236 Sum_probs=264.5
Q ss_pred CcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccC-----CCC----ccccCCC
Q 039322 4 LSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTS-----YLP----HNVCRGG 73 (708)
Q Consensus 4 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~-----~~~----~~~~~l~ 73 (708)
|++|+|++|+++.+.+..|.++++|++|+|++|.+.+..+..+.. ++|+.|++++|.... .+| ..+..++
T Consensus 250 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~ 329 (680)
T 1ziw_A 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329 (680)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCT
T ss_pred CCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCC
Confidence 555555555555555555555555555555555555555544443 455555555443221 111 2455566
Q ss_pred CccEEeccCCccccccCccCcCCCCCcEEEccCCccc--cccccccCCC--CCCCEEEcccCcceeeCCCCCCCCCCCCE
Q 039322 74 ALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLT--GNISEALGIY--PNLTFIDLSRNDFYGEISSNWGKCPKLGT 149 (708)
Q Consensus 74 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~--~~~~~~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 149 (708)
+|++|++++|.+++..+..|.++++|++|++++|.++ .+....|..+ ++|++|++++|+++++.+..|..+++|+.
T Consensus 330 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 409 (680)
T 1ziw_A 330 CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEV 409 (680)
T ss_dssp TCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCE
Confidence 6666666666666666666666667777777666532 3333334332 46777777778888888888888889999
Q ss_pred EEcccCcccccCC-ccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCcccc--ccCCcccCCCCCCCeEeccC
Q 039322 150 LNVSMNNITGGIP-REIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFT--GRLPPEIGSLVDLEYLDLSA 226 (708)
Q Consensus 150 L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~--~~~~~~~~~~~~L~~L~l~~ 226 (708)
|+|++|.+++..+ ..|..+++|++|++++|++.+..+..|..+++|+.|++++|.++ +..|..|..+++|++|+|++
T Consensus 410 L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~ 489 (680)
T 1ziw_A 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489 (680)
T ss_dssp EECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCS
T ss_pred EeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCC
Confidence 9999998875444 67888889999999999888777888888899999999998886 46788899999999999999
Q ss_pred CcccccCCCCCCccccceeecccCcccccCCC--------hhhhhhcccchhhcccccCCCCCchhhcCcccCCceeccc
Q 039322 227 NRFNNSVPENLGNLLKLHYLGLSNNQFVLELP--------KELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSH 298 (708)
Q Consensus 227 N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~--------~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~ 298 (708)
|++++..+..|.++++|+.|++++|++++..+ ..|.++++|+.|+|++|+++...+..|..+++|+.|++++
T Consensus 490 N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 569 (680)
T 1ziw_A 490 NNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGL 569 (680)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCC
Confidence 99998888889999999999999999986422 2478899999999999999966666789999999999999
Q ss_pred ccccCCCCCcccccccccEEecCCCcCCCCCCCcc--ccccCcccccccccCcCCCC
Q 039322 299 NNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNST--AFRNAPVEALKGNKGLCGGV 353 (708)
Q Consensus 299 N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~--~~~~~~~~~~~~n~~~c~~~ 353 (708)
|++++..+..|..+++|+.|++++|.+++..+... .++.++.+.+.+|||.|+|.
T Consensus 570 N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 570 NNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred CCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 99998888889999999999999999999877633 57889999999999999996
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=352.97 Aligned_cols=255 Identities=16% Similarity=0.217 Sum_probs=204.0
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~ 512 (708)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|+++++++ +||||+++++++..++..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 36899999999999999999975 5789999999875321 23578899999999 8999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc-----EEEeecc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE-----AHVADFG 587 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg 587 (708)
+||||+ +++|.+++.... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++. +||+|||
T Consensus 82 lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred EEEEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 999999 899999997542 4589999999999999999999999 9999999999999999887 9999999
Q ss_pred cccccCCCCCc-------cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 039322 588 IAKFLKPESSN-------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALD 660 (708)
Q Consensus 588 ~a~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 660 (708)
++..+...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~-----~~~~~~ 230 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT-----LKERYQ 230 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS-----HHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc-----HHHHHH
Confidence 99876543321 245679999999999999999999999999999999999999997432110 001111
Q ss_pred cccCCCCCCCCch-hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 661 EILDPRLPPPSRS-VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 661 ~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.......+... ....+ .+.+++.+||+.||.+||+++++.+.|+
T Consensus 231 ~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~ 277 (330)
T 2izr_A 231 KIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT 277 (330)
T ss_dssp HHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred HHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence 1111111111000 00112 6889999999999999999999998774
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=347.58 Aligned_cols=257 Identities=23% Similarity=0.385 Sum_probs=207.9
Q ss_pred hccccccceeccccCccEEEEEe------CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSH 507 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~ 507 (708)
.++|++.+.||+|+||.||+|.. .+++.||||.++... .....+.+.+|+++++++ +||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 47899999999999999999974 356789999997642 234567899999999999 89999999999999
Q ss_pred CCeeEEEEEeccCCCHHHHhccccc---------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 039322 508 ARHSFLVYELLERGSLAAILSSDTA---------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKN 572 (708)
Q Consensus 508 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N 572 (708)
++..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ |++||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 9999999999999999999976542 12489999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccc
Q 039322 573 LLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLIS 649 (708)
Q Consensus 573 ill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~ 649 (708)
|+++.++.+||+|||++......... .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||.......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 99999999999999999876544332 233456789999999999899999999999999999999 999987432110
Q ss_pred ccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 650 SSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. ............. + . ..+..+.+++.+||+.||++|||++|++++|+
T Consensus 256 ~----~~~~~~~~~~~~~--~-~---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 303 (313)
T 1t46_A 256 K----FYKMIKEGFRMLS--P-E---HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (313)
T ss_dssp H----HHHHHHHTCCCCC--C-T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H----HHHHhccCCCCCC--c-c---cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 0 0001111111111 1 1 12235889999999999999999999999885
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=347.65 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=196.9
Q ss_pred ccccccceeccccCccEEEEEeC-CCc----EEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQ----VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
++|++.+.||+|+||.||+|.+. +++ .||+|.++... .....+.+.+|++++++++||||+++++++..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 68999999999999999999753 444 36888876422 2234678999999999999999999999998765
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++|+||+.+|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred eEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence 778999999999999997643 4589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 039322 591 FLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 591 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
........ .....+|..|+|||++.+..++.++||||||+++|||+| |+.||+..... .....+.....
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~~~~~~~ 237 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSILEKGER 237 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHHHHTTCC
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--------HHHHHHHcCCC
Confidence 76544332 233456789999999999999999999999999999999 99999743221 11111111111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.... ....+.+++.+||+.||++|||++|++++|+
T Consensus 238 ~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 274 (327)
T 3poz_A 238 LPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELIIEFS 274 (327)
T ss_dssp CCCCTT---BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred CCCCcc---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 111111 2235888999999999999999999999874
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=363.26 Aligned_cols=348 Identities=17% Similarity=0.172 Sum_probs=305.1
Q ss_pred cEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEeccCC
Q 039322 5 SILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSEN 83 (708)
Q Consensus 5 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n 83 (708)
+.++.++++++.+ |..+ .++|++|+|++|+|++..+..|.. ++|+.|++++|.+.+..|..|..+++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~i-p~~~--~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFVAV-PEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCSSC-CSCC--CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCcC-CCCC--CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 5788999999854 4444 368999999999999888888866 88999999999999988999999999999999999
Q ss_pred ccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCc
Q 039322 84 HFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPR 163 (708)
Q Consensus 84 ~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~ 163 (708)
.+++..+..|.++++|++|+|++|.++++.+..|..+++|++|++++|.+..+.+..|..+++|+.|+|++|.++...+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 99977777889999999999999999999899999999999999999999999999999999999999999999977777
Q ss_pred cccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccc
Q 039322 164 EIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKL 243 (708)
Q Consensus 164 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L 243 (708)
.|..+++|+.|+|++|.+.+..+..|..+++|++|++++|.+.+..+.......+|++|+|++|+++...+..+..+++|
T Consensus 171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 250 (477)
T 2id5_A 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250 (477)
T ss_dssp HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTC
T ss_pred HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCcccc
Confidence 89999999999999999998878889999999999999988777777766667799999999999996555678889999
Q ss_pred eeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCC
Q 039322 244 HYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDN 323 (708)
Q Consensus 244 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 323 (708)
+.|+|++|++++..+..|..+++|+.|+|++|.+++..+..+..+++|+.|+|++|++++..+..|..+++|+.|++++|
T Consensus 251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 330 (477)
T 2id5_A 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN 330 (477)
T ss_dssp CEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS
T ss_pred CeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC
Confidence 99999999999888888999999999999999999888889999999999999999999888888899999999999999
Q ss_pred cCCCCCCCccccccCcccccccccCcCCCCCC
Q 039322 324 QLQGPVPNSTAFRNAPVEALKGNKGLCGGVKG 355 (708)
Q Consensus 324 ~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~ 355 (708)
++.|.++..+.+.......+.++.+.|++|..
T Consensus 331 ~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~~ 362 (477)
T 2id5_A 331 PLACDCRLLWVFRRRWRLNFNRQQPTCATPEF 362 (477)
T ss_dssp CEECSGGGHHHHTTTTSSCCTTCCCBEEESGG
T ss_pred CccCccchHhHHhhhhccccCccCceeCCchH
Confidence 99988766554444555667778888877643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=342.42 Aligned_cols=258 Identities=25% Similarity=0.382 Sum_probs=206.7
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee--CCee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH--ARHS 511 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~ 511 (708)
.++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+.+|++++++++||||+++++++.. ++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 478999999999999999999664 789999999975322 23456789999999999999999999998854 5688
Q ss_pred EEEEEeccCCCHHHHhccccc-ccCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEEccCCCCCeeeCCCCcEEEee
Q 039322 512 FLVYELLERGSLAAILSSDTA-AQELGWSQRMNVIKGVADALSYLHHDCFPP-----IVHQDISSKNLLLDLEYEAHVAD 585 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~-----ivH~dlk~~Nill~~~~~~kl~D 585 (708)
++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. + ++||||||+||+++.++.+||+|
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~d 159 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGD 159 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence 999999999999999975432 33489999999999999999999998 7 99999999999999999999999
Q ss_pred cccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 039322 586 FGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDP 665 (708)
Q Consensus 586 fg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 665 (708)
||++..............+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~i~~~ 231 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREG 231 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHT
T ss_pred CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--------HHHHHHHhhc
Confidence 99998765443333456789999999999988899999999999999999999999874321 1111111111
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 666 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.....+.. .+..+.+++.+||+.||++|||++|+++++++
T Consensus 232 ~~~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 232 KFRRIPYR---YSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CCCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ccccCCcc---cCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11111111 22358899999999999999999999998764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=353.05 Aligned_cols=255 Identities=21% Similarity=0.265 Sum_probs=195.3
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.++++++||||+++++++..++..++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-----AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-----TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-----cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 378999999999999999999765 78999999997532 223567899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc--EEEeecccccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE--AHVADFGIAKF 591 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~~ 591 (708)
||||+++|+|.+++.... .+++..++.++.|++.||+|||++ ||+||||||+||+++.++. +||+|||+++.
T Consensus 94 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 94 IMEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 999999999999996533 489999999999999999999999 9999999999999987765 99999999974
Q ss_pred cCCCCCccccccccccccCccccccCCCCcc-hhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 592 LKPESSNWTEFAGTYGYVAPELAYTMKITEK-CDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
.... .......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||....... ........+.......+
T Consensus 168 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~~~~~~~~~~~~~~ 242 (361)
T 3uc3_A 168 SVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR----DYRKTIQRILSVKYSIP 242 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC----CHHHHHHHHHTTCCCCC
T ss_pred cccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH----HHHHHHHHHhcCCCCCC
Confidence 4322 22344579999999999988877665 899999999999999999997432210 11111222222222111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. ......+.+++.+||+.||++|||++|+++|-+
T Consensus 243 ~~--~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 243 DD--IRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp TT--SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred Cc--CCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 11 011235788999999999999999999998754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=356.34 Aligned_cols=254 Identities=22% Similarity=0.261 Sum_probs=193.1
Q ss_pred cccccc-ceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHh-ccCCceeeEEEEEee----C
Q 039322 436 NDFDAQ-YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTE-IRHRNIVKFYGFCSH----A 508 (708)
Q Consensus 436 ~~~~~~-~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~l~~~~~~----~ 508 (708)
++|.+. +.||+|+||.||+|... +|+.||||++.. ...+.+|++++.+ .+||||+++++++.. .
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~---------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc---------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 567766 68999999999999654 689999999864 2346678888644 489999999999875 5
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC---CCcEEEee
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL---EYEAHVAD 585 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~D 585 (708)
+..|+||||+++|+|.+++.... ...+++..++.++.||+.||+|||++ ||+||||||+|||++. ++.+||+|
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence 67899999999999999997643 24589999999999999999999999 9999999999999998 78999999
Q ss_pred cccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 039322 586 FGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDP 665 (708)
Q Consensus 586 fg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 665 (708)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......+...
T Consensus 208 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~i~~~ 282 (400)
T 1nxk_A 208 FGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKTRIRMG 282 (400)
T ss_dssp CTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC----CSHHHHHHHT
T ss_pred cccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc----HHHHHHHHcC
Confidence 9999865432 2334567899999999999999999999999999999999999999743221110 0011111111
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 666 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+...+......+.+++.+||+.||++|||++|+++|-+
T Consensus 283 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 283 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 111111111223345889999999999999999999999865
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=337.88 Aligned_cols=251 Identities=24% Similarity=0.395 Sum_probs=206.1
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 6899999999999999999988888999999998632 22467899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++++|.+++.... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999999997543 3589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CC-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 596 SS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 596 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
.. ......++..|+|||.+.+..++.++||||+|+++|+|++ |+.||..... ......+........+..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~i~~~~~~~~~~~ 229 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFRLYKPRL 229 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCCCCCCTT
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--------HHHHHHHhcCCcCCCCcc
Confidence 11 1223456788999999998889999999999999999999 8999874321 111111111111111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+.+++.+||+.||++|||++|++++|+
T Consensus 230 ---~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 260 (267)
T 3t9t_A 230 ---ASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260 (267)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---CcHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1235788999999999999999999999885
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=366.41 Aligned_cols=252 Identities=24% Similarity=0.413 Sum_probs=206.7
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
..+|++.+.||+|+||.||+|.+. +++.||||.++... ...+.|.+|++++++++||||+++++++..++..++
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 468999999999999999999775 48899999997532 235779999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 294 v~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 9999999999999975432 4589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCC
Q 039322 594 PESSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP-RLPPP 670 (708)
Q Consensus 594 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 670 (708)
..... .....++..|+|||++.+..++.++||||||+++|||+| |+.||...... .....+... +...+
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~ 441 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKDYRMERP 441 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------GHHHHHHTTCCCCCC
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCC
Confidence 33221 223345789999999998899999999999999999999 99998743221 111111111 11111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. ..+..+.+++.+||+.||++|||++++++.|+
T Consensus 442 -~---~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~ 474 (495)
T 1opk_A 442 -E---GCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474 (495)
T ss_dssp -T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -C---CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 1 12235788999999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=346.27 Aligned_cols=256 Identities=21% Similarity=0.371 Sum_probs=205.6
Q ss_pred hccccccceeccccCccEEEEEe--------CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL--------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFC 505 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~ 505 (708)
.++|++.+.||+|+||.||+|.. .+++.||||+++... .....+.+.+|+++++++ +||||+++++++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 47899999999999999999975 346789999997632 234567899999999999 899999999999
Q ss_pred eeCCeeEEEEEeccCCCHHHHhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 039322 506 SHARHSFLVYELLERGSLAAILSSDTA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKN 572 (708)
Q Consensus 506 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N 572 (708)
..++..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ ||+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence 999999999999999999999976542 23489999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccc
Q 039322 573 LLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLIS 649 (708)
Q Consensus 573 ill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~ 649 (708)
|+++.++.+||+|||++......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~- 266 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 266 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH-
Confidence 99999999999999999876543321 233456789999999988889999999999999999999 99998743211
Q ss_pred ccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 650 SSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+.......... .....+.+++.+||+.||++|||++|++++|+
T Consensus 267 -------~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 314 (334)
T 2pvf_A 267 -------ELFKLLKEGHRMDKPA---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314 (334)
T ss_dssp -------HHHHHHHHTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -------HHHHHHhcCCCCCCCc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1111111111111111 12235888999999999999999999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=361.59 Aligned_cols=263 Identities=21% Similarity=0.249 Sum_probs=209.1
Q ss_pred HHHHHHHhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEe
Q 039322 428 YDEIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCS 506 (708)
Q Consensus 428 ~~~~~~~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 506 (708)
+.++....++|++.++||+|+||.||+|..+ +++.||+|++.+.. .........+.+|..++..++||||++++++|.
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-MLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH-HHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHH-hhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 3455556789999999999999999999765 57899999986410 001112234888999999999999999999999
Q ss_pred eCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeec
Q 039322 507 HARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADF 586 (708)
Q Consensus 507 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 586 (708)
+++..|+||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 9999999999999999999997532 4589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCc-cccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 039322 587 GIAKFLKPESSN-WTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALD 660 (708)
Q Consensus 587 g~a~~~~~~~~~-~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 660 (708)
|+|+........ .....||+.|+|||++. .+.++.++|||||||++|||++|+.||..... .....
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--------~~~~~ 291 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYG 291 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh--------hHHHH
Confidence 999866544332 23467999999999987 45689999999999999999999999974321 11111
Q ss_pred cccC----CCCCCCCchhHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHhh
Q 039322 661 EILD----PRLPPPSRSVQEKLISIMEVAFSCLNESPES--RPTMKVVTQQVR 707 (708)
Q Consensus 661 ~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l~ 707 (708)
.++. ..++..... ....+.+++.+|+..+|++ ||+++|+++|-+
T Consensus 292 ~i~~~~~~~~~p~~~~~---~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpf 341 (437)
T 4aw2_A 292 KIMNHKERFQFPTQVTD---VSENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341 (437)
T ss_dssp HHHTHHHHCCCCSSCCC---SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred hhhhccccccCCccccc---CCHHHHHHHHHHhcccccccCCCCHHHHhCCCc
Confidence 1111 111111111 1234778999999999988 999999998854
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=343.07 Aligned_cols=255 Identities=23% Similarity=0.383 Sum_probs=208.8
Q ss_pred HHhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
...++|++.+.||+|+||.||+|... +++.||+|.+... ....+.+.+|++++++++||||+++++++.+++..
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 35588999999999999999999765 4889999998753 23467789999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++||||+++++|.+++..... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++..
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEEEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 999999999999999976432 4589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCC
Q 039322 592 LKPESSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 592 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
....... .....+++.|+|||.+.+..++.++||||+|+++|+|++ |..||...... .....+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--------~~~~~~~~~~~~~ 232 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKDYRME 232 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------GHHHHHHTTCCCC
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHhccCCCC
Confidence 6543322 233456789999999998899999999999999999999 99998743221 1111111111111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+. ..+..+.+++.+||+.||++|||++|+++.|+
T Consensus 233 ~~~---~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~ 267 (288)
T 3kfa_A 233 RPE---GCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267 (288)
T ss_dssp CCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCC---CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHH
Confidence 111 12235889999999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=339.60 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=205.8
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcc--hhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCD--QIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
.++|++.+.||+|+||.||+|... +++.||+|.++...... .....+.+.+|++++++++||||+++++++.+++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 367999999999999999999765 68999999987532211 112367899999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC----cEEEeecc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY----EAHVADFG 587 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg 587 (708)
++||||+++++|.+++... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999999653 3489999999999999999999999 999999999999998877 89999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
++....... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.....
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--------QETLTNISAVNY 228 (283)
T ss_dssp TCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTCC
T ss_pred cceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--------HHHHHHhHhccc
Confidence 998765332 23445689999999999988899999999999999999999999874321 111122222222
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..........+..+.+++.+||+.||++|||++|+++|-+
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 268 (283)
T 3bhy_A 229 DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSW 268 (283)
T ss_dssp CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHH
T ss_pred CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHH
Confidence 1111111222346889999999999999999999998743
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=346.16 Aligned_cols=250 Identities=21% Similarity=0.348 Sum_probs=205.5
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcch----hHhHHHHHHHHHHHHhccCCceeeEEEEEeeC
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQ----IADQKEFLIEVKALTEIRHRNIVKFYGFCSHA 508 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 508 (708)
..++|++.+.||+|+||.||+|.. .+++.||||++........ ......+.+|++++++++||||+++++++.++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 357899999999999999999964 5788999999976432111 11234577899999999999999999999999
Q ss_pred CeeEEEEEeccCC-CHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecc
Q 039322 509 RHSFLVYELLERG-SLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFG 587 (708)
Q Consensus 509 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 587 (708)
+..++||||+.+| +|.+++.... .+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 9999997543 489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPR 666 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (708)
++....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||..... .....
T Consensus 176 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------~~~~~ 240 (335)
T 3dls_A 176 SAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------------TVEAA 240 (335)
T ss_dssp TCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------GTTTC
T ss_pred cceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------HHhhc
Confidence 998765433 3345678999999999988776 7899999999999999999999873211 11111
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 667 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
...+.. ....+.+++.+||+.||++|||++|++++-++
T Consensus 241 ~~~~~~----~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 278 (335)
T 3dls_A 241 IHPPYL----VSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278 (335)
T ss_dssp CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred cCCCcc----cCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 111111 12358899999999999999999999998653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=346.69 Aligned_cols=258 Identities=21% Similarity=0.361 Sum_probs=191.2
Q ss_pred HhccccccceeccccCccEEEEEeCCC----cEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELPSG----QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
..++|++.+.||+|+||.||+|..... ..||||+++.... .....+.+.+|++++++++||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 347899999999999999999976543 2799999976321 2244678999999999999999999999998776
Q ss_pred ee------EEEEEeccCCCHHHHhccccc---ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc
Q 039322 510 HS------FLVYELLERGSLAAILSSDTA---AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE 580 (708)
Q Consensus 510 ~~------~lv~e~~~~g~L~~~l~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~ 580 (708)
.. ++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ ||+||||||+||+++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence 55 999999999999999965432 12589999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccc
Q 039322 581 AHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDI 657 (708)
Q Consensus 581 ~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 657 (708)
+||+|||+++........ .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~ 247 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--------AE 247 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GG
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh--------HH
Confidence 999999999866443322 223456789999999999999999999999999999999 9999874322 11
Q ss_pred ccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 ALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+.......... ..+..+.+++.+||+.||++|||+.++++.|+
T Consensus 248 ~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 294 (323)
T 3qup_A 248 IYNYLIGGNRLKQPP---ECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294 (323)
T ss_dssp HHHHHHTTCCCCCCT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCC---ccCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 122222221111111 12235889999999999999999988888764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.29 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=199.1
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccC--CceeeEEEEEeeCCeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH--RNIVKFYGFCSHARHSF 512 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~l~~~~~~~~~~~ 512 (708)
.++|++.+.||+|+||.||+|...+++.||||++.... ......+.+.+|++++++++| +||+++++++..++..+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc--cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 36799999999999999999988889999999987532 233456789999999999986 99999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+||| +.+|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++ ++.+||+|||++...
T Consensus 86 lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEEC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEe-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9999 56789999997643 489999999999999999999999 999999999999997 678999999999876
Q ss_pred CCCCCc--cccccccccccCcccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccc
Q 039322 593 KPESSN--WTEFAGTYGYVAPELAYT-----------MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIAL 659 (708)
Q Consensus 593 ~~~~~~--~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 659 (708)
...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~ 230 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKL 230 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-------HHHHH
Confidence 543322 235679999999999865 6688899999999999999999999963211 11112
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 660 DEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....++........ .....+.+++.+||+.||++|||++|+++|-+
T Consensus 231 ~~~~~~~~~~~~~~--~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 231 HAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp HHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHhcCCcccCCcc--cCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 22222221111000 01235788999999999999999999998865
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=350.16 Aligned_cols=251 Identities=28% Similarity=0.404 Sum_probs=202.5
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.+.|+..+.||+|+||.||+|.. .+|+.||||++..... ......+.+.+|++++++++||||+++++++..++..++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 35689999999999999999965 5789999999875322 233455789999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+. |++.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 132 v~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EEECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EEecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 999997 58888885433 4589999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC-CC
Q 039322 594 PESSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL-PP 669 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 669 (708)
.. ....||+.|+|||++. .+.++.++||||||+++|||++|+.||....... ....+..... ..
T Consensus 206 ~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------~~~~~~~~~~~~~ 273 (348)
T 1u5q_A 206 PA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPAL 273 (348)
T ss_dssp SB----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCCCCC
T ss_pred CC----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHhcCCCCC
Confidence 32 3457899999999884 5678999999999999999999999986432211 0111111111 11
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.... .+..+.+++.+||+.||++|||+++++++.+
T Consensus 274 ~~~~---~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 274 QSGH---WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp CCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred CCCC---CCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 1111 1235788999999999999999999998754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=338.69 Aligned_cols=254 Identities=28% Similarity=0.452 Sum_probs=200.3
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHh---HHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIAD---QKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
++|++.+.||+|+||.||+|.. .+++.||+|++........... .+.+.+|++++++++||||+++++++.++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 7899999999999999999965 5789999999876433222221 267899999999999999999999997665
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEccCCCCCeeeCCCCc-----EEEe
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP--IVHQDISSKNLLLDLEYE-----AHVA 584 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~~-----~kl~ 584 (708)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ + ++||||||+||+++.++. +||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 69999999999999886543 4589999999999999999999999 8 999999999999988876 9999
Q ss_pred ecccccccCCCCCccccccccccccCccccc--cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 039322 585 DFGIAKFLKPESSNWTEFAGTYGYVAPELAY--TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEI 662 (708)
Q Consensus 585 Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 662 (708)
|||+++.... ......|++.|+|||.+. ...++.++||||+|+++|||++|+.||+......... ........
T Consensus 172 Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~ 246 (287)
T 4f0f_A 172 DFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF--INMIREEG 246 (287)
T ss_dssp CCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH--HHHHHHSC
T ss_pred CCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH--HHHHhccC
Confidence 9999975432 334567899999999983 4557889999999999999999999997432110000 00000111
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 663 LDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+..+. ..+..+.+++.+||+.||++|||++|+++.|+
T Consensus 247 ~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 285 (287)
T 4f0f_A 247 LRPTIPE------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285 (287)
T ss_dssp CCCCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCc------ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 1111111 12335889999999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=352.65 Aligned_cols=269 Identities=22% Similarity=0.264 Sum_probs=207.7
Q ss_pred hHHHHHHHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-----CCceee
Q 039322 427 VYDEIVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-----HRNIVK 500 (708)
Q Consensus 427 ~~~~~~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~ 500 (708)
++.+.....++|++.+.||+|+||.||+|.. .+++.||||+++.. ......+..|+++++.++ ||||++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-----KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-----hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 3334444568999999999999999999966 57899999998742 234566788999999996 999999
Q ss_pred EEEEEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC---
Q 039322 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL--- 577 (708)
Q Consensus 501 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--- 577 (708)
+++++...+..++||||+ +++|.+++..... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence 999999999999999999 8899999976542 3489999999999999999999999 9999999999999975
Q ss_pred ----------------------CCcEEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHH
Q 039322 578 ----------------------EYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEA 635 (708)
Q Consensus 578 ----------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el 635 (708)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||+||++|||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 789999999999865432 2345789999999999999999999999999999999
Q ss_pred HhCCCCCCccccccccc-------cccccc--------c-----ccccCCCCCCCCchhH--------------HHHHHH
Q 039322 636 IKGKHPRDFLSLISSSS-------LNTDIA--------L-----DEILDPRLPPPSRSVQ--------------EKLISI 681 (708)
Q Consensus 636 ltg~~p~~~~~~~~~~~-------~~~~~~--------~-----~~~~~~~~~~~~~~~~--------------~~~~~l 681 (708)
++|+.||.......... ...... . ........+....... .....+
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 99999996432110000 000000 0 0000000111100000 011457
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 682 MEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 682 ~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.+++.+||+.||++|||++|+++|-++
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~hp~f 359 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLKHKFL 359 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred HHHHHHHhcCChhhCCCHHHHhcCccc
Confidence 799999999999999999999998653
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=360.69 Aligned_cols=342 Identities=18% Similarity=0.127 Sum_probs=295.9
Q ss_pred cEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCC-CCccccCCCCccEEeccC
Q 039322 5 SILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSY-LPHNVCRGGALQYFGVSE 82 (708)
Q Consensus 5 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~-~~~~~~~l~~L~~L~l~~ 82 (708)
+.++.++++++.+ |. + .++|++|+|++|.+++..|..+.. ++|+.|++++|.+... .+..|..+++|++|+|++
T Consensus 13 ~~~~c~~~~l~~l-p~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 13 YNAICINRGLHQV-PE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp TEEECCSSCCSSC-CC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred cccCcCCCCcccC-CC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 4688899999854 44 3 378999999999999988888876 8999999999999744 467899999999999999
Q ss_pred CccccccCccCcCCCCCcEEEccCCcccccc--ccccCCCCCCCEEEcccCcceeeCCCC-CCCCCCCCEEEcccCcccc
Q 039322 83 NHFQGTIPKILRNCSSLIRVRLNSNNLTGNI--SEALGIYPNLTFIDLSRNDFYGEISSN-WGKCPKLGTLNVSMNNITG 159 (708)
Q Consensus 83 n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~--~~~~~~~~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~L~~N~i~~ 159 (708)
|.+++..|..|.++++|++|+|++|++++.. ...|..+++|++|+|++|+++++.+.. +..+++|++|++++|.+++
T Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~ 168 (455)
T 3v47_A 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS 168 (455)
T ss_dssp CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence 9999888999999999999999999999743 345999999999999999999887766 8899999999999999998
Q ss_pred cCCccccCC--CCCCEEecccccccccCCcc--------cCCCCCCCEEEccCccccccCCcccCCC---CCCCeEeccC
Q 039322 160 GIPREIGNS--SQLQALDLSLNHIVGEIPKE--------LGKLNSLTELILRGNQFTGRLPPEIGSL---VDLEYLDLSA 226 (708)
Q Consensus 160 ~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~--------~~~l~~L~~L~l~~n~l~~~~~~~~~~~---~~L~~L~l~~ 226 (708)
..+..+..+ .+|+.|++++|.+.+..+.. +..+++|++|++++|++++..+..+... ++|+.|++++
T Consensus 169 ~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~ 248 (455)
T 3v47_A 169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSN 248 (455)
T ss_dssp CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTT
T ss_pred cChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecc
Confidence 888888776 78999999999998655443 3366899999999999998777766544 7899999999
Q ss_pred Cccccc----------CCCCCCc--cccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCce
Q 039322 227 NRFNNS----------VPENLGN--LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKL 294 (708)
Q Consensus 227 N~i~~~----------~~~~~~~--l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L 294 (708)
|.+.+. .+..+.. .++|+.|++++|.+++..|..|..+++|+.|++++|.+++..+..+..+++|++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 328 (455)
T 3v47_A 249 SYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKL 328 (455)
T ss_dssp CTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEE
Confidence 866532 2222332 2689999999999999999999999999999999999998888899999999999
Q ss_pred ecccccccCCCCCcccccccccEEecCCCcCCCCCCC-ccccccCcccccccccCcC
Q 039322 295 NLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPN-STAFRNAPVEALKGNKGLC 350 (708)
Q Consensus 295 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~~~c 350 (708)
++++|++++..+..+..+++|+.|++++|.+++..|. ...+++++.+.+.+|....
T Consensus 329 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 385 (455)
T 3v47_A 329 NLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS 385 (455)
T ss_dssp ECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred ECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCcccc
Confidence 9999999988899999999999999999999987664 5567889999999997654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=353.16 Aligned_cols=253 Identities=22% Similarity=0.337 Sum_probs=200.2
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc--CCceeeEEEEEeeCCeeEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR--HRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~l~~~~~~~~~~~l 513 (708)
.+|++.+.||+|+||.||+|...+++.||||++.... ......+.+.+|++++++++ ||||+++++++..++..++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccc--ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 5699999999999999999988889999999987532 22345678999999999996 5999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||| +.+++|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||++ ++.+||+|||++....
T Consensus 134 v~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 999 56789999997543 488999999999999999999999 999999999999995 5899999999998765
Q ss_pred CCCC--ccccccccccccCcccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 039322 594 PESS--NWTEFAGTYGYVAPELAYT-----------MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALD 660 (708)
Q Consensus 594 ~~~~--~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 660 (708)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ....+.
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~~~~ 278 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKLH 278 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-------HHHHHH
Confidence 4332 2245679999999999865 3688899999999999999999999963211 111222
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 661 EILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.++......... ....+.+++.+||+.||++|||++|+++|-+
T Consensus 279 ~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 279 AIIDPNHEIEFPDI--PEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp HHHCTTSCCCCCCC--SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHhCccccCCCCcc--chHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 23332221111000 1235788999999999999999999998754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=344.20 Aligned_cols=262 Identities=24% Similarity=0.354 Sum_probs=198.0
Q ss_pred HHHHhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc--cCCceeeEEEEEeeC
Q 039322 431 IVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI--RHRNIVKFYGFCSHA 508 (708)
Q Consensus 431 ~~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~l~~~~~~~ 508 (708)
.....++|++.+.||+|+||.||+|... ++.||||++.. .....+..|.+++... +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~-------~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT-------TEEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEG-------GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEec-------cccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 3445589999999999999999999875 89999999854 2234455566665554 899999999999887
Q ss_pred ----CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEccCCCCCeeeCCCC
Q 039322 509 ----RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC-----FPPIVHQDISSKNLLLDLEY 579 (708)
Q Consensus 509 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----~~~ivH~dlk~~Nill~~~~ 579 (708)
...++||||+++|+|.++++.. .+++..++.++.|++.||+|||++. .+||+||||||+||+++.++
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 6889999999999999999653 3899999999999999999999762 23899999999999999999
Q ss_pred cEEEeecccccccCCCCCcc----ccccccccccCccccccCCCCcc------hhHHHHHHHHHHHHhC----------C
Q 039322 580 EAHVADFGIAKFLKPESSNW----TEFAGTYGYVAPELAYTMKITEK------CDVYSFGVLVLEAIKG----------K 639 (708)
Q Consensus 580 ~~kl~Dfg~a~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~------~DvwslG~~l~elltg----------~ 639 (708)
.+||+|||++.......... ....||+.|+|||++.+...+.+ +|||||||++|||+|| +
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999999998665433221 24578999999999987766654 9999999999999999 4
Q ss_pred CCCCccccccccccccccccccccCCCCCCC-C--chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 640 HPRDFLSLISSSSLNTDIALDEILDPRLPPP-S--RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 640 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.||....... ................+. + .........+.+++.+||+.||++|||++|++++|+
T Consensus 260 ~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 327 (337)
T 3mdy_A 260 LPYHDLVPSD---PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327 (337)
T ss_dssp CTTTTTSCSS---CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ccHhhhcCCC---CchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence 5543211100 000001111111111111 1 112355667999999999999999999999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=362.44 Aligned_cols=252 Identities=26% Similarity=0.448 Sum_probs=201.1
Q ss_pred HhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
..++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|++++++++||||+++++++.+ +..++
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 347899999999999999999998888889999997632 235679999999999999999999999876 67899
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 256 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp EECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 999999999999997532 24589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCC
Q 039322 594 PESSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP-RLPPP 670 (708)
Q Consensus 594 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 670 (708)
..... .....++..|+|||.+.++.++.++||||||+++|||++ |+.||..... ......+... +.+.+
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~~~~~ 403 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMPCP 403 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCC
T ss_pred CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC
Confidence 33221 223456789999999998899999999999999999999 9999874321 1111111111 11111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. ..+..+.+++.+||+.||++|||++++++.|+
T Consensus 404 -~---~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~ 436 (452)
T 1fmk_A 404 -P---ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436 (452)
T ss_dssp -T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -C---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1 12335888999999999999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.67 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=209.2
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|.+.+.||+|+||.||+|... +++.||+|++..... ......+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 478999999999999999999664 588999999865321 123456788999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++++|.+++... ..+++.+++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus 119 v~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999998653 3489999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
..........|+..|+|||++.+..++.++||||||+++|+|++|+.||...... .....+.......+..
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~- 263 (335)
T 2owb_A 193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------ETYLRIKKNEYSIPKH- 263 (335)
T ss_dssp STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCCCCTT-
T ss_pred cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHHHhcCCCCCCcc-
Confidence 5444455667899999999999888999999999999999999999999743211 1111111111111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+.+++.+||+.||++|||++|++++-+
T Consensus 264 ---~~~~~~~li~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 264 ---INPVAASLIQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 1234778999999999999999999998743
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=359.74 Aligned_cols=262 Identities=23% Similarity=0.239 Sum_probs=207.4
Q ss_pred HHHHHHHhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEe
Q 039322 428 YDEIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCS 506 (708)
Q Consensus 428 ~~~~~~~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 506 (708)
+.+.....++|++.+.||+|+||.||+|..+ +|+.||||++++.. .......+.+.+|.+++.+++||||+++++++.
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~-~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD-MLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-HHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-hhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3444555789999999999999999999764 79999999986411 011122345888999999999999999999999
Q ss_pred eCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeec
Q 039322 507 HARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADF 586 (708)
Q Consensus 507 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 586 (708)
+++..|+||||+++|+|.+++...+ ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence 9999999999999999999997543 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCc-cccccccccccCccccc-------cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccc
Q 039322 587 GIAKFLKPESSN-WTEFAGTYGYVAPELAY-------TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIA 658 (708)
Q Consensus 587 g~a~~~~~~~~~-~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 658 (708)
|++......... .....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ...
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~ 278 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST--------AET 278 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHH
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH--------HHH
Confidence 999876544332 23467999999999987 35689999999999999999999999974321 111
Q ss_pred cccccC----CCCCCCCchhHHHHHHHHHHHHhccCCCCCCC---CCHHHHHHHhh
Q 039322 659 LDEILD----PRLPPPSRSVQEKLISIMEVAFSCLNESPESR---PTMKVVTQQVR 707 (708)
Q Consensus 659 ~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~l~ 707 (708)
...+.. ..++.. ....+.++.++|.+||. +|++| |+++|+++|-+
T Consensus 279 ~~~i~~~~~~~~~p~~---~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 279 YGKIVHYKEHLSLPLV---DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp HHHHHTHHHHCCCC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred HHHHHhcccCcCCCcc---ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 111111 111110 01123357889999999 99998 69999998754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=341.28 Aligned_cols=261 Identities=21% Similarity=0.320 Sum_probs=197.5
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... .......+.+.+|++++++++||||+++++++..++..++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD-LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTS-SCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhh-ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 46899999999999999999965 579999999987522 2234556789999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 514 VYELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999996532 234589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
...........+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... .......+.....+...
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~- 259 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQCDYPPLP- 259 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC------HHHHHHHHHTTCSCCCC-
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh------HHHHHHHhhcccCCCCc-
Confidence 54444444567899999999999989999999999999999999999998632210 01111111111211111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+.+++.+||+.||++|||++++++.|+
T Consensus 260 -~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~ 293 (310)
T 2wqm_A 260 -SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293 (310)
T ss_dssp -TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 0112235889999999999999999999999875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=340.17 Aligned_cols=251 Identities=26% Similarity=0.400 Sum_probs=207.5
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+.|+..+.||+|+||.||+|.. .+++.||+|++..... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC---STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 6799999999999999999965 5689999999875422 23467799999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++.. ..+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus 99 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 999999999999964 3489999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.........|++.|+|||.+.+..++.++||||||+++|+|++|+.||......... ........+....
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~----- 241 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL-----FLIPKNNPPTLEG----- 241 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHHSCCCCCCS-----
T ss_pred cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH-----HHhhcCCCCCCcc-----
Confidence 444445567899999999999989999999999999999999999998743221100 0000001111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+..+.+++.+||+.||++|||++|++++.+
T Consensus 242 -~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 242 -NYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp -SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred -ccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 11235889999999999999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=366.76 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=211.3
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +|+.||||++..... ......+.+.+|++++++++||||+++++++.+.+..++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQV-KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhc-ccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 468999999999999999999764 789999999865322 122346789999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee---CCCCcEEEeeccccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL---DLEYEAHVADFGIAK 590 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~ 590 (708)
||||+.+|+|.+++.... .+++..++.++.|++.||+|||++ ||+||||||+||++ +.++.+||+|||++.
T Consensus 104 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999986543 489999999999999999999999 99999999999999 567899999999998
Q ss_pred ccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 591 FLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
.+.... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ......+........
T Consensus 178 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 178 HFEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--------YDILKKVEKGKYTFE 247 (484)
T ss_dssp HBCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCC
T ss_pred Eccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCCCCC
Confidence 765433 3455679999999999866 689999999999999999999999974321 122223333333333
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+...+..+.+++.+||++||++|||++|+++|-+
T Consensus 248 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 248 LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 2233334456889999999999999999999998865
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=336.19 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=202.3
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC--CeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA--RHSF 512 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~ 512 (708)
.++|++.+.||+|+||.||+|... ++.||||++.... ......+.+.+|++++++++||||+++++++.++ +..+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRD--WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTT--CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 378999999999999999999884 8899999998642 2234567799999999999999999999999887 7889
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP--IVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
+||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ + ++||||||+||+++.++.++|+|||++.
T Consensus 86 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred eeecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecccee
Confidence 99999999999999976442 3589999999999999999999998 8 9999999999999999999999999876
Q ss_pred ccCCCCCccccccccccccCccccccCCCCc---chhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 039322 591 FLKPESSNWTEFAGTYGYVAPELAYTMKITE---KCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
.... ....+|+.|+|||.+.+...+. ++||||||+++|||++|+.||......... .........+..
T Consensus 162 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~ 232 (271)
T 3kmu_A 162 SFQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG----MKVALEGLRPTI 232 (271)
T ss_dssp TTSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH----HHHHHSCCCCCC
T ss_pred eecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH----HHHHhcCCCCCC
Confidence 4332 2346789999999988765544 799999999999999999999743221100 000001111111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+. ..+..+.+++.+||+.||++|||++|+++.|+
T Consensus 233 ~~------~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~ 266 (271)
T 3kmu_A 233 PP------GISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266 (271)
T ss_dssp CT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11 12235889999999999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=362.50 Aligned_cols=260 Identities=20% Similarity=0.299 Sum_probs=209.3
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|...+.||+|+||.||+|..+ +|+.||+|++.+.. .........+..|++++++++||||+++++++...+..|+|
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~-~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR-LKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHH-hhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 68999999999999999999764 69999999986521 01112346788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccccc-ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 515 YELLERGSLAAILSSDTA-AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
|||++||+|.+++..... ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999975432 34589999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .........+.......+..
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~----~~~~~~~~~i~~~~~~~p~~- 415 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKELKQRVLEQAVTYPDK- 415 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC----CCHHHHHHHHHHCCCCCCTT-
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc----hhHHHHHHHHhhcccCCCcc-
Confidence 5544445568999999999999999999999999999999999999999743210 01111122222222222211
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTM-----KVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~l~ 707 (708)
.+..+.+++.+||++||++||++ +++++|-+
T Consensus 416 ---~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpf 451 (543)
T 3c4z_A 416 ---FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451 (543)
T ss_dssp ---SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGG
T ss_pred ---cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcc
Confidence 22357889999999999999964 77877643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=344.73 Aligned_cols=263 Identities=20% Similarity=0.307 Sum_probs=200.5
Q ss_pred cccccc-ceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeE
Q 039322 436 NDFDAQ-YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 436 ~~~~~~-~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~ 512 (708)
+.|++. +.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++.++ +||||+++++++.+++..+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 567774 7899999999999975 478999999997632 23456788999999885 7999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc---EEEeecccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE---AHVADFGIA 589 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~a 589 (708)
+||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++
T Consensus 88 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 9999999999999997543 489999999999999999999999 9999999999999998776 999999999
Q ss_pred cccCCCCC-------ccccccccccccCcccccc-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc---
Q 039322 590 KFLKPESS-------NWTEFAGTYGYVAPELAYT-----MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN--- 654 (708)
Q Consensus 590 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~--- 654 (708)
........ ......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 76542211 1223458999999999875 45788999999999999999999999743221100000
Q ss_pred ----cccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 655 ----TDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 655 ----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.......+.......+..........+.+++.+||+.||++|||++|+++|-++
T Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 299 (316)
T 2ac3_A 242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299 (316)
T ss_dssp CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence 011112222222222211112234468899999999999999999999998654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=357.52 Aligned_cols=260 Identities=22% Similarity=0.281 Sum_probs=196.3
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCc----chhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPC----DQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA 508 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 508 (708)
..++|.+.+.||+|+||.||+|.. .+++.||||++...... ........+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 457899999999999999999965 46899999998652110 111223358899999999999999999999854
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC---cEEEee
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY---EAHVAD 585 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~~kl~D 585 (708)
+..++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 56799999999999999986543 489999999999999999999999 999999999999997544 599999
Q ss_pred cccccccCCCCCccccccccccccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 039322 586 FGIAKFLKPESSNWTEFAGTYGYVAPELAYT---MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEI 662 (708)
Q Consensus 586 fg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 662 (708)
||+++..... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..... .......+
T Consensus 286 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-------~~~~~~~i 357 (419)
T 3i6u_A 286 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-------QVSLKDQI 357 (419)
T ss_dssp SSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS-------SCCHHHHH
T ss_pred cccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc-------hHHHHHHH
Confidence 9999876532 23345679999999999853 5678899999999999999999999973211 11111222
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 663 LDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
........+.........+.+++.+||+.||++|||++|+++|-++
T Consensus 358 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 403 (419)
T 3i6u_A 358 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403 (419)
T ss_dssp HTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred hcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence 2222222222222334568899999999999999999999998653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=334.78 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=203.4
Q ss_pred ccccccc-eeccccCccEEEEEeC---CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 436 NDFDAQY-CIGNGGHGSVYRAELP---SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 436 ~~~~~~~-~ig~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
++|.+.. .||+|+||.||+|... +++.||||+++... .....+.+.+|++++++++||||+++++++ ..+..
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc---chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence 5666666 8999999999999653 57789999998642 234567899999999999999999999999 55678
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence 99999999999999996433 4589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc---cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 039322 592 LKPESSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 592 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~~i~~~~~ 231 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFIEQGKR 231 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHHHHHHTTCC
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHhcCCc
Confidence 6544332 123346789999999988889999999999999999998 9999874321 111111111111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+. ..+..+.+++.+||+.||++||++.|++++|+
T Consensus 232 ~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 232 MECPP---ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp CCCCT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCC---CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111 12345889999999999999999999999885
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=337.37 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=199.3
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR---SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG---CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc---cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 37899999999999999999965 468899999987532 12235778999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee---CCCCcEEEeecccc
Q 039322 514 VYELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL---DLEYEAHVADFGIA 589 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a 589 (708)
||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ ||+||||||+||++ +.++.+||+|||++
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 999999999999986432 234589999999999999999999999 99999999999999 45678999999999
Q ss_pred cccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 039322 590 KFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
...... .......+++.|+|||.+. +.++.++||||+|+++|||++|+.||.......... ......+....
T Consensus 175 ~~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~------~~~~~~~~~~~ 246 (285)
T 3is5_A 175 ELFKSD-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ------KATYKEPNYAV 246 (285)
T ss_dssp CC-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCCCCCC
T ss_pred eecCCc-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh------hhccCCccccc
Confidence 866533 2334567899999999875 468899999999999999999999997432211000 00001111111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.... ....+.+++.+||+.||++|||++|++++-+
T Consensus 247 ~~~~---~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 281 (285)
T 3is5_A 247 ECRP---LTPQAVDLLKQMLTKDPERRPSAAQVLHHEW 281 (285)
T ss_dssp --CC---CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred ccCc---CCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 1000 1235778999999999999999999998755
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=342.39 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=198.4
Q ss_pred ccccccceeccccCccEEEEEeCC-----CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPS-----GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
.+|...+.||+|+||.||+|.... +..||||.++... .......+.+|++++++++||||+++++++...+.
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 577888999999999999996542 2359999997632 23456679999999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++.
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence 999999999999999997543 4589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc---cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC
Q 039322 591 FLKPESSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPR 666 (708)
Q Consensus 591 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (708)
........ .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~~~~~~~~ 267 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKAINDGF 267 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTC
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHCCC
Confidence 76543221 122345778999999998899999999999999999999 9999864321 11112222221
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 667 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+... ..+..+.+++.+||+.||++||+++|++++|+
T Consensus 268 ~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 305 (333)
T 1mqb_A 268 RLPTPM---DCPSAIYQLMMQCWQQERARRPKFADIVSILD 305 (333)
T ss_dssp CCCCCT---TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred cCCCcc---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111111 12335889999999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=341.41 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=203.9
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|.+.+.||+|+||.||+|... +|+.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP----AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc----ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 478999999999999999999764 78999999997532 2234578899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee---CCCCcEEEeeccccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL---DLEYEAHVADFGIAK 590 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~ 590 (708)
||||+++++|.+++.... .+++..++.++.|++.||+|||++ |++||||||+||++ +.++.+||+|||++.
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 84 VMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp EECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EEEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 999999999999986543 489999999999999999999999 99999999999999 778999999999997
Q ss_pred ccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 591 FLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
.... .......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||..... ......+.......+
T Consensus 158 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~~~~~ 227 (304)
T 2jam_A 158 MEQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--------SKLFEKIKEGYYEFE 227 (304)
T ss_dssp CCCC--BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHCCCCCC
T ss_pred ecCC--CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCCCCC
Confidence 5432 223445689999999999998999999999999999999999999864221 111111111111111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+..+.+++.+||+.||++|||++|+++|-+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 1111222346889999999999999999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=333.18 Aligned_cols=257 Identities=24% Similarity=0.325 Sum_probs=206.5
Q ss_pred HhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
..++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG---CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc---chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 3478999999999999999999764 78999999986422 1234577899999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+||||+++++|.+++... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||.+...
T Consensus 82 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp EEEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 999999999999998654 3489999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCC--CccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 039322 593 KPES--SNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 593 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
.... .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||+..... ......+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~ 228 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-------CQEYSDWKEKKTYL 228 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT-------SHHHHHHHTTCTTS
T ss_pred CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH-------HHHHHHhhhccccc
Confidence 4322 12344578999999999887665 67899999999999999999999743211 01111111111111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
. ........+.+++.+||+.||++|||++|++++-++
T Consensus 229 ~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (276)
T 2yex_A 229 N--PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265 (276)
T ss_dssp T--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred C--chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccc
Confidence 1 111223457889999999999999999999987653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=353.58 Aligned_cols=266 Identities=21% Similarity=0.298 Sum_probs=208.9
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC--ee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR--HS 511 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--~~ 511 (708)
.++|.+.+.||+|+||.||+|... +|+.||||++... ......+.+.+|++++++++||||+++++++...+ ..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI---SFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGG---GGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccc---cccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 368999999999999999999764 5899999998752 12234567889999999999999999999998765 78
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee----CCCCcEEEeecc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL----DLEYEAHVADFG 587 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg 587 (708)
++||||+++|+|.+++........+++..++.++.|++.||+|||++ ||+||||||+||++ +.++.+||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 99999999999999998766555589999999999999999999999 99999999999999 777889999999
Q ss_pred cccccCCCCCccccccccccccCcccccc--------CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc-----
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYT--------MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN----- 654 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~----- 654 (708)
+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 162 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 162 AARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp GCEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred CceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 998765432 2344678999999998865 45778999999999999999999998632211000000
Q ss_pred ------ccccccc------ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 655 ------TDIALDE------ILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 655 ------~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....... ......+............+.+++.+||+.||++||+++|+++.++
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~ 305 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHH
Confidence 0000000 0111222222333556677889999999999999999999988764
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=368.78 Aligned_cols=349 Identities=19% Similarity=0.162 Sum_probs=241.6
Q ss_pred CCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEecc
Q 039322 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVS 81 (708)
Q Consensus 3 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~ 81 (708)
++++|||++|+|+.+.+..|.++++|++|+|++|++++..+..|.. ++|+.|++++|.+++..+..|..+++|++|+++
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 4556666666666555555666666666666666665555555543 556666666666555555555555555555555
Q ss_pred CCccccccCccCcCCCCCcEEEccCCccccc-cccccCCCCCCCEEEcccCcceeeC-----------------------
Q 039322 82 ENHFQGTIPKILRNCSSLIRVRLNSNNLTGN-ISEALGIYPNLTFIDLSRNDFYGEI----------------------- 137 (708)
Q Consensus 82 ~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~-~~~~~~~~~~L~~L~l~~n~l~~~~----------------------- 137 (708)
+|.+++..+..++++++|++|++++|.++++ .+..|.++++|++|++++|+++++.
T Consensus 109 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~ 188 (570)
T 2z63_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (570)
T ss_dssp TSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred ccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCC
Confidence 5555544444455555555555555555543 2445555555555555555544332
Q ss_pred -----CCC------------------------------------------------------------------------
Q 039322 138 -----SSN------------------------------------------------------------------------ 140 (708)
Q Consensus 138 -----~~~------------------------------------------------------------------------ 140 (708)
+..
T Consensus 189 l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~ 268 (570)
T 2z63_A 189 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268 (570)
T ss_dssp CCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETT
T ss_pred ceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcch
Confidence 221
Q ss_pred ---------CCCCCCCCEEEcccCcccccCCccc------------------------------------------cCCC
Q 039322 141 ---------WGKCPKLGTLNVSMNNITGGIPREI------------------------------------------GNSS 169 (708)
Q Consensus 141 ---------~~~l~~L~~L~L~~N~i~~~~~~~~------------------------------------------~~l~ 169 (708)
+..+++|+.|++++|.++. .|..+ ..++
T Consensus 269 ~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~ 347 (570)
T 2z63_A 269 YYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP 347 (570)
T ss_dssp EEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCT
T ss_pred hhhhhchhhhcCcCcccEEEecCccchh-hhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCC
Confidence 2223455555555555542 23222 2345
Q ss_pred CCCEEecccccccccC--CcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCC-CCCCccccceee
Q 039322 170 QLQALDLSLNHIVGEI--PKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVP-ENLGNLLKLHYL 246 (708)
Q Consensus 170 ~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L 246 (708)
+|++|++++|++++.. +..+..+++|++|++++|.+++..+ .+..+++|++|++++|.+++..+ ..+..+++|+.|
T Consensus 348 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 426 (570)
T 2z63_A 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426 (570)
T ss_dssp TCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEE
T ss_pred CCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEE
Confidence 5555556566555332 4456667777777777777774443 38888899999999999887665 568899999999
Q ss_pred cccCcccccCCChhhhhhcccchhhcccccCC-CCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcC
Q 039322 247 GLSNNQFVLELPKELEKLVQLSELDASHNLFG-GEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQL 325 (708)
Q Consensus 247 ~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~-~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l 325 (708)
++++|.+++..+..|.++++|+.|++++|.++ +..|..+..+++|+.|++++|++++..|..+..+++|+.|++++|.+
T Consensus 427 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 506 (570)
T 2z63_A 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506 (570)
T ss_dssp ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred eCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcC
Confidence 99999999889999999999999999999997 46788899999999999999999988899999999999999999999
Q ss_pred CCCCCC-ccccccCcccccccccCcCCCC
Q 039322 326 QGPVPN-STAFRNAPVEALKGNKGLCGGV 353 (708)
Q Consensus 326 ~~~~~~-~~~~~~~~~~~~~~n~~~c~~~ 353 (708)
++.++. ...++.++.+.+.+|++.|+|+
T Consensus 507 ~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 507 KSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 998775 4567889999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=342.02 Aligned_cols=269 Identities=25% Similarity=0.329 Sum_probs=201.1
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcc-hhHhHHHHHHHHHHHHhcc---CCceeeEEEEEeeC
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCD-QIADQKEFLIEVKALTEIR---HRNIVKFYGFCSHA 508 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~---h~~iv~l~~~~~~~ 508 (708)
..++|++.+.||+|+||.||+|.. .+++.||||++....... .......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357999999999999999999975 578999999986422111 1112345667777777664 99999999999875
Q ss_pred C-----eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEE
Q 039322 509 R-----HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHV 583 (708)
Q Consensus 509 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl 583 (708)
. ..++||||+. |+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 5 5799999997 599999976543 3489999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc---------
Q 039322 584 ADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN--------- 654 (708)
Q Consensus 584 ~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~--------- 654 (708)
+|||++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||............
T Consensus 162 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 162 ADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp CSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 999999866533 2335567899999999999999999999999999999999999999643221100000
Q ss_pred ----ccccc-ccccCCCCCCC-CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 655 ----TDIAL-DEILDPRLPPP-SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 655 ----~~~~~-~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
..... .....+..+.. ..........+.+++.+||+.||++|||++|+++|-++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~ 300 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccc
Confidence 00000 00000000000 00001123467899999999999999999999998653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=349.93 Aligned_cols=263 Identities=17% Similarity=0.234 Sum_probs=195.2
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|... +++.||+|++..... ......+.+|++++++++||||+++++++..++..++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc---cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 57999999999999999999764 789999999875321 11122455799999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||++ |+|.+++.... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 79 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp EECCS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred ecccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 99997 49999887543 4589999999999999999999999 999999999999999999999999999987655
Q ss_pred CCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc----------------ccccc
Q 039322 595 ESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS----------------LNTDI 657 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~----------------~~~~~ 657 (708)
.........+|+.|+|||++.+ ..++.++||||+|+++|+|++|+.||.......... .....
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 4444556678999999998876 568999999999999999999999997532111000 00000
Q ss_pred ccccccCCCCCCCC--chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 ALDEILDPRLPPPS--RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+...... .........+.+++.+||+.||++|||++|+++|-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence 00000001110000 000112345789999999999999999999998765
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=342.17 Aligned_cols=257 Identities=22% Similarity=0.333 Sum_probs=197.0
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +++.||+|++..... ......+.+.+|++++++++||||+++++++..++..++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 478999999999999999999764 688999999875321 222345788999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++++|.+++... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999999754 3489999999999999999999999 99999999999999999999999999998664
Q ss_pred CCC-CccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 594 PES-SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 594 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
... .......+++.|+|||.+.+..++.++||||||+++|||++|+.||...... ...............
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------~~~~~~~~~~~~~~~ 256 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---------VMGAHINQAIPRPST 256 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---------HHHHHHHSCCCCGGG
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---------HHHHHhccCCCCccc
Confidence 432 2233457899999999999888999999999999999999999999743221 011111111111111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRP-TMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~l~ 707 (708)
.....+..+.+++.+||+.||++|| +++++++.|+
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~ 292 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAH 292 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence 1112223588899999999999999 9999998874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.90 Aligned_cols=266 Identities=19% Similarity=0.262 Sum_probs=207.9
Q ss_pred hHHHHHHHhcccccc-ceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEE
Q 039322 427 VYDEIVRATNDFDAQ-YCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYG 503 (708)
Q Consensus 427 ~~~~~~~~~~~~~~~-~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~ 503 (708)
.+.......+.|.+. +.||+|+||.||+|... +++.||+|++..... .......+.+|+.++++++ ||||+++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 344455566788887 88999999999999654 689999999876322 1234677899999999995 699999999
Q ss_pred EEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC---CCc
Q 039322 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL---EYE 580 (708)
Q Consensus 504 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~ 580 (708)
++..++..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ ||+||||||+||+++. ++.
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCC
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCc
Confidence 9999999999999999999999986533 34589999999999999999999999 9999999999999988 789
Q ss_pred EEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 039322 581 AHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALD 660 (708)
Q Consensus 581 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 660 (708)
+||+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... ....
T Consensus 173 ~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~ 243 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ--------ETYL 243 (327)
T ss_dssp EEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHH
T ss_pred EEEeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--------HHHH
Confidence 9999999998765332 234467899999999999999999999999999999999999999743211 1111
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 661 EILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+..................+.+++.+||+.||++|||++|+++|-+
T Consensus 244 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 244 NISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp HHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred HHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 11111111111111222345788999999999999999999998765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=334.80 Aligned_cols=253 Identities=20% Similarity=0.378 Sum_probs=204.8
Q ss_pred HhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
..++|++.+.||+|+||.||+|...+++.||+|.+.... ...+.+.+|++++++++||||+++++++.. +..++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-----ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 347899999999999999999998888899999987532 235678999999999999999999999864 56899
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++++|.+++.... ...+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++....
T Consensus 85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 999999999999997543 23589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 594 PESSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 594 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
..... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+.........
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~ 232 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--------EVIQNLERGYRMVRP 232 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCCCCCC
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--------HHHHHHhcccCCCCc
Confidence 43221 233456788999999988889999999999999999999 99998743211 111111111111111
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. ..+..+.+++.+||+.||++|||++++++.|+
T Consensus 233 ~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 265 (279)
T 1qpc_A 233 D---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (279)
T ss_dssp T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred c---cccHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 1 12235889999999999999999999998874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=340.43 Aligned_cols=256 Identities=18% Similarity=0.244 Sum_probs=204.1
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~ 512 (708)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+++++++ +|++++++++++..+...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT------TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC------ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 36799999999999999999974 579999999986532 233577899999999 7999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc-----EEEeecc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE-----AHVADFG 587 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg 587 (708)
+||||+ +++|.+++.... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++. +||+|||
T Consensus 83 lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 999999 999999997543 3589999999999999999999999 9999999999999987776 9999999
Q ss_pred cccccCCCCC-------ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 039322 588 IAKFLKPESS-------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALD 660 (708)
Q Consensus 588 ~a~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 660 (708)
++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-----~~~~~ 231 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-----KQKYE 231 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-----HHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc-----HHHHH
Confidence 9987654332 12445789999999999998999999999999999999999999975321110 01111
Q ss_pred cccCCCCCCC-CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 661 EILDPRLPPP-SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 661 ~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.......+ .......+..+.+++.+||+.||++|||+++|++.|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~ 279 (298)
T 1csn_A 232 RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 279 (298)
T ss_dssp HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred HHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 1100000000 0000112346889999999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=346.39 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=197.4
Q ss_pred ccccccceeccccCccEEEEEeC-CCcE----EEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQV----VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
++|++.+.||+|+||.||+|.+. +++. ||+|.+..... ......+.+|+.++++++||||+++++++. ++.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG---RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS---CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc---HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 68999999999999999999753 4443 88888764321 122345678999999999999999999986 456
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred cEEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccc
Confidence 889999999999999997643 3588999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 039322 591 FLKPESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 591 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
....... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||...... .....+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~ 235 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--------EVPDLLEKGER 235 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--------HHHHHHHTTCB
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--------HHHHHHHcCCC
Confidence 7754432 2344567889999999999999999999999999999999 99999743211 11111111111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+.. ....+.+++.+||+.||++|||++|++++|+
T Consensus 236 ~~~~~~---~~~~~~~li~~~l~~dp~~Rps~~el~~~l~ 272 (325)
T 3kex_A 236 LAQPQI---CTIDVYMVMVKCWMIDENIRPTFKELANEFT 272 (325)
T ss_dssp CCCCTT---BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHH
T ss_pred CCCCCc---CcHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111111 1124778999999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=349.81 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=191.7
Q ss_pred ccccccceeccccCccEEEEEeC--CC--cEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee-CCe
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP--SG--QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH-ARH 510 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~ 510 (708)
..|.+.+.||+|+||.||+|... ++ ..||+|.++.. ......+.+.+|+.++++++||||+++++++.. ++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence 45778889999999999999653 22 36899998753 223456789999999999999999999998754 567
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccc
Confidence 899999999999999997543 4578999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc----cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC
Q 039322 591 FLKPESSN----WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP 665 (708)
Q Consensus 591 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 665 (708)
........ .....+++.|+|||.+.+..++.++||||||+++|||+| |..||...... .....+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--------~~~~~~~~~ 312 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--------DITVYLLQG 312 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--------CHHHHHHTT
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--------HHHHHHHcC
Confidence 65433211 233456789999999999999999999999999999999 67777632211 111111121
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 666 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+.. .+..+.+++.+||+.||++|||++|++++|+
T Consensus 313 ~~~~~p~~---~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 351 (373)
T 3c1x_A 313 RRLLQPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351 (373)
T ss_dssp CCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111111 1235888999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=340.33 Aligned_cols=261 Identities=20% Similarity=0.337 Sum_probs=203.7
Q ss_pred ccccccceeccccCccEEEEEe-----CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC--
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA-- 508 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-- 508 (708)
..|++.+.||+|+||.||+|.+ .+++.||+|++.... .....+.+.+|++++++++||||+++++++..+
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 5689999999999999999973 468899999997532 223457789999999999999999999999876
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||+
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence 66899999999999999996543 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc---cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccc-------cccccccccc
Q 039322 589 AKFLKPESSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLI-------SSSSLNTDIA 658 (708)
Q Consensus 589 a~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~-------~~~~~~~~~~ 658 (708)
+......... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.|+...... ..........
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 9877654432 23456788899999999988999999999999999999999986532110 0000000111
Q ss_pred cccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 659 LDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..........+.+. ..+..+.+++.+||+.||++|||++|+++.|+
T Consensus 253 ~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 298 (302)
T 4e5w_A 253 VNTLKEGKRLPCPP---NCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298 (302)
T ss_dssp HHHHHTTCCCCCCT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhccCCCCCCC---CCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 11111111111111 12235889999999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=334.68 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=202.9
Q ss_pred HhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCee
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~ 511 (708)
..++|++.+.||+|+||.||+|... +++.||+|++...... ......+.+|+..+.++ +||||+++++++.+++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG--SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT--SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 3478999999999999999999765 7999999999864322 23466788999999999 899999999999999999
Q ss_pred EEEEEeccCCCHHHHhccccc-ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC------------
Q 039322 512 FLVYELLERGSLAAILSSDTA-AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE------------ 578 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~------------ 578 (708)
++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ ||+||||||+||+++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccc
Confidence 999999999999999976432 24589999999999999999999999 99999999999999844
Q ss_pred -------CcEEEeecccccccCCCCCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccc
Q 039322 579 -------YEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISS 650 (708)
Q Consensus 579 -------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~ 650 (708)
..+||+|||.+....... ...|++.|+|||.+.+. .++.++||||||+++|+|++|..|+.....
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--- 236 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred ccccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence 479999999998765432 24589999999998765 566799999999999999999987642211
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 651 SSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
...+.....+..+.. ....+.+++.+||+.||++|||++|+++|-++
T Consensus 237 --------~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 283 (289)
T 1x8b_A 237 --------WHEIRQGRLPRIPQV---LSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283 (289)
T ss_dssp --------HHHHHTTCCCCCSSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred --------HHHHHcCCCCCCCcc---cCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence 111122222111111 12358899999999999999999999998654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=333.67 Aligned_cols=253 Identities=21% Similarity=0.337 Sum_probs=200.1
Q ss_pred hccccccceeccccCccEEEEEeCC----CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
.++|++.+.||+|+||.||+|.... +..||+|.+.... .....+.+.+|++++++++||||+++++++.+ +.
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 4789999999999999999996532 3469999987642 23456789999999999999999999999865 45
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++.
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred CEEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCc
Confidence 689999999999999996543 4589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCC
Q 039322 591 FLKPESS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 591 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--------~~~~~~~~~~~ 233 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--------VIGVLEKGDRL 233 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--------HHHHHHHTCCC
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--------HHHHHhcCCCC
Confidence 7654322 2233456789999999998899999999999999999998 999986432211 11111111111
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+.+.. .+..+.+++.+||+.||++|||++|++++|+
T Consensus 234 ~~~~~---~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 269 (281)
T 3cc6_A 234 PKPDL---CPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269 (281)
T ss_dssp CCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCC---CCHHHHHHHHHHccCCchhCcCHHHHHHHHH
Confidence 11111 1235889999999999999999999999885
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=337.75 Aligned_cols=257 Identities=23% Similarity=0.403 Sum_probs=192.7
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.++|++.+.||+|+||.||+|... ..||+|+++... ......+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccC--CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 478999999999999999999864 359999997543 2334567899999999999999999999965 45568999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 98 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999999996543 4589999999999999999999999 999999999999999999999999999986543
Q ss_pred C--CCccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 039322 595 E--SSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 595 ~--~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
. ........|++.|+|||.+. +..++.++||||||+++|+|++|+.||......... ..........+....
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~ 249 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI---IEMVGRGSLSPDLSK 249 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH---HHHHHHTSCCCCTTS
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH---HHHhcccccCcchhh
Confidence 2 22234467899999999886 566888999999999999999999999743211000 000001111111111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+..+.+++.+||+.||++|||++|+++.|+
T Consensus 250 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 284 (289)
T 3og7_A 250 ---VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284 (289)
T ss_dssp ---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 11122346889999999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=353.47 Aligned_cols=264 Identities=22% Similarity=0.336 Sum_probs=192.5
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCC--
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHAR-- 509 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~-- 509 (708)
..++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+.+++++. ||||+++++++..++
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF--QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc--cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 457899999999999999999965 578999999987532 23345677889999999997 999999999997654
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccc
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA 589 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 589 (708)
..|+||||++ |+|.+++... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+|
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 7899999998 5899998653 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC---------------------CCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 039322 590 KFLKPE---------------------SSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSL 647 (708)
Q Consensus 590 ~~~~~~---------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~ 647 (708)
+.+... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 865321 112244579999999999876 6789999999999999999999999974322
Q ss_pred ccccccc-------ccccccccc------------------CCCCCCCCchhH----------HHHHHHHHHHHhccCCC
Q 039322 648 ISSSSLN-------TDIALDEIL------------------DPRLPPPSRSVQ----------EKLISIMEVAFSCLNES 692 (708)
Q Consensus 648 ~~~~~~~-------~~~~~~~~~------------------~~~~~~~~~~~~----------~~~~~l~~li~~cl~~d 692 (708)
....... .......+. ..........+. .....+.+++.+||+.|
T Consensus 237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 1100000 000000000 000000000000 11235789999999999
Q ss_pred CCCCCCHHHHHHHhh
Q 039322 693 PESRPTMKVVTQQVR 707 (708)
Q Consensus 693 P~~RPs~~evl~~l~ 707 (708)
|++|||++|+++|-+
T Consensus 317 P~~R~t~~e~l~Hp~ 331 (388)
T 3oz6_A 317 PNKRISANDALKHPF 331 (388)
T ss_dssp GGGSCCHHHHTTSTT
T ss_pred cccCCCHHHHhCCHH
Confidence 999999999998854
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=367.07 Aligned_cols=259 Identities=20% Similarity=0.251 Sum_probs=208.1
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +|+.||+|++.+.. .........+.+|++++++++||||+++++++.+++..++
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~-~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR-IKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHh-hhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 478999999999999999999764 79999999986421 0111234668899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||++||+|.+++.... ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999997644 23489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........+.......+
T Consensus 338 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~----~~~~i~~~i~~~~~~~p--- 409 (576)
T 2acx_A 338 EGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----KREEVERLVKEVPEEYS--- 409 (576)
T ss_dssp TTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC----CHHHHHHHHHHCCCCCC---
T ss_pred cCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch----hHHHHHHHhhcccccCC---
Confidence 432 3345689999999999999889999999999999999999999997432110 00111111111111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRP-----TMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~ 707 (708)
......+.+++.+||++||++|| +++|+++|-+
T Consensus 410 -~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf 447 (576)
T 2acx_A 410 -ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447 (576)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred -ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence 11223578899999999999999 7899998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.12 Aligned_cols=265 Identities=19% Similarity=0.254 Sum_probs=195.1
Q ss_pred HHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
...++|++.+.||+|+||.||+|.. .+++.||||+++... ........+.+|++++++++||||+++++++.+++..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH--EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc--cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 3457899999999999999999964 578999999997542 2223356678999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC-----CCCcEEEeec
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD-----LEYEAHVADF 586 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-----~~~~~kl~Df 586 (708)
++||||+++ +|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++ .++.+||+||
T Consensus 109 ~lv~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 109 HLIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 999999985 9999997554 389999999999999999999999 999999999999994 4556999999
Q ss_pred ccccccCCCCCccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCcccccccccc------------
Q 039322 587 GIAKFLKPESSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL------------ 653 (708)
Q Consensus 587 g~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~------------ 653 (708)
|++..............+|+.|+|||++.+.. ++.++|||||||++|||++|+.||...........
T Consensus 182 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 182 GLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp THHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 99987765544555667899999999988754 79999999999999999999999974321100000
Q ss_pred -ccccccccccCCCCCCC-CchhH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 -NTDIALDEILDPRLPPP-SRSVQ-----EKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 -~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........+.. ..+.. ..... .....+.+++.+||+.||++|||++|+++|-+
T Consensus 262 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 321 (329)
T 3gbz_A 262 WPGVTALPDWKQ-SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321 (329)
T ss_dssp STTGGGSTTCCT-TCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred hhhhhhhhhhhh-hhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence 00000000000 00000 00001 02246789999999999999999999999765
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=363.31 Aligned_cols=258 Identities=22% Similarity=0.296 Sum_probs=206.9
Q ss_pred HhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcch---------hHhHHHHHHHHHHHHhccCCceeeEEE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQ---------IADQKEFLIEVKALTEIRHRNIVKFYG 503 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~l~~ 503 (708)
..++|.+.+.||+|+||.||+|... +++.||+|++........ ....+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999764 688999999876321110 123567899999999999999999999
Q ss_pred EEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC---c
Q 039322 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY---E 580 (708)
Q Consensus 504 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~---~ 580 (708)
++.+++..++||||+++|+|.+++... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999998654 3489999999999999999999999 999999999999998776 6
Q ss_pred EEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 039322 581 AHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALD 660 (708)
Q Consensus 581 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 660 (708)
+||+|||++...... .......||+.|+|||++. +.++.++||||+||++|+|++|+.||..... .....
T Consensus 188 ~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~ 257 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND--------QDIIK 257 (504)
T ss_dssp EEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH
T ss_pred EEEEECCCCEEcCCC-CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHH
Confidence 999999999876543 3334567999999999876 4689999999999999999999999974321 22223
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 661 EILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.......+...+...+..+.+++.+||+.||++|||++|+++|-+
T Consensus 258 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 258 KVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp HHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 33333333222222233456889999999999999999999998865
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=366.25 Aligned_cols=346 Identities=21% Similarity=0.188 Sum_probs=238.4
Q ss_pred CCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEec
Q 039322 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGV 80 (708)
Q Consensus 2 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l 80 (708)
+++++|||++|+|+++.+..|.++++|++|+|++|++.++.|..|.. ++|+.|++++|.+.+..|..+..+++|++|++
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 46788888888888888888888888888888888888887887765 78888888888888888888888888888888
Q ss_pred cCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCC--EEEcccCccc
Q 039322 81 SENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLG--TLNVSMNNIT 158 (708)
Q Consensus 81 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~--~L~L~~N~i~ 158 (708)
++|.+++..+..+.++++|++|++++|.++++....+..+++|++|++++|+++++.+..|..+++|+ .|++++|.++
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~ 192 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCC
T ss_pred cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccC
Confidence 88888877677788888888888888888876656666688888888888888877777777777777 7777777777
Q ss_pred ccCCccccCC---------------------------------------------------CCCCEEecccccccccCCc
Q 039322 159 GGIPREIGNS---------------------------------------------------SQLQALDLSLNHIVGEIPK 187 (708)
Q Consensus 159 ~~~~~~~~~l---------------------------------------------------~~L~~L~L~~n~l~~~~~~ 187 (708)
+..+..|... .+|+.|++++|.+++..+.
T Consensus 193 ~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~ 272 (606)
T 3t6q_A 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272 (606)
T ss_dssp EECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTT
T ss_pred ccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHH
Confidence 6555444321 0455666666666655555
Q ss_pred ccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCC-hhhhhhcc
Q 039322 188 ELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELP-KELEKLVQ 266 (708)
Q Consensus 188 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~ 266 (708)
.|..+++|++|++++|+++ .+|..+..+++|++|++++|++++..|..+..+++|+.|++++|.+.+..+ ..+..+++
T Consensus 273 ~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~ 351 (606)
T 3t6q_A 273 TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351 (606)
T ss_dssp TTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTT
T ss_pred HhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCc
Confidence 5666666666666666666 555566666666666666666665555556666666666666666553333 33556666
Q ss_pred cchhhcccccCCCCC--chhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCCC--ccccccCcccc
Q 039322 267 LSELDASHNLFGGEI--PFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPN--STAFRNAPVEA 342 (708)
Q Consensus 267 L~~L~ls~N~i~~~~--~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~--~~~~~~~~~~~ 342 (708)
|+.|++++|.+++.. +..+..+++|+.|++++|++++..+..+..+++|+.|++++|.+++..+. ...++.++.+.
T Consensus 352 L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 431 (606)
T 3t6q_A 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431 (606)
T ss_dssp CCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEE
T ss_pred CCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEE
Confidence 666666666665433 44555566666666666666655556666666666666666666554332 23445555555
Q ss_pred cccccC
Q 039322 343 LKGNKG 348 (708)
Q Consensus 343 ~~~n~~ 348 (708)
+++|..
T Consensus 432 l~~n~l 437 (606)
T 3t6q_A 432 LSHSLL 437 (606)
T ss_dssp CTTCCC
T ss_pred CCCCcc
Confidence 555543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=362.80 Aligned_cols=255 Identities=24% Similarity=0.339 Sum_probs=203.8
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +++.||+|++...... ......+.+|+++++.++||||+++++++.+++..++
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS--TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 468999999999999999999764 6889999999763211 2235678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC---CcEEEeeccccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE---YEAHVADFGIAK 590 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~ 590 (708)
||||+++|+|.+++... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.. +.+||+|||++.
T Consensus 114 v~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 114 VMECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 99999999999988654 3489999999999999999999999 99999999999999764 459999999998
Q ss_pred ccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 591 FLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
...... ......||+.|+|||++. +.++.++||||+||++|+|++|+.||..... ......+........
T Consensus 188 ~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~~ 257 (494)
T 3lij_A 188 VFENQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--------QEILRKVEKGKYTFD 257 (494)
T ss_dssp ECBTTB-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCCC
T ss_pred ECCCCc-cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCC
Confidence 765432 334567999999999876 4689999999999999999999999974321 122222233333322
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+...+..+.+++.+||+.||++|||++|+++|-+
T Consensus 258 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 258 SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294 (494)
T ss_dssp SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence 2223333456889999999999999999999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=362.84 Aligned_cols=255 Identities=22% Similarity=0.341 Sum_probs=207.1
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +++.||||++.... ........+.+|++++++++||||+++++++.+++..++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS--AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHH--HBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 478999999999999999999764 78999999986421 111235678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC---CCCcEEEeeccccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD---LEYEAHVADFGIAK 590 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~ 590 (708)
||||+.+|+|.+++... ..+++..++.++.|++.||+|||++ ||+||||||+||+++ .++.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999999988654 3489999999999999999999999 999999999999995 45679999999998
Q ss_pred ccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 591 FLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
..... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ......+........
T Consensus 173 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~~ 242 (486)
T 3mwu_A 173 CFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKRVETGKYAFD 242 (486)
T ss_dssp TBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCSC
T ss_pred ECCCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCC
Confidence 76543 23345679999999999876 589999999999999999999999964321 122223333333333
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+...+..+.+++.+||+.||++|||+.|+++|-+
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 2333334456889999999999999999999999854
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=341.26 Aligned_cols=263 Identities=21% Similarity=0.349 Sum_probs=208.5
Q ss_pred HHHHHHhccccccceeccccCccEEEEEe------CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeE
Q 039322 429 DEIVRATNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKF 501 (708)
Q Consensus 429 ~~~~~~~~~~~~~~~ig~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l 501 (708)
.+.....++|++.+.||+|+||.||+|.. .+++.||||+++... .......+.+|+++++++ +||||+++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34445568999999999999999999963 356889999997642 234456789999999999 69999999
Q ss_pred EEEEeeCC-eeEEEEEeccCCCHHHHhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcc
Q 039322 502 YGFCSHAR-HSFLVYELLERGSLAAILSSDTA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQD 567 (708)
Q Consensus 502 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~d 567 (708)
++++..++ ..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ |++|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99997765 58999999999999999976542 12278999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCc
Q 039322 568 ISSKNLLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDF 644 (708)
Q Consensus 568 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~ 644 (708)
|||+||+++.++.+||+|||++......... .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999876543322 234567889999999999899999999999999999998 9999874
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 645 LSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.... ......+........+.. ....+.+++.+||+.||++|||++|++++|+
T Consensus 254 ~~~~-------~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 306 (316)
T 2xir_A 254 VKID-------EEFCRRLKEGTRMRAPDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306 (316)
T ss_dssp CCCS-------HHHHHHHHHTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cchh-------HHHHHHhccCccCCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 3211 011111111111111111 1235888999999999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=335.60 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=205.7
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +++.||+|++.... .........+.+|++++++++||||+++++++.+++..++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQ-LEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccc-cchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 378999999999999999999664 67889999986411 0111224678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++.... .+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++....
T Consensus 92 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999997543 489999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
.. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||+.... ......+.......+..
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~- 234 (284)
T 2vgo_A 166 SL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--------TETHRRIVNVDLKFPPF- 234 (284)
T ss_dssp SS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTCCCCCTT-
T ss_pred cc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH--------hHHHHHHhccccCCCCc-
Confidence 32 23345789999999999998899999999999999999999999974321 11112222222221111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+.+++.+||+.||++|||++|+++|-+
T Consensus 235 ---~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 235 ---LSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265 (284)
T ss_dssp ---SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHH
T ss_pred ---CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHH
Confidence 1235788999999999999999999998754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=342.64 Aligned_cols=260 Identities=23% Similarity=0.332 Sum_probs=204.3
Q ss_pred HHHHHhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHh--ccCCceeeEEEEEee
Q 039322 430 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTE--IRHRNIVKFYGFCSH 507 (708)
Q Consensus 430 ~~~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~l~~~~~~ 507 (708)
......++|++.+.||+|+||.||+|.. +|+.||||++.. .....+.+|.++++. ++||||+++++++..
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~-------~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS-------REERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG-------GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc-------hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 3445568999999999999999999987 589999999864 234567888998887 689999999999988
Q ss_pred CC----eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEccCCCCCeee
Q 039322 508 AR----HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH--------HDCFPPIVHQDISSKNLLL 575 (708)
Q Consensus 508 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--------~~~~~~ivH~dlk~~Nill 575 (708)
++ ..++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+||++
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll 180 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILV 180 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEE
Confidence 76 789999999999999999653 3899999999999999999999 77 99999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCc----cccccccccccCccccccCC------CCcchhHHHHHHHHHHHHhC-------
Q 039322 576 DLEYEAHVADFGIAKFLKPESSN----WTEFAGTYGYVAPELAYTMK------ITEKCDVYSFGVLVLEAIKG------- 638 (708)
Q Consensus 576 ~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~------~~~~~DvwslG~~l~elltg------- 638 (708)
+.++.+||+|||++......... .....|++.|+|||++.+.. ++.++||||||+++|||+||
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 99999999999999876544322 23457899999999987652 33689999999999999999
Q ss_pred ---CCCCCccccccccccccccccccccCCCCCCCC-c--hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 639 ---KHPRDFLSLISSSSLNTDIALDEILDPRLPPPS-R--SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 639 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..||....... .........+......+.. . ........+.+++.+||+.||++|||++||+++|+
T Consensus 261 ~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 261 EDYQLPYYDLVPSD---PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332 (342)
T ss_dssp CCCCCTTTTTSCSS---CCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred cccccCccccCcCc---ccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 66765321100 0001111112222221111 1 12345567899999999999999999999999985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=337.96 Aligned_cols=246 Identities=21% Similarity=0.388 Sum_probs=198.5
Q ss_pred hccccccceeccccCccEEEEEeC-CC-------cEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEe
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SG-------QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCS 506 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 506 (708)
.++|.+.+.||+|+||.||+|... ++ +.||+|++.. ......+.+.+|++++++++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK----AHRNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECG----GGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccc----ccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 378999999999999999999654 23 4799999865 23345678999999999999999999999999
Q ss_pred eCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc------
Q 039322 507 HARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE------ 580 (708)
Q Consensus 507 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~------ 580 (708)
.++..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccc
Confidence 9999999999999999999997543 3489999999999999999999999 9999999999999998887
Q ss_pred --EEEeecccccccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCC-CCccccccccccccc
Q 039322 581 --AHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHP-RDFLSLISSSSLNTD 656 (708)
Q Consensus 581 --~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p-~~~~~~~~~~~~~~~ 656 (708)
+||+|||++..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|..| |......
T Consensus 158 ~~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-------- 225 (289)
T 4fvq_A 158 PFIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-------- 225 (289)
T ss_dssp CEEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------
T ss_pred ceeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH--------
Confidence 99999999975432 234567899999999887 6789999999999999999996554 4321110
Q ss_pred ccccccc-CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 657 IALDEIL-DPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 657 ~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....... ....+... ...+.+++.+||+.||++|||++|++++|+
T Consensus 226 ~~~~~~~~~~~~~~~~------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 271 (289)
T 4fvq_A 226 RKLQFYEDRHQLPAPK------AAELANLINNCMDYEPDHRPSFRAIIRDLN 271 (289)
T ss_dssp HHHHHHHTTCCCCCCS------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhhccCCCCCCC------CHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 0000001 11111110 124778999999999999999999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=339.35 Aligned_cols=257 Identities=23% Similarity=0.350 Sum_probs=202.6
Q ss_pred ccccceeccccCccEEEEEeC-----CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC--Ce
Q 039322 438 FDAQYCIGNGGHGSVYRAELP-----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA--RH 510 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~ 510 (708)
|++.+.||+|+||.||++.+. +++.||||+++... .....+.+.+|++++++++||||+++++++.+. ..
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA---GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc---ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 499999999999999988542 68899999998642 234567899999999999999999999999874 67
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++||||+++|+|.+++.... +++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccc
Confidence 899999999999999996543 89999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc---cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccc------ccccccccccc
Q 039322 591 FLKPESSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISS------SSLNTDIALDE 661 (708)
Q Consensus 591 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~------~~~~~~~~~~~ 661 (708)
........ .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||........ ...........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 77544322 2344578889999999998899999999999999999999999864221100 00000000111
Q ss_pred cc-CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 662 IL-DPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 662 ~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. .....+... ..+..+.+++.+||+.||++|||++|+++.|+
T Consensus 263 ~~~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 306 (318)
T 3lxp_A 263 LLERGERLPRPD---KCPAEVYHLMKNCWETEASFRPTFENLIPILK 306 (318)
T ss_dssp HHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhcccCCCCCc---cccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11 111111111 12345889999999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=342.32 Aligned_cols=260 Identities=23% Similarity=0.329 Sum_probs=206.1
Q ss_pred ccccccceeccccCccEEEEEe-----CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEe--eC
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCS--HA 508 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~--~~ 508 (708)
++|++.+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|++++++++||||+++++++. +.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 7899999999999999999973 46889999998763 3345677999999999999999999999986 45
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred ceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence 67899999999999999997543 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc---cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc------ccc-cccc
Q 039322 589 AKFLKPESSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS------SLN-TDIA 658 (708)
Q Consensus 589 a~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~------~~~-~~~~ 658 (708)
+......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......... ... ....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 9876544322 23345788899999999888999999999999999999999998643211000 000 0011
Q ss_pred cccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 659 LDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..........+... ..+..+.+++.+||+.||++|||++|++++|+
T Consensus 254 ~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 299 (327)
T 3lxl_A 254 LELLEEGQRLPAPP---ACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299 (327)
T ss_dssp HHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhhcccCCCCCC---cccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111111111111 12345889999999999999999999999885
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=342.38 Aligned_cols=265 Identities=23% Similarity=0.359 Sum_probs=201.7
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+.+|++++++++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 478999999999999999999764 58999999986532 223445678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++++|.++..... .+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||++....
T Consensus 102 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp EEECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred EEecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 999999999998865433 489999999999999999999999 99999999999999999999999999998766
Q ss_pred CCCCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc----------------ccc
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL----------------NTD 656 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~----------------~~~ 656 (708)
..........+++.|+|||++.+. .++.++||||+|+++|+|++|+.||........... ...
T Consensus 176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 554455566789999999998775 688999999999999999999999975332110000 000
Q ss_pred cccccccCCCCCCCCc---hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 657 IALDEILDPRLPPPSR---SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 657 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........+....... .....+..+.+++.+||+.||++|||++|+++|-+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 309 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 0001111111111100 01122356889999999999999999999998744
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=355.07 Aligned_cols=262 Identities=22% Similarity=0.306 Sum_probs=198.5
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC-----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA----- 508 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~----- 508 (708)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+++++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG--GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc--cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 47899999999999999999964 468999999997532 2334567889999999999999999999999654
Q ss_pred -CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecc
Q 039322 509 -RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFG 587 (708)
Q Consensus 509 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 587 (708)
...|+||||+++ ++.+.+.. .+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CCeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence 357999999986 56666632 388999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc--------------
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL-------------- 653 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-------------- 653 (708)
+|+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...........
T Consensus 210 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 210 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp CC-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eeeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 99876533 234556899999999999999999999999999999999999999975321100000
Q ss_pred ccccccccccCCC----------------CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 654 NTDIALDEILDPR----------------LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 654 ~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
........+.... .+............+.+|+.+||+.||++|||++|+++|-++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~ 359 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence 0000000011100 111111122235568899999999999999999999998653
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=371.92 Aligned_cols=345 Identities=20% Similarity=0.240 Sum_probs=305.2
Q ss_pred CCCCcEEECCCCccccc-----------------CCcccc--CCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCC
Q 039322 1 MRSLSILDLNQNQFKGV-----------------LPPSVS--NLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNH 60 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~-----------------~~~~~~--~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~ 60 (708)
|++|++|+|++|++++. .|..+. ++++|++|+|++|.+.+.+|..+.. ++|+.|++++|.
T Consensus 205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 57899999999999985 888888 9999999999999999999988876 899999999998
Q ss_pred -ccC-CCCccccCC------CCccEEeccCCccccccCc--cCcCCCCCcEEEccCCccccccccccCCCCCCCEEEccc
Q 039322 61 -FTS-YLPHNVCRG------GALQYFGVSENHFQGTIPK--ILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSR 130 (708)
Q Consensus 61 -~~~-~~~~~~~~l------~~L~~L~l~~n~i~~~~~~--~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~ 130 (708)
+++ .+|..++.+ ++|++|++++|+++ .+|. .++++++|++|++++|++++..+ .|..+++|++|++++
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~ 362 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY 362 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCS
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCC
Confidence 887 788888876 99999999999999 7888 89999999999999999996666 899999999999999
Q ss_pred CcceeeCCCCCCCCCC-CCEEEcccCcccccCCccccCCC--CCCEEecccccccccCCcccC-------CCCCCCEEEc
Q 039322 131 NDFYGEISSNWGKCPK-LGTLNVSMNNITGGIPREIGNSS--QLQALDLSLNHIVGEIPKELG-------KLNSLTELIL 200 (708)
Q Consensus 131 n~l~~~~~~~~~~l~~-L~~L~L~~N~i~~~~~~~~~~l~--~L~~L~L~~n~l~~~~~~~~~-------~l~~L~~L~l 200 (708)
|+++ ..+..+..+++ |+.|++++|.++ .+|..+..++ +|++|++++|++++..|..+. .+++|++|+|
T Consensus 363 N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~L 440 (636)
T 4eco_A 363 NQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINL 440 (636)
T ss_dssp SEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEEC
T ss_pred Cccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEEC
Confidence 9999 55667999999 999999999999 6777887765 899999999999998888888 7889999999
Q ss_pred cCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCcc-------ccceeecccCcccccCCChhhh--hhcccchhh
Q 039322 201 RGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNL-------LKLHYLGLSNNQFVLELPKELE--KLVQLSELD 271 (708)
Q Consensus 201 ~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l-------~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~ 271 (708)
++|+++...+..+..+++|++|+|++|+++...+..+... ++|+.|+|++|+++ .+|..+. .+++|+.|+
T Consensus 441 s~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~ 519 (636)
T 4eco_A 441 SNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGID 519 (636)
T ss_dssp CSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEE
T ss_pred cCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEE
Confidence 9999995555556779999999999999994433444333 39999999999999 6777776 999999999
Q ss_pred cccccCCCCCchhhcCcccCCceec------ccccccCCCCCcccccccccEEecCCCcCCCCCCCccccccCccccccc
Q 039322 272 ASHNLFGGEIPFQICSLKSLEKLNL------SHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKG 345 (708)
Q Consensus 272 ls~N~i~~~~~~~~~~~~~L~~L~l------~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~ 345 (708)
|++|++++ +|..+..+++|+.|+| ++|++.+.+|..+..+++|+.|++++|++. .+|.. ..+.++.+.+++
T Consensus 520 Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~-~~~~L~~L~Ls~ 596 (636)
T 4eco_A 520 LSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEK-ITPNISVLDIKD 596 (636)
T ss_dssp CCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSC-CCTTCCEEECCS
T ss_pred CCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcCC-ccCHh-HhCcCCEEECcC
Confidence 99999996 7888999999999999 568888999999999999999999999995 44543 237899999999
Q ss_pred ccCcCCCC
Q 039322 346 NKGLCGGV 353 (708)
Q Consensus 346 n~~~c~~~ 353 (708)
|++.|-..
T Consensus 597 N~l~~~~~ 604 (636)
T 4eco_A 597 NPNISIDL 604 (636)
T ss_dssp CTTCEEEC
T ss_pred CCCccccH
Confidence 99988553
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=347.67 Aligned_cols=268 Identities=23% Similarity=0.279 Sum_probs=200.2
Q ss_pred HhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcch-hHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQ-IADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
..++|++.+.||+|+||.||+|... +|+.||||++........ ......+.+|++++++++||||+++++++.+++..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3578999999999999999999764 589999999875322111 11124678999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++||||+++ +|.+++.... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++..
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 8998886543 4578899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc--------c-----ccc
Q 039322 592 LKPESSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL--------N-----TDI 657 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~--------~-----~~~ 657 (708)
............+|+.|+|||.+.+. .++.++||||+|+++|||++|..||........... . ...
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence 76555555567889999999998764 478899999999999999999999874321100000 0 000
Q ss_pred ccccccC-CCCCCCC--chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 ALDEILD-PRLPPPS--RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~~~~~~-~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....... ...+..+ .........+.+++.+||+.||++|||++|+++|-+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 0000000 0011000 000112346889999999999999999999999865
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.01 Aligned_cols=256 Identities=23% Similarity=0.312 Sum_probs=200.3
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|.....||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC----C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence 3455566899999999999965 568899999987532 23456789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-CCcEEEeecccccccC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL-EYEAHVADFGIAKFLK 593 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~ 593 (708)
|||+++++|.+++........+++..++.++.|++.||+|||++ |++||||||+||+++. ++.+||+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 99999999999997654444578999999999999999999999 9999999999999987 8999999999998765
Q ss_pred CCCCccccccccccccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMK--ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
..........|++.|+|||++.+.. ++.++||||||+++|+|++|+.||.......... .........+.++.
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~-- 249 (295)
T 2clq_A 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM---FKVGMFKVHPEIPE-- 249 (295)
T ss_dssp C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH---HHHHHHCCCCCCCT--
T ss_pred CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH---Hhhccccccccccc--
Confidence 4433344567899999999987643 7889999999999999999999986322110000 00000011111111
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+.+++.+||+.||++|||++|++++-+
T Consensus 250 ----~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 281 (295)
T 2clq_A 250 ----SMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281 (295)
T ss_dssp ----TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred ----cCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 12235788999999999999999999998744
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.59 Aligned_cols=258 Identities=22% Similarity=0.360 Sum_probs=195.7
Q ss_pred HhccccccceeccccCccEEEEEeC----CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
..++|.+.+.||+|+||.||+|... .++.||+|.++.... .....+.+.+|++++++++||||+++++++...+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc--chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 4578999999999999999999653 345899999875322 2344677999999999999999999999997755
Q ss_pred -----eeEEEEEeccCCCHHHHhcccc---cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcE
Q 039322 510 -----HSFLVYELLERGSLAAILSSDT---AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEA 581 (708)
Q Consensus 510 -----~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 581 (708)
..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ |++||||||+||+++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence 3599999999999999985332 234589999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccc
Q 039322 582 HVADFGIAKFLKPESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIA 658 (708)
Q Consensus 582 kl~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 658 (708)
||+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ...
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~ 258 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--------HEM 258 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------GGH
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHH
Confidence 9999999986644322 1233456789999999999899999999999999999999 8899874321 111
Q ss_pred cccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 659 LDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+.......... ..+..+.+++.+||+.||++|||+++++++|+
T Consensus 259 ~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 304 (313)
T 3brb_A 259 YDYLLHGHRLKQPE---DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304 (313)
T ss_dssp HHHHHTTCCCCCBT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHcCCCCCCCc---cccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11122221111111 12235889999999999999999999999885
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=363.36 Aligned_cols=331 Identities=20% Similarity=0.212 Sum_probs=284.9
Q ss_pred CCCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEe
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFG 79 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~ 79 (708)
+++|++|+|++|+|+++.+.+|.++++|++|+|++|.+++..|..+.. ++|+.|++++|.+.+..+..++.+++|++|+
T Consensus 55 l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 134 (606)
T 3vq2_A 55 FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLN 134 (606)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEE
T ss_pred CccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEe
Confidence 467888888888888888888888888888888888888777777765 7888888888888887777788888888888
Q ss_pred ccCCcccc-ccCccCcCCCCCcEEEccCCccccccccc------------------------------------------
Q 039322 80 VSENHFQG-TIPKILRNCSSLIRVRLNSNNLTGNISEA------------------------------------------ 116 (708)
Q Consensus 80 l~~n~i~~-~~~~~~~~l~~L~~L~l~~n~i~~~~~~~------------------------------------------ 116 (708)
+++|.+++ .+|..|+++++|++|++++|+++++.+..
T Consensus 135 L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n 214 (606)
T 3vq2_A 135 VAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGN 214 (606)
T ss_dssp CCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred CCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCC
Confidence 88888875 45777888888888888887766443221
Q ss_pred --------------------------------------------------------------------------------
Q 039322 117 -------------------------------------------------------------------------------- 116 (708)
Q Consensus 117 -------------------------------------------------------------------------------- 116 (708)
T Consensus 215 ~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~ 294 (606)
T 3vq2_A 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAG 294 (606)
T ss_dssp CSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEES
T ss_pred ccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecC
Confidence
Q ss_pred ---------------------------------------------------cCCCCCCCEEEcccCcceeeC--CCCCCC
Q 039322 117 ---------------------------------------------------LGIYPNLTFIDLSRNDFYGEI--SSNWGK 143 (708)
Q Consensus 117 ---------------------------------------------------~~~~~~L~~L~l~~n~l~~~~--~~~~~~ 143 (708)
+..+++|++|++++|++++.. +..+..
T Consensus 295 ~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~ 374 (606)
T 3vq2_A 295 VSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374 (606)
T ss_dssp CCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHC
T ss_pred ccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhcc
Confidence 123456777777778877663 667788
Q ss_pred CCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCC-cccCCCCCCCEEEccCccccccCCcccCCCCCCCeE
Q 039322 144 CPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIP-KELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYL 222 (708)
Q Consensus 144 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L 222 (708)
+++|++|++++|.++. .+..|..+++|++|++++|++.+..+ ..+..+++|++|++++|.+++..|..+..+++|++|
T Consensus 375 ~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 453 (606)
T 3vq2_A 375 TNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTL 453 (606)
T ss_dssp CSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred CCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEE
Confidence 9999999999999985 55889999999999999999997777 689999999999999999998899999999999999
Q ss_pred eccCCcccc-cCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccc
Q 039322 223 DLSANRFNN-SVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNL 301 (708)
Q Consensus 223 ~l~~N~i~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l 301 (708)
++++|++++ ..|..+..+++|+.|++++|++++..|..|.++++|+.|++++|++++..|..+..+++|+.|++++|++
T Consensus 454 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l 533 (606)
T 3vq2_A 454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533 (606)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCC
T ss_pred ECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcC
Confidence 999999997 4788899999999999999999999999999999999999999999988899999999999999999999
Q ss_pred cCCCCCcccccc-cccEEecCCCcCCCCCCCcc
Q 039322 302 SGSIPNCFEGIR-GISVIDISDNQLQGPVPNST 333 (708)
Q Consensus 302 ~~~~~~~~~~l~-~L~~l~l~~N~l~~~~~~~~ 333 (708)
+ .+|..+..++ +|+.|++++|++.|.++..+
T Consensus 534 ~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~ 565 (606)
T 3vq2_A 534 E-TSKGILQHFPKSLAFFNLTNNSVACICEHQK 565 (606)
T ss_dssp C-CEESCGGGSCTTCCEEECCSCCCCCSSTTHH
T ss_pred c-ccCHhHhhhcccCcEEEccCCCcccCCccHH
Confidence 9 6677788887 59999999999999877643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=340.13 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=202.3
Q ss_pred HhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
..++|++.+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|++++++++||||+++++++..++..+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 3478999999999999999999664 58999999987531 2456889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||++...
T Consensus 101 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp EEEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 9999999999999986322 4589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
...........+++.|+|||.+.+..++.++||||||+++|+|++|+.||......... ........+....
T Consensus 176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~--- 247 (314)
T 3com_A 176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI-----FMIPTNPPPTFRK--- 247 (314)
T ss_dssp BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHHSCCCCCSS---
T ss_pred hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHhcCCCcccCC---
Confidence 55444445567899999999999888999999999999999999999998743221100 0000011111111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+.+++.+||+.||++|||+.+++++-+
T Consensus 248 -~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~ 281 (314)
T 3com_A 248 -PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281 (314)
T ss_dssp -GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred -cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 1112345889999999999999999999998643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=334.25 Aligned_cols=254 Identities=25% Similarity=0.370 Sum_probs=199.4
Q ss_pred hccccccceeccccCccEEEEEeCC----CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEe-eCC
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCS-HAR 509 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-~~~ 509 (708)
..+|++.+.||+|+||.||+|...+ +..||+|.+... ......+.+.+|++++++++||||+++++++. .++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC---CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 4678899999999999999997542 235899998753 23345678999999999999999999999864 456
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccc
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA 589 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 589 (708)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred ceEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccc
Confidence 7899999999999999996533 4579999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC----ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC
Q 039322 590 KFLKPESS----NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILD 664 (708)
Q Consensus 590 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 664 (708)
........ ......+++.|+|||.+.+..++.++||||+|+++|+|++ |..||..... .........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--------~~~~~~~~~ 247 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------FDITVYLLQ 247 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT--------TTHHHHHHT
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH--------HHHHHHHhc
Confidence 86643221 1233456789999999999999999999999999999999 5555543221 111111111
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 665 PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 665 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+... +..+.+++.+||+.||++|||++|+++.|+
T Consensus 248 ~~~~~~~~~~---~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 287 (298)
T 3f66_A 248 GRRLLQPEYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287 (298)
T ss_dssp TCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111111111 235888999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=340.47 Aligned_cols=256 Identities=25% Similarity=0.404 Sum_probs=201.9
Q ss_pred hccccccceeccccCccEEEEEe------CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA 508 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 508 (708)
.++|++.+.||+|+||.||+|.. .+++.||||.+.... .......+.+|+.++++++||||+++++++..+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc---chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 47899999999999999999974 357789999997532 234456789999999999999999999999999
Q ss_pred CeeEEEEEeccCCCHHHHhccccc----ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC---CCcE
Q 039322 509 RHSFLVYELLERGSLAAILSSDTA----AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL---EYEA 581 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~ 581 (708)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ |++||||||+||+++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999976542 23489999999999999999999999 9999999999999984 4469
Q ss_pred EEeecccccccCCCCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccc
Q 039322 582 HVADFGIAKFLKPESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIA 658 (708)
Q Consensus 582 kl~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 658 (708)
||+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|+| |+.||..... ...
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~ 254 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEV 254 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHH
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--------HHH
Confidence 9999999975543322 2234567889999999998899999999999999999998 9999874321 111
Q ss_pred cccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 659 LDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+........... .+..+.+++.+||+.||++|||++|++++|+
T Consensus 255 ~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 300 (327)
T 2yfx_A 255 LEFVTSGGRMDPPKN---CPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300 (327)
T ss_dssp HHHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 111111111111111 2235888999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=353.69 Aligned_cols=260 Identities=21% Similarity=0.292 Sum_probs=203.7
Q ss_pred hccccccceeccccCccEEEEEe----CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCC
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHAR 509 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~ 509 (708)
.++|++.+.||+|+||.||+|.. .+++.||||+++...........+.+.+|+++++++ +||||+++++++..++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 37899999999999999999976 378999999987532111122345577799999999 5999999999999999
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccc
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA 589 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 589 (708)
..++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999997543 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC-ccccccccccccCccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 039322 590 KFLKPESS-NWTEFAGTYGYVAPELAYTM--KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPR 666 (708)
Q Consensus 590 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (708)
+.+..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .......+....
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----~~~~~~~~~~~~ 282 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISRRILKSE 282 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHHHHHHCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch----HHHHHHHHhccC
Confidence 86543222 23345789999999998853 478899999999999999999999974321110 011111111111
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhhC
Q 039322 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRP-----TMKVVTQQVRI 708 (708)
Q Consensus 667 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~ 708 (708)
...+. .....+.+++.+||+.||++|| +++|++++.++
T Consensus 283 ~~~~~----~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 283 PPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp CCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred CCCCc----ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 11111 1223477899999999999999 99999998753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=351.12 Aligned_cols=261 Identities=17% Similarity=0.251 Sum_probs=197.6
Q ss_pred hccccccceeccccCccEEEEEeCC------CcEEEEEEcCCCCCcchhHh--------HHHHHHHHHHHHhccCCceee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPS------GQVVAIKKFHSPLPCDQIAD--------QKEFLIEVKALTEIRHRNIVK 500 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~ 500 (708)
.++|++.+.||+|+||.||+|.+.. ++.||||++...... ...+ ...+..|+..++.++||||++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-LFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH-HHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh-HHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 4689999999999999999997754 478999998763210 0001 123445666677888999999
Q ss_pred EEEEEeeC----CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC
Q 039322 501 FYGFCSHA----RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD 576 (708)
Q Consensus 501 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~ 576 (708)
+++++... ...++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++ ||+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 99999765 4589999999 999999997642 4589999999999999999999999 999999999999999
Q ss_pred --CCCcEEEeecccccccCCCCCc-------cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 039322 577 --LEYEAHVADFGIAKFLKPESSN-------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSL 647 (708)
Q Consensus 577 --~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~ 647 (708)
.++.+||+|||+++.+...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999876433211 1334599999999999999999999999999999999999999974211
Q ss_pred cccc----ccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 648 ISSS----SLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 648 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.... ..........+.++.+... ..+..+.+++..||+.||++||+++++++.|+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~ 325 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFPAA-----NAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSCTT-----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhcccc-----cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence 1000 0000011111221111110 11235889999999999999999999998874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=333.38 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=200.9
Q ss_pred hccccccc-eeccccCccEEEEEe---CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 435 TNDFDAQY-CIGNGGHGSVYRAEL---PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 435 ~~~~~~~~-~ig~G~~g~vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
.++|.+.+ .||+|+||.||+|.. .+++.||||+++... ......+.+.+|++++++++||||+++++++ ..+.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 36788888 999999999999943 346789999997632 2223467899999999999999999999999 5677
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++||||+++++|.+++.... .+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++.
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred cEEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 899999999999999997543 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcc---ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC
Q 039322 591 FLKPESSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPR 666 (708)
Q Consensus 591 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (708)
......... ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... .....+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~ 237 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGE 237 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTC
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC
Confidence 765443321 22345688999999988889999999999999999999 99998743221 1111111111
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 667 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+. ..+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 238 ~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 275 (291)
T 1xbb_A 238 RMGCPA---GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275 (291)
T ss_dssp CCCCCT---TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111111 12335889999999999999999999999875
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=370.35 Aligned_cols=254 Identities=20% Similarity=0.298 Sum_probs=210.4
Q ss_pred HhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCee
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~ 511 (708)
..++|++.+.||+|+||.||+|... +++.||||++++... ......+.+..|.+++..+ +||+|+++++++.+.+..
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH-HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4578999999999999999999654 688999999875210 1112345678899999887 699999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999997543 489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 592 LKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
............||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.......+.
T Consensus 492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~~~~p~ 563 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEHNVAYPK 563 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHSSCCCCCT
T ss_pred cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhCCCCCCc
Confidence 5544455566789999999999999999999999999999999999999997422 22333344444433332
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHHh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTM-----KVVTQQV 706 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~l 706 (708)
. ...++.+++.+||++||++||++ +||++|-
T Consensus 564 ~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ 599 (674)
T 3pfq_A 564 S----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 599 (674)
T ss_dssp T----SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSG
T ss_pred c----CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCc
Confidence 2 22357889999999999999997 8888764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=340.45 Aligned_cols=259 Identities=23% Similarity=0.286 Sum_probs=199.6
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCc----chhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPC----DQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA 508 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 508 (708)
..++|++.+.||+|+||.||+|.. .+++.||||++...... ........+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 347899999999999999999965 46889999998753211 1112234688999999999999999999998766
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc---EEEee
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE---AHVAD 585 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~D 585 (708)
+ .++||||+++|+|.+++... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 89999999999999998654 3489999999999999999999999 9999999999999987664 99999
Q ss_pred cccccccCCCCCccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 039322 586 FGIAKFLKPESSNWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEI 662 (708)
Q Consensus 586 fg~a~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 662 (708)
||++...... .......|++.|+|||++. ...++.++||||||+++|+|++|+.||...... ......+
T Consensus 161 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~ 232 (322)
T 2ycf_A 161 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-------VSLKDQI 232 (322)
T ss_dssp CTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-------SCHHHHH
T ss_pred Cccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-------HHHHHHH
Confidence 9999876432 2234456899999999874 456889999999999999999999998732211 0111111
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 663 LDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........+......+..+.+++.+||+.||++|||++|+++|-+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~ 277 (322)
T 2ycf_A 233 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 277 (322)
T ss_dssp HHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred HhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcC
Confidence 112221111112223456889999999999999999999998754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=340.61 Aligned_cols=252 Identities=23% Similarity=0.375 Sum_probs=195.2
Q ss_pred ccccccceeccccCccEEEEEeC-CCcE----EEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQV----VAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
++|++.+.||+|+||.||+|.+. +++. ||+|.+.... .....+.+.+|++++++++||||+++++++..+.
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 68999999999999999999753 4443 5778776432 2234678899999999999999999999998765
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++|+||+.+|+|.+++.... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred ceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 789999999999999997543 4589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 039322 591 FLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 591 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
........ .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||+..... .....+.....
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~~~~~~~~~~~ 237 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSILEKGER 237 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHHHHTTCC
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHcCCC
Confidence 76543322 233456789999999999999999999999999999999 99999743221 11111111111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.... ....+.+++.+||+.||++|||++|+++.|+
T Consensus 238 ~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 274 (327)
T 3lzb_A 238 LPQPPI---CTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274 (327)
T ss_dssp CCCCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCcc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 111111 2235888999999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=333.83 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=207.6
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCc-----chhHhHHHHHHHHHHHHhcc-CCceeeEEEEEee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPC-----DQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSH 507 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~ 507 (708)
.++|++.+.||+|+||.||+|... +|+.||||++...... ......+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999764 6899999998753211 11223567889999999996 9999999999999
Q ss_pred CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecc
Q 039322 508 ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFG 587 (708)
Q Consensus 508 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 587 (708)
++..++||||+++++|.+++... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999999753 3489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCccccc------cCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAY------TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDE 661 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 661 (708)
++....... ......+++.|+|||++. ...++.++||||||+++|+|++|+.||..... ......
T Consensus 170 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~ 240 (298)
T 1phk_A 170 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLMLRM 240 (298)
T ss_dssp TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred chhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--------HHHHHH
Confidence 998765432 334567899999999875 45678899999999999999999999864321 111111
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 662 ILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+...............+..+.+++.+||+.||++|||++|+++|-+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (298)
T 1phk_A 241 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 286 (298)
T ss_dssp HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred HhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence 2222222211122233446889999999999999999999998754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=345.30 Aligned_cols=261 Identities=20% Similarity=0.218 Sum_probs=195.3
Q ss_pred ccccccceeccccCccEEEEEeC----CCcEEEEEEcCCCCCcchhH-------hHHHHHHHHHHHHhccCCceeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPCDQIA-------DQKEFLIEVKALTEIRHRNIVKFYGF 504 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~l~~~ 504 (708)
++|++.+.||+|+||.||+|... ++..||+|++.........+ ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 68999999999999999999765 57889999987642211000 12346778889999999999999999
Q ss_pred Eee----CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-
Q 039322 505 CSH----ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY- 579 (708)
Q Consensus 505 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~- 579 (708)
+.. .+..++||||+ +++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSST
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCC
Confidence 987 67899999999 899999997554 589999999999999999999999 999999999999998887
Q ss_pred -cEEEeecccccccCCCCC-------ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc
Q 039322 580 -EAHVADFGIAKFLKPESS-------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS 651 (708)
Q Consensus 580 -~~kl~Dfg~a~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~ 651 (708)
.+||+|||+++.+..... ......|++.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999987643221 124457899999999999988999999999999999999999999632110000
Q ss_pred ccccccccccccCCCCCCCCch---hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 652 SLNTDIALDEILDPRLPPPSRS---VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
............+..... ....+..+.+++.+||+.||++|||+++|++.|+
T Consensus 270 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 324 (345)
T 2v62_A 270 ----VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILN 324 (345)
T ss_dssp ----HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHC
T ss_pred ----HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 000000000001000000 0012236889999999999999999999999885
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=342.71 Aligned_cols=265 Identities=22% Similarity=0.278 Sum_probs=200.8
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee------
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH------ 507 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~------ 507 (708)
.++|++.+.||+|+||.||+|.. .+|+.||||++...... ......+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS--SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc--ccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 37899999999999999999976 57899999998764322 2234567899999999999999999999977
Q ss_pred --CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEee
Q 039322 508 --ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVAD 585 (708)
Q Consensus 508 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 585 (708)
.+..++||||+++ ++.+.+.... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred cCCceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEcc
Confidence 3468999999986 7777775443 3489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCC----CccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc---------
Q 039322 586 FGIAKFLKPES----SNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS--------- 651 (708)
Q Consensus 586 fg~a~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~--------- 651 (708)
||+++.+.... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.........
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99998764321 22345678999999998876 45799999999999999999999999743211000
Q ss_pred ---cc-ccccccccccCCCC-CCCCchhHHH------HHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 652 ---SL-NTDIALDEILDPRL-PPPSRSVQEK------LISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 652 ---~~-~~~~~~~~~~~~~~-~~~~~~~~~~------~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. .............. .......... ...+.+++.+||+.||++|||++|+++|-+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 314 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence 00 00000000000000 0000011111 235789999999999999999999999855
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=332.45 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=196.5
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|.+.+.||+|+||.||+|... +|+.||||++.... .......+.+.+|+++++.++||||+++++++..++..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK-IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc-ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 378999999999999999999765 78999999986411 0111235678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++++|.+++.... .+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999996543 489999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
.. .......+++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||+..... .....+.......+..
T Consensus 163 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~ 233 (276)
T 2h6d_A 163 DG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--------TLFKKIRGGVFYIPEY 233 (276)
T ss_dssp C--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCTT
T ss_pred CC-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--------HHHHHhhcCcccCchh
Confidence 33 22344578999999999887665 57999999999999999999998742211 1111111111111111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+.+++.+||+.||++|||++|+++|-+
T Consensus 234 ----~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 234 ----LNRSVATLLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred ----cCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence 1235788999999999999999999998743
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=331.45 Aligned_cols=253 Identities=24% Similarity=0.335 Sum_probs=199.5
Q ss_pred ccccccceeccccCccEEEEEeC-C---CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-S---GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
..|...+.||+|+||.||+|... + +..||+|.+... ......+.+.+|++++++++||||+++++++..++..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI---TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL 97 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc---ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence 35667789999999999999643 2 237999998753 2334567899999999999999999999999876655
Q ss_pred -EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 512 -FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 512 -~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
++||||+.+|+|.+++.... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||+++
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred cEEEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 99999999999999997633 4579999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC----CccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCC-CccccccccccccccccccccCC
Q 039322 591 FLKPES----SNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPR-DFLSLISSSSLNTDIALDEILDP 665 (708)
Q Consensus 591 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~ 665 (708)
...... .......+++.|+|||.+.+..++.++||||+|+++|+|++|..|+ ..... ......+...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--------~~~~~~~~~~ 244 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--------FDLTHFLAQG 244 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--------GGHHHHHHTT
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--------HHHHHHhhcC
Confidence 654321 1223456788999999999999999999999999999999966664 32111 1111111111
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 666 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+.... .+..+.+++.+||+.||++|||++++++.|+
T Consensus 245 ~~~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~ 283 (298)
T 3pls_A 245 RRLPQPEY---CPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283 (298)
T ss_dssp CCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCcc---chHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11111111 1235889999999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.63 Aligned_cols=248 Identities=26% Similarity=0.399 Sum_probs=195.2
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC-CeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA-RHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-~~~~l 513 (708)
.++|++.+.||+|+||.||+|... |+.||||.++.. ...+.+.+|++++++++||||+++++++... +..++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 478999999999999999999874 889999998753 2356789999999999999999999997654 47899
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 9999999999999975432 2378999999999999999999999 99999999999999999999999999997554
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
.. .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..........
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~ 237 (278)
T 1byg_A 169 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRVEKGYKMDAPD 237 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--------GGHHHHHTTTCCCCCCT
T ss_pred cc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCCCCcc
Confidence 32 223457889999999998899999999999999999998 9999874321 11111111111111111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 238 ---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 269 (278)
T 1byg_A 238 ---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269 (278)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHH
Confidence 12345889999999999999999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=346.80 Aligned_cols=259 Identities=10% Similarity=0.008 Sum_probs=185.4
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc--cCCceeeEE-------EEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI--RHRNIVKFY-------GFC 505 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~l~-------~~~ 505 (708)
.+|.+.+.||+|+||.||+|.+ .+|+.||||++..... ......+.+.+|+++++.+ +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-THHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 5699999999999999999975 4789999999987432 2334566788886655555 599988866 444
Q ss_pred eeC-----------------CeeEEEEEeccCCCHHHHhcccccccCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 039322 506 SHA-----------------RHSFLVYELLERGSLAAILSSDTAAQELGWSQR------MNVIKGVADALSYLHHDCFPP 562 (708)
Q Consensus 506 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~Lh~~~~~~ 562 (708)
..+ ...++||||++ |+|.+++.... ..+.+..+ ..++.|++.||+|||++ |
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 332 33799999999 89999997643 22455555 78889999999999999 9
Q ss_pred eEEccCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHhCCC
Q 039322 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLVLEAIKGKH 640 (708)
Q Consensus 563 ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~ 640 (708)
|+||||||+|||++.++.+||+|||+|+.... ......+++.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999986542 2224566799999999987 678999999999999999999999
Q ss_pred CCCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 641 PRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 641 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
||............ ..............+ .....+..+.+++.+||+.||++|||++|+++|-+
T Consensus 292 Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 292 PFGLVTPGIKGSWK-RPSLRVPGTDSLAFG--SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp STTBCCTTCTTCCC-BCCTTSCCCCSCCCT--TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred CCCCcCcccccchh-hhhhhhccccccchh--hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 99754221111100 000001111111111 01122345889999999999999999999998754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=338.94 Aligned_cols=254 Identities=25% Similarity=0.383 Sum_probs=200.2
Q ss_pred ccccccceeccccCccEEEEEeC-CCcE--EEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQV--VAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~ 511 (708)
++|++.+.||+|+||.||+|... ++.. ||+|.+.... .....+.+.+|+++++++ +||||+++++++.+++..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc---chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 78999999999999999999654 5654 4999987532 223456789999999999 899999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccc-------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC
Q 039322 512 FLVYELLERGSLAAILSSDT-------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE 578 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~ 578 (708)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ ||+||||||+||+++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence 99999999999999997653 224589999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccc
Q 039322 579 YEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDI 657 (708)
Q Consensus 579 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 657 (708)
+.+||+|||++...... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .
T Consensus 179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--------~ 249 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------E 249 (327)
T ss_dssp GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------H
T ss_pred CeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--------H
Confidence 99999999999743321 12233456789999999988889999999999999999998 99999743221 1
Q ss_pred ccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 ALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+........+. ..+..+.+++.+||+.||++|||++|++++|+
T Consensus 250 ~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 296 (327)
T 1fvr_A 250 LYEKLPQGYRLEKPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296 (327)
T ss_dssp HHHHGGGTCCCCCCT---TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCC---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 111111111111111 12235889999999999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=339.63 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=199.3
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++..++..++
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC----CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 478999999999999999999765 5889999998753 22346788999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++++|.+++.... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++....
T Consensus 94 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp EEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred EEEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999986532 4489999999999999999999999 99999999999999999999999999976432
Q ss_pred CCCCccccccccccccCcccc-----ccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 039322 594 PESSNWTEFAGTYGYVAPELA-----YTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
..........|++.|+|||.+ .+..++.++||||||+++|+|++|+.||....... ..........+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~ 240 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--------VLLKIAKSDPP 240 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCCC
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH--------HHHHHhccCCc
Confidence 211122345689999999987 35678899999999999999999999987432211 01111111110
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. .......+..+.+++.+||+.||++|||++|+++|-+
T Consensus 241 ~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 278 (302)
T 2j7t_A 241 T-LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278 (302)
T ss_dssp C-CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred c-cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence 0 0011122345889999999999999999999998754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=331.13 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=200.4
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee----CCe
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH----ARH 510 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----~~~ 510 (708)
..|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+.+|++++++++||||+++++++.. ...
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchh--hCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 4578888999999999999965 468899999987522 123456789999999999999999999999865 356
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEccCCCCCeeeC-CCCcEEEeecc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP--IVHQDISSKNLLLD-LEYEAHVADFG 587 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfg 587 (708)
.++||||+++|+|.+++... ..+++..++.++.|++.||+|||+. + ++||||||+||+++ .++.+||+|||
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 89999999999999999654 3489999999999999999999998 7 99999999999998 78999999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
++..... .......|++.|+|||.+. +.++.++||||+|+++|+|++|+.||...... ............
T Consensus 178 ~~~~~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~ 247 (290)
T 1t4h_A 178 LATLKRA--SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGVK 247 (290)
T ss_dssp GGGGCCT--TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTCC
T ss_pred Ccccccc--cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-------HHHHHHHhccCC
Confidence 9975433 2334557899999999876 45899999999999999999999998742211 111111111111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+. .........+.+++.+||+.||++|||++|+++|-+
T Consensus 248 ~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 248 PA--SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp CG--GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred cc--ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 11 111111235889999999999999999999999865
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=344.32 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=197.9
Q ss_pred HHHHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEee-
Q 039322 431 IVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSH- 507 (708)
Q Consensus 431 ~~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~- 507 (708)
+....++|++.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 334568899999999999999999976 578999999987532 2346788999999999 79999999999977
Q ss_pred -----CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEE
Q 039322 508 -----ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAH 582 (708)
Q Consensus 508 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 582 (708)
.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ |++||||||+||+++.++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence 467899999999999999997653 24589999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccc
Q 039322 583 VADFGIAKFLKPESSNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDI 657 (708)
Q Consensus 583 l~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~ 657 (708)
|+|||++..............|++.|+|||++. +..++.++||||||+++|+|++|+.||..........
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----- 244 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF----- 244 (326)
T ss_dssp ECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----
T ss_pred EeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH-----
Confidence 999999987654433344567899999999986 5668899999999999999999999986432211000
Q ss_pred ccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 ALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+.... . ..+..+.+++.+||+.||++|||++|+++|-+
T Consensus 245 ~~~~~~~~~~~~--~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~ 289 (326)
T 2x7f_A 245 LIPRNPAPRLKS--K---KWSKKFQSFIESCLVKNHSQRPATEQLMKHPF 289 (326)
T ss_dssp HHHHSCCCCCSC--S---CSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHH
T ss_pred HhhcCccccCCc--c---ccCHHHHHHHHHHhccChhhCCCHHHHhhChH
Confidence 000000111111 1 11235889999999999999999999998743
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=354.53 Aligned_cols=194 Identities=25% Similarity=0.387 Sum_probs=155.1
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC-----C
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA-----R 509 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~ 509 (708)
++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+.+|++++++++||||+++++++... +
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF--EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh--cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 6899999999999999999965 478999999987532 2345567899999999999999999999999543 5
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccc
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA 589 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 589 (708)
..|+||||+. |+|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccc-cchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 6899999984 6999998654 3489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---------------------------ccccccccccccCcccc-ccCCCCcchhHHHHHHHHHHHHhC
Q 039322 590 KFLKPESS---------------------------NWTEFAGTYGYVAPELA-YTMKITEKCDVYSFGVLVLEAIKG 638 (708)
Q Consensus 590 ~~~~~~~~---------------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~elltg 638 (708)
+....... .....+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 87643211 22345789999999976 456699999999999999999994
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=364.54 Aligned_cols=252 Identities=26% Similarity=0.442 Sum_probs=205.2
Q ss_pred HhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
..++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|++++++++|+||+++++++.+ +..++
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 347899999999999999999998888889999998632 235679999999999999999999999876 67899
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++.... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 339 v~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 999999999999997532 24589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCC-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCC
Q 039322 594 PESS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP-RLPPP 670 (708)
Q Consensus 594 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 670 (708)
.... ......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+... +.+.+
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~~~~~ 486 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMPCP 486 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HHHHHHHHTTCCCCCC
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC
Confidence 3211 1122346788999999998899999999999999999999 9999874321 1111111111 11111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. ....+.+++.+||+.||++|||+++|++.|+
T Consensus 487 -~~---~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~ 519 (535)
T 2h8h_A 487 -PE---CPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519 (535)
T ss_dssp -TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -CC---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 11 2335888999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=341.24 Aligned_cols=247 Identities=18% Similarity=0.198 Sum_probs=197.8
Q ss_pred HhccccccceeccccCccEEEEE------eCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc---CCceeeEEEE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAE------LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR---HRNIVKFYGF 504 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~l~~~ 504 (708)
..++|.+.+.||+|+||.||+|. ..+++.||||+++.. ...++..|+++++.++ |+||++++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-------NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-------CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-------ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 34789999999999999999993 456889999999753 2446777788877776 9999999999
Q ss_pred EeeCCeeEEEEEeccCCCHHHHhcccc--cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-----
Q 039322 505 CSHARHSFLVYELLERGSLAAILSSDT--AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL----- 577 (708)
Q Consensus 505 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~----- 577 (708)
+..++..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ ||+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence 999999999999999999999997532 234589999999999999999999999 9999999999999998
Q ss_pred ------CCcEEEeecccccccC--CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc
Q 039322 578 ------EYEAHVADFGIAKFLK--PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLIS 649 (708)
Q Consensus 578 ------~~~~kl~Dfg~a~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~ 649 (708)
++.+||+|||+|+... ..........||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~- 291 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG- 291 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT-
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC-
Confidence 8999999999997543 2223345567999999999999999999999999999999999999998632210
Q ss_pred ccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHh
Q 039322 650 SSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESR-PTMKVVTQQV 706 (708)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~l 706 (708)
.... ...+.... . ...+.+++..|++.+|.+| |+++++.+.|
T Consensus 292 ------~~~~----~~~~~~~~--~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 292 ------ECKP----EGLFRRLP--H---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp ------EEEE----CSCCTTCS--S---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred ------ceee----chhccccC--c---HHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 0111 11111111 1 2246678889999999998 5677766654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=349.62 Aligned_cols=200 Identities=24% Similarity=0.387 Sum_probs=169.1
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC-----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA----- 508 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~----- 508 (708)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+.+|++++++++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT--TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh--cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 37899999999999999999965 468899999997632 2344567899999999999999999999999776
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
+..|+||||+. |+|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CeEEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 57899999986 5999999654 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC----------------------ccccccccccccCcccc-ccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 039322 589 AKFLKPESS----------------------NWTEFAGTYGYVAPELA-YTMKITEKCDVYSFGVLVLEAIKGKHPRD 643 (708)
Q Consensus 589 a~~~~~~~~----------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~elltg~~p~~ 643 (708)
|+....... ......||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 987653321 13556789999999986 55669999999999999999999776654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.29 Aligned_cols=257 Identities=18% Similarity=0.281 Sum_probs=197.2
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEE-eeCCee
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFC-SHARHS 511 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~-~~~~~~ 511 (708)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+++++.++|++++..++++ ..++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc------cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 457899999999999999999975 578999999876532 223577899999999987766666555 667788
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee---CCCCcEEEeeccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL---DLEYEAHVADFGI 588 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~ 588 (708)
++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEEEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 9999999 899999997433 3589999999999999999999999 99999999999999 7889999999999
Q ss_pred ccccCCCCC-------ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 039322 589 AKFLKPESS-------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDE 661 (708)
Q Consensus 589 a~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 661 (708)
+........ ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......... .....
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~ 229 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-----QKYER 229 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-----SHHHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-----hhhhh
Confidence 987654332 123457899999999999999999999999999999999999999743321111 11111
Q ss_pred ccCCCCCCCC-chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 662 ILDPRLPPPS-RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 662 ~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+.......+. ......+..+.+++.+||+.||++|||++++++.|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (296)
T 4hgt_A 230 ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 276 (296)
T ss_dssp HHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred hhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHH
Confidence 1110000000 000111346889999999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=340.93 Aligned_cols=261 Identities=24% Similarity=0.357 Sum_probs=195.0
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHH--HHhccCCceeeEEEEEee-----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKA--LTEIRHRNIVKFYGFCSH----- 507 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~--l~~l~h~~iv~l~~~~~~----- 507 (708)
.++|++.+.||+|+||.||+|.. +++.||||++... ....+..|.++ +..++||||+++++++..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-------NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc-------chhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 47899999999999999999977 6899999998641 23344445544 455899999999986542
Q ss_pred CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEEccCCCCCeeeCCCCcE
Q 039322 508 ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC------FPPIVHQDISSKNLLLDLEYEA 581 (708)
Q Consensus 508 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~------~~~ivH~dlk~~Nill~~~~~~ 581 (708)
....++||||+++|+|.+++.... .++..++.++.|++.||+|||+.. .++|+||||||+||+++.++.+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred CceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 336789999999999999996544 588999999999999999999862 2389999999999999999999
Q ss_pred EEeecccccccCCCC--------CccccccccccccCcccccc-------CCCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 039322 582 HVADFGIAKFLKPES--------SNWTEFAGTYGYVAPELAYT-------MKITEKCDVYSFGVLVLEAIKGKHPRDFLS 646 (708)
Q Consensus 582 kl~Dfg~a~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~elltg~~p~~~~~ 646 (708)
||+|||++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 999999998764321 11234568999999999876 346678999999999999999987754221
Q ss_pred cccccccc---------ccc-----ccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 647 LISSSSLN---------TDI-----ALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 647 ~~~~~~~~---------~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........ ... .......+.++.........+..+.+++.+||+.||++|||++|+++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 11100000 000 00111122233222223345567999999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=363.33 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=197.4
Q ss_pred cccccc-eeccccCccEEEEEeC---CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 437 DFDAQY-CIGNGGHGSVYRAELP---SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 437 ~~~~~~-~ig~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
++.+.. .||+|+||.||+|.+. ++..||||+++... .....+.+.+|++++++++||||+++++++.. +..+
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC---SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 344444 7999999999999653 46679999998642 22346789999999999999999999999976 5689
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 412 lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEEECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEEEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 9999999999999996543 4589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcc---ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCC
Q 039322 593 KPESSNW---TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 593 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
....... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+......
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~~i~~~~~~ 558 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFIEQGKRM 558 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--------HHHHHHHHTTCCC
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence 5433221 22345689999999999999999999999999999998 9999974322 1111222222111
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+. ..+..+.+++.+||+.||++||++++|++.|+
T Consensus 559 ~~p~---~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~ 594 (613)
T 2ozo_A 559 ECPP---ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594 (613)
T ss_dssp CCCT---TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHH
T ss_pred CCCC---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 1111 12345888999999999999999999998875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=346.24 Aligned_cols=261 Identities=24% Similarity=0.340 Sum_probs=204.8
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+.+|++++++++||||+++++++..++..++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 368999999999999999999664 68999999997642 23456789999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ ||+||||||+||+++.++.+||+|||++....
T Consensus 109 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999996543 4899999999999999999999842 89999999999999999999999999997543
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc-------------------
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN------------------- 654 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~------------------- 654 (708)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||............
T Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 184 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp HH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred cc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 21 223457899999999999999999999999999999999999999743211000000
Q ss_pred ---------------cccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 655 ---------------TDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 655 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+.....+... .......+.+++.+||+.||++|||++|+++|-+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCC--TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCC--cccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 00000000011100000 0112335889999999999999999999998865
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.85 Aligned_cols=260 Identities=22% Similarity=0.316 Sum_probs=195.9
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR---- 509 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~---- 509 (708)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|++++++++||||+++++++..++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 36899999999999999999965 579999999997543 23345677899999999999999999999997653
Q ss_pred --eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecc
Q 039322 510 --HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFG 587 (708)
Q Consensus 510 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 587 (708)
..|+||||+ +++|.+++.. ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeee
Confidence 469999999 7899999865 3489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------ccccccc
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS-------LNTDIAL 659 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-------~~~~~~~ 659 (708)
+++.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.......... .......
T Consensus 174 ~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 174 LARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp TCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9987543 2344578999999998877 678999999999999999999999997432210000 0000000
Q ss_pred c--------cccC--CCCCCC--CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 660 D--------EILD--PRLPPP--SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 660 ~--------~~~~--~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. .++. +..... ..........+.+++.+||+.||++|||++|+++|-+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence 0 0000 000000 0001112345788999999999999999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=351.14 Aligned_cols=248 Identities=15% Similarity=0.120 Sum_probs=192.0
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHH---HHHhccCCceeeEE-------E
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVK---ALTEIRHRNIVKFY-------G 503 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~---~l~~l~h~~iv~l~-------~ 503 (708)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... ......+.+.+|++ ++++++||||++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC--CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccc-cchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 47899999999999999999975 5699999999875321 12235678899994 55566899999998 6
Q ss_pred EEeeCC-----------------eeEEEEEeccCCCHHHHhccccc----ccCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 039322 504 FCSHAR-----------------HSFLVYELLERGSLAAILSSDTA----AQELGWSQRMNVIKGVADALSYLHHDCFPP 562 (708)
Q Consensus 504 ~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ 562 (708)
++..++ ..++||||+ +|+|.+++..... ...+++..++.++.|++.||+|||++ |
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 665543 278999999 6799999975432 11234588889999999999999999 9
Q ss_pred eEEccCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccccccCccccccC-----------CCCcchhHHHHHHH
Q 039322 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTM-----------KITEKCDVYSFGVL 631 (708)
Q Consensus 563 ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslG~~ 631 (708)
|+||||||+|||++.++.+||+|||+|+... .......| +.|+|||++.+. .++.++|||||||+
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~---~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETT---CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecC---CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999998533 23344567 999999999887 79999999999999
Q ss_pred HHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 632 VLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 632 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+|||++|+.||...... .....+.... . ..+..+.+++.+||+.||++|||+.|++++-+
T Consensus 303 l~elltg~~Pf~~~~~~--------~~~~~~~~~~-~-------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 362 (377)
T 3byv_A 303 IYWIWCADLPITKDAAL--------GGSEWIFRSC-K-------NIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 362 (377)
T ss_dssp HHHHHHSSCCC--------------CCSGGGGSSC-C-------CCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHH
T ss_pred HHHHHHCCCCCcccccc--------cchhhhhhhc-c-------CCCHHHHHHHHHHcCCCchhCCCHHHHhhChH
Confidence 99999999999743211 1111111111 0 11235788999999999999999999998643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=332.79 Aligned_cols=256 Identities=18% Similarity=0.282 Sum_probs=200.1
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEE-eeCCeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFC-SHARHSF 512 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~-~~~~~~~ 512 (708)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+++++.++|++++..++++ ..++..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS------SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc------chhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 47899999999999999999975 679999999986532 123588899999999987766555554 6677889
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC---CCCcEEEeecccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD---LEYEAHVADFGIA 589 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a 589 (708)
+||||+ +++|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++ .++.+||+|||++
T Consensus 82 lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 999999 889999997433 4589999999999999999999999 999999999999994 7889999999999
Q ss_pred cccCCCCCc-------cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 039322 590 KFLKPESSN-------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEI 662 (708)
Q Consensus 590 ~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 662 (708)
......... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......... .....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~ 230 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-----QKYERI 230 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-----SHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh-----hhhhhh
Confidence 876544321 24457899999999999999999999999999999999999999743221111 111111
Q ss_pred cCCCCCCCC-chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 663 LDPRLPPPS-RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 663 ~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+. ......+..+.+++.+||+.||++|||++++++.|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 276 (296)
T 3uzp_A 231 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 276 (296)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred cccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHH
Confidence 110000000 000112345889999999999999999999999875
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=364.38 Aligned_cols=342 Identities=21% Similarity=0.228 Sum_probs=240.0
Q ss_pred CCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEec
Q 039322 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGV 80 (708)
Q Consensus 2 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l 80 (708)
++|++|+|++|+|+++.+..|.++++|++|+|++|++.+..|..+.. ++|+.|++++|.+.+..+..+..+++|++|++
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 105 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence 57999999999999999999999999999999999999988888876 89999999999999988888999999999999
Q ss_pred cCCccccc-cCccCcCCCCCcEEEccCCc-cccccccccCCCCCCCEEEcccCcceeeCCCCCCC---------------
Q 039322 81 SENHFQGT-IPKILRNCSSLIRVRLNSNN-LTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGK--------------- 143 (708)
Q Consensus 81 ~~n~i~~~-~~~~~~~l~~L~~L~l~~n~-i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~--------------- 143 (708)
++|.+++. .|..+.++++|++|++++|. ++.+.+..|..+++|++|++++|++++..+..+..
T Consensus 106 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~ 185 (549)
T 2z81_A 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185 (549)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST
T ss_pred CCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc
Confidence 99999863 46789999999999999998 67777789999999999999999999888877765
Q ss_pred ---------CCCCCEEEcccCcccccC--C--------------------------------------------------
Q 039322 144 ---------CPKLGTLNVSMNNITGGI--P-------------------------------------------------- 162 (708)
Q Consensus 144 ---------l~~L~~L~L~~N~i~~~~--~-------------------------------------------------- 162 (708)
+++|++|++++|++++.. +
T Consensus 186 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~ 265 (549)
T 2z81_A 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265 (549)
T ss_dssp THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEEC
T ss_pred ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccc
Confidence 456666666666665421 0
Q ss_pred -------------------------------------------------------------ccc-cCCCCCCEEeccccc
Q 039322 163 -------------------------------------------------------------REI-GNSSQLQALDLSLNH 180 (708)
Q Consensus 163 -------------------------------------------------------------~~~-~~l~~L~~L~L~~n~ 180 (708)
..+ ..+++|++|+|++|+
T Consensus 266 ~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~ 345 (549)
T 2z81_A 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENL 345 (549)
T ss_dssp CSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSC
T ss_pred cccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCc
Confidence 000 123334444444444
Q ss_pred ccccCC---cccCCCCCCCEEEccCccccccCC--cccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCccccc
Q 039322 181 IVGEIP---KELGKLNSLTELILRGNQFTGRLP--PEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVL 255 (708)
Q Consensus 181 l~~~~~---~~~~~l~~L~~L~l~~n~l~~~~~--~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~ 255 (708)
+++..+ ..+..+++|++|+|++|++++..+ ..+..+++|++|+|++|+++ ..|..+..+++|+.|++++|+++.
T Consensus 346 l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~ 424 (549)
T 2z81_A 346 MVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV 424 (549)
T ss_dssp CCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC
T ss_pred cccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc
Confidence 433221 113334444444444444432211 22344444444444444444 334444444444444444444442
Q ss_pred CCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCCC-ccc
Q 039322 256 ELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPN-STA 334 (708)
Q Consensus 256 ~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~ 334 (708)
.+..+. ++|+.|++++|++++. ...+++|++|++++|+++ .+|. ...+++|+.|++++|++++.+|. ...
T Consensus 425 -l~~~~~--~~L~~L~Ls~N~l~~~----~~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 495 (549)
T 2z81_A 425 -VKTCIP--QTLEVLDVSNNNLDSF----SLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDR 495 (549)
T ss_dssp -CCTTSC--TTCSEEECCSSCCSCC----CCCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGG
T ss_pred -ccchhc--CCceEEECCCCChhhh----cccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhc
Confidence 222111 2455555555555432 136788999999999988 4554 45788999999999999988776 467
Q ss_pred cccCcccccccccCcCCCC
Q 039322 335 FRNAPVEALKGNKGLCGGV 353 (708)
Q Consensus 335 ~~~~~~~~~~~n~~~c~~~ 353 (708)
++.++.+.+.+|+|.|+|+
T Consensus 496 l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 496 LTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CTTCCEEECCSSCBCCCHH
T ss_pred CcccCEEEecCCCccCCCc
Confidence 7889999999999999875
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=360.51 Aligned_cols=351 Identities=21% Similarity=0.242 Sum_probs=292.5
Q ss_pred CCCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEe
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFG 79 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~ 79 (708)
+++|++|+|++|+|+.+.+..|+++++|++|+|++|.+++..+..|.. ++|+.|++++|.+.+..+..++.+++|++|+
T Consensus 51 l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 130 (570)
T 2z63_A 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130 (570)
T ss_dssp CSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEE
T ss_pred CCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEe
Confidence 578999999999999999999999999999999999999888888866 7899999999999887777788999999999
Q ss_pred ccCCccccc-cCccCcCCCCCcEEEccCCccccccccc------------------------------------------
Q 039322 80 VSENHFQGT-IPKILRNCSSLIRVRLNSNNLTGNISEA------------------------------------------ 116 (708)
Q Consensus 80 l~~n~i~~~-~~~~~~~l~~L~~L~l~~n~i~~~~~~~------------------------------------------ 116 (708)
+++|.+++. +|..|+++++|++|++++|.++++.+..
T Consensus 131 L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n 210 (570)
T 2z63_A 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210 (570)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred cCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEecccc
Confidence 999999863 5888999999999999988876543221
Q ss_pred -------------------------------------------------------------------cCCCCCCCEEEcc
Q 039322 117 -------------------------------------------------------------------LGIYPNLTFIDLS 129 (708)
Q Consensus 117 -------------------------------------------------------------------~~~~~~L~~L~l~ 129 (708)
|..+++|++|+++
T Consensus 211 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~ 290 (570)
T 2z63_A 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290 (570)
T ss_dssp CSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEE
T ss_pred cccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEec
Confidence 2234566666666
Q ss_pred cCcceeeCCCC----------------------C-------------------CCCCCCCEEEcccCcccccC--Ccccc
Q 039322 130 RNDFYGEISSN----------------------W-------------------GKCPKLGTLNVSMNNITGGI--PREIG 166 (708)
Q Consensus 130 ~n~l~~~~~~~----------------------~-------------------~~l~~L~~L~L~~N~i~~~~--~~~~~ 166 (708)
+|.+..+.... + ..+++|+.|++++|.++... +..+.
T Consensus 291 ~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~ 370 (570)
T 2z63_A 291 SVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370 (570)
T ss_dssp SCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHH
T ss_pred CccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCcccccccccc
Confidence 66665332110 0 45678888888888888554 67788
Q ss_pred CCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCC-cccCCCCCCCeEeccCCcccccCCCCCCcccccee
Q 039322 167 NSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLP-PEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHY 245 (708)
Q Consensus 167 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~ 245 (708)
.+++|++|++++|.+.+..+ .+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+++..+..+..+++|+.
T Consensus 371 ~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 449 (570)
T 2z63_A 371 GTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 449 (570)
T ss_dssp TCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCE
T ss_pred ccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcE
Confidence 99999999999999996544 49999999999999999997665 57899999999999999999889999999999999
Q ss_pred ecccCcccc-cCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCc
Q 039322 246 LGLSNNQFV-LELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQ 324 (708)
Q Consensus 246 L~l~~n~l~-~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~ 324 (708)
|++++|+++ +..|..|..+++|+.|++++|++++..|..+..+++|+.|++++|++++..+..+..+++|+.|++++|+
T Consensus 450 L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 529 (570)
T 2z63_A 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNP 529 (570)
T ss_dssp EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred EECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCc
Confidence 999999997 5688899999999999999999998889999999999999999999999988899999999999999999
Q ss_pred CCCCCCCcccc-ccC--cccccccccCcCCCC
Q 039322 325 LQGPVPNSTAF-RNA--PVEALKGNKGLCGGV 353 (708)
Q Consensus 325 l~~~~~~~~~~-~~~--~~~~~~~n~~~c~~~ 353 (708)
++|.+|....+ ..+ ....+.+.+ .|..+
T Consensus 530 ~~~~~~~~~~~~~wl~~~~~~~~~~~-~C~~~ 560 (570)
T 2z63_A 530 WDCSCPRIDYLSRWLNKNSQKEQGSA-KCSGS 560 (570)
T ss_dssp BCCCTTTTHHHHHHHHHTGGGEESCC-BBTTT
T ss_pred ccCCCcchHHHHHHHHhccccCCCch-hhCCC
Confidence 99998875433 111 112344444 66554
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=330.33 Aligned_cols=245 Identities=22% Similarity=0.376 Sum_probs=202.3
Q ss_pred HhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee-----
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH----- 507 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----- 507 (708)
...+|++.+.||+|+||.||+|... +++.||+|.+.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 3478999999999999999999765 79999999987531 346689999999999999999998864
Q ss_pred -----------CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC
Q 039322 508 -----------ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD 576 (708)
Q Consensus 508 -----------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~ 576 (708)
....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ |++||||||+||+++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV 156 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence 445899999999999999997543 24589999999999999999999999 999999999999999
Q ss_pred CCCcEEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccc
Q 039322 577 LEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTD 656 (708)
Q Consensus 577 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~ 656 (708)
.++.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++|..|+.....
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--------- 226 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--------- 226 (284)
T ss_dssp ETTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH---------
T ss_pred CCCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH---------
Confidence 99999999999998765433 23445789999999999988899999999999999999999998642111
Q ss_pred cccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 657 IALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..........+.. .+..+.+++.+||+.||++|||+.|++++|+
T Consensus 227 -~~~~~~~~~~~~~------~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~ 270 (284)
T 2a19_B 227 -FFTDLRDGIISDI------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLT 270 (284)
T ss_dssp -HHHHHHTTCCCTT------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HHHHhhccccccc------CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1111112222111 1234778999999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=333.16 Aligned_cols=256 Identities=20% Similarity=0.266 Sum_probs=199.6
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEe--eCCee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCS--HARHS 511 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~--~~~~~ 511 (708)
.++|++.+.||+|+||.||+|.. .+++.||+|++............+.+.+|++++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999976 4688999999875211111234577999999999999999999999984 45678
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++||||++++ +.+++.... ...+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999886 777776543 34589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC--CccccccccccccCccccccCC--CCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 039322 592 LKPES--SNWTEFAGTYGYVAPELAYTMK--ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 592 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
..... .......|++.|+|||++.+.. .+.++||||||+++|||++|+.||+.... ......+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~i~~~~~ 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--------YKLFENIGKGSY 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHCCC
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--------HHHHHHHhcCCC
Confidence 65322 2234456899999999987644 37799999999999999999999974321 111111111121
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+.. ....+.+++.+||+.||++|||++|++++-+
T Consensus 231 ~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 231 AIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp CCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred CCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 11111 1235788999999999999999999998754
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.77 Aligned_cols=324 Identities=19% Similarity=0.165 Sum_probs=299.3
Q ss_pred CCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCC
Q 039322 28 LKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSN 107 (708)
Q Consensus 28 L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n 107 (708)
-+.++.+++.++ .+|..+. ++++.|++++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 13 ~~~v~c~~~~l~-~ip~~~~-~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 13 DRAVLCHRKRFV-AVPEGIP-TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TTEEECCSCCCS-SCCSCCC-TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCEEEeCCCCcC-cCCCCCC-CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 467889999987 4555443 58999999999999988999999999999999999999988999999999999999999
Q ss_pred ccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCc
Q 039322 108 NLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPK 187 (708)
Q Consensus 108 ~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 187 (708)
+++.+++..|.++++|++|+|++|++..+.+..|..+++|+.|+|++|.++...+..|..+++|++|+|++|++++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999977677
Q ss_pred ccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhccc
Q 039322 188 ELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQL 267 (708)
Q Consensus 188 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 267 (708)
.+..+++|+.|+|++|.+.+..+..|..+++|++|++++|.+.+..+.......+|+.|++++|+++...+..|..+++|
T Consensus 171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 250 (477)
T 2id5_A 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250 (477)
T ss_dssp HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTC
T ss_pred HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCcccc
Confidence 89999999999999999998888899999999999999998877777777777799999999999997666789999999
Q ss_pred chhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCCCc-cccccCcccccccc
Q 039322 268 SELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNS-TAFRNAPVEALKGN 346 (708)
Q Consensus 268 ~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n 346 (708)
+.|+|++|.+++..+..+..+++|+.|+|++|++++..+..|..+++|+.|++++|.+++..+.. ..++.++.+.+.+|
T Consensus 251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 330 (477)
T 2id5_A 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN 330 (477)
T ss_dssp CEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS
T ss_pred CeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC
Confidence 99999999999888888999999999999999999999999999999999999999999877653 45788999999999
Q ss_pred cCcCCCC
Q 039322 347 KGLCGGV 353 (708)
Q Consensus 347 ~~~c~~~ 353 (708)
||.|+|.
T Consensus 331 ~l~c~c~ 337 (477)
T 2id5_A 331 PLACDCR 337 (477)
T ss_dssp CEECSGG
T ss_pred CccCccc
Confidence 9999884
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=359.84 Aligned_cols=341 Identities=20% Similarity=0.168 Sum_probs=234.5
Q ss_pred CCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEec
Q 039322 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGV 80 (708)
Q Consensus 2 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l 80 (708)
++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..|..|.. ++|+.|++++|.++. +|.. .+++|++|++
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-ISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCE-ECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCc-cCcc--ccccCCEEEC
Confidence 35666666666666666666666666666666666666666665544 566666666666664 3333 5666666666
Q ss_pred cCCccccc-cCccCcCCCCCcEEEccCCccccccccccCCCCCC--CEEEcccCcc--eeeCCCCCCCCC----------
Q 039322 81 SENHFQGT-IPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNL--TFIDLSRNDF--YGEISSNWGKCP---------- 145 (708)
Q Consensus 81 ~~n~i~~~-~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L--~~L~l~~n~l--~~~~~~~~~~l~---------- 145 (708)
++|.+++. .|..|+++++|++|+|++|.+++. .+..+++| ++|++++|++ ++..+..+..+.
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~ 205 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHP 205 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECS
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecC
Confidence 66666642 245666666666666666666643 23333333 6666666666 444433333221
Q ss_pred -----------------------------------------------------------------------CCCEEEccc
Q 039322 146 -----------------------------------------------------------------------KLGTLNVSM 154 (708)
Q Consensus 146 -----------------------------------------------------------------------~L~~L~L~~ 154 (708)
+|++|++++
T Consensus 206 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~ 285 (562)
T 3a79_B 206 NSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYN 285 (562)
T ss_dssp SSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEE
T ss_pred ccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEec
Confidence 344444444
Q ss_pred CcccccCCccc-----cCC--------------------------CCCCEEecccccccccCCcccCCCCCCCEEEccCc
Q 039322 155 NNITGGIPREI-----GNS--------------------------SQLQALDLSLNHIVGEIPKELGKLNSLTELILRGN 203 (708)
Q Consensus 155 N~i~~~~~~~~-----~~l--------------------------~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 203 (708)
|.+++.+|..+ ..+ .+|++|++++|.+.... ....+++|++|++++|
T Consensus 286 n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n 363 (562)
T 3a79_B 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQN 363 (562)
T ss_dssp EEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSS
T ss_pred cEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCC
Confidence 44443333332 111 12333444444333111 1167889999999999
Q ss_pred cccccCCcccCCCCCCCeEeccCCcccccC--CCCCCccccceeecccCccccc-CCChhhhhhcccchhhcccccCCCC
Q 039322 204 QFTGRLPPEIGSLVDLEYLDLSANRFNNSV--PENLGNLLKLHYLGLSNNQFVL-ELPKELEKLVQLSELDASHNLFGGE 280 (708)
Q Consensus 204 ~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~--~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~ls~N~i~~~ 280 (708)
++++..|..+..+++|++|+|++|++++.. |..+.++++|+.|++++|++++ ..+..+..+++|+.|++++|++++.
T Consensus 364 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 443 (562)
T 3a79_B 364 VFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443 (562)
T ss_dssp CCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGG
T ss_pred ccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcc
Confidence 999888999999999999999999999633 4668899999999999999997 4444688899999999999999866
Q ss_pred CchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCCC-ccccccCcccccccccCcCCCC
Q 039322 281 IPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPN-STAFRNAPVEALKGNKGLCGGV 353 (708)
Q Consensus 281 ~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~~~c~~~ 353 (708)
.+..+. ++|+.|++++|+++ .+|..+..+++|+.|++++|++++.++. ...++.++.+.+.+|||.|+|+
T Consensus 444 ~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 444 VFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp GGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred hhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 555443 79999999999999 5666666999999999999999987666 5677889999999999999885
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=339.83 Aligned_cols=261 Identities=21% Similarity=0.288 Sum_probs=195.3
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR---- 509 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~---- 509 (708)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 37899999999999999999965 468899999997532 23345677889999999999999999999997654
Q ss_pred --eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecc
Q 039322 510 --HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFG 587 (708)
Q Consensus 510 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 587 (708)
..++||||+++ +|.+++. ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ccceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEee
Confidence 78999999975 7888874 2378999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc-------c-----
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN-------T----- 655 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-------~----- 655 (708)
+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||............ .
T Consensus 173 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 173 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp C-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred cccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99865432 2234567899999999999988999999999999999999999999743221000000 0
Q ss_pred --ccc---------------cccccC-CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 656 --DIA---------------LDEILD-PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 656 --~~~---------------~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
... ...... ...+............+.+++.+||+.||++|||++|+++|-+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 000 000000 0011111122333567899999999999999999999999854
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=336.94 Aligned_cols=261 Identities=23% Similarity=0.349 Sum_probs=204.0
Q ss_pred hccccccceeccccCccEEEEEe-----CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR 509 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 509 (708)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 36799999999999999999973 46889999998763 2345678999999999999999999999987654
Q ss_pred --eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecc
Q 039322 510 --HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFG 587 (708)
Q Consensus 510 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 587 (708)
..++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred CCceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCc
Confidence 7899999999999999997643 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCc---cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccc----cccc----cc
Q 039322 588 IAKFLKPESSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISS----SSLN----TD 656 (708)
Q Consensus 588 ~a~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~----~~~~----~~ 656 (708)
++......... .....++..|+|||.+.+..++.++||||||+++|||+||..||........ .... ..
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 99876544332 1234567789999999988899999999999999999999999763211000 0000 00
Q ss_pred cccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 657 IALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+......+.+. ..+..+.+++.+||+.||++|||++|+++.|+
T Consensus 271 ~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~ 318 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPD---GCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318 (326)
T ss_dssp HHHHHHHTTCCCCCCT---TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhhcCCCCCCCC---cccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 0011111111111111 12345889999999999999999999999875
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=360.06 Aligned_cols=341 Identities=18% Similarity=0.197 Sum_probs=263.4
Q ss_pred CCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEec
Q 039322 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGV 80 (708)
Q Consensus 2 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l 80 (708)
++|++|+|++|+|+++.+..|.++++|++|+|++|++++..|..+.. ++|+.|++++|.++. +|.. .+++|++|++
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc--ccCCccEEec
Confidence 46888888888888877788888888888888888888877777765 788888888888886 4444 7788888888
Q ss_pred cCCcccc-ccCccCcCCCCCcEEEccCCccccccccccCCCCCC--CEEEcccCcc--eeeCCCCCCCCC----------
Q 039322 81 SENHFQG-TIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNL--TFIDLSRNDF--YGEISSNWGKCP---------- 145 (708)
Q Consensus 81 ~~n~i~~-~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L--~~L~l~~n~l--~~~~~~~~~~l~---------- 145 (708)
++|.+++ ..|..|+++++|++|++++|.+++ ..|..+++| ++|++++|.+ .+..+..+..+.
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~ 174 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCS
T ss_pred cCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEecc
Confidence 8888886 357788888888888888888875 345666666 8888888877 445554444422
Q ss_pred -------------------------------------------------------------------------CCCEEEc
Q 039322 146 -------------------------------------------------------------------------KLGTLNV 152 (708)
Q Consensus 146 -------------------------------------------------------------------------~L~~L~L 152 (708)
+|++|++
T Consensus 175 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l 254 (520)
T 2z7x_B 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254 (520)
T ss_dssp SSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEE
T ss_pred CcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEe
Confidence 5666666
Q ss_pred ccCcccccCCccc-----cCCCCCCEEecccccc--------------------------cccCCcccCCCCCCCEEEcc
Q 039322 153 SMNNITGGIPREI-----GNSSQLQALDLSLNHI--------------------------VGEIPKELGKLNSLTELILR 201 (708)
Q Consensus 153 ~~N~i~~~~~~~~-----~~l~~L~~L~L~~n~l--------------------------~~~~~~~~~~l~~L~~L~l~ 201 (708)
++|++++..|..+ ..+++|+.+++++|.+ .... .+..+++|++|+++
T Consensus 255 ~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls 332 (520)
T 2z7x_B 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFS 332 (520)
T ss_dssp EEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECC
T ss_pred ecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeE
Confidence 6666665556555 4555544444444444 2110 12677889999999
Q ss_pred CccccccCCcccCCCCCCCeEeccCCcccc--cCCCCCCccccceeecccCcccccCCCh-hhhhhcccchhhcccccCC
Q 039322 202 GNQFTGRLPPEIGSLVDLEYLDLSANRFNN--SVPENLGNLLKLHYLGLSNNQFVLELPK-ELEKLVQLSELDASHNLFG 278 (708)
Q Consensus 202 ~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~ls~N~i~ 278 (708)
+|++++..|..+..+++|++|+|++|++++ ..|..+..+++|+.|++++|++++.+|. .+..+++|+.|++++|+++
T Consensus 333 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~ 412 (520)
T 2z7x_B 333 NNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412 (520)
T ss_dssp SSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCC
T ss_pred CCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCC
Confidence 999998788888899999999999999986 4456688889999999999999874454 4778889999999999998
Q ss_pred CCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCCC-ccccccCcccccccccCcCCCC
Q 039322 279 GEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPN-STAFRNAPVEALKGNKGLCGGV 353 (708)
Q Consensus 279 ~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~n~~~c~~~ 353 (708)
+..+..+. ++|+.|++++|+++ .+|..+..+++|+.|++++|+++..++. ...++.++.+.+.+|++.|+|+
T Consensus 413 ~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 413 DTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp GGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence 66665543 78999999999999 6777777999999999999999976665 5567889999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=348.30 Aligned_cols=198 Identities=21% Similarity=0.303 Sum_probs=172.2
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc------cCCceeeEEEEEee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI------RHRNIVKFYGFCSH 507 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~l~~~~~~ 507 (708)
..+|++.+.||+|+||.||+|.. .+++.||||+++.. ......+.+|+++++.+ +|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 36799999999999999999965 46899999999752 23456778888888887 46799999999999
Q ss_pred CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc--EEEee
Q 039322 508 ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE--AHVAD 585 (708)
Q Consensus 508 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~--~kl~D 585 (708)
.+..++||||+. ++|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++. +||+|
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECC
T ss_pred CCeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEee
Confidence 999999999996 599999876542 3489999999999999999999999 9999999999999999987 99999
Q ss_pred cccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 039322 586 FGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFL 645 (708)
Q Consensus 586 fg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~ 645 (708)
||+|+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 246 FG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 246 FGSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CTTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 9999765432 23457899999999999989999999999999999999999999743
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=332.10 Aligned_cols=255 Identities=26% Similarity=0.392 Sum_probs=194.1
Q ss_pred ccccccceeccccCccEEEEEeC--CCc--EEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP--SGQ--VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
++|++.+.||+|+||.||+|.+. +++ .||||+++.... ......+.+.+|++++++++||||+++++++..++ .
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 68999999999999999999753 333 689999875321 12345678999999999999999999999998765 8
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++|+||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 89999999999999997543 3489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc---cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 039322 592 LKPESSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 592 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
....... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ......+.....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~ 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKEGE 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTSCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------HHHHHHHHccCC
Confidence 6544332 223456788999999988889999999999999999999 9999874321 111111111111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+. ....+..+.+++.+||+.||++|||+++++++|+
T Consensus 243 ~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 280 (291)
T 1u46_A 243 RLPR--PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280 (291)
T ss_dssp CCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCC--CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 1100 0112345889999999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=332.96 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=195.4
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee-----
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH----- 507 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----- 507 (708)
..++|++.+.||+|+||.||+|.. .+++.||||.+.. .....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 357899999999999999999975 4789999999864 23456789999999999999999999998865
Q ss_pred --------CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC
Q 039322 508 --------ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY 579 (708)
Q Consensus 508 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~ 579 (708)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESR 153 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTS
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCC
Confidence 356899999999999999997543 3478899999999999999999999 999999999999999999
Q ss_pred cEEEeecccccccCCCC--------------CccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCc
Q 039322 580 EAHVADFGIAKFLKPES--------------SNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDF 644 (708)
Q Consensus 580 ~~kl~Dfg~a~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~ 644 (708)
.+||+|||++....... .......|++.|+|||++.+. .++.++||||+|+++|||++ ||..
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 99999999998654321 122345689999999998764 68899999999999999998 5432
Q ss_pred cccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 645 LSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
... .......+.......+.......+..+.+++.+||+.||++|||++|++++-++
T Consensus 231 ~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (303)
T 1zy4_A 231 GME-------RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287 (303)
T ss_dssp HHH-------HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred chh-------HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence 110 011111111111111111112223457889999999999999999999998653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=335.88 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=185.3
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEe------
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCS------ 506 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~------ 506 (708)
..+|++.+.||+|+||.||+|.. .+++.||||++... .......+.+|+.+++++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 36899999999999999999975 47899999998542 3345677899999999996 999999999994
Q ss_pred --eCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEccCCCCCeeeCCCCcEE
Q 039322 507 --HARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP--IVHQDISSKNLLLDLEYEAH 582 (708)
Q Consensus 507 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~~~~~~k 582 (708)
.....++||||+. |+|.+++........+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence 3345799999996 69999987644445699999999999999999999998 8 99999999999999999999
Q ss_pred EeecccccccCCCCCc------------cccccccccccCcccc---ccCCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 039322 583 VADFGIAKFLKPESSN------------WTEFAGTYGYVAPELA---YTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSL 647 (708)
Q Consensus 583 l~Dfg~a~~~~~~~~~------------~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~ 647 (708)
|+|||++......... .....+++.|+|||++ .+..++.++||||||+++|+|++|+.||+....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999999876543221 1134589999999998 566788999999999999999999999874321
Q ss_pred ccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 648 ISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. ....... .+.... ....+.+++.+||+.||++|||++|++++|+
T Consensus 259 ~~--------~~~~~~~--~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 259 LR--------IVNGKYS--IPPHDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ---------------CC--CCTTCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HH--------hhcCccc--CCcccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11 0111010 001100 1123778999999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=335.26 Aligned_cols=257 Identities=21% Similarity=0.350 Sum_probs=199.9
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee----CC
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH----AR 509 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----~~ 509 (708)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++.. ..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 37899999999999999999975 57899999998642 33456789999999999999999999999873 34
Q ss_pred eeEEEEEeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 510 HSFLVYELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 7899999999999999997532 234589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc---------cccccccccccCccccccCC---CCcchhHHHHHHHHHHHHhCCCCCCccccccccccccc
Q 039322 589 AKFLKPESSN---------WTEFAGTYGYVAPELAYTMK---ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTD 656 (708)
Q Consensus 589 a~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~ 656 (708)
+......... .....|++.|+|||.+.+.. ++.++||||||+++|||++|+.||+....... ...
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~ 257 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---SVA 257 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS---CHH
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc---hhh
Confidence 8765321111 12345689999999987554 68899999999999999999999863211000 000
Q ss_pred cccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 657 IALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..... ....+... .....+.+++.+||+.||++|||++|++++|+
T Consensus 258 ~~~~~--~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 302 (317)
T 2buj_A 258 LAVQN--QLSIPQSP----RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302 (317)
T ss_dssp HHHHC--C--CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhhc--cCCCCccc----cCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence 00011 11111111 12235889999999999999999999999885
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.43 Aligned_cols=266 Identities=26% Similarity=0.392 Sum_probs=186.6
Q ss_pred HhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
..++|++.+.||+|+||.||+|.. .+++.||||.+.... .....+.+.+|++++++++||||+++++++..++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK---CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh---cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 347899999999999999999965 468899999987532 1234567889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccc-----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecc
Q 039322 513 LVYELLERGSLAAILSSDT-----AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFG 587 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~-----~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 587 (708)
+||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence 9999999999999986421 234589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC-----ccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 039322 588 IAKFLKPESS-----NWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDE 661 (708)
Q Consensus 588 ~a~~~~~~~~-----~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 661 (708)
++........ ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence 9986643321 1234568999999998875 568899999999999999999999997432211000000000000
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 662 ILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
... ... ...........+.+++.+||+.||++|||++|+++|-+
T Consensus 247 ~~~-~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 290 (303)
T 2vwi_A 247 LET-GVQ-DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 290 (303)
T ss_dssp TTC-------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred ccc-ccc-cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 000 000 00000111235789999999999999999999998754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=329.70 Aligned_cols=256 Identities=22% Similarity=0.334 Sum_probs=205.5
Q ss_pred HhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
..++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++..++..+
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB--SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 4578999999999999999999764 789999999865321 1234677899999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC---CcEEEeecccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE---YEAHVADFGIA 589 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a 589 (708)
+||||+++++|.+++.... .+++..++.++.|++.||+|||++ |++||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999999886543 489999999999999999999999 99999999999999764 46999999999
Q ss_pred cccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 039322 590 KFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
....... ......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||..... ......+.......
T Consensus 172 ~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~ 241 (287)
T 2wei_A 172 TCFQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKRVETGKYAF 241 (287)
T ss_dssp GTBCCCS-SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCC
T ss_pred eeecCCC-ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence 8665432 2334568999999998765 488999999999999999999999874321 11112222222222
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........+..+.+++.+||+.||++|||++|++++-+
T Consensus 242 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~ 279 (287)
T 2wei_A 242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (287)
T ss_dssp CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHH
Confidence 21112222346889999999999999999999998743
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=362.75 Aligned_cols=246 Identities=24% Similarity=0.369 Sum_probs=194.8
Q ss_pred ceeccccCccEEEEEe---CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEec
Q 039322 442 YCIGNGGHGSVYRAEL---PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELL 518 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 518 (708)
+.||+|+||.||+|.+ ..++.||||+++... ......+++.+|++++++++||||+++++++.. +..++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG--GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence 4799999999999954 246789999997532 222346789999999999999999999999965 5578999999
Q ss_pred cCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 039322 519 ERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN 598 (708)
Q Consensus 519 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 598 (708)
++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 452 ~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 452 ELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp TTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 999999999654 3489999999999999999999999 9999999999999999999999999999876544322
Q ss_pred ---cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 599 ---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 599 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+........+..
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~~i~~~~~~~~p~~- 596 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGERMGCPAG- 596 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCCTT-
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCCC-
Confidence 223456789999999999999999999999999999998 9999974322 111111212111111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+..+.+++.+||+.||++|||+++|++.|+
T Consensus 597 --~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~ 627 (635)
T 4fl3_A 597 --CPREMYDLMNLCWTYDVENRPGFAAVELRLR 627 (635)
T ss_dssp --CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred --CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 2345889999999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=334.02 Aligned_cols=255 Identities=20% Similarity=0.273 Sum_probs=199.5
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEee--CCee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSH--ARHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~--~~~~ 511 (708)
++|++.+.||+|+||.||+|.. .+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.+ ....
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 7899999999999999999964 57899999998752 2567889999999997 9999999999988 5678
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-cEEEeeccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY-EAHVADFGIAK 590 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~ 590 (708)
++||||+++++|.+++. .+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus 109 ~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 99999999999999884 278899999999999999999999 999999999999999776 89999999998
Q ss_pred ccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccc-------------------
Q 039322 591 FLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISS------------------- 650 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~------------------- 650 (708)
...... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||........
T Consensus 180 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 180 FYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp ECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred EcCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 765433 3345678999999999877 6689999999999999999999999842211000
Q ss_pred -cccccccccccccCCCCCC------CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 651 -SSLNTDIALDEILDPRLPP------PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 651 -~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
................... ...........+.+++.+||+.||++|||++|+++|-+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~ 322 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence 0000000000000000000 00001112346889999999999999999999999865
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=340.29 Aligned_cols=259 Identities=19% Similarity=0.313 Sum_probs=204.9
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcch-------------hHhHHHHHHHHHHHHhccCCceeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQ-------------IADQKEFLIEVKALTEIRHRNIVKF 501 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~iv~l 501 (708)
.++|++.+.||+|+||.||+|.. +|+.||||++........ ....+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 37899999999999999999988 899999999864211000 0112789999999999999999999
Q ss_pred EEEEeeCCeeEEEEEeccCCCHHHH------hcccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEccCCCCCee
Q 039322 502 YGFCSHARHSFLVYELLERGSLAAI------LSSDTAAQELGWSQRMNVIKGVADALSYLHH-DCFPPIVHQDISSKNLL 574 (708)
Q Consensus 502 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nil 574 (708)
++++.+++..++||||+++|+|.++ +.... ...+++..++.++.|++.||+|||+ + |++||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999999998 54321 3568999999999999999999999 8 9999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCCccccccccccccCccccccC-CCCc-chhHHHHHHHHHHHHhCCCCCCccccccccc
Q 039322 575 LDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTM-KITE-KCDVYSFGVLVLEAIKGKHPRDFLSLISSSS 652 (708)
Q Consensus 575 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DvwslG~~l~elltg~~p~~~~~~~~~~~ 652 (708)
++.++.+||+|||.+...... ......++..|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence 999999999999999876433 33456789999999998877 5666 999999999999999999999743220
Q ss_pred cccccccccccCCCCCCCC---------------chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 653 LNTDIALDEILDPRLPPPS---------------RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+.......+. .........+.+++.+||+.||++|||++|+++|-+
T Consensus 259 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~ 325 (348)
T 2pml_X 259 ---VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325 (348)
T ss_dssp ---HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred ---HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 0111111111111000 000122346889999999999999999999998754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=329.40 Aligned_cols=257 Identities=21% Similarity=0.355 Sum_probs=188.6
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|.. .+|+.||+|+++... ........+.++...++.++||||+++++++.+++..++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc--CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 47899999999999999999965 578999999997632 222333445555556888899999999999999999999
Q ss_pred EEEeccCCCHHHHhccc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 514 VYELLERGSLAAILSSD-TAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
||||+++ +|.+++... .....+++..++.++.|++.||+|||++. |++||||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9999975 888877542 12345899999999999999999999853 8999999999999999999999999999866
Q ss_pred CCCCCccccccccccccCcccc----ccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC-CCC
Q 039322 593 KPESSNWTEFAGTYGYVAPELA----YTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD-PRL 667 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 667 (708)
.... ......|++.|+|||.+ .+..++.++||||+|+++|+|++|+.||+..... ......... ...
T Consensus 161 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~ 232 (290)
T 3fme_A 161 VDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-------FQQLKQVVEEPSP 232 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-------HHHHHHHHHSCCC
T ss_pred cccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-------HHHHHHHhccCCC
Confidence 5432 23345789999999996 4567889999999999999999999998732110 111111111 111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+.. ..+..+.+++.+||+.||++|||++|+++|-+
T Consensus 233 ~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~ 269 (290)
T 3fme_A 233 QLPAD---KFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269 (290)
T ss_dssp CCCTT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred Ccccc---cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcc
Confidence 11111 12335889999999999999999999998754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=341.31 Aligned_cols=274 Identities=21% Similarity=0.265 Sum_probs=202.1
Q ss_pred hHHHHHHHhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcc-------hhHhHHHHHHHHHHHHhccCCcee
Q 039322 427 VYDEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCD-------QIADQKEFLIEVKALTEIRHRNIV 499 (708)
Q Consensus 427 ~~~~~~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv 499 (708)
...++....++|++.+.||+|+||.||+|...+|+.||||++....... .....+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4567788889999999999999999999988889999999986532211 122347899999999999999999
Q ss_pred eEEEEEee-----CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCee
Q 039322 500 KFYGFCSH-----ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLL 574 (708)
Q Consensus 500 ~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nil 574 (708)
++++++.. ....++||||+. |+|.+++.... ..+++..++.++.|++.||+|||++ ||+||||||+||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 99999854 336799999998 58888886443 4589999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeecccccccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 039322 575 LDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL 653 (708)
Q Consensus 575 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~ 653 (708)
++.++.+||+|||++...... .......+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||...........
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp ECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999999754432 23345678999999998876 6789999999999999999999999974321100000
Q ss_pred c---------------cccccccccCCCCCC-CCchh----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 N---------------TDIALDEILDPRLPP-PSRSV----QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 ~---------------~~~~~~~~~~~~~~~-~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. ............... +.... ......+.+++.+||+.||++|||++|+++|-+
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence 0 000000111111100 00011 112345889999999999999999999998854
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.21 Aligned_cols=255 Identities=18% Similarity=0.235 Sum_probs=198.4
Q ss_pred ccccccceeccccCccEEEEEeCC---------CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceee------
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPS---------GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK------ 500 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~------ 500 (708)
++|++.+.||+|+||.||+|.... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 689999999999999999997653 789999998752 35778999999999999887
Q ss_pred ---------EEEEEee-CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCC
Q 039322 501 ---------FYGFCSH-ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISS 570 (708)
Q Consensus 501 ---------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~ 570 (708)
+++++.. ++..++||||+ +++|.+++.... ...+++..++.++.|++.||+|||++ ||+||||||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp 187 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA 187 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCG
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCH
Confidence 6777776 67889999999 999999997652 24589999999999999999999999 999999999
Q ss_pred CCeeeCCCC--cEEEeecccccccCCCCC-------ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 039322 571 KNLLLDLEY--EAHVADFGIAKFLKPESS-------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641 (708)
Q Consensus 571 ~Nill~~~~--~~kl~Dfg~a~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p 641 (708)
+||+++.++ .+||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999998 899999999986643221 12335789999999999998999999999999999999999999
Q ss_pred CCccccccccccccccccccccC--CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 642 RDFLSLISSSSLNTDIALDEILD--PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
|.......... ......+.. ..+..........+..+.+++.+||+.||++|||++++++.|+
T Consensus 268 f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 332 (352)
T 2jii_A 268 WTNCLPNTEDI---MKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLE 332 (352)
T ss_dssp TGGGTTCHHHH---HHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred cccCCcCHHHH---HHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence 97432110000 000000000 0000000000011245889999999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=341.68 Aligned_cols=260 Identities=22% Similarity=0.341 Sum_probs=184.5
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC-----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA----- 508 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~----- 508 (708)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+++++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 37899999999999999999964 578999999997633 2334567888999999999999999999998654
Q ss_pred -CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecc
Q 039322 509 -RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFG 587 (708)
Q Consensus 509 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 587 (708)
...++|+|++ +++|.+++.. ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred CCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence 5679999999 6799998864 3489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc-------------
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL------------- 653 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~------------- 653 (708)
+++.... ......+|..|+|||++.+ ..++.++||||+||++|||++|+.||...........
T Consensus 178 ~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 178 LARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ccccccc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9986542 2344678999999999876 6789999999999999999999999975332110000
Q ss_pred --ccccccccccC--CCCCCCC--chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 --NTDIALDEILD--PRLPPPS--RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 --~~~~~~~~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........+.. +..+... .........+.+|+.+||+.||++|||++|+++|-+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 00000000000 0000000 000111245789999999999999999999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=339.36 Aligned_cols=262 Identities=22% Similarity=0.312 Sum_probs=201.0
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC-----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA----- 508 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~----- 508 (708)
.++|++.+.||+|+||.||+|.. .+++.||||++... ......+.+.+|++++++++||||+++++++..+
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc---cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 36899999999999999999965 46889999999752 2234457789999999999999999999999765
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
...++||||+.+ +|.+++... .+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~iv~e~~~~-~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 103 KDVYIVQDLMET-DLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp CCEEEEEECCSE-EHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEcccCc-CHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence 368999999975 999998643 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc---cccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc-------ccc
Q 039322 589 AKFLKPESSN---WTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN-------TDI 657 (708)
Q Consensus 589 a~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-------~~~ 657 (708)
+......... .....||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||............ ...
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9876533221 244578999999998654 45899999999999999999999999743221100000 000
Q ss_pred cc------------ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 AL------------DEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. .........+...........+.+++.+||+.||++|||++|+++|-+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 00 000000000000000112345889999999999999999999998755
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=343.64 Aligned_cols=261 Identities=23% Similarity=0.242 Sum_probs=194.8
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC-----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR----- 509 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 509 (708)
..+|++.+.||+|+||.||+|....+..||+|++...... ..+|+++++.++||||+++++++...+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 3679999999999999999998877777999988653211 225999999999999999999996543
Q ss_pred -eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC-CCCcEEEeecc
Q 039322 510 -HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD-LEYEAHVADFG 587 (708)
Q Consensus 510 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg 587 (708)
..++||||++++.+............+++..++.++.|++.||+|||++ ||+||||||+||+++ .++.+||+|||
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 3789999998754444333222345689999999999999999999999 999999999999998 78999999999
Q ss_pred cccccCCCCCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc-------cc---
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN-------TD--- 656 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-------~~--- 656 (708)
+|+...... ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||............ ..
T Consensus 188 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 188 SAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp TCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 998764433 23455789999999998765 5899999999999999999999999753321000000 00
Q ss_pred -cccccccCCCCCCCC-chhH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 657 -IALDEILDPRLPPPS-RSVQ-----EKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 657 -~~~~~~~~~~~~~~~-~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..........++... .... .....+.+++.+||+.||++|||+.|+++|-+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence 000011111111100 0000 12346889999999999999999999998754
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=361.16 Aligned_cols=339 Identities=18% Similarity=0.242 Sum_probs=255.0
Q ss_pred CCcEEECCCCcccccCCccccCCCCCCEEEeeCc----------------------------------------------
Q 039322 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYN---------------------------------------------- 36 (708)
Q Consensus 3 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n---------------------------------------------- 36 (708)
.++.|+|++|++++..|.+++++++|++|+|++|
T Consensus 82 ~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~ 161 (636)
T 4eco_A 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDL 161 (636)
T ss_dssp CEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHH
T ss_pred CEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHH
Confidence 4678888888888888888888888888888877
Q ss_pred --------------------------------eeeeeCCCCCCC-CCcccccccCCCccCC-----------------CC
Q 039322 37 --------------------------------NLSGFIPPSLEN-PMLTRPGLDFNHFTSY-----------------LP 66 (708)
Q Consensus 37 --------------------------------~i~~~~~~~~~~-~~l~~l~l~~n~~~~~-----------------~~ 66 (708)
++++ +|..+.. ++|+.|++++|.+++. +|
T Consensus 162 ~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip 240 (636)
T 4eco_A 162 IKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT 240 (636)
T ss_dssp HHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTT
T ss_pred HHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCc
Confidence 4444 5555544 6788888888888774 77
Q ss_pred cccc--CCCCccEEeccCCccccccCccCcCCCCCcEEEccCCc-ccc-ccccccCCC------CCCCEEEcccCcceee
Q 039322 67 HNVC--RGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNN-LTG-NISEALGIY------PNLTFIDLSRNDFYGE 136 (708)
Q Consensus 67 ~~~~--~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~-i~~-~~~~~~~~~------~~L~~L~l~~n~l~~~ 136 (708)
..++ .+++|++|++++|.+.+.+|..|.++++|++|+|++|+ +++ ..|..+..+ ++|++|++++|+++ .
T Consensus 241 ~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ 319 (636)
T 4eco_A 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-T 319 (636)
T ss_dssp SCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-S
T ss_pred hhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-c
Confidence 7777 88888888888888888888888888888888888887 776 556666555 78888888888887 4
Q ss_pred CCC--CCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCC-CCEEEccCccccccCCccc
Q 039322 137 ISS--NWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNS-LTELILRGNQFTGRLPPEI 213 (708)
Q Consensus 137 ~~~--~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~ 213 (708)
.+. .+..+++|+.|++++|++++.+| .|..+++|++|+|++|+++ .+|..+..+++ |++|++++|.++ .+|..+
T Consensus 320 ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~ 396 (636)
T 4eco_A 320 FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIF 396 (636)
T ss_dssp CCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCC
T ss_pred cCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhh
Confidence 455 67788888888888888886666 7777888888888888887 66777777777 888888888888 667666
Q ss_pred CCCC--CCCeEeccCCcccccCCCCCC-------ccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchh
Q 039322 214 GSLV--DLEYLDLSANRFNNSVPENLG-------NLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQ 284 (708)
Q Consensus 214 ~~~~--~L~~L~l~~N~i~~~~~~~~~-------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~ 284 (708)
..++ +|++|++++|.+++..|..+. .+++|+.|+|++|+++...+..+..+++|+.|+|++|.++...+..
T Consensus 397 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~ 476 (636)
T 4eco_A 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNS 476 (636)
T ss_dssp CTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSS
T ss_pred hhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHH
Confidence 6554 788888888888877777777 6778888888888888555555666788888888888887333333
Q ss_pred hcCc-------ccCCceecccccccCCCCCccc--ccccccEEecCCCcCCCCCCCccccccCccccccccc
Q 039322 285 ICSL-------KSLEKLNLSHNNLSGSIPNCFE--GIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNK 347 (708)
Q Consensus 285 ~~~~-------~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~ 347 (708)
+... ++|+.|+|++|+++ .+|..+. .+++|+.|++++|++++.+.....++.++.+.+.+|+
T Consensus 477 ~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~Ls~N~ 547 (636)
T 4eco_A 477 LKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQR 547 (636)
T ss_dssp SEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCSSCCEEECCSCB
T ss_pred hccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCCcChhhhcCCCCCEEECCCCc
Confidence 3322 27888888888887 5666665 7788888888888888755555667777777776665
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.12 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=198.8
Q ss_pred HHhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc--CCceeeEEEEEeeCCe
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR--HRNIVKFYGFCSHARH 510 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~l~~~~~~~~~ 510 (708)
...++|++.+.||+|+||.||+|...+++.||||++.... ......+.+.+|++++++++ |+||+++++++..++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccc--ccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 3457899999999999999999988889999999987532 22345678999999999997 5999999999999999
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++||| +.+++|.+++.... .+++..++.++.|++.||+|||++ +++||||||+||+++ ++.+||+|||++.
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~ 174 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIAN 174 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred EEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeeccccc
Confidence 999999 56789999997543 489999999999999999999999 999999999999996 4899999999998
Q ss_pred ccCCCCCc--cccccccccccCcccccc-----------CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccc
Q 039322 591 FLKPESSN--WTEFAGTYGYVAPELAYT-----------MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDI 657 (708)
Q Consensus 591 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~ 657 (708)
........ .....|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------~~~ 247 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QIS 247 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHH
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-------HHH
Confidence 76543321 234568999999999865 4678899999999999999999999863211 111
Q ss_pred ccccccCCCCCCC-CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 ALDEILDPRLPPP-SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......++..... +... ...+.+++.+||+.||++|||++|++++-+
T Consensus 248 ~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 248 KLHAIIDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HHHHHHCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHHhcccccCCcccc---hHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 1122222211111 0111 235788999999999999999999998754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.49 Aligned_cols=262 Identities=22% Similarity=0.279 Sum_probs=201.6
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc--------CCceeeEEEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR--------HRNIVKFYGFC 505 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~l~~~~ 505 (708)
.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++ |+||+++++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 37899999999999999999964 56889999999752 244677889999999996 78899999999
Q ss_pred e----eCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC--
Q 039322 506 S----HARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY-- 579 (708)
Q Consensus 506 ~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-- 579 (708)
. .....++||||+ ++++.+++.... ...+++..++.++.||+.||+|||+++ ||+||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence 7 456889999999 556666665432 245899999999999999999999964 899999999999999775
Q ss_pred -----------------------------------------------cEEEeecccccccCCCCCccccccccccccCcc
Q 039322 580 -----------------------------------------------EAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE 612 (708)
Q Consensus 580 -----------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE 612 (708)
.+||+|||++...... .....||+.|+|||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE 263 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCCh
Confidence 7999999999876432 34457899999999
Q ss_pred ccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc-------------c------ccccccccCC--------
Q 039322 613 LAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN-------------T------DIALDEILDP-------- 665 (708)
Q Consensus 613 ~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-------------~------~~~~~~~~~~-------- 665 (708)
++.+..++.++|||||||++|||++|+.||............ . ......+...
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 999988999999999999999999999999743211100000 0 0000000000
Q ss_pred CCCC---------CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 666 RLPP---------PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 666 ~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
...+ ...........+.+++.+||+.||++|||++|+++|-++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 395 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGG
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccc
Confidence 0000 001124455678999999999999999999999998653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=333.75 Aligned_cols=255 Identities=21% Similarity=0.235 Sum_probs=174.1
Q ss_pred hccccccc-eeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee----C
Q 039322 435 TNDFDAQY-CIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH----A 508 (708)
Q Consensus 435 ~~~~~~~~-~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----~ 508 (708)
.++|.+.+ .||+|+||.||+|... +|+.||||++... .. ...+....++.++||||+++++++.. +
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 47898854 6999999999999765 6899999998652 11 11222233566789999999999976 4
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC---CcEEEee
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE---YEAHVAD 585 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~---~~~kl~D 585 (708)
...++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||++ ||+||||||+||+++.+ +.+||+|
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence 568999999999999999976542 4589999999999999999999999 99999999999999864 5599999
Q ss_pred cccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 039322 586 FGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDP 665 (708)
Q Consensus 586 fg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 665 (708)
||++...... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.......... .....+...
T Consensus 175 fg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~ 248 (336)
T 3fhr_A 175 FGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----GMKRRIRLG 248 (336)
T ss_dssp CTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred cccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----hHHHhhhcc
Confidence 9999865432 2344578999999999988889999999999999999999999996433211100 001111111
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 666 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+..........+.+++.+||+.||++|||++|+++|-+
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 111111111122345889999999999999999999999764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=330.77 Aligned_cols=260 Identities=18% Similarity=0.277 Sum_probs=202.8
Q ss_pred hccccccceeccccCccEEEEEe--CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCc------eeeEEEEEe
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL--PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN------IVKFYGFCS 506 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~l~~~~~ 506 (708)
.++|++.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+++++.++|++ ++++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 36899999999999999999965 36889999998742 244677889999999997654 999999999
Q ss_pred eCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC---------
Q 039322 507 HARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL--------- 577 (708)
Q Consensus 507 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--------- 577 (708)
..+..++||||+ +++|.+++..... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCC
Confidence 999999999999 8899999976542 3588999999999999999999999 9999999999999987
Q ss_pred ----------CCcEEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 039322 578 ----------EYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSL 647 (708)
Q Consensus 578 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~ 647 (708)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 668999999999865432 2345789999999999998999999999999999999999999974322
Q ss_pred ccccccc-------cccccc-----ccc-C-------------------CCCCCCCchhHHHHHHHHHHHHhccCCCCCC
Q 039322 648 ISSSSLN-------TDIALD-----EIL-D-------------------PRLPPPSRSVQEKLISIMEVAFSCLNESPES 695 (708)
Q Consensus 648 ~~~~~~~-------~~~~~~-----~~~-~-------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 695 (708)
....... ...... ... . ................+.+++.+||+.||++
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 1100000 000000 000 0 0000000011233457889999999999999
Q ss_pred CCCHHHHHHHhh
Q 039322 696 RPTMKVVTQQVR 707 (708)
Q Consensus 696 RPs~~evl~~l~ 707 (708)
|||++|+++|-+
T Consensus 320 Rpt~~ell~hp~ 331 (339)
T 1z57_A 320 RITLREALKHPF 331 (339)
T ss_dssp SCCHHHHTTSGG
T ss_pred ccCHHHHhcCHH
Confidence 999999998754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=331.42 Aligned_cols=261 Identities=23% Similarity=0.294 Sum_probs=192.9
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEe-------
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCS------- 506 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~------- 506 (708)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 368999999999999999999765 5899999998752 3345678899999999999999999999873
Q ss_pred -------eCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC-CC
Q 039322 507 -------HARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD-LE 578 (708)
Q Consensus 507 -------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~ 578 (708)
+.+..++||||++ |+|.+++.. ..+++..++.++.|++.||+|||++ |++||||||+||+++ .+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTED 157 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTT
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence 3467899999998 599999864 3489999999999999999999999 999999999999997 56
Q ss_pred CcEEEeecccccccCCCCC---ccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc-
Q 039322 579 YEAHVADFGIAKFLKPESS---NWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL- 653 (708)
Q Consensus 579 ~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~- 653 (708)
+.+||+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 7999999999987643221 2234567899999998765 6789999999999999999999999974332110000
Q ss_pred ------cccccccc-----------ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 ------NTDIALDE-----------ILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 ------~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+ .......+...........+.+++.+||+.||++|||++|+++|-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence 00000000 0000000000000112346889999999999999999999998754
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=366.44 Aligned_cols=351 Identities=21% Similarity=0.167 Sum_probs=274.9
Q ss_pred CCCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeee-eCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEE
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSG-FIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYF 78 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L 78 (708)
+++|++|||++|+|+.+.+..|.++++|++|+|++|...+ +.|..|.. ++|+.|++++|.+.+..|..|..+++|++|
T Consensus 23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 102 (844)
T 3j0a_A 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102 (844)
T ss_dssp CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCE
T ss_pred CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEe
Confidence 3689999999999999999999999999999999995444 44777866 899999999999999999999999999999
Q ss_pred eccCCccccccCcc--CcCCCCCcEEEccCCccccccc-cccCCCCCCCEEEcccCcceeeCCCCCCC------------
Q 039322 79 GVSENHFQGTIPKI--LRNCSSLIRVRLNSNNLTGNIS-EALGIYPNLTFIDLSRNDFYGEISSNWGK------------ 143 (708)
Q Consensus 79 ~l~~n~i~~~~~~~--~~~l~~L~~L~l~~n~i~~~~~-~~~~~~~~L~~L~l~~n~l~~~~~~~~~~------------ 143 (708)
+|++|.+++..+.. |.++++|++|+|++|.++++.+ ..|+++++|++|+|++|.++++.+..+..
T Consensus 103 ~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~ 182 (844)
T 3j0a_A 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182 (844)
T ss_dssp ECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEEC
T ss_pred eCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECC
Confidence 99999999866655 9999999999999999997765 57999999999999999886543322211
Q ss_pred --------------------------------------------------------------------------------
Q 039322 144 -------------------------------------------------------------------------------- 143 (708)
Q Consensus 144 -------------------------------------------------------------------------------- 143 (708)
T Consensus 183 ~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~ 262 (844)
T 3j0a_A 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAG 262 (844)
T ss_dssp CSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTT
T ss_pred CCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhc
Confidence
Q ss_pred --CCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCe
Q 039322 144 --CPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEY 221 (708)
Q Consensus 144 --l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~ 221 (708)
.++|+.|+|++|.+++..+..|..+++|+.|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++
T Consensus 263 l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 342 (844)
T 3j0a_A 263 LARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY 342 (844)
T ss_dssp TTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCE
T ss_pred cccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCE
Confidence 134566666666666666667777778888888888887777777778888888888888887777777888888888
Q ss_pred EeccCCcccccCCCCCCccccceeecccCcccccCCC----------------------------------------hhh
Q 039322 222 LDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELP----------------------------------------KEL 261 (708)
Q Consensus 222 L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~----------------------------------------~~~ 261 (708)
|+|++|+++...+..|..+++|+.|+|++|.+++... ..+
T Consensus 343 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~ 422 (844)
T 3j0a_A 343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFL 422 (844)
T ss_dssp EECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHH
T ss_pred EECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhh
Confidence 8888888877767777778888888887777664210 113
Q ss_pred hhhcccchhhcccccCCCCC------------------------------chhhcCcccCCceecccccccCCCCCcccc
Q 039322 262 EKLVQLSELDASHNLFGGEI------------------------------PFQICSLKSLEKLNLSHNNLSGSIPNCFEG 311 (708)
Q Consensus 262 ~~l~~L~~L~ls~N~i~~~~------------------------------~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~ 311 (708)
..+++|+.|+|++|++++.. +..+..+++|+.|+|++|++++..+..|..
T Consensus 423 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 502 (844)
T 3j0a_A 423 LRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSH 502 (844)
T ss_dssp TTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSS
T ss_pred hcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccc
Confidence 35566666666666665321 233556788888888888888888888889
Q ss_pred cccccEEecCCCcCCCCCCCccccccCcccccccccCcCCC
Q 039322 312 IRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGG 352 (708)
Q Consensus 312 l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~ 352 (708)
+++|+.|+|++|.+++.++.... +.++.+.+++|....-.
T Consensus 503 l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~ 542 (844)
T 3j0a_A 503 LTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPN 542 (844)
T ss_dssp CCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCC
T ss_pred hhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCC
Confidence 99999999999999987765443 67888888888765543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=338.35 Aligned_cols=269 Identities=19% Similarity=0.195 Sum_probs=189.0
Q ss_pred HHHHHHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee
Q 039322 429 DEIVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH 507 (708)
Q Consensus 429 ~~~~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 507 (708)
.+.....++|++.+.||+|+||.||+|.. .+|+.||||++.... .....+.++++.++.++||||+++++++..
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~l~~l~h~niv~~~~~~~~ 90 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLAVLHHPNIVQLQSYFYT 90 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-----TCCCHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-----cccHHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence 44566778999999999999999999976 468999999986532 122345677888889999999999999966
Q ss_pred CCe-------eEEEEEeccCCCHHHHhcc-cccccCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEEccCCCCCeeeCC
Q 039322 508 ARH-------SFLVYELLERGSLAAILSS-DTAAQELGWSQRMNVIKGVADALSYLH--HDCFPPIVHQDISSKNLLLDL 577 (708)
Q Consensus 508 ~~~-------~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~Lh--~~~~~~ivH~dlk~~Nill~~ 577 (708)
.+. .++||||+++ ++.+.+.. ......+++..++.++.|++.|++||| ++ ||+||||||+||+++.
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~ 166 (360)
T 3e3p_A 91 LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNE 166 (360)
T ss_dssp ECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEET
T ss_pred cccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeC
Confidence 433 7899999987 55444432 223345889999999999999999999 87 9999999999999997
Q ss_pred -CCcEEEeecccccccCCCCCccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccccccc-
Q 039322 578 -EYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN- 654 (708)
Q Consensus 578 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~- 654 (708)
++.+||+|||++....... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||............
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 245 (360)
T 3e3p_A 167 ADGTLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245 (360)
T ss_dssp TTTEEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCcEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH
Confidence 8999999999998765433 234457899999999986654 899999999999999999999999753221000000
Q ss_pred ------ccccccc---------ccCCCCCCC----CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 655 ------TDIALDE---------ILDPRLPPP----SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 655 ------~~~~~~~---------~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....... ..+....+. ..........+.+++.+||+.||++|||++|+++|-+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 317 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence 0000000 000000000 0000012446889999999999999999999998865
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.88 Aligned_cols=262 Identities=24% Similarity=0.336 Sum_probs=199.7
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC-----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA----- 508 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~----- 508 (708)
.++|++.+.||+|+||.||+|... +|+.||||++... ........+.+|++++++++||||+++++++..+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 478999999999999999999764 6899999999652 2234466788999999999999999999998664
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
...++||||+. |+|.+++... .+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 67899999997 5999998653 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc----------cccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc-----
Q 039322 589 AKFLKPESSN----------WTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS----- 652 (708)
Q Consensus 589 a~~~~~~~~~----------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~----- 652 (708)
+......... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..........
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 238 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 9876532211 123468999999998754 678999999999999999999999997533110000
Q ss_pred -----------cccccccccccC--CCCCCCC--chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 653 -----------LNTDIALDEILD--PRLPPPS--RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 653 -----------~~~~~~~~~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........+... +..+... .........+.+++.+||+.||++|||++|+++|-+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 000000000000 0000000 001122346789999999999999999999998755
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=347.02 Aligned_cols=262 Identities=19% Similarity=0.267 Sum_probs=183.7
Q ss_pred hccccc-cceeccccCccEEEEEeC---CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee--C
Q 039322 435 TNDFDA-QYCIGNGGHGSVYRAELP---SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH--A 508 (708)
Q Consensus 435 ~~~~~~-~~~ig~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~ 508 (708)
.+.|++ .++||+|+||.||+|... +++.||||++.... ....+.+|++++++++||||+++++++.. +
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS------CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC------CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence 355766 457999999999999864 57889999997532 13457889999999999999999999954 6
Q ss_pred CeeEEEEEeccCCCHHHHhcccc------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee----CCC
Q 039322 509 RHSFLVYELLERGSLAAILSSDT------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL----DLE 578 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----~~~ 578 (708)
...++||||+.+ +|.+++.... ....+++..++.++.||+.||+|||++ ||+||||||+|||+ +.+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTT
T ss_pred CeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCC
Confidence 789999999975 8888875432 122489999999999999999999999 99999999999999 677
Q ss_pred CcEEEeecccccccCCCC---CccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-cc
Q 039322 579 YEAHVADFGIAKFLKPES---SNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS-SL 653 (708)
Q Consensus 579 ~~~kl~Dfg~a~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-~~ 653 (708)
+.+||+|||+|+...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||......... ..
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 899999999998765332 123446789999999998874 4899999999999999999999999643211000 00
Q ss_pred ccccccccc----------------------------cCCCCCCCCchhHH--------HHHHHHHHHHhccCCCCCCCC
Q 039322 654 NTDIALDEI----------------------------LDPRLPPPSRSVQE--------KLISIMEVAFSCLNESPESRP 697 (708)
Q Consensus 654 ~~~~~~~~~----------------------------~~~~~~~~~~~~~~--------~~~~l~~li~~cl~~dP~~RP 697 (708)
.....+..+ ........ .... ....+.+|+.+||+.||++||
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ 326 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNC--SLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI 326 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTC--CHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcc--hhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC
Confidence 000000000 00000000 0000 023577899999999999999
Q ss_pred CHHHHHHHhhC
Q 039322 698 TMKVVTQQVRI 708 (708)
Q Consensus 698 s~~evl~~l~~ 708 (708)
|++|+++|-++
T Consensus 327 ta~e~L~hp~f 337 (405)
T 3rgf_A 327 TSEQAMQDPYF 337 (405)
T ss_dssp CHHHHHTSGGG
T ss_pred CHHHHhcChhh
Confidence 99999998653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=340.17 Aligned_cols=262 Identities=21% Similarity=0.223 Sum_probs=194.9
Q ss_pred HHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC---
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA--- 508 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--- 508 (708)
...++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 4557899999999999999999965 5799999999875321 123699999999999999999998543
Q ss_pred -----------------------------------CeeEEEEEeccCCCHHHHhccc-ccccCCCHHHHHHHHHHHHHHH
Q 039322 509 -----------------------------------RHSFLVYELLERGSLAAILSSD-TAAQELGWSQRMNVIKGVADAL 552 (708)
Q Consensus 509 -----------------------------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l 552 (708)
...++||||+++ +|.+.+... .....+++..++.++.|++.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 348899999985 888777542 2234589999999999999999
Q ss_pred HHHHhCCCCCeEEccCCCCCeeeC-CCCcEEEeecccccccCCCCCccccccccccccCccccccC-CCCcchhHHHHHH
Q 039322 553 SYLHHDCFPPIVHQDISSKNLLLD-LEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGV 630 (708)
Q Consensus 553 ~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~ 630 (708)
+|||++ ||+||||||+||+++ .++.+||+|||+|....... ......+|+.|+|||.+.+. .++.++||||+||
T Consensus 155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 999999 999999999999997 68899999999998765433 23445789999999988765 4899999999999
Q ss_pred HHHHHHhCCCCCCccccccccccc-------cc-------cccccccCCCCCCCCc---hhHHHHHHHHHHHHhccCCCC
Q 039322 631 LVLEAIKGKHPRDFLSLISSSSLN-------TD-------IALDEILDPRLPPPSR---SVQEKLISIMEVAFSCLNESP 693 (708)
Q Consensus 631 ~l~elltg~~p~~~~~~~~~~~~~-------~~-------~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP 693 (708)
++|||++|+.||............ .. .......-+....... .....+..+.+++.+||+.||
T Consensus 231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 999999999999753321100000 00 0000000011100000 000123357899999999999
Q ss_pred CCCCCHHHHHHHhh
Q 039322 694 ESRPTMKVVTQQVR 707 (708)
Q Consensus 694 ~~RPs~~evl~~l~ 707 (708)
++|||+.|+++|-+
T Consensus 311 ~~R~t~~e~l~hp~ 324 (383)
T 3eb0_A 311 DLRINPYEAMAHPF 324 (383)
T ss_dssp GGSCCHHHHHTSGG
T ss_pred hhCCCHHHHhcCHH
Confidence 99999999998754
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=355.00 Aligned_cols=352 Identities=21% Similarity=0.159 Sum_probs=289.7
Q ss_pred CCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEec
Q 039322 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGV 80 (708)
Q Consensus 2 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l 80 (708)
+++++|||++|+|+++.+.+|.++++|++|+|++|+|+++.+.+|.. ++|+.|+|++|.+++..+..|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 47899999999999999999999999999999999999888888875 89999999999999988888999999999999
Q ss_pred cCCccccccCccCcCCCCCcEEEccCCccccc-cccccCCCCCCCEEEcccCcceeeCCCCCCCC---------------
Q 039322 81 SENHFQGTIPKILRNCSSLIRVRLNSNNLTGN-ISEALGIYPNLTFIDLSRNDFYGEISSNWGKC--------------- 144 (708)
Q Consensus 81 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~-~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l--------------- 144 (708)
++|++++..+..|+++++|++|+|++|.++.+ .+..+..+++|++|++++|+++++.+..|..+
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n 211 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 211 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence 99999988788899999999999999999865 46778899999999999998876554332211
Q ss_pred --------------------------------------------------------------------------------
Q 039322 145 -------------------------------------------------------------------------------- 144 (708)
Q Consensus 145 -------------------------------------------------------------------------------- 144 (708)
T Consensus 212 ~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~ 291 (635)
T 4g8a_A 212 PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 291 (635)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECC
T ss_pred cccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhh
Confidence
Q ss_pred ------------------------------------CCCCEEEcccCcccccCCc-------------------cccCCC
Q 039322 145 ------------------------------------PKLGTLNVSMNNITGGIPR-------------------EIGNSS 169 (708)
Q Consensus 145 ------------------------------------~~L~~L~L~~N~i~~~~~~-------------------~~~~l~ 169 (708)
..|+.|++.+|.+....+. .+..++
T Consensus 292 ~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~ 371 (635)
T 4g8a_A 292 DYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP 371 (635)
T ss_dssp CSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCT
T ss_pred cccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCccccccc
Confidence 1233334444333221111 122456
Q ss_pred CCCEEeccccccccc--C-----------------------CcccCCCCCCCEEEccCccccccCC-cccCCCCCCCeEe
Q 039322 170 QLQALDLSLNHIVGE--I-----------------------PKELGKLNSLTELILRGNQFTGRLP-PEIGSLVDLEYLD 223 (708)
Q Consensus 170 ~L~~L~L~~n~l~~~--~-----------------------~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~~~~L~~L~ 223 (708)
+|+.|++++|.+... . +..+..+++|+.+++.+|......+ ..|..+++++.++
T Consensus 372 ~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ 451 (635)
T 4g8a_A 372 SLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 451 (635)
T ss_dssp TCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEE
T ss_pred ccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccccccccccc
Confidence 788888888877421 1 2234556777777777766654433 4577888999999
Q ss_pred ccCCcccccCCCCCCccccceeecccCccc-ccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceeccccccc
Q 039322 224 LSANRFNNSVPENLGNLLKLHYLGLSNNQF-VLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS 302 (708)
Q Consensus 224 l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l-~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 302 (708)
++.|.+.+..+..+..+++|+.|++++|.+ ....|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+
T Consensus 452 ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~ 531 (635)
T 4g8a_A 452 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 531 (635)
T ss_dssp CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred ccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCC
Confidence 999999988888999999999999999975 4457888999999999999999999888999999999999999999999
Q ss_pred CCCCCcccccccccEEecCCCcCCCCCCCc-ccc-ccCcccccccccCcCCCC
Q 039322 303 GSIPNCFEGIRGISVIDISDNQLQGPVPNS-TAF-RNAPVEALKGNKGLCGGV 353 (708)
Q Consensus 303 ~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~-~~~~~~~~~~n~~~c~~~ 353 (708)
+..+..|..+++|+.||+++|++++..|.. ..+ ..++.+.+++|||.|+|.
T Consensus 532 ~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 532 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp BCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 999999999999999999999999988764 334 578999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.85 Aligned_cols=267 Identities=21% Similarity=0.323 Sum_probs=200.4
Q ss_pred HHhccccccceeccccCccEEEEEe--CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc---cCCceeeEEEEEe-
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAEL--PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI---RHRNIVKFYGFCS- 506 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~- 506 (708)
.+.++|++.+.||+|+||.||+|.. .+|+.||+|+++...... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc--cCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 3458899999999999999999976 468899999986422111 1123456677777666 8999999999987
Q ss_pred ----eCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEE
Q 039322 507 ----HARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAH 582 (708)
Q Consensus 507 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~k 582 (708)
.....++||||+. |+|.+++..... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEE
Confidence 4567899999998 599999976442 3489999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc----------
Q 039322 583 VADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS---------- 652 (708)
Q Consensus 583 l~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~---------- 652 (708)
|+|||++...... .......++..|+|||++.+..++.++||||||+++|+|++|+.||..........
T Consensus 161 l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 161 LADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp ECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EecCcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9999999865422 22344678999999999999899999999999999999999999997432110000
Q ss_pred ---cccccc-cccccC-CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 653 ---LNTDIA-LDEILD-PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 653 ---~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...... ...... ....+...........+.+++.+||+.||++|||++|+++|-+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 299 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 000000 000000 0000000111122345789999999999999999999998743
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=341.16 Aligned_cols=254 Identities=23% Similarity=0.339 Sum_probs=188.6
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv 514 (708)
+.|...+.||+|+||+||.+...+|+.||||++.. ...+.+.+|+++++++ +||||+++++++.+++..++|
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~-------~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG-------GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH-------HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 44566788999999999877666899999999864 1245678899999887 899999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccC----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC------------
Q 039322 515 YELLERGSLAAILSSDTAAQE----LGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE------------ 578 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~----l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~------------ 578 (708)
|||+. |+|.+++........ .++..++.++.||+.||+|||++ ||+||||||+||+++.+
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCC
Confidence 99996 699999976542111 13334678999999999999999 99999999999999754
Q ss_pred -CcEEEeecccccccCCCCCc----cccccccccccCcccccc-------CCCCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 039322 579 -YEAHVADFGIAKFLKPESSN----WTEFAGTYGYVAPELAYT-------MKITEKCDVYSFGVLVLEAIK-GKHPRDFL 645 (708)
Q Consensus 579 -~~~kl~Dfg~a~~~~~~~~~----~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ellt-g~~p~~~~ 645 (708)
+.+||+|||++......... .....||+.|+|||++.+ ..++.++|||||||++|||+| |+.||...
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 48999999999877544322 234579999999999865 568899999999999999999 99998632
Q ss_pred ccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 646 SLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.... ............. ...........+.+++.+||+.||++|||+.|+++|-+
T Consensus 244 ~~~~------~~i~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~ 298 (434)
T 2rio_A 244 YSRE------SNIIRGIFSLDEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298 (434)
T ss_dssp TTHH------HHHHHTCCCCCCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred hhhH------HHHhcCCCCcccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence 2110 0111111111100 11112344567889999999999999999999998754
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=335.83 Aligned_cols=336 Identities=20% Similarity=0.185 Sum_probs=271.1
Q ss_pred CCCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEe
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFG 79 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~ 79 (708)
++++++|++++|.++.+.+..|..+++|++|+|++|.+.+..+..+.. ++|+.|++++|.+.+..+..+..+++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 467889999999999888888889999999999999998877777765 7899999999998888888888889999999
Q ss_pred ccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccc
Q 039322 80 VSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITG 159 (708)
Q Consensus 80 l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 159 (708)
+++|.++...+..|.++++|++|++++|.++++.+..|..+++|++|++++|+++.+ .+..+++|+.|++++|.++.
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~ 200 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST 200 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc
Confidence 999999866556678889999999999999888888888899999999999988765 35677889999999988874
Q ss_pred cCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCc
Q 039322 160 GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239 (708)
Q Consensus 160 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~ 239 (708)
. ...++|++|++++|.+... +. ...++|+.|++++|.+++. ..+..+++|++|+|++|.+++..|..|..
T Consensus 201 ~-----~~~~~L~~L~l~~n~l~~~-~~--~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~ 270 (390)
T 3o6n_A 201 L-----AIPIAVEELDASHNSINVV-RG--PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVK 270 (390)
T ss_dssp E-----ECCSSCSEEECCSSCCCEE-EC--CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTT
T ss_pred c-----CCCCcceEEECCCCeeeec-cc--cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccc
Confidence 3 3446789999999988844 32 2347899999999998853 56888889999999999998887888888
Q ss_pred cccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEe
Q 039322 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVID 319 (708)
Q Consensus 240 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~ 319 (708)
+++|+.|+|++|++++ .+..+..+++|+.|++++|+++ ..|..+..+++|+.|++++|+++... +..+++|+.|+
T Consensus 271 l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~ 345 (390)
T 3o6n_A 271 MQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLT 345 (390)
T ss_dssp CSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEE
T ss_pred cccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC---chhhccCCEEE
Confidence 8999999999999885 4555677888999999999888 55666778889999999999988542 66778889999
Q ss_pred cCCCcCCCCCCCccccccCcccccccccCcCCCCCC
Q 039322 320 ISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKG 355 (708)
Q Consensus 320 l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~ 355 (708)
+++|++.+... ...+.......+.+++..|.++..
T Consensus 346 l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~c~~~~~ 380 (390)
T 3o6n_A 346 LSHNDWDCNSL-RALFRNVARPAVDDADQHCKIDYQ 380 (390)
T ss_dssp CCSSCEEHHHH-HHHTTTCCTTTBCCCCSCCCTTCE
T ss_pred cCCCCccchhH-HHHHHHHHhhcccccCceeccccc
Confidence 99998887432 233455566667788888877543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=336.30 Aligned_cols=259 Identities=21% Similarity=0.301 Sum_probs=197.3
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee--
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS-- 511 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~-- 511 (708)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc--cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 36899999999999999999965 468999999997643 2234467889999999999999999999999877654
Q ss_pred ----EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecc
Q 039322 512 ----FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFG 587 (708)
Q Consensus 512 ----~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 587 (708)
++||||+. ++|.+++. ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred ceeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999997 58888873 2389999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc-------ccc---
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL-------NTD--- 656 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-------~~~--- 656 (708)
+++..... .....+|+.|+|||++.+ ..++.++||||+|+++|+|++|+.||........... ...
T Consensus 190 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 190 LARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp CC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence 99865432 334578999999999877 6789999999999999999999999974321100000 000
Q ss_pred -----c----ccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 657 -----I----ALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 657 -----~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. .......................+.+++.+||+.||++|||++|+++|-+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 0 00000000000000000112346889999999999999999999998854
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=342.42 Aligned_cols=256 Identities=19% Similarity=0.291 Sum_probs=201.2
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccC-CceeeEEEEEeeCCeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH-RNIVKFYGFCSHARHSF 512 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~~~~ 512 (708)
.++|++.+.||+|+||.||+|.. .+++.||||++..... ..++..|+++++.++| +++..+..++...+..+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS------SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc------cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 47899999999999999999975 5789999998765322 2347789999999976 66777777778888999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee---CCCCcEEEeecccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL---DLEYEAHVADFGIA 589 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a 589 (708)
+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 80 lvme~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 999999 899999997433 4589999999999999999999999 99999999999999 58899999999999
Q ss_pred cccCCCCCc-------cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 039322 590 KFLKPESSN-------WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEI 662 (708)
Q Consensus 590 ~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 662 (708)
+.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~-----~~~~~~i 228 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-----KQKYEKI 228 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH-----HHHHHHH
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH-----HHHHHHH
Confidence 876544322 1256789999999999999999999999999999999999999975322110 0001111
Q ss_pred cCCCCCCCC-chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 663 LDPRLPPPS-RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 663 ~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......... ......+.++.+++.+||+.||++||++++|++.|+
T Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~ 274 (483)
T 3sv0_A 229 SEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR 274 (483)
T ss_dssp HHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred hhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 000000000 000112346889999999999999999999998875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=332.74 Aligned_cols=254 Identities=22% Similarity=0.318 Sum_probs=196.3
Q ss_pred HhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
..++|++.+.||+|+||.||+|.... .||+|+++.... .....+.+.+|++++++++||||+++++++.+++..++
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSC--CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCC--CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 34789999999999999999998753 499999875322 11233457789999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++++|.+++.... ..+++..++.++.|++.||+|||++ |++||||||+||+++ ++.+||+|||++....
T Consensus 107 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp ECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred EeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 999999999999997543 4588999999999999999999999 999999999999998 6899999999987543
Q ss_pred CC-----CCccccccccccccCcccccc---------CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccc
Q 039322 594 PE-----SSNWTEFAGTYGYVAPELAYT---------MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIAL 659 (708)
Q Consensus 594 ~~-----~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 659 (708)
.. ........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~ 252 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--------AII 252 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--------HHH
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHH
Confidence 21 122234568999999998864 34788999999999999999999999743211 111
Q ss_pred ccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 660 DEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+.....+.... ...+..+.+++.+||+.||++|||++++++.|+
T Consensus 253 ~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~ 298 (319)
T 2y4i_B 253 WQMGTGMKPNLSQ--IGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298 (319)
T ss_dssp HHHHTTCCCCCCC--SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHT
T ss_pred HHhccCCCCCCCc--CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 1111111110000 011224788999999999999999999999885
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=356.04 Aligned_cols=255 Identities=22% Similarity=0.340 Sum_probs=201.0
Q ss_pred HHhccccccceeccccCccEEEEEeC----CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAELP----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA 508 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 508 (708)
...++|++.+.||+|+||.||+|... .+..||+|.++... .....+.+.+|+.++++++||||+++++++. +
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 34577899999999999999999763 24679999987532 2344578999999999999999999999985 4
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCC
Confidence 56899999999999999997543 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC
Q 039322 589 AKFLKPESSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPR 666 (708)
Q Consensus 589 a~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (708)
++........ .....+++.|+|||++.+..++.++||||||+++|||++ |..||...... .....+....
T Consensus 538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--------~~~~~i~~~~ 609 (656)
T 2j0j_A 538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIENGE 609 (656)
T ss_dssp CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHHTC
T ss_pred CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHcCC
Confidence 9876543222 233456789999999998899999999999999999997 99998743221 1111111111
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 667 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+.+. ..+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 610 ~~~~~~---~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~ 647 (656)
T 2j0j_A 610 RLPMPP---NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647 (656)
T ss_dssp CCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCc---cccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 111111 12235888999999999999999999999874
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=351.13 Aligned_cols=322 Identities=20% Similarity=0.238 Sum_probs=268.4
Q ss_pred CCCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCC-CCccccCCCCccEEe
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSY-LPHNVCRGGALQYFG 79 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~-~~~~~~~l~~L~~L~ 79 (708)
+++|++|+|++|+|+++.|+.|.++++|++|+|++|+|+. +|.. ..++|+.|++++|.+.+. .|..+..+++|++|+
T Consensus 75 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~-~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~ 152 (562)
T 3a79_B 75 LSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-ISCC-PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLG 152 (562)
T ss_dssp CTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCE-ECSC-CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEE
T ss_pred CCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCc-cCcc-ccccCCEEECCCCCccccCchHhhcccCcccEEe
Confidence 5789999999999999999999999999999999999985 4444 668999999999999985 468999999999999
Q ss_pred ccCCccccccCccCcCCCCC--cEEEccCCcc--ccccccccCCCC----------------------------------
Q 039322 80 VSENHFQGTIPKILRNCSSL--IRVRLNSNNL--TGNISEALGIYP---------------------------------- 121 (708)
Q Consensus 80 l~~n~i~~~~~~~~~~l~~L--~~L~l~~n~i--~~~~~~~~~~~~---------------------------------- 121 (708)
+++|.+++. .+..+++| ++|++++|.+ ++..+..|..+.
T Consensus 153 L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~ 229 (562)
T 3a79_B 153 LSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229 (562)
T ss_dssp EECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEE
T ss_pred cCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEeccc
Confidence 999999863 45666666 9999999998 655555554432
Q ss_pred -----------------------------------------------CCCEEEcccCcceeeCCCCC-----CCC-----
Q 039322 122 -----------------------------------------------NLTFIDLSRNDFYGEISSNW-----GKC----- 144 (708)
Q Consensus 122 -----------------------------------------------~L~~L~l~~n~l~~~~~~~~-----~~l----- 144 (708)
+|++|++++|.+++..+..+ ..+
T Consensus 230 ~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~ 309 (562)
T 3a79_B 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMI 309 (562)
T ss_dssp CCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEE
T ss_pred ccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheeh
Confidence 67788888888875555544 222
Q ss_pred ---------------------CCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCc
Q 039322 145 ---------------------PKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGN 203 (708)
Q Consensus 145 ---------------------~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 203 (708)
.+|+.|++++|.+.... .+..+++|++|++++|++++..|..+.++++|++|+|++|
T Consensus 310 ~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 387 (562)
T 3a79_B 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387 (562)
T ss_dssp EEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSS
T ss_pred hhcccceeecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCC
Confidence 34777778888775322 2268899999999999999888999999999999999999
Q ss_pred cccccC--CcccCCCCCCCeEeccCCcccccCC-CCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCC
Q 039322 204 QFTGRL--PPEIGSLVDLEYLDLSANRFNNSVP-ENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGE 280 (708)
Q Consensus 204 ~l~~~~--~~~~~~~~~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~ 280 (708)
++++.. |..+..+++|++|++++|++++..| ..+..+++|+.|++++|++++..|..+. ++|+.|+|++|+|+ .
T Consensus 388 ~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ 464 (562)
T 3a79_B 388 GLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-S 464 (562)
T ss_dssp CCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-C
T ss_pred CcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-c
Confidence 999633 4578999999999999999997444 5688999999999999999876655443 69999999999999 6
Q ss_pred CchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCCCc
Q 039322 281 IPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNS 332 (708)
Q Consensus 281 ~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~ 332 (708)
+|..+..+++|+.|++++|++++..+..+..+++|+.|++++|++.|.++..
T Consensus 465 ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~ 516 (562)
T 3a79_B 465 IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGI 516 (562)
T ss_dssp CCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHHH
T ss_pred cChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcchH
Confidence 6666669999999999999999655555999999999999999999987654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=331.96 Aligned_cols=200 Identities=24% Similarity=0.297 Sum_probs=170.5
Q ss_pred HhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CC-----ceeeEEEEEe
Q 039322 434 ATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HR-----NIVKFYGFCS 506 (708)
Q Consensus 434 ~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~l~~~~~ 506 (708)
..++|++.+.||+|+||.||+|... +++.||||+++.. .....++..|+++++.++ |+ +|+++++++.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 3578999999999999999999654 6889999999742 234566788888888885 44 4999999999
Q ss_pred eCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC--CCCcEEEe
Q 039322 507 HARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD--LEYEAHVA 584 (708)
Q Consensus 507 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~ 584 (708)
..+..++||||+. |+|.+++..... ..+++..++.++.|++.||+|||++ ..||+||||||+||+++ .++.+||+
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999996 499999976542 3489999999999999999999952 12999999999999995 46789999
Q ss_pred ecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 039322 585 DFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDF 644 (708)
Q Consensus 585 Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~ 644 (708)
|||+++..... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 204 DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 204 DFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999876432 2346789999999999999999999999999999999999999974
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=352.22 Aligned_cols=264 Identities=25% Similarity=0.308 Sum_probs=202.6
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee------
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH------ 507 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~------ 507 (708)
.++|++.+.||+|+||.||+|.. .+|+.||||+++... .....+.+.+|++++++++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC---CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 37899999999999999999965 468999999987632 23456789999999999999999999999765
Q ss_pred CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc---EEEe
Q 039322 508 ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYE---AHVA 584 (708)
Q Consensus 508 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~---~kl~ 584 (708)
++..++||||+++|+|.+++........+++..++.++.|++.||+|||+. ||+||||||+||+++.++. +||+
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence 677899999999999999998766555689999999999999999999999 9999999999999997765 9999
Q ss_pred ecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccc-cc-----------c
Q 039322 585 DFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLIS-SS-----------S 652 (708)
Q Consensus 585 Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~-~~-----------~ 652 (708)
|||++....... ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||....... .. .
T Consensus 167 DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 167 DLGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245 (676)
T ss_dssp SCCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred cccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence 999998765433 3345678999999999999999999999999999999999999996421100 00 0
Q ss_pred cccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 653 LNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
...............+.+..........+.+++.+||+.||++|||++|++++
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h 298 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV 298 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC
Confidence 00000000011111222222233345678899999999999999999886654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.39 Aligned_cols=259 Identities=25% Similarity=0.251 Sum_probs=193.2
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC------
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA------ 508 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------ 508 (708)
.+|+..+.||+|+||.||+|... +|+.||||++..... .+.+|++++++++||||+++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 57999999999999999999764 689999999865321 123699999999999999999998542
Q ss_pred CeeEEEEEeccCCCHHHHhccc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC-CcEEEeec
Q 039322 509 RHSFLVYELLERGSLAAILSSD-TAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE-YEAHVADF 586 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Df 586 (708)
...++||||+++ ++.+.+... .....+++..++.++.||++||+|||++ ||+||||||+|||++.+ +.+||+||
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DF 201 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDF 201 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccc
Confidence 236799999986 666665432 2235689999999999999999999999 99999999999999965 56899999
Q ss_pred ccccccCCCCCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc-------ccccc
Q 039322 587 GIAKFLKPESSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL-------NTDIA 658 (708)
Q Consensus 587 g~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-------~~~~~ 658 (708)
|+++...... ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||........... .....
T Consensus 202 G~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 202 GSAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp TTCEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9998765432 23445789999999998765 689999999999999999999999975332110000 00000
Q ss_pred -------cccccCCCCCCCCc---hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 659 -------LDEILDPRLPPPSR---SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 659 -------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+..+....... ........+.+|+.+||+.||++|||+.|+++|-+
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 00111111111000 00011346889999999999999999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=329.80 Aligned_cols=258 Identities=25% Similarity=0.351 Sum_probs=179.9
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHH-HHHhccCCceeeEEEEEeeCCeeEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVK-ALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
++|+..+.||+|+||.||+|.. .+|+.||||+++... ......++..|+. +++.++||||+++++++..++..++
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 7899999999999999999976 478999999997642 2233445566666 6777899999999999999999999
Q ss_pred EEEeccCCCHHHHhcccc--cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 514 VYELLERGSLAAILSSDT--AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
||||+++ +|.+++.... ....+++..+..++.|++.||+|||+.. |++||||||+||+++.++.+||+|||++..
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 9999986 8888775311 1345899999999999999999999953 899999999999999999999999999986
Q ss_pred cCCCCCccccccccccccCcccc----ccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 039322 592 LKPESSNWTEFAGTYGYVAPELA----YTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
..... ......|++.|+|||++ .+..++.++||||||+++|+|++|+.||...... ............
T Consensus 176 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~ 247 (327)
T 3aln_A 176 LVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-------FDQLTQVVKGDP 247 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCC
T ss_pred ccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-------HHHHHHHhcCCC
Confidence 64332 22344789999999998 4566889999999999999999999999742211 011111111111
Q ss_pred CC-CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PP-PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+. ...........+.+++.+||+.||++|||++|++++-+
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 10 00001112335889999999999999999999988754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=339.29 Aligned_cols=251 Identities=21% Similarity=0.295 Sum_probs=188.0
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~l 513 (708)
..+|...+.||+|+||+||.....+|+.||||++.... ...+.+|+++++++ +||||+++++++.+++..++
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC-------FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT-------EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 35799999999999999766655679999999987532 12245799999999 79999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC-----CcEEEeeccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE-----YEAHVADFGI 588 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfg~ 588 (708)
||||+. |+|.+++.... ....+..++.++.|++.||+|||++ +|+||||||+||+++.+ ..+||+|||+
T Consensus 96 v~E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EEECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EEECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 999996 59999997654 2244456789999999999999999 99999999999999532 3588999999
Q ss_pred ccccCCCCC---ccccccccccccCccccc---cCCCCcchhHHHHHHHHHHHHh-CCCCCCcccccccccccccccccc
Q 039322 589 AKFLKPESS---NWTEFAGTYGYVAPELAY---TMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDE 661 (708)
Q Consensus 589 a~~~~~~~~---~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 661 (708)
|........ ......||+.|+|||++. ...++.++||||+||++|||++ |..||...... ....
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---------~~~~ 240 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---------QANI 240 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---------HHHH
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---------HHHH
Confidence 987654321 234467999999999987 4567789999999999999999 99998532110 0011
Q ss_pred ccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 662 ILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...................+.+++.+||+.||++|||++|+++|-+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~ 286 (432)
T 3p23_A 241 LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286 (432)
T ss_dssp HTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTT
T ss_pred HhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcc
Confidence 1111100111111223345778999999999999999999998754
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=359.95 Aligned_cols=340 Identities=22% Similarity=0.270 Sum_probs=292.2
Q ss_pred CCCCcEEECCCCcccc-----------------cCCcccc--CCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCC
Q 039322 1 MRSLSILDLNQNQFKG-----------------VLPPSVS--NLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNH 60 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~-----------------~~~~~~~--~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~ 60 (708)
|++|++|+|++|+|++ ..|..++ ++++|++|+|++|.+.+.+|..+.. ++|+.|++++|.
T Consensus 447 L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 5799999999999998 2788877 9999999999999999999988765 899999999998
Q ss_pred -ccC-CCCccccCC-------CCccEEeccCCccccccCc--cCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcc
Q 039322 61 -FTS-YLPHNVCRG-------GALQYFGVSENHFQGTIPK--ILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLS 129 (708)
Q Consensus 61 -~~~-~~~~~~~~l-------~~L~~L~l~~n~i~~~~~~--~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~ 129 (708)
+++ .+|..+..+ ++|++|+|++|+++ .+|. .|.++++|++|+|++|+++.++ .|..+++|++|+|+
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~~lp--~~~~L~~L~~L~Ls 603 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRHLE--AFGTNVKLTDLKLD 603 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCCBCC--CCCTTSEESEEECC
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcccch--hhcCCCcceEEECc
Confidence 877 677766555 49999999999999 7888 8999999999999999999544 89999999999999
Q ss_pred cCcceeeCCCCCCCCCC-CCEEEcccCcccccCCccccCCCC--CCEEecccccccccCCcc---cC--CCCCCCEEEcc
Q 039322 130 RNDFYGEISSNWGKCPK-LGTLNVSMNNITGGIPREIGNSSQ--LQALDLSLNHIVGEIPKE---LG--KLNSLTELILR 201 (708)
Q Consensus 130 ~n~l~~~~~~~~~~l~~-L~~L~L~~N~i~~~~~~~~~~l~~--L~~L~L~~n~l~~~~~~~---~~--~l~~L~~L~l~ 201 (708)
+|+++ ..+..+..+++ |+.|+|++|.|+ .+|..+..++. |+.|+|++|++.+.+|.. +. .+++|+.|+|+
T Consensus 604 ~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls 681 (876)
T 4ecn_A 604 YNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLS 681 (876)
T ss_dssp SSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECC
T ss_pred CCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEcc
Confidence 99999 56667899999 999999999999 67788877754 999999999998765532 22 34689999999
Q ss_pred CccccccCCcc-cCCCCCCCeEeccCCcccccCCCCC-C-------ccccceeecccCcccccCCChhhh--hhcccchh
Q 039322 202 GNQFTGRLPPE-IGSLVDLEYLDLSANRFNNSVPENL-G-------NLLKLHYLGLSNNQFVLELPKELE--KLVQLSEL 270 (708)
Q Consensus 202 ~n~l~~~~~~~-~~~~~~L~~L~l~~N~i~~~~~~~~-~-------~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L 270 (708)
+|.++ .+|.. +..+++|+.|+|++|+|+ .+|..+ . ++++|+.|+|++|+|+ .+|..+. .+++|+.|
T Consensus 682 ~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L 758 (876)
T 4ecn_A 682 YNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNM 758 (876)
T ss_dssp SSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEE
T ss_pred CCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEE
Confidence 99999 45554 458899999999999999 455443 3 2349999999999999 6777776 89999999
Q ss_pred hcccccCCCCCchhhcCcccCCceeccc------ccccCCCCCcccccccccEEecCCCcCCCCCCCccccccCcccccc
Q 039322 271 DASHNLFGGEIPFQICSLKSLEKLNLSH------NNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALK 344 (708)
Q Consensus 271 ~ls~N~i~~~~~~~~~~~~~L~~L~l~~------N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~ 344 (708)
+|++|.|++ +|..+..+++|+.|+|++ |++.+.+|..+..+++|+.|++++|++ +.+|.. ..+.++.+.++
T Consensus 759 ~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~-l~~~L~~LdLs 835 (876)
T 4ecn_A 759 DVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEK-LTPQLYILDIA 835 (876)
T ss_dssp ECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCSSSCEEECC
T ss_pred EeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHh-hcCCCCEEECC
Confidence 999999996 688889999999999976 888889999999999999999999999 555553 23688999999
Q ss_pred cccCcCC
Q 039322 345 GNKGLCG 351 (708)
Q Consensus 345 ~n~~~c~ 351 (708)
+|++..-
T Consensus 836 ~N~l~~i 842 (876)
T 4ecn_A 836 DNPNISI 842 (876)
T ss_dssp SCTTCEE
T ss_pred CCCCCcc
Confidence 9987553
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.59 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=200.8
Q ss_pred HHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcc--hhHhHHHHHHHHHHHHhcc--CCceeeEEEEEee
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCD--QIADQKEFLIEVKALTEIR--HRNIVKFYGFCSH 507 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~--h~~iv~l~~~~~~ 507 (708)
...++|++.+.||+|+||.||+|.. .+++.||||.+....... .......+.+|+.++++++ |+||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457899999999999999999964 578999999987532111 0112345677999999996 5999999999999
Q ss_pred CCeeEEEEEeccC-CCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC-CCCcEEEee
Q 039322 508 ARHSFLVYELLER-GSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD-LEYEAHVAD 585 (708)
Q Consensus 508 ~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~kl~D 585 (708)
++..++|+|++.+ ++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+||+++ .++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999986 8999999653 3489999999999999999999999 999999999999999 789999999
Q ss_pred cccccccCCCCCccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC
Q 039322 586 FGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD 664 (708)
Q Consensus 586 fg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 664 (708)
||++...... ......|++.|+|||++.+..+ +.++||||||+++|||++|+.||+...... .
T Consensus 194 fg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----------~---- 257 (320)
T 3a99_A 194 FGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----------R---- 257 (320)
T ss_dssp CTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----------H----
T ss_pred Cccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh----------c----
Confidence 9999876532 2344578999999999887665 678999999999999999999997432110 0
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 665 PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 665 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+.. .+..+.+++.+||+.||++|||++|++++-+
T Consensus 258 ~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 258 GQVFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp CCCCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred cccccccc----CCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 00000101 1235789999999999999999999998754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=329.58 Aligned_cols=258 Identities=21% Similarity=0.305 Sum_probs=196.3
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe----
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH---- 510 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~---- 510 (708)
++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 6899999999999999999965 468999999997643 223446778999999999999999999999987654
Q ss_pred --eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 511 --SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 511 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
.++||||+. |+|.+++. ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 58888774 2389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc-------c------
Q 039322 589 AKFLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL-------N------ 654 (708)
Q Consensus 589 a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-------~------ 654 (708)
+...... .....+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||........... .
T Consensus 173 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 173 ARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp TTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred ccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9865422 234578999999998876 6788999999999999999999999975331100000 0
Q ss_pred --ccc----ccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 655 --TDI----ALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 655 --~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
... .......................+.+++.+||+.||++|||++|+++|-+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 000 00000000000000011122346889999999999999999999998754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.98 Aligned_cols=260 Identities=19% Similarity=0.257 Sum_probs=199.9
Q ss_pred hccccccceeccccCccEEEEEeC-CC-cEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCc------eeeEEEEEe
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SG-QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN------IVKFYGFCS 506 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~l~~~~~ 506 (708)
.++|++.+.||+|+||.||+|... ++ +.||+|+++.. ....+.+.+|++++++++|++ ++.+++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 378999999999999999999753 34 68999999752 244667889999999998765 999999999
Q ss_pred eCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee-----------
Q 039322 507 HARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL----------- 575 (708)
Q Consensus 507 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill----------- 575 (708)
..+..++||||+ ++++.+++..... ..+++..++.++.|++.||+|||++ ||+||||||+||++
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECC
T ss_pred eCCeEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccc
Confidence 999999999999 5677777755432 4589999999999999999999999 99999999999999
Q ss_pred --------CCCCcEEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 039322 576 --------DLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSL 647 (708)
Q Consensus 576 --------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~ 647 (708)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 56789999999999865432 2345789999999999998999999999999999999999999974321
Q ss_pred ccccc-------ccccccc------ccccCCC--CC-----------------CCCchhHHHHHHHHHHHHhccCCCCCC
Q 039322 648 ISSSS-------LNTDIAL------DEILDPR--LP-----------------PPSRSVQEKLISIMEVAFSCLNESPES 695 (708)
Q Consensus 648 ~~~~~-------~~~~~~~------~~~~~~~--~~-----------------~~~~~~~~~~~~l~~li~~cl~~dP~~ 695 (708)
..... ....... ....... .. ............+.+++.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 10000 0000000 0000000 00 000011123446889999999999999
Q ss_pred CCCHHHHHHHhh
Q 039322 696 RPTMKVVTQQVR 707 (708)
Q Consensus 696 RPs~~evl~~l~ 707 (708)
|||++|+++|-+
T Consensus 325 Rpt~~e~l~hp~ 336 (355)
T 2eu9_A 325 RITLAEALLHPF 336 (355)
T ss_dssp SCCHHHHTTSGG
T ss_pred CcCHHHHhcChh
Confidence 999999998754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=332.86 Aligned_cols=260 Identities=20% Similarity=0.247 Sum_probs=199.1
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-----------CCceeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-----------HRNIVKFYG 503 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~l~~ 503 (708)
++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++ |+||+++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 6899999999999999999965 57899999998752 234567888999998886 899999999
Q ss_pred EEeeCC----eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC---
Q 039322 504 FCSHAR----HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD--- 576 (708)
Q Consensus 504 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--- 576 (708)
++...+ ..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+++ ||+||||||+||+++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence 997654 789999999 8899999976442 34899999999999999999999953 899999999999994
Q ss_pred ---CCCcEEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc
Q 039322 577 ---LEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL 653 (708)
Q Consensus 577 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~ 653 (708)
..+.+||+|||++...... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999866432 2345789999999999998999999999999999999999999974321100000
Q ss_pred c-----------------------------cccccccccCCCCC-------CCCchhHHHHHHHHHHHHhccCCCCCCCC
Q 039322 654 N-----------------------------TDIALDEILDPRLP-------PPSRSVQEKLISIMEVAFSCLNESPESRP 697 (708)
Q Consensus 654 ~-----------------------------~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~RP 697 (708)
. .......+...... ............+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 0 00000000000000 00011234566789999999999999999
Q ss_pred CHHHHHHHhh
Q 039322 698 TMKVVTQQVR 707 (708)
Q Consensus 698 s~~evl~~l~ 707 (708)
|++|+++|-+
T Consensus 327 t~~ell~hp~ 336 (373)
T 1q8y_A 327 DAGGLVNHPW 336 (373)
T ss_dssp CHHHHHTCGG
T ss_pred CHHHHhhChh
Confidence 9999998755
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=346.55 Aligned_cols=347 Identities=23% Similarity=0.241 Sum_probs=307.9
Q ss_pred CCCcEEECCCCcccccCCccccCCCC--CCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEE
Q 039322 2 RSLSILDLNQNQFKGVLPPSVSNLTN--LKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYF 78 (708)
Q Consensus 2 ~~L~~L~l~~n~i~~~~~~~~~~l~~--L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L 78 (708)
++|+.|+|++|+++++.+..|.+++. |++|+|++|++.+..+..+.. ++|+.|++++|.+.+..+..+..+++|++|
T Consensus 222 ~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 301 (680)
T 1ziw_A 222 TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301 (680)
T ss_dssp SCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEE
T ss_pred ccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEE
Confidence 57899999999999999999988865 999999999999888888865 899999999999999999999999999999
Q ss_pred eccCCcccc-----ccC----ccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcc--eeeCCCCCCCC--C
Q 039322 79 GVSENHFQG-----TIP----KILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDF--YGEISSNWGKC--P 145 (708)
Q Consensus 79 ~l~~n~i~~-----~~~----~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l--~~~~~~~~~~l--~ 145 (708)
++++|...+ .+| ..|..+++|++|++++|.++++.+..|..+++|++|++++|.+ ..+....|..+ +
T Consensus 302 ~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~ 381 (680)
T 1ziw_A 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381 (680)
T ss_dssp ECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTS
T ss_pred eccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccC
Confidence 999876543 222 3788999999999999999999999999999999999999974 45555566544 5
Q ss_pred CCCEEEcccCcccccCCccccCCCCCCEEecccccccccCC-cccCCCCCCCEEEccCccccccCCcccCCCCCCCeEec
Q 039322 146 KLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIP-KELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDL 224 (708)
Q Consensus 146 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l 224 (708)
+|+.|++++|++++..+..|..+++|++|+|++|++.+.++ ..+.++++|++|++++|++++..+..|..+++|+.|++
T Consensus 382 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l 461 (680)
T 1ziw_A 382 PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLML 461 (680)
T ss_dssp CCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEEC
T ss_pred cCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchh
Confidence 89999999999999999999999999999999999987555 68999999999999999999888999999999999999
Q ss_pred cCCccc--ccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCc--------hhhcCcccCCce
Q 039322 225 SANRFN--NSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIP--------FQICSLKSLEKL 294 (708)
Q Consensus 225 ~~N~i~--~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~--------~~~~~~~~L~~L 294 (708)
++|.++ +..|..|..+++|+.|++++|++++..+..|.++++|+.|++++|.+++..+ ..+..+++|+.|
T Consensus 462 ~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L 541 (680)
T 1ziw_A 462 RRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHIL 541 (680)
T ss_dssp TTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEE
T ss_pred ccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEE
Confidence 999987 5678889999999999999999998888889999999999999999986422 237889999999
Q ss_pred ecccccccCCCCCcccccccccEEecCCCcCCCCCCCc-cccccCcccccccccC
Q 039322 295 NLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNS-TAFRNAPVEALKGNKG 348 (708)
Q Consensus 295 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~ 348 (708)
+|++|+++.+.+..|.++++|+.|++++|.+++.++.. ..++.++.+.+.+|..
T Consensus 542 ~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l 596 (680)
T 1ziw_A 542 NLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596 (680)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred ECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcC
Confidence 99999999777778999999999999999999877764 4667889999998854
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=324.48 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=193.4
Q ss_pred HHHHhccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcch--hHhHHHHHHHHHHHHhc----cCCceeeEEE
Q 039322 431 IVRATNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQ--IADQKEFLIEVKALTEI----RHRNIVKFYG 503 (708)
Q Consensus 431 ~~~~~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~~e~~~l~~l----~h~~iv~l~~ 503 (708)
.....++|++.+.||+|+||.||+|.. .+++.||||++........ ......+.+|+++++++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344467899999999999999999965 4688999999976322111 12234566799999998 8999999999
Q ss_pred EEeeCCeeEEEEEe-ccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC-CCCcE
Q 039322 504 FCSHARHSFLVYEL-LERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD-LEYEA 581 (708)
Q Consensus 504 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~-~~~~~ 581 (708)
++...+..++|+|+ +.+++|.+++.... .+++..++.++.|++.||+|||++ |++||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 99999999999999 78899999997543 489999999999999999999999 999999999999999 88999
Q ss_pred EEeecccccccCCCCCccccccccccccCccccccCCCC-cchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 039322 582 HVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKIT-EKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALD 660 (708)
Q Consensus 582 kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 660 (708)
||+|||++...... ......|+..|+|||++.+..+. .++||||||+++|||++|+.||+.....
T Consensus 180 kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------------ 245 (312)
T 2iwi_A 180 KLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI------------ 245 (312)
T ss_dssp EECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------
T ss_pred EEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH------------
Confidence 99999999876533 23455689999999998877664 4899999999999999999998742211
Q ss_pred cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 661 EILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.......+.. ....+.+++.+||+.||++|||++|++++-++
T Consensus 246 --~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~ 287 (312)
T 2iwi_A 246 --LEAELHFPAH----VSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287 (312)
T ss_dssp --HHTCCCCCTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred --hhhccCCccc----CCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 0011111111 12357889999999999999999999997653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=324.42 Aligned_cols=256 Identities=20% Similarity=0.292 Sum_probs=180.9
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|... +|+.||||++.... ........+.++..+++.++||||+++++++..++..++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS--CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 478999999999999999999764 78999999997632 122233445555567888899999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH-DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
||||+ ++.+..+.... ...+++..++.++.|++.||+|||+ . |++||||||+||+++.++.+||+|||++...
T Consensus 102 v~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp EECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 99999 44565555432 2458999999999999999999998 5 8999999999999999999999999999765
Q ss_pred CCCCCccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 039322 593 KPESSNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
.... ......+++.|+|||++. ...++.++||||||+++|||++|+.||...... ............
T Consensus 176 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~ 247 (318)
T 2dyl_A 176 VDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-------FEVLTKVLQEEP 247 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHHHHHHSCC
T ss_pred cCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-------HHHHHHHhccCC
Confidence 4332 234457899999999984 456888999999999999999999998742110 111111111111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+..+ .....+..+.+++.+||+.||++|||++|+++|-+
T Consensus 248 ~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 248 PLLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp CCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred CCCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 1000 00012235888999999999999999999998743
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=347.11 Aligned_cols=336 Identities=20% Similarity=0.182 Sum_probs=282.0
Q ss_pred CCCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEe
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFG 79 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~ 79 (708)
+++++.|++++|.++.+.+..|.++++|++|+|++|.|.+..+..+.. ++|+.|++++|.+++..|..|+.+++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 367899999999999888888899999999999999999888877765 7899999999999998888889999999999
Q ss_pred ccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccc
Q 039322 80 VSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITG 159 (708)
Q Consensus 80 l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 159 (708)
|++|.+++..+..|.++++|++|+|++|.++++.+..|..+++|++|+|++|.++++. +..+++|+.|++++|.+++
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~ 206 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST 206 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc
Confidence 9999999776677899999999999999999988889999999999999999988653 5677899999999998874
Q ss_pred cCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCc
Q 039322 160 GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239 (708)
Q Consensus 160 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~ 239 (708)
. ...++|+.|++++|.+....+. + .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|..|..
T Consensus 207 l-----~~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 276 (597)
T 3oja_B 207 L-----AIPIAVEELDASHNSINVVRGP-V--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVK 276 (597)
T ss_dssp E-----ECCTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTT
T ss_pred c-----cCCchhheeeccCCcccccccc-c--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcC
Confidence 3 4456899999999998844332 2 3689999999999985 367888999999999999999888888999
Q ss_pred cccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEe
Q 039322 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVID 319 (708)
Q Consensus 240 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~ 319 (708)
+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|++++.. +..+++|+.|+
T Consensus 277 l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~ 351 (597)
T 3oja_B 277 MQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLT 351 (597)
T ss_dssp CSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEE
T ss_pred ccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEE
Confidence 9999999999999985 4556677889999999999998 56777888999999999999998553 56778999999
Q ss_pred cCCCcCCCCCCCccccccCcccccccccCcCCCCCC
Q 039322 320 ISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKG 355 (708)
Q Consensus 320 l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~ 355 (708)
+++|++.|... ...+.......+.+++..|+.+..
T Consensus 352 l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~C~~~~~ 386 (597)
T 3oja_B 352 LSHNDWDCNSL-RALFRNVARPAVDDADQHCKIDYQ 386 (597)
T ss_dssp CCSSCEEHHHH-HHHTTTCCTTTBCCCCCCCCTTCE
T ss_pred eeCCCCCChhH-HHHHHHHhhhccccccccCCcchh
Confidence 99999987642 233455566667888888887543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=354.63 Aligned_cols=338 Identities=19% Similarity=0.230 Sum_probs=254.1
Q ss_pred CCcEEECCCCcccccCCccccCCCCCCEEEe-eCceeeee----------------------------------------
Q 039322 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVL-LYNNLSGF---------------------------------------- 41 (708)
Q Consensus 3 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L-~~n~i~~~---------------------------------------- 41 (708)
.++.|+|++|++++..|..|++|++|++|+| ++|.+.+.
T Consensus 324 ~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l 403 (876)
T 4ecn_A 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDL 403 (876)
T ss_dssp CEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHH
T ss_pred CEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHH
Confidence 5788999999999889999999999999999 77654333
Q ss_pred ------------------------------------CCCCCCC-CCcccccccCCCccC-----------------CCCc
Q 039322 42 ------------------------------------IPPSLEN-PMLTRPGLDFNHFTS-----------------YLPH 67 (708)
Q Consensus 42 ------------------------------------~~~~~~~-~~l~~l~l~~n~~~~-----------------~~~~ 67 (708)
+|..+.. ++|+.|+|++|.+++ .+|.
T Consensus 404 ~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~ 483 (876)
T 4ecn_A 404 LQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE 483 (876)
T ss_dssp HHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS
T ss_pred HHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCCh
Confidence 4444443 678888888888877 3777
Q ss_pred ccc--CCCCccEEeccCCccccccCccCcCCCCCcEEEccCCc-ccc-cccccc-------CCCCCCCEEEcccCcceee
Q 039322 68 NVC--RGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNN-LTG-NISEAL-------GIYPNLTFIDLSRNDFYGE 136 (708)
Q Consensus 68 ~~~--~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~-i~~-~~~~~~-------~~~~~L~~L~l~~n~l~~~ 136 (708)
.++ .+++|++|+|++|.+.+.+|..|.++++|++|+|++|+ +++ ..|..+ ..+++|++|+|++|+++ .
T Consensus 484 ~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ 562 (876)
T 4ecn_A 484 ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-E 562 (876)
T ss_dssp CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-B
T ss_pred hhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-c
Confidence 776 88888888888888887888888888888888888887 776 444433 34458888888888887 4
Q ss_pred CCC--CCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCC-CCEEEccCccccccCCccc
Q 039322 137 ISS--NWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNS-LTELILRGNQFTGRLPPEI 213 (708)
Q Consensus 137 ~~~--~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~ 213 (708)
.|. .|..+++|+.|+|++|+++ .+| .|..+++|+.|+|++|+++ .+|..+..+++ |++|+|++|.++ .+|..+
T Consensus 563 ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~ 638 (876)
T 4ecn_A 563 FPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIF 638 (876)
T ss_dssp CCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCC
T ss_pred cCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhh
Confidence 455 6778888888888888887 555 7788888888888888887 67777778877 888888888888 667776
Q ss_pred CCCCC--CCeEeccCCcccccCCCCC---C--ccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhc
Q 039322 214 GSLVD--LEYLDLSANRFNNSVPENL---G--NLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQIC 286 (708)
Q Consensus 214 ~~~~~--L~~L~l~~N~i~~~~~~~~---~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~ 286 (708)
..++. |+.|+|++|++++..|... . .+++|+.|+|++|+++...+..+..+++|+.|+|++|.|+ .+|..+.
T Consensus 639 ~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~ 717 (876)
T 4ecn_A 639 NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSL 717 (876)
T ss_dssp CTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSS
T ss_pred hccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHh
Confidence 66543 8888888888876555322 2 3447888888888888443344557888888888888888 4444333
Q ss_pred C--------cccCCceecccccccCCCCCccc--ccccccEEecCCCcCCCCCCCccccccCccccccccc
Q 039322 287 S--------LKSLEKLNLSHNNLSGSIPNCFE--GIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNK 347 (708)
Q Consensus 287 ~--------~~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~ 347 (708)
. +++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++.+.....++.++.+.+++|+
T Consensus 718 ~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~ 787 (876)
T 4ecn_A 718 KPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQR 787 (876)
T ss_dssp SCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCB
T ss_pred ccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCC
Confidence 2 238888888888888 6677766 8888888888888888865556677788888888776
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=338.66 Aligned_cols=321 Identities=21% Similarity=0.243 Sum_probs=269.2
Q ss_pred CCCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCC-CCccccCCCCccEEe
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSY-LPHNVCRGGALQYFG 79 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~-~~~~~~~l~~L~~L~ 79 (708)
+++|++|+|++|+|+++.|..|.++++|++|+|++|+|+.+ |.. ..++|+.|++++|.+.+. .|..+..+++|++|+
T Consensus 44 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l-p~~-~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~ 121 (520)
T 2z7x_B 44 LSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKI-SCH-PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121 (520)
T ss_dssp CTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEE-ECC-CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEE
T ss_pred cccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeec-Ccc-ccCCccEEeccCCccccccchhhhccCCcceEEE
Confidence 57899999999999999999999999999999999999854 444 668999999999999984 789999999999999
Q ss_pred ccCCccccccCccCcCCCCC--cEEEccCCcc--ccccccccCCCC----------------------------------
Q 039322 80 VSENHFQGTIPKILRNCSSL--IRVRLNSNNL--TGNISEALGIYP---------------------------------- 121 (708)
Q Consensus 80 l~~n~i~~~~~~~~~~l~~L--~~L~l~~n~i--~~~~~~~~~~~~---------------------------------- 121 (708)
+++|.+++ ..+..+++| ++|++++|.+ ++..+..+..+.
T Consensus 122 L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~ 198 (520)
T 2z7x_B 122 LSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK 198 (520)
T ss_dssp EEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEE
T ss_pred ecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeecccc
Confidence 99999986 457777777 9999999988 544444444422
Q ss_pred -------------------------------------------------CCCEEEcccCcceeeCCCCC-----CCCCCC
Q 039322 122 -------------------------------------------------NLTFIDLSRNDFYGEISSNW-----GKCPKL 147 (708)
Q Consensus 122 -------------------------------------------------~L~~L~l~~n~l~~~~~~~~-----~~l~~L 147 (708)
+|++|++++|++++..+..+ ..+++|
T Consensus 199 ~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L 278 (520)
T 2z7x_B 199 CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKAL 278 (520)
T ss_dssp ECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEE
T ss_pred ccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCcee
Confidence 78888888888886666666 666665
Q ss_pred CEEEcccCcc--------------------------cccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEcc
Q 039322 148 GTLNVSMNNI--------------------------TGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILR 201 (708)
Q Consensus 148 ~~L~L~~N~i--------------------------~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 201 (708)
+.+++++|.+ .... .+..+++|++|++++|++++..|..+..+++|++|+++
T Consensus 279 ~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 356 (520)
T 2z7x_B 279 SIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356 (520)
T ss_dssp EEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECC
T ss_pred EeccccccceecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEcc
Confidence 5555555554 3211 12678999999999999998889999999999999999
Q ss_pred Cccccc--cCCcccCCCCCCCeEeccCCcccccCC-CCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCC
Q 039322 202 GNQFTG--RLPPEIGSLVDLEYLDLSANRFNNSVP-ENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFG 278 (708)
Q Consensus 202 ~n~l~~--~~~~~~~~~~~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~ 278 (708)
+|++++ ..|..+..+++|++|+|++|++++..| ..+..+++|+.|++++|++++..|..+. ++|+.|++++|+|+
T Consensus 357 ~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 357 MNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK 434 (520)
T ss_dssp SSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC
T ss_pred CCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc
Confidence 999996 455678999999999999999997455 4588899999999999999877666554 69999999999999
Q ss_pred CCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCCC
Q 039322 279 GEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPN 331 (708)
Q Consensus 279 ~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 331 (708)
.+|..+..+++|+.|++++|+++...+..+..+++|+.|++++|+++|.++.
T Consensus 435 -~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 435 -SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp -CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred -ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCc
Confidence 6777777999999999999999965555599999999999999999998764
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=307.50 Aligned_cols=230 Identities=11% Similarity=0.075 Sum_probs=182.1
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|... +++.||||++...... .....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL-PDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccccc-CHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 67999999999999999999764 5899999999864322 234567899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++... ....++.+++.|++.||+|||++ ||+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999999532 35567899999999999999999 99999999999999999999998543
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
|++ .++.++||||||+++|||+||+.||......... ..................
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 229 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-----APAERDTAGQPIEPADID 229 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-----EECCBCTTSCBCCHHHHC
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-----HHHHHHhccCCCChhhcc
Confidence 222 2688999999999999999999999743321100 000011111111111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+..+.+++.+||++||++| |++|+++.|+
T Consensus 230 ~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~ 261 (286)
T 3uqc_A 230 RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQ 261 (286)
T ss_dssp TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHH
Confidence 1233468899999999999999 9999999875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.91 Aligned_cols=233 Identities=21% Similarity=0.266 Sum_probs=181.6
Q ss_pred cccccc-ceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHH-HhccCCceeeEEEEEee----C
Q 039322 436 NDFDAQ-YCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKAL-TEIRHRNIVKFYGFCSH----A 508 (708)
Q Consensus 436 ~~~~~~-~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~l~~~~~~----~ 508 (708)
++|.+. +.||+|+||.||+|.. .+++.||+|++.. ...+.+|++++ +..+||||+++++++.. .
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 677776 7799999999999965 5789999999864 23466788887 55589999999999977 6
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC---CCcEEEee
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL---EYEAHVAD 585 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~D 585 (708)
...++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ ||+||||||+||+++. ++.+||+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred ceEEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEec
Confidence 778999999999999999976442 4589999999999999999999999 9999999999999998 78899999
Q ss_pred cccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 039322 586 FGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDP 665 (708)
Q Consensus 586 fg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 665 (708)
||++.... +..++.++||||+|+++|||++|+.||......... ......+...
T Consensus 164 fg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----~~~~~~~~~~ 217 (299)
T 3m2w_A 164 FGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKTRIRMG 217 (299)
T ss_dssp CTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------CCSCCSSCTT
T ss_pred cccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh----HHHHHHHhhc
Confidence 99987542 234677899999999999999999999643221110 0011111111
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 666 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+..........+.+++.+||+.||++|||++|+++|-+
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 221111111223456889999999999999999999998754
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.29 Aligned_cols=313 Identities=18% Similarity=0.163 Sum_probs=278.8
Q ss_pred CCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEE
Q 039322 24 NLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRV 102 (708)
Q Consensus 24 ~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 102 (708)
.+++|+.|++++|.+....+..+.. ++|+.|++++|.+.+..+..+..+++|++|++++|.+++..|..|.++++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 4689999999999998665554543 899999999999999888899999999999999999998888999999999999
Q ss_pred EccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEeccccccc
Q 039322 103 RLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIV 182 (708)
Q Consensus 103 ~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~ 182 (708)
+|++|.++.+++..|..+++|++|++++|+++++.+..|..+++|+.|++++|+++.. .+..+++|+.|++++|.++
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 199 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc
Confidence 9999999988888899999999999999999999999999999999999999999865 3667899999999999988
Q ss_pred ccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhh
Q 039322 183 GEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELE 262 (708)
Q Consensus 183 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 262 (708)
+ +...++|++|++++|.++.. +.. ..++|+.|++++|.+++. ..+..+++|+.|++++|.+++..|..|.
T Consensus 200 ~-----~~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~ 269 (390)
T 3o6n_A 200 T-----LAIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFV 269 (390)
T ss_dssp E-----EECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred c-----cCCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHcc
Confidence 4 34457899999999999955 332 357999999999999854 5788999999999999999988899999
Q ss_pred hhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCCCccccccCcccc
Q 039322 263 KLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEA 342 (708)
Q Consensus 263 ~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~ 342 (708)
.+++|+.|++++|++++ .+..+..+++|+.|++++|+++ .+|..+..+++|+.|++++|+++... ...++.++.+.
T Consensus 270 ~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~L~~L~ 345 (390)
T 3o6n_A 270 KMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLT 345 (390)
T ss_dssp TCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEE
T ss_pred ccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC--chhhccCCEEE
Confidence 99999999999999984 5666678999999999999998 56777889999999999999999764 45678899999
Q ss_pred cccccCcCCCC
Q 039322 343 LKGNKGLCGGV 353 (708)
Q Consensus 343 ~~~n~~~c~~~ 353 (708)
+.+|+|.|+|.
T Consensus 346 l~~N~~~~~~~ 356 (390)
T 3o6n_A 346 LSHNDWDCNSL 356 (390)
T ss_dssp CCSSCEEHHHH
T ss_pred cCCCCccchhH
Confidence 99999999763
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.74 Aligned_cols=326 Identities=24% Similarity=0.310 Sum_probs=234.0
Q ss_pred CCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEeccC
Q 039322 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSE 82 (708)
Q Consensus 3 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~ 82 (708)
+|+.|++++|.++.+ + .+..+++|++|+|++|.+.+..+ ....++|+.|++++|.+.+..+ +..+++|++|++++
T Consensus 47 ~l~~L~l~~~~i~~l-~-~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~ 121 (466)
T 1o6v_A 47 QVTTLQADRLGIKSI-D-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFN 121 (466)
T ss_dssp TCCEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred cccEEecCCCCCccC-c-chhhhcCCCEEECCCCccCCchh-hhccccCCEEECCCCccccChh--hcCCCCCCEEECCC
Confidence 455555555555532 2 24555555555555555554333 1122455555555555555333 55555555555555
Q ss_pred CccccccCccCcCCCCCcEEEccCCccccccc-------------------cccCCCCCCCEEEcccCcceeeCCCCCCC
Q 039322 83 NHFQGTIPKILRNCSSLIRVRLNSNNLTGNIS-------------------EALGIYPNLTFIDLSRNDFYGEISSNWGK 143 (708)
Q Consensus 83 n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-------------------~~~~~~~~L~~L~l~~n~l~~~~~~~~~~ 143 (708)
|.+++..+ +.++++|++|++++|.++++.. ..+..+++|++|++++|.+..+. .+..
T Consensus 122 n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~l~~ 197 (466)
T 1o6v_A 122 NQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS--VLAK 197 (466)
T ss_dssp SCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCG--GGGG
T ss_pred CCCCCChH--HcCCCCCCEEECCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCCh--hhcc
Confidence 55553322 5555555555555555543221 23677788888888888887653 4778
Q ss_pred CCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEe
Q 039322 144 CPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLD 223 (708)
Q Consensus 144 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~ 223 (708)
+++|++|++++|.+++..+ ++.+++|++|++++|++++. ..+..+++|++|++++|.+++..+ +..+++|++|+
T Consensus 198 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 271 (466)
T 1o6v_A 198 LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 271 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred CCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEE
Confidence 8888889998888886544 77788899999999988843 457788999999999999885543 88889999999
Q ss_pred ccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccC
Q 039322 224 LSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSG 303 (708)
Q Consensus 224 l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~ 303 (708)
+++|++++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|++++
T Consensus 272 l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~ 345 (466)
T 1o6v_A 272 LGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD 345 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred CCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCC
Confidence 99999986544 7888999999999999986543 7888999999999999987655 6788999999999999986
Q ss_pred CCCCcccccccccEEecCCCcCCCCCCCccccccCcccccccccCcCCC
Q 039322 304 SIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGG 352 (708)
Q Consensus 304 ~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~ 352 (708)
. ..+..+++|+.|++++|++++..| ...++.++.+.+.+|+|...+
T Consensus 346 ~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~~~~p 391 (466)
T 1o6v_A 346 V--SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAWTNAP 391 (466)
T ss_dssp C--GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEEECCC
T ss_pred c--hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcccCCc
Confidence 5 468889999999999999998877 667788889999999887743
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=342.21 Aligned_cols=321 Identities=21% Similarity=0.199 Sum_probs=265.6
Q ss_pred CCCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCC-CCccccCCCCccEE
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSY-LPHNVCRGGALQYF 78 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~-~~~~~~~l~~L~~L 78 (708)
|++|++|+|++|+|+.+.+..|.++++|++|+|++|++++..+..+.. ++|+.|++++|.+.+. .+..+..+++|++|
T Consensus 49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 578999999999999888899999999999999999998776665654 7899999999998864 56778888999999
Q ss_pred eccCCc-cccccCccCcCCCCCcEEEccCCccccccccccCC------------------------CCCCCEEEcccCcc
Q 039322 79 GVSENH-FQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI------------------------YPNLTFIDLSRNDF 133 (708)
Q Consensus 79 ~l~~n~-i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~------------------------~~~L~~L~l~~n~l 133 (708)
++++|. ++...+..|.++++|++|++++|.+++..+..+.. +++|++|++++|++
T Consensus 129 ~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l 208 (549)
T 2z81_A 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208 (549)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBC
T ss_pred ECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCcc
Confidence 999988 44444467888888999999988888766665543 66788888888877
Q ss_pred eeeC--C-------------------------------------------------------------------------
Q 039322 134 YGEI--S------------------------------------------------------------------------- 138 (708)
Q Consensus 134 ~~~~--~------------------------------------------------------------------------- 138 (708)
++.. +
T Consensus 209 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l 288 (549)
T 2z81_A 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTI 288 (549)
T ss_dssp TTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEE
T ss_pred ccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccc
Confidence 6531 0
Q ss_pred --------------------------------------CC-CCCCCCCCEEEcccCcccccCC---ccccCCCCCCEEec
Q 039322 139 --------------------------------------SN-WGKCPKLGTLNVSMNNITGGIP---REIGNSSQLQALDL 176 (708)
Q Consensus 139 --------------------------------------~~-~~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~L 176 (708)
.. +..+++|+.|+|++|++++..+ ..++.+++|++|+|
T Consensus 289 ~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~L 368 (549)
T 2z81_A 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368 (549)
T ss_dssp ESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEEC
T ss_pred cccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEc
Confidence 00 0247889999999999987553 34788999999999
Q ss_pred ccccccccCC--cccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccc
Q 039322 177 SLNHIVGEIP--KELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFV 254 (708)
Q Consensus 177 ~~n~l~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~ 254 (708)
++|++++..+ ..+..+++|++|++++|+++ .+|..+..+++|++|++++|+++. .+..+. ++|+.|++++|+++
T Consensus 369 s~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~Ls~N~l~ 444 (549)
T 2z81_A 369 SQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLD 444 (549)
T ss_dssp TTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TTCSEEECCSSCCS
T ss_pred cCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchhc--CCceEEECCCCChh
Confidence 9999985432 45889999999999999999 678889999999999999999984 444332 58999999999999
Q ss_pred cCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCCC
Q 039322 255 LELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPN 331 (708)
Q Consensus 255 ~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 331 (708)
+.. ..+++|+.|+|++|+|+ .+|. ...+++|+.|++++|++++..|..+..+++|+.|++++|++.|.+|.
T Consensus 445 ~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 445 SFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp CCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred hhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 653 47889999999999998 5554 46789999999999999999999999999999999999999998774
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=309.16 Aligned_cols=304 Identities=21% Similarity=0.311 Sum_probs=244.3
Q ss_pred CCCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEec
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGV 80 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l 80 (708)
+++|++|++++|.++.+ ..+..+++|++|+|++|.+++..+ ....++|+.|++++|.++.. ..+..+++|++|++
T Consensus 43 l~~L~~L~l~~~~i~~~--~~~~~~~~L~~L~l~~n~i~~~~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~l 117 (347)
T 4fmz_A 43 LESITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQITDISP-LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYL 117 (347)
T ss_dssp HTTCSEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEEC
T ss_pred cccccEEEEeCCccccc--hhhhhcCCccEEEccCCccccchh-hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEEC
Confidence 36789999999999854 248889999999999999886544 22337899999999988874 36888899999999
Q ss_pred cCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCccccc
Q 039322 81 SENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGG 160 (708)
Q Consensus 81 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~ 160 (708)
++|.+++..+ +.++++|++|++++|...... ..+..+++|++|++++|.+..+.+ +..+++|+.|++++|.++..
T Consensus 118 ~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~ 192 (347)
T 4fmz_A 118 NEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI 192 (347)
T ss_dssp TTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCC
T ss_pred cCCcccCchh--hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccc
Confidence 9999885433 888899999999998554333 348888999999999998876554 77888999999999988854
Q ss_pred CCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCcc
Q 039322 161 IPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNL 240 (708)
Q Consensus 161 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l 240 (708)
.+ +..+++|+.|++++|.+++..+ +..+++|++|++++|.+++..+ +..+++|++|++++|.+++. ..+..+
T Consensus 193 ~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l 264 (347)
T 4fmz_A 193 SP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDL 264 (347)
T ss_dssp GG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTC
T ss_pred cc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcC
Confidence 33 7888899999999998885433 7788899999999999884433 88888999999999988854 457888
Q ss_pred ccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEec
Q 039322 241 LKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDI 320 (708)
Q Consensus 241 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l 320 (708)
++|+.|++++|++++. ..+..+++|+.|++++|++++..+..+..+++|+.|++++|++++..| +..+++|+.|++
T Consensus 265 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l 340 (347)
T 4fmz_A 265 TKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADF 340 (347)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESS
T ss_pred CCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeeh
Confidence 8999999999988854 458888899999999999988888888889999999999999886666 778889999999
Q ss_pred CCCcCC
Q 039322 321 SDNQLQ 326 (708)
Q Consensus 321 ~~N~l~ 326 (708)
++|+++
T Consensus 341 ~~N~i~ 346 (347)
T 4fmz_A 341 ANQVIK 346 (347)
T ss_dssp SCC---
T ss_pred hhhccc
Confidence 999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=341.77 Aligned_cols=234 Identities=24% Similarity=0.349 Sum_probs=190.0
Q ss_pred ccccccceeccccCccEEEEEeC--CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe---
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP--SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH--- 510 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~--- 510 (708)
++|++.+.||+|+||.||+|.+. +|+.||||++... ........+.+|++++++++||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 78999999999999999999764 6899999998753 223456678999999999999999999999987665
Q ss_pred --eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 511 --SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 511 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
.|+||||+++++|.+++.. .+++.+++.++.||+.||+|||++ ||+||||||+||+++.+ .+||+|||+
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 6999999999999987753 489999999999999999999999 99999999999999975 899999999
Q ss_pred ccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 039322 589 AKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 589 a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
+...... ....||+.|+|||++.++ ++.++||||||+++|+|++|..||..... . ..+
T Consensus 228 a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~------------~-----~~~ 285 (681)
T 2pzi_A 228 VSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV------------D-----GLP 285 (681)
T ss_dssp CEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC------------S-----SCC
T ss_pred chhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc------------c-----ccc
Confidence 9876533 345789999999998765 48899999999999999999888762110 0 001
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQ 704 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 704 (708)
...........+.+++.+||++||++||+..+.+.
T Consensus 286 -~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 320 (681)
T 2pzi_A 286 -EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMS 320 (681)
T ss_dssp -TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred -ccccccccCHHHHHHHhhhccCChhhCCCHHHHHH
Confidence 11122233456889999999999999996554443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=332.52 Aligned_cols=356 Identities=19% Similarity=0.232 Sum_probs=288.4
Q ss_pred CCCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEe
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFG 79 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~ 79 (708)
|++|++|||++|+|+.+.+++|.++++|++|+|++|+|++..+..|.. ++|+.|++++|.+++..+..|+.+++|++|+
T Consensus 75 l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~ 154 (635)
T 4g8a_A 75 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 154 (635)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeec
Confidence 578999999999999999999999999999999999999887777765 8999999999999998888899999999999
Q ss_pred ccCCccccc-cCccCcCCCCCcEEEccCCccccccccccCC---------------------------------------
Q 039322 80 VSENHFQGT-IPKILRNCSSLIRVRLNSNNLTGNISEALGI--------------------------------------- 119 (708)
Q Consensus 80 l~~n~i~~~-~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~--------------------------------------- 119 (708)
+++|.+++. .|..+.++++|++|+|++|+|+++.+..|..
T Consensus 155 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n 234 (635)
T 4g8a_A 155 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 234 (635)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred cccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcc
Confidence 999999864 5788899999999999999887654433211
Q ss_pred --------------------------------------------------------------------------------
Q 039322 120 -------------------------------------------------------------------------------- 119 (708)
Q Consensus 120 -------------------------------------------------------------------------------- 119 (708)
T Consensus 235 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 314 (635)
T 4g8a_A 235 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLV 314 (635)
T ss_dssp CSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEE
T ss_pred cccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccc
Confidence
Q ss_pred ------------CCCCCEEEcccCcceeeCCC-------------------CCCCCCCCCEEEcccCccccc--------
Q 039322 120 ------------YPNLTFIDLSRNDFYGEISS-------------------NWGKCPKLGTLNVSMNNITGG-------- 160 (708)
Q Consensus 120 ------------~~~L~~L~l~~n~l~~~~~~-------------------~~~~l~~L~~L~L~~N~i~~~-------- 160 (708)
...|+.|++++|.+..+... .+..+++|+.|++++|.+...
T Consensus 315 ~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~ 394 (635)
T 4g8a_A 315 SVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 394 (635)
T ss_dssp SCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHH
T ss_pred ccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchh
Confidence 12344445555444322221 123467888888888877521
Q ss_pred -----------------CCccccCCCCCCEEecccccccccCC-cccCCCCCCCEEEccCccccccCCcccCCCCCCCeE
Q 039322 161 -----------------IPREIGNSSQLQALDLSLNHIVGEIP-KELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYL 222 (708)
Q Consensus 161 -----------------~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L 222 (708)
.+..+..+++|+.++++.|......+ ..+..+++++.+++++|.+.+..+..+..+++|+.|
T Consensus 395 ~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L 474 (635)
T 4g8a_A 395 GTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 474 (635)
T ss_dssp SCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred hhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhh
Confidence 23345667788888888777764443 467889999999999999998889999999999999
Q ss_pred eccCCcc-cccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccc
Q 039322 223 DLSANRF-NNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNL 301 (708)
Q Consensus 223 ~l~~N~i-~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l 301 (708)
+|++|.+ .+..|..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|+|
T Consensus 475 ~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l 554 (635)
T 4g8a_A 475 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 554 (635)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCC
T ss_pred hhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcC
Confidence 9999985 456788899999999999999999999999999999999999999999998899999999999999999999
Q ss_pred cCCCCCccccc-ccccEEecCCCcCCCCCCCcccc---ccCcccccccccCcCCCCCCC
Q 039322 302 SGSIPNCFEGI-RGISVIDISDNQLQGPVPNSTAF---RNAPVEALKGNKGLCGGVKGM 356 (708)
Q Consensus 302 ~~~~~~~~~~l-~~L~~l~l~~N~l~~~~~~~~~~---~~~~~~~~~~n~~~c~~~~~~ 356 (708)
++..|..+..+ ++|+.|++++|++.|.+...+.. ..............|+.|...
T Consensus 555 ~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~~~wl~~~~~~~~~~~~~~C~~P~~~ 613 (635)
T 4g8a_A 555 MTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 613 (635)
T ss_dssp CBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHHHHHHHHTTTTBSCGGGCBBCSSTTT
T ss_pred CCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHHHHHHHhCCCccCCCCCceeCCchHH
Confidence 99999999988 68999999999999987643221 111111222344678776643
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=334.40 Aligned_cols=313 Identities=19% Similarity=0.166 Sum_probs=280.4
Q ss_pred CCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEE
Q 039322 24 NLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRV 102 (708)
Q Consensus 24 ~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 102 (708)
.+.+++.|++++|.+...++..+.. ++|+.|++++|.+.+..+..|..+++|++|+|++|.+++..|..|+++++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 3578999999999998766655543 899999999999999888899999999999999999999888899999999999
Q ss_pred EccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEeccccccc
Q 039322 103 RLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIV 182 (708)
Q Consensus 103 ~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~ 182 (708)
+|++|.++++++..|..+++|++|+|++|.++++.+..|..+++|+.|+|++|.+++.. +..+++|+.|++++|.++
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~ 205 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLS 205 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCS
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccc
Confidence 99999999999888999999999999999999999999999999999999999998653 566899999999999988
Q ss_pred ccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhh
Q 039322 183 GEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELE 262 (708)
Q Consensus 183 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 262 (708)
+ +...++|+.|++++|.++...+. + .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|..|.
T Consensus 206 ~-----l~~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 275 (597)
T 3oja_B 206 T-----LAIPIAVEELDASHNSINVVRGP-V--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFV 275 (597)
T ss_dssp E-----EECCTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred c-----ccCCchhheeeccCCcccccccc-c--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhc
Confidence 4 34557899999999999854433 2 3689999999999985 46789999999999999999999999999
Q ss_pred hhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCCCccccccCcccc
Q 039322 263 KLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEA 342 (708)
Q Consensus 263 ~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~ 342 (708)
.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|++.+.. ...++.++.+.
T Consensus 276 ~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~L~~L~ 351 (597)
T 3oja_B 276 KMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLT 351 (597)
T ss_dssp TCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEE
T ss_pred CccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC--hhhcCCCCEEE
Confidence 99999999999999985 5666778999999999999999 67778899999999999999999874 45678899999
Q ss_pred cccccCcCCCC
Q 039322 343 LKGNKGLCGGV 353 (708)
Q Consensus 343 ~~~n~~~c~~~ 353 (708)
+.+|+|.|+|.
T Consensus 352 l~~N~~~~~~~ 362 (597)
T 3oja_B 352 LSHNDWDCNSL 362 (597)
T ss_dssp CCSSCEEHHHH
T ss_pred eeCCCCCChhH
Confidence 99999999873
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=320.97 Aligned_cols=246 Identities=15% Similarity=0.112 Sum_probs=180.8
Q ss_pred hccccccceeccccCccEEEEE-eCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccC-Cce--------------
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH-RNI-------------- 498 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i-------------- 498 (708)
...|...+.||+|+||.||+|. ..+|+.||||++..... ......+.+.+|+.+++.++| ++.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC-ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3568888999999999999997 45799999999884322 222345678999999999976 211
Q ss_pred -------eeEEEEEee-----CCeeEEEEEeccCCCHHHHhccc----ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 039322 499 -------VKFYGFCSH-----ARHSFLVYELLERGSLAAILSSD----TAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562 (708)
Q Consensus 499 -------v~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~----~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ 562 (708)
..+..++.. ....+++|+++ +++|.+++... .....+++..++.++.|+++||+|||++ +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 111111211 12356777765 57999988421 1123477889999999999999999999 9
Q ss_pred eEEccCCCCCeeeCCCCcEEEeecccccccCCCCCccccccccccccCcccc----------ccCCCCcchhHHHHHHHH
Q 039322 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA----------YTMKITEKCDVYSFGVLV 632 (708)
Q Consensus 563 ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DvwslG~~l 632 (708)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 999999999999999999999999999865432 344567 999999998 555688899999999999
Q ss_pred HHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 633 LEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 633 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
|||++|+.||...... .....++..... .+..+.+++.+||+.||++|||+.|++++
T Consensus 308 ~elltg~~Pf~~~~~~--------~~~~~~~~~~~~--------~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 308 YWIWCADLPNTDDAAL--------GGSEWIFRSCKN--------IPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHSSCCCCTTGGG--------SCSGGGGSSCCC--------CCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHCCCCCCCcchh--------hhHHHHHhhccc--------CCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999999999743221 111122221111 11358899999999999999999998775
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=313.75 Aligned_cols=302 Identities=26% Similarity=0.294 Sum_probs=194.2
Q ss_pred cCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEE
Q 039322 23 SNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRV 102 (708)
Q Consensus 23 ~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 102 (708)
..+++|+.|++++|.+.. ++..-..++|+.|++++|.+.+..+ +..+++|++|++++|.+++..+ +.++++|++|
T Consensus 43 ~~l~~l~~L~l~~~~i~~-l~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L 117 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGL 117 (466)
T ss_dssp HHHHTCCEEECCSSCCCC-CTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred hHhccccEEecCCCCCcc-CcchhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEE
Confidence 457899999999999974 4543334899999999999998655 8999999999999999996655 9999999999
Q ss_pred EccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCC---------------------CCCCEEEcccCcccccC
Q 039322 103 RLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKC---------------------PKLGTLNVSMNNITGGI 161 (708)
Q Consensus 103 ~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l---------------------~~L~~L~L~~N~i~~~~ 161 (708)
++++|.++++.+ +..+++|++|++++|.+.++. .+..+ ++|+.|++++|.++..
T Consensus 118 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~- 192 (466)
T 1o6v_A 118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI- 192 (466)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCG--GGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC-
T ss_pred ECCCCCCCCChH--HcCCCCCCEEECCCCccCCCh--hhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC-
Confidence 999999997754 899999999999999987653 24444 4455555555555432
Q ss_pred CccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccc
Q 039322 162 PREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLL 241 (708)
Q Consensus 162 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~ 241 (708)
..+..+++|++|++++|++++..+ ++.+++|++|++++|++++. ..+..+++|++|++++|.+++..+ +..++
T Consensus 193 -~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~ 265 (466)
T 1o6v_A 193 -SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLT 265 (466)
T ss_dssp -GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCT
T ss_pred -hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCC
Confidence 234455555555555555543322 44455555555555555532 234555555555555555554333 55555
Q ss_pred cceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecC
Q 039322 242 KLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDIS 321 (708)
Q Consensus 242 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~ 321 (708)
+|+.|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|++++..| +..+++|+.|+++
T Consensus 266 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~ 339 (466)
T 1o6v_A 266 KLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFY 339 (466)
T ss_dssp TCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECC
T ss_pred CCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECC
Confidence 55566666655553322 5555556666666665554332 4555566666666666654443 4555666666666
Q ss_pred CCcCCCCCCCccccccCcccccccccC
Q 039322 322 DNQLQGPVPNSTAFRNAPVEALKGNKG 348 (708)
Q Consensus 322 ~N~l~~~~~~~~~~~~~~~~~~~~n~~ 348 (708)
+|++++. +....++.++.+.+.+|+.
T Consensus 340 ~n~l~~~-~~l~~l~~L~~L~l~~n~l 365 (466)
T 1o6v_A 340 NNKVSDV-SSLANLTNINWLSAGHNQI 365 (466)
T ss_dssp SSCCCCC-GGGTTCTTCCEEECCSSCC
T ss_pred CCccCCc-hhhccCCCCCEEeCCCCcc
Confidence 6665554 3333445555555555543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=299.40 Aligned_cols=287 Identities=18% Similarity=0.182 Sum_probs=170.4
Q ss_pred CCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccC
Q 039322 27 NLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNS 106 (708)
Q Consensus 27 ~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~ 106 (708)
+|+.++++++.+. .+|..+. ++++.|++++|.+.+..+..+..+++|++|++++|.+++..|..|.++++|++|+|++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~-~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS-PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC-TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred cCCEEECCCCCcc-ccCCCCC-CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 5777777777776 3443332 4566666666666665555666666666666666666655566666666666666666
Q ss_pred CccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccc--cCCccccCCCCCCEEeccccccccc
Q 039322 107 NNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITG--GIPREIGNSSQLQALDLSLNHIVGE 184 (708)
Q Consensus 107 n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~n~l~~~ 184 (708)
|.++.++...+ ++|++|++++|+++.+.+..|..+++|+.|++++|.++. ..+..|..+ +|++|++++|++++
T Consensus 112 n~l~~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~- 186 (332)
T 2ft3_A 112 NHLVEIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG- 186 (332)
T ss_dssp SCCCSCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-
T ss_pred CcCCccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-
Confidence 66664444333 566666666666665555556666666666666666642 445555555 66666666666663
Q ss_pred CCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhh
Q 039322 185 IPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKL 264 (708)
Q Consensus 185 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 264 (708)
+|..+. ++|++|++++|.+++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|+++ .+|..+..+
T Consensus 187 l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 263 (332)
T 2ft3_A 187 IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDL 263 (332)
T ss_dssp CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGC
T ss_pred cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcC
Confidence 333332 46666666666666555556666666666666666666555555666666666666666666 445556666
Q ss_pred cccchhhcccccCCCCCchhhcC------cccCCceeccccccc--CCCCCcccccccccEEecCCC
Q 039322 265 VQLSELDASHNLFGGEIPFQICS------LKSLEKLNLSHNNLS--GSIPNCFEGIRGISVIDISDN 323 (708)
Q Consensus 265 ~~L~~L~ls~N~i~~~~~~~~~~------~~~L~~L~l~~N~l~--~~~~~~~~~l~~L~~l~l~~N 323 (708)
++|+.|++++|+|++..+..+.. .+.|+.|++++|++. +..+.+|..+++|+.+++++|
T Consensus 264 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n 330 (332)
T 2ft3_A 264 KLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330 (332)
T ss_dssp TTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred ccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhcccc
Confidence 66666666666666544444433 244566666666655 455555666666666666655
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=313.75 Aligned_cols=250 Identities=16% Similarity=0.141 Sum_probs=190.4
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCc----chhHhHHHHHHHHHHHHhcc---------CCceeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPC----DQIADQKEFLIEVKALTEIR---------HRNIVKF 501 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~---------h~~iv~l 501 (708)
.++|++.+.||+|+||.||+|.. +|+.||||++...... ......+.+.+|++++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 47899999999999999999987 6899999999764321 11223467889999988886 7777777
Q ss_pred EEEEe------------------------------eCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHH
Q 039322 502 YGFCS------------------------------HARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADA 551 (708)
Q Consensus 502 ~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~ 551 (708)
.+.+. .++..++||||+++|++.+.+.. ..+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 76642 26789999999999977666643 347999999999999999
Q ss_pred HHHHH-hCCCCCeEEccCCCCCeeeCCCC--------------------cEEEeecccccccCCCCCccccccccccccC
Q 039322 552 LSYLH-HDCFPPIVHQDISSKNLLLDLEY--------------------EAHVADFGIAKFLKPESSNWTEFAGTYGYVA 610 (708)
Q Consensus 552 l~~Lh-~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~a 610 (708)
|+||| ++ +|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence 99999 88 999999999999999887 8999999999876532 3578999999
Q ss_pred ccccccCCCCcchhHHHHHHH-HHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhcc
Q 039322 611 PELAYTMKITEKCDVYSFGVL-VLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCL 689 (708)
Q Consensus 611 PE~~~~~~~~~~~DvwslG~~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 689 (708)
||++.+.. +.++||||+|++ .+++++|..||....... .......... ................++.+++.+||
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dli~~~L 320 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH---YLTDKMLKQM-TFKTKCNTPAMKQIKRKIQEFHRTML 320 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH---HHHHHHHHTC-CCSSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh---HHHHhhhhhh-ccCcccchhhhhhcCHHHHHHHHHHh
Confidence 99988765 889999998776 788889999975311000 0000111111 11111222334556778999999999
Q ss_pred CCCCCCCCCHHHHH-HHhh
Q 039322 690 NESPESRPTMKVVT-QQVR 707 (708)
Q Consensus 690 ~~dP~~RPs~~evl-~~l~ 707 (708)
++| |++|++ +|-+
T Consensus 321 ~~d-----sa~e~l~~Hp~ 334 (336)
T 2vuw_A 321 NFS-----SATDLLCQHSL 334 (336)
T ss_dssp GSS-----SHHHHHHHCGG
T ss_pred ccC-----CHHHHHhcCCC
Confidence 976 999999 8754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=301.46 Aligned_cols=257 Identities=24% Similarity=0.387 Sum_probs=154.4
Q ss_pred CCccEEeccCCcccc--ccCccCcCCCCCcEEEccC-CccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCE
Q 039322 73 GALQYFGVSENHFQG--TIPKILRNCSSLIRVRLNS-NNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGT 149 (708)
Q Consensus 73 ~~L~~L~l~~n~i~~--~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 149 (708)
.+++.|++++|.+++ .+|..|.++++|++|+|++ |++.+..+..|..+++|++|+|++|++++..+..|..+++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 345555555555555 4555555555555555553 5555444555555555555555555554444444445555555
Q ss_pred EEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCC-CCCeEeccCCc
Q 039322 150 LNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLV-DLEYLDLSANR 228 (708)
Q Consensus 150 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~-~L~~L~l~~N~ 228 (708)
|+|++|.+++..|..|. .+++|++|+|++|++++..|..+..++ +|++|++++|+
T Consensus 130 L~Ls~N~l~~~~p~~~~------------------------~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~ 185 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSIS------------------------SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185 (313)
T ss_dssp EECCSSEEESCCCGGGG------------------------GCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSE
T ss_pred EeCCCCccCCcCChHHh------------------------cCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCe
Confidence 55555555444444444 444555555555555444444444444 45555555555
Q ss_pred ccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCc
Q 039322 229 FNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNC 308 (708)
Q Consensus 229 i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~ 308 (708)
+++..|..+..++ |+.|++++|++++..|..|..+++|+.|++++|.+++..+. +..+++|++|++++|++++..|..
T Consensus 186 l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~ 263 (313)
T 1ogq_A 186 LTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQG 263 (313)
T ss_dssp EEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGG
T ss_pred eeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChH
Confidence 5544555555444 55555555555555555555566666666666666544433 566677888888888887777888
Q ss_pred ccccccccEEecCCCcCCCCCCCccccccCcccccccccCcCCCCCC
Q 039322 309 FEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCGGVKG 355 (708)
Q Consensus 309 ~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~~~ 355 (708)
+..+++|+.|++++|++++.+|....++.++.+.+.+|++.|+.|..
T Consensus 264 l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~ 310 (313)
T 1ogq_A 264 LTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp GGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred HhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC
Confidence 88888888888888888877777777788888888999999987543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=295.78 Aligned_cols=290 Identities=20% Similarity=0.192 Sum_probs=212.8
Q ss_pred CCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEcc
Q 039322 26 TNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLN 105 (708)
Q Consensus 26 ~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~ 105 (708)
.+|+.++++++.+. .+|..+. ++++.|++++|.+++..+..+..+++|++|++++|.+++..|..|.++++|++|+|+
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~-~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP-PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC-TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCCeEEEecCCCcc-ccCccCC-CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 36788888888876 3444332 567777777777777666677788888888888888887777778888888888888
Q ss_pred CCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccc--cCCccccCCCCCCEEecccccccc
Q 039322 106 SNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITG--GIPREIGNSSQLQALDLSLNHIVG 183 (708)
Q Consensus 106 ~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~n~l~~ 183 (708)
+|.++.++...+ ++|++|++++|+++++.+..|..+++|+.|++++|.++. ..+..|..+++|++|++++|+++.
T Consensus 109 ~n~l~~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 109 KNQLKELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp SSCCSBCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCcCCccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 888876554433 678888888888877776677778888888888888753 556677778888888888888773
Q ss_pred cCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhh
Q 039322 184 EIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEK 263 (708)
Q Consensus 184 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 263 (708)
+|..+. ++|++|++++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|+++ .+|..+..
T Consensus 186 -l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 261 (330)
T 1xku_A 186 -IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261 (330)
T ss_dssp -CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred -CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhcc
Confidence 444333 67888888888888777777888888888888888887766667777888888888888887 56667777
Q ss_pred hcccchhhcccccCCCCCchhhcC------cccCCceecccccccC--CCCCcccccccccEEecCCCc
Q 039322 264 LVQLSELDASHNLFGGEIPFQICS------LKSLEKLNLSHNNLSG--SIPNCFEGIRGISVIDISDNQ 324 (708)
Q Consensus 264 l~~L~~L~ls~N~i~~~~~~~~~~------~~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~l~l~~N~ 324 (708)
+++|+.|++++|+|++..+..|.. .+.|+.|++++|++.. ..|..|..+.+++.+++++|+
T Consensus 262 l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 788888888888887666555543 3667778888887753 566777777888888887774
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=302.34 Aligned_cols=299 Identities=22% Similarity=0.247 Sum_probs=251.9
Q ss_pred CCCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEec
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGV 80 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l 80 (708)
+++|++|+|++|+|+++ | .+..+++|++|+|++|++++. + ....++|+.|++++|.+++. + +..+++|++|++
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~-~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D-LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNC 113 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C-CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c-cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEEC
Confidence 47899999999999975 4 699999999999999999875 3 22348999999999999985 3 889999999999
Q ss_pred cCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCccccc
Q 039322 81 SENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGG 160 (708)
Q Consensus 81 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~ 160 (708)
++|++++. + ++++++|++|++++|+++++ .++.+++|++|++++|+..+.. .+..+++|+.|++++|++++.
T Consensus 114 ~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l 185 (457)
T 3bz5_A 114 DTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL 185 (457)
T ss_dssp CSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC
T ss_pred CCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcccee
Confidence 99999964 4 89999999999999999986 3889999999999999543332 578899999999999999964
Q ss_pred CCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCcc
Q 039322 161 IPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNL 240 (708)
Q Consensus 161 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l 240 (708)
+ +..+++|+.|++++|++++. .+..+++|+.|++++|++++ +| +..+++|++|++++|++++..+..+.++
T Consensus 186 -~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L 256 (457)
T 3bz5_A 186 -D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKL 256 (457)
T ss_dssp -C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTC
T ss_pred -c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCC
Confidence 3 88899999999999999965 48899999999999999996 55 8899999999999999998765555554
Q ss_pred c-------cceeecccCcccccCCChhhhhhcccchhhcccccCCCCCch--------hhcCcccCCceecccccccCCC
Q 039322 241 L-------KLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPF--------QICSLKSLEKLNLSHNNLSGSI 305 (708)
Q Consensus 241 ~-------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~--------~~~~~~~L~~L~l~~N~l~~~~ 305 (708)
. +|+.|++++|.+.+..| +..+++|+.|++++|...+.+|. .+..+++|+.|++++|++++.
T Consensus 257 ~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l- 333 (457)
T 3bz5_A 257 TTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL- 333 (457)
T ss_dssp CEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-
T ss_pred CEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-
Confidence 4 45666777776655444 46788999999999986554442 356678999999999999975
Q ss_pred CCcccccccccEEecCCCcCCCC
Q 039322 306 PNCFEGIRGISVIDISDNQLQGP 328 (708)
Q Consensus 306 ~~~~~~l~~L~~l~l~~N~l~~~ 328 (708)
+ +..+++|+.|++++|++++.
T Consensus 334 ~--l~~l~~L~~L~l~~N~l~~l 354 (457)
T 3bz5_A 334 D--VSHNTKLKSLSCVNAHIQDF 354 (457)
T ss_dssp C--CTTCTTCSEEECCSSCCCBC
T ss_pred c--cccCCcCcEEECCCCCCCCc
Confidence 3 88899999999999999974
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-34 Score=297.42 Aligned_cols=308 Identities=21% Similarity=0.283 Sum_probs=266.4
Q ss_pred ccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCC
Q 039322 20 PSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSL 99 (708)
Q Consensus 20 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L 99 (708)
..+..+++|++|++++|.+.. ++..-..++|+.|++++|.+++..+ +..+++|++|++++|.+++. ..+.++++|
T Consensus 38 ~~~~~l~~L~~L~l~~~~i~~-~~~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L 112 (347)
T 4fmz_A 38 VTQEELESITKLVVAGEKVAS-IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNL 112 (347)
T ss_dssp ECHHHHTTCSEEECCSSCCCC-CTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTC
T ss_pred ccchhcccccEEEEeCCcccc-chhhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcC
Confidence 345689999999999999975 3432234899999999999998544 89999999999999999863 469999999
Q ss_pred cEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccc
Q 039322 100 IRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179 (708)
Q Consensus 100 ~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n 179 (708)
++|++++|.++++.+ +..+++|++|++++|...... ..+..+++|++|++++|.+....+ +..+++|++|++++|
T Consensus 113 ~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187 (347)
T ss_dssp SEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred CEEECcCCcccCchh--hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence 999999999997655 899999999999999654333 348899999999999999985543 889999999999999
Q ss_pred cccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCCh
Q 039322 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPK 259 (708)
Q Consensus 180 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 259 (708)
++++..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|++++..+ +..+++|+.|++++|.++.. .
T Consensus 188 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~ 259 (347)
T 4fmz_A 188 QIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--N 259 (347)
T ss_dssp CCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--G
T ss_pred ccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--h
Confidence 9985433 8889999999999999995443 8889999999999999996554 88999999999999999854 5
Q ss_pred hhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCCCccccccCc
Q 039322 260 ELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAP 339 (708)
Q Consensus 260 ~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~ 339 (708)
.+..+++|+.|++++|.+++. ..+..+++|+.|++++|++++..+..+..+++|+.|++++|++++.+| ...++.++
T Consensus 260 ~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~ 336 (347)
T 4fmz_A 260 AVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMD 336 (347)
T ss_dssp GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCS
T ss_pred hHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC-hhhhhccc
Confidence 689999999999999999864 357889999999999999998888999999999999999999999877 66788899
Q ss_pred ccccccccC
Q 039322 340 VEALKGNKG 348 (708)
Q Consensus 340 ~~~~~~n~~ 348 (708)
.+.+.+|+.
T Consensus 337 ~L~l~~N~i 345 (347)
T 4fmz_A 337 SADFANQVI 345 (347)
T ss_dssp EESSSCC--
T ss_pred eeehhhhcc
Confidence 999999864
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=289.54 Aligned_cols=288 Identities=18% Similarity=0.195 Sum_probs=253.4
Q ss_pred CCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEecc
Q 039322 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVS 81 (708)
Q Consensus 3 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~ 81 (708)
+++.++++++.++. .|..+ .++|++|+|++|++++..+..+.. ++|+.|++++|.+++..|..+..+++|++|+++
T Consensus 32 ~l~~l~~~~~~l~~-lp~~~--~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLEK-VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCCS-CCCSC--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCccc-cCccC--CCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 58899999999995 44444 368999999999999887777765 899999999999999889999999999999999
Q ss_pred CCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCccee--eCCCCCCCCCCCCEEEcccCcccc
Q 039322 82 ENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYG--EISSNWGKCPKLGTLNVSMNNITG 159 (708)
Q Consensus 82 ~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~L~~N~i~~ 159 (708)
+|.++ .+|..+. ++|++|++++|.++++.+..|..+++|++|++++|.+.. +.+..|..+++|+.|++++|.++.
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 99999 5555554 799999999999999999999999999999999999964 677889999999999999999995
Q ss_pred cCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCc
Q 039322 160 GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239 (708)
Q Consensus 160 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~ 239 (708)
.|..+. ++|++|++++|++++..+..+..+++|++|+|++|++++..+..+..+++|++|+|++|+++ ..|..+..
T Consensus 186 -l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 261 (330)
T 1xku_A 186 -IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261 (330)
T ss_dssp -CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred -CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhcc
Confidence 444443 89999999999999888899999999999999999999888888999999999999999999 77888999
Q ss_pred cccceeecccCcccccCCChhhhh------hcccchhhcccccCCC--CCchhhcCcccCCceeccccc
Q 039322 240 LLKLHYLGLSNNQFVLELPKELEK------LVQLSELDASHNLFGG--EIPFQICSLKSLEKLNLSHNN 300 (708)
Q Consensus 240 l~~L~~L~l~~n~l~~~~~~~~~~------l~~L~~L~ls~N~i~~--~~~~~~~~~~~L~~L~l~~N~ 300 (708)
+++|+.|++++|+|++..+..|.. ...|+.|++++|++.. ..|..+..+++++.++|++|+
T Consensus 262 l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 999999999999999887777754 3788999999999974 567888899999999999985
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=297.07 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=223.9
Q ss_pred CCcccccccCCCccC--CCCccccCCCCccEEeccC-CccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCE
Q 039322 49 PMLTRPGLDFNHFTS--YLPHNVCRGGALQYFGVSE-NHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTF 125 (708)
Q Consensus 49 ~~l~~l~l~~n~~~~--~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~ 125 (708)
.+++.|++++|.+.+ .+|..+..+++|++|++++ |.+++.+|..|.++++|++|+|++|++++..+..|..+++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 579999999999998 8999999999999999995 9999999999999999999999999999999999999999999
Q ss_pred EEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCC-CCCEEecccccccccCCcccCCCCCCCEEEccCcc
Q 039322 126 IDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSS-QLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQ 204 (708)
Q Consensus 126 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 204 (708)
|++++|.+++..+..|..+++|++|+|++|++++..|..+..++ +|++|+|++|++++..|..+..++ |++|++++|+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 99999999988899999999999999999999988999999998 999999999999988999998887 9999999999
Q ss_pred ccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchh
Q 039322 205 FTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQ 284 (708)
Q Consensus 205 l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~ 284 (708)
+++..+..|..+++|+.|+|++|++++..+. +..+++|+.|++++|++++..|..|..+++|+.|+|++|++++.+|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 9988888899999999999999999865554 777888888888888888778888888888888888888887666654
Q ss_pred hcCcccCCceeccccc
Q 039322 285 ICSLKSLEKLNLSHNN 300 (708)
Q Consensus 285 ~~~~~~L~~L~l~~N~ 300 (708)
..+++|+.|++++|+
T Consensus 288 -~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 288 -GNLQRFDVSAYANNK 302 (313)
T ss_dssp -TTGGGSCGGGTCSSS
T ss_pred -ccccccChHHhcCCC
Confidence 667777777777776
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=291.17 Aligned_cols=287 Identities=21% Similarity=0.229 Sum_probs=253.4
Q ss_pred CCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEecc
Q 039322 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVS 81 (708)
Q Consensus 3 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~ 81 (708)
+++.++++++.++. .|..+ .++|++|+|++|.+.+..+..+.. ++|+.|++++|.+++..|..+..+++|++|+++
T Consensus 34 ~l~~l~~~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLKA-VPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCSS-CCSCC--CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCccc-cCCCC--CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 58999999999995 45544 378999999999999888877766 899999999999999889999999999999999
Q ss_pred CCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCccee--eCCCCCCCCCCCCEEEcccCcccc
Q 039322 82 ENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYG--EISSNWGKCPKLGTLNVSMNNITG 159 (708)
Q Consensus 82 ~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~L~~N~i~~ 159 (708)
+|.++ .+|..+. ++|++|++++|.++.+.+..|..+++|++|++++|.++. +.+..+..+ +|+.|++++|+++.
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 99999 5555554 899999999999999999999999999999999999964 677888888 99999999999996
Q ss_pred cCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCc
Q 039322 160 GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239 (708)
Q Consensus 160 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~ 239 (708)
.|..+. ++|++|+|++|++++..+..+..+++|++|+|++|++++..+..+..+++|++|+|++|+++ .+|..+..
T Consensus 187 -l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 262 (332)
T 2ft3_A 187 -IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262 (332)
T ss_dssp -CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGG
T ss_pred -cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhc
Confidence 444443 78999999999999888889999999999999999999888888999999999999999999 77888999
Q ss_pred cccceeecccCcccccCCChhhhhh------cccchhhcccccCC--CCCchhhcCcccCCceeccccc
Q 039322 240 LLKLHYLGLSNNQFVLELPKELEKL------VQLSELDASHNLFG--GEIPFQICSLKSLEKLNLSHNN 300 (708)
Q Consensus 240 l~~L~~L~l~~n~l~~~~~~~~~~l------~~L~~L~ls~N~i~--~~~~~~~~~~~~L~~L~l~~N~ 300 (708)
+++|+.|++++|+|+...+..|... ..|+.|++++|++. +..+..+..+++|+.+++++|+
T Consensus 263 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 263 LKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 9999999999999998877777653 67999999999997 5778889999999999999985
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-31 Score=290.28 Aligned_cols=308 Identities=19% Similarity=0.222 Sum_probs=259.6
Q ss_pred cccccCCccccCCCCCCEEEeeCceeeeeCCCCCC-CCCcccccccCCCccCCCCccccCCCCccEEeccCCccccccCc
Q 039322 13 QFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLE-NPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPK 91 (708)
Q Consensus 13 ~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~ 91 (708)
.+....+..++++++|++|+|++|.+++. | .+. .++|+.|++++|.+++. + ++.+++|++|++++|.+++. +
T Consensus 29 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~- 101 (457)
T 3bz5_A 29 EMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D- 101 (457)
T ss_dssp TCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C-
T ss_pred CcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e-
Confidence 34444566788999999999999999864 5 344 38999999999999985 3 88999999999999999974 3
Q ss_pred cCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCC
Q 039322 92 ILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQL 171 (708)
Q Consensus 92 ~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L 171 (708)
++++++|++|++++|+++++. +..+++|++|++++|+++++ .+..+++|+.|++++|+..+.. .+..+++|
T Consensus 102 -~~~l~~L~~L~L~~N~l~~l~---~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L 172 (457)
T 3bz5_A 102 -VTPLTKLTYLNCDTNKLTKLD---VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQL 172 (457)
T ss_dssp -CTTCTTCCEEECCSSCCSCCC---CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTC
T ss_pred -cCCCCcCCEEECCCCcCCeec---CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcC
Confidence 899999999999999999863 89999999999999999876 3788999999999999644343 58889999
Q ss_pred CEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCc
Q 039322 172 QALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNN 251 (708)
Q Consensus 172 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n 251 (708)
++|++++|++++ ++ +..+++|+.|++++|++++. .+..+++|++|++++|++++ .| +..+++|+.|++++|
T Consensus 173 ~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N 243 (457)
T 3bz5_A 173 TTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVN 243 (457)
T ss_dssp CEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSS
T ss_pred CEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCC
Confidence 999999999996 44 88999999999999999965 48899999999999999997 45 889999999999999
Q ss_pred ccccCCChhhhhhc-------ccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCC--------ccccccccc
Q 039322 252 QFVLELPKELEKLV-------QLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPN--------CFEGIRGIS 316 (708)
Q Consensus 252 ~l~~~~~~~~~~l~-------~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~--------~~~~l~~L~ 316 (708)
++++..+..+..+. +|+.|++++|.+.+..| +..+++|+.|++++|+..+.+|. .+..+++|+
T Consensus 244 ~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~ 321 (457)
T 3bz5_A 244 PLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLV 321 (457)
T ss_dssp CCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCC
T ss_pred cCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCC
Confidence 99987766666555 56778888887766555 56789999999999986554443 356778999
Q ss_pred EEecCCCcCCCCCCCccccccCcccccccccCc
Q 039322 317 VIDISDNQLQGPVPNSTAFRNAPVEALKGNKGL 349 (708)
Q Consensus 317 ~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~ 349 (708)
.|++++|.+++. + ...++.++.+.+++|...
T Consensus 322 ~L~L~~N~l~~l-~-l~~l~~L~~L~l~~N~l~ 352 (457)
T 3bz5_A 322 YLYLNNTELTEL-D-VSHNTKLKSLSCVNAHIQ 352 (457)
T ss_dssp EEECTTCCCSCC-C-CTTCTTCSEEECCSSCCC
T ss_pred EEECCCCccccc-c-cccCCcCcEEECCCCCCC
Confidence 999999999996 3 566778889999888754
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=276.53 Aligned_cols=276 Identities=20% Similarity=0.229 Sum_probs=211.4
Q ss_pred cEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeC--CCCCCCCCCCCEEEcc
Q 039322 76 QYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEI--SSNWGKCPKLGTLNVS 153 (708)
Q Consensus 76 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~L~ 153 (708)
+.++++++.++ .+|..+. ++|++|+|++|+++.++...|..+++|++|+|++|+++.+. +..+..+++|++|+|+
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 46777777777 4555443 57888888888888777777778888888888888776442 3455567888888888
Q ss_pred cCcccccCCccccCCCCCCEEecccccccccCC-cccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccc-
Q 039322 154 MNNITGGIPREIGNSSQLQALDLSLNHIVGEIP-KELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNN- 231 (708)
Q Consensus 154 ~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~- 231 (708)
+|.++. .+..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..+..+..+++|++|++++|.+++
T Consensus 87 ~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 165 (306)
T 2z66_A 87 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165 (306)
T ss_dssp SCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred CCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence 888873 45567788888888888888875544 467788888888888888887777778888888888888888875
Q ss_pred cCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccc
Q 039322 232 SVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEG 311 (708)
Q Consensus 232 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~ 311 (708)
..|..+..+++|+.|++++|++++..|..|..+++|+.|++++|.+++..+..+..+++|+.|++++|++++..+..+..
T Consensus 166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 245 (306)
T 2z66_A 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 245 (306)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCC
T ss_pred cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHh
Confidence 56777888888888888888888777888888888888888888888777777888889999999999998888888888
Q ss_pred cc-cccEEecCCCcCCCCCCCc---cccccCcccccccccCcCCCCCC
Q 039322 312 IR-GISVIDISDNQLQGPVPNS---TAFRNAPVEALKGNKGLCGGVKG 355 (708)
Q Consensus 312 l~-~L~~l~l~~N~l~~~~~~~---~~~~~~~~~~~~~n~~~c~~~~~ 355 (708)
++ +|+.|++++|+++|.++.. .++...+......+...|..|..
T Consensus 246 ~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~ 293 (306)
T 2z66_A 246 FPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 293 (306)
T ss_dssp CCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGG
T ss_pred hhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchh
Confidence 84 8999999999998876542 22334455556667777766544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=281.59 Aligned_cols=262 Identities=25% Similarity=0.287 Sum_probs=126.3
Q ss_pred CcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcc
Q 039322 50 MLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLS 129 (708)
Q Consensus 50 ~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~ 129 (708)
+|+.|++++|.+++ +| .++.+++|++|++++|++++ +|..+ ++|++|++++|++++++ .|..+++|++|+++
T Consensus 132 ~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l~--~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 132 LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEELP--ELQNLPFLTAIYAD 203 (454)
T ss_dssp TCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSCC--CCTTCTTCCEEECC
T ss_pred CCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcCc--cccCCCCCCEEECC
Confidence 45555555555544 33 34455555555555555543 23221 34555555555555432 34555555555555
Q ss_pred cCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccC
Q 039322 130 RNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRL 209 (708)
Q Consensus 130 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 209 (708)
+|+++++.. ..++|+.|++++|.++ .+| .+..+++|++|++++|++++ +|. .+++|++|++++|++++ +
T Consensus 204 ~N~l~~l~~----~~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~---~~~~L~~L~l~~N~l~~-l 272 (454)
T 1jl5_A 204 NNSLKKLPD----LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTD-L 272 (454)
T ss_dssp SSCCSSCCC----CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSC-C
T ss_pred CCcCCcCCC----CcCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-ccc---cccccCEEECCCCcccc-c
Confidence 555543221 1134555555555554 233 25555555555555555552 222 12455555555555553 2
Q ss_pred CcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhh-cccchhhcccccCCCCCchhhcCc
Q 039322 210 PPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKL-VQLSELDASHNLFGGEIPFQICSL 288 (708)
Q Consensus 210 ~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~ls~N~i~~~~~~~~~~~ 288 (708)
|.. .++|++|++++|++++. +.. .++|+.|++++|++++. ..+ ++|+.|++++|++++ +|.. +
T Consensus 273 ~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i-----~~~~~~L~~L~Ls~N~l~~-lp~~---~ 336 (454)
T 1jl5_A 273 PEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSL-----CDLPPSLEELNVSNNKLIE-LPAL---P 336 (454)
T ss_dssp CCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEE-----CCCCTTCCEEECCSSCCSC-CCCC---C
T ss_pred Ccc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCcc-----cCCcCcCCEEECCCCcccc-cccc---C
Confidence 222 24555555555555531 110 13455555555555431 122 377778888888774 3332 4
Q ss_pred ccCCceecccccccCCCCCcccccccccEEecCCCcCCC--CCCC-cccc-------------ccCcccccccccCcC
Q 039322 289 KSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQG--PVPN-STAF-------------RNAPVEALKGNKGLC 350 (708)
Q Consensus 289 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~--~~~~-~~~~-------------~~~~~~~~~~n~~~c 350 (708)
++|+.|++++|+++. +|. .+++|+.|++++|++++ ..|. ...+ ++++.+.+++|+...
T Consensus 337 ~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~ 410 (454)
T 1jl5_A 337 PRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE 410 (454)
T ss_dssp TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC------------------------
T ss_pred CcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCc
Confidence 778888888888874 444 36778888888888887 3333 2222 456777777777654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-31 Score=283.76 Aligned_cols=253 Identities=21% Similarity=0.220 Sum_probs=193.4
Q ss_pred CccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcc
Q 039322 74 ALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVS 153 (708)
Q Consensus 74 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 153 (708)
....++++++.++ .+|..+. ++++.|+|++|+|+.+.+..|.++++|++|+|++|+++.+.+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 3567777777777 5565554 677778888888877777777788888888888888877777777778888888888
Q ss_pred cCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccC-ccccccCCcccCCCCCCCeEeccCCccccc
Q 039322 154 MNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRG-NQFTGRLPPEIGSLVDLEYLDLSANRFNNS 232 (708)
Q Consensus 154 ~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~ 232 (708)
+|+|+...+..|..+++|++|+|++|+++...+..|..+++|++|+|++ |.+....+..|.++++|++|+|++|+++ .
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~ 199 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-E 199 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-S
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-c
Confidence 8888766666777778888888888887766666777778888888877 4555455556777888888888888887 3
Q ss_pred CCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCccccc
Q 039322 233 VPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGI 312 (708)
Q Consensus 233 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l 312 (708)
.| .+..+++|+.|+|++|++++..+..|.++++|+.|+|++|.|++..+..+..+++|+.|+|++|++++..+..|..+
T Consensus 200 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 278 (440)
T 3zyj_A 200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278 (440)
T ss_dssp CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence 34 46777788888888888887777778888888888888888887777777788888888888888887777777888
Q ss_pred ccccEEecCCCcCCCCCCC
Q 039322 313 RGISVIDISDNQLQGPVPN 331 (708)
Q Consensus 313 ~~L~~l~l~~N~l~~~~~~ 331 (708)
++|+.|++++|++.|.+..
T Consensus 279 ~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 279 HHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp TTCCEEECCSSCEECSSTT
T ss_pred cCCCEEEcCCCCccCCCCc
Confidence 8888888888888876654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=281.72 Aligned_cols=253 Identities=22% Similarity=0.207 Sum_probs=218.4
Q ss_pred CccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcc
Q 039322 74 ALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVS 153 (708)
Q Consensus 74 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 153 (708)
....++++++.++ .+|..+. ++|++|+|++|+|+++.+..|..+++|++|+|++|+++++.+..|.++++|++|+|+
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 4567888888888 5666554 688999999999998888889999999999999999988888889999999999999
Q ss_pred cCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccC-ccccccCCcccCCCCCCCeEeccCCccccc
Q 039322 154 MNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRG-NQFTGRLPPEIGSLVDLEYLDLSANRFNNS 232 (708)
Q Consensus 154 ~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~ 232 (708)
+|+|+...+..|..+++|++|+|++|+++...+..|..+++|++|++++ |.+....+..|.++++|++|+|++|++++.
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 211 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence 9999887777888899999999999999877777888899999999998 566655566788899999999999999854
Q ss_pred CCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCccccc
Q 039322 233 VPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGI 312 (708)
Q Consensus 233 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l 312 (708)
| .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|.+++..+..+..+++|+.|+|++|++++..+..|..+
T Consensus 212 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 289 (452)
T 3zyi_A 212 -P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289 (452)
T ss_dssp -C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred -c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence 3 47888899999999999998888889999999999999999988888888889999999999999998888888889
Q ss_pred ccccEEecCCCcCCCCCCC
Q 039322 313 RGISVIDISDNQLQGPVPN 331 (708)
Q Consensus 313 ~~L~~l~l~~N~l~~~~~~ 331 (708)
++|+.|++++|++.|.+..
T Consensus 290 ~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 290 RYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp TTCCEEECCSSCEECSTTT
T ss_pred cCCCEEEccCCCcCCCCCc
Confidence 9999999999999887654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=282.30 Aligned_cols=258 Identities=17% Similarity=0.154 Sum_probs=135.6
Q ss_pred CccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcc
Q 039322 74 ALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVS 153 (708)
Q Consensus 74 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 153 (708)
+|++|++++|++++..+..|.++++|++|+|++|+++++.+..|..+++|++|++++|+++++.+..|..+++|++|+|+
T Consensus 53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 132 (353)
T 2z80_A 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLL 132 (353)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECT
T ss_pred cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECC
Confidence 45555555555554444445555555555555555554444445555555555555555544443334445555555555
Q ss_pred cCcccccCC-ccccCCCCCCEEecccc-cccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccc
Q 039322 154 MNNITGGIP-REIGNSSQLQALDLSLN-HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNN 231 (708)
Q Consensus 154 ~N~i~~~~~-~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~ 231 (708)
+|+++.... ..|..+++|++|++++| .++...+..+.++++|++|++++|++++..|..+..+++|++|++++|+++.
T Consensus 133 ~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~ 212 (353)
T 2z80_A 133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL 212 (353)
T ss_dssp TCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTT
T ss_pred CCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcccc
Confidence 555543322 24445555555555555 2443334445555555555555555554445555555555555555555542
Q ss_pred cCCCCCCccccceeecccCcccccCCChhhh---hhcccchhhcccccCCC----CCchhhcCcccCCceecccccccCC
Q 039322 232 SVPENLGNLLKLHYLGLSNNQFVLELPKELE---KLVQLSELDASHNLFGG----EIPFQICSLKSLEKLNLSHNNLSGS 304 (708)
Q Consensus 232 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~---~l~~L~~L~ls~N~i~~----~~~~~~~~~~~L~~L~l~~N~l~~~ 304 (708)
.....+..+++|+.|++++|++++..+..+. ....++.+++++|.+.+ .+|..+..+++|+.|++++|+++..
T Consensus 213 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i 292 (353)
T 2z80_A 213 LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSV 292 (353)
T ss_dssp HHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCC
T ss_pred chhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCcc
Confidence 2222223345555555555555543333222 22344445555554443 3455667777888888888888754
Q ss_pred CCCcccccccccEEecCCCcCCCCCCC
Q 039322 305 IPNCFEGIRGISVIDISDNQLQGPVPN 331 (708)
Q Consensus 305 ~~~~~~~l~~L~~l~l~~N~l~~~~~~ 331 (708)
.+..|..+++|+.|++++|++.|.+|.
T Consensus 293 ~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 293 PDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 444467778888888888888777653
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=278.38 Aligned_cols=278 Identities=18% Similarity=0.143 Sum_probs=240.3
Q ss_pred CCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEc
Q 039322 73 GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNV 152 (708)
Q Consensus 73 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 152 (708)
+.....+++++.++ .+|..+. ++|++|++++|+++++.+..|..+++|++|++++|+++++.+..|.++++|++|+|
T Consensus 31 ~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 31 DRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp CTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 44556899999999 5666655 59999999999999998889999999999999999999999999999999999999
Q ss_pred ccCcccccCCccccCCCCCCEEecccccccccCC-cccCCCCCCCEEEccCc-cccccCCcccCCCCCCCeEeccCCccc
Q 039322 153 SMNNITGGIPREIGNSSQLQALDLSLNHIVGEIP-KELGKLNSLTELILRGN-QFTGRLPPEIGSLVDLEYLDLSANRFN 230 (708)
Q Consensus 153 ~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~~~~L~~L~l~~N~i~ 230 (708)
++|+|+...+..|..+++|++|+|++|+++.... ..+..+++|++|++++| .+++..+..|..+++|++|++++|+++
T Consensus 108 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~ 187 (353)
T 2z80_A 108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ 187 (353)
T ss_dssp CSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcC
Confidence 9999997766669999999999999999995444 47899999999999999 588777888999999999999999999
Q ss_pred ccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhc---CcccCCceecccccccC----
Q 039322 231 NSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQIC---SLKSLEKLNLSHNNLSG---- 303 (708)
Q Consensus 231 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~---~~~~L~~L~l~~N~l~~---- 303 (708)
+..|..+..+++|+.|++++|+++......+..+++|+.|++++|.+++..+..+. ..+.++.+++++|.+++
T Consensus 188 ~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~ 267 (353)
T 2z80_A 188 SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF 267 (353)
T ss_dssp EECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHH
T ss_pred ccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchh
Confidence 88899999999999999999999855445566789999999999999976554433 35667788888887764
Q ss_pred CCCCcccccccccEEecCCCcCCCCCCCc-cccccCcccccccccCcCCCC
Q 039322 304 SIPNCFEGIRGISVIDISDNQLQGPVPNS-TAFRNAPVEALKGNKGLCGGV 353 (708)
Q Consensus 304 ~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~n~~~c~~~ 353 (708)
.+|..+..+++|+.|++++|.++..++.. ..++.++.+.+.+|+|.|+|+
T Consensus 268 ~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 268 QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 35677889999999999999999766654 578889999999999999885
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-29 Score=272.96 Aligned_cols=299 Identities=26% Similarity=0.289 Sum_probs=208.3
Q ss_pred CCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEeccC
Q 039322 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSE 82 (708)
Q Consensus 3 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~ 82 (708)
++++|++++|+++++. .. .++|++|+|++|.+++ +|..+ ++|+.|++++|.+++. +.. .++|++|++++
T Consensus 72 ~l~~L~l~~~~l~~lp-~~---~~~L~~L~l~~n~l~~-lp~~~--~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~ 140 (454)
T 1jl5_A 72 QAHELELNNLGLSSLP-EL---PPHLESLVASCNSLTE-LPELP--QSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSN 140 (454)
T ss_dssp TCSEEECTTSCCSCCC-SC---CTTCSEEECCSSCCSS-CCCCC--TTCCEEECCSSCCSCC-CSC---CTTCCEEECCS
T ss_pred CCCEEEecCCccccCC-CC---cCCCCEEEccCCcCCc-ccccc--CCCcEEECCCCccCcc-cCC---CCCCCEEECcC
Confidence 3567777777776532 21 3567777777777765 44322 5677777777777652 211 15777888888
Q ss_pred CccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCC
Q 039322 83 NHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIP 162 (708)
Q Consensus 83 n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~ 162 (708)
|++++ +| .|+++++|++|++++|++++++. . .++|++|++++|+++++. .+..+++|+.|++++|++++ .|
T Consensus 141 n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~-~---~~~L~~L~L~~n~l~~l~--~~~~l~~L~~L~l~~N~l~~-l~ 211 (454)
T 1jl5_A 141 NQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPD-L---PPSLEFIAAGNNQLEELP--ELQNLPFLTAIYADNNSLKK-LP 211 (454)
T ss_dssp SCCSS-CC-CCTTCTTCCEEECCSSCCSCCCC-C---CTTCCEEECCSSCCSSCC--CCTTCTTCCEEECCSSCCSS-CC
T ss_pred CCCCC-Cc-ccCCCCCCCEEECCCCcCcccCC-C---cccccEEECcCCcCCcCc--cccCCCCCCEEECCCCcCCc-CC
Confidence 87775 55 47777888888888887775432 1 247788888888777643 47777888888888887774 33
Q ss_pred ccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCcccc
Q 039322 163 REIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLK 242 (708)
Q Consensus 163 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~ 242 (708)
.. .++|++|++++|+++ .+| .+..+++|++|++++|++++ +|.. .++|++|++++|++++ .|.. .++
T Consensus 212 ~~---~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~ 278 (454)
T 1jl5_A 212 DL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQS 278 (454)
T ss_dssp CC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTT
T ss_pred CC---cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCc
Confidence 22 247788888888777 455 37777888888888888774 4432 3678888888888874 4433 367
Q ss_pred ceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCc-ccCCceecccccccCCCCCcccccccccEEecC
Q 039322 243 LHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSL-KSLEKLNLSHNNLSGSIPNCFEGIRGISVIDIS 321 (708)
Q Consensus 243 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~ 321 (708)
|+.|++++|++++.. . + .++|+.|++++|.+++. ..+ ++|+.|++++|++++ +|.. +++|+.|+++
T Consensus 279 L~~L~ls~N~l~~l~-~-~--~~~L~~L~l~~N~l~~i-----~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~ 345 (454)
T 1jl5_A 279 LTFLDVSENIFSGLS-E-L--PPNLYYLNASSNEIRSL-----CDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIAS 345 (454)
T ss_dssp CCEEECCSSCCSEES-C-C--CTTCCEEECCSSCCSEE-----CCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECC
T ss_pred CCEEECcCCccCccc-C-c--CCcCCEEECcCCcCCcc-----cCCcCcCCEEECCCCcccc-cccc---CCcCCEEECC
Confidence 888888888887521 1 1 15788888888888742 223 589999999999996 5544 5899999999
Q ss_pred CCcCCCCCCCccccccCcccccccccCcC
Q 039322 322 DNQLQGPVPNSTAFRNAPVEALKGNKGLC 350 (708)
Q Consensus 322 ~N~l~~~~~~~~~~~~~~~~~~~~n~~~c 350 (708)
+|.+++.++ .+..++.+.+++|+..+
T Consensus 346 ~N~l~~lp~---~l~~L~~L~L~~N~l~~ 371 (454)
T 1jl5_A 346 FNHLAEVPE---LPQNLKQLHVEYNPLRE 371 (454)
T ss_dssp SSCCSCCCC---CCTTCCEEECCSSCCSS
T ss_pred CCccccccc---hhhhccEEECCCCCCCc
Confidence 999997544 46789999999998877
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-30 Score=263.99 Aligned_cols=280 Identities=19% Similarity=0.152 Sum_probs=137.2
Q ss_pred cEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEeccCCc
Q 039322 5 SILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENH 84 (708)
Q Consensus 5 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~ 84 (708)
+.++++++.++.+. ..+ .++|++|+|++|+++...+. .+..+++|++|++++|.
T Consensus 10 ~~l~c~~~~l~~ip-~~~--~~~l~~L~L~~n~l~~i~~~-----------------------~~~~l~~L~~L~L~~n~ 63 (306)
T 2z66_A 10 TEIRCNSKGLTSVP-TGI--PSSATRLELESNKLQSLPHG-----------------------VFDKLTQLTKLSLSSNG 63 (306)
T ss_dssp TEEECCSSCCSSCC-SCC--CTTCCEEECCSSCCCCCCTT-----------------------TTTTCTTCSEEECCSSC
T ss_pred CEEEcCCCCcccCC-CCC--CCCCCEEECCCCccCccCHh-----------------------HhhccccCCEEECCCCc
Confidence 35666666666433 222 24566666666666543332 34444555555555555
Q ss_pred cccc--cCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCC-CCCCCCCCCCEEEcccCcccccC
Q 039322 85 FQGT--IPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEIS-SNWGKCPKLGTLNVSMNNITGGI 161 (708)
Q Consensus 85 i~~~--~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~ 161 (708)
++.. .+..+..+++|++|+|++|.++.++ ..+..+++|++|++++|+++++.+ ..+..+++|++|++++|.++...
T Consensus 64 l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~l~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 142 (306)
T 2z66_A 64 LSFKGCCSQSDFGTTSLKYLDLSFNGVITMS-SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 142 (306)
T ss_dssp CCEEEEEEHHHHSCSCCCEEECCSCSEEEEE-EEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECS
T ss_pred cCcccCcccccccccccCEEECCCCccccCh-hhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccc
Confidence 4422 1333444455555555555554322 234445555555555555544433 34445555555555555555444
Q ss_pred CccccCCCCCCEEecccccccc-cCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCcc
Q 039322 162 PREIGNSSQLQALDLSLNHIVG-EIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNL 240 (708)
Q Consensus 162 ~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l 240 (708)
+..|..+++|++|+|++|.+++ ..|..+..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..+..+
T Consensus 143 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 222 (306)
T 2z66_A 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 222 (306)
T ss_dssp TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTC
T ss_pred hhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCc
Confidence 4445555555555555555543 344445555555555555555554444455555555555555555554444444555
Q ss_pred ccceeecccCcccccCCChhhhhhc-ccchhhcccccCCCCCc--hhhcCcccCCceecccccccCCCCCcccc
Q 039322 241 LKLHYLGLSNNQFVLELPKELEKLV-QLSELDASHNLFGGEIP--FQICSLKSLEKLNLSHNNLSGSIPNCFEG 311 (708)
Q Consensus 241 ~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~ls~N~i~~~~~--~~~~~~~~L~~L~l~~N~l~~~~~~~~~~ 311 (708)
++|+.|++++|++++..+..+..++ +|+.|+|++|++..... .....+...+.+.+..+.+.+..|..+.+
T Consensus 223 ~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g 296 (306)
T 2z66_A 223 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG 296 (306)
T ss_dssp TTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTT
T ss_pred ccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhCC
Confidence 5555555555555544444454442 55555555555543211 11122333444444555555555554444
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-30 Score=263.35 Aligned_cols=251 Identities=19% Similarity=0.155 Sum_probs=126.5
Q ss_pred cEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccC
Q 039322 76 QYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMN 155 (708)
Q Consensus 76 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 155 (708)
+.++++++.++ .+|..+ .++|++|+|++|.++++.+..|..+++|++|++++|.++++.+..|..+++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 34455555544 223222 234555555555555554445555555555555555555554555555555555555555
Q ss_pred c-ccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCC
Q 039322 156 N-ITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVP 234 (708)
Q Consensus 156 ~-i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~ 234 (708)
. ++...+..|..+++|++|+|++|++++..+..+..+++|++|++++|++++..+..|..+++|++|+|++|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 4 444444455555555555555555554444445555555555555555554444445555555555555555554444
Q ss_pred CCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCccccccc
Q 039322 235 ENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRG 314 (708)
Q Consensus 235 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~ 314 (708)
..|..+++|+.|++++|++++..|..|..+++|+.|++++|.+++..+..+..+++|+.|++++|++.+..+ ...-+..
T Consensus 171 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~-~~~~~~~ 249 (285)
T 1ozn_A 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAW 249 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHH
T ss_pred HHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC-cHHHHHH
Confidence 445555555555555555555545555555555555555555554444445555555555555555553221 1122233
Q ss_pred ccEEecCCCcCCCCCC
Q 039322 315 ISVIDISDNQLQGPVP 330 (708)
Q Consensus 315 L~~l~l~~N~l~~~~~ 330 (708)
++.+..+.|.+.|..|
T Consensus 250 l~~~~~~~~~~~c~~p 265 (285)
T 1ozn_A 250 LQKFRGSSSEVPCSLP 265 (285)
T ss_dssp HHHCCSEECCCBEEES
T ss_pred HHhcccccCccccCCc
Confidence 4444455555555444
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-30 Score=277.76 Aligned_cols=248 Identities=20% Similarity=0.217 Sum_probs=189.5
Q ss_pred cccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEccc
Q 039322 51 LTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSR 130 (708)
Q Consensus 51 l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~ 130 (708)
...++++++.++. +|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|.|+.+.+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLRE-VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCSS-CCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcCc-CCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 3445555555554 444443 5677888888888877777788888888888888888877777888888888888888
Q ss_pred CcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEeccc-ccccccCCcccCCCCCCCEEEccCccccccC
Q 039322 131 NDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSL-NHIVGEIPKELGKLNSLTELILRGNQFTGRL 209 (708)
Q Consensus 131 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 209 (708)
|+++.+.+..|..+++|++|+|++|.|+...+..|..+++|++|+|++ |.+....+..|.++++|++|+|++|.++ .+
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~ 200 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EI 200 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SC
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cc
Confidence 888777777788888888888888888877777788888888888887 4455444556777888888888888887 44
Q ss_pred CcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcc
Q 039322 210 PPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLK 289 (708)
Q Consensus 210 ~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~ 289 (708)
| .+..+++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|++++..+..+..++
T Consensus 201 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 279 (440)
T 3zyj_A 201 P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279 (440)
T ss_dssp C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCT
T ss_pred c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcccc
Confidence 4 467778888888888888877777888888888888888888877777788888888888888888877777777788
Q ss_pred cCCceecccccccC
Q 039322 290 SLEKLNLSHNNLSG 303 (708)
Q Consensus 290 ~L~~L~l~~N~l~~ 303 (708)
+|+.|+|++|++.+
T Consensus 280 ~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 280 HLERIHLHHNPWNC 293 (440)
T ss_dssp TCCEEECCSSCEEC
T ss_pred CCCEEEcCCCCccC
Confidence 88888888888763
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-30 Score=278.84 Aligned_cols=248 Identities=22% Similarity=0.215 Sum_probs=199.7
Q ss_pred cccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEccc
Q 039322 51 LTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSR 130 (708)
Q Consensus 51 l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~ 130 (708)
...++++++.++. +|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus 56 ~~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLSE-VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcCc-cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 3455566666655 444443 5788888888888887788888888888888888888888888888888888888888
Q ss_pred CcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEeccc-ccccccCCcccCCCCCCCEEEccCccccccC
Q 039322 131 NDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSL-NHIVGEIPKELGKLNSLTELILRGNQFTGRL 209 (708)
Q Consensus 131 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 209 (708)
|+++.+.+..|..+++|++|+|++|+|+...+..|..+++|++|+|++ |.+....+..|.++++|++|+|++|++++.
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~- 211 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM- 211 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-
Confidence 888888777888888888888888888877777888888888888888 455544455688888888888888888843
Q ss_pred CcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcc
Q 039322 210 PPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLK 289 (708)
Q Consensus 210 ~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~ 289 (708)
| .+..+++|++|+|++|+|++..|..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|+|++..+..+..++
T Consensus 212 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 290 (452)
T 3zyi_A 212 P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290 (452)
T ss_dssp C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCT
T ss_pred c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcccc
Confidence 3 477888888888888888887788888888888888888888888888888888888888888888877777778888
Q ss_pred cCCceecccccccC
Q 039322 290 SLEKLNLSHNNLSG 303 (708)
Q Consensus 290 ~L~~L~l~~N~l~~ 303 (708)
+|+.|+|++|++.+
T Consensus 291 ~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 291 YLVELHLHHNPWNC 304 (452)
T ss_dssp TCCEEECCSSCEEC
T ss_pred CCCEEEccCCCcCC
Confidence 88888998888874
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-30 Score=259.94 Aligned_cols=255 Identities=22% Similarity=0.191 Sum_probs=173.4
Q ss_pred ccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccC
Q 039322 52 TRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRN 131 (708)
Q Consensus 52 ~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n 131 (708)
+.++++++.++. +|..+ .++|++|++++|.+++..+..|.++++|++|+|++|.++++.+..|..+++|++|++++|
T Consensus 14 ~~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCSS-CCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCccc-CCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 445666666655 33333 356777777777777666666777777777777777777776777777777777777777
Q ss_pred c-ceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCC
Q 039322 132 D-FYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLP 210 (708)
Q Consensus 132 ~-l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 210 (708)
. +..+.+..|..+++|++|++++|.++...+..|..+++|++|+|++|++++..+..+..+++|++|+|++|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 5 666666677777777777777777776666667777777777777777775555566777777777777777776555
Q ss_pred cccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCccc
Q 039322 211 PEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKS 290 (708)
Q Consensus 211 ~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~ 290 (708)
..|..+++|++|+|++|++++..|..|..+++|+.|++++|++++..+..|..+++|+.|++++|++....+.. .-...
T Consensus 171 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~ 249 (285)
T 1ozn_A 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAW 249 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHH
T ss_pred HHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHH
Confidence 56777777777777777777666777777777777777777777655566777777777777777776432221 22234
Q ss_pred CCceecccccccCCCCCccc
Q 039322 291 LEKLNLSHNNLSGSIPNCFE 310 (708)
Q Consensus 291 L~~L~l~~N~l~~~~~~~~~ 310 (708)
++.+..+.+.+.+..|..+.
T Consensus 250 l~~~~~~~~~~~c~~p~~l~ 269 (285)
T 1ozn_A 250 LQKFRGSSSEVPCSLPQRLA 269 (285)
T ss_dssp HHHCCSEECCCBEEESGGGT
T ss_pred HHhcccccCccccCCchHhC
Confidence 55556666666666666554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-34 Score=311.14 Aligned_cols=347 Identities=20% Similarity=0.142 Sum_probs=193.5
Q ss_pred CCCcEEECCCCcccccCCcc-ccCCCCCCEEEeeCceeeee----CCCCCC-CCCcccccccCCCccCCCCcccc-CCC-
Q 039322 2 RSLSILDLNQNQFKGVLPPS-VSNLTNLKELVLLYNNLSGF----IPPSLE-NPMLTRPGLDFNHFTSYLPHNVC-RGG- 73 (708)
Q Consensus 2 ~~L~~L~l~~n~i~~~~~~~-~~~l~~L~~L~L~~n~i~~~----~~~~~~-~~~l~~l~l~~n~~~~~~~~~~~-~l~- 73 (708)
++|++|||++|+++...... +..+++|++|+|++|.++.. ++..+. .++|+.|++++|.+.+..+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 45667777777766544333 56667777777777766532 122222 25677777777766553332222 233
Q ss_pred ---CccEEeccCCcccc----ccCccCcCCCCCcEEEccCCccccccccc-----cCCCCCCCEEEcccCcceeeC----
Q 039322 74 ---ALQYFGVSENHFQG----TIPKILRNCSSLIRVRLNSNNLTGNISEA-----LGIYPNLTFIDLSRNDFYGEI---- 137 (708)
Q Consensus 74 ---~L~~L~l~~n~i~~----~~~~~~~~l~~L~~L~l~~n~i~~~~~~~-----~~~~~~L~~L~l~~n~l~~~~---- 137 (708)
+|++|++++|.+++ .++..+.++++|++|+|++|.++...... +...++|++|++++|+++...
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 57777777777663 33566666777777777777766433322 222456777777777665432
Q ss_pred CCCCCCCCCCCEEEcccCcccccCCcccc-----CCCCCCEEeccccccccc----CCcccCCCCCCCEEEccCcccccc
Q 039322 138 SSNWGKCPKLGTLNVSMNNITGGIPREIG-----NSSQLQALDLSLNHIVGE----IPKELGKLNSLTELILRGNQFTGR 208 (708)
Q Consensus 138 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~-----~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~ 208 (708)
+..+..+++|++|++++|.++...+..+. ..++|++|+|++|.++.. ++..+..+++|++|++++|.+++.
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~ 242 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence 23344556677777777766544333332 245666777776666642 244455566666666666666532
Q ss_pred C-----CcccCCCCCCCeEeccCCccccc----CCCCCCccccceeecccCcccccCCChhhhhh-----cccchhhccc
Q 039322 209 L-----PPEIGSLVDLEYLDLSANRFNNS----VPENLGNLLKLHYLGLSNNQFVLELPKELEKL-----VQLSELDASH 274 (708)
Q Consensus 209 ~-----~~~~~~~~~L~~L~l~~N~i~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-----~~L~~L~ls~ 274 (708)
. +..+..+++|++|++++|.++.. .+..+..+++|+.|++++|.++...+..+... ++|+.|++++
T Consensus 243 ~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~ 322 (461)
T 1z7x_W 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 322 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred HHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCC
Confidence 1 12223456666666666666643 33444556666666666666654444444332 4666666666
Q ss_pred ccCCCC----CchhhcCcccCCceecccccccCCCCCcccc-----cccccEEecCCCcCCC----CCC-CccccccCcc
Q 039322 275 NLFGGE----IPFQICSLKSLEKLNLSHNNLSGSIPNCFEG-----IRGISVIDISDNQLQG----PVP-NSTAFRNAPV 340 (708)
Q Consensus 275 N~i~~~----~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~l~l~~N~l~~----~~~-~~~~~~~~~~ 340 (708)
|.+++. .+..+..+++|+.|++++|++++..+..+.. .++|+.|++++|.+++ .++ .....+.++.
T Consensus 323 n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~ 402 (461)
T 1z7x_W 323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE 402 (461)
T ss_dssp SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCE
T ss_pred CCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccE
Confidence 666643 2334445566666666666665443333322 4566666666666653 222 1233455666
Q ss_pred cccccccC
Q 039322 341 EALKGNKG 348 (708)
Q Consensus 341 ~~~~~n~~ 348 (708)
+.+.+|+.
T Consensus 403 L~l~~N~i 410 (461)
T 1z7x_W 403 LDLSNNCL 410 (461)
T ss_dssp EECCSSSC
T ss_pred EECCCCCC
Confidence 66666643
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-34 Score=310.82 Aligned_cols=328 Identities=18% Similarity=0.180 Sum_probs=264.8
Q ss_pred CCCCcEEECCCCccccc----CCccccCCCCCCEEEeeCceeeeeCCCCC----CC--CCcccccccCCCccC----CCC
Q 039322 1 MRSLSILDLNQNQFKGV----LPPSVSNLTNLKELVLLYNNLSGFIPPSL----EN--PMLTRPGLDFNHFTS----YLP 66 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~~~----~~--~~l~~l~l~~n~~~~----~~~ 66 (708)
+++|++|+|++|+++.. .+..+..+++|++|+|++|.+....+..+ .. ++|+.|++++|.++. .++
T Consensus 27 ~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~ 106 (461)
T 1z7x_W 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLS 106 (461)
T ss_dssp HTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred cCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHH
Confidence 47899999999999853 36678889999999999999876433222 21 269999999999985 458
Q ss_pred ccccCCCCccEEeccCCccccccCccCc-----CCCCCcEEEccCCcccccc----ccccCCCCCCCEEEcccCcceeeC
Q 039322 67 HNVCRGGALQYFGVSENHFQGTIPKILR-----NCSSLIRVRLNSNNLTGNI----SEALGIYPNLTFIDLSRNDFYGEI 137 (708)
Q Consensus 67 ~~~~~l~~L~~L~l~~n~i~~~~~~~~~-----~l~~L~~L~l~~n~i~~~~----~~~~~~~~~L~~L~l~~n~l~~~~ 137 (708)
..+..+++|++|++++|.+++..+..+. ..++|++|+|++|+++... +..+..+++|++|++++|.++...
T Consensus 107 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~ 186 (461)
T 1z7x_W 107 STLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAG 186 (461)
T ss_dssp HHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred HHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHH
Confidence 8889999999999999999865544333 3678999999999999644 556777899999999999987654
Q ss_pred CCCCC-----CCCCCCEEEcccCccccc----CCccccCCCCCCEEecccccccccC-----CcccCCCCCCCEEEccCc
Q 039322 138 SSNWG-----KCPKLGTLNVSMNNITGG----IPREIGNSSQLQALDLSLNHIVGEI-----PKELGKLNSLTELILRGN 203 (708)
Q Consensus 138 ~~~~~-----~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~~-----~~~~~~l~~L~~L~l~~n 203 (708)
...+. ..++|++|++++|.++.. .+..+..+++|++|+|++|++++.. +..+..+++|++|++++|
T Consensus 187 ~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n 266 (461)
T 1z7x_W 187 VRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWEC 266 (461)
T ss_dssp HHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred HHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCC
Confidence 44443 356999999999999864 4667788999999999999998543 223446899999999999
Q ss_pred ccccc----CCcccCCCCCCCeEeccCCcccccCCCCCCc-----cccceeecccCcccccC----CChhhhhhcccchh
Q 039322 204 QFTGR----LPPEIGSLVDLEYLDLSANRFNNSVPENLGN-----LLKLHYLGLSNNQFVLE----LPKELEKLVQLSEL 270 (708)
Q Consensus 204 ~l~~~----~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~-----l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L 270 (708)
.++.. ++..+..+++|++|+|++|.+++..+..+.. .++|+.|++++|.+++. .+..+..+++|+.|
T Consensus 267 ~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L 346 (461)
T 1z7x_W 267 GITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL 346 (461)
T ss_dssp CCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEE
T ss_pred CCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEE
Confidence 99853 5667778999999999999998654444433 36999999999999865 35567778999999
Q ss_pred hcccccCCCCCchhhcC-----cccCCceecccccccC----CCCCcccccccccEEecCCCcCCCC
Q 039322 271 DASHNLFGGEIPFQICS-----LKSLEKLNLSHNNLSG----SIPNCFEGIRGISVIDISDNQLQGP 328 (708)
Q Consensus 271 ~ls~N~i~~~~~~~~~~-----~~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~l~l~~N~l~~~ 328 (708)
++++|.+++..+..+.. .++|+.|++++|++++ .++..+..+++|+.|++++|++++.
T Consensus 347 ~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 347 QISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp ECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred EccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence 99999998765555543 6799999999999985 6778888899999999999999853
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-32 Score=299.86 Aligned_cols=237 Identities=20% Similarity=0.182 Sum_probs=180.2
Q ss_pred CCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEE
Q 039322 71 RGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTL 150 (708)
Q Consensus 71 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 150 (708)
..++|++|+|++|.+++..|..|.++++|++|+|++|.+++..+ |..+++|++|+|++|.++++.+. ++|+.|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~-----~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG-----PSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC-----TTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC-----CCcCEE
Confidence 33478999999999988777888889999999999999887665 88888999999999988876543 788888
Q ss_pred EcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccC-CCCCCCeEeccCCcc
Q 039322 151 NVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIG-SLVDLEYLDLSANRF 229 (708)
Q Consensus 151 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~~~~L~~L~l~~N~i 229 (708)
++++|.|++..+. .+++|+.|+|++|.+++..+..++.+++|+.|+|++|.+++..|..+. .+++|++|+|++|.|
T Consensus 105 ~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 105 HAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp ECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred ECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 8888888866554 347788888888888877777788888888888888888877777765 678888888888888
Q ss_pred cccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceeccccccc-CCCCCc
Q 039322 230 NNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS-GSIPNC 308 (708)
Q Consensus 230 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~-~~~~~~ 308 (708)
++..+ +..+++|+.|+|++|.|++..+. |..+++|+.|+|++|.+++ +|..+..+++|+.|++++|++. +.+|..
T Consensus 182 ~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~ 257 (487)
T 3oja_A 182 YDVKG--QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF 257 (487)
T ss_dssp CEEEC--CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHH
T ss_pred ccccc--cccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHH
Confidence 85532 33477888888888888754443 7777778888888887773 4555667777777777777776 344555
Q ss_pred ccccccccEEecC
Q 039322 309 FEGIRGISVIDIS 321 (708)
Q Consensus 309 ~~~l~~L~~l~l~ 321 (708)
+..++.|+.++++
T Consensus 258 ~~~l~~L~~l~~~ 270 (487)
T 3oja_A 258 FSKNQRVQTVAKQ 270 (487)
T ss_dssp HTTCHHHHHHHHH
T ss_pred HHhCCCCcEEecc
Confidence 5556666555553
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-30 Score=266.47 Aligned_cols=255 Identities=19% Similarity=0.154 Sum_probs=198.4
Q ss_pred ccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcc
Q 039322 54 PGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDF 133 (708)
Q Consensus 54 l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l 133 (708)
++++.+.+...+...+..+++|++|++++|.+++..|..|.++++|++|+|++|.+++..+ |..+++|++|++++|++
T Consensus 15 ~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l 92 (317)
T 3o53_A 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV 92 (317)
T ss_dssp ESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEE
T ss_pred eeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcc
Confidence 4555666655455555566788888888888887777788888888888888888886654 88888888888888888
Q ss_pred eeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCccc
Q 039322 134 YGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI 213 (708)
Q Consensus 134 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 213 (708)
+++.+ .++|+.|++++|+|++..+.. +++|++|++++|++++..+..+..+++|++|+|++|.+++..+..+
T Consensus 93 ~~l~~-----~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 164 (317)
T 3o53_A 93 QELLV-----GPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164 (317)
T ss_dssp EEEEE-----CTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGG
T ss_pred ccccC-----CCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHH
Confidence 76653 378888888888888665443 5778888888888887767778888888888888888887666666
Q ss_pred C-CCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCC
Q 039322 214 G-SLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLE 292 (708)
Q Consensus 214 ~-~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~ 292 (708)
. .+++|++|+|++|.|++. +. ...+++|+.|++++|++++.. ..|..+++|+.|++++|+|+ .+|..+..+++|+
T Consensus 165 ~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~-~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~ 240 (317)
T 3o53_A 165 AASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240 (317)
T ss_dssp GGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEEC-GGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCC
T ss_pred hhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcch-hhhcccCcccEEECcCCccc-chhhHhhcCCCCC
Confidence 3 678888888888888855 32 234788888888888888544 44888888888888888888 4566777888888
Q ss_pred ceeccccccc-CCCCCcccccccccEEecCC
Q 039322 293 KLNLSHNNLS-GSIPNCFEGIRGISVIDISD 322 (708)
Q Consensus 293 ~L~l~~N~l~-~~~~~~~~~l~~L~~l~l~~ 322 (708)
.|++++|++. +..+..+..++.|+.+++++
T Consensus 241 ~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~ 271 (317)
T 3o53_A 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271 (317)
T ss_dssp EEECTTCCCBHHHHHHHHHTCHHHHHHHHHH
T ss_pred EEEccCCCccCcCHHHHHhccccceEEECCC
Confidence 8888888887 56677777888888888873
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-30 Score=265.85 Aligned_cols=267 Identities=23% Similarity=0.217 Sum_probs=168.3
Q ss_pred CcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEeccCC
Q 039322 4 LSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSEN 83 (708)
Q Consensus 4 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n 83 (708)
++.++++.+.+.......+..+++|++|+|++|++++ ..+..+..+++|++|++++|
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~-----------------------~~~~~~~~l~~L~~L~Ls~n 68 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ-----------------------ISAADLAPFTKLELLNLSSN 68 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCC-----------------------CCHHHHTTCTTCCEEECTTS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCc-----------------------CCHHHhhCCCcCCEEECCCC
Confidence 4445555555555555555555566666666666654 34455666667777777777
Q ss_pred ccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCc
Q 039322 84 HFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPR 163 (708)
Q Consensus 84 ~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~ 163 (708)
.+++..+ +..+++|++|+|++|.++++.. .++|++|++++|+++++.+.. +++|+.|++++|+++...+.
T Consensus 69 ~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~-----~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~ 138 (317)
T 3o53_A 69 VLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDL 138 (317)
T ss_dssp CCEEEEE--ETTCTTCCEEECCSSEEEEEEE-----CTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGB
T ss_pred cCCcchh--hhhcCCCCEEECcCCccccccC-----CCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccch
Confidence 7765443 6667777777777777665432 267777777777776655443 45677777777777766666
Q ss_pred cccCCCCCCEEecccccccccCCcccC-CCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCcccc
Q 039322 164 EIGNSSQLQALDLSLNHIVGEIPKELG-KLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLK 242 (708)
Q Consensus 164 ~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~ 242 (708)
.|..+++|++|+|++|++++..+..+. .+++|++|+|++|.+++. + ....+++|++|+|++|+|++. |..+..+++
T Consensus 139 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~ 215 (317)
T 3o53_A 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAG 215 (317)
T ss_dssp CTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTT
T ss_pred hhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcc-hhhhcccCc
Confidence 666677777777777777655555543 566777777777777644 2 223466777777777777643 334666777
Q ss_pred ceeecccCcccccCCChhhhhhcccchhhcccccCC-CCCchhhcCcccCCceecccc-cccCCCCC
Q 039322 243 LHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFG-GEIPFQICSLKSLEKLNLSHN-NLSGSIPN 307 (708)
Q Consensus 243 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~-~~~~~~~~~~~~L~~L~l~~N-~l~~~~~~ 307 (708)
|+.|++++|+++ .+|..+..+++|+.|++++|++. +..+..+..+++|+.|++++| .+++..+.
T Consensus 216 L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 216 VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp CSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred ccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 777777777776 34555666677777777777776 455666666777777777733 45544443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-28 Score=252.42 Aligned_cols=219 Identities=21% Similarity=0.283 Sum_probs=118.0
Q ss_pred CCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCC
Q 039322 65 LPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKC 144 (708)
Q Consensus 65 ~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 144 (708)
+|..+..+++|++|+|++|.++ .+|..+.++++|++|+|++|.++ ..+..|..+++|++|++++|++.+..+..+..
T Consensus 96 lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~- 172 (328)
T 4fcg_A 96 FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS- 172 (328)
T ss_dssp CCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEE-
T ss_pred cChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhh-
Confidence 3444445555555555555555 45555555555555555555555 22444555555555555555444444433322
Q ss_pred CCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEec
Q 039322 145 PKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDL 224 (708)
Q Consensus 145 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l 224 (708)
. ..+..|..+++|++|+|++|+++ .+|..+..+++|++|+|++|+++ .+|..+..+++|++|+|
T Consensus 173 -----~---------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~L 236 (328)
T 4fcg_A 173 -----T---------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDL 236 (328)
T ss_dssp -----E---------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEEC
T ss_pred -----c---------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEEC
Confidence 0 00011223555555555555555 44555555555555555555555 34444555555666666
Q ss_pred cCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceeccccccc
Q 039322 225 SANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS 302 (708)
Q Consensus 225 ~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 302 (708)
++|.+.+..|..+..+++|+.|++++|.+.+.+|..+..+++|+.|+|++|++.+.+|..+..+++|+.+++..|.+.
T Consensus 237 s~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp TTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred cCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 665555555555555666666666665555555555666666666666666655556666666666666666555444
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-28 Score=253.63 Aligned_cols=227 Identities=19% Similarity=0.241 Sum_probs=183.2
Q ss_pred CCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEec
Q 039322 97 SSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDL 176 (708)
Q Consensus 97 ~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 176 (708)
++++.|+|++|.++.+ +..+..+++|++|+|++|.++ ..+..+..+++|++|+|++|.++ .+|..|..+++|++|+|
T Consensus 81 ~~l~~L~L~~n~l~~l-p~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLPQF-PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCSSC-CSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCchhc-ChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence 5566666666666633 333445666666666666665 44455666666666666666666 45666666666777777
Q ss_pred ccccccccCCccc---------CCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeec
Q 039322 177 SLNHIVGEIPKEL---------GKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLG 247 (708)
Q Consensus 177 ~~n~l~~~~~~~~---------~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~ 247 (708)
++|++.+.+|..+ .++++|++|+|++|+++ .+|..+..+++|++|+|++|++++ .|..+..+++|+.|+
T Consensus 158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~ 235 (328)
T 4fcg_A 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELD 235 (328)
T ss_dssp EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEE
T ss_pred CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEE
Confidence 6666655555554 45999999999999999 888899999999999999999995 566799999999999
Q ss_pred ccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCC
Q 039322 248 LSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQG 327 (708)
Q Consensus 248 l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 327 (708)
+++|.+.+..|..|.++++|+.|+|++|.+.+..|..+..+++|+.|+|++|++.+.+|..+..+++|+.+++..|.+..
T Consensus 236 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315 (328)
T ss_dssp CTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC
T ss_pred CcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999887775
Q ss_pred C
Q 039322 328 P 328 (708)
Q Consensus 328 ~ 328 (708)
.
T Consensus 316 l 316 (328)
T 4fcg_A 316 L 316 (328)
T ss_dssp -
T ss_pred H
Confidence 4
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-30 Score=285.44 Aligned_cols=188 Identities=19% Similarity=0.148 Sum_probs=133.0
Q ss_pred eccccCccEEEE-EeCCCcEEEEEEcCCCCCc------chhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCeeEEEE
Q 039322 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPC------DQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 444 ig~G~~g~vy~~-~~~~~~~vavK~~~~~~~~------~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
.+.|+.|.+..+ +...|+.||||++.+.... ......++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 455666655554 2335888999999764321 1123356799999999999 6999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||++|++|.+++...+ .++.. +|+.||+.||+|+|++ |||||||||+|||++.++.+||+|||+|+....+
T Consensus 322 Eyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999999997654 35543 5899999999999999 9999999999999999999999999999877665
Q ss_pred CCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 039322 596 SSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p 641 (708)
.......+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 556667789999999999875 467789999999998877665444
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-28 Score=267.61 Aligned_cols=259 Identities=25% Similarity=0.297 Sum_probs=137.2
Q ss_pred CcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEeccCC
Q 039322 4 LSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSEN 83 (708)
Q Consensus 4 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n 83 (708)
++.|++++|.|+. .|..+. ++|++|+|++|.|+. +| . .+++|++|+|++|
T Consensus 42 l~~L~ls~n~L~~-lp~~l~--~~L~~L~L~~N~l~~-lp-----------------------~---~l~~L~~L~Ls~N 91 (622)
T 3g06_A 42 NAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTS-LP-----------------------A---LPPELRTLEVSGN 91 (622)
T ss_dssp CCEEECCSSCCSC-CCSCCC--TTCSEEEECSCCCSC-CC-----------------------C---CCTTCCEEEECSC
T ss_pred CcEEEecCCCcCc-cChhhC--CCCcEEEecCCCCCC-CC-----------------------C---cCCCCCEEEcCCC
Confidence 5566666666663 333332 566666666666653 22 2 2345555555555
Q ss_pred ccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCc
Q 039322 84 HFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPR 163 (708)
Q Consensus 84 ~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~ 163 (708)
+|++ +|. .+++|++|+|++|+|++++. .+++|++|++++|+++.+.. .+++|++|+|++|+|++. |.
T Consensus 92 ~l~~-lp~---~l~~L~~L~Ls~N~l~~l~~----~l~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~l-~~ 158 (622)
T 3g06_A 92 QLTS-LPV---LPPGLLELSIFSNPLTHLPA----LPSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASL-PA 158 (622)
T ss_dssp CCSC-CCC---CCTTCCEEEECSCCCCCCCC----CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCC-CC
T ss_pred cCCc-CCC---CCCCCCEEECcCCcCCCCCC----CCCCcCEEECCCCCCCcCCC----CCCCCCEEECcCCcCCCc-CC
Confidence 5552 332 44555555555555554433 34555555555555554332 125555666666655532 22
Q ss_pred cccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccc
Q 039322 164 EIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKL 243 (708)
Q Consensus 164 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L 243 (708)
.+++|+.|++++|+|++ +| ..+++|+.|++++|.+++ +|.. +++|+.|++++|.++. .|.. +++|
T Consensus 159 ---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L 223 (622)
T 3g06_A 159 ---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGL 223 (622)
T ss_dssp ---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCC---CTTC
T ss_pred ---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCCC---CCCC
Confidence 23455566666665553 23 234556666666666553 2221 2456666666666652 2321 2456
Q ss_pred eeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCC
Q 039322 244 HYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDN 323 (708)
Q Consensus 244 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 323 (708)
+.|++++|+|++ +| ..+++|+.|+|++|.|+. +|. .+++|+.|+|++|+|+ .+|..+..+++|+.|++++|
T Consensus 224 ~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N 294 (622)
T 3g06_A 224 KELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294 (622)
T ss_dssp CEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSC
T ss_pred CEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCC
Confidence 666666666653 23 233556666666666653 332 4456666666666666 44555666666666666666
Q ss_pred cCCCCC
Q 039322 324 QLQGPV 329 (708)
Q Consensus 324 ~l~~~~ 329 (708)
++++..
T Consensus 295 ~l~~~~ 300 (622)
T 3g06_A 295 PLSERT 300 (622)
T ss_dssp CCCHHH
T ss_pred CCCCcC
Confidence 666543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-29 Score=274.54 Aligned_cols=246 Identities=19% Similarity=0.191 Sum_probs=182.2
Q ss_pred CCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEE
Q 039322 95 NCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQAL 174 (708)
Q Consensus 95 ~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 174 (708)
.+++|++|+|++|.++++.+..|..+++|++|+|++|.+++..+ |..+++|++|+|++|.|++..+ .++|++|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 44578888888888888877888888888888888888876665 7788888888888888875432 3778888
Q ss_pred ecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCC-ccccceeecccCccc
Q 039322 175 DLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLG-NLLKLHYLGLSNNQF 253 (708)
Q Consensus 175 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~-~l~~L~~L~l~~n~l 253 (708)
+|++|.|++..+. .+++|+.|+|++|.+++..|..+..+++|++|+|++|.+++..|..+. .+++|+.|+|++|.|
T Consensus 105 ~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 105 HAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp ECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred ECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 8888888755443 357788888888888877777788888888888888888877777665 678888888888888
Q ss_pred ccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCC-CCC-
Q 039322 254 VLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGP-VPN- 331 (708)
Q Consensus 254 ~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~-~~~- 331 (708)
++..+ +..+++|+.|+|++|.|++..+ .+..+++|+.|++++|.+++ +|..+..+++|+.|++++|++.|. +|.
T Consensus 182 ~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~ 257 (487)
T 3oja_A 182 YDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF 257 (487)
T ss_dssp CEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHH
T ss_pred ccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHH
Confidence 75532 3347788888888888885444 47778888888888888884 566677788888888888888732 221
Q ss_pred ccccccCcccccc-------cccCcCCCCC
Q 039322 332 STAFRNAPVEALK-------GNKGLCGGVK 354 (708)
Q Consensus 332 ~~~~~~~~~~~~~-------~n~~~c~~~~ 354 (708)
...++.+..+.+. .+++.|.|+.
T Consensus 258 ~~~l~~L~~l~~~~~~~~~~~~~~~c~~~~ 287 (487)
T 3oja_A 258 FSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287 (487)
T ss_dssp HTTCHHHHHHHHHHHHHHTSSSSCCCSSTT
T ss_pred HHhCCCCcEEeccccccccCCCcccccCCc
Confidence 2233334444444 7788887753
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-30 Score=264.01 Aligned_cols=249 Identities=21% Similarity=0.196 Sum_probs=112.2
Q ss_pred cCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccC-CCCcccc-------CCCCccEEeccCCccccccCccC-
Q 039322 23 SNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTS-YLPHNVC-------RGGALQYFGVSENHFQGTIPKIL- 93 (708)
Q Consensus 23 ~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~-------~l~~L~~L~l~~n~i~~~~~~~~- 93 (708)
.+.++|+.|++++|.+ .+|..+.. .|+.|++++|.+.. ..+..+. .+++|++|++++|.+++..|..+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~-~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 116 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTD-IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL 116 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHH-HHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSS
T ss_pred ccCCCceeEeeccccc--ccHHHHHH-HHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHH
Confidence 3444455555555555 22222211 15555555555422 2232222 34455555555555554444443
Q ss_pred -cCCCCCcEEEccCCccccccccccCCC-----CCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCccccc--CCccc
Q 039322 94 -RNCSSLIRVRLNSNNLTGNISEALGIY-----PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGG--IPREI 165 (708)
Q Consensus 94 -~~l~~L~~L~l~~n~i~~~~~~~~~~~-----~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~--~~~~~ 165 (708)
..+++|++|+|++|+++++ +..+..+ ++|++|+|++|+++++.+..|..+++|++|+|++|++.+. .+..+
T Consensus 117 ~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 195 (312)
T 1wwl_A 117 EATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195 (312)
T ss_dssp SCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHS
T ss_pred HhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHH
Confidence 4455555555555555544 3333333 4455555555555444444444455555555555544322 11111
Q ss_pred cCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccc---cCCcccCCCCCCCeEeccCCcccccCC-CCCCccc
Q 039322 166 GNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTG---RLPPEIGSLVDLEYLDLSANRFNNSVP-ENLGNLL 241 (708)
Q Consensus 166 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~---~~~~~~~~~~~L~~L~l~~N~i~~~~~-~~~~~l~ 241 (708)
.+..+++|++|+|++|++++ .....+..+++|++|+|++|++++..| ..+..++
T Consensus 196 ----------------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~ 253 (312)
T 1wwl_A 196 ----------------------CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253 (312)
T ss_dssp ----------------------CTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCT
T ss_pred ----------------------HhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcC
Confidence 11444445555555544441 111122334455555555555544332 2333344
Q ss_pred cceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceeccccccc
Q 039322 242 KLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS 302 (708)
Q Consensus 242 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 302 (708)
+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|++|++++|+++
T Consensus 254 ~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 254 QLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp TCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred CCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 5555555555554 3333333 4555555555555533 33 445555555555555554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-27 Score=262.15 Aligned_cols=258 Identities=23% Similarity=0.243 Sum_probs=207.6
Q ss_pred cccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEccc
Q 039322 51 LTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSR 130 (708)
Q Consensus 51 l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~ 130 (708)
++.|++++|.++. +|..+. ++|++|+|++|+|+ .+|. .+++|++|+|++|+|+.++. .+++|++|+|++
T Consensus 42 l~~L~ls~n~L~~-lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~ 110 (622)
T 3g06_A 42 NAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSLPV----LPPGLLELSIFS 110 (622)
T ss_dssp CCEEECCSSCCSC-CCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCCCC----CCTTCCEEEECS
T ss_pred CcEEEecCCCcCc-cChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcCCC----CCCCCCEEECcC
Confidence 3344444444443 444444 78999999999999 4554 57999999999999997665 679999999999
Q ss_pred CcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCC
Q 039322 131 NDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLP 210 (708)
Q Consensus 131 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 210 (708)
|+++++.. .+++|+.|++++|+|+. +|.. +++|++|+|++|++++ +|. .+++|+.|++++|.+++ +|
T Consensus 111 N~l~~l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~ 177 (622)
T 3g06_A 111 NPLTHLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP 177 (622)
T ss_dssp CCCCCCCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC
T ss_pred CcCCCCCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc
Confidence 99987654 57899999999999995 4433 4899999999999984 343 35789999999999994 55
Q ss_pred cccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCccc
Q 039322 211 PEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKS 290 (708)
Q Consensus 211 ~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~ 290 (708)
..+++|+.|++++|.|++ +|.. +++|+.|++++|.++. +|.. +++|+.|++++|.|++ +| ..+++
T Consensus 178 ---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~ 242 (622)
T 3g06_A 178 ---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LP---VLPSE 242 (622)
T ss_dssp ---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CC---CCCTT
T ss_pred ---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCc-CC---CCCCc
Confidence 457899999999999995 4433 4789999999999994 4432 4789999999999995 44 45689
Q ss_pred CCceecccccccCCCCCcccccccccEEecCCCcCCCCCCCccccccCcccccccccCcCC
Q 039322 291 LEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGLCG 351 (708)
Q Consensus 291 L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~ 351 (708)
|+.|++++|+|+. +|. .+++|+.|++++|.++..++....+++++.+.+.+|++...
T Consensus 243 L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~N~l~~~ 299 (622)
T 3g06_A 243 LKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSER 299 (622)
T ss_dssp CCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCSCCCCHH
T ss_pred CcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecCCCCCCc
Confidence 9999999999994 454 56899999999999997765567788899999999987653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-30 Score=263.68 Aligned_cols=250 Identities=17% Similarity=0.176 Sum_probs=199.8
Q ss_pred ccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCcccc-ccccccC-------CCCCCCEEEcccCcceeeCCCC
Q 039322 69 VCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTG-NISEALG-------IYPNLTFIDLSRNDFYGEISSN 140 (708)
Q Consensus 69 ~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~-~~~~~~~-------~~~~L~~L~l~~n~l~~~~~~~ 140 (708)
++..++|++|++++|.+ .+|..+... |++|+|++|.++. ..+..+. .+++|++|+|++|++++..+..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 44556788888888888 556655543 8888888888853 2333333 6889999999999998777776
Q ss_pred C--CCCCCCCEEEcccCcccccCCccccCC-----CCCCEEecccccccccCCcccCCCCCCCEEEccCcccccc--CCc
Q 039322 141 W--GKCPKLGTLNVSMNNITGGIPREIGNS-----SQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGR--LPP 211 (708)
Q Consensus 141 ~--~~l~~L~~L~L~~N~i~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~ 211 (708)
+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..+..|+.+++|++|+|++|++.+. .+.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 5 8889999999999999876 7777776 8999999999999987778899999999999999997654 233
Q ss_pred cc--CCCCCCCeEeccCCccccc---CCCCCCccccceeecccCcccccCCC-hhhhhhcccchhhcccccCCCCCchhh
Q 039322 212 EI--GSLVDLEYLDLSANRFNNS---VPENLGNLLKLHYLGLSNNQFVLELP-KELEKLVQLSELDASHNLFGGEIPFQI 285 (708)
Q Consensus 212 ~~--~~~~~L~~L~l~~N~i~~~---~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~ls~N~i~~~~~~~~ 285 (708)
.+ ..+++|++|+|++|+|++. ....+..+++|+.|++++|++++..| ..+..+++|+.|+|++|.|+ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 33 7889999999999999832 12334567899999999999997664 45667889999999999998 666665
Q ss_pred cCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCC
Q 039322 286 CSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGP 328 (708)
Q Consensus 286 ~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 328 (708)
. ++|++|++++|++++. |. +..+++|+.|++++|++++.
T Consensus 273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 5 8899999999999966 55 88999999999999999864
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-27 Score=236.49 Aligned_cols=229 Identities=25% Similarity=0.239 Sum_probs=143.5
Q ss_pred EEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCc
Q 039322 77 YFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNN 156 (708)
Q Consensus 77 ~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 156 (708)
.+++++..++ .+|..+. ++|++|+|++|+++++.+..|..+++|++|++++|+++.+.+..|..+++|++|+|++|.
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 4555555555 4444443 456666666666666555566666666666666666665555555556666666666666
Q ss_pred ccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCccccc-CCC
Q 039322 157 ITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNS-VPE 235 (708)
Q Consensus 157 i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~-~~~ 235 (708)
+++..+..|..+++|++|++++|++++..+ ..+..+++|++|++++|++++. .|.
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~------------------------~~~~~l~~L~~L~l~~n~l~~~~l~~ 143 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVAVETNLASLEN------------------------FPIGHLKTLKELNVAHNLIQSFKLPE 143 (276)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCCSTT------------------------CCCTTCTTCCEEECCSSCCCCCCCCG
T ss_pred cCccChhhhcCCccccEEECCCCCccccCc------------------------hhcccCCCCCEEECcCCccceecCch
Confidence 555555555555555555555555553333 3444455555555555555432 245
Q ss_pred CCCccccceeecccCcccccCCChhhhhhcccc----hhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccc
Q 039322 236 NLGNLLKLHYLGLSNNQFVLELPKELEKLVQLS----ELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEG 311 (708)
Q Consensus 236 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~----~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~ 311 (708)
.+..+++|+.|++++|++++..+..|..+.+|+ .|++++|.+++..+..+ ...+|+.|++++|++++..+..|..
T Consensus 144 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~~ 222 (276)
T 2z62_A 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLKELALDTNQLKSVPDGIFDR 222 (276)
T ss_dssp GGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSS-CSCCEEEEECCSSCCSCCCTTTTTT
T ss_pred hhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCcccc-CCCcccEEECCCCceeecCHhHhcc
Confidence 555566666666666666655555666666666 67788888875544444 3457889999999998777777888
Q ss_pred cccccEEecCCCcCCCCCCCcc
Q 039322 312 IRGISVIDISDNQLQGPVPNST 333 (708)
Q Consensus 312 l~~L~~l~l~~N~l~~~~~~~~ 333 (708)
+++|+.|++++|+++|.++...
T Consensus 223 l~~L~~L~l~~N~~~c~c~~l~ 244 (276)
T 2z62_A 223 LTSLQKIWLHTNPWDCSCPRID 244 (276)
T ss_dssp CCSCCEEECCSSCBCCCTTTTH
T ss_pred cccccEEEccCCcccccCCchH
Confidence 9999999999999998877543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.5e-27 Score=235.64 Aligned_cols=221 Identities=19% Similarity=0.176 Sum_probs=179.5
Q ss_pred ccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcc
Q 039322 54 PGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDF 133 (708)
Q Consensus 54 l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l 133 (708)
.+.....+.. +|..+. ++|++|++++|++++..+..|.++++|++|+|++|.++++.+..|..+++|++|+|++|++
T Consensus 12 ~~c~~~~l~~-ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 88 (276)
T 2z62_A 12 YQCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (276)
T ss_dssp EECTTSCCSS-CCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEecCCCccc-cCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence 3444445544 455543 5799999999999988888999999999999999999999999999999999999999999
Q ss_pred eeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEeccccccccc-CCcccCCCCCCCEEEccCccccccCCcc
Q 039322 134 YGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGE-IPKELGKLNSLTELILRGNQFTGRLPPE 212 (708)
Q Consensus 134 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 212 (708)
+++.+..|..+++|++|++++|.++...+..+..+++|++|+|++|++++. +|..+..+++|++|++++|++++..+..
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 168 (276)
T 2z62_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (276)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred CccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHH
Confidence 999999999999999999999999988777899999999999999999864 4788889999999999999998777777
Q ss_pred cCCCCCCC----eEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCC
Q 039322 213 IGSLVDLE----YLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFG 278 (708)
Q Consensus 213 ~~~~~~L~----~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~ 278 (708)
+..+++|+ .|++++|++++..+..+.. .+|+.|++++|++++..+..|..+++|+.|++++|++.
T Consensus 169 ~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 237 (276)
T 2z62_A 169 LRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237 (276)
T ss_dssp GHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred hhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence 77776666 7777888777554444433 36777777777776555555566666666666666665
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-25 Score=225.84 Aligned_cols=201 Identities=22% Similarity=0.222 Sum_probs=118.0
Q ss_pred CccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcc
Q 039322 74 ALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVS 153 (708)
Q Consensus 74 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 153 (708)
+++.++++++.++ .+|..+. ++|++|+|++|+++++.+..|..+++|++|+|++|+++.+.+..|..+++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 4566777777776 3454443 466666777666666666666666666666666666666666666666666666666
Q ss_pred cCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccC
Q 039322 154 MNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSV 233 (708)
Q Consensus 154 ~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~ 233 (708)
+|.++...+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 66666555555666666666666666666555555555666666666666655444444555555555555555555444
Q ss_pred CCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccC
Q 039322 234 PENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLF 277 (708)
Q Consensus 234 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i 277 (708)
+..|..+++|+.|++++|+++...+..|..+++|+.|+|++|++
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 217 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPW 217 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCe
Confidence 44455555555555555555544444444444444444444444
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-25 Score=225.47 Aligned_cols=206 Identities=22% Similarity=0.225 Sum_probs=115.5
Q ss_pred CCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecc
Q 039322 98 SLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLS 177 (708)
Q Consensus 98 ~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 177 (708)
+.+++++++++++.++.. + .++|++|+|++|+++.+.+..|..+++|++|+|++|.|+...+..|..+++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~~ip~~-~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAIPSN-I--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCSSCCSC-C--CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCCccCCC-C--CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 456667776666654332 1 1456666666666666655566666666666666666665555555666666666666
Q ss_pred cccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCC
Q 039322 178 LNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLEL 257 (708)
Q Consensus 178 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 257 (708)
+|+++...+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|++++|+++...
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 66666444445555556666666665555544445555555555555555555444444455555555555555554433
Q ss_pred ChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCC
Q 039322 258 PKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVP 330 (708)
Q Consensus 258 ~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 330 (708)
+..+..+++|+.|++++|++++..+..|..+++|+.|++++|++.+.++
T Consensus 174 ------------------------~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 174 ------------------------EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp ------------------------TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred ------------------------hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 3344445555555555555554444445555555566666555555443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=225.40 Aligned_cols=207 Identities=19% Similarity=0.175 Sum_probs=117.9
Q ss_pred ccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCC
Q 039322 69 VCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLG 148 (708)
Q Consensus 69 ~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 148 (708)
+..+++|+.|++++|.++.. ..+..+++|++|+|++|.++++ ..+..+++|++|++++|+++++.+..|..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 33456666666666666532 2356666666666666666643 2556666666666666666655555566666666
Q ss_pred EEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCc
Q 039322 149 TLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANR 228 (708)
Q Consensus 149 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~ 228 (708)
+|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|++|++++|++++..+..|..+++|++|+|++|+
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence 66666666665555555666666666666666665444445555666666666666655444445555556666666665
Q ss_pred ccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhc
Q 039322 229 FNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQIC 286 (708)
Q Consensus 229 i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~ 286 (708)
+++..+..+..+++|+.|++++|.+.+. +++|+.|+++.|.+++.+|..++
T Consensus 193 l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~ 243 (272)
T 3rfs_A 193 LKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAG 243 (272)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTS
T ss_pred CCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccc
Confidence 5555554455555555555555555422 22344444444444444444433
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-25 Score=225.61 Aligned_cols=205 Identities=24% Similarity=0.225 Sum_probs=101.9
Q ss_pred CcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCC
Q 039322 93 LRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQ 172 (708)
Q Consensus 93 ~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 172 (708)
++++++++++++++|.++.++.... +++++|+|++|+++++.+..|..+++|+.|+|++|.|+...+. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCSSCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCCcCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 4455666666666666664443321 4555666666655555555555555555555555555543221 4445555
Q ss_pred EEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcc
Q 039322 173 ALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQ 252 (708)
Q Consensus 173 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~ 252 (708)
+|+|++|+++ .+|..+..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~------------------- 140 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLP------------------- 140 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCC-------------------
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccC-------------------
Confidence 5555555554 33444444455555555555554443344444444444444444444433
Q ss_pred cccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCC
Q 039322 253 FVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGP 328 (708)
Q Consensus 253 l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 328 (708)
+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+++ .+|..+..+++|+.+++++|++.|.
T Consensus 141 -----~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 141 -----PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp -----TTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred -----hhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence 334444444444444444444333333444455555555555554 3344444444555555555555443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.3e-25 Score=223.17 Aligned_cols=205 Identities=24% Similarity=0.255 Sum_probs=171.0
Q ss_pred ccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCC
Q 039322 67 HNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPK 146 (708)
Q Consensus 67 ~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 146 (708)
..+..+++++++++++|.++ .+|..+. ++++.|+|++|.++++.+..|..+++|++|+|++|.++.+... ..+++
T Consensus 4 C~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~ 78 (290)
T 1p9a_G 4 CEVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPV 78 (290)
T ss_dssp SEEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTT
T ss_pred ccccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCc
Confidence 34667788999999999998 5565554 6889999999999988888899999999999999999877654 68899
Q ss_pred CCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccC
Q 039322 147 LGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSA 226 (708)
Q Consensus 147 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~ 226 (708)
|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++
T Consensus 79 L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 157 (290)
T 1p9a_G 79 LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157 (290)
T ss_dssp CCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCC
Confidence 999999999998 5677888899999999999999977778899999999999999999977777788899999999999
Q ss_pred CcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCC
Q 039322 227 NRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFG 278 (708)
Q Consensus 227 N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~ 278 (708)
|+|+...+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++.
T Consensus 158 N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 9998766667788888888888888888 55665666667777777777765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-25 Score=222.09 Aligned_cols=225 Identities=17% Similarity=0.215 Sum_probs=174.5
Q ss_pred EEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEeccCCcc
Q 039322 6 ILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHF 85 (708)
Q Consensus 6 ~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i 85 (708)
.+++.++.++.. ..+..+++|+.|++++|.+.. ...+..+++|++|++++|.+
T Consensus 23 ~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-------------------------~~~l~~l~~L~~L~l~~n~l 75 (272)
T 3rfs_A 23 KANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-------------------------VQGIQYLPNVRYLALGGNKL 75 (272)
T ss_dssp HHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-------------------------CTTGGGCTTCCEEECTTSCC
T ss_pred HHHhcCcccccc--cccccccceeeeeeCCCCccc-------------------------ccccccCCCCcEEECCCCCC
Confidence 345556666533 446778899999999998863 12356677888888888888
Q ss_pred ccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccc
Q 039322 86 QGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREI 165 (708)
Q Consensus 86 ~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~ 165 (708)
++. ..+.++++|++|+|++|.++++.+..|..+++|++|++++|+++++.+..|..+++|++|++++|++++..+..|
T Consensus 76 ~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 153 (272)
T 3rfs_A 76 HDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVF 153 (272)
T ss_dssp CCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred CCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHh
Confidence 753 467788888888888888888777778888888888888888887777778888888888888888887777777
Q ss_pred cCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCcccccee
Q 039322 166 GNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHY 245 (708)
Q Consensus 166 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~ 245 (708)
..+++|++|+|++|++++..+..+..+++|++|++++|++++..+..+..+++|++|+|++|.+.+. +++|+.
T Consensus 154 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~ 226 (272)
T 3rfs_A 154 DKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRY 226 (272)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHH
T ss_pred ccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHH
Confidence 8888888888888888876666678888888888888888877777788888888888888887633 456888
Q ss_pred ecccCcccccCCChhhhhhcc
Q 039322 246 LGLSNNQFVLELPKELEKLVQ 266 (708)
Q Consensus 246 L~l~~n~l~~~~~~~~~~l~~ 266 (708)
|+++.|.+++.+|..+..+..
T Consensus 227 l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 227 LSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp HHHHHHHTGGGBBCTTSCBCG
T ss_pred HHHHHHhCCCcccCcccccCC
Confidence 888888888888877765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=247.46 Aligned_cols=187 Identities=14% Similarity=0.189 Sum_probs=146.7
Q ss_pred cccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcch----hHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 439 DAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQ----IADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 439 ~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
...+.||+|+||.||+|.. .++.+++|.......... ....+.+.+|++++++++||||+++..++..++..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4466899999999999955 578889988654222111 12245689999999999999999666666677788999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+|+....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999864 558999999999999999 9999999999999998 999999999997754
Q ss_pred CCCc-------cccccccccccCcccccc--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 039322 595 ESSN-------WTEFAGTYGYVAPELAYT--MKITEKCDVYSFGVLVLEAIKGKHPR 642 (708)
Q Consensus 595 ~~~~-------~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~elltg~~p~ 642 (708)
.... .....||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3221 135679999999999876 55778899999999888888777765
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=214.31 Aligned_cols=197 Identities=20% Similarity=0.148 Sum_probs=127.6
Q ss_pred CCCcEEEccCCccccccccccCCCCCCCEEEcccCc-ceeeCCCCCCCCCCCCEEEccc-CcccccCCccccCCCCCCEE
Q 039322 97 SSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRND-FYGEISSNWGKCPKLGTLNVSM-NNITGGIPREIGNSSQLQAL 174 (708)
Q Consensus 97 ~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L 174 (708)
++|++|+|++|+++++.+..|..+++|++|++++|+ ++.+.+..|.++++|++|++++ |+++...+..|..+++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 367777777777777777677777777777777775 7767666777777777777776 77776666677777777777
Q ss_pred ecccccccccCCcccCCCCCCC---EEEccCc-cccccCCcccCCCCCCC-eEeccCCcccccCCCCCCccccceeeccc
Q 039322 175 DLSLNHIVGEIPKELGKLNSLT---ELILRGN-QFTGRLPPEIGSLVDLE-YLDLSANRFNNSVPENLGNLLKLHYLGLS 249 (708)
Q Consensus 175 ~L~~n~l~~~~~~~~~~l~~L~---~L~l~~n-~l~~~~~~~~~~~~~L~-~L~l~~N~i~~~~~~~~~~l~~L~~L~l~ 249 (708)
++++|++++ +|. +..+++|+ +|++++| .+++..+..|.++++|+ +|++++|+++...+..|.. ++|+.|+++
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~ 187 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLN 187 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECT
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcC
Confidence 777777764 443 66666666 7777777 66655555666666666 6777666666333333333 566666666
Q ss_pred Ccc-cccCCChhhhhh-cccchhhcccccCCCCCchhhcCcccCCceecccc
Q 039322 250 NNQ-FVLELPKELEKL-VQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299 (708)
Q Consensus 250 ~n~-l~~~~~~~~~~l-~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N 299 (708)
+|+ ++...+..|.++ ++|+.|++++|++++..+. .+++|+.|+++++
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 663 665555556666 6666666666666533222 3455555555544
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-26 Score=241.91 Aligned_cols=252 Identities=19% Similarity=0.225 Sum_probs=162.8
Q ss_pred EEeccCCccccccCccCcCCCCCcEEEccCCccccccc----cccCCCC-CCCEEEcccCcceeeCCCCCCCC-----CC
Q 039322 77 YFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNIS----EALGIYP-NLTFIDLSRNDFYGEISSNWGKC-----PK 146 (708)
Q Consensus 77 ~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~----~~~~~~~-~L~~L~l~~n~l~~~~~~~~~~l-----~~ 146 (708)
+++++.|.+++.+|..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|+++...+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 34566666666666655555557777777777666555 5566666 67777777777665555444443 67
Q ss_pred CCEEEcccCcccccCCccc----cCC-CCCCEEecccccccccCCcc----cCC-CCCCCEEEccCccccccCC----cc
Q 039322 147 LGTLNVSMNNITGGIPREI----GNS-SQLQALDLSLNHIVGEIPKE----LGK-LNSLTELILRGNQFTGRLP----PE 212 (708)
Q Consensus 147 L~~L~L~~N~i~~~~~~~~----~~l-~~L~~L~L~~n~l~~~~~~~----~~~-l~~L~~L~l~~n~l~~~~~----~~ 212 (708)
|++|+|++|.++...+..+ ..+ ++|++|+|++|++++..+.. +.. .++|++|+|++|.+++... ..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 7777777777765544433 333 67777777777776544433 333 2477777777777774332 22
Q ss_pred cCCCC-CCCeEeccCCcccccCCCCCC----cc-ccceeecccCcccccCC----Chhhhhh-cccchhhcccccCCCCC
Q 039322 213 IGSLV-DLEYLDLSANRFNNSVPENLG----NL-LKLHYLGLSNNQFVLEL----PKELEKL-VQLSELDASHNLFGGEI 281 (708)
Q Consensus 213 ~~~~~-~L~~L~l~~N~i~~~~~~~~~----~l-~~L~~L~l~~n~l~~~~----~~~~~~l-~~L~~L~ls~N~i~~~~ 281 (708)
+..++ +|++|+|++|+|++..+..+. .+ ++|+.|+|++|.|+... +..+..+ ++|+.|+|++|.|++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 34444 788888888877765554333 33 47888888888887543 3344443 47888888888887655
Q ss_pred ch----hhcCcccCCceecccccccCCCC-------CcccccccccEEecCCCcCCCC
Q 039322 282 PF----QICSLKSLEKLNLSHNNLSGSIP-------NCFEGIRGISVIDISDNQLQGP 328 (708)
Q Consensus 282 ~~----~~~~~~~L~~L~l~~N~l~~~~~-------~~~~~l~~L~~l~l~~N~l~~~ 328 (708)
+. .+..+++|+.|++++|.+....+ ..+..+++|+.||+++|++...
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 43 33556888888888888554333 3566788899999999998765
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=212.26 Aligned_cols=197 Identities=17% Similarity=0.167 Sum_probs=156.6
Q ss_pred CCccEEeccCCccccccCccCcCCCCCcEEEccCCc-cccccccccCCCCCCCEEEccc-CcceeeCCCCCCCCCCCCEE
Q 039322 73 GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNN-LTGNISEALGIYPNLTFIDLSR-NDFYGEISSNWGKCPKLGTL 150 (708)
Q Consensus 73 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~-i~~~~~~~~~~~~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L 150 (708)
.+|++|++++|++++..+..|.++++|++|++++|+ ++.+.+..|..+++|++|++++ |+++.+.+..|..+++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 378888888888887777778888888888888886 8888888888888888888888 88888888888888888888
Q ss_pred EcccCcccccCCccccCCCCCC---EEecccc-cccccCCcccCCCCCCC-EEEccCccccccCCcccCCCCCCCeEecc
Q 039322 151 NVSMNNITGGIPREIGNSSQLQ---ALDLSLN-HIVGEIPKELGKLNSLT-ELILRGNQFTGRLPPEIGSLVDLEYLDLS 225 (708)
Q Consensus 151 ~L~~N~i~~~~~~~~~~l~~L~---~L~L~~n-~l~~~~~~~~~~l~~L~-~L~l~~n~l~~~~~~~~~~~~~L~~L~l~ 225 (708)
++++|++++ .|. |..+++|+ +|++++| ++++..+..|.++++|+ +|++++|+++.+.+..|.. ++|++|+|+
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~ 187 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLN 187 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECT
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcC
Confidence 888888885 444 77788887 8888888 88866667788888888 8888888888554445555 788888888
Q ss_pred CCc-ccccCCCCCCcc-ccceeecccCcccccCCChhhhhhcccchhhcccc
Q 039322 226 ANR-FNNSVPENLGNL-LKLHYLGLSNNQFVLELPKELEKLVQLSELDASHN 275 (708)
Q Consensus 226 ~N~-i~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N 275 (708)
+|+ ++...+..|..+ ++|+.|++++|+++...+. .+++|+.|+++++
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 885 887767778888 8888888888888855444 4567777777765
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=219.40 Aligned_cols=240 Identities=20% Similarity=0.118 Sum_probs=184.3
Q ss_pred cEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCccee-eCCCCCCCCCCCCE-EEcc
Q 039322 76 QYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYG-EISSNWGKCPKLGT-LNVS 153 (708)
Q Consensus 76 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~-L~L~ 153 (708)
+.+++++++++ .+|..+. +++++|+|++|+|+.+++++|.++++|++|+|++|++.+ +.+..|.+++++.. +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 57889999998 5676553 689999999999998888899999999999999999744 66678888888775 5667
Q ss_pred cCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccC-ccccccCCcccCCCC-CCCeEeccCCcccc
Q 039322 154 MNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRG-NQFTGRLPPEIGSLV-DLEYLDLSANRFNN 231 (708)
Q Consensus 154 ~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~~~-~L~~L~l~~N~i~~ 231 (708)
+|+|+.+.+..|..+++|++|++++|+++...+..+....++..|++.+ |++..+.+..|..+. .++.|+|++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 7999988888999999999999999999866666677777888888865 677766667777765 58889999999985
Q ss_pred cCCCCCCccccceeecccC-cccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccc-cccCCCCCcc
Q 039322 232 SVPENLGNLLKLHYLGLSN-NQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN-NLSGSIPNCF 309 (708)
Q Consensus 232 ~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N-~l~~~~~~~~ 309 (708)
..+. .....+|+.|++++ |.++.+.++.|.++++|+.|+|++|+|+...+..+.. |+.|.+.++ .++ .+| .+
T Consensus 169 i~~~-~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~---L~~L~~l~~~~l~-~lP-~l 242 (350)
T 4ay9_X 169 IHNS-AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN---LKKLRARSTYNLK-KLP-TL 242 (350)
T ss_dssp ECTT-SSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT---CCEEECTTCTTCC-CCC-CT
T ss_pred CChh-hccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhcc---chHhhhccCCCcC-cCC-Cc
Confidence 4444 44556888888874 6777666677888999999999999988555544444 444444433 343 455 36
Q ss_pred cccccccEEecCCCc
Q 039322 310 EGIRGISVIDISDNQ 324 (708)
Q Consensus 310 ~~l~~L~~l~l~~N~ 324 (708)
..+++|+.++++++.
T Consensus 243 ~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 243 EKLVALMEASLTYPS 257 (350)
T ss_dssp TTCCSCCEEECSCHH
T ss_pred hhCcChhhCcCCCCc
Confidence 778888888887543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.7e-23 Score=206.88 Aligned_cols=176 Identities=21% Similarity=0.219 Sum_probs=79.3
Q ss_pred CcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEeccc
Q 039322 99 LIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSL 178 (708)
Q Consensus 99 L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 178 (708)
.++++++++.++.++.... ++|++|+|++|+++++.+..|..+++|++|+|++|.|++..+..|..+++|++|+|++
T Consensus 16 ~~~l~~~~~~l~~~p~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLDSVPSGIP---ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCSSCCSCCC---TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCccccCCCCC---CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 3455555555554332211 3455555555555544444455555555555555555544444444445555555555
Q ss_pred ccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCC
Q 039322 179 NHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELP 258 (708)
Q Consensus 179 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 258 (708)
|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 172 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH 172 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence 55444333444444444444444444443333334444444444444444443333334444444444444444443333
Q ss_pred hhhhhhcccchhhcccccC
Q 039322 259 KELEKLVQLSELDASHNLF 277 (708)
Q Consensus 259 ~~~~~l~~L~~L~ls~N~i 277 (708)
..|..+++|+.|+|++|++
T Consensus 173 ~~~~~l~~L~~L~l~~N~~ 191 (251)
T 3m19_A 173 GAFDRLGKLQTITLFGNQF 191 (251)
T ss_dssp TTTTTCTTCCEEECCSCCB
T ss_pred HHHhCCCCCCEEEeeCCce
Confidence 3333333333333333333
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=7.1e-23 Score=203.82 Aligned_cols=181 Identities=21% Similarity=0.244 Sum_probs=156.7
Q ss_pred CCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEc
Q 039322 73 GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNV 152 (708)
Q Consensus 73 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 152 (708)
.+.++++++++.++ .+|..+. ++|++|+|++|.++++.+..|..+++|++|+|++|+++++.+..|..+++|++|+|
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 35678888888888 5666555 68899999999999888888899999999999999998888888889999999999
Q ss_pred ccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCccccc
Q 039322 153 SMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNS 232 (708)
Q Consensus 153 ~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~ 232 (708)
++|+|+...+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++.
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 170 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV 170 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence 99999888888888999999999999999877677788899999999999999977777888999999999999999987
Q ss_pred CCCCCCccccceeecccCcccccC
Q 039322 233 VPENLGNLLKLHYLGLSNNQFVLE 256 (708)
Q Consensus 233 ~~~~~~~l~~L~~L~l~~n~l~~~ 256 (708)
.+..|..+++|+.|++++|++...
T Consensus 171 ~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 171 PHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CHHHHhCCCCCCEEEeeCCceeCC
Confidence 777888999999999999999754
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.3e-26 Score=238.43 Aligned_cols=250 Identities=17% Similarity=0.162 Sum_probs=146.5
Q ss_pred cccCCCccCCCCccccCCCCccEEeccCCccccccC----ccCcCCC-CCcEEEccCCccccccccccCCC-----CCCC
Q 039322 55 GLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIP----KILRNCS-SLIRVRLNSNNLTGNISEALGIY-----PNLT 124 (708)
Q Consensus 55 ~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~----~~~~~l~-~L~~L~l~~n~i~~~~~~~~~~~-----~~L~ 124 (708)
.+++|.+++.+|..+...++|++|+|++|.+++..+ ..|.+++ +|++|+|++|.|++..+..|..+ ++|+
T Consensus 4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~ 83 (362)
T 3goz_A 4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83 (362)
T ss_dssp ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCC
T ss_pred ccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCcc
Confidence 345555555555555555557777777777665554 5566666 67777777777766555555443 6677
Q ss_pred EEEcccCcceeeCCCCC----CCC-CCCCEEEcccCcccccCCcccc----C-CCCCCEEecccccccccCC----cccC
Q 039322 125 FIDLSRNDFYGEISSNW----GKC-PKLGTLNVSMNNITGGIPREIG----N-SSQLQALDLSLNHIVGEIP----KELG 190 (708)
Q Consensus 125 ~L~l~~n~l~~~~~~~~----~~l-~~L~~L~L~~N~i~~~~~~~~~----~-l~~L~~L~L~~n~l~~~~~----~~~~ 190 (708)
+|+|++|+++...+..+ ..+ ++|++|+|++|+|+...+..+. . .++|++|+|++|++++... ..+.
T Consensus 84 ~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~ 163 (362)
T 3goz_A 84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILA 163 (362)
T ss_dssp EEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred EEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHh
Confidence 77777777665444322 233 5677777777777655443332 2 2467777777777764332 2233
Q ss_pred CCC-CCCEEEccCccccccCCccc----CCC-CCCCeEeccCCcccccC----CCCCCc-cccceeecccCcccccCCCh
Q 039322 191 KLN-SLTELILRGNQFTGRLPPEI----GSL-VDLEYLDLSANRFNNSV----PENLGN-LLKLHYLGLSNNQFVLELPK 259 (708)
Q Consensus 191 ~l~-~L~~L~l~~n~l~~~~~~~~----~~~-~~L~~L~l~~N~i~~~~----~~~~~~-l~~L~~L~l~~n~l~~~~~~ 259 (708)
.++ +|++|+|++|++++..+..+ ..+ ++|++|+|++|+|++.. +..+.. .++|+.|+|++|++++..+.
T Consensus 164 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~ 243 (362)
T 3goz_A 164 AIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLE 243 (362)
T ss_dssp TSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHH
T ss_pred cCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHH
Confidence 444 67777777777765444332 333 46777777777776422 223333 24677777777777655443
Q ss_pred h----hhhhcccchhhcccccCCCCCc-------hhhcCcccCCceecccccccCC
Q 039322 260 E----LEKLVQLSELDASHNLFGGEIP-------FQICSLKSLEKLNLSHNNLSGS 304 (708)
Q Consensus 260 ~----~~~l~~L~~L~ls~N~i~~~~~-------~~~~~~~~L~~L~l~~N~l~~~ 304 (708)
. +..+++|+.|+|++|.+.+..+ ..+..+++|+.|++++|++...
T Consensus 244 ~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 244 NLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 2 3445677777777777443322 2345566777777777777644
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.1e-24 Score=220.93 Aligned_cols=224 Identities=20% Similarity=0.173 Sum_probs=174.1
Q ss_pred CcccccccCCCccCCCCc---cccCCCCccEEeccCCccccccCccC--cCCCCCcEEEccCCccccccc----cccCCC
Q 039322 50 MLTRPGLDFNHFTSYLPH---NVCRGGALQYFGVSENHFQGTIPKIL--RNCSSLIRVRLNSNNLTGNIS----EALGIY 120 (708)
Q Consensus 50 ~l~~l~l~~n~~~~~~~~---~~~~l~~L~~L~l~~n~i~~~~~~~~--~~l~~L~~L~l~~n~i~~~~~----~~~~~~ 120 (708)
.++.+.+..+.+....-. .+..+++|++|++++|.+++..|..+ .++++|++|+|++|.+++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 455666666555321101 11223669999999999998888887 889999999999999986433 445678
Q ss_pred CCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccc---cC-CccccCCCCCCEEecccccccccCCc----ccCCC
Q 039322 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITG---GI-PREIGNSSQLQALDLSLNHIVGEIPK----ELGKL 192 (708)
Q Consensus 121 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~---~~-~~~~~~l~~L~~L~L~~n~l~~~~~~----~~~~l 192 (708)
++|++|+|++|++.++.+..|..+++|++|+|++|++.+ .. +..+..+++|++|+|++|+++. .+. .+..+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcC
Confidence 899999999999988888899999999999999998764 22 2334678899999999999973 222 24678
Q ss_pred CCCCEEEccCccccccCCcccCCC---CCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccch
Q 039322 193 NSLTELILRGNQFTGRLPPEIGSL---VDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSE 269 (708)
Q Consensus 193 ~~L~~L~l~~n~l~~~~~~~~~~~---~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 269 (708)
++|++|+|++|++++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence 999999999999997777777776 69999999999999 5566664 7999999999999864 33 677899999
Q ss_pred hhcccccCCC
Q 039322 270 LDASHNLFGG 279 (708)
Q Consensus 270 L~ls~N~i~~ 279 (708)
|+|++|++++
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 9999999874
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=215.87 Aligned_cols=194 Identities=23% Similarity=0.305 Sum_probs=121.2
Q ss_pred cCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 039322 94 RNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQA 173 (708)
Q Consensus 94 ~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 173 (708)
.++++|++|++++|.++.+. .+..+++|++|++++|+++++.+ +..+++|++|+|++|.++.. ..+..+++|++
T Consensus 38 ~~l~~L~~L~l~~~~i~~l~--~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~ 111 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKT 111 (308)
T ss_dssp HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred HHcCCcCEEEeeCCCccCch--hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCE
Confidence 34555666666666555432 35555666666666666654444 55666666666666666532 24666666666
Q ss_pred EecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCccc
Q 039322 174 LDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQF 253 (708)
Q Consensus 174 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l 253 (708)
|+|++|++++. + .+..+++|++|++++|.+++..+ +..+++|++|+|++|++++..+ +..+++|+.|++++|++
T Consensus 112 L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l 185 (308)
T 1h6u_A 112 LDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI 185 (308)
T ss_dssp EECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCcc
Confidence 66666666642 2 26666667777777766663322 6666777777777777764333 66677777777777777
Q ss_pred ccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccC
Q 039322 254 VLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSG 303 (708)
Q Consensus 254 ~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~ 303 (708)
++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|++++
T Consensus 186 ~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 186 SDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred CcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 64332 6677777777777777775442 6677777777777777763
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.2e-24 Score=219.90 Aligned_cols=200 Identities=17% Similarity=0.172 Sum_probs=98.7
Q ss_pred CCCCEEEcccCcceeeCCCCC--CCCCCCCEEEcccCcccccCC----ccccCCCCCCEEecccccccccCCcccCCCCC
Q 039322 121 PNLTFIDLSRNDFYGEISSNW--GKCPKLGTLNVSMNNITGGIP----REIGNSSQLQALDLSLNHIVGEIPKELGKLNS 194 (708)
Q Consensus 121 ~~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~L~~N~i~~~~~----~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 194 (708)
++|++|++++|++.+..+..+ ..+++|++|+|++|.+++..+ ..+..+++|++|+|++|++.+..+..+..+++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 345555555555554444444 445555555555555543222 22234455555555555555444445555555
Q ss_pred CCEEEccCcccccc---C-CcccCCCCCCCeEeccCCcccccCCC----CCCccccceeecccCcccccCCChhhhhh--
Q 039322 195 LTELILRGNQFTGR---L-PPEIGSLVDLEYLDLSANRFNNSVPE----NLGNLLKLHYLGLSNNQFVLELPKELEKL-- 264 (708)
Q Consensus 195 L~~L~l~~n~l~~~---~-~~~~~~~~~L~~L~l~~N~i~~~~~~----~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-- 264 (708)
|++|+|++|++.+. . +..+..+++|++|+|++|+++. .+. .+..+++|+.|+|++|++++..|..+..+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 249 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW 249 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence 55555555554321 1 1122445555555555555542 111 12344555555555555554444444333
Q ss_pred -cccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCC
Q 039322 265 -VQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQ 326 (708)
Q Consensus 265 -~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 326 (708)
++|+.|+|++|+|+ .+|..+. ++|+.|+|++|++++. |. +..+++|+.|++++|+++
T Consensus 250 ~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 250 SSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred cCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence 45555555555555 3343332 5566666666666543 22 455566666666666655
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=6.3e-25 Score=229.14 Aligned_cols=157 Identities=22% Similarity=0.269 Sum_probs=70.0
Q ss_pred CCCCccEEeccCCccccc-cCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccC-cceee-CCCCCCCCCCC
Q 039322 71 RGGALQYFGVSENHFQGT-IPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRN-DFYGE-ISSNWGKCPKL 147 (708)
Q Consensus 71 ~l~~L~~L~l~~n~i~~~-~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n-~l~~~-~~~~~~~l~~L 147 (708)
.+++|++|++++|.+++. .+..+..+++|++|+|++|.+++..+..+..+++|++|++++| .+++. .+..+..+++|
T Consensus 91 ~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L 170 (336)
T 2ast_B 91 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 170 (336)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred cCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCC
Confidence 344555555555554433 3444445555555555555554444444444555555555555 33321 12223344455
Q ss_pred CEEEcccC-ccccc-CCccccCCC-CCCEEeccccc--cc-ccCCcccCCCCCCCEEEccCcc-ccccCCcccCCCCCCC
Q 039322 148 GTLNVSMN-NITGG-IPREIGNSS-QLQALDLSLNH--IV-GEIPKELGKLNSLTELILRGNQ-FTGRLPPEIGSLVDLE 220 (708)
Q Consensus 148 ~~L~L~~N-~i~~~-~~~~~~~l~-~L~~L~L~~n~--l~-~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~~~~L~ 220 (708)
++|++++| .++.. .+..+..++ +|++|+|++|. ++ +.++..+..+++|++|++++|. +++..+..+..+++|+
T Consensus 171 ~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~ 250 (336)
T 2ast_B 171 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 250 (336)
T ss_dssp CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred CEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCC
Confidence 55555555 44422 233344444 45555555542 22 1222333344444444444444 3333333444444444
Q ss_pred eEeccCC
Q 039322 221 YLDLSAN 227 (708)
Q Consensus 221 ~L~l~~N 227 (708)
+|+|++|
T Consensus 251 ~L~l~~~ 257 (336)
T 2ast_B 251 HLSLSRC 257 (336)
T ss_dssp EEECTTC
T ss_pred EeeCCCC
Confidence 4444444
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5.5e-26 Score=241.86 Aligned_cols=190 Identities=18% Similarity=0.172 Sum_probs=89.5
Q ss_pred CCccccCCCCccEEeccCCccccccC----ccCcCCCCCcEEEccCCccc---cccccc-------cCCCCCCCEEEccc
Q 039322 65 LPHNVCRGGALQYFGVSENHFQGTIP----KILRNCSSLIRVRLNSNNLT---GNISEA-------LGIYPNLTFIDLSR 130 (708)
Q Consensus 65 ~~~~~~~l~~L~~L~l~~n~i~~~~~----~~~~~l~~L~~L~l~~n~i~---~~~~~~-------~~~~~~L~~L~l~~ 130 (708)
++..+..+++|++|+|++|.+++..+ ..+..+++|++|+|++|.+. +..+.. |..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 34445555666666666666664422 23555666666666664332 222222 24555566666666
Q ss_pred Cccee----eCCCCCCCCCCCCEEEcccCcccccCCccccC----C---------CCCCEEecccccccc-cCC---ccc
Q 039322 131 NDFYG----EISSNWGKCPKLGTLNVSMNNITGGIPREIGN----S---------SQLQALDLSLNHIVG-EIP---KEL 189 (708)
Q Consensus 131 n~l~~----~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~----l---------~~L~~L~L~~n~l~~-~~~---~~~ 189 (708)
|.++. ..+..+..+++|++|+|++|.|+...+..+.. + ++|++|+|++|+++. ..+ ..+
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 183 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence 55543 12233445555555555555554332222222 2 455555555555541 111 233
Q ss_pred CCCCCCCEEEccCccccc-----cCCcccCCCCCCCeEeccCCccc----ccCCCCCCccccceeecccCcccc
Q 039322 190 GKLNSLTELILRGNQFTG-----RLPPEIGSLVDLEYLDLSANRFN----NSVPENLGNLLKLHYLGLSNNQFV 254 (708)
Q Consensus 190 ~~l~~L~~L~l~~n~l~~-----~~~~~~~~~~~L~~L~l~~N~i~----~~~~~~~~~l~~L~~L~l~~n~l~ 254 (708)
..+++|++|+|++|+++. ..+..+..+++|++|+|++|.|+ ...|..+..+++|+.|+|++|.++
T Consensus 184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~ 257 (386)
T 2ca6_A 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257 (386)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCc
Confidence 344455555555555441 12223444445555555555543 233333444444444444444444
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=7.5e-26 Score=240.78 Aligned_cols=255 Identities=19% Similarity=0.243 Sum_probs=202.9
Q ss_pred CccEEeccCCccccccCccCcCCCCCcEEEccCCccccccc----cccCCCCCCCEEEcccCcce---eeCCCC------
Q 039322 74 ALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNIS----EALGIYPNLTFIDLSRNDFY---GEISSN------ 140 (708)
Q Consensus 74 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~----~~~~~~~~L~~L~l~~n~l~---~~~~~~------ 140 (708)
.|+...++...+. .++..+..+++|++|+|++|.|+...+ ..|..+++|++|+|++|.+. +..+..
T Consensus 10 ~L~~~~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~ 88 (386)
T 2ca6_A 10 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQ 88 (386)
T ss_dssp CCEESSCCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHH
T ss_pred ccccCCCCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHH
Confidence 3444444555554 566778889999999999999996644 44778999999999997553 222323
Q ss_pred -CCCCCCCCEEEcccCcccc----cCCccccCCCCCCEEecccccccccCCcccC----CC---------CCCCEEEccC
Q 039322 141 -WGKCPKLGTLNVSMNNITG----GIPREIGNSSQLQALDLSLNHIVGEIPKELG----KL---------NSLTELILRG 202 (708)
Q Consensus 141 -~~~l~~L~~L~L~~N~i~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~----~l---------~~L~~L~l~~ 202 (708)
+..+++|++|+|++|.++. ..+..+..+++|++|+|++|.++...+..+. .+ ++|++|+|++
T Consensus 89 ~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~ 168 (386)
T 2ca6_A 89 ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR 168 (386)
T ss_dssp HHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCS
T ss_pred HHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCC
Confidence 3678999999999999986 4667888999999999999999754443333 33 8999999999
Q ss_pred cccc-ccCC---cccCCCCCCCeEeccCCcccc-----cCCCCCCccccceeecccCcccc----cCCChhhhhhcccch
Q 039322 203 NQFT-GRLP---PEIGSLVDLEYLDLSANRFNN-----SVPENLGNLLKLHYLGLSNNQFV----LELPKELEKLVQLSE 269 (708)
Q Consensus 203 n~l~-~~~~---~~~~~~~~L~~L~l~~N~i~~-----~~~~~~~~l~~L~~L~l~~n~l~----~~~~~~~~~l~~L~~ 269 (708)
|+++ ...+ ..+..+++|++|+|++|+|+. ..+..+..+++|+.|+|++|.++ ..+|..+..+++|+.
T Consensus 169 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~ 248 (386)
T 2ca6_A 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 248 (386)
T ss_dssp SCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCE
T ss_pred CCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCE
Confidence 9997 3333 356788999999999999983 34557889999999999999996 457778899999999
Q ss_pred hhcccccCCCC----Cchhhc--CcccCCceecccccccC----CCCCcc-cccccccEEecCCCcCCCCC
Q 039322 270 LDASHNLFGGE----IPFQIC--SLKSLEKLNLSHNNLSG----SIPNCF-EGIRGISVIDISDNQLQGPV 329 (708)
Q Consensus 270 L~ls~N~i~~~----~~~~~~--~~~~L~~L~l~~N~l~~----~~~~~~-~~l~~L~~l~l~~N~l~~~~ 329 (708)
|+|++|.|++. ++..+. .+++|+.|+|++|+++. .+|..+ ..+++|+.|++++|++++..
T Consensus 249 L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 249 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp EECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred EECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 99999999865 345553 38999999999999996 366666 56899999999999998764
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-23 Score=213.04 Aligned_cols=191 Identities=23% Similarity=0.254 Sum_probs=105.2
Q ss_pred CCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEE
Q 039322 72 GGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLN 151 (708)
Q Consensus 72 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 151 (708)
+++|++|++++|.++. ++ .+..+++|++|+|++|.++++.+ +..+++|++|++++|+++++. .+..+++|+.|+
T Consensus 40 l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~ 113 (308)
T 1h6u_A 40 LDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNVS--AIAGLQSIKTLD 113 (308)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCCG--GGTTCTTCCEEE
T ss_pred cCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCch--hhcCCCCCCEEE
Confidence 4455555555555543 22 35555555555555555554433 555555555555555555432 355555556666
Q ss_pred cccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccc
Q 039322 152 VSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNN 231 (708)
Q Consensus 152 L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~ 231 (708)
+++|+++... .+..+++|++|+|++|++++..+ +..+++|++|++++|++++. +. +..+++|+.|++++|++++
T Consensus 114 l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~ 187 (308)
T 1h6u_A 114 LTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNKISD 187 (308)
T ss_dssp CTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCccCc
Confidence 6665555321 25555666666666665553322 55556666666666666532 22 5556666666666666654
Q ss_pred cCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCC
Q 039322 232 SVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFG 278 (708)
Q Consensus 232 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~ 278 (708)
..+ +..+++|+.|++++|++++.. .+..+++|+.|++++|+++
T Consensus 188 ~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 188 ISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp CGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred Chh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence 332 555666666666666666433 2566666666666666665
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.7e-26 Score=258.90 Aligned_cols=342 Identities=14% Similarity=0.073 Sum_probs=170.1
Q ss_pred CCcEEECCCCc-cccc-CCccccCCCCCCEEEeeCceeeeeCCC----CC-CCCCcccccccCCCccC----CCCccccC
Q 039322 3 SLSILDLNQNQ-FKGV-LPPSVSNLTNLKELVLLYNNLSGFIPP----SL-ENPMLTRPGLDFNHFTS----YLPHNVCR 71 (708)
Q Consensus 3 ~L~~L~l~~n~-i~~~-~~~~~~~l~~L~~L~L~~n~i~~~~~~----~~-~~~~l~~l~l~~n~~~~----~~~~~~~~ 71 (708)
+|++|+|++|. ++.. .+....++++|++|+|++|.+.+.... .. ..++|+.|++++|.++. .++..+..
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 37888888876 3211 122234678888888888877543211 11 12678888888887763 23344456
Q ss_pred CCCccEEeccCCccccccCccCcCCCCCcEEEccCCccc---cccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCC
Q 039322 72 GGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLT---GNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLG 148 (708)
Q Consensus 72 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~---~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 148 (708)
+++|++|++++|.+.+ ++..+.++++|++|+++.+... ......+..+++|+.|+++++... ..+..+..+++|+
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~ 296 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIR 296 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCC
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCc
Confidence 6788888888887774 4566777777777777643222 122234455556666666554322 2233344555666
Q ss_pred EEEcccCcccccCC-ccccCCCCCCEEecccccccc-cCCcccCCCCCCCEEEcc-----------CccccccCC-cccC
Q 039322 149 TLNVSMNNITGGIP-REIGNSSQLQALDLSLNHIVG-EIPKELGKLNSLTELILR-----------GNQFTGRLP-PEIG 214 (708)
Q Consensus 149 ~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~l~-----------~n~l~~~~~-~~~~ 214 (708)
+|+|++|.++.... ..+..+++|++|+++ +.+.. ..+..+..+++|++|+++ .|.+++... ..+.
T Consensus 297 ~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~ 375 (592)
T 3ogk_B 297 KLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQ 375 (592)
T ss_dssp EEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHH
T ss_pred EEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHh
Confidence 66666665543222 224455566666665 32321 112222345555666555 233332111 1122
Q ss_pred CCCCCCeEeccCCcccccCCCCCCc-cccceeeccc----CcccccC-----CChhhhhhcccchhhcccc--cCCCCCc
Q 039322 215 SLVDLEYLDLSANRFNNSVPENLGN-LLKLHYLGLS----NNQFVLE-----LPKELEKLVQLSELDASHN--LFGGEIP 282 (708)
Q Consensus 215 ~~~~L~~L~l~~N~i~~~~~~~~~~-l~~L~~L~l~----~n~l~~~-----~~~~~~~l~~L~~L~ls~N--~i~~~~~ 282 (708)
.+++|++|+++.|.+++..+..+.. +++|+.|+++ .|.+++. .+..+.++++|+.|++++| .+++...
T Consensus 376 ~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~ 455 (592)
T 3ogk_B 376 GCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGL 455 (592)
T ss_dssp HCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHH
T ss_pred hCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHH
Confidence 3455555555555555443333333 4555555553 4444432 1122444555555555432 2333222
Q ss_pred hhhc-CcccCCceecccccccCC-CCCcccccccccEEecCCCcCCCC-CCC-ccccccCccccccccc
Q 039322 283 FQIC-SLKSLEKLNLSHNNLSGS-IPNCFEGIRGISVIDISDNQLQGP-VPN-STAFRNAPVEALKGNK 347 (708)
Q Consensus 283 ~~~~-~~~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~l~l~~N~l~~~-~~~-~~~~~~~~~~~~~~n~ 347 (708)
..+. .+++|+.|++++|++++. .+..+.++++|+.|++++|+++.. ++. ...++.++.+.+++|+
T Consensus 456 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 456 SYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred HHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 2222 245555555555555431 222234445555555555554321 111 1233445555555554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-24 Score=227.62 Aligned_cols=249 Identities=17% Similarity=0.195 Sum_probs=129.8
Q ss_pred ccEEeccCCccccccCccCcCC--CCCcEEEccCCccccccccccCCCCCCCEEEcccCcceee-CCCCCCCCCCCCEEE
Q 039322 75 LQYFGVSENHFQGTIPKILRNC--SSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGE-ISSNWGKCPKLGTLN 151 (708)
Q Consensus 75 L~~L~l~~n~i~~~~~~~~~~l--~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~ 151 (708)
++.+++++|.+. +..+..+ ++++.|++++|.+++..+. +..+++|++|++++|.++.. .+..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 445555555544 2333444 5555555555555544333 33455555555555555432 333444555555555
Q ss_pred cccCcccccCCccccCCCCCCEEecccc-ccccc-CCcccCCCCCCCEEEccCc-ccccc-CCcccCCCC-CCCeEeccC
Q 039322 152 VSMNNITGGIPREIGNSSQLQALDLSLN-HIVGE-IPKELGKLNSLTELILRGN-QFTGR-LPPEIGSLV-DLEYLDLSA 226 (708)
Q Consensus 152 L~~N~i~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~l~~n-~l~~~-~~~~~~~~~-~L~~L~l~~ 226 (708)
|++|.++...+..++.+++|++|+|++| .+++. .+..+..+++|++|++++| .+++. .+..+..++ +|++|+|++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 5555555444555555555555555555 34431 3333445555666666655 55532 334445555 666666666
Q ss_pred Cc--cc-ccCCCCCCccccceeecccCcc-cccCCChhhhhhcccchhhccccc-CCCCCchhhcCcccCCceecccccc
Q 039322 227 NR--FN-NSVPENLGNLLKLHYLGLSNNQ-FVLELPKELEKLVQLSELDASHNL-FGGEIPFQICSLKSLEKLNLSHNNL 301 (708)
Q Consensus 227 N~--i~-~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~ls~N~-i~~~~~~~~~~~~~L~~L~l~~N~l 301 (708)
|. ++ +..+..+..+++|+.|++++|. +++..+..+..+++|+.|++++|. +.......+..+++|+.|++++| +
T Consensus 205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i 283 (336)
T 2ast_B 205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-V 283 (336)
T ss_dssp CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-S
T ss_pred CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-c
Confidence 62 33 2233344555666666666666 444455556666666666666663 22222224556666777777766 2
Q ss_pred cCCCCCccccc-ccccEEecCCCcCCCCCCC
Q 039322 302 SGSIPNCFEGI-RGISVIDISDNQLQGPVPN 331 (708)
Q Consensus 302 ~~~~~~~~~~l-~~L~~l~l~~N~l~~~~~~ 331 (708)
+ ...+..+ ..++.|++++|.+++..|.
T Consensus 284 ~---~~~~~~l~~~l~~L~l~~n~l~~~~~~ 311 (336)
T 2ast_B 284 P---DGTLQLLKEALPHLQINCSHFTTIARP 311 (336)
T ss_dssp C---TTCHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred C---HHHHHHHHhhCcceEEecccCccccCC
Confidence 2 2233333 2366666777777766554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-22 Score=213.02 Aligned_cols=222 Identities=15% Similarity=0.076 Sum_probs=118.7
Q ss_pred CCccEEeccCCccccccCccCcCCCCCcEEEccCCcccc-ccccccCCCCCCCE-EEcccCcceeeCCCCCCCCCCCCEE
Q 039322 73 GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTG-NISEALGIYPNLTF-IDLSRNDFYGEISSNWGKCPKLGTL 150 (708)
Q Consensus 73 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~-~~~~~~~~~~~L~~-L~l~~n~l~~~~~~~~~~l~~L~~L 150 (708)
+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+ +...+|.+++++++ +.+..|+++.+.+..|..+++|++|
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L 109 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence 345566666666654444455666666666666665532 34445555555543 4444456665656666666666666
Q ss_pred EcccCcccccCCccccCCCCCCEEeccc-ccccccCCcccCCCC-CCCEEEccCccccccCCcccCCCCCCCeEeccC-C
Q 039322 151 NVSMNNITGGIPREIGNSSQLQALDLSL-NHIVGEIPKELGKLN-SLTELILRGNQFTGRLPPEIGSLVDLEYLDLSA-N 227 (708)
Q Consensus 151 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~-N 227 (708)
++++|+|+...+..+....++..|++.+ |++....+..|..++ .++.|+|++|+|+.+.+..| ...+|++|++++ |
T Consensus 110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n 188 (350)
T 4ay9_X 110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNN 188 (350)
T ss_dssp EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCT
T ss_pred cccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhc-cccchhHHhhccCC
Confidence 6666666555444454555555555543 445544444454443 45566666666663333333 344566666653 4
Q ss_pred cccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccc
Q 039322 228 RFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299 (708)
Q Consensus 228 ~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N 299 (708)
.++...++.|..+++|+.|+|++|+|+...+..|.++.+|+.+++ +.++ ..| .+..+++|+.++++++
T Consensus 189 ~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 189 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLEKLVALMEASLTYP 256 (350)
T ss_dssp TCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCH
T ss_pred cccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-CchhCcChhhCcCCCC
Confidence 555444445566666666666666666444445555555554443 2233 333 2455666666666543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.88 E-value=6.4e-26 Score=255.90 Aligned_cols=323 Identities=14% Similarity=0.053 Sum_probs=161.8
Q ss_pred CCCCCCEEEeeCceeeeeCCCCCCC--CC-cccccccCCCc-cC-CCCccccCCCCccEEeccCCcccccc----CccCc
Q 039322 24 NLTNLKELVLLYNNLSGFIPPSLEN--PM-LTRPGLDFNHF-TS-YLPHNVCRGGALQYFGVSENHFQGTI----PKILR 94 (708)
Q Consensus 24 ~l~~L~~L~L~~n~i~~~~~~~~~~--~~-l~~l~l~~n~~-~~-~~~~~~~~l~~L~~L~l~~n~i~~~~----~~~~~ 94 (708)
.+++|++|+|++|.+++..+..+.. ++ |+.|++++|.. .. .++.....+++|++|+|++|.+++.. +..+.
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 4555666666665554333222221 22 55555555541 10 01111224455555555555554331 12233
Q ss_pred CCCCCcEEEccCCccccc----cccccCCCCCCCEEEcccCcceeeC--------------------------CCCCCCC
Q 039322 95 NCSSLIRVRLNSNNLTGN----ISEALGIYPNLTFIDLSRNDFYGEI--------------------------SSNWGKC 144 (708)
Q Consensus 95 ~l~~L~~L~l~~n~i~~~----~~~~~~~~~~L~~L~l~~n~l~~~~--------------------------~~~~~~l 144 (708)
++++|++|+|++|.++++ .+..+..+++|++|++++|.+.++. ...+..+
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~ 269 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFP 269 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCC
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhhHHHhhcccccccccchHHHHHHhhcc
Confidence 445555555555555421 2222344555555555555544321 1233444
Q ss_pred CCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCC-cccCCCCCCCEEEccCccccccCCcccCCCCCCCeEe
Q 039322 145 PKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIP-KELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLD 223 (708)
Q Consensus 145 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~ 223 (708)
++|+.|+++++... ..+..+..+++|++|+|++|.+++... ..+..+++|++|+++++...+.++..+..+++|++|+
T Consensus 270 ~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~ 348 (592)
T 3ogk_B 270 RKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLR 348 (592)
T ss_dssp TTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEE
T ss_pred ccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEE
Confidence 55555555554322 344555566667777777766553222 2345667777777763322222222334566677777
Q ss_pred cc-----------CCcccccCCCC-CCccccceeecccCcccccCCChhhhh-hcccchhhcc----cccCCCC-----C
Q 039322 224 LS-----------ANRFNNSVPEN-LGNLLKLHYLGLSNNQFVLELPKELEK-LVQLSELDAS----HNLFGGE-----I 281 (708)
Q Consensus 224 l~-----------~N~i~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~ls----~N~i~~~-----~ 281 (708)
|+ .|.+++..... +..+++|+.|+++.|.+++..+..+.. +++|+.|+++ .|.+++. .
T Consensus 349 L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~ 428 (592)
T 3ogk_B 349 IERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGV 428 (592)
T ss_dssp EECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHH
T ss_pred eecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHH
Confidence 77 34554322211 234667777777777776555555544 6677777775 5566643 2
Q ss_pred chhhcCcccCCceeccccc--ccCCCCCccc-ccccccEEecCCCcCCCC-CCC-ccccccCccccccccc
Q 039322 282 PFQICSLKSLEKLNLSHNN--LSGSIPNCFE-GIRGISVIDISDNQLQGP-VPN-STAFRNAPVEALKGNK 347 (708)
Q Consensus 282 ~~~~~~~~~L~~L~l~~N~--l~~~~~~~~~-~l~~L~~l~l~~N~l~~~-~~~-~~~~~~~~~~~~~~n~ 347 (708)
+..+..+++|+.|+++.|. +++.....+. .+++|+.|++++|.+++. ++. ....++++.+.+.+|+
T Consensus 429 ~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~ 499 (592)
T 3ogk_B 429 RSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCC 499 (592)
T ss_dssp HHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCC
T ss_pred HHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCC
Confidence 2334556777777776432 4433232222 356677777777776542 111 1234556666666664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-22 Score=204.79 Aligned_cols=155 Identities=16% Similarity=0.138 Sum_probs=120.8
Q ss_pred HHHHHhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcch-----h---------HhHHHHHHHHHHHHhccC
Q 039322 430 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQ-----I---------ADQKEFLIEVKALTEIRH 495 (708)
Q Consensus 430 ~~~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~-----~---------~~~~~~~~e~~~l~~l~h 495 (708)
........|.+.+.||+|+||.||+|...+|+.||+|+++....... . .....+.+|++++++++|
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~ 163 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 163 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence 33444556777899999999999999887799999999975321100 0 235678999999999984
Q ss_pred CceeeEEEEEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee
Q 039322 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLL 575 (708)
Q Consensus 496 ~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill 575 (708)
+++.+++.. +..++||||++||+|.+ +.. .....++.|++.||+|||++ ||+||||||+||++
T Consensus 164 ---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl 226 (282)
T 1zar_A 164 ---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV 226 (282)
T ss_dssp ---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred ---CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEE
Confidence 555555433 55699999999999998 522 22447999999999999999 99999999999999
Q ss_pred CCCCcEEEeecccccccCCCCCccccccccccccCccccc
Q 039322 576 DLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAY 615 (708)
Q Consensus 576 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~ 615 (708)
+ ++.+||+|||+|+.. ..+.|||++.
T Consensus 227 ~-~~~vkl~DFG~a~~~-------------~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVEV-------------GEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCEET-------------TSTTHHHHHH
T ss_pred E-CCcEEEEECCCCeEC-------------CCCCHHHHHH
Confidence 9 999999999999732 3467888764
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-21 Score=187.21 Aligned_cols=152 Identities=20% Similarity=0.206 Sum_probs=79.5
Q ss_pred cEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccC
Q 039322 76 QYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMN 155 (708)
Q Consensus 76 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 155 (708)
+.++++++.++ .+|..+ .++|++|++++|+++++.+..|..+++|++|++++|+++.+.+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 34555555555 233322 245566666666665555555555555666666555555555555555555555555555
Q ss_pred cccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCccc
Q 039322 156 NITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFN 230 (708)
Q Consensus 156 ~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~ 230 (708)
+|+...+..|..+++|++|+|++|++++..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|.+.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 161 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 161 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence 555444444555555555555555555444444445555555555555555433333444455555555555443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.86 E-value=5.4e-25 Score=248.45 Aligned_cols=202 Identities=17% Similarity=0.132 Sum_probs=103.5
Q ss_pred CCCCCEEEcccCcccccCC-ccccCCCCCCEEecccccccccCCc-ccCCCCCCCEEEccC---------ccccccCCcc
Q 039322 144 CPKLGTLNVSMNNITGGIP-REIGNSSQLQALDLSLNHIVGEIPK-ELGKLNSLTELILRG---------NQFTGRLPPE 212 (708)
Q Consensus 144 l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~l~~---------n~l~~~~~~~ 212 (708)
+++|++|+|++|.++.... ..+..+++|++|++++| +...... ....+++|++|++.+ +.+++.....
T Consensus 288 ~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~ 366 (594)
T 2p1m_B 288 CSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVS 366 (594)
T ss_dssp HTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHH
T ss_pred hCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHH
Confidence 4556666666665543221 12345566666666655 3311111 122355666666522 3333211111
Q ss_pred cC-CCCCCCeEeccCCcccccCCCCCC-ccccceeeccc--C----cccccCCC-----hhhhhhcccchhhcccccCCC
Q 039322 213 IG-SLVDLEYLDLSANRFNNSVPENLG-NLLKLHYLGLS--N----NQFVLELP-----KELEKLVQLSELDASHNLFGG 279 (708)
Q Consensus 213 ~~-~~~~L~~L~l~~N~i~~~~~~~~~-~l~~L~~L~l~--~----n~l~~~~~-----~~~~~l~~L~~L~ls~N~i~~ 279 (708)
+. .+++|++|.++.|.+++.....+. .+++|+.|+++ + |.++.... ..+..+++|+.|++++ .+++
T Consensus 367 l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~ 445 (594)
T 2p1m_B 367 VSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTD 445 (594)
T ss_dssp HHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCH
T ss_pred HHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccH
Confidence 21 256666666666666544333333 35677777776 3 44542211 1245566777777765 5554
Q ss_pred CCchhhcC-cccCCceecccccccCCCCCcc-cccccccEEecCCCcCCCCCC--CccccccCccccccccc
Q 039322 280 EIPFQICS-LKSLEKLNLSHNNLSGSIPNCF-EGIRGISVIDISDNQLQGPVP--NSTAFRNAPVEALKGNK 347 (708)
Q Consensus 280 ~~~~~~~~-~~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~l~l~~N~l~~~~~--~~~~~~~~~~~~~~~n~ 347 (708)
..+..+.. +++|+.|++++|.+++.....+ .++++|+.|++++|++++... ....+++++.+.+.+|+
T Consensus 446 ~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~ 517 (594)
T 2p1m_B 446 KVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCS 517 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSC
T ss_pred HHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCC
Confidence 44444443 6777777777777654433333 456777777777777743211 12234556666666653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=5.6e-21 Score=184.27 Aligned_cols=181 Identities=20% Similarity=0.183 Sum_probs=136.5
Q ss_pred cEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccc
Q 039322 100 IRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179 (708)
Q Consensus 100 ~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n 179 (708)
+.++.+++.++.++... .++|++|++++|+++++.+..|..+++|++|+|++|+++...+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~~~p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTSVPTGI---PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSSCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccCCCCCC---CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 56778888877665432 357888888888888777777888888888888888888776667788888888888888
Q ss_pred cccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCCh
Q 039322 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPK 259 (708)
Q Consensus 180 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 259 (708)
++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|.+.+.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~--- 163 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT--- 163 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC---
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC---
Confidence 88866666677888888888888888866666677788888888888888866666677778888888888876532
Q ss_pred hhhhhcccchhhcccccCCCCCchhhcCccc
Q 039322 260 ELEKLVQLSELDASHNLFGGEIPFQICSLKS 290 (708)
Q Consensus 260 ~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~ 290 (708)
+++|+.|+++.|.+++.+|..++.++.
T Consensus 164 ----~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 164 ----CPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ----TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ----CCCHHHHHHHHHhCCceeeccCccccC
Confidence 346777777777777777766665543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.2e-24 Score=242.10 Aligned_cols=324 Identities=14% Similarity=0.088 Sum_probs=215.0
Q ss_pred CCCCcEEECCCCcccccCCcccc-CCCCCCEEEeeCc-eeeee-CCCCC-CCCCcccccccCCCccCCCCcccc----CC
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVS-NLTNLKELVLLYN-NLSGF-IPPSL-ENPMLTRPGLDFNHFTSYLPHNVC----RG 72 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~-~l~~L~~L~L~~n-~i~~~-~~~~~-~~~~l~~l~l~~n~~~~~~~~~~~----~l 72 (708)
+++|++|+|++|.++...+..+. .+++|++|+|++| .++.. ++..+ ..++|++|++++|.+++..+..+. .+
T Consensus 104 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~ 183 (594)
T 2p1m_B 104 YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY 183 (594)
T ss_dssp CTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred CCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence 35778888888877766655554 5778888888877 44432 11222 236777888887776654433332 45
Q ss_pred CCccEEeccCCc--cccc-cCccCcCCCCCcEEEccCC-cc---------------------------------------
Q 039322 73 GALQYFGVSENH--FQGT-IPKILRNCSSLIRVRLNSN-NL--------------------------------------- 109 (708)
Q Consensus 73 ~~L~~L~l~~n~--i~~~-~~~~~~~l~~L~~L~l~~n-~i--------------------------------------- 109 (708)
++|++|++++|. ++.. .+..+.++++|++|+|++| .+
T Consensus 184 ~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~ 263 (594)
T 2p1m_B 184 TSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSG 263 (594)
T ss_dssp CCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHT
T ss_pred CcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhc
Confidence 577777777775 2211 1111234566777777665 11
Q ss_pred ----------ccc----cccccCCCCCCCEEEcccCcceeeCC-CCCCCCCCCCEEEcccCcccccC-CccccCCCCCCE
Q 039322 110 ----------TGN----ISEALGIYPNLTFIDLSRNDFYGEIS-SNWGKCPKLGTLNVSMNNITGGI-PREIGNSSQLQA 173 (708)
Q Consensus 110 ----------~~~----~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~ 173 (708)
... .+..+..+++|++|+|++|.++.... ..+..+++|++|++++| ++... +.....+++|++
T Consensus 264 ~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~ 342 (594)
T 2p1m_B 264 CKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRE 342 (594)
T ss_dssp CTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCE
T ss_pred CCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCE
Confidence 111 11112256889999999998754322 22457899999999998 54322 223345899999
Q ss_pred Eecc---------cccccccCCcccC-CCCCCCEEEccCccccccCCcccC-CCCCCCeEecc--C----CcccccC---
Q 039322 174 LDLS---------LNHIVGEIPKELG-KLNSLTELILRGNQFTGRLPPEIG-SLVDLEYLDLS--A----NRFNNSV--- 233 (708)
Q Consensus 174 L~L~---------~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~-~~~~L~~L~l~--~----N~i~~~~--- 233 (708)
|+++ .+.+++.....+. ++++|++|.++.|.+++.....+. .+++|+.|+|+ + |.++...
T Consensus 343 L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~ 422 (594)
T 2p1m_B 343 LRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDI 422 (594)
T ss_dssp EEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHH
T ss_pred EEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhh
Confidence 9994 3555533333333 479999999999998865555554 58899999999 4 5666221
Q ss_pred --CCCCCccccceeecccCcccccCCChhhhh-hcccchhhcccccCCCCCchhh-cCcccCCceecccccccCCCCC-c
Q 039322 234 --PENLGNLLKLHYLGLSNNQFVLELPKELEK-LVQLSELDASHNLFGGEIPFQI-CSLKSLEKLNLSHNNLSGSIPN-C 308 (708)
Q Consensus 234 --~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~ls~N~i~~~~~~~~-~~~~~L~~L~l~~N~l~~~~~~-~ 308 (708)
+..+..+++|+.|++++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++.... .
T Consensus 423 ~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~ 501 (594)
T 2p1m_B 423 GFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLAN 501 (594)
T ss_dssp HHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHT
T ss_pred HHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHH
Confidence 11256778999999987 666555555555 7899999999999976555555 6689999999999999644333 3
Q ss_pred ccccccccEEecCCCcCC
Q 039322 309 FEGIRGISVIDISDNQLQ 326 (708)
Q Consensus 309 ~~~l~~L~~l~l~~N~l~ 326 (708)
...+++|+.|++++|+++
T Consensus 502 ~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 502 ASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp GGGGGGSSEEEEESSCCB
T ss_pred HHhCCCCCEEeeeCCCCC
Confidence 456899999999999884
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.8e-20 Score=206.18 Aligned_cols=189 Identities=20% Similarity=0.292 Sum_probs=149.3
Q ss_pred CccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcc
Q 039322 74 ALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVS 153 (708)
Q Consensus 74 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 153 (708)
+|+.|+|++|++++ +|..+. ++|++|+|++|+|+.++ ..+++|++|+|++|+|+++.. +.. +|+.|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~ip----~~l~~L~~L~Ls~N~l~~ip~--l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALISLP----ELPASLEYLDACDNRLSTLPE--LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCSCCCC--CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcccc----cccCCCCEEEccCCCCCCcch--hhc--CCCEEECC
Confidence 78899999999886 565553 78999999999988655 456889999999999887544 544 89999999
Q ss_pred cCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccC
Q 039322 154 MNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSV 233 (708)
Q Consensus 154 ~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~ 233 (708)
+|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 999986 444 57889999999999985 454 56889999999999985 555 65 88999999999998 55
Q ss_pred CCCCCccccc-------eeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCccc
Q 039322 234 PENLGNLLKL-------HYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKS 290 (708)
Q Consensus 234 ~~~~~~l~~L-------~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~ 290 (708)
|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|++++..|..+..++.
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 55 554 67 99999999998 56777777999999999999998888877776543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.2e-20 Score=205.47 Aligned_cols=189 Identities=24% Similarity=0.305 Sum_probs=151.4
Q ss_pred CCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecc
Q 039322 98 SLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLS 177 (708)
Q Consensus 98 ~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 177 (708)
+|+.|+|++|+|++++... +++|++|+|++|+|+.+. ..+++|+.|+|++|+|++ +|. |.. +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~lp~~l---~~~L~~L~Ls~N~l~~ip----~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDNL---PPQITVLEITQNALISLP----ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSCCCSCC---CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCccCHhH---cCCCCEEECcCCCCcccc----cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 8999999999999865543 378999999999998554 456899999999999986 555 554 89999999
Q ss_pred cccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCC
Q 039322 178 LNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLEL 257 (708)
Q Consensus 178 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 257 (708)
+|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 999986 554 67899999999999985 554 56889999999999986 555 65 88999999999998 45
Q ss_pred Chhhhhhccc-------chhhcccccCCCCCchhhcCcccCCceecccccccCCCCCccccccc
Q 039322 258 PKELEKLVQL-------SELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRG 314 (708)
Q Consensus 258 ~~~~~~l~~L-------~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~ 314 (708)
|. |.. +| +.|+|++|.|+ .+|..+..+++|+.|+|++|++++..|..+..+..
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 55 554 67 99999999998 56777777999999999999999888887776544
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.84 E-value=6.1e-21 Score=185.38 Aligned_cols=152 Identities=19% Similarity=0.238 Sum_probs=86.9
Q ss_pred CEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCC
Q 039322 148 GTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSAN 227 (708)
Q Consensus 148 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N 227 (708)
+.+++++|.++. +|..+. ++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 456666666663 333332 45666666666666555555666666666666666666555666666666666666666
Q ss_pred cccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceeccccccc
Q 039322 228 RFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS 302 (708)
Q Consensus 228 ~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 302 (708)
+|+...+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.|++..+..+..+++|+.|++++|++.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 666444444555666666666666665555555555555555555555555444444445555555555555554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.83 E-value=3.5e-21 Score=195.70 Aligned_cols=171 Identities=23% Similarity=0.275 Sum_probs=92.3
Q ss_pred CCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEE
Q 039322 71 RGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTL 150 (708)
Q Consensus 71 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 150 (708)
.+++|++|++++|.+++. + .+..+++|++|+|++|+++++.+ +..+++|++|++++|+++++. .+..+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLS--SLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCGG--GGTTCTTCCEE
T ss_pred hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCCh--hhccCCCCCEE
Confidence 344555555555555432 2 24555555555555555554433 555555555555555554432 25555555555
Q ss_pred EcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCccc
Q 039322 151 NVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFN 230 (708)
Q Consensus 151 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~ 230 (708)
+|++|+++.. ..+..+++|+.|+|++|++++. ..+..+++|++|++++|++++..+ +..+++|++|+|++|.|+
T Consensus 118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence 5555555532 3455555666666666655533 345555666666666666653332 555666666666666665
Q ss_pred ccCCCCCCccccceeecccCccccc
Q 039322 231 NSVPENLGNLLKLHYLGLSNNQFVL 255 (708)
Q Consensus 231 ~~~~~~~~~l~~L~~L~l~~n~l~~ 255 (708)
+. + .+..+++|+.|++++|+++.
T Consensus 192 ~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 192 DL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp BC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred CC-h-hhccCCCCCEEECcCCcccC
Confidence 32 2 25556666666666666653
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.83 E-value=6.9e-21 Score=193.53 Aligned_cols=191 Identities=22% Similarity=0.236 Sum_probs=150.1
Q ss_pred ccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEccc
Q 039322 75 LQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSM 154 (708)
Q Consensus 75 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 154 (708)
+..+.+..+.+++..+ +..+++|++|++++|.++.+. .+..+++|++|++++|+++++.+ +..+++|+.|++++
T Consensus 26 ~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~~--~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~ 99 (291)
T 1h6t_A 26 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE 99 (291)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred HHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccCh--hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence 3444556666654332 456788899999998888663 47788899999999998887665 88888999999999
Q ss_pred CcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCC
Q 039322 155 NNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVP 234 (708)
Q Consensus 155 N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~ 234 (708)
|.++.. ..+..+++|++|+|++|++++. ..+..+++|+.|++++|++++. ..+..+++|++|++++|++++..+
T Consensus 100 n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 100 NKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp SCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh
Confidence 988853 3488888899999999988853 4677888899999999988854 578888889999999998886555
Q ss_pred CCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCC
Q 039322 235 ENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEI 281 (708)
Q Consensus 235 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~ 281 (708)
+..+++|+.|++++|.+++. + .+..+++|+.|++++|++....
T Consensus 174 --l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~~ 216 (291)
T 1h6t_A 174 --LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNKP 216 (291)
T ss_dssp --GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEECCC
T ss_pred --hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccCCc
Confidence 88888899999999988853 3 4888888999999999887543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.8e-20 Score=196.91 Aligned_cols=152 Identities=26% Similarity=0.238 Sum_probs=93.4
Q ss_pred cEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccC-CCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEccc
Q 039322 76 QYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALG-IYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSM 154 (708)
Q Consensus 76 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~-~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 154 (708)
+.++++++.++ .+|..+. +.++.|+|++|+|+++.+..|. .+++|++|+|++|+|+.+.+..|..+++|+.|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 46777777776 3454443 3466777777777766666666 667777777777777666666666666777777777
Q ss_pred CcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCccc---CCCCCCCeEeccCCccc
Q 039322 155 NNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI---GSLVDLEYLDLSANRFN 230 (708)
Q Consensus 155 N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~---~~~~~L~~L~l~~N~i~ 230 (708)
|+|+...+..|..+++|++|+|++|+|+...+..|.++++|++|+|++|+|++..+..| ..+++|+.|+|++|+|+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 76666655566666666666666666665555556666666666666666663333333 23444444444444444
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=7.1e-20 Score=177.81 Aligned_cols=151 Identities=23% Similarity=0.218 Sum_probs=80.7
Q ss_pred cEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccC
Q 039322 76 QYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMN 155 (708)
Q Consensus 76 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 155 (708)
+.++++++.++ .+|..+. ++|++|+|++|+|+++.+..|..+++|++|+|++|+++.+.+..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 45666666666 3444333 45666666666666555555555566666666666655555555555555555555555
Q ss_pred cccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcc
Q 039322 156 NITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRF 229 (708)
Q Consensus 156 ~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i 229 (708)
+|+.+.+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 164 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCc
Confidence 55544444455555555555555555544444444455555555555554444333444444444444444444
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=6.9e-21 Score=184.98 Aligned_cols=136 Identities=19% Similarity=0.197 Sum_probs=75.7
Q ss_pred CCEEEccCccccccCC-cccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcc
Q 039322 195 LTELILRGNQFTGRLP-PEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDAS 273 (708)
Q Consensus 195 L~~L~l~~n~l~~~~~-~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls 273 (708)
+++|+|++|++++..+ ..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|+|+
T Consensus 34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 113 (220)
T 2v70_A 34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR 113 (220)
T ss_dssp CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECT
T ss_pred CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECC
Confidence 3444455554443322 234455555555555555554444455555555555555555555555555555555555555
Q ss_pred cccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCC
Q 039322 274 HNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVP 330 (708)
Q Consensus 274 ~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 330 (708)
+|.|++..+..+..+++|+.|+|++|++++..|..|..+++|+.|++++|++.|.++
T Consensus 114 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 114 SNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 555555555555556666666666666665556666666666666666666666544
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.83 E-value=6.8e-21 Score=212.03 Aligned_cols=170 Identities=21% Similarity=0.232 Sum_probs=104.0
Q ss_pred CCcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEc
Q 039322 49 PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDL 128 (708)
Q Consensus 49 ~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l 128 (708)
++|+.|++++|.+.+. + .+..+++|+.|+|++|.+++..+ +.++++|+.|+|++|.|+++. .+..+++|++|+|
T Consensus 43 ~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~--~l~~l~~L~~L~L 116 (605)
T 1m9s_A 43 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLS--SLKDLKKLKSLSL 116 (605)
T ss_dssp TTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCT--TSTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCCh--hhccCCCCCEEEe
Confidence 3444444444444442 2 35566667777777776665443 666667777777777666532 4666666666666
Q ss_pred ccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCcccccc
Q 039322 129 SRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGR 208 (708)
Q Consensus 129 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 208 (708)
++|++..+ ..+..+++|+.|+|++|.|+.. ..+..+++|+.|+|++|+|++..+ +..+++|+.|+|++|+|++.
T Consensus 117 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l 190 (605)
T 1m9s_A 117 EHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL 190 (605)
T ss_dssp TTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred cCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC
Confidence 66666643 2356666666666666666643 456666666666666666664433 66666666666666666643
Q ss_pred CCcccCCCCCCCeEeccCCccccc
Q 039322 209 LPPEIGSLVDLEYLDLSANRFNNS 232 (708)
Q Consensus 209 ~~~~~~~~~~L~~L~l~~N~i~~~ 232 (708)
..+..+++|+.|+|++|++.+.
T Consensus 191 --~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 191 --RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp --GGGTTCTTCSEEECCSEEEECC
T ss_pred --hHHccCCCCCEEEccCCcCcCC
Confidence 3466666666666666666643
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.6e-20 Score=194.60 Aligned_cols=176 Identities=22% Similarity=0.160 Sum_probs=145.5
Q ss_pred cEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCC-CCCCCCEEEcccCcccccCCccccCCCCCCEEeccc
Q 039322 100 IRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWG-KCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSL 178 (708)
Q Consensus 100 ~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 178 (708)
+.+++++|+++.++... .+.+++|+|++|+|+++.+..|. .+++|+.|+|++|+|+...+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~~iP~~~---~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPNVPQSL---PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSSCCSSC---CTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCccCccC---CCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 68899999998765432 24689999999999988888887 899999999999999988888899999999999999
Q ss_pred ccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCC---CccccceeecccCccccc
Q 039322 179 NHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENL---GNLLKLHYLGLSNNQFVL 255 (708)
Q Consensus 179 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~---~~l~~L~~L~l~~n~l~~ 255 (708)
|+|+...+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..| ..+++|+.|+|++|+|+.
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 99987777788889999999999999998888888889999999999999986555545 568888888888888886
Q ss_pred CCChhhhhhcc--cchhhcccccCC
Q 039322 256 ELPKELEKLVQ--LSELDASHNLFG 278 (708)
Q Consensus 256 ~~~~~~~~l~~--L~~L~ls~N~i~ 278 (708)
..+..|..++. ++.|+|++|++.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCHHHhhhccHhhcceEEecCCCcc
Confidence 66677777776 377888888776
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1e-19 Score=176.77 Aligned_cols=152 Identities=23% Similarity=0.244 Sum_probs=74.1
Q ss_pred cEEeccCCccccccCccCcCCCCCcEEEccCCccccccc-cccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEccc
Q 039322 76 QYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNIS-EALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSM 154 (708)
Q Consensus 76 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 154 (708)
+.+++++|.++ .+|..+. +.+++|+|++|+|+++.+ ..|..+++|++|+|++|+|+++.+..|..+++|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 35666666665 3344332 234555555555555432 3345555555555555555555555555555555555555
Q ss_pred CcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCccc
Q 039322 155 NNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFN 230 (708)
Q Consensus 155 N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~ 230 (708)
|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|++.
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 5555444444444455555555555444444444444444444444444444333444444444444444444433
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.8e-20 Score=208.54 Aligned_cols=203 Identities=22% Similarity=0.235 Sum_probs=154.8
Q ss_pred CcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcc
Q 039322 50 MLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLS 129 (708)
Q Consensus 50 ~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~ 129 (708)
.+..+.++.+.+....+ +..+.+|+.|++++|.+... + .+..+++|+.|+|++|.|+++.+ +..+++|++|+|+
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls 95 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD 95 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence 34555666666555433 45678889999999998853 3 58888999999999999887665 8888899999999
Q ss_pred cCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccC
Q 039322 130 RNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRL 209 (708)
Q Consensus 130 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 209 (708)
+|.+..+. .+..+++|+.|+|++|+|+.. ..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++..
T Consensus 96 ~N~l~~l~--~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~ 169 (605)
T 1m9s_A 96 ENKIKDLS--SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV 169 (605)
T ss_dssp SSCCCCCT--TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCG
T ss_pred CCCCCCCh--hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCch
Confidence 99887643 678888899999999988853 4688888888888888888854 56788888888888888888654
Q ss_pred CcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccc
Q 039322 210 PPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLS 268 (708)
Q Consensus 210 ~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 268 (708)
| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++.......+..+..+.
T Consensus 170 ~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~~~~ 224 (605)
T 1m9s_A 170 P--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPN 224 (605)
T ss_dssp G--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSSCEEEC
T ss_pred h--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccccEEecc
Confidence 4 78888888888888888854 3577888888888888888755444444433333
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=4.6e-19 Score=173.34 Aligned_cols=151 Identities=19% Similarity=0.204 Sum_probs=76.2
Q ss_pred cEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccC
Q 039322 76 QYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMN 155 (708)
Q Consensus 76 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 155 (708)
+.++++++.++ .+|..+. ++|++|+|++|+|+++.+..|..+++|++|+|++|+++.+.+..|..+++|+.|+|++|
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 45666666665 3444333 55555555555555555555555555555555555555554455555555555555555
Q ss_pred cccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCccc
Q 039322 156 NITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFN 230 (708)
Q Consensus 156 ~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~ 230 (708)
+|+...+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|++++..+..|..+++|+.|+|++|++.
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 555444444455555555555555554 33444444444444444444444333333444444444444444433
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=181.52 Aligned_cols=168 Identities=18% Similarity=0.225 Sum_probs=107.5
Q ss_pred CcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcc
Q 039322 50 MLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLS 129 (708)
Q Consensus 50 ~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~ 129 (708)
+++.++++.|.+++.. .+..+++|++|++++|.++. ++ .+..+++|++|+|++|+|+++.+ +..+++|++|+|+
T Consensus 20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~ 93 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN 93 (263)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence 3455555555555432 45566777777777777763 33 56677777777777777776554 6777777777777
Q ss_pred cCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccC
Q 039322 130 RNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRL 209 (708)
Q Consensus 130 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 209 (708)
+|+++++... .. ++|+.|+|++|+|++. ..+..+++|++|+|++|++++. + .+..+++|+.|+|++|++++.
T Consensus 94 ~N~l~~l~~~--~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~- 165 (263)
T 1xeu_A 94 RNRLKNLNGI--PS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT- 165 (263)
T ss_dssp SSCCSCCTTC--CC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-
T ss_pred CCccCCcCcc--cc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch-
Confidence 7777654332 22 6677777777777643 3466667777777777777643 2 466666777777777766644
Q ss_pred CcccCCCCCCCeEeccCCccccc
Q 039322 210 PPEIGSLVDLEYLDLSANRFNNS 232 (708)
Q Consensus 210 ~~~~~~~~~L~~L~l~~N~i~~~ 232 (708)
..+..+++|+.|++++|+++..
T Consensus 166 -~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 166 -GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -TTSTTCCCCCEEEEEEEEEECC
T ss_pred -HHhccCCCCCEEeCCCCcccCC
Confidence 4566666666666666666643
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.7e-20 Score=194.61 Aligned_cols=237 Identities=11% Similarity=0.014 Sum_probs=139.0
Q ss_pred cEEeccCCccccccCccCcC--------CCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCC
Q 039322 76 QYFGVSENHFQGTIPKILRN--------CSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKL 147 (708)
Q Consensus 76 ~~L~l~~n~i~~~~~~~~~~--------l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 147 (708)
..+.+..|.| ...+|.+ +++|++|+|.+ +++.+...+|.++++|++|++++|.+..+.+.+|..+.++
T Consensus 75 ~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l 150 (329)
T 3sb4_A 75 KFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTA 150 (329)
T ss_dssp CCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCE
T ss_pred cccccccccc---CHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCce
Confidence 4444444432 2455666 88888888887 7777777888888888888888888877888888777777
Q ss_pred CEEEcccCcc----cccCCccccCCCCCC-EEecccccc-cccCCcccCCCCCCCEEEccCccccccCCccc-CCCCCCC
Q 039322 148 GTLNVSMNNI----TGGIPREIGNSSQLQ-ALDLSLNHI-VGEIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVDLE 220 (708)
Q Consensus 148 ~~L~L~~N~i----~~~~~~~~~~l~~L~-~L~L~~n~l-~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~~~~L~ 220 (708)
..+.+..+.. ......+|.++.+|+ .+.+....- .......-....++..+.+.++-.. .....+ ..+++|+
T Consensus 151 ~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~ 229 (329)
T 3sb4_A 151 IFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLV 229 (329)
T ss_dssp EEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCC
T ss_pred EEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCe
Confidence 7666655322 233445566666666 444432211 0000011112345555555544221 111111 1245666
Q ss_pred eEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccc-hhhcccccCCCCCchhhcCcccCCceecccc
Q 039322 221 YLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLS-ELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299 (708)
Q Consensus 221 ~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~-~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N 299 (708)
.|+|++|+++......|.++++|+.|+|.+| ++.+.+.+|.++.+|+ .|++.+ .++.+.+..|.++++|+.+++++|
T Consensus 230 ~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n 307 (329)
T 3sb4_A 230 SLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGD 307 (329)
T ss_dssp EEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSS
T ss_pred EEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCC
Confidence 6666666666555556666666666666665 5555556666666666 666666 555455566666666666666666
Q ss_pred cccCCCCCcccccccccEEe
Q 039322 300 NLSGSIPNCFEGIRGISVID 319 (708)
Q Consensus 300 ~l~~~~~~~~~~l~~L~~l~ 319 (708)
.++.+.+.+|.++++|+.++
T Consensus 308 ~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 308 KITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp CCCEECTTTTCTTCCCCEEE
T ss_pred ccCccchhhhcCCcchhhhc
Confidence 66666666666666666654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.7e-20 Score=184.29 Aligned_cols=171 Identities=22% Similarity=0.257 Sum_probs=128.2
Q ss_pred CCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEE
Q 039322 71 RGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTL 150 (708)
Q Consensus 71 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 150 (708)
.+.++..+++++|.+++.. .+.++++|++|++++|.|+.+. .+..+++|++|+|++|+++++.+ +..+++|+.|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSLA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccch--HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 3456777788888887544 5777888888888888888654 57778888888888888877665 7788888888
Q ss_pred EcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCccc
Q 039322 151 NVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFN 230 (708)
Q Consensus 151 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~ 230 (708)
+|++|+++...+ +.. ++|++|+|++|++++. ..+..+++|+.|+|++|++++. + .+..+++|++|+|++|+|+
T Consensus 91 ~L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 91 SVNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp ECCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred ECCCCccCCcCc--ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence 888888875432 223 7788888888888753 3577788888888888888754 3 5777788888888888887
Q ss_pred ccCCCCCCccccceeecccCcccccC
Q 039322 231 NSVPENLGNLLKLHYLGLSNNQFVLE 256 (708)
Q Consensus 231 ~~~~~~~~~l~~L~~L~l~~n~l~~~ 256 (708)
+. ..+..+++|+.|++++|+++..
T Consensus 164 ~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 164 NT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ch--HHhccCCCCCEEeCCCCcccCC
Confidence 55 5677777888888888877744
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1e-18 Score=170.85 Aligned_cols=153 Identities=21% Similarity=0.167 Sum_probs=110.0
Q ss_pred CcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEeccc
Q 039322 99 LIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSL 178 (708)
Q Consensus 99 L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 178 (708)
-+.++.+++.++.++... .++|++|+|++|+++++.+..|..+++|+.|+|++|+|+...+..|..+++|++|+|++
T Consensus 21 ~~~v~c~~~~l~~ip~~~---~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHASVPAGI---PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCSSCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcCccCCCC---CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 456777777777655432 26777888888887777777777777788888887777766666677777777777777
Q ss_pred ccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCccccc
Q 039322 179 NHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVL 255 (708)
Q Consensus 179 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~ 255 (708)
|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|++++|.+..
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 7777655566677777777777777777 566666777777777777777776555666677777777777777663
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.78 E-value=9.8e-18 Score=177.42 Aligned_cols=266 Identities=13% Similarity=0.124 Sum_probs=179.8
Q ss_pred CCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEc
Q 039322 25 LTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRL 104 (708)
Q Consensus 25 l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l 104 (708)
...++.+.+-.+ ++.+...+|...+|+.+.+..+ +.......|.. .+|+.+.+.. .++.+...+|.++++|++++|
T Consensus 112 ~~~l~~i~ip~~-i~~I~~~aF~~~~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 112 LKGYNEIILPNS-VKSIPKDAFRNSQIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp CSSCSEEECCTT-CCEECTTTTTTCCCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred cCCccEEEECCc-cCEehHhhcccCCccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 344555544432 3334444454445555555443 44444444544 3577777765 555566677777777777777
Q ss_pred cCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEeccccccccc
Q 039322 105 NSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGE 184 (708)
Q Consensus 105 ~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 184 (708)
.+|+++.+...+|. ..+|+.+.|.++ ++.+...+|.++++|+.++|.+| ++.+...+|.+ .+|+.+.+ .+.++..
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I 262 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNI 262 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEE
T ss_pred CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEE
Confidence 77777777777776 467777777643 76777777777777887777764 55566677776 67777777 4446555
Q ss_pred CCcccCCCCCCCEEEccCcccc-----ccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCCh
Q 039322 185 IPKELGKLNSLTELILRGNQFT-----GRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPK 259 (708)
Q Consensus 185 ~~~~~~~l~~L~~L~l~~n~l~-----~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 259 (708)
...+|.++++|+.+.+.+|.+. .+.+.+|.++++|+.++|. +.++......|.++++|+.|.|..| ++.+...
T Consensus 263 ~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~ 340 (401)
T 4fdw_A 263 ASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFS 340 (401)
T ss_dssp CTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTT
T ss_pred ChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHH
Confidence 6667777778888877776654 4566677888888888887 4476666777788888888888554 6656677
Q ss_pred hhhhhcccchhhcccccCCCCCchhhcCcc-cCCceeccccccc
Q 039322 260 ELEKLVQLSELDASHNLFGGEIPFQICSLK-SLEKLNLSHNNLS 302 (708)
Q Consensus 260 ~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~-~L~~L~l~~N~l~ 302 (708)
+|.++ +|+.|++++|.+.......|..++ ++..|++..+.+.
T Consensus 341 aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 341 AFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp SSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred hCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 78877 888888888877766666676664 6777887777654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=8.1e-19 Score=167.38 Aligned_cols=154 Identities=17% Similarity=0.259 Sum_probs=87.8
Q ss_pred ccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcE
Q 039322 22 VSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIR 101 (708)
Q Consensus 22 ~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~ 101 (708)
...+++|++|++++|.+.. ++ .+..+++|++|++++|.++. +..+..+++|++
T Consensus 40 ~~~l~~L~~L~l~~n~i~~------------------------l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~ 92 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVTD------------------------LT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLER 92 (197)
T ss_dssp HHHHHTCCEEEEESSCCSC------------------------CT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCE
T ss_pred hhhcCCccEEeccCCCccC------------------------hH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCE
Confidence 3667778888888887762 12 24445555555655554442 234555566666
Q ss_pred EEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCc-ccccCCccccCCCCCCEEeccccc
Q 039322 102 VRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNN-ITGGIPREIGNSSQLQALDLSLNH 180 (708)
Q Consensus 102 L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~n~ 180 (708)
|++++|.+++..+..|..+++|++|++++|++++..+..+..+++|++|+|++|. ++.. + .+..+++|++|++++|+
T Consensus 93 L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~-~l~~l~~L~~L~l~~n~ 170 (197)
T 4ezg_A 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M-PLKTLPELKSLNIQFDG 170 (197)
T ss_dssp EEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-G-GGGGCSSCCEEECTTBC
T ss_pred EEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-H-hhcCCCCCCEEECCCCC
Confidence 6666666655555555566666666666666655444555556666666666665 4422 2 45666666666666666
Q ss_pred ccccCCcccCCCCCCCEEEccCcccc
Q 039322 181 IVGEIPKELGKLNSLTELILRGNQFT 206 (708)
Q Consensus 181 l~~~~~~~~~~l~~L~~L~l~~n~l~ 206 (708)
+++. + .+..+++|++|++++|++.
T Consensus 171 i~~~-~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 171 VHDY-R-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CCCC-T-TGGGCSSCCEEEECBC---
T ss_pred CcCh-H-HhccCCCCCEEEeeCcccC
Confidence 6532 2 4556666666666666654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=5.4e-19 Score=168.62 Aligned_cols=150 Identities=16% Similarity=0.176 Sum_probs=61.7
Q ss_pred CCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEe
Q 039322 96 CSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALD 175 (708)
Q Consensus 96 l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 175 (708)
+++|++|++++|.++.+. .+..+++|++|++++|.++.+ ..+..+++|++|++++|.+++..+..|..+++|++|+
T Consensus 43 l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 118 (197)
T 4ezg_A 43 MNSLTYITLANINVTDLT--GIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118 (197)
T ss_dssp HHTCCEEEEESSCCSCCT--TGGGCTTCSEEEEESCCCSCC--GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred cCCccEEeccCCCccChH--HHhcCCCCCEEEccCCCCCcc--hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence 334444444444444222 233444444444444433221 1333444444444444444433344444444444444
Q ss_pred cccccccccCCcccCCCCCCCEEEccCcc-ccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCccc
Q 039322 176 LSLNHIVGEIPKELGKLNSLTELILRGNQ-FTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQF 253 (708)
Q Consensus 176 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l 253 (708)
|++|++++..+..+..+++|++|++++|. ++ .++ .+..+++|++|++++|++++. + .+..+++|+.|++++|+|
T Consensus 119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC--
T ss_pred ecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCccc
Confidence 44444443333444444444444444444 33 222 344444444444444444421 1 334444444444444444
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-17 Score=176.18 Aligned_cols=265 Identities=13% Similarity=0.084 Sum_probs=219.7
Q ss_pred CCcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEc
Q 039322 49 PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDL 128 (708)
Q Consensus 49 ~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l 128 (708)
..++...+.. .++......|.. .+|+.+.+..+ ++.+...+|.++ +|++++|.+ .++.+...+|.++++|+.++|
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~-~~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRN-SQIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTT-CCCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhccc-CCccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 3455555543 455556667766 47999999877 776888889884 799999985 788899999999999999999
Q ss_pred ccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCcccccc
Q 039322 129 SRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGR 208 (708)
Q Consensus 129 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 208 (708)
++|+++.+...+|. ..+|+.+.|.++ ++.+...+|.++++|+.+++..| ++.....+|.+ .+|+.+.+. +.++.+
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I 262 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNI 262 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEE
T ss_pred CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEE
Confidence 99999999999998 589999999854 88788899999999999999875 66566777887 799999995 456768
Q ss_pred CCcccCCCCCCCeEeccCCccc-----ccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCch
Q 039322 209 LPPEIGSLVDLEYLDLSANRFN-----NSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPF 283 (708)
Q Consensus 209 ~~~~~~~~~~L~~L~l~~N~i~-----~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~ 283 (708)
...+|.++++|+.+++.+|.+. ......|.++++|+.+.|. +.++.+...+|.++.+|+.++|..| ++.....
T Consensus 263 ~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~ 340 (401)
T 4fdw_A 263 ASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFS 340 (401)
T ss_dssp CTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTT
T ss_pred ChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHH
Confidence 8889999999999999998775 4667789999999999999 4587778889999999999999665 7667788
Q ss_pred hhcCcccCCceecccccccCCCCCcccccc-cccEEecCCCcCC
Q 039322 284 QICSLKSLEKLNLSHNNLSGSIPNCFEGIR-GISVIDISDNQLQ 326 (708)
Q Consensus 284 ~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~l~l~~N~l~ 326 (708)
.|.++ +|+.+++++|.+.......|.+++ .++.|++..+.+.
T Consensus 341 aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 341 AFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp SSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred hCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 89998 999999999999888888888884 6788888766543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.3e-18 Score=173.32 Aligned_cols=141 Identities=18% Similarity=0.174 Sum_probs=108.7
Q ss_pred cccccceeccccCccEEEEEe-CCCcE--EEEEEcCCCCCcc--------------------hhHhHHHHHHHHHHHHhc
Q 039322 437 DFDAQYCIGNGGHGSVYRAEL-PSGQV--VAIKKFHSPLPCD--------------------QIADQKEFLIEVKALTEI 493 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~-~~~~~--vavK~~~~~~~~~--------------------~~~~~~~~~~e~~~l~~l 493 (708)
-|++.+.||+|+||.||+|.. .+|+. ||||+++...... .......+.+|+++++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 467888999999999999977 68989 9999976532110 011224688999999999
Q ss_pred cCCce--eeEEEEEeeCCeeEEEEEeccC-C----CHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEE
Q 039322 494 RHRNI--VKFYGFCSHARHSFLVYELLER-G----SLAAILSSDTAAQELGWSQRMNVIKGVADALSYLH-HDCFPPIVH 565 (708)
Q Consensus 494 ~h~~i--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~~~~ivH 565 (708)
.|+++ +.++++ +..++||||+.+ | +|.++... .++..+..++.|++.|++||| +. ||+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 88754 444443 356899999942 4 67766432 124467789999999999999 88 9999
Q ss_pred ccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 566 QDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 566 ~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1e-21 Score=217.47 Aligned_cols=104 Identities=29% Similarity=0.286 Sum_probs=46.0
Q ss_pred CCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhccc
Q 039322 195 LTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASH 274 (708)
Q Consensus 195 L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~ 274 (708)
|+.|+|++|.|++ +|. |..+++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|++ +| .|..+++|+.|+|++
T Consensus 443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred ceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 4444444444442 222 444444444444444444 334444444444444444444443 22 344444444444444
Q ss_pred ccCCCCC-chhhcCcccCCceecccccccC
Q 039322 275 NLFGGEI-PFQICSLKSLEKLNLSHNNLSG 303 (708)
Q Consensus 275 N~i~~~~-~~~~~~~~~L~~L~l~~N~l~~ 303 (708)
|.|++.. |..+..+++|+.|+|++|++++
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~ 547 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 547 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCCC
Confidence 4444333 4444444444444444444443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.8e-21 Score=213.85 Aligned_cols=204 Identities=22% Similarity=0.205 Sum_probs=128.9
Q ss_pred cCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCc-------------cccccccccCCCCCCCEEE-cccCccee
Q 039322 70 CRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNN-------------LTGNISEALGIYPNLTFID-LSRNDFYG 135 (708)
Q Consensus 70 ~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~-------------i~~~~~~~~~~~~~L~~L~-l~~n~l~~ 135 (708)
..+++|+.|+|++|.++ .+|..++++++|+.|++++|. +.+..+..++.+++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 44566777777777776 567777777777777776554 3455566677777777777 5655442
Q ss_pred eCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCC
Q 039322 136 EISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGS 215 (708)
Q Consensus 136 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 215 (708)
+|+.+.+++|.|+...+ ..|+.|+|++|+|++ +|. ++.+++|+.|+|++|+|+ .+|..|+.
T Consensus 424 ----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence 34455556666553322 136666777776664 444 666667777777777766 55666666
Q ss_pred CCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCC-ChhhhhhcccchhhcccccCCCCCch---hhcCcccC
Q 039322 216 LVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLEL-PKELEKLVQLSELDASHNLFGGEIPF---QICSLKSL 291 (708)
Q Consensus 216 ~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~ls~N~i~~~~~~---~~~~~~~L 291 (708)
+++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.. |..|..+++|+.|+|++|++++..+. .+..+|+|
T Consensus 485 l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L 562 (567)
T 1dce_A 485 LRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 562 (567)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTC
T ss_pred CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCccc
Confidence 7777777777777764 34 5666677777777777776554 66677777777777777777654332 22336667
Q ss_pred Cceec
Q 039322 292 EKLNL 296 (708)
Q Consensus 292 ~~L~l 296 (708)
+.|++
T Consensus 563 ~~L~l 567 (567)
T 1dce_A 563 SSILT 567 (567)
T ss_dssp SEEEC
T ss_pred CccCC
Confidence 66653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=9.4e-19 Score=199.88 Aligned_cols=189 Identities=24% Similarity=0.247 Sum_probs=120.0
Q ss_pred EcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCcccc
Q 039322 127 DLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFT 206 (708)
Q Consensus 127 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 206 (708)
+++.|.+. +.+..|..+++|+.|+|++|.|. .++..+..+++|++|+|++|.|+ .+|..|+.+++|+.|+|++|.|+
T Consensus 207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~ 283 (727)
T 4b8c_D 207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT 283 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence 44455555 56778888999999999999998 55666668999999999999998 78888999999999999999999
Q ss_pred ccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcc-cchhhcccccCCCCCchhh
Q 039322 207 GRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQ-LSELDASHNLFGGEIPFQI 285 (708)
Q Consensus 207 ~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~ls~N~i~~~~~~~~ 285 (708)
.+|..|..+++|++|+|++|.|+ .+|..|..+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++..|.
T Consensus 284 -~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~-- 359 (727)
T 4b8c_D 284 -SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH-- 359 (727)
T ss_dssp -SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC--
T ss_pred -ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc--
Confidence 77888999999999999999998 66777999999999999999999888888766533 34588999999876664
Q ss_pred cCcccCCceecccc--------cccCCCCCcccccccccEEecCCCcCC
Q 039322 286 CSLKSLEKLNLSHN--------NLSGSIPNCFEGIRGISVIDISDNQLQ 326 (708)
Q Consensus 286 ~~~~~L~~L~l~~N--------~l~~~~~~~~~~l~~L~~l~l~~N~l~ 326 (708)
.|+.|++++| .+.+..+..+..+..+....+++|.+.
T Consensus 360 ----~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 360 ----ERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp ----C-----------------------------------------CCC
T ss_pred ----ccceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 4556667766 333334444445555555666666554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.3e-18 Score=178.47 Aligned_cols=285 Identities=13% Similarity=0.004 Sum_probs=197.6
Q ss_pred CCCcEEECCCCcccccCCccccC-CCCCCEEEeeCceee--eeCCCCCCCCCcccccccCCCccCCCCccccC-------
Q 039322 2 RSLSILDLNQNQFKGVLPPSVSN-LTNLKELVLLYNNLS--GFIPPSLENPMLTRPGLDFNHFTSYLPHNVCR------- 71 (708)
Q Consensus 2 ~~L~~L~l~~n~i~~~~~~~~~~-l~~L~~L~L~~n~i~--~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~------- 71 (708)
.+++.|.++++ +.......+.. +++|++|+|++|+|. ......+ +.+..+.+..|. .....|..
T Consensus 25 ~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~--~~~~~~~~~~~~---I~~~aF~~~~~~~~~ 98 (329)
T 3sb4_A 25 NSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY--PNGKFYIYMANF---VPAYAFSNVVNGVTK 98 (329)
T ss_dssp HHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS--GGGCCEEECTTE---ECTTTTEEEETTEEE
T ss_pred CceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc--cccccccccccc---cCHHHhccccccccc
Confidence 35788888875 33223334444 889999999999998 3333222 223444444443 34566777
Q ss_pred -CCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCc----ceeeCCCCCCCCCC
Q 039322 72 -GGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRND----FYGEISSNWGKCPK 146 (708)
Q Consensus 72 -l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~----l~~~~~~~~~~l~~ 146 (708)
+++|+.|+|.. .++.+.+.+|.++++|++|++.+|.++.+.+.+|..+.++..+.+..+. ...+...+|..+..
T Consensus 99 g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~ 177 (329)
T 3sb4_A 99 GKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEP 177 (329)
T ss_dssp ECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCC
T ss_pred ccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccc
Confidence 99999999999 8888888999999999999999999999999999999888888887743 23455667777777
Q ss_pred CC-EEEcccCc-ccccCCccccCCCCCCEEecccccccccCCccc-CCCCCCCEEEccCccccccCCcccCCCCCCCeEe
Q 039322 147 LG-TLNVSMNN-ITGGIPREIGNSSQLQALDLSLNHIVGEIPKEL-GKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLD 223 (708)
Q Consensus 147 L~-~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~ 223 (708)
|+ .+.+.... +.......-....+++.+.+.++-.. .....+ ..+++|++|+|++|+++.+.+.+|.++++|+.|+
T Consensus 178 L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~ 256 (329)
T 3sb4_A 178 LETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIK 256 (329)
T ss_dssp CEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEE
T ss_pred cceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEE
Confidence 77 55554432 11111111122455666666554222 111111 1367888888888878777777788888888888
Q ss_pred ccCCcccccCCCCCCccccce-eecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceec
Q 039322 224 LSANRFNNSVPENLGNLLKLH-YLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNL 296 (708)
Q Consensus 224 l~~N~i~~~~~~~~~~l~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l 296 (708)
|++| ++...+..|.++++|+ .|++.+ .++.+.+.+|.++++|+.|++++|.++...+..|.++++|+.++.
T Consensus 257 l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 257 LPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred CCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 8877 7667777788888887 888877 666667778888888888888888887777777888888887763
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=1.8e-18 Score=164.13 Aligned_cols=130 Identities=25% Similarity=0.299 Sum_probs=83.5
Q ss_pred CEEecccccccccCCcccCCCCCCCEEEccCccccccCCc-ccCCCCCCCeEeccCCcccccCCCCCCccccceeecccC
Q 039322 172 QALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPP-EIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSN 250 (708)
Q Consensus 172 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~ 250 (708)
+++++++|+++ .+|..+.. +|++|++++|++++..+. .|..+++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56777777775 44544432 677777777777655443 366667777777777777666666666666777777777
Q ss_pred cccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCC
Q 039322 251 NQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGS 304 (708)
Q Consensus 251 n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~ 304 (708)
|+|++..+..|.++++|+.|+|++|+|++..|..+..+++|++|++++|++++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 776666666666666666666666666655566666666666666666666543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=7.5e-18 Score=159.77 Aligned_cols=131 Identities=26% Similarity=0.344 Sum_probs=109.3
Q ss_pred CEEEcccCcccccCCccccCCCCCCEEecccccccccCCc-ccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccC
Q 039322 148 GTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPK-ELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSA 226 (708)
Q Consensus 148 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~ 226 (708)
+.|++++|+++ .+|..+. .+|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 67889999887 4454443 3789999999998866554 478889999999999999888888888899999999999
Q ss_pred CcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCC
Q 039322 227 NRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEI 281 (708)
Q Consensus 227 N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~ 281 (708)
|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|++....
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 9998888888888899999999999998888888888889999999999887543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.2e-18 Score=199.02 Aligned_cols=188 Identities=24% Similarity=0.244 Sum_probs=110.9
Q ss_pred ccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccc
Q 039322 104 LNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVG 183 (708)
Q Consensus 104 l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~ 183 (708)
+..|++. +.++.|..+++|++|+|++|.+..+.. .+..+++|++|+|++|.|+ .+|..|..+++|++|+|++|+|+
T Consensus 208 ~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~~l~~-~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 208 DIENRMV-MPKDSKYDDQLWHALDLSNLQIFNISA-NIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ---------------CCCCCCEEECTTSCCSCCCG-GGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred cccccee-cChhhhccCCCCcEEECCCCCCCCCCh-hhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 3344444 557778888888888888888874443 4457888888888888888 67778888888888888888888
Q ss_pred cCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCcccc-ceeecccCcccccCCChhhh
Q 039322 184 EIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLK-LHYLGLSNNQFVLELPKELE 262 (708)
Q Consensus 184 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~~ 262 (708)
.+|..|+.+++|++|+|++|.|+ .+|..|..+++|++|+|++|+|++..|..+..+.. +..|+|++|.+++.+|.
T Consensus 284 ~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~--- 359 (727)
T 4b8c_D 284 SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH--- 359 (727)
T ss_dssp SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC---
T ss_pred ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc---
Confidence 66888888888888888888887 66777888888888888888888777776654422 23478888888877776
Q ss_pred hhcccchhhcccc--------cCCCCCchhhcCcccCCceeccccccc
Q 039322 263 KLVQLSELDASHN--------LFGGEIPFQICSLKSLEKLNLSHNNLS 302 (708)
Q Consensus 263 ~l~~L~~L~ls~N--------~i~~~~~~~~~~~~~L~~L~l~~N~l~ 302 (708)
.|..|+++.| .+.+..+..+..++.+....++.|-+.
T Consensus 360 ---~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 360 ---ERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp ---C-----------------------------------------CCC
T ss_pred ---ccceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 4455666666 333333334445555566666666654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.1e-17 Score=156.63 Aligned_cols=112 Identities=29% Similarity=0.331 Sum_probs=63.2
Q ss_pred CCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecc
Q 039322 218 DLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLS 297 (708)
Q Consensus 218 ~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~ 297 (708)
+|++|+|++|.|+ .+|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|.|++..+..|..+++|+.|+|+
T Consensus 32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~ 110 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110 (193)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence 4444555555444 333444455555555555555554444455555555555555555555555555566666666666
Q ss_pred cccccCCCCCcccccccccEEecCCCcCCCCCC
Q 039322 298 HNNLSGSIPNCFEGIRGISVIDISDNQLQGPVP 330 (708)
Q Consensus 298 ~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 330 (708)
+|+|+...+..|..+++|+.|++++|++.|.+.
T Consensus 111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 111 GNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 666665555556666667777777777766544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=9.4e-17 Score=148.80 Aligned_cols=132 Identities=27% Similarity=0.278 Sum_probs=77.6
Q ss_pred CCCcEEEccCCccc-cccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEe
Q 039322 97 SSLIRVRLNSNNLT-GNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALD 175 (708)
Q Consensus 97 ~~L~~L~l~~n~i~-~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 175 (708)
++|++|++++|.++ +..+..+..+++|++|++++|.++.+ ..+..+++|++|+|++|+++...|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 44555555555554 23334455555555666666555544 4555566666666666666654555555566666666
Q ss_pred cccccccccC-CcccCCCCCCCEEEccCccccccCC---cccCCCCCCCeEeccCCccc
Q 039322 176 LSLNHIVGEI-PKELGKLNSLTELILRGNQFTGRLP---PEIGSLVDLEYLDLSANRFN 230 (708)
Q Consensus 176 L~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~---~~~~~~~~L~~L~l~~N~i~ 230 (708)
|++|++++.. +..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 6666666432 1456666666666666666664433 35666667777777766665
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.7e-16 Score=147.01 Aligned_cols=132 Identities=21% Similarity=0.174 Sum_probs=60.7
Q ss_pred CCccEEeccCCccc-cccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEE
Q 039322 73 GALQYFGVSENHFQ-GTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLN 151 (708)
Q Consensus 73 ~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 151 (708)
++|++|++++|.++ +.+|..+..+++|+.|++++|.++++ ..|..+++|++|++++|++++..+..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 34445555555444 33344444444555555555544443 3444444555555555544443333333444455555
Q ss_pred cccCcccccC-CccccCCCCCCEEecccccccccCC---cccCCCCCCCEEEccCcccc
Q 039322 152 VSMNNITGGI-PREIGNSSQLQALDLSLNHIVGEIP---KELGKLNSLTELILRGNQFT 206 (708)
Q Consensus 152 L~~N~i~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~l~~n~l~ 206 (708)
|++|.|++.. +..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 5555444321 1344444445555555554443322 23444445555555544444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=7.3e-16 Score=146.00 Aligned_cols=126 Identities=25% Similarity=0.295 Sum_probs=65.4
Q ss_pred cEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccC
Q 039322 76 QYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMN 155 (708)
Q Consensus 76 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 155 (708)
+++++++|.++ .+|..+. ++|++|+|++|+|+.++ ..|..+++|++|+|++|+|+.+.+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~ip-~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVP-KELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSCC-GGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchhH-HHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45666666665 3444332 45666666666665333 45555555555555555555555555555555555555555
Q ss_pred cccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccc
Q 039322 156 NITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQF 205 (708)
Q Consensus 156 ~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 205 (708)
+|+...+..|..+++|++|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 138 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPL 138 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCe
Confidence 55544444555555555555555555433333344444444444444443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.65 E-value=7.5e-15 Score=156.01 Aligned_cols=296 Identities=11% Similarity=0.019 Sum_probs=166.8
Q ss_pred ccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEEeccCC---------
Q 039322 14 FKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSEN--------- 83 (708)
Q Consensus 14 i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n--------- 83 (708)
++++...+|.++.+|+++.|..+ ++.+...+|.. .+|+.+++..+ +.......|..+.+|+.+.+..+
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF 136 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAF 136 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTT
T ss_pred EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceee
Confidence 44455555555555555555432 44444445544 45555555432 33333444444444444443322
Q ss_pred ------------ccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEE
Q 039322 84 ------------HFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLN 151 (708)
Q Consensus 84 ------------~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 151 (708)
.+......+|.++++|+++.+.++ +..+...+|.++.+|+.+++..| ++.+...+|.++..|+.+.
T Consensus 137 ~~~~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~ 214 (394)
T 4fs7_A 137 KGCDFKEITIPEGVTVIGDEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENME 214 (394)
T ss_dssp TTCCCSEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCC
T ss_pred ecccccccccCccccccchhhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceee
Confidence 111233445556666666666533 23355556666666666666544 4445555666666666665
Q ss_pred cccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccc
Q 039322 152 VSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNN 231 (708)
Q Consensus 152 L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~ 231 (708)
+..+... . .+.+....+|+.+.+..+ ++......+..+.+|+.+.+..+... +....|..+..++.+.+..+.+.
T Consensus 215 ~~~~~~~-i-~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~- 289 (394)
T 4fs7_A 215 FPNSLYY-L-GDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP- 289 (394)
T ss_dssp CCTTCCE-E-CTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC-
T ss_pred cCCCceE-e-ehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec-
Confidence 5554432 1 222233345666655433 22233445666667777777666544 55566666667776666655432
Q ss_pred cCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccc
Q 039322 232 SVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEG 311 (708)
Q Consensus 232 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~ 311 (708)
...|..+.+|+.+.+.++ ++.+...+|.++.+|+.++|..+ ++......|.++.+|+.+.+..| ++.+...+|.+
T Consensus 290 --~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~ 364 (394)
T 4fs7_A 290 --EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQG 364 (394)
T ss_dssp --TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTT
T ss_pred --cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhC
Confidence 235666777777777654 55456667777777777777643 55556667777777887777666 66666777777
Q ss_pred cccccEEecCCC
Q 039322 312 IRGISVIDISDN 323 (708)
Q Consensus 312 l~~L~~l~l~~N 323 (708)
+.+|+.+++..+
T Consensus 365 C~~L~~i~lp~~ 376 (394)
T 4fs7_A 365 CINLKKVELPKR 376 (394)
T ss_dssp CTTCCEEEEEGG
T ss_pred CCCCCEEEECCC
Confidence 777777777543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.6e-15 Score=141.73 Aligned_cols=109 Identities=23% Similarity=0.216 Sum_probs=48.0
Q ss_pred CCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEecc
Q 039322 146 KLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLS 225 (708)
Q Consensus 146 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~ 225 (708)
+|+.|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 108 (177)
T 2o6r_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALD 108 (177)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECc
Confidence 33444444444433333333444444444444444443333333444444444444444443333334444455555555
Q ss_pred CCcccccCCCCCCccccceeecccCcccc
Q 039322 226 ANRFNNSVPENLGNLLKLHYLGLSNNQFV 254 (708)
Q Consensus 226 ~N~i~~~~~~~~~~l~~L~~L~l~~n~l~ 254 (708)
+|++++..+..+..+++|+.|++++|.+.
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 109 TNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 55554333333444555555555555554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=2.3e-15 Score=140.63 Aligned_cols=109 Identities=23% Similarity=0.217 Sum_probs=56.2
Q ss_pred CCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEcc
Q 039322 122 NLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILR 201 (708)
Q Consensus 122 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 201 (708)
+|++|++++|+++++.+..|..+++|++|++++|+|+...+..|..+++|++|+|++|++++..+..+..+++|++|+++
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 108 (177)
T 2o6r_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALD 108 (177)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECc
Confidence 44444444444444444444444555555555555544444444555555555555555554444444555555555555
Q ss_pred CccccccCCcccCCCCCCCeEeccCCccc
Q 039322 202 GNQFTGRLPPEIGSLVDLEYLDLSANRFN 230 (708)
Q Consensus 202 ~n~l~~~~~~~~~~~~~L~~L~l~~N~i~ 230 (708)
+|++++..+..|..+++|++|+|++|+++
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 109 TNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 55555444444455566666666666555
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=2.4e-16 Score=142.82 Aligned_cols=127 Identities=24% Similarity=0.225 Sum_probs=61.7
Q ss_pred CCCCEEEcccCccc-ccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEe
Q 039322 145 PKLGTLNVSMNNIT-GGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLD 223 (708)
Q Consensus 145 ~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~ 223 (708)
++|+.|++++|.++ +..|..+..+++|++|++++|.+++. ..+..+++|++|++++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 34444444444444 33344444444555555555544432 3344445555555555555533444444455555555
Q ss_pred ccCCccccc-CCCCCCccccceeecccCcccccCCC---hhhhhhcccchhhcc
Q 039322 224 LSANRFNNS-VPENLGNLLKLHYLGLSNNQFVLELP---KELEKLVQLSELDAS 273 (708)
Q Consensus 224 l~~N~i~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~---~~~~~l~~L~~L~ls 273 (708)
+++|++++. .+..+..+++|+.|++++|++++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 555555532 12445555555555555555554443 345555555555544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=6e-16 Score=159.48 Aligned_cols=141 Identities=11% Similarity=0.117 Sum_probs=102.9
Q ss_pred cccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCc--------------chhH----hHHHHHHHHHHHHhccCCce
Q 039322 437 DFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPC--------------DQIA----DQKEFLIEVKALTEIRHRNI 498 (708)
Q Consensus 437 ~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~--------------~~~~----~~~~~~~e~~~l~~l~h~~i 498 (708)
=|++.+.||+|++|.||+|...+|+.||||+++..... .... ......+|...+.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 48899999999999999999889999999997642110 0000 01123456777777765544
Q ss_pred e--eEEEEEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC
Q 039322 499 V--KFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD 576 (708)
Q Consensus 499 v--~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~ 576 (708)
. ..+++ . ..++||||++|++|.++... +....++.|++.+|.+||+. |||||||||.|||++
T Consensus 176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR 239 (397)
T ss_dssp SCCCEEEE--E--TTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred CCCeeeec--c--CceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence 2 23322 1 23799999999888765421 23456889999999999999 999999999999998
Q ss_pred CCC----------cEEEeecccccccC
Q 039322 577 LEY----------EAHVADFGIAKFLK 593 (708)
Q Consensus 577 ~~~----------~~kl~Dfg~a~~~~ 593 (708)
+++ .+.|+||+-+....
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCCcccccccccceEEEEeCCcccCC
Confidence 876 38999999876543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=3.3e-16 Score=141.88 Aligned_cols=128 Identities=25% Similarity=0.277 Sum_probs=89.1
Q ss_pred CCCCEEEccCcccc-ccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhh
Q 039322 193 NSLTELILRGNQFT-GRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELD 271 (708)
Q Consensus 193 ~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 271 (708)
++|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|+.|++++|++++..|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 56666666666666 45566666667777777777777644 5566777777777777777765666666777777777
Q ss_pred cccccCCCC-CchhhcCcccCCceecccccccCCCC---CcccccccccEEecCC
Q 039322 272 ASHNLFGGE-IPFQICSLKSLEKLNLSHNNLSGSIP---NCFEGIRGISVIDISD 322 (708)
Q Consensus 272 ls~N~i~~~-~~~~~~~~~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~l~l~~ 322 (708)
+++|.+++. .+..+..+++|+.|++++|++++..+ ..+..+++|+.||+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 777777753 23667777788888888888776555 4677777888777763
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.60 E-value=1.1e-15 Score=142.74 Aligned_cols=132 Identities=22% Similarity=0.156 Sum_probs=65.0
Q ss_pred CcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCC
Q 039322 93 LRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQ 172 (708)
Q Consensus 93 ~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 172 (708)
+.++++|++|++++|+++.+ +......++|++|++++|+++++ ..|..+++|+.|+|++|+|++..+..|..+++|+
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred cCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 44455555555555555543 22222223555666666555544 3455555566666666655544434445555555
Q ss_pred EEecccccccccCCc--ccCCCCCCCEEEccCccccccCCc----ccCCCCCCCeEeccCCcc
Q 039322 173 ALDLSLNHIVGEIPK--ELGKLNSLTELILRGNQFTGRLPP----EIGSLVDLEYLDLSANRF 229 (708)
Q Consensus 173 ~L~L~~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~----~~~~~~~L~~L~l~~N~i 229 (708)
+|+|++|+|+ .++. .+..+++|+.|++++|.++ ..|. .+..+++|+.|++++|.+
T Consensus 92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence 5555555554 2222 3444555555555555554 2222 134444444444444443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.58 E-value=7.8e-14 Score=148.13 Aligned_cols=301 Identities=11% Similarity=0.039 Sum_probs=237.1
Q ss_pred CCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCC-CCcccccccCC---------------------
Q 039322 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN--------------------- 59 (708)
Q Consensus 2 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n--------------------- 59 (708)
++|+.+.|.. .++.+...+|.++.+|+.++|..+ +..+...+|.. .+|+.+.+..+
T Consensus 71 ~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~~~~~~~~ 148 (394)
T 4fs7_A 71 RKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDFKEITIPE 148 (394)
T ss_dssp TTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCCSEEECCT
T ss_pred CCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeecccccccccCc
Confidence 5789999975 488899999999999999999866 55565666655 56666555432
Q ss_pred CccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCC
Q 039322 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISS 139 (708)
Q Consensus 60 ~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 139 (708)
.+.......|..+.+|+.+.+..+..+ +....|.++.+|+.+++..| ++.+...+|.++..|+.+.+..+... +...
T Consensus 149 ~~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~-i~~~ 225 (394)
T 4fs7_A 149 GVTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY-LGDF 225 (394)
T ss_dssp TCCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE-ECTT
T ss_pred cccccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE-eehh
Confidence 111223456777889999999876544 77888999999999999876 77788999999999999999877543 4443
Q ss_pred CCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCC
Q 039322 140 NWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDL 219 (708)
Q Consensus 140 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L 219 (708)
+....+|+.+.+..+ ++.+...+|..+..|+.+.+..+... .....|..++.++.+....+.+ ....|..+.+|
T Consensus 226 -~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L 299 (394)
T 4fs7_A 226 -ALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSL 299 (394)
T ss_dssp -TTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTC
T ss_pred -hcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee---ccccccccccc
Confidence 344578999999754 45577788999999999999888655 6677889999999999887654 34578899999
Q ss_pred CeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccc
Q 039322 220 EYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHN 299 (708)
Q Consensus 220 ~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N 299 (708)
+.+.+..+ ++......|.++.+|+.+++.++ ++.+...+|.++.+|+.+++..| ++.....+|.++++|+.+++..+
T Consensus 300 ~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 300 TEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred cccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 99999866 66677788999999999999755 77677889999999999999877 77677889999999999999765
Q ss_pred cccCCCCCcccccccccEE
Q 039322 300 NLSGSIPNCFEGIRGISVI 318 (708)
Q Consensus 300 ~l~~~~~~~~~~l~~L~~l 318 (708)
++ ....+|.+.++|+.+
T Consensus 377 -~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 377 -LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp -GG-GGGGGBCTTCEEEEE
T ss_pred -CE-EhhheecCCCCCcEE
Confidence 44 335678888888764
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.57 E-value=3.1e-15 Score=139.60 Aligned_cols=134 Identities=10% Similarity=0.057 Sum_probs=103.0
Q ss_pred cccCCCCccEEeccCCccccccCccCcCC-CCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCC
Q 039322 68 NVCRGGALQYFGVSENHFQGTIPKILRNC-SSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPK 146 (708)
Q Consensus 68 ~~~~l~~L~~L~l~~n~i~~~~~~~~~~l-~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 146 (708)
.+....+|+.|++++|+++. ++. +..+ ++|+.|+|++|.|+++ ..|..+++|++|++++|+++++.+..|..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 34556788888888888884 344 4444 4888888888888876 57888888888888888888776666688888
Q ss_pred CCEEEcccCcccccCC-ccccCCCCCCEEecccccccccCCc----ccCCCCCCCEEEccCcccc
Q 039322 147 LGTLNVSMNNITGGIP-REIGNSSQLQALDLSLNHIVGEIPK----ELGKLNSLTELILRGNQFT 206 (708)
Q Consensus 147 L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~----~~~~l~~L~~L~l~~n~l~ 206 (708)
|+.|+|++|+|+...+ ..+..+++|+.|++++|.++ ..+. .+..+++|+.|++++|.+.
T Consensus 90 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 90 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 8888888888874332 26788888888888888887 4444 3778888899988888776
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.55 E-value=6.4e-17 Score=154.30 Aligned_cols=156 Identities=22% Similarity=0.240 Sum_probs=113.8
Q ss_pred cCCCCCCEEecccccccccCCc------ccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCc
Q 039322 166 GNSSQLQALDLSLNHIVGEIPK------ELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239 (708)
Q Consensus 166 ~~l~~L~~L~L~~n~l~~~~~~------~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~ 239 (708)
.....++.++++.|.+.+..|. .+..+++|++|+|++|.+++ +| .+..+++|++|++++|+++ ..|..+..
T Consensus 15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~ 91 (198)
T 1ds9_A 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV 91 (198)
T ss_dssp HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence 3445566666666666655554 67777788888888888774 45 6777788888888888887 55666667
Q ss_pred cccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCc-hhhcCcccCCceecccccccCCCCCc----------
Q 039322 240 LLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIP-FQICSLKSLEKLNLSHNNLSGSIPNC---------- 308 (708)
Q Consensus 240 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~-~~~~~~~~L~~L~l~~N~l~~~~~~~---------- 308 (708)
+++|+.|++++|++++ +| .+..+++|+.|++++|.+++..+ ..+..+++|++|++++|++++..|..
T Consensus 92 ~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~ 169 (198)
T 1ds9_A 92 ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV 169 (198)
T ss_dssp HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHH
T ss_pred CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHH
Confidence 7888888888888875 33 58888888888888888875332 46778888999999999887665542
Q ss_pred ccccccccEEecCCCcCCCC
Q 039322 309 FEGIRGISVIDISDNQLQGP 328 (708)
Q Consensus 309 ~~~l~~L~~l~l~~N~l~~~ 328 (708)
+..+++|+.|| +|+++..
T Consensus 170 ~~~l~~L~~Ld--~~~i~~~ 187 (198)
T 1ds9_A 170 VKRLPNLKKLD--GMPVDVD 187 (198)
T ss_dssp HHHCSSCSEEC--CGGGTTT
T ss_pred HHhCCCcEEEC--CcccCHH
Confidence 67788888876 6766643
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.53 E-value=1e-12 Score=139.55 Aligned_cols=299 Identities=9% Similarity=0.058 Sum_probs=143.5
Q ss_pred ccccCCccccCCC-CCCEEEeeCceeeeeCCCCCCC-CCcccccccCCC---ccCCCCccccCCCCccEEeccCCccccc
Q 039322 14 FKGVLPPSVSNLT-NLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNH---FTSYLPHNVCRGGALQYFGVSENHFQGT 88 (708)
Q Consensus 14 i~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~-~~l~~l~l~~n~---~~~~~~~~~~~l~~L~~L~l~~n~i~~~ 88 (708)
++++...+|.+.+ .|+.+.+-.+ ++.+...+|.. .+|+.+.++.|. ++......|....+|+.+.+..+ ++.+
T Consensus 51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I 128 (394)
T 4gt6_A 51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEI 128 (394)
T ss_dssp EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEE
T ss_pred eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-ccee
Confidence 4445555555553 3566655433 44445555554 555555555442 44444455555555665555443 3334
Q ss_pred cCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCC
Q 039322 89 IPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNS 168 (708)
Q Consensus 89 ~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l 168 (708)
....|.++.+|+.+.+.. .++.+...+|..+.+|+.+.+.++ +..+...+|.. .+|+.+.+..+-.. ....+|..+
T Consensus 129 ~~~aF~~c~~L~~i~lp~-~~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c 204 (394)
T 4gt6_A 129 DSEAFHHCEELDTVTIPE-GVTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSEC 204 (394)
T ss_dssp CTTTTTTCTTCCEEECCT-TCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTC
T ss_pred hhhhhhhhcccccccccc-eeeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhc
Confidence 455566666666666653 334455566666666666666543 44455555543 34666666543322 445555555
Q ss_pred CCCCEEecccccccccCCc-------------ccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCC
Q 039322 169 SQLQALDLSLNHIVGEIPK-------------ELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPE 235 (708)
Q Consensus 169 ~~L~~L~L~~n~l~~~~~~-------------~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~ 235 (708)
.+++......+........ .+.....+..+.+.. .++.+...+|.++.+|+.+.+..+..+ ....
T Consensus 205 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~ 282 (394)
T 4gt6_A 205 FALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVVS-IGTG 282 (394)
T ss_dssp TTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCCE-ECTT
T ss_pred cccceecccccccccccceeecccccccccccccccccccceEEcCC-cceEcccceeeecccccEEecccccce-ecCc
Confidence 5555555443332210000 001112233333322 222233344555555555555443332 3344
Q ss_pred CCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccc
Q 039322 236 NLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGI 315 (708)
Q Consensus 236 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L 315 (708)
.|.++++|+.+.+. +.++.+...+|.++.+|+.++|..+ ++.+....|.++.+|+.+.|..+ ++.+...+|.++.+|
T Consensus 283 aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L 359 (394)
T 4gt6_A 283 AFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTAL 359 (394)
T ss_dssp TTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTC
T ss_pred ccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCC
Confidence 45555555555553 2333344444555555555555432 33333444555555555555332 444444555555555
Q ss_pred cEEecCCC
Q 039322 316 SVIDISDN 323 (708)
Q Consensus 316 ~~l~l~~N 323 (708)
+.+++.+|
T Consensus 360 ~~i~~~~~ 367 (394)
T 4gt6_A 360 NNIEYSGS 367 (394)
T ss_dssp CEEEESSC
T ss_pred CEEEECCc
Confidence 55555544
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.51 E-value=6e-17 Score=154.48 Aligned_cols=132 Identities=23% Similarity=0.222 Sum_probs=84.7
Q ss_pred cccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccc
Q 039322 164 EIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKL 243 (708)
Q Consensus 164 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L 243 (708)
.|..+++|++|+|++|++++ +| .+..+++|+.|++++|.++ .+|..+..+++|++|++++|++++ .| .+..+++|
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L 117 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence 56666666666666666664 34 5666666666666666666 455555555667777777777764 23 46666777
Q ss_pred eeecccCcccccCCC-hhhhhhcccchhhcccccCCCCCch----------hhcCcccCCceeccccccc
Q 039322 244 HYLGLSNNQFVLELP-KELEKLVQLSELDASHNLFGGEIPF----------QICSLKSLEKLNLSHNNLS 302 (708)
Q Consensus 244 ~~L~l~~n~l~~~~~-~~~~~l~~L~~L~ls~N~i~~~~~~----------~~~~~~~L~~L~l~~N~l~ 302 (708)
+.|++++|+++...+ ..+..+++|+.|++++|++.+..|. .+..+++|+.|+ +|+++
T Consensus 118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 777777777764322 3566777777777777777644332 266677788776 66665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=1.6e-13 Score=126.92 Aligned_cols=104 Identities=17% Similarity=0.134 Sum_probs=56.7
Q ss_pred cEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccC
Q 039322 76 QYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMN 155 (708)
Q Consensus 76 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 155 (708)
+.+++++|.++ .+|..+. ++|++|+|++|+|+++.+..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 45666666665 3443332 55555555555555555555555555555555555555555555555555555555555
Q ss_pred cccccCCccccCCCCCCEEeccccccc
Q 039322 156 NITGGIPREIGNSSQLQALDLSLNHIV 182 (708)
Q Consensus 156 ~i~~~~~~~~~~l~~L~~L~L~~n~l~ 182 (708)
+|++..+..|..+++|++|+|++|.+.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 555444444555555555555555544
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.6e-13 Score=125.93 Aligned_cols=104 Identities=16% Similarity=0.157 Sum_probs=57.5
Q ss_pred cEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccC
Q 039322 76 QYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMN 155 (708)
Q Consensus 76 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 155 (708)
+.+++++|.++ .+|..+. ++|++|+|++|+|+++.+..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 55666666665 3444333 55666666666666555555555555555555555555555555555555555555555
Q ss_pred cccccCCccccCCCCCCEEeccccccc
Q 039322 156 NITGGIPREIGNSSQLQALDLSLNHIV 182 (708)
Q Consensus 156 ~i~~~~~~~~~~l~~L~~L~L~~n~l~ 182 (708)
+|+...+..|..+++|++|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 555444444555555555555555544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.46 E-value=5.8e-12 Score=133.67 Aligned_cols=309 Identities=12% Similarity=0.098 Sum_probs=225.9
Q ss_pred CCcEEECCCCcccccCCccccCCCCCCEEEeeCce---eeeeCCCCCCC-CCcccccccCCCccCCCCccccCCCCccEE
Q 039322 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNN---LSGFIPPSLEN-PMLTRPGLDFNHFTSYLPHNVCRGGALQYF 78 (708)
Q Consensus 3 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~---i~~~~~~~~~~-~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L 78 (708)
.|+.+.|..+ ++.+...+|.++.+|+.+.++.|. ++.+...+|.. .+|+.+.+..+ ++......+....+|+.+
T Consensus 65 ~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i 142 (394)
T 4gt6_A 65 VLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTV 142 (394)
T ss_dssp CCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEE
T ss_pred cCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhcccccc
Confidence 3778888754 788899999999999999998774 66666777766 67888777654 556567778888999999
Q ss_pred eccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCccc
Q 039322 79 GVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNIT 158 (708)
Q Consensus 79 ~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~ 158 (708)
.+..+. +.+....|.++.+|+.+.+.++ ++.+...+|.. .+|+.+.+..+ +..+...+|..+.++.......+...
T Consensus 143 ~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~-~~~i~~~af~~c~~l~~~~~~~~~~~ 218 (394)
T 4gt6_A 143 TIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAK-VTRIGTNAFSECFALSTITSDSESYP 218 (394)
T ss_dssp ECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTT-CCEECTTTTTTCTTCCEEEECCSSSC
T ss_pred ccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCc-ccccccchhhhccccceecccccccc
Confidence 997654 4477788999999999999755 66677888865 57999998765 44588888999999998887766554
Q ss_pred ccCCccc-------------cCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEecc
Q 039322 159 GGIPREI-------------GNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLS 225 (708)
Q Consensus 159 ~~~~~~~-------------~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~ 225 (708)
......+ .....+..+.+.. .++.....+|.++.+|+.+.+.++..+ +...+|.++++|+.+.+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~ 296 (394)
T 4gt6_A 219 AIDNVLYEKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS 296 (394)
T ss_dssp BSSSCEEEECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC
T ss_pred cccceeecccccccccccccccccccceEEcCC-cceEcccceeeecccccEEecccccce-ecCcccccccccccccCC
Confidence 2221111 1223344454432 344355667888999999999877655 777889999999999996
Q ss_pred CCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCC
Q 039322 226 ANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSI 305 (708)
Q Consensus 226 ~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~ 305 (708)
+.++......|.++.+|+.+.+..+ ++.+...+|.++.+|+.+.+..+ ++.....+|.++++|+.+++.+|....
T Consensus 297 -~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~-- 371 (394)
T 4gt6_A 297 -SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW-- 371 (394)
T ss_dssp -TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH--
T ss_pred -CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh--
Confidence 4566577778999999999999865 66577788999999999999754 666778889999999999999886642
Q ss_pred CCcccccccccEEecCCCcC
Q 039322 306 PNCFEGIRGISVIDISDNQL 325 (708)
Q Consensus 306 ~~~~~~l~~L~~l~l~~N~l 325 (708)
.++....+|+.+.+..|.+
T Consensus 372 -~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 372 -NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp -HTCBCCCCC----------
T ss_pred -hhhhccCCCCEEEeCCCCE
Confidence 3566677788877766544
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.45 E-value=3.2e-13 Score=124.90 Aligned_cols=104 Identities=25% Similarity=0.195 Sum_probs=62.6
Q ss_pred CEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCc
Q 039322 124 TFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGN 203 (708)
Q Consensus 124 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 203 (708)
++|++++|+++.+.... .++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 12 ~~l~~s~n~l~~ip~~~---~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLASVPTGI---PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSSCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCccCccC---CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 45555555555433222 145666666666666555556666666666666666666555555566666666666666
Q ss_pred cccccCCcccCCCCCCCeEeccCCccc
Q 039322 204 QFTGRLPPEIGSLVDLEYLDLSANRFN 230 (708)
Q Consensus 204 ~l~~~~~~~~~~~~~L~~L~l~~N~i~ 230 (708)
+|++..+..|..+++|++|+|++|+++
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 666555555666667777777777666
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.43 E-value=6e-13 Score=123.48 Aligned_cols=104 Identities=20% Similarity=0.172 Sum_probs=56.1
Q ss_pred CEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCc
Q 039322 124 TFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGN 203 (708)
Q Consensus 124 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 203 (708)
+.+++++|+++.++.. +. ++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~~iP~~-~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLASVPAG-IP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCSSCCSC-CC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCCccCCC-cC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 3444555544433221 11 45555555555555555555555555555555555555444444555566666666666
Q ss_pred cccccCCcccCCCCCCCeEeccCCccc
Q 039322 204 QFTGRLPPEIGSLVDLEYLDLSANRFN 230 (708)
Q Consensus 204 ~l~~~~~~~~~~~~~L~~L~l~~N~i~ 230 (708)
+|++..+..|..+++|++|+|++|++.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 666444444666666666666666665
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=3.5e-15 Score=156.26 Aligned_cols=88 Identities=22% Similarity=0.228 Sum_probs=37.8
Q ss_pred CCCCEEeccccccccc----CCcccCCCCCCCEEEccCcccccc----CCcccCCCCCCCeEeccCCcccccCC----CC
Q 039322 169 SQLQALDLSLNHIVGE----IPKELGKLNSLTELILRGNQFTGR----LPPEIGSLVDLEYLDLSANRFNNSVP----EN 236 (708)
Q Consensus 169 ~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~~~~L~~L~l~~N~i~~~~~----~~ 236 (708)
++|++|+|++|.|+.. ++..+...++|++|+|++|.|+.. ++..+...++|++|+|++|.|+.... ..
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 4444444444444321 122223344455555555544421 12233344455555555555543211 12
Q ss_pred CCccccceeecccCcccccC
Q 039322 237 LGNLLKLHYLGLSNNQFVLE 256 (708)
Q Consensus 237 ~~~l~~L~~L~l~~n~l~~~ 256 (708)
+...++|+.|+|++|.|+..
T Consensus 235 L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 235 AREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HHHCSSCCEEECTTSSCCHH
T ss_pred HHhCCCCCEEeccCCCCCHH
Confidence 22334555555555555433
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=9.8e-15 Score=152.85 Aligned_cols=143 Identities=18% Similarity=0.125 Sum_probs=88.3
Q ss_pred CCCCEEEcccCcccccCCccc-cCCCCCCEEecccccccccCCccc-----CCCCCCCEEEccCcccccc----CCcccC
Q 039322 145 PKLGTLNVSMNNITGGIPREI-GNSSQLQALDLSLNHIVGEIPKEL-----GKLNSLTELILRGNQFTGR----LPPEIG 214 (708)
Q Consensus 145 ~~L~~L~L~~N~i~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~l~~n~l~~~----~~~~~~ 214 (708)
++|++|+|++|.|+......+ ..+++|+.|+|++|+|+......+ ...++|++|+|++|.|+.. ++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 456666666666553322222 223567777777777764333333 3457788888888887632 333445
Q ss_pred CCCCCCeEeccCCcccccC----CCCCCccccceeecccCcccccCCC----hhhhhhcccchhhcccccCCCCCchhhc
Q 039322 215 SLVDLEYLDLSANRFNNSV----PENLGNLLKLHYLGLSNNQFVLELP----KELEKLVQLSELDASHNLFGGEIPFQIC 286 (708)
Q Consensus 215 ~~~~L~~L~l~~N~i~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L~ls~N~i~~~~~~~~~ 286 (708)
.+++|++|+|++|.|+... ...+...++|+.|+|++|.|+.... ..+...++|+.|+|++|.|++.....+.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~ 260 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLR 260 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence 6777888888888877432 3345566778888888888865322 3344557788888888888765544444
Q ss_pred C
Q 039322 287 S 287 (708)
Q Consensus 287 ~ 287 (708)
.
T Consensus 261 ~ 261 (372)
T 3un9_A 261 D 261 (372)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.34 E-value=9.5e-11 Score=123.65 Aligned_cols=128 Identities=13% Similarity=0.057 Sum_probs=53.5
Q ss_pred cCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccc
Q 039322 189 LGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLS 268 (708)
Q Consensus 189 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 268 (708)
+....+|+.+.+..+ ++.+....|.++.+|+.+.+..+ ++......|.++.+|+.+.+..+ ++.+...+|.++.+|+
T Consensus 213 f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~ 289 (379)
T 4h09_A 213 FSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLT 289 (379)
T ss_dssp TTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCC
T ss_pred cccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccc
Confidence 333444444444333 22233334444444444444433 33233334444444444444322 2223333444444444
Q ss_pred hhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEec
Q 039322 269 ELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDI 320 (708)
Q Consensus 269 ~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l 320 (708)
.+.+.++.++......|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+
T Consensus 290 ~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 290 KVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISY 340 (379)
T ss_dssp EEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCC
T ss_pred cccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEE
Confidence 4444444444333444444444444444322 33333444444444444444
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.3e-11 Score=123.19 Aligned_cols=146 Identities=12% Similarity=0.065 Sum_probs=114.1
Q ss_pred HHHhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCe
Q 039322 432 VRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARH 510 (708)
Q Consensus 432 ~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~ 510 (708)
......|++....+.|+.+.||++... ++.+++|....... .....+.+|+++++.+. +..++++++++...+.
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~----~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~ 84 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC----CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence 344567888888998999999999864 68899999864211 11235788999999884 6778899999999899
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC------------------------------- 559 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~------------------------------- 559 (708)
.|+||||++|.++.+.+. +......++.+++++++.||+..
T Consensus 85 ~~lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred eEEEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 999999999999987642 11223478899999999999811
Q ss_pred -------------------------CCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 560 -------------------------FPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 560 -------------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.+.++|||+++.||+++++..+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0358999999999999876666799999875
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.26 E-value=1.3e-11 Score=128.73 Aligned_cols=103 Identities=17% Similarity=0.186 Sum_probs=72.9
Q ss_pred EEeccCC-ccccccCccCcCCCCCcEEEccC-CccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEccc
Q 039322 77 YFGVSEN-HFQGTIPKILRNCSSLIRVRLNS-NNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSM 154 (708)
Q Consensus 77 ~L~l~~n-~i~~~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 154 (708)
.++++++ +++ .+|. +..+++|++|+|++ |.|+++++..|..+++|++|+|++|+|+++.+..|.++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4577776 676 4555 77777777777775 777777777777777777777777777777777777777777777777
Q ss_pred CcccccCCccccCCCCCCEEeccccccc
Q 039322 155 NNITGGIPREIGNSSQLQALDLSLNHIV 182 (708)
Q Consensus 155 N~i~~~~~~~~~~l~~L~~L~L~~n~l~ 182 (708)
|+|++..+..|..++ |+.|+|++|.+.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 777765555555554 777777777665
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.25 E-value=2.6e-11 Score=126.40 Aligned_cols=103 Identities=19% Similarity=0.199 Sum_probs=65.2
Q ss_pred EEEcccC-cccccCCccccCCCCCCEEeccc-ccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccC
Q 039322 149 TLNVSMN-NITGGIPREIGNSSQLQALDLSL-NHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSA 226 (708)
Q Consensus 149 ~L~L~~N-~i~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~ 226 (708)
.++++++ +|+. +|. +..+++|++|+|++ |+|++..+..|.++++|+.|+|++|+|+++.+..|.++++|++|+|++
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3566665 5653 444 66666666666664 666655555666666666666666666666666666666677777777
Q ss_pred CcccccCCCCCCccccceeecccCcccc
Q 039322 227 NRFNNSVPENLGNLLKLHYLGLSNNQFV 254 (708)
Q Consensus 227 N~i~~~~~~~~~~l~~L~~L~l~~n~l~ 254 (708)
|+|++..+..|..++ |+.|+|++|.+.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 766655555555444 777777777665
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.1e-09 Score=115.58 Aligned_cols=299 Identities=12% Similarity=0.057 Sum_probs=213.3
Q ss_pred CCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEecc
Q 039322 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVS 81 (708)
Q Consensus 2 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~ 81 (708)
++|+.+.+.. .++.+...+|.++.+|+.+.|..+ ++.+...+|...+|+.+.+..+ +.......|.. .+|+.+.+.
T Consensus 46 ~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp 121 (379)
T 4h09_A 46 DRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADTKLQSYTGMER-VKKFGDYVFQG-TDLDDFEFP 121 (379)
T ss_dssp GGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCCCCEEEECTT-CCEECTTTTTT-CCCSEEECC
T ss_pred cCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCCCCceEECCce-eeEeccceecc-CCcccccCC
Confidence 3567777764 588899999999999999999765 6667778888777777776543 55544455544 579999998
Q ss_pred CCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeC------------CCCCCCCCCCCE
Q 039322 82 ENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEI------------SSNWGKCPKLGT 149 (708)
Q Consensus 82 ~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~------------~~~~~~l~~L~~ 149 (708)
.+. +......|.+. +|+.+.+-. .++.+...+|..+.+++.+.+..+...... ...+.....+..
T Consensus 122 ~~~-~~i~~~~F~~~-~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (379)
T 4h09_A 122 GAT-TEIGNYIFYNS-SVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTE 198 (379)
T ss_dssp TTC-CEECTTTTTTC-CCCEEEECT-TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSE
T ss_pred Ccc-ccccccccccc-eeeeeeccc-eeeccccchhcccccccccccccccceeecccceecccccceeccccccccccc
Confidence 764 33666667665 677777664 466677888999999998888765432111 112344456666
Q ss_pred EEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcc
Q 039322 150 LNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRF 229 (708)
Q Consensus 150 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i 229 (708)
+.+..+.- ......+....+|+.+.+..+ +......+|.++.+|+.+.+..+ ++.+...+|.++.+|+.+.+..+ +
T Consensus 199 ~~~~~~~~-~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i 274 (379)
T 4h09_A 199 FTIPSTVK-TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-V 274 (379)
T ss_dssp EECCTTCC-EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-C
T ss_pred ccccccee-EEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-c
Confidence 66654433 355667777888888888655 44355667788888888888776 55566777888888888888654 5
Q ss_pred cccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcc
Q 039322 230 NNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCF 309 (708)
Q Consensus 230 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~ 309 (708)
+......|.++++|+.+.+.++.++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++.+...+|
T Consensus 275 ~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF 352 (379)
T 4h09_A 275 KTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAF 352 (379)
T ss_dssp SEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTT
T ss_pred eeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHh
Confidence 5466677888888888888888887777788888888888888654 66566777888888888888654 665666777
Q ss_pred cccc
Q 039322 310 EGIR 313 (708)
Q Consensus 310 ~~l~ 313 (708)
.+..
T Consensus 353 ~~c~ 356 (379)
T 4h09_A 353 EGSS 356 (379)
T ss_dssp TTSS
T ss_pred hCCC
Confidence 6653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=6.9e-11 Score=117.73 Aligned_cols=138 Identities=17% Similarity=0.123 Sum_probs=101.9
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCc--eeeEEEEEeeCCeeEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN--IVKFYGFCSHARHSFL 513 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~l~~~~~~~~~~~l 513 (708)
.++.+....+.|..+.||++...+|+.+++|..... ....+..|+++++.+.+.+ +++++++...++..++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 445544344466679999998777888999997642 1234677899998886544 5668998888888999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC---------------------------------- 559 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~---------------------------------- 559 (708)
||||++|.++. ... .+ ...++.++++.++.||+..
T Consensus 93 v~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 93 LLGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EEEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 99999998884 211 11 2357778888888888752
Q ss_pred ---------------------CCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 560 ---------------------FPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 560 ---------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
.+.++|||++|.||+++.++.+.|+|||.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01389999999999998776677999999863
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.03 E-value=4.9e-11 Score=123.62 Aligned_cols=83 Identities=19% Similarity=0.260 Sum_probs=43.5
Q ss_pred CCCCCeEeccCCcccccCCCCC---CccccceeecccCcccccCC----ChhhhhhcccchhhcccccCCCCCchhhcC-
Q 039322 216 LVDLEYLDLSANRFNNSVPENL---GNLLKLHYLGLSNNQFVLEL----PKELEKLVQLSELDASHNLFGGEIPFQICS- 287 (708)
Q Consensus 216 ~~~L~~L~l~~N~i~~~~~~~~---~~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~- 287 (708)
+++|++|+|++|.+....+..+ ..+++|+.|+|+.|.|++.. +..+..+++|+.|+|++|.|++.....+..
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a 330 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence 4556666666555543221111 23566666666666665432 222345666777777777666443333332
Q ss_pred cccCCceeccccc
Q 039322 288 LKSLEKLNLSHNN 300 (708)
Q Consensus 288 ~~~L~~L~l~~N~ 300 (708)
+ ...+++++++
T Consensus 331 l--g~~~~~~~~~ 341 (362)
T 2ra8_A 331 L--PMKIDVSDSQ 341 (362)
T ss_dssp C--CSEEECCSBC
T ss_pred c--CCEEEecCCc
Confidence 2 2456666665
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.8e-09 Score=112.90 Aligned_cols=143 Identities=15% Similarity=0.269 Sum_probs=107.2
Q ss_pred ccceeccccCccEEEEEeCCCcEEEEEEcC--CCCCcchhHhHHHHHHHHHHHHhcc--CCceeeEEEEEeeC---CeeE
Q 039322 440 AQYCIGNGGHGSVYRAELPSGQVVAIKKFH--SPLPCDQIADQKEFLIEVKALTEIR--HRNIVKFYGFCSHA---RHSF 512 (708)
Q Consensus 440 ~~~~ig~G~~g~vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~l~~~~~~~---~~~~ 512 (708)
..+.++.|.++.||+.... +..+++|+.. ... .......+.+|.++++.+. +..++++++++.+. +..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~---~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSK---LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCC---CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 3567899999999999875 4678899876 311 1122456788999999997 45688999998776 4589
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC--------------------------------- 559 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--------------------------------- 559 (708)
+||||++|..+.+.. ...++..++..++.+++++|+.||+..
T Consensus 118 ~vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 999999997775421 123678888999999999999999731
Q ss_pred ----------------------CCCeEEccCCCCCeeeCCCCc--EEEeecccccc
Q 039322 560 ----------------------FPPIVHQDISSKNLLLDLEYE--AHVADFGIAKF 591 (708)
Q Consensus 560 ----------------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~~ 591 (708)
.+.++|||+++.||+++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 146899999999999997753 68999999874
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.99 E-value=4.9e-11 Score=123.58 Aligned_cols=85 Identities=24% Similarity=0.268 Sum_probs=48.2
Q ss_pred ccccceeecccCcccccCCChhhh---hhcccchhhcccccCCCCCch----hhcCcccCCceecccccccCCCCCcccc
Q 039322 239 NLLKLHYLGLSNNQFVLELPKELE---KLVQLSELDASHNLFGGEIPF----QICSLKSLEKLNLSHNNLSGSIPNCFEG 311 (708)
Q Consensus 239 ~l~~L~~L~l~~n~l~~~~~~~~~---~l~~L~~L~ls~N~i~~~~~~----~~~~~~~L~~L~l~~N~l~~~~~~~~~~ 311 (708)
.+++|+.|+|++|.++...+..+. .+++|+.|+|+.|.|++..+. .+..+++|+.|+|++|.++...-..+..
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~ 329 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence 356777777777777643333333 366777777777777653222 2234577777777777665332222222
Q ss_pred cccccEEecCCCc
Q 039322 312 IRGISVIDISDNQ 324 (708)
Q Consensus 312 l~~L~~l~l~~N~ 324 (708)
.- ...+++++|+
T Consensus 330 al-g~~~~~~~~~ 341 (362)
T 2ra8_A 330 SL-PMKIDVSDSQ 341 (362)
T ss_dssp HC-CSEEECCSBC
T ss_pred Hc-CCEEEecCCc
Confidence 00 2446777665
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.85 E-value=1.6e-09 Score=110.41 Aligned_cols=184 Identities=20% Similarity=0.206 Sum_probs=123.5
Q ss_pred cceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CC--ceeeEEEEEeeCC---eeEEE
Q 039322 441 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HR--NIVKFYGFCSHAR---HSFLV 514 (708)
Q Consensus 441 ~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~--~iv~l~~~~~~~~---~~~lv 514 (708)
.+.++.|....||+.. +.+++|+.... .....+.+|.++++.+. +. .+.++++.....+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3458999999999864 45889986531 34567889999998883 33 2456665554433 35899
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC----------------------------------- 559 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~----------------------------------- 559 (708)
||+++|.++.+... ..++..++..++.++++.++.||+..
T Consensus 95 m~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp EECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred EcccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 99999988765321 23677788888889999888888621
Q ss_pred --------------------CCCeEEccCCCCCeeeCC--CCcEEEeecccccccCCCCCccccccccccc---cCcccc
Q 039322 560 --------------------FPPIVHQDISSKNLLLDL--EYEAHVADFGIAKFLKPESSNWTEFAGTYGY---VAPELA 614 (708)
Q Consensus 560 --------------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y---~aPE~~ 614 (708)
.+.++|+|+++.||+++. +..+.++||+.+....+.... .....+ ..|+..
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl----~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF----ISLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH----HTTCCTTTSCCHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH----HHHHhhccccCHHHH
Confidence 135799999999999998 456789999998754321100 000011 122211
Q ss_pred cc-----CC---------CCcchhHHHHHHHHHHHHhCCCCCC
Q 039322 615 YT-----MK---------ITEKCDVYSFGVLVLEAIKGKHPRD 643 (708)
Q Consensus 615 ~~-----~~---------~~~~~DvwslG~~l~elltg~~p~~ 643 (708)
.. +. .....+.|++|.++|.+.+|..+|-
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 10 11 1123689999999999999998864
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.52 E-value=6.4e-09 Score=97.13 Aligned_cols=41 Identities=22% Similarity=0.148 Sum_probs=17.8
Q ss_pred CcCCCCCcEEEccCC-ccccc----cccccCCCCCCCEEEcccCcc
Q 039322 93 LRNCSSLIRVRLNSN-NLTGN----ISEALGIYPNLTFIDLSRNDF 133 (708)
Q Consensus 93 ~~~l~~L~~L~l~~n-~i~~~----~~~~~~~~~~L~~L~l~~n~l 133 (708)
+...++|++|+|++| .|+.. ....+...++|++|+|++|+|
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i 77 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRS 77 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCC
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCC
Confidence 334445555555554 44421 122333344444444444444
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.51 E-value=1.1e-08 Score=95.58 Aligned_cols=117 Identities=9% Similarity=0.101 Sum_probs=77.2
Q ss_pred CccccCCCCccEEeccCC-ccccc----cCccCcCCCCCcEEEccCCccccc----cccccCCCCCCCEEEcccCcceee
Q 039322 66 PHNVCRGGALQYFGVSEN-HFQGT----IPKILRNCSSLIRVRLNSNNLTGN----ISEALGIYPNLTFIDLSRNDFYGE 136 (708)
Q Consensus 66 ~~~~~~l~~L~~L~l~~n-~i~~~----~~~~~~~l~~L~~L~l~~n~i~~~----~~~~~~~~~~L~~L~l~~n~l~~~ 136 (708)
...+...++|++|+|++| .|++. +...+...++|++|+|++|.|+.. ....+...++|++|+|++|.|+..
T Consensus 29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~ 108 (185)
T 1io0_A 29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS 108 (185)
T ss_dssp HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHH
Confidence 345566789999999999 88753 334566678999999999999843 234455567788888888887643
Q ss_pred C----CCCCCCCCCCCEEEc--ccCcccccC----CccccCCCCCCEEeccccccc
Q 039322 137 I----SSNWGKCPKLGTLNV--SMNNITGGI----PREIGNSSQLQALDLSLNHIV 182 (708)
Q Consensus 137 ~----~~~~~~l~~L~~L~L--~~N~i~~~~----~~~~~~l~~L~~L~L~~n~l~ 182 (708)
. ...+...++|++|+| ++|.|+... ...+...++|++|+|++|.+.
T Consensus 109 g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 109 GILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2 334455566777777 667766332 223334456666666666554
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=9.1e-07 Score=88.18 Aligned_cols=135 Identities=17% Similarity=0.159 Sum_probs=99.5
Q ss_pred eeccccCc-cEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCeeEEEEEecc
Q 039322 443 CIGNGGHG-SVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 443 ~ig~G~~g-~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
.+..|..| .||+.... ++..+++|.-.. .....+.+|...++.+. +-.+.++++++.+++..++|||+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence 35556665 58988654 466799998653 23456888999998884 4457889999999999999999999
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC---------------------------------------- 559 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~---------------------------------------- 559 (708)
|.++.+...... .....++.+++..++.||...
T Consensus 104 G~~~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 104 GKTAFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp SEEHHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred CccccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 988877653221 233456667777777777521
Q ss_pred ---------------CCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 560 ---------------FPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 560 ---------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
.+.++|||+.+.||+++.++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12378999999999999877778999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=3.4e-06 Score=85.48 Aligned_cols=137 Identities=18% Similarity=0.162 Sum_probs=95.4
Q ss_pred cceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCC---ceeeEEEEEe-eCCeeEEEEE
Q 039322 441 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHR---NIVKFYGFCS-HARHSFLVYE 516 (708)
Q Consensus 441 ~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~l~~~~~-~~~~~~lv~e 516 (708)
.+.++.|....||+. |+.+++|+... ......+..|.++++.+.+. .+.+++.+.. ..+..++|||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 345788888899988 56688898532 13356788999999999642 4677777774 4456789999
Q ss_pred eccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 039322 517 LLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD-------------------------------------- 558 (708)
Q Consensus 517 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-------------------------------------- 558 (708)
|++|.++.+..- ..++..+...++.++++.|+.||+.
T Consensus 94 ~i~G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 94 KVQGQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CCCSEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred ccCCeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 999988765321 1134445555555555555555542
Q ss_pred -------------------CCCCeEEccCCCCCeeeCC---CCc-EEEeeccccccc
Q 039322 559 -------------------CFPPIVHQDISSKNLLLDL---EYE-AHVADFGIAKFL 592 (708)
Q Consensus 559 -------------------~~~~ivH~dlk~~Nill~~---~~~-~kl~Dfg~a~~~ 592 (708)
..+.++|+|+++.||+++. ++. +.|+||+.+...
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1235699999999999987 455 489999988754
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.32 E-value=4.5e-08 Score=95.97 Aligned_cols=30 Identities=30% Similarity=0.296 Sum_probs=14.8
Q ss_pred cceeecccCcccccCCC-------hhhhhhcccchhh
Q 039322 242 KLHYLGLSNNQFVLELP-------KELEKLVQLSELD 271 (708)
Q Consensus 242 ~L~~L~l~~n~l~~~~~-------~~~~~l~~L~~L~ 271 (708)
+|+.|+|++|.+.+..| ..+..+++|+.||
T Consensus 221 ~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 221 KLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp CCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred CcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 45555555555543332 1245555666554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.29 E-value=3.6e-08 Score=96.62 Aligned_cols=80 Identities=29% Similarity=0.310 Sum_probs=48.9
Q ss_pred CCCCCCCEEEcccCcceeeC--CCCCCCCCCCCEEEcccCcccccCCccccCCC--CCCEEecccccccccCCc------
Q 039322 118 GIYPNLTFIDLSRNDFYGEI--SSNWGKCPKLGTLNVSMNNITGGIPREIGNSS--QLQALDLSLNHIVGEIPK------ 187 (708)
Q Consensus 118 ~~~~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~--~L~~L~L~~n~l~~~~~~------ 187 (708)
.++++|++|+|++|+|+++. +..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+..|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 45667777777777776533 23445667777777777777644 2233333 677777777777654431
Q ss_pred -ccCCCCCCCEEE
Q 039322 188 -ELGKLNSLTELI 199 (708)
Q Consensus 188 -~~~~l~~L~~L~ 199 (708)
.+..+|+|+.|+
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 345667777765
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.19 E-value=3.9e-07 Score=82.64 Aligned_cols=84 Identities=10% Similarity=0.014 Sum_probs=52.5
Q ss_pred CCccEEeccCCccccccCccCcCCCCCcEEEccCCc-cccccccccCCC----CCCCEEEcccC-cceeeCCCCCCCCCC
Q 039322 73 GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNN-LTGNISEALGIY----PNLTFIDLSRN-DFYGEISSNWGKCPK 146 (708)
Q Consensus 73 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~-i~~~~~~~~~~~----~~L~~L~l~~n-~l~~~~~~~~~~l~~ 146 (708)
-.|+.||++++.|++..-..+..+++|++|+|++|. |+......+..+ ++|++|+|++| +|+...-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 467777777777776666666777777777777773 665444445543 35666666665 355444444555666
Q ss_pred CCEEEcccCc
Q 039322 147 LGTLNVSMNN 156 (708)
Q Consensus 147 L~~L~L~~N~ 156 (708)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 6666666653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=4.2e-06 Score=86.99 Aligned_cols=84 Identities=5% Similarity=-0.013 Sum_probs=56.0
Q ss_pred ccee-ccccCccEEEEEeC-------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-C--CceeeEEEEEeeC-
Q 039322 441 QYCI-GNGGHGSVYRAELP-------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-H--RNIVKFYGFCSHA- 508 (708)
Q Consensus 441 ~~~i-g~G~~g~vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~~iv~l~~~~~~~- 508 (708)
.+.| +.|....+|+.... +++.+++|........ .......+..|..+++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~-~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDV-PVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGC-CSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcc-ccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 3567 88888999998654 2678999986542100 0001134667888888884 3 3578888887665
Q ss_pred --CeeEEEEEeccCCCHHH
Q 039322 509 --RHSFLVYELLERGSLAA 525 (708)
Q Consensus 509 --~~~~lv~e~~~~g~L~~ 525 (708)
+..++||||++|..+.+
T Consensus 104 ~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTSSCEEEEECCCCBCCCB
T ss_pred ccCCceEEEEecCCCChhh
Confidence 35689999999876543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.10 E-value=5.9e-07 Score=81.48 Aligned_cols=84 Identities=12% Similarity=0.082 Sum_probs=51.1
Q ss_pred CCCCeEeccCCcccccCCCCCCccccceeecccCcc-cccCCChhhhhh----cccchhhccccc-CCCCCchhhcCccc
Q 039322 217 VDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQ-FVLELPKELEKL----VQLSELDASHNL-FGGEIPFQICSLKS 290 (708)
Q Consensus 217 ~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l----~~L~~L~ls~N~-i~~~~~~~~~~~~~ 290 (708)
.+|++||++++.|+......+.++++|+.|+|++|. |++.....+..+ ++|++|+|++|. |++..-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 356666666666665555555666677777777764 554333344442 357777777764 66555555666677
Q ss_pred CCceeccccc
Q 039322 291 LEKLNLSHNN 300 (708)
Q Consensus 291 L~~L~l~~N~ 300 (708)
|++|++++++
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 7777777764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=2.7e-05 Score=82.18 Aligned_cols=79 Identities=16% Similarity=0.077 Sum_probs=50.2
Q ss_pred cceeccccCccEEEEEeC-CCcEEEEEEcCCCCC-cch--hHhHHHHHHHHHHHHhccC--C-ceeeEEEEEeeCCeeEE
Q 039322 441 QYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLP-CDQ--IADQKEFLIEVKALTEIRH--R-NIVKFYGFCSHARHSFL 513 (708)
Q Consensus 441 ~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~-~~~--~~~~~~~~~e~~~l~~l~h--~-~iv~l~~~~~~~~~~~l 513 (708)
.+.+|.|..+.||++... +++.++||....... ... ......+..|.++++.+.. + .+++++.+ +++..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999654 467899998754221 000 0123456778888887742 3 45566654 3455689
Q ss_pred EEEeccCC
Q 039322 514 VYELLERG 521 (708)
Q Consensus 514 v~e~~~~g 521 (708)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.89 E-value=3.9e-05 Score=79.06 Aligned_cols=141 Identities=22% Similarity=0.335 Sum_probs=80.2
Q ss_pred ceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccC--CceeeEEE------EEeeCCeeEE
Q 039322 442 YCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH--RNIVKFYG------FCSHARHSFL 513 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~l~~------~~~~~~~~~l 513 (708)
+.|+.|..+.||+....+| .+++|..... ...+..|.++++.+.. -.+++++. +....+..++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~--------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP--------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC--------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC--------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 3466677889999987655 5899998741 1233345555555531 13344443 1234667899
Q ss_pred EEEeccCCCHH--------------HHhccccc----c-------cCCCHHHH---------------------------
Q 039322 514 VYELLERGSLA--------------AILSSDTA----A-------QELGWSQR--------------------------- 541 (708)
Q Consensus 514 v~e~~~~g~L~--------------~~l~~~~~----~-------~~l~~~~~--------------------------- 541 (708)
+|||++|.++. ..++.... . ....|...
T Consensus 109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 188 (346)
T 2q83_A 109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY 188 (346)
T ss_dssp EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence 99999986542 11111100 0 00123211
Q ss_pred ----HHHHHHHHHHHHHHHh----------CCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 542 ----MNVIKGVADALSYLHH----------DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 542 ----~~i~~~i~~~l~~Lh~----------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
..+..++..++++|++ ...+.++|||+++.||+++.++.+.|+||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111223445666653 0124899999999999998888999999998863
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.86 E-value=7.4e-05 Score=75.32 Aligned_cols=138 Identities=17% Similarity=0.190 Sum_probs=92.3
Q ss_pred cceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc---CCceeeEEEEEeeCCeeEEEEEe
Q 039322 441 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR---HRNIVKFYGFCSHARHSFLVYEL 517 (708)
Q Consensus 441 ~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~l~~~~~~~~~~~lv~e~ 517 (708)
.+.|+.|....+|+... ++..+++|.... .....+..|.+.++.+. ...+++++++...++..++||||
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~-------~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINER-------SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEG-------GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCc-------ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 45689999999999987 467889998653 13567888999988884 36788999998888899999999
Q ss_pred ccCCCHH--------H---Hhccccc--c-----------------cCCCHHHHH---HHHH----------------HH
Q 039322 518 LERGSLA--------A---ILSSDTA--A-----------------QELGWSQRM---NVIK----------------GV 548 (708)
Q Consensus 518 ~~~g~L~--------~---~l~~~~~--~-----------------~~l~~~~~~---~i~~----------------~i 548 (708)
+++..+. + .++.... . -.-+|.... ++.. .+
T Consensus 113 l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l 192 (312)
T 3jr1_A 113 LNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLI 192 (312)
T ss_dssp CCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHH
T ss_pred ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHH
Confidence 9997542 1 1222111 0 012454322 1111 11
Q ss_pred HHH-HHHHHh-CCCCCeEEccCCCCCeeeCCCCcEEEeecc
Q 039322 549 ADA-LSYLHH-DCFPPIVHQDISSKNLLLDLEYEAHVADFG 587 (708)
Q Consensus 549 ~~~-l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 587 (708)
+.. ...|.. ...+.++|+|+.+.|++++.++ +.|.|++
T Consensus 193 ~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 193 VQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 111 223432 2235899999999999999887 8899974
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.69 E-value=7e-06 Score=75.88 Aligned_cols=63 Identities=21% Similarity=0.210 Sum_probs=26.4
Q ss_pred CCCCcEEEccCC-cccc----ccccccCCCCCCCEEEcccCcceeeCCCCCC----CCCCCCEEEcccCccc
Q 039322 96 CSSLIRVRLNSN-NLTG----NISEALGIYPNLTFIDLSRNDFYGEISSNWG----KCPKLGTLNVSMNNIT 158 (708)
Q Consensus 96 l~~L~~L~l~~n-~i~~----~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~----~l~~L~~L~L~~N~i~ 158 (708)
-+.|++|+|++| +|.. ....++.....|++|+|++|+|.......+. .-+.|++|+|++|.|+
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 344445555443 4431 1223334444455555555554433332222 2234444444444444
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00038 Score=73.79 Aligned_cols=76 Identities=11% Similarity=0.093 Sum_probs=45.9
Q ss_pred CCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCccccccc--cccccCccccccC---CCCcchhHHHHHHHHHHH
Q 039322 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAG--TYGYVAPELAYTM---KITEKCDVYSFGVLVLEA 635 (708)
Q Consensus 561 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~--~~~y~aPE~~~~~---~~~~~~DvwslG~~l~el 635 (708)
+.++|||+++.||+++.++ ++++||+.+....+.-. ...... ...|.+|+..... ......++......+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4899999999999998776 99999999875332111 111111 1345666554321 111234455677777777
Q ss_pred HhC
Q 039322 636 IKG 638 (708)
Q Consensus 636 ltg 638 (708)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.53 E-value=1.7e-05 Score=73.26 Aligned_cols=115 Identities=10% Similarity=0.104 Sum_probs=77.7
Q ss_pred cccCCCCccEEeccCC-ccccc----cCccCcCCCCCcEEEccCCcccccc----ccccCCCCCCCEEEcccCcceeeCC
Q 039322 68 NVCRGGALQYFGVSEN-HFQGT----IPKILRNCSSLIRVRLNSNNLTGNI----SEALGIYPNLTFIDLSRNDFYGEIS 138 (708)
Q Consensus 68 ~~~~l~~L~~L~l~~n-~i~~~----~~~~~~~l~~L~~L~l~~n~i~~~~----~~~~~~~~~L~~L~l~~n~l~~~~~ 138 (708)
.+...+.|++|+|++| +|.+. +...+..-+.|++|+|++|.|+... ..++...+.|++|+|++|.|+....
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 3455678999999985 77642 3345666788999999999998443 3445567889999999999965433
Q ss_pred C----CCCCCCCCCEEEcccC---ccccc----CCccccCCCCCCEEeccccccc
Q 039322 139 S----NWGKCPKLGTLNVSMN---NITGG----IPREIGNSSQLQALDLSLNHIV 182 (708)
Q Consensus 139 ~----~~~~l~~L~~L~L~~N---~i~~~----~~~~~~~l~~L~~L~L~~n~l~ 182 (708)
. ++..-+.|++|+|++| .+... +...+..-++|+.|+++.|.+.
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 2 3445567888888765 33321 2334455567777777766553
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00029 Score=70.53 Aligned_cols=80 Identities=20% Similarity=0.233 Sum_probs=57.8
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-C--CceeeEEEEEeeCCeeE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-H--RNIVKFYGFCSHARHSF 512 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~~iv~l~~~~~~~~~~~ 512 (708)
.+......+|.|..+.||+.+..+|+.|++|+...... .....|..|.+.|+.+. . -.+++++++. ..+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP----ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC----CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc----chhhHHHHHHHHHHHHHhhCCCCcceEEecc----Cce
Confidence 35666778999999999999999999999998654221 12345778999988884 2 2455666542 247
Q ss_pred EEEEeccCCCH
Q 039322 513 LVYELLERGSL 523 (708)
Q Consensus 513 lv~e~~~~g~L 523 (708)
+||||++++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999988643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00065 Score=69.52 Aligned_cols=141 Identities=18% Similarity=0.151 Sum_probs=73.9
Q ss_pred eeccccCcc-EEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccC--CceeeEEEEEeeCCeeEEEEEecc
Q 039322 443 CIGNGGHGS-VYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH--RNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 443 ~ig~G~~g~-vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
.++.|.... +|+....+|+.+++|...... ...+..|+.+++.+.. -.+.+++.+....+ +++||++.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~-------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~ 95 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE-------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLG 95 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT-------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCC
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC-------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCC
Confidence 455555444 677776446778888754321 0223446666666642 23566777643333 78999997
Q ss_pred CCCHHHHhccccc-----------------------ccCCCHHHHH-------H-H------------HHHHHHHHHHHH
Q 039322 520 RGSLAAILSSDTA-----------------------AQELGWSQRM-------N-V------------IKGVADALSYLH 556 (708)
Q Consensus 520 ~g~L~~~l~~~~~-----------------------~~~l~~~~~~-------~-i------------~~~i~~~l~~Lh 556 (708)
+.++.+++..... ...++..... . + ...+...++.+.
T Consensus 96 ~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~ 175 (333)
T 3csv_A 96 DALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQIL 175 (333)
T ss_dssp SCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred CcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence 7666554432110 0111111110 0 0 001111222221
Q ss_pred h---CCCCCeEEccCCCCCeeeCCC----CcEEEeeccccccc
Q 039322 557 H---DCFPPIVHQDISSKNLLLDLE----YEAHVADFGIAKFL 592 (708)
Q Consensus 557 ~---~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~~~ 592 (708)
+ ...+.++|||+.+.||+++.+ +.+.|+||+.+...
T Consensus 176 ~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 176 SAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1 122478999999999999875 67999999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00076 Score=67.90 Aligned_cols=71 Identities=11% Similarity=-0.000 Sum_probs=44.0
Q ss_pred cceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCce-eeEEEEEeeCCeeEEEEEec-
Q 039322 441 QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI-VKFYGFCSHARHSFLVYELL- 518 (708)
Q Consensus 441 ~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~l~~~~~~~~~~~lv~e~~- 518 (708)
.+.|+.|....+|+. +.+++|+....... ......|..+++.+...++ .++++++ ++.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC---------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 677889999999998 45889987642111 1112457777777743222 4666543 33457899999
Q ss_pred cCCCH
Q 039322 519 ERGSL 523 (708)
Q Consensus 519 ~~g~L 523 (708)
++.++
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 55443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0029 Score=64.37 Aligned_cols=157 Identities=13% Similarity=0.151 Sum_probs=87.6
Q ss_pred hHHHHHHHhccccc-----cceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCc--ee
Q 039322 427 VYDEIVRATNDFDA-----QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN--IV 499 (708)
Q Consensus 427 ~~~~~~~~~~~~~~-----~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv 499 (708)
+.+.+......|.+ ...++ |....||+....+|+.+++|...... .....+..|..+++.+.... ++
T Consensus 12 ~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-----~~~~~~~~E~~~~~~L~~~g~~vp 85 (328)
T 1zyl_A 12 HPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-----WTADQILEEHQFALQLVNDEVPVA 85 (328)
T ss_dssp CHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-----SCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred CHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-----CCHHHHHHHHHHHHHHHHcCCeec
Confidence 34444444444432 23466 88889999987778789999986421 12345667888877774222 34
Q ss_pred eEEEE-----EeeCCeeEEEEEeccCCCHH-----H------H---hccc----cc--ccCCCHHHH----HHH------
Q 039322 500 KFYGF-----CSHARHSFLVYELLERGSLA-----A------I---LSSD----TA--AQELGWSQR----MNV------ 544 (708)
Q Consensus 500 ~l~~~-----~~~~~~~~lv~e~~~~g~L~-----~------~---l~~~----~~--~~~l~~~~~----~~i------ 544 (708)
+++.. ....+..+++|||++|..+. . . ++.. .. ....++... ..+
T Consensus 86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 165 (328)
T 1zyl_A 86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL 165 (328)
T ss_dssp CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence 44443 22345668899999885431 1 1 1110 00 011222211 001
Q ss_pred ---------HHHHHHHHHHHHhC----CCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 545 ---------IKGVADALSYLHHD----CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 545 ---------~~~i~~~l~~Lh~~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
...+...++.+.+. ..+.++|||+++.||+++ + .+.++||+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111223333221 223678999999999999 4 899999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0032 Score=63.86 Aligned_cols=159 Identities=13% Similarity=0.170 Sum_probs=87.5
Q ss_pred chHHHHHHHhccccc-----cceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCc--e
Q 039322 426 LVYDEIVRATNDFDA-----QYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN--I 498 (708)
Q Consensus 426 ~~~~~~~~~~~~~~~-----~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i 498 (708)
++.+++......|.. .+.|+.|....+|+....+| .+++|...... ....+..|..+++.+...+ +
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~------~~~~l~~e~~~l~~L~~~g~~v 79 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSC 79 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC------CHHHHHHHHHHHHHHHHCCCCC
Confidence 344555555555654 23467788889999987655 68899886521 1223456777777664222 3
Q ss_pred eeEEEE------EeeCCeeEEEEEeccCCCHHH--------------Hhcccc----cc--cCC---CHHHHHH------
Q 039322 499 VKFYGF------CSHARHSFLVYELLERGSLAA--------------ILSSDT----AA--QEL---GWSQRMN------ 543 (708)
Q Consensus 499 v~l~~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~----~~--~~l---~~~~~~~------ 543 (708)
.+++.. ....+..+++++|++|..+.. .++... .. ... .|.....
T Consensus 80 P~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~ 159 (322)
T 2ppq_A 80 PLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERA 159 (322)
T ss_dssp CCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred CcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHH
Confidence 333321 123456789999999864311 011110 00 001 1222110
Q ss_pred ------HHHHHHHHHHHHHhC----CCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 544 ------VIKGVADALSYLHHD----CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 544 ------i~~~i~~~l~~Lh~~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
+...+...++++++. ..++++|+|+.+.||+++.++.+.++||+.+..
T Consensus 160 ~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 160 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 001134445555532 124789999999999998776668999998763
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0004 Score=59.89 Aligned_cols=42 Identities=17% Similarity=0.267 Sum_probs=28.5
Q ss_pred ccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCC
Q 039322 289 KSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVP 330 (708)
Q Consensus 289 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 330 (708)
++|+.|+|++|+|+.+.+..|..+++|+.|+|++|++.+...
T Consensus 31 ~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~ 72 (130)
T 3rfe_A 31 VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCR 72 (130)
T ss_dssp TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGG
T ss_pred cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCc
Confidence 356677777777776666667777777777777777766543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0011 Score=57.17 Aligned_cols=55 Identities=20% Similarity=0.287 Sum_probs=26.1
Q ss_pred EEeccCCccc-cccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcc
Q 039322 77 YFGVSENHFQ-GTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDF 133 (708)
Q Consensus 77 ~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l 133 (708)
.++.+++.++ ..+|..+. ++|++|+|++|+|+.+..+.|..+++|++|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 4555555554 22333222 2455555555555555555555555555555544443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0039 Score=57.79 Aligned_cols=102 Identities=22% Similarity=0.167 Sum_probs=66.0
Q ss_pred CHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCcccc
Q 039322 522 SLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTE 601 (708)
Q Consensus 522 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 601 (708)
+|.+.|...+ .+++++++|.++.|.+.+|.-.-.... . ..+=+.|..|++..+|.|...+ +.+.
T Consensus 34 SL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 7999997655 569999999999999999887622110 1 1223456889999999988764 1110
Q ss_pred ccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCC
Q 039322 602 FAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641 (708)
Q Consensus 602 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p 641 (708)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123467888753 3456788899999999998854443
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0012 Score=70.06 Aligned_cols=72 Identities=18% Similarity=0.253 Sum_probs=49.0
Q ss_pred cceeccccCccEEEEEeCC--------CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCc-eeeEEEEEeeCCee
Q 039322 441 QYCIGNGGHGSVYRAELPS--------GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN-IVKFYGFCSHARHS 511 (708)
Q Consensus 441 ~~~ig~G~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~l~~~~~~~~~~ 511 (708)
.+.|+.|....+|+....+ ++.+++|+.... .. .+.+..|..+++.+...+ .+++++.+..
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ET--ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----Cc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 3467888889999997653 578999998431 11 134557888888885333 3677776543
Q ss_pred EEEEEeccCCC
Q 039322 512 FLVYELLERGS 522 (708)
Q Consensus 512 ~lv~e~~~~g~ 522 (708)
.+|+||++|.+
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 38999998643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0036 Score=64.72 Aligned_cols=141 Identities=16% Similarity=0.254 Sum_probs=83.8
Q ss_pred ceeccccCccEEEEEeC--------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCeeE
Q 039322 442 YCIGNGGHGSVYRAELP--------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~ 512 (708)
+.+..|....+|+.... +++.|++|+.... ......+.+|.++++.+. +.-..++++.+.+ .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 45777888899999764 2578999986331 123455668999988885 3334667776654 2
Q ss_pred EEEEeccCCCHHHH-----------------hcccc--cccCCC--HHHHHHHHHHHHH-------------------HH
Q 039322 513 LVYELLERGSLAAI-----------------LSSDT--AAQELG--WSQRMNVIKGVAD-------------------AL 552 (708)
Q Consensus 513 lv~e~~~~g~L~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~i~~-------------------~l 552 (708)
+||||++|.++..- ++... ..+... +.++.++..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 89999998654310 11111 111222 4555556554422 12
Q ss_pred HH----HHhC-CCCCeEEccCCCCCeeeCCC----CcEEEeecccccc
Q 039322 553 SY----LHHD-CFPPIVHQDISSKNLLLDLE----YEAHVADFGIAKF 591 (708)
Q Consensus 553 ~~----Lh~~-~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~~ 591 (708)
.. |... ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 2221 12367899999999999876 7899999998863
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0093 Score=63.39 Aligned_cols=73 Identities=18% Similarity=0.129 Sum_probs=46.5
Q ss_pred ceeccccCccEEEEEeCC-CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCc-eeeEEEEEeeCCeeEEEEEecc
Q 039322 442 YCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN-IVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
+.|+.|-...+|+....+ +..+++|+...... ... ....|..+++.+...+ .+++++.+. + .+|+||++
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~~i---dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--EII---NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CC--SCS---CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChh--hhc---CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 467888889999998764 47899998754211 111 1146888888886433 367777763 2 35999998
Q ss_pred CCCH
Q 039322 520 RGSL 523 (708)
Q Consensus 520 ~g~L 523 (708)
|.++
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.52 E-value=0.008 Score=61.42 Aligned_cols=32 Identities=22% Similarity=0.282 Sum_probs=28.1
Q ss_pred CCeEEccCCCCCeeeCCCCcEEEeeccccccc
Q 039322 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFL 592 (708)
Q Consensus 561 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 592 (708)
+.++|+|+.+.||+++.++.+.++||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 47899999999999998888999999887643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0037 Score=64.89 Aligned_cols=72 Identities=10% Similarity=0.069 Sum_probs=43.4
Q ss_pred ceeccccCccEEEEEeCC---------CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCc-eeeEEEEEeeCCee
Q 039322 442 YCIGNGGHGSVYRAELPS---------GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN-IVKFYGFCSHARHS 511 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~l~~~~~~~~~~ 511 (708)
..++.|....+|+....+ ++.+++|+..... ........|.++++.+...+ .+++++.+ + -
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~ 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-----DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-----cceecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence 457788888999997653 2689999875421 11112356788888775333 45666554 2 2
Q ss_pred EEEEEeccCCC
Q 039322 512 FLVYELLERGS 522 (708)
Q Consensus 512 ~lv~e~~~~g~ 522 (708)
++||||++|.+
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999998754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.58 E-value=0.17 Score=52.91 Aligned_cols=141 Identities=10% Similarity=0.105 Sum_probs=82.8
Q ss_pred cceeccccCccEEEEEeCC--------CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCee
Q 039322 441 QYCIGNGGHGSVYRAELPS--------GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARHS 511 (708)
Q Consensus 441 ~~~ig~G~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~ 511 (708)
.+.+..|-...+|+....+ ++.+++|+...... ......+|.++++.+. +.-..++++.+. -
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-----~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~ 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-----KFYDSKVELDVFRYLSNINIAPNIIADFP----E 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC------CCCCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-----hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----C
Confidence 3457778888999997753 57899999654211 1112345777777774 333456665432 2
Q ss_pred EEEEEeccCCCHHH--------------H---hccccc---------ccC-CCHHHHHHHHHHHH---------------
Q 039322 512 FLVYELLERGSLAA--------------I---LSSDTA---------AQE-LGWSQRMNVIKGVA--------------- 549 (708)
Q Consensus 512 ~lv~e~~~~g~L~~--------------~---l~~~~~---------~~~-l~~~~~~~i~~~i~--------------- 549 (708)
++|+||++|.++.. . ++.... ... ..+.++.++..++-
T Consensus 146 ~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~ 225 (424)
T 3mes_A 146 GRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELY 225 (424)
T ss_dssp EEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHH
T ss_pred CEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccH
Confidence 68999999865321 0 011000 111 12445444443322
Q ss_pred ----HHHHHHHh---------------------CCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 550 ----DALSYLHH---------------------DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 550 ----~~l~~Lh~---------------------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
..+.+|.+ .....++|+|+.+.||+ +.++.+.++||..|..
T Consensus 226 ~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 226 SKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 12233221 11135789999999999 7788999999998864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.00 E-value=0.14 Score=33.62 Aligned_cols=27 Identities=30% Similarity=0.571 Sum_probs=12.6
Q ss_pred eeehhhHHHH-HHHHHHHHH-HHhhhcCC
Q 039322 375 AIVFPVLGAL-FLSMALIAI-FILRKRKS 401 (708)
Q Consensus 375 ~i~~~~~~~~-~~~~~~~~~-~~~r~R~~ 401 (708)
+|+.+|+|.+ +++++++++ +++|+|+.
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 4666666644 333333333 34444433
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=91.80 E-value=0.085 Score=34.54 Aligned_cols=26 Identities=19% Similarity=0.468 Sum_probs=12.8
Q ss_pred eeehhhHHHHHHHHHHHH-HHHhhhcC
Q 039322 375 AIVFPVLGALFLSMALIA-IFILRKRK 400 (708)
Q Consensus 375 ~i~~~~~~~~~~~~~~~~-~~~~r~R~ 400 (708)
.++.+++|+++++++++. ++++|||+
T Consensus 13 ~Ia~~vVGvll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 13 SIISAVVGILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred chHHHHHHHHHHHHHHHHHHhheehhh
Confidence 456666665544444333 33444443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.59 E-value=0.35 Score=50.38 Aligned_cols=29 Identities=24% Similarity=0.445 Sum_probs=24.7
Q ss_pred eEEccCCCCCeee------CCCCcEEEeecccccc
Q 039322 563 IVHQDISSKNLLL------DLEYEAHVADFGIAKF 591 (708)
Q Consensus 563 ivH~dlk~~Nill------~~~~~~kl~Dfg~a~~ 591 (708)
++|+|+.+.||++ +++..+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5699999999999 4567799999998863
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.25 E-value=0.61 Score=43.17 Aligned_cols=117 Identities=9% Similarity=0.112 Sum_probs=81.7
Q ss_pred cCCceeeEEEEEeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCe
Q 039322 494 RHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNL 573 (708)
Q Consensus 494 ~h~~iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Ni 573 (708)
.||+++.. .+-..++...+.++.-+ +..+|-. -+..+...+++++.+|+....+++.. +|--++|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence 58888876 45566666555555443 2332221 23478899999999999998777766 8999999999
Q ss_pred eeCCCCcEEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 039322 574 LLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDF 644 (708)
Q Consensus 574 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~ 644 (708)
+++.++.+++.-.|+-..+. |. ..+...=.-.+=+++..+++++..|+.
T Consensus 111 ~f~~~~~p~i~~RGik~~l~-----------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVVD-----------------PL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp EECTTSCEEESCCEETTTBS-----------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEcCCCCEEEEEccCccCCC-----------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999998777654332 21 112222344567788899999999863
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.40 E-value=0.21 Score=32.73 Aligned_cols=26 Identities=23% Similarity=0.502 Sum_probs=11.8
Q ss_pred eeehhhHHHHHH-HHHHHHH-HHhhhcC
Q 039322 375 AIVFPVLGALFL-SMALIAI-FILRKRK 400 (708)
Q Consensus 375 ~i~~~~~~~~~~-~~~~~~~-~~~r~R~ 400 (708)
+|+.+|+|.+++ +++++.+ +++|+|+
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence 366666664433 3333333 3344433
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.20 E-value=1.8 Score=40.22 Aligned_cols=114 Identities=13% Similarity=0.113 Sum_probs=79.5
Q ss_pred cCCceeeEEEEEeeCCeeEEEEEeccCC-CHHHHhcccccccCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEEccCCCC
Q 039322 494 RHRNIVKFYGFCSHARHSFLVYELLERG-SLAAILSSDTAAQELGWSQRMNVIKGVADALS-YLHHDCFPPIVHQDISSK 571 (708)
Q Consensus 494 ~h~~iv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~-~Lh~~~~~~ivH~dlk~~ 571 (708)
.||++ -...-.+++...+.++.-+++ ++.. + +.++...+++++.+|+.... +++.. +|--++|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i------~~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I------RKTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H------HTSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H------HhcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCc
Confidence 57887 444446677777777755443 3332 2 23788999999999999888 66665 89999999
Q ss_pred CeeeCCCCcEEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 039322 572 NLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRD 643 (708)
Q Consensus 572 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~ 643 (708)
|++++.++.+++.-.|.-..+ +|.- .+...=.-.+=+++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~l-----------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESL-----------------PPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTTB-----------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcccC-----------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999877765433 2221 1222223456678888888888876
|
| >2lz0_A Uncharacterized protein; hypothetical leucine rich repeat protein, structural genomic unknown function; NMR {Bacteroides capillosus} | Back alignment and structure |
|---|
Probab=84.01 E-value=2.2 Score=34.10 Aligned_cols=47 Identities=13% Similarity=0.072 Sum_probs=26.3
Q ss_pred ccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccC
Q 039322 108 NLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMN 155 (708)
Q Consensus 108 ~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 155 (708)
.++.+...+|.++.+|+.+.|-.+ ++.+...+|.++.+|+.+.+.+.
T Consensus 7 ~vt~I~~~aF~~c~~L~~i~iP~~-v~~Ig~~aF~~C~~L~~i~~~~~ 53 (100)
T 2lz0_A 7 PVVGMDKSLFAGNTVIREITVQPN-IGLLYDGMFSGCTALEKLILTGE 53 (100)
T ss_dssp CCCSSCSCTTTTCTTCCCEEECTT-SSCCCTTSSTTCTTCCCEEECCS
T ss_pred ccCEecHHHhcCCCCCcEEEcCCc-hheEcHHHHhccCCccEEEEcCC
Confidence 444555555666666666655442 44455556666666666665543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 708 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-51 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-15 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-08 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-57
Identities = 63/275 (22%), Positives = 116/275 (42%), Gaps = 21/275 (7%)
Query: 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
IG+G G+VY+ + VA+K + P Q + F EV L + RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQ--QLQAFKNEVGVLRKTRH 63
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
NI+ F G+ + +V + E SL L + + +++ + A + YL
Sbjct: 64 VNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYL 120
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPEL 613
H I+H+D+ S N+ L + + DFG+A S + + + +G+ ++APE+
Sbjct: 121 HA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 614 AYTMK---ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670
+ + DVY+FG+++ E + G+ P S I++ + L P L
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
+ + + +M CL + + RP +
Sbjct: 235 RSNCPKAMKRLMA---ECLKKKRDERPLFPQILAS 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-57
Identities = 63/270 (23%), Positives = 120/270 (44%), Gaps = 19/270 (7%)
Query: 437 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
D++ Y IG G +G + G+++ K+ + +++ + EV L E++H
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA--EKQMLVSEVNLLRELKH 62
Query: 496 RNIVKFYGFCSHARHS--FLVYELLERGSLAAILSSDTAAQE-LGWSQRMNVIKGVADAL 552
NIV++Y ++ ++V E E G LA++++ T ++ L + V+ + AL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 553 SYLH--HDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVA 610
H D ++H+D+ N+ LD + + DFG+A+ L ++S F GT Y++
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182
Query: 611 PELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670
PE M EK D++S G L+ E P + + +I + +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT--------AFSQKELAGKIREGKFRRI 234
Query: 671 SRSVQEKLISIMEVAFSCLNESPESRPTMK 700
++L I+ LN RP+++
Sbjct: 235 PYRYSDELNEIIT---RMLNLKDYHRPSVE 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 4e-55
Identities = 53/271 (19%), Positives = 106/271 (39%), Gaps = 21/271 (7%)
Query: 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
+G G G V+ VA+K FL E + +++H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQH 67
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
+ +V+ Y + +++ E +E GSL L + + +L ++ +++ +A+ ++++
Sbjct: 68 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 125
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP-ESSNWTEFAGTYGYVAPELA 614
+H+D+ + N+L+ +ADFG+A+ ++ E + + APE
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674
T K DV+SFG+L+ E + + + + +
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPY-------PGMTNPEVIQNLERGYRMVRPDNC 235
Query: 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
E+L +M C E PE RPT +
Sbjct: 236 PEELYQLMR---LCWKERPEDRPTFDYLRSV 263
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-54
Identities = 55/271 (20%), Positives = 109/271 (40%), Gaps = 21/271 (7%)
Query: 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
++ IG+G G V+ + VAIK + +++F+ E + + ++ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSH 59
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
+V+ YG C LV+E +E G L+ L + + + V + +
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEG---M 114
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTE-FAGTYGYVAPELA 614
+ ++H+D++++N L+ V+DFG+ +F+ + + + +PE+
Sbjct: 115 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674
+ + K DV+SFGVL+ E + + +++I R
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKI-------PYENRSNSEVVEDISTGFRLYKPRLA 227
Query: 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
+ IM C E PE RP + +Q
Sbjct: 228 STHVYQIMN---HCWKERPEDRPAFSRLLRQ 255
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-53
Identities = 67/300 (22%), Positives = 117/300 (39%), Gaps = 43/300 (14%)
Query: 434 ATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTE 492
+DF+ +G G G V++ PSG V+A K H + + A + + + E++ L E
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHE 60
Query: 493 IRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADAL 552
IV FYG + E ++ GSL +L A + V V L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGL 117
Query: 553 SYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE 612
+YL I+H+D+ N+L++ E + DFG++ L + F GT Y++PE
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPE 173
Query: 613 LAYTMKITEKCDVYSFGVLVLEAIKGKHP------------------------------R 642
+ + D++S G+ ++E G++P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 643 DFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAF--SCLNESPESRPTMK 700
+A+ E+LD + P + + S+ F CL ++P R +K
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-53
Identities = 64/274 (23%), Positives = 114/274 (41%), Gaps = 23/274 (8%)
Query: 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
D +G G G V + VAIK + + EF+ E K + + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSH 58
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
+V+ YG C+ R F++ E + G L L Q + + K V +A+ YL
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYL 116
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP-ESSNWTEFAGTYGYVAPELA 614
+H+D++++N L++ + V+DFG+++++ E ++ + PE+
Sbjct: 117 ES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 615 YTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673
K + K D+++FGVL+ E GK P + + I
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYE--------RFTNSETAEHIAQGLRLYRPHL 225
Query: 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707
EK+ +IM SC +E + RPT K++ +
Sbjct: 226 ASEKVYTIMY---SCWHEKADERPTFKILLSNIL 256
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 3e-52
Identities = 62/271 (22%), Positives = 106/271 (39%), Gaps = 25/271 (9%)
Query: 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
+ IG G G V + G VA+K + A + FL E +T++RH
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND------ATAQAFLAEASVMTQLRH 59
Query: 496 RNIVKFYGFCSHARHS-FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
N+V+ G + ++V E + +GSL L S LG + V +A+ Y
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEY 118
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
L VH+D++++N+L+ + A V+DFG+ K SS + APE
Sbjct: 119 LEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEAL 172
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674
K + K DV+SFG+L+ E + + +
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRV-------PYPRIPLKDVVPRVEKGYKMDAPDGC 225
Query: 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
+ +M+ +C + RP+ + +Q
Sbjct: 226 PPAVYEVMK---NCWHLDAAMRPSFLQLREQ 253
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 1e-51
Identities = 70/266 (26%), Positives = 110/266 (41%), Gaps = 22/266 (8%)
Query: 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
DF+ +G G G+VY A S ++A+K + + EV+ + +R
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA-GVEHQLRREVEIQSHLR 64
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
H NI++ YG+ A +L+ E G++ L + + I +A+ALSY
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSY 121
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
H ++H+DI +NLLL E +ADFG + SS T GT Y+ PE+
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMI 176
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674
EK D++S GVL E + GK P + + I P V
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE--------ANTYQETYKRISRVEFTFPDF-V 227
Query: 675 QEKLISIMEVAFSCLNESPESRPTMK 700
E ++ L +P RP ++
Sbjct: 228 TEGARDLIS---RLLKHNPSQRPMLR 250
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-51
Identities = 67/276 (24%), Positives = 112/276 (40%), Gaps = 23/276 (8%)
Query: 430 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKA 489
EI R + +G G G V+ VAIK + FL E +
Sbjct: 13 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQV 65
Query: 490 LTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA 549
+ ++RH +V+ Y S ++V E + +GSL L +T + L Q +++ +A
Sbjct: 66 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIA 123
Query: 550 DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP-ESSNWTEFAGTYGY 608
++Y+ VH+D+ + N+L+ VADFG+A+ ++ E + +
Sbjct: 124 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180
Query: 609 VAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668
APE A + T K DV+SFG+L+ E + LD++
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY-------PGMVNREVLDQVERGYRM 233
Query: 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQ 704
P E L +M C + PE RPT + +
Sbjct: 234 PCPPECPESLHDLMC---QCWRKEPEERPTFEYLQA 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 178 bits (453), Expect = 2e-51
Identities = 64/297 (21%), Positives = 118/297 (39%), Gaps = 38/297 (12%)
Query: 428 YDEIVRATNDFDAQY---------CIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPC 474
+++ A +F + IG G G V L VAIK S
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 475 DQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQ 534
Q ++FL E + + H N++ G + + ++ E +E GSL + L +
Sbjct: 69 KQR---RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125
Query: 535 ELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594
Q + +++G+A + YL VH+D++++N+L++ V+DFG+++FL+
Sbjct: 126 T--VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 595 ESSNWTE-----FAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLI 648
++S+ T + APE K T DV+S+G+++ E + G+ P
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW----- 235
Query: 649 SSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
+ ++ I PP L +M C + RP +
Sbjct: 236 ---DMTNQDVINAIEQDYRLPPPMDCPSALHQLML---DCWQKDRNHRPKFGQIVNT 286
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 6e-51
Identities = 66/271 (24%), Positives = 113/271 (41%), Gaps = 27/271 (9%)
Query: 444 IGNGGHGSVYRAEL---PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
+G G GSV + VAIK + AD +E + E + + ++ + IV+
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLK---QGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
G C A LV E+ G L L +E+ S ++ V+ + YL
Sbjct: 74 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE--- 127
Query: 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTE---FAGTYGYVAPELAYTM 617
VH+D++++N+LL + A ++DFG++K L + S +T + APE
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187
Query: 618 KITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQE 676
K + + DV+S+GV + EA+ G+ P + + I +
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQKPYK--------KMKGPEVMAFIEQGKRMECPPECPP 239
Query: 677 KLISIMEVAFSCLNESPESRPTMKVVTQQVR 707
+L ++M C E RP V Q++R
Sbjct: 240 ELYALMS---DCWIYKWEDRPDFLTVEQRMR 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 4e-50
Identities = 61/271 (22%), Positives = 113/271 (41%), Gaps = 27/271 (9%)
Query: 444 IGNGGHGSVYRAELP---SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
+G+G G+V + + VA+K + + A + E L E + ++ + IV+
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVR 72
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
G C LV E+ E G L L + + + + ++ V+ + YL
Sbjct: 73 MIGICEA-ESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEE--- 125
Query: 561 PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW---TEFAGTYGYVAPELAYTM 617
VH+D++++N+LL ++ A ++DFG++K L+ + + + T + APE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 618 KITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQE 676
K + K DV+SFGVL+ EA G+ P + +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYR--------GMKGSEVTAMLEKGERMGCPAGCPR 237
Query: 677 KLISIMEVAFSCLNESPESRPTMKVVTQQVR 707
++ +M C E+RP V ++R
Sbjct: 238 EMYDLMN---LCWTYDVENRPGFAAVELRLR 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (445), Expect = 4e-50
Identities = 69/262 (26%), Positives = 116/262 (44%), Gaps = 27/262 (10%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG+G G+VY A + + +VVAIKK ++ + EV+ L ++RH N +++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-EKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
G ++LV E + + + L + V G L+YLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HN 135
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTM---KI 619
++H+D+ + N+LL + DFG A + P +S F GT ++APE+ M +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAMDEGQY 191
Query: 620 TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEIL-DPRLPPPSRSVQEKL 678
K DV+S G+ +E + K P ++N AL I + S E
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLF--------NMNAMSALYHIAQNESPALQSGHWSEYF 243
Query: 679 ISIMEVAFSCLNESPESRPTMK 700
+ ++ SCL + P+ RPT +
Sbjct: 244 RNFVD---SCLQKIPQDRPTSE 262
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-50
Identities = 68/285 (23%), Positives = 123/285 (43%), Gaps = 33/285 (11%)
Query: 428 YDEIVRATN---DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEF 483
Y+ + R N ++ +G+G G VY+A+ + + A K + + +++
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT----KSEEELEDY 56
Query: 484 LIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMN 543
++E+ L H NIVK + + +++ E G++ A++ + L SQ
Sbjct: 57 MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLTESQIQV 114
Query: 544 VIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFA 603
V K DAL+YLH I+H+D+ + N+L L+ + +ADFG++ F
Sbjct: 115 VCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171
Query: 604 GTYGYVAPELAYTM-----KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIA 658
GT ++APE+ K DV+S G+ ++E + + P LN
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH--------ELNPMRV 223
Query: 659 LDEILD---PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
L +I P L PSR ++ CL ++ ++R T
Sbjct: 224 LLKIAKSEPPTLAQPSR-WSSNFKDFLK---KCLEKNVDARWTTS 264
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (442), Expect = 6e-50
Identities = 62/312 (19%), Positives = 123/312 (39%), Gaps = 47/312 (15%)
Query: 425 KLVYDEIVRATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIA 478
KL+ E R N+ + IG G G V++A P +VA+K D
Sbjct: 4 KLLSLEYPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM-- 59
Query: 479 DQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSS--------- 529
Q +F E + E + NIVK G C+ + L++E + G L L S
Sbjct: 60 -QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118
Query: 530 ------------DTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL 577
L ++++ + + VA ++YL VH+D++++N L+
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGE 175
Query: 578 EYEAHVADFGIAKFLKPESSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEA 635
+ADFG+++ + A ++ PE + + T + DV+++GV++ E
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235
Query: 636 IKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPES 695
+ + + + + D + + +L ++M C ++ P
Sbjct: 236 FSYGLQPYY-------GMAHEEVIYYVRDGNILACPENCPLELYNLMR---LCWSKLPAD 285
Query: 696 RPTMKVVTQQVR 707
RP+ + + ++
Sbjct: 286 RPSFCSIHRILQ 297
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 7e-50
Identities = 62/293 (21%), Positives = 111/293 (37%), Gaps = 41/293 (13%)
Query: 443 CIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G G V+R + G+ VA+K F S + E+ +RH NI+ F
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFI 63
Query: 503 GFCSHARHS----FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
+ + +LV + E GSL L+ + + + A L++LH +
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHME 119
Query: 559 CF-----PPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW----TEFAGTYGYV 609
P I H+D+ SKN+L+ +AD G+A + GT Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 610 APELAYTM------KITEKCDVYSFGVLVLEAIKGKHP-----------RDFLSLISSSS 652
APE+ + ++ D+Y+ G++ E + D + S
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 653 LNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
+ ++ L P +P +S E L + ++ C + +R T + +
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIKKT 291
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 1e-49
Identities = 59/264 (22%), Positives = 107/264 (40%), Gaps = 26/264 (9%)
Query: 444 IGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G +VY+ + VA + +++ F E + L ++H NIV+FY
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS--ERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 503 GFCSHA----RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
+ LV EL+ G+L L + + + + + L +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 559 CFPPIVHQDISSKNLLLDLE-YEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTM 617
PPI+H+D+ N+ + + D G+A + + GT ++APE+ Y
Sbjct: 132 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAPEM-YEE 187
Query: 618 KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP-SRSVQE 676
K E DVY+FG+ +LE ++P S N + P +
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYP-------YSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 677 KLISIMEVAFSCLNESPESRPTMK 700
++ I+E C+ ++ + R ++K
Sbjct: 241 EVKEIIE---GCIRQNKDERYSIK 261
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 9e-49
Identities = 65/258 (25%), Positives = 115/258 (44%), Gaps = 21/258 (8%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G G+VY A ++ +GQ VAI++ + Q ++ + E+ + E ++ NIV +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMN----LQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
++V E L GSL +++ Q V + AL +LH +
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHSNQ--- 136
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEK 622
++H+DI S N+LL ++ + DFG + PE S + GT ++APE+ K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 623 CDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIM 682
D++S G++ +E I+G+ P + + L + P L P + + +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYL-----NENPLRALYLIATNGTPELQNPEK-LSAIFRDFL 250
Query: 683 EVAFSCLNESPESRPTMK 700
CL+ E R + K
Sbjct: 251 N---RCLDMDVEKRGSAK 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (431), Expect = 2e-48
Identities = 60/282 (21%), Positives = 115/282 (40%), Gaps = 21/282 (7%)
Query: 428 YDEIVRATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIE 486
YD+ D ++ +G G +G VY VA+K + + +EFL E
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 63
Query: 487 VKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIK 546
+ EI+H N+V+ G C+ +++ E + G+L L + QE+ + +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMAT 122
Query: 547 GVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN-WTEFAGT 605
++ A+ YL +H+D++++N L+ + VADFG+++ + ++
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 606 YGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDP 665
+ APE K + K DV++FGVL+ E ++ + +
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-------PGIDLSQVYELLEKD 232
Query: 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707
EK+ +M +C +P RP+ + Q
Sbjct: 233 YRMERPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFE 271
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-48
Identities = 63/314 (20%), Positives = 118/314 (37%), Gaps = 53/314 (16%)
Query: 425 KLVYD---EIVRATNDFDAQYCIGNGGHGSVYRAELPS------GQVVAIKKFHSPLPCD 475
+ YD E R + + +G+G G V A VA+K
Sbjct: 25 EYEYDLKWEFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKA 79
Query: 476 QIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSS----- 529
++++ + E+K +T++ H NIV G C+ + +L++E G L L S
Sbjct: 80 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 139
Query: 530 ---------------DTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLL 574
+ L + + VA + +L VH+D++++N+L
Sbjct: 140 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVL 196
Query: 575 LDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLV 632
+ + DFG+A+ + +S+ ++APE + T K DV+S+G+L+
Sbjct: 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 256
Query: 633 LEAI-KGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP-SRSVQEKLISIMEVAFSCLN 690
E G +P + D +++ E++ IM+ SC
Sbjct: 257 WEIFSLGVNPYP--------GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ---SCWA 305
Query: 691 ESPESRPTMKVVTQ 704
RP+ +T
Sbjct: 306 FDSRKRPSFPNLTS 319
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 4e-48
Identities = 63/269 (23%), Positives = 104/269 (38%), Gaps = 22/269 (8%)
Query: 436 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
D+D +G G +G V A + + VA+K + + E+ +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPENIKKEICINKMLN 61
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
H N+VKFYG +L E G L + D + + + Y
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVY 118
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPE 612
LH I H+DI +NLLLD ++DFG+A + + + GT YVAPE
Sbjct: 119 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 613 LAYTMKI-TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671
L + E DV+S G+++ + G+ P D S + D P
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD------QPSDSCQEYSDWKEKKTYLNPW 229
Query: 672 RSVQEKLISIMEVAFSCLNESPESRPTMK 700
+ + ++++ L E+P +R T+
Sbjct: 230 KKIDSAPLALLH---KILVENPSARITIP 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 3e-47
Identities = 61/271 (22%), Positives = 104/271 (38%), Gaps = 27/271 (9%)
Query: 444 IGNGGHGSVYRAELP----SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIV 499
IG G G VY L A+K + I + +FL E + + H N++
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 500 KFYGFCSHARHS-FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
G C + S +V ++ G L + ++T + + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFL 146
Query: 559 CFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPES----SNWTEFAGTYGYVAPELA 614
VH+D++++N +LD ++ VADFG+A+ + + N T ++A E
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674
T K T K DV+SFGVL+ E + P +NT +L R
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPY-------PDVNTFDITVYLLQGRRLLQPEYC 259
Query: 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
+ L +M C + E RP+ + +
Sbjct: 260 PDPLYEVML---KCWHPKAEMRPSFSELVSR 287
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 168 bits (426), Expect = 4e-47
Identities = 54/271 (19%), Positives = 103/271 (38%), Gaps = 27/271 (9%)
Query: 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
+ +D +G G G V+R E +G A K +P +D++ E++ ++ +R
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLR 81
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
H +V + ++YE + G L ++ ++ + + ++ V L +
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCH 139
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAKFLKPESSNWTEFAGTYGYVAPE 612
+H + VH D+ +N++ + + DFG+ L P+ S GT + APE
Sbjct: 140 MHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-TTGTAEFAAPE 195
Query: 613 LAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672
+A + D++S GVL + G P N D L +
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFG--------GENDDETLRNVKSCDWNMDDS 247
Query: 673 ---SVQEKLISIMEVAFSCLNESPESRPTMK 700
+ E + L P +R T+
Sbjct: 248 AFSGISEDGKDFIR---KLLLADPNTRMTIH 275
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 6e-47
Identities = 60/284 (21%), Positives = 110/284 (38%), Gaps = 28/284 (9%)
Query: 429 DEIVRATNDFDAQYCIGNGGHGSVYRAELPSGQ-----VVAIKKFHSPLPCDQIADQKEF 483
EI + Q IG G G VY+ L + VAIK + +F
Sbjct: 2 TEI--HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDF 56
Query: 484 LIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMN 543
L E + + H NI++ G S + ++ E +E G+L L E Q +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVG 114
Query: 544 VIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW---T 600
+++G+A + + + VH+D++++N+L++ V+DFG+++ L+ + +
Sbjct: 115 MLRGIA---AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171
Query: 601 EFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALD 660
+ APE K T DV+SFG+++ E + + L+ +
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW-------ELSNHEVMK 224
Query: 661 EILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQ 704
I D P + +M C + RP +
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMM---QCWQQERARRPKFADIVS 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-46
Identities = 61/287 (21%), Positives = 110/287 (38%), Gaps = 34/287 (11%)
Query: 436 NDFDAQYCIGNGGHGSVYRAELPSG---QVVAIKKFHSPLPCDQIADQKEFLIEVKALTE 492
ND Q IG G G V +A + AIK+ D D ++F E++ L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 66
Query: 493 I-RHRNIVKFYGFCSHARHSFLVYELLERGSLAAIL-------------SSDTAAQELGW 538
+ H NI+ G C H + +L E G+L L +++ A L
Sbjct: 67 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 539 SQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN 598
Q ++ VA + YL +H+D++++N+L+ Y A +ADFG+++ +
Sbjct: 127 QQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183
Query: 599 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIA 658
++A E T DV+S+GVL+ E + +
Sbjct: 184 TM-GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-------PYCGMTCAEL 235
Query: 659 LDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
+++ + +++ +M C E P RP+ +
Sbjct: 236 YEKLPQGYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVS 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-46
Identities = 63/308 (20%), Positives = 116/308 (37%), Gaps = 46/308 (14%)
Query: 425 KLVYD---EIVRATNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCD 475
+L YD E R N +G G G V A + VA+K P
Sbjct: 11 QLPYDHKWEFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSA 65
Query: 476 QIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLVYELLERGSLAAIL------- 527
+ +++ + E+K L+ + H NIV G C+ + ++ E G L L
Sbjct: 66 HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 125
Query: 528 --------SSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY 579
+ L ++ VA +++L +H+D++++N+LL
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGR 182
Query: 580 EAHVADFGIAKFLKPESSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK 637
+ DFG+A+ +K +S+ ++APE + T + DV+S+G+ + E
Sbjct: 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
Query: 638 GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS-RSVQEKLISIMEVAFSCLNESPESR 696
+ D +++ S ++ IM+ +C + P R
Sbjct: 243 LGSSPYP-------GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKR 292
Query: 697 PTMKVVTQ 704
PT K + Q
Sbjct: 293 PTFKQIVQ 300
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-46
Identities = 57/271 (21%), Positives = 96/271 (35%), Gaps = 22/271 (8%)
Query: 433 RATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALT 491
+ DF +G G +V A EL + + AIK + E ++
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMS 63
Query: 492 EIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADA 551
+ H VK Y + + G L + + + A
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSA 120
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW--TEFAGTYGYV 609
L YLH I+H+D+ +N+LL+ + + DFG AK L PES F GT YV
Sbjct: 121 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 610 APELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669
+PEL + D+++ G ++ + + G P + N + +I+
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR--------AGNEYLIFQKIIKLEYDF 229
Query: 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
P + K ++E L R +
Sbjct: 230 PEK-FFPKARDLVE---KLLVLDATKRLGCE 256
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 163 bits (413), Expect = 3e-45
Identities = 53/271 (19%), Positives = 108/271 (39%), Gaps = 27/271 (9%)
Query: 436 NDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
+ +D +G+G G V+R E +G+V K ++P P D+ E+ + ++
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP----LDKYTVKNEISIMNQLH 84
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
H ++ + L+ E L G L ++++ ++ ++ +N ++ + L +
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKH 142
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHV--ADFGIAKFLKPESSNWTEFAGTYGYVAPE 612
+H IVH DI +N++ + + + V DFG+A L P+ T + APE
Sbjct: 143 MHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-TTATAEFAAPE 198
Query: 613 LAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672
+ + D+++ GVL + G P + L +
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFA--------GEDDLETLQNVKRCDWEFDED 250
Query: 673 ---SVQEKLISIMEVAFSCLNESPESRPTMK 700
SV + ++ + L + P R T+
Sbjct: 251 AFSSVSPEAKDFIK---NLLQKEPRKRLTVH 278
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-44
Identities = 64/284 (22%), Positives = 114/284 (40%), Gaps = 28/284 (9%)
Query: 430 EIVRATNDFDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPCDQIADQKEFLI 485
EI R + CIG G G V++ S VAIK C + +++FL
Sbjct: 3 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQ 57
Query: 486 EVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVI 545
E + + H +IVK G + +++ EL G L + L L + +
Sbjct: 58 EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYA 114
Query: 546 KGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS-NWTEFAG 604
++ AL+YL VH+DI+++N+L+ + DFG++++++ + ++
Sbjct: 115 YQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 171
Query: 605 TYGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEIL 663
++APE + T DV+ FGV + E + G P + + + I
Sbjct: 172 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ--------GVKNNDVIGRIE 223
Query: 664 DPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707
+ P + L S+M C P RP + Q+
Sbjct: 224 NGERLPMPPNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLS 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-44
Identities = 68/279 (24%), Positives = 103/279 (36%), Gaps = 29/279 (10%)
Query: 436 NDFDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPCDQIADQKEFLIEVKALT 491
D +G+G G V R E + VA+K + +F+ EV A+
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP-EAMDDFIREVNAMH 66
Query: 492 EIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADA 551
+ HRN+++ YG +V EL GSL L VA+
Sbjct: 67 SLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEG 123
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW---TEFAGTYGY 608
+ YL +H+D++++NLLL + DFG+ + L ++ + +
Sbjct: 124 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 609 VAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDEIL--DP 665
APE T + D + FGV + E G+ P LN L +I
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI--------GLNGSQILHKIDKEGE 232
Query: 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQ 704
RLP P Q+ I V C PE RPT +
Sbjct: 233 RLPRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 2e-44
Identities = 61/267 (22%), Positives = 100/267 (37%), Gaps = 16/267 (5%)
Query: 435 TNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI 493
+ +D + +G G V AE + ++VAIK + E+ L +I
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA---KKALEGKEGSMENEIAVLHKI 64
Query: 494 RHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALS 553
+H NIV H +L+ +L+ G L + +I V DA+
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVK 121
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL 613
YLH + + LD + + ++DFG++K P S T GT GYVAPE+
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAPEV 180
Query: 614 AYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673
++ D +S GV+ + G P N ++IL S
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFY--------DENDAKLFEQILKAEYEFDSPY 232
Query: 674 VQEKLISIMEVAFSCLNESPESRPTMK 700
+ S + + + PE R T +
Sbjct: 233 WDDISDSAKDFIRHLMEKDPEKRFTCE 259
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 5e-44
Identities = 57/260 (21%), Positives = 103/260 (39%), Gaps = 22/260 (8%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
+G G G V+R E S + K + DQ E+ L RHRNI+ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVLVKKEISILNIARHRNILHLH 67
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
+++E + + + +T+A EL + ++ + V +AL +LH
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HN 122
Query: 563 IVHQDISSKNLLLDLEYEAHV--ADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKIT 620
I H DI +N++ + + +FG A+ LKP + Y APE+ ++
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPEVHQHDVVS 181
Query: 621 EKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLIS 680
D++S G LV + G +P + ++ I++ + +E I
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFL--------AETNQQIIENIMNAEYTFDEEAFKEISIE 233
Query: 681 IMEVAFSCLNESPESRPTMK 700
M+ L + +SR T
Sbjct: 234 AMDFVDRLLVKERKSRMTAS 253
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 9e-44
Identities = 59/305 (19%), Positives = 119/305 (39%), Gaps = 37/305 (12%)
Query: 422 FEGKLVYD----EIVRATNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSP 471
F VY E+ R +G G G VY VAIK +
Sbjct: 4 FSAADVYVPDEWEVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-- 59
Query: 472 LPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAIL---- 527
+ ++ EFL E + E ++V+ G S + + ++ EL+ RG L + L
Sbjct: 60 -EAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR 118
Query: 528 ---SSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVA 584
+++ S+ + + +AD ++YL+ VH+D++++N ++ ++ +
Sbjct: 119 PAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 175
Query: 585 DFGIAKFLKPESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPR 642
DFG+ + + + +++PE T DV+SFGV++ E
Sbjct: 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ- 234
Query: 643 DFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVV 702
L+ + L +++ L + + L +M C +P+ RP+ +
Sbjct: 235 ------PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEI 285
Query: 703 TQQVR 707
++
Sbjct: 286 ISSIK 290
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 9e-44
Identities = 62/267 (23%), Positives = 103/267 (38%), Gaps = 21/267 (7%)
Query: 436 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALT-EI 493
DF +G G G V+ AE + Q AIK + D + ++E + L+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAW 60
Query: 494 RHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALS 553
H + + + F V E L G L + S + S+ + L
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQ 117
Query: 554 YLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPEL 613
+LH IV++D+ N+LLD + +ADFG+ K + F GT Y+APE+
Sbjct: 118 FLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 174
Query: 614 AYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673
K D +SFGVL+ E + G+ P + + I P R
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFH--------GQDEEELFHSIRMDNPFYP-RW 225
Query: 674 VQEKLISIMEVAFSCLNESPESRPTMK 700
++++ ++ PE R ++
Sbjct: 226 LEKEAKDLLV---KLFVREPEKRLGVR 249
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 8e-43
Identities = 61/284 (21%), Positives = 111/284 (39%), Gaps = 29/284 (10%)
Query: 430 EIVRATNDFDAQYCIGNGGHGSVYRAE-LPSGQV----VAIKKFHSPLPCDQIADQKEFL 484
I++ T +F +G+G G+VY+ +P G+ VAIK+ KE L
Sbjct: 4 RILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEIL 59
Query: 485 IEVKALTEIRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNV 544
E + + + ++ + G C + L+ +L+ G L + +G +N
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHK--DNIGSQYLLNW 116
Query: 545 IKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW--TEF 602
+A ++YL +VH+D++++N+L+ + DFG+AK L E +
Sbjct: 117 CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 603 AGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAI-KGKHPRDFLSLISSSSLNTDIALDE 661
++A E T + DV+S+GV V E + G P D +
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD--------GIPASEISSI 225
Query: 662 ILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
+ P + IM C +SRP + + +
Sbjct: 226 LEKGERLPQPPICTIDVYMIMV---KCWMIDADSRPKFRELIIE 266
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 152 bits (385), Expect = 3e-42
Identities = 61/274 (22%), Positives = 118/274 (43%), Gaps = 27/274 (9%)
Query: 435 TNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI 493
++ ++ +G GG V+ A L + VA+K + L D + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP-SFYLRFRREAQNAAAL 64
Query: 494 RHRNIVKFYGFCSHARHS----FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA 549
H IV Y + ++V E ++ +L I+ ++ + + + VI
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADAC 121
Query: 550 DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTE---FAGTY 606
AL++ H I+H+D+ N+++ V DFGIA+ + ++ T+ GT
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 607 GYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPR 666
Y++PE A + + DVYS G ++ E + G+ P S +A + +
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-------PVSVAYQHVREDP 231
Query: 667 LPPPSR--SVQEKLISIMEVAFSCLNESPESRPT 698
+PP +R + L +++ L ++PE+R
Sbjct: 232 IPPSARHEGLSADLDAVVL---KALAKNPENRYQ 262
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 5e-42
Identities = 59/300 (19%), Positives = 111/300 (37%), Gaps = 42/300 (14%)
Query: 430 EIVRATNDFDAQYCIGNGGHGSVYRAELPS--------GQVVAIKKFHSPLPCDQIADQK 481
E+ R + +G G G V AE VA+K S D
Sbjct: 9 ELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---DLS 63
Query: 482 EFLIEVKALTEI-RHRNIVKFYGFCSHARHSFLVYELLERGSLAAIL------------- 527
+ + E++ + I +H+NI+ G C+ +++ E +G+L L
Sbjct: 64 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 123
Query: 528 SSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFG 587
S ++L ++ VA + YL +H+D++++N+L+ + +ADFG
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFG 180
Query: 588 IAKFLKPESSNWT--EFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFL 645
+A+ + ++APE + T + DV+SFGVL+ E
Sbjct: 181 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-- 238
Query: 646 SLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705
+ + + + + +L +M C + P RPT K + +
Sbjct: 239 -----PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVED 290
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 147 bits (372), Expect = 2e-40
Identities = 58/277 (20%), Positives = 111/277 (40%), Gaps = 28/277 (10%)
Query: 437 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKE-----FLIEVKAL 490
+++ + +G G V R P+ + A+K A++ + L EV L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 491 TEIR-HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA 549
++ H NI++ FLV++L+++G L L+ L + +++ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALL 120
Query: 550 DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYV 609
+ + LH IVH+D+ +N+LLD + + DFG + L P E GT Y+
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVCGTPSYL 176
Query: 610 APELAYTM------KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEIL 663
APE+ ++ D++S GV++ + G P + L I+
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW--------HRKQMLMLRMIM 228
Query: 664 DPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
S + ++ ++ L P+ R T +
Sbjct: 229 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 265
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 149 bits (377), Expect = 3e-40
Identities = 53/268 (19%), Positives = 95/268 (35%), Gaps = 21/268 (7%)
Query: 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQ--KEFLIEVKALTE 492
NDF IG GG G VY +G++ A+K + + I + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 493 IRHRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADAL 552
IV + +L+ G L LS E + + L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE---ADMRFYAAEIILGL 120
Query: 553 SYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE 612
++H+ +V++D+ N+LLD ++D G+A + + + GT+GY+APE
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPE 175
Query: 613 -LAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671
L + D +S G ++ + ++G P +D +
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR------QHKTKDKHEIDRMTLTMAVELP 229
Query: 672 RSVQEKLISIMEVAFSCLNESPESRPTM 699
S +L S++E L R
Sbjct: 230 DSFSPELRSLLE---GLLQRDVNRRLGC 254
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (373), Expect = 4e-40
Identities = 56/269 (20%), Positives = 102/269 (37%), Gaps = 23/269 (8%)
Query: 436 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
DF +G G G V+ +G+ A+K + ++ + E L+ +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI-VVRLKQVEHTNDERLMLSIVT 62
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
H I++ +G A+ F++ + +E G L ++L A+
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA------AEVCLA 116
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
L + I+++D+ +N+LLD + DFG AK++ GT Y+APE+
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAPEVV 173
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674
T + D +SFG+L+ E + G P NT ++IL+ L P
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFY--------DSNTMKTYEKILNAELRFPP-FF 224
Query: 675 QEKLISIMEVAFSCLNESPESRPTMKVVT 703
E + ++ + R
Sbjct: 225 NEDVKDLLS---RLITRDLSQRLGNLQNG 250
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 47/264 (17%), Positives = 91/264 (34%), Gaps = 22/264 (8%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFH--SPLPCDQIADQKEFLIEVKALTEIRHRNIVK 500
+G+G V + E +G A K + +++ EV L EI+H N++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 501 FYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCF 560
+ + L+ EL+ G L E + + L+ +++
Sbjct: 78 LHEVYENKTDVILILELVAGGEL------FDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 561 PPIVHQDISSKNLLLDLE----YEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYT 616
I H D+ +N++L + DFG+A + + + GT +VAPE+
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 190
Query: 617 MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQE 676
+ + D++S GV+ + G P L +
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFL--------GDTKQETLANVSAVNYEFEDEYFSN 242
Query: 677 KLISIMEVAFSCLNESPESRPTMK 700
+ L + P+ R T++
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQ 266
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 144 bits (363), Expect = 3e-39
Identities = 64/275 (23%), Positives = 111/275 (40%), Gaps = 26/275 (9%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503
IG G +G VY+A+ G+ A+KK L + + E+ L E++H NIVK Y
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIR--LEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 504 FCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPI 563
+ LV+E L++ + + L + + + + ++Y H +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD---RRV 121
Query: 564 VHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE-LAYTMKITEK 622
+H+D+ +NLL++ E E +ADFG+A+ +T T Y AP+ L + K +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 623 CDVYSFGVLVLEAIKGKHP------RDFLSLI------SSSSLNTDIALDEILDPRLPPP 670
D++S G + E + G D L I +S ++ DP
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 671 SRSVQEKLISIMEVAF-----SCLNESPESRPTMK 700
E + ++ + L P R T K
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (360), Expect = 1e-38
Identities = 44/290 (15%), Positives = 97/290 (33%), Gaps = 32/290 (11%)
Query: 432 VRATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKAL 490
+R N + IG+G G +Y + +G+ VAIK + IE K
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK------TKHPQLHIESKIY 56
Query: 491 TEIRHRNIVKFYGFC-SHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA 549
++ + +C + ++ +V ELL ++ + + +
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMI 113
Query: 550 DALSYLHHDCFPPIVHQDISSKNLL---LDLEYEAHVADFGIAKFLKPESSN-------W 599
+ Y+H +H+D+ N L ++ DFG+AK + ++
Sbjct: 114 SRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
Query: 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIAL 659
GT Y + ++ + + D+ S G +++ G P + +++
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG---LKAATKRQKYER 227
Query: 660 DEILDPRLPPPS--RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707
P + + + + C + + +P + Q R
Sbjct: 228 ISEKKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-38
Identities = 64/279 (22%), Positives = 105/279 (37%), Gaps = 31/279 (11%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFH-SPLPCDQIADQKEFLIEVKALTEIRHRNIVKF 501
+G G +VY+A + Q+VAIKK + + L E+K L E+ H NI+
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 502 YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFP 561
H + LV++ +E I + L S + L YLH
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 562 PIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMK-IT 620
I+H+D+ NLLLD +ADFG+AK + +T T Y APEL + +
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 621 EKCDVYSFGVLVLEAIKGKHP------RDFLSLI-------------SSSSLNTDIALDE 661
D+++ G ++ E + D L+ I SL +
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 662 ILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
L + + L+ +++ +P +R T
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITAT 275
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 6e-38
Identities = 59/264 (22%), Positives = 105/264 (39%), Gaps = 32/264 (12%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCD--QIADQKEFLIEVKALTEIR--HRNI 498
+G+GG GSVY + VAIK D ++ + +EV L ++ +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 499 VKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD 558
++ + L+ E E ++ L + V +A+ + H+
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN- 128
Query: 559 CFPPIVHQDISSKNLLLDLE-YEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE-LAYT 616
++H+DI +N+L+DL E + DFG LK + +T+F GT Y PE + Y
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRYH 184
Query: 617 MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQE 676
V+S G+L+ + + G P + +EI+ ++ R V
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFE--------------HDEEIIRGQVFFRQR-VSS 229
Query: 677 KLISIMEVAFSCLNESPESRPTMK 700
+ ++ CL P RPT +
Sbjct: 230 ECQHLIR---WCLALRPSDRPTFE 250
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 61/267 (22%), Positives = 105/267 (39%), Gaps = 29/267 (10%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKF 501
+G G +G V + + + A+K D + EV+ + +IV+
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRASQCPHIVRI 70
Query: 502 YGFCSHA----RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH 557
+ + +V E L+ G L + + D Q + ++K + +A+ YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 558 DCFPPIVHQDISSKNLLLDLEYE---AHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
I H+D+ +NLL + + DFG AK +S T T YVAPE+
Sbjct: 130 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAPEVL 185
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS- 673
K + CD++S GV++ + G P F S + + P P S
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 674 VQEKLISIMEVAFSCLNESPESRPTMK 700
V E++ ++ + L P R T+
Sbjct: 244 VSEEVKMLIR---NLLKTEPTQRMTIT 267
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 4e-37
Identities = 58/298 (19%), Positives = 109/298 (36%), Gaps = 40/298 (13%)
Query: 430 EIVRATNDFDAQYCIGNGGHGSVYRA------ELPSGQVVAIKKFHSPLPCDQIADQKEF 483
E R + +G G G V A + + + VA+K ++ +
Sbjct: 9 EFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRAL 63
Query: 484 LIEVKALTEIRHR-NIVKFYGFCSHARHS-FLVYELLERGSLAAILSS------------ 529
+ E+K L I H N+V G C+ ++ E + G+L+ L S
Sbjct: 64 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 123
Query: 530 -DTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588
D L + VA + +L +H+D++++N+LL + + DFG+
Sbjct: 124 EDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGL 180
Query: 589 AKFLKPESSNW--TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLS 646
A+ + + + ++APE + T + DV+SFGVL+ E
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--- 237
Query: 647 LISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQ 704
++ + R+ P + E + + C + P RPT + +
Sbjct: 238 --PGVKIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 4e-37
Identities = 57/269 (21%), Positives = 100/269 (37%), Gaps = 20/269 (7%)
Query: 436 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
NDFD +G G G V +G+ A+K + + + + E + L R
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-DEVAHTVTESRVLQNTR 63
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
H + V E G L LS + E A+ +S
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE------ERARFYGAEIVSA 117
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
L + +V++DI +NL+LD + + DFG+ K + + F GT Y+APE+
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674
D + GV++ E + G+ P + + + + IL + P R++
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFY--------NQDHERLFELILMEEIRFP-RTL 228
Query: 675 QEKLISIMEVAFSCLNESPESRPTMKVVT 703
+ S++ L + P+ R
Sbjct: 229 SPEAKSLLA---GLLKKDPKQRLGGGPSD 254
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-36
Identities = 63/283 (22%), Positives = 111/283 (39%), Gaps = 26/283 (9%)
Query: 437 DFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
+F IG G +G VY+A +G+VVA+KK + + + E+ L E+ H
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV--PSTAIREISLLKELNH 60
Query: 496 RNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYL 555
NIVK +LV+E L + + +S + + + + L++
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 118
Query: 556 HHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPE-LA 614
H ++H+D+ +NLL++ E +ADFG+A+ +T T Y APE L
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGKHP------RDFLSLISSSSLNTDIALDEI------ 662
+ D++S G + E + + D L I + D +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 663 LDPRLPPPSRSVQEKLISIMEVAF-----SCLNESPESRPTMK 700
P P +R K++ ++ L+ P R + K
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 136 bits (343), Expect = 2e-36
Identities = 46/279 (16%), Positives = 91/279 (32%), Gaps = 32/279 (11%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN-IVKF 501
IG G G ++ L + Q VAIK +D + E + + I
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRR------SDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 502 YGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFP 561
Y F H+ LV +LL + ++ K + + +H
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---K 120
Query: 562 PIVHQDISSKNLLLDLEYEAH-----VADFGIAKFLKPESSN-------WTEFAGTYGYV 609
+V++DI N L+ + V DFG+ KF + + +GT Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 610 APELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669
+ + + + D+ + G + + ++G P L + + I + +
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL-----KAATNKQKYERIGEKKQST 235
Query: 670 PSRSVQEKL-ISIMEVAFSCLNESPESRPTMKVVTQQVR 707
P R + + N + ++ P +
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-35
Identities = 56/293 (19%), Positives = 107/293 (36%), Gaps = 33/293 (11%)
Query: 433 RATNDFDAQYCIGNGGHGSVYRAE--LPSGQVVAIKKFHSPLPCDQIADQKEFLIEV--- 487
RA ++ IG G +G V++A G+ VA+K+ + + + EV
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVL 61
Query: 488 KALTEIRHRNIVKFYGFCSHAR-----HSFLVYELLERGSLAAILSSDTAAQELGWSQRM 542
+ L H N+V+ + C+ +R LV+E +++ + +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIK 119
Query: 543 NVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEF 602
+++ + L +LH +VH+D+ +N+L+ + +ADFG+A+ + + +
Sbjct: 120 DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-V 175
Query: 603 AGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP-------------RDFLSLIS 649
T Y APE+ D++S G + E + K D + L
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 650 SSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAF--SCLNESPESRPTMK 700
D+AL I + CL +P R +
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 3e-35
Identities = 66/289 (22%), Positives = 104/289 (35%), Gaps = 36/289 (12%)
Query: 437 DFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH 495
+ IGNG G VY+A+L SG++VAIKK D++ E++ + ++ H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLDH 72
Query: 496 RNIVKFYGFCSHA------RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVA 549
NIV+ F + + LV + + A Q L + +
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 550 DALSYLHHDCFPPIVHQDISSKNLLLDLEYEAH-VADFGIAKFLKPESSNWTEFAGTYGY 608
+L+Y+H I H+DI +NLLLD + + DFG AK L N + Y
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 609 VAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP------RDFLSLISSSSLNTDIALDEI 662
+ T DV+S G ++ E + G+ D L I
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 663 LDPRL---------PPPSRSVQEKLISIMEVAF--SCLNESPESRPTMK 700
++P P V +A L +P +R T
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 8e-35
Identities = 59/284 (20%), Positives = 104/284 (36%), Gaps = 36/284 (12%)
Query: 444 IGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFY 502
IG G +G V A + + VAIKK P + + L E+K L RH NI+
Sbjct: 16 IGEGAYGMVCSAYDNVNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 503 GFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP 562
+ L + A L Q L + + L Y+H
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 129
Query: 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN---WTEFAGTYGYVAPELAYT-MK 618
++H+D+ NLLL+ + + DFG+A+ P+ + TE+ T Y APE+
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 619 ITEKCDVYSFGVLVLEAIKGKHP----------------------RDFLSLISSSSLNTD 656
T+ D++S G ++ E + + D +I+ + N
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 657 IALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMK 700
++L + K + +++ L +P R ++
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVE 290
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-34
Identities = 54/285 (18%), Positives = 109/285 (38%), Gaps = 28/285 (9%)
Query: 436 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
++ IG G +G+V++A+ + ++VA+K+ L D L E+ L E++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELK 59
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
H+NIV+ + + LV+E ++ G V + L
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLK------KYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
L ++H+D+ +NLL++ E +A+FG+A+ ++ T Y P++
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 615 YTMKI-TEKCDVYSFGVLVLEAIKGKHP-------RDFLSLI-------SSSSLNTDIAL 659
+ K+ + D++S G + E P D L I + + L
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 660 DEILDPRLPPPSRSVQEKLISIMEVAFS----CLNESPESRPTMK 700
+ + P + S+ + + L +P R + +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 8e-34
Identities = 52/276 (18%), Positives = 100/276 (36%), Gaps = 22/276 (7%)
Query: 436 NDFDAQYCIGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALT 491
+F+ +G G +G V+ +G++ A+K + + E + L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 492 EIRHR-NIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVAD 550
IR +V + L+ + + G L LS E + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137
Query: 551 ALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWT-EFAGTYGYV 609
+ L H I+++DI +N+LLD + DFG++K + + +F GT Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 610 APELAYTMK--ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667
AP++ + D +S GVL+ E + G P N+ + +
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP-----FTVDGEKNSQAEISRRILKSE 252
Query: 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVT 703
PP + + +++ L + P+ R
Sbjct: 253 PPYPQEMSALAKDLIQ---RLLMKDPKKRLGCGPRD 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 9e-33
Identities = 53/303 (17%), Positives = 104/303 (34%), Gaps = 42/303 (13%)
Query: 432 VRATNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKAL 490
+ ++ IG G G V++A +GQ VA+KK + ++ L E+K L
Sbjct: 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKIL 63
Query: 491 TEIRHRNIVKFYGFCSHA--------RHSFLVYELLERGSLAAILSSDTAAQELGWSQRM 542
++H N+V C +LV++ E + L
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA------GLLSNVLVKFTLS 117
Query: 543 NVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS----N 598
+ + + L+ L++ I+H+D+ + N+L+ + +ADFG+A+ +
Sbjct: 118 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177
Query: 599 WTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLVLEAIKGKHP------RDFLSLIS-- 649
+T T Y PEL + D++ G ++ E + L+LIS
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 650 ----------SSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAF--SCLNESPESRP 697
+ E++ + ++ + + L P R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 698 TMK 700
Sbjct: 298 DSD 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (313), Expect = 8e-32
Identities = 51/263 (19%), Positives = 92/263 (34%), Gaps = 23/263 (8%)
Query: 436 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
+ FD +G G G V + SG A+K ++ + L E + L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 495 HRNIVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSY 554
+VK + ++V E + G + + L + Y
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEY 156
Query: 555 LHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELA 614
LH ++++D+ +NLL+D + V DFG AK GT +APE+
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTWTLCGTPEALAPEII 210
Query: 615 YTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674
+ + D ++ GVL+ E G P + ++I+ ++ PS
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFF--------ADQPIQIYEKIVSGKVRFPSH-F 261
Query: 675 QEKLISIMEVAFSCLNESPESRP 697
L ++ + L R
Sbjct: 262 SSDLKDLLR---NLLQVDLTKRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 7e-31
Identities = 57/304 (18%), Positives = 109/304 (35%), Gaps = 48/304 (15%)
Query: 430 EIVRATNDFDAQY----CIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFL 484
E+ + + A Y +G+G +G+V A + +G VAIKK + P + K
Sbjct: 8 EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL--FAKRAY 65
Query: 485 IEVKALTEIRHRNIVKFYGFCSHARHS------FLVYELLERGSLAAILSSDTAAQELGW 538
E++ L +RH N++ + +LV + + ++LG
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGE 120
Query: 539 SQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN 598
+ ++ + L Y+H H+D+ NL ++ + E + DFG+A+ E +
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTG 177
Query: 599 WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP----------------- 641
+ + + M+ T+ D++S G ++ E I GK
Sbjct: 178 YVVT--RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235
Query: 642 -----RDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESR 696
L S + N L E+ + ++++E L E R
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQR 292
Query: 697 PTMK 700
T
Sbjct: 293 VTAG 296
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 118 bits (297), Expect = 7e-30
Identities = 59/297 (19%), Positives = 106/297 (35%), Gaps = 49/297 (16%)
Query: 436 NDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR 494
+D+ +G G + V+ A + + + V +K +K+ E+K L +R
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLR 87
Query: 495 -HRNIVKFYGFCSHA--RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADA 551
NI+ R LV+E + + Q L + + A
Sbjct: 88 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKA 141
Query: 552 LSYLHHDCFPPIVHQDISSKNLLLDLE-YEAHVADFGIAKFLKPESSNWTEFAGTYGYVA 610
L Y H I+H+D+ N+++D E + + D+G+A+F P + + +
Sbjct: 142 LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 197
Query: 611 PELAYTMK-ITEKCDVYSFGVLVLEAIKGKHP-------RDFLSLI-------------S 649
PEL + D++S G ++ I K P D L I
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257
Query: 650 SSSLNTDIALDEILD----PRLPPPSRSVQEKLISIMEVAF--SCLNESPESRPTMK 700
++ D ++IL R S + L+S + F L +SR T +
Sbjct: 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 8e-28
Identities = 47/222 (21%), Positives = 85/222 (38%), Gaps = 19/222 (8%)
Query: 427 VYDEIVRATNDFDAQYCIGNGGHGSVYRA-ELPSGQVVAIKKFHSPLPCDQIADQKEFLI 485
V D + IG+G G V A + + VAIKK P K
Sbjct: 8 VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT--HAKRAYR 65
Query: 486 EVKALTEIRHRNIVKFYGFCSHARHS------FLVYELLERGSLAAILSSDTAAQELGWS 539
E+ + + H+NI+ + + +LV EL++ I
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HE 119
Query: 540 QRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNW 599
+ ++ + + +LH +H+D+ N+++ + + DFG+A+ S
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMM 175
Query: 600 TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP 641
T + T Y APE+ M E D++S G ++ E ++ K
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-27
Identities = 56/291 (19%), Positives = 99/291 (34%), Gaps = 36/291 (12%)
Query: 435 TNDFDAQYCIGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI 493
+ +G+G +GSV A +G VA+KK P I K E++ L +
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHM 74
Query: 494 RHRNIVKFYGFCSHAR-----HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGV 548
+H N++ + AR + + L L I+ Q+L +I +
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQI 130
Query: 549 ADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSNWTEFAGTYGY 608
L Y+H H+D+ NL ++ + E + DFG+A+ E A +
Sbjct: 131 LRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYR 185
Query: 609 VAPELAYTMKITEKCDVYSFGVLVLEAIKGKHP------RDFLSLI---------SSSSL 653
+ M + D++S G ++ E + G+ D L LI
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245
Query: 654 NTDIALDEILDPRLPPPSRSVQEKLISIMEVAF----SCLNESPESRPTMK 700
+ + + P + I +A L + R T
Sbjct: 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 99.7 bits (247), Expect = 5e-23
Identities = 67/355 (18%), Positives = 116/355 (32%), Gaps = 46/355 (12%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIP----PSLE--------N 48
+ ++ L ++ K + V L NL ++ N L+ P L
Sbjct: 43 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQI 100
Query: 49 PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNN 108
+T N L +N + N + + I + L +
Sbjct: 101 ADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLS 160
Query: 109 LTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNS 168
+++ + T L + S K L +L + N I+ P I +
Sbjct: 161 FGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTN 220
Query: 169 SQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANR 228
L L L+ N + L L +LT+L L NQ + + L L L L AN+
Sbjct: 221 --LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQ 274
Query: 229 FNNSVP--------------------ENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLS 268
+N P + NL L YL L N P + L +L
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQ 332
Query: 269 ELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDN 323
L ++N + +L ++ L+ HN +S P + I+ + ++D
Sbjct: 333 RLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 95.2 bits (235), Expect = 5e-22
Identities = 57/259 (22%), Positives = 106/259 (40%), Gaps = 6/259 (2%)
Query: 4 LSILDLNQNQFKGV--LPPSVSNLTNLKELVLLYN-NLSGFIPPSL-ENPMLTRPGLDFN 59
++ LDL+ +P S++NL L L + NL G IPP++ + L +
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
+ + +P + + L S N GT+P + + +L+ + + N ++G I ++ G
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
+ L + L +++S N + G G+ Q + L+ N
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
+ ++ K N LR N+ G LP + L L L++S N +P+ GN
Sbjct: 232 SLAFDLGKVGLSKNLNGLD-LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGN 289
Query: 240 LLKLHYLGLSNNQFVLELP 258
L + +NN+ + P
Sbjct: 290 LQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 86.0 bits (211), Expect = 6e-19
Identities = 57/258 (22%), Positives = 97/258 (37%), Gaps = 6/258 (2%)
Query: 99 LIRVRLNSNNLTGN--ISEALGIYPNLTFIDLSRND-FYGEISSNWGKCPKLGTLNVSMN 155
+ + L+ NL I +L P L F+ + + G I K +L L ++
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 156 NITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGS 215
N++G IP + L LD S N + G +P + L +L + GN+ +G +P GS
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 216 LVDLEYLDLSA-NRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASH 274
L + NR +P NL N A +
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 275 NLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTA 334
+L + + +L +N + G++P ++ + +++S N L G +P
Sbjct: 232 SLAFDLGKVGLSKNLNGL--DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289
Query: 335 FRNAPVEALKGNKGLCGG 352
+ V A NK LCG
Sbjct: 290 LQRFDVSAYANNKCLCGS 307
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 79.0 bits (193), Expect = 1e-16
Identities = 74/307 (24%), Positives = 113/307 (36%), Gaps = 32/307 (10%)
Query: 8 DLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGF--IPPSLEN-PMLTRPGLDFNH-FTS 63
D + GVL + + + L L NL IP SL N P L + +
Sbjct: 32 DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91
Query: 64 YLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNL 123
+P + + L Y ++ + G IP L +L+ + + N L+G + ++ PNL
Sbjct: 92 PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151
Query: 124 TFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVG 183
I N G I ++G KL T N G + L +DLS N + G
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEG 211
Query: 184 EIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKL 243
+ G + ++ L N L S DL NR ++P+ L L L
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGL-DLRNNRIYGTLPQGLTQLKFL 270
Query: 244 HYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNN-LS 302
H L +S N GEIP Q +L+ + ++N L
Sbjct: 271 HSLNVSFNNLC------------------------GEIP-QGGNLQRFDVSAYANNKCLC 305
Query: 303 GS-IPNC 308
GS +P C
Sbjct: 306 GSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 52.1 bits (123), Expect = 1e-07
Identities = 20/70 (28%), Positives = 28/70 (40%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
++L+ LDL N+ G LP ++ L L L + +NNL G IP N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 61 FTSYLPHNVC 70
P C
Sbjct: 303 CLCGSPLPAC 312
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 95.1 bits (235), Expect = 5e-22
Identities = 51/279 (18%), Positives = 89/279 (31%), Gaps = 14/279 (5%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNH 60
++LDL N+ + NL NL L+L+ N +S P + L R L N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
L+ + ++ L + + N +G + A
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGM 149
Query: 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNH 180
L++I ++ + + G P L L++ N IT + + L L LS N
Sbjct: 150 KKLSYIRIADTNI---TTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 181 IVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNN------SVP 234
I L L EL L N+ P + ++ + L N + P
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCPP 265
Query: 235 ENLGNLLKLHYLGLSNN--QFVLELPKELEKLVQLSELD 271
+ L +N Q+ P + + +
Sbjct: 266 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.9 bits (224), Expect = 1e-20
Identities = 54/287 (18%), Positives = 91/287 (31%), Gaps = 14/287 (4%)
Query: 42 IPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIR 101
+P L P L N T + L + N P L R
Sbjct: 25 VPKDL-PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLER 83
Query: 102 VRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGI 161
+ L+ N L + L + + + + + L + +G
Sbjct: 84 LYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIE 142
Query: 162 PREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEY 221
+L + ++ +I IP+ L SLTEL L GN+ T + L +L
Sbjct: 143 NGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAK 199
Query: 222 LDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGG-- 279
L LS N + +L N L L L+NN+ V P L + + +N
Sbjct: 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIG 258
Query: 280 ----EIPFQICSLKSLEKLNLSHNNLSGS--IPNCFEGIRGISVIDI 320
P S ++L N + P+ F + + + +
Sbjct: 259 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.5 bits (223), Expect = 2e-20
Identities = 47/268 (17%), Positives = 85/268 (31%), Gaps = 11/268 (4%)
Query: 75 LQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFY 134
+ N +N +L + L +N ++ A L + LS+N
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 135 GEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNS 194
+L + + + + ++ L + G +
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMKK 151
Query: 195 LTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFV 254
L+ + + T +P G L L L N+ +L L L LGLS N
Sbjct: 152 LSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208
Query: 255 LELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRG 314
L L EL ++N ++P + K ++ + L +NN+S N F
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 267
Query: 315 ------ISVIDISDNQLQGPVPNSTAFR 336
S + + N +Q + FR
Sbjct: 268 NTKKASYSGVSLFSNPVQYWEIQPSTFR 295
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 86.2 bits (212), Expect = 5e-19
Identities = 43/236 (18%), Positives = 81/236 (34%), Gaps = 10/236 (4%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
+++L L L N+ + P + + L L+ L L N L + R +
Sbjct: 54 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEIT 113
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
N + G + G + L +R+ N+T + G+
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLP 170
Query: 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNH 180
P+LT + L N +++ L L +S N+I+ + N+ L+ L L+ N
Sbjct: 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230
Query: 181 IVGEIPKELGKLNSLTELILRGNQFTG------RLPPEIGSLVDLEYLDLSANRFN 230
+V ++P L + + L N + P + L +N
Sbjct: 231 LV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 79.3 bits (194), Expect = 1e-16
Identities = 47/264 (17%), Positives = 88/264 (33%), Gaps = 33/264 (12%)
Query: 94 RNCS-SLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNV 152
C L V+ + L + P+ +DL N ++ L TL +
Sbjct: 6 FRCQCHLRVVQCSDLGLE---KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLIL 62
Query: 153 SMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELG---------------------- 190
N I+ P +L+ L LS N + E+P+++
Sbjct: 63 INNKISKISPGAFAPLVKLERLYLSKNQL-KELPEKMPKTLQELRVHENEITKVRKSVFN 121
Query: 191 --KLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGL 248
+ EL + +G + L Y+ ++ +L +LH L
Sbjct: 122 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELH---L 178
Query: 249 SNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNC 308
N+ L+ L L++L S N + + L +L+L++N L +P
Sbjct: 179 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 237
Query: 309 FEGIRGISVIDISDNQLQGPVPNS 332
+ I V+ + +N + N
Sbjct: 238 LADHKYIQVVYLHNNNISAIGSND 261
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 74.7 bits (182), Expect = 3e-15
Identities = 36/214 (16%), Positives = 68/214 (31%), Gaps = 6/214 (2%)
Query: 161 IPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLE 220
+P+++ LDL N I + L +L LIL N+ + P LV LE
Sbjct: 25 VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 221 YLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGE 280
L LS N+ + L +L + + L +++ + EL + G
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGI 141
Query: 281 IPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPV 340
+K L + ++ N++ + + + N++ S N
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT---ELHLDGNKITKVDAASLKGLNNLA 198
Query: 341 EALKGNKGLCGGVKGMQPCKVFLSHKQNSRVKWF 374
+ + G L + K
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 95.5 bits (236), Expect = 9e-22
Identities = 45/250 (18%), Positives = 89/250 (35%), Gaps = 26/250 (10%)
Query: 444 IGNGGHGSVYRAE-LPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN----- 497
+G G +V+ A+ + + VA+K + E+K L + +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKED 75
Query: 498 ------IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWS--QRMNVIKGVA 549
I+K +H + + ++ +L+ + G + K +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 550 DALSYLHHDCFPPIVHQDISSKNLLLDLE-YEAHVADFGIAKFLKPESS--NWTEFAGTY 606
L Y+H C I+H DI +N+L+++ ++ IA ++T T
Sbjct: 136 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 607 GYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPR 666
Y +PE+ D++S L+ E I G F S D + +I++
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTKDDDHIAQIIELL 251
Query: 667 LPPPSRSVQE 676
PS ++
Sbjct: 252 GELPSYLLRN 261
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.4 bits (208), Expect = 2e-19
Identities = 30/207 (14%), Positives = 61/207 (29%), Gaps = 39/207 (18%)
Query: 444 IGNGGHGSVYRAELPSGQVVAIKKFHSPLP------CDQIADQKEFLIEVKALTEIRHRN 497
+G G +V+ +K + F + R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 498 IVKFYGFCSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH 557
+ K G +++ E ++ L + V+ + + ++ +H
Sbjct: 68 LQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 558 DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK---------FLKPESSNWTE-FAGTYG 607
IVH D+S N+L+ E + DF + L+ + N F+ TY
Sbjct: 122 RG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYR 177
Query: 608 YVAPELAYTMKITEKCDVYSFGVLVLE 634
+ D+ S +L+
Sbjct: 178 T-------------EKDINSAIDRILQ 191
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.3 bits (204), Expect = 3e-18
Identities = 53/287 (18%), Positives = 87/287 (30%), Gaps = 30/287 (10%)
Query: 42 IPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIR 101
+P + R L N + + L + N + L +
Sbjct: 26 VPVGI-PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQ 84
Query: 102 VRLNSNNLTGNI-SEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGG 160
+ L+ N ++ L + L R + L L + N +
Sbjct: 85 LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQAL 144
Query: 161 IPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLE 220
+ L L L N I + L+SL L+L N+ P L L
Sbjct: 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204
Query: 221 YLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGE 280
L L AN + E L L L YL L++N +V + L
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR--------ARPL---------- 246
Query: 281 IPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQG 327
L+K S + + S+P + + G + ++ N LQG
Sbjct: 247 -------WAWLQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.3 bits (191), Expect = 2e-16
Identities = 47/251 (18%), Positives = 84/251 (33%), Gaps = 4/251 (1%)
Query: 97 SSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNN 156
++ R+ L+ N ++ + + NLT + L N ++ + L L++S N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 157 ITGGI-PREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGS 215
+ P +L L L + P L +L L L+ N
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 216 LVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHN 275
L +L +L L NR ++ L L L L N+ P L +L L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 276 LFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAF 335
+ L++L+ L L+ N + S +++ +P
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQR--L 268
Query: 336 RNAPVEALKGN 346
++ L N
Sbjct: 269 AGRDLKRLAAN 279
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.8 bits (187), Expect = 5e-16
Identities = 48/254 (18%), Positives = 79/254 (31%), Gaps = 6/254 (2%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHF 61
+ + L+ N+ V S NL L L N L+ + L ++
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 62 --TSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
S P G L + Q P + R ++L + L N L +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
NLT + L N + L L + N + P + +L L L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGN 239
++ + L L +L L L N + L+ S++ S+P+ L
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEVPCSLPQRLAG 270
Query: 240 LLKLHYLGLSNNQF 253
L+ N
Sbjct: 271 RDLKR---LAANDL 281
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.2 bits (144), Expect = 2e-10
Identities = 36/184 (19%), Positives = 67/184 (36%), Gaps = 5/184 (2%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPM-LTRPGLDFN 59
+ L L L++ + + P L L+ L L N L + + LT L N
Sbjct: 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
+S +L + +N P R+ L+ + L +NNL+ +EAL
Sbjct: 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
L ++ L+ N + + + L S + + +P+ + L+ N
Sbjct: 224 LRALQYLRLNDNPWVCDCRARPLW-AWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAAN 279
Query: 180 HIVG 183
+ G
Sbjct: 280 DLQG 283
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (140), Expect = 5e-10
Identities = 37/178 (20%), Positives = 55/178 (30%), Gaps = 3/178 (1%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHF 61
+ +IL L++N ++ T L +L L + P+L L N
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLN-LDRAELTKLQVDGTLPVLGTLDLSHNQL 89
Query: 62 TSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYP 121
S VS N LR L + L N L L P
Sbjct: 90 QSLPLLGQTLPAL-TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTP 148
Query: 122 NLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
L + L+ N+ + L TL + N++ IP+ S L L N
Sbjct: 149 KLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 1e-07
Identities = 42/206 (20%), Positives = 68/206 (33%), Gaps = 25/206 (12%)
Query: 142 GKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILR 201
K +N N+T +P ++ L LS N + L LT+L L
Sbjct: 7 SKVASHLEVNCDKRNLTA-LPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 202 GNQFTGRLPPEIGSLVDL---------------------EYLDLSANRFNNSVPENLGNL 240
+ T ++ LD+S NR + L L
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 241 LKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNN 300
+L L L N+ P L +L +L ++N + L++L+ L L N+
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 301 LSGSIPNCFEGIRGISVIDISDNQLQ 326
L +IP F G + + N
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (115), Expect = 8e-07
Identities = 38/208 (18%), Positives = 63/208 (30%), Gaps = 24/208 (11%)
Query: 164 EIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLD 223
E+ + ++ ++ +P +L K T L L N + L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 224 LSANRFNNSVPENLGNLLKLHYLGLSNNQFVLE---------------------LPKELE 262
L + +L L + Q + L
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 263 KLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISD 322
L +L EL N P + LEKL+L++NNL+ G+ + + + +
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 323 NQLQGPVPNSTAFRNAPVEALKGNKGLC 350
N L P L GN LC
Sbjct: 182 NSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.1 bits (138), Expect = 2e-09
Identities = 14/98 (14%), Positives = 31/98 (31%), Gaps = 5/98 (5%)
Query: 217 VDLEYLDLSANRFNNS-VPENLGNLLKLHYLGLSNNQF----VLELPKELEKLVQLSELD 271
+D++ LD+ +++ E L L + + L + ++ L L+EL+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 272 ASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCF 309
N G + + +L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.4 bits (131), Expect = 1e-08
Identities = 18/96 (18%), Positives = 30/96 (31%), Gaps = 10/96 (10%)
Query: 168 SSQLQALDLSLNHIVGEIPKEL-GKLNSLTELILRGNQFTGR----LPPEIGSLVDLEYL 222
S +Q+LD+ + EL L + L T + + L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 223 DLSANRFNNSVPENLGNLL-----KLHYLGLSNNQF 253
+L +N + + L K+ L L N
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 6e-08
Identities = 17/83 (20%), Positives = 30/83 (36%), Gaps = 9/83 (10%)
Query: 193 NSLTELILRGNQFTGR----LPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLK-----L 243
+ L L L + L + + L LDLS N ++ L ++ L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 244 HYLGLSNNQFVLELPKELEKLVQ 266
L L + + E+ L+ L +
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 2e-07
Identities = 19/87 (21%), Positives = 30/87 (34%), Gaps = 9/87 (10%)
Query: 167 NSSQLQALDLSLNHIVGE----IPKELGKLNSLTELILRGNQFTGRLPPEIGSLVD---- 218
S L+ L L+ + + L +SL EL L N ++ V
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 219 -LEYLDLSANRFNNSVPENLGNLLKLH 244
LE L L ++ + + L L K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 2e-07
Identities = 15/92 (16%), Positives = 29/92 (31%), Gaps = 13/92 (14%)
Query: 120 YPNLTFIDLSRNDFYGE----ISSNWGKCPKLGTLNVSMNNITGGIPREIG-----NSSQ 170
L + L+ D +++ L L++S N + ++
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 171 LQALDLSLNHIVGEIPKELGKL----NSLTEL 198
L+ L L + E+ L L SL +
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 3e-07
Identities = 18/81 (22%), Positives = 27/81 (33%), Gaps = 9/81 (11%)
Query: 242 KLHYLGLSNNQF----VLELPKELEKLVQLSELDASHNLFGGEIPFQICS-----LKSLE 292
L L L++ L L L ELD S+N G Q+ LE
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 293 KLNLSHNNLSGSIPNCFEGIR 313
+L L S + + + +
Sbjct: 430 QLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 3e-06
Identities = 9/94 (9%), Positives = 28/94 (29%), Gaps = 10/94 (10%)
Query: 122 NLTFIDLSRNDFYGE-ISSNWGKCPKLGTLNVSMNNITG----GIPREIGNSSQLQALDL 176
++ +D+ + + + + + +T I + + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 177 SLNHIVGEIPKELGKL-----NSLTELILRGNQF 205
N + + + + +L L+
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 8/68 (11%), Positives = 23/68 (33%), Gaps = 5/68 (7%)
Query: 265 VQLSELDASHNLFGGEIPFQICS-LKSLEKLNLSHNNLSG----SIPNCFEGIRGISVID 319
+ + LD ++ L+ + + L L+ I + ++ ++
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 320 ISDNQLQG 327
+ N+L
Sbjct: 62 LRSNELGD 69
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 5e-05
Identities = 17/92 (18%), Positives = 31/92 (33%), Gaps = 10/92 (10%)
Query: 75 LQYFGVSENHFQGT-IPKILRNCSSLIRVRLNSNNLTG----NISEALGIYPNLTFIDLS 129
+Q + ++L VRL+ LT +IS AL + P L ++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 130 RNDFYGEISSNWGK-----CPKLGTLNVSMNN 156
N+ + K+ L++
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.5 bits (137), Expect = 2e-09
Identities = 56/326 (17%), Positives = 98/326 (30%), Gaps = 30/326 (9%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHF 61
R L+LN LP +L+ LV N+L+ +P ++ L +D N+
Sbjct: 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTE-LPELPQS--LKSLLVDNNNL 90
Query: 62 TSY------LPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISE 115
+ L + L+ +N I + N + S +
Sbjct: 91 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNN 150
Query: 116 ALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALD 175
L P L + + S L ++ N E+ N L +
Sbjct: 151 QLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIY 210
Query: 176 LSLNHIVGEIPKELGKLNSLTELILRGNQF--------TGRLPPEIGSLVDLEYLDLSAN 227
N + + L +L N
Sbjct: 211 ADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLN 270
Query: 228 RFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICS 287
+N + L L +SNN+ + ELP +L L AS N E+P
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVP---EL 322
Query: 288 LKSLEKLNLSHNNLSGSIPNCFEGIR 313
++L++L++ +N L P+ E +
Sbjct: 323 PQNLKQLHVEYNPLR-EFPDIPESVE 347
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.6 bits (132), Expect = 8e-09
Identities = 28/107 (26%), Positives = 39/107 (36%), Gaps = 17/107 (15%)
Query: 125 FIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGE 184
N EI S P L LNVS N + +P L+ L S NH+ E
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHL-AE 318
Query: 185 IPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNN 231
+P+ +L +L + N P S+ DL R N+
Sbjct: 319 VPELPQ---NLKQLHVEYNPLRE-FPDIPESVEDL--------RMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 8e-06
Identities = 19/92 (20%), Positives = 35/92 (38%), Gaps = 9/92 (9%)
Query: 104 LNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPR 163
N + I + P+L +++S N ++ P+L L S N++ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNN----KLIELPALPPRLERLIASFNHLA-EVPE 321
Query: 164 EIGNSSQLQALDLSLNHIVGEIPKELGKLNSL 195
N L+ L + N + E P + L
Sbjct: 322 LPQN---LKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.001
Identities = 22/98 (22%), Positives = 32/98 (32%), Gaps = 11/98 (11%)
Query: 9 LNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHN 68
N + +L+EL + N L +P L R FNH +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR--LERLIASFNHLAE-VPEL 322
Query: 69 VCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNS 106
L+ V N + P I + L R+NS
Sbjct: 323 P---QNLKQLHVEYNPLR-EFPDIPESVEDL---RMNS 353
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.9 bits (133), Expect = 5e-09
Identities = 38/267 (14%), Positives = 88/267 (32%), Gaps = 16/267 (5%)
Query: 81 SENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGE-ISS 139
+ + + L + +I R + + ++E + +DLS + +
Sbjct: 8 TGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEVSTLHG 65
Query: 140 NWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKE--------LGK 191
+C KL L++ ++ I + +S L L+LS E + L +
Sbjct: 66 ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125
Query: 192 LNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNN 251
LN + ++ L N + + + L +L LS++
Sbjct: 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDS 185
Query: 252 QFV-LELPKELEKLVQLSELDASH-NLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCF 309
+ + +E +L L L S E ++ + +L+ L + G++
Sbjct: 186 VMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLK 245
Query: 310 EGIRGISVIDISDNQLQGPVPNSTAFR 336
E + + I+ + + +
Sbjct: 246 EALPH---LQINCSHFTTIARPTIGNK 269
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 6e-06
Identities = 51/288 (17%), Positives = 94/288 (32%), Gaps = 27/288 (9%)
Query: 31 LVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQG-TI 89
L L NL + L + + + L + +Q+ +S + + T+
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEVSTL 63
Query: 90 PKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLS--RNDFYGEISSNWGKCPKL 147
IL CS L + L L+ I L NL ++LS + + C +L
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123
Query: 148 GTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTG 207
LN+S + H+ + + L R N
Sbjct: 124 DELNLSWCFDF------------------TEKHVQVAVAHVSETITQLNLSGYRKNLQKS 165
Query: 208 RLPPEIGSLVDLEYLDLSAN-RFNNSVPENLGNLLKLHYLGLSNNQFVL-ELPKELEKLV 265
L + +L +LDLS + N + L L +L LS ++ E EL ++
Sbjct: 166 DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIP 225
Query: 266 QLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIR 313
L L + G + ++L L ++ ++ + +
Sbjct: 226 TLKTLQVFGIVPDGTLQL---LKEALPHLQINCSHFTTIARPTIGNKK 270
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.3 bits (122), Expect = 2e-08
Identities = 30/107 (28%), Positives = 42/107 (39%), Gaps = 6/107 (5%)
Query: 198 LILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLEL 257
L L T + L+ + +LDLS NR ++P L L L L + LE
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVL--QASDNALEN 57
Query: 258 PKELEKLVQLSELDASHN-LFGGEIPFQICSLKSLEKLNLSHNNLSG 303
+ L +L EL +N L + S L LNL N+L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 1e-07
Identities = 29/127 (22%), Positives = 48/127 (37%), Gaps = 9/127 (7%)
Query: 172 QALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNN 231
+ L L+ + + L +L +T L L N+ PP + +L LE L A+
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQ--ASDNAL 55
Query: 232 SVPENLGNLLKLHYLGLSNNQFV-LELPKELEKLVQLSELDASHNLF---GGEIPFQICS 287
+ + NL +L L L NN+ + L +L L+ N G
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 288 LKSLEKL 294
L S+ +
Sbjct: 116 LPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 4e-07
Identities = 25/108 (23%), Positives = 41/108 (37%), Gaps = 6/108 (5%)
Query: 221 YLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGE 280
L L+ +V +L LL + +L LS+N+ P L L L L AS N
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 281 IPFQICSLKSLEKLNLSHNNL-SGSIPNCFEGIRGISVIDISDNQLQG 327
L++L L +N L + + ++++ N L
Sbjct: 59 DGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 6e-07
Identities = 22/123 (17%), Positives = 38/123 (30%), Gaps = 8/123 (6%)
Query: 6 ILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYL 65
+L L + L + L L +N L P L +
Sbjct: 2 VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVL--QASDNALEN 57
Query: 66 PHNVCRGGALQYFGVSENHFQGT-IPKILRNCSSLIRVRLNSNNLT---GNISEALGIYP 121
V LQ + N Q + + L +C L+ + L N+L G + P
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 122 NLT 124
+++
Sbjct: 118 SVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 7e-07
Identities = 26/117 (22%), Positives = 39/117 (33%), Gaps = 7/117 (5%)
Query: 104 LNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPR 163
L +LT + L +T +DLS N + L L S N +
Sbjct: 5 LAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALE--NVD 59
Query: 164 EIGNSSQLQALDLSLNHIVG-EIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDL 219
+ N +LQ L L N + + L L L L+GN L ++
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.0 bits (121), Expect = 5e-08
Identities = 22/138 (15%), Positives = 44/138 (31%), Gaps = 5/138 (3%)
Query: 208 RLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQL 267
+L + D L + +L L ++ L E + +L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPEL 67
Query: 268 SELDASHN--LFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQL 325
L+ S+N ++ + +L+ LNLS N L + + + N L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 326 QGPVPNSTAFRNAPVEAL 343
+ + + +A E
Sbjct: 128 SDTFRDQSTYISAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (94), Expect = 2e-04
Identities = 29/145 (20%), Positives = 49/145 (33%), Gaps = 14/145 (9%)
Query: 89 IPKILRNCSSLIRVRLNSNNLTGNIS-EALGIYPNLTFIDLSRNDFYGEISSNWGKCPKL 147
+ I+ + L+ L + A I L R+ + P+L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN----RRSSMAATLRIIEENIPEL 67
Query: 148 GTLNVSMNNITG--GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQF 205
+LN+S N + + + + L+ L+LS N + E + K L EL L GN
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 206 TGRLPPE-------IGSLVDLEYLD 223
+ + L LD
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.9 bits (115), Expect = 6e-07
Identities = 27/225 (12%), Positives = 65/225 (28%), Gaps = 17/225 (7%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
+ + + ++ + + ++L + L ++ ++ L
Sbjct: 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYL----NNLIGLE 69
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
++ L E I+ ++ I++ +
Sbjct: 70 LKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTST---QITDVTPLA 126
Query: 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNH 180
L + I++ +S+ N + N S+L L N
Sbjct: 127 GLSNLQVLYLDLNQ--ITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 181 IVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLS 225
I P L L +L E+ L+ NQ + + + +L + L+
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 5e-06
Identities = 35/218 (16%), Positives = 64/218 (29%), Gaps = 22/218 (10%)
Query: 95 NCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSM 154
++ I++ +N+T +++A +T + L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQAD--LDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 155 NNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNS-------LTELILRGNQFTG 207
N IT P + L + V I L G
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 208 RLPPEIGSLVDLEYLDL-------SANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKE 260
L ++ + ++ L S S L NL KL L +N+ +
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK--ISDISP 190
Query: 261 LEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSH 298
L L L E+ +N P + +L + L++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTN 226
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 1e-06
Identities = 31/177 (17%), Positives = 55/177 (31%), Gaps = 13/177 (7%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNH 60
+ S+ + N + K V + L N+ +L L N L+ P + L G F
Sbjct: 45 LNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKPLA----NLKNLGWLFLD 98
Query: 61 FTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIY 120
+ + E++ I ++ N+ + L
Sbjct: 99 ENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKL 158
Query: 121 PNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLS 177
L+ D +D KL L +S N+I+ R + L L+L
Sbjct: 159 DTLSLEDNQISDI-----VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 3e-05
Identities = 35/205 (17%), Positives = 70/205 (34%), Gaps = 20/205 (9%)
Query: 95 NCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWG--KCPKLGTLNV 152
+ I+ L ++T +++ ++ I + + +I S G P + L +
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQNE--LNSIDQIIANNS----DIKSVQGIQYLPNVTKLFL 75
Query: 153 SMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPE 212
+ N +T + + N L L L N + + K + +
Sbjct: 76 NGNKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKL-------KSLSLEHNGISD 126
Query: 213 IGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDA 272
I LV L L+ N + + L + + ++ L L +L L
Sbjct: 127 INGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYL 185
Query: 273 SHNLFGGEIPFQICSLKSLEKLNLS 297
S N ++ + LK+L+ L L
Sbjct: 186 SKNHI-SDLR-ALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 4e-04
Identities = 26/226 (11%), Positives = 63/226 (27%), Gaps = 41/226 (18%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
+L + + + + L ++ +++ +++ ++ P +T+ L+ N
Sbjct: 23 FAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
T P + + ++ ++ + + L+ + + L
Sbjct: 79 KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLK------SLSLEHNGISDINGLVH 132
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
P L + L N + +N I
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKL---DTLSLEDNQISDIV----------------- 172
Query: 180 HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLS 225
L L L L L N + + L +L+ L+L
Sbjct: 173 --------PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 9e-04
Identities = 35/193 (18%), Positives = 72/193 (37%), Gaps = 29/193 (15%)
Query: 150 LNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRL 209
N+ ++T + + + + + + + I + L ++T+L L GN+ T
Sbjct: 29 DNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTD-- 82
Query: 210 PPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLEL------------ 257
+ +L +L +L L N+ + LK L + + L
Sbjct: 83 IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLG 142
Query: 258 ------PKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEG 311
L +L +L L N +P L L+ L LS N++S + G
Sbjct: 143 NNKITDITVLSRLTKLDTLSLEDNQISDIVPL--AGLTKLQNLYLSKNHIS-DLRA-LAG 198
Query: 312 IRGISVIDISDNQ 324
++ + V+++ +Q
Sbjct: 199 LKNLDVLELF-SQ 210
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.004
Identities = 35/176 (19%), Positives = 62/176 (35%), Gaps = 14/176 (7%)
Query: 75 LQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFY 134
+ + + + ++ ++ ++ LN N LT A NL + D
Sbjct: 48 IDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKPLA-----NLKNLGWLFLDEN 100
Query: 135 GEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNS 194
+ K K ++S+ + + + QL++L L N I +L
Sbjct: 101 KVKDLSSLKDLKKLK-SLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLS--RLTK 157
Query: 195 LTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSN 250
L L L NQ + + L L+ L LS N ++ L L L L L +
Sbjct: 158 LDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 45.6 bits (106), Expect = 5e-06
Identities = 45/196 (22%), Positives = 75/196 (38%), Gaps = 13/196 (6%)
Query: 144 CPK-----LGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKEL-GKLNSLTE 197
CP T++ + + IPR+I L L+ N + L G+L L +
Sbjct: 2 CPAMCHCEGTTVDCTGRGLKE-IPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVK 58
Query: 198 LILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLEL 257
L L+ NQ TG P ++ L L N+ + L +L L L +NQ +
Sbjct: 59 LELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVM 118
Query: 258 PKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISV 317
P E L L+ L+ + N F + L K +L+ P +R + +
Sbjct: 119 PGSFEHLNSLTSLNLASNPFNCNCHLAWF-AEWLRKKSLNGGAARCGAP---SKVRDVQI 174
Query: 318 IDISDNQLQGPVPNST 333
D+ ++ + NS
Sbjct: 175 KDLPHSEFKCSSENSE 190
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.2 bits (92), Expect = 3e-04
Identities = 34/216 (15%), Positives = 58/216 (26%), Gaps = 33/216 (15%)
Query: 94 RNCS-SLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNV 152
C V L I + T + L+ N+ S
Sbjct: 4 AMCHCEGTTVDCTGRGLK---EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLE 60
Query: 153 SMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPE 212
N GI + + + EI
Sbjct: 61 LKRNQLTGIEPNAFEGASHIQELQLGENKIKEIS-----------------------NKM 97
Query: 213 IGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDA 272
L L+ L+L N+ + +P + +L L L L++N F L +E
Sbjct: 98 FLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-----LAWFAEWLR 152
Query: 273 SHNLFGGEIPFQI-CSLKSLEKLNLSHNNLSGSIPN 307
+L GG ++ ++ +L H+ S N
Sbjct: 153 KKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSSEN 188
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 7e-06
Identities = 27/215 (12%), Positives = 57/215 (26%), Gaps = 8/215 (3%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHF 61
R+ L + + + + S +L+++ + N++ I + + + +
Sbjct: 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88
Query: 62 TSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYP 121
+ L N L G + ++ L NI
Sbjct: 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 148
Query: 122 NLTF-----IDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDL 176
+ L++N + + NN+ +S LD+
Sbjct: 149 VGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 208
Query: 177 SLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPP 211
S I L L L + +LP
Sbjct: 209 SRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (96), Expect = 1e-04
Identities = 27/229 (11%), Positives = 59/229 (25%), Gaps = 10/229 (4%)
Query: 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFNHF 61
S + +++ + P + N EL + L + L + + N
Sbjct: 9 SNRVFLCQESKVTEI-PSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 62 TSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLT----GNISEAL 117
+ +V + E + L +N ++ +
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 118 GIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLS 177
+ L I + N E +S G + L ++ N I + +
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 178 LNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLS 225
N++ + L + + LP +L L
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHS-LPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.001
Identities = 23/236 (9%), Positives = 57/236 (24%), Gaps = 8/236 (3%)
Query: 94 RNCS-SLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNV 152
R C S + +T + N + + L + +
Sbjct: 4 RICHCSNRVFLCQESKVT---EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEI 60
Query: 153 SMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPE 212
S N++ I ++ ++ N L + + P+
Sbjct: 61 SQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD 120
Query: 213 IGSLVDLEYLDLSANRFNNSVPENLGNLLKLHY----LGLSNNQFVLELPKELEKLVQLS 268
+ + L+ + L N + + L + L L+ N
Sbjct: 121 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDE 180
Query: 269 ELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQ 324
+ +N L++S + E ++ + + +
Sbjct: 181 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.002
Identities = 44/246 (17%), Positives = 69/246 (28%), Gaps = 11/246 (4%)
Query: 66 PHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTF 125
H +C + + F E+ IP L + I +R L A + +L
Sbjct: 2 HHRICHC-SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 126 IDLSRNDFYGEISSNWGKCPKLGTLNVSM--NNITGGIPREIGNSSQLQALDLSLNHIVG 183
I++S+ND I ++ NN+ P N LQ L +S I
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 184 EIPKELGKLNSLTELILRG--NQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLL 241
L ++ N T +G + L L+ N
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177
Query: 242 KLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNL 301
NN LD S + + +LK L + NL
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNL 235
Query: 302 SGSIPN 307
+P
Sbjct: 236 K-KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.003
Identities = 11/47 (23%), Positives = 19/47 (40%), Gaps = 4/47 (8%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLE 47
ILD+++ + + + NL L+ NL P+LE
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKL--PTLE 242
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 8e-05
Identities = 22/86 (25%), Positives = 35/86 (40%), Gaps = 11/86 (12%)
Query: 171 LQALDLSLNHI----VGEIPKELGKLNSLTELILRGNQFTGR----LPPEIGSLVDLEYL 222
++ L L+ I + L + +S+ E++L GN L I S DLE
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 223 DLSAN---RFNNSVPENLGNLLKLHY 245
+ S R + +PE L LL+
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALL 90
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 19/104 (18%), Positives = 35/104 (33%), Gaps = 13/104 (12%)
Query: 133 FYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGN------SSQLQALDLSLNHIVGEIP 186
++ P L L ++ ++ + + + LQ L L N I +
Sbjct: 231 GSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV 290
Query: 187 KEL-----GKLNSLTELILRGNQFT--GRLPPEIGSLVDLEYLD 223
+ L K+ L L L GN+F+ + EI +
Sbjct: 291 RTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 3e-04
Identities = 42/311 (13%), Positives = 83/311 (26%), Gaps = 40/311 (12%)
Query: 1 MRSLSILDLNQNQFKG----VLPPSVSNLTNLKELVLLYN---NLSGFIPPSLE-----N 48
S+ + L+ N L ++++ +L+ + IP +L
Sbjct: 30 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQAL 89
Query: 49 PMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNN 108
+ ++ P H + + I L
Sbjct: 90 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELA 149
Query: 109 LTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNS 168
+ A + + + N E + + L T+ + N I +
Sbjct: 150 VNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLE 209
Query: 169 SQLQALDLSLNHIV---------GEIPKELGKLNSLTELILRGNQFTGRLPPEIG----- 214
+L + + + L +L EL L + R +
Sbjct: 210 GLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSK 269
Query: 215 -SLVDLEYLDLSANRFNNSVPENL-----GNLLKLHYLGLSNNQF------VLELPKELE 262
+ L+ L L N L + L +L L+ N+F V E+ +
Sbjct: 270 LENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFS 329
Query: 263 K--LVQLSELD 271
+L ELD
Sbjct: 330 TRGRGELDELD 340
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 8e-04
Identities = 39/331 (11%), Positives = 86/331 (25%), Gaps = 37/331 (11%)
Query: 2 RSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSG----FIPPSLE-NPMLTRPGL 56
+SL + + K + + ++KE+VL N + ++ ++ L
Sbjct: 8 KSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 57 DFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEA 116
+ + L C L VRL+ N E
Sbjct: 67 SDIFTGR--------------VKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEP 112
Query: 117 LGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDL 176
L + + + G +++N P L+
Sbjct: 113 LIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172
Query: 177 SLNHIVGEIPKELGKLNSL------TELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFN 230
+ + L+++ + L V + + +
Sbjct: 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 232
Query: 231 NSVPENLGNLLKLHYLGLSNNQFVLELPKEL------EKLVQLSELDASHNLFGGEIPFQ 284
+++ L + L LGL++ + + + L L +N +
Sbjct: 233 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 292
Query: 285 ICS-----LKSLEKLNLSHNNLSGSIPNCFE 310
+ + + L L L+ N S E
Sbjct: 293 LKTVIDEKMPDLLFLELNGNRFSEEDDVVDE 323
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.6 bits (85), Expect = 0.004
Identities = 11/91 (12%), Positives = 29/91 (31%), Gaps = 5/91 (5%)
Query: 71 RGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGN----ISEALGIYPNLTFI 126
G +L+ ++ + ++ +L S+ + L+ N + +SE + +L
Sbjct: 6 EGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 127 DLSRNDFYGEISSNWGKCPKLGTLNVSMNNI 157
+ S L + +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 31/199 (15%), Positives = 54/199 (27%), Gaps = 17/199 (8%)
Query: 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLEN-PMLTRPGLDFN 59
+ L + S ++L + L + +E LT+ N
Sbjct: 17 LAEKMKTVLGKTNVTDT--VSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72
Query: 60 HFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
T P ++ + + + ++ L
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 120 YPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLN 179
L + S L LN S N +T P + N + L+ LD+S N
Sbjct: 133 --------LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSN 182
Query: 180 HIVGEIPKELGKLNSLTEL 198
+ L KL +L L
Sbjct: 183 KVSD--ISVLAKLTNLESL 199
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 4e-04
Identities = 27/148 (18%), Positives = 45/148 (30%), Gaps = 8/148 (5%)
Query: 169 SQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEI-GSLVDLEYLDLSAN 227
L + + + + L +LTEL + Q L L +L L + +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 228 RFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICS 287
P+ +L L LS N L + + + L EL S N +
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPL--HCSCALRW 123
Query: 288 LKSLEKLNLSH---NNLSGSIPNCFEGI 312
L+ E+ L L +
Sbjct: 124 LQRWEEEGLGGVPEQKLQCHGQGPLAHM 151
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 29/134 (21%), Positives = 45/134 (33%), Gaps = 7/134 (5%)
Query: 144 CPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGN 203
+ L++ I I Q A+D S N I L L L++ N
Sbjct: 17 AVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNNN 73
Query: 204 QFTGRLPPEIGSLVDLEYLDLSANRFNN-SVPENLGNLLKLHYLGLSNNQFVLE---LPK 259
+ +L DL L L+ N + L +L L YL + N +
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133
Query: 260 ELEKLVQLSELDAS 273
+ K+ Q+ LD
Sbjct: 134 VIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.001
Identities = 16/131 (12%), Positives = 34/131 (25%), Gaps = 6/131 (4%)
Query: 4 LSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTS 63
LDL + V+ + L + N + + L ++ N
Sbjct: 20 DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICR 77
Query: 64 YLPHNVCRGGALQYFGVSENHFQG----TIPKILRNCSSLIRVRLNSNNLTGNISEALGI 119
L ++ N L++ + L +R N +
Sbjct: 78 IGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYK 137
Query: 120 YPNLTFIDLSR 130
P + +D +
Sbjct: 138 VPQVRVLDFQK 148
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.002
Identities = 27/135 (20%), Positives = 43/135 (31%), Gaps = 7/135 (5%)
Query: 167 NSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSA 226
N+ + + LDL I I L+ + N+ L L+ L ++
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLKTLLVNN 72
Query: 227 NRFNNSVPENLGNLLKLHYLGLSNNQFV----LELPKELEKLVQLSELDASHNLFGGEIP 282
NR L L L L+NN V L+ L+ L L L
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132
Query: 283 FQICSLKSLEKLNLS 297
+ I + + L+
Sbjct: 133 YVIYKVPQVRVLDFQ 147
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 708 | |||
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.94 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.82 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.81 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.8 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.78 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.78 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.71 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.67 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.61 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.6 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.58 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.56 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.56 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.55 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.52 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.51 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.43 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.41 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.36 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.36 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.64 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.62 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.54 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.03 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.9 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.8 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.5 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.33 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.2 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.09 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.65 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.12 |
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=409.58 Aligned_cols=260 Identities=25% Similarity=0.374 Sum_probs=199.8
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee--CCeeE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH--ARHSF 512 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~ 512 (708)
++|++.+.||+|+||.||+|.. .+|+.||||.+..... .....+.+.+|++++++++||||+++++++.+ ++..|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 6899999999999999999965 5789999999976432 23456779999999999999999999999865 45689
Q ss_pred EEEEeccCCCHHHHhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhCCC--CCeEEccCCCCCeeeCCCCcEEEeecccc
Q 039322 513 LVYELLERGSLAAILSSDT-AAQELGWSQRMNVIKGVADALSYLHHDCF--PPIVHQDISSKNLLLDLEYEAHVADFGIA 589 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~--~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 589 (708)
+||||+++|+|.+++.... ....+++..++.++.|++.||+|||++.. .+|+||||||+|||++.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 9999999999999996543 23568999999999999999999998710 13999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 039322 590 KFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
+.............||+.|+|||++.+..++.++|||||||++|||+||+.||+.... ......+.......
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~~~~~i~~~~~~~ 233 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREGKFRR 233 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCCCC
T ss_pred eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence 9876655555667899999999999999999999999999999999999999974322 11222222222222
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.+... +.++.+++.+||+.||++|||++|+++|-+|
T Consensus 234 ~~~~~---s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 234 IPYRY---SDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCccc---CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 22222 2357889999999999999999999998765
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=405.40 Aligned_cols=251 Identities=27% Similarity=0.421 Sum_probs=209.4
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|.. .+|+.||+|++.+.. .......+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH-ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 6899999999999999999976 468999999986421 11122356789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|.....
T Consensus 85 mEy~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EeecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999997543 489999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||+.... ......+.......+..
T Consensus 159 --~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~p~~-- 226 (263)
T d2j4za1 159 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISRVEFTFPDF-- 226 (263)
T ss_dssp --CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTCCCCCTT--
T ss_pred --CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCcc--
Confidence 233456799999999999999999999999999999999999999974321 22222233333322211
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.++.+++.+||++||++|||++|+++|-+
T Consensus 227 --~s~~~~~li~~~L~~dp~~R~t~~eil~hp~ 257 (263)
T d2j4za1 227 --VTEGARDLISRLLKHNPSQRPMLREVLEHPW 257 (263)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred --CCHHHHHHHHHHccCCHhHCcCHHHHHcCcC
Confidence 2235788999999999999999999998754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-51 Score=410.70 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=209.7
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGG----GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecc----cChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 4799999999999999999965 57999999998752 223456799999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++... .+++.+++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+....
T Consensus 96 mEy~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999999988643 489999999999999999999999 999999999999999999999999999998766
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.........||+.|+|||++.+..++.++||||+||++|||+||+.||....... ....+.....+ .....
T Consensus 169 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~~~~~~~~~~~-~~~~~ 239 (293)
T d1yhwa1 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--------ALYLIATNGTP-ELQNP 239 (293)
T ss_dssp TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHHCSC-CCSSG
T ss_pred ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH--------HHHHHHhCCCC-CCCCc
Confidence 6556667789999999999999999999999999999999999999997432211 11111110000 00111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+..+.+++.+||++||++|||++|+++|=+
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~ 272 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGG
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 122345788999999999999999999998743
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-51 Score=405.19 Aligned_cols=251 Identities=24% Similarity=0.395 Sum_probs=196.9
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
++|++.+.||+|+||.||+|.+.+++.||||+++... ...++|.+|++++++++||||++++|++..++..++||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-----CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 5788999999999999999998888999999997532 23467999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++|+|.+++.... ..+++..++.++.|||.||+|||++ +|+||||||+||++++++.+||+|||+|+.....
T Consensus 80 E~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp ECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred EecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCC
Confidence 9999999999987543 4588999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 596 SSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKG-KHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 596 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
... .....||+.|+|||++.+..++.++|||||||++|||+|+ +.||..... ......+........+..
T Consensus 155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--------~~~~~~i~~~~~~~~p~~ 226 (263)
T d1sm2a_ 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFRLYKPRL 226 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--------HHHHHHHHHTCCCCCCTT
T ss_pred CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHhcCCCCCccc
Confidence 322 2345789999999999999999999999999999999995 555542211 111111111111111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. +.++.+++.+||+.||++||||+||+++|+
T Consensus 227 ~---~~~l~~li~~cl~~~p~~Rps~~~il~~L~ 257 (263)
T d1sm2a_ 227 A---STHVYQIMNHCWKERPEDRPAFSRLLRQLA 257 (263)
T ss_dssp S---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred c---CHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 1 235789999999999999999999999985
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=406.38 Aligned_cols=256 Identities=24% Similarity=0.334 Sum_probs=205.3
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||+||+|.+ .+|+.||||++..... ....+.+.+|++++++++||||+++++++.+++..|+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 36899999999999999999976 4689999999875321 2234578999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++.... .+++.+++.++.|++.||+|||++ ||+||||||+|||+++++.+||+|||+|+...
T Consensus 81 vmEy~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp EEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEeccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeec
Confidence 999999999999996543 489999999999999999999999 99999999999999999999999999998764
Q ss_pred CCC--CccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 594 PES--SNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 594 ~~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
... ......+||+.|+|||++.+..+ +.++||||+||++|||+||+.||+.... ................
T Consensus 155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~-------~~~~~~~~~~~~~~~~ 227 (271)
T d1nvra_ 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD-------SCQEYSDWKEKKTYLN 227 (271)
T ss_dssp ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST-------TSHHHHHHHTTCTTST
T ss_pred cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCCCCCC
Confidence 332 22345689999999999988776 5689999999999999999999974221 1111111111111111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
.....+.++.+++.+||+.||++|||++|+++|-++
T Consensus 228 --~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf 263 (271)
T d1nvra_ 228 --PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263 (271)
T ss_dssp --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 111223457789999999999999999999987553
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-50 Score=408.59 Aligned_cols=253 Identities=23% Similarity=0.436 Sum_probs=195.0
Q ss_pred ccccccceeccccCccEEEEEeC-CC---cEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SG---QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
++|++.+.||+|+||+||+|.++ ++ ..||||.+.... .....+.|.+|++++++++|||||+++|++.+++..
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc---CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 45667789999999999999764 23 358999987532 234567899999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++||||+++|+|.+++.... ..+++.++..++.|||+||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceE
Confidence 99999999999999887543 3589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcc-----ccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC
Q 039322 592 LKPESSNW-----TEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDP 665 (708)
Q Consensus 592 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 665 (708)
........ ....+|+.|+|||.+.++.++.++|||||||++|||+| |+.||..... ......+...
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--------~~~~~~i~~~ 249 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--------QDVINAIEQD 249 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTT
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcC
Confidence 65433221 22457899999999999999999999999999999998 8999874322 1122222222
Q ss_pred CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 666 RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 666 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+.+.. .+..+.+++.+||+.||++||||+||++.|+
T Consensus 250 ~~~~~~~~---~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~ 288 (299)
T d1jpaa_ 250 YRLPPPMD---CPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288 (299)
T ss_dssp CCCCCCTT---CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCCCCcc---chHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 21111122 2345888999999999999999999999874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-51 Score=407.66 Aligned_cols=257 Identities=23% Similarity=0.395 Sum_probs=200.2
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.++|++.+.||+|+||+||+|+.+ ..||||+++.... .....+.|.+|++++++++|||||+++|++.+ +..++|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 368999999999999999999874 3699999975432 23456789999999999999999999998765 568999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... ..+++..+..++.|||+||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999999996543 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC--ccccccccccccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 039322 595 ESS--NWTEFAGTYGYVAPELAYT---MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 595 ~~~--~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||+........ ..........+....
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~---~~~~~~~~~~p~~~~ 233 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI---IFMVGRGYLSPDLSK 233 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH---HHHHHHTSCCCCGGG
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH---HHHHhcCCCCCcchh
Confidence 322 2345679999999999864 34788999999999999999999999743211100 000011111111111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. ....+..+.+++.+||+.||++||||+|++++|+
T Consensus 234 ~---~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le 268 (276)
T d1uwha_ 234 V---RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268 (276)
T ss_dssp S---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred c---cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 1 1122346889999999999999999999999885
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-50 Score=397.49 Aligned_cols=251 Identities=24% Similarity=0.420 Sum_probs=210.3
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
++|++.++||+|+||+||+|++++++.||||+++... ...++|.+|++++++++||||++++|++.+++..++||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-----~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-----SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-----CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 6899999999999999999999888899999998632 23467999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++|++.+++.... ..+++..+++++.|+++||+|||++ ||+||||||+||++++++.+||+|||+|+.....
T Consensus 79 Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp ECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred EccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 9999999999976543 4588999999999999999999999 9999999999999999999999999999876544
Q ss_pred CC-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 596 SS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 596 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
.. ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+.... ......+......+.+..
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--------~~~~~~i~~~~~~~~p~~ 225 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHIAQGLRLYRPHL 225 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHHTTCCCCCCTT
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH--------HHHHHHHHhCCCCCCccc
Confidence 33 2334678999999999999999999999999999999998 8999874332 112222222221122222
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. +..+.+++.+||+.||++||||+|++++|.
T Consensus 226 ~---~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 226 A---SEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp C---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred c---cHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 2 235889999999999999999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-50 Score=407.62 Aligned_cols=256 Identities=22% Similarity=0.337 Sum_probs=208.0
Q ss_pred HHhccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 433 RATNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 433 ~~~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
...++|++.+.||+|+||+||+|.+. +|+.||||+++... ...++|.+|++++++++|||||+++|+|.+++..
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-----chHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 34578999999999999999999764 58899999987532 2356799999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++||||+++|+|.+++.... ...+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EEEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999999996543 24589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc-cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 592 LKPESSN-WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 592 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
....... .....|++.|+|||++.+..++.++|||||||++|||++|+.||..... .....+.+......+.
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-------~~~~~~~i~~~~~~~~ 237 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYELLEKDYRMER 237 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHHHHHTTCCCCC
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-------HHHHHHHHhcCCCCCC
Confidence 6544332 2345688999999999999999999999999999999997777542111 1111111111111111
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
+.. .+.++.+++.+||+.||++||||+||++.|+
T Consensus 238 ~~~---~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~ 271 (287)
T d1opja_ 238 PEG---CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271 (287)
T ss_dssp CTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred Ccc---chHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 111 2335889999999999999999999998774
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=403.39 Aligned_cols=253 Identities=19% Similarity=0.344 Sum_probs=205.2
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.++|++.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-----CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 46899999999999999999999888899999997532 235679999999999999999999998755 567899
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... ..++++..+.+++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 86 ~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccC
Confidence 99999999999886544 34589999999999999999999999 999999999999999999999999999987754
Q ss_pred CCC-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 595 ESS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 595 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
... ......|++.|+|||++.++.++.++|||||||++|||+||+.|+..... .......+........+..
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------~~~~~~~i~~~~~~~~p~~ 234 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRPDN 234 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTTCCCCCCTT
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhcCCCCCccc
Confidence 332 23445788999999999999999999999999999999996665432111 1111222222221111112
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.++.+++.+||+.||++||||+||++.|+
T Consensus 235 ---~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~ 265 (272)
T d1qpca_ 235 ---CPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (272)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 2235788999999999999999999998774
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=407.75 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=206.4
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+.|++.+.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..++|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence 4689999999999999999975 468999999997632 23456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++.... ..+++.++..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|.....
T Consensus 88 mEy~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred EecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 99999999999976432 4589999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCccccccccccccCccccc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 039322 595 ESSNWTEFAGTYGYVAPELAY-----TMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
.........||+.|+|||++. +..++.++||||+||++|||+||+.||..... ...+..+.....+.
T Consensus 163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--------~~~~~~i~~~~~~~ 234 (288)
T d2jfla1 163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--------MRVLLKIAKSEPPT 234 (288)
T ss_dssp HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--------GGHHHHHHHSCCCC
T ss_pred CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence 323334567999999999874 45578999999999999999999999974322 11122222211111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. ......+.++.+++.+||++||++|||++|+++|-+
T Consensus 235 ~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~ 271 (288)
T d2jfla1 235 L-AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271 (288)
T ss_dssp C-SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred C-CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 1 111223346889999999999999999999998744
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-50 Score=406.02 Aligned_cols=254 Identities=26% Similarity=0.314 Sum_probs=193.5
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+.|++.+.||+|+||+||+|... +|+.||||++.+... ....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL---EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 56999999999999999999764 689999999976322 12345688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC---CCCcEEEeecccccc
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD---LEYEAHVADFGIAKF 591 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~~ 591 (708)
|||++||+|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+||+++ +++.+||+|||+|+.
T Consensus 86 mE~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp ECCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EeccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 9999999999999654 3489999999999999999999999 999999999999995 478999999999986
Q ss_pred cCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 592 LKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+.
T Consensus 160 ~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~~~~~~ 230 (307)
T d1a06a_ 160 EDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--------AKLFEQILKAEYEFDS 230 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHTTCCCCCT
T ss_pred ccCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHhccCCCCCC
Confidence 6533 233456799999999999999999999999999999999999999974221 1222223332222222
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+.++.+++.+||++||++|||++|+++|-+
T Consensus 231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 266 (307)
T d1a06a_ 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 266 (307)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 222223346889999999999999999999999754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=398.28 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=204.1
Q ss_pred ccccccce-eccccCccEEEEEeC---CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 436 NDFDAQYC-IGNGGHGSVYRAELP---SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 436 ~~~~~~~~-ig~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
++|.+... ||+|+||.||+|.++ ++..||||+++... .....++|.+|++++++++|||||+++|++.. +..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc---CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 46666664 999999999999653 35579999997642 23456789999999999999999999999865 567
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
|+||||+++|+|.+++...+ ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+.
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence 89999999999999986443 4589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc---cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 039322 592 LKPESSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 592 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
....... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||..... ......+..+..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--------~~~~~~i~~~~~ 230 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFIEQGKR 230 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHHHHHHTTCC
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCC
Confidence 7544332 234568899999999999999999999999999999998 9999974322 111222222222
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.+.. .+.++.+++.+||+.||++||||.+|.+.|+
T Consensus 231 ~~~p~~---~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 231 MECPPE---CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp CCCCTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCc---CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 222122 2235788999999999999999999998875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-50 Score=402.96 Aligned_cols=251 Identities=21% Similarity=0.291 Sum_probs=204.5
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|.. .+|+.||||++.+.. .......+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH-IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHH-ccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 6799999999999999999976 579999999986421 01122356799999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|.+++...+ .+++..++.++.|++.||+|||++ +|+||||||+||++++++.+||+|||+|+.+..
T Consensus 87 mEy~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999986543 489999999999999999999999 999999999999999999999999999987754
Q ss_pred CCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 595 ESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 595 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
... ......||+.|+|||++.+..++.++||||+||++|||+||+.||..... ......+.......+..
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~~~~p~~ 232 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQKIIKLEYDFPEK 232 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTTCCCCCTT
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--------HHHHHHHHcCCCCCCcc
Confidence 322 23456799999999999999999999999999999999999999974321 12222233333222211
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQ 705 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 705 (708)
.+.++.++|.+||++||++|||++|++++
T Consensus 233 ----~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 233 ----FFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ----CCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ----CCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 12357889999999999999999996543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.1e-49 Score=407.51 Aligned_cols=254 Identities=20% Similarity=0.325 Sum_probs=212.4
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 6899999999999999999975 57999999999763 234567899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC--CCcEEEeeccccccc
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL--EYEAHVADFGIAKFL 592 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~ 592 (708)
||||++|+|.+++.... ..+++..+..++.||+.||+|||++ ||+||||||+|||++. ++.+||+|||+|+..
T Consensus 102 mE~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 102 YEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp ECCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 99999999999986433 3589999999999999999999999 9999999999999964 578999999999876
Q ss_pred CCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ....+..+.......+..
T Consensus 177 ~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~~~~~~~ 247 (350)
T d1koaa2 177 DPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKSCDWNMDDS 247 (350)
T ss_dssp CTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCSCCG
T ss_pred ccc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCcc
Confidence 543 33455789999999999999999999999999999999999999997422 122223333333333322
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+..+.+++.+||+.||++|||++|+++|=+
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~ 282 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 23333456889999999999999999999999744
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-49 Score=391.49 Aligned_cols=250 Identities=22% Similarity=0.330 Sum_probs=199.1
Q ss_pred ccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee----CCeeE
Q 039322 438 FDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH----ARHSF 512 (708)
Q Consensus 438 ~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----~~~~~ 512 (708)
|++.+.||+|+||+||+|.. .+++.||+|++.... ......+.+.+|++++++++|||||++++++.. +...+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 36677899999999999965 468899999986532 123456789999999999999999999999865 34679
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEccCCCCCeeeC-CCCcEEEeecccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPP--IVHQDISSKNLLLD-LEYEAHVADFGIA 589 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfg~a 589 (708)
+||||+++|+|.+++.... .+++..++.++.||++||+|||++ + |+||||||+|||++ +++.+||+|||+|
T Consensus 89 ivmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 9999999999999996543 489999999999999999999998 6 99999999999997 4789999999999
Q ss_pred cccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 039322 590 KFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 590 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
+.... .......||+.|+|||++.+ +++.++||||+||++|||++|+.||..... .......+.....+.
T Consensus 163 ~~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-------~~~~~~~i~~~~~~~ 232 (270)
T d1t4ha_ 163 TLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGVKPA 232 (270)
T ss_dssp GGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTTCCCG
T ss_pred eeccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-------HHHHHHHHHcCCCCc
Confidence 86432 33456789999999998865 599999999999999999999999963221 111112222211111
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
........++.+++.+||++||++|||++|+++|-+
T Consensus 233 --~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 233 --SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268 (270)
T ss_dssp --GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred --ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence 111112335789999999999999999999999754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.8e-49 Score=406.20 Aligned_cols=254 Identities=19% Similarity=0.274 Sum_probs=211.3
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|.. .+|+.||||+++.. ...+.+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc----chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 5799999999999999999965 57999999998763 234466788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC--CCCcEEEeeccccccc
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLD--LEYEAHVADFGIAKFL 592 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~a~~~ 592 (708)
||||++|+|.+++.... ..+++.+++.++.||+.||+|||++ ||+||||||+|||++ .++.+||+|||+|...
T Consensus 105 mE~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 105 LEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceec
Confidence 99999999999876443 4589999999999999999999999 999999999999997 5789999999999987
Q ss_pred CCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 593 KPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 593 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
... .......||+.|+|||++.+..++.++||||+||++|||+||+.||..... ...+..+.......+..
T Consensus 180 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~~ 250 (352)
T d1koba_ 180 NPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVKRCDWEFDED 250 (352)
T ss_dssp CTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHHCCCCCCSS
T ss_pred CCC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCcc
Confidence 644 334556799999999999999999999999999999999999999974322 12222222222222222
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.....+.++.+++.+||++||++|||++|+++|-+
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~ 285 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 22223345789999999999999999999998744
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-49 Score=397.55 Aligned_cols=257 Identities=20% Similarity=0.273 Sum_probs=212.1
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcc--hhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCD--QIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 512 (708)
+.|++.+.||+|+||+||+|.. .+|+.||||++++..... .....+.+.+|++++++++|||||++++++.+++..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 6799999999999999999976 579999999986532211 1224678999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC----cEEEeeccc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY----EAHVADFGI 588 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~ 588 (708)
+|||||++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+|++|||+
T Consensus 90 iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999997543 489999999999999999999999 999999999999998876 499999999
Q ss_pred ccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 039322 589 AKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLP 668 (708)
Q Consensus 589 a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (708)
|...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+......
T Consensus 164 a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~~~ 234 (293)
T d1jksa_ 164 AHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANVSAVNYE 234 (293)
T ss_dssp CEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTTCCC
T ss_pred hhhcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--------HHHHHHHHhcCCC
Confidence 9876543 333456789999999999999999999999999999999999999974321 2222333333332
Q ss_pred CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 669 PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 669 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.......+..+.+++++||++||++|||++|+++|-+
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 273 (293)
T d1jksa_ 235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273 (293)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 222222233456889999999999999999999998754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-49 Score=392.81 Aligned_cols=246 Identities=24% Similarity=0.367 Sum_probs=195.9
Q ss_pred ceeccccCccEEEEEeC---CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEec
Q 039322 442 YCIGNGGHGSVYRAELP---SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELL 518 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 518 (708)
++||+|+||.||+|.+. .++.||||+++... ......++|.+|++++++++|||||+++|+|.. +..++||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh--CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcC
Confidence 57999999999999654 35689999997532 223446789999999999999999999999865 4578999999
Q ss_pred cCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 039322 519 ERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN 598 (708)
Q Consensus 519 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 598 (708)
++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+........
T Consensus 90 ~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 90 ELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp TTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 9999999997543 489999999999999999999999 9999999999999999999999999999876544332
Q ss_pred ---cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 599 ---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 599 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... ......+..+...+.+..
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~~~~~~i~~~~~~~~p~~- 234 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGERMGCPAG- 234 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCCTT-
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCcc-
Confidence 233568999999999999999999999999999999998 8999974322 111122222222221122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.++.+++.+||+.||++||||+||.+.|+
T Consensus 235 --~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 235 --CPREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp --CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred --cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 2335788999999999999999999987664
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=405.18 Aligned_cols=255 Identities=22% Similarity=0.377 Sum_probs=204.1
Q ss_pred ccccccceeccccCccEEEEEeCC------CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeC
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPS------GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHA 508 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~ 508 (708)
++|++.+.||+|+||+||+|++.. ...||+|++.... .......+.+|+.++.++ +|||||++++++.++
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 689999999999999999997542 2369999987532 223456789999999998 899999999999999
Q ss_pred CeeEEEEEeccCCCHHHHhccccc--------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccC
Q 039322 509 RHSFLVYELLERGSLAAILSSDTA--------------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDI 568 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dl 568 (708)
+..++||||+++|+|.++++.... ...+++..++.++.||+.||+|||++ +|+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 999999999999999999975431 23489999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 039322 569 SSKNLLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFL 645 (708)
Q Consensus 569 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~ 645 (708)
||+||+++.++.+||+|||+|+........ .....||+.|+|||++.++.++.++|||||||++|||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876544332 234568999999999999999999999999999999998 89998743
Q ss_pred ccccccccccccccccccCCCCC-CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 646 SLISSSSLNTDIALDEILDPRLP-PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. ...+..++..... +.+.. .+.++.+||.+||+.||++||||+||+++|.
T Consensus 271 ~~--------~~~~~~~~~~~~~~~~p~~---~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PV--------DANFYKLIQNGFKMDQPFY---ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CC--------SHHHHHHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CH--------HHHHHHHHhcCCCCCCCCc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 1111111111111 11111 2235889999999999999999999999984
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=407.26 Aligned_cols=261 Identities=24% Similarity=0.353 Sum_probs=205.3
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||+||+|.. .+|+.||+|+++.... ....+++.+|++++++++|||||+++++|.+++..++
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK---PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC---TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 47899999999999999999975 4789999999976422 2345678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++.+.+ .+++..++.++.|++.||+|||+++ ||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 VmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999999997543 4899999999999999999999632 89999999999999999999999999998664
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc-----c------------c
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN-----T------------D 656 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-----~------------~ 656 (708)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||............ . .
T Consensus 157 ~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 157 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp HH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred CC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 32 224568999999999999999999999999999999999999999643211000000 0 0
Q ss_pred -----------------cccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 657 -----------------IALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 657 -----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...........+.. .....+.++.+++.+||+.||++|||++|+++|-+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf 300 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCC--CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ccccccccccccchhHHHHHhhhhccCCccC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHh
Confidence 00000000000000 00011235788999999999999999999998743
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-49 Score=400.94 Aligned_cols=249 Identities=27% Similarity=0.389 Sum_probs=203.1
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
+.|+..+.||+|+||.||+|.. .+|+.||||+++.... ......+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 4599999999999999999965 5788999999976322 2334567799999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
||||++|++..++... ..+++.+++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|.....
T Consensus 94 ~E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999998776543 3589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCccccccccccccCcccccc---CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC-C
Q 039322 595 ESSNWTEFAGTYGYVAPELAYT---MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPP-P 670 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 670 (708)
. ....||+.|+|||++.+ +.++.++|||||||++|||++|+.||..... ......+.....+. .
T Consensus 168 ~----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--------~~~~~~i~~~~~~~~~ 235 (309)
T d1u5ra_ 168 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNESPALQ 235 (309)
T ss_dssp B----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSCCCCCS
T ss_pred C----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCCCCCCC
Confidence 2 34579999999999864 4588999999999999999999999864321 11111111111111 1
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
... .+..+.+++.+||++||++|||++|+++|-
T Consensus 236 ~~~---~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp 268 (309)
T d1u5ra_ 236 SGH---WSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (309)
T ss_dssp CTT---SCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CCC---CCHHHHHHHHHHCcCChhHCcCHHHHHhCH
Confidence 111 123578899999999999999999998864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=392.41 Aligned_cols=254 Identities=23% Similarity=0.386 Sum_probs=198.9
Q ss_pred ccccccceeccccCccEEEEEeCCC-----cEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSG-----QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
.+|+..++||+|+||.||+|.++.. ..||||+++... ......+|.+|++++++++|||||+++|++.+++.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc---ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 5788999999999999999976532 369999997532 22345679999999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++||||+.+|++.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhh
Confidence 999999999999999886543 4589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc---cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 039322 591 FLKPESSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 591 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
........ .....||+.|+|||++.++.++.++|||||||++|||++|+.|+.... ........+.++..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-------~~~~~~~~i~~~~~ 231 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-------SNHEVMKAINDGFR 231 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHHHHHHTTCC
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-------CHHHHHHHHhccCC
Confidence 76543322 233467899999999999999999999999999999999766654211 11222233333322
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
++.+.. .+..+.+++.+||+.||++||||+||++.|+
T Consensus 232 ~~~~~~---~~~~l~~li~~cl~~~p~~RPt~~eil~~L~ 268 (283)
T d1mqba_ 232 LPTPMD---CPSAIYQLMMQCWQQERARRPKFADIVSILD 268 (283)
T ss_dssp CCCCTT---CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCchh---hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHH
Confidence 222222 2345889999999999999999999998774
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=397.03 Aligned_cols=254 Identities=23% Similarity=0.275 Sum_probs=212.1
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||.||+|.. .+|+.||||++++... ......+.+.+|++++++++||||+++++++.+++..|+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 47899999999999999999975 5799999999875211 112235678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++...+ .+++..++.++.|++.||+|||++ ||+||||||+|||++.+|.+||+|||+|+...
T Consensus 83 v~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred ceeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999997644 489999999999999999999999 99999999999999999999999999998766
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
.........+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+..
T Consensus 157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~~~~i~~~~~~~p~~- 227 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEEIRFPRT- 227 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCTT-
T ss_pred cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHHHHHHhcCCCCCCcc-
Confidence 555556677899999999999999999999999999999999999999974322 12222222223222222
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPT-----MKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~ 707 (708)
.+.++.++|.+||++||++||+ ++|+++|-+
T Consensus 228 ---~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 228 ---LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp ---SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred ---CCHHHHHHHHhhccCCchhhcccccccHHHHHcCcc
Confidence 1234778999999999999994 899988743
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=389.54 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=199.6
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
.++|++.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-----CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 36899999999999999999999888899999997532 235679999999999999999999999854 567899
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+++|+|..++.... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 90 ~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp ECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence 99999999999986543 24589999999999999999999999 999999999999999999999999999987653
Q ss_pred CCC-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 595 ESS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 595 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
... ......||+.|+|||++..+.++.++|||||||++|||+||+.|+..... ....+..+......+.+..
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-------~~~~~~~i~~~~~~~~~~~ 238 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVERGYRMPCPPE 238 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTTCCCCCCTT
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhcCCCCCCcc
Confidence 332 23446789999999999999999999999999999999997666542111 1111222222111111112
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.++.+++.+||+.||++||||++|++.|+
T Consensus 239 ---~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 269 (285)
T d1fmka3 239 ---CPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269 (285)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---cCHHHHHHHHHHcccCHhHCcCHHHHHHHHh
Confidence 2335889999999999999999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.7e-48 Score=384.40 Aligned_cols=257 Identities=22% Similarity=0.324 Sum_probs=209.8
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcch-----hHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeC
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQ-----IADQKEFLIEVKALTEIR-HRNIVKFYGFCSHA 508 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~-----~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~ 508 (708)
++|++.+.||+|+||+||+|+. .+|+.||||++++...... ....+.+.+|++++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999965 5789999999876432211 123456889999999997 99999999999999
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
+..|+||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999997543 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCcccccc------CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 039322 589 AKFLKPESSNWTEFAGTYGYVAPELAYT------MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEI 662 (708)
Q Consensus 589 a~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 662 (708)
++...+.. ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ......+
T Consensus 157 a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~~~~~i 227 (277)
T d1phka_ 157 SCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLMLRMI 227 (277)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH
T ss_pred eeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HHHHHHH
Confidence 98776533 3455689999999998853 3467899999999999999999999974321 1122222
Q ss_pred cCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 663 LDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 663 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.......+.......+.++.+++.+||++||++|||++|+++|=+
T Consensus 228 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~ 272 (277)
T d1phka_ 228 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272 (277)
T ss_dssp HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred HhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 222222222222233446889999999999999999999998844
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=383.49 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=196.1
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee-CCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH-ARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~~~l 513 (708)
.++|++.+.||+|+||.||+|.. .|+.||||+++++ ...++|.+|++++++++||||++++|++.+ ++..++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence 36789999999999999999988 4789999999763 234678999999999999999999999865 456899
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++..... ..+++..+++++.||+.||+|||+. +|+||||||+||+++.++.+|++|||+++...
T Consensus 79 v~ey~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp EECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC
Confidence 9999999999999975432 3489999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCc
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSR 672 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (708)
.. .....++..|+|||++.++.++.++||||||+++|||+| |+.||+.... ......+.....++.+.
T Consensus 155 ~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--------~~~~~~i~~~~~~~~~~ 223 (262)
T d1byga_ 155 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRVEKGYKMDAPD 223 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--------GGHHHHHTTTCCCCCCT
T ss_pred CC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHcCCCCCCCc
Confidence 32 234567899999999999999999999999999999998 6888764322 11122222222111111
Q ss_pred hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 673 SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 673 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
. .+.++.+++.+||+.||++||||+|++++|+
T Consensus 224 ~---~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~ 255 (262)
T d1byga_ 224 G---CPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255 (262)
T ss_dssp T---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred c---CCHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 1 2235789999999999999999999999985
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-47 Score=390.41 Aligned_cols=250 Identities=23% Similarity=0.340 Sum_probs=207.6
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||+||+|.. .+|+.||||++++.. .......+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~-~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI-VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHH-ccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 6899999999999999999976 569999999986421 01123356789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||++||++.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+....
T Consensus 83 mE~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eeecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999986544 478899999999999999999999 999999999999999999999999999987653
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
. .....||+.|+|||++.+..++.++||||+||++|||+||+.||..... ......+.......+...
T Consensus 157 ~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~~~~p~~~- 224 (316)
T d1fota_ 157 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNAELRFPPFF- 224 (316)
T ss_dssp C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHCCCCCCTTS-
T ss_pred c---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH--------HHHHHHHHcCCCCCCCCC-
Confidence 2 3456899999999999999999999999999999999999999974321 122222222222222211
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRP-----TMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~ 707 (708)
+.++.+++.+||++||++|| |++|+++|-+
T Consensus 225 ---s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~ 259 (316)
T d1fota_ 225 ---NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259 (316)
T ss_dssp ---CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred ---CHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcc
Confidence 23478899999999999996 9999998744
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=392.22 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=211.3
Q ss_pred hccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 513 (708)
.++|++.+.||+|+||+||+|... +|+.||||+++.. ..+...+.+|++++++++||||+++++++.+++..|+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 478999999999999999999764 6889999999763 1335568899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC--CcEEEeecccccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE--YEAHVADFGIAKF 591 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~a~~ 591 (708)
|||||+||+|.+++.... ..+++.+++.++.||+.||+|||++ ||+||||||+|||++.+ ..+||+|||+++.
T Consensus 79 vmE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhc
Confidence 999999999999997543 3589999999999999999999999 99999999999999854 4799999999987
Q ss_pred cCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 592 LKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
.... .......+++.|+|||...+..++.++||||+||++|+|++|+.||.... .......+.......+.
T Consensus 154 ~~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~--------~~~~~~~i~~~~~~~~~ 224 (321)
T d1tkia_ 154 LKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNAEYTFDE 224 (321)
T ss_dssp CCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCCCCH
T ss_pred cccC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCh
Confidence 6533 33455678999999999999999999999999999999999999997422 12233334444433332
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
......+.++.+++.+||++||++|||++|+++|-
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp 259 (321)
T d1tkia_ 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 22223345688999999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-47 Score=390.58 Aligned_cols=261 Identities=21% Similarity=0.383 Sum_probs=210.5
Q ss_pred HHHHHhccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEE
Q 039322 430 EIVRATNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYG 503 (708)
Q Consensus 430 ~~~~~~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~ 503 (708)
+++...++|++.+.||+|+||.||+|+.+ +++.||||+++... .....++|.+|++++++++||||+++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc---ChHHHHHHHHHHHHHHhcCCCCccccee
Confidence 33445578999999999999999999753 45789999987632 2334678999999999999999999999
Q ss_pred EEeeCCeeEEEEEeccCCCHHHHhcccc---------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 039322 504 FCSHARHSFLVYELLERGSLAAILSSDT---------------------AAQELGWSQRMNVIKGVADALSYLHHDCFPP 562 (708)
Q Consensus 504 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ 562 (708)
++..++..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ 160 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K 160 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---C
Confidence 9999999999999999999999996432 123489999999999999999999999 9
Q ss_pred eEEccCCCCCeeeCCCCcEEEeecccccccCCCCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCC-
Q 039322 563 IVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGK- 639 (708)
Q Consensus 563 ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~- 639 (708)
+|||||||+|||++.++.+||+|||+|+....... ......+++.|+|||.+.+..++.++|||||||++|||++|.
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence 99999999999999999999999999986643322 223456889999999999999999999999999999999986
Q ss_pred CCCCccccccccccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 640 HPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 640 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.||..... ......+.++..++.+... +.++.+|+.+||+.||++||||.||++.|+
T Consensus 241 ~p~~~~~~--------~e~~~~v~~~~~~~~p~~~---~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 241 QPYYGMAH--------EEVIYYVRDGNILACPENC---PLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp CTTTTSCH--------HHHHHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCH--------HHHHHHHHcCCCCCCCccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 56663321 2222333333333222222 235889999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=382.15 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=195.0
Q ss_pred ccccccceeccccCccEEEEEeCC----CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPS----GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
++|++.+.||+|+||.||+|.+.. +..||||+++... .....+.|.+|++++++++||||++++|++. ++..
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 689999999999999999997642 3568999986532 2344678999999999999999999999996 4678
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++||||+++|++.+++.... ..+++..++.++.||++||+|||++ +++||||||+||+++.++.+||+|||+|+.
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence 99999999999999876443 4589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCC
Q 039322 592 LKPESS-NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRLPP 669 (708)
Q Consensus 592 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (708)
...... ......||+.|+|||++.+..++.++|||||||++|||+| |..||..... ......+......+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--------~~~~~~i~~~~~~~ 229 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRIENGERLP 229 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHHHHTTCCCC
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence 654332 2344568899999999999999999999999999999998 8999874332 12222222222222
Q ss_pred CCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 670 PSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 670 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.. .+..+.+++.+||+.||++|||++||+++|+
T Consensus 230 ~~~~---~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~ 264 (273)
T d1mp8a_ 230 MPPN---CPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264 (273)
T ss_dssp CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCC---CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 2222 2345889999999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=382.63 Aligned_cols=255 Identities=26% Similarity=0.386 Sum_probs=194.9
Q ss_pred ccccccceeccccCccEEEEEeC--CC--cEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP--SG--QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
++|++.+.||+|+||.||+|... ++ ..||||++.+.... .....++|.+|++++++++||||++++|++.+ +..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 67999999999999999999653 22 36899998764322 22445789999999999999999999999976 467
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
++||||+++|++.+++.... ..+++..++.++.|+|.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 89999999999999886543 4589999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCc---cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 039322 592 LKPESSN---WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 592 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
....... .....++..|+|||.+.+..++.++||||||+++|||+| |+.||..... ......+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--------~~~~~~i~~~~~ 232 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKEGE 232 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTSCC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--------HHHHHHHHhCCC
Confidence 7544332 233457889999999999999999999999999999998 8999874322 122222222221
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.++. ....+..+.+++.+||+.||++||||+||.+.|+
T Consensus 233 ~~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~ 270 (273)
T d1u46a_ 233 RLPR--PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270 (273)
T ss_dssp CCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 1110 0112235889999999999999999999998874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.2e-47 Score=384.14 Aligned_cols=257 Identities=23% Similarity=0.342 Sum_probs=200.3
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR---- 509 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~---- 509 (708)
.++|++.+.||+|+||.||+|.. .+|+.||||++++.... .....+.+.+|++++++++||||+++++++...+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhcc-CHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 36799999999999999999965 57999999999864332 2344668999999999999999999999997654
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccc
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA 589 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 589 (708)
..|+||||++||+|.+++...+ .+++.+++.++.||+.||+|||++ ||+||||||+||+++.++.++++|||.+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred eEEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 3789999999999999886543 489999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCC---ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 039322 590 KFLKPESS---NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPR 666 (708)
Q Consensus 590 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (708)
........ ......||+.|+|||++.+..++.++||||+||++|||+||+.||...... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~~~~~~ 230 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--------SVAYQHVRED 230 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH--------HHHHHHHhcC
Confidence 76543322 234567999999999999999999999999999999999999999743221 1111111111
Q ss_pred CCCCCchhHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHh
Q 039322 667 LPPPSRSVQEKLISIMEVAFSCLNESPESRP-TMKVVTQQV 706 (708)
Q Consensus 667 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~l 706 (708)
..++.......+.++.+++.+||++||++|| |++++++.|
T Consensus 231 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l 271 (277)
T d1o6ya_ 231 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271 (277)
T ss_dssp CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHH
Confidence 1111111122234688999999999999999 899988765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-47 Score=388.62 Aligned_cols=254 Identities=22% Similarity=0.262 Sum_probs=203.3
Q ss_pred hccccccc-eeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEee----
Q 039322 435 TNDFDAQY-CIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSH---- 507 (708)
Q Consensus 435 ~~~~~~~~-~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~---- 507 (708)
.++|.+.. .||+|+||.||+|.. .+++.||||+++. .+.+.+|++++.++ +||||++++++|.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---------CPKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC---------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 36888765 699999999999965 5789999999864 24567899987655 89999999999875
Q ss_pred CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC---CCcEEEe
Q 039322 508 ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL---EYEAHVA 584 (708)
Q Consensus 508 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~ 584 (708)
....|+|||||+||+|.+++.... ...+++.+++.++.||+.||+|||++ ||+||||||+|||++. ++.+||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred CCEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence 457899999999999999997643 24589999999999999999999999 9999999999999986 4679999
Q ss_pred ecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC
Q 039322 585 DFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILD 664 (708)
Q Consensus 585 Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 664 (708)
|||+|+...... ......||+.|+|||++.+..++.++||||+||++|+|+||+.||........ .......+..
T Consensus 157 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~----~~~~~~~i~~ 231 (335)
T d2ozaa1 157 DFGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----SPGMKTRIRM 231 (335)
T ss_dssp CCTTCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCS
T ss_pred ccceeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH----HHHHHHHHhc
Confidence 999998765433 34556899999999999999999999999999999999999999974322111 1111122222
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 665 PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 665 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.....+.......+.++.+++.+||++||++|||++|+++|-
T Consensus 232 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 273 (335)
T d2ozaa1 232 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 273 (335)
T ss_dssp CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence 333333333444556789999999999999999999999873
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=387.78 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=198.4
Q ss_pred ccccccceeccccCccEEEEEeC-CCc----EEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCe
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQ----VVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARH 510 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 510 (708)
.+|++.+.||+|+||+||+|.+. +|+ .||+|+++... .....++|.+|++++++++|||||+++|+|.++ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 57999999999999999999654 444 58999887532 223467899999999999999999999999875 5
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.++++||+.+|+|.+++.... ..+++..+++++.|||.||+|||++ +|+||||||+||+++.++.+||+|||+|+
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred eeEEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccce
Confidence 678899999999999886543 4589999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 039322 591 FLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 591 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
........ .....||+.|+|||++.++.++.++|||||||++|||+| |+.||+..... .....+..+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--------~~~~~i~~~~~ 231 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSILEKGER 231 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--------GHHHHHHHTCC
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHcCCC
Confidence 77544333 233568999999999999999999999999999999998 78898743221 11111111111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.+.+.. .+..+.+++.+||+.||++|||++|++++|.
T Consensus 232 ~~~p~~---~~~~~~~li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 232 LPQPPI---CTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp CCCCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCcc---cCHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence 111111 2235888999999999999999999998863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=389.75 Aligned_cols=252 Identities=25% Similarity=0.328 Sum_probs=206.0
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHH-hccCCceeeEEEEEeeCCeeEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALT-EIRHRNIVKFYGFCSHARHSFL 513 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~l~~~~~~~~~~~l 513 (708)
++|++.+.||+|+||+||+|.. .+|+.||||++++... ......+.+..|..++. .++||||+++++++.+++..|+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~-~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc-cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 5799999999999999999966 4799999999864210 11123456677777665 6899999999999999999999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccC
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLK 593 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 593 (708)
||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 81 vmEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999997543 489999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCch
Q 039322 594 PESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRS 673 (708)
Q Consensus 594 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (708)
..........||+.|+|||++.+..++.++||||+||++|||+||+.||..... ......+.......+. .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~~~~p~-~ 225 (320)
T d1xjda_ 155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMDNPFYPR-W 225 (320)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCT-T
T ss_pred cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCc-c
Confidence 555556667899999999999999999999999999999999999999974322 1112222222222211 1
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHHh
Q 039322 674 VQEKLISIMEVAFSCLNESPESRPTMK-VVTQQV 706 (708)
Q Consensus 674 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~l 706 (708)
.+.++.+++.+||++||++|||+. |+++|-
T Consensus 226 ---~s~~~~dli~~~L~~dP~~R~s~~~~l~~hp 256 (320)
T d1xjda_ 226 ---LEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 256 (320)
T ss_dssp ---SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred ---CCHHHHHHHHHhcccCCCCCcCHHHHHHhCc
Confidence 123478999999999999999996 787653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.4e-47 Score=390.53 Aligned_cols=250 Identities=20% Similarity=0.245 Sum_probs=208.1
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||.||+|.+ .+|+.||||++.+.. .......+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~-~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK-VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHH-ccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 6899999999999999999976 479999999986421 01123356789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+.+|+|.+++...+ .+++..++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 120 ~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999996543 489999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCchh
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPSRSV 674 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (708)
. .....||+.|+|||++.+..++.++||||+||++|||+||+.||..... ......+.......+..
T Consensus 194 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~~~~p~~-- 260 (350)
T d1rdqe_ 194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGKVRFPSH-- 260 (350)
T ss_dssp C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCTT--
T ss_pred c---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHHHHhcCCCCCCcc--
Confidence 2 3456899999999999999999999999999999999999999974321 12222233333222221
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 039322 675 QEKLISIMEVAFSCLNESPESRP-----TMKVVTQQVR 707 (708)
Q Consensus 675 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~ 707 (708)
.+.++.+++.+||++||++|+ |++|+++|=+
T Consensus 261 --~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~ 296 (350)
T d1rdqe_ 261 --FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp --CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred --CCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcc
Confidence 123578999999999999994 9999998744
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=380.34 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=199.1
Q ss_pred cceeccccCccEEEEEeCCC----cEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee-CCeeEEEE
Q 039322 441 QYCIGNGGHGSVYRAELPSG----QVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH-ARHSFLVY 515 (708)
Q Consensus 441 ~~~ig~G~~g~vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~~~lv~ 515 (708)
.++||+|+||+||+|.+.++ ..||||+++.. ......++|.+|++++++++||||++++|++.. ++..++||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 56899999999999976432 35899998753 234556889999999999999999999999876 45889999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+++|+|.+++.... ...++..+.+++.|++.||.|+|+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 109 E~~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp ECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EEeecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 9999999999987544 4578899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc----cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 039322 596 SSN----WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPPS 671 (708)
Q Consensus 596 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (708)
... .....||+.|+|||.+.++.++.++||||||+++|||+||+.||..... .......+.....+..+
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-------~~~~~~~i~~g~~~~~p 256 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDITVYLLQGRRLLQP 256 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCCCCCC
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHcCCCCCCc
Confidence 222 2335689999999999999999999999999999999998888753211 11111222222222222
Q ss_pred chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 672 RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 672 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
... +..+.+++.+||+.||++||||.||+++|+
T Consensus 257 ~~~---~~~l~~li~~cl~~dP~~RPs~~ei~~~L~ 289 (311)
T d1r0pa_ 257 EYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289 (311)
T ss_dssp TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccC---cHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 222 235888999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6e-47 Score=393.82 Aligned_cols=254 Identities=19% Similarity=0.222 Sum_probs=200.4
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHH---HHHHHHhccCCceeeEEEEEeeCCee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLI---EVKALTEIRHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~---e~~~l~~l~h~~iv~l~~~~~~~~~~ 511 (708)
++|++.+.||+|+||.||+|.. .+|+.||||++.+... ........+.+ |+++++.++|||||++++++.+++..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHc-chhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 6899999999999999999976 4699999999864210 11111233444 46667777899999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999997543 478999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 039322 592 LKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRLPPP 670 (708)
Q Consensus 592 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (708)
.... ......||+.|+|||++.. ..++.++||||+||++|||+||+.||....... ...............+
T Consensus 157 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~ 229 (364)
T d1omwa3 157 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLTMAVELP 229 (364)
T ss_dssp CSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-----HHHHHHHSSSCCCCCC
T ss_pred cCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcccCCCCCC
Confidence 6543 2345679999999999875 468999999999999999999999997432110 0111112222222211
Q ss_pred CchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 039322 671 SRSVQEKLISIMEVAFSCLNESPESRPT-----MKVVTQQVR 707 (708)
Q Consensus 671 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~ 707 (708)
.. .+.++.++|.+||++||++||| ++|+++|-+
T Consensus 230 ~~----~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 230 DS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267 (364)
T ss_dssp SS----SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred CC----CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence 11 2235789999999999999999 799998754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=382.33 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=200.8
Q ss_pred ccccccceeccccCccEEEEEeC-CCc--EEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEeeCCee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQ--VVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSHARHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~ 511 (708)
++|++.++||+|+||.||+|.++ +|. .||||+++... .....+.|.+|+++++++ +||||++++|++.+++..
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc---ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 78999999999999999999764 344 47888876422 123456799999999999 799999999999999999
Q ss_pred EEEEEeccCCCHHHHhcccc-------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC
Q 039322 512 FLVYELLERGSLAAILSSDT-------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE 578 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~ 578 (708)
++||||+++|+|.++++... ....+++..+.+++.|||.||.|+|++ +|+||||||+|||++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 163 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCC
Confidence 99999999999999997542 235689999999999999999999999 99999999999999999
Q ss_pred CcEEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCC-CCCcccccccccccccc
Q 039322 579 YEAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKH-PRDFLSLISSSSLNTDI 657 (708)
Q Consensus 579 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~-p~~~~~~~~~~~~~~~~ 657 (708)
+.+||+|||+|+...... ......||..|+|||.+.++.++.++|||||||++|||++|.. ||..... ..
T Consensus 164 ~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~--------~~ 234 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AE 234 (309)
T ss_dssp GCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HH
T ss_pred CceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH--------HH
Confidence 999999999998654322 2234568999999999999999999999999999999999764 6653221 11
Q ss_pred ccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 658 ALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+.....++.+.. .+.++.++|.+||+.||++||||+||+++|+
T Consensus 235 ~~~~i~~~~~~~~~~~---~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 281 (309)
T d1fvra_ 235 LYEKLPQGYRLEKPLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLN 281 (309)
T ss_dssp HHHHGGGTCCCCCCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCcc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 2222222211111112 2235888999999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=380.64 Aligned_cols=257 Identities=21% Similarity=0.345 Sum_probs=194.4
Q ss_pred hccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSH 507 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~ 507 (708)
-++|++.+.||+|+||.||+|.+. +++.||||+++... .....+.+..|..++.++ +|+||+.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 478999999999999999999653 34689999987532 234456788888888877 68999999999876
Q ss_pred C-CeeEEEEEeccCCCHHHHhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCe
Q 039322 508 A-RHSFLVYELLERGSLAAILSSDTA-------------AQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNL 573 (708)
Q Consensus 508 ~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Ni 573 (708)
+ +..++|||||++|+|.+++..... ...+++.++..++.||++||+|||++ +|+||||||+||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NI 165 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 165 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccce
Confidence 5 468999999999999999975432 23489999999999999999999999 999999999999
Q ss_pred eeCCCCcEEEeecccccccCCCCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCccccccc
Q 039322 574 LLDLEYEAHVADFGIAKFLKPESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGK-HPRDFLSLISS 650 (708)
Q Consensus 574 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~-~p~~~~~~~~~ 650 (708)
|++.++.+||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||+||. .||......
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-- 243 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-- 243 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999986654333 234567999999999999999999999999999999999964 567532211
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 651 SSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+..+.....+.. .+.++.+++.+||+.||++||||+|++++|+
T Consensus 244 -----~~~~~~~~~~~~~~~~~~---~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~ 292 (299)
T d1ywna1 244 -----EEFCRRLKEGTRMRAPDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292 (299)
T ss_dssp -----HHHHHHHHHTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -----HHHHHHHhcCCCCCCCcc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 011111111111111111 1235789999999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=380.14 Aligned_cols=256 Identities=21% Similarity=0.372 Sum_probs=210.3
Q ss_pred hccccccceeccccCccEEEEEeC------CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELP------SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA 508 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 508 (708)
.++|++.+.||+|+||+||+|.+. +++.||||+++... .......|.+|++++++++||||++++|++..+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc---ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 378999999999999999999653 35789999997532 334566799999999999999999999999999
Q ss_pred CeeEEEEEeccCCCHHHHhcccc-------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcE
Q 039322 509 RHSFLVYELLERGSLAAILSSDT-------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEA 581 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~ 581 (708)
+..++||||+++|+|.+++.... ....+++..+.+++.|+|+||.|||++ +|+||||||+|||++.++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence 99999999999999999986432 123468999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCC-CCCCccccccccccccccc
Q 039322 582 HVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGK-HPRDFLSLISSSSLNTDIA 658 (708)
Q Consensus 582 kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~-~p~~~~~~~~~~~~~~~~~ 658 (708)
||+|||+|+........ .....+++.|+|||.+.++.++.++||||||+++|||+||. .||... .....
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~--------~~~~~ 244 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--------SNEQV 244 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--------CHHHH
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC--------CHHHH
Confidence 99999999866543332 23346899999999999999999999999999999999985 666532 22233
Q ss_pred cccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 659 LDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+.++...+.+... +..+.+++.+||+.||++||||+||+++|+
T Consensus 245 ~~~i~~~~~~~~p~~~---~~~l~~li~~cl~~~P~~RPs~~~il~~L~ 290 (308)
T d1p4oa_ 245 LRFVMEGGLLDKPDNC---PDMLFELMRMCWQYNPKMRPSFLEIISSIK 290 (308)
T ss_dssp HHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred HHHHHhCCCCCCcccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 3344444433322222 235889999999999999999999999885
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=376.62 Aligned_cols=261 Identities=23% Similarity=0.325 Sum_probs=197.8
Q ss_pred hccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHH--HHHHHHHhccCCceeeEEEEEeeCC---
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFL--IEVKALTEIRHRNIVKFYGFCSHAR--- 509 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~--~e~~~l~~l~h~~iv~l~~~~~~~~--- 509 (708)
..+|...+.||+|+||.||+|+. +|+.||||+++.. ....+. .|+..+.+++||||+++++++.+++
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~-------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc-------chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence 36788899999999999999987 5899999998642 223333 4555566789999999999997654
Q ss_pred -eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEccCCCCCeeeCCCCcEEE
Q 039322 510 -HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHD-----CFPPIVHQDISSKNLLLDLEYEAHV 583 (708)
Q Consensus 510 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-----~~~~ivH~dlk~~Nill~~~~~~kl 583 (708)
..++||||+++|+|.+++++. .++|..+++++.|+|.||+|+|+. +.+||+||||||+|||++.++.+||
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl 149 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 149 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred eEEEEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence 579999999999999999754 389999999999999999999973 1239999999999999999999999
Q ss_pred eecccccccCCCCC----ccccccccccccCccccccCC------CCcchhHHHHHHHHHHHHhCCCCCCccccccccc-
Q 039322 584 ADFGIAKFLKPESS----NWTEFAGTYGYVAPELAYTMK------ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS- 652 (708)
Q Consensus 584 ~Dfg~a~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~------~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~- 652 (708)
+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||..........
T Consensus 150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~ 229 (303)
T d1vjya_ 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred EecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence 99999987654332 223467999999999987542 5678999999999999999998875432211110
Q ss_pred ------cccccccccccCCCCCCCC-c--hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 653 ------LNTDIALDEILDPRLPPPS-R--SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 653 ------~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...........+....+.. . ...+....+.+++.+||+.||++||||.||+++|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~ 293 (303)
T d1vjya_ 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 0111111222222222211 1 12334566889999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-46 Score=376.62 Aligned_cols=255 Identities=22% Similarity=0.370 Sum_probs=203.0
Q ss_pred ccccccceeccccCccEEEEEeCC--------CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEe
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPS--------GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCS 506 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~ 506 (708)
++|++.+.||+|+||.||+|+... +..||||+++... ......++.+|...+.++ +|||||+++++|.
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc---ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 789999999999999999996532 3479999997643 234467889999999888 7999999999999
Q ss_pred eCCeeEEEEEeccCCCHHHHhcccc-------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCe
Q 039322 507 HARHSFLVYELLERGSLAAILSSDT-------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNL 573 (708)
Q Consensus 507 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Ni 573 (708)
+++..++||||+++|+|.+++.... ....+++.++++++.|++.||+|||++ +||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 9999999999999999999997553 224589999999999999999999999 999999999999
Q ss_pred eeCCCCcEEEeecccccccCCCCC--ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHh-CCCCCCccccccc
Q 039322 574 LLDLEYEAHVADFGIAKFLKPESS--NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIK-GKHPRDFLSLISS 650 (708)
Q Consensus 574 ll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ellt-g~~p~~~~~~~~~ 650 (708)
|++.++.+||+|||+++....... ......+++.|+|||.+.++.++.++||||||+++|||++ |..||.....
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--- 243 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 243 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---
Confidence 999999999999999987654332 2344678999999999999999999999999999999998 7888864332
Q ss_pred cccccccccccccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 651 SSLNTDIALDEILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
......+.++...+.+.. .+.++.+++.+||++||++||||+||++.|+
T Consensus 244 -----~~~~~~i~~~~~~~~p~~---~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 292 (299)
T d1fgka_ 244 -----EELFKLLKEGHRMDKPSN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292 (299)
T ss_dssp -----HHHHHHHHTTCCCCCCSS---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -----HHHHHHHHcCCCCCCCcc---chHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 111122222222211122 2235889999999999999999999999874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=380.09 Aligned_cols=261 Identities=23% Similarity=0.246 Sum_probs=196.7
Q ss_pred cceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchh-HhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEEEec
Q 039322 441 QYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQI-ADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVYELL 518 (708)
Q Consensus 441 ~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 518 (708)
.++||+|+||+||+|.. .+|+.||||+++........ ...+.+.+|++++++++|||||++++++.++++.|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 46799999999999976 46899999999763221111 11346889999999999999999999999999999999999
Q ss_pred cCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCCCCc
Q 039322 519 ERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPESSN 598 (708)
Q Consensus 519 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 598 (708)
.++++..+.... ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+........
T Consensus 83 ~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 998777665433 3488899999999999999999999 9999999999999999999999999999877655555
Q ss_pred cccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------------cccccccccc-cc
Q 039322 599 WTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS-------------SLNTDIALDE-IL 663 (708)
Q Consensus 599 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~-------------~~~~~~~~~~-~~ 663 (708)
.....||+.|+|||++... .++.++||||+||++|||+||+.||......... .......... ..
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 5567899999999988754 5789999999999999999999999743221100 0000000000 00
Q ss_pred CCCCCCCCc--hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 664 DPRLPPPSR--SVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 664 ~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....+.... ........+.+++.+||+.||++|||++|+++|=+
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 282 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence 001111000 00112346889999999999999999999998743
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=377.31 Aligned_cols=264 Identities=23% Similarity=0.321 Sum_probs=201.8
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||+||+|.. .+|+.||||+++... ......+++.+|++++++++||||+++++++.+++..|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh--cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 5899999999999999999965 579999999997532 1222356789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
|||+.++ +.+++.... ...+++..++.++.|++.||+|||++ |||||||||+|||++.++.+||+|||.|+....
T Consensus 80 ~e~~~~~-~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 80 FEFLHQD-LKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp EECCSEE-HHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred EeecCCc-hhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccC
Confidence 9999764 444443322 24589999999999999999999999 999999999999999999999999999988766
Q ss_pred CCCccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccc----------ccccccccccccc
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISS----------SSLNTDIALDEIL 663 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~p~~~~~~~~~----------~~~~~~~~~~~~~ 663 (708)
.........||+.|+|||.+.... ++.++||||+||++|+|++|+.||+....... .............
T Consensus 155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 555566678999999999877665 57899999999999999999999974321100 0000000000000
Q ss_pred --CCCCCC-CCch----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 664 --DPRLPP-PSRS----VQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 664 --~~~~~~-~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
....+. .... .......+.+++.+||+.||++|||++|+++|=
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ 284 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 284 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCH
Confidence 000000 0000 011224678899999999999999999999974
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-46 Score=379.07 Aligned_cols=256 Identities=21% Similarity=0.382 Sum_probs=206.5
Q ss_pred hccccccceeccccCccEEEEEe------CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc-cCCceeeEEEEEee
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL------PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI-RHRNIVKFYGFCSH 507 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~ 507 (708)
.++|++.+.||+|+||.||+|++ .+++.||||+++... ......+|.+|+.+++++ +|||||+++|++.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 37899999999999999999965 346789999997632 334567899999999999 69999999999999
Q ss_pred CCeeEEEEEeccCCCHHHHhcccc---------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 039322 508 ARHSFLVYELLERGSLAAILSSDT---------------AAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKN 572 (708)
Q Consensus 508 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~N 572 (708)
++..++||||+++|+|.+++.... ....+++..+..++.||++||+|||++ +++||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 999999999999999999996543 223589999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeecccccccCCCCCc--cccccccccccCccccccCCCCcchhHHHHHHHHHHHHhC-CCCCCcccccc
Q 039322 573 LLLDLEYEAHVADFGIAKFLKPESSN--WTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKG-KHPRDFLSLIS 649 (708)
Q Consensus 573 ill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg-~~p~~~~~~~~ 649 (708)
|+++.++.+|++|||.++........ .....||+.|+|||.+.++.++.++||||||+++|||+|+ ..||.....
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~-- 253 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-- 253 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS--
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH--
Confidence 99999999999999999876544332 2346789999999999999999999999999999999995 555542211
Q ss_pred ccccccccccccccCCCCCCC-CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 650 SSSLNTDIALDEILDPRLPPP-SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
...+..++.....+. +.. .+..+.+|+.+||+.||++||||+||++.|+
T Consensus 254 ------~~~~~~~i~~~~~~~~~~~---~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 254 ------DSKFYKMIKEGFRMLSPEH---APAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (311)
T ss_dssp ------SHHHHHHHHHTCCCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ------HHHHHHHHhcCCCCCCccc---ccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 111112211111111 111 2235889999999999999999999999884
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-45 Score=374.16 Aligned_cols=264 Identities=23% Similarity=0.313 Sum_probs=201.9
Q ss_pred ccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLVY 515 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 515 (708)
++|++.+.||+|+||+||+|.+++|+.||||+++... ......+.+.+|+.++++++||||+++++++..++..++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSS--GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhh--cChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 5899999999999999999998899999999997642 22233578999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCCC
Q 039322 516 ELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKPE 595 (708)
Q Consensus 516 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 595 (708)
||+.++.+..+.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||.|......
T Consensus 80 e~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp ECCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EeehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 999887776665433 4589999999999999999999999 9999999999999999999999999999887655
Q ss_pred CCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccc-------------cc---cccccc
Q 039322 596 SSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISS-------------SS---LNTDIA 658 (708)
Q Consensus 596 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~-------------~~---~~~~~~ 658 (708)
........+++.|+|||.+.+. .++.++||||+||++|||++|+.||........ .. ......
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 5555566789999999988754 468999999999999999999999974321100 00 000000
Q ss_pred cccccCCCCCCC-CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 659 LDEILDPRLPPP-SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 659 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.........+.+ ..........+.+++++||+.||++|||++|+++|-+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~ 283 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 000000000000 0011112245789999999999999999999998754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-46 Score=371.70 Aligned_cols=246 Identities=23% Similarity=0.355 Sum_probs=198.5
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcc--hhHhHHHHHHHHHHHHhcc--CCceeeEEEEEeeCCe
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCD--QIADQKEFLIEVKALTEIR--HRNIVKFYGFCSHARH 510 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~--h~~iv~l~~~~~~~~~ 510 (708)
++|++.+.||+|+||+||+|.. .+|+.||||++++..... ......++.+|+.++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 6899999999999999999965 579999999987532111 1122344678999999996 8999999999999999
Q ss_pred eEEEEEeccC-CCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC-CcEEEeeccc
Q 039322 511 SFLVYELLER-GSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLE-YEAHVADFGI 588 (708)
Q Consensus 511 ~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~ 588 (708)
.++||||+.+ +++.+++... ..+++.+++.++.|++.||+|||++ ||+||||||+||+++.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 9999999986 5788887643 3489999999999999999999999 99999999999999854 7999999999
Q ss_pred ccccCCCCCccccccccccccCccccccCCC-CcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 039322 589 AKFLKPESSNWTEFAGTYGYVAPELAYTMKI-TEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 589 a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
|+.... .......||+.|+|||++.+..+ +.++||||+||++|||+||+.||+...... ....
T Consensus 158 a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~--------------~~~~ 221 (273)
T d1xwsa_ 158 GALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------------RGQV 221 (273)
T ss_dssp CEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------------HCCC
T ss_pred ceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh--------------hccc
Confidence 986543 23455689999999999987765 567899999999999999999997432110 0111
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..+.. .+.++.+++.+||++||++|||++|+++|-+
T Consensus 222 ~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 222 FFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred CCCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 11111 1235788999999999999999999998754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=369.71 Aligned_cols=265 Identities=20% Similarity=0.297 Sum_probs=196.7
Q ss_pred hccccccceeccccCccEEEEEe-CC-CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhc---cCCceeeEEEEEee--
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PS-GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEI---RHRNIVKFYGFCSH-- 507 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~~-- 507 (708)
.++|++.+.||+|+||+||+|.+ ++ ++.||||+++...... .....+.+|+++++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc--hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 47899999999999999999976 34 6679999986532111 1223456677777666 79999999999853
Q ss_pred ---CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEe
Q 039322 508 ---ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVA 584 (708)
Q Consensus 508 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~ 584 (708)
....+++|||+.+|++....... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cccCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeec
Confidence 34689999999987766554332 24589999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccc-------------
Q 039322 585 DFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSS------------- 651 (708)
Q Consensus 585 Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~------------- 651 (708)
|||++..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.........
T Consensus 159 dfg~~~~~~~-~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 159 DFGLARIYSF-QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp SCCSCCCCCG-GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred chhhhhhhcc-cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 9999975432 23345678999999999999999999999999999999999999999743211000
Q ss_pred ccccccc-ccccc-CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 652 SLNTDIA-LDEIL-DPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 652 ~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
....... ..... .....+...........+.+|+.+||++||++|||++|+++|-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf 295 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 0000000 00000 00000000111112235778999999999999999999998854
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-43 Score=354.07 Aligned_cols=264 Identities=19% Similarity=0.261 Sum_probs=206.8
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCCeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 514 (708)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ......+++.+|+.+++.++||||+++++++.+++..++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC--SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh--CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 5799999999999999999965 578999999997543 2234567899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccccccCC
Q 039322 515 YELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAKFLKP 594 (708)
Q Consensus 515 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 594 (708)
+|++.++++..++... +.+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.|+....
T Consensus 80 ~~~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp EECCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eeeccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccC
Confidence 9999999988887654 3478999999999999999999999 999999999999999999999999999998766
Q ss_pred CCCccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccc--------------ccccccccc
Q 039322 595 ESSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISS--------------SSLNTDIAL 659 (708)
Q Consensus 595 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~p~~~~~~~~~--------------~~~~~~~~~ 659 (708)
.........++..|+|||.+.... ++.++||||+||++|||++|+.||........ .........
T Consensus 154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 555555667889999999887665 68999999999999999999999632111000 000000000
Q ss_pred ccccC----CCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 660 DEILD----PRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 660 ~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
..... +...............+.+++.+|++.||++|||++|+++|=+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~ 285 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChh
Confidence 00000 0000111111122335778999999999999999999998754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=367.55 Aligned_cols=258 Identities=22% Similarity=0.298 Sum_probs=203.7
Q ss_pred ccccccceeccccCccEEEEEe----CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccC-CceeeEEEEEeeCCe
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL----PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH-RNIVKFYGFCSHARH 510 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~~ 510 (708)
++|++.+.||+|+||+||+|.. .+|+.||||++++..........+.+.+|++++++++| |||+++++++.++..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999964 24789999998753222222335668889999999977 899999999999999
Q ss_pred eEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 511 SFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 511 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
.+++|||+.+|+|.+++...+ .+++..+..++.|++.|++|+|++ +|+||||||+||+++.++.+||+|||+|.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999997554 368899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC-CccccccccccccCccccccC--CCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 039322 591 FLKPES-SNWTEFAGTYGYVAPELAYTM--KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEILDPRL 667 (708)
Q Consensus 591 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (708)
.+.... .......|++.|+|||.+.+. .++.++||||+||++|||++|+.||........ .............
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~----~~~i~~~~~~~~~ 253 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISRRILKSEP 253 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHHHHHHCCC
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhcccCCC
Confidence 664332 233456789999999998754 467899999999999999999999974332111 1111111112222
Q ss_pred CCCCchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 039322 668 PPPSRSVQEKLISIMEVAFSCLNESPESRP-----TMKVVTQQVR 707 (708)
Q Consensus 668 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~ 707 (708)
+.+. ..+..+.+++.+||++||++|| |++|+++|-+
T Consensus 254 ~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 254 PYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp CCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred CCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence 2111 1234588899999999999999 5899998754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-43 Score=363.54 Aligned_cols=262 Identities=21% Similarity=0.262 Sum_probs=195.8
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR---- 509 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~---- 509 (708)
+.+|++.+.||+|+||+||+|.. .+|+.||||++++.. .....+.+.+|+++|++++||||+++++++..+.
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 36799999999999999999964 589999999997532 2344678899999999999999999999997653
Q ss_pred eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeecccc
Q 039322 510 HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGIA 589 (708)
Q Consensus 510 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 589 (708)
..+++++|+.+|+|.+++... .+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+|
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence 235556677799999999643 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---ccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccc-------c---
Q 039322 590 KFLKPESS---NWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLN-------T--- 655 (708)
Q Consensus 590 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~-------~--- 655 (708)
........ ......||+.|+|||++.. ..++.++||||+||++|||++|+.||............ .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 86643322 2344678999999998754 55788999999999999999999999743211000000 0
Q ss_pred -------ccccccccCCCCCCCC--chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 656 -------DIALDEILDPRLPPPS--RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 656 -------~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.........+...... ........++.+++.+|++.||++|||++|+++|=
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hp 296 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 296 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 0000000000100000 00011123578999999999999999999999873
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-43 Score=362.69 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=193.4
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeCC-----
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHAR----- 509 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 509 (708)
++|++.+.||+|+||+||+|.. .+|+.||||+++.... .....+.+.+|+++|++++|||||+++++|...+
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS--SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc--ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 6899999999999999999965 5699999999986432 2345678999999999999999999999997654
Q ss_pred -eeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 510 -HSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 510 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
+.|+||||+ +++|..+.+. ..+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 469999999 5578877653 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCccccccccc---------------
Q 039322 589 AKFLKPESSNWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS--------------- 652 (708)
Q Consensus 589 a~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~--------------- 652 (708)
|+.... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||..........
T Consensus 168 a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 168 ARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 987643 23456789999999998764 46889999999999999999999997432110000
Q ss_pred -ccc--ccccccccCC-CCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 653 -LNT--DIALDEILDP-RLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 653 -~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
... .......... ...............+.+|+.+||..||++|||++|+++|=+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~ 303 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 000 0000000000 000000000111234678999999999999999999998743
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=363.66 Aligned_cols=259 Identities=24% Similarity=0.237 Sum_probs=192.9
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC------
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA------ 508 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------ 508 (708)
.+|+..++||+|+||+||+|+. .+|+.||||++..... .+.+|++++++++||||++++++|...
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 4788899999999999999976 4699999999976321 123699999999999999999998543
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-cEEEeecc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY-EAHVADFG 587 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg 587 (708)
.+.++||||+++|.+............+++.+++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEeccc
Confidence 35789999998764444433333345689999999999999999999999 999999999999999775 89999999
Q ss_pred cccccCCCCCccccccccccccCcccccc-CCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc-------cccccc-
Q 039322 588 IAKFLKPESSNWTEFAGTYGYVAPELAYT-MKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS-------LNTDIA- 658 (708)
Q Consensus 588 ~a~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~-------~~~~~~- 658 (708)
++....... ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.......... ......
T Consensus 169 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 169 SAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp TCEECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred chhhccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence 998765433 3345679999999998765 468999999999999999999999997432111000 000000
Q ss_pred ---cccccCCCC---CCCC---chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 659 ---LDEILDPRL---PPPS---RSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 659 ---~~~~~~~~~---~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.....+..+ .... .........+.+|+.+||+.||++|||++|+++|=
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 304 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 000001111 0000 00011223578899999999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=355.93 Aligned_cols=264 Identities=21% Similarity=0.278 Sum_probs=195.6
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee------
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH------ 507 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~------ 507 (708)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... ......++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 37899999999999999999975 5799999999876422 22345678899999999999999999999855
Q ss_pred --CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEee
Q 039322 508 --ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVAD 585 (708)
Q Consensus 508 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~D 585 (708)
++..++||||+.++.+..+.... ..++...++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred ccCceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeee
Confidence 34689999999887766554332 4588999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCC----ccccccccccccCccccccC-CCCcchhHHHHHHHHHHHHhCCCCCCcccccccccc-------
Q 039322 586 FGIAKFLKPESS----NWTEFAGTYGYVAPELAYTM-KITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL------- 653 (708)
Q Consensus 586 fg~a~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~------- 653 (708)
||++........ ......||+.|+|||++.+. .++.++||||+||++|||++|+.||+..........
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999986653322 22335689999999998765 588999999999999999999999974221110000
Q ss_pred --------ccccccccccCCCCCCCCchhHH------HHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 --------NTDIALDEILDPRLPPPSRSVQE------KLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 --------~~~~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
............. ........+ ....+.+|+.+||+.||++|||++|+++|=+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELV-KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp CCTTTSTTCCCC-------CC-SSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CChhhccccchhhhhhhhccc-ccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 0000000000000 000111111 1235678999999999999999999999854
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.2e-42 Score=354.02 Aligned_cols=255 Identities=20% Similarity=0.279 Sum_probs=197.1
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeC--Cee
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHA--RHS 511 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~--~~~ 511 (708)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|++++ ||||+++++++..+ ...
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 6899999999999999999976 57899999998752 2467889999999995 99999999999754 568
Q ss_pred EEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-cEEEeeccccc
Q 039322 512 FLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY-EAHVADFGIAK 590 (708)
Q Consensus 512 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~ 590 (708)
++||||+.+|+|.++. +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus 108 ~~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred eEEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccce
Confidence 9999999999997764 3489999999999999999999999 999999999999998765 68999999998
Q ss_pred ccCCCCCccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCccccccc-------------------
Q 039322 591 FLKPESSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISS------------------- 650 (708)
Q Consensus 591 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~p~~~~~~~~~------------------- 650 (708)
...... ......+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||........
T Consensus 179 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 179 FYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp ECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred eccCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 765433 335567899999999987654 78999999999999999999999864221000
Q ss_pred -cccccccccccccCCCCC------CCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 651 -SSLNTDIALDEILDPRLP------PPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 651 -~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.................. ...........++.+|+.+|++.||++|||++|+++|=+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 321 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 000000000011100000 000011112335788999999999999999999999754
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-42 Score=351.17 Aligned_cols=256 Identities=19% Similarity=0.266 Sum_probs=192.3
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCc-eeeEEEEEeeCCeeEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRN-IVKFYGFCSHARHSFL 513 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~l~~~~~~~~~~~l 513 (708)
++|++.+.||+|+||.||+|.+ .+|+.||||++.... ..+++..|++++++++|++ |+.+.+++.+++..++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~------~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT------TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc------cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 5799999999999999999965 568999999987532 1234778999999998765 5555666678889999
Q ss_pred EEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC---CCcEEEeeccccc
Q 039322 514 VYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL---EYEAHVADFGIAK 590 (708)
Q Consensus 514 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~ 590 (708)
||||+. |++.+.+.... ..+++..+..++.|++.||+|||++ ||+||||||+||+++. +..+|++|||+|+
T Consensus 81 vme~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 81 VMELLG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEECCC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEEcC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 999994 56766664333 4589999999999999999999999 9999999999999864 4579999999999
Q ss_pred ccCCCCC-------ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 039322 591 FLKPESS-------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALDEIL 663 (708)
Q Consensus 591 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 663 (708)
.+..... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||................ ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~-~~~~ 233 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-EKKM 233 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH-HHHH
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh-cccC
Confidence 7754322 1234579999999999999999999999999999999999999997433211111000000 0000
Q ss_pred CCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 664 DPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 664 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
.. +........+.++.+++.+||+.+|++||+++++.+.|+
T Consensus 234 ~~---~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 274 (299)
T d1ckia_ 234 ST---PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274 (299)
T ss_dssp HS---CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred CC---ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 00 000001112345889999999999999999998876653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-42 Score=355.98 Aligned_cols=261 Identities=21% Similarity=0.284 Sum_probs=193.6
Q ss_pred ccccccceeccccCccEEEEEeC-CCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEee------C
Q 039322 436 NDFDAQYCIGNGGHGSVYRAELP-SGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSH------A 508 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~------~ 508 (708)
++|++.+.||+|+||+||+|.+. +|+.||||++..... .....+.+.+|+.++++++||||++++++|.. .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc--CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 67999999999999999999764 699999999976432 23455678999999999999999999999964 3
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
.+.|+||||+.++.+. .+. ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|||+
T Consensus 95 ~~~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp CEEEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred ceeEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence 6789999999775554 442 3479999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc--------------cc
Q 039322 589 AKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS--------------LN 654 (708)
Q Consensus 589 a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~--------------~~ 654 (708)
++..... .......+|+.|+|||++.+..++.++||||+||++|||++|+.||.......... ..
T Consensus 166 ~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 166 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hhccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 8865432 33455678999999999999999999999999999999999999996322110000 00
Q ss_pred cccccc----------------cccCCCCCCCCchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhC
Q 039322 655 TDIALD----------------EILDPRLPPPSRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQVRI 708 (708)
Q Consensus 655 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 708 (708)
...... ...+................+.+|+.+|++.||++|||++|+++|=++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~ 314 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 000000 000111112222334456678899999999999999999999998543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.4e-42 Score=345.88 Aligned_cols=255 Identities=18% Similarity=0.243 Sum_probs=199.1
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccC-CceeeEEEEEeeCCeeE
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH-RNIVKFYGFCSHARHSF 512 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~~~~ 512 (708)
.++|++.+.||+|+||.||+|.+ .+|+.||||++.... ..+.+.+|++.++.++| +|++.+++++..+...+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT------TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc------CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 36899999999999999999975 468999999986532 22346778899999975 89999999999999999
Q ss_pred EEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-----CCcEEEeecc
Q 039322 513 LVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDL-----EYEAHVADFG 587 (708)
Q Consensus 513 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg 587 (708)
+||||+ +++|.+++.... ..+++.++..++.|++.||+|||++ ||+||||||+||+++. ++.+||+|||
T Consensus 78 ~vme~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccc
Confidence 999999 679999886543 4589999999999999999999999 9999999999999975 5789999999
Q ss_pred cccccCCCCC-------ccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 039322 588 IAKFLKPESS-------NWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSLNTDIALD 660 (708)
Q Consensus 588 ~a~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 660 (708)
+|+.+..... ......||+.|+|||++.+..++.++||||||+++|||+||+.||......... ....
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~-----~~~~ 226 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-----QKYE 226 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-----HHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH-----HHHH
Confidence 9987653321 223467999999999999999999999999999999999999999743221110 0001
Q ss_pred cccCCCCCCC-CchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 039322 661 EILDPRLPPP-SRSVQEKLISIMEVAFSCLNESPESRPTMKVVTQQV 706 (708)
Q Consensus 661 ~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 706 (708)
.+...+...+ .......+.++.+++..|++.+|++||+++.+.+.|
T Consensus 227 ~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l 273 (293)
T d1csna_ 227 RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273 (293)
T ss_dssp HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred HHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 1100000000 000011224588899999999999999998887765
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=354.05 Aligned_cols=261 Identities=21% Similarity=0.297 Sum_probs=196.5
Q ss_pred hccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCceeeEEEEEeeC-----
Q 039322 435 TNDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNIVKFYGFCSHA----- 508 (708)
Q Consensus 435 ~~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~----- 508 (708)
.++|++.+.||+|+||+||+|.. .+|+.||||++++.. ......+++.+|++++++++||||+++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 46899999999999999999965 579999999998643 2334566789999999999999999999998643
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEeeccc
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVADFGI 588 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 588 (708)
...+++++|+.+|+|.+++... .+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|||.
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred CceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccch
Confidence 3456778888999999998643 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCccccccCC-CCcchhHHHHHHHHHHHHhCCCCCCcccccccccc--------------
Q 039322 589 AKFLKPESSNWTEFAGTYGYVAPELAYTMK-ITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSSL-------------- 653 (708)
Q Consensus 589 a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~~-------------- 653 (708)
|.... .......|++.|+|||...+.. ++.++||||+||++|+|++|+.||...........
T Consensus 168 a~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 168 ARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp --CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hcccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 97543 2334567899999999876654 68899999999999999999999974321100000
Q ss_pred -ccccccccccCCCCCCCCchh----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 039322 654 -NTDIALDEILDPRLPPPSRSV----QEKLISIMEVAFSCLNESPESRPTMKVVTQQVR 707 (708)
Q Consensus 654 -~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 707 (708)
................+.... ......+.+|+.+|++.||++|||++|+++|=+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~ 303 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence 000000000000000000000 112245788999999999999999999998744
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.1e-37 Score=321.08 Aligned_cols=262 Identities=18% Similarity=0.209 Sum_probs=191.7
Q ss_pred ccccccceeccccCccEEEEEe-CCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-----------CCceeeEEE
Q 039322 436 NDFDAQYCIGNGGHGSVYRAEL-PSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-----------HRNIVKFYG 503 (708)
Q Consensus 436 ~~~~~~~~ig~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~l~~ 503 (708)
++|++.+.||+|+||+||+|+. .+|+.||||++++. ....+.+.+|++++++++ |+||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 4599999999999999999975 57999999999862 233467788998888875 578999998
Q ss_pred EEee--CCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC--
Q 039322 504 FCSH--ARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEY-- 579 (708)
Q Consensus 504 ~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~-- 579 (708)
++.. ....+++++++..+..............+++..++.++.||+.|++|||+.. ||+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcc
Confidence 8864 3566777777766654443333344456899999999999999999999832 999999999999998665
Q ss_pred ----cEEEeecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHHHHHHhCCCCCCccccccccc---
Q 039322 580 ----EAHVADFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLVLEAIKGKHPRDFLSLISSSS--- 652 (708)
Q Consensus 580 ----~~kl~Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~elltg~~p~~~~~~~~~~~--- 652 (708)
.++++|||.|..... ......||+.|+|||++.+..++.++||||+||++++|++|+.||..........
T Consensus 166 ~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cccceeeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 399999999986542 2244679999999999999999999999999999999999999997432110000
Q ss_pred ----------ccccc------ccccccC-----CCCCC------------CCchhHHHHHHHHHHHHhccCCCCCCCCCH
Q 039322 653 ----------LNTDI------ALDEILD-----PRLPP------------PSRSVQEKLISIMEVAFSCLNESPESRPTM 699 (708)
Q Consensus 653 ----------~~~~~------~~~~~~~-----~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 699 (708)
..... ......+ ..... ...........+.+|+.+|+..||++|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 00000 0000000 00000 011223455678899999999999999999
Q ss_pred HHHHHHhh
Q 039322 700 KVVTQQVR 707 (708)
Q Consensus 700 ~evl~~l~ 707 (708)
+|+++|=+
T Consensus 323 ~e~L~Hp~ 330 (362)
T d1q8ya_ 323 GGLVNHPW 330 (362)
T ss_dssp HHHHTCGG
T ss_pred HHHhcCcc
Confidence 99999743
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=3.3e-30 Score=263.68 Aligned_cols=253 Identities=25% Similarity=0.437 Sum_probs=148.7
Q ss_pred CcEEEccCCccccc--cccccCCCCCCCEEEccc-CcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEe
Q 039322 99 LIRVRLNSNNLTGN--ISEALGIYPNLTFIDLSR-NDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALD 175 (708)
Q Consensus 99 L~~L~l~~n~i~~~--~~~~~~~~~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 175 (708)
++.|+|++|.+++. .+..++++++|++|+|++ |++.+..|..|.++++|++|+|++|++.+..+..+..+..|+.++
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~ 131 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence 34444444444431 234444444444444443 444444444455555555555555555555555555555555555
Q ss_pred cccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCC-CeEeccCCcccccCCCCCCccccceeecccCcccc
Q 039322 176 LSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDL-EYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFV 254 (708)
Q Consensus 176 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L-~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~ 254 (708)
+++|.+.+.+|..+.++++|+.+++++|.+++.+|..+..+.++ +.+++++|++++..+..+..+..+ .+++++|...
T Consensus 132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~ 210 (313)
T d1ogqa_ 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE 210 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred cccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence 55555555555555555555555555555555555555555443 555556666655555555544333 4666666666
Q ss_pred cCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCCCCCccc
Q 039322 255 LELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGPVPNSTA 334 (708)
Q Consensus 255 ~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~ 334 (708)
+..|..+..+++++.|++++|.+.+.++ .+..+++|+.|+|++|++++.+|..+..+++|+.|+|++|+++|.+|....
T Consensus 211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~ 289 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred cccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCccc
Confidence 6666666666666666666666664433 456667777777777777777777777777777777777777776676666
Q ss_pred cccCcccccccccCcCCCC
Q 039322 335 FRNAPVEALKGNKGLCGGV 353 (708)
Q Consensus 335 ~~~~~~~~~~~n~~~c~~~ 353 (708)
+..++.+.+.+|+..||.|
T Consensus 290 L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 290 LQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp GGGSCGGGTCSSSEEESTT
T ss_pred CCCCCHHHhCCCccccCCC
Confidence 7777777888888888875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=2e-29 Score=257.83 Aligned_cols=252 Identities=27% Similarity=0.436 Sum_probs=184.4
Q ss_pred CccEEeccCCcccc--ccCccCcCCCCCcEEEccC-CccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEE
Q 039322 74 ALQYFGVSENHFQG--TIPKILRNCSSLIRVRLNS-NNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTL 150 (708)
Q Consensus 74 ~L~~L~l~~n~i~~--~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 150 (708)
+++.|+|++|.+++ .+|..++++++|++|+|++ |++++..|..|+++++|++|+|++|++.++.+..+..+..|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 57777777777766 3567777777777777775 67776666777777777777777777777777777777777777
Q ss_pred EcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCC-CEEEccCccccccCCcccCCCCCCCeEeccCCcc
Q 039322 151 NVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSL-TELILRGNQFTGRLPPEIGSLVDLEYLDLSANRF 229 (708)
Q Consensus 151 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i 229 (708)
++++|.+....|..+..++.|+.+++++|.+.+.+|..+..+.++ +.+++++|++++..+..+..+.. ..+++++|.+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence 777777777777777777777777777777777777777766654 67777777777777766665543 3677777777
Q ss_pred cccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcc
Q 039322 230 NNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCF 309 (708)
Q Consensus 230 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~ 309 (708)
.+..|..+..+++|+.|++++|.+.+.+ ..+..+++|+.|+|++|++++.+|..+..+++|++|+|++|+|++.+|. +
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~ 287 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-G 287 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-S
T ss_pred cccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-c
Confidence 7777777777777777777777777543 3466677777788888877777777777778888888888888776664 4
Q ss_pred cccccccEEecCCCc-CCCC
Q 039322 310 EGIRGISVIDISDNQ-LQGP 328 (708)
Q Consensus 310 ~~l~~L~~l~l~~N~-l~~~ 328 (708)
..+.+|+.+++++|+ ++|.
T Consensus 288 ~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 288 GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp TTGGGSCGGGTCSSSEEEST
T ss_pred ccCCCCCHHHhCCCccccCC
Confidence 667777778888776 4553
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=2.1e-28 Score=258.03 Aligned_cols=322 Identities=23% Similarity=0.293 Sum_probs=200.2
Q ss_pred CCCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEec
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGV 80 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l 80 (708)
|.+|++|++++|+|+.+ +.+..+++|++|+|++|+|++..+ .-..++|+.|++++|.+.+.. .+..+++|+.|++
T Consensus 43 l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~-l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~ 117 (384)
T d2omza2 43 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTL 117 (384)
T ss_dssp HTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEEC
T ss_pred hCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCcc-ccCCccccccccccccccccc--ccccccccccccc
Confidence 35788888888888854 457788888888888888875432 223377888888888887643 3777888888888
Q ss_pred cCCccccccCccCcCCCCCcEEEccCCccccccc-------------------cccCCCCCCCEEEcccCcceeeCCCCC
Q 039322 81 SENHFQGTIPKILRNCSSLIRVRLNSNNLTGNIS-------------------EALGIYPNLTFIDLSRNDFYGEISSNW 141 (708)
Q Consensus 81 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-------------------~~~~~~~~L~~L~l~~n~l~~~~~~~~ 141 (708)
+++.+++..+ ......+..+....|.+..... ..+.............|... ....+
T Consensus 118 ~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 193 (384)
T d2omza2 118 FNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS--DISVL 193 (384)
T ss_dssp CSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCC--CCGGG
T ss_pred cccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccc--ccccc
Confidence 8888775433 3344566666665555432211 11222223333333333321 12334
Q ss_pred CCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCe
Q 039322 142 GKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEY 221 (708)
Q Consensus 142 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~ 221 (708)
..+++++.+++++|.++...+ +..+++|++|++++|+++.. ..+..+++|+.|++++|.+++.. .+..+++|++
T Consensus 194 ~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~ 267 (384)
T d2omza2 194 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTE 267 (384)
T ss_dssp GGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSE
T ss_pred ccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--cccccccCCE
Confidence 556677777777777664432 34556677777777776632 34566677777777777766432 3566677777
Q ss_pred EeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccc
Q 039322 222 LDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNL 301 (708)
Q Consensus 222 L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l 301 (708)
|++++|++++.. .+..++.++.+++++|.+++ ...+..+++++.|++++|++++.. .+..+++|+.|++++|++
T Consensus 268 L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l 341 (384)
T d2omza2 268 LKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKV 341 (384)
T ss_dssp EECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCC
T ss_pred eeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCC
Confidence 777777776432 25556667777777777663 234666667777777777776443 256667777777777777
Q ss_pred cCCCCCcccccccccEEecCCCcCCCCCCCccccccCcccccccc
Q 039322 302 SGSIPNCFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGN 346 (708)
Q Consensus 302 ~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n 346 (708)
++ ++ .+..+++|+.|++++|++++.+| ...+++++.+.+++|
T Consensus 342 ~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 342 SD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp CC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 63 23 46667777777777777776544 344556666666655
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=4.8e-27 Score=239.05 Aligned_cols=264 Identities=20% Similarity=0.187 Sum_probs=177.0
Q ss_pred ccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcc
Q 039322 54 PGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDF 133 (708)
Q Consensus 54 l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l 133 (708)
++.+++.+++ +|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+..+.+..|.++++|++|++++|++
T Consensus 15 ~~C~~~~L~~-lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l 91 (305)
T d1xkua_ 15 VQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91 (305)
T ss_dssp EECTTSCCCS-CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCC
T ss_pred EEecCCCCCc-cCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCcc
Confidence 3344444443 343442 4577777777777755555677777777777777777777677777777777777777777
Q ss_pred eeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEeccccccc--ccCCcccCCCCCCCEEEccCccccccCCc
Q 039322 134 YGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIV--GEIPKELGKLNSLTELILRGNQFTGRLPP 211 (708)
Q Consensus 134 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 211 (708)
+.+... ....++.|++.+|.+....+..+.....+..++...|... ...+..+..+++|+.+++++|.++ .++.
T Consensus 92 ~~l~~~---~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~ 167 (305)
T d1xkua_ 92 KELPEK---MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ 167 (305)
T ss_dssp SBCCSS---CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCS
T ss_pred CcCccc---hhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCc
Confidence 655432 2346677777777777666666666667777777766543 233445666777777777777776 3343
Q ss_pred ccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccC
Q 039322 212 EIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSL 291 (708)
Q Consensus 212 ~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L 291 (708)
.+ +++|+.|++++|.++...+..|.++++++.|++++|.+++..+..|.++++|++|+|++|+|+ .+|..+..+++|
T Consensus 168 ~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L 244 (305)
T d1xkua_ 168 GL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 244 (305)
T ss_dssp SC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSC
T ss_pred cc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCC
Confidence 32 467777777777777666667777777777777777777777777777777777777777777 446667777777
Q ss_pred CceecccccccCCCCCcc------cccccccEEecCCCcCCC
Q 039322 292 EKLNLSHNNLSGSIPNCF------EGIRGISVIDISDNQLQG 327 (708)
Q Consensus 292 ~~L~l~~N~l~~~~~~~~------~~l~~L~~l~l~~N~l~~ 327 (708)
+.|+|++|+|+.+....| ..+.+|+.|++++|+++.
T Consensus 245 ~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 245 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp CEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred CEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 777777777775544333 345777778888887763
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=5.5e-27 Score=238.66 Aligned_cols=279 Identities=19% Similarity=0.185 Sum_probs=163.3
Q ss_pred cEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEeccCCc
Q 039322 5 SILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENH 84 (708)
Q Consensus 5 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~ 84 (708)
+++|.++++++++ |..+ .+++++|+|++|+|+. ..+..|..+++|++|++++|.
T Consensus 13 ~~~~C~~~~L~~l-P~~l--~~~l~~L~Ls~N~i~~-----------------------l~~~~f~~l~~L~~L~l~~n~ 66 (305)
T d1xkua_ 13 RVVQCSDLGLEKV-PKDL--PPDTALLDLQNNKITE-----------------------IKDGDFKNLKNLHTLILINNK 66 (305)
T ss_dssp TEEECTTSCCCSC-CCSC--CTTCCEEECCSSCCCC-----------------------BCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEecCCCCCcc-CCCC--CCCCCEEECcCCcCCC-----------------------cChhHhhcccccccccccccc
Confidence 4555555556543 3333 2456666666666554 333445556666666666666
Q ss_pred cccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCccc--ccCC
Q 039322 85 FQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNIT--GGIP 162 (708)
Q Consensus 85 i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~--~~~~ 162 (708)
++...|..|.++++|++|++++|+++.++.. ..+.++.|++++|.+..+....+.....+..++...|... ...+
T Consensus 67 ~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~---~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~ 143 (305)
T d1xkua_ 67 ISKISPGAFAPLVKLERLYLSKNQLKELPEK---MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN 143 (305)
T ss_dssp CCCBCTTTTTTCTTCCEEECCSSCCSBCCSS---CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCT
T ss_pred ccccchhhhhCCCccCEecccCCccCcCccc---hhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCc
Confidence 6655555666666666666666666644432 2245666666666666555555555556666666655433 2334
Q ss_pred ccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCcccc
Q 039322 163 REIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLK 242 (708)
Q Consensus 163 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~ 242 (708)
..|..+++|+.+++++|.+. .++..+ +++|++|++++|.+++..+..|..++.+++|++++|.+++..+..+.++++
T Consensus 144 ~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~ 220 (305)
T d1xkua_ 144 GAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH 220 (305)
T ss_dssp TGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTT
T ss_pred cccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccccccc
Confidence 45566666666666666665 233222 456666666666666666666666666666666666666666666666666
Q ss_pred ceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchh------hcCcccCCceeccccccc--CCCCCccccccc
Q 039322 243 LHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQ------ICSLKSLEKLNLSHNNLS--GSIPNCFEGIRG 314 (708)
Q Consensus 243 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~------~~~~~~L~~L~l~~N~l~--~~~~~~~~~l~~ 314 (708)
|+.|+|++|+|+ .+|..|..+++|+.|+|++|+|+...... ...+++|+.|+|++|+++ ...|.+|.-+..
T Consensus 221 L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~ 299 (305)
T d1xkua_ 221 LRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 299 (305)
T ss_dssp CCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCC
T ss_pred ceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhccccc
Confidence 666666666666 34556666666666666666666433222 234567888888888775 355555554443
Q ss_pred cc
Q 039322 315 IS 316 (708)
Q Consensus 315 L~ 316 (708)
..
T Consensus 300 ~~ 301 (305)
T d1xkua_ 300 RA 301 (305)
T ss_dssp GG
T ss_pred Cc
Confidence 33
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.2e-27 Score=237.56 Aligned_cols=204 Identities=21% Similarity=0.182 Sum_probs=90.5
Q ss_pred CcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcc-cCcccccCCccccCCCCCCEEecc
Q 039322 99 LIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVS-MNNITGGIPREIGNSSQLQALDLS 177 (708)
Q Consensus 99 L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~-~N~i~~~~~~~~~~l~~L~~L~L~ 177 (708)
+++|+|++|+|+.+++..|.++++|++|++++|++..+.+..+..+..++.+... .|.++...+..|.++++|++|+++
T Consensus 34 ~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~ 113 (284)
T d1ozna_ 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113 (284)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECT
T ss_pred CCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecC
Confidence 4444444444444444444444444444444444444444444444444444332 233333334444444444444444
Q ss_pred cccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCC
Q 039322 178 LNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLEL 257 (708)
Q Consensus 178 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 257 (708)
+|.+....+..+...++|+.+++++|+++++.+..|..+++|+.|++++|++++..+..|.++++|+.+++++|++++..
T Consensus 114 ~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~ 193 (284)
T d1ozna_ 114 RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193 (284)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccC
Confidence 44444333333444444444444444444333344444444444444444444444444444444444444444444444
Q ss_pred ChhhhhhcccchhhcccccCCCCCchhhcCcccCCceeccccccc
Q 039322 258 PKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLS 302 (708)
Q Consensus 258 ~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 302 (708)
|..|.++++|+.|++++|++.+..+..+..+++|++|++++|++.
T Consensus 194 ~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred hhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence 444444444444444444444444444444444444444444444
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=7.8e-27 Score=234.72 Aligned_cols=268 Identities=22% Similarity=0.207 Sum_probs=220.8
Q ss_pred cccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcc-cC
Q 039322 53 RPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLS-RN 131 (708)
Q Consensus 53 ~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~-~n 131 (708)
...++++.+++ +|..+. +++++|+|++|+|+...+.+|.++++|++|++++|++..+....+..+..++.++.. .|
T Consensus 15 ~v~c~~~~L~~-iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQA-VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCSS-CCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCCc-cCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 34666666766 455554 568999999999997777789999999999999999999999999999999998775 56
Q ss_pred cceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCc
Q 039322 132 DFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPP 211 (708)
Q Consensus 132 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 211 (708)
.++.+.+..|.++++|++|++++|.+....+..+....+|+.+++++|+|++..+..|..+++|++|++++|++++..+.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 78888888999999999999999999877788888899999999999999977777888899999999999999988888
Q ss_pred ccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccC
Q 039322 212 EIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSL 291 (708)
Q Consensus 212 ~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L 291 (708)
.|.++++|+.+++++|++++..|..|..+++|+.|++++|++.+..+..|..+++|+.|++++|++...-+ ...-...+
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l 250 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWL 250 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHH
T ss_pred hhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHHHH
Confidence 99999999999999999998889999999999999999999998888889999999999999999875432 11122346
Q ss_pred CceecccccccCCCCCcccccccccEEecCCCcCCC
Q 039322 292 EKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQG 327 (708)
Q Consensus 292 ~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~ 327 (708)
+.+....+.+.+..|..+.+ ....+++.+.++|
T Consensus 251 ~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 251 QKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp HHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred HhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 66777777777666665543 3444555555554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.94 E-value=1.1e-26 Score=244.81 Aligned_cols=317 Identities=24% Similarity=0.255 Sum_probs=240.2
Q ss_pred ECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCC-CCCcccccccCCCccCCCCccccCCCCccEEeccCCccc
Q 039322 8 DLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLE-NPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQ 86 (708)
Q Consensus 8 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~ 86 (708)
.+..+.+++... .+.+.+|++|++++|.|+.. . .++ .++|++|++++|.+++.. .+..+++|++|++++|.++
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l-~-gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI-D-GVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc-c-ccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccc
Confidence 345555554332 35677899999999998743 2 232 378888899998888753 3888888899999988888
Q ss_pred cccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCC-------------------CCCCCCC
Q 039322 87 GTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSN-------------------WGKCPKL 147 (708)
Q Consensus 87 ~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~-------------------~~~l~~L 147 (708)
+.. .++++++|+.|++++|.++++.. ......+..+....|.+....... +......
T Consensus 102 ~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (384)
T d2omza2 102 DIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTL 177 (384)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTC
T ss_pred ccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhcccccc
Confidence 543 37888888888888888886544 344456777777666654332211 1223334
Q ss_pred CEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCC
Q 039322 148 GTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSAN 227 (708)
Q Consensus 148 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N 227 (708)
.......|... ....+..+++++.+++++|.+++..+ +...++|++|++++|+++. + ..+..+++|+.|++++|
T Consensus 178 ~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n 251 (384)
T d2omza2 178 ERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANN 251 (384)
T ss_dssp CEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSS
T ss_pred ccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccC
Confidence 44444444443 34567888999999999999986544 4667899999999999984 3 36888999999999999
Q ss_pred cccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCC
Q 039322 228 RFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPN 307 (708)
Q Consensus 228 ~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~ 307 (708)
.+++..+ +..+++|+.|++++|++++.. .+..++.++.++++.|.+++. ..+..+++++.|++++|++++..
T Consensus 252 ~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~-- 323 (384)
T d2omza2 252 QISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS-- 323 (384)
T ss_dssp CCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--
T ss_pred ccCCCCc--ccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--
Confidence 9986543 788899999999999998543 478889999999999999853 34788899999999999999654
Q ss_pred cccccccccEEecCCCcCCCCCCCccccccCcccccccccCc
Q 039322 308 CFEGIRGISVIDISDNQLQGPVPNSTAFRNAPVEALKGNKGL 349 (708)
Q Consensus 308 ~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~ 349 (708)
.+..+++|+.|++++|++++. +....+++++.+.+++|+..
T Consensus 324 ~l~~l~~L~~L~L~~n~l~~l-~~l~~l~~L~~L~l~~N~l~ 364 (384)
T d2omza2 324 PVSSLTKLQRLFFANNKVSDV-SSLANLTNINWLSAGHNQIS 364 (384)
T ss_dssp GGGGCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECCSSCCC
T ss_pred ccccCCCCCEEECCCCCCCCC-hhHcCCCCCCEEECCCCcCC
Confidence 378899999999999999875 45667788999999998753
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=4.3e-25 Score=219.30 Aligned_cols=204 Identities=22% Similarity=0.162 Sum_probs=142.4
Q ss_pred CCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCE
Q 039322 118 GIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTE 197 (708)
Q Consensus 118 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 197 (708)
.....+.++|.++++++.+++ .+. ++|++|+|++|+|+.+.+..|..+++|++|+|++|+|+.. + .++.+++|++
T Consensus 7 ~~~~~~~~v~C~~~~L~~iP~-~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLTALPP-DLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCSSCCS-CCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCCeeCc-CcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccc
Confidence 445566777888888875533 332 4678888888888776667778888888888888887733 2 3566777888
Q ss_pred EEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccC
Q 039322 198 LILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLF 277 (708)
Q Consensus 198 L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i 277 (708)
|+|++|+++ ..+..+..+++|+.|++++|.+....+..+..+.+++.|++++|.++...+..+..+++|+.|++++|++
T Consensus 82 L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred ccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence 888888777 4556677777777777777777766666677777777777777777766666666777777777777777
Q ss_pred CCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCCCcCCCC
Q 039322 278 GGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISDNQLQGP 328 (708)
Q Consensus 278 ~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 328 (708)
++..+..+..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.|.
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred cccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence 7666666666777777777777776 5555555566666666665555443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=4.2e-24 Score=212.07 Aligned_cols=200 Identities=25% Similarity=0.254 Sum_probs=121.5
Q ss_pred CCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEE
Q 039322 71 RGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTL 150 (708)
Q Consensus 71 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 150 (708)
....+..+++++++++ .+|..+. ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+.+.. +..+++|+.|
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~--~~~l~~L~~L 82 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTL 82 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCEE
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc--cccccccccc
Confidence 3455666777777777 4565543 467777777777777777777777777777777777765543 4556677777
Q ss_pred EcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCccc
Q 039322 151 NVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFN 230 (708)
Q Consensus 151 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~ 230 (708)
+|++|+++. .+..+..+++|++|++++|.+....+..+..+.++++|++++|.++...+..+..+++|+.|++++|+|+
T Consensus 83 ~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 83 DLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp ECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred ccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence 777777663 3455666666666666666666555555555566666666666665544455555555555655555555
Q ss_pred ccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccC
Q 039322 231 NSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLF 277 (708)
Q Consensus 231 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i 277 (708)
+..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++
T Consensus 162 ~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred ccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence 554555555555555555555555 3444444444444444444444
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=4.8e-23 Score=193.25 Aligned_cols=173 Identities=16% Similarity=0.165 Sum_probs=122.4
Q ss_pred cccceeccccCccEEEEEeCCCcEEEEEEcCCCCCc--------------chhHhHHHHHHHHHHHHhccCCceeeEEEE
Q 039322 439 DAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPC--------------DQIADQKEFLIEVKALTEIRHRNIVKFYGF 504 (708)
Q Consensus 439 ~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~ 504 (708)
.+.++||+|+||.||+|...+|+.||||+++..... ........+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 457889999999999998888999999987642211 001123445678888999999999988866
Q ss_pred EeeCCeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEe
Q 039322 505 CSHARHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDCFPPIVHQDISSKNLLLDLEYEAHVA 584 (708)
Q Consensus 505 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ivH~dlk~~Nill~~~~~~kl~ 584 (708)
.. .+++|||++++.+.+ ++......++.|++.+++|||++ ||+||||||+|||++++ .++|+
T Consensus 83 ~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred cC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 42 379999998855432 34455678999999999999999 99999999999999865 58999
Q ss_pred ecccccccCCCCCccccccccccccCccccccCCCCcchhHHHHHHHH
Q 039322 585 DFGIAKFLKPESSNWTEFAGTYGYVAPELAYTMKITEKCDVYSFGVLV 632 (708)
Q Consensus 585 Dfg~a~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 632 (708)
|||.|.....+... .....+...+ .+. ....++.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~-~~l~rd~~~~-~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWR-EILERDVRNI-ITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHH-HHHHHHHHHH-HHH-HHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcH-HHHHHHHHHH-HHH-HcCCCCCcccHHHHHHHH
Confidence 99999765432211 1000000000 111 235678899999986543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=3.2e-19 Score=184.43 Aligned_cols=284 Identities=27% Similarity=0.338 Sum_probs=195.2
Q ss_pred CCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCC-CCccEEecc
Q 039322 3 SLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRG-GALQYFGVS 81 (708)
Q Consensus 3 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l-~~L~~L~l~ 81 (708)
+++.|||++|.+++ .|+. .++|++|+|++|+|+ .+|..+ .+|+.|++++|.++.. + .+ +.|++|+++
T Consensus 39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~--~~L~~L~l~~n~l~~l-~----~lp~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP--QSLKSLLVDNNNLKAL-S----DLPPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC--TTCCEEECCSSCCSCC-C----SCCTTCCEEECC
T ss_pred CCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccch--hhhhhhhhhhcccchh-h----hhcccccccccc
Confidence 68999999999995 4543 578999999999998 456554 4799999999998763 2 22 469999999
Q ss_pred CCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccC
Q 039322 82 ENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGI 161 (708)
Q Consensus 82 ~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~ 161 (708)
+|.++ .+|. ++++++|++|++++|.++.... ....+..+.+..+... ....+..++.++.|++++|.+...
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~- 177 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKL- 177 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSC-
T ss_pred ccccc-cccc-hhhhccceeecccccccccccc----ccccccchhhcccccc--ccccccccccceeccccccccccc-
Confidence 99998 4454 6789999999999999874432 3467788888776653 345567788899999998887632
Q ss_pred CccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCcc-
Q 039322 162 PREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNL- 240 (708)
Q Consensus 162 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l- 240 (708)
+. .....+.+.+.++.+. ..+ .+..++.|+.+++++|... ..+. ...++..+.+.+|.+.. .+.....+
T Consensus 178 ~~---~~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~-~~~~---~~~~l~~~~~~~~~~~~-~~~~~~~l~ 247 (353)
T d1jl5a_ 178 PD---LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTD-LPELPQSLT 247 (353)
T ss_dssp CC---CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS-SCCS---CCTTCCEEECCSSCCSC-CCCCCTTCC
T ss_pred cc---cccccccccccccccc-ccc-ccccccccccccccccccc-cccc---ccccccccccccccccc-ccccccccc
Confidence 21 1233456666666555 232 3566778888888887766 3332 23456677777776653 22211111
Q ss_pred ----------------ccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCC
Q 039322 241 ----------------LKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGS 304 (708)
Q Consensus 241 ----------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~ 304 (708)
......++..|.+.+. ...+++|++|+|++|+|+ .+|. .+++|+.|++++|+|+ .
T Consensus 248 ~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~ 318 (353)
T d1jl5a_ 248 FLDVSENIFSGLSELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-E 318 (353)
T ss_dssp EEECCSSCCSEESCCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-C
T ss_pred ccccccccccccccccchhcccccccCccccc----cccCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCC-c
Confidence 1122333444443321 233568999999999998 4453 3678999999999998 4
Q ss_pred CCCcccccccccEEecCCCcCCCCC
Q 039322 305 IPNCFEGIRGISVIDISDNQLQGPV 329 (708)
Q Consensus 305 ~~~~~~~l~~L~~l~l~~N~l~~~~ 329 (708)
+|.. +++|+.|++++|+++..+
T Consensus 319 l~~~---~~~L~~L~L~~N~L~~lp 340 (353)
T d1jl5a_ 319 VPEL---PQNLKQLHVEYNPLREFP 340 (353)
T ss_dssp CCCC---CTTCCEEECCSSCCSSCC
T ss_pred cccc---cCCCCEEECcCCcCCCCC
Confidence 5543 467899999999988654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=3e-20 Score=181.47 Aligned_cols=218 Identities=19% Similarity=0.106 Sum_probs=137.6
Q ss_pred cEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCccee-eCCCCCCCCCCCCEEEccc
Q 039322 76 QYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYG-EISSNWGKCPKLGTLNVSM 154 (708)
Q Consensus 76 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~ 154 (708)
+.+++++++++ .+|..+. +++++|+|++|+|+.++..+|.++++|++|++++|.+.. +.+..|..++++++|.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 57777777777 5555443 467888888888887777778888888888888887654 4556677788888887654
Q ss_pred -CcccccCCccccCCCCCCEEecccccccccCCc-ccCCCCCCCEEEccCccccccCCcccCCCC-CCCeEeccCCcccc
Q 039322 155 -NNITGGIPREIGNSSQLQALDLSLNHIVGEIPK-ELGKLNSLTELILRGNQFTGRLPPEIGSLV-DLEYLDLSANRFNN 231 (708)
Q Consensus 155 -N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~-~L~~L~l~~N~i~~ 231 (708)
|++....+..|..+++|++|++++|++....+. .+..+..+..+...++.+....+..|..++ .++.|++++|+++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 667767777778888888888888877633221 223345555555666666655555665554 56666777777764
Q ss_pred cCCCCCCccccce-eecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecc
Q 039322 232 SVPENLGNLLKLH-YLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLS 297 (708)
Q Consensus 232 ~~~~~~~~l~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~ 297 (708)
..+..+. .++++ .+++++|+|+.+.+..|.++++|+.|+|++|+|+...+..+..+++|+.+++.
T Consensus 168 i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 168 IHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp ECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred ccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 4333333 33333 33456666664444556666666666666666654444445555555555443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=1.3e-19 Score=176.79 Aligned_cols=221 Identities=11% Similarity=0.007 Sum_probs=179.3
Q ss_pred CcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccc-cCCccccCCCCCCEEecc
Q 039322 99 LIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITG-GIPREIGNSSQLQALDLS 177 (708)
Q Consensus 99 L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~ 177 (708)
.+.++.++++++.++...+ +++++|+|++|+|+.+.+..|.++++|++|+|++|.+.. ..+..|..++++++|.+.
T Consensus 10 ~~~i~c~~~~l~~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 10 NRVFLCQESKVTEIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SSEEEEESCSCSSCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CCEEEEeCCCCCCcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 3688899999997665443 589999999999999999999999999999999999875 446678999999999976
Q ss_pred c-ccccccCCcccCCCCCCCEEEccCccccccCCc-ccCCCCCCCeEeccCCcccccCCCCCCccc-cceeecccCcccc
Q 039322 178 L-NHIVGEIPKELGKLNSLTELILRGNQFTGRLPP-EIGSLVDLEYLDLSANRFNNSVPENLGNLL-KLHYLGLSNNQFV 254 (708)
Q Consensus 178 ~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~-~L~~L~l~~n~l~ 254 (708)
. |.+....+..|.++++|++|++++|.+....+. .+..++.+..+..+++.+....+..|..++ .++.|++++|+++
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 4 678877788899999999999999999844332 234456666777788888877777777765 7899999999999
Q ss_pred cCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCcccccccccEEecCC
Q 039322 255 LELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNCFEGIRGISVIDISD 322 (708)
Q Consensus 255 ~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~ 322 (708)
...+..|....-++.+++++|.++...+..|..+++|+.|++++|+++...+..|.+++.|+.+++.+
T Consensus 167 ~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 167 EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 76666565433344456788999866667789999999999999999977778899999998887754
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=9e-20 Score=175.95 Aligned_cols=188 Identities=22% Similarity=0.278 Sum_probs=90.6
Q ss_pred cCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 039322 94 RNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQA 173 (708)
Q Consensus 94 ~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 173 (708)
+.+.+|++|++.+|+|+.+ ..+..+++|++|++++|+++++.+ +..+++|+.+++++|.++.. ..+..+++|+.
T Consensus 38 ~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~ 111 (227)
T d1h6ua2 38 ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKT 111 (227)
T ss_dssp HHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred HHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccccccccc--ccccccccccc
Confidence 4445555555555555533 224455555555555555543322 44555555555555555422 23445555555
Q ss_pred EecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCccc
Q 039322 174 LDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQF 253 (708)
Q Consensus 174 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l 253 (708)
++++++...+. ..+...+.++.+.++++.+... ..+..+++|++|++++|.++... .+.++++|+.|+|++|++
T Consensus 112 l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l 185 (227)
T d1h6ua2 112 LDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKI 185 (227)
T ss_dssp EECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred ccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCCCcc
Confidence 55555544421 2234445555555555554421 12444455555555555554222 244555555555555555
Q ss_pred ccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecc
Q 039322 254 VLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLS 297 (708)
Q Consensus 254 ~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~ 297 (708)
++. + .+.++++|++|+|++|+|++..+ +..+++|+.|+++
T Consensus 186 ~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 186 SDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp CCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred CCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence 432 1 24555555555555555553221 4455555555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.80 E-value=1.1e-19 Score=175.22 Aligned_cols=205 Identities=20% Similarity=0.199 Sum_probs=158.2
Q ss_pred ccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccC
Q 039322 52 TRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRN 131 (708)
Q Consensus 52 ~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n 131 (708)
..++++.+.+++.. .+..+.+|+.|++++|+|++. ..+.++++|++|++++|.++++.+ +..+++|+++++++|
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN 95 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccccccc
Confidence 34566666665532 445677889999999988853 358889999999999998886543 788889999999998
Q ss_pred cceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCc
Q 039322 132 DFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPP 211 (708)
Q Consensus 132 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 211 (708)
.++.+. .+.++++|+.+++++|.+... ..+...+.++.+.++++.+... ..+..+++|++|++++|.++.. .
T Consensus 96 ~~~~i~--~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~ 167 (227)
T d1h6ua2 96 PLKNVS--AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--T 167 (227)
T ss_dssp CCSCCG--GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--G
T ss_pred cccccc--ccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--h
Confidence 887543 477888999999998887643 4567778889999988888633 3467788899999999988733 3
Q ss_pred ccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhccc
Q 039322 212 EIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASH 274 (708)
Q Consensus 212 ~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~ 274 (708)
.+.++++|+.|+|++|++++. + .+.++++|++|+|++|+|+... .++++++|+.|++++
T Consensus 168 ~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 168 PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN 226 (227)
T ss_dssp GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEE
T ss_pred hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEeeC
Confidence 478889999999999998853 2 3788899999999999988543 378888999998864
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.78 E-value=1.5e-19 Score=169.21 Aligned_cols=128 Identities=21% Similarity=0.216 Sum_probs=86.6
Q ss_pred CEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccc-cCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccC
Q 039322 124 TFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITG-GIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRG 202 (708)
Q Consensus 124 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 202 (708)
++++.++++++.++.+.. +++++|+|++|+|+. ..+..|..+++|+.|+|++|++....+..+..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~~iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLKEIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSSCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcCccCCCCC---CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 467777777765543321 467777777777754 3455566777777777777777766666677777777777777
Q ss_pred ccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccc
Q 039322 203 NQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFV 254 (708)
Q Consensus 203 n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~ 254 (708)
|+|+.+.+.+|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 7777666666777777777777777777666666666777777777776665
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.78 E-value=9.9e-19 Score=163.55 Aligned_cols=128 Identities=27% Similarity=0.297 Sum_probs=71.6
Q ss_pred cEEEccCCccccccccccCCCCCCCEEEcccCccee-eCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEeccc
Q 039322 100 IRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYG-EISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSL 178 (708)
Q Consensus 100 ~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 178 (708)
++++.++++++.++.+. .+++++|+|++|+|+. +....|.++++|+.|+|++|.+....+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~~iP~~l---p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLKEIPRDI---PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSSCCSCC---CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcCccCCCC---CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 34555555555444322 1355556666665543 3344455555666666666665555555555555566666666
Q ss_pred ccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCccc
Q 039322 179 NHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFN 230 (708)
Q Consensus 179 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~ 230 (708)
|+|+...+.+|.++++|++|+|++|+|+++.+..|..+++|++|+|++|.+.
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 6655555555555566666666666665555555555555666666555554
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.76 E-value=5.1e-17 Score=167.61 Aligned_cols=279 Identities=26% Similarity=0.289 Sum_probs=188.2
Q ss_pred CCCCcEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCCCCccccCCCCccEEec
Q 039322 1 MRSLSILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSYLPHNVCRGGALQYFGV 80 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l 80 (708)
+++|++|+|++|+|+++ |.. +.+|++|++++|+++.+ +.. .+.|+.|++++|.+... |. +..+++|++|++
T Consensus 57 ~~~L~~L~Ls~N~l~~l-p~~---~~~L~~L~l~~n~l~~l-~~l--p~~L~~L~L~~n~l~~l-p~-~~~l~~L~~L~l 127 (353)
T d1jl5a_ 57 PPHLESLVASCNSLTEL-PEL---PQSLKSLLVDNNNLKAL-SDL--PPLLEYLGVSNNQLEKL-PE-LQNSSFLKIIDV 127 (353)
T ss_dssp CTTCSEEECCSSCCSSC-CCC---CTTCCEEECCSSCCSCC-CSC--CTTCCEEECCSSCCSSC-CC-CTTCTTCCEEEC
T ss_pred CCCCCEEECCCCCCccc-ccc---hhhhhhhhhhhcccchh-hhh--ccccccccccccccccc-cc-hhhhccceeecc
Confidence 36899999999999954 554 46899999999998743 321 14699999999999874 43 578899999999
Q ss_pred cCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCccccc
Q 039322 81 SENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGG 160 (708)
Q Consensus 81 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~ 160 (708)
++|.++.. +. ....+..+.+..+.... ...+..++.++.|++++|.+..... .....+.+...++.+..
T Consensus 128 ~~~~~~~~-~~---~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~~~~~----~~~~~~~l~~~~~~~~~- 196 (353)
T d1jl5a_ 128 DNNSLKKL-PD---LPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKKLPD----LPLSLESIVAGNNILEE- 196 (353)
T ss_dssp CSSCCSCC-CC---CCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSSCCC----CCTTCCEEECCSSCCSS-
T ss_pred cccccccc-cc---ccccccchhhccccccc--cccccccccceeccccccccccccc----ccccccccccccccccc-
Confidence 99998743 32 24667788887766553 3457778889999999988764332 12334566666666552
Q ss_pred CCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCC----------------C-CCCCeEe
Q 039322 161 IPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGS----------------L-VDLEYLD 223 (708)
Q Consensus 161 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~----------------~-~~L~~L~ 223 (708)
. ..+..++.|+.+++++|.... .+ ....++..+.+.+|.+.. .+..... + ......+
T Consensus 197 ~-~~~~~l~~L~~l~l~~n~~~~-~~---~~~~~l~~~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~ 270 (353)
T d1jl5a_ 197 L-PELQNLPFLTTIYADNNLLKT-LP---DLPPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPNLYYLN 270 (353)
T ss_dssp C-CCCTTCTTCCEEECCSSCCSS-CC---SCCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSEESCCCTTCCEEE
T ss_pred c-ccccccccccccccccccccc-cc---cccccccccccccccccc-cccccccccccccccccccccccccchhcccc
Confidence 2 235667778888888776652 22 223566677777766652 2211110 1 1223334
Q ss_pred ccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccC
Q 039322 224 LSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSG 303 (708)
Q Consensus 224 l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~ 303 (708)
+..|.+.+. ...+++|++|++++|+|+ .+|.. +++|+.|+|++|+|+ .+|. .+++|++|++++|+++
T Consensus 271 ~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~---~~~~L~~L~L~~N~L~- 337 (353)
T d1jl5a_ 271 ASSNEIRSL----CDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLR- 337 (353)
T ss_dssp CCSSCCSEE----CCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-
T ss_pred cccCccccc----cccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-cccc---ccCCCCEEECcCCcCC-
Confidence 444444321 233578999999999998 45543 578999999999998 4553 2568999999999998
Q ss_pred CCCCcccccccccEEecC
Q 039322 304 SIPNCFEGIRGISVIDIS 321 (708)
Q Consensus 304 ~~~~~~~~l~~L~~l~l~ 321 (708)
.+|.... +|+.|.+.
T Consensus 338 ~lp~~~~---~L~~L~~~ 352 (353)
T d1jl5a_ 338 EFPDIPE---SVEDLRMN 352 (353)
T ss_dssp SCCCCCT---TCCEEECC
T ss_pred CCCcccc---ccCeeECc
Confidence 5565443 45555543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.3e-18 Score=163.50 Aligned_cols=164 Identities=24% Similarity=0.268 Sum_probs=88.7
Q ss_pred CCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEE
Q 039322 72 GGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLN 151 (708)
Q Consensus 72 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 151 (708)
+.+|++|++++|.+++.. .+..+++|++|+|++|+|+++. .+..+++|++|++++|+++++. .+..+++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLS--SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCGG--GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccccc--cccccccccccc
Confidence 445666666666665322 2555666666666666666543 2455666666666666665432 355556666666
Q ss_pred cccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccc
Q 039322 152 VSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNN 231 (708)
Q Consensus 152 L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~ 231 (708)
+++|.+.. ...+..+++++.+++++|.+++ +..+..+++|+.+++++|++++. + .+.++++|++|+|++|+|+.
T Consensus 119 l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~ 192 (210)
T d1h6ta2 119 LEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD 192 (210)
T ss_dssp CTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB
T ss_pred cccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC
Confidence 66665542 2345555566666666665542 22344555555566655555532 2 25555555555555555553
Q ss_pred cCCCCCCccccceeeccc
Q 039322 232 SVPENLGNLLKLHYLGLS 249 (708)
Q Consensus 232 ~~~~~~~~l~~L~~L~l~ 249 (708)
++ .+.++++|+.|+|+
T Consensus 193 -l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 193 -LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp -CG-GGTTCTTCSEEEEE
T ss_pred -Ch-hhcCCCCCCEEEcc
Confidence 22 35555555555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.8e-18 Score=162.89 Aligned_cols=163 Identities=20% Similarity=0.210 Sum_probs=129.8
Q ss_pred CcccccccCCCccCCCCccccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcc
Q 039322 50 MLTRPGLDFNHFTSYLPHNVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLS 129 (708)
Q Consensus 50 ~l~~l~l~~n~~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~ 129 (708)
+|+.|++++|.+.+. .++..+++|++|++++|.|++.. .++++++|+.|++++|+|+++. .+..+++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~l--~~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLS--SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCGG--GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCCc--hhHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccccc--cccccccccccccc
Confidence 344445555544442 24677889999999999998643 3678999999999999998654 58889999999999
Q ss_pred cCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccC
Q 039322 130 RNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRL 209 (708)
Q Consensus 130 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 209 (708)
+|.+..+ ..+.++++++.+++++|.++. +..+..+++|+++++++|++++. + .+.++++|++|+|++|++++ +
T Consensus 121 ~~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l 193 (210)
T d1h6ta2 121 HNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD-L 193 (210)
T ss_dssp TSCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-C
T ss_pred ccccccc--ccccccccccccccccccccc--ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC-C
Confidence 9988654 357888999999999999874 44677889999999999999853 2 48889999999999999984 4
Q ss_pred CcccCCCCCCCeEeccC
Q 039322 210 PPEIGSLVDLEYLDLSA 226 (708)
Q Consensus 210 ~~~~~~~~~L~~L~l~~ 226 (708)
+ .+.++++|++|+|++
T Consensus 194 ~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 194 R-ALAGLKNLDVLELFS 209 (210)
T ss_dssp G-GGTTCTTCSEEEEEE
T ss_pred h-hhcCCCCCCEEEccC
Confidence 4 588999999999864
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=4.1e-18 Score=160.24 Aligned_cols=147 Identities=24% Similarity=0.269 Sum_probs=68.7
Q ss_pred CCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEE
Q 039322 72 GGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLN 151 (708)
Q Consensus 72 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 151 (708)
+.++++|++++|.|+.. +.++.+++|++|++++|+++++.+ +.++++|++|++++|.+..+. .+.++++|+.|+
T Consensus 39 l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~ 112 (199)
T d2omxa2 39 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLT 112 (199)
T ss_dssp HTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEE
T ss_pred hcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccccccc--cccccccccccc
Confidence 44555555555555532 234455555555555555554332 455555555555555544332 244455555555
Q ss_pred cccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCccc
Q 039322 152 VSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFN 230 (708)
Q Consensus 152 L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~ 230 (708)
+++|.+... ..+..+++|+.|++++|++.. + ..+..+++|+.|++.+|++++. + .+.++++|++|++++|+|+
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred ccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCC
Confidence 555544421 234444555555555554442 1 2344444555555555544422 1 2444444444444444444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=5.5e-18 Score=159.38 Aligned_cols=143 Identities=25% Similarity=0.331 Sum_probs=118.5
Q ss_pred cccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCC
Q 039322 68 NVCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKL 147 (708)
Q Consensus 68 ~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 147 (708)
++..+++|++|++++|++++..+ ++++++|++|++++|.+..+. .+..+++|+.|++++|.+..+. .+..+++|
T Consensus 57 ~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~~--~~~~l~~L 130 (199)
T d2omxa2 57 GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDID--PLKNLTNL 130 (199)
T ss_dssp TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTC
T ss_pred ccccCCCcCcCccccccccCccc--ccCCccccccccccccccccc--cccccccccccccccccccccc--ccchhhhh
Confidence 46778899999999999986543 889999999999999988654 4889999999999999887543 47788999
Q ss_pred CEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeE
Q 039322 148 GTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYL 222 (708)
Q Consensus 148 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L 222 (708)
+.|++++|++... +.+..+++|+.|++++|++++. ..++++++|++|++++|++++ ++ .++.+++|++|
T Consensus 131 ~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l--~~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 131 NRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDL--KPLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp SEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred HHhhhhhhhhccc--ccccccccccccccccccccCC--ccccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 9999999998743 4688899999999999999854 348899999999999999984 33 57788888876
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=8.8e-21 Score=203.83 Aligned_cols=325 Identities=18% Similarity=0.170 Sum_probs=211.5
Q ss_pred CCcEEECCCCcccccC-CccccCCCCCCEEEeeCceeeeeC----CCCC-CCCCcccccccCCCccCC----CCccccC-
Q 039322 3 SLSILDLNQNQFKGVL-PPSVSNLTNLKELVLLYNNLSGFI----PPSL-ENPMLTRPGLDFNHFTSY----LPHNVCR- 71 (708)
Q Consensus 3 ~L~~L~l~~n~i~~~~-~~~~~~l~~L~~L~L~~n~i~~~~----~~~~-~~~~l~~l~l~~n~~~~~----~~~~~~~- 71 (708)
+|+.||++.|+|+... .+.+..+++|++|+|++|.|+... ...+ ..++|+.|++++|.++.. +...+..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6899999999999754 344678899999999999886432 2222 237899999999988632 2223322
Q ss_pred CCCccEEeccCCccccc----cCccCcCCCCCcEEEccCCccccccccc-------------------------------
Q 039322 72 GGALQYFGVSENHFQGT----IPKILRNCSSLIRVRLNSNNLTGNISEA------------------------------- 116 (708)
Q Consensus 72 l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~l~~n~i~~~~~~~------------------------------- 116 (708)
..+|++|++++|++++. ++..+..+++|++|+|++|.|+......
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 35799999999998753 3456778899999999999876321111
Q ss_pred --cCCCCCCCEEEcccCcceeeCCC----CC-CCCCCCCEEEcccCccccc----CCccccCCCCCCEEeccccccccc-
Q 039322 117 --LGIYPNLTFIDLSRNDFYGEISS----NW-GKCPKLGTLNVSMNNITGG----IPREIGNSSQLQALDLSLNHIVGE- 184 (708)
Q Consensus 117 --~~~~~~L~~L~l~~n~l~~~~~~----~~-~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~n~l~~~- 184 (708)
+.....++.++++++.+...... .+ ........+++..+.+... ....+...+.++.+++++|++...
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 12234566666666554211000 00 1123455666666655421 112334567888888888876521
Q ss_pred ----CCcccCCCCCCCEEEccCccccccC----CcccCCCCCCCeEeccCCcccccCCCCC-----CccccceeecccCc
Q 039322 185 ----IPKELGKLNSLTELILRGNQFTGRL----PPEIGSLVDLEYLDLSANRFNNSVPENL-----GNLLKLHYLGLSNN 251 (708)
Q Consensus 185 ----~~~~~~~l~~L~~L~l~~n~l~~~~----~~~~~~~~~L~~L~l~~N~i~~~~~~~~-----~~l~~L~~L~l~~n 251 (708)
.........+++.+++++|.+.... ...+...+.++.+++++|.++......+ .....|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 2233445678999999998876322 2234557788999999998864322211 23357889999999
Q ss_pred ccccCCChhh----hhhcccchhhcccccCCCCCchh----hc-CcccCCceecccccccCC----CCCcccccccccEE
Q 039322 252 QFVLELPKEL----EKLVQLSELDASHNLFGGEIPFQ----IC-SLKSLEKLNLSHNNLSGS----IPNCFEGIRGISVI 318 (708)
Q Consensus 252 ~l~~~~~~~~----~~l~~L~~L~ls~N~i~~~~~~~----~~-~~~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l 318 (708)
.++......+ ...++|++|+|++|+|++..... +. ..+.|+.|+|++|.|+.. +...+...++|++|
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L 402 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEE
Confidence 8875544433 34458999999999987533222 22 356799999999998742 33445667889999
Q ss_pred ecCCCcCCC
Q 039322 319 DISDNQLQG 327 (708)
Q Consensus 319 ~l~~N~l~~ 327 (708)
++++|+++.
T Consensus 403 ~Ls~N~i~~ 411 (460)
T d1z7xw1 403 DLSNNCLGD 411 (460)
T ss_dssp ECCSSSCCH
T ss_pred ECCCCcCCH
Confidence 999998874
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=1.4e-19 Score=194.34 Aligned_cols=327 Identities=18% Similarity=0.122 Sum_probs=225.3
Q ss_pred CCCCcEEECCCCcccccC----CccccCCCCCCEEEeeCceeeee----CCCCCCC--CCcccccccCCCccCC----CC
Q 039322 1 MRSLSILDLNQNQFKGVL----PPSVSNLTNLKELVLLYNNLSGF----IPPSLEN--PMLTRPGLDFNHFTSY----LP 66 (708)
Q Consensus 1 l~~L~~L~l~~n~i~~~~----~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~--~~l~~l~l~~n~~~~~----~~ 66 (708)
|+++++|+|++|+|+... ..++..+++|++|+|++|.|+.. +...+.. .+|+.|++++|.++.. ++
T Consensus 26 l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~ 105 (460)
T d1z7xw1 26 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLS 105 (460)
T ss_dssp HTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCcccccccccc
Confidence 478999999999998533 45678899999999999998632 2223322 5799999999998764 45
Q ss_pred ccccCCCCccEEeccCCccccccCc---------------------------------cCcCCCCCcEEEccCCcccccc
Q 039322 67 HNVCRGGALQYFGVSENHFQGTIPK---------------------------------ILRNCSSLIRVRLNSNNLTGNI 113 (708)
Q Consensus 67 ~~~~~l~~L~~L~l~~n~i~~~~~~---------------------------------~~~~l~~L~~L~l~~n~i~~~~ 113 (708)
..+..+++|++|++++|.++..... .+.....++.++++.+.+....
T Consensus 106 ~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~ 185 (460)
T d1z7xw1 106 STLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAG 185 (460)
T ss_dssp HHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred chhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccccccccccccccccccccccccccc
Confidence 5677889999999999998632110 1122356788888877765211
Q ss_pred ----cccc-CCCCCCCEEEcccCcceeeC----CCCCCCCCCCCEEEcccCcccc-----cCCccccCCCCCCEEecccc
Q 039322 114 ----SEAL-GIYPNLTFIDLSRNDFYGEI----SSNWGKCPKLGTLNVSMNNITG-----GIPREIGNSSQLQALDLSLN 179 (708)
Q Consensus 114 ----~~~~-~~~~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~L~~N~i~~-----~~~~~~~~l~~L~~L~L~~n 179 (708)
...+ ........+++..+.+.... ...+...+.++.+++.+|.+.. .....+.....++.|++++|
T Consensus 186 ~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n 265 (460)
T d1z7xw1 186 VRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWEC 265 (460)
T ss_dssp HHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred ccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhcccccccccccccccccc
Confidence 1111 22346778888888764221 1223456889999999998752 22334455688999999999
Q ss_pred cccccC----CcccCCCCCCCEEEccCccccccCCcc-----cCCCCCCCeEeccCCcccccCCCCC----Cccccceee
Q 039322 180 HIVGEI----PKELGKLNSLTELILRGNQFTGRLPPE-----IGSLVDLEYLDLSANRFNNSVPENL----GNLLKLHYL 246 (708)
Q Consensus 180 ~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~~~-----~~~~~~L~~L~l~~N~i~~~~~~~~----~~l~~L~~L 246 (708)
.+.... ...+...+.++.+++++|.++...... ......|+.+++++|.++......+ ...++|+.|
T Consensus 266 ~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L 345 (460)
T d1z7xw1 266 GITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL 345 (460)
T ss_dssp CCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEE
T ss_pred cccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhh
Confidence 887332 223456789999999999987322211 1234689999999999875443333 345689999
Q ss_pred cccCcccccCCChh----hh-hhcccchhhcccccCCCC----CchhhcCcccCCceecccccccCCCCCcc----c-cc
Q 039322 247 GLSNNQFVLELPKE----LE-KLVQLSELDASHNLFGGE----IPFQICSLKSLEKLNLSHNNLSGSIPNCF----E-GI 312 (708)
Q Consensus 247 ~l~~n~l~~~~~~~----~~-~l~~L~~L~ls~N~i~~~----~~~~~~~~~~L~~L~l~~N~l~~~~~~~~----~-~l 312 (708)
+|++|+|+...... +. ..+.|+.|+|++|.|++. ++..+..+++|++|+|++|+|+......+ . ..
T Consensus 346 ~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~ 425 (460)
T d1z7xw1 346 QISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425 (460)
T ss_dssp ECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTT
T ss_pred heeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCC
Confidence 99999987532222 32 356799999999999853 23445667999999999999874322222 1 22
Q ss_pred ccccEEecCCCcCCC
Q 039322 313 RGISVIDISDNQLQG 327 (708)
Q Consensus 313 ~~L~~l~l~~N~l~~ 327 (708)
..|+.|++.+|.+..
T Consensus 426 ~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 426 CLLEQLVLYDIYWSE 440 (460)
T ss_dssp CCCCEEECTTCCCCH
T ss_pred CccCEEECCCCCCCH
Confidence 468999999998874
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=3.8e-17 Score=162.65 Aligned_cols=179 Identities=22% Similarity=0.231 Sum_probs=96.9
Q ss_pred CCccEEeccCCccccc-cCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccC-cceeeCCC-CCCCCCCCCE
Q 039322 73 GALQYFGVSENHFQGT-IPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRN-DFYGEISS-NWGKCPKLGT 149 (708)
Q Consensus 73 ~~L~~L~l~~n~i~~~-~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n-~l~~~~~~-~~~~l~~L~~ 149 (708)
.+|++||++++.++.. +...+.++++|++|+|++|.++......+..+++|++|+++++ .++..... .+..+++|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 4667777777766532 2334566777777777777776555566666777777777764 44322111 1234566777
Q ss_pred EEcccC-ccccc-CCcccc-CCCCCCEEecccc--ccccc-CCcccCCCCCCCEEEccCc-cccccCCcccCCCCCCCeE
Q 039322 150 LNVSMN-NITGG-IPREIG-NSSQLQALDLSLN--HIVGE-IPKELGKLNSLTELILRGN-QFTGRLPPEIGSLVDLEYL 222 (708)
Q Consensus 150 L~L~~N-~i~~~-~~~~~~-~l~~L~~L~L~~n--~l~~~-~~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~~~~L~~L 222 (708)
|+++++ .++.. ....+. ..++|+.|+++++ .++.. +...+.++++|++|++++| .+++.....+..+++|++|
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L 205 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 205 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence 777664 33311 111122 2356666666654 23211 1112234566666666654 3444444455556666666
Q ss_pred eccCC-cccccCCCCCCccccceeecccCc
Q 039322 223 DLSAN-RFNNSVPENLGNLLKLHYLGLSNN 251 (708)
Q Consensus 223 ~l~~N-~i~~~~~~~~~~l~~L~~L~l~~n 251 (708)
+|+++ .|++.....++++++|+.|+++++
T Consensus 206 ~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 206 SLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp ECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 66663 455444444555566666666555
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=7.9e-16 Score=138.48 Aligned_cols=111 Identities=23% Similarity=0.115 Sum_probs=62.6
Q ss_pred CcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCC
Q 039322 93 LRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQ 172 (708)
Q Consensus 93 ~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 172 (708)
+.+..+|++|+|++|+|+.+ ++.+..+++|++|+|++|+|+.+ ..|..+++|++|++++|+|+...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 44555666666666666644 34445556666666666666554 2355666666666666666655444455566666
Q ss_pred EEecccccccccCC-cccCCCCCCCEEEccCcccc
Q 039322 173 ALDLSLNHIVGEIP-KELGKLNSLTELILRGNQFT 206 (708)
Q Consensus 173 ~L~L~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~ 206 (708)
.|+|++|+|+.... ..+..+++|++|++++|.++
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cceeccccccccccccccccccccchhhcCCCccc
Confidence 66666666653211 23445555555555555554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=1.2e-15 Score=137.39 Aligned_cols=128 Identities=10% Similarity=0.027 Sum_probs=103.1
Q ss_pred ccCCCCccEEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCC
Q 039322 69 VCRGGALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLG 148 (708)
Q Consensus 69 ~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 148 (708)
+.+..+|++|+|++|+|+. ++..+..+++|+.|+|++|.|+.+ +.|..+++|++|++++|+++.+.+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 4566788999999999984 466678889999999999999876 3588899999999999999888877778899999
Q ss_pred EEEcccCcccccCC-ccccCCCCCCEEecccccccccCC---cccCCCCCCCEEE
Q 039322 149 TLNVSMNNITGGIP-REIGNSSQLQALDLSLNHIVGEIP---KELGKLNSLTELI 199 (708)
Q Consensus 149 ~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~ 199 (708)
.|++++|+|+.... ..+..+++|++|++++|.++.... ..+..+|+|+.|+
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 99999999985432 568888999999999999873321 2466678888776
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.56 E-value=5.5e-17 Score=166.81 Aligned_cols=188 Identities=18% Similarity=0.157 Sum_probs=89.8
Q ss_pred ccccCCCCccEEeccCCccccc----cCccCcCCCCCcEEEccCCccccc----------cccccCCCCCCCEEEcccCc
Q 039322 67 HNVCRGGALQYFGVSENHFQGT----IPKILRNCSSLIRVRLNSNNLTGN----------ISEALGIYPNLTFIDLSRND 132 (708)
Q Consensus 67 ~~~~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~l~~n~i~~~----------~~~~~~~~~~L~~L~l~~n~ 132 (708)
..+.....|+.|+|++|.|+.. +...+...++|+.|+++++.+... ....+..+++|++|+|++|.
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~ 104 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 104 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence 3344556677777777766532 223455567777777766544311 12334455666666666666
Q ss_pred ceeeCC----CCCCCCCCCCEEEcccCcccccCCcc-------------ccCCCCCCEEecccccccccC----CcccCC
Q 039322 133 FYGEIS----SNWGKCPKLGTLNVSMNNITGGIPRE-------------IGNSSQLQALDLSLNHIVGEI----PKELGK 191 (708)
Q Consensus 133 l~~~~~----~~~~~l~~L~~L~L~~N~i~~~~~~~-------------~~~l~~L~~L~L~~n~l~~~~----~~~~~~ 191 (708)
++.... ..+...++|+.|++++|.++...... ....+.|+.|++++|+++... ...+..
T Consensus 105 i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~ 184 (344)
T d2ca6a1 105 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184 (344)
T ss_dssp CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH
T ss_pred cccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhh
Confidence 543211 11234456666666666654211111 122345555555555554211 112233
Q ss_pred CCCCCEEEccCcccccc-----CCcccCCCCCCCeEeccCCccccc----CCCCCCccccceeecccCcccc
Q 039322 192 LNSLTELILRGNQFTGR-----LPPEIGSLVDLEYLDLSANRFNNS----VPENLGNLLKLHYLGLSNNQFV 254 (708)
Q Consensus 192 l~~L~~L~l~~n~l~~~-----~~~~~~~~~~L~~L~l~~N~i~~~----~~~~~~~l~~L~~L~l~~n~l~ 254 (708)
.++|++|+|++|+++.. +...+...++|+.|+|++|.++.. ....+..+++|+.|+|++|.|+
T Consensus 185 ~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred hhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccC
Confidence 45555555555554421 122334444555555555554321 1122334444555555555444
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=1.4e-16 Score=158.50 Aligned_cols=222 Identities=17% Similarity=0.154 Sum_probs=163.3
Q ss_pred cEEECCCCcccccCCccccCCCCCCEEEeeCceeeeeCCCCCCCCCcccccccCCCccCC-CCccccCCCCccEEeccCC
Q 039322 5 SILDLNQNQFKGVLPPSVSNLTNLKELVLLYNNLSGFIPPSLENPMLTRPGLDFNHFTSY-LPHNVCRGGALQYFGVSEN 83 (708)
Q Consensus 5 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~~l~~l~l~~n~~~~~-~~~~~~~l~~L~~L~l~~n 83 (708)
+.|||+++.+.......+-. ..+..+.++++.+.......+...+|+.|++++|.++.. +...+..+++|++|++++|
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~ 81 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence 57899998875322222211 135677788777765455555567899999999987643 4455677899999999999
Q ss_pred ccccccCccCcCCCCCcEEEccCC-ccccccc-cccCCCCCCCEEEcccC-cceeeC-CCCC-CCCCCCCEEEcccC--c
Q 039322 84 HFQGTIPKILRNCSSLIRVRLNSN-NLTGNIS-EALGIYPNLTFIDLSRN-DFYGEI-SSNW-GKCPKLGTLNVSMN--N 156 (708)
Q Consensus 84 ~i~~~~~~~~~~l~~L~~L~l~~n-~i~~~~~-~~~~~~~~L~~L~l~~n-~l~~~~-~~~~-~~l~~L~~L~L~~N--~ 156 (708)
.+++..+..++.+++|++|++++| .++.... ..+..+++|++|+++++ .++... ...+ ...++|+.|+++++ .
T Consensus 82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~ 161 (284)
T d2astb2 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN 161 (284)
T ss_dssp BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGG
T ss_pred CCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccc
Confidence 999888888999999999999995 6764322 23457899999999986 443211 1122 23478999999975 3
Q ss_pred cccc-CCccccCCCCCCEEecccc-cccccCCcccCCCCCCCEEEccCc-cccccCCcccCCCCCCCeEeccCC
Q 039322 157 ITGG-IPREIGNSSQLQALDLSLN-HIVGEIPKELGKLNSLTELILRGN-QFTGRLPPEIGSLVDLEYLDLSAN 227 (708)
Q Consensus 157 i~~~-~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~~~~L~~L~l~~N 227 (708)
++.. ....+..+++|++|++++| .+++.....+.++++|++|+|++| .+++.....++++++|+.|+++++
T Consensus 162 i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 162 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp SCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 4422 2233466899999999986 577667778889999999999995 677666667888999999999987
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.55 E-value=6.8e-17 Score=166.11 Aligned_cols=241 Identities=18% Similarity=0.196 Sum_probs=175.9
Q ss_pred ccCccCcCCCCCcEEEccCCccccc----cccccCCCCCCCEEEcccCcceeeC----------CCCCCCCCCCCEEEcc
Q 039322 88 TIPKILRNCSSLIRVRLNSNNLTGN----ISEALGIYPNLTFIDLSRNDFYGEI----------SSNWGKCPKLGTLNVS 153 (708)
Q Consensus 88 ~~~~~~~~l~~L~~L~l~~n~i~~~----~~~~~~~~~~L~~L~l~~n~l~~~~----------~~~~~~l~~L~~L~L~ 153 (708)
.+...+.+...|++|+|++|.|... ....+...++|+.|+++++...... ...+...++|+.|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 3345577789999999999998743 3345678899999999987653221 1224567899999999
Q ss_pred cCcccccC----CccccCCCCCCEEecccccccccCCcc-------------cCCCCCCCEEEccCcccccc----CCcc
Q 039322 154 MNNITGGI----PREIGNSSQLQALDLSLNHIVGEIPKE-------------LGKLNSLTELILRGNQFTGR----LPPE 212 (708)
Q Consensus 154 ~N~i~~~~----~~~~~~l~~L~~L~L~~n~l~~~~~~~-------------~~~l~~L~~L~l~~n~l~~~----~~~~ 212 (708)
+|.++... ...+...++|+.|++++|.+....... ....+.|+.+.+++|.++.. +...
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~ 181 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred ccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccch
Confidence 99987542 334456799999999999886321111 13467899999999988732 2233
Q ss_pred cCCCCCCCeEeccCCccccc-----CCCCCCccccceeecccCcccccC----CChhhhhhcccchhhcccccCCCCCch
Q 039322 213 IGSLVDLEYLDLSANRFNNS-----VPENLGNLLKLHYLGLSNNQFVLE----LPKELEKLVQLSELDASHNLFGGEIPF 283 (708)
Q Consensus 213 ~~~~~~L~~L~l~~N~i~~~-----~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~ls~N~i~~~~~~ 283 (708)
+...+.|+.|+|++|.|+.. ....+..+++|+.|+|++|.++.. +...+..+++|++|+|++|.|++....
T Consensus 182 l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~ 261 (344)
T d2ca6a1 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261 (344)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred hhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhH
Confidence 55678999999999998742 334577889999999999998643 234567888999999999999865433
Q ss_pred hh----c--CcccCCceecccccccCCC----CCccc-ccccccEEecCCCcCCCC
Q 039322 284 QI----C--SLKSLEKLNLSHNNLSGSI----PNCFE-GIRGISVIDISDNQLQGP 328 (708)
Q Consensus 284 ~~----~--~~~~L~~L~l~~N~l~~~~----~~~~~-~l~~L~~l~l~~N~l~~~ 328 (708)
.+ . ..+.|++|++++|+|+... ...+. +.+.|+.|++++|++...
T Consensus 262 ~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~ 317 (344)
T d2ca6a1 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317 (344)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred HHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCc
Confidence 33 2 2467999999999987432 22232 467899999999999754
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.52 E-value=1.7e-14 Score=123.09 Aligned_cols=87 Identities=26% Similarity=0.344 Sum_probs=35.3
Q ss_pred ccCCCCCCEEecccccccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCC-CCCCccccc
Q 039322 165 IGNSSQLQALDLSLNHIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVP-ENLGNLLKL 243 (708)
Q Consensus 165 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~-~~~~~l~~L 243 (708)
+..+++|++|++++|+|+ .+|..++.+++|+.|++++|+|++ ++ .+..+++|++|++++|+|+.... ..+..+++|
T Consensus 16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L 92 (124)
T d1dcea3 16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 92 (124)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccCCCCCchhhcCCCCC
Confidence 344444444444444443 233334444444444444444442 11 23444444444444444442211 223444444
Q ss_pred eeecccCcccc
Q 039322 244 HYLGLSNNQFV 254 (708)
Q Consensus 244 ~~L~l~~n~l~ 254 (708)
+.|++++|+++
T Consensus 93 ~~L~l~~N~i~ 103 (124)
T d1dcea3 93 VLLNLQGNSLC 103 (124)
T ss_dssp CEEECTTSGGG
T ss_pred CEEECCCCcCC
Confidence 44444444443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.51 E-value=1.9e-14 Score=122.84 Aligned_cols=117 Identities=17% Similarity=0.168 Sum_probs=63.6
Q ss_pred EEeccCCccccccCccCcCCCCCcEEEccCCccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCc
Q 039322 77 YFGVSENHFQGTIPKILRNCSSLIRVRLNSNNLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNN 156 (708)
Q Consensus 77 ~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 156 (708)
+|+|++|+++. ++ .+.++++|++|++++|+|+.++ ..|+.+++|++|++++|+|+.+. .+..+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~~lp-~~~~~l~~L~~L~l~~N~i~~l~--~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLRALP-PALAALRCLEVLQASDNALENVD--GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCCCCC-GGGGGCTTCCEEECCSSCCCCCG--GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccCcch-hhhhhhhcccccccccccccccC--ccccccccCeEECCCCc
Confidence 45555555552 22 2555666666666666665442 34555666666666666665442 35566666666666666
Q ss_pred ccccC-CccccCCCCCCEEecccccccccC---CcccCCCCCCCEE
Q 039322 157 ITGGI-PREIGNSSQLQALDLSLNHIVGEI---PKELGKLNSLTEL 198 (708)
Q Consensus 157 i~~~~-~~~~~~l~~L~~L~L~~n~l~~~~---~~~~~~l~~L~~L 198 (708)
|+... ...+..+++|++|++++|+++... ......+|+|+.|
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 65432 244566666666666666665221 1223335666554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=1.6e-13 Score=122.33 Aligned_cols=108 Identities=16% Similarity=0.111 Sum_probs=84.2
Q ss_pred CCccEEeccCCccccccCccCcCCCCCcEEEccCC-ccccccccccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEE
Q 039322 73 GALQYFGVSENHFQGTIPKILRNCSSLIRVRLNSN-NLTGNISEALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLN 151 (708)
Q Consensus 73 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n-~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 151 (708)
...+.++++++.++ ..|..+..+++|++|++++| .|+.+.+++|.++++|+.|+|++|+|+.+.+.+|..+++|++|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34556788888887 55677888888888888765 48888888888888888888888888888888888888888888
Q ss_pred cccCcccccCCccccCCCCCCEEeccccccc
Q 039322 152 VSMNNITGGIPREIGNSSQLQALDLSLNHIV 182 (708)
Q Consensus 152 L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~ 182 (708)
|++|+|+.+.+..|..+ +|+.|+|++|.+.
T Consensus 87 Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 87 LSFNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp CCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred ccCCCCcccChhhhccc-cccccccCCCccc
Confidence 88888886666666544 5888888888775
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.41 E-value=4.6e-15 Score=138.35 Aligned_cols=128 Identities=23% Similarity=0.241 Sum_probs=82.7
Q ss_pred cccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccCCCCCCccccceeecccCcccccCCChhhhhhcc
Q 039322 187 KELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSVPENLGNLLKLHYLGLSNNQFVLELPKELEKLVQ 266 (708)
Q Consensus 187 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 266 (708)
..+..+++|++|+|++|+|+. ++ .+..+++|++|+|++|+|+ .++..+..+++|+.|++++|+|+.. ..+..+++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~ 116 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVN 116 (198)
T ss_dssp HHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHH
T ss_pred hHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccccc
Confidence 445556666666666666663 32 3666667777777777766 3344344456677777777777632 34777778
Q ss_pred cchhhcccccCCCCCc-hhhcCcccCCceecccccccCCCCCc----------ccccccccEEe
Q 039322 267 LSELDASHNLFGGEIP-FQICSLKSLEKLNLSHNNLSGSIPNC----------FEGIRGISVID 319 (708)
Q Consensus 267 L~~L~ls~N~i~~~~~-~~~~~~~~L~~L~l~~N~l~~~~~~~----------~~~l~~L~~l~ 319 (708)
|+.|++++|+|++... ..+..+++|+.|++++|++....+.. +..+|+|+.||
T Consensus 117 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 8888888888774322 45677788888888888776443332 44567777765
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.36 E-value=5.2e-15 Score=137.93 Aligned_cols=110 Identities=24% Similarity=0.218 Sum_probs=55.6
Q ss_pred ccCCCCCCCEEEcccCcceeeCCCCCCCCCCCCEEEcccCcccccCCccccCCCCCCEEecccccccccCCcccCCCCCC
Q 039322 116 ALGIYPNLTFIDLSRNDFYGEISSNWGKCPKLGTLNVSMNNITGGIPREIGNSSQLQALDLSLNHIVGEIPKELGKLNSL 195 (708)
Q Consensus 116 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 195 (708)
.+..+++|++|+|++|+|+.+. .+..+++|+.|+|++|+|+. ++..+..+++|++|++++|+|+.. ..+..+++|
T Consensus 43 sl~~L~~L~~L~Ls~n~I~~i~--~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L 117 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIEKIS--SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--SGIEKLVNL 117 (198)
T ss_dssp HHHHTTTCCEEECSEEEESCCC--CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHS
T ss_pred HHhcccccceeECcccCCCCcc--cccCCccccChhhccccccc-cccccccccccccccccccccccc--ccccccccc
Confidence 3445555555555555555331 34555555555555555552 233333334555555555555532 224445555
Q ss_pred CEEEccCccccccCC-cccCCCCCCCeEeccCCccc
Q 039322 196 TELILRGNQFTGRLP-PEIGSLVDLEYLDLSANRFN 230 (708)
Q Consensus 196 ~~L~l~~n~l~~~~~-~~~~~~~~L~~L~l~~N~i~ 230 (708)
+.|++++|+++.... ..+..+++|+.|+|++|++.
T Consensus 118 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred cccccccchhccccccccccCCCccceeecCCCccc
Confidence 555555555552211 23455555666666655554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=2.9e-12 Score=113.96 Aligned_cols=105 Identities=19% Similarity=0.172 Sum_probs=55.1
Q ss_pred CEEEcccCcccccCCccccCCCCCCEEecccc-cccccCCcccCCCCCCCEEEccCccccccCCcccCCCCCCCeEeccC
Q 039322 148 GTLNVSMNNITGGIPREIGNSSQLQALDLSLN-HIVGEIPKELGKLNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSA 226 (708)
Q Consensus 148 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~ 226 (708)
+.++++++.+. ..|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34555555554 23444555555555555443 35544444555555555555555555555555555555666666666
Q ss_pred CcccccCCCCCCccccceeecccCcccc
Q 039322 227 NRFNNSVPENLGNLLKLHYLGLSNNQFV 254 (708)
Q Consensus 227 N~i~~~~~~~~~~l~~L~~L~l~~n~l~ 254 (708)
|+|+...+..|..+ +|+.|+|++|.+.
T Consensus 90 N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 90 NALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp SCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred CCCcccChhhhccc-cccccccCCCccc
Confidence 66653333333332 4666666666553
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.64 E-value=1.8e-09 Score=96.19 Aligned_cols=81 Identities=27% Similarity=0.217 Sum_probs=40.9
Q ss_pred ccccceeecccCcccccCC--ChhhhhhcccchhhcccccCCCCCchhhcCcccCCceecccccccCCCCCc-------c
Q 039322 239 NLLKLHYLGLSNNQFVLEL--PKELEKLVQLSELDASHNLFGGEIPFQICSLKSLEKLNLSHNNLSGSIPNC-------F 309 (708)
Q Consensus 239 ~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~-------~ 309 (708)
.+++|+.|+|++|+|+... +..+..+++|+.|+|++|.|++.....+....+|+.|++++|++....... +
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~ 142 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIR 142 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHH
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHH
Confidence 3455555555555555332 233455556666666666665433333334445666666666665433321 3
Q ss_pred cccccccEEe
Q 039322 310 EGIRGISVID 319 (708)
Q Consensus 310 ~~l~~L~~l~ 319 (708)
..+|+|+.||
T Consensus 143 ~~~P~L~~LD 152 (162)
T d1koha1 143 ERFPKLLRLD 152 (162)
T ss_dssp TTSTTCCEET
T ss_pred HHCCCCCEEC
Confidence 3455665554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.62 E-value=1.4e-09 Score=96.86 Aligned_cols=107 Identities=22% Similarity=0.129 Sum_probs=67.0
Q ss_pred CCCCCEEEccCccccccCCcccCCCCCCCeEeccCCcccccC--CCCCCccccceeecccCcccccCCChhhhhhcccch
Q 039322 192 LNSLTELILRGNQFTGRLPPEIGSLVDLEYLDLSANRFNNSV--PENLGNLLKLHYLGLSNNQFVLELPKELEKLVQLSE 269 (708)
Q Consensus 192 l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~N~i~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 269 (708)
+..+..+....+... .++..+..+++|++|+|++|+|+... +..+..+++|+.|+|++|.|+...+-.+....+|+.
T Consensus 41 ~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~ 119 (162)
T d1koha1 41 QNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119 (162)
T ss_dssp TTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSS
T ss_pred ccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccce
Confidence 334444444444333 33334455677777777777777543 234566788888888888887554444455567888
Q ss_pred hhcccccCCCCCc-------hhhcCcccCCceecccccc
Q 039322 270 LDASHNLFGGEIP-------FQICSLKSLEKLNLSHNNL 301 (708)
Q Consensus 270 L~ls~N~i~~~~~-------~~~~~~~~L~~L~l~~N~l 301 (708)
|++++|++..... ..+..+|+|+.|| |..+
T Consensus 120 L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 120 LWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp CCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred eecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence 8888888875433 2355678888775 4444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.54 E-value=1.6e-07 Score=90.77 Aligned_cols=149 Identities=13% Similarity=0.082 Sum_probs=103.1
Q ss_pred HHHHHhccccccceeccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeC
Q 039322 430 EIVRATNDFDAQYCIGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHA 508 (708)
Q Consensus 430 ~~~~~~~~~~~~~~ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~ 508 (708)
++.+..+.|+..+..+.++.+.||+... +++.+++|..... .......+.+|...+..+. +--+.+++.+...+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~----~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~ 82 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSR----YKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGG----GTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCC----cccchhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence 4555567777766655555678999876 4666788886542 1122334667888877774 44478888888888
Q ss_pred CeeEEEEEeccCCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 039322 509 RHSFLVYELLERGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHHDC----------------------------- 559 (708)
Q Consensus 509 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~----------------------------- 559 (708)
+..++||++++|.++.+..... .....++.++++.++.||+..
T Consensus 83 ~~~~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp TEEEEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred CceEEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 9999999999998886654211 112335566666666666421
Q ss_pred ---------------------------CCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 560 ---------------------------FPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 560 ---------------------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
.+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 02378999999999999776677999998863
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.03 E-value=2e-06 Score=82.31 Aligned_cols=131 Identities=18% Similarity=0.126 Sum_probs=86.6
Q ss_pred eeccccC-ccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccC--CceeeEEEEEeeCCeeEEEEEecc
Q 039322 443 CIGNGGH-GSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRH--RNIVKFYGFCSHARHSFLVYELLE 519 (708)
Q Consensus 443 ~ig~G~~-g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~l~~~~~~~~~~~lv~e~~~ 519 (708)
.+..|.. +.||+....++..+++|...... ...+..|...++.+.. -.+.+++++..+++..++|||+++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 3455554 57899988888889999876421 2235667777777642 346778888888888999999998
Q ss_pred CCCHHHHhcccccccCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 039322 520 RGSLAAILSSDTAAQELGWSQRMNVIKGVADALSYLHH------------------------------------------ 557 (708)
Q Consensus 520 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~------------------------------------------ 557 (708)
|.++.+.. ... ...+.++++.++.||+
T Consensus 90 G~~~~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (255)
T d1nd4a_ 90 GQDLLSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 158 (255)
T ss_dssp SEETTTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred cccccccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHH
Confidence 86553311 111 1122233333333432
Q ss_pred ---------CC----CCCeEEccCCCCCeeeCCCCcEEEeecccccc
Q 039322 558 ---------DC----FPPIVHQDISSKNLLLDLEYEAHVADFGIAKF 591 (708)
Q Consensus 558 ---------~~----~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 591 (708)
.. .+.++|+|+.|.||+++.+..+-|+||+.+..
T Consensus 159 ~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 159 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 11 12479999999999999877678999998863
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.90 E-value=1.7e-06 Score=76.68 Aligned_cols=63 Identities=21% Similarity=0.230 Sum_probs=27.9
Q ss_pred CCCCcEEEccCC-ccccc----cccccCCCCCCCEEEcccCcceeeCCCCC----CCCCCCCEEEcccCccc
Q 039322 96 CSSLIRVRLNSN-NLTGN----ISEALGIYPNLTFIDLSRNDFYGEISSNW----GKCPKLGTLNVSMNNIT 158 (708)
Q Consensus 96 l~~L~~L~l~~n-~i~~~----~~~~~~~~~~L~~L~l~~n~l~~~~~~~~----~~l~~L~~L~L~~N~i~ 158 (708)
.++|++|+|+++ .++.. ...++...++|++|+|++|.+.......+ ...+.|++|+|++|.|+
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 455555555542 34311 22234444555555555555543222222 22344555555555544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.80 E-value=2.5e-06 Score=75.57 Aligned_cols=109 Identities=10% Similarity=0.126 Sum_probs=67.6
Q ss_pred CCCccEEeccCC-ccccc----cCccCcCCCCCcEEEccCCccccc----cccccCCCCCCCEEEcccCcceeeC----C
Q 039322 72 GGALQYFGVSEN-HFQGT----IPKILRNCSSLIRVRLNSNNLTGN----ISEALGIYPNLTFIDLSRNDFYGEI----S 138 (708)
Q Consensus 72 l~~L~~L~l~~n-~i~~~----~~~~~~~l~~L~~L~l~~n~i~~~----~~~~~~~~~~L~~L~l~~n~l~~~~----~ 138 (708)
.++|+.|+|+++ .++.. +...+...++|++|+|++|.++.. ....+...+.|++|+|++|.++... .
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 467888888763 46532 233456677888888888888732 2334556678888888888886432 2
Q ss_pred CCCCCCCCCCEEEcccCccccc-------CCccccCCCCCCEEeccccc
Q 039322 139 SNWGKCPKLGTLNVSMNNITGG-------IPREIGNSSQLQALDLSLNH 180 (708)
Q Consensus 139 ~~~~~l~~L~~L~L~~N~i~~~-------~~~~~~~l~~L~~L~L~~n~ 180 (708)
.++...+.|++|+|++|.+... +...+...++|+.|+++.+.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 2345567788888877765422 22333445666666665553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.50 E-value=9.1e-05 Score=75.15 Aligned_cols=79 Identities=18% Similarity=0.102 Sum_probs=48.6
Q ss_pred ceeccccCccEEEEEeCC-CcEEEEEEcCCCCCc---chhHhHHHHHHHHHHHHhcc-C--CceeeEEEEEeeCCeeEEE
Q 039322 442 YCIGNGGHGSVYRAELPS-GQVVAIKKFHSPLPC---DQIADQKEFLIEVKALTEIR-H--RNIVKFYGFCSHARHSFLV 514 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~~~~~e~~~l~~l~-h--~~iv~l~~~~~~~~~~~lv 514 (708)
+.||.|....||+....+ ++.|+||.-...... .......+...|.+.++.+. + ..+++++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999997654 678999975431111 01112233456777777663 2 356666655 44556899
Q ss_pred EEeccCCC
Q 039322 515 YELLERGS 522 (708)
Q Consensus 515 ~e~~~~g~ 522 (708)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.33 E-value=6.4e-06 Score=72.88 Aligned_cols=39 Identities=23% Similarity=0.171 Sum_probs=16.8
Q ss_pred CCCCCcEEEccC-Cccccc----cccccCCCCCCCEEEcccCcc
Q 039322 95 NCSSLIRVRLNS-NNLTGN----ISEALGIYPNLTFIDLSRNDF 133 (708)
Q Consensus 95 ~l~~L~~L~l~~-n~i~~~----~~~~~~~~~~L~~L~l~~n~l 133 (708)
+.++|++|+|++ +.|+.. ...++...++|++|+|++|.+
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l 58 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRS 58 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCC
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcc
Confidence 344555555554 234311 122333444455555555544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.20 E-value=2.3e-05 Score=69.10 Aligned_cols=111 Identities=10% Similarity=0.141 Sum_probs=65.8
Q ss_pred cCCCCccEEeccC-Cccccc----cCccCcCCCCCcEEEccCCcccccc----ccccCCCCCCCEEEcccCcceeeC---
Q 039322 70 CRGGALQYFGVSE-NHFQGT----IPKILRNCSSLIRVRLNSNNLTGNI----SEALGIYPNLTFIDLSRNDFYGEI--- 137 (708)
Q Consensus 70 ~~l~~L~~L~l~~-n~i~~~----~~~~~~~l~~L~~L~l~~n~i~~~~----~~~~~~~~~L~~L~l~~n~l~~~~--- 137 (708)
...++|++|+|++ +.++.. +...+...++|++|+|++|.++... ...+...+.++.+++++|.+....
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3457888888887 456532 2344567788999999999887432 334555677788887777764322
Q ss_pred -CCCCCCCCCCCEEEcc--cCccccc----CCccccCCCCCCEEeccccc
Q 039322 138 -SSNWGKCPKLGTLNVS--MNNITGG----IPREIGNSSQLQALDLSLNH 180 (708)
Q Consensus 138 -~~~~~~l~~L~~L~L~--~N~i~~~----~~~~~~~l~~L~~L~L~~n~ 180 (708)
...+...++|+.++|+ +|.+... +...+...++|+.|+++.+.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 2334455666654443 4455421 22333445556666655443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.09 E-value=0.00094 Score=65.53 Aligned_cols=70 Identities=11% Similarity=0.121 Sum_probs=47.0
Q ss_pred ccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCce--eeEE-----EEEeeCCeeEEEEEecc
Q 039322 447 GGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI--VKFY-----GFCSHARHSFLVYELLE 519 (708)
Q Consensus 447 G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~l~-----~~~~~~~~~~lv~e~~~ 519 (708)
+.--.||++...+|+.|++|+.+.. ....+++..|...+..|....+ +..+ ..+...+..+.+++++.
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~-----~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPE-----RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTT-----TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred cccceeEEEEcCCCCEEEEEEeCCC-----CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 3345799999989999999998752 1235667788888887753222 2111 12244567789999998
Q ss_pred CC
Q 039322 520 RG 521 (708)
Q Consensus 520 ~g 521 (708)
|.
T Consensus 108 G~ 109 (325)
T d1zyla1 108 GR 109 (325)
T ss_dssp CE
T ss_pred Cc
Confidence 73
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.65 E-value=0.0014 Score=63.93 Aligned_cols=158 Identities=13% Similarity=0.120 Sum_probs=84.0
Q ss_pred chHHHHHHHhccccccce-----eccccCccEEEEEeCCCcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhccCCce--
Q 039322 426 LVYDEIVRATNDFDAQYC-----IGNGGHGSVYRAELPSGQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIRHRNI-- 498 (708)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~-----ig~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-- 498 (708)
++.+++.....+|.+.+. |..|---+.|+.+..+|+ +++|++.... ..+++..|++++..+...++
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~------~~~~l~~~~~~l~~L~~~g~pv 75 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSC 75 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---------CCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC------CHHHHHHHHHHHHhhhhccccc
Confidence 456778888888877554 345666788999886664 8999986521 12334456666666643222
Q ss_pred eeEEE------EEeeCCeeEEEEEeccCCCHHH--------------Hhccc----c--cccCC----------------
Q 039322 499 VKFYG------FCSHARHSFLVYELLERGSLAA--------------ILSSD----T--AAQEL---------------- 536 (708)
Q Consensus 499 v~l~~------~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~----~--~~~~l---------------- 536 (708)
+..+. +.......+.++.+..+..... .++.. . .....
T Consensus 76 p~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (316)
T d2ppqa1 76 PLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERA 155 (316)
T ss_dssp CCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred cccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhh
Confidence 11111 1223445666777776632211 00000 0 00000
Q ss_pred --CHHHHHHHHHHHHHHHHHHHh-CCCCCeEEccCCCCCeeeCCCCcEEEeeccccc
Q 039322 537 --GWSQRMNVIKGVADALSYLHH-DCFPPIVHQDISSKNLLLDLEYEAHVADFGIAK 590 (708)
Q Consensus 537 --~~~~~~~i~~~i~~~l~~Lh~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 590 (708)
........+..+...+...+. ....|++|+|+.+.||+++.+...-|.||+.+.
T Consensus 156 ~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 156 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 001111222222222222222 122489999999999999988777899999986
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.12 E-value=0.008 Score=60.38 Aligned_cols=72 Identities=18% Similarity=0.225 Sum_probs=48.5
Q ss_pred ceeccccCccEEEEEeCC--------CcEEEEEEcCCCCCcchhHhHHHHHHHHHHHHhcc-CCceeeEEEEEeeCCeeE
Q 039322 442 YCIGNGGHGSVYRAELPS--------GQVVAIKKFHSPLPCDQIADQKEFLIEVKALTEIR-HRNIVKFYGFCSHARHSF 512 (708)
Q Consensus 442 ~~ig~G~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~ 512 (708)
+.|+.|-.-.+|+...++ .+.|++++.-... ......+|..+++.+. +.-.+++++++.+ +
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~------~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE------TESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC------CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc------hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 467778888999997653 3567788765321 1223457888888884 4445678887754 5
Q ss_pred EEEEeccCCCH
Q 039322 513 LVYELLERGSL 523 (708)
Q Consensus 513 lv~e~~~~g~L 523 (708)
+|+||++|.++
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 89999987543
|